<SEC-DOCUMENT>0000950170-23-007929.txt : 20230315
<SEC-HEADER>0000950170-23-007929.hdr.sgml : 20230315
<ACCEPTANCE-DATETIME>20230314184503
ACCESSION NUMBER:		0000950170-23-007929
CONFORMED SUBMISSION TYPE:	10-K
PUBLIC DOCUMENT COUNT:		77
CONFORMED PERIOD OF REPORT:	20221231
FILED AS OF DATE:		20230315
DATE AS OF CHANGE:		20230314

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			89bio, Inc.
		CENTRAL INDEX KEY:			0001785173
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				831114349
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-39122
		FILM NUMBER:		23732603

	BUSINESS ADDRESS:	
		STREET 1:		142 SANSOME STREET
		STREET 2:		SECOND FLOOR
		CITY:			SAN FRANCISCO
		STATE:			CA
		ZIP:			94104
		BUSINESS PHONE:		(415) 432-9270

	MAIL ADDRESS:	
		STREET 1:		142 SANSOME STREET
		STREET 2:		SECOND FLOOR
		CITY:			SAN FRANCISCO
		STATE:			CA
		ZIP:			94104
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-K
<SEQUENCE>1
<FILENAME>etnb-20221231.htm
<DESCRIPTION>10-K
<TEXT>
<XBRL>
<?xml version="1.0" encoding="ASCII"?><!-- DFIN New ActiveDisclosure (SM) Inline XBRL Document - http://www.dfinsolutions.com/ --><!-- Creation Date :2023-03-14T17:27:59.4811+00:00 --><!-- Copyright (c) 2023 Donnelly Financial Solutions, Inc. All Rights Reserved. -->
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:nonNumeric="http://www.xbrl.org/dtr/type/non-numeric" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:stpr="http://xbrl.sec.gov/stpr/2022" xmlns:us-gaap="http://fasb.org/us-gaap/2022" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:country="http://xbrl.sec.gov/country/2022" xmlns:etnb="http://www.89bio.com/20221231" xmlns:srt="http://fasb.org/srt/2022" xmlns:utr="http://www.xbrl.org/2009/utr">
 <head>
  <title>10-K</title>
  <meta http-equiv="Content-Type" content="text/html" />
 </head>
 <body style="margin: auto!important;padding: 8px;">
  <div style="display:none;"><ix:header><ix:hidden><ix:nonNumeric id="F_703f3df4-9b30-4bef-999b-4bd968b26d0f" name="dei:DocumentFiscalPeriodFocus" contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698">FY</ix:nonNumeric><ix:nonFraction id="F_e1912fb5-f606-4ce8-b68f-a7633b9e5662" name="us-gaap:PreferredStockValue" contextRef="C_21f769c6-c78d-41d0-b871-ec3d93d7d343" unitRef="U_USD" xsi:nil="true"></ix:nonFraction><ix:nonNumeric id="F_79bc5d0a-fb68-4600-adad-d1cd8af005e1" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" contextRef="C_e7fc2234-7fe0-49dd-acdd-725cb91a9889" format="ixt-sec:duryear">2</ix:nonNumeric><ix:nonNumeric id="F_defb74fb-9462-4aa7-89d5-78bfd546ccf3" name="dei:EntityCentralIndexKey" contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698">0001785173</ix:nonNumeric><ix:nonNumeric id="F_4640215a-3a60-4f28-a85d-e6242af9c877" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" contextRef="C_f440b0bc-74ad-45cd-9077-8182fe07c5ea" format="ixt-sec:durwordsen">three years</ix:nonNumeric><ix:nonFraction id="F_4a26968b-e9d0-4e69-8f86-01a61afe4e4c" name="us-gaap:VariableLeasePayment" contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698" unitRef="U_USD" decimals="INF">0</ix:nonFraction><ix:nonFraction id="F_104effa9-00d2-42bf-9012-ca94303c5178" name="us-gaap:ShortTermLeaseCost" contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698" unitRef="U_USD" decimals="INF">0</ix:nonFraction><ix:nonNumeric id="F_334737a3-eb1d-48a1-9363-2f3248ac80ff" name="dei:EntityIncorporationDateOfIncorporation" contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698" format="ixt:datemonthdayyearen">June 30, 2019</ix:nonNumeric><ix:nonFraction id="F_efdfecff-bd47-4d7b-8ae8-57805d2e5e13" name="us-gaap:CommitmentsAndContingencies" contextRef="C_85e3a5e5-8ff2-4682-901b-9d79336e863a" unitRef="U_USD" xsi:nil="true"></ix:nonFraction><ix:nonFraction id="F_99a22a6a-88e9-4b21-a48d-ce39d2be3156" name="us-gaap:PreferredStockValue" contextRef="C_85e3a5e5-8ff2-4682-901b-9d79336e863a" unitRef="U_USD" xsi:nil="true"></ix:nonFraction><ix:nonNumeric id="F_0ace362a-a29d-4bd6-bec6-ad058eb196ff" name="dei:AmendmentFlag" contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698">false</ix:nonNumeric><ix:nonFraction id="F_e78dfece-2abd-4287-b218-712a41c88b40" name="us-gaap:CommitmentsAndContingencies" contextRef="C_21f769c6-c78d-41d0-b871-ec3d93d7d343" unitRef="U_USD" xsi:nil="true"></ix:nonFraction><ix:nonFraction id="F_f41dc902-b0a0-44c4-a2f2-3886c58e26bf" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" contextRef="C_830ace7d-9785-41d6-a516-94d2fda5e208" unitRef="U_pure" decimals="3" scale="0" format="ixt:numdotdecimal">0.333</ix:nonFraction></ix:hidden><ix:references><link:schemaRef xlink:type="simple" xlink:href="etnb-20221231.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="C_dbf7afe5-d66f-4aec-9806-312b0e5b4e3e"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_50e7e18a-0655-4c7d-95a8-7ac3e1648249"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IL</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_6047d52d-d8de-4ffd-998c-b1093834c8c7"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-07-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_a1422313-a35e-45e5-a7d0-20aa6422feb3"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_3292f652-c40f-4507-b87c-efc3bf396c08"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">etnb:PerformanceRSUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ExecutiveOfficerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-02-01</xbrli:startDate><xbrli:endDate>2021-02-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_a4e466da-eda8-431d-8082-79eb5a6b4d5f"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_b2381809-b584-4634-835b-de401b34febb"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">etnb:ATMFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-03-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_63713aa3-3b7f-4c18-95ec-d7881a249606"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">etnb:TermALoanFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">etnb:LoanAndSecurityAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_ab53d079-3181-47b2-85e6-cb6ceba1d67b"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-07-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_5a34cef0-4d09-47ec-a8ce-379fe69ed741"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_46a37282-7c21-4f91-b5bc-d6bf1cfad31b"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">etnb:TwoThousandAndTwentyOneLoanAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">etnb:TrancheOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_7c6e4cd6-6b45-4e07-9ce7-b8efe5b967e5"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_dd9c4882-66d0-4386-bb9e-0f1c29a674cb"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_6d3eea61-86b7-46b5-8fc7-9a6e90984a96"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">etnb:LoanAndSecurityAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">etnb:TermBLoanFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-05-01</xbrli:startDate><xbrli:endDate>2021-05-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_346ebc1d-56b1-4b67-95cf-d70e9efff187"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">etnb:TevaAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_d5d69a12-3d32-411c-82ae-eca2bf142f5c"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_ccc34858-a5d1-4e90-8bb9-0ff6d83c6b06"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_42e28a41-a2c7-4703-9012-632c3a4117b3"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_0fbbd6d9-9bd7-49b6-8f27-ad8d51a5afad"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">etnb:LoanAndSecurityAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">etnb:TermBLoanFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_b714c872-cbb8-40d3-a8b0-eb87e6092698"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_64505050-8754-453d-9384-3e8a3e7ed1c7"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">etnb:LoanAndSecurityAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_0d8efc73-e669-470d-b4ba-623e328b895c"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">etnb:LoanAndSecurityAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-05-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_51c95b33-c300-4ddf-9044-8f1a7525082b"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">etnb:TwoThousandAndNineteenEquityIncentivePlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_7b31e452-ba3b-4180-9ddd-8faae2f90f0c"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_c47682c6-cd12-4afc-8813-6a33a11740fe"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">etnb:EightyNineBioLtdMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_538d2ebd-ca46-4eb6-a0b9-787839675985"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_debc9f51-b90f-43f6-af8a-b00f128671e2"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">etnb:EquityIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_0d9500dd-d242-4ed4-9f39-2450c5d10363"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_4fde072e-5fc4-4cda-9482-54bac5203fd9"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">etnb:TwoThousandAndNineteenEquityIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_04dfbd26-115a-4a0f-a7b5-f27eb17ef112"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_dbe06daf-d12f-4df8-b30b-9d91c12d257a"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-07-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_531e15c8-1e50-4083-9eba-30220f5c7c10"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">etnb:ATMFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_19145334-f911-4daa-9ab2-e1eab1d17cbf"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueOptionPricingModelMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">etnb:LoanAndSecurityAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-05-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_af7928d4-1306-45db-9bad-07933e9c282a"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">etnb:ATMFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_d18bd1f4-38fc-4415-8797-86a51c6f011c"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">etnb:PreFundedWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-07-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_da14e69b-ecb1-4491-93da-01275cadc2ed"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IL</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_b3ec4959-576f-4e65-ad23-76ebb075c512"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_8abdad68-ec68-4b1c-a08b-9c7a8ad9e2f6"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IL</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_c666f3b9-1ce5-4d4c-88e3-dbd7868d4edb"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">etnb:TwoThousandAndTwentyThreeLoanAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_a21cd459-9352-4988-ba87-d4355aa42746"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_7c501227-02e2-4e44-b377-8e6109e76507"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_cd860230-54ad-4af3-82dc-6e430002fe8e"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">etnb:TwoThousandAndNineteenEquityIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_cd124b4e-13d9-4079-ac85-a4d1fd6601fc"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">etnb:ServiceBasedRSUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">us-gaap:ShareBasedPaymentArrangementEmployeeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_9153c97c-b82f-4cb0-9b13-074c71823603"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-07-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_3d0b52b1-23df-4031-9043-36966d3bfe8f"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">etnb:UnvestedRestrictedStockUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_5e92a8a9-dc98-44f0-9e1f-f9aa3e8099bf"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">etnb:TwoThousandAndTwentyThreeLoanAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">etnb:TrancheTwoAndThreeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_b88d9973-f0e9-45f8-b4fb-a6e4faea7667"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_c6fb4616-5254-4cb5-bb2e-278e7e88bcc9"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">us-gaap:ResearchMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_8aa0101e-eb8f-4a89-baf5-0cb6983f48c3"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">etnb:ATMFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_a901fd1a-d6e9-4b6f-a2ee-b46b58ae4f7c"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">etnb:TwoThousandAndTwentyEquityIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_17df92a5-2cb5-48c9-9462-299e5b922342"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">etnb:PreFundedWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-07-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_21f769c6-c78d-41d0-b871-ec3d93d7d343"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_2927c45f-85bc-4b1d-bb2a-c302c8ed2347"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">etnb:UnvestedRestrictedStockUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_23fb22c1-879a-41c9-8fba-6e9ff39f555d"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">etnb:TwoThousandAndNineteenEquityIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_f6790208-fa53-4c6a-a9e8-0e12a839f2fc"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">etnb:LoanAndSecurityAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_d381e235-d260-40df-bd20-65af96cdfcaa"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">etnb:PreFundedWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_13fd21a7-f190-41ce-8a3b-79cba6a70fbb"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">etnb:ServiceBasedRSUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">us-gaap:ShareBasedPaymentArrangementEmployeeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_9e2050fc-7421-4f2f-bf7c-de15ccbc149f"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_0f35f69d-3f7b-4b23-8802-ee13a747affc"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_012d970f-64c4-41b0-8040-d4774ce38bd6"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">etnb:PerformanceRSUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">us-gaap:ShareBasedPaymentArrangementEmployeeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_f1a66cb6-d1cc-4146-839d-52664c4b4ab3"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-10-01</xbrli:startDate><xbrli:endDate>2019-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_43d7ae38-fb0a-4a4d-a3e8-a44b58f48f12"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CashEquivalentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_8c4669a8-efdc-43fe-b27c-54cf3b35bd79"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_20129c45-1d42-4b18-a135-f79c3916f000"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AgencySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_0e17628a-1540-4372-9673-4bccb929190b"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2023-03-03</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_e7406d64-9fbe-4053-8474-7c07e64b9b1a"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">etnb:SVBLeerinkLLCAndCantorFitzgeraldCoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_71719056-4c35-44bc-be7b-ed47745f7284"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_85e3a5e5-8ff2-4682-901b-9d79336e863a"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_aecfb132-37f5-4d9c-98a7-d5475beefa29"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">etnb:LoanAndSecurityAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">etnb:TermBLoanFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-05-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_486ea18d-a98b-4e2c-a648-7ba74ce82df4"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">etnb:TermALoanFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">etnb:LoanAndSecurityAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_9d22496e-a5ce-4a93-a7b9-674d6c8a803f"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:LT</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_034c3248-20ba-45f1-8c7f-941617fb2bea"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">etnb:SVBLeerinkLLCAndCantorFitzgeraldCoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_06c8eb12-56da-4f0a-a557-1a9ee843de7a"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_f85e5250-59a9-43e3-a14f-d55368e20822"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">etnb:TwoThousandAndTwentyThreeLoanAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">etnb:TrancheFourMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_8bc8599c-0290-4c23-8007-773265c83e34"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">etnb:TwoThousandAndNineteenEquityIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_e78e7a90-a47d-407c-a473-ef6d15843240"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">etnb:TwoThousandAndTwentyEquityIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_4aecf5de-d743-4793-84fb-ed9efd04841d"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IL</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_4c47692e-9e97-459b-a109-c6bc7bbaa9fe"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">etnb:WarrantPublicOfferingsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_eb4154dd-05cb-44b2-b1f9-253eb264f041"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201602Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-01-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_2e474f95-87bf-4927-8cbe-0c9312719cd9"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">etnb:TwoThousandAndTwentyThreeLoanAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_06409d28-ba8c-475e-bda2-06ff8506b41a"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">etnb:TevaAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-04-01</xbrli:startDate><xbrli:endDate>2018-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_a518f01f-6e57-482e-afd5-51c9629b2a7c"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_dc1a49be-d8e3-4484-be45-e163fe0ca28e"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_2ab554fe-0a65-4e18-9da1-d18c79433fba"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">etnb:UABEightyNineBioLithuaniaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_b79c1273-b7ef-4512-a77c-8f09b7dd034b"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_acf3ac7f-4345-415e-b39a-8425a9a0a3db"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_6fdc6413-db9e-4bdf-ac0c-0aec29016321"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">etnb:SVBLeerinkLLCAndCantorFitzgeraldCoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_3b993bd4-a1f0-42fb-959d-d02b87902727"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">etnb:ATMFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_d417399a-7793-4c07-aa7a-f9d877495dd9"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueOptionPricingModelMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">etnb:LoanAndSecurityAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-05-01</xbrli:startDate><xbrli:endDate>2021-05-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_a8dbb74d-cae4-4460-96f9-3662ead67daa"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_48d6b2ed-10f4-4276-9857-7ff818488c18"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_9b3365b2-21c7-49a6-ad95-a43fd3b9d2c1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">etnb:TrancheOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">etnb:TwoThousandAndTwentyThreeLoanAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_6cebf0eb-4166-4c8e-ac4c-8137ee3b770e"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">etnb:TwoThousandAndTwentyThreeLoanAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">etnb:TrancheTwoAndThreeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_cf4ea6ad-4896-41f4-bc1c-7f4a0b1286f8"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">etnb:ExerciseOfWarrantsAndPreFundedWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_68ccb2ee-ab2d-44ed-a5ee-a3a09c44b31c"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">etnb:PreFundedWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_7120f124-ce25-4ba7-a030-21bd1b4579e6"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_3b1b99d2-654c-455a-a33a-422592ad8d08"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_0db42b13-ed32-4464-a128-9b3738d1e9ec"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_ba27f631-5055-4b5d-bcd3-1dcdfae2eb5e"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">etnb:AgencyDiscountSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_aa8067f4-0c3d-4c66-b916-2f5abd46e15d"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_276795d2-8680-4e1e-a7b3-60b4f187b181"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesShorttermDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_bbce1ed1-a8d8-49f8-afbe-c78e9685dbd3"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">etnb:TevaAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_17d9d5b5-1459-459f-8bc2-52f76629e915"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:CA</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_8ec6682c-a0df-42a7-9596-2e31ddf5f5fb"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">etnb:LoanAndSecurityAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-05-01</xbrli:startDate><xbrli:endDate>2021-05-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_302d3395-cf3f-4431-8710-ee66bc04c06d"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_f983776b-3b07-4d5d-8f04-c89f752dbbb3"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">etnb:WarrantTermLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_6cd8e184-e243-4a3c-818f-9a1ebfd43667"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_9705961e-ee8d-42ab-94ee-ccd3d976ce3a"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">etnb:PreFundedWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-07-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_15a836b6-6096-4e2c-9574-cf11b7149853"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasuryBillSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_3f47fde3-7be3-4bb6-ae2b-29bc39fcd38d"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">etnb:TermALoanFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_1294a0d4-82df-4aeb-86a3-c974a5339679"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_8c46fb5d-0dfa-460a-9514-f05dd04eb080"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">etnb:ATMFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-02-15</xbrli:startDate><xbrli:endDate>2023-02-15</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_f1364984-27a4-4b53-9cb3-49e5885e056f"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">etnb:LoanAndSecurityAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_b49f5ccf-6e36-469f-8160-42229bc94d1d"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_fc374840-0f9a-49dd-a75c-57c70ae81f21"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_0ff1dce8-b806-4a8c-ae9b-bef81ddaf302"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">etnb:LoanAndSecurityAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_a099857d-ead8-4784-88ce-373b780df01d"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignGovernmentDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_f440b0bc-74ad-45cd-9077-8182fe07c5ea"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_0cf9d23c-1397-46c1-b3b5-e40c57e51864"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">etnb:TevaAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">etnb:TevasDevelopmentProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-04-01</xbrli:startDate><xbrli:endDate>2018-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_23eaed33-b0aa-4e33-a2c8-2f2897791170"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_69b35aed-7994-41dd-a070-5ef370bb6088"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">etnb:LoanAndSecurityAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_68b35e56-1e54-4bd6-9c91-36e41d1c9359"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">etnb:TevasGlycoPEGylatedFGF21ProgramMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">etnb:TevaAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-04-01</xbrli:startDate><xbrli:endDate>2018-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_a858f07d-a85c-4d7d-b3d7-e709eceaafec"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-07-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_1993c206-41b8-40d0-bb47-7bbec84e9bd6"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_32b3ec32-95c9-46d8-a321-86d1f6774b73"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_a98c76fd-bd2e-47b8-b425-7f631d600233"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignGovernmentDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_28004ded-ab04-4f21-ace5-a081ac2e28b8"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_37523fff-f632-40a8-b39a-8f096f5c4549"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">etnb:TwoThousandAndTwentyOneLoanAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_4052b109-a3b7-4114-87b7-faa0a4118dc7"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_42491eea-6b09-4865-930d-85d82115fafd"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">etnb:TwentyTwentyThreeLoanAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_92977a81-ddbb-4449-8219-ba10dfb38d5c"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">etnb:TwoThousandAndNineteenEquityIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_7063e2f9-3a0a-44ed-964f-cc213bf88e2e"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CashEquivalentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_219ac1f1-456b-400e-b032-64201f1a5313"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">etnb:SanFranciscoOfficeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-01-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_59a670e1-2243-40d1-b43e-339c260c91b8"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_fda4865a-3df9-43f1-b274-1756046b954d"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_e79cc86e-7f21-4169-93d3-9ca5f3198b26"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">etnb:PerformanceRSUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-02-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_5c814fa2-557e-430f-a964-0b757b56fdfd"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesShorttermDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_293baad2-fb24-4c8f-af10-1f5af83b558f"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">etnb:TevaAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_cc8b62e3-7c1c-4b52-9dfb-ede005f6e5b4"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_336bc7db-2eb9-4265-a863-9aea3514e4c0"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">etnb:TevaAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_e7fc2234-7fe0-49dd-acdd-725cb91a9889"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">etnb:ServiceBasedRSUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">us-gaap:ShareBasedPaymentArrangementEmployeeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_6201b105-b38d-4bd4-81b7-a6dfd189c83e"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">etnb:ATMFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-02-15</xbrli:startDate><xbrli:endDate>2023-02-15</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_6bb5134f-3725-49c2-9eda-5f0d3a108db3"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AgencySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_ebcdeb7b-03e6-4e92-b422-7eb9e015b4a8"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_46b0f71c-7508-426b-9a1f-56cebecab4e1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_2b1c0a70-b0ce-43af-b3bb-a102024bd750"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">etnb:WarrantTermLoanOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_830ace7d-9785-41d6-a516-94d2fda5e208"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">etnb:PerformanceRSUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-02-01</xbrli:startDate><xbrli:endDate>2021-02-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_9179a407-98a4-4470-bd80-a8d43f35e053"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:PrimeRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">etnb:LoanAndSecurityAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_2b56b0d1-cc3c-4206-95ae-ff3e5aa3e43c"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">etnb:ServiceBasedRSUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">us-gaap:ShareBasedPaymentArrangementEmployeeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_a9902439-f289-45b6-ae67-7a0087e98dc3"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueOptionPricingModelMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">etnb:LoanAndSecurityAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-05-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_73cdaea6-5d5f-4d31-9b38-a90fc6b9008e"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_19418b37-9af5-4eb2-b38a-a9070fc599d5"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_e0c8525e-1484-4af4-8900-61b9edf6a79c"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">etnb:EightyNineBioManagementIncorporationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_c220af16-8191-4926-94c1-499324d13fdf"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_1987e38f-7346-406e-addf-f3687776929f"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_143dfe4f-b7a0-4c4a-acd0-9cacd6c072d0"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">etnb:EightyNineBioLtdMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_0ec77485-e315-49c3-9a79-2d048ec76494"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_d924e5a5-d3dd-4acb-a359-d2a055d67e71"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">etnb:LoanAndSecurityAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_6abe1517-994e-40d2-af02-3d1364d02449"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_4e61ffe1-5dad-4c7d-9e54-54ccdddb6379"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">etnb:LoanAndSecurityAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedDividendPaymentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-05-01</xbrli:startDate><xbrli:endDate>2021-05-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_81b08a03-90f7-43af-84a8-8e9dbb83a6d9"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">etnb:SanFranciscoOfficeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-08-31</xbrli:startDate><xbrli:endDate>2022-08-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_94f92680-1f20-47c3-8d22-07184c19f444"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">etnb:ATMFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_400e8f6e-3cb0-4806-ab40-9ea3fbda15da"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">etnb:LoanAndSecurityAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_9e28330b-37ae-4c55-b6c8-5ab5971501f1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_9cece5f1-3203-491d-9c15-ee835dbf4586"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_2091a5b2-f30d-4935-bc83-ed0ef862f4d5"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">etnb:UABEightyNineBioLithuaniaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_cb2cbb74-aff7-499d-b6a9-60e3aa3581f8"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MunicipalBondsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_b7499103-4103-44cf-b691-30ec371253b5"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_cb272169-7edb-4636-b3d0-11b4570d0a11"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_3b188b92-032b-457e-ad3c-a951f340f11a"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">etnb:ATMFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_97306f73-aa83-44a7-88e9-fbb26c9074bd"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">etnb:EightyNineBioManagementIncorporationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_e52ac035-0be2-420f-b034-790f9ecc0826"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:LT</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_86dde930-3c82-4da9-903f-d12ea942a22e"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_f1c306e8-9d11-4882-bc7e-9eb378ceb757"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">etnb:PreFundedWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-07-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_3c40b2dc-88af-4c40-8a0c-0d6d05ae9073"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">etnb:ATMFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-02-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_7333b298-4d64-4dc2-818f-293d2d952a7c"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_d6793a0d-ddc1-4bea-8729-61b96d2fd8c6"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">etnb:PreFundedWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-07-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_d0cc41a8-af59-48aa-9362-9afbe6438bb6"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201602Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_87d79f22-a66f-4528-9561-7c899b8a6f71"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">etnb:PerformanceRSUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">us-gaap:ShareBasedPaymentArrangementEmployeeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_24b84e4a-2d9f-418f-bf86-e74e1b8c81af"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-08-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_9b6ffafb-d759-4fb6-a478-e6f9c964ba52"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-10-01</xbrli:startDate><xbrli:endDate>2019-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_a7b7da7e-fb0a-4f4b-a318-753b03bdad64"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001785173</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="U_pure"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:unit id="U_shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:unit id="U_Segment"><xbrli:measure>etnb:Segment</xbrli:measure></xbrli:unit><xbrli:unit id="U_UnitedStatesOfAmericaDollarsShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:unit id="U_USD"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit></ix:resources></ix:header></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="border-top:2.25pt double;padding-top:1.0pt;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:1.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:14.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">UNITED STATES</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:14.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">SECURITIES AND EXCHANGE COMMISSION</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Washington, D.C. 20549</span></p>
  <p style="margin-left:40.0%;text-indent:0.0%;padding-bottom:1.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;border-bottom:1pt solid;margin-right:40.0%;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:2.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:14.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">FORM </span><span style="font-size:14.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_ebbbab57-a787-406d-91d6-11b602546437" contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698" name="dei:DocumentType"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:14.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10-K</span></ix:nonNumeric></span></p>
  <p style="margin-left:40.0%;text-indent:0.0%;padding-bottom:1.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;border-bottom:1pt solid;margin-right:40.0%;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:2.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(Mark One)</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:3.996%;"></td>
    <td style="width:96.004%;"></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Segoe UI Symbol&quot;, sans-serif;"><ix:nonNumeric id="F_7c1e4f27-785f-4670-8cd4-9117682e5069" contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698" name="dei:DocumentAnnualReport" format="ixt-sec:boolballotbox"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Segoe UI Symbol&quot;, sans-serif;min-width:fit-content;">&#9746;</span></ix:nonNumeric></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:2.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:2.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">For the fiscal year ended </span><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_c39f9d88-cf45-4722-8658-54c3c891a18b" contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698" name="dei:DocumentPeriodEndDate" format="ixt:datemonthdayyearen"><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_c072aa71-ec96-4a03-870f-d29622870cc0" contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698" name="dei:CurrentFiscalYearEndDate" format="ixt:datemonthdayen"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, </span><span style="font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_fde47d20-d312-46ec-9c12-0be561e586d2" contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698" name="dei:DocumentFiscalYearFocus"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2022</span></ix:nonNumeric></span></ix:nonNumeric></span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:2.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">OR</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:3.996%;"></td>
    <td style="width:96.004%;"></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:2.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Segoe UI Symbol&quot;, sans-serif;"><ix:nonNumeric id="F_0065ab08-56fa-41d6-ad40-2003755bbc88" contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698" name="dei:DocumentTransitionReport" format="ixt-sec:boolballotbox"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Segoe UI Symbol&quot;, sans-serif;min-width:fit-content;">&#9744;</span></ix:nonNumeric></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:2.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM                      TO</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">                     </span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:3.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Commission File Number </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_8a0b9cf3-9621-4843-8acb-fced9e8a4661" contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698" name="dei:EntityFileNumber"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">001-39122</span></ix:nonNumeric></span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="margin-left:40.0%;text-indent:0.0%;padding-bottom:1.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;border-bottom:1pt solid;margin-right:40.0%;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:3.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:18.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_e42b3bf0-1655-47be-8403-2ffb74b012c4" contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698" name="dei:EntityRegistrantName"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:18.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">89bio, Inc.</span></ix:nonNumeric></span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(Exact name of Registrant as specified in its Charter)</span></p>
  <p style="margin-left:40.0%;text-indent:0.0%;padding-bottom:1.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;border-bottom:1pt solid;margin-right:40.0%;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:49.006%;"></td>
    <td style="width:1.998%;"></td>
    <td style="width:48.996%;"></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_8f7d2c11-75ac-4f26-b7e1-f99b004d315a" contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Delaware</span></ix:nonNumeric></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_69916b46-784e-45a9-97ff-9692b00df284" contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698" name="dei:EntityTaxIdentificationNumber"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">36-4946844</span></ix:nonNumeric></span></p></td>
   </tr>
   <tr style="height:7.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(State or other jurisdiction of</span></p><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">incorporation or organization)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(I.R.S. Employer</span></p><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Identification No.)</span></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:3.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:3.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:3.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_fdab1b92-03f6-4633-9093-51ff8b9e8e02" contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698" name="dei:EntityAddressAddressLine1"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">142 Sansome Street</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_c99dccef-997a-4a3c-88f4-11a93e490221" contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698" name="dei:EntityAddressAddressLine2"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Second Floor</span></ix:nonNumeric></span></p><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_9517c09b-0138-42c2-941b-238421f8f318" contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698" name="dei:EntityAddressCityOrTown"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">San Francisco</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_a1f5d1ae-1cf9-46ad-9529-0de7f0fd7151" contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698" name="dei:EntityAddressStateOrProvince" format="ixt-sec:stateprovnameen"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">California</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_b09e032d-9494-4a74-8ac5-3dde63565fd6" contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698" name="dei:EntityAddressPostalZipCode"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">94104</span></ix:nonNumeric></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">94104</span></p></td>
   </tr>
   <tr style="height:7.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(Address of principal executive offices)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(Zip Code)</span></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:3.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:3.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:3.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Registrant&#x2019;s telephone number, including area code: (</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_4282684d-3faf-4f67-8d7c-32ef45abf457" contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698" name="dei:CityAreaCode"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">415</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">) </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_e3d6c59e-1056-4ded-a732-b5f9032b6bd0" contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698" name="dei:LocalPhoneNumber"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">432-9270</span></ix:nonNumeric></span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="margin-left:40.0%;text-indent:0.0%;padding-bottom:1.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;border-bottom:1pt solid;margin-right:40.0%;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:2.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Securities registered pursuant to Section 12(b) of the Act:</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:38.996%;"></td>
    <td style="width:1.004%;"></td>
    <td style="width:20.0%;"></td>
    <td style="width:1.004%;"></td>
    <td style="width:38.996%;"></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Title of each class</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Trading<br />Symbol(s)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Name of each exchange on which registered</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:8.5pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_d49f29b1-a3fd-48e1-b5e1-aab929f0c9d2" contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698" name="dei:Security12bTitle"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Common stock, par value $0.001 per share</span></ix:nonNumeric></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:8.5pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_9df0f8ae-5b6e-4eb8-9969-a13b03823464" contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698" name="dei:TradingSymbol"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">ETNB</span></ix:nonNumeric></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:8.5pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_405d3d3f-adc8-4bb8-af22-548b275c6395" contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Nasdaq Global Market</span></ix:nonNumeric></span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Securities registered pursuant to Section 12(g) of the Act: </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">None</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:2.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Indicate by check mark if the Registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. </span><span style="background-color:rgba(0,0,0,0);text-transform:uppercase;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Yes</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Segoe UI Symbol&quot;, sans-serif;min-width:fit-content;">&#9744;</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_1c86da6f-143f-4d65-9cac-8a95c01a0d39" contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698" name="dei:EntityWellKnownSeasonedIssuer"><span style="background-color:rgba(0,0,0,0);text-transform:uppercase;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">No</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Segoe UI Symbol&quot;, sans-serif;min-width:fit-content;">&#9746;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:2.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Indicate by check mark if the Registrant is not required to file reports pursuant to Section 13 or 15(d) of the Act.  </span><span style="background-color:rgba(0,0,0,0);text-transform:uppercase;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Yes</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Segoe UI Symbol&quot;, sans-serif;min-width:fit-content;">&#9744;</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_ac411a00-3090-45ca-82b5-975237e19555" contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698" name="dei:EntityVoluntaryFilers"><span style="background-color:rgba(0,0,0,0);text-transform:uppercase;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">No</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Segoe UI Symbol&quot;, sans-serif;min-width:fit-content;">&#9746;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:2.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Indicate by check mark whether the Registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.  </span><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_6bfbed1a-08e6-49c5-a0c8-571377871663" contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698" name="dei:EntityCurrentReportingStatus"><span style="background-color:rgba(0,0,0,0);text-transform:uppercase;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Yes</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Segoe UI Symbol&quot;, sans-serif;min-width:fit-content;">&#9746;</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span><span style="background-color:rgba(0,0,0,0);text-transform:uppercase;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">No</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.5pt;font-family:&quot;Segoe UI Symbol&quot;, sans-serif;min-width:fit-content;">&#9744;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:2.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Indicate by check mark whether the Registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (&#167;232.405 of this chapter) during the preceding 12 months (or for such shorter period that the Registrant was required to submit such files).  </span><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_d61ae325-a894-4f62-b955-7e16404a6998" contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698" name="dei:EntityInteractiveDataCurrent"><span style="background-color:rgba(0,0,0,0);text-transform:uppercase;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Yes</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Segoe UI Symbol&quot;, sans-serif;min-width:fit-content;">&#9746;</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span><span style="background-color:rgba(0,0,0,0);text-transform:uppercase;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">No</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Segoe UI Symbol&quot;, sans-serif;min-width:fit-content;">&#9744;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:2.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Indicate by check mark whether the Registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of &#x201c;large accelerated filer,&#x201d; &#x201c;accelerated filer,&#x201d; &#x201c;smaller reporting company,&#x201d; and &#x201c;emerging growth company&#x201d; in Rule 12b-2 of the Exchange Act</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:20.214%;"></td>
    <td style="width:1.111%;"></td>
    <td style="width:53.964%;"></td>
    <td style="width:1.122%;"></td>
    <td style="width:20.224%;"></td>
    <td style="width:1.122%;"></td>
    <td style="width:2.244%;"></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Large accelerated filer</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Segoe UI Symbol&quot;, sans-serif;min-width:fit-content;">&#9744;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">  &#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Accelerated filer</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Segoe UI Symbol&quot;, sans-serif;min-width:fit-content;">&#9744;</span></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:2.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:2.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:2.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:2.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:2.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:2.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:2.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:2.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:2.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:2.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:2.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:2.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:2.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:2.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:5.05pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_40d0b1b7-82ed-4b95-a43c-ef785569a8f3" contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698" name="dei:EntityFilerCategory" format="ixt-sec:entityfilercategoryen"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Non-accelerated filer</span></ix:nonNumeric></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Segoe UI Symbol&quot;, sans-serif;min-width:fit-content;">&#9746;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">  &#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Smaller reporting company</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Segoe UI Symbol&quot;, sans-serif;"><ix:nonNumeric id="F_97c06ee3-0a0c-4184-9e56-0a8e82a6fada" contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698" name="dei:EntitySmallBusiness" format="ixt-sec:boolballotbox"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Segoe UI Symbol&quot;, sans-serif;min-width:fit-content;">&#9746;</span></ix:nonNumeric></span></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:2.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:2.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:2.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:2.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:2.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:2.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:2.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:2.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:2.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:2.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:2.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:2.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:2.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:2.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Emerging growth company</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Segoe UI Symbol&quot;, sans-serif;"><ix:nonNumeric id="F_c7808672-8689-4332-8c30-edb43f83aed4" contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698" name="dei:EntityEmergingGrowthCompany" format="ixt-sec:boolballotbox"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Segoe UI Symbol&quot;, sans-serif;min-width:fit-content;">&#9746;</span></ix:nonNumeric></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.5pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:2.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">If an emerging growth company, indicate by check mark if the Registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  </span><span style="font-size:8.0pt;font-family:&quot;Segoe UI Symbol&quot;, sans-serif;"><ix:nonNumeric id="F_f43fa156-01d9-4069-af64-93f8b8ea8315" contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698" name="dei:EntityExTransitionPeriod" format="ixt-sec:boolballotbox"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Segoe UI Symbol&quot;, sans-serif;min-width:fit-content;">&#9744;</span></ix:nonNumeric></span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:2.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Indicate by check mark whether the Registrant has filed a report on and attestation to its management&#x2019;s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report.  </span><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_95717b3a-3c47-4d20-b156-32d91997abc3" contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698" name="dei:IcfrAuditorAttestationFlag" format="ixt-sec:boolballotbox"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#9744;</span></ix:nonNumeric></span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:2.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Indicate by check mark whether the Registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).  Yes &#9744; No </span><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_49adc556-cde7-4a51-b313-a2f6dcad16e7" contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698" name="dei:EntityShellCompany" format="ixt:booleanfalse"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#9746;</span></ix:nonNumeric></span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:2.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant included in the filing reflect the correction of an error to previously issued financial statements. &#9744;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:2.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation received by any of the registrant&#x2019;s executive o&#xfb03;cers during the relevant recovery period pursuant to &#167;240.10D-1(b). &#9744;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:2.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The aggregate market value of the voting and non-voting common equity held by non-affiliates of the Registrant, based on the closing price of the shares of common stock on The Nasdaq Global Market on June 30, 2022, the last business day of the Registrant&#x2019;s most recently completed second fiscal quarter, was approximately $</span><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_44b64144-d7f2-4b8c-bbda-ff85137e7658" contextRef="C_32b3ec32-95c9-46d8-a321-86d1f6774b73" name="dei:EntityPublicFloat" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">30.4</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. Shares of common stock held by each officer and director and by each person who is known to own 10% or more of the outstanding common stock have been excluded in that such persons may be deemed to be affiliates of the Registrant. This determination of affiliate status is not necessarily a conclusive determination for other purposes.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:2.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The number of shares of Registrant&#x2019;s common stock outstanding as of March 3, 2023 was </span><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_4ab5e111-8d54-44cc-a2ff-f65cbd37feb7" contextRef="C_0e17628a-1540-4372-9673-4bccb929190b" name="dei:EntityCommonStockSharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">52,230,621</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">DOCUMENTS INCORPORATED BY REFERENCE</span></p>
  <div><ix:nonNumeric id="F_43b49404-9572-40bb-8cb9-ef21ce01b235" contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698" name="dei:DocumentsIncorporatedByReferenceTextBlock" escape="true"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Portions of the Registrant&#x2019;s definitive proxy statement relating to its 2023 Annual Meeting of Stockholders, to be held on or about May 31, 2023, are incorporated by reference into Part III of this Annual Report on Form 10-K where indicated. Such proxy statement will be filed with the U.S. Securities and Exchange Commission within 120 days after the end of the fiscal year to which this report relates.</span></p></ix:nonNumeric></div>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:97.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:14.561%;"></td>
    <td style="width:14.44%;"></td>
    <td style="width:14.043%;"></td>
    <td style="width:15.2%;"></td>
    <td style="width:15.795%;"></td>
    <td style="width:25.961%;"></td>
   </tr>
   <tr style="height:7.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Auditor Firm Id:</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_befe64d6-e22c-4753-9cb5-53b8d3e63ae2" contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698" name="dei:AuditorFirmId"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">185</span></ix:nonNumeric></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Auditor Name:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_16e47b55-bae9-4532-941e-ed2adf191677" contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698" name="dei:AuditorName"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">KPMG LLP</span></ix:nonNumeric></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Auditor Location:</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_190e5df1-370e-4f1a-b9bc-0b66ac0aa8dd" contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698" name="dei:AuditorLocation"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">San Francisco, California, USA</span></ix:nonNumeric></span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;padding-bottom:1.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;border-bottom:2.25pt double;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Table of Contents</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:10.0%;"></td>
    <td style="width:81.795%;"></td>
    <td style="width:8.205%;"></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.25pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Page</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">PART I</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:6.85pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:6.85pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Item 1.</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#business"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Busine</span></a><a href="#business"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">ss</span></a></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:6.85pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:6.85pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Item 1A.</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#item_1a_risk_factors"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Risk Factors</span></a></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">36</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:6.85pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:6.85pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Item 1B.</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#item_1b_unresolved_staff_comments"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Unresolved Staff Comments</span></a></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">59</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:6.85pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:6.85pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Item 2.</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#item_2_properties"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Properties</span></a></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">59</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:6.85pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:6.85pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Item 3.</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#item_3_legal_proceedings"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Legal Proceedings</span></a></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">59</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:6.85pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:6.85pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Item 4.</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#item_4_mine_safety_disclosures"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Mine Safety Disclosures</span></a></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">59</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(5,99,193,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">PART II</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(5,99,193,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:6.85pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:6.85pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Item 5.</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#item_5_market_for_registrants_common_equ"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Market for Registrant&#x2019;s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities</span></a></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">60</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:6.85pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:6.85pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Item 6.</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#item_6_reserved"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">[Reserved]</span></a></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">60</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:6.85pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:6.85pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Item 7.</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#item_7_managements_discussion_analysis_f"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Management&#x2019;s Discussion and Analysis of Financial Condition and Results of Operations</span></a></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">61</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:6.85pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:6.85pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Item 7A.</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#item_7a_quantitative_qualitative_disclos"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Quantitative and Qualitative Disclosures About Market Risk</span></a></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">69</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:6.85pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:6.85pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Item 8.</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#item_8_financial_statements_supplementar"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Financial Statements and Supplementary Data</span></a></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">70</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:6.85pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:6.85pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Item 9.</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#item_9_changes_in_disagreements_with_acc"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Changes in and Disagreements With Accountants on Accounting and Financial Disclosure</span></a></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">94</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:6.85pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:6.85pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Item 9A.</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#item_9a_controls_procedures"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Controls and Procedures</span></a></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">94</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:6.85pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:6.85pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Item 9B.</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#item_9b_or_information"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Other Information</span></a></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">95</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:6.85pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:6.85pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Item 9C.</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#item_9c_disclosure_regarding"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Disclosure Regarding Foreign Jurisdictions that Prevent Inspections</span></a></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">95</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(5,99,193,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">PART III</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(5,99,193,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:6.85pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:6.85pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Item 10.</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#item_10_directors_executive_ficers_corpo"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Directors, Executive Officers and Corporate Governance</span></a></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">96</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:6.85pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:6.85pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Item 11.</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#item_11_executive_compensation"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Executive Compensation</span></a></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">96</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:6.85pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:6.85pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Item 12.</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#item_12_security_ownership_certain_benef"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters</span></a></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">96</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:6.85pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:6.85pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Item 13.</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#item_13_certain_relationships_related_tr"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Certain Relationships and Related Transactions, and Director Independence</span></a></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">96</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:6.85pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:6.85pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Item 14.</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#item_14_principal_accounting_fees_servic"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Principal Accountant Fees and Services</span></a></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">96</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(5,99,193,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">PART IV</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(5,99,193,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:6.85pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:6.85pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Item 15.</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#item_15_exhibits_financial_statement_sch"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Exhibits, Financial Statement Schedules</span></a></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">97</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:6.85pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:6.85pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Item 16.</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#item_16_form_10k_summary"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Form 10-K Summary</span></a></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">100</span></p></td>
   </tr>
   <tr style="height:6.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#signatures"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">SIGNATURES</span></a></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">101</span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">FORWARD-LOOKING STATEMENTS</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">This Annual Report on Form 10-K contains &#x201c;forward-looking statements&#x201d; within the meaning of the federal securities laws, which statements involve substantial risks and uncertainties. All statements, other than statements of historical facts included in this Annual Report on Form 10-K, including statements concerning our plans, objectives, goals, strategies, future events, future revenues or performance, financing needs, plans or intentions relating to acquisitions, business trends and other information referred to in &#x201c;Business,&#x201d; &#x201c;Risk Factors&#x201d; and &#x201c;Management&#x2019;s Discussion and Analysis of Financial Condition and Results of Operations&#x201d; are forward-looking statements. Forward-looking statements generally relate to future events or our future financial or operating performance. In some cases, you can identify forward-looking statements by terms such as &#x201c;may,&#x201d; &#x201c;might,&#x201d; &#x201c;will,&#x201d; &#x201c;objective,&#x201d; &#x201c;intend,&#x201d; &#x201c;should,&#x201d; &#x201c;could,&#x201d; &#x201c;can,&#x201d; &#x201c;would,&#x201d; &#x201c;expect,&#x201d; &#x201c;believe,&#x201d; &#x201c;design,&#x201d; &#x201c;estimate,&#x201d; &#x201c;predict,&#x201d; &#x201c;potential,&#x201d; &#x201c;plan,&#x201d; &#x201c;anticipate,&#x201d; &#x201c;target,&#x201d; &#x201c;forecast,&#x201d; or the negative of these terms, and similar expressions intended to identify forward-looking statements. Forward-looking statements are not historical facts and reflect our current views with respect to future events and are based on assumptions and subject to risks and uncertainties. Given these uncertainties, you should not place undue reliance on these forward-looking statements.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">There are a number of risks, uncertainties and other important factors that could cause our actual results to differ materially from the forward-looking statements contained in this Annual Report on Form 10-K. Such risks, uncertainties and other important factors include, among others, the risks, uncertainties and factors set forth in &#x201c;Risk Factors,&#x201d; and the following risks, uncertainties and factors:</span></p>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">our plans to develop and commercialize pegozafermin (previously BIO89-100) or any future product candidates;</span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">our ongoing and planned clinical trials;</span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the timing of and our ability to obtain regulatory approvals for pegozafermin or any future product candidates;</span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">our estimates regarding expenses, future revenue, capital requirements and needs for additional financing;</span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">our ability to obtain additional capital;</span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the effect of the ongoing COVID-19 pandemic on our business;</span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">our ability to identify additional products or product candidates with significant commercial potential that are consistent with our commercial objectives;</span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the rate and degree of market acceptance and clinical utility of pegozafermin or any future product candidates, if approved;</span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">our commercialization, marketing and manufacturing capabilities and strategy;</span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">substantial competition in our industry and with respect to the product candidates that we are developing;</span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">our intellectual property position;</span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">loss of key members of management;</span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">failure to successfully execute our growth strategy, including any delays in our planned future growth; and</span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">our failure to maintain effective internal controls.</span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">There may be other factors that may cause our actual results to differ materially from the forward-looking statements, including factors disclosed in &#x201c;Risk Factors&#x201d; and &#x201c;Management&#x2019;s Discussion and Analysis of Financial Condition and Results of Operations.&#x201d; You should evaluate all forward-looking statements made in this Annual Report on Form 10-K in the context of these risks and uncertainties.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We caution you that the risks, uncertainties and other factors referred to above may not contain all of the risks, uncertainties and other factors that are important to you. In addition, we cannot assure you that we will realize the results, benefits or developments that we expect or anticipate or, even if substantially realized, that they will result in the consequences or affect us or our business in the way expected. All forward-looking statements in this Annual Report on Form 10-K apply only as of the date made and are expressly qualified in their entirety by the cautionary statements included in this Annual Report on Form 10-K. We undertake no obligation to publicly update or revise any forward-looking statements to reflect subsequent events or circumstances.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">PART I</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">In this Annual Report on Form 10-K, unless context otherwise requires or where otherwise indicated, the terms &#x201c;89bio&#x201d; &#x201c;we,&#x201d; &#x201c;us,&#x201d; &#x201c;our,&#x201d; &#x201c;our company,&#x201d; &#x201c;the company,&#x201d; and &#x201c;our business&#x201d; refer to 89bio, Inc. and its consolidated subsidiaries.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;" id="business"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Item 1. Business.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Overview</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We are a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of liver and cardio-metabolic diseases. Our lead product candidate, pegozafermin (previously BIO89-100), a specifically engineered glycoPEGylated analog of fibroblast growth factor 21 (&#x201c;FGF21&#x201d;), is currently being developed for the treatment of nonalcoholic steatohepatitis (&#x201c;NASH&#x201d;) and for the treatment of severe hypertriglyceridemia (&#x201c;SHTG&#x201d;). NASH is a severe form of nonalcoholic fatty liver disease (&#x201c;NAFLD&#x201d;), characterized by inflammation and fibrosis in the liver that can progress to cirrhosis, liver failure, hepatocellular carcinoma (&#x201c;HCC&#x201d;) and death. There are currently no approved products for the treatment of NASH. In 2020 and 2022, we presented positive topline results from cohorts 1 through 6 and cohort 7, respectively, in our Phase 1b/2a trial of pegozafermin in NASH patients, which has informed the advancement of our clinical strategy in NASH. We initiated a Phase 2b trial (ENLIVEN) evaluating pegozafermin in fibrosis stage 2 or 3 NASH patients in June 2021. In the ENLIVEN trial, patients receive weekly doses or an every two-week dose of pegozafermin or placebo for 24 weeks followed by a blinded extension phase of an additional 24 weeks for a total treatment period of 48 weeks. ENLIVEN completed enrollment in August 2022 and we are expecting to report topline data from this trial in March 2023. In 2021, we completed a pharmacokinetic study of pegozafermin in NASH patients with compensated cirrhosis (fibrosis stage F4) demonstrating that a 30 mg dose of pegozafermin has similar single-dose pharmacokinetics and pharmacodynamics in F4 as it does in non-cirrhotic NASH. We are currently evaluating the potential opportunity for pegozafermin in these fibrosis stage F4 patients. We are also developing pegozafermin for the treatment of SHTG. In June 2022, we announced positive topline results from the ENTRIGUE Phase 2 trial of pegozafermin in SHTG patients. SHTG is a condition identified by severely elevated levels of triglycerides (&#x2265;500 mg/dL), which is associated with an increased risk of NASH, cardiovascular events and acute pancreatitis. The trial met its primary endpoint demonstrating statistically significant and clinically meaningful reductions in triglycerides from baseline and key secondary endpoints. We have received feedback from the FDA supporting the advancement of pegozafermin into Phase 3 and are planning to initiate the first of two recommended Phase 3 trials in the second quarter of 2023. In parallel, we have developed plans to optimize our clinical development program across both indications that would leverage the safety database from our SHTG Phase 3 program to support our NASH program. We expect to finalize these plans after we have reviewed results from the ENLIVEN trial.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">FGF21 is a metabolic hormone that regulates energy expenditure and glucose and lipid metabolism. FGF21 analogs represent a promising class of drugs to treat NASH, because they not only address the liver manifestations, but also have an effect on the multiple co-morbidities that worsen NASH. FGF21 is a clinically validated mechanism that has been shown in humans to reduce steatosis, improve the histological features of NASH and address cardio-metabolic dysregulation. It is thought to exert effects on liver fibrosis by improving metabolic regulation, which reduces ongoing liver injury thus giving the liver time to heal. FGF21 also generates an on-target effect to increase adiponectin, a hormone released from adipose tissue that, among other functions, can suppress development and progression of hepatic fibrosis. However, FGF21 in its native form suffers from a short half-life and a tendency to aggregate in solution, both of which impact its suitability as a viable drug. To address these challenges, we have specifically engineered pegozafermin to extend the half-life of the molecule while maintaining potency and thereby the clinical benefits of FGF21.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Pegozafermin may be a differentiated FGF21 therapy based on its robust and durable biological effects, a favorable tolerability profile and its potential for every two-week dosing. Given its ability to address the key liver pathologies in NASH, as well as the underlying metabolic dysregulation in NASH patients, pegozafermin has the potential to become a backbone of treatment in NASH. Pegozafermin is the only FGF21 analog being developed for the treatment of SHTG and its broad metabolic effects could potentially differentiate it from competitors in this market. Pegozafermin has a long half-life which allows convenient weekly or every two-week dosing and is currently the only FGF21 analog being tested for every two-week dosing. The convenient dosing regimen may support adoption and compliance amongst patients living with these chronic and generally asymptomatic diseases. Pegozafermin is self-administered by patients subcutaneously in a liquid formulation. We have developed a new pre-filled syringe using our approved liquid formulation and plan to utilize this presentation in our planned SHTG Phase 3 trial in the second quarter of 2023.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Strategy</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Our goal is to become a leading biopharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of liver and cardio-metabolic diseases. The key components of our strategy are to:</span></p>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Rapidly advance pegozafermin through clinical development for the treatment of NASH</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">. </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We believe pegozafermin may be a differentiated FGF21 therapy based on its robust and durable biological effects, a favorable tolerability profile and its potential for every two-week dosing. We have reported positive topline results from our Phase 1b/2a trial in NASH patients and have an ongoing Phase 2b trial (ENLIVEN) in NASH patients with F2 and F3 fibrosis that is expected to report topline data in March 2023. We are also evaluating the potential opportunity for pegozafermin in NASH patients with compensated cirrhosis.</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Progress pegozafermin for the treatment of SHTG. </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Pegozafermin&#x2019;s mechanism of action and profile relative to currently available therapies, as well as new therapies in development, support its potential to become a differentiated treatment for SHTG patients with metabolic co-morbidities. We reported positive topline results from our Phase 2 ENTRIGUE trial.</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Based on these positive results and defined regulatory path to approval based on FDA feedback, we plan to initiate the first Phase 3 trial in this indication in the second quarter of 2023.</span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Scale-up and optimize the manufacturing of pegozafermin. </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We currently use external contract manufacturing organizations (&#x201c;CMOs&#x201d;) to manufacture pegozafermin for our ongoing and planned clinical trials. While these trials are ongoing, we plan to work with our CMOs to optimize and scale-up the manufacturing process for pegozafermin to support the increased production that will be needed for later-stage clinical trials and commercialization, if pegozafermin is approved.</span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Establish a commercial infrastructure in key geographies</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. We have worldwide rights to pegozafermin and intend to develop the sales infrastructure required for commercialization in the United States. We also plan to evaluate options, including strategic collaborations, for commercializing pegozafermin, if approved, in other key markets, such as Europe and China.</span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Our Focus on Liver and Cardio-Metabolic Disease</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We are focused on developing and commercializing therapeutic interventions that have a clinically meaningful impact on patients with liver and cardio-metabolic diseases. These diseases, including NASH and SHTG, represent leading global causes of morbidity and mortality. Despite a wave of public health campaigns to promote better diet and exercise habits and a range of treatment options available for many of these diseases, there is a significant unmet medical need for more effective therapies to improve patient outcomes and reduce the burden on global healthcare systems.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We are currently developing our lead product candidate, pegozafermin, a specifically engineered glycoPEGylated analog of FGF21, for the treatment of NASH and SHTG. We believe pegozafermin is an ideal candidate for the treatment of NASH based on its ability to address the key liver pathologies in NASH, its ability to address the underlying metabolic dysregulation in NASH patients, its favorable tolerability profile, and its potential</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">6</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">for a longer dosing interval. Multiple epidemiological studies have linked NAFLD to increased cardiovascular disease, concluding that the majority of deaths among NAFLD patients are attributable to cardiovascular disease. As a result, we believe it is important that new therapeutics options for NASH address the underlying cardiovascular and metabolic dysregulations in these patients. We are also developing pegozafermin for the treatment of SHTG given the potential of pegozafermin to meaningfully reduce triglycerides. Pegozafermin may have a competitive differentiation from approved therapies and other molecules in development based on its impact on improving liver fat and other metabolic markers in addition to triglyceride reduction.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Disease Overview - NASH</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">NASH, a severe form of NAFLD, is characterized histologically by the additional presence of inflammation and hepatocellular injury such as visible ballooning and has a significantly worse prognosis, with the potential to progress to liver fibrosis, cirrhosis or HCC.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">NASH represents a large and rapidly growing problem in the United States and worldwide. Diagnoses have been on the rise and are expected to increase dramatically in the next decade. The prevalence of NAFLD, which affects approximately 25% of the global population, and NASH, which develops in approximately 20% to 25% of NAFLD patients, is driven primarily by the worldwide obesity epidemic. As a result, the prevalence of NASH has increased significantly in recent decades, paralleling similar trends in the prevalence of obesity, insulin resistance and Type 2 diabetes. The prevalence of these conditions is expected to increase further in view of the unhealthy nutrition habits, such as consumption of a diet high in fructose, sucrose and saturated fats, and sedentary behavior that characterize modern lifestyle.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The critical pathophysiologic mechanisms underlying the development and progression of NASH include reduced ability to handle lipids, increased insulin resistance, injury to hepatocytes and liver fibrosis in response to hepatocyte injury. NASH patients have an excessive accumulation of fat in the liver resulting primarily from a caloric intake above and beyond energy needs. A healthy liver contains less than 5% fat, but a liver in someone with NASH can contain more than 20% fat. This abnormal liver fat contributes to the progression to NASH, a liver necro-inflammatory state, that can lead to scarring, also known as fibrosis, and, for some, can progress to cirrhosis and liver failure&#x2014;cirrhosis develops in approximately 20% to 45% of patients. In some cases, cirrhosis progresses to decompensated cirrhosis, which results in permanent liver damage that can lead to liver failure. In addition, it is estimated that 8% of patients with advanced fibrosis will develop HCC. NASH is a complex, multifaceted disease that doesn&#x2019;t just affect the liver. Patients with NASH frequently have other significant metabolic co-morbidities such as obesity, hyperglycemia, dyslipidemia and systemic hypertension (a constellation of which is commonly referred to as metabolic syndrome) and these further contribute to the risk of cardiovascular disease.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Disease Overview - SHTG</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We are also developing pegozafermin for the treatment of SHTG. Hypertriglyceridemia (&#x201c;HTG&#x201d;) is characterized by elevated fasting plasma triglyceride levels &gt; 200 mg/dL and SHTG is typically defined as triglyceride levels of &#x2265; 500 mg/dL. SHTG is associated with an increased risk of NAFLD, NASH and cardiovascular diseases, as well as acute pancreatitis, accounting for up to 10% of all acute pancreatitis episodes. A third-party study utilizing an omega-3 fatty acid (&#x201c;omega-3 FA&#x201d;) demonstrated the linkage between a reduction in triglycerides and favorable cardiovascular clinical outcomes.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">It is estimated that there are 4 million patients in the United States with triglyceride levels of &#x2265; 500 mg/dL of which approximately 800,000 patients are inadequately treated with existing therapies and are thereby at increased risk for acute pancreatitis and atherosclerotic cardiovascular events. Of these patients, it is estimated that up to 100% have clinically meaningful hepatic fat using magnetic resonance imaging &#x2013; proton density fat factor (&#x201c;MRI-PDFF&#x201d;) &#x2265; 5%; baseline data from the sub-study in ENTRIGUE; n=24), up to 70% have Type 2 diabetes, and up to 65% have high LDL. This patient population is expected to increase due to the triple epidemic of obesity, metabolic syndrome and Type 2 diabetes. In addition, the addressable market has the potential to expand as a result of increasing awareness of the importance of treating elevated triglyceride levels, similar to the focus today of physicians on managing LDL levels, as well as the commercial efforts of other companies that are expected to promote triglyceride reduction.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">7</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The treatment regimen for SHTG includes dietary restrictions and lipid-lowering drug treatment such as fibrates, omega-3 fish oils and niacin. Some statins are indicated in HTG but do not have an indication for use in SHTG. Despite multiple agents approved for the treatment of SHTG, these agents have limitations that may not make them ideal for all patients. In third-party studies, up to 50% of treated SHTG patients were unable to reduce their triglyceride levels to &lt; 500 mg/dL despite using approved drugs and are considered refractory patients. These refractory patients have substantial unmet medical need and represent a significant market opportunity for pegozafermin as an add-on therapy along with the opportunity for pegozafermin to be used in patients not on any background therapy. Given the continuing unmet need in SHTG and limitations of current treatments, there are other novel agents in development for the treatment of SHTG, including ANGPTL3 and APOC3 inhibitors.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Diagnosis</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Most people with NASH are asymptomatic and their disease is often discovered incidentally following a liver imaging procedure, such as an ultrasound, prescribed for other reasons or as part of an investigation for elevated liver enzymes. Once suspected clinically, a liver biopsy is required to definitively diagnose NASH, which necessitates the joint presence of steatosis, ballooning and lobular inflammation. Once pathologically confirmed, the severity of NAFLD and NASH is determined using the histologically validated NAS, which grades disease activity on a scale of 0 to 8. The NAS is the sum of the individual scores for steatosis (0 to 3), lobular inflammation (0 to 3), and hepatocellular ballooning (0 to 2) but does not include a score for fibrosis. Fibrosis staging (F0-F4) relies on the Kleiner classification (F0 = no fibrosis; F1 = perisinusoidal or periportal fibrosis (not both); F2 = both perisinusoidal and periportal fibrosis; F3 = bridging fibrosis; F4 = cirrhosis).</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Histological diagnosis remains the gold standard for assessment of NASH and fibrosis. However, given that liver biopsy is associated with risks of pain, bleeding and other morbidity, as well as significant cost, the procedure is not practical for general patient screening. Additionally, histology diagnosis is confounded by evaluation of a small sliver of a large heterogenous organ that may not represent the full organ, and significant variability in reading of slides including inter- and intra-reader variability. Several non-invasive tools such as clinical risk scores, serum markers and imaging techniques are increasingly used to assess NASH patients. Non-invasive tests (&#x201c;NITs&#x201d;) such as the Fibroscan-AST (&#x201c;FAST&#x201d;) score, Fibrosis-4 index, the Enhanced Liver Fibrosis score and vibration-controlled transient elastography, (&#x201c;VCTE&#x201d;), have been validated and are increasingly used. These NITs have an excellent negative predictive value and an acceptable positive predictive value for detection of advanced (&#x2265; F3) fibrosis and are increasingly used in clinical settings. Additionally, evidence is emerging that shows a correlation between reduction in steatosis as measured by MRI-PDFF and reduction in ALT &#x2265;17 U/L and histologic improvement on liver biopsy. In draft guidance, the FDA encouraged sponsors to identify biochemical or noninvasive imaging biomarkers that, once characterized and agreed by the FDA, could replace liver biopsies for patient selection and efficacy assessment in clinical trials.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We expect that the validation and subsequent adoption of these NITs will result in an increase in the diagnosis and treatment rates for NASH in the future.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">FGF21 Overview</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Fibroblast growth factors (&#x201c;FGFs&#x201d;), including FGF21 and FGF19, are a large family of cell-signaling proteins involved in the regulation of many processes within the body. FGF21 is an endogenous metabolic hormone that regulates energy homeostasis, glucose-lipid-protein metabolism and insulin sensitivity, and modulates the pathways that mitigate against intracellular stress. FGF21 is secreted primarily by the liver but is also secreted by the white adipose tissue (&#x201c;WAT&#x201d;), skeletal muscle and the pancreas. FGF21 exerts its biological benefits through the activation of three fibroblast growth factor receptors (&#x201c;FGFRs&#x201d;), FGFR1c, FGFR2c and FGFR3c, and requires co-activation of the transmembrane protein cofactor beta Klotho (&#x201c;&#xdf;-Klotho&#x201d;). FGF21 is not believed to activate FGFR4, which has been associated with adverse effects. FGF21 can act directly or indirectly on target organs by mediating downstream regulators, such as adiponectin, and upstream regulators that induce FGF21, such as nutritional stress or transcription factors.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">8</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Biological Effects of FGF21:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Reducing Liver Steatosis by Improving Lipid Handling and Insulin Sensitivity</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">FGF21 has been clinically shown to reduce liver steatosis. FGF21 reduces liver steatosis by (1) increasing fatty acid oxidation in the liver, (2) reducing the deposition of free fatty acids from peripheral tissue to the liver and (3) reducing DNL in the liver. FGF21 exerts its systemic effects by reducing the serum levels of lipids (e.g., triglycerides, LDL cholesterol) and increasing insulin sensitivity. Increasing insulin sensitivity reduces lipolysis and can also reduce serum levels of lipids. In particular, FGF21 has been demonstrated to reduce liver fat in patients with NASH in multiple clinical trials.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Improving Liver Inflammation and Fibrosis</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">FGF21 is also believed to reduce liver fibrosis, the pathological change most clearly linked to liver-related morbidity in NASH patients via two potential pathways. One pathway is through the metabolic benefits of FGF21 described above. Long-term improvements in metabolic regulation reduce the ongoing liver injury that drives fibrosis and thus allows the liver time to heal. The other pathway is a direct anti-fibrotic effect mediated via adiponectin, an adipokine that is upregulated by FGF21. Increased adiponectin downregulates the hepatic stellate cells that are activated upon hepatic injury and responsible for collagen deposition and subsequent fibrosis. FGF21 demonstrated an improvement in liver fibrosis in patients in NASH in a clinical trial.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">FGF21 Signaling</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As noted above, FGF21 exerts its biological benefits through the co-activation of FGFRs and &#xdf;-Klotho. FGFRs are expressed widely throughout the body whereas &#xdf;-Klotho is primarily expressed in metabolic tissues such as adipose tissue, liver, and pancreas, thereby providing organ specificity to FGF21. The binding of FGF21 is a two-step process. The C-terminus of FGF21 initially binds to &#xdf;-Klotho enabling the N-terminus to form an expanded complex with one of the FGFRs. Once the co-receptor complex has formed with &#xdf;</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">-</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Klotho and one of the FGFRs, a series of intracellular signaling cascades is initiated. These signaling cascades enable FGF21 to exert its biological functions.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">FGF21 activates three specific FGFRs (FGFR1c, FGFR2c and FGFR3c), which based on nonclinical studies and clinical trials, appear to be responsible for mediating the desired therapeutic actions of FGF21 in NASH. FGF21 is not believed to activate FGFR4. Activation of FGFR4 results in an increase in LDL cholesterol and has been implicated in the etiology or progression of HCC.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Pegozafermin</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Overview</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We are developing pegozafermin, a specifically engineered glycoPEGylated analog of FGF21, for the treatment of NASH and SHTG. Pegozafermin has been specifically engineered to retain the activity of native FGF21 while extending its half-life. Specifically, it has been engineered to: (1) protect against proteolysis and reduce renal clearance, (2) have an extended half-life, (3) minimize susceptibility to aggregate in solution and (4) optimize its potency, enabling the potential use of lower dosage/doses. Additionally, we believe that pegozafermin may enhance binding affinity for &#xdf;-Klotho, by altering the conformation of the C-terminus which could have a positive impact on efficacy.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">9</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Primary Structure and Protein Engineering of Pegozafermin</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Pegozafermin has been optimally constructed with two mutations via substitutions with natural amino acids at site-specific positions (173 and 176) toward the C-terminus end of the hormone. The mutations were incorporated into the FGF21 sequence after existing proline to create a consensus sequence for glycosylation. Subsequently, the glycosyl linker and a single 20 kDa glycoPEG moiety were enzymatically introduced at the O-linked glycosylation consensus site (position 173) via the proprietary glycoPEGylation technology. Our glycoPEG moiety is an activated form of the PEG molecule with the use of Sialic Acid, CMP-SA-PEG. The proximity of the mutations ensures consistent and efficient attachment of the glycoPEG moiety.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Pegozafermin has two modified natural amino acid residues:</span></p>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">S173T: Serine modified to Threonine at position 173; and</span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">R176A: Arginine modified to Alanine at position 176.</span></div></div>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In addition, a Methionine residue was introduced at the N-terminus which acts as the translation initiation signal. Figure 1 below shows the structure of pegozafermin.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Figure 1: Structure of Pegozafermin</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><img src="img32108071_0.jpg" alt="img32108071_0.jpg" style="width:554px;height:231px;" />&#160;</p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:2.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The increase in the size of the molecule from 19.4 kDa to 40 kDa together with the site-specific mutations adjacent to the primary cleavage site of FGF21 (by the FAP enzyme between positions 171 and 172 on the native amino acid chain, which would be represented by positions 172 and 173 in our molecule starting with Methionine in position 1) are designed to prolong the half-life of the molecule. Additionally, we believe that the use of glycoPEGylation technology produces a comparatively stronger and more flexible structure, which aids in the development of a stable formulation. PEGylation technology has been used successfully in many pharmaceutical products including products that have been marketed for more than 10 years. Similar moles of FGF21 are delivered with pegozafermin 30mg and efruxifermin 50mg.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Pegozafermin uses a proprietary glycoPEGylation technology that has been previously validated by a third party, as this technology is incorporated in another pharmaceutical product (Lonquex&#174; by Teva) that has received regulatory approval and is currently commercialized in the European Union.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Figure 2: Summary of Pegozafermin Attributes and Benefits</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:22.0%;"></td>
    <td style="width:48.642%;"></td>
    <td style="width:29.358%;"></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="border-top:0.5pt solid rgba(35,31,32,1);background-color:rgba(50,151,211,1);border-right:0.5pt solid rgba(35,31,32,1);text-indent:28.3pt;word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid rgba(35,31,32,1);vertical-align:top;text-align:left;"><p style="margin-left:28.3pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.15pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(255,255,255,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Features</span></p></td>
    <td style="border-top:0.5pt solid rgba(35,31,32,1);background-color:rgba(50,151,211,1);border-right:0.5pt solid rgba(35,31,32,1);text-indent:0.4pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(35,31,32,1);text-align:left;"><p style="margin-left:0.4pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.15pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(255,255,255,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Description</span></p></td>
    <td style="border-top:0.5pt solid rgba(35,31,32,1);background-color:rgba(50,151,211,1);border-right:0.5pt solid rgba(35,31,32,1);text-indent:34.25pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(35,31,32,1);text-align:left;"><p style="margin-left:34.25pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.15pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(255,255,255,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Potential Benefit</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td rowspan="3" style="background-color:rgba(0,0,0,0);border-right:0.5pt solid rgba(35,31,32,1);text-indent:4.5pt;word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid rgba(35,31,32,1);vertical-align:top;"><p style="margin-left:4.5pt;text-indent:0.0pt;font-size:10.0pt;margin-top:2.65pt;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:0.30763888888888885in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Use of PEG (via glycoPEGylation)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid rgba(35,31,32,1);text-indent:48.95pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(35,31,32,1);"><div style="margin-left:0.33958333333333335in;text-indent:0.0pt;display:flex;margin-top:0.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.552459393356607%;">&#x25aa;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Increases protein size and hydrodynamic volume that reduces renal filtration </span><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></div></div><div style="margin-left:0.33958333333333335in;text-indent:0.0pt;display:flex;margin-top:0.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.552459393356607%;">&#x25aa;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Prevents degradation by endocytosis and proteolytic enzymes</span></div></div></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid rgba(35,31,32,1);text-indent:48.95pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(35,31,32,1);"><div style="margin-left:0.33958333333333335in;text-indent:0.0pt;display:flex;margin-top:0.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.552459393356607%;">&#x25aa;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Prolongs half-life</span></div></div></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid rgba(35,31,32,1);text-indent:48.95pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(35,31,32,1);"><div style="margin-left:0.33958333333333335in;text-indent:0.0pt;display:flex;margin-top:0.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.552459393356607%;">&#x25aa;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Protects antigenic sites present on the protein surface (i.e. antigenic epitopes)</span></div></div></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid rgba(35,31,32,1);text-indent:48.95pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(35,31,32,1);"><div style="margin-left:0.33958333333333335in;text-indent:0.0pt;display:flex;margin-top:0.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.552459393356607%;">&#x25aa;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Reduces immunogenicity</span></div></div></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid rgba(35,31,32,1);text-indent:48.95pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(35,31,32,1);"><div style="margin-left:0.33958333333333335in;text-indent:0.0pt;display:flex;margin-top:0.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.552459393356607%;">&#x25aa;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Steric repulsion between the PEGylated surfaces increases water solubility and reduces aggregates</span></div></div></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid rgba(35,31,32,1);text-indent:48.95pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(35,31,32,1);"><div style="margin-left:0.33958333333333335in;text-indent:0.0pt;display:flex;margin-top:0.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.552459393356607%;">&#x25aa;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Results in more stable formulation</span></div></div></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="border-top:0.5pt solid rgba(35,31,32,1);background-color:rgba(0,0,0,0);border-right:0.5pt solid rgba(35,31,32,1);text-indent:4.5pt;word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid rgba(35,31,32,1);vertical-align:top;border-bottom:0.5pt solid rgba(35,31,32,1);"><p style="margin-left:4.5pt;text-indent:0.0pt;font-size:10.0pt;margin-top:2.15pt;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:0.5930555555555556in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Site-Specific Mutations</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid rgba(35,31,32,1);text-indent:48.95pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(35,31,32,1);"><div style="margin-left:0.33958333333333335in;text-indent:0.0pt;display:flex;margin-top:0.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.552459393356607%;">&#x25aa;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Mutation at position 173 is immediately adjacent to the primary cleavage (FAP enzyme) site of FGF21</span></div></div></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid rgba(35,31,32,1);text-indent:48.95pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(35,31,32,1);"><div style="margin-left:0.33958333333333335in;text-indent:0.0pt;display:flex;margin-top:0.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.552459393356607%;">&#x25aa;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Prolongs half-life</span></div></div></td>
   </tr>
   <tr style="height:10.0pt;">
    <td rowspan="2" style="background-color:rgba(0,0,0,0);border-right:0.5pt solid rgba(35,31,32,1);text-indent:4.5pt;word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid rgba(35,31,32,1);vertical-align:top;border-bottom:0.5pt solid;"><p style="margin-left:4.5pt;text-indent:0.0pt;font-size:10.0pt;margin-top:2.65pt;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:0.3229166666666667in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">GlycoPEGylation Technology</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid rgba(35,31,32,1);text-indent:48.95pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(35,31,32,1);"><div style="margin-left:0.33958333333333335in;text-indent:0.0pt;display:flex;margin-top:0.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.552459393356607%;">&#x25aa;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Allows site specific linkage (glycoPEG moiety to position 173)</span></div></div><div style="margin-left:0.33958333333333335in;text-indent:0.0pt;display:flex;margin-top:0.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.552459393356607%;">&#x25aa;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Proximity of the glycoPEG moiety to the C-terminus induces conformational changes to the molecule</span></div></div></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid rgba(35,31,32,1);text-indent:48.95pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(35,31,32,1);"><div style="margin-left:0.33958333333333335in;text-indent:0.0pt;display:flex;margin-top:0.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.552459393356607%;">&#x25aa;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Retains potency against receptor to improve efficacy</span></div></div></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid rgba(35,31,32,1);text-indent:48.95pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(35,31,32,1);"><div style="margin-left:0.33958333333333335in;text-indent:0.0pt;display:flex;margin-top:0.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.552459393356607%;">&#x25aa;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Provides a strong and flexible glycosyl bond that helps the glycoPEG moiety to remain intact, further reducing degradation</span></div></div></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid rgba(35,31,32,1);text-indent:48.95pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(35,31,32,1);"><div style="margin-left:0.33958333333333335in;text-indent:0.0pt;display:flex;margin-top:0.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.3402777777777778in;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.552459393356607%;">&#x25aa;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Further enhances half-life</span></div></div></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:8.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Therapeutic Potential of Pegozafermin Supported by Preclinical Animal Models of NASH, Diabetes and Obesity</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Pegozafermin has been evaluated in three animal models of direct relevance to NASH. These included: (1) Stelic Animal Model, (&#x201c;STAM&#x201d;), (2) Diet-induced NASH (&#x201c;DIN&#x201d;) model and (3) spontaneous diabetic obese cynomolgus monkey model. Additional studies done in diabetes mouse model and diet induced obesity mouse model showed benefits in key markers of relevance in NASH.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">A wide range of doses were tested in these studies as well as weekly and once every two-week dosing regimen was tested in a cynomolgus monkey study. The key outcomes of these studies are summarized in Figure 3 below.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Figure 3: Summary of NASH Pharmacology Studies</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:31.027%;"></td>
    <td style="width:11.497%;"></td>
    <td style="width:14.396%;"></td>
    <td style="width:13.401%;"></td>
    <td style="width:17.262%;"></td>
    <td style="width:12.417%;"></td>
   </tr>
   <tr style="height:37.45pt;">
    <td style="border-top:0.5pt solid rgba(35,31,32,1);background-color:rgba(50,151,211,1);border-right:0.5pt solid rgba(35,31,32,1);word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid rgba(35,31,32,1);vertical-align:middle;border-bottom:0.5pt solid rgba(35,31,32,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(255,255,255,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Preclinical pharmacology study with</span></p><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(255,255,255,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">pegozafermin</span></p></td>
    <td style="border-top:0.5pt solid rgba(35,31,32,1);background-color:rgba(50,151,211,1);border-right:0.5pt solid rgba(35,31,32,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid rgba(35,31,32,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(255,255,255,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Improved</span></p><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(255,255,255,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Insulin</span></p><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(255,255,255,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Sensitivity</span></p></td>
    <td style="border-top:0.5pt solid rgba(35,31,32,1);background-color:rgba(50,151,211,1);border-right:0.5pt solid rgba(35,31,32,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid rgba(35,31,32,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(255,255,255,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Improved Triglycerides and Cholesterol</span></p></td>
    <td style="border-top:0.5pt solid rgba(35,31,32,1);background-color:rgba(50,151,211,1);border-right:0.5pt solid rgba(35,31,32,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid rgba(35,31,32,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(255,255,255,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Reduced</span></p><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(255,255,255,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Hepatocyte</span></p><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(255,255,255,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Injury</span></p></td>
    <td style="border-top:0.5pt solid rgba(35,31,32,1);background-color:rgba(50,151,211,1);border-right:0.5pt solid rgba(35,31,32,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid rgba(35,31,32,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(255,255,255,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Reduced Liver Steatosis, Inflammation &amp;</span><span style="color:rgba(255,255,255,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(255,255,255,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Fibrosis</span></p></td>
    <td style="border-top:0.5pt solid rgba(35,31,32,1);background-color:rgba(50,151,211,1);border-right:0.5pt solid rgba(35,31,32,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid rgba(35,31,32,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(255,255,255,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Body</span></p><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(255,255,255,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Weight</span></p><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(255,255,255,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Reduction</span></p></td>
   </tr>
   <tr style="height:18.0pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid rgba(35,31,32,1);word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid rgba(35,31,32,1);vertical-align:middle;border-bottom:0.5pt solid rgba(35,31,32,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:2.0pt;font-family:Times New Roman;margin-bottom:2.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">DIN mouse model I (10 weeks)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid rgba(35,31,32,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid rgba(35,31,32,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:2.0pt;font-family:Times New Roman;margin-bottom:2.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Segoe UI Symbol&quot;, sans-serif;min-width:fit-content;">&#x2713;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid rgba(35,31,32,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid rgba(35,31,32,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:2.0pt;font-family:Times New Roman;margin-bottom:2.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Segoe UI Symbol&quot;, sans-serif;min-width:fit-content;">&#x2713;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid rgba(35,31,32,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid rgba(35,31,32,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:2.0pt;font-family:Times New Roman;margin-bottom:2.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Segoe UI Symbol&quot;, sans-serif;min-width:fit-content;">&#x2713;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid rgba(35,31,32,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid rgba(35,31,32,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:2.0pt;font-family:Times New Roman;margin-bottom:2.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Segoe UI Symbol&quot;, sans-serif;min-width:fit-content;">&#x2713;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid rgba(35,31,32,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid rgba(35,31,32,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:2.0pt;font-family:Times New Roman;margin-bottom:2.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Segoe UI Symbol&quot;, sans-serif;min-width:fit-content;">&#x2713;</span></p></td>
   </tr>
   <tr style="height:18.0pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid rgba(35,31,32,1);word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid rgba(35,31,32,1);vertical-align:middle;border-bottom:0.5pt solid rgba(35,31,32,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:2.0pt;font-family:Times New Roman;margin-bottom:2.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">DIN mouse model II (19 weeks)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid rgba(35,31,32,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid rgba(35,31,32,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:2.0pt;font-family:Times New Roman;margin-bottom:2.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Segoe UI Symbol&quot;, sans-serif;min-width:fit-content;">&#x2713;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid rgba(35,31,32,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid rgba(35,31,32,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:2.0pt;font-family:Times New Roman;margin-bottom:2.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Segoe UI Symbol&quot;, sans-serif;min-width:fit-content;">&#x2713;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid rgba(35,31,32,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid rgba(35,31,32,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:2.0pt;font-family:Times New Roman;margin-bottom:2.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Segoe UI Symbol&quot;, sans-serif;min-width:fit-content;">&#x2713;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid rgba(35,31,32,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid rgba(35,31,32,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:2.0pt;font-family:Times New Roman;margin-bottom:2.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Segoe UI Symbol&quot;, sans-serif;min-width:fit-content;">&#x2713;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid rgba(35,31,32,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid rgba(35,31,32,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:2.0pt;font-family:Times New Roman;margin-bottom:2.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Segoe UI Symbol&quot;, sans-serif;min-width:fit-content;">&#x2713;</span></p></td>
   </tr>
   <tr style="height:28.8pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid rgba(35,31,32,1);word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid rgba(35,31,32,1);vertical-align:middle;border-bottom:0.5pt solid rgba(35,31,32,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:2.0pt;font-family:Times New Roman;margin-bottom:2.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Diabetic obese cynomolgus monkey study 1 (8 weeks; weekly dosing)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid rgba(35,31,32,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid rgba(35,31,32,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:2.0pt;font-family:Times New Roman;margin-bottom:2.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Segoe UI Symbol&quot;, sans-serif;min-width:fit-content;">&#x2713;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid rgba(35,31,32,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid rgba(35,31,32,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:2.0pt;font-family:Times New Roman;margin-bottom:2.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Segoe UI Symbol&quot;, sans-serif;min-width:fit-content;">&#x2713;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid rgba(35,31,32,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid rgba(35,31,32,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:2.0pt;font-family:Times New Roman;margin-bottom:2.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Segoe UI Symbol&quot;, sans-serif;min-width:fit-content;">&#x2713;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid rgba(35,31,32,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid rgba(35,31,32,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:2.0pt;font-family:Times New Roman;margin-bottom:2.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Not evaluated</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid rgba(35,31,32,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid rgba(35,31,32,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:2.0pt;font-family:Times New Roman;margin-bottom:2.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Segoe UI Symbol&quot;, sans-serif;min-width:fit-content;">&#x2713;</span></p></td>
   </tr>
   <tr style="height:28.8pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid rgba(35,31,32,1);word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid rgba(35,31,32,1);vertical-align:middle;border-bottom:0.5pt solid rgba(35,31,32,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:2.0pt;font-family:Times New Roman;margin-bottom:2.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Diabetic obese cynomolgus monkey study 2 (4 weeks; QW or Q2W dosing)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid rgba(35,31,32,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid rgba(35,31,32,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:2.0pt;font-family:Times New Roman;margin-bottom:2.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Segoe UI Symbol&quot;, sans-serif;min-width:fit-content;">&#x2713;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid rgba(35,31,32,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid rgba(35,31,32,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:2.0pt;font-family:Times New Roman;margin-bottom:2.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Segoe UI Symbol&quot;, sans-serif;min-width:fit-content;">&#x2713;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid rgba(35,31,32,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid rgba(35,31,32,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:2.0pt;font-family:Times New Roman;margin-bottom:2.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Segoe UI Symbol&quot;, sans-serif;min-width:fit-content;">&#x2713;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid rgba(35,31,32,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid rgba(35,31,32,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:2.0pt;font-family:Times New Roman;margin-bottom:2.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Not evaluated</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid rgba(35,31,32,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid rgba(35,31,32,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:2.0pt;font-family:Times New Roman;margin-bottom:2.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Segoe UI Symbol&quot;, sans-serif;min-width:fit-content;">&#x2713;</span></p></td>
   </tr>
  </table>
  <div style="margin-left:4.537%;text-indent:0.0%;margin-top:0.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:5.246527777777779%;">&#x2713;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Statistically significant benefit observed.</span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">11</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Pegozafermin Clinical Development in NASH</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Phase 1a Clinical Trial of Single-Dose of Pegozafermin in Healthy Volunteers</span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:2.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:4.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We conducted a Phase 1a clinical trial to evaluate the safety, tolerability and pharmacokinetics (&#x201c;PK&#x201d;) of pegozafermin in 58 healthy volunteers. In this randomized, double-blind, placebo-controlled, Phase 1a, first-in-human, SAD clinical trial the PK profile of pegozafermin was generally dose-proportional or slightly more than dose-proportional with a half-life of approximately 55 to 100 hours. At single doses of 9.1 mg and higher, significant improvements were observed in key lipid parameters measured at Day 8 and Day 15 after dosing on Day 1. The mean changes versus baseline include significant reductions in triglycerides (up to 51%) and LDL-C (up to 37%) and increase in HDL-C (up to 36%) despite the baseline values being in the normal range. Pegozafermin demonstrated rapid (starting from Day 2), sustained and durable improvements on lipid parameters for two weeks or more after single-dose administration. Pegozafermin was well tolerated across the dose range and there were no deaths, serious adverse events or discontinuations due to adverse events. The most commonly observed treatment-related adverse events, occurring in at least two subjects in the pooled pegozafermin group, were injection site reactions and headache, all of which were reported as mild. No clinically meaningful trends were observed in gastrointestinal events, laboratories or vital signs including blood pressure or heart rate changes.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Phase 1b/2a Proof of Concept Clinical Trial in NASH Patients</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In 2020 and 2022, we presented positive topline results from cohorts 1 to 6 and cohort 7, respectively, in our Phase 1b/2a trial in NASH patients which has informed the advancement of our clinical strategy in NASH. The Phase 1b/2a trial for cohorts 1 to 6 was multicenter, randomized, double-blind, placebo-controlled, multiple ascending dose-ranging and enrolled a total of 81 patients to receive weekly (3 mg/9 mg/18 mg/27 mg) or every two-week (18 mg/36 mg) dosing of pegozafermin or placebo for up to 12 weeks. Key endpoints assessed were safety, tolerability, and PK of pegozafermin as well as change in liver fat measured by MRI-PDFF and other metabolic markers. Cohort 7 was an open label cohort that enrolled 20 patients who received weekly dosing of pegozafermin at 27 mg for 20 weeks. Key endpoints assessed were changes in histology from baseline, liver fat changes from baseline and safety and tolerability. The trial design is shown in Figure 4 below.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Figure 4: Phase 1b/2a Trial Design</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><img src="img32108071_1.jpg" alt="img32108071_1.jpg" style="width:624px;height:156px;" />&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:2.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As shown in Figure 5 below, all dose groups in cohorts 1 to 6 demonstrated significant reductions in liver fat at week 13, with relative reductions up to 60% versus baseline and up to 70% versus placebo, as measured by MRI-PDFF. 43% of the patients at the highest dose achieved normal liver fat content of &lt; 5%. A significant proportion of patients responded to therapy with up to 88% and 71% of patients achieving a &#x2265; 30% or a &#x2265; 50% reduction in liver fat versus baseline, respectively.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">12</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Figure 5: Relative Reduction in Liver Fat vs. Placebo at Week 13</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><img src="img32108071_2.jpg" alt="img32108071_2.jpg" style="width:470px;height:307px;" />&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><img src="img32108071_3.jpg" alt="img32108071_3.jpg" style="width:620px;height:25px;" />&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:2.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As shown in Figure 6 below for cohorts 1 to 6, treatment with pegozafermin also resulted in significant improvements in liver transaminases, with up to a 44% reduction in ALT and a 35 U/L decrease in ALT in patients with elevated baseline levels. Treatment with pegozafermin resulted in significant reductions in triglycerides (up to 28%; p&lt;0.05), non-HDL (up to 16%; p&lt;0.01) and LDL-C (up to 16%; p&lt;0.05). Triglycerides were reduced to a greater extent in patients with elevated triglycerides at baseline (TG &#x2265; 200 mg/dL), and 53% of the pegozafermin patients in this group normalized triglyceride levels versus 0% in the placebo group. Pegozafermin also demonstrated significant increases in the insulin-sensitizing hormone adiponectin (up to 61%; p&lt;0.001). Improvements were also noted across the spectrum of metabolic marker data vs. placebo for the 27 mg QW dose group including HOMA-IR, glucose, HbA1c, and body weight (p&lt;0.05).</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">13</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Figure 6: Clinically Meaningful ALT Reduction; Greater Reduction in Patients with High ALT</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><img src="img32108071_4.jpg" alt="img32108071_4.jpg" style="width:624px;height:322px;" />&#160;</p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Additional analyses demonstrated that pegozafermin treatment resulted in significant reductions in liver volume of up to 15% and liver fat volume of up to 65% in treated patients at 13 weeks compared to baseline, as measured by MRI-PDFF. A post-hoc analysis presented at The Liver Meeting of AASLD in November 2021 assessed the effect of pegozafermin on spleen volume (SV) in NASH patients without advanced fibrosis. SV was evaluated by MRI in all eligible patients on pegozafermin 27 mg every week dose (n=8), pegozafermin 36 mg every two-week dose (n=8) and 16 patients on placebo. At baseline, it was observed that SV was correlated with liver volume, vibration-controlled transient elastography (VCTE) score and body mass index (BMI), and negatively correlated with platelet count. Findings at study Day 50 and Day 92 demonstrated that treatment with pegozafermin led to a progressive and significant decrease in SV compared to placebo (on Day 50, treated patients saw an average 7.4% decrease in SV and by Day 92 patients saw an average 11.8% decrease in SV).</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Paired-biopsy, Open-label Histology Cohort (Cohort 7)</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Cohort 7 in the Phase 1b/2a trial was a single-arm cohort that enrolled 20 patients with biopsy-confirmed fibrosis stage F2 and F3 NASH who were treated once weekly for 20 weeks with 27 mg of pegozafermin. 19 of 20 patents received an end of treatment biopsy and one patient withdrew consent. A greater than or equal to 2-point improvement in NAS (with 1-point from either ballooning or inflammation) and no worsening of fibrosis was the nominal primary endpoint. Key secondary endpoints included response rates on NASH resolution without worsening of fibrosis, improvement in at least one stage of fibrosis without worsening NAS and safety/tolerability. Patients had a mean BMI of 37 and type 2 diabetes was prevalent in most patients. 65% had fibrosis stage F3 NASH and 35% had fibrosis stage F2 NASH. The baseline values for VCTE, ProC3, and transaminases were consistent with a more advanced population.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">74% of patients achieved a greater than or equal to 2-point improvement in NAS with at least a 1-point improvement in ballooning or inflammation. Substantial reductions were observed across all 3 NAS components (&#x2265;1 point change) &#x2013; ballooning (79%), inflammation (47%), and steatosis (74%). All patients had improvement or no change in ballooning and inflammation. The histology results demonstrate proof-of-concept for the translation of pegozafermin&#x2019;s effects on liver fat, ALT, and other relevant non-invasive measures into histological improvement.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">14</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Figure 7: Histology Results</span></p>
  <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:74.021%;"></td>
    <td style="width:25.979%;"></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="border-top:0.5pt solid;background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2265;2-point improvement in NAS without worsening of fibrosis</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);top:-4.6899999999999995pt;white-space:pre-wrap;font-weight:normal;font-size:6.7pt;font-family:&quot;Times New Roman&quot;, serif;position:relative;min-width:fit-content;">1</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;(primary endpoint)</span></p></td>
    <td style="border-top:0.5pt solid;background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">63%</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2265;2-point improvement in NAS</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);top:-4.6899999999999995pt;white-space:pre-wrap;font-weight:normal;font-size:6.7pt;font-family:&quot;Times New Roman&quot;, serif;position:relative;min-width:fit-content;">1</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">74%</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">NASH resolution without worsening of fibrosis</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">32%; 95% CI: 13%-57%</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">One-stage improvement of fibrosis without worsening of NASH</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">26%; 95% CI:   9%-51%</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">NASH resolution or fibrosis improvement</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">47%</span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">NAS = NAFLD Activity Score</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;vertical-align:super;font-size:5.36pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">A 2-point improvement in NAS score required a 1-point improvement in either ballooning or inflammation</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Data from a new analysis of the same histology slides by a panel of an additional three expert liver pathologists resulted in a wide range of response rates, with rates of NASH resolution without worsening of fibrosis up to 47% (range: 26%-47%) and rates of &#x2265; 1-stage improvement in fibrosis without worsening of NASH up to 42% (range: 12%-42%). This three-reader panel scored six of the nineteen patients as having F4 fibrosis at baseline (putative F4), which was an exclusion criterion for the Phase 1b/2a trial. Excluding the putative F4 patients (n=6) resulted in a higher proportion of patients meeting the registration enabling histological endpoints compared to the primary analysis based on the single central reader, as shown in Figure 8 below.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Figure 8: New Analysis of Cohort 7 Histology Slides By a Panel of Three Experts</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><img src="img32108071_5.jpg" alt="img32108071_5.jpg" style="width:624px;height:315px;" />&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">15</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Pegozafermin also demonstrated beneficial effects in the subset of patients with F4 stage fibrosis as shown in Figure 9 below.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Figure 9: Pegozafermin Effects in Fibrosis Stage F4 Patients</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><img src="img32108071_6.jpg" alt="img32108071_6.jpg" style="width:624px;height:308px;" />&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">To assess pegozafermin&#x2019;s effect on the whole liver, a number of NITs including imaging, serum biomarkers, and risk stratification scores were built into the study. Clinically meaningful and significant changes were observed across these key NITs associated with fibrosis, risk of fibrosis, or NASH resolution. The consistency of data across all these endpoints and the magnitude of changes observed in these NITs suggest that pegozafermin is improving total liver health.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Figure 10: Non-Invasive Tests (NITs) [marker of]</span></p>
  <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:46.0%;"></td>
    <td style="width:23.219%;"></td>
    <td style="width:30.781%;"></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="border-top:0.5pt solid;background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;"><p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:11.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="border-top:0.5pt solid;background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Mean change from baseline at Week 20</span></p></td>
    <td style="border-top:0.5pt solid;background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Responder rates by clinically relevant thresholds</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">MRI-PDFF [liver fat content]</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);top:-4.6899999999999995pt;white-space:pre-wrap;font-weight:normal;font-size:6.7pt;font-family:&quot;Times New Roman&quot;, serif;position:relative;min-width:fit-content;">1</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">-64%</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);top:-4.6899999999999995pt;white-space:pre-wrap;font-weight:normal;font-size:6.7pt;font-family:&quot;Times New Roman&quot;, serif;position:relative;min-width:fit-content;">***</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">100%/78%  [&#x2265; 30%/&#x2265; 50%]</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">ALT (Alanine aminotransferase) [liver damage]</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);top:-4.6899999999999995pt;white-space:pre-wrap;font-weight:normal;font-size:6.7pt;font-family:&quot;Times New Roman&quot;, serif;position:relative;min-width:fit-content;">2</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">-46%</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);top:-4.6899999999999995pt;white-space:pre-wrap;font-weight:normal;font-size:6.7pt;font-family:&quot;Times New Roman&quot;, serif;position:relative;min-width:fit-content;">***</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;71%</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);top:-4.6899999999999995pt;white-space:pre-wrap;font-weight:normal;font-size:6.7pt;font-family:&quot;Times New Roman&quot;, serif;position:relative;min-width:fit-content;">3</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;[&#x2265; 17 U/L]</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">FAST Score [risk for advanced fibrosis]</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);top:-4.6899999999999995pt;white-space:pre-wrap;font-weight:normal;font-size:6.7pt;font-family:&quot;Times New Roman&quot;, serif;position:relative;min-width:fit-content;">4</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">-76%</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);top:-4.6899999999999995pt;white-space:pre-wrap;font-weight:normal;font-size:6.7pt;font-family:&quot;Times New Roman&quot;, serif;position:relative;min-width:fit-content;">***</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;88%  [&#x2264; 0.35]</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">VCTE [liver stiffness]</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);top:-4.6899999999999995pt;white-space:pre-wrap;font-weight:normal;font-size:6.7pt;font-family:&quot;Times New Roman&quot;, serif;position:relative;min-width:fit-content;">5</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">-31%</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);top:-4.6899999999999995pt;white-space:pre-wrap;font-weight:normal;font-size:6.7pt;font-family:&quot;Times New Roman&quot;, serif;position:relative;min-width:fit-content;">***</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;72%  [&gt; 20% decrease]</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Pro-C3 [collagen deposition]</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);top:-4.6899999999999995pt;white-space:pre-wrap;font-weight:normal;font-size:6.7pt;font-family:&quot;Times New Roman&quot;, serif;position:relative;min-width:fit-content;">6</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">-20%</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);top:-4.6899999999999995pt;white-space:pre-wrap;font-weight:normal;font-size:6.7pt;font-family:&quot;Times New Roman&quot;, serif;position:relative;min-width:fit-content;">***</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;63%  [&gt; 15% decrease]</span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">*** p&lt;0.001</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1 Changes from baseline &#x2265; 30% and &#x2265; 50% have been correlated with NASH improvement</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2 ALT changes &#x2265; 17 U/L have been correlated with histological improvement</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3 In patients with elevated ALT as defined by &#x2265; 30 U/L in women and &#x2265; 40 U/L in men (n=14)</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4 FAST score is a composite of imaging and blood markers and measured on 0-1 scale, a score &#x2264; 0.35 predicts Fibrosis Stage F0/F1 and NAS &lt; 4</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5 VCTE is a Fibroscan assessment, &gt; 20% reduction has been correlated with fibrosis improvement</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">6 Pro-C3 is a blood-based measurement, &gt; 15% reduction has been correlated with fibrosis improvement</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In addition to significant improvement in liver health, treatment with pegozafermin also had significant positive effects on glycemic control, lipids, adiponectin, and body weight.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">16</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:8.0pt;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Figure 11: Cardio-Metabolic Endpoints</span></p>
  <table style="border-spacing:0;table-layout:fixed;width:88.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:49.964%;"></td>
    <td style="width:50.036%;"></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="border-top:0.5pt solid;background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="border-top:0.5pt solid;background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Mean change from baseline at Week 20</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">HbA1c absolute change</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);top:-4.6899999999999995pt;white-space:pre-wrap;font-weight:normal;font-size:6.7pt;font-family:&quot;Times New Roman&quot;, serif;position:relative;min-width:fit-content;">1</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;-0.9%**</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Triglycerides</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);top:-4.6899999999999995pt;white-space:pre-wrap;font-weight:normal;font-size:6.7pt;font-family:&quot;Times New Roman&quot;, serif;position:relative;min-width:fit-content;">2</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;-32%***</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">LDL-C</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;-13%*</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">HDL-C</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;+23%***</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Adiponectin</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;+88%***</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Body Weight</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid;word-break:break-word;white-space:pre-wrap;padding-left:0.075in;vertical-align:top;border-bottom:0.5pt solid;padding-right:0.075in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;-4%***</span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">*p&lt;0.05; **p&lt;0.01; ***p&lt;0.001</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;vertical-align:super;font-size:5.36pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> In patients with HbA1c &#x2265; 6.5% at baseline (n=10); patients were all on concomitant diabetes medications</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;vertical-align:super;font-size:5.36pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> In patients with elevated triglycerides at baseline (n=11); reduction was -26% across total population</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In 83 patients treated with pegozafermin across the full Phase 1b/2a trial in cohorts 1 to 7, pegozafermin continues to be generally well tolerated with a favorable safety profile. There have been no drug-related serious adverse events and only one treatment-related discontinuation. Pooled pegozafermin treatment related adverse events in greater than or equal to 10% of patients were increased appetite (13% vs 0% placebo), diarrhea (13% vs 11% placebo), and nausea (12% vs 11% placebo). Most of the GI adverse events were mild and of short duration. A few mild injection site reactions were reported and there were no tremors and no hypersensitivity adverse events observed. Pegozafermin had no adverse effects on blood pressure or heart rate.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Phase 2b (ENLIVEN) Trial in Fibrosis Stage 2 or 3 NASH Patients</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">ENLIVEN is a multicenter, randomized, double-blind, placebo-controlled Phase 2b trial in biopsy-confirmed NASH patients with fibrosis stage 2 or 3 and NAS &#x2265; 4. The trial enrolled a total of 219 patients who receive either a weekly dose (15 mg or 30 mg) or an every two-week dose (44 mg) of pegozafermin in a liquid formulation or placebo for 24 weeks with a randomization schema of 4: 4: 2.5: 1 (placebo: 30 mg QW: 44 mg Q2W: 15 mg QW). All patients will continue treatment in a blinded extension phase for 24 weeks for a total treatment period of 48 weeks, with some of the placebo patients re-randomized to receive pegozafermin in the extension phase. The primary analysis will evaluate the effect of pegozafermin on the two FDA approvable histology endpoints 1-point fibrosis improvement with no worsening of NASH and NASH resolution with no worsening of fibrosis and will include patients who met histologic entry criteria F2/F3 patients and NAS &#x2265; 4 based on the three-panel consensus read of biopsies at baseline to ensure consistency between baseline and end of treatment biopsy reading methods. This three-panel consensus read was instituted after receipt of data from the expansion cohort of the Phase 1b/2a trial (cohort 7) to address biopsy reading variability and increase the likelihood of showing the true benefit of pegozafermin while maintaining adequate study power. Prior to this change, biopsy entry criteria for ENLIVEN was based on a single reader. We expect to report topline data in March 2023.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Pegozafermin Clinical Development in SHTG</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In June 2022 we reported positive topline results from the ENTRIGUE Phase 2 trial of pegozafermin in SHTG patients. ENTRIGUE was a randomized, double-blind, placebo-controlled trial that enrolled a total of 85 SHTG patients either on stable background therapy (55% - statin/statin combos, and/or prescription fish oil, and/or fibrates) or not on any background therapy treated weekly (9 mg, 18 mg or 27 mg) or every two weeks (36 mg) with pegozafermin or placebo over an eight-week treatment period. The trial enrolled an advanced population of patients with high risk of cardiovascular disease as evidenced by mean baseline values of treated patients with TGs of 733 mg/dL, non-HDL-C of 211 mg/dL, 43.5% with HbA1c &#x2265; 6.5%, and liver fat content of 20.1%. The primary endpoint was the percentage change in fasting triglyceride levels from baseline.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As shown in Figure 12 below, results demonstrated statistically significant reductions in median triglycerides from baseline across all dose groups treated with pegozafermin compared to placebo after 8 weeks. Additionally, as shown in Figure 13 below, results were consistent in patients not on background therapy or on background therapy (consistent results on statins or statin combos, prescription fish oils, and fibrates) and across various subgroups, including those with the greatest disease burden, such as Type 2 diabetes and baseline TG levels &#x2265; 750 mg/dL.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">17</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Figure 12: Median Percent Change in Triglycerides from Baseline at Week 8</span></p>
  <table style="border-spacing:0;table-layout:fixed;width:52.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:50.307%;"></td>
    <td style="width:49.693%;"></td>
   </tr>
   <tr style="height:22.0pt;">
    <td style="border-top:0.5pt solid rgba(0,0,0,1);background-color:rgba(0,0,0,0);border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid rgba(0,0,0,1);padding-left:0.08in;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.08in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Dosing group</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p></td>
    <td style="border-top:0.5pt solid rgba(0,0,0,1);background-color:rgba(0,0,0,0);border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.08in;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.08in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Median TG reduction</span></p></td>
   </tr>
   <tr style="height:12.45pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid rgba(0,0,0,1);padding-left:0.08in;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.08in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Placebo (n=18)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.08in;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.08in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">-12%</span></p></td>
   </tr>
   <tr style="height:12.45pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid rgba(0,0,0,1);padding-left:0.08in;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.08in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;&#160;9 mg QW (n=16)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.08in;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.08in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">-57%</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);top:-4.6899999999999995pt;white-space:pre-wrap;font-weight:normal;font-size:6.7pt;font-family:&quot;Times New Roman&quot;, serif;position:relative;min-width:fit-content;">***</span></p></td>
   </tr>
   <tr style="height:11.75pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid rgba(0,0,0,1);padding-left:0.08in;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.08in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">18 mg QW (n=17)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.08in;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.08in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">-56%</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);top:-4.6899999999999995pt;white-space:pre-wrap;font-weight:normal;font-size:6.7pt;font-family:&quot;Times New Roman&quot;, serif;position:relative;min-width:fit-content;">***</span></p></td>
   </tr>
   <tr style="height:12.45pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid rgba(0,0,0,1);padding-left:0.08in;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.08in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">27 mg QW (n=18)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.08in;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.08in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">-63%</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);top:-4.6899999999999995pt;white-space:pre-wrap;font-weight:normal;font-size:6.7pt;font-family:&quot;Times New Roman&quot;, serif;position:relative;min-width:fit-content;">***</span></p></td>
   </tr>
   <tr style="height:11.75pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid rgba(0,0,0,1);padding-left:0.08in;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.08in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">36 mg Q2W (n=16)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.08in;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.08in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">-36%</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);top:-4.6899999999999995pt;white-space:pre-wrap;font-weight:normal;font-size:6.7pt;font-family:&quot;Times New Roman&quot;, serif;position:relative;min-width:fit-content;">*</span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">* p&lt;0.05; *** p&lt;0.001 versus placebo based on Wilcoxon Rank-Sum Test</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Figure 13: Median Percent Change in Triglycerides from Baseline at Week 8</span></p>
  <table style="border-spacing:0;table-layout:fixed;width:99.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:26.452%;"></td>
    <td style="width:34.253%;"></td>
    <td style="width:39.295%;"></td>
   </tr>
   <tr style="height:22.0pt;">
    <td style="border-top:0.5pt solid rgba(0,0,0,1);background-color:rgba(0,0,0,0);border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid rgba(0,0,0,1);padding-left:0.08in;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.08in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Dosing group</span></p></td>
    <td style="border-top:0.5pt solid rgba(0,0,0,1);background-color:rgba(0,0,0,0);border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.08in;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.08in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Patients on background therapy</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);top:-4.6899999999999995pt;white-space:pre-wrap;font-weight:bold;font-size:6.7pt;font-family:&quot;Times New Roman&quot;, serif;position:relative;min-width:fit-content;">1</span></p></td>
    <td style="border-top:0.5pt solid rgba(0,0,0,1);background-color:rgba(0,0,0,0);border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.08in;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.08in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Patients not on background therapy</span></p></td>
   </tr>
   <tr style="height:12.45pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid rgba(0,0,0,1);padding-left:0.08in;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.08in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Placebo</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.08in;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.08in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">-18%</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.08in;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.08in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;&#160;&#160;5%</span></p></td>
   </tr>
   <tr style="height:12.45pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid rgba(0,0,0,1);padding-left:0.08in;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.08in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;&#160;9 mg QW</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.08in;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.08in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">-59%</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.08in;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.08in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">-50%</span></p></td>
   </tr>
   <tr style="height:11.75pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid rgba(0,0,0,1);padding-left:0.08in;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.08in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">18 mg QW</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.08in;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.08in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">-56%</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.08in;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.08in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">-59%</span></p></td>
   </tr>
   <tr style="height:12.45pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid rgba(0,0,0,1);padding-left:0.08in;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.08in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">27 mg QW</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.08in;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.08in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">-68%</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.08in;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.08in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">-62%</span></p></td>
   </tr>
   <tr style="height:11.75pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid rgba(0,0,0,1);padding-left:0.08in;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.08in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">36 mg Q2W</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.08in;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.08in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">-45%</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.08in;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.08in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">-21%</span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1. Background therapy defined as concomitant lipid modifying therapy</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Patients on background therapy: placebo (n=11), 9 mg QW (n=8), 18 mg QW (n=9), 27 mg QW (n=10), 36 mg Q2W (n=8)</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Patients not on background therapy: placebo (n=6), 9 mg QW (n=8), 18 mg QW (n=8), 27 mg QW (n=6), 36 mg Q2W (n=8)</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Responder analysis on primary endpoint of TG reduction demonstrated:</span></p>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">A significantly higher proportion of patients reached the initial treatment goal of reducing TG &lt; 500 mg/dL on pooled pegozafermin vs. placebo (80% vs. 29%; p&lt;0.001). </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Treatment with 27 mg QW resulted in a significantly higher proportion of patients achieving TG normalization (&lt; 150 mg/dL) vs. placebo (31% vs. 0%; p&lt;0.05) and </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Greater proportion of patients achieved significant TG reduction of &#x2265; 50% from baseline vs. placebo (75% vs. 6%; p&lt;0.001).</span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:2.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Pegozafermin treatment also resulted in significant improvements compared to placebo (mean percent change from baseline) and clinically meaningful changes on an absolute basis in non-HDL-C and apo B that are key markers of cardiovascular risk (absolute change from baseline of 55 mg/dL and 22 mg/dL in non-HDL-C and apo B respectively with 27 mg QW dose). As shown in Figure 14 below, patients treated across all doses with pegozafermin also demonstrated an improvement in HDL-C and no change in LDL-C vs. placebo.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Figure 14: Mean Percent Change in non-HDL-C and apo B from Baseline at Week 8</span></p>
  <table style="border-spacing:0;table-layout:fixed;width:61.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:35.782%;"></td>
    <td style="width:32.907%;"></td>
    <td style="width:31.311%;"></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="border-top:0.5pt solid rgba(0,0,0,1);background-color:rgba(0,0,0,0);border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid rgba(0,0,0,1);padding-left:0.08in;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.08in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Dosing group</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p></td>
    <td style="border-top:0.5pt solid rgba(0,0,0,1);background-color:rgba(0,0,0,0);border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.08in;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.08in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">non-HDL-C</span></p></td>
    <td style="border-top:0.5pt solid rgba(0,0,0,1);background-color:rgba(0,0,0,0);border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.08in;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.08in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">apo B</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid rgba(0,0,0,1);padding-left:0.08in;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.08in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Placebo</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.08in;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.08in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;&#160;-3%</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.08in;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.08in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;&#160;-1%</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid rgba(0,0,0,1);padding-left:0.08in;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.08in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;&#160;9 mg QW</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.08in;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.08in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">-14%</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.08in;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.08in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">-11%</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid rgba(0,0,0,1);padding-left:0.08in;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.08in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">18 mg QW</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.08in;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.08in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">-22%</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);top:-4.6899999999999995pt;white-space:pre-wrap;font-weight:normal;font-size:6.7pt;font-family:&quot;Times New Roman&quot;, serif;position:relative;min-width:fit-content;">**</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.08in;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.08in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">-14%</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);top:-4.6899999999999995pt;white-space:pre-wrap;font-weight:normal;font-size:6.7pt;font-family:&quot;Times New Roman&quot;, serif;position:relative;min-width:fit-content;">*</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid rgba(0,0,0,1);padding-left:0.08in;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.08in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">27 mg QW</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.08in;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.08in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">-29%</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);top:-4.6899999999999995pt;white-space:pre-wrap;font-weight:normal;font-size:6.7pt;font-family:&quot;Times New Roman&quot;, serif;position:relative;min-width:fit-content;">***</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.08in;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.08in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">-18%</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);top:-4.6899999999999995pt;white-space:pre-wrap;font-weight:normal;font-size:6.7pt;font-family:&quot;Times New Roman&quot;, serif;position:relative;min-width:fit-content;">**</span></p></td>
   </tr>
   <tr style="height:10.3pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid rgba(0,0,0,1);padding-left:0.08in;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.08in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">36 mg Q2W</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.08in;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.08in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;&#160;-9%</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.08in;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.08in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;&#160;-1%</span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">* p&lt;0.05; ** p&lt;0.01; *** p&lt;0.001 versus placebo based on MMRM analysis</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">18</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:2.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Pegozafermin treatment resulted in a mean relative reduction in liver fat from baseline at week 8 across all dose groups versus placebo in the sub-study of patients with MRI-PDFF. The results are summarized in Figure 15 below.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:10.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Figure 15: Mean Relative Reduction in Liver Fat vs. Baseline at Week 8 in Sub-study</span></p>
  <table style="border-spacing:0;table-layout:fixed;width:42.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:52.228%;"></td>
    <td style="width:47.772%;"></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="border-top:0.5pt solid rgba(0,0,0,1);background-color:rgba(0,0,0,0);border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid rgba(0,0,0,1);padding-left:0.08in;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.08in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Dosing group</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p></td>
    <td style="border-top:0.5pt solid rgba(0,0,0,1);background-color:rgba(0,0,0,0);border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.08in;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.08in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">MRI-PDFF</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid rgba(0,0,0,1);padding-left:0.08in;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.08in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Placebo (n=6)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.08in;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.08in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;&#160;-5%</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid rgba(0,0,0,1);padding-left:0.08in;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.08in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;&#160;9 mg QW (n=3)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.08in;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.08in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">-55%</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);top:-4.6899999999999995pt;white-space:pre-wrap;font-weight:normal;font-size:6.7pt;font-family:&quot;Times New Roman&quot;, serif;position:relative;min-width:fit-content;">*</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid rgba(0,0,0,1);padding-left:0.08in;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.08in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">18 mg QW (n=5)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.08in;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.08in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">-38%</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid rgba(0,0,0,1);padding-left:0.08in;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.08in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">27 mg QW (n=7)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.08in;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.08in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">-44%</span></p></td>
   </tr>
   <tr style="height:10.3pt;">
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;border-left:0.5pt solid rgba(0,0,0,1);padding-left:0.08in;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.08in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">36 mg Q2W (n=2)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);border-right:0.5pt solid rgba(0,0,0,1);word-break:break-word;white-space:pre-wrap;padding-left:0.08in;vertical-align:top;border-bottom:0.5pt solid rgba(0,0,0,1);padding-right:0.08in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">-37%</span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">* p&lt;0.05 versus placebo based on ANCOVA analysis</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:2.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">A significant proportion of patients responded to therapy with up to 88% and 41% of treated patients vs. 0% of placebo patients achieving a &#x2265; 30% or a &#x2265; 50% reduction in liver fat versus baseline, respectively. </span></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Results also demonstrated a significant reduction in liver enzymes and an improvement in glycemic control markers in pegozafermin treated patients.</span></div></div>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Pegozafermin continues to be generally well tolerated with a favorable safety profile across doses consistent with prior studies. In ENTRIGUE, the most commonly reported treatment-related adverse events were nausea, diarrhea and injection site reactions, all which were classified as mild or moderate. No tremors or transaminase elevation adverse events were observed. There were no drug-related serious adverse events and two Grade 2 treatment-related discontinuations.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We received feedback from the FDA supporting the advancement of pegozafermin into Phase 3. The FDA agreed that the pre-clinical and clinical data package support the advancement of pegozafermin into Phase 3 with the proposed primary endpoint of reduction in triglycerides from baseline without the need for a clinical outcome study. The FDA also agreed to the proposed doses and proposed secondary endpoints and were generally aligned with other trial parameters. Since SHTG is a common, chronic condition and pegozafermin is a novel investigational biologic therapy, the agency recommended conducting two Phase 3 trials in SHTG, each of one year duration as part of the efficacy and safety database required to support the registration package. We have incorporated the agency&#x2019;s feedback into our protocol and plan to initiate the first of two recommended Phase 3 trials in SHTG in the second quarter of 2023. The primary endpoint in the planned Phase 3 trials is anticipated to be assessed at week 26.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Agreements with Teva</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Agreements Relating to FGF21 Program</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In April 2018, we entered into an Asset Transfer and License Agreement (the &#x201c;FGF21 Agreement&#x201d;) with Teva Pharmaceutical Industries Ltd (&#x201c;Teva&#x201d;), under which we acquired certain patents, intellectual property and other assets relating to Teva&#x2019;s glycoPEGylated FGF21 program. Under this agreement, Teva also granted a perpetual, non-exclusive (but exclusive as to pegozafermin), non-transferable, worldwide license to patents and know-how related to glycoPEGylation technology for use in the research, development, manufacture and commercialization of the compound pegozafermin and products containing pegozafermin. In addition, we entered into a Sublicense Agreement with ratiopharm (the &#x201c;ratiopharm Sublicense&#x201d;), under which we were granted a perpetual, exclusive, worldwide sublicense to patents and know-how related to glycoPEGylation technology used in the development, manufacture and commercialization of pegozafermin and products containing pegozafermin.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">19</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Under the FGF21 Agreement, we are obligated to use commercially reasonable efforts to develop and commercialize pegozafermin in each of the United States and five major European countries. We have the right to sublicense all rights licensed to us by Teva under the FGF21 Agreement.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Pursuant to the FGF21 Agreement and the FASN Agreement (as defined and described below), we paid Teva a nonrefundable upfront payment of $6.0 million. In addition, under the FGF21 Agreement, we are required to make certain payments to Teva totaling $2.5 million for the achievement of certain clinical development milestones, and additional payments totaling up to $65.0 million upon achievement of certain commercial milestones. We are also obligated to pay Teva tiered royalties at percentages in the low-to-mid single-digits on worldwide net sales of products containing pegozafermin. Our royalty obligations will terminate, on a product-by-product and country-by-country basis, at the later of: (1) the date of expiration of the last to expire valid claim in the assigned patents that covers pegozafermin in such country, (2) the expiration of data or regulatory exclusivity for pegozafermin in such country and (3) 10 years from the first commercial sale of pegozafermin in such country. We are not required to make any payments to ratiopharm pursuant to the ratiopharm Sublicense.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The term of the FGF21 Agreement will continue, on a product-by-product and country-by-country basis, until the royalty term with respect to pegozafermin in such country expires. The ratiopharm Sublicense will continue until terminated in accordance with its terms. We may terminate the FGF21 Agreement and the ratiopharm Sublicense for any reason. Either party may terminate the FGF21 Agreement for cause for the other party&#x2019;s uncured material breach. ratiopharm may terminate the ratiopharm Sublicense for certain material breaches by us. Either party may terminate the FGF21 Agreement or the ratiopharm Sublicense in the event of bankruptcy of the other party. Teva may terminate the FGF21 Agreement if we challenge the validity of any patent licensed to us under the FGF21 Agreement. Termination of the FGF21 Agreement or the ratiopharm Sublicense will impact our rights under the intellectual property licensed to us by Teva and ratiopharm, respectively, but will not affect our rights under the assets assigned to us.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In April 2018, we also entered into a Reagent Supply and Technology Transfer Agreement, under which Teva supplied us with certain reagents required for the glycoPEGylation process that are necessary for our development and commercialization of pegozafermin, and transfer to us certain know-how required for the production of such reagents. This agreement expired in accordance with its terms on December 31, 2022. We transferred the manufacturing of such reagents to new suppliers prior to the end of 2022.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">FASN Agreements</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In April 2018, we entered into an Asset Transfer and License Agreement with Teva under which we acquired from Teva patents, intellectual property and other assets relating to Teva&#x2019;s development program of small molecule inhibitors of FASN (the &#x201c;FASN Agreement&#x201d;). Under the FASN Agreement we are obligated to use commercially reasonable efforts to develop and commercialize FASN in the United States and five major European countries. We have the right to sublicense all rights licensed to us by Teva under the FASN Agreement.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Pursuant to the FASN Agreement and the FGF21 Agreement (as described above), we paid Teva a nonrefundable upfront payment of $6.0 million. In addition, under the FASN Agreement, we are required to make certain payments to Teva totaling $2.5 million for the achievement of certain clinical development milestones, and additional payments totaling up to $65.0 million upon achievement of certain commercial milestones. We are also obligated to pay Teva tiered royalties at percentages in the low-to-mid single-digits on worldwide net sales of products arising from the FASN program. Our royalty obligations will terminate, on a product-by-product and country-by-country basis, at the later of: (1) the date of expiration of the last to expire valid claim in the assigned patents that covers FASN in such country, (2) the expiration of data or regulatory exclusivity for such product arising from the FASN program in such country and (3) 10 years from the first commercial sale of a product arising from the FASN program in such country.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The term of the FASN Agreement will continue, on a product-by-product and country-by-country basis, until the royalty term with respect to the product arising from the FASN program in such country expires. We may terminate the FASN Agreement for any reason. Either party may terminate the agreement for cause for the other party&#x2019;s uncured material breach, or in the event of bankruptcy of the other party.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">20</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Government Regulation and Product Approval</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The FDA and other regulatory authorities at federal, state and local levels, as well as in foreign countries, extensively regulate, among other things, the research, development, testing, manufacture, quality control, import, export, safety, effectiveness, labeling, packaging, storage, distribution, record keeping, approval, advertising, promotion, marketing, post-approval monitoring and post-approval reporting of biologics, such as those we are developing. We, along with third-party contractors, will be required to navigate the various preclinical, clinical and commercial approval requirements of the governing regulatory agencies of the countries in which we wish to conduct studies or seek approval or licensure of our product candidates.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The process required by the FDA before biologic product candidates may be marketed in the United States is expensive and time-consuming. Generally, this process involves completing pre-clinical laboratory studies before the FDA will allow human clinical trials to commence. We are then required to complete human clinical trials to demonstrate that a product candidate is safe and effective. Following the completion of these clinical trials, we are required to prepare and submit a biologics license application (&#x201c;BLA&#x201d;), which presents the FDA with detailed clinical and safety data, as well as manufacturing data. As part of the review of a BLA, the FDA may inspect manufacturing facilities to assure the facilities, methods and controls are adequate to preserve the biological product&#x2019;s continued safety, purity and potency, and may also inspect selected clinical investigation sites to assess compliance with current Good Clinical Practices (&#x201c;cGCP&#x201d;). This process takes many years from inception through filing of a BLA application and the likelihood of success is highly uncertain.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Preclinical and Clinical Development</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Prior to beginning the first clinical trial with a product candidate, we must submit an investigational new drug (&#x201c;IND&#x201d;) application to the FDA. An IND is a request for authorization from the FDA to administer an investigational new drug product to humans. The central focus of an IND submission is the general investigational plan and the protocol(s) for clinical studies. Submission of an IND may or may not result in FDA authorization to begin a clinical trial.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Clinical trials involve the administration of the investigational product to human subjects under the supervision of qualified investigators in accordance with cGCPs, which include the requirement that all research subjects provide their informed consent for their participation in any clinical study. Furthermore, an independent review board (&#x201c;IRB&#x201d;) for each site proposing to conduct the clinical trial must review and approve the plan for any clinical trial and its informed consent form before the clinical trial begins at that site, and must monitor the study until completed. Regulatory authorities, the IRB or the sponsor may suspend a clinical trial at any time on various grounds, including a finding that the subjects are being exposed to an unacceptable health risk or that the trial is unlikely to meet its stated objectives.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">For purposes of BLA approval, human clinical trials are typically conducted in three sequential phases that may overlap.</span></p>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Phase 1</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;The investigational product is initially introduced into healthy human subjects or patients with the target disease or condition. These studies are designed to test the safety, dosage tolerance, absorption, metabolism and distribution of the investigational product in humans, the side effects associated with increasing doses, and, if possible, to gain early evidence on effectiveness.</span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Phase 2</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;The investigational product is administered to a limited patient population with a specified disease or condition to evaluate the preliminary efficacy, optimal dosages and dosing schedule and to identify possible adverse side effects and safety risks. Multiple Phase 2 clinical trials may be conducted to obtain information prior to beginning larger and more expensive Phase 3 clinical trials.</span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Phase 3</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;The investigational product is administered to an expanded patient population to further evaluate dosage, to provide statistically significant evidence of clinical efficacy and to further test for safety, generally at multiple geographically dispersed clinical trial sites. These clinical trials are intended to establish the overall risk/benefit ratio of the investigational product and to provide an adequate basis for product approval.</span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">21</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Concurrent with clinical trials, companies must finalize a process for manufacturing the product in commercial quantities in accordance with current good manufacturing practices (&#x201c;cGMP&#x201d;) requirements. The manufacturing process must be capable of consistently producing quality batches of the product candidate and, among other things, must develop methods for testing the identity, strength, quality and purity of the final product, or for biologics, the safety, purity and potency.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">BLA Submission and Review</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Assuming successful completion of all required testing in accordance with all applicable regulatory requirements, the results of product development, nonclinical studies and clinical trials are submitted to the FDA as part of a BLA requesting approval to market the product for one or more indications. The submission of a BLA requires payment of a substantial application user fee to FDA, unless a waiver or exemption applies.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Once a BLA has been submitted, the FDA&#x2019;s goal is to review standard applications within ten months after it accepts the application for filing, or, if the application qualifies for priority review, six months after the FDA accepts the application for filing. In both standard and priority reviews, the review process may be extended by FDA requests for additional information or clarification. The FDA reviews a BLA to determine, among other things, whether a product is safe, pure and potent and the facility in which it is manufactured, processed, packed, or held meets standards designed to assure the product&#x2019;s continued safety, purity and potency. The FDA may convene an advisory committee to provide clinical insight on application review questions. Before approving a BLA, the FDA will typically inspect the facility or facilities where the product is manufactured. The FDA will not approve an application unless it determines that the manufacturing processes and facilities are in compliance with cGMP requirements and adequate to assure consistent production of the product within required specifications. Additionally, before approving a BLA, the FDA will typically inspect one or more clinical sites to assure compliance with cGCP. If the FDA determines that the application, manufacturing process or manufacturing facilities are not acceptable, it will outline the deficiencies in the submission and often will request additional testing or information. Notwithstanding the submission of any requested additional information, the FDA ultimately may decide that the application does not satisfy the regulatory criteria for approval.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">After the FDA evaluates a BLA and conducts necessary inspections, the FDA may either issue an approval letter or a Complete Response letter. An approval letter authorizes commercial marketing of the product with specific prescribing information for specific indications. A Complete Response letter will describe deficiencies that the FDA has identified in the BLA. The FDA may delay or refuse approval of a BLA if applicable regulatory criteria are not satisfied, require additional testing or information and/or require post-marketing testing and surveillance to monitor safety or efficacy of a product.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">If regulatory approval of a product is granted, such approval will be granted for particular indications and may entail limitations on the indicated uses for which such product may be marketed. For example, the FDA may approve the BLA with a Risk Evaluation and Mitigation Strategy (&#x201c;REMS&#x201d;) to ensure the benefits of the product outweigh its risks. A REMS is a safety strategy to manage a known or potential serious risk associated with a product and to enable patients to have continued access to such medicines by managing their safe use, and could include medication guides, physician communication plans, or elements to assure safe use, such as restricted distribution methods, patient registries and other risk minimization tools. The FDA also may condition approval on, among other things, changes to proposed labeling or the development of adequate controls and specifications. Once approved, the FDA may withdraw the product approval if compliance with pre- and post-marketing requirements is not maintained or if problems occur after the product reaches the marketplace. The FDA may require, or companies may voluntarily pursue, one or more Phase 4 post-market studies and surveillance to further assess and monitor the product&#x2019;s safety and effectiveness after commercialization, and may limit further marketing of the product based on the results of these post-marketing studies.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">22</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Expedited Programs for Serious Conditions</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The FDA maintains several programs intended to facilitate and expedite development and review of new drugs and biologics to address unmet medical needs in the treatment of serious or life-threatening diseases or conditions. These programs include Fast Track designation, Breakthrough Therapy designation, Priority Review and Accelerated Approval. These programs can significantly reduce the time it takes for the FDA to review a BLA, but they do not guarantee that a product will receive FDA approval. Even if a product qualifies initially, the FDA may later decide that the product no longer meets the conditions for qualification or decide that the time period for FDA review will not be shortened. The Consolidated Appropriations Act 2023 strengthens the FDA&#x2019;s authority to require and regulate post-approval studies of accelerated approval drugs and to expedite the rescission of accelerated approval based on these post-approval studies.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Post-Approval Requirements</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Any products manufactured or distributed pursuant to FDA approvals are subject to pervasive and continuing regulation by the FDA, including, among other things, requirements relating to record-keeping, reporting of adverse experiences, periodic reporting, product sampling and distribution, and advertising and promotion of the product. After approval, most changes to the approved product, such as adding new indications or other labeling claims, are subject to prior FDA review and approval. Biologic manufacturers and their subcontractors are required to register their establishments with the FDA and certain state agencies, and are subject to periodic unannounced inspections by the FDA and certain state agencies for compliance with cGMP. Changes to the manufacturing process are strictly regulated, and, depending on the significance of the change, may require prior FDA approval before being implemented. FDA regulations also require investigation and correction of any deviations from cGMP and impose reporting requirements upon companies and third-party manufacturers. Accordingly, manufacturers must continue to expend time, money and effort in the area of production and quality control to maintain compliance with cGMP and other aspects of regulatory compliance.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The FDA may withdraw approval if compliance with regulatory requirements and standards is not maintained or if problems occur after the product reaches the market. Later discovery of previously unknown problems with a product, including adverse events of unanticipated severity or frequency, or with manufacturing processes, or failure to comply with regulatory requirements, may result in revisions to the approved labeling to add new safety information; imposition of post-market studies or clinical studies to assess new safety risks; or imposition of distribution restrictions or other restrictions under a REMS program, among other potential consequences.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The FDA closely regulates the marketing, labeling, advertising and promotion of biologics. A company can make only those claims relating to safety and efficacy, purity and potency that are approved by the FDA and in accordance with the provisions of the approved label. The FDA and other agencies actively enforce the laws and regulations prohibiting the promotion of off-label uses. Failure to comply with these requirements can result in, among other things, adverse publicity, warning letters, corrective advertising and potential civil and criminal penalties.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Biosimilars and Reference Product Exclusivity</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Patient Protection and Affordable Care Act, as amended (collectively, the &#x201c;Affordable Care Act&#x201d;) includes a provision called the Biologics Price Competition and Innovation Act of 2009 (&#x201c;BPCIA&#x201d;), which created an abbreviated approval pathway for biological products that are biosimilar to or interchangeable with an FDA-approved reference biological product.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Biosimilarity, which requires that there be no clinically meaningful differences between the biological product and the reference product in terms of safety, purity and potency, can be shown through analytical studies, animal studies, and a clinical study or studies.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">23</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Under the BPCIA, an application for a biosimilar product may not be submitted to the FDA until four years following the date that the reference product was first licensed by the FDA. In addition, the approval of a biosimilar product may not be made effective by the FDA until 12 years from the date on which the reference product was first licensed. During this 12-year period of exclusivity, another company may still market a competing version of the reference product if the FDA approves a full BLA for the competing product containing that applicant&#x2019;s own preclinical data and data from adequate and well-controlled clinical trials to demonstrate the safety, purity and potency of its product. At this juncture, it is unclear whether products deemed &#x201c;interchangeable&#x201d; by the FDA will, in fact, be readily substituted by pharmacies, which are governed by state pharmacy law.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The BPCIA is complex and continues to be interpreted and implemented by the FDA. In addition, recent government proposals have sought to reduce the 12-year reference product exclusivity period. Other aspects of the BPCIA, some of which may impact the BPCIA exclusivity provisions, have also been the subject of recent litigation. As a result, the ultimate impact, implementation, and impact of the BPCIA is subject to significant uncertainty.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As discussed below, the Inflation Reduction Act of 2022 (&#x201c;IRA&#x201d;) is a significant new law that intends to foster generic and biosimilar competition and to lower drug and biologic costs.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Other U.S. Healthcare Laws and Compliance Requirements</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Pharmaceutical companies are subject to additional healthcare regulation and enforcement by the federal government and by authorities in the states and foreign jurisdictions in which they conduct their business. Such laws include, without limitation: the federal Anti-Kickback Statute (&#x201c;AKS&#x201d;), the federal False Claims Act (&#x201c;FCA&#x201d;), the Health Insurance Portability and Accountability Act (&#x201c;HIPAA&#x201d;) and similar foreign, federal and state fraud, abuse and transparency laws.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The federal AKS prohibits, among other things, any person or entity from knowingly and willfully offering, paying, soliciting or receiving any remuneration, to induce or in return for either the referral of an individual, or the purchase or recommendation of an item or service for which payment may be made under any federal healthcare program. The term remuneration has been interpreted broadly to include anything of value. The AKS has been interpreted to apply to arrangements between pharmaceutical manufacturers on one hand, and prescribers and purchasers on the other. Our practices may not in all cases meet all of the criteria for protection under a statutory exception or regulatory safe harbor. Failure to meet all of the requirements of a particular applicable statutory exception or regulatory safe harbor does not make the conduct per se illegal under the AKS. Instead, the legality of the arrangement will be evaluated on a case-by-case basis based on a cumulative review of all of its facts and circumstances. A person or entity does not need to have actual knowledge of the statute or specific intent to violate it in order to have committed a violation.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The federal false claims laws, including the FCA, which imposes significant penalties and can be enforced by private citizens through civil qui tam actions, and civil monetary penalty laws prohibit any person or entity from, among other things, knowingly presenting, or causing to be presented, a false or fraudulent claim for payment of federal government funds, including federal healthcare programs, such as Medicare and Medicaid. Pharmaceutical and other healthcare companies have been prosecuted under these laws for engaging in a variety of different types of conduct that caused the submission of false claims to federal healthcare programs. Under the AKS, for example, a claim resulting from a violation of the AKS is deemed to be a false or fraudulent claim for purposes of the FCA. The FCA imposes mandatory treble damages and per-violation civil penalties up to approximately $25,000.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">HIPAA created additional federal criminal statutes that prohibit, among other things, executing a scheme to defraud any healthcare benefit program, including private third-party payors, and making false statements relating to healthcare matters. A person or entity does not need to have actual knowledge of the healthcare fraud statute implemented under HIPAA or specific intent to violate the statute in order to have committed a violation.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Also, many states have similar, and typically more prohibitive, fraud and abuse statutes or regulations that apply to items and services reimbursed under Medicaid and other state programs, or, in several states, apply regardless of the payor.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">24</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The U.S. federal Physician Payments Sunshine Act requires certain manufacturers of drugs and biologics covered by Medicare, Medicaid or the Children&#x2019;s Health Insurance Program, with specific exceptions, to annually report to the Centers for Medicare &amp; Medicaid Services (&#x201c;CMS&#x201d;) information related to payments or other transfers of value made to various healthcare professionals including physicians, physician assistants, nurse practitioners, and teaching hospitals, as well as ownership and investment interests held by physicians and their immediate family members.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Ensuring business arrangements with third parties comply with applicable healthcare laws and regulations is a difficult and costly endeavor. If our operations are found to be in violation of any of the federal and state healthcare laws described above or any other current or future governmental regulations that apply to us, we may be subject to significant penalties, including without limitation, civil, criminal and/or administrative penalties, damages, fines, disgorgement, imprisonment, exclusion from participation in government programs, such as Medicare and Medicaid, injunctions, private &#x201c;qui tam&#x201d; actions brought by individual whistleblowers in the name of the government, or refusal to allow us to enter into government contracts, contractual damages, reputational harm, administrative burdens, diminished profits and future earnings, additional reporting obligations and oversight if we become subject to a corporate integrity agreement or other agreement to resolve allegations of non-compliance with these laws, and the curtailment or restructuring of our operations, any of which could adversely affect our ability to operate our business and our results of operations.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Data Privacy and Security</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Numerous state, federal and foreign laws, govern the collection, dissemination, use, access to, confidentiality and security of personal information, including health-related information. In the United States, numerous federal and state laws and regulations, including state data breach notification laws, state health information privacy laws, and federal and state consumer protection laws and regulations, govern the collection, use, disclosure, and protection of health-related and other personal information could apply to our operations or the operations of our partners. Entities that are found to be in violation of HIPAA or other laws may be subject to significant civil, criminal and administrative fines and penalties and/or additional reporting and oversight obligations. Further, entities that knowingly obtain, use, or disclose certain individually identifiable health information in an improper fashion may be subject to criminal penalties.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Coverage, Pricing and Reimbursement</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Significant uncertainty exists as to the coverage and reimbursement status of any product candidates for which we may obtain regulatory approval. In the United States and in foreign markets, sales of any products for which we receive regulatory approval for commercial sale will depend, in part, on the extent to which third-party payors provide coverage and establish adequate reimbursement levels for such products. In the United States, third-party payors include federal and state healthcare programs, private managed care providers, private health insurers and other organizations. Adequate coverage and reimbursement from governmental healthcare programs, such as Medicare and Medicaid in the United States, and commercial payors are critical to new product acceptance.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Third-party payors are increasingly challenging the prices charged for medical products and services, examining the medical necessity and reviewing the cost effectiveness of pharmaceutical or biological products, medical devices and medical services, in addition to questioning safety and efficacy. Adoption of price controls and cost-containment measures, and adoption of more restrictive policies in jurisdictions with existing controls and measures, could further limit sales of any product that receives approval. Decreases in third-party reimbursement for any product or a decision by a third-party not to cover a product could reduce physician usage and patient demand for the product.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">25</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Decisions regarding whether to cover any of our product candidates, if approved, the extent of coverage and amount of reimbursement to be provided are made on a plan-by-plan basis. Further, no uniform policy for coverage and reimbursement exists in the United States, and coverage and reimbursement can differ significantly from payor to payor. Third-party payors often rely upon Medicare coverage policy and payment limitations in setting their own reimbursement rates, but also have their own methods and approval process apart from Medicare determinations. As a result, the coverage determination process is often a time-consuming and costly process that will require us to provide scientific and clinical support for the use of our product candidates to each payor separately, with no assurance that coverage and adequate reimbursement will be applied consistently or obtained in the first instance.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">For products administered under the supervision of a physician, obtaining coverage and adequate reimbursement may be particularly difficult because of the higher prices often associated with such drugs. Additionally, separate reimbursement for the product itself or the treatment or procedure in which the product is used may not be available, which may impact physician utilization. In addition, companion diagnostic tests require coverage and reimbursement separate and apart from the coverage and reimbursement for their companion pharmaceutical or biological products. Similar challenges to obtaining coverage and reimbursement, applicable to pharmaceutical or biological products, will apply to companion diagnostics.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In addition, the U.S. government, state legislatures and foreign governments have continued implementing cost-containment programs, including price controls, restrictions on coverage and reimbursement and requirements for substitution of generic products. The IRA provides CMS with significant new authorities intended to curb drug costs and to encourage market competition. For the first time, CMS will be able to directly negotiate prescription drug prices and to cap out-of-pocket costs. Each year, CMS will select and negotiate a preset number of high-spend drugs and biologics that are covered under Medicare Part B and Part D that do not have generic or biosimilar competition. These price negotiations will begin in 2023. The IRA also provides a new &#x201c;inflation rebate&#x201d; covering Medicare patients that will take effect in 2023 and is intended to counter certain price increases in prescriptions drugs. The inflation rebate provision will require drug manufacturers to pay a rebate to the federal government if the price for a drug or biologic under Medicare Part B and Part D increases faster than the rate of inflation. To support biosimilar competition, beginning in October 2022, qualifying biosimilars whose average sales price (&#x201c;ASP&#x201d;) is less than the ASP of its biologic reference product may receive a Medicare Part B payment increase for a period of five years. Separately, if a biologic drug for which no biosimilar exists delays a biosimilar&#x2019;s market entry beyond two years, CMS will be authorized to subject the biologics manufacturer to price negotiations intended to ensure fair competition. Notwithstanding these provisions, the IRA&#x2019;s impact on commercialization and competition remains largely uncertain.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Healthcare Reform</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In the United States and some foreign jurisdictions, there have been, and continue to be, several legislative and regulatory changes and proposed changes regarding the healthcare system that could prevent or delay marketing approval of product candidates, restrict or regulate post-approval activities, and affect the ability to profitably sell product candidates for which marketing approval is obtained. Among policy makers and payors in the United States and elsewhere, there is significant interest in promoting changes in healthcare systems with the stated goals of containing healthcare costs, improving quality and/or expanding access. In the United States, the pharmaceutical industry has been a particular focus of these efforts and has been significantly affected by major legislative initiatives.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">For example, the Affordable Care Act has substantially changed healthcare financing and delivery by both governmental and private insurers. The Affordable Care Act and its implementing regulations, among other things, revised the methodology for calculating rebates for covered outpatient drugs and certain biologics owed by manufacturers to the state and federal government under the Medicaid Drug Rebate Program, increased the minimum Medicaid rebates owed by most manufacturers under the Medicaid Drug Rebate Program, extended the Medicaid Drug Rebate program to utilization of prescriptions of individuals enrolled in Medicaid managed care organizations, subjected manufacturers to new annual fees and taxes for certain branded prescription drugs, and expanded programs designed to test innovative payment models, service delivery models, or value-based arrangements, and fund comparative effectiveness research.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">26</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We anticipate that the Affordable Care Act will continue to result in additional downward pressure on coverage and the price that we receive for any approved product, and could seriously harm our business. Any reduction in reimbursement from Medicare and other government programs may result in a similar reduction in payments from private payors. The implementation of cost containment measures or other healthcare reforms may prevent us from being able to generate revenue, attain profitability, or commercialize our products. Such reforms could have an adverse effect on anticipated revenue from product candidates that we may successfully develop and for which we may obtain regulatory approval and may affect our overall financial condition and ability to develop product candidates.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In addition, further legislation or regulation could be passed that could harm our business, financial condition and results of operations. Other legislative changes have been proposed and adopted since the Affordable Care Act was enacted.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Notwithstanding the Inflation Reduction Act, continued legislative and enforcement interest exist in the United States with respect to specialty drug pricing practices. Specifically, we expect regulators to continue pushing for transparency to drug pricing, reducing the cost of prescription drugs under Medicare, reviewing the relationship between pricing and manufacturer patient programs, and reforming government program reimbursement methodologies for drugs.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Drug and Biologic Development Process in the European Union</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The conduct of clinical trials in the EU is governed by the EU Clinical Trials Regulation (EU) No. 536/2014 (&#x201c;CTR&#x201d;) which entered into force on January 31, 2022. Under the CTR, a sponsor will be able to submit a single application for approval of a clinical trial through a centralized EU clinical trials portal. One national regulatory authority (the reporting EU member state proposed by the applicant) will take the lead in validating and evaluating the application consult and coordinate with the other concerned member states. If an application is rejected, it may be amended and resubmitted through the EU clinical trials portal. If an approval is issued, the sponsor may start the clinical trial in all concerned member states. However, a concerned EU member state may in limited circumstances declare an &#x201c;opt-out&#x201d; from an approval and prevent the clinical trial from being conducted in such member state. The CTR also aims to streamline and simplify the rules on safety reporting, and introduces enhanced transparency requirements such as mandatory submission of a summary of the clinical trial results to the EU Database.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">National laws, regulations and the applicable Good Clinical Practice (&#x201c;GCP&#x201d;) and Good Laboratory Practice standards must also be respected during the conduct of the trials, including the International Council for Harmonization of Technical Requirements for Pharmaceuticals for Human Use (&#x201c;ICH&#x201d;) guidelines on Good Clinical Practice and the ethical principles that have their origin in the Declaration of Helsinki.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">During the development of a medicinal product, the European Medical Agency (&#x201c;EMA&#x201d;) and national regulators within the EU provide the opportunity for dialogue and guidance on the development program. At the EMA level, this is usually done in the form of scientific advice, which is given by the Committee for Medicinal Products for Human Use (&#x201c;CHMP&#x201d;) on the recommendation of the Scientific Advice Working Party (&#x201c;SAWP&#x201d;). A fee is incurred with each scientific advice procedure, but is significantly reduced for designated orphan medicines. Advice from the EMA is typically provided based on questions concerning, for example, quality (chemistry, manufacturing and controls testing), nonclinical testing and clinical studies, and pharmacovigilance plans and risk-management programs. Advice is not legally binding with regard to any future Marketing Authorization Application (&#x201c;MAA&#x201d;) of the product concerned.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Drug Marketing Authorization in the European Union</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In the EU and in Iceland, Norway and Liechtenstein (together the European Economic Area or &#x201c;EEA&#x201d;), after completion of all required clinical testing, pharmaceutical products may only be placed on the market after obtaining a Marketing Authorization (&#x201c;MA&#x201d;). To obtain an MA of a drug under European Union regulatory systems, an applicant can submit an MAA through, amongst others, a centralized or decentralized procedure.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">27</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The centralized procedure provides for the grant of a single MA by the European Commission (&#x201c;EC&#x201d;) that is valid for all EU Member States and, after respective national implementing decisions, in the three additional EEA Member States. The centralized procedure is compulsory for specific medicinal products, including for medicines developed by means of certain biotechnological processes, products designated as orphan medicinal products, advanced therapy medicinal products (&#x201c;ATMP&#x201d;) and medicinal products with a new active substance indicated for the treatment of certain diseases (AIDS, cancer, neurodegenerative disorders, diabetes, auto-immune and viral diseases). For medicinal products containing a new active substance not yet authorized in the EEA before May 20, 2004 and indicated for the treatment of other diseases, medicinal products that constitute significant therapeutic, scientific or technical innovations or for which the grant of a MA through the centralized procedure would be in the interest of public health at EU level, an applicant may voluntarily submit an application for a marketing authorization through the centralized procedure.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Under the centralized procedure, the Committee for Medicinal Products for Human Use (&#x201c;CHMP&#x201d;), established at the EMA, is responsible for conducting the initial assessment of a drug. The CHMP is also responsible for several post-authorization and maintenance activities, such as the assessment of modifications or extensions to an existing marketing authorization. Under the centralized procedure, the timeframe for the evaluation of an MAA by the EMA&#x2019;s CHMP is, in principle, 210 days from receipt of a valid MAA. However, this timeline excludes clock stops, when additional written or oral information is to be provided by the applicant in response to questions asked by the CHMP, so the overall process typically takes a year or more, unless the application is eligible for an accelerated assessment. Accelerated assessment might be granted by the CHMP in exceptional cases when a medicinal product is of major interest from the point of view of public health and in particular from the viewpoint of therapeutic innovation. On request, the CHMP can reduce the time frame to 150 days if the applicant provides sufficient justification for an accelerated assessment. The CHMP will provide a positive opinion regarding the application only if it meets certain quality, safety and efficacy requirements. However, the EC has final authority for granting the MA within 67 days after receipt of the CHMP opinion.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The decentralized procedure permits companies to file identical MA applications for a medicinal product to the competent authorities in various EU Member States simultaneously if such medicinal product has not received marketing approval in any EU Member State before. This procedure is available for pharmaceutical products not falling within the mandatory scope of the centralized procedure. The competent authority of a single EU Member State, known as the reference EU Member State, is appointed to review the application and provide an assessment report. Under this procedure, an applicant submits an application based on identical dossiers and related materials, including a draft summary of product characteristics, and draft labeling and package leaflet, to the reference EU Member State and concerned EU Member States. The reference EU Member State prepares a draft assessment report and drafts of the related materials within 120 days after receipt of a valid application. Subsequently each concerned EU Member State must decide whether to approve the assessment report and related materials. If an EU Member State cannot approve the assessment report and related materials on the grounds of potential serious risk to public health, the disputed points are subject to a dispute resolution mechanism and may eventually be referred to the EC, whose decision is binding for all EU Member States.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">All new MAAs must include a Risk Management Plan (&#x201c;RMP&#x201d;), describing the risk management system that the company will put in place and documenting measures to prevent or minimize the risks associated with the product. The regulatory authorities may also impose specific obligations as a condition of the MA. RMPs and Periodic Safety Update Reports (&#x201c;PSURs&#x201d;) are routinely available to third parties requesting access, subject to limited redactions.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Marketing Authorizations have an initial duration of five years. After these five years, the authorization may subsequently be renewed on the basis of a reevaluation of the risk-benefit balance. Once renewed, the MA is valid for an unlimited period unless the EC or the national competent authority decides, on justified grounds relating to pharmacovigilance, to proceed with only one additional five-year renewal. Applications for renewal must be made to the EMA at least nine months before the five-year period expires.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">28</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Data and Market Exclusivity in the European Union</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As in the United States, it may be possible to obtain a period of market and/</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:line-through;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">or data exclusivity in the EU that would have the effect of postponing the entry into the marketplace of a competitor&#x2019;s generic, hybrid or biosimilar product (even if the pharmaceutical product has already received a MA) and prohibiting another applicant from relying on the MA holder&#x2019;s pharmacological, toxicological and clinical data in support of another MA for the purposes of submitting an application, obtaining MA or placing the product on the market. New Chemical Entities (&#x201c;NCE&#x201d;) approved in the EU qualify for eight years of data exclusivity and 10 years of marketing exclusivity.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">An additional non-cumulative one-year period of marketing exclusivity is possible if during the data exclusivity period (the first eight years of the 10-year marketing exclusivity period), the MA holder obtains an authorization for one or more new therapeutic indications that are deemed to bring a significant clinical benefit compared to existing therapies.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The data exclusivity period begins on the date of the product&#x2019;s first MA in the EU. After eight years, a generic product application may be submitted and generic companies may rely on the MA holder&#x2019;s data. However, a generic product cannot launch until two years later (or a total of 10 years after the first MA in the EU of the innovator product), or three years later (or a total of 11 years after the first MA in the EU of the innovator product) if the MA holder obtains MA for a new indication with significant clinical benefit within the eight-year data exclusivity period. Additionally, another noncumulative one-year period of data exclusivity can be added to the eight years of data exclusivity where an application is made for a new indication for a well-established substance, provided that significant pre-clinical or clinical studies were carried out in relation to the new indication. Another year of data exclusivity may be added to the eight years, where a change of classification of a pharmaceutical product has been authorized on the basis of significant pre-trial tests or clinical trials (when examining an application by another applicant for or holder of market authorization for a change of classification of the same substance the competent authority will not refer to the results of those tests or trials for one year after the initial chance was authorized).</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Products may not be granted data exclusivity since there is no guarantee that a product will be considered by the European Union&#x2019;s regulatory authorities to include a NCE. Even if a compound is considered to be a NCE and the MA applicant is able to gain the prescribed period of data exclusivity, another company nevertheless could also market another version of the medicinal product if such company can complete a full MAA with their own complete database of pharmaceutical tests, preclinical studies and clinical trials and obtain MA of its product.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">  </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">European Data Laws</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The collection and use of personal health data and other personal data in the EU is governed by the provisions of the European General Data Protection Regulation (EU) 2016/679 (&#x201c;GDPR&#x201d;) and related data protection laws in individual EU Member States</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The GDPR imposes a number of strict obligations and restrictions on the ability to process (processing includes collecting, analyzing and transferring) personal data of individuals, in particular with respect to health data from clinical trials and adverse event reporting. The GDPR includes requirements relating to the legal basis of the processing (such as consent of the individuals to whom the personal data relates), the information provided to the individuals prior to processing their personal data, the notification obligations to the national data protection authorities, and the security and confidentiality of the personal data. EU Member States may also impose additional requirements in relation to health, genetic and biometric data through their national legislation.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In addition, the GDPR imposes specific restrictions on the transfer of personal data to countries outside of the EU/EEA that are not considered by the EC to provide an adequate level of data protection (including the United States). Appropriate safeguards are required to enable such transfers.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Failure to comply with the requirements of the GDPR and the related national data protection laws of the EU Member States may result in significant monetary fines for noncompliance of up to &#x20ac;20 million or 4% of the annual global revenues of the noncompliant company, whichever is greater, other administrative penalties and a number of criminal offenses (punishable by uncapped fines) for organizations and, in certain cases, their directors and officers, as well as civil liability claims from individuals whose personal data was processed. Data protection authorities from</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">29</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the different EU Member States may still implement certain variations, enforce the GDPR and national data protection laws differently, and introduce additional national regulations and guidelines, which adds to the complexity of processing personal data in the EU. Guidance developed at both the EU level and at the national level in individual EU Member States concerning implementation and compliance practices are often updated or otherwise revised.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Furthermore, there is a growing trend towards the required public disclosure of clinical trial data in the EU, which adds to the complexity of obligations relating to processing health data from clinical trials. Such public disclosure obligations are provided in the new EU CTR, EMA disclosure initiatives and voluntary commitments by industry. Failing to comply with these obligations could lead to government enforcement actions and significant penalties against us, harm to our reputation, and adversely impact our business and operating results. The uncertainty regarding the interplay between different regulatory frameworks, such as the CTR and the GDPR, further adds to the complexity that we face with regard to data protection regulation.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Additional Regulation</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In addition to the foregoing, local, state and federal laws, including in the United States and Israel, regarding such matters as safe working conditions, manufacturing practices, environmental protection, fire hazard control and hazardous substances, including the Occupational Safety and Health Act, the Resource Conservancy and Recovery Act and the Toxic Substances Control Act, affect our business. These and other laws govern our use, handling and disposal of various biological, chemical and radioactive substances used in, and wastes generated by, our operations. If our operations result in contamination of the environment or expose individuals to hazardous or biohazardous substances, we could be liable for damages, environmental remediation, and/or governmental fines. We believe that we are in material compliance with applicable environmental laws and occupational health and safety laws that continued compliance therewith will not have a material adverse effect on our business. We cannot predict, however, how changes in these laws may affect our future operations. We may incur significant costs to comply with such laws and regulations now or in the future.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Competition</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The biopharmaceutical industry is intensely competitive and subject to rapid innovation and significant technological advancements. We believe the key competitive factors that will affect the development and commercial success of pegozafermin and any future product candidates are efficacy, safety and tolerability profile, reliability, convenience of dosing, price, the level of generic competition and reimbursement. Our competitors include multinational pharmaceutical companies, specialized biotechnology companies, universities and other research institutions. A number of biotechnology and pharmaceutical companies are pursuing the development or marketing of pharmaceuticals that target the same diseases that we are targeting. Smaller or earlier-stage companies may also prove to be significant competitors, particularly through collaborative arrangements with large, established companies. Given the high incidence of NASH, it is likely that the number of companies seeking to develop products and therapies for the treatment of liver and cardio-metabolic diseases, such as NASH, will increase.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">If pegozafermin is approved for the treatment of NASH, future competition could also arise from select products currently in development, including: Firsocostat/GS-0976, an ACC inhibitor, and Cilofexor/GS-9674, an FXR agonist, from Gilead Sciences, Inc.; Ervogastat/PF-06865571, a DGAT2 inhibitor, and Clesacostat/PF-05221304, an ACC inhibitor from Pfizer Inc.; Ocaliva, an FXR agonist from Intercept Pharmaceuticals, Inc.; Resmetirom, a beta-thyroid hormone receptor agonist from Madrigal Pharmaceuticals, Inc.; VK2809, a beta-thyroid hormone receptor agonist from Viking Therapeutics, Inc.; Aldafermin, an FGF19 analog from NGM Biopharmaceuticals, Inc.; Efruxifermin, a FGF21 analog from Akero Therapeutics, Inc.; Belapectin, a Galectin-3 inhibitor from Galectin Therapeutics Inc.; Semaglutide, a GLP-1 receptor agonist from Novo Nordisk A/S; Pemvidutide/ALT-801, a dual GLP-1/glucagon agonist from Altimmune; Tirzepatide, a dual GIP/GLP-1 receptor agonist from Eli Lilly and Company; Lanifibranor, a PPAR alpha/delta/gamma agonist from Inventiva; NNC0194-0499, an FGF21 analog from Novo Nordisk; and BOS-580, an FGF21 analog from Boston Pharmaceuticals.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">30</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">If pegozafermin is approved for the treatment of SHTG, we would face competition from currently approved and marketed products, including statins, fibrates, Vascepa (Pure EPA), and Lovaza (EPA and DHA), as well as generic products. Further competition could arise from products currently in development, including: Olezarsen/AKCEA-APOCIII-LRx, an APOC3 inhibitor from Ionis; Evinacumab, an Anti-ANGPTL3 from Regeneron Pharmaceuticals, Inc.; and ARO-APOC3, an ApoC-III inhibitor from Arrowhead Pharmaceuticals, Inc.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Many of our competitors have substantially greater financial, technical, human and other resources than we do and may be better equipped to develop, manufacture and market technologically superior products. In addition, many of these competitors have significantly longer operating histories and greater experience than we have in undertaking nonclinical studies and human clinical trials of new pharmaceutical products and in obtaining regulatory approvals of human therapeutic products. Many of our competitors have established distribution channels for the commercialization of their products, whereas we have no such channel or capabilities. In addition, many competitors have greater name recognition and more extensive collaborative relationships. As a result, our competitors may obtain regulatory approval of their products more rapidly than we do or may obtain patent protection or other intellectual property rights that limit our ability to develop or commercialize our product candidate or any future product candidates. Our competitors may also develop and succeed in obtaining approval for drugs that are more effective, more convenient, more widely used and less costly or have a better safety profile than our products and these competitors may also be more successful than we are in manufacturing and marketing their products. If we are unable to compete effectively against these companies, then we may not be able to commercialize our product candidate or any future product candidates or achieve a competitive position in the market. This would adversely affect our ability to generate revenue. Our competitors also compete with us in recruiting and retaining qualified scientific, management and commercial personnel, establishing clinical trial sites and enrolling patients for clinical trials, as well as in acquiring technologies complementary to, or necessary for, our programs.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Manufacturing and Supply</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We do not own or operate manufacturing facilities for the production of pegozafermin, nor do we have plans to develop our own manufacturing operations in the foreseeable future. We currently rely, and expect to continue to rely, on third parties for the manufacturing of our product candidates for preclinical and clinical testing, as well as for commercial manufacturing if pegozafermin or any future product candidate receives marketing approval.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Pegozafermin drug substance is manufactured by fermentation of a recombinant strain of the bacterium E. coli. Product accumulates as insoluble particles (inclusion bodies) within the cells and is recovered by cell disruption, followed by solubilization of the inclusion bodies, protein refolding and purification with two chromatographic separation columns. Purified material is glycoPEGylated in a 2-step enzymatic reaction where a 20kDa linear glycoPEG moiety is attached to the protein through GalNAc and Sialic Acid linkers.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">GlycoPEGylated protein is purified with two chromatographic columns to yield product with target quality attributes. Purified glycoPEGylated protein is concentrated and then formulated to a target concentration with formulation buffer as drug product.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Northway Biotechpharma (&#x201c;BTPH&#x201d;) is currently our sole source supplier for pegozafermin. Any reduction or halt in supply of drug substance from BTPH could limit our ability to develop pegozafermin until a replacement contract manufacturer is found and qualified. We are working with BTPH and a second CMO currently based in China (with plans to expand into the United States) on process optimization to support large-scale production for future trials and commercialization.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We have successfully developed a new refrigerated liquid formulation. This formulation is approved by the FDA and is currently in use in our trials. We are currently developing an additional liquid formulation at various concentrations in Pre-Filled Syringe (&#x201c;PFS&#x201d;). In addition, we have entered into a contract with a commercial fill vendor.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">31</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">BTPH Agreement</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In May 2018, we entered into a master services agreement with BTPH, under which BTPH agreed to provide us certain services, including development, manufacturing, and storing of pegozafermin, under statements of work for such services to be agreed by the parties from time to time.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Sales and Marketing</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We currently have no marketing, sales or distribution capabilities. In order to commercialize any products that are approved for commercial sale, we must either develop a sales and marketing infrastructure or collaborate with third parties that have sales and marketing experience.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We may elect to establish our own sales force to market and sell a product for which we obtain regulatory approval if we expect that the geographic market for a product we develop on our own is limited or that the prescriptions for the product will be written principally by a relatively small number of physicians. If we decide to market and sell any products ourselves, we do not expect to establish direct sales capability until shortly before the products are approved for commercial sale.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We plan to seek third-party support from established pharmaceutical and biotechnology companies for those products that would benefit from the promotional support of a large sales and marketing force. In these cases, we might seek to promote our products in collaboration with marketing partners or rely on relationships with one or more companies with large established sales forces and distribution systems.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Intellectual Property</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Our success depends in part upon our ability to protect our core technology and intellectual property. To protect our intellectual property rights, we rely on patents, trademarks, copyrights and trade secret laws, confidentiality procedures, and employee disclosure and invention assignment agreements. Our intellectual property is critical to our business and we strive to protect it through a variety of approaches, including by obtaining and maintaining patent protection in the United States and internationally for our product candidates, novel biological discoveries, new targets and applications, and other inventions that are important to our business. For our product candidates, we generally intend to pursue patent protection covering compositions of matter, methods of making and methods of use. As we continue the development of our product candidates, we plan to identify additional means of obtaining patent protection that would potentially enhance commercial success, including pursuit of claims directed to new therapeutic indications.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">FGF21 Patents</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Our FGF21 patent portfolio includes six families:</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The first family is entitled &#x201c;Remodeling and GlycoPEGylation of Fibroblast Growth Factor (FGF)&#x201d;. This patent family provides granted patent protection in 39 countries around the globe, including the United States (U.S. Patent Number 9,200,049, expiry date: June 25, 2028; and U.S. Patent Number 10,874,714, expiry date: October 10, 2028), Canada, Europe (broadly), and Japan (latter three expire October 31, 2025) for FGF21 conjugates comprising a variety of modifying groups that can be attached at several different amino acid positions. GlycoPEGylated FGF21 is specifically claimed. The granted claims broadly protect our lead drug candidate pegozafermin and pharmaceutical compositions thereof, as well as methods for making and using pegozafermin to treat FGF21 deficiency in a patient in need thereof.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">32</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The second family is entitled &#x201c;Mutant FGF-21 Peptide Conjugate and Uses Thereof&#x201d; and is specifically directed to pegozafermin. The Patent Cooperation Treaty (&#x201c;PCT&#x201d;) Patent Application for this family was filed on September 4, 2018 (PCT/IB2018/00112). A U.S. Prioritized Examination Continuation Patent Application (Application Serial No. 16/225,640) was filed on December 19, 2018 as a continuation of PCT/IB2018/0112 and from which U.S. Patent Number 10,407,479 was issued on September 10, 2019. The term of the U.S. Patent Number 10,407,479 is September 4, 2038. The issued claims are directed to pegozafermin and a defined genus specifically encompassing pegozafermin and compositions thereof (including site-specific mutations at positions 173 and 176), as well as methods for making and using pegozafermin for a variety of therapeutic indications. Such indications include methods for treating NASH or metabolic syndrome. Subjects where there is a need to reduce blood glucose or to reduce HbA1C include those afflicted with diabetes Type 2, NASH and metabolic syndrome. The claims encompass different therapeutic regimens for administering pegozafermin (e.g., once a week or once every two weeks), which regimens are based on pegozafermin&#x2019;s surprisingly long half-life in vivo. This patent family provides granted patent protection of pegozafermin in 24 ex-United States jurisdictions around the globe: Australia, Canada, China, Europe (broadly), Israel, Japan, Korea and Hong Kong (expiry date: September 4, 2038). One U.S. Patent Application and one China Patent Application are pending in this family.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">  </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The third family is entitled &#x201c;Methods Of Treatment Using Mutant FGF-21 Peptide Conjugates&#x201d;. This patent family provides granted patent protection in United States (U.S. Patent Number 11,427,623). The term of the U.S. Patent Number 11,427,623 is September 4, 2038. One U.S. Patent Application is pending in this family.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">   </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The fourth family is entitled &#x201c;Methods for promoting weight loss&#x201d;. A PCT application was filed January 29, 2021 (PCT/IB2021/000044) with claims directed towards method to reduce total body weight, body fat content and/or BMI. A United States National phase application was filed July 20, 2022. This patent application has not yet been published.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The fifth family is entitled &#x201c;Liquid Formulations Comprising Mutant FGF-21 Peptide Pegylated Conjugates&#x201d; with claims directed to on stable liquid formulation of FGF21. A PCT Patent Application for this family was filed on March 10, 2022. A U.S. Prioritized Examination Patent Application was filed on March 10, 2022. We will continue to file patent applications to cover various formulations of FGF21.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The sixth family is entitled &#x201c;Chemical Synthesis of Cytidine-5'-Monophospho-N-Glycyl-Sialic Acid&#x201d; with claims directed to the chemical synthesis of Cytidine-5'-Monophospho-N-Glycyl-Sialic Acid. A PCT Patent Application for this family was filed on December 20, 2022.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">  </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We expect to continue to file patent applications to cover method of treating different indications.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">FASN Patents</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Our FASN patent portfolio currently consists of three patent families, including patents and/or patent applications in the United States, the European Patent Convention, Canada, Mexico, Israel, China and Japan.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The first patent family, directed to TEV-48317, which we acquired from Teva under the FASN Agreement, and other 1,4-substituted piperidine-based FASN inhibitors, is currently protected by three granted U.S. patents that cover these compounds, pharmaceutical compositions comprising these compounds, and/or methods of treating FASN-mediated disorders using these compounds. The non-extended term for these patents would expire on June 17, 2036. A pending U.S. application has also been filed. The first patent family also includes twelve foreign patents and two foreign patent applications. The second patent family is directed to other 1,4-substituted piperidine-based FASN inhibitors, pharmaceutical compositions, and methods of treating FASN-mediated disorders. The second patent family includes one granted U.S. patent, one U.S. patent application, nine foreign patents, and two foreign patent applications. The third patent family is directed to spiropiperidine FASN inhibitors, pharmaceutical compositions containing these compounds, and methods of treating FASN-mediated disorders using these compounds. The third patent family includes one granted U.S. patent, one U.S. patent application and five foreign patent applications.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">33</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Employees</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As of December 31, 2022, we had 45 full-time employees, of which 33 employees are engaged in research and development activities. None of our employees are represented by labor unions or covered by collective bargaining agreements. We consider our relationship with our employees to be good.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Corporate Information</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We were incorporated in January 2018 in Israel under the name 89Bio Ltd. 89bio, Inc., the registrant whose name appears on the cover page of this Annual Report on Form 10-K, was incorporated in June 2019 for the purpose of an internal reorganization transaction. In September 2019, all of the equity holders of 89Bio Ltd. exchanged 100% of the equity of 89Bio Ltd. for 100% of the equity of 89bio, Inc. Following this exchange, 89Bio Ltd. became a wholly owned subsidiary of 89bio, Inc.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Our principal executive offices are located at 142 Sansome Street, San Francisco, California 94104 and our telephone number is (415) 432-9270. Our website is </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">www.89bio.com</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. Information contained on or accessible through our website is not a part of this Annual Report on Form 10-K, and the inclusion of our website address in this Annual Report on Form 10-K is an inactive textual reference only.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We file electronically with the SEC our Annual Report on Form 10-K, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K and amendments to those reports filed or furnished pursuant to Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended (the &#x201c;Exchange Act&#x201d;). We make available on our website at </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">www.89bio.com</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, under &#x201c;Investors,&#x201d; free of charge, copies of these reports as soon as reasonably practicable after filing or furnishing these reports with the SEC.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Implications of Being an Emerging Growth Company and a Smaller Reporting Company</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We are an &#x201c;emerging growth company&#x201d;, as defined in Section 2(a) of the Securities Act of 1933, as amended (the &#x201c;Securities Act&#x201d;), as modified by the Jumpstart Our Business Startups Act of 2012 (the &#x201c;JOBS Act&#x201d;), and we may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies, including relief from the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act of 2002, as amended, less extensive disclosure obligations regarding executive compensation in our registration statements, periodic reports and proxy statements, exemptions from the requirements to hold a nonbinding advisory vote on executive compensation, and exemptions from stockholder approval of any golden parachute payments not previously approved. We may also elect to take advantage of other reduced reporting requirements in future filings. As a result, our stockholders may not have access to certain information that they may deem important and the information that we provide to our stockholders may be different than, and not comparable to, information presented by other public reporting companies. We could remain an emerging growth company until the earlier of (1) the last day of the year following the fifth anniversary of the completion of our initial public offering (&#x201c;IPO&#x201d;), (2) the last day of the year in which we have total annual gross revenue of at least $1.235 billion, (3) the last day of the year in which we are deemed to be a &#x201c;large accelerated filer&#x201d; as defined in Rule 12b-2 under the Exchange Act, which would occur if the market value of our common stock held by non-affiliates exceeded $700.0 million as of the last business day of the second fiscal quarter of such year or (4) the date on which we have issued more than $1.0 billion in non-convertible debt securities during the prior three-year period.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">34</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In addition, the JOBS Act also provides that an emerging growth company may take advantage of the extended transition period provided in the Securities Act for complying with new or revised accounting standards. An emerging growth company may therefore delay the adoption of certain accounting standards until those standards would otherwise apply to private companies. We have elected to avail ourselves of this exemption and, as a result, will not be subject to the same implementation timing for new or revised accounting standards as are required of other public companies that are not emerging growth companies, which may make comparison of our consolidated financial information to those of other public companies more difficult.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We are also a smaller reporting company, as defined in the Exchange Act. We may continue to be a smaller reporting company even after we are no longer an emerging growth company. We may take advantage of certain of the scaled disclosures available to smaller reporting companies and will be able to take advantage of these scaled disclosures for so long as (i) our voting and non-voting common stock held by non-affiliates is less than $250.0 million measured on the last business day of our second fiscal quarter or (ii) our annual revenue is less than $100.0 million during the most recently completed fiscal year and our voting and non-voting common stock held by non-affiliates is less than $700.0 million measured on the last business day of our second fiscal quarter.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">35</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;" id="item_1a_risk_factors"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Item 1A. Ri</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">sk Factors.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">An investment in our common stock involves a high degree of risk. You should carefully consider the risks and uncertainties described below before deciding whether to make an investment decision with respect to shares of our common stock. You should also refer to the other information contained in this Annual Report on Form 10-K, including &#x201c;Management&#x2019;s Discussion and Analysis of Financial Condition and Results of Operations&#x201d; and our audited consolidated financial statements and related notes. Our business, financial condition, results of operations and prospects could be materially and adversely affected by any of these risks or uncertainties. In any such case, the trading price of our common stock could decline, and you could lose all or part of your investment. We caution you that the risks, uncertainties and other factors referred to below and elsewhere in this Annual Report on Form 10-K may not contain all of the risks, uncertainties and other factors that may affect our future results and operations. Moreover, new risks will emerge from time to time. It is not possible for our management to predict all risks.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Risk Factor Summary</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Investing in our common stock involves significant risks. You should carefully consider the risks described below before making a decision to invest in our common stock. If we are unable to successfully address these risks and challenges, our business, financial condition, results of operations, or prospects could be materially adversely affected. In such case, the trading price of our common stock would likely decline, and you may lose all or part of your investment. Below is a summary of some of the risks we face.</span></p>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We are a clinical-stage biopharmaceutical company with a limited operating history and no products approved for commercial sale. We have incurred net losses since our inception, we expect to incur significant and increasing operating losses and we may never be profitable. Our stock is a highly speculative investment.</span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Our business depends on the success of pegozafermin, our only product candidate under clinical development, which has not completed a pivotal trial. If we are unable to obtain regulatory approval for and successfully commercialize pegozafermin or other future product candidates, or we experience significant delays in doing so, our business will be materially harmed.</span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We will require substantial additional capital to finance our operations, which may not be available to us on acceptable terms, or at all. As a result, we may not complete the development and commercialization of pegozafermin or develop new product candidates.</span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Clinical drug development involves a lengthy and expensive process with uncertain timelines and uncertain outcomes, and the results of prior preclinical or clinical trials are not necessarily predictive of our future results.</span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The ongoing COVID-19 pandemic has resulted and may in the future result in significant disruptions to our clinical trials or other business operations, which could have a material adverse effect on our business.</span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">If we experience delays in clinical testing, our commercial prospects will be adversely affected, our costs may increase and our business may be harmed.</span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">If we encounter difficulties in enrolling patients in our clinical trials, our clinical development activities could be delayed or otherwise adversely affected.</span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We have relied on, and expect to continue to rely on, third-party manufacturers and vendors to produce and release pegozafermin or any future product candidates. Any failure by a third-party to produce and release acceptable product candidates for us pursuant to our specifications and regulatory standards may delay or impair our ability to initiate or complete our clinical trials, obtain and maintain regulatory approvals or commercialize approved products.</span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Pegozafermin and any future product candidates may cause undesirable side effects or have other properties that could delay or prevent their regulatory approval or limit the commercial profile of an approved label.</span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">36</span></p>
  <hr style="page-break-after:always;" />
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We are developing pegozafermin for the treatment of NASH, an indication for which there are no approved products, and the treatment of SHTG. The requirements for approval of pegozafermin by the FDA and comparable foreign regulatory authorities may be difficult to predict and may change over time, which makes it difficult to predict the timing and costs of the clinical development.</span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Lack of efficacy, adverse events or undesirable side effects may emerge in clinical trials conducted by third parties developing FGF product candidates, which could adversely affect our stock price, our ability to attract additional capital and our development program.</span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Interim, topline and preliminary data from our clinical trials that we announce or publish from time to time may change as more patient data become available and are subject to audit and verification procedures that could result in material changes in the final data.</span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The manufacture of biologic products is complex and we are subject to many manufacturing risks, any of which could substantially increase our costs and limit supply of our products.</span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We face substantial competition, which may result in others discovering, developing or commercializing competing products before or more successfully than us.</span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Unstable market and economic conditions may have serious adverse consequences on our business and financial condition.</span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Our Loan and Security Agreement contains certain covenants that could adversely affect our operations and, if an event of default were to occur, we could be forced to repay any outstanding indebtedness sooner than planned and possibly at a time when we do not have sufficient capital to meet this obligation.</span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Pegozafermin has not received regulatory approval. If we are unable to obtain regulatory approvals to market pegozafermin or any future product candidates, our business will be adversely affected.</span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Our success depends upon our ability to obtain and maintain intellectual property protection for our products and technologies.</span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We rely on a license from Teva and a sublicense from ratiopharm to patents and know-how related to glycoPEGylation technology that are used in the development, manufacture and commercialization of pegozafermin. Any termination or loss of significant rights, including the right to glycoPEGylation technology, or breach, under these agreements or any future license agreement related to our product candidates, would materially and adversely affect our ability to continue the development and commercialization of the related product candidates.</span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Risks Related to Our Business and Industry</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">We are a clinical-stage biopharmaceutical company with a limited operating history and no products approved for commercial sale. We have incurred net losses since our inception, we expect to incur significant and increasing operating losses and we may never be profitable. Our stock is a highly speculative investment.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We are a clinical-stage biopharmaceutical company with a limited operating history that may make it difficult to evaluate the success of our business to date and to assess our future viability. We commenced operations in 2018, and to date, our operations have been focused on organizing and staffing our company, raising capital, acquiring our initial product candidate, pegozafermin, licensing certain related technology, conducting research and development activities, including preclinical studies and clinical trials, and providing general and administrative support for these operations. Investment in biopharmaceutical product development is highly speculative because it entails substantial upfront capital expenditures and significant risk that any potential product candidate will fail to demonstrate adequate effect and/or an acceptable safety profile, gain regulatory approval and become commercially viable. We have no products approved for commercial sale, we have not generated any revenue from product sales to date and we continue to incur significant research and development and other expenses related to our ongoing operations. We have limited experience as a company conducting clinical trials and no experience as a company commercializing any products.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">37</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Pegozafermin is in development and, to date, we have not generated any revenue from the licensing or commercialization of pegozafermin. We will not be able to generate product revenue unless and until pegozafermin or any future product candidate, alone or with future partners, successfully completes clinical trials, receives regulatory approval and is successfully commercialized. As pegozafermin is in development, we do not expect to receive revenue from it for a number of years, if ever. Although we may seek to obtain revenue from collaboration or licensing agreements with third parties, we currently have no such agreements that could provide us with material, ongoing future revenue and we may never enter into any such agreements.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We are not profitable and have incurred net losses since our inception. Consequently, predictions about our future success or viability may not be as accurate as they would be if we had a longer operating history or a history of successfully developing and commercializing pharmaceutical products. We have spent, and expect to continue to spend, significant resources to fund research and development of, and seek regulatory approvals for, pegozafermin and any future product candidates. We expect to incur substantial and increasing operating losses over the next several years as our research and development, clinical trials and manufacturing activities increase. In addition, because of the numerous risks and uncertainties associated with pharmaceutical product development, including that our product candidates may not advance or may take longer than expected to advance through development or may not achieve the endpoints of applicable clinical trials, we are unable to predict the timing or amount of increased expenses, or if or when we will achieve or maintain profitability. The size of our future net losses will depend, in part, on the rate of future growth of our expenses and our ability to generate revenue. The net losses we incur may fluctuate significantly from quarter-to-quarter such that a period-to-period comparison of our results of operations may not be a good indication of our future performance. Even if we eventually generate product revenue, we may never be profitable and, if we do achieve profitability, we may not be able to sustain or increase profitability on a quarterly or annual basis.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Our business depends on the success of pegozafermin, our only product candidate under clinical development, which has not completed a pivotal trial. If we are unable to obtain regulatory approval for and successfully commercialize pegozafermin or other future product candidates, or we experience significant delays in doing so, our business will be materially harmed.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The primary focus of our product development is pegozafermin for the treatment of patients with NASH and the treatment of patients with SHTG. Currently, pegozafermin is our only product candidate under clinical development. This may make an investment in our company riskier than similar companies that have multiple product candidates in active development and that therefore may be able to better sustain a failure of a lead candidate. Successful continued development and ultimate regulatory approval of pegozafermin for the treatment of NASH or SHTG is critical to the future success of our business. We have invested, and will continue to invest, a significant portion of our time and financial resources in the clinical development of pegozafermin. If we cannot successfully develop, obtain regulatory approval for and commercialize pegozafermin, we may not be able to continue our operations. The future regulatory and commercial success of pegozafermin is subject to a number of risks, including that if approved for NASH or SHTG, pegozafermin will likely compete with products that may reach approval for the treatment of NASH prior to pegozafermin, products that are currently approved for the treatment of SHTG and the off-label use of currently marketed products for NASH and SHTG.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">We will require substantial additional capital to finance our operations, which may not be available to us on acceptable terms, or at all. As a result, we may not complete the development and commercialization of pegozafermin or develop new product candidates.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As a clinical-stage biopharmaceutical company, our operations have consumed significant amounts of cash since our inception. We expect our research and development expenses to increase in connection with our ongoing activities, particularly as we conduct clinical trials of and seek regulatory approvals for pegozafermin. We believe that our existing cash and cash equivalents and short-term available-for-sale securities will fund our projected operating requirements for a period of at least one year from the date this Annual Report on Form 10-K is filed with the SEC.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">38</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We will require additional capital to discover, develop, obtain regulatory approval for and commercialize pegozafermin and any future product candidates. Our ability to complete new and ongoing clinical trials for pegozafermin may be subject to our ability to raise additional capital. We do not have any committed external source of funds other than as a result of any sales that we may make pursuant to the Sales Agreement for our ATM Facility (defined below) and proceeds from our 2023 Loan Agreement, which are subject to the achievement of certain milestones and/or consent of the lenders. We expect to finance future cash needs through public or private equity or debt offerings or product collaborations. Additional capital may not be available in sufficient amounts or on reasonable terms, if at all. The current market environment for small biotechnology companies, like 89bio, and broader macroeconomic factors may preclude us from successfully raising additional capital.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">If we do not raise additional capital, we may not be able to expand our operations or otherwise capitalize on our business opportunities, our business and financial condition will be negatively impacted and we may need to: significantly delay, scale back or discontinue research and discovery efforts and the development or commercialization of any product candidates or cease operations altogether; seek strategic alliances for research and development programs when we otherwise would not, or at an earlier stage than we would otherwise desire or on terms less favorable than might otherwise be available; or relinquish, or license on unfavorable terms, our rights to technologies or any product candidates that we otherwise would seek to develop or commercialize ourselves.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In addition, if pegozafermin receives approval and is commercialized, we will be required to make milestone and royalty payments to Teva Pharmaceutical Industries Ltd (&#x201c;Teva&#x201d;), from whom we acquired certain patents and intellectual property rights relating to pegozafermin, and from whom we licensed patents and know-how related to glycoPEGylation technology that is used in the manufacture of pegozafermin. For additional information regarding this license agreement, please see Note 5 of our accompanying audited consolidated financial statements.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Clinical drug development involves a lengthy and expensive process with uncertain timelines and uncertain outcomes, and the results of prior preclinical or clinical trials are not necessarily predictive of our future results.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Pegozafermin and any future product candidates will be subject to rigorous and extensive clinical trials and extensive regulatory approval processes implemented by the FDA and comparable foreign regulatory authorities before obtaining marketing approval from these regulatory authorities. The drug development and approval process is lengthy and expensive, and approval is never certain. Investigational new drugs, such as pegozafermin, may not prove to be safe and effective in clinical trials. We have no direct experience as a company in conducting pivotal trials required to obtain regulatory approval. We may be unable to conduct clinical trials at preferred sites, enlist clinical investigators, enroll sufficient numbers of participants or begin or successfully complete clinical trials in a timely fashion, if at all. In addition, the design of a clinical trial can determine whether its results will support approval of a product, and flaws in the design of a clinical trial may not become apparent until the clinical trial is well advanced. We may be unable to design and execute a clinical trial to support regulatory approval. Even if a current clinical trial is successful, it may be insufficient to demonstrate that pegozafermin is safe or effective for registration purposes.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">There is a high failure rate for drugs and biologic products proceeding through clinical trials. Failure can occur at any time during the clinical trial process. The results of preclinical studies and early clinical trials of pegozafermin or any future product candidate may not be predictive of the results of later-stage clinical studies or trials and the results of studies or trials in one set of patients or line of treatment may not be predictive of those obtained in another. In fact, many companies in the pharmaceutical and biotechnology industries have suffered significant setbacks in late-stage clinical trials even after achieving promising results in preclinical studies and earlier stage clinical trials. In addition, data obtained from preclinical and clinical activities is subject to varying interpretations, which may delay, limit or prevent regulatory approval. It is impossible to predict when or if pegozafermin or any future product candidate will prove effective or safe in humans or will receive regulatory approval. Owing in part to the complexity of biological pathways, pegozafermin or any future product candidate may not demonstrate in patients the biochemical and pharmacological properties we anticipate based on laboratory studies or earlier stage clinical trials, and they may interact with human biological systems or other drugs in unforeseen, ineffective or harmful ways. The number of patients exposed to product candidates and the average exposure time in the clinical development programs may be inadequate to detect rare adverse events or findings that may only be detected once a product candidate is administered to more patients and for greater periods of time. To date, our Phase 1a, Phase 1b/2a and Phase 2 clinical trials have involved small patient populations and, because of the small sample size in</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">39</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">such trials, the results of these clinical trials may be subject to substantial variability, including the inherent variability associated with biopsies in NASH patients, and may not be indicative of either future interim results or final results in future trials of patients with liver or cardio-metabolic diseases. If we are unable to successfully demonstrate the safety and efficacy of pegozafermin or other future product candidates and receive the necessary regulatory approvals, our business will be materially harmed.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">The ongoing COVID-19 pandemic has resulted and may in the future result in significant disruptions to our clinical trials or other business operations, which could have a material adverse effect on our business.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Our business and its operations, including but not limited to our research and development activities, have been adversely affected by health epidemics in regions where we have business operations, and such health epidemics have caused and could continue to cause significant disruption in the operations of third parties upon whom we rely. In response to COVID-19, we have implemented hybrid work policy. The effects of which may negatively impact our growth, including our ability to recruit and onboard new employees, and productivity.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The COVID-19 pandemic has impacted execution and enrollment of our trials. Given the surges in cases of COVID-19 experienced previously and uncertainty regarding other variants, we cannot predict how our ongoing or future trials may be impacted.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In addition, COVID-19 has impacted and may continue to impact personnel at third-party manufacturing facilities in the United States, Europe and other countries, or the availability or cost of materials we use or require to conduct our business, including product development, which would disrupt our supply chain.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The COVID-19 pandemic continues to evolve. The ultimate impact of the COVID-19 pandemic or a similar public health emergency is highly uncertain and subject to change. We do not yet know the full extent of potential delays or impacts on our business, our clinical trials, healthcare systems or the global economy as a whole. However, any one or a combination of these events could have an adverse effect on the operation of and results from our clinical trials and on our other business operations, including preventing or delaying approval for pegozafermin.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">40</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">If we experience delays in clinical testing, our commercial prospects will be adversely affected, our costs may increase and our business may be harmed.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We cannot guarantee that we will be able to initiate and complete clinical trials and successfully accomplish all required regulatory activities or other activities necessary to gain approval and commercialize pegozafermin or any future product candidates. We currently have two active investigational new drug (&#x201c;IND&#x201d;) applications with the FDA in the United States for pegozafermin. In the future, we may file an additional IND with another division for any future indications or future product candidates. If any such future IND is not approved by the FDA, our clinical development timeline may be negatively impacted and any future clinical programs may be delayed or terminated. As a result, we may be unable to obtain regulatory approvals or successfully commercialize our products. We do not know whether any other clinical trials will begin as planned, will need to be restructured or will be completed on schedule, or at all. Our product development costs will increase if we experience delays in clinical testing. Significant clinical trial delays also could shorten any periods during which we may have the exclusive right to commercialize pegozafermin and any future product candidates or allow our competitors to bring products to market before we do, which would impair our ability to successfully commercialize pegozafermin or any future product candidates and may harm our business, results of operations and prospects. Our or our future collaborators&#x2019; inability to timely complete clinical development could result in additional costs to us as well as impair our ability to generate product revenue, continue development, commercialize pegozafermin and any future product candidates, reach sales milestone payments and receive royalties on product sales. In addition, if we make changes to a product candidate including, for example, a new formulation, we may need to conduct additional nonclinical studies or clinical trials to bridge or demonstrate the comparability of our modified product candidate to earlier versions, which could delay our clinical development plan or marketing approval for our current product candidate and any future product candidates.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">If we encounter difficulties in enrolling patients in our clinical trials, our clinical development activities could be delayed or otherwise adversely affected.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The timely completion of clinical trials largely depends on patient enrollment. We may encounter delays in enrolling, or be unable to enroll, a sufficient number of patients to complete any of our future clinical trials, and even once enrolled, we may be unable to retain a sufficient number of patients to complete any of our trials. Furthermore, there are inherent difficulties in diagnosing NASH, which can currently only be definitively diagnosed through a liver biopsy, and identifying SHTG patients. Specifically, identifying patients most likely to meet NASH enrollment criteria on biopsy is an on-going challenge, with existing clinical indicators lacking both sensitivity and specificity. As a result, NASH trials often suffer from high levels of screen failure following central review of the baseline liver biopsy, which can lead to lower enrollment. As a result of such difficulties and the significant competition for recruiting NASH and SHTG patients in clinical trials, we or our future collaborators may be unable to enroll the patients we need to complete clinical trials on a timely basis, or at all. We plan to leverage the safety database from the SHTG Phase 3 program across both the SHTG and NASH indications. If we are not able enroll enough patients in our trials sufficient to support the safety database, our ability to advance the development of pegozafermin may be adversely affected.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In addition, our competitors, some of whom have significantly greater resources than we do, are conducting clinical trials for the same indications and seek to enroll patients in their studies that may otherwise be eligible for our clinical studies or trials. Since the number of qualified clinical investigators is limited, we expect to conduct some of our clinical trials at the same clinical trial sites that some of our competitors use, which could further reduce the number of patients who are available for our clinical trials in these sites. Our inability to enroll a sufficient number of patients for our clinical trials would result in significant delays or may require us to abandon one or more clinical trials altogether. Even if we are able to enroll a sufficient number of patients in our clinical studies or trials, delays in patient enrollment may result in increased costs or may affect the timing or outcome of our clinical trials, which could prevent completion of these trials and adversely affect our ability to advance the development of pegozafermin and any future product candidates.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">41</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">We have relied on, and expect to continue to rely on, third-party manufacturers and vendors to produce and release pegozafermin or any future product candidates. Any failure by a third-party to produce and release acceptable product candidates for us pursuant to our specifications and regulatory standards may delay or impair our ability to initiate or complete our clinical trials, obtain and maintain regulatory approvals or commercialize approved products.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We do not own or operate manufacturing facilities for the production of clinical or commercial quantities of our product candidates, and we lack the resources and the capabilities to do so. As a result, we currently rely, and expect to rely for the foreseeable future, on third-party manufacturers to supply us with pegozafermin and any future product candidates. We currently have a sole source relationship with BTPH pursuant to which they supply us with pegozafermin. If there should be any disruption in our supply arrangement with BTPH, including any adverse events affecting BTPH, it could have a negative effect on the clinical development of pegozafermin and other operations while we work to identify and qualify an alternate supply source. In addition, we will require large quantities of pegozafermin for large clinical trials and to commercialize pegozafermin. Our current manufacturer may not be able to scale production to the larger quantities. We have identified a manufacturing partner for commercial-scale manufacturing, however, we cannot guarantee that such partner will be able to scale up and produce the quantities we would require to commercialize pegozafermin.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We do not have a long-term supply agreement with any third-party manufacturer. Reliance on third-party manufacturers entails risks to which we would not be subject if we manufacture product candidates or products ourselves. For example, if we do not maintain our key manufacturing relationships, we may fail to find replacement manufacturers or develop our own manufacturing capabilities in a timely manner or at all, which could delay or impair our ability to obtain regulatory approval for our products and substantially increase our costs or deplete profit margins, if any. If we do find replacement manufacturers, we may not be able to enter into agreements with them on terms and conditions favorable to us, and there could be a substantial delay before new facilities could be qualified and registered with the FDA and other comparable foreign regulatory authorities.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We have begun producing certain of the reagents required for the glycoPEGylation at BTPH using the know-how transferred to us from Teva under our Reagent Supply and Technology Transfer Agreement. We have not completed the manufacturing process for all these reagents and cannot guarantee that we will be able to produce them successfully, or scale up our production for the quantities needed for commercialization.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Teva supplied us with certain reagents until December 31, 2022. We transferred the manufacturing of such reagents to new suppliers prior to the end of 2022. Any significant delay in the acquisition or decrease in the availability of these raw materials from suppliers could considerably delay the manufacture of pegozafermin, which could adversely impact the timing of any planned trials or the regulatory approvals of pegozafermin.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We rely on third-party vendors for our assay development and testing. If such third-party vendors are unable to successfully produce or test such assays, it may substantially increase our cost or could adversely impact the timing of any planned trials or the regulatory approvals of pegozafermin.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The FDA and other comparable foreign regulatory authorities require manufacturers to register manufacturing facilities. The FDA and other comparable foreign regulatory authorities also inspect these facilities to confirm compliance with cGMP. We have little to no control regarding the occurrence of third-party manufacturer incidents. Any failure to comply with cGMP requirements or other FDA or comparable foreign regulatory requirements could adversely affect our clinical research activities and our ability to develop pegozafermin or any future product candidates and market our products following approval. Our sole source supplier, BTPH, has not yet manufactured a commercial product, and as a result, has not been subject to inspection by the FDA and other comparable foreign regulatory authorities.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Our current and anticipated future dependence upon others for the manufacture of our product candidates may adversely affect our future profit margins and our ability to develop our product candidates and commercialize any products that receive regulatory approval on a timely basis. Supply chain issues, including those resulting from the COVID-19 pandemic and the ongoing war in Ukraine, may affect our third-party vendors and cause delays. Furthermore, since we have engaged a manufacturer located in China, we are exposed to the possibility of product supply disruption and increased costs in the event of changes in the policies of the United States or Chinese</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">42</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">governments, political unrest or unstable economic conditions in China. If we are required to change manufacturers for any reason, we will be required to verify that the new manufacturer maintains facilities and procedures that comply with quality standards and with all applicable regulations and guidelines. For example, in the event that we need to switch our third-party manufacturer of pegozafermin from BTPH, which is our sole manufacturing source for pegozafermin, we anticipate that the complexity of the glycoPEGylation manufacturing process may materially impact the amount of time it may take to secure a replacement manufacturer. The delays associated with the verification of a new manufacturer, if we are able to identify an alternative source, could negatively affect our ability to develop product candidates in a timely manner or within budget.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Pegozafermin and any future product candidates may cause undesirable side effects or have other properties that could delay or prevent their regulatory approval or limit the commercial profile of an approved label.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Undesirable side effects caused by pegozafermin or any future product candidates could cause us or regulatory authorities to interrupt, delay or halt clinical trials and could result in a more restrictive label or the delay or denial of regulatory approval by the FDA or other comparable foreign regulatory authorities. Additional clinical studies may be required to evaluate the safety profile of pegozafermin or any future product candidates. As with other drugs, we have seen evidence of adverse effects in animal and human studies and it is possible that other adverse effects will become apparent in ongoing or future animal or human safety studies. It may be difficult to discern whether certain events or symptoms observed during our clinical trials or by patients using our approved products are related to pegozafermin or any future product candidates or approved products or some other factor. As a result, we and our development programs may be negatively affected even if such events or symptoms are ultimately determined to be unlikely related to pegozafermin or any future product candidates or approved products. Further, we expect that pegozafermin will require multiple administrations via subcutaneous injection in the course of a clinical trial. This chronic administration increases the risk that rare adverse events or chance findings are discovered in the commercial setting, where pegozafermin would be administered to more patients or for greater periods of time, that were not uncovered by our clinical drug development programs.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">We are developing pegozafermin for the treatment of NASH, an indication for which there are no approved products, and the treatment of SHTG. The requirements for approval of pegozafermin by the FDA and comparable foreign regulatory authorities may be difficult to predict and may change over time, which makes it difficult to predict the timing and costs of the clinical development.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We are developing pegozafermin for the treatment of NASH, an indication for which there are no approved products. Although there are guidelines issued by the FDA for the development of drugs for the treatment of NASH, the development of a novel product candidates such as pegozafermin may be more expensive and take longer than for other, better known or extensively studied product candidates. As other companies are in later stages of clinical trials for their potential NASH therapies, we expect that the path for regulatory approval for NASH therapies may continue to evolve in the near term as these other companies refine their regulatory approval strategies and interact with regulatory authorities. Such evolution may impact our future clinical trial designs, including trial size and endpoints, in ways that we cannot predict today. In particular, regulatory authority expectations about liver biopsy data may evolve especially as more information is published about the inherent variability in liver biopsy data. Certain of our competitors have experienced regulatory setbacks for NASH therapies following communications from the FDA. We currently do not know the impact, if any, that these setbacks could have on the path for regulatory approval for NASH therapies generally or for pegozafermin. Furthermore, the histology endpoints from our Phase 2b ENLIVEN trial may not be accepted as primary endpoints for a pivotal Phase 3 trial or for FDA approval.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We are also developing pegozafermin for the treatment of SHTG. Clinical trials for the treatment of SHTG may be relatively costly and time-consuming. In addition, the requirements for approval by the FDA and comparable foreign regulatory authorities may change over time. If the FDA disagrees with our trial and program design for our planned Phase 3 program for SHTG or requires additional evidence to support a successful submission for approval, we may be required to make changes to our program design that could impact timelines and cost.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">43</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Our anticipated development costs would likely increase if development of pegozafermin or any future product candidate is delayed because we are required by the FDA to perform studies or trials in addition to, or different from, those that we currently anticipate, or make changes to ongoing or future clinical trial designs. In addition, if we are unable to leverage our safety database for both SHTG and NASH indications, we may be required to perform additional trials, which would result in increased costs and may affect the timing or outcome of our clinical trials.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Lack of efficacy, adverse events or undesirable side effects may emerge in clinical trials conducted by third parties developing FGF product candidates, which could adversely affect our stock price, our ability to attract additional capital and our development program.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Lack of efficacy, adverse events or undesirable side effects may emerge in clinical trials conducted by third parties developing FGF product candidates like ours. For example, Novo Nordisk, Akero Therapeutics, Inc. and Boston Pharmaceuticals are also developing FGF21 product candidates for the treatment of NASH. We have no control over their clinical trials or development program, and lack of efficacy, adverse events or undesirable side effects experienced by subjects in their clinical trials could adversely affect our stock price, our ability to attract additional capital and our clinical development plans for pegozafermin or even the viability or prospects of pegozafermin</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">as a product candidate, including by creating a negative perception of FGF therapeutics by healthcare providers or patients.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Interim, topline and preliminary data from our clinical trials that we announce or publish from time to time may change as more patient data become available and are subject to audit and verification procedures that could result in material changes in the final data.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">From time to time, we may publicly disclose preliminary or topline data from our clinical trials, which are based on a preliminary analysis of then-available data, and the results and related findings and conclusions are subject to change following a more comprehensive review of the data related to the particular study or trial. We also make assumptions, estimations, calculations and conclusions as part of our analyses of data, and we may not have received or had the opportunity to fully and carefully evaluate all data. As a result, the topline results that we report may differ from future results of the same studies, or different conclusions or considerations may qualify such results, once additional data have been received and fully evaluated. Topline data also remain subject to audit and verification procedures that may result in the final data being materially different from the preliminary data we previously published. As a result, topline data should be viewed with caution until the final data are available. From time to time, we may also disclose interim data from our clinical trials. In addition, we may report interim analyses of only certain endpoints rather than all endpoints. Interim data from clinical trials that we may complete are subject to the risk that one or more of the clinical outcomes may materially change as patient enrollment continues and more patient data become available.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">The manufacture of biologic products is complex and we are subject to many manufacturing risks, any of which could substantially increase our costs and limit supply of our products.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">To date, pegozafermin has been manufactured by a single third-party manufacturer, BTPH, solely for preclinical studies and clinical trials. The process of manufacturing pegozafermin, and in particular, the glycoPEGylation process, is complex, highly regulated and subject to several risks and requires significant expertise and capital investment, including for the development of advanced manufacturing techniques and process controls. Manufacturers of biologic products often encounter difficulties in production, including difficulties with production costs and yields, quality control, including stability of the product, quality assurance testing, operator error and shortages of qualified personnel, as well as compliance with strictly enforced federal, state and foreign regulations. We cannot assure you that any stability or other issues relating to the manufacture of pegozafermin will not occur in the future. We have limited process development capabilities and have access only to external manufacturing capabilities. We do not have and we do not currently plan to acquire or develop the facilities or capabilities to manufacture bulk drug substance or filled drug product for use in human clinical trials or commercialization.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">44</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">We face substantial competition, which may result in others discovering, developing or commercializing competing products before or more successfully than us.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The biopharmaceutical industry is intensely competitive and subject to rapid innovation and significant technological advancements. Our competitors include multinational pharmaceutical companies, specialized biotechnology companies, universities and other research institutions. A number of biotechnology and pharmaceutical companies are pursuing the development or marketing of pharmaceuticals that target the same diseases that we are targeting. Certain of these companies have recently published positive data regarding their clinical trials, which may further increase the competition we face. Smaller or earlier-stage companies may also prove to be significant competitors, particularly through collaborative arrangements with large, established companies. Given the high incidence of NASH and SHTG, it is likely that the number of companies seeking to develop products and therapies for the treatment of liver and cardio-metabolic diseases, such as NASH and SHTG, will increase.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">There are numerous currently approved therapies for treating diseases other than NASH and some of these currently approved therapies may exert effects that could be similar to pegozafermin in NASH. Many of these approved drugs are well-established therapies or products and are widely accepted by physicians, patients and third-party payors. Some of these drugs are branded and subject to patent protection, and others are available on a generic basis. This may make it difficult for us to differentiate our products from currently approved therapies, which may adversely impact our business strategy. We expect that if pegozafermin or any future product candidates are approved, they will be priced at a significant premium over competitive generic products, including branded generic products. Insurers and other third-party payors may also encourage the use of generic products or specific branded products prior to utilization of pegozafermin. In addition, many companies are developing new therapeutics, and we cannot predict what the standard of care will be as pegozafermin or any future product candidates progress through clinical development. In addition, to the extent pegozafermin or any future product candidates are approved for liver or cardio-metabolic indications, such as SHTG, the commercial success of our products will also depend on our ability to demonstrate benefits over the then-prevailing standard of care, including diet, exercise and lifestyle modifications.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Further, if pegozafermin or any future product candidates are approved for the treatment of SHTG, we will compete with currently approved therapies and therapies further along in development. Our competitors both in the United States and abroad include large, well-established pharmaceutical and generic companies with significantly greater name recognition. Our competitors may be able to charge lower prices than we can, which may adversely affect our market acceptance. Many of these competitors have greater resources than we do, including financial, product development, marketing, personnel and other resources.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">If our competitors market products that are more effective, safer or cheaper than our products or that reach the market sooner than our products, we may not achieve commercial success. Many of our competitors have substantially greater financial, technical, human and other resources than we do and may be better equipped to develop, manufacture and market technologically superior products. As a result, our competitors may obtain regulatory approval of their products more rapidly than we do or may obtain patent protection or other intellectual property rights that limit our ability to develop or commercialize our product candidate or any future product candidates. Our competitors may also develop and succeed in obtaining approval for drugs that are more effective, more convenient, more widely used and less costly or have a better safety profile than our products and these competitors may also be more successful than we are in manufacturing and marketing their products.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Unstable market and economic conditions, inflation, increases in interest rates, natural disasters, public health crises such as the COVID-19 pandemic, political crises, geopolitical events, such as the crisis in Ukraine, or other macroeconomic conditions, may have serious adverse consequences on our business and financial condition.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The global economy, including credit and financial markets, have experienced extreme volatility and disruptions at various points over the last few decades, including, among other things, diminished liquidity and credit availability, declines in consumer confidence, declines in economic growth, supply chain shortages, increases in inflation rates, higher interest rates, and uncertainty about economic stability. For example, the COVID-19 pandemic resulted in widespread unemployment, economic slowdown and extreme volatility in the capital markets. The Federal Reserve has raised interest rates multiple times in response to concerns about inflation and it may raise</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">45</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">them again. Higher interest rates, coupled with reduced government spending and volatility in financial markets, may increase economic uncertainty and affect consumer spending. Similarly, the ongoing military conflict between Russia and Ukraine and the rising tensions between China and Taiwan have created extreme volatility in the global capital markets and may have further global economic consequences, including disruptions of the global supply chain. Any such volatility and disruptions may adversely affect our business or the third parties on whom we rely. If the equity and credit markets deteriorate, including as a result of political unrest or war, it may make any necessary debt or equity financing more difficult to complete, more costly, and more dilutive. Failure to secure any necessary financing in a timely manner and on favorable terms could have a material adverse effect on our growth strategy, financial performance and share price and could require us to delay or abandon development or commercialization plans. In addition, there is a risk that one or more of our service providers, manufacturers or other partners would not survive or be able to meet their commitments to us under such circumstances, which could directly affect our ability to attain our operating goals on schedule and on budget.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We have experienced and may in the future experience disruptions as a result of such macroeconomic conditions, including delays or difficulties in initiating or expanding clinical trials and manufacturing sufficient quantities of materials. Any one or a combination of these events could have a material and adverse effect on our results of operations and financial condition.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:8.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">The 2023 Loan Agreement contains certain covenants that could adversely affect our operations and, if an event of default were to occur, we could be forced to repay any outstanding indebtedness sooner than planned and possibly at a time when we do not have sufficient capital to meet this obligation.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Pursuant to the 2023 Loan Agreement, we have pledged substantially all of our assets, other than our intellectual property rights, and have agreed that we may not sell or assign rights to our patents and other intellectual property without the prior consent of our lenders. Additionally, the 2023 Loan Agreement contains certain affirmative and negative covenants that could prevent us from taking certain actions without the consent of our lenders. These covenants may limit our flexibility in operating our business and our ability to take actions that might be advantageous to us and our stockholders. The 2023 Loan Agreement also includes customary events of default, including, among other things, an event of default upon a change of control. Upon the occurrence and continuation of an event of default, all amounts due under the 2023 Loan Agreement become automatically (in the case of a bankruptcy event of default) or may become (in the case of all other events of default and at the option of the administrative agent), immediately due and payable. If an event of default under the 2023 Loan Agreement should occur and be continuing, we could be required to immediately repay any outstanding indebtedness. If we are unable to repay such debt, the lenders would be able to foreclose on the secured collateral, including our cash accounts, and take other remedies permitted under the 2023 Loan Agreement. Even if we are able to repay such accelerated debt amount under the 2023 Loan Agreement upon an event of default, the repayment of these sums may significantly reduce our working capital and impair our ability to operate as planned.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">We may encounter difficulties in managing our growth, which could adversely affect our operations.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We are in the early stages of building the full team that we anticipate we will need to complete the development pegozafermin and other future product candidates. As we advance our preclinical and clinical development programs for product candidates, seek regulatory approval in the United States and elsewhere and increase the number of ongoing product development programs, we anticipate that we will need to increase our product development, scientific and administrative headcount. We will also need to establish commercial capabilities in order to commercialize any product candidates that may be approved. Such an evolution may impact our strategic focus and our deployment and allocation of resources. Our ability to manage our operations and growth effectively depends upon the continual improvement of our procedures, reporting systems and operational, financial and management controls. We may not be able to implement administrative and operational improvements in an efficient or timely manner and may discover deficiencies in existing systems and controls. In addition, in order to continue to meet our obligations as a public company and to support our anticipated long-term growth, we will need to increase our general and administrative capabilities. Our management, personnel and systems may experience difficulty in adjusting to our growth and strategic focus.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">46</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">We must attract and retain highly skilled employees in order to succeed. If we are not able to retain our current senior management team and our scientific advisors or continue to attract and retain qualified scientific, technical and business personnel, our business will suffer.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We may not be able to attract or retain qualified personnel and consultants due to the intense competition for such individuals in the biotechnology and pharmaceutical industries. If we are not able to attract and retain necessary personnel and consultants to accomplish our business objectives, it may significantly impede the achievement of our development and commercial objectives and our ability to implement our business strategy. In addition, we are highly dependent on the development, regulatory, manufacturing, commercialization and financial expertise of the members of our executive team, as well as other key employees and consultants. If we lose one or more of our executive officers or other key employees or consultants, our ability to implement our business strategy successfully could be seriously harmed.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">We are developing new presentations for the liquid formulation of pegozafermin and we may be unsuccessful. Any changes in methods of product candidate manufacturing may result in the need to perform new clinical trials or obtain new drug product, which would require additional costs and cause delay.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We are developing a pre-filled syringe and plan to begin development of a pen-type autoinjector to deliver the liquid formulation of pegozafermin. Any formulation and presentation intended for commercialization is subject to regulatory approval. While the FDA has approved our new drug product formulation, there is no assurance that we will be successful in developing and receiving approval of a pre-filled syringe or an autoinjector on a timely basis or at all, any of which could impede our development and commercialization strategy for pegozafermin. In addition, there is no assurance comparable foreign regulatory authorities will approve our new drug product formulation. The FDA or other comparable foreign regulatory authorities could require nonclinical studies or clinical trials to support introduction of any new formulation, pre-filled syringe and autoinjector, which could delay completion of clinical trials, require the conduct of bridging clinical trials or the repetition of one or more clinical trials, increase our clinical trial costs, delay approval of pegozafermin and jeopardize our ability to commence product sales and generate revenue from pegozafermin, if approved.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">We rely on third parties for certain aspects of our product candidate development process and we may not be able to obtain and maintain the third-party relationships that are necessary to develop, commercialize and manufacture some or all of our product candidates.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We expect to depend on collaborators, partners, licensees, clinical investigators, contract research organizations, manufacturers and other third parties to support our discovery efforts, to formulate product candidates, to conduct clinical trials for some or all of our product candidates, to manufacture clinical and commercial scale quantities of our drug substance and drug product and to market, sell and distribute any products we successfully develop. Any of these third parties may terminate their engagements with us at any time. If we need to enter into alternative arrangements, it would delay our product development activities and such alternative arrangements may not be available on terms acceptable to us. We also expect to rely on other third parties to store and distribute drug supplies for our clinical trials. Any performance failure on the part of our distributors could delay clinical development, marketing approval and/or commercialization of pegozafermin or any future product candidates, producing additional losses and depriving us of potential revenue.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Business disruptions could seriously harm our future revenue and financial condition and increase our costs and expenses.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Our operations, and those of our contract research organizations, CMO, suppliers, and other contractors and consultants, could be subject to earthquakes, power shortages, telecommunications failures, water shortages, floods, hurricanes, typhoons, fires, extreme weather conditions, acts of war, medical pandemics or epidemics, such as the novel coronavirus, and other natural or man-made disasters or business interruptions. The occurrence of any of these business disruptions could seriously harm our operations and financial condition and increase our costs and expenses.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">47</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">If we fail to develop and commercialize additional product candidates, we may be unable to grow our business.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Although the development and commercialization of pegozafermin is currently our primary focus, as part of our longer-term growth strategy, we plan to evaluate the development and commercialization of other therapies related to NASH and other liver and cardio-metabolic diseases. The success of this strategy depends primarily upon our ability to identify and validate new therapeutic candidates, and to identify, develop and commercialize new drugs and biologics. Our research efforts may initially show promise in discovering potential new drugs and biologics yet fail to yield product candidates for clinical development for a number of reasons.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">We may use our limited financial and human resources to pursue a particular research program or product candidate that is ultimately unsuccessful or less successful than other programs or product candidates that we may have forgone or delayed.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Because we have limited personnel and financial resources, we may forego or delay the development of certain programs or product candidates that later prove to have greater commercial potential than the programs or product candidates that we do pursue. Our resource allocation decisions may cause us to fail to capitalize on viable commercial products or profitable market opportunities. Our spending on current and future research and development programs for product candidates may not yield any commercially viable products. Similarly, our decisions to delay or terminate drug development programs may also be incorrect and could cause us to miss valuable opportunities.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">We may seek to establish commercial collaborations for our product candidates, and, if we are not able to establish them on commercially reasonable terms, we may have to alter our development and commercialization plans.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Our drug development programs and the potential commercialization of our product candidates will require substantial additional cash to fund expenses. We may decide to collaborate with other pharmaceutical and biotechnology companies for the development and potential commercialization of our product candidates. Collaborations are complex and time-consuming to negotiate and document. We may not be able to negotiate collaborations on a timely basis, on acceptable terms, or at all. If we are unable to do so, we may have to curtail the development of the product candidate for which we are seeking to collaborate, reduce or delay its development program or one or more of our other development programs, delay its potential commercialization or reduce the scope of any sales or marketing activities or increase our expenditures and undertake development or commercialization activities at our own expense.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">We may not be successful in our efforts to identify, in-license or acquire, discover, develop or commercialize additional product candidates.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We may seek to identify, in-license or acquire, discover, develop and commercialize additional product candidates. We cannot assure you that our effort to in-license or acquire additional product candidates will be successful. Even if we are successful in in-licensing or acquiring additional product candidates, their requisite development activities may require substantial resources, and we cannot assure you that these development activities will result in regulatory approvals.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Our international operations may expose us to business, regulatory, political, operational, financial, pricing and reimbursement risks associated with doing business outside of the United States.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Our use of our international facilities subjects us to U.S. and foreign governmental trade, import and export, and customs regulations and laws, including various economic and trade sanctions regulations administered by the U.S. Treasury Department&#x2019;s Office of Foreign Assets Controls and the U.S. Export Administration Regulations. Compliance with these regulations and laws is costly and exposes us to penalties for non-compliance. Doing business internationally potentially involves a number of risks, any of which could harm our ongoing international clinical operations and supply chain, as well as any future international expansion and operations and, consequently, our business, financial condition, prospects and results of operations.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">48</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Product liability lawsuits against us could cause us to incur substantial liabilities and to limit commercialization of any products that we may develop.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We face an inherent risk of product liability exposure related to the testing of our product candidates in human clinical trials and will face an even greater risk if we commercialize any resulting products. Product liability claims may be brought against us by subjects enrolled in our clinical trials, patients, or others using our products. Our clinical trial liability insurance coverage may not adequately cover all liabilities that we may incur.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Our employees, contractors, vendors, principal investigators, consultants and future partners may engage in misconduct or other improper activities, including noncompliance with regulatory standards and requirements and insider trading.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We are exposed to the risk of fraud or other misconduct by our employees, contractors, vendors, principal investigators, consultants or future partners. Misconduct by these parties could include failures to comply with FDA regulations, to provide accurate information to the FDA, to comply with federal and state healthcare fraud and abuse laws and regulations, to report financial information or data timely, completely or accurately, or to disclose unauthorized activities to us. Most states also have statutes or regulations similar to these federal laws, which may apply to items such as pharmaceutical products and services reimbursed by private insurers. We and/or our future partners may be subject to administrative, civil and criminal sanctions for violations of any of these laws.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">We depend on our information technology systems and those of our third-party collaborators, service providers, contractors or consultants. Our internal computer systems, or those of our third-party collaborators, service providers, contractors or consultants, may fail or suffer security breaches, disruptions, or incidents, which could result in a material disruption of our development programs or loss of data or compromise the privacy, security, integrity or confidentiality of sensitive information related to our business and have a material adverse effect on our reputation, business, financial condition or results of operations.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In the ordinary course of our business, we collect, store and transmit large amounts of confidential information, including intellectual property, proprietary business information and personal information. Our internal technology systems and infrastructure, and those of our current or future third-party collaborators, service providers, contractors and consultants are vulnerable to damage from computer viruses, unauthorized access or use resulting from malware, natural disasters, terrorism, war and telecommunication and electrical failures, denial-of-service attacks, cyber-attacks or cyber-intrusions over the Internet, hacking, phishing and other social engineering attacks, persons inside our organizations (including employees or contractors), loss or theft, or persons with access to systems inside our organization. From time to time, we are subject to periodic phishing attempts. In the third quarter of 2021, we discovered a business email compromise caused by phishing. The phishing attack did not result in the misappropriation of any funds and we do not believe that it had a material adverse effect on our business. We implemented remedial measures promptly following this incident, however, we cannot guarantee that our implemented remedial measures will prevent additional related, as well as unrelated, incidents. If a material system failure, accident or security breach were to occur and cause interruptions in our operations or the operations of third-party collaborators, service providers, contractors and consultants, it could result in a material disruption of our development programs and significant reputational, financial, legal, regulatory, business or operational harm.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">To the extent that any real or perceived security breach affects our systems (or those of our third-party collaborators, service providers, contractors or consultants), or results in the loss of or accidental, unlawful or unauthorized access to, use of, release of, or other processing of personally identifiable information or damage to our data or applications or other data or applications relating to our technology or product candidates, or inappropriate disclosure of confidential or proprietary information, we could incur liabilities and the further development of our product candidates could be delayed. Any failure or perceived failure by us or any third-party collaborators, service providers, contractors or consultants to comply with our privacy, confidentiality, data security or similar obligations, or any data security incidents or other security breaches that result in the accidental, unlawful or unauthorized access to, use of, release of, processing of, or transfer of sensitive information, including personally identifiable information, may result in negative publicity, harm to our reputation, governmental investigations, enforcement actions, regulatory fines, litigation or public statements against us, could cause third parties to lose trust in us or could result in claims by third parties, including those that assert that we have breached our privacy,</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">49</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">confidentiality, data security or similar obligations, any of which could have a material adverse effect on our reputation, business, financial condition or results of operations.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Risks Related to Regulatory Approvals</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Pegozafermin has not received regulatory approval. If we are unable to obtain regulatory approvals to market pegozafermin or any future product candidates, our business will be adversely affected.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We do not expect pegozafermin or any future product candidate to be commercially available for several years, if at all. Pegozafermin is and any future product candidate will be subject to strict regulation by regulatory authorities in the United States and in other countries. We cannot market any product candidate until we have completed all necessary preclinical studies and clinical trials and have obtained the necessary regulatory approvals. We do not know whether regulatory agencies will grant approval for pegozafermin or any future product candidate. Even if we complete preclinical studies and clinical trials successfully, we may not be able to obtain regulatory approvals or we may not receive approvals to make claims about our products that we believe to be necessary to effectively market our products. Data obtained from preclinical studies and clinical trials is subject to varying interpretations that could delay, limit or prevent regulatory approval, and failure to comply with regulatory requirements or inadequate manufacturing processes are examples of other problems that could prevent approval.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The regulatory authorities in the United States and the EU have not approved any products for the treatment of NASH, and while there are guidelines issued by the FDA for the development of drugs for the treatment of NASH, it is unclear whether the requirements for approval will change in the future or whether the FDA will rely on regulatory precedent for future regulatory approvals. Any such changes may require us to conduct new trials that could delay our timeframe and increase the costs of our programs related to pegozafermin or any future product candidate for the treatment of NASH or SHTG. In addition, we cannot be certain which efficacy endpoints or presentation thereof clinical or regulatory agencies may require in a Phase 3 clinical trial of NASH or for approval of our product candidates.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Even if we are able to obtain regulatory approvals for pegozafermin or any future product candidate, if they exhibit harmful side effects after approval, our regulatory approvals could be revoked or otherwise negatively impacted, and we could be subject to costly and damaging product liability claims.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Even if we receive regulatory approval for pegozafermin or any future product candidates, we will have tested them in only a small number of patients during our clinical trials. If our applications for marketing are approved and more patients begin to use our product, new risks and side effects associated with our products may be discovered. As a result, regulatory authorities may revoke their approvals. We have not had any discussions with the FDA regarding a surrogate endpoint or accelerated approval regulations. However, based on recent guidelines issued by the FDA for the development of drugs for the treatment of NASH, if pegozafermin is approved by the FDA based on a surrogate endpoint pursuant to section 506(c) of the Federal Food, Drug, and Cosmetic Act and the accelerated approval regulations (21 C.F.R. part 314, subpart H; 21 C.F.R. part 601, subpart E), consistent with FDA guidance, we will be required to conduct additional clinical trials establishing clinical benefit on the ultimate outcome of NASH. If pegozafermin is approved by the FDA for the treatment of SHTG based on an endpoint of the reduction of triglycerides, the FDA may still require a cardiovascular outcomes study as part of a post-marketing authorization commitment. Such a study would be time-consuming and costly and we cannot guarantee that we will see positive results, which could result in the revocation of the approval. Additionally, we may be required to conduct additional clinical trials, make changes in labeling of our product, reformulate our product or make changes and obtain new approvals for our and our suppliers&#x2019; manufacturing facilities for pegozafermin and any future product candidates. We might have to withdraw or recall our products from the marketplace. We may also experience a significant drop in the potential sales of our product if and when regulatory approvals for such product are revoked. As a result, we may experience harm to our reputation in the marketplace or become subject to lawsuits, including class actions. Any of these results could decrease or prevent any sales of our approved product or substantially increase the costs and expenses of commercializing and marketing our product.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">50</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">The regulatory approval processes of the FDA and comparable foreign regulatory authorities are lengthy, time-consuming and inherently unpredictable. Our inability to obtain regulatory approval for pegozafermin</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">or any future product candidates would substantially harm our business.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Currently, we do not have any product candidates that have received regulatory approval. The time required to obtain approval from the FDA and comparable foreign regulatory authorities is unpredictable but typically takes many years following the commencement of preclinical studies and clinical trials and depends upon numerous factors, including the substantial discretion of the regulatory authorities. In addition, approval policies, regulations or the type and amount of clinical data necessary to gain approval may change during the course of a product candidate&#x2019;s development and may vary among jurisdictions. It is possible that none of pegozafermin or any future product candidates will ever obtain regulatory approval. Pegozafermin or any future product candidate could fail to receive regulatory approval from the FDA or comparable foreign regulatory authorities for many reasons, including those referenced in Part I, Item 1. &#x201c;Business-Government Regulation and Product Approval&#x201d; in this Annual Report on Form 10-K. If we were to obtain approval, regulatory authorities may approve any of our product candidates for fewer or more limited indications than we request, may grant approval contingent on the performance of costly post-marketing clinical trials or may approve a product candidate with a label that does not include the labeling claims necessary or desirable for the successful commercialization of the product candidate.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Even if pegozafermin or any future product candidate receives regulatory approval, it may still face future development and regulatory difficulties.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Even if we obtained regulatory approval for a product candidate, it would be subject to ongoing requirements by the FDA and comparable foreign regulatory authorities governing the manufacture, quality control, further development, labeling, packaging, storage, distribution, safety surveillance, import, export, advertising, promotion, recordkeeping and reporting of safety and other post-market information. In addition, manufacturers of drug products and their facilities are subject to continual review and periodic inspections by the FDA and other regulatory authorities for compliance with cGMP, regulations and standards. If we or a regulatory agency discover previously unknown problems with a product, such as adverse events of unanticipated severity or frequency, or problems with the facility where the product is manufactured, a regulatory agency may impose restrictions on that product, the manufacturing facility or us, including requiring recall or withdrawal of the product from the market or suspension of manufacturing. If we, our product candidates or the manufacturing facilities for our product candidates fail to comply with applicable regulatory requirements, or undesirable side effects caused by such products are identified, a regulatory agency may: issue safety alerts, Dear Healthcare Provider letters, press releases or other communications containing warnings about such product; mandate modifications to promotional materials or require us to provide corrective information to healthcare practitioners; require that we conduct post-marketing studies; require us to enter into a consent decree, which can include imposition of various fines, reimbursements for inspection costs, required due dates for specific actions and penalties for noncompliance; seek an injunction or impose civil or criminal penalties or monetary fines; suspend marketing of, withdraw regulatory approval of or recall such product; suspend any ongoing clinical studies; refuse to approve pending applications or supplements to applications filed by us; suspend or impose restrictions on operations, including costly new manufacturing requirements; or seize or detain products, refuse to permit the import or export of products or require us to initiate a product recall. The occurrence of any event or penalty described above may inhibit our ability to commercialize our products and generate product revenue.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">51</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Current and future legislation may increase the difficulty and cost for us, and any collaborators, to obtain marketing approval of and commercialize our drug candidates and affect the prices we, or they, may obtain.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Heightened governmental scrutiny over the manner in which manufacturers set prices for their marketed products has resulted in several recent Congressional inquiries and proposed and enacted federal and state legislation designed to, among other things, bring more transparency to product pricing, review the relationship between pricing and manufacturer patient programs, and reform government program reimbursement methodologies for products. We expect that additional state and federal healthcare reform measures will be adopted in the future, any of which could limit the amounts that federal and state governments will pay for healthcare therapies, which could result in reduced demand for our product candidates or additional pricing pressures. Most recently, on August 16, 2022, President Biden signed into law the Inflation Reduction Act of 2022 (&#x201c;IRA&#x201d;), which, among other provisions, included several measures intended to lower the cost of prescription drugs and related healthcare reforms. We cannot be sure whether additional legislation or rulemaking related to the IRA will be issued or enacted, or what impact, if any, such changes will have on the profitability of any of our drug candidates, if approved for commercial use, in the future.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:8.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Healthcare insurance coverage and reimbursement may be limited or unavailable for our product candidate, if approved, which could make it difficult for us to sell our product candidate or other therapies profitably.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The success of pegozafermin, if approved, depends on the availability of coverage and adequate reimbursement from third-party payors including governmental healthcare programs, such as Medicare and Medicaid, commercial payors, and health maintenance organizations. We cannot be sure that coverage and reimbursement will be available for, or accurately estimate the potential revenue from, our product candidates or assure that coverage and reimbursement will be available for any product that we may develop.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:8.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Governments outside the United States tend to impose strict price controls, which may adversely affect our revenue, if any.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In some countries, particularly the countries of the European Union, the pricing of prescription pharmaceuticals is subject to governmental control. In these countries, pricing negotiations with governmental authorities can take considerable time after the receipt of marketing approval for a drug. In addition, there can be considerable pressure by governments and other stakeholders on prices and reimbursement levels, including as part of cost containment measures. Political, economic and regulatory developments may further complicate pricing negotiations. To obtain coverage and reimbursement or pricing approval in some countries, we may be required to conduct a clinical trial that compares the cost-effectiveness of our drug candidate to other available procedures. If reimbursement of our drugs is unavailable or limited in scope or amount, or if pricing is set at unsatisfactory levels, our business could be harmed, possibly materially.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">52</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Risks Relating to Intellectual Property</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Our success depends upon our ability to obtain and maintain intellectual property protection for our products and technologies.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Our success will depend in significant part on our current or future licensors&#x2019;, licensees&#x2019; or collaborators&#x2019; ability to establish and maintain adequate protection of our owned and licensed intellectual property covering the product candidates we plan to develop, and the ability to develop these product candidates and commercialize the products resulting therefrom, without infringing the intellectual property rights of others. In addition to taking other steps to protect our intellectual property, we hold issued patents, we have applied for patents, and we intend to continue to apply for patents, with claims covering our technologies, processes and product candidates when and where we deem it appropriate to do so. We have filed numerous patent applications both in the United States and in certain foreign jurisdictions to obtain patent rights to inventions we have discovered, with claims directed to compositions of matter, methods of use and other technologies relating to our programs. There can be no assurance that any of these patent applications will issue as patents or, for those applications that do mature into patents, that the claims of the patents will exclude others from making, using or selling our product candidates or products that compete with or are similar to our product candidates. In countries where we have not sought and do not seek patent protection, third parties may be able to manufacture and sell our product candidates without our permission, and we may not be able to stop them from doing so.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">With respect to patent rights, we do not know whether any of the pending patent applications for any of our product candidates will result in the issuance of patents that effectively protect our technologies, processes and product candidates, or if any of our issued patents or our current or future licensors&#x2019;, licensees&#x2019; or collaborators&#x2019; issued patents will effectively prevent others from commercializing competitive technologies, processes and products. We cannot be certain that we or our current or future licensors, licensees or collaborators were the first to make the inventions claimed in our owned or licensed patents or pending patent applications, or that we or our current or future licensors, licensees or collaborators were the first to file for patent protection of such inventions.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Any changes we make to our pegozafermin or any future product candidates to cause them to have what we view as more advantageous properties may not be covered by our existing patents and patent applications, and we may be required to file new applications and/or seek other forms of protection for any such altered product candidates. The patent landscape surrounding the technology underlying our product candidates is crowded, and there can be no assurance that we would be able to secure patent protection that would adequately cover an alternative to pegozafermin or any future product candidates.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We and our current or future licensors, licensees or collaborators may not be able to prepare, file and prosecute all necessary or desirable patent applications at a reasonable cost or in a timely manner. It is also possible that we or our current or future licensors, licensees or collaborators will fail to identify patentable aspects of inventions made in the course of development and commercialization activities before it is too late to obtain patent protection for them. Moreover, in some circumstances, we may not have the right to control the preparation, filing and prosecution of patent applications, or to maintain or enforce the patents, covering technology that we license from or license to third parties and may be reliant on our current or future licensors, licensees or collaborators to perform these activities, which means that these patent applications may not be prosecuted, and these patents enforced, in a manner consistent with the best interests of our business. If our current or future licensors, licensees or collaborators fail to establish, maintain, protect or enforce such patents and other intellectual property rights, such rights may be reduced or eliminated. If our current or future licensors, licensees or collaborators are not fully cooperative or disagree with us as to the prosecution, maintenance or enforcement of any patent rights, such patent rights could be compromised.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Similar to the patent rights of other biotechnology companies, the scope, validity and enforceability of our owned and licensed patent rights generally are highly uncertain and involve complex legal and factual questions. The issuance of a patent is not conclusive as to its inventorship, scope, validity or enforceability, and our patents may be challenged in the courts or patent offices in the United States and abroad. In recent years, these areas have been the subject of much litigation in the industry. As a result, the issuance, scope, validity, enforceability and commercial value of our and our current or future licensors&#x2019;, licensees&#x2019; or collaborators&#x2019; patent rights are highly uncertain. Our and our current or future licensors&#x2019;, licensees&#x2019; or collaborators&#x2019; pending and future patent applications may not result in patents being issued that protect our technology or product candidates, or products</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">53</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">resulting therefrom, in whole or in part, or that effectively prevent others from commercializing competitive technologies and products. The patent examination process may require us or our current or future licensors, licensees or collaborators to narrow the scope of the claims of pending and future patent applications, which would limit the scope of patent protection that is obtained, if any. Our and our current or future licensors&#x2019;, licensees&#x2019; or collaborators&#x2019; patent applications cannot be enforced against third parties practicing the technology that is currently claimed in such applications unless and until a patent issues from such applications, and then only to the extent the claims that issue are broad enough to cover the technology being practiced by those third parties.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Furthermore, given the amount of time required for the development, testing and regulatory review of new product candidates, patents protecting such candidates might expire before or shortly after the resulting products are commercialized. As a result, our owned and in-licensed patents may not provide us with sufficient rights to exclude others from commercializing products similar or identical to ours. We expect to seek extensions of patent terms for our issued patents, where available. The applicable authorities, including the FDA in the United States, and any comparable foreign regulatory authorities, may not agree with our assessment of whether such extensions are available, and may refuse to grant extensions to our patents, or may grant more limited extensions than we request. In addition, we may not be granted an extension because of, for example, failing to apply within applicable deadlines, failing to apply prior to the expiration of relevant patents or otherwise failing to satisfy applicable requirements.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">We may not be able to protect our intellectual property rights throughout the world.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The legal protection afforded to inventors and owners of intellectual property in countries outside of the United States may not be as protective or effective as that in the United States and we may, therefore, be unable to acquire and enforce intellectual property rights outside the United States to the same extent as in the United States. Whether filed in the United States or abroad, our patent applications may be challenged or may fail to result in issued patents. Filing, prosecuting, enforcing and defending patents on product candidates in all countries throughout the world would be prohibitively expensive, and our intellectual property rights in some countries outside the United States are less extensive than those in the United States. In addition, the laws of some foreign countries do not protect intellectual property rights to the same extent as federal and certain state laws in the United States.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Consequently, we may not be able to prevent third parties from practicing our inventions in all countries outside the United States, or from selling or importing products made using our inventions in and into the United States or other jurisdictions. Competitors may use technologies in jurisdictions where we have not obtained patent protection to develop their own products and, further, may export otherwise infringing products to territories where we have patent protection, but enforcement is not as strong as that in the United States. These products may compete with pegozafermin or any future product candidates and our patents or other intellectual property rights may not be effective or sufficient to prevent them from competing.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">54</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">We rely on a license from Teva and a sublicense from ratiopharm to patents and know-how related to glycoPEGylation technology that are used in the development, manufacture and commercialization of </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">pegozafermin</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">. Any termination or loss of significant rights, including the right to glycoPEGylation technology, or breach, under these agreements or any future license agreement related to our product candidates, would materially and adversely affect our ability to continue the development and commercialization of the related product candidates.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In April 2018, we entered into an Asset Transfer and License Agreement (the &#x201c;FGF21 Agreement&#x201d;) with Teva under which we acquired certain patents, intellectual property and other assets relating to Teva&#x2019;s glycoPEGylated FGF21 program, including pegozafermin. Under this agreement, we were granted a perpetual, non-exclusive (but exclusive as to pegozafermin), non-transferable, worldwide license to patents and know-how related to glycoPEGylation technology used in the development, manufacture and commercialization of pegozafermin and products containing pegozafermin. The FGF21 Agreement also contains numerous covenants with which we must comply, including the utilization of commercially reasonable efforts to develop and ultimately commercialize pegozafermin, as well as certain reporting covenants and the obligation to make royalty payments, if and when pegozafermin is approved for commercialization. Our failure to satisfy any of these covenants could result in the termination of the FGF21 Agreement. In addition, we entered into a Sublicense Agreement with ratiopharm (the &#x201c;ratiopharm Sublicense&#x201d;), under which we were granted a perpetual, exclusive, worldwide sublicense to patents and know-how related to glycoPEGylation technology used in the development, manufacture and commercialization of pegozafermin and products containing pegozafermin. Termination of the FGF21 Agreement or the ratiopharm Sublicense will impact our rights under the intellectual property licensed to us by Teva and ratiopharm, respectively, including our license to glycoPEGylation technology, but will not affect our rights under the assets assigned to us.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Beyond this agreement, our commercial success will also depend upon our ability, and the ability of our licensors, to develop, manufacture, market and sell our product candidates and use our proprietary technologies without infringing the proprietary rights of third parties. A third party may hold intellectual property rights, including patent rights, that are important or necessary to the development of our product candidates. As a result, we may enter into additional license agreements in the future. If we fail to comply with the obligations under these agreements, including payment and diligence obligations, our licensors may have the right to terminate these agreements, in which event we may not be able to develop, manufacture, market or sell any product that is covered by these agreements or to engage in any other activities necessary to our business that require the freedom to operate afforded by the agreements, or we may face other penalties under the agreements.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">We may be unable to obtain intellectual property rights or technology necessary to develop and commercialize pegozafermin and any future product candidates.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The patent landscape around our programs is complex, and we are aware of several third-party patents and patent applications containing subject matter that might be relevant to pegozafermin. Depending on what claims ultimately issue from these patent applications, and how courts construe the issued patent claims, as well as depending on the ultimate formulation and method of use of pegozafermin or any future product candidates, we may need to obtain a license to practice the technology claimed in such patents. There can be no assurance that such licenses will be available on commercially reasonable terms, or at all.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">We may become involved in lawsuits or other proceedings to protect or enforce our intellectual property, which could be expensive, time-consuming and unsuccessful and have a material adverse effect on the success of our business.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Third parties may infringe our patents or misappropriate or otherwise violate our intellectual property rights. In the future, we may initiate legal proceedings to enforce or defend our intellectual property rights, to protect our trade secrets or to determine the validity or scope of intellectual property rights we own or control. Also, third parties may initiate legal proceedings against us to challenge the validity or scope of intellectual property rights we own, control or to which we have rights. An adverse result in any litigation proceeding could put one or more of our patents at risk of being invalidated, narrowed, held unenforceable or interpreted in such a manner that would not preclude third parties from entering the market with competing products.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">55</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Third-party pre-issuance submission of prior art to the USPTO, or opposition, derivation, revocation, reexamination, </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">inter partes </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">review or interference proceedings, or other pre-issuance or post-grant proceedings or other patent office proceedings or litigation in the United States or other jurisdictions provoked by third parties or brought by us, may be necessary to determine the inventorship, priority, patentability or validity of inventions with respect to our patents or patent applications. An unfavorable outcome could leave our technology or product candidates without patent protection, allow third parties to commercialize our technology or product candidates and compete directly with us, without payment to us, or could require us to obtain license rights from the prevailing party in order to be able to manufacture or commercialize our product candidates without infringing third-party patent rights. Our business could be harmed if the prevailing party in such a case does not offer us a license on commercially reasonable terms, or at all. Even if we obtain a license, it may be non-exclusive, thereby giving our competitors access to the same technologies licensed to us. In addition, if the breadth or strength of protection provided by our patents and patent applications is threatened, it could dissuade companies from collaborating with us to license, develop or commercialize current or future product candidates. Even if we successfully defend such litigation or proceeding, we may incur substantial costs and our defense may distract our management and other employees.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Furthermore, because of the substantial amount of discovery required in connection with intellectual property litigation, there is a risk that some of our confidential information could be compromised by disclosure during this type of litigation. In addition, many foreign jurisdictions have rules of discovery that are different than those in the United States and that may make defending or enforcing our patents extremely difficult. There could also be public announcements of the results of hearings, motions or other interim proceedings or developments. If securities analysts or investors perceive these results to be negative, it could have a material adverse effect on the price of shares of our common stock.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Third parties may initiate legal proceedings against us alleging that we infringe their intellectual property rights or we may initiate legal proceedings against third parties to challenge the validity or scope of intellectual property rights controlled by third parties.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Third parties may initiate legal proceedings against us alleging that we infringe their intellectual property rights or we may initiate legal proceedings against third parties to challenge the validity or scope of intellectual property rights controlled by third parties, including in oppositions, interferences, revocations, reexaminations, </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">inter partes </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">review or derivation proceedings before the USPTO or its counterparts in other jurisdictions. These proceedings can be expensive and time-consuming and many of our adversaries in these proceedings may have the ability to dedicate substantially greater resources to prosecuting these legal actions than we can. We could be found liable for monetary damages, including treble damages and attorneys&#x2019; fees, if we are found to have willfully infringed a patent of a third party. A finding of infringement could prevent us from commercializing our pegozafermin or any future product candidates or force us to cease some of our business operations, which could materially harm our business.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Although we have reviewed certain third-party patents and patent filings that we believe may be relevant to our therapeutic candidates or products, we have not conducted a freedom-to-operate search or analysis for any of our therapeutic candidates or products, and we may not be aware of patents or pending or future patent applications that, if issued, would block us from commercializing our product candidates. Thus, we cannot guarantee that our product candidates, or our commercialization thereof, do not and will not infringe any third party&#x2019;s intellectual property.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Risks Related to Ownership of Our Common Stock</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">The price of our common stock may be volatile, and you may lose all or part of your investment.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The market price of our common stock could fluctuate significantly, and you may not be able to resell your shares at or above the price you paid for your shares. Those fluctuations could be based on various factors in addition to those otherwise described in this Annual Report on Form 10-K, including those described in these &#x201c;Risk Factors.&#x201d; Any of these factors may result in large and sudden changes in the volume and trading price of our common stock. In the past, following periods of volatility in the market price of a company&#x2019;s securities, stockholders have often instituted securities class action litigation against that company.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">56</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Sales of our common stock, or the perception that such sales may occur, or issuance of shares of our common stock upon exercise of warrants could depress the price of our common stock.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Sales of a substantial number of shares of our common stock in the public market, or the perception that such sales may occur, could depress the market price of our common stock. Certain holders of shares of our common stock have rights, subject to certain conditions, to require us to file registration statements covering their shares or to include their shares in registration statements that we may file for ourselves or other stockholders. In addition, we have filed a registration statement registering under the Securities Act the shares of our common stock reserved for issuance under our 2019 Equity Incentive Plan, including shares issuable upon exercise of outstanding options. These shares can be freely sold in the public market upon issuance, subject to volume limitations applicable to affiliates. Further, as opportunities present themselves, we may enter into financing or similar arrangements in the future, including the issuance of debt or equity securities.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In addition, we must settle exercises of our outstanding warrants in shares of our common stock. The issuance of shares of our common stock upon exercise of the warrants will dilute the ownership interests of our stockholders, which could depress the trading price of our common stock. In addition, the market&#x2019;s expectation that exercises may occur could depress the trading price of our common stock even in the absence of actual exercises. Moreover, the expectation of exercises could encourage the short selling of our common stock, which could place further downward pressure on the trading price of our common stock.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Raising additional capital may cause dilution to existing stockholders, restrict our operations or require us to relinquish rights to our technologies.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Existing stockholders could suffer dilution or be negatively affected by fixed payment obligations we may incur if we raise additional funds through the issuance of additional equity securities, including under the ATM Facility (defined below), or debt. Furthermore, these securities may have rights senior to those of our common stock and could contain covenants or protective rights that would restrict our operations and potentially impair our competitiveness, such as limitations on our ability to incur additional debt, limitations on our ability to acquire, sell or license intellectual property rights and other operating restrictions that could adversely impact our ability to conduct our business.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Hedging activity by investors in the warrants could depress the trading price of our common stock.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We expect that many investors in our warrants will seek to employ an arbitrage strategy. Under this strategy, investors typically short sell a certain number of shares of our common stock and adjust their short position over time while they continue to hold the warrants. Investors may also implement this type of strategy by entering into swaps on our common stock in lieu of, or in addition to, short selling shares of our common stock. This market activity, or the market&#x2019;s perception that it will occur, could depress the trading price of our common stock.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">General Risk Factors</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Our directors, executive officers and current holders of 5% or more of our capital stock have substantial control over our company, which could limit your ability to influence the outcome of matters subject to stockholder approval, including a change of control.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As of December 31, 2022, our executive officers, directors and other holders of 5% or more of our common stock beneficially owned a majority of our outstanding common stock. As a result, our executive officers, directors and other holders of 5% or more of our common stock, if they act, will be able to influence or control matters requiring approval by our stockholders, including the election of directors and the approval of mergers, acquisitions or other extraordinary transactions. In addition, our current directors, executive officers and other holders of 5% or more of our common stock, acting together, would have the ability to control the management and affairs of our company. They may also have interests that differ from yours and may vote in a way with which you disagree and that may be adverse to your interests. This concentration of ownership may have the effect of delaying, preventing or deterring a change of control of our company, could deprive our stockholders of an opportunity to receive a premium for their shares of our common stock as part of a sale of our company.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">57</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:8.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Our disclosure controls and procedures may not prevent or detect all errors or acts of fraud.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We designed our disclosure controls and procedures to reasonably assure that information we must disclose in reports we file or submit under the Exchange Act is accumulated and communicated to management, and recorded, processed, summarized and reported within the time periods specified in the rules and forms of the SEC. We believe that any disclosure controls and procedures or internal controls and procedures, no matter how well-conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the control system are met.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">These inherent limitations include the realities that judgments in decision-making can be faulty, and that breakdowns can occur because of simple error or mistake. Additionally, controls can be circumvented by the individual acts of some persons, by collusion of two or more people or by an unauthorized override of the controls. Accordingly, because of the inherent limitations in our control system, misstatements due to error or fraud may occur and not be detected.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Our amended and restated certificate of incorporation, amended and restated bylaws and Delaware law could prevent a third party from acquiring us (even if an acquisition would benefit our stockholders), may limit the ability of our stockholders to replace our management and limit the price that investors might be willing to pay for shares of our common stock.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Our amended and restated certificate of incorporation and our amended and restated bylaws could have the effect of making it more difficult for a third party to acquire, or of discouraging a third party from attempting to acquire, control of us. These provisions could delay or prevent a change in control of the Company and could limit the price that investors might be willing to pay in the future for shares of our common stock. In addition, as a Delaware corporation, we are subject to the anti-takeover provisions of Section 203 of the Delaware General Corporation Law, which prohibits a Delaware corporation from engaging in a business combination specified in the statute with an interested stockholder (as defined in the statute) for a period of three years after the date of the transaction in which the person first becomes an interested stockholder, unless the business combination is approved in advance by a majority of the independent directors or by the holders of at least two-thirds of the outstanding disinterested shares. The application of Section 203 of the Delaware General Corporation Law could also have the effect of delaying or preventing a change of control of us.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Our amended and restated certificate of incorporation provides that the Court of Chancery of the State of Delaware and the federal district courts of the United States will be the exclusive forum for substantially all disputes between us and our stockholders, which could limit our stockholders&#x2019; ability to obtain a favorable judicial forum for disputes with us or our directors, officers or employees.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Our amended and restated certificate of incorporation provides that the Court of Chancery of the State of Delaware is the exclusive forum for certain actions or proceedings under Delaware statutory or common law. Our amended and restated certificate of incorporation provides further that the federal district courts of the United States will be the exclusive forum for resolving any complaint asserting a cause of action arising under the Securities Act. These choice of forum provisions may limit a stockholder&#x2019;s ability to bring a claim in a judicial forum that it finds favorable for disputes with us or our directors, officers or other employees. If a court were to find the choice of forum provision contained in our amended and restated certificate of incorporation to be inapplicable or unenforceable, we may incur additional costs associated with resolving such action in other jurisdictions.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Our ability to use our net operating loss carryforwards and other tax attributes may be limited.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As of December 31, 2022, we had U.S. federal and state net operating loss (&#x201c;NOL&#x201d;) carryforwards of $160.9 million and $169.8 million, respectively, which may be available to offset future taxable income. As of December 31, 2022, we also had gross federal tax credits of $4.3 million, which may be used to offset future tax liabilities. These NOLs and tax credit carryforwards will begin to expire in 2040. Use of our NOL carryforwards and tax credit carryforwards depends on many factors, including having current or future taxable income, which cannot be assured. In addition, the Company is currently under examination by the Israeli tax authorities for 2018 and 2019, which could impact our NOL carryforwards.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">58</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;" id="item_1b_unresolved_staff_comments"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Item 1B. Unresolve</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">d Staff Comments.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">None.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;" id="item_2_properties"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Item 2. Pr</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">operties.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We lease office space at 142 Sansome Street, San Francisco, California 94104, which consists of approximately 3,600 square feet. This lease expires on January 14, 2025. We believe that our current space is adequate for our needs. We also believe we will be able to obtain additional space, as needed, on commercially reasonable terms</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;" id="item_3_legal_proceedings"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Item 3. Legal</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> Proceedings.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We are currently not a party to any material legal proceedings. From time to time, we may become involved in legal proceedings arising in the ordinary course of our business. Regardless of outcome, litigation can have an adverse impact on us due to defense and settlement costs, diversion of management resources, negative publicity, reputational harm and other factors, and there can be no assurances that favorable outcomes will be obtained.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;" id="item_4_mine_safety_disclosures"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Item 4. Mine Saf</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">ety Disclosures.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Not applicable.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">59</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;" id="part_ii"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">PAR</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">T II</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;" id="item_5_market_for_registrants_common_equ"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Item 5. Market for Registrant&#x2019;s Common Equity, Related Stoc</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">kholder Matters and Issuer Purchases of Equity Securities.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Market Information</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Our common stock is traded on The Nasdaq Global Market under the symbol &#x201c;ETNB.&#x201d;</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As of March 3, 2023, there were approximately 6 stockholders of record of our common stock. Since many of our shares of common stock are held by brokers and other institutions on behalf of stockholders, we are unable to estimate the total number of stockholders represented by these record holders.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Dividend Policy</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We have never declared or paid cash dividends on our capital stock and have no present intention to pay cash dividends on our common stock for the foreseeable future. Any determination to pay dividends to holders of our common stock will be at the discretion of our board of directors and will depend on many factors, including our financial condition, results of operations, liquidity, earnings, projected capital and other cash requirements, legal requirements, restrictions in the agreements governing any indebtedness we may enter into, business prospects and other factors that our board of directors deems relevant.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;" id="item_6_reserved"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Item 6. [R</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">eserved].</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">60</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;" id="item_7_managements_discussion_analysis_f"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Item 7. Management&#x2019;s Discussion and Analysis of</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> Financial Condition and Results of Operations.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">You should read the following discussion and analysis of our financial condition and results of operations together with our consolidated financial statements and related notes and other financial information included elsewhere in this Annual Report on Form 10-K. </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Some of the information contained in this discussion and analysis includes forward-looking statements that involve risks and uncertainties. Our actual results could differ materially from those described in or implied by these forward-looking statements. Factors that could cause or contribute to such differences include, but are not limited to, those identified below and those discussed in the section titled &#x201c;Risk Factors&#x201d; included elsewhere in this </span><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Annual Report on Form 10-K</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Overview</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We are a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of liver and cardio-metabolic diseases. Our lead product candidate, pegozafermin (previously BIO89-100), a specifically engineered glycoPEGylated analog of fibroblast growth factor 21 (&#x201c;FGF21&#x201d;), is currently being developed for the treatment of nonalcoholic steatohepatitis (&#x201c;NASH</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;) and for the treatment of severe hypertriglyceridemia (&#x201c;SHTG&#x201d;)</span><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. NASH is a severe form of nonalcoholic fatty liver disease </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(&#x201c;NAFLD&#x201d;),</span><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> characterized by inflammation and fibrosis in the liver that can progress to cirrhosis, liver failure, hepatocellular carcinoma </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(&#x201c;HCC&#x201d;) </span><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">and death. There are currently no approved products for the treatment of NASH. In 2020 and 2022, we presented positive topline results from cohorts 1 through 6 and cohort 7 respectively, in our Phase 1b/2a trial </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">of pegozafermin </span><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">in NASH patients which has informed the advancement of our clinical strategy in NASH. We initiated a Phase 2b trial (ENLIVEN) evaluating pegozafermin in fibrosis stage 2 or 3 NASH patients in June 2021. </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In the ENLIVEN trial, p</span><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">atients receive weekly doses or an every two-week dose of pegozafermin or placebo for 24 weeks followed by a blinded extension phase of an additional 24 weeks for a total treatment period of 48 weeks. ENLIVEN completed enrollment in August 2022 and we are expecting to report topline data from this trial in March 2023. In 2021, we completed a pharmacokinetic study of pegozafermin in NASH patients with compensated cirrhosis (fibrosis stage F4) demonstrating that a 30 mg </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">dose of pegozafermin </span><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">has similar single-dose pharmacokinetics and pharmacodynamics in F4 as it does in non-cirrhotic NASH. We are currently evaluating the potential opportunity for pegozafermin in these fibrosis stage F4 patients. We are also developing pegozafermin for the treatment of SHTG. In June 2022, we announced positive topline results from the ENTRIGUE Phase 2 trial of pegozafermin in SHTG patients. SHTG is a condition identified by severely elevated levels of triglycerides (&#x2265;500 mg/dL), which is associated with an increased risk of NASH, cardiovascular events and acute pancreatitis. The trial met its primary endpoint demonstrating statistically significant and clinically meaningful reductions in triglycerides from baseline and key secondary endpoints. We have received feedback from the FDA supporting the advancement of pegozafermin into Phase 3 and are planning to initiate the first of two recommended Phase 3 trials in the second quarter of 2023. In parallel, we have developed plans to optimize our clinical development program across both indications that would leverage the safety database from our SHTG Phase 3 program to support our NASH program. We expect to finalize these plans after we have reviewed results from the ENLIVEN trial.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We commenced operations in 2018 and have devoted substantially all of our resources to raising capital, acquiring our initial product candidate, identifying and developing pegozafermin, licensing certain related technology, conducting research and development activities (including preclinical studies and clinical trials) and providing general and administrative support for these operations.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As of December 31, 2022, our cash and cash equivalents and short-term available-for-sale securities totaled $188.2 million. Based on our current operating plan, we believe that our cash and cash equivalents and short-term available-for-sale securities as of December 31, 2022, together with the proceeds received in January and February 2023 from our ATM Facility (defined below) and the 2023 Loan Agreement (defined below), will be sufficient to meet our anticipated cash requirements for a period of at least one year from the date this Annual Report on Form 10-K is filed with the Securities and Exchange Commission (&#x201c;SEC&#x201d;).</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We have incurred net losses since our inception. Our net losses for the year ended December 31, 2022 and 2021 were $102.0 million and $90.1 million, respectively. As of December 31, 2022, we had an accumulated deficit of $315.2 million. We expect to continue to incur significant expenses and increasing operating losses as we advance pegozafermin and any future product candidates through clinical trials, seek regulatory approval for pegozafermin and any future product candidates, expand our clinical, regulatory, quality, manufacturing and</span><span style="color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">61</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">commercialization capabilities, protect our intellectual property, prepare for and, if approved, proceed to commercialization of pegozafermin and any future product candidates, expand our general and administrative support functions, including hiring additional personnel, and incur additional costs associated with operating as a public company. Our net losses may fluctuate significantly from quarter-to-quarter and year-to-year, depending on the timing of our clinical trials and our expenditures on other research and development activities.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Ongoing COVID-19 Pandemic</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The ongoing COVID-19 pandemic has disrupted and may continue to disrupt our business and delay our development timeline. The extent to which the COVID-19 pandemic may impact our future operating results and financial condition is uncertain. For more information regarding risks related to the ongoing COVID-19 pandemic, please see the risk factor entitled &#x201c;The ongoing COVID-19 pandemic has resulted and may in the future result in significant disruptions to our clinical trials or other business operations, which could have a material adverse effect on our business,&#x201d; in Part I, Item 1A of this Annual Report on Form 10-K.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Components of Results of Operations</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Research and Development Expenses</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Research and development expenses consist primarily of costs incurred for the development of our lead product candidate, pegozafermin. Our research and development expenses consist primarily of external costs related to preclinical and clinical development, including costs related to acquiring patents and intellectual property, expenses incurred under license agreements and agreements with contract research organizations and consultants, costs related to acquiring and manufacturing clinical trial materials, including under agreements with contract manufacturing organizations and other vendors, costs related to the preparation of regulatory submissions and expenses related to laboratory supplies and services, as well as personnel costs. Personnel costs consist of salaries, employee benefits and stock-based compensation for individuals involved in research and development efforts.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We expense all research and development expenses in the periods in which they are incurred. We accrue for costs incurred as services are provided by monitoring the status of specific activities and invoices received from our external service providers. We adjust our accrued expenses as actual costs become known.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Payments associated with licensing agreements to acquire licenses to develop, use, manufacture and commercialize products that have not reached technological feasibility and do not have alternate commercial use are expensed as incurred. Where contingent milestone payments are due to third parties under research and development arrangements or license agreements, the milestone payment obligations are expensed when the milestone results are probable and estimable, which is generally upon achievement of milestones.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We expect our research and development expenses to increase for the foreseeable future as we continue the development of pegozafermin and continue to invest in research and development activities. The process of conducting the necessary clinical research to obtain regulatory approval is costly and time-consuming, and the successful development of pegozafermin and any future product candidates is highly uncertain. To the extent that pegozafermin continues to advance into larger and later stage clinical trials, our expenses will increase substantially and may become more variable. The actual probability of success for pegozafermin or any future product candidate may be affected by a variety of factors, including the safety and efficacy of our product candidates, investment in our clinical programs, manufacturing capability and competition with other products. As a result, we are unable to determine the timing of initiation, duration and completion costs of our research and development efforts or when and to what extent we will generate revenue from the commercialization and sale of pegozafermin or any future product candidate.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">General and Administrative Expenses</span><span style="color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">General and administrative expenses consist primarily of personnel costs, expenses for outside professional services, including legal, human resource, audit and accounting services, consulting costs and allocated facilities costs. Personnel and related costs consist of salaries, employee benefits and stock-based compensation for personnel in executive, finance, commercial and other administrative functions. Facilities costs consist of rent and maintenance</span><span style="color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">62</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">of facilities. We expect our general and administrative expenses to increase for the foreseeable future as we increase the size of our administrative function to support the growth of our business and support our continued research and development activities.</span><span style="color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Interest Expense</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Interest expense consists of interest expense, accretion of final payment fees and amortization of deferred debt issuance costs related to our term loan facility.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Interest Income and Other, Net</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Interest income and other, net primarily consists of interest income including accretion of discount on available-for-sale securities, offset by amortization of premium on available-for-sale securities</span><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Results of Operations</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Year Ended December 31, 2022</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">and 2021</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The following table summarizes our results of operations for the periods presented (in thousands):</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:83.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:53.13%;"></td>
    <td style="width:1.271%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:13.578%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:1.258%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:9.777999999999999%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:1.258%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:13.727%;"></td>
    <td style="width:1.0%;"></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Year Ended December 31,</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2022</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2021</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Change</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Operating expenses:</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Research and development</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">80,796</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">70,330</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10,466</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">General and administrative</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">21,453</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">19,413</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2,040</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:20.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:20.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total operating expenses</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">102,249</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">89,743</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">12,506</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Loss from operations</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(102,249</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(89,743</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(12,506</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Interest expense</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(1,922</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(674</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(1,248</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Interest income and other, net</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2,164</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">148</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2,016</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Income tax (expense) benefit</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(19</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">147</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(166</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Net loss</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(102,026</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(90,122</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(11,904</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:8.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Research and Development Expenses</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The following table summarizes the period-over-period changes in research and development expenses for the periods presented (in thousands):</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:82.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:52.681%;"></td>
    <td style="width:1.241%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:14.341999999999999%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:1.254%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:10.912999999999998%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:1.254%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:12.314%;"></td>
    <td style="width:1.0%;"></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Year Ended December 31,</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2022</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2021</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Change</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Clinical development</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">44,683</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">29,500</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">15,183</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Contract manufacturing</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">19,515</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">27,584</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(8,069</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Personnel-related expenses</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">15,156</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">11,725</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3,431</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Preclinical costs</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">66</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(66</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Other expenses</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1,442</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1,455</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(13</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total research and development expenses</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">80,796</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">70,330</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10,466</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:2.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Research and development expenses increased by $10.5 million, or 15%, to $80.8 million, for the year ended December 31, 2022 compared to $70.3 million for the year ended December 31, 2021. The change was primarily due to an increase of $15.2 million in clinical development costs related to our ongoing clinical trials and an increase of $3.4 million in personnel-related costs due to higher headcount and stock-based compensation, partially offset by a $8.1 million decrease in contract manufacturing costs, mainly as a result of the completion of the manufacture of batches to cater to our current supply requirements for our ongoing clinical trials.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">63</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">General and Administrative Expenses</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">General and administrative expenses increased by $2.0 million, or 11%, to $21.5 million, for the year ended December 31, 2022 compared to $19.4 million for the year ended December 31, 2021. The change was primarily due to an increase of $1.7 million in personnel-related costs, due to higher headcount and stock-based compensation and an increase of $0.5 million in professional services primarily due to consulting services, partially offset by a decrease of $0.2 million in insurance related costs.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Interest Expense</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Interest expense increased by $1.2 million, or 185%, to $1.9 million, for the year ended December 31, 2022 compared to $0.7 million for the year ended December 31, 2021, primarily due to a larger outstanding balance on our term loan facility during the year ended December 31, 2022 as compared to the year ended December 31, 2021, as well as higher interest rates and higher accretion of the final payment fee and amortization of debt issuance costs during the year ended December 31, 2022.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Interest Income and Other, Net</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Interest income and other, net increased by $2.0 million to $2.2 million, for the year ended December 31, 2022 compared to $0.1 million, for the year ended December 31, 2021, primarily due to higher cash equivalents and short-term available-for-sale securities in the latter half of 2022 compared to 2021, as well as the impact of favorable interest rates in 2022.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Liquidity and Capital Resources</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">To date, we have incurred significant net losses and negative cash flows from operations. </span><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As of December 31, 2022, we had available cash and cash equivalents and short-term available-for-sale securities of $188.2 million and an accumulated deficit of $315.2 million.</span><span style="color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In March 2021, we entered into a sales agreement (as amended, the &#x201c;Sales Agreement&#x201d;) with SVB Securities LLC and Cantor Fitzgerald &amp; Co. (the &#x201c;Sales Agents&#x201d;) pursuant to which we may offer and sell up to $75.0 million of shares of our common stock, from time to time, in &#x201c;at-the-market&#x201d; offerings (the &#x201c;ATM Facility&#x201d;). The Sales Agents are entitled to compensation at a commission equal to 3.0% of the aggregate gross sales price per share sold under the Sales Agreement. Pursuant to the ATM Facility, in 2021, we received aggregate proceeds of $3.3 million, net of commissions and offering expenses from sales of 186,546 shares of our common stock. During the third quarter of 2022, we received proceeds of $8.4 million, net of commissions from the sales of 1,242,132 shares of our common stock. During the fourth quarter of 2022, we received proceeds of $20.1 million, net of commissions from the sales of 2,706,479 shares of our common stock. In January and February 2023, we received aggregate proceeds of $13.4 million, net of commissions from sales of 968,000 shares of our common stock. In February 2023, we entered into Amendment No. 1 to the Sales Agreement with the Sales Agents, pursuant to which we may offer and sell up to $150.0 million shares of our common stock, from time to time, through the ATM Facility.</span><span style="color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In July 2022, we completed an underwritten public offering of our common stock, warrants to purchase shares of our common stock and pre-funded warrants to purchase shares of our common stock and raised aggregate proceeds of $88.2 million, net of underwriting discounts and commissions of $5.7 million and other offering costs of $0.6 million. As of December 31, 2022, warrants to purchase 13,107,360 shares of our common stock at an exercise price of $5.325 per share remain outstanding. Our pre-funded warrants to purchase shares of our common stock are exercisable for a nominal amount.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In January 2023, we executed a loan and security agreement (the &#x201c;2023 Loan Agreement&#x201d;) with the lenders named therein (the &#x201c;Lenders&#x201d;). The 2023 Loan Agreement provides up to $100.0 million principal in term loans, consisting of a first tranche of $25.0 million that was funded at closing, two subsequent tranches totaling $25.0 million that may be funded upon the achievement of certain time-based, clinical and regulatory milestones, and a fourth tranche of up to $50.0 million that may be funded upon discretionary approval by the Lenders. Additionally, in January 2023, the first tranche of $25.0 million that was funded at closing pursuant to our 2023 Loan Agreement was primarily used to repay our outstanding obligations under our term loan facility, as amended in May 2021 (the</span><span style="color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">64</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201c;2021 Loan Agreement&#x201d;), including the total principal amount outstanding as of December 31, 2022 of $20.0 million, the total final payment fee of $1.0 million and an early prepayment fee of $0.4 million.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Our primary use of cash is to fund operating expenses, which consist primarily of research and development expenditures related to our lead product candidate, pegozafermin. We plan to increase our research and development expenses for the foreseeable future as we continue the clinical development of our current and future product candidates. At this time, due to the inherently unpredictable nature of clinical development, we cannot reasonably estimate the costs we will incur and the timelines that will be required to complete development, obtain marketing approval, and commercialize our current product candidate or any future product candidates. For the same reasons, we are also unable to predict when, if ever, we will generate revenue from product sales or our current or any future license agreements which we may enter into or whether, or when, if ever, we may achieve profitability. Clinical and preclinical development timelines, the probability of success, and development costs can differ materially from expectations. In addition, we cannot forecast the timing and amounts of milestone, royalty and other revenue from licensing activities, which future product candidates may be subject to future collaborations, when such arrangements will be secured, if at all, and to what degree such arrangements would affect our development plans and capital requirements.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Based on our research and development plans, we expect that our existing cash and cash equivalents and short-term available-for-sale securities as of December 31, 2022, together with the proceeds received in January and February 2023 from our ATM Facility, and proceeds available from the 2023 Loan Agreement, will be sufficient to fund our operations for a period of at least one year from the date this Annual Report on Form 10-K is filed with the SEC. However, our operating plans and other demands on our cash resources may change as a result of many factors, and we may seek additional funds sooner than planned. There can be no assurance that we will be successful in acquiring additional funding at levels sufficient to fund our operations or on terms favorable to us.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Our future funding requirements will depend on many factors, including the following:</span></p>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the progress, timing, scope, results and costs of our clinical trials of pegozafermin and preclinical studies or clinical trials of other potential product candidates we may choose to pursue in the future, including the ability to enroll patients in a timely manner for our clinical trials;</span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the costs and timing of obtaining clinical and commercial supplies and validating the commercial manufacturing process for pegozafermin and any other product candidates we may identify and develop;</span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the cost, timing and outcomes of regulatory approvals;</span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the timing and amount of any milestone, royalty or other payments we are required to make pursuant to current or any future collaboration or license agreements;</span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">costs of acquiring or in-licensing other product candidates and technologies;</span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the terms and timing of establishing and maintaining collaborations, licenses and other similar arrangements;</span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the costs associated with attracting, hiring and retaining additional qualified personnel as our business grows;</span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">our efforts to enhance operational systems and hire additional personnel to satisfy our obligations as a public company, including enhanced internal controls over financial reporting; and</span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the cost of preparing, filing, prosecuting, defending and enforcing any patent claims and other intellectual property rights.</span></div></div>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We expect to continue to generate substantial operating losses for the foreseeable future as we expand our research and development activities. We will continue to fund our operations primarily through utilization of our current financial resources and through additional raises of capital to advance our current product candidate through clinical development, to develop, acquire or in-license other potential product candidates and to fund operations for the foreseeable future. However, there is no assurance that such funding will be available to us or that it will be obtained on terms favorable to us or will provide us with sufficient funds to meet our objectives. Any failure to raise</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">65</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">capital as and when needed could have a negative impact on our financial condition and on our ability to pursue our business plans and strategies.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">To the extent that we raise additional capital through partnerships or licensing arrangements with third parties, we may have to relinquish valuable rights to our product candidates, future revenue streams or research programs or to grant licenses on terms that may not be favorable to us. If we raise additional capital through public or private equity offerings, the ownership interest of our then-existing stockholders will be diluted, and the terms of these securities may include liquidation or other preferences that adversely affect our stockholders&#x2019; rights. If we raise additional capital through debt financing, we may be subject to covenants limiting or restricting our ability to take specific actions, such as incurring additional debt, making capital expenditures or declaring dividends. If we are unable to obtain adequate financing when needed, we may have to delay, reduce the scope of or suspend one or more of our clinical trials or preclinical studies, research and development programs or commercialization efforts or grant rights to develop and market our product candidates even if we would otherwise prefer to develop and market such product candidates ourselves.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Cash Flows</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The following table summarizes our cash flows for the periods presented (in thousands):</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:80.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:65.883%;"></td>
    <td style="width:1.586%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:13.474%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:1.586%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:13.474%;"></td>
    <td style="width:1.0%;"></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Year Ended December 31,</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2022</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2021</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Net cash (used in) provided by</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:5.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Operating activities</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(81,090</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(76,781</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:5.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Investing activities</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(33,943</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">7,159</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:5.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Financing activities</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">117,831</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">23,871</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Net change in cash and cash equivalents, and<br />&#160;&#160;&#160;restricted cash</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2,798</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(45,751</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Operating Activities</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">During the year ended December 31, 2022, net cash used in operating activities was $81.1 million, which consisted of a net loss of $102.0 million, partially offset by non-cash charges of $10.4 million and a net change of $10.6 million in our net operating assets and liabilities. The non-cash charges were primarily comprised of $10.4 million in stock-based compensation, $0.8 million in amortization of debt issuance costs and accretion of the final payment fee related to our term loan facility, offset in part by $1.0 million in net accretion of discount on available-for-sale securities. The change in our operating assets and liabilities was primarily due to a $7.4 million increase in accounts payable and accrued expenses and a $3.3 million decrease in prepaid and other current assets due to timing of payments.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">During the year ended December 31, 2021, net cash used in operating activities was $76.8 million, which consisted of a net loss of $90.1 million, partially offset by non-cash charges of $10.1 million and a net change of $3.3 million in our net operating assets and liabilities. The non-cash charges were primarily comprised of $8.7 million in stock-based compensation, $0.9 million in amortization of premium on available-for-sale securities and $0.6 million in amortization of debt issuance costs. The change in our operating assets and liabilities was due to a $8.9 million increase in accounts payable and accrued expenses due to the timing of our accounts payable as well as continued expansion of our operations, offset in part by a $5.7 million increase in prepaid and other current assets due to timing of payments.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Investing Activities</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">During the year ended December 31, 2022, net cash used in investing activities was $33.9 million, which consisted primarily of $152.7 million in purchases of available-for-sale securities, offset by $118.8 million in proceeds from sales and maturities of available-for-sale securities.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">66</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">During the year ended December 31, 2021, net cash provided by investing activities was $7.2 million, which consisted primarily of $148.4 million in proceeds from sales and maturities of available-for-sale securities, offset by $141.2 million in purchases of available-for-sale securities.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Financing Activities</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">During the year ended December 31, 2022, net cash provided by financing activities was $117.8 million, which consisted primarily of net proceeds of $88.2 million from the sale of common stock and warrants from our public offering, net proceeds of $28.5 million pursuant to the sale of common stock from our ATM Facility and $1.1 million in net proceeds from the exercise of warrants to purchase our common stock.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">During the year ended December 31, 2021, net cash provided by financing activities was $23.9 million, which consisted of $20.0 million in proceeds from our term loan facility, $3.3 million in net proceeds from the sale and issuance of common stock pursuant to our ATM Facility and $0.6 million in proceeds from the issuance of common stock upon exercise of stock options and employee stock purchase plan purchases.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Contractual Obligations and Commitments</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Debt Obligations</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As of December 31, 2022, our outstanding total principal amount under our 2021 Loan Agreement was $20.0 million. In January 2023, the first tranche of $25.0 million that was funded at closing pursuant to our 2023 Loan Agreement was primarily used to repay the outstanding obligations under our 2021 Loan Agreement, including the total principal amount outstanding of $20.0 million, the total final payment fee of $1.0 million and an early prepayment fee of $0.4 million.</span><span style="color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The term loans under our 2023 Loan Agreement mature on January 1, 2027. The maturity date may be extended to July 1, 2027, provided that the second and third tranches are funded, and we achieve certain other financing milestones. The term loans bear interest equal to the greater of (i) 8.45% and (ii) the sum of (a) the Prime Rate as reported in The Wall Street Journal plus (b) 2.25%. Consecutive monthly payments of interest commence in February 2023 and consecutive monthly payments of principal commence in February 2025, or February 2026 provided that certain extension milestones are achieved.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Other Contractual Obligations and Commitments</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Our cash requirements greater than one year related to other contractual obligations and commitments include the following:</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In April 2018, we entered into two agreements (the &#x201c;Teva Agreements&#x201d;) with Teva Pharmaceutical Industries Ltd (&#x201c;Teva&#x201d;) under which we acquired certain patents and intellectual property relating to two programs. Pursuant to the Teva Agreements, we could be obligated to pay Teva up to $67.5 million under each program, for a total of $135.0 million, upon the achievement of certain clinical development and commercial milestones. In addition, we are obligated to pay Teva tiered royalties at percentages in the low-to-mid single-digits on worldwide net sales on all products containing the Teva compounds. As of December 31, 2022, the timing and likelihood of achieving the milestones and generating product sales are uncertain.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We lease office space for our corporate headquarters in San Francisco under a lease that expires in January 2025. As of December 31, 2022, undiscounted future minimum lease payments of $0.4 million remain on our lease.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In addition, we enter into agreements in the normal course of business with contract research organizations, contract manufacturing organizations and other vendors for research and development services. Such agreements generally provide for termination upon written notice but obligate us to reimburse vendors for any time or costs incurred through the date of termination.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">67</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Critical Accounting Estimates</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Our management&#x2019;s discussion and analysis of our financial condition and results of operations is based on our consolidated financial statements, which have been prepared in accordance with United States generally accepted accounting principles. The preparation of these consolidated financial statements requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities as of the date of the consolidated financial statements, as well as the reported expenses incurred during the reporting periods. Our estimates are based on our historical experience and on various other factors that we believe are reasonable under the circumstances, the results of which form the basis for making judgments about the carrying value of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates under different assumptions or conditions. We believe that the accounting policies discussed below are critical to understanding our historical and future performance, as these policies relate to the more significant areas involving management&#x2019;s judgments and estimate</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">s.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">While our significant accounting policies are described in the notes to our consolidated financial statements included elsewhere in this Annual Report on Form 10-K, we believe that the following critical accounting policies are most important to understanding and evaluating our reported financial results.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Accrued Research and Development Expenses</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We record accrued expenses for estimated preclinical and clinical trial and research expenses related to the services performed but not yet invoiced pursuant to contracts with research institutions, contract research organizations and clinical manufacturing organizations that conduct and manage preclinical studies, and clinical trials, and research services on our behalf. Payments for these services are based on the terms of individual agreements and payment timing may differ significantly from the period in which the services were performed. Our estimates are based on factors such as the work completed, including patient enrollment levels. We monitor patient enrollment levels and related activity to the extent reasonably possible and make judgments and estimates in determining the accrued balance in each reporting period. Our estimates of accrued expenses are based on the facts and circumstances known at the time. If we underestimate or overestimate the level of services performed or the costs of these services, our actual expenses could differ from our estimates. As actual costs become known, we adjust our accrued expenses. To date, we have not experienced significant changes in our estimates of preclinical studies and clinical trial accruals.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Stock-Based Compensation</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We measure compensation related to all equity awards granted to employees, directors, and non-employee service providers, including stock options and restricted stock units based on the estimated fair value. We recognize forfeitures as they occur.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We estimate the fair value of stock option awards on the date of grant, and the resulting stock-based compensation, using the Black-Scholes option-pricing model. The grant date fair value of stock option awards, which have graded vesting, is recognized as an expense using the straight-line method over the requisite service period of each award, which is generally the vesting period of the respective awards.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We use the Black-Scholes option-pricing model to estimate the fair value of stock option awards that requires the use of subjective assumptions to determine the fair value of equity awards. These assumptions include:</span></p>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Expected volatility&#x2014; Since we have limited trading history for our common stock, expected volatility is estimated based on weighting our volatility and the volatility of comparable publicly traded biotechnology companies during the equivalent period of the calculated expected term of the options granted. We chose comparable companies based on their similar size, stage in the life cycle, or area of specialty. There is a degree of uncertainty in determining a comparable peer group as each of the peers are engaged in varied research and development activities, the timing and progress of which differ within the peer group.</span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">68</span></p>
  <hr style="page-break-after:always;" />
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Expected term&#x2014;The expected term of options granted to employees and directors is determined using the &#x201c;simplified&#x201d; method. Under this approach, the expected term is presumed to be the midpoint between the weighted-average vesting term and the contractual term of the option. The simplified method makes the assumption that the employee will exercise stock options evenly over the period when the stock options are vested and ending on the date when the stock options would expire. The expected option term for options granted to non-employees is estimated on a grant-by-grant basis.</span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Risk-free interest rate&#x2014;The risk-free interest rate is based on the U.S. Treasury zero coupon bonds in effect on the grant date for periods with an equivalent expected term as the option.</span></div></div>
  <div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Expected dividend&#x2014;We have never paid dividends and have no foreseeable plans to pay dividends on our shares of common stock. Therefore, we use an expected dividend of zero.</span></div></div>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We will continue to use judgment in evaluating the expected volatility and expected term utilized for our stock-based compensation calculations on a prospective basis.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The fair value of </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">restricted stock units is based on the fair value of our common stock on the date of grant</span><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. The grant date fair value of restricted stock units with service vesting conditions is recognized over the requisite service period on a straight-line basis. For restricted stock units with performance vesting conditions, we evaluate the probability of achieving the performance condition at each reporting date and recognize expense for such performance awards over the requisite service period using the accelerated attribution method. </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We recognize forfeitures as they occur.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Recent Accounting Pronouncements</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">See Note 2 to our consolidated financial statements appearing under Part II, Item 8 for more information about recent accounting pronouncements, the timing of their adoption, and our assessment, to the extent we have made one yet, of their potential impact on our financial condition of results of operations.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">JOBS Act Accounting Election</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We are an emerging growth company, as defined in the </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Jumpstart Our Business Startups Act of 2012 (the &#x201c;JOBS Act&#x201d;)</span><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. Under the JOBS Act, emerging growth companies can delay adopting new or revised accounting standards issued subsequent to the enactment of the JOBS Act until such time as those standards apply to private companies.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We have elected to use this extended transition period to enable us to comply with new or revised accounting standards that have different effective dates for public and private companies until the earlier of the date we (i) are no longer an emerging growth company or (ii) affirmatively and irrevocably opt out of the extended transition period provided in the JOBS Act. As a result, our consolidated financial statements and our interim consolidated financial statements may not be comparable to companies that comply with new or revised accounting pronouncements.</span><span style="color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;" id="item_7a_quantitative_qualitative_disclos"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Item 7A. Quantitative and Qualitat</span><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">ive Disclosures About Market Risk.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We are a smaller reporting company, as defined by Rule 12b-2 under the Securities and Exchange Act of 1934 and in Item 10(f)(1) of Regulation S-K, and are not required to provide the information under this item.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">69</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;" id="item_8_financial_statements_supplementar"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Item 8. Financial Statemen</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">ts and Supplementary Data.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">89BIO, INC.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">INDEX TO CONSOLIDATED FINANCIAL STATEMENTS</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:2.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:91.998%;"></td>
    <td style="width:1.004%;"></td>
    <td style="width:6.998%;"></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:middle;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Page</span></p></td>
   </tr>
   <tr style="height:9.35pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:middle;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:3.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:center;"><p style="text-indent:0.0pt;font-size:3.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:middle;padding-right:0.01in;text-align:center;"><p style="text-indent:0.0pt;font-size:3.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:middle;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#report_of_independent_registered_public"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Report of Independent Registered Public Accounting Firm</span><span style="color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></a></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:middle;padding-right:0.01in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">71</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:middle;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Financial Statements:</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:middle;padding-right:0.01in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:middle;padding-right:0.01in;"><p style="text-indent:36.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#consolidated_balance_sheets"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Consolidated Balance Sheets</span></a></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:middle;padding-right:0.01in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">72</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:middle;padding-right:0.01in;"><p style="text-indent:36.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#consolidated_statements_operations_compr"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Consolidated Statements of Operations and Comprehensive Loss</span></a></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:middle;padding-right:0.01in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">73</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:middle;padding-right:0.01in;"><p style="text-indent:36.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#consolidated_statements_stockholders_equ"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Consolidated Statements of Stockholders&#x2019; Equity</span></a></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:middle;padding-right:0.01in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">74</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:middle;padding-right:0.01in;"><p style="text-indent:36.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#consolidated_statements_cash_flows"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Consolidated Statements of Cash Flows</span></a></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:middle;padding-right:0.01in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">75</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:middle;padding-right:0.01in;"><p style="text-indent:36.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#notes_to_consolidated"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Notes to Consolidated Financial Statements</span></a></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:middle;padding-right:0.01in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">76</span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">70</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;" id="report_of_independent_registered_public"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Report of Independent Registered Public Accounting Firm</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">To the Stockholders and Board of Directors<br />89bio, Inc.:</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Opinion on the Consolidated Financial Statements</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We have audited the accompanying consolidated balance sheets of 89bio, Inc. and subsidiaries (the Company) as of December 31, 2022 and 2021, the related consolidated statements of operations and comprehensive loss, stockholders&#x2019; equity, and cash flows for each of the years in the two-year period ended December 31, 2022, and the related notes (collectively, the consolidated financial statements). In our opinion, the consolidated financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2022 and 2021, and the results of its operations and its cash flows for each of the years in the two-year period ended December 31, 2022, in conformity with U.S. generally accepted accounting principles.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Basis for Opinion</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">These consolidated financial statements are the responsibility of the Company&#x2019;s management. Our responsibility is to express an opinion on these consolidated financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the consolidated financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audits, we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the Company&#x2019;s internal control over financial reporting. Accordingly, we express no such opinion.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Our audits included performing procedures to assess the risks of material misstatement of the consolidated financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the consolidated financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the consolidated financial statements. We believe that our audits provide a reasonable basis for our opinion.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">/s/ KPMG LLP</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We have served as the Company&#x2019;s auditor since 2020.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">San Francisco, California<br />March 14, 2023<br /></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">71</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">89bio, Inc.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;" id="consolidated_balance_sheets"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Consolidated </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Balance Sheets</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">(in thousands, except share and per share amounts)</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:66.599%;"></td>
    <td style="width:1.614%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:13.049%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:1.614%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:13.123%;"></td>
    <td style="width:1.0%;"></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As of December 31,</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2022</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2021</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Assets</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Current assets:</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Cash and cash equivalents</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_da09ee58-fd6d-491b-a5e6-b2e816d67e6f" contextRef="C_85e3a5e5-8ff2-4682-901b-9d79336e863a" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">55,255</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_947944c1-262b-4a4c-ac66-112c8b71cc65" contextRef="C_21f769c6-c78d-41d0-b871-ec3d93d7d343" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">52,432</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Restricted cash</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_8eb44520-e906-4c7a-9ff1-aa4258971181" contextRef="C_21f769c6-c78d-41d0-b871-ec3d93d7d343" name="us-gaap:RestrictedCashCurrent" unitRef="U_USD" scale="3" decimals="-3">25</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Short-term available-for-sale securities</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_bd1d7444-7bba-4eb8-956e-6da5c6307e92" contextRef="C_85e3a5e5-8ff2-4682-901b-9d79336e863a" name="etnb:ShortTermAvailableForSaleSecuritiesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">132,905</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_8cb54c51-6a09-48b2-a037-5b9529bd6a3e" contextRef="C_21f769c6-c78d-41d0-b871-ec3d93d7d343" name="etnb:ShortTermAvailableForSaleSecuritiesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">98,288</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Prepaid and other current assets</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_f69f8d95-9036-43d7-837e-7f9afcacee7c" contextRef="C_85e3a5e5-8ff2-4682-901b-9d79336e863a" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">7,920</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_6d4a68aa-2a44-40eb-9987-bd68d6786bcb" contextRef="C_21f769c6-c78d-41d0-b871-ec3d93d7d343" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">11,237</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:20.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:20.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total current assets</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_86c5d835-da8a-4a4c-bf1c-bd55893a15f3" contextRef="C_85e3a5e5-8ff2-4682-901b-9d79336e863a" name="us-gaap:AssetsCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">196,080</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_4a7e329c-f42c-4aa7-b33f-d6045f68fb5d" contextRef="C_21f769c6-c78d-41d0-b871-ec3d93d7d343" name="us-gaap:AssetsCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">161,982</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Operating lease right-of-use asset</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_288da890-65c9-40ff-a0c8-a41ca5acf189" contextRef="C_85e3a5e5-8ff2-4682-901b-9d79336e863a" name="us-gaap:OperatingLeaseRightOfUseAsset" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">363</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Property and equipment, net</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_5eb3079f-0370-4f41-9e1c-cde33ba153f9" contextRef="C_85e3a5e5-8ff2-4682-901b-9d79336e863a" name="us-gaap:PropertyPlantAndEquipmentNet" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">92</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_a1e94062-b129-40ef-ae53-35c756905836" contextRef="C_21f769c6-c78d-41d0-b871-ec3d93d7d343" name="us-gaap:PropertyPlantAndEquipmentNet" unitRef="U_USD" scale="3" decimals="-3">150</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Other assets</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_4a9b850c-fd7b-43a0-95ca-8efea475b172" contextRef="C_85e3a5e5-8ff2-4682-901b-9d79336e863a" name="us-gaap:OtherAssetsNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">289</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_bbacf923-bf88-4c7b-b66c-413d7dcc54f1" contextRef="C_21f769c6-c78d-41d0-b871-ec3d93d7d343" name="us-gaap:OtherAssetsNoncurrent" unitRef="U_USD" scale="3" decimals="-3">290</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:20.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:20.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total assets</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_79942e51-f048-40f8-a39b-326401c5445d" contextRef="C_85e3a5e5-8ff2-4682-901b-9d79336e863a" name="us-gaap:Assets" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">196,824</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_f75c455e-c200-42f0-8ff3-7b5fc0706f5c" contextRef="C_21f769c6-c78d-41d0-b871-ec3d93d7d343" name="us-gaap:Assets" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">162,422</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Liabilities and stockholders&#x2019; equity</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Current liabilities:</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Accounts payable</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_8b9ede69-de43-447b-8cb3-6aa78457ae5a" contextRef="C_85e3a5e5-8ff2-4682-901b-9d79336e863a" name="us-gaap:AccountsPayableCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">12,502</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_f8d3a521-5202-4f68-8daa-737c7d377362" contextRef="C_21f769c6-c78d-41d0-b871-ec3d93d7d343" name="us-gaap:AccountsPayableCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">6,843</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Accrued expenses</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_a004059c-d38a-47f3-8c4e-9189217f4054" contextRef="C_85e3a5e5-8ff2-4682-901b-9d79336e863a" name="us-gaap:AccruedLiabilitiesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">11,944</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_79240120-9ebd-423e-99e3-c5f257d88d2d" contextRef="C_21f769c6-c78d-41d0-b871-ec3d93d7d343" name="us-gaap:AccruedLiabilitiesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">10,194</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Operating lease liability, current</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_3e4980ed-d2c8-4484-a49a-65915428503e" contextRef="C_85e3a5e5-8ff2-4682-901b-9d79336e863a" name="us-gaap:OperatingLeaseLiabilityCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">168</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Term loan, current</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_6c2db3f2-00e0-4696-b244-c06065718a9d" contextRef="C_21f769c6-c78d-41d0-b871-ec3d93d7d343" name="etnb:TermLoanCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">2,500</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:20.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:20.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total current liabilities</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_72f75644-8667-4184-9dfc-62000094d08b" contextRef="C_85e3a5e5-8ff2-4682-901b-9d79336e863a" name="us-gaap:LiabilitiesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">24,614</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_7c4aecec-a4e2-482e-bbec-06dc177c4330" contextRef="C_21f769c6-c78d-41d0-b871-ec3d93d7d343" name="us-gaap:LiabilitiesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">19,537</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Operating lease liability, non-current</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_a85196be-33c5-45cf-917e-bb751c5464e3" contextRef="C_85e3a5e5-8ff2-4682-901b-9d79336e863a" name="us-gaap:OperatingLeaseLiabilityNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">186</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Term loan, non-current, net</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_1bb92955-cc7b-4334-961a-1ccdf99f1fd5" contextRef="C_85e3a5e5-8ff2-4682-901b-9d79336e863a" name="us-gaap:LongTermDebtNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">19,691</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_b0ef7e9e-f5ec-41d4-8125-a62ea0ccc384" contextRef="C_21f769c6-c78d-41d0-b871-ec3d93d7d343" name="us-gaap:LongTermDebtNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">16,898</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Other non-current liability</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_052289e9-8f39-4f6b-a9f9-87aa77eb6fa3" contextRef="C_85e3a5e5-8ff2-4682-901b-9d79336e863a" name="etnb:OtherNonCurrentLiability" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">501</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_b7430192-8675-4b4c-ba62-0d7ff6112d89" contextRef="C_21f769c6-c78d-41d0-b871-ec3d93d7d343" name="etnb:OtherNonCurrentLiability" unitRef="U_USD" scale="3" decimals="-3">30</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:20.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:20.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total liabilities</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_6a2ed62a-4e69-4c54-b72b-e8470effccba" contextRef="C_85e3a5e5-8ff2-4682-901b-9d79336e863a" name="us-gaap:Liabilities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">44,992</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_b0838a8f-cc37-4eb1-9c6e-ca10472b6451" contextRef="C_21f769c6-c78d-41d0-b871-ec3d93d7d343" name="us-gaap:Liabilities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">36,465</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="-sec-ix-hidden:F_efdfecff-bd47-4d7b-8ae8-57805d2e5e13;"><span style="-sec-ix-hidden:F_e78dfece-2abd-4287-b218-712a41c88b40;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Commitments and contingencies (Note 5)</span></span></span></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Stockholders&#x2019; equity:</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Preferred stock, $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_7a5f1e40-38fe-456f-9d54-7e60b5999b3e" contextRef="C_85e3a5e5-8ff2-4682-901b-9d79336e863a" name="us-gaap:PreferredStockParOrStatedValuePerShare" unitRef="U_UnitedStatesOfAmericaDollarsShare" decimals="INF"><ix:nonFraction id="F_d518864f-3206-4ee6-8e69-b7794db41190" contextRef="C_21f769c6-c78d-41d0-b871-ec3d93d7d343" name="us-gaap:PreferredStockParOrStatedValuePerShare" unitRef="U_UnitedStatesOfAmericaDollarsShare" decimals="INF">0.001</ix:nonFraction></ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;par value, </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_ad405406-36c2-43d9-90f9-8a6c558dffbc" contextRef="C_85e3a5e5-8ff2-4682-901b-9d79336e863a" name="us-gaap:PreferredStockSharesAuthorized" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal"><ix:nonFraction id="F_2c2c27e5-541b-4c6d-94ae-9d2260d98313" contextRef="C_21f769c6-c78d-41d0-b871-ec3d93d7d343" name="us-gaap:PreferredStockSharesAuthorized" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">10,000,000</ix:nonFraction></ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;shares authorized <br />&#160;&#160;&#160;as of December 31, 2022 and 2021; </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_28158db3-68d0-4827-b4bc-71e64693c876" contextRef="C_85e3a5e5-8ff2-4682-901b-9d79336e863a" name="us-gaap:PreferredStockSharesIssued" unitRef="U_shares" decimals="INF" format="ixt-sec:numwordsen"><ix:nonFraction id="F_63a966e1-b08b-4bff-bc4f-2b368e901740" contextRef="C_85e3a5e5-8ff2-4682-901b-9d79336e863a" name="us-gaap:PreferredStockSharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt-sec:numwordsen"><ix:nonFraction id="F_6ddae077-04dd-4419-881f-1eab2ccfb1f8" contextRef="C_21f769c6-c78d-41d0-b871-ec3d93d7d343" name="us-gaap:PreferredStockSharesIssued" unitRef="U_shares" decimals="INF" format="ixt-sec:numwordsen"><ix:nonFraction id="F_19d4656c-f57b-4cef-9771-37bfd2c819e7" contextRef="C_21f769c6-c78d-41d0-b871-ec3d93d7d343" name="us-gaap:PreferredStockSharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt-sec:numwordsen">no</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;shares <br />&#160;&#160;&#160;issued and outstanding as of December 31, 2022 and 2021</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="-sec-ix-hidden:F_99a22a6a-88e9-4b21-a48d-ce39d2be3156;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></span></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="-sec-ix-hidden:F_e1912fb5-f606-4ce8-b68f-a7633b9e5662;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></span></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Common stock, $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_c5801225-72cf-4f07-a232-bd1390330ffe" contextRef="C_85e3a5e5-8ff2-4682-901b-9d79336e863a" name="us-gaap:CommonStockParOrStatedValuePerShare" unitRef="U_UnitedStatesOfAmericaDollarsShare" decimals="INF"><ix:nonFraction id="F_fc156722-d64a-4402-ba4b-a791d2676fea" contextRef="C_21f769c6-c78d-41d0-b871-ec3d93d7d343" name="us-gaap:CommonStockParOrStatedValuePerShare" unitRef="U_UnitedStatesOfAmericaDollarsShare" decimals="INF">0.001</ix:nonFraction></ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;par value, </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_c57b1dc1-2719-48f1-9532-a102295552de" contextRef="C_85e3a5e5-8ff2-4682-901b-9d79336e863a" name="us-gaap:CommonStockSharesAuthorized" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal"><ix:nonFraction id="F_13f92f2a-8192-4483-8a04-c26f92e109d4" contextRef="C_21f769c6-c78d-41d0-b871-ec3d93d7d343" name="us-gaap:CommonStockSharesAuthorized" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">100,000,000</ix:nonFraction></ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;shares authorized <br />&#160;&#160;&#160;as of December 31, 2022 and 2021; </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_d96b6e9c-5039-4b5f-a4ca-1a4df08d9829" contextRef="C_85e3a5e5-8ff2-4682-901b-9d79336e863a" name="us-gaap:CommonStockSharesIssued" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal"><ix:nonFraction id="F_9701e0f4-1e08-44a0-9310-e2ad59b5013a" contextRef="C_85e3a5e5-8ff2-4682-901b-9d79336e863a" name="us-gaap:CommonStockSharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">50,560,590</ix:nonFraction></ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;and<br />&#160;&#160;&#160;</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_5ee8f27a-3126-45d0-84dd-21451dab77c6" contextRef="C_21f769c6-c78d-41d0-b871-ec3d93d7d343" name="us-gaap:CommonStockSharesIssued" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal"><ix:nonFraction id="F_9da7f21c-80c1-41a1-a67e-08e7a86a6d27" contextRef="C_21f769c6-c78d-41d0-b871-ec3d93d7d343" name="us-gaap:CommonStockSharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">20,317,204</ix:nonFraction></ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;shares issued and outstanding as of December 31, 2022 <br />&#160;&#160;&#160;and 2021, respectively</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_8ee67c54-99cf-47f6-b098-90603da8f236" contextRef="C_85e3a5e5-8ff2-4682-901b-9d79336e863a" name="us-gaap:CommonStockValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">51</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_848dbb4d-8f8f-4c71-9da4-27048f739bf6" contextRef="C_21f769c6-c78d-41d0-b871-ec3d93d7d343" name="us-gaap:CommonStockValue" unitRef="U_USD" scale="3" decimals="-3">20</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Additional paid-in capital</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_8bedc65b-04ee-4a08-a270-e417c0f8abec" contextRef="C_85e3a5e5-8ff2-4682-901b-9d79336e863a" name="us-gaap:AdditionalPaidInCapitalCommonStock" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">467,374</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_b3544685-5a73-4deb-8700-ae2892a30e9e" contextRef="C_21f769c6-c78d-41d0-b871-ec3d93d7d343" name="us-gaap:AdditionalPaidInCapitalCommonStock" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">339,218</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Accumulated other comprehensive loss</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_1cf0a93b-47ed-44a9-852f-91d759169f7f" contextRef="C_85e3a5e5-8ff2-4682-901b-9d79336e863a" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">350</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_1c1eee46-6de0-4c62-936a-b3d29c81ed8d" contextRef="C_21f769c6-c78d-41d0-b871-ec3d93d7d343" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" unitRef="U_USD" scale="3" decimals="-3" sign="-">64</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Accumulated deficit</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_2aea3c25-edbc-4f91-abbe-7696801d46ca" contextRef="C_85e3a5e5-8ff2-4682-901b-9d79336e863a" name="us-gaap:RetainedEarningsAccumulatedDeficit" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">315,243</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_61c041d7-ca5d-46fa-9e20-f7da04a6cc8b" contextRef="C_21f769c6-c78d-41d0-b871-ec3d93d7d343" name="us-gaap:RetainedEarningsAccumulatedDeficit" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">213,217</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:20.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:20.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total stockholders&#x2019; equity</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_0c435a81-574e-447d-83a8-349233e1f2a0" contextRef="C_85e3a5e5-8ff2-4682-901b-9d79336e863a" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">151,832</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_27501c4f-a121-4dff-9e2d-ad78fd3d5987" contextRef="C_21f769c6-c78d-41d0-b871-ec3d93d7d343" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">125,957</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:25.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:25.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total liabilities and stockholders&#x2019; equity</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_5e12ce00-f63e-4539-8d2b-835012bd116c" contextRef="C_85e3a5e5-8ff2-4682-901b-9d79336e863a" name="us-gaap:LiabilitiesAndStockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">196,824</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_e5d82ea9-3f95-4335-b6af-19261f16531f" contextRef="C_21f769c6-c78d-41d0-b871-ec3d93d7d343" name="us-gaap:LiabilitiesAndStockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">162,422</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:2.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">The accompanying notes are an integral part of these consolidated financial statements.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">72</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">89bio, Inc.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;" id="consolidated_statements_operations_compr"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Consolidated Statements of Ope</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">rations and Comprehensive Loss</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">(In thousands, except share and per share amounts)</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:66.599%;"></td>
    <td style="width:1.614%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:13.049%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:1.614%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:13.123%;"></td>
    <td style="width:1.0%;"></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Year Ended December 31,</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2022</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2021</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Operating expenses:</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Research and development</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_ed8c35bb-d4c4-40a0-a275-801199112fab" contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698" name="us-gaap:ResearchAndDevelopmentExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">80,796</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_c8fbc13a-e581-462e-82d5-f5f2e65c1258" contextRef="C_7b31e452-ba3b-4180-9ddd-8faae2f90f0c" name="us-gaap:ResearchAndDevelopmentExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">70,330</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">General and administrative</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_788f29a7-5c32-4ba3-a645-4fe6d64389ab" contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698" name="us-gaap:GeneralAndAdministrativeExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">21,453</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_6bdc9158-9244-4cea-8726-dc126afcaec6" contextRef="C_7b31e452-ba3b-4180-9ddd-8faae2f90f0c" name="us-gaap:GeneralAndAdministrativeExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">19,413</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:20.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:20.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total operating expenses</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_e21d1ba1-0417-4669-b0af-c043bd05ed1f" contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698" name="us-gaap:OperatingExpenses" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">102,249</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_fb75a2af-2002-40cf-94d0-1c4d4c2160b4" contextRef="C_7b31e452-ba3b-4180-9ddd-8faae2f90f0c" name="us-gaap:OperatingExpenses" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">89,743</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Loss from operations</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_5a5fc69d-7504-49e9-ac2d-cec92f1e0221" contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698" name="us-gaap:OperatingIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">102,249</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_ef645e63-d45e-49ba-b93b-aefa9505ef0b" contextRef="C_7b31e452-ba3b-4180-9ddd-8faae2f90f0c" name="us-gaap:OperatingIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">89,743</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Interest expense</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_d678c3c3-0b47-4967-9675-867c1d8b1435" contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698" name="us-gaap:InterestExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,922</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:11.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_78ede651-a71e-4553-94f3-c5b8e9ad8b02" contextRef="C_7b31e452-ba3b-4180-9ddd-8faae2f90f0c" name="us-gaap:InterestExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">674</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Interest income and other, net</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_dc725776-f3f5-4608-be58-e17ff943b419" contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698" name="us-gaap:InterestAndOtherIncome" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">2,164</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:11.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_ab1285d9-8e3b-4981-abf7-f35ea6a6b98e" contextRef="C_7b31e452-ba3b-4180-9ddd-8faae2f90f0c" name="us-gaap:InterestAndOtherIncome" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">148</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Net loss before income tax</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_87dc0a22-176f-4f8d-bbe9-1addf5484b10" contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">102,007</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:11.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_b7ae000d-b5cb-445a-bbf2-9875cfcd469f" contextRef="C_7b31e452-ba3b-4180-9ddd-8faae2f90f0c" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">90,269</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Income tax (expense) benefit</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_d3a8da56-e9db-4c79-ab36-bdb8f2cf40ad" contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698" name="us-gaap:IncomeTaxExpenseBenefit" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">19</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_13d25d6c-3fbc-466b-adce-3efb58a15f43" contextRef="C_7b31e452-ba3b-4180-9ddd-8faae2f90f0c" name="us-gaap:IncomeTaxExpenseBenefit" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">147</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Net loss</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_cc31fb6b-25ae-49f9-a9c8-89acac410532" contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698" name="us-gaap:NetIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">102,026</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_2ea8e52a-f093-4e1b-90d7-5dd522c5b927" contextRef="C_7b31e452-ba3b-4180-9ddd-8faae2f90f0c" name="us-gaap:NetIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">90,122</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Other comprehensive (loss) income:</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Unrealized loss on available-for-sale securities</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_18fbd5f3-ca89-44d1-a0f9-a94fe6cd865b" contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">299</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_f3ec3fdc-ca53-4ab4-9bac-351176f48dc3" contextRef="C_7b31e452-ba3b-4180-9ddd-8faae2f90f0c" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">71</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Foreign currency translation adjustments</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_57366eda-7bb3-4bb2-883f-3c4b963101c9" contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">13</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_8b174395-01a4-480a-b5b8-14558f6c2f48" contextRef="C_7b31e452-ba3b-4180-9ddd-8faae2f90f0c" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">17</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:20.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:20.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total other comprehensive loss</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_8063cde2-dcfb-41a0-83f7-3741834aefb5" contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" unitRef="U_USD" scale="3" decimals="-3" sign="-">286</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_75173259-8a0e-4d21-8712-2a0c599e789a" contextRef="C_7b31e452-ba3b-4180-9ddd-8faae2f90f0c" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" unitRef="U_USD" scale="3" decimals="-3" sign="-">54</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Comprehensive loss</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_f139cd9a-26ff-4cfd-8c1a-2484cf534006" contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698" name="us-gaap:ComprehensiveIncomeNetOfTax" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">102,312</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_0895263f-045c-45dc-8bdb-a47e33af0b54" contextRef="C_7b31e452-ba3b-4180-9ddd-8faae2f90f0c" name="us-gaap:ComprehensiveIncomeNetOfTax" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">90,176</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Net loss per share, basic and diluted</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_282515fb-14de-479a-896b-664d23c0d0ba" contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698" name="us-gaap:EarningsPerShareBasic" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" sign="-" format="ixt:numdotdecimal"><ix:nonFraction id="F_410b9e1e-75b6-412c-9c77-48fc63875fe9" contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698" name="us-gaap:EarningsPerShareDiluted" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" sign="-" format="ixt:numdotdecimal">2.93</ix:nonFraction></ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_267fba5f-1036-4dc9-959d-4a42d9e7c85b" contextRef="C_7b31e452-ba3b-4180-9ddd-8faae2f90f0c" name="us-gaap:EarningsPerShareBasic" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" sign="-" format="ixt:numdotdecimal"><ix:nonFraction id="F_73c0d5ea-717c-444e-90aa-59472c975358" contextRef="C_7b31e452-ba3b-4180-9ddd-8faae2f90f0c" name="us-gaap:EarningsPerShareDiluted" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" sign="-" format="ixt:numdotdecimal">4.48</ix:nonFraction></ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Weighted-average shares used to compute net loss per share,<br />&#160;&#160;&#160;basic and diluted</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_558dd7a8-baf8-4f21-88d5-9f45f9487dc2" contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" unitRef="U_shares" decimals="0" format="ixt:numdotdecimal"><ix:nonFraction id="F_e7dec432-cc3f-4be3-a420-aa893b04212a" contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" unitRef="U_shares" decimals="0" format="ixt:numdotdecimal">34,806,349</ix:nonFraction></ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_1be38f71-68bb-40ac-accc-d32c6c8438da" contextRef="C_7b31e452-ba3b-4180-9ddd-8faae2f90f0c" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" unitRef="U_shares" decimals="0" format="ixt:numdotdecimal"><ix:nonFraction id="F_1dcbb390-fcd8-4cd6-bee9-6b24e1b2f167" contextRef="C_7b31e452-ba3b-4180-9ddd-8faae2f90f0c" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" unitRef="U_shares" decimals="0" format="ixt:numdotdecimal">20,098,340</ix:nonFraction></ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:2.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">The accompanying notes are an integral part of these consolidated financial statements.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">73</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">89bio, Inc.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;" id="consolidated_statements_stockholders_equ"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Consolidated Statements </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">of Stockholders&#x2019; Equity</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">(In thousands, except share amounts)</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:40.763%;"></td>
    <td style="width:0.822%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:6.949999999999999%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:0.822%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:6.925999999999999%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:0.822%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:6.925999999999999%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:0.822%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:6.925999999999999%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:0.822%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:6.819%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:0.822%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:7.764%;"></td>
    <td style="width:1.0%;"></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Accumulated</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Additional</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Other</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Common Stock</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Paid-in</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Comprehensive</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Accumulated</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Stockholders&#x2019;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Shares</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Amounts</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Capital</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Loss</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Deficit</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Equity</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Balance as of December 31, 2020</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_54dcbe78-4cf1-4985-b596-7fbe6410f485" contextRef="C_3b1b99d2-654c-455a-a33a-422592ad8d08" name="us-gaap:SharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">19,931,660</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_61c461f4-e022-4fd4-a2e7-56de8ce5e4a9" contextRef="C_3b1b99d2-654c-455a-a33a-422592ad8d08" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3">20</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_bb903fd2-57f0-446c-b74b-71dd1858f8f3" contextRef="C_9cece5f1-3203-491d-9c15-ee835dbf4586" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">326,046</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_2f8d282a-ca70-4c63-8919-76b5aac8bb72" contextRef="C_48d6b2ed-10f4-4276-9857-7ff818488c18" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" sign="-">10</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_9ac75bcc-3327-4836-b6fe-818f646ddb29" contextRef="C_7c501227-02e2-4e44-b377-8e6109e76507" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">123,095</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_04b757ad-8c08-459f-8938-9c147ea3e957" contextRef="C_19418b37-9af5-4eb2-b38a-a9070fc599d5" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">202,961</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Issuance of common stock in at-the-market public <br />&#160;&#160;&#160;offerings, net of issuance costs</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_5a5a04f2-69ae-455f-b7d0-da9b544c8a3f" contextRef="C_3b188b92-032b-457e-ad3c-a951f340f11a" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">186,546</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_b1cbaabb-786a-4520-8b01-339a1857cfb8" contextRef="C_531e15c8-1e50-4083-9eba-30220f5c7c10" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">3,289</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_6b35287a-2053-4afe-807e-20cb3c952aed" contextRef="C_af7928d4-1306-45db-9bad-07933e9c282a" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">3,289</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Issuance of common stock upon exercise of stock options</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_9c8a8348-5f28-4fc0-9008-758edca95fc2" contextRef="C_a8dbb74d-cae4-4460-96f9-3662ead67daa" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">188,286</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_1e68b03f-12aa-4cf8-9084-fb30bfa8fe4d" contextRef="C_73cdaea6-5d5f-4d31-9b38-a90fc6b9008e" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" unitRef="U_USD" scale="3" decimals="-3">487</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_ab77b6c1-bd9d-47ca-8e4e-b47f79406378" contextRef="C_7b31e452-ba3b-4180-9ddd-8faae2f90f0c" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" unitRef="U_USD" scale="3" decimals="-3">487</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Issuance of common stock upon ESPP purchases</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_2d2ba69e-ad75-411a-85fd-0f4b56995277" contextRef="C_a8dbb74d-cae4-4460-96f9-3662ead67daa" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">10,712</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_a4c7e668-eb52-48f5-8f10-0dde28932ceb" contextRef="C_73cdaea6-5d5f-4d31-9b38-a90fc6b9008e" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" unitRef="U_USD" scale="3" decimals="-3">144</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_e235235d-b29f-43e2-a356-e5492fb43599" contextRef="C_7b31e452-ba3b-4180-9ddd-8faae2f90f0c" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" unitRef="U_USD" scale="3" decimals="-3">144</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Issuance of common stock warrant in connection with term loan facility</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_d599e941-4898-42ef-8784-a1b8badb30bc" contextRef="C_73cdaea6-5d5f-4d31-9b38-a90fc6b9008e" name="etnb:IssuanceOfCommonStockWarrantInConnectionWithTermLoanFacility" unitRef="U_USD" scale="3" decimals="-3">574</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_aa15bbd3-c4b5-4d88-8328-19303cc0b843" contextRef="C_7b31e452-ba3b-4180-9ddd-8faae2f90f0c" name="etnb:IssuanceOfCommonStockWarrantInConnectionWithTermLoanFacility" unitRef="U_USD" scale="3" decimals="-3">574</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Stock-based compensation</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_4d83e3ab-2e36-4064-b2cc-0a4c802949c2" contextRef="C_73cdaea6-5d5f-4d31-9b38-a90fc6b9008e" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">8,678</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_73f43674-32fc-4351-80f8-e6c64ee086ea" contextRef="C_7b31e452-ba3b-4180-9ddd-8faae2f90f0c" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">8,678</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Net loss</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_5bfe8f43-b833-48f1-8efb-9b8c04e46c45" contextRef="C_6abe1517-994e-40d2-af02-3d1364d02449" name="us-gaap:NetIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">90,122</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_ab7fd1de-2871-42a5-9609-2b58580a4d85" contextRef="C_7b31e452-ba3b-4180-9ddd-8faae2f90f0c" name="us-gaap:NetIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">90,122</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Other comprehensive loss</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_e628551b-9e63-4b74-b6e1-e809410e19ca" contextRef="C_28004ded-ab04-4f21-ace5-a081ac2e28b8" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" unitRef="U_USD" scale="3" decimals="-3" sign="-">54</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_c3e01b5b-09f2-49ab-b471-d33201de4a64" contextRef="C_7b31e452-ba3b-4180-9ddd-8faae2f90f0c" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" unitRef="U_USD" scale="3" decimals="-3" sign="-">54</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Balance as of December 31, 2021</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_c99fb41f-f125-4538-96c1-4350291d7b63" contextRef="C_acf3ac7f-4345-415e-b39a-8425a9a0a3db" name="us-gaap:SharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">20,317,204</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_0cf4f931-09a7-4d8f-922d-a0e6a77118c2" contextRef="C_acf3ac7f-4345-415e-b39a-8425a9a0a3db" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3">20</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_124369e1-62f5-4e74-9ca4-0d5ad5945495" contextRef="C_06c8eb12-56da-4f0a-a557-1a9ee843de7a" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">339,218</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_1c5113f8-646f-4c13-a2fe-a262f0bcf6cf" contextRef="C_86dde930-3c82-4da9-903f-d12ea942a22e" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" sign="-">64</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_4b017835-b552-4f49-82fd-8042adb63c66" contextRef="C_6cd8e184-e243-4a3c-818f-9a1ebfd43667" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">213,217</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_70ef5614-f5dd-4c25-a201-43ddb4c5302c" contextRef="C_21f769c6-c78d-41d0-b871-ec3d93d7d343" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">125,957</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Issuance of common stock and warrants in public <br />&#160;&#160;&#160;offering, net of issuance costs</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_cdec43f9-832d-4cba-90f6-e72ba0e4cdee" contextRef="C_538d2ebd-ca46-4eb6-a0b9-787839675985" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">18,675,466</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_5a4aabd5-91b0-4072-a117-0b96a33736db" contextRef="C_538d2ebd-ca46-4eb6-a0b9-787839675985" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">20</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_c6617507-2c85-4ae7-b0e1-864605ff1dc8" contextRef="C_0ec77485-e315-49c3-9a79-2d048ec76494" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">88,219</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_e070bea3-2dfa-4155-a84b-2628f699b08b" contextRef="C_ccc34858-a5d1-4e90-8bb9-0ff6d83c6b06" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">88,239</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Issuance of common stock in at-the-market public <br />&#160;&#160;&#160;offering, net of issuance costs</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_c94ef3a2-fe02-48e0-a6d3-c867ee209534" contextRef="C_8aa0101e-eb8f-4a89-baf5-0cb6983f48c3" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">3,948,611</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_4104b808-db65-45dd-ac6d-edde50aca731" contextRef="C_8aa0101e-eb8f-4a89-baf5-0cb6983f48c3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">4</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_51a93ae8-37d3-4b2f-a9bf-933d031653d2" contextRef="C_94f92680-1f20-47c3-8d22-07184c19f444" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">28,449</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_29954017-8b21-44c6-a794-8312856c347e" contextRef="C_3b993bd4-a1f0-42fb-959d-d02b87902727" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">28,453</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Issuance of common stock upon exercise of warrants</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_1f3ce629-c12c-4ef4-b156-8e84f628696b" contextRef="C_0f35f69d-3f7b-4b23-8802-ee13a747affc" name="etnb:StockIssuedDuringPeriodSharesWarrantsExercised" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">4,202,499</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_afe9a43a-e875-4606-80d4-ea00b6c15e54" contextRef="C_0f35f69d-3f7b-4b23-8802-ee13a747affc" name="etnb:StockIssuedDuringPeriodValueWarrantsExercised" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">4</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_dfddbe8e-1ec9-4939-9640-4f22d713cceb" contextRef="C_a7b7da7e-fb0a-4f4b-a318-753b03bdad64" name="etnb:StockIssuedDuringPeriodValueWarrantsExercised" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,078</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_a99d4451-38d4-42a5-83d6-18fe228be074" contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698" name="etnb:StockIssuedDuringPeriodValueWarrantsExercised" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,082</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Issuance of common stock upon cashless exercise of warrants</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_1d8e6738-7c05-4a00-8059-28303d1f4ca7" contextRef="C_0f35f69d-3f7b-4b23-8802-ee13a747affc" name="etnb:StockIssuedDuringPeriodSharesCashlessExerciseOfWarrants" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">3,143,682</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_43f65416-164d-4862-b9b2-33c9f297b1a6" contextRef="C_0f35f69d-3f7b-4b23-8802-ee13a747affc" name="etnb:StockIssuedDuringPeriodValueCashlessExerciseOfWarrants" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">3</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_29188b4f-205d-47f0-ad2f-cbfaa86ac78f" contextRef="C_a7b7da7e-fb0a-4f4b-a318-753b03bdad64" name="etnb:StockIssuedDuringPeriodValueCashlessExerciseOfWarrants" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">3</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Issuance of common stock upon exercise of stock options</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_f2937f30-2c86-4c32-a30b-c4cf1743324a" contextRef="C_0f35f69d-3f7b-4b23-8802-ee13a747affc" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">151,061</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_261b6c8e-a514-493b-a065-10cc53ad60cb" contextRef="C_a7b7da7e-fb0a-4f4b-a318-753b03bdad64" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">305</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_c08e0580-fb5f-448f-bb97-3fb580e2a2a0" contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">305</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Issuance of common stock upon ESPP purchases</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_08d04161-af58-479a-8ac2-44cfc0658551" contextRef="C_0f35f69d-3f7b-4b23-8802-ee13a747affc" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">18,364</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_c55b30be-9ff5-4384-b4d0-a7459bb6005e" contextRef="C_a7b7da7e-fb0a-4f4b-a318-753b03bdad64" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">50</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_a1e87752-b4c7-4ac3-bd37-2ac24180a6f2" contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">50</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Issuance of common stock upon vesting of restricted stock units,<br />&#160;&#160;&#160;net of withholding taxes</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_aa2026d3-f084-401e-8628-3768d6c00e53" contextRef="C_0f35f69d-3f7b-4b23-8802-ee13a747affc" name="etnb:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfWithholdingTaxes" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">103,703</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_1dcbc011-6d1c-4ce0-b0d7-4257f1c8f613" contextRef="C_a7b7da7e-fb0a-4f4b-a318-753b03bdad64" name="etnb:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfWithholdingTaxes" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">298</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_bb7bac03-98ad-4893-89c1-ab398f8650de" contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698" name="etnb:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfWithholdingTaxes" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">298</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Stock-based compensation</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_0d7748ce-126b-4a4d-9947-e7ea0a105290" contextRef="C_a7b7da7e-fb0a-4f4b-a318-753b03bdad64" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">10,356</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_e82676c9-d435-4e43-9c18-d0f7872dd8b6" contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">10,356</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Net loss</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_328c0dba-f9f5-47b9-8ce2-95077e10b209" contextRef="C_0db42b13-ed32-4464-a128-9b3738d1e9ec" name="us-gaap:NetIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">102,026</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_d8dad5ec-9e75-47cb-a519-cc1c4de5fe3f" contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698" name="us-gaap:NetIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">102,026</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Other comprehensive loss</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_02fcdc95-0041-4b9e-909d-dfa458dd6745" contextRef="C_ebcdeb7b-03e6-4e92-b422-7eb9e015b4a8" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">286</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_b8597f43-ad9c-41ae-8f18-ad677c1f68fb" contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">286</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Balance as of December 31, 2022</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_5e438d05-eda3-49c2-b6f1-e8d7ae1aad8c" contextRef="C_7333b298-4d64-4dc2-818f-293d2d952a7c" name="us-gaap:SharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">50,560,590</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_a54e2709-3832-46e1-822f-e997af07b5cd" contextRef="C_7333b298-4d64-4dc2-818f-293d2d952a7c" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3">51</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_3d250aaf-7e96-488d-8543-b8594e394d04" contextRef="C_59a670e1-2243-40d1-b43e-339c260c91b8" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">467,374</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_bd95d6c8-10a5-4906-ad28-a8efd3e60171" contextRef="C_9e2050fc-7421-4f2f-bf7c-de15ccbc149f" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">350</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_5d207642-49a6-458a-8ace-a2e15d9d1ec4" contextRef="C_a21cd459-9352-4988-ba87-d4355aa42746" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">315,243</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_fa20a70c-9fc1-4dcf-a8be-3f5dac1f08a8" contextRef="C_85e3a5e5-8ff2-4682-901b-9d79336e863a" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">151,832</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:2.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">The accompanying notes are an integral part of these consolidated financial statements.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">74</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">89bio, Inc.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;" id="consolidated_statements_cash_flows"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Consolidated Statements of </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Cash Flows</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">(In thousands)</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:67.513%;"></td>
    <td style="width:1.636%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:11.754%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:1.636%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:13.463%;"></td>
    <td style="width:1.0%;"></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Year Ended December 31,</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2022</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2021</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Cash flows from operating activities:</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Net loss</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_b9d73e7b-b2fa-4787-a410-665bb780731f" contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698" name="us-gaap:ProfitLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">102,026</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_e92f6321-4d9d-4ee5-a022-663fc040369a" contextRef="C_7b31e452-ba3b-4180-9ddd-8faae2f90f0c" name="us-gaap:ProfitLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">90,122</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Adjustments to reconcile net loss to net cash used in operating activities:</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Stock-based compensation</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_601a561c-b305-493e-9be7-448ae0a529aa" contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698" name="us-gaap:ShareBasedCompensation" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">10,356</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_2e34ff36-9ce8-472e-84a6-b38404f833c5" contextRef="C_7b31e452-ba3b-4180-9ddd-8faae2f90f0c" name="us-gaap:ShareBasedCompensation" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">8,678</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Net (accretion) amortization on available-for-sale securities</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_3c2c2e8c-0d2e-490a-b686-747ae0ef62d3" contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698" name="us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">980</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_95ecddef-b330-47fe-917e-04d56d440090" contextRef="C_7b31e452-ba3b-4180-9ddd-8faae2f90f0c" name="us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">865</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Amortization of debt issuance costs and accretion of final payment fee</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_d1397cd3-6c24-4ea6-9093-c3a1f2b669fb" contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698" name="etnb:AmortizationOfDebtIssuanceCostsAndAccretionOfFinalPaymentFee" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">764</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_bfef1398-971f-4e8d-9939-34a239263f0d" contextRef="C_7b31e452-ba3b-4180-9ddd-8faae2f90f0c" name="etnb:AmortizationOfDebtIssuanceCostsAndAccretionOfFinalPaymentFee" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">617</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Non-cash operating lease expense</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_2169eeec-3d61-49c3-ae0d-6767469d958f" contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698" name="us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">175</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Depreciation</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_f8aaf113-2c94-4feb-9438-d7e8c82789b5" contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698" name="us-gaap:Depreciation" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">65</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_644eb05c-ff23-456d-a196-260d96371956" contextRef="C_7b31e452-ba3b-4180-9ddd-8faae2f90f0c" name="us-gaap:Depreciation" unitRef="U_USD" scale="3" decimals="-3">79</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Deferred tax assets</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_0b849682-36ee-4c39-aaba-6db7c6d1e58a" contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698" name="etnb:DeferredTaxAssets" unitRef="U_USD" scale="3" decimals="-3" format="ixt:zerodash">&#x2014;</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_63f38bc0-fd47-41c3-9eec-ec30ee9970e9" contextRef="C_7b31e452-ba3b-4180-9ddd-8faae2f90f0c" name="etnb:DeferredTaxAssets" unitRef="U_USD" scale="3" decimals="-3">150</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:10.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Changes in operating assets and liabilities:</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:20.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:20.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Prepaid and other current assets</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_7324e5d7-be24-46f6-8505-1c2ed69bd654" contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">3,331</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_21533ecb-f307-4a7e-943d-1e4e3a565f74" contextRef="C_7b31e452-ba3b-4180-9ddd-8faae2f90f0c" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">5,672</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:20.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:20.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Accounts payable</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_a5032463-0893-448e-af45-8dc2d1df9f2c" contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698" name="us-gaap:IncreaseDecreaseInAccountsPayable" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">5,659</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_38b9d654-070b-406d-b75b-ec034a6d698f" contextRef="C_7b31e452-ba3b-4180-9ddd-8faae2f90f0c" name="us-gaap:IncreaseDecreaseInAccountsPayable" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">4,778</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:20.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:20.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Accrued expenses</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_e6ad07ad-d0b9-41ba-bc7f-785a8dd9e62f" contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698" name="us-gaap:IncreaseDecreaseInAccruedLiabilities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,750</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_b30d1420-b409-44a2-a12e-0a0af3107cff" contextRef="C_7b31e452-ba3b-4180-9ddd-8faae2f90f0c" name="us-gaap:IncreaseDecreaseInAccruedLiabilities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">4,146</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);text-indent:20.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:20.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Operating lease liability</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_5ccab3af-3c98-4820-b10f-672d5f38a62c" contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698" name="us-gaap:IncreaseDecreaseInOperatingLeaseLiability" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">184</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Net cash used in operating activities</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_cceb805a-5971-4d68-adfc-15dd5a50de0b" contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">81,090</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_e549fe33-ed2e-48cd-bc5e-66f60ee10967" contextRef="C_7b31e452-ba3b-4180-9ddd-8faae2f90f0c" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">76,781</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Cash flows from investing activities:</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Proceeds from sales and maturities of available-for-sale securities</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_fcf28eb2-5288-4c1a-873c-f8cf4bfe41b5" contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698" name="us-gaap:ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">118,760</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_4505642b-ee1c-4813-94cf-8509aafae377" contextRef="C_7b31e452-ba3b-4180-9ddd-8faae2f90f0c" name="us-gaap:ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">148,422</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Purchases of available-for-sale securities</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_0ccb4f04-11c9-4f5c-b6f4-eebd00c101dc" contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698" name="etnb:PaymentForPurchaseOfAvailableForSaleSecurities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">152,696</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_9a9a9d41-b7d0-490b-ab69-353bb6d7e4c5" contextRef="C_7b31e452-ba3b-4180-9ddd-8faae2f90f0c" name="etnb:PaymentForPurchaseOfAvailableForSaleSecurities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">141,200</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Purchases of property and equipment</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_6161098f-a99b-4e69-9b69-023608721e81" contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">7</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_68c46389-600c-4d17-ba48-7edb370ecafc" contextRef="C_7b31e452-ba3b-4180-9ddd-8faae2f90f0c" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" unitRef="U_USD" scale="3" decimals="-3">63</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Net cash (used in) provided by investing activities</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_7cdd8705-27da-491f-be3f-e3ca63534020" contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">33,943</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_e074c0e6-906e-4fa0-bf17-bf7304098bbc" contextRef="C_7b31e452-ba3b-4180-9ddd-8faae2f90f0c" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">7,159</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Cash flows from financing activities:</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Proceeds from issuance of common stock and warrants in public offering,<br />&#160;&#160;&#160;net of issuance costs</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_00f7ad02-0569-4386-9de7-f364867e41d7" contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698" name="etnb:ProceedsFromIssuancePublicOffering" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">88,239</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Proceeds from issuance of common stock in at-the-market public offering,<br />&#160;&#160;&#160;net of issuance costs</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_1445e165-fa9d-401b-8d1c-590798dc078a" contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698" name="etnb:ProceedsFromIssuancePublicOfferingAtTheMarketOffering" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">28,453</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_e30b4269-7740-49ee-978d-736b70c310c2" contextRef="C_7b31e452-ba3b-4180-9ddd-8faae2f90f0c" name="etnb:ProceedsFromIssuancePublicOfferingAtTheMarketOffering" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">3,289</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Proceeds from issuance of common stock upon exercise of warrants</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_fe37486a-4723-4790-8a26-34ddc379e9e1" contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698" name="us-gaap:ProceedsFromWarrantExercises" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,082</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Proceeds from issuance of common stock upon exercise of stock options</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_e65437cb-b460-489d-a32d-323860acb9fc" contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698" name="us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">305</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_9e1f75a6-7963-475f-91af-e3bf55a2da24" contextRef="C_7b31e452-ba3b-4180-9ddd-8faae2f90f0c" name="us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">487</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Proceeds from issuance of common stock upon ESPP purchases</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_5a29fbf7-e8d3-4292-b61e-6e7cb7c29c65" contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698" name="us-gaap:ProceedsFromIssuanceOfCommonStock" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">50</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_a4cc769e-de67-4ebe-b2cb-3aeac2091a76" contextRef="C_7b31e452-ba3b-4180-9ddd-8faae2f90f0c" name="us-gaap:ProceedsFromIssuanceOfCommonStock" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">144</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Payment of withholding taxes related to restricted stock units</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_24348080-11f9-404c-a2c2-3156a7b4521a" contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">298</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Proceeds from term loan facility, net of issuance costs</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_22377c54-f596-4ed5-8d82-626e27452603" contextRef="C_7b31e452-ba3b-4180-9ddd-8faae2f90f0c" name="us-gaap:ProceedsFromIssuanceOfOtherLongTermDebt" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">19,951</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Net cash provided by financing activities</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_5e98a7ea-21cd-4d4c-9550-be033a2be27d" contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">117,831</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_c60938ca-4e30-49cf-937a-f9c1e76c1647" contextRef="C_7b31e452-ba3b-4180-9ddd-8faae2f90f0c" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">23,871</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Net change in cash and cash equivalents, and restricted cash</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_d27e2957-bd95-415d-9e45-32401674ff4b" contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">2,798</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_23f41b95-9a5a-4e2c-9fd2-fc6193b03ef0" contextRef="C_7b31e452-ba3b-4180-9ddd-8faae2f90f0c" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">45,751</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Cash and cash equivalents, and restricted cash at beginning of period</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_90a79a02-0fcb-464f-ab47-221c16e9b51b" contextRef="C_21f769c6-c78d-41d0-b871-ec3d93d7d343" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">52,457</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_b77e291b-3196-46f8-b827-621eac17fc8f" contextRef="C_19418b37-9af5-4eb2-b38a-a9070fc599d5" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">98,208</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Cash and cash equivalents, and restricted cash at end of period</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_bac4bacc-6dd2-479e-be69-220f1f65bf16" contextRef="C_85e3a5e5-8ff2-4682-901b-9d79336e863a" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">55,255</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_bab84bd9-1c7d-44b4-a68f-8203887367d6" contextRef="C_21f769c6-c78d-41d0-b871-ec3d93d7d343" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">52,457</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Components of cash and cash equivalents, and restricted cash:</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Cash and cash equivalents</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_5e227785-e31c-468b-a202-be3277ceb08e" contextRef="C_85e3a5e5-8ff2-4682-901b-9d79336e863a" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">55,255</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_d27b65d9-e159-4e24-bcab-c5104eb5b29e" contextRef="C_21f769c6-c78d-41d0-b871-ec3d93d7d343" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">52,432</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Restricted cash</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_a089d72c-b93f-4353-a82a-f638f5babb30" contextRef="C_85e3a5e5-8ff2-4682-901b-9d79336e863a" name="us-gaap:RestrictedCashCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:zerodash">&#x2014;</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_ed0d2fd2-b2af-4bef-96d8-50ebefe7462d" contextRef="C_21f769c6-c78d-41d0-b871-ec3d93d7d343" name="us-gaap:RestrictedCashCurrent" unitRef="U_USD" scale="3" decimals="-3">25</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total cash and cash equivalents, and restricted cash</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_ed3b1662-2b2f-45d4-9ba5-42b880b8bc9e" contextRef="C_85e3a5e5-8ff2-4682-901b-9d79336e863a" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">55,255</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_a5e7751c-d45a-431b-a750-b9d7613a11ce" contextRef="C_21f769c6-c78d-41d0-b871-ec3d93d7d343" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">52,457</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Supplemental disclosures of cash information:</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Cash paid for interest</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_a7f63b04-3ca7-4cc0-92da-7e467819ca55" contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698" name="us-gaap:InterestPaidNet" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,076</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_e517021d-6a40-46d1-bdb6-a178adbcdfab" contextRef="C_7b31e452-ba3b-4180-9ddd-8faae2f90f0c" name="us-gaap:InterestPaidNet" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">16</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Cash paid for operating leases</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_cd34ecf8-0650-4438-9d97-05ee6f5aa3c0" contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698" name="us-gaap:OperatingLeasePaymentsUse" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">234</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Supplemental disclosures of noncash information:</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Remeasurement of lease liability and right of use asset in connection <br />&#160;&#160;&#160;with lease modification</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_676e8e50-4a8a-4b0d-8e5d-bb84e815cd84" contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698" name="etnb:RemeasurementOfLeaseLiabilityAndRightOfUseAssetInConnectionWithLeaseModification" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">338</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Issuance of common stock warrant in connection with term loan facility</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_8c30df29-d1af-4741-9f3b-6d8f126e4cb2" contextRef="C_7b31e452-ba3b-4180-9ddd-8faae2f90f0c" name="etnb:IssuanceOfCommonStockWarrantInConnectionWithTermLoanFacility" unitRef="U_USD" scale="3" decimals="-3">574</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:2.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">The accompanying notes are an integral part of these consolidated financial statements.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">75</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">89bio, Inc.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;" id="notes_to_consolidated"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Notes to C</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">onsolidated Financial Statements</span></p>
  <div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_2dc48b74-04b2-484d-b496-c04c295d281a" contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698" name="us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" escape="true"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1. Organization and Basis of Presentation</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Description of Business</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">89bio, Inc. (&#x201c;89bio&#x201d; or the &#x201c;Company&#x201d;) is a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of liver and cardio-metabolic diseases. The Company&#x2019;s lead product candidate, pegozafermin (previously BIO89-100), a specifically engineered glycoPEGylated analog of fibroblast growth factor 21, is currently being developed for the treatment of nonalcoholic steatohepatitis and for the treatment of severe hypertriglyceridemia.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">89bio, Inc. was formed as a Delaware corporation in </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="-sec-ix-hidden:F_334737a3-eb1d-48a1-9363-2f3248ac80ff;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">June 2019</span></span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> to carry on the business of 89Bio Ltd., which was incorporated in Israel in January 2018.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Liquidity</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The accompanying consolidated financial statements have been prepared assuming the Company will continue as a going concern, which contemplates the realization of assets and liquidation of liabilities in the normal course of business. To date, the Company has not generated revenues from its activities and has incurred substantial operating losses. Management expects the Company to continue to generate substantial operating losses for the foreseeable future until it completes development of its products and seeks regulatory approvals to market such products. The Company had cash and cash equivalents and short-term available-for-sale securities of </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_59cffc5e-66fb-4775-a2cb-e5c6508d23b6" contextRef="C_85e3a5e5-8ff2-4682-901b-9d79336e863a" name="us-gaap:CashCashEquivalentsAndShortTermInvestments" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">188.2</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> as of December 31, 2022.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company expects that its cash and cash equivalents and short-term available-for-sale securities as of December 31, 2022</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, together with proceeds received in January and February 2023 from its ATM Facility (see Note 7 and Note 11), and proceeds available from the 2023 Loan Agreement (see Note 6 and Note 11), will be sufficient to fund operating expenses and capital expenditure requirements for a period of at least one year from the date these audited consolidated financial statements are filed with the Securities and Exchange Commission.</span></p></ix:nonNumeric></div>
  <div style="font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_0113dd9c-7a54-46d4-b2af-f75d5f600aae" contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698" name="us-gaap:SignificantAccountingPoliciesTextBlock" escape="true"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2. Summary of Significant Accounting Policie</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">s</span></p><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_7a9fe441-fa43-4796-8110-f5fa315cbd14" contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698" name="us-gaap:BasisOfAccountingPolicyPolicyTextBlock" escape="true"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Basis of Presentation</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States (&#x201c;U.S. GAAP&#x201d;).</span></p></ix:nonNumeric></div><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_56cbf108-fa42-4d24-9ba3-44b16e32b023" contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698" name="us-gaap:PriorPeriodReclassificationAdjustmentDescription" escape="true"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Reclassification</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Certain prior year amounts in the Company&#x2019;s consolidated statements of operations and comprehensive loss have been reclassified to conform to the current year presentation. Specifically, interest expense is disclosed separately on the Company&#x2019;s consolidated statements of operations and comprehensive loss, which had no impact on reported net loss, comprehensive loss, or loss per share.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p></ix:nonNumeric></div><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_4ceadd5c-c2d5-486b-88c9-3d770e940ddc" contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698" name="us-gaap:ConsolidationPolicyTextBlock" escape="true"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Principles of Consolidation</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The accompanying consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries. All intercompany balances and transactions have been eliminated in consolidation.</span></p></ix:nonNumeric></div><ix:exclude><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">76</span></p>
     <hr style="page-break-after:always;" /><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></ix:exclude><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_38ab0099-3b70-4c2b-8d68-e0712d8bdeb4" contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698" name="us-gaap:UseOfEstimates" escape="true"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Use of Estimates</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the consolidated financial statements and the reported amounts of expenses during the reporting period. Significant estimates and assumptions made in the accompanying consolidated financial statements include but are not limited to accrued research and development expenses and to the fair value of stock options. The Company evaluates its estimates and assumptions on an ongoing basis using historical experience and other factors and adjusts those estimates and assumptions when facts and circumstances dictate. Actual results could differ from those estimates.</span></p></ix:nonNumeric></div><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_60864ff6-6971-4880-b410-5e2265136724" contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698" name="us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" escape="true"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Foreign Currencies</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Certain transactions during the year ended December 31, 2022 and 2021</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> were denominated in currencies other than the U.S. dollar. Gains and losses from foreign currency transactions were not material for all periods presented and are reflected in the consolidated statements of operations and comprehensive loss as a component of interest income and other, net. The Company&#x2019;s subsidiary in Lithuania uses the Euro as its functional currency for financial reporting. The re-measurement from Euros to U.S. dollars results in translation gain and loss adjustments, which are reflected as a component of comprehensive loss as foreign currency translation adjustments.</span></p></ix:nonNumeric></div><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_213170f3-46b7-4cfe-98e5-ef2422abd886" contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698" name="us-gaap:FairValueMeasurementPolicyPolicyTextBlock" escape="true"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Fair Value Measurements</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Financial assets and liabilities are recorded at fair value on a recurring basis in the consolidated balance sheets. The carrying values of Company&#x2019;s financial assets and liabilities, including cash and cash equivalents, restricted cash, prepaid and other current assets, accounts payable, and accrued expenses approximate to their fair value due to the short-term nature of these instruments. The fair value of the Company&#x2019;s term loan approximates its carrying value, or amortized cost, due to the prevailing market rates of interest rates it bears. Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability (an exit price) in an orderly transaction between market participants at the reporting date. Assets and liabilities recorded at fair value are categorized based upon the level of judgment associated with the inputs used to measure their fair value. Hierarchical levels are directly related to the amount of subjectivity with the inputs to the valuation of these assets or liabilities as follows:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Level 1</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;Observable inputs such as unadjusted, quoted prices in active markets for identical assets or liabilities at the measurement date;</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Level 2</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;Inputs (other than quoted prices included in Level 1) are either directly or indirectly observable inputs for similar assets or liabilities. These include quoted prices for identical or similar assets or liabilities in active markets and quoted prices for identical or similar assets or liabilities in markets that are not active; and</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Level 3</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.</span></p></ix:nonNumeric></div><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_a4cbcfbe-a3db-4795-b210-164cce33363e" contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698" name="us-gaap:ConcentrationRiskCreditRisk" escape="true"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Concentrations of Credit Risk</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Financial instruments that potentially subject the Company to a concentration of credit risk consist primarily of cash and cash equivalents and short-term available-for-sale securities. Bank deposits are held by accredited financial institutions and these deposits may at times be in excess of insured limits. The Company limits its credit risk associated with cash and cash equivalents by placing them with financial institutions that it believes are of high quality. The Company has not experienced any losses on its deposits of cash or cash equivalents. The Company </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">limits amounts invested in available-for-sale securities by credit rating, maturity, industry group, investment type and issuer, except for securities issued by the U.S. government. The Company is not exposed to any significant concentrations of credit risk from these financial instruments.</span></p></ix:nonNumeric></div><ix:exclude><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">77</span></p>
     <hr style="page-break-after:always;" /><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></ix:exclude><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_844a119d-a43a-45aa-a3c9-abb5ea397812" contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698" name="etnb:OtherRisksAndUncertaintiesPolicyTextBlock" escape="true"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Other Risks and Uncertainties</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company&#x2019;s future results of operations involve a number of other risks and uncertainties. Factors that could affect the Company&#x2019;s future operating results and cause actual results to vary materially from expectations include, but are not limited to, the Company&#x2019;s early stages of clinical drug development; the Company&#x2019;s ability to advance product candidates into, and successfully complete, clinical trials on the timelines it projects; the Company&#x2019;s ability to adequately demonstrate sufficient safety and efficacy of its product candidates; the Company&#x2019;s ability to enroll patients in its ongoing and future clinical trials; the Company&#x2019;s ability to successfully manufacture and supply its product candidates for clinical trials; the Company&#x2019;s ability to obtain additional capital to finance its operations; uncertainties related to the projections of the size of patient populations suffering from the diseases the Company is targeting; the Company&#x2019;s ability to obtain, maintain, and protect its intellectual property rights; developments relating to the Company&#x2019;s competitors and its industry, including competing product candidates and therapies; general economic and market conditions; and other risks and uncertainties.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company&#x2019;s product candidates will require approvals from the U.S. Food and Drug Administration and comparable foreign regulatory agencies prior to commercial sales in their respective jurisdictions. There can be no assurance that any product candidates will receive the necessary approvals. If the Company is denied approval, approval is delayed or the Company is unable to maintain approval for any product candidate, it could have a materially adverse impact on the Company.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The ongoing COVID-19 pandemic has disrupted and may continue to disrupt the Company&#x2019;s business and delay its preclinical and clinical programs and timelines. The extent to which the COVID-19 pandemic may impact the Company&#x2019;s future operating results and financial condition is uncertain.</span></p></ix:nonNumeric></div><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_01d84835-a15f-4c19-9267-092704ebb4b0" contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698" name="us-gaap:SegmentReportingPolicyPolicyTextBlock" escape="true"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Segment Reporting</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company has </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_7870d154-27fe-46a4-88af-712cf5ae81a5" contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698" name="us-gaap:NumberOfOperatingSegments" unitRef="U_Segment" decimals="INF" format="ixt-sec:numwordsen">one</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> operating segment. The Company&#x2019;s chief operating decision maker, its Chief Executive Officer, manages the Company&#x2019;s operations on a consolidated basis for the purposes of allocating resources and evaluating financial performance.</span></p></ix:nonNumeric></div><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_b6872a82-5227-4294-932b-1fcadfd2b9ed" contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698" name="us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" escape="true"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Cash and Cash Equivalents</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company considers all highly liquid investments purchased with original maturities of three months or less from the purchase date to be cash equivalents. Cash equivalents consist primarily of amounts invested in money market funds and commercial paper that are stated at fair value.</span></p></ix:nonNumeric></div><div style="font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_8458bbdf-d81c-46f0-bb7a-67fae80d90dc" contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698" name="us-gaap:InvestmentPolicyTextBlock" escape="true"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Investments</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Investments have been classified as available-for-sale and are carried at estimated fair value as determined based upon quoted market prices or pricing models for similar securities. Management determines the appropriate classification of its available-for-sale investments in debt securities at the time of purchase. Generally, investments with original maturities beyond three months at the date of purchase are classified as short-term because it is management&#x2019;s intent to use the investments to fund current operations or to make them available for current operations.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><ix:exclude><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">78</span></p>
       <hr style="page-break-after:always;" /><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></ix:exclude><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Unrealized gains and losses are excluded from net loss and are reported as a component of comprehensive loss. The Company periodically evaluates whether declines in fair values of its available-for-sale securities below their book value are other-than-temporary. This evaluation consists of several qualitative and quantitative factors regarding the severity and duration of the unrealized loss as well as the Company&#x2019;s ability and intent to hold the available-for-sale security until a forecasted recovery occurs. Additionally, the Company assesses whether it has plans to sell the security or it is more likely than not it will be required to sell any available-for-sale securities before recovery of its amortized cost basis. Realized gains and losses and declines in fair value judged to be other than temporary, if any, on available-for-sale securities are included in interest income and other, net. The cost of investments sold is based on the specific-identification method. The Company has </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_352954e8-c29e-4444-9ab7-06966c782b08" contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698" name="us-gaap:OtherThanTemporaryImpairmentLossDebtSecuritiesPortionRecognizedInEarnings" unitRef="U_USD" decimals="INF" format="ixt-sec:numwordsen"><ix:nonFraction id="F_f710d6b7-69c3-4b55-99a1-12c23edaabe1" contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698" name="us-gaap:RealizedInvestmentGainsLosses" unitRef="U_USD" decimals="INF" format="ixt-sec:numwordsen">no</ix:nonFraction></ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">t experienced any material realized gains or losses or other-than-temporary losses in the periods presented.</span></p></ix:nonNumeric></div><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_a8b136ae-4d1c-4160-94d8-d18b234cee3a" contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698" name="us-gaap:LesseeLeasesPolicyTextBlock" escape="true"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Leases</span><span style="color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company is a lessee in noncancellable operating leases for office space. Beginning in 2022, the Company accounts for leases in accordance with Accounting Standards Update (&#x201c;ASU&#x201d;) 2016-02,</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> Leases</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> (</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Topic 842</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">). The Company determines if an arrangement is a lease or contains an embedded lease at inception. The Company accounts for a contract as a lease when it has the right to control the asset for a period of time while obtaining substantially all of the asset&#x2019;s economic benefits. For arrangements that meet the definition of a lease, the Company determines the initial classification and measurement of its right-of-use (&#x201c;ROU&#x201d;) asset and lease liability at the lease commencement date and thereafter if modified. Operating lease ROU assets represent the Company&#x2019;s right to use an underlying asset for the lease term and lease liabilities represent the Company&#x2019;s obligation to make the contractual lease payments over the lease term. The ROU asset is initially measured at cost, which comprises the initial amount of the lease liability adjusted for lease payments made at or before the lease commencement date, plus any initial direct costs incurred less any lease incentives received. The operating lease liability is initially measured at the present value of the unpaid lease payments at the lease commencement date. The lease liability is subsequently measured at amortized cost using the effective-interest method. The lease term includes any renewal options that the Company is reasonably assured to exercise. The present value of lease payments is determined by using the interest rate implicit in the lease, if that rate is readily determinable, otherwise, the Company uses its estimated collateralized incremental borrowing rate for the lease term. The Company has elected not to record leases with an original term of twelve months or less on its consolidated balance sheets and recognizes those lease payments in operating expenses in the consolidated statements of operations and comprehensive loss. The Company&#x2019;s short-term lease is not material.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In addition, the Company&#x2019;s leases may require it to pay additional costs, such as utilities, maintenance, and other operating costs, which are generally referred to as non-lease components and vary based on future outcomes. The Company has elected to not separate lease and non-lease components. Only the fixed costs for lease components and their associated non-lease components are accounted for as a single lease component and recognized as part of a ROU </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">asset and lease liability. Any variable expenses are recognized in operating expenses as incurred. Rent expense for an operating lease liability is recognized on a straight-line basis over the lease term and is included in operating expenses in the consolidated statements of operations and comprehensive loss.</span></p></ix:nonNumeric></div><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_1a4ac4f6-956e-4948-9e49-67d30c91a3cb" contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698" name="us-gaap:PropertyPlantAndEquipmentPolicyTextBlock" escape="true"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Property and Equipment, Net</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Property and equipment are stated at cost, less accumulated depreciation. Depreciation is calculated on a straight-line basis over the estimated useful lives of the related assets, generally ranging from </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="-sec-ix-hidden:F_4640215a-3a60-4f28-a85d-e6242af9c877;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">three</span></span></span><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> to </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_327e735f-0ce7-4eb7-9f80-02c6635b0d08" contextRef="C_a1422313-a35e-45e5-a7d0-20aa6422feb3" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:durwordsen"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">seven years</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_a8f8825b-0591-4fff-8be7-2e05f61bd09a" contextRef="C_23eaed33-b0aa-4e33-a2c8-2f2897791170" name="us-gaap:PropertyPlantAndEquipmentEstimatedUsefulLives"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Leasehold improvements are amortized on a straight-line basis over the shorter of the assets&#x2019; estimated useful life or the remaining term of the lease.</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Upon retirement or sale of the assets, the cost and related accumulated depreciation and amortization are removed from the consolidated balance sheets and the resulting gains or losses are recorded in the consolidated statements of operations and comprehensive loss. </span><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Maintenance and repair costs are expensed as incurred.</span></p></ix:nonNumeric></div><ix:exclude><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">79</span></p>
     <hr style="page-break-after:always;" /><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></ix:exclude><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_a31482b6-df2e-4bc2-894e-43ea967864dc" contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698" name="us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" escape="true"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Impairment of Long-Lived Assets</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company periodically evaluates its long-lived assets, including property and equipment, for impairment whenever events or changes in business circumstances indicate that the carrying amount of the assets or group of assets may not be fully recoverable. If indicators of impairment exist and the undiscounted future cash flows that the assets are expected to generate are less than the carrying value of the assets, then the Company will reduce the carrying amount of the assets through an impairment charge, to their estimated fair values based on a discounted cash flow approach or, when available and appropriate, to comparable market values. There were no such indicators for the periods presented.</span></p></ix:nonNumeric></div><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_45c813e9-bf45-4977-887b-319764dbf4ec" contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698" name="etnb:AccruedResearchAndDevelopmentExpensesPolicyTextBlock" escape="true"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Accrued Research and Development Expenses</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company estimates preclinical and clinical study and research expenses based on the services performed, pursuant to contracts with research institutions that conduct and manage preclinical and clinical studies and research services on its behalf. The Company records the costs of research and development activities based upon the estimated services provided but not yet invoiced and includes these costs in accrued expenses in the consolidated balance sheets. These costs are a component of the Company&#x2019;s research and development expenses.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company accrues for these costs based on factors such as estimates of the work completed in accordance with agreements established with its third-party service providers. The Company makes judgments and estimates in determining the accrued expenses balance. As actual costs become known, the Company adjusts its accrued expenses. The Company has not experienced any material differences between accrued costs and actual costs incurred. However, the status and timing of actual services performed may vary from the Company&#x2019;s estimates, resulting in adjustments to expense in future periods. Changes in these estimates that result in material changes to the Company&#x2019;s accrued expenses could materially affect the Company&#x2019;s results of operations. Contingent milestone payments, if any, are expensed when the milestone results are probable and estimable, which is generally upon achievement of the milestone.</span></p></ix:nonNumeric></div><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_30ab2a38-e7a1-4354-b37f-7c7d2ca3ff12" contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698" name="etnb:WarrantsToPurchaseCommonStockPolicyTextBlock" escape="true"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Warrants to Purchase Common Stock</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company classifies warrants indexed to its common stock and meeting the requirements for equity classification within stockholders&#x2019; equity. This assessment is conducted at the time of warrant issuance and as of each reporting period that the warrants remain outstanding.</span></p></ix:nonNumeric></div><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_1b58e503-377a-4f9e-a992-753c94220c41" contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698" name="us-gaap:ResearchAndDevelopmentExpensePolicy" escape="true"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Research and Development Expenses</span><span style="color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Research and development expenses consist primarily of costs incurred for the development of the Company&#x2019;s lead product candidate, pegozafermin. Research and development expenses consist primarily of external costs related to preclinical and clinical development and related supplies and personnel costs. Personnel costs consist of salaries, employee benefits and stock-based compensation for individuals involved in research and development efforts. Payments associated with agreements to acquire licenses to develop, use, manufacture and commercialize products and purchases of pegozafermin from contract manufacturing organizations that have not reached technological feasibility and do not have alternate future commercial use are expensed as incurred.</span></p></ix:nonNumeric></div><div style="font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_c96fbbf3-7b4f-4ee6-aacd-916d902ec7fc" contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698" name="us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy" escape="true"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Stock-Based Compensation</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company provides equity awards in the form of stock options and restricted stock units. The Company measures its equity awards made to employees, directors, and</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">non-employee service providers based on estimated fair values and recognizes stock-based compensation over the requisite service period. The Company accounts for forfeitures as they occur.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company estimates the fair value of stock option awards on the date of grant using a</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Black-Scholes option pricing model. The Company recognizes compensation for the value of stock options awards, which have graded vesting, using the straight-line method over the requisite service period of each award.</span><span style="color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><ix:exclude><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">80</span></p>
       <hr style="page-break-after:always;" /><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></ix:exclude><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Black-Scholes option pricing model requires a number of assumptions, of which the most significant are expected volatility, expected option term (the time from the grant date until the options are exercised or expire), risk-free rate, and expected dividend rate. These assumptions include:</span></p><div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Expected volatility&#x2014;Since the Company has limited trading history for its common stock, expected volatility is estimated based on weighting the Company&#x2019;s volatility and the volatility of comparable publicly traded biotechnology companies during the equivalent period of the calculated expected term of the options granted. The comparable companies were chosen based on their similar size, stage in the life cycle, or area of specialty. There is a degree of uncertainty in determining a comparable peer group as each of the peers are engaged in varied research and development activities, the timing and progress of which differ within the peer group. </span></div></div><div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Expected term&#x2014;The expected term of options granted to employees and directors is determined using the &#x201c;simplified&#x201d; method. Under this approach, the expected term is presumed to be the midpoint between the weighted-average vesting term and the contractual term of the option. The simplified method makes the assumption that the employee will exercise stock options evenly over the period when the stock options are vested and ending on the date when the stock options would expire. The expected option term for options granted to non-employees is estimated on a grant-by-grant basis.</span></div></div><div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Risk-free interest rate&#x2014;The risk-free interest rate is based on the U.S. Treasury zero coupon bonds in effect on the grant date for periods with an equivalent expected term as the option.</span></div></div><div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Expected dividend&#x2014;The Company has never paid dividends and has no foreseeable plans to pay dividends on its shares of common stock. Therefore, an expected dividend of zero is used.</span></div></div><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The fair value of restricted stock units is based on the fair value of the Company&#x2019;s common stock on the date of grant. The grant date fair value of restricted stock units with service vesting conditions is recognized over the requisite service period on a straight-line basis. For restricted stock units with performance vesting conditions, the Company evaluates the probability of achieving the performance condition at each reporting date and recognizes expense for such performance awards over the requisite service period using the accelerated attribution method.</span></p></ix:nonNumeric></div><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_58ed21cc-54db-452b-956b-cc0cd95d76cb" contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698" name="us-gaap:IncomeTaxPolicyTextBlock" escape="true"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Income Taxes</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Income taxes are accounted for under the asset and liability method. Under this method, deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the consolidated financial statements carrying amounts of existing assets and liabilities and their respective tax bases and operating loss and tax credit carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates applied to taxable income in the years in which those temporary differences are expected to be realized. The effect on deferred tax assets and liabilities of a change in tax rates is recognized as income or loss in the period that includes the enactment date. A valuation allowance is established when necessary to reduce deferred tax assets to the amount expected to be realized. Interest and penalties related to unrecognized tax benefits are included within the provision of income tax.</span><span style="color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p></ix:nonNumeric></div><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_8dafbc4e-a686-4c98-b0bc-e47280f82eaf" contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698" name="us-gaap:EarningsPerSharePolicyTextBlock" escape="true"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Basic and Diluted Net Loss per Share</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Basic loss per share is computed by dividing net loss by the weighted-average number of shares of common stock outstanding during the period. Diluted loss per share is computed by dividing net loss by the weighted-average number of shares of common stock outstanding together with the number of additional shares of common stock that would have been outstanding if all potentially dilutive shares of common stock had been issued. Since the Company is in a loss position for the periods presented, basic net loss per share is the same as diluted net loss per share since the effects of potentially dilutive securities are antidilutive. </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Shares of the Company&#x2019;s common stock underlying pre-funded warrants exercisable for nominal consideration are included in the computation of basic and diluted net loss per share, even if antidilutive.</span></p></ix:nonNumeric></div><ix:exclude><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">81</span></p>
     <hr style="page-break-after:always;" /><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></ix:exclude><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_813f3f8b-cb9a-49e5-8283-4dd4e52d1062" contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698" name="us-gaap:ComprehensiveIncomePolicyPolicyTextBlock" escape="true"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Comprehensive Loss</span><span style="color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company&#x2019;s comprehensive loss is comprised of net loss and changes in unrealized gains or losses on available-for-sale securities and foreign currency translation adjustments.</span></p></ix:nonNumeric></div><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_a2a49d29-df24-4166-bf41-ea953bb6fde0" contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" escape="true"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Recently Adopted Accounting Standards</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> &#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In February 2016, the Financial Accounting Standards Board (&#x201c;FASB&#x201d;) issued ASU 2016-02,</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> Leases</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> (</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Topic 842</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">), or Accounting Standards Codification (&#x201c;ASC&#x201d;) 842, which requires lessees to recognize leases on the balance sheet and disclose key information about leasing arrangements. ASC 842 establishes a ROU model that requires a lessee to recognize a ROU asset and lease liability on the balance sheet for all leases with a term longer than 12 months. Leases are classified as finance or operating, with classification affecting the pattern and classification of expense recognition in the income statement.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">On</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_9c2549a0-5464-4473-96b4-e9924594fda1" contextRef="C_d0cc41a8-af59-48aa-9362-9afbe6438bb6" name="us-gaap:ChangeInAccountingPrincipleAccountingStandardsUpdateAdoptionDate" format="ixt:datemonthdayyearen"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> January 1, 2022</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, the Company adopted </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_114209c8-d181-47b1-b75e-c4e8b71cbb0c" contextRef="C_d0cc41a8-af59-48aa-9362-9afbe6438bb6" name="us-gaap:ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted" format="ixt:booleantrue"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">ASC 842</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> using the modified retrospective transition method and elected the practical expedients to not reassess whether any expired or existing contracts are or contain leases, carry forward its historical lease classification and not reassess initial direct costs for existing leases. Upon adoption of ASC 842, the Company recorded an operating ROU asset of $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_61ab1b21-99f0-482a-8569-c37a71533b30" contextRef="C_eb4154dd-05cb-44b2-b1f9-253eb264f041" name="us-gaap:OperatingLeaseRightOfUseAsset" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">0.2</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million and an operating lease liability of $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_aa094a7b-1392-482d-9513-982d879d7792" contextRef="C_eb4154dd-05cb-44b2-b1f9-253eb264f041" name="us-gaap:OperatingLeaseLiabilityCurrent" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">0.2</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million on its consolidated balance sheet. There was </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_620d8eb0-dce7-46c6-8ba1-7f3fd876be92" contextRef="C_eb4154dd-05cb-44b2-b1f9-253eb264f041" name="us-gaap:RetainedEarningsAccumulatedDeficit" unitRef="U_USD" scale="3" decimals="-3" format="ixt-sec:numwordsen">no</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> adjustment to the opening balance of accumulated deficit as a result of adoption. Results for the year ended December 31, 2022 are presented under ASC 842. Prior period amounts preceding January 1, 2022 continue to be reported in accordance with the Company&#x2019;s historical accounting under the previous lease guidance, ASC 840.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Recent Accounting Pronouncements</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In June 2016, the FASB issued ASU 2016-13, </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Financial Instruments&#x2014;Credit Losses (Topic 326)</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">: </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Measurement of Credit Losses on Financial Instruments </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(&#x201c;ASU 2016-13&#x201d;), which replaces the existing incurred loss impairment model with an expected credit loss model and requires a financial asset measured at amortized cost to be presented at the net amount expected to be collected. As an emerging growth company, ASU 2016-13 is effective for the Company for the year ending December 31, 2023 and interim periods within that fiscal year and must be adopted using a modified retrospective approach, with certain exceptions. The Company is evaluating the impact of this standard and </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">does not expect the adoption of ASU 2016-13 to have a material impact on the Company&#x2019;s consolidated financial statements and related disclosures.</span></p></ix:nonNumeric></div></ix:nonNumeric></div>
  <div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_f37fdc10-16e1-4dad-831d-6104386e5cce" contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698" name="us-gaap:FairValueDisclosuresTextBlock" escape="true"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3. Fair Value Measurements</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><div style="font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_fab889e1-ba2a-4959-b238-a6df438d4698" contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698" name="us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" escape="true" continuedAt="F_fab889e1-ba2a-4959-b238-a6df438d4698_1"><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The following table presents the Company&#x2019;s financial assets measured at fair value on a recurring basis by level within the fair value hierarchy as of </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31, 2022 (in thousands):</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:90.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:45.662%;"></td>
        <td style="width:0.122%;"></td>
        <td style="width:10.9%;"></td>
        <td style="width:0.122%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:8.655%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:0.081%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:8.384%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:0.108%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:9.225%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:0.081%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:8.655%;"></td>
        <td style="width:1.0%;"></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Valuation</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Amortized</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Unrealized</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Unrealized</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Fair</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Hierarchy</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Cost</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Gains</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Losses</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Value</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Money market funds</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Level 1</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_a35a6189-e82d-4816-965f-1fa64a96f795" contextRef="C_fc374840-0f9a-49dd-a75c-57c70ae81f21" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">18,224</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_e7182cb7-9bd3-4e51-8711-11e0a0905505" contextRef="C_fc374840-0f9a-49dd-a75c-57c70ae81f21" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">18,224</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Commercial paper</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Level 2</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_819ce257-be3d-4236-91b7-501ca7ca670e" contextRef="C_9e28330b-37ae-4c55-b6c8-5ab5971501f1" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">104,279</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_5f95696d-36a3-4ee4-9ba4-d48962c1f9d5" contextRef="C_9e28330b-37ae-4c55-b6c8-5ab5971501f1" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_c0d2d37b-607c-4316-881b-db648d7e97fc" contextRef="C_9e28330b-37ae-4c55-b6c8-5ab5971501f1" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">84</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_d53092cd-9fc3-4828-95ae-878803d38d55" contextRef="C_9e28330b-37ae-4c55-b6c8-5ab5971501f1" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">104,196</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">U.S. government bonds</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Level 2</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_705e05f3-7357-4bc0-b4c1-500527c9312c" contextRef="C_5c814fa2-557e-430f-a964-0b757b56fdfd" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">18,225</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_82329a41-ef52-4459-b77c-30486f6a329b" contextRef="C_5c814fa2-557e-430f-a964-0b757b56fdfd" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_5e39789b-4542-4f5f-929f-4dc9637cb6a5" contextRef="C_5c814fa2-557e-430f-a964-0b757b56fdfd" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">109</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_b3858c51-93a3-4fe1-afe1-838cfff5dad8" contextRef="C_5c814fa2-557e-430f-a964-0b757b56fdfd" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">18,117</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Agency bonds</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Level 2</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_d3eb2143-a97a-422d-b478-f80822e908ca" contextRef="C_20129c45-1d42-4b18-a135-f79c3916f000" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">13,986</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_8ee7c5bf-93e4-4c24-95ae-56533a8a0165" contextRef="C_20129c45-1d42-4b18-a135-f79c3916f000" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">78</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_458c29d8-869f-47d6-a4d4-7a11705bb32d" contextRef="C_20129c45-1d42-4b18-a135-f79c3916f000" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">13,908</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Corporate debt securities</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Level 2</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_92056759-393d-4794-bd43-156ca2f0ee90" contextRef="C_0d9500dd-d242-4ed4-9f39-2450c5d10363" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">10,488</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_77e6bb81-9281-4f83-935e-67d92c253f43" contextRef="C_0d9500dd-d242-4ed4-9f39-2450c5d10363" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">62</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_b2cd630c-b1b8-4de9-b362-188d502a1ae4" contextRef="C_0d9500dd-d242-4ed4-9f39-2450c5d10363" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">10,426</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">U.S. treasury bills</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Level 2</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_e229c840-0411-484f-8ddf-428ab6b67d28" contextRef="C_15a836b6-6096-4e2c-9574-cf11b7149853" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">7,414</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_a7d5b8e2-de69-485d-96f2-141a29d21a40" contextRef="C_15a836b6-6096-4e2c-9574-cf11b7149853" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_a9c61df8-1416-4e0f-ae6c-4ace4225c918" contextRef="C_15a836b6-6096-4e2c-9574-cf11b7149853" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">21</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_d56db9fe-b737-4d3c-beea-1b4494efc57c" contextRef="C_15a836b6-6096-4e2c-9574-cf11b7149853" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">7,394</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Agency discount securities</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Level 2</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_66934ec4-e323-44ed-86a6-204cd8389742" contextRef="C_ba27f631-5055-4b5d-bcd3-1dcdfae2eb5e" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">5,216</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_78d83cea-a110-4680-91f4-6c360f1a0080" contextRef="C_ba27f631-5055-4b5d-bcd3-1dcdfae2eb5e" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">9</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_49186687-2134-44fd-8262-822001dfc503" contextRef="C_ba27f631-5055-4b5d-bcd3-1dcdfae2eb5e" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">5,225</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Non-U.S. debt securities</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Level 2</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_40f44c05-ad16-4287-a3fa-09712b95b392" contextRef="C_a98c76fd-bd2e-47b8-b425-7f631d600233" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">3,975</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_5f379c98-8db2-4148-be0d-cad80e422410" contextRef="C_a98c76fd-bd2e-47b8-b425-7f631d600233" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">20</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_bda3d27f-4b9e-4a7d-bb9c-da23e2ae76f8" contextRef="C_a98c76fd-bd2e-47b8-b425-7f631d600233" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">3,955</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:5.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total cash equivalents and available-for-<br />&#160;&#160;&#160;sale securities</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_f3a5a101-7e49-4e36-ad46-8fa83fbecd5e" contextRef="C_b49f5ccf-6e36-469f-8160-42229bc94d1d" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">181,807</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_7519b91b-536c-4b34-8aff-e0f24e204a9a" contextRef="C_b49f5ccf-6e36-469f-8160-42229bc94d1d" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">12</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_ae6e7061-fa66-42e3-bea7-d3dbba17bb53" contextRef="C_b49f5ccf-6e36-469f-8160-42229bc94d1d" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">374</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_11c0a24b-f765-4034-8a4f-b68a6ce610bf" contextRef="C_b49f5ccf-6e36-469f-8160-42229bc94d1d" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">181,445</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Classified as:</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Cash equivalents</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_d86fe17d-c76b-4590-b736-11cacb8f1d26" contextRef="C_43d7ae38-fb0a-4a4d-a3e8-a44b58f48f12" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">48,540</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Short-term available-for-sale securities</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_5301359c-f6d3-4667-9e2b-1e7a75309294" contextRef="C_a518f01f-6e57-482e-afd5-51c9629b2a7c" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">132,905</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:5.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total cash equivalents and available-for-<br />&#160;&#160;&#160;sale securities</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_bf66deec-f094-4fd8-a4e6-d2d4c4b830f4" contextRef="C_b49f5ccf-6e36-469f-8160-42229bc94d1d" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">181,445</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p><ix:exclude><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">82</span></p>
       <hr style="page-break-after:always;" /><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></ix:exclude><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></ix:nonNumeric></div><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_ced9b6d2-9d83-4ed5-9869-104a8dd26498" contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698" name="us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock" escape="true" continuedAt="F_ced9b6d2-9d83-4ed5-9869-104a8dd26498_1"><p style="text-indent:4.533%;font-size:10.0pt;margin-top:2.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The following table summarizes the Company&#x2019;s cash equivalents and available-for-sale securities by contractual maturity as of </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31, 2022 (in thousands):</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:90.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:77.695%;"></td>
        <td style="width:2.196%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:18.109%;"></td>
        <td style="width:1.0%;"></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Within one year</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_223e85ec-e7c2-40d2-a00a-cba3720748d5" contextRef="C_85e3a5e5-8ff2-4682-901b-9d79336e863a" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">175,243</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">After one year through two years</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_b5a45df0-7ab9-40d3-ac2d-987eaf6f1aee" contextRef="C_85e3a5e5-8ff2-4682-901b-9d79336e863a" name="etnb:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughTwoYearsFairValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">6,202</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:5.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total cash equivalents and available-for-sale securities</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_c7458e36-977b-4c6a-95e1-8e2fa206445e" contextRef="C_85e3a5e5-8ff2-4682-901b-9d79336e863a" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">181,445</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></ix:nonNumeric></div><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:continuation id="F_fab889e1-ba2a-4959-b238-a6df438d4698_1"><p style="text-indent:4.533%;font-size:10.0pt;margin-top:2.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The following table presents the Company&#x2019;s financial assets measured at fair value on a recurring basis by level within the fair value hierarchy as of </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31, 2021 (in thousands):</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:90.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:45.662%;"></td>
        <td style="width:0.122%;"></td>
        <td style="width:10.9%;"></td>
        <td style="width:0.122%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:8.655%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:0.081%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:8.384%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:0.108%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:9.225%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:0.081%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:8.655%;"></td>
        <td style="width:1.0%;"></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Valuation</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Amortized</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Unrealized</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Unrealized</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Fair</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Hierarchy</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Cost</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Gains</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Losses</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Value</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Money market funds</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Level 1</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_a04955dd-c5c4-4a50-bb44-9521e7722435" contextRef="C_8c4669a8-efdc-43fe-b27c-54cf3b35bd79" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">21,477</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_191a1919-ddc1-4aa9-87e0-82a116ffc395" contextRef="C_8c4669a8-efdc-43fe-b27c-54cf3b35bd79" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">21,477</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Commercial paper</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Level 2</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_25bca5b4-b46a-4cd9-a2c1-77c861cba6b0" contextRef="C_b79c1273-b7ef-4512-a77c-8f09b7dd034b" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">59,647</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_343b43da-b3f1-4271-8936-17b73c588f35" contextRef="C_b79c1273-b7ef-4512-a77c-8f09b7dd034b" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">10</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_35a73eb9-23b2-4040-8b16-9031f74ff38f" contextRef="C_b79c1273-b7ef-4512-a77c-8f09b7dd034b" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">59,637</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">U.S. government bonds</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Level 2</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_48a93900-9967-44a8-aa55-607fff1924a9" contextRef="C_276795d2-8680-4e1e-a7b3-60b4f187b181" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">21,662</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_ab0cdfef-a489-4eb0-8e5f-719fac219b7c" contextRef="C_276795d2-8680-4e1e-a7b3-60b4f187b181" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">42</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_757a9143-4d49-4965-9141-bb3a3532a0b6" contextRef="C_276795d2-8680-4e1e-a7b3-60b4f187b181" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">21,620</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Corporate debt securities</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Level 2</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_a376d0da-3e38-439d-ab92-7612ab070ba4" contextRef="C_5a34cef0-4d09-47ec-a8ce-379fe69ed741" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">8,776</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_68953e26-9ffb-4638-9942-8b545d4280a5" contextRef="C_5a34cef0-4d09-47ec-a8ce-379fe69ed741" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_16ac5f3e-9893-423e-ac68-c5497d39f1d0" contextRef="C_5a34cef0-4d09-47ec-a8ce-379fe69ed741" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_dfed356f-2eb7-43eb-a4ea-c393330b1e20" contextRef="C_5a34cef0-4d09-47ec-a8ce-379fe69ed741" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">8,776</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Agency bonds</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Level 2</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_d3c5acfc-9ba9-47da-a600-0857d96892c7" contextRef="C_6bb5134f-3725-49c2-9eda-5f0d3a108db3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">7,747</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_bf737465-540e-4b1b-9921-4050a84c265c" contextRef="C_6bb5134f-3725-49c2-9eda-5f0d3a108db3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_d8f03420-243b-4af3-bb44-235cce55ec40" contextRef="C_6bb5134f-3725-49c2-9eda-5f0d3a108db3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">7</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_bfd5caec-b18f-41af-8d3c-b1dc1ac5331e" contextRef="C_6bb5134f-3725-49c2-9eda-5f0d3a108db3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">7,741</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Municipal bonds</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Level 2</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_8d243ace-9891-4b89-ba02-4f1440883e36" contextRef="C_cb2cbb74-aff7-499d-b6a9-60e3aa3581f8" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">4,251</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_935370a4-dfcc-4538-bda6-f82faa2cc6e2" contextRef="C_cb2cbb74-aff7-499d-b6a9-60e3aa3581f8" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">4</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_4a371b7c-2ffe-4b70-a8bf-457d6b4cad0e" contextRef="C_cb2cbb74-aff7-499d-b6a9-60e3aa3581f8" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">4,247</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Non-U.S. debt securities</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Level 2</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_3726da44-f45e-4d27-864f-fc91b197ef84" contextRef="C_a099857d-ead8-4784-88ce-373b780df01d" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">2,506</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_53c5aaf6-4818-4975-9292-1346e5892c82" contextRef="C_a099857d-ead8-4784-88ce-373b780df01d" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_e8534637-bb95-47f5-bccc-6fa85f282a84" contextRef="C_a099857d-ead8-4784-88ce-373b780df01d" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">2,505</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:5.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total cash equivalents and available-for-<br />&#160;&#160;&#160;sale securities</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_394ee3c4-9972-4211-86ea-1b7dbc526bdc" contextRef="C_7120f124-ce25-4ba7-a030-21bd1b4579e6" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">126,066</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_1c7aa7fe-5a6f-4b78-aa9a-38b569c4cddf" contextRef="C_7120f124-ce25-4ba7-a030-21bd1b4579e6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">2</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_9a40297e-2490-4f9a-a3b9-fd696c412f08" contextRef="C_7120f124-ce25-4ba7-a030-21bd1b4579e6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">65</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_582bf28c-e344-40a1-a0fe-4dad30f69625" contextRef="C_7120f124-ce25-4ba7-a030-21bd1b4579e6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">126,003</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Classified as:</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Cash equivalents</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_c10b9f9f-0610-42b8-a34b-0cb1d2756c57" contextRef="C_7063e2f9-3a0a-44ed-964f-cc213bf88e2e" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">27,715</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Short-term available-for-sale securities</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_0b590360-e57b-4e2c-809a-0dc40ee26941" contextRef="C_aa8067f4-0c3d-4c66-b916-2f5abd46e15d" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">98,288</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:5.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total cash equivalents and available-for-<br />&#160;&#160;&#160;sale securities</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_1e8077e1-f2f6-480b-97e2-4bde5d770834" contextRef="C_7120f124-ce25-4ba7-a030-21bd1b4579e6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">126,003</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></ix:continuation></div><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:continuation id="F_ced9b6d2-9d83-4ed5-9869-104a8dd26498_1"><p style="text-indent:4.533%;font-size:10.0pt;margin-top:2.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The following table summarizes the Company&#x2019;s cash equivalents and available-for-sale securities by contractual maturity as of </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31, 2021 (in thousands):</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:90.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:77.695%;"></td>
        <td style="width:2.196%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:18.109%;"></td>
        <td style="width:1.0%;"></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Within one year</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_490796d4-603b-48e9-aafe-b975500c95ac" contextRef="C_21f769c6-c78d-41d0-b871-ec3d93d7d343" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">120,726</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">After one year through two years</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_de384d4a-446f-4557-884e-92497d3c86b0" contextRef="C_21f769c6-c78d-41d0-b871-ec3d93d7d343" name="etnb:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughTwoYearsFairValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">5,277</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:5.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total cash equivalents and available-for-sale securities</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_2cc2670f-dd59-4add-9975-ab1419d61517" contextRef="C_21f769c6-c78d-41d0-b871-ec3d93d7d343" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">126,003</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></ix:continuation></div></ix:nonNumeric></div>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <div style="font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_ff7d5107-f238-4bd9-9ade-bea505cca9b6" contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698" name="us-gaap:SupplementalBalanceSheetDisclosuresTextBlock" escape="true"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4. Consolidated Balance Sheet Components</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_a3b9c4e9-2474-45e6-a889-8d3259ea2a7b" contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698" name="etnb:ScheduleOfPrepaidAndOtherCurrentAssetsTableTextBlock" escape="true"><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Prepaid and other current assets consist of the following as of the periods presented (in thousands):</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:70.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:65.777%;"></td>
        <td style="width:1.589%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:13.515%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:1.589%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:13.530000000000001%;"></td>
        <td style="width:1.0%;"></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As of December 31,</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2022</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2021</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Prepaid research and development</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_b8ffb099-e868-4be4-ae6a-c131a2673ec8" contextRef="C_85e3a5e5-8ff2-4682-901b-9d79336e863a" name="etnb:PrepaidResearchAndDevelopmentCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">5,727</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_f4375c76-261c-4b83-99ce-c5e77c438512" contextRef="C_21f769c6-c78d-41d0-b871-ec3d93d7d343" name="etnb:PrepaidResearchAndDevelopmentCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">7,895</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Prepaid taxes</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_94e2312b-929f-46c4-8f76-c6d783e33c55" contextRef="C_85e3a5e5-8ff2-4682-901b-9d79336e863a" name="us-gaap:PrepaidTaxes" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">646</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_a5e4f3eb-a618-4bd0-85c1-a887f3db219f" contextRef="C_21f769c6-c78d-41d0-b871-ec3d93d7d343" name="us-gaap:PrepaidTaxes" unitRef="U_USD" scale="3" decimals="-3">836</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Prepaid other</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_4d45478f-8e58-4ba2-acc7-8d514d13ff07" contextRef="C_85e3a5e5-8ff2-4682-901b-9d79336e863a" name="us-gaap:OtherPrepaidExpenseCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,547</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_dee67f19-3901-4a30-8fdc-7474be076657" contextRef="C_21f769c6-c78d-41d0-b871-ec3d93d7d343" name="us-gaap:OtherPrepaidExpenseCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">2,506</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:5.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total prepaid and other current assets</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_105b422e-b61f-4685-8773-6166915b2e03" contextRef="C_85e3a5e5-8ff2-4682-901b-9d79336e863a" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">7,920</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_566043d3-e449-4671-bea3-3a6e6db0fb58" contextRef="C_21f769c6-c78d-41d0-b871-ec3d93d7d343" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">11,237</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></ix:nonNumeric></div><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p><ix:exclude><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">83</span></p>
     <hr style="page-break-after:always;" /><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></ix:exclude><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_85c8c31f-4638-495b-b98f-f062c313ad26" contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698" name="us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock" escape="true"><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Accrued expenses consist of the following as of the periods presented (in thousands):</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:70.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:65.777%;"></td>
        <td style="width:1.589%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:13.515%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:1.589%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:13.530000000000001%;"></td>
        <td style="width:1.0%;"></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As of December 31,</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2022</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2021</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Accrued research and development expenses</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_e9789773-7fea-4423-accc-ab4856106d28" contextRef="C_85e3a5e5-8ff2-4682-901b-9d79336e863a" name="etnb:AccruedResearchAndDevelopmentExpenseCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">6,499</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_f24bf758-228f-44e7-a275-929f1b977b0c" contextRef="C_21f769c6-c78d-41d0-b871-ec3d93d7d343" name="etnb:AccruedResearchAndDevelopmentExpenseCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">6,195</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Accrued employee and related expenses</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_785e79dd-1d09-4301-867c-f9712939c1cf" contextRef="C_85e3a5e5-8ff2-4682-901b-9d79336e863a" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">4,165</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_434479a8-1485-422e-8c1c-47001e9dbfe3" contextRef="C_21f769c6-c78d-41d0-b871-ec3d93d7d343" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">3,168</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Accrued professional and legal fees</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_e624f393-eb38-49df-940f-58e0cf3f63ee" contextRef="C_85e3a5e5-8ff2-4682-901b-9d79336e863a" name="us-gaap:AccruedProfessionalFeesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,052</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_1cfca89e-b9a5-4f20-abad-555e6571e318" contextRef="C_21f769c6-c78d-41d0-b871-ec3d93d7d343" name="us-gaap:AccruedProfessionalFeesCurrent" unitRef="U_USD" scale="3" decimals="-3">495</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Accrued other expenses</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_4caeabf2-9acb-4354-bf42-7b790e877c16" contextRef="C_85e3a5e5-8ff2-4682-901b-9d79336e863a" name="us-gaap:OtherAccruedLiabilitiesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">228</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_b15e0339-61c5-4533-8262-ecebe7c13f54" contextRef="C_21f769c6-c78d-41d0-b871-ec3d93d7d343" name="us-gaap:OtherAccruedLiabilitiesCurrent" unitRef="U_USD" scale="3" decimals="-3">336</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:5.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total accrued expenses</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_f213a3c0-abd1-4a70-9057-b26b1862d203" contextRef="C_85e3a5e5-8ff2-4682-901b-9d79336e863a" name="us-gaap:AccruedLiabilitiesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">11,944</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_3dda551d-94d8-4143-9b04-52dac5ce1842" contextRef="C_21f769c6-c78d-41d0-b871-ec3d93d7d343" name="us-gaap:AccruedLiabilitiesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">10,194</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></ix:nonNumeric></div></ix:nonNumeric></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <div><ix:nonNumeric id="F_226e1fdb-01f4-4fc2-a05a-fb7e5adb5be2" contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" escape="true"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:8.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5. Commitments and Contingencies</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Leases</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">On January 1, 2022, the Company adopted ASC 842 (see Note 2), and the following disclosures as of and for the year ended December 31, 2022 are presented under ASC 842, while prior period amounts have not been adjusted and continue to be reported in accordance with the historical accounting under ASC 840. Upon adoption, the Company recorded an operating lease ROU asset and lease liability for its lease in San Francisco, which was due to expire in </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_6720c86d-7a46-45b8-bcc7-4327f58c00f2" contextRef="C_219ac1f1-456b-400e-b032-64201f1a5313" name="etnb:OperatingLeaseExpirationMonthAndYear" format="ixt:datemonthyearen"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">January 2023</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. Effective August 31, 2022, the Company amended the lease to extend the expiration date of the lease to </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_1379858a-dd9b-48d7-9fad-ec219eb19dd2" contextRef="C_81b08a03-90f7-43af-84a8-8e9dbb83a6d9" name="etnb:OperatingLeaseExpirationMonthAndYear" format="ixt:datemonthyearen"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">January 2025</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, with one option to renew for an additional year that is not reasonably certain to be exercised. The amendment resulted in the remeasurement of the lease liability and ROU asset as of the modification date to reflect the extended term and the Company recorded an incremental ROU asset and lease liability of $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_d801ff6c-d3d8-4595-8c7e-477a191eae13" contextRef="C_24b84e4a-2d9f-418f-bf86-e74e1b8c81af" name="us-gaap:OperatingLeaseRightOfUseAsset" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal"><ix:nonFraction id="F_1caea5a9-07b6-47e5-8c52-6249e230cda4" contextRef="C_24b84e4a-2d9f-418f-bf86-e74e1b8c81af" name="us-gaap:OperatingLeaseLiabilityCurrent" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">0.3</ix:nonFraction></ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">For the year ended December 31, 2022, the Company incurred </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_b420af8b-f307-4d5d-84d6-ef9f918155e2" contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698" name="us-gaap:LeaseAndRentalExpense" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">0.2</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> in rent expense. For the year ended December 31, 2022, variable lease payments and short-term lease costs were </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="-sec-ix-hidden:F_4a26968b-e9d0-4e69-8f86-01a61afe4e4c;"><span style="-sec-ix-hidden:F_104effa9-00d2-42bf-9012-ca94303c5178;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">immaterial</span></span></span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. As of </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31, 2022, the remaining lease term was </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_2aa968e4-bbe8-464d-9110-eb2033554c48" contextRef="C_85e3a5e5-8ff2-4682-901b-9d79336e863a" name="us-gaap:LesseeOperatingLeaseRemainingLeaseTerm" format="ixt-sec:duryear"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2.0</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> years and the Company&#x2019;s incremental borrowing rate used to determine the operating lease liability was </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_4acb8ef5-9f48-4ca3-aefd-06136da7d33e" contextRef="C_85e3a5e5-8ff2-4682-901b-9d79336e863a" name="us-gaap:LesseeOperatingLeaseDiscountRate" unitRef="U_pure" scale="-2" decimals="3" format="ixt:numdotdecimal">6.5</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_5d2492f0-28a5-4ff3-b8cb-d63dfb11ec27" contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698" name="us-gaap:ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock" escape="true" continuedAt="F_5d2492f0-28a5-4ff3-b8cb-d63dfb11ec27_1"><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As of </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31, 2022, the undiscounted future minimum lease payments due under the Company&#x2019;s non-cancellable operating lease are as follows (in thousands):</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:70.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:69.795%;"></td>
        <td style="width:2.701%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:25.503%;"></td>
        <td style="width:1.0%;"></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2023</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_ac16b0b6-0312-4488-9517-fb82b1ffba96" contextRef="C_85e3a5e5-8ff2-4682-901b-9d79336e863a" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">185</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2024</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_45041c40-8110-4327-9c2a-87c010aadf71" contextRef="C_85e3a5e5-8ff2-4682-901b-9d79336e863a" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">185</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2025</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_3d13af88-fa62-4068-8786-dd23c7139ff7" contextRef="C_85e3a5e5-8ff2-4682-901b-9d79336e863a" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">7</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total undiscounted future minimum lease payments</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_08238efa-e4d8-4cea-bc7d-90e908456e91" contextRef="C_85e3a5e5-8ff2-4682-901b-9d79336e863a" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">377</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Less: imputed interest</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_f541477e-188e-405c-8f2c-a9a5e7401319" contextRef="C_85e3a5e5-8ff2-4682-901b-9d79336e863a" name="us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">23</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:5.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Present value of operating lease liability</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_53634014-d430-4674-803c-fbbf23d3f9f5" contextRef="C_85e3a5e5-8ff2-4682-901b-9d79336e863a" name="us-gaap:OperatingLeaseLiability" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">354</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></ix:nonNumeric></div><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In accordance with ASC 840, rent expense for the year ended December 31, 2021 was $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_95a01482-8b68-41f2-80aa-41fd1e3d7348" contextRef="C_7b31e452-ba3b-4180-9ddd-8faae2f90f0c" name="us-gaap:LeaseAndRentalExpense" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">0.3</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million. </span><span style="font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:continuation id="F_5d2492f0-28a5-4ff3-b8cb-d63dfb11ec27_1" continuedAt="F_5d2492f0-28a5-4ff3-b8cb-d63dfb11ec27_2"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The total future minimum annual payments for operating leases in effect as of December 31, 2021 were as follows (in thousands):</span></ix:continuation></span></p><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:continuation id="F_5d2492f0-28a5-4ff3-b8cb-d63dfb11ec27_2"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:70.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:70.024%;"></td>
        <td style="width:2.946%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:25.03%;"></td>
        <td style="width:1.0%;"></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2022</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_8089bc20-6417-4ed1-80af-83833aa12907" contextRef="C_21f769c6-c78d-41d0-b871-ec3d93d7d343" name="us-gaap:OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">212</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2023</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_8a7f4413-424e-45da-8690-423449fddb3c" contextRef="C_21f769c6-c78d-41d0-b871-ec3d93d7d343" name="us-gaap:OperatingLeasesFutureMinimumPaymentsDueInTwoYears" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">7</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:5.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total future minimum annual payments</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_0b76ff50-1e3c-416c-91cd-9fb910c0d25e" contextRef="C_21f769c6-c78d-41d0-b871-ec3d93d7d343" name="us-gaap:OperatingLeasesFutureMinimumPaymentsDue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">219</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></ix:continuation></div><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Asset Transfer and License Agreement with Teva Pharmaceutical Industries Ltd</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In April 2018, the Company concurrently entered into two Asset Transfer and License Agreements (the &#x201c;Teva Agreements&#x201d;) with Teva Pharmaceutical Industries Ltd (&#x201c;Teva&#x201d;) under which it acquired certain patents and intellectual property relating to two programs: (1) Teva&#x2019;s glycoPEGylated FGF21 </span><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">fibroblast growth factor 21 (&#x201c;</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">FGF21&#x201d;) program, including the compound TEV-47948 (pegozafermin), a glycoPEGylated long-acting FGF21 and (2) Teva&#x2019;s development program of small molecule inhibitors of fatty acid synthase. Pursuant to the Teva Agreements, the Company paid Teva an initial nonrefundable upfront payment of $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_7606b1c0-ca3e-495b-9aa0-47a665f5fa63" contextRef="C_06409d28-ba8c-475e-bda2-06ff8506b41a" name="etnb:AssetTransferAndLicenseAgreementInitialNonrefundableUpfrontPayment" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">6.0</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">and the Company</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><ix:exclude><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">84</span></p>
     <hr style="page-break-after:always;" /><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></ix:exclude><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">could </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">be obligated to pay Teva up to $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_57bc8d0d-bbdb-48e8-b45c-da2b590023a5" contextRef="C_0cf9d23c-1397-46c1-b3b5-e40c57e51864" name="etnb:ObligationToPaymentUponMaximumAchievementOfCertainClinicalAndCommercialMilestones" unitRef="U_USD" scale="6" decimals="INF" format="ixt:numdotdecimal"><ix:nonFraction id="F_60a5356f-207b-4663-925f-8bebdf654e36" contextRef="C_68b35e56-1e54-4bd6-9c91-36e41d1c9359" name="etnb:ObligationToPaymentUponMaximumAchievementOfCertainClinicalAndCommercialMilestones" unitRef="U_USD" scale="6" decimals="INF" format="ixt:numdotdecimal">67.5</ix:nonFraction></ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million under each program, for a total of $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_3e4332f4-5f81-49c7-8a8e-449aa4ab59f7" contextRef="C_06409d28-ba8c-475e-bda2-06ff8506b41a" name="etnb:ObligationToPaymentUponMaximumAchievementOfCertainClinicalAndCommercialMilestones" unitRef="U_USD" scale="6" decimals="INF" format="ixt:numdotdecimal">135.0</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million, upon the achievement of certain clinical development and commercial milestones. In addition, the Company is obligated to pay Teva tiered royalties at percentages in the low-to-mid single-digits on worldwide net sales on all products containing the Teva compounds.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Teva Agreements can be terminated (i) by the Company without cause upon </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_3bc2b452-a5aa-4c73-9c55-62eaf0aac6a5" contextRef="C_346ebc1d-56b1-4b67-95cf-d70e9efff187" name="etnb:AssetTransferAndLicenseAgreementTerminationPeriodAfterWrittenNotice" format="ixt-sec:durwordsen"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">120 days</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2019; written notice to Teva, (ii) by either party, if the other party materially breaches any of its obligations under the Teva Agreements and fails to cure such breach within </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_174294a0-a6e8-48a8-904b-0bab20d502cd" contextRef="C_346ebc1d-56b1-4b67-95cf-d70e9efff187" name="etnb:AssetTransferAndLicenseAgreementTerminationPeriodNoticeOfFailure" format="ixt-sec:durwordsen"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">60 days</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> after receiving notice thereof, or (iii) by either party, if a bankruptcy petition is filed against the other party and is not dismissed within </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_07b1c449-001a-4f98-80f3-e327990648a9" contextRef="C_346ebc1d-56b1-4b67-95cf-d70e9efff187" name="etnb:AssetTransferAndLicenseAgreementTerminationNoticePeriodIfBankruptcyPetitionFiled" format="ixt-sec:durwordsen"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">60 days</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. In addition, Teva can also terminate the agreement related to the Company&#x2019;s glycoPEGylated FGF21 program in the event the Company, or any of its affiliates or sublicensees, challenges any of the Teva patents licensed to the Company, and the challenge is not withdrawn within 30 days of written notice from Teva.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">During the year ended December 31, 2022 and 2021</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_25bf8be7-db43-4b30-91c9-88a59fce3d7f" contextRef="C_293baad2-fb24-4c8f-af10-1f5af83b558f" name="etnb:MilestonePayment" unitRef="U_USD" decimals="INF" format="ixt-sec:numwordsen"><ix:nonFraction id="F_870863c0-71b1-4e2b-8878-d95ef987d77e" contextRef="C_bbce1ed1-a8d8-49f8-afbe-c78e9685dbd3" name="etnb:MilestonePayment" unitRef="U_USD" decimals="INF" format="ixt-sec:numwordsen">no</ix:nonFraction></ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">ne of the development and commercial milestones were met and accordingly, there were </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_4b77db21-7694-4459-bb70-1073f79f4463" contextRef="C_346ebc1d-56b1-4b67-95cf-d70e9efff187" name="etnb:MilestonePayment" unitRef="U_USD" decimals="INF" format="ixt-sec:numwordsen"><ix:nonFraction id="F_181e2452-b947-4111-afd9-35f72dbd83ba" contextRef="C_336bc7db-2eb9-4265-a863-9aea3514e4c0" name="etnb:MilestonePayment" unitRef="U_USD" decimals="INF" format="ixt-sec:numwordsen">no</ix:nonFraction></ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> milestone payments related to the Teva Agreements.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p></ix:nonNumeric></div>
  <div style="font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_3e5a2c98-4a17-463a-8778-16077508d368" contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698" name="us-gaap:LongTermDebtTextBlock" escape="true"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">6. Term Loan</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Loan and Security Agreement</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_a1b9f431-67fa-4855-bc19-b160e30311e0" contextRef="C_d924e5a5-d3dd-4acb-a359-d2a055d67e71" name="us-gaap:LineOfCreditFacilityDescription"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In April 2020, the Company entered into a Loan and Security Agreement, (the &#x201c;Loan Agreement&#x201d;) with the lenders referred to therein, and Silicon Valley Bank (&#x201c;SVB&#x201d;), as collateral agent. The Loan Agreement provided for (i) a secured term A loan facility (the &#x201c;Term A Loan Facility&#x201d;) of up to $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_43de351f-d1bd-46f8-ae02-db575e08e610" contextRef="C_63713aa3-3b7f-4c18-95ec-d7881a249606" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">10.0</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million and (ii) a secured term B loan facility (the &#x201c;Term B Loan Facility&#x201d;) of up to $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_4b4d6a45-9f53-4a37-befb-5a4c53504e83" contextRef="C_0fbbd6d9-9bd7-49b6-8f27-ad8d51a5afad" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">5.0</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million that became available upon the satisfaction of certain milestones, each of which was available to be drawn through May 31, 2021. The term loan is secured by certain assets of the Borrowers (as defined in the Loan Agreement), including substantially all of the assets of the Company, excluding the Company&#x2019;s intellectual property. The term loan contains customary representations, warranties, affirmative covenants and also certain restrictive covenants.</span></ix:nonNumeric></span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In April 2020, in connection with the execution of the Loan Agreement, the Company issued SVB a warrant to purchase </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_075dd073-be98-4574-9605-a9db8ba35757" contextRef="C_63713aa3-3b7f-4c18-95ec-d7881a249606" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">25,000</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> shares of the Company&#x2019;s common stock with a warrant exercise price of $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_390a2b3d-653e-4a31-ae4b-563b4aece500" contextRef="C_63713aa3-3b7f-4c18-95ec-d7881a249606" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:numdotdecimal">22.06</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> per share that is immediately exercisable and expires on </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_3b1359e5-0297-473c-9f75-0e924266557f" contextRef="C_f1364984-27a4-4b53-9cb3-49e5885e056f" name="us-gaap:WarrantsAndRightsOutstandingMaturityDate" format="ixt:datemonthdayyearen"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">June 30, 2025</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, as amended. The fair value of the warrant at the issuance date was determined by using the Black-Scholes option-pricing model and the fair value allocated to the warrant of $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_a71a3e13-000a-472c-9813-a6659edcb43c" contextRef="C_f1364984-27a4-4b53-9cb3-49e5885e056f" name="us-gaap:DeferredFinanceCostsGross" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">0.6</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million met the requirements for equity classification within additional paid-in capital. Additionally, the Company incurred $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_897946a9-ec58-4055-a475-2bcd55771720" contextRef="C_64505050-8754-453d-9384-3e8a3e7ed1c7" name="us-gaap:DeferredFinanceCostsGross" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">0.2</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million in closing costs, which together with the value of the warrants, were recorded as debt issuance costs.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_ec539fd9-1cba-4c8e-bb72-9fb4a7a5d7e8" contextRef="C_8ec6682c-a0df-42a7-9596-2e31ddf5f5fb" name="us-gaap:LineOfCreditFacilityDescription"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In May 2021, the parties further amended the Loan Agreement (as amended, the &#x201c;2021 Loan Agreement&#x201d;). The 2021 Loan Agreement increased the Term A Loan Facility to up to $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_b8a680c1-c8f1-4897-bfed-69fefdcbef30" contextRef="C_486ea18d-a98b-4e2c-a648-7ba74ce82df4" name="us-gaap:ProceedsFromLinesOfCredit" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">20.0</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million, which was fully drawn as of December 2021. The Term B Loan Facility of up to $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_5c25d4ee-2d68-4edb-8828-3df8744c26aa" contextRef="C_6d3eea61-86b7-46b5-8fc7-9a6e90984a96" name="etnb:LineOfCreditFacilityIncreaseInBorrowingCapacity" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">5.0</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million was available to be drawn upon on achievement of certain additional milestones, on or before September 30, 2022, which expired unused.</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> The 2021 Loan Agreement provided for interest-only payments until October 1, 2022, which could be extended to April 1, 2023, if on or before September 30, 2022, the Company received net cash proceeds of at least $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_e1fbd306-e850-4cb8-b904-0a25c7f4c09a" contextRef="C_f6790208-fa53-4c6a-a9e8-0e12a839f2fc" name="etnb:NetCashProceedsFromSaleOfEquitySecurities" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">75.0</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million from the sale of its equity securities. In July 2022, the Company met the net cash proceeds requirement (see Note 7) and on September 1, 2022, the interest-only period was extended to April 1, 2023. Consecutive monthly payments of principal and interest commence on April 1, 2023 and continue through </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_a5d48ece-d2fe-4494-9648-5aa9c4a4af7d" contextRef="C_486ea18d-a98b-4e2c-a648-7ba74ce82df4" name="us-gaap:LineOfCreditFacilityExpirationDate1" format="ixt:datemonthdayyearen"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">September 1, 2024</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, the maturity date of the term loan. The term loan bears interest at the greater of (i) </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_55d01b50-b4e9-436e-8117-77a4336e0d0f" contextRef="C_400e8f6e-3cb0-4806-ab40-9ea3fbda15da" name="us-gaap:DebtInstrumentInterestRateDuringPeriod" unitRef="U_pure" scale="-2" decimals="4" format="ixt:numdotdecimal">4.25</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">% and (ii) the sum of (a) the Prime Rate as reported in The Wall Street Journal plus (b) </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_04d6e119-5994-452a-b774-d67a2355d537" contextRef="C_9179a407-98a4-4470-bd80-a8d43f35e053" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" unitRef="U_pure" scale="-2" decimals="4" format="ixt:numdotdecimal">1.00</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%. The interest rate on the term loan was </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_27f6dd67-97c2-4db6-854d-84a1645426a0" contextRef="C_d924e5a5-d3dd-4acb-a359-d2a055d67e71" name="us-gaap:DebtInstrumentInterestRateDuringPeriod" unitRef="U_pure" scale="-2" decimals="4" format="ixt:numdotdecimal">4.25</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">% at inception and </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_57673a97-8448-4559-8081-539938facca2" contextRef="C_f6790208-fa53-4c6a-a9e8-0e12a839f2fc" name="us-gaap:DebtInstrumentInterestRateDuringPeriod" unitRef="U_pure" scale="-2" decimals="4" format="ixt:numdotdecimal">8.50</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">% as of December 31, 2022. In addition, a final payment fee of </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_4ade9814-651f-41b4-b2a5-4c3a2c447de0" contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698" name="etnb:PercentageOfFeeOnLoan" unitRef="U_pure" scale="-2" decimals="3" format="ixt:numdotdecimal">5.0</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">% of the principal amount of the loan is due when the term loan becomes due or upon prepayment of the term loan. If the Company elects to prepay the loan, there is also a prepayment fee of between </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_24fc7f98-34cb-416e-8669-2af124120be4" contextRef="C_400e8f6e-3cb0-4806-ab40-9ea3fbda15da" name="etnb:PrepaymentFeePercentage" unitRef="U_pure" scale="-2" decimals="INF" format="ixt:numdotdecimal">1.0</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">% and </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_16800543-b225-452f-992c-2819ffb6a488" contextRef="C_0ff1dce8-b806-4a8c-ae9b-bef81ddaf302" name="etnb:PrepaymentFeePercentage" unitRef="U_pure" scale="-2" decimals="INF" format="ixt:numdotdecimal">3.0</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">% of the principal amount of the term loan depending on the timing of prepayment.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In May 2021, in connection with the execution of the 2021 Loan Agreement, the Company issued SVB a warrant to purchase </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_4066208a-6bda-4ba2-9431-f5b6b4b6e4b1" contextRef="C_0d8efc73-e669-470d-b4ba-623e328b895c" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">33,923</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> shares of the Company&#x2019;s common stock with a warrant exercise price of $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_7ceb76fc-de33-45e4-ab4e-f15339c8be87" contextRef="C_0d8efc73-e669-470d-b4ba-623e328b895c" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:numdotdecimal">19.12</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> per share that is immediately exercisable and expires on </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_0e861141-4d91-4339-b976-aa1603c76fad" contextRef="C_0d8efc73-e669-470d-b4ba-623e328b895c" name="us-gaap:WarrantsAndRightsOutstandingMaturityDate" format="ixt:datemonthdayyearen"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">May 28, 2031</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company determined the fair value of the</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><ix:exclude><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">85</span></p>
     <hr style="page-break-after:always;" /><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></ix:exclude><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">warrant </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">at the issuance date by using the Black-Scholes option-pricing model with the following assumptions: risk-free interest rate of </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_b80ce7b6-76f6-4f18-a4cc-5e18253e6097" contextRef="C_a9902439-f289-45b6-ae67-7a0087e98dc3" name="us-gaap:DebtInstrumentMeasurementInput" unitRef="U_pure" scale="-2" decimals="3" format="ixt:numdotdecimal">1.6</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%, </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_cc54c9d8-b2d0-4442-ba87-c0edab0ce1b5" contextRef="C_4e61ffe1-5dad-4c7d-9e54-54ccdddb6379" name="etnb:FairValueOfWarrantsAssumptionsDividends" unitRef="U_USD" scale="3" decimals="-3" format="ixt-sec:numwordsen">no</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> dividends, expected volatility of </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_9ed1ff01-5772-459f-bed2-bd726c980256" contextRef="C_19145334-f911-4daa-9ab2-e1eab1d17cbf" name="us-gaap:DebtInstrumentMeasurementInput" unitRef="U_pure" scale="-2" decimals="3" format="ixt:numdotdecimal">98.6</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">% and expected term of </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_3e16d252-b817-4983-8849-13a27308ae69" contextRef="C_d417399a-7793-4c07-aa7a-f9d877495dd9" name="us-gaap:DebtInstrumentTerm" format="ixt-sec:duryear"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10.0</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> years. Upon issuance, the fair value of the warrant of $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_329e1645-9f3e-4665-bf9f-b6c792ac4408" contextRef="C_0d8efc73-e669-470d-b4ba-623e328b895c" name="us-gaap:DeferredFinanceCostsGross" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">0.6</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million was recorded as a debt issuance cost and met the requirements for equity classification within additional paid-in capital in the consolidated balance sheets. In addition, closing costs incurred were not material. In connection with Term B Loan Facility, if funded, the Company was to issue an additional warrant to purchase </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_7a7e3d99-c3a7-4303-9d69-83d9cf2e4763" contextRef="C_aecfb132-37f5-4d9c-98a7-d5475beefa29" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">11,305</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> shares of the Company&#x2019;s common stock with the exercise price at the Company&#x2019;s stock price at the time of issuance. However, the Term Loan B Facility expired unused and therefore no additional warrant was issued.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The 2021 Loan Agreement was accounted for as a modification to a credit facility. The related debt issuance costs incurred in May 2021, including the fair value of the warrant, together with the remaining unamortized debt issuance costs related to the Loan Agreement of $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_77789bb8-dd3e-4d55-b0c2-9c8250538255" contextRef="C_0d8efc73-e669-470d-b4ba-623e328b895c" name="us-gaap:DeferredTaxAssetsGross" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">0.4</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million were recorded as deferred assets and recognized on a straight-line basis as interest expense over the availability of the draw period. </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_3fde94e7-112a-40f5-811e-13c33229c804" contextRef="C_3f47fde3-7be3-4bb6-ae2b-29bc39fcd38d" name="us-gaap:LineOfCreditFacilityDescription"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As of December 31, 2021, all amounts were drawn under the Term Loan A Facility such that all debt issuance costs were recorded as a debt discount.</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> The carrying value of the debt discount, together with the final payment fee, are recognized using the effective interest method.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In September 2022, the parties agreed the extension of the interest-only period was met as a result of the July 2022 public offering (see Note 7), which was accounted for as a debt modification. A new effective interest rate equating to the revised cash flows of the carrying amount of the original debt was applied prospectively. The Company did not incur any costs in relation to the extension.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_1e110157-dc4e-4bc2-9348-fc9078fb0e11" contextRef="C_42491eea-6b09-4865-930d-85d82115fafd" name="us-gaap:LineOfCreditFacilityDescription"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In January 2023, the Company executed a loan and security agreement with new lenders (the &#x201c;2023 Loan Agreement</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x201d;</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">) and repaid its outstanding obligations under the 2021 Loan Agreement (see Note 11). As the Company had the intent and ability to refinance amounts due under the 2021 Loan Agreement pursuant to the terms of the 2023 Loan Agreement, as of December 31, 2022, the current portion of the outstanding principal obligation under the 2021 Loan Agreement was classified as long-term. As of December 31, 2022, the Company&#x2019;s total obligations under the 2021 Loan Agreement were $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_a7a9cade-d646-4749-ac1d-755dc2bec35a" contextRef="C_69b35aed-7994-41dd-a070-5ef370bb6088" name="us-gaap:LongTermDebtNoncurrent" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">19.7</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million classified as term loan, non-current, net and $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_0c283b4e-fa1f-4f26-9df5-ca478ab74a42" contextRef="C_69b35aed-7994-41dd-a070-5ef370bb6088" name="etnb:OtherNonCurrentLiability" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">0.5</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million classified as other non-current liability related to the final payment fee. The term loan, non-current, net is comprised of the outstanding principal amount of $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_55285722-48f9-4de9-8388-0f44cf986474" contextRef="C_69b35aed-7994-41dd-a070-5ef370bb6088" name="us-gaap:DebtInstrumentCarryingAmount" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">20.0</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million net of $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_8563e93b-88b4-466b-974c-48de2e2b1ccc" contextRef="C_69b35aed-7994-41dd-a070-5ef370bb6088" name="us-gaap:DebtInstrumentUnamortizedDiscount" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">0.3</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million of unamortized debt discount.</span></ix:nonNumeric></span></p></ix:nonNumeric></div>
  <div style="font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_1e73f7d8-6f08-4d9b-88be-7b219529cbbf" contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698" name="us-gaap:StockholdersEquityNoteDisclosureTextBlock" escape="true"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">7. Stockholders&#x2019; Equity</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_cb8f063f-da5d-49b3-a430-88237039d116" contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698" name="etnb:ScheduleOfCommonStockReservedForIssuanceTableTextBlock" escape="true"><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As of </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31, 2022, the Company&#x2019;s shares of common stock available for future issuance were as follows:</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:79.712%;"></td>
        <td style="width:1.464%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:16.823999999999998%;"></td>
        <td style="width:1.0%;"></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Shares available for future grant under the equity incentive plan</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_617fdc1e-e24d-47af-9213-0fe9c688fdcc" contextRef="C_debc9f51-b90f-43f6-af8a-b00f128671e2" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">241,635</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Shares available for future issuance under the employee stock purchase plan</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_21d6b732-8d07-4be2-9f37-e72de8c03500" contextRef="C_1294a0d4-82df-4aeb-86a3-c974a5339679" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">729,218</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Shares available for future issuance upon the exercise of warrants and pre-funded warrants</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_da8360df-3441-43cb-b791-ae3d4dd29c96" contextRef="C_cf4ea6ad-4896-41f4-bc1c-7f4a0b1286f8" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">13,966,283</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:5.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total available for future issuance</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_bbc5ac90-69f0-41eb-a40a-3fabbcbe4665" contextRef="C_85e3a5e5-8ff2-4682-901b-9d79336e863a" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">14,937,136</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></ix:nonNumeric></div><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:8.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Public Offerings</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">At-the-Market Offerings</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In March 2021, the Company entered into a sales agreement (as amended, the &#x201c;Sales Agreement&#x201d;) with SVB Securities LLC and Cantor Fitzgerald &amp; Co. (the &#x201c;Sales Agents&#x201d;) pursuant to which the Company may offer and sell up to $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_b6d3bc41-d229-4548-a393-a93cab2b8b93" contextRef="C_b2381809-b584-4634-835b-de401b34febb" name="etnb:MaximumAmountOfEquitySharesIssuable" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">75.0</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million of shares of its common stock, from time to time, in &#x201c;at-the-market&#x201d; offerings (the &#x201c;ATM Facility&#x201d;). The Sales Agents are entitled to compensation at a commission equal to </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_170b55e1-5a95-41d8-af75-d5225b21442c" contextRef="C_034c3248-20ba-45f1-8c7f-941617fb2bea" name="etnb:SellingCommissionPerSharesSoldPercentage" unitRef="U_pure" scale="-2" decimals="3" format="ixt:numdotdecimal">3.0</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">% of the aggregate gross sales price per share sold under the Sales Agreement. Pursuant to the ATM Facility, in 2021, the Company received aggregate proceeds of $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_962d02b4-6e86-4f06-a4ae-8fe5a4f067ee" contextRef="C_6fdc6413-db9e-4bdf-ac0c-0aec29016321" name="us-gaap:ProceedsFromIssuanceOfCommonStock" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">3.3</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million, net of commissions and offering expenses from sales of </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_0ef9b358-9f02-48a2-97c1-735b1bd112c9" contextRef="C_6fdc6413-db9e-4bdf-ac0c-0aec29016321" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" unitRef="U_shares" decimals="0" format="ixt:numdotdecimal">186,546</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> shares of its common stock and, in 2022, received aggregate proceeds of $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_fcde17a8-5d79-456c-b0ec-6dd333b957dc" contextRef="C_e7406d64-9fbe-4053-8474-7c07e64b9b1a" name="us-gaap:ProceedsFromIssuanceOfCommonStock" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">28.5</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million, net of commissions from the sales of </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_d877c80d-803c-4b18-829e-65b19b749598" contextRef="C_e7406d64-9fbe-4053-8474-7c07e64b9b1a" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" unitRef="U_shares" decimals="0" format="ixt:numdotdecimal">3,948,611</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> shares of its common stock.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p><ix:exclude><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">86</span></p>
     <hr style="page-break-after:always;" /><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></ix:exclude><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">July 2022 Public Offering</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_eb3734b4-e27b-4558-a54a-c79aaa9e5017" contextRef="C_9153c97c-b82f-4cb0-9b13-074c71823603" name="us-gaap:SaleOfStockDescriptionOfTransaction"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In July 2022, the Company completed an underwritten public offering of its common stock, warrants to purchase shares of its common stock and pre-funded warrants to purchase shares of its common stock. The Company sold </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_deb61b28-b865-4868-b235-b5caedec1401" contextRef="C_9153c97c-b82f-4cb0-9b13-074c71823603" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">18,675,466</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> shares of its common stock with accompanying warrants to purchase up to </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_b494e5f3-e57f-4465-a934-0c2f3c1ef543" contextRef="C_dbe06daf-d12f-4df8-b30b-9d91c12d257a" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">9,337,733</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> shares of its common stock at a combined public offering price of $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_150bd0b7-2fda-4065-8ec9-9ebfe7862c57" contextRef="C_6047d52d-d8de-4ffd-998c-b1093834c8c7" name="etnb:CommonStockAndWarrantsCombinedOfferingPricePerShare" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:numdotdecimal">3.55</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> per share. The Company also sold </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_7be8504b-a39c-4b95-b23d-30a9fa6c8d87" contextRef="C_d6793a0d-ddc1-4bea-8729-61b96d2fd8c6" name="etnb:NumberOfPrefundedWarrantsIssuedDuringPeriod" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">7,944,252</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> pre-funded warrants to purchase shares of its common stock with accompanying warrants to purchase up to </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_827419ec-51cc-405c-9234-ef5fb8555bad" contextRef="C_f1c306e8-9d11-4882-bc7e-9eb378ceb757" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">3,972,126</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> shares of its common stock at a combined public offering price of $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_bf2a8e9c-10c9-4f29-95ed-75cad9e9b55e" contextRef="C_17df92a5-2cb5-48c9-9462-299e5b922342" name="etnb:PrefundedAndCommonStockWarrants" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="3" format="ixt:numdotdecimal">3.549</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> per pre-funded warrant, which represents the per share public offering price for the common stock less $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_b2f6ca90-8c7b-4370-ade7-229ac8ddbf89" contextRef="C_6047d52d-d8de-4ffd-998c-b1093834c8c7" name="us-gaap:CommonStockParOrStatedValuePerShare" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="3" format="ixt:numdotdecimal">0.001</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> per share, the exercise price for each pre-funded warrant. The Company raised net proceeds of $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_c9f4b15c-49f6-4f28-a153-5922db4b73f7" contextRef="C_9153c97c-b82f-4cb0-9b13-074c71823603" name="us-gaap:ProceedsFromIssuanceOfCommonStock" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">88.2</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million, after deducting underwriting discounts and commissions of $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_85776f56-fca9-4b48-b634-d72f15b2febb" contextRef="C_9153c97c-b82f-4cb0-9b13-074c71823603" name="etnb:UnderwritingDiscountsAndCommissions" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">5.7</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million and other offering costs of $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_1dc5a8e0-e813-4c41-8cfa-4ad8ab04a197" contextRef="C_9153c97c-b82f-4cb0-9b13-074c71823603" name="us-gaap:PaymentsOfStockIssuanceCosts" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">0.6</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million. </span></ix:nonNumeric></span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"></span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The exercise of the outstanding warrants is subject to a beneficial ownership limitation of </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_8ab54452-8a9e-4a9b-8741-e5489695a0a4" contextRef="C_a858f07d-a85c-4d7d-b3d7-e709eceaafec" name="etnb:BeneficialOwnershipLimitationOnExerciseOfWarrant" unitRef="U_pure" scale="-2" decimals="4" format="ixt:numdotdecimal">9.99</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%, or at the election of the holder prior to the issuance of the warrant, </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_a0a52fe6-dbcf-4cd9-a88b-574a62cf8a22" contextRef="C_a858f07d-a85c-4d7d-b3d7-e709eceaafec" name="etnb:SaleOfStockPercentageOfBeneficialOwnershipLimitationBeforeTransaction" unitRef="U_pure" scale="-2" decimals="4" format="ixt:numdotdecimal">4.99</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%. The exercise of the outstanding pre-funded warrants is subject to a beneficial ownership limitation of </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_35d4d080-cd83-42e7-8ad5-2e3c739dc985" contextRef="C_9705961e-ee8d-42ab-94ee-ccd3d976ce3a" name="etnb:BeneficialOwnershipLimitationOnExerciseOfWarrant" unitRef="U_pure" scale="-2" decimals="4" format="ixt:numdotdecimal">9.99</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%, or at the election of the holder prior to the issuance of the pre-funded warrant, </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_1d599092-87b7-41c0-88e7-79bcb6728371" contextRef="C_9705961e-ee8d-42ab-94ee-ccd3d976ce3a" name="etnb:SaleOfStockPercentageOfBeneficialOwnershipLimitationBeforeTransaction" unitRef="U_pure" scale="-2" decimals="4" format="ixt:numdotdecimal">4.99</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%, which a holder may increase or decrease from time to time but shall not exceed </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_486972b5-715c-4bba-836d-3bc59f357537" contextRef="C_d18bd1f4-38fc-4415-8797-86a51c6f011c" name="etnb:BeneficialOwnershipLimitationOnExerciseOfWarrant" unitRef="U_pure" scale="-2" decimals="4" format="ixt:numdotdecimal"><ix:nonFraction id="F_b0ec2f6b-7dd1-49fe-8a08-fa65ab54b2aa" contextRef="C_ab53d079-3181-47b2-85e6-cb6ceba1d67b" name="etnb:BeneficialOwnershipLimitationOnExerciseOfWarrant" unitRef="U_pure" scale="-2" decimals="4" format="ixt:numdotdecimal">19.99</ix:nonFraction></ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%. The exercise price and number of shares of common stock issuable upon the exercise of the warrants and pre-funded warrants are subject to adjustment in the event of any stock dividends, stock splits, reverse stock split, recapitalization, or reorganization or similar transaction, as described in the agreements. Under certain circumstances, the warrants and pre-funded warrants may be exercisable on a &#x201c;cashless&#x201d; basis. The warrants and pre-funded warrants were classified as a component of stockholders&#x2019; equity and additional paid-in capital because such warrants and pre-funded warrants (i) are freestanding financial instruments that are legally detachable and separately exercisable from the equity instruments, (ii) are immediately exercisable, (iii) do not embody an obligation for the Company to repurchase its shares, (iv) permit the holders to receive a fixed number of common shares upon exercise, (v) are indexed to the Company&#x2019;s common stock and (vi) meet the equity classification criteria. In addition, the warrants and pre-funded warrants do not provide any guarantee of value or return.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Common Stock Warrants</span></p><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_0e657d5a-048b-44f2-9ab0-70792a2b6001" contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698" name="us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" escape="true"><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As of </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31, 2022, the Company&#x2019;s outstanding warrants to purchase shares of its common stock were as follows:</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:57.363%;"></td>
        <td style="width:0.996%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:10.953999999999999%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:1.384%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:11.152000000000001%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:1.384%;"></td>
        <td style="width:12.766%;"></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Shares of<br />Common Stock<br />Underlying<br />Warrants</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Exercise Price<br />Per Share</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Expiration<br />Date</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Warrant issued with term loan</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_75a99ede-0152-47b9-aee8-17cecb9f5452" contextRef="C_f983776b-3b07-4d5d-8f04-c89f752dbbb3" name="us-gaap:ClassOfWarrantOrRightOutstanding" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">25,000</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_5358322e-2d4e-48ec-9d0f-9e892490c381" contextRef="C_f983776b-3b07-4d5d-8f04-c89f752dbbb3" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:numdotdecimal">22.06</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_db8eb939-0454-4b04-adbb-88acade2111a" contextRef="C_f983776b-3b07-4d5d-8f04-c89f752dbbb3" name="us-gaap:WarrantsAndRightsOutstandingMaturityDate" format="ixt:datemonthdayyearen"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">June 30, 2025</span></ix:nonNumeric></span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Warrant issued with term loan</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_1163ff6f-b43a-4ed7-9961-6b6ff9fd1324" contextRef="C_2b1c0a70-b0ce-43af-b3bb-a102024bd750" name="us-gaap:ClassOfWarrantOrRightOutstanding" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">33,923</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_1e32e94f-8208-49e1-a867-534555be7e36" contextRef="C_2b1c0a70-b0ce-43af-b3bb-a102024bd750" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:numdotdecimal">19.12</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_6c3af337-04bf-4a2c-b489-22947de02602" contextRef="C_2b1c0a70-b0ce-43af-b3bb-a102024bd750" name="us-gaap:WarrantsAndRightsOutstandingMaturityDate" format="ixt:datemonthdayyearen"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">May 28, 2031</span></ix:nonNumeric></span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Warrants issued in public offering</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_4070d5bb-3526-4b77-8195-bbaf1b8c9e9d" contextRef="C_4c47692e-9e97-459b-a109-c6bc7bbaa9fe" name="us-gaap:ClassOfWarrantOrRightOutstanding" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">13,107,360</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_362bb192-3644-4f09-b16d-7c866068a0ce" contextRef="C_4c47692e-9e97-459b-a109-c6bc7bbaa9fe" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="3" format="ixt:numdotdecimal">5.325</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_dc7daf6b-023a-4330-97ee-e28912997ffc" contextRef="C_4c47692e-9e97-459b-a109-c6bc7bbaa9fe" name="us-gaap:WarrantsAndRightsOutstandingMaturityDate" format="ixt:datemonthdayyearen"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">July 1, 2024</span></ix:nonNumeric></span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Pre-funded warrants issued in public offering</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_8736e0df-412d-444d-81f5-169a3d300dd6" contextRef="C_d381e235-d260-40df-bd20-65af96cdfcaa" name="us-gaap:ClassOfWarrantOrRightOutstanding" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">800,000</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_28c4d671-443e-4a73-b4a5-e7aeb5268f90" contextRef="C_d381e235-d260-40df-bd20-65af96cdfcaa" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="3" format="ixt:numdotdecimal">0.001</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_71f3b678-7023-4eb3-96df-21bbcba62838" contextRef="C_68ccb2ee-ab2d-44ed-a5ee-a3a09c44b31c" name="etnb:WarrantsAndRightsOutstandingMaturityDateDescription"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Do not expire</span></ix:nonNumeric></span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:5.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total outstanding</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_8a6d9887-81f4-43de-a24b-1dea17ab1090" contextRef="C_85e3a5e5-8ff2-4682-901b-9d79336e863a" name="us-gaap:ClassOfWarrantOrRightOutstanding" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">13,966,283</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);text-indent:25.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="margin-left:25.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
       </tr>
      </table></ix:nonNumeric></div></ix:nonNumeric></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_67fca452-e0fc-49a4-8775-2face657e749" contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698" name="us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" escape="true" continuedAt="F_67fca452-e0fc-49a4-8775-2face657e749_1"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">8</span></ix:nonNumeric></span><span><ix:continuation id="F_67fca452-e0fc-49a4-8775-2face657e749_1" continuedAt="F_67fca452-e0fc-49a4-8775-2face657e749_2"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. Stock-Based Compensation </span></ix:continuation></span><span style=""></span></p>
  <div><ix:continuation id="F_67fca452-e0fc-49a4-8775-2face657e749_2"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Equity Incentive Plan</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In September 2019, the Company&#x2019;s board of directors adopted the 2019 Equity Incentive Plan (the &#x201c;2019 Plan&#x201d;), which also became effective in September 2019. The Company initially reserved </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_7dfb91c0-bcf9-4e4b-83d6-4baec09bbd81" contextRef="C_92977a81-ddbb-4449-8219-ba10dfb38d5c" name="etnb:NumberOfSharesIssuableUnderShareBasedPaymentArrangement" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">2,844,193</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> shares of common stock for issuance under the 2019 Plan. In addition, the number of shares of common stock reserved for issuance under the 2019 Plan will automatically increase on the first day of January for a period of up to </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_d1c16262-51c8-4ddd-9225-b3f6151eb700" contextRef="C_51c95b33-c300-4ddf-9044-8f1a7525082b" name="etnb:PeriodForIncreaseInNumberOfSharesOfCommonStockReservedForIssuance" format="ixt-sec:durwordsen"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">ten years</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> in an amount equal to </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_a41ab557-7dc1-415f-8b2d-ee67cf3a7b01" contextRef="C_92977a81-ddbb-4449-8219-ba10dfb38d5c" name="etnb:PercentageOfIncreaseInNumberOfSharesOfCapitalStockIssuedAndOutstanding" unitRef="U_pure" scale="-2" decimals="2" format="ixt:numdotdecimal">4</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">% of the total number of shares of the Company&#x2019;s capital stock outstanding on the immediately preceding December 31, or a lesser number of shares determined by the Company&#x2019;s board of directors.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_c8c31bea-ec79-4d00-a0b1-73afb4bb0be6" contextRef="C_8bc8599c-0290-4c23-8007-773265c83e34" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAward" continuedAt="F_c8c31bea-ec79-4d00-a0b1-73afb4bb0be6_1"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The board of directors determines the period over which options become exercisable and options generally vest over a </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_7cee5955-8158-4596-b82b-911b22bd4c76" contextRef="C_8bc8599c-0290-4c23-8007-773265c83e34" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">four-year</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> period, with </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_c7479279-1f7f-4f8f-8c5d-a698d8d47c0d" contextRef="C_8bc8599c-0290-4c23-8007-773265c83e34" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" unitRef="U_pure" scale="-2" decimals="2" format="ixt:numdotdecimal">25</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">% of options vesting on the first anniversary of employment, and thereafter, the remaining options vesting quarterly, over the following </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_feac36f7-be3c-4817-9c8f-371f7b1e03a9" contextRef="C_8bc8599c-0290-4c23-8007-773265c83e34" name="etnb:ShareBasedCompensationArrangementByShareBasedPaymentAwardRemainingOptionsVestingPeriod" format="ixt-sec:durwordsen"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">36-month</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> period. The options expire within </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_10058569-3627-4a0f-91f2-61c6b07addd9" contextRef="C_8bc8599c-0290-4c23-8007-773265c83e34" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" format="ixt-sec:durwordsen"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">ten years</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> from </span></ix:nonNumeric></span><span style=""></span></p><ix:exclude><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">87</span></p>
     <hr style="page-break-after:always;" /><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></ix:exclude><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:continuation id="F_c8c31bea-ec79-4d00-a0b1-73afb4bb0be6_1"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">date of grant. The exercise price of awards granted will not be less than the estimated fair value of the shares on the date of grant. The 2019 Plan also permits the board of directors to grant restricted stock units, which are subject to continued service conditions.</span></p></ix:continuation></div><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Employee Stock Purchase Plan</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In October 2019, the Company&#x2019;s board of directors adopted the 2019 Employee Stock Purchase Plan (&#x201c;ESPP&#x201d;), which became effective in November 2019. The Company initially reserved </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_f6dc3348-60cb-4ac8-b1e5-763ab5f57f82" contextRef="C_9b6ffafb-d759-4fb6-a478-e6f9c964ba52" name="etnb:NumberOfSharesIssuableUnderShareBasedPaymentArrangement" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">225,188</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> shares of common stock for purchase under the ESPP. The number of shares of common stock reserved for issuance under the ESPP will automatically increase on the first day of January for a period of up to </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_3f988196-1c1b-4f46-abb8-e7451c19c191" contextRef="C_f1a66cb6-d1cc-4146-839d-52664c4b4ab3" name="etnb:PeriodForIncreaseInNumberOfSharesOfCommonStockReservedForIssuance" format="ixt-sec:durwordsen"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">ten years</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> in an amount equal to </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_1a195cbf-25d2-454d-927e-a41fe4a8ffcc" contextRef="C_9b6ffafb-d759-4fb6-a478-e6f9c964ba52" name="etnb:PercentageOfIncreaseInNumberOfSharesOfCapitalStockIssuedAndOutstanding" unitRef="U_pure" scale="-2" decimals="2" format="ixt:numdotdecimal">1</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">% of the total number of shares of the Company&#x2019;s common stock outstanding on the immediately preceding December 31, or a lesser number of shares determined by the Company&#x2019;s board of directors. Purchases are accomplished through the participation of discrete offering periods and each offering is expected to be six months in duration. For each offering period, ESPP participants will purchase shares of common stock at a price per share equal to </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_90ba07fe-60ff-4e3d-94f7-36102125ebfb" contextRef="C_9b6ffafb-d759-4fb6-a478-e6f9c964ba52" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" unitRef="U_pure" scale="-2" decimals="2" format="ixt:numdotdecimal">85</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">% of the lesser of the fair market value of the Company&#x2019;s common stock on (1) the first trading day of the applicable offering period or (2) the last trading day of the applicable offering period.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Stock Options</span></p><div style="font-size:11.0pt;font-family:&quot;Calibri&quot;, sans-serif;"><ix:nonNumeric id="F_c372db17-e895-407e-b22d-6c7edbfc75f9" contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698" name="us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" escape="true"><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The following table summarizes stock option activity for the year ended </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31, 2022:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:95.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:55.851%;"></td>
        <td style="width:0.081%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:10.520999999999999%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:0.081%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:7.231%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:0.081%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:8.775%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:0.269%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:9.112%;"></td>
        <td style="width:1.0%;"></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Weighted</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Weighted</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Average</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Average</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Remaining</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Aggregate</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Number of</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Exercise</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Contractual</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Intrinsic</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Options</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Price</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Term</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Value</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(In years)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(In thousands)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Balance outstanding as of December 31, 2021</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_0237387a-81d5-4fcf-94e1-4afcf56b93cc" contextRef="C_23fb22c1-879a-41c9-8fba-6e9ff39f555d" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">2,406,668</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_6e003a85-adf3-480f-b26f-3a661f8bcfd1" contextRef="C_23fb22c1-879a-41c9-8fba-6e9ff39f555d" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:numdotdecimal">16.46</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_3c3321c2-2a5d-4169-8eb1-058f1be0f24f" contextRef="C_4fde072e-5fc4-4cda-9482-54bac5203fd9" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">8.1</span></ix:nonNumeric></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_8b8930b9-9abb-4a92-8af3-7c89544e0767" contextRef="C_23fb22c1-879a-41c9-8fba-6e9ff39f555d" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">9,970</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Granted</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_1a2b74e4-343d-448c-94b2-6d5464d97bfc" contextRef="C_8bc8599c-0290-4c23-8007-773265c83e34" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">1,149,816</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_786835ac-5442-42c3-86e1-1700fceeda33" contextRef="C_8bc8599c-0290-4c23-8007-773265c83e34" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:numdotdecimal">4.48</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Exercised</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_db04508a-2757-44dc-b8e7-6ac82d42c8bb" contextRef="C_8bc8599c-0290-4c23-8007-773265c83e34" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">151,061</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_c75225de-2692-4a99-b092-0ca75787399a" contextRef="C_8bc8599c-0290-4c23-8007-773265c83e34" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:numdotdecimal">2.09</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Cancelled and forfeited</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_e72548a4-3cb8-465a-a14a-f61e4e9290ad" contextRef="C_8bc8599c-0290-4c23-8007-773265c83e34" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">243,506</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_c75dca32-a93d-4154-b345-32d246066cb8" contextRef="C_8bc8599c-0290-4c23-8007-773265c83e34" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:numdotdecimal">16.34</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:11.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:11.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Balance outstanding as of December 31, 2022</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_3146bffa-d72e-4c37-8460-0f902e52a1a8" contextRef="C_cd860230-54ad-4af3-82dc-6e430002fe8e" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">3,161,917</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_2162f4e0-784b-4565-a056-ca2736ecb2dd" contextRef="C_cd860230-54ad-4af3-82dc-6e430002fe8e" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:numdotdecimal">12.80</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_832ab5d7-e5cc-46e6-8602-5af663a9fb08" contextRef="C_8bc8599c-0290-4c23-8007-773265c83e34" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">7.9</span></ix:nonNumeric></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_6d8edb06-5d06-431f-b69f-82ebb2f93faa" contextRef="C_cd860230-54ad-4af3-82dc-6e430002fe8e" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">16,612</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Exercisable as of December 31, 2022</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_40574c18-81cd-4636-97b5-660eb460b920" contextRef="C_cd860230-54ad-4af3-82dc-6e430002fe8e" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">1,460,685</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_75221aa4-9995-4583-80e6-9e9fe05fda1b" contextRef="C_cd860230-54ad-4af3-82dc-6e430002fe8e" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:numdotdecimal">14.60</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_eabe6a90-8b32-4062-95cd-0fc5989c97cd" contextRef="C_8bc8599c-0290-4c23-8007-773265c83e34" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" format="ixt-sec:duryear"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">7.0</span></ix:nonNumeric></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_526bfedc-7ac9-4756-baa2-e3592ee0d4e2" contextRef="C_cd860230-54ad-4af3-82dc-6e430002fe8e" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">7,320</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></ix:nonNumeric></div><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_eb7aa860-c2dc-403e-a972-d7e1ef9cde20" contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698" name="us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" escape="true"><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The fair value of stock options granted for the periods presented was estimated at the date of grant using a Black-Scholes option-pricing model with the following assumptions:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:90.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:59.283%;"></td>
        <td style="width:1.994%;"></td>
        <td style="width:18.364%;"></td>
        <td style="width:1.994%;"></td>
        <td style="width:18.364%;"></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="3" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Year Ended December 31,</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2022</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2021</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Expected term (years)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_0eef074f-633a-48fa-9d60-1cf32f173fff" contextRef="C_f440b0bc-74ad-45cd-9077-8182fe07c5ea" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5.5</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">-</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_5ee5eafa-60bd-4b5b-8a57-bcaa5687c6fb" contextRef="C_a1422313-a35e-45e5-a7d0-20aa6422feb3" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">6.3</span></ix:nonNumeric></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_4c3af7ec-1886-4331-aee8-bd234e923b25" contextRef="C_dc1a49be-d8e3-4484-be45-e163fe0ca28e" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5.5</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">-</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_3d7fdcb8-a846-4311-b7be-310b171b8dd4" contextRef="C_46b0f71c-7508-426b-9a1f-56cebecab4e1" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">6.1</span></ix:nonNumeric></span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Expected volatility</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_11ad37f0-9c08-4a4f-9040-b49c569b9f64" contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" unitRef="U_pure" scale="-2" decimals="INF" format="ixt:numdotdecimal">89.9</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">-</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_49b4cb36-c5e3-478b-8687-a880c2afc839" contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" unitRef="U_pure" scale="-2" decimals="INF" format="ixt:numdotdecimal">91.0</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_253466f9-1d27-410d-ab85-e0b01904d632" contextRef="C_7b31e452-ba3b-4180-9ddd-8faae2f90f0c" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" unitRef="U_pure" scale="-2" decimals="INF" format="ixt:numdotdecimal">86.9</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">-</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_9c4c072e-0349-4f86-8edb-4dc9525c8ae6" contextRef="C_7b31e452-ba3b-4180-9ddd-8faae2f90f0c" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" unitRef="U_pure" scale="-2" decimals="INF" format="ixt:numdotdecimal">91.9</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Risk-free interest rate</span></p></td>
        <td style="background-color:rgba(207,240,252,1);text-indent:5.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_99b13a68-b746-4cba-97b0-0f6ebd0fdecb" contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" unitRef="U_pure" scale="-2" decimals="INF" format="ixt:numdotdecimal">1.6</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">-</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_4bd1ada1-b60d-4e91-980d-ac0cacdf29a9" contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" unitRef="U_pure" scale="-2" decimals="INF" format="ixt:numdotdecimal">3.9</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_e082fa46-28ad-41e4-9fa3-aa99c8274336" contextRef="C_7b31e452-ba3b-4180-9ddd-8faae2f90f0c" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" unitRef="U_pure" scale="-2" decimals="INF" format="ixt:numdotdecimal">0.7</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">-</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_815f5fe9-73a2-48b7-a6cd-3e829983ce46" contextRef="C_7b31e452-ba3b-4180-9ddd-8faae2f90f0c" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" unitRef="U_pure" scale="-2" decimals="INF" format="ixt:numdotdecimal">1.3</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Expected dividend</span></p></td>
        <td style="background-color:rgba(255,255,255,1);text-indent:15.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:15.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
       </tr>
      </table><p style="text-indent:4.533%;font-size:10.0pt;margin-top:2.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></ix:nonNumeric></div><p style="text-indent:4.533%;font-size:10.0pt;margin-top:2.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The weighted-average grant date fair value of stock options that were granted during the year ended December 31, 2022 and 2021 was </span><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_db238d32-e8a9-40a1-a9e3-c7a9f0ef3d61" contextRef="C_e78e7a90-a47d-407c-a473-ef6d15843240" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:numdotdecimal">3.38</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> and $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_ab13e6d5-a934-4807-bb9d-4b7a0253325d" contextRef="C_a901fd1a-d6e9-4b6f-a2ee-b46b58ae4f7c" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:numdotdecimal">16.18</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> per share, respectively. As of </span><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31, 2022, there was </span><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_dfb0dfca-a15f-4e47-a45d-2ac5bfb10579" contextRef="C_cd860230-54ad-4af3-82dc-6e430002fe8e" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">12.2</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million</span><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> of unrecognized stock-based compensation related to stock options granted under the 2019 Plan, which is expected to be recognized over a weighted-average period of </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_c176ef9e-eb5c-4a55-9a20-74efaf043aad" contextRef="C_8bc8599c-0290-4c23-8007-773265c83e34" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" format="ixt-sec:duryear"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2.2</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> years.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Restricted Stock Units (&#x201c;RSUs&#x201d;)</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company has granted certain employees service-based RSUs that generally vest annually over a </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="-sec-ix-hidden:F_79bc5d0a-fb68-4600-adad-d1cd8af005e1;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">two</span></span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> or </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_8e75ed7f-74bc-46f2-a178-a1b94ff9629b" contextRef="C_2b56b0d1-cc3c-4206-95ae-ff3e5aa3e43c" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">three-year</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> period. The restrictions lapse over time for these service-based RSUs. In the event of termination of the holder&#x2019;s continuous service to the Company, any unvested portion of the service-based RSUs are cancelled. For the year ended </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31, 2022 and 2021, the Company recognized expense of </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_788e02eb-cdae-4598-9952-dbc5a9483909" contextRef="C_cd124b4e-13d9-4079-ac85-a4d1fd6601fc" name="us-gaap:AllocatedShareBasedCompensationExpense" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">1.2</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> and $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_2cb172b2-c202-4db6-b892-d686ecc52859" contextRef="C_13fd21a7-f190-41ce-8a3b-79cba6a70fbb" name="us-gaap:AllocatedShareBasedCompensationExpense" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">0.3</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million, respectively, related to the service-based RSUs.</span></p><ix:exclude><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">88</span></p>
     <hr style="page-break-after:always;" /><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></ix:exclude><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_34650133-f234-46d4-8b53-9b00c6508f99" contextRef="C_830ace7d-9785-41d6-a516-94d2fda5e208" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In February 2021, the Company granted performance-based RSUs that vest as to </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="-sec-ix-hidden:F_f41dc902-b0a0-44c4-a2f2-3886c58e26bf;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">one-third</span></span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> on each </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_9afdf5c9-4b07-4b2a-9074-aa3763069224" contextRef="C_3292f652-c40f-4507-b87c-efc3bf396c08" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">one-year </span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">anniversary date, subject to achievement of a development milestone and continued service to the Company. In February 2022, a portion of the performance-based RSUs vested upon achievement of the development milestone and satisfaction of the continued service condition. </span></ix:nonNumeric></span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"></span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_ab86540d-dafc-4585-b349-1e8992df1096" contextRef="C_e79cc86e-7f21-4169-93d3-9ca5f3198b26" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In February and September 2022, the Company granted performance-based RSUs that vest during the applicable performance period, subject to the achievement of certain corporate or department targets and continued service to the Company. In September 2022, a portion of the performance-based RSUs that were granted in February 2022 vested upon achievement of specific targets and satisfaction of the continued service condition. </span></ix:nonNumeric></span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"></span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As of December 31, 2022, it was probable that the remaining performance conditions would be met for the Company&#x2019;s performance-based RSUs and expense was recognized using the accelerated attribution method. For the year ended December 31, 2022 and 2021, the Company recognized expense of </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_1ba5f397-1377-4474-b378-72435c40f24f" contextRef="C_012d970f-64c4-41b0-8040-d4774ce38bd6" name="us-gaap:AllocatedShareBasedCompensationExpense" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">1.5</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> and $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_bc1f3277-780f-4fd1-ad90-3f59669c41d3" contextRef="C_87d79f22-a66f-4528-9561-7c899b8a6f71" name="us-gaap:AllocatedShareBasedCompensationExpense" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">0.8</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million, respectively, related to performance-based RSUs.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_c91b9d92-b766-4819-b2eb-810f3044a491" contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698" name="us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" escape="true"><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The following table summarizes RSU activity for the year ended </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31, 2022:</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:90.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:53.677%;"></td>
        <td style="width:1.783%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:19.008%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:2.253%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:19.279999999999998%;"></td>
        <td style="width:1.0%;"></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Number of<br />RSUs</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Weighted Average<br />Fair Value at <br />Date of Grant per Unit</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Balance outstanding as of December 31, 2021</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_a3bb308f-9291-40fc-a60d-562a922bb132" contextRef="C_42e28a41-a2c7-4703-9012-632c3a4117b3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">106,394</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_735d1e5e-d1d7-4287-bfc8-24d4f6a94b56" contextRef="C_42e28a41-a2c7-4703-9012-632c3a4117b3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:numdotdecimal">23.10</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Granted</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_f373d6f6-f96a-4b30-bcef-3fc59bac3957" contextRef="C_d5d69a12-3d32-411c-82ae-eca2bf142f5c" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">1,224,391</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_74599355-226a-4383-8d71-401f05ddf660" contextRef="C_d5d69a12-3d32-411c-82ae-eca2bf142f5c" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:numdotdecimal">4.61</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Vested / released</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_714830a7-5d54-45fc-b3d4-c5211964b792" contextRef="C_d5d69a12-3d32-411c-82ae-eca2bf142f5c" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">103,703</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_523d33b1-a158-4f82-9a80-056d4b56e10d" contextRef="C_d5d69a12-3d32-411c-82ae-eca2bf142f5c" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:numdotdecimal">8.61</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Cancelled / forfeited</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_2e4075d4-5a6b-4930-86c1-94c1005b43c3" contextRef="C_d5d69a12-3d32-411c-82ae-eca2bf142f5c" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">131,344</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_67d1fd20-deb8-4d60-a390-06564c545c98" contextRef="C_d5d69a12-3d32-411c-82ae-eca2bf142f5c" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:numdotdecimal">5.53</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:5.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Balance outstanding as of December 31, 2022</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_5c3e22c7-e437-4c01-a882-f195c8eff934" contextRef="C_b3ec4959-576f-4e65-ad23-76ebb075c512" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">1,095,738</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_80018dbc-35c7-41e0-b2f4-9b844d286cfb" contextRef="C_b3ec4959-576f-4e65-ad23-76ebb075c512" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:numdotdecimal">5.77</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></ix:nonNumeric></div><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:2.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As of December 31, 2022, there was $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_dc693a49-f801-4c58-b7dc-5a80d7d5bc5e" contextRef="C_b3ec4959-576f-4e65-ad23-76ebb075c512" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">3.9</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million of total unrecognized expense related to RSUs, which is expected to be recognized over a weighted-average period of </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_8deb54ef-db19-4e8f-929b-da28ff99f015" contextRef="C_d5d69a12-3d32-411c-82ae-eca2bf142f5c" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" format="ixt-sec:duryear"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.4</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> years.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:2.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_60a629d8-f7f2-4f94-8346-62ee6bf960c1" contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698" name="us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" escape="true"><p style="text-indent:4.533%;font-size:10.0pt;margin-top:2.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company recorded stock-based compensation for the periods indicated as follows (in thousands):</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:90.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:66.521%;"></td>
        <td style="width:1.603%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:13.025%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:1.603%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:13.249%;"></td>
        <td style="width:1.0%;"></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Year Ended December 31,</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2022</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2021</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Research and development</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_36501638-eafa-4b69-8e8d-0e1737984b6c" contextRef="C_302d3395-cf3f-4431-8710-ee66bc04c06d" name="us-gaap:AllocatedShareBasedCompensationExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">4,094</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_16800c04-ee61-49f9-b827-f005905d2a54" contextRef="C_1993c206-41b8-40d0-bb47-7bbec84e9bd6" name="us-gaap:AllocatedShareBasedCompensationExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">2,966</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">General and administrative</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_96f4f085-b097-4401-84d7-f3257887aa46" contextRef="C_dbf7afe5-d66f-4aec-9806-312b0e5b4e3e" name="us-gaap:AllocatedShareBasedCompensationExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">6,262</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_893a4ab1-2b28-4d1f-89a0-b9ba32c2f5ee" contextRef="C_c220af16-8191-4926-94c1-499324d13fdf" name="us-gaap:AllocatedShareBasedCompensationExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">5,712</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:5.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total stock-based compensation</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_9bae9e20-7882-4620-a13d-f50bbdafbc5c" contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698" name="us-gaap:AllocatedShareBasedCompensationExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">10,356</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_e3fba1d1-2fcb-4bd3-adb9-82ea8f6cf040" contextRef="C_7b31e452-ba3b-4180-9ddd-8faae2f90f0c" name="us-gaap:AllocatedShareBasedCompensationExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">8,678</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></ix:nonNumeric></div></ix:continuation></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">89</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:8.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_99c7a10b-dff2-4124-8154-32e99ba02921" contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698" name="us-gaap:IncomeTaxDisclosureTextBlock" escape="true" continuedAt="F_99c7a10b-dff2-4124-8154-32e99ba02921_1"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">9</span></ix:nonNumeric></span><span><ix:continuation id="F_99c7a10b-dff2-4124-8154-32e99ba02921_1" continuedAt="F_99c7a10b-dff2-4124-8154-32e99ba02921_2"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. Income Taxes</span></ix:continuation></span></p>
  <div><ix:continuation id="F_99c7a10b-dff2-4124-8154-32e99ba02921_2"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Tax Rates Applicable to the Income of the Company and its Subsidiaries</span></p><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_b006d36d-227f-471b-9d27-a6ad0dfc8d1a" contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698" name="etnb:ScheduleOfEffectiveIncomeTaxRateOfCompanyAndSubsidiariesTableTextBlock" escape="true"><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company is taxed according to U.S. federal and state tax laws and Israeli tax laws. The statutory tax rates applicable to the income of the Company and its subsidiaries for the periods presented are as follows:</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:70.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:60.742%;"></td>
        <td style="width:1.438%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:16.341%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:1.438%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:16.04%;"></td>
        <td style="width:1.0%;"></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Year Ended December 31,</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2022</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2021</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">89bio, Inc.</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_2c34583f-6a0a-4a57-bac5-20a3516c3931" contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" unitRef="U_pure" scale="-2" decimals="2" format="ixt:numdotdecimal">21</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_2fded13a-6a3d-4775-bdaf-25b76b9690a1" contextRef="C_7b31e452-ba3b-4180-9ddd-8faae2f90f0c" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" unitRef="U_pure" scale="-2" decimals="2">21</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">89Bio Ltd.</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_1bbcc514-6f17-47db-a8c7-fa2f9959c226" contextRef="C_143dfe4f-b7a0-4c4a-acd0-9cacd6c072d0" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" unitRef="U_pure" scale="-2" decimals="2" format="ixt:numdotdecimal">23</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_8262b022-0a16-4f12-a4f0-5eaa3f0452c0" contextRef="C_c47682c6-cd12-4afc-8813-6a33a11740fe" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" unitRef="U_pure" scale="-2" decimals="2">23</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">89bio Management, Inc.</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_ba67dd78-8cda-4844-8bff-afc6b8392ba9" contextRef="C_97306f73-aa83-44a7-88e9-fbb26c9074bd" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" unitRef="U_pure" scale="-2" decimals="2" format="ixt:numdotdecimal">21</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_0aca0556-73eb-4580-a482-04f75f61b6cd" contextRef="C_e0c8525e-1484-4af4-8900-61b9edf6a79c" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" unitRef="U_pure" scale="-2" decimals="2">21</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">UAB 89bio Lithuania</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_59408670-cf32-4a57-8cd2-1523b5f40e66" contextRef="C_2091a5b2-f30d-4935-bc83-ed0ef862f4d5" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" unitRef="U_pure" scale="-2" decimals="2" format="ixt:numdotdecimal">15</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_23b2bfb2-a9d4-4ff6-9f58-f369359cbfa8" contextRef="C_2ab554fe-0a65-4e18-9da1-d18c79433fba" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" unitRef="U_pure" scale="-2" decimals="2">15</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
       </tr>
      </table></ix:nonNumeric></div><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_1104fa9a-1d7c-4367-9f98-680c635be042" contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698" name="us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" escape="true"><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The income tax (expense) benefit for the periods presented is comprised of (in thousands):</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:70.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:59.085%;"></td>
        <td style="width:1.409%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:17.119999999999997%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:1.409%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:16.978%;"></td>
        <td style="width:1.0%;"></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Year Ended December 31,</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2022</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2021</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Current:</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:5.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Federal</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:5.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">State</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_9c9025e2-95c3-4c31-889a-4553be9af70d" contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698" name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">3</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_2748fcbd-4d65-46b4-94cc-6ce2a4bf4722" contextRef="C_7b31e452-ba3b-4180-9ddd-8faae2f90f0c" name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" unitRef="U_USD" scale="3" decimals="-3">2</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:5.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Foreign</span></p></td>
        <td style="background-color:rgba(255,255,255,1);text-indent:5.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_e1cb0bcb-b587-43e1-b1b7-90b040cd1f72" contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698" name="us-gaap:CurrentForeignTaxExpenseBenefit" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">16</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_00a3d3ee-b06b-477a-9835-cb0442447e34" contextRef="C_7b31e452-ba3b-4180-9ddd-8faae2f90f0c" name="us-gaap:CurrentForeignTaxExpenseBenefit" unitRef="U_USD" scale="3" decimals="-3">1</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:5.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total</span></p></td>
        <td style="background-color:rgba(207,240,252,1);text-indent:15.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:15.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_8daf6e3a-8c61-4409-8b67-eb48fc98a946" contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698" name="us-gaap:CurrentIncomeTaxExpenseBenefit" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">19</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_0eecc895-daca-477c-8670-a0d2fa4de14d" contextRef="C_7b31e452-ba3b-4180-9ddd-8faae2f90f0c" name="us-gaap:CurrentIncomeTaxExpenseBenefit" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">3</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Deferred:</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:5.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Federal</span></p></td>
        <td style="background-color:rgba(207,240,252,1);text-indent:5.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_78adf752-25f8-48f0-9568-e36be7e12164" contextRef="C_7b31e452-ba3b-4180-9ddd-8faae2f90f0c" name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">150</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:5.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">State</span></p></td>
        <td style="background-color:rgba(255,255,255,1);text-indent:5.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:5.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Foreign</span></p></td>
        <td style="background-color:rgba(207,240,252,1);text-indent:5.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:5.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total</span></p></td>
        <td style="background-color:rgba(255,255,255,1);text-indent:15.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:15.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_d4f87b4d-36f1-47af-9311-27128b6c1df5" contextRef="C_7b31e452-ba3b-4180-9ddd-8faae2f90f0c" name="us-gaap:DeferredIncomeTaxExpenseBenefit" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">150</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:5.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Income tax (expense) benefit</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_50bac7b3-621d-49f7-8565-152b32def7f1" contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698" name="us-gaap:IncomeTaxExpenseBenefit" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">19</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_00ddbb10-14c6-4f09-92f5-2b2c1a2be965" contextRef="C_7b31e452-ba3b-4180-9ddd-8faae2f90f0c" name="us-gaap:IncomeTaxExpenseBenefit" unitRef="U_USD" scale="3" decimals="-3" sign="-">147</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></ix:nonNumeric></div><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Deferred Income Taxes</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Deferred income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. </span><span style="font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_9ee8bc24-e03d-435b-af30-b742d720c103" contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698" name="us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" escape="true" continuedAt="F_9ee8bc24-e03d-435b-af30-b742d720c103_1"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Significant components of the Company&#x2019;s deferred tax assets for the periods presented are as follows (in thousands):</span></ix:nonNumeric></span></p><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:continuation id="F_9ee8bc24-e03d-435b-af30-b742d720c103_1"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:70.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:58.709%;"></td>
        <td style="width:1.422%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:17.192%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:1.422%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:17.253%;"></td>
        <td style="width:1.0%;"></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As of December 31,</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2022</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2021</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">U.S. net operating loss carryforwards</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_b18b43e0-c87b-436b-8d72-b0fbbe7bc05b" contextRef="C_fda4865a-3df9-43f1-b274-1756046b954d" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">45,002</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_4ba5aeb6-3dc9-4689-b8e6-8a632921308c" contextRef="C_a4e466da-eda8-431d-8082-79eb5a6b4d5f" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">29,094</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Research and development expenses</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_697d8023-7ee9-40d5-af80-e8b8b70ac349" contextRef="C_85e3a5e5-8ff2-4682-901b-9d79336e863a" name="us-gaap:DeferredTaxAssetsInProcessResearchAndDevelopment" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">18,927</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_5d71d059-8937-4983-8fa6-2d85ac09ee9a" contextRef="C_21f769c6-c78d-41d0-b871-ec3d93d7d343" name="us-gaap:DeferredTaxAssetsInProcessResearchAndDevelopment" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">6,529</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Israel net operating loss carryforwards</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_b3f669b0-917c-40d8-a65e-abae0f94682c" contextRef="C_4aecf5de-d743-4793-84fb-ed9efd04841d" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">7,385</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_6317aebd-fdc9-4fde-bd5a-1ed6f01d825c" contextRef="C_8abdad68-ec68-4b1c-a08b-9c7a8ad9e2f6" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">4,262</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Stock-based compensation</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_1bb39bb6-5354-46bd-bb13-0f6840c9b4c8" contextRef="C_85e3a5e5-8ff2-4682-901b-9d79336e863a" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">4,328</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_37c179a7-38fe-48a7-9803-e25cd7d78af9" contextRef="C_21f769c6-c78d-41d0-b871-ec3d93d7d343" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,969</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Accrued expenses</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_9eb86cbb-e751-418d-895f-eda422b6ba31" contextRef="C_85e3a5e5-8ff2-4682-901b-9d79336e863a" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">317</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_e7232eef-7906-45a9-8897-add4b24ba226" contextRef="C_21f769c6-c78d-41d0-b871-ec3d93d7d343" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" unitRef="U_USD" scale="3" decimals="-3">220</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Operating Lease Liability</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_9f9676de-c7c6-4a76-bd29-a3c8c27eb05c" contextRef="C_85e3a5e5-8ff2-4682-901b-9d79336e863a" name="etnb:DeferredTaxAssetsLeaseLiability" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">98</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Other</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_083f6274-9cc4-4a3c-8ee3-1aa60427d20a" contextRef="C_85e3a5e5-8ff2-4682-901b-9d79336e863a" name="us-gaap:DeferredTaxAssetsOther" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">244</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_3388bb9b-a07e-4d1e-891e-24334bf62767" contextRef="C_21f769c6-c78d-41d0-b871-ec3d93d7d343" name="us-gaap:DeferredTaxAssetsOther" unitRef="U_USD" scale="3" decimals="-3">191</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Gross deferred tax assets</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_fbfc8448-f34f-4a99-ac40-fea38ccd916c" contextRef="C_85e3a5e5-8ff2-4682-901b-9d79336e863a" name="us-gaap:DeferredTaxAssetsGross" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">76,301</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_7c86aad0-a9d3-4d80-b86d-3c7e52c67203" contextRef="C_21f769c6-c78d-41d0-b871-ec3d93d7d343" name="us-gaap:DeferredTaxAssetsGross" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">42,265</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Less: valuation allowance</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_5f5574ed-45c9-42a3-8cce-7903e37faf7b" contextRef="C_85e3a5e5-8ff2-4682-901b-9d79336e863a" name="us-gaap:DeferredTaxAssetsValuationAllowance" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">75,982</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_aad6fc21-746e-468e-b3db-1eaf25c413c5" contextRef="C_21f769c6-c78d-41d0-b871-ec3d93d7d343" name="us-gaap:DeferredTaxAssetsValuationAllowance" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">42,046</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;Total deferred tax assets</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_9c606ad4-d1ce-48d6-8fe4-95c93b4afe7c" contextRef="C_85e3a5e5-8ff2-4682-901b-9d79336e863a" name="us-gaap:DeferredTaxAssetsNet" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">319</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_8e542958-18ca-4b97-b326-cbf72e7ff8d8" contextRef="C_21f769c6-c78d-41d0-b871-ec3d93d7d343" name="us-gaap:DeferredTaxAssetsNet" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">219</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">  &#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Operating lease right-of-use asset</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_1a79c331-59c6-43d4-8fa0-d9ba21d7bcc9" contextRef="C_85e3a5e5-8ff2-4682-901b-9d79336e863a" name="etnb:DeferredTaxLiabilitiesRightsOfUseAssets" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">100</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total deferred tax liabilities</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_9f2b0941-11b4-4601-92c7-fd544460b374" contextRef="C_85e3a5e5-8ff2-4682-901b-9d79336e863a" name="us-gaap:DeferredIncomeTaxLiabilities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">100</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;Net deferred tax assets</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_262577e5-e871-453e-9b91-9ef63bdb0a51" contextRef="C_85e3a5e5-8ff2-4682-901b-9d79336e863a" name="us-gaap:DeferredTaxAssetsLiabilitiesNet" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">219</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_7af9d06d-e0e8-42fc-93ed-ce13f31b7602" contextRef="C_21f769c6-c78d-41d0-b871-ec3d93d7d343" name="us-gaap:DeferredTaxAssetsLiabilitiesNet" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">219</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></ix:continuation></div><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As of December 31, 2022 and 2021, the Company recorded a valuation allowance of </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_cfc9cc06-f56b-4c9b-93db-8570b664567b" contextRef="C_85e3a5e5-8ff2-4682-901b-9d79336e863a" name="us-gaap:DeferredTaxAssetsValuationAllowance" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">76.0</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> and $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_b59a0ecd-85f9-4354-a104-34d64cddc3f4" contextRef="C_21f769c6-c78d-41d0-b871-ec3d93d7d343" name="us-gaap:DeferredTaxAssetsValuationAllowance" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">42.0</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million, </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">respectively, in respect of deferred tax assets resulting from tax loss carryforwards and other temporary differences. Realization of deferred tax assets is dependent upon future earnings, if any, the time and amount of</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><ix:exclude><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">90</span></p>
     <hr style="page-break-after:always;" /><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></ix:exclude><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">which </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">are uncertain. The Company regularly assesses the likelihood that its deferred tax assets will be recovered from future taxable income and, to the extent it believes based upon the weight of available evidence that it is more likely than not that all or a portion of deferred tax assets will not be realized, a valuation allowance is established through an adjustment to income tax expense. The valuation allowance increased by </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_6b7669cc-0cdb-40d3-8e3c-8e31ba46ceff" contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698" name="us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">34.0</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> in 2022, which primarily relates to significant taxable losses. The Company continues to record a partial valuation allowance against the deferred tax assets in Israel due to achievement of recent profitability and the expectation of future profitability in the jurisdiction.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Available Carryforward Tax Losses and Credits</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As of December 31, 2022, the Company had an accumulated tax loss carryforward of approximately </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_cb60df1e-a62e-4400-b875-a954e11c46b0" contextRef="C_4052b109-a3b7-4114-87b7-faa0a4118dc7" name="etnb:AccumulatedTaxLossCarryForward" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">160.9</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_e667a75b-4e5d-4017-84ca-d47be55ab30e" contextRef="C_cb272169-7edb-4636-b3d0-11b4570d0a11" name="etnb:AccumulatedTaxLossCarryForward" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">169.8</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, and </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_2a2b20c2-74da-4a62-8a42-1088ecdc3b9e" contextRef="C_4aecf5de-d743-4793-84fb-ed9efd04841d" name="etnb:AccumulatedTaxLossCarryForward" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">32.1</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> for Federal, State and Israeli tax purposes, respectively. As of December 31, 2021</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, the Company had an accumulated tax loss carryforward of approximately $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_a106afb8-6d50-495a-b68e-51bee674fb6a" contextRef="C_a4e466da-eda8-431d-8082-79eb5a6b4d5f" name="etnb:AccumulatedTaxLossCarryForward" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">138.5</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million and $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_2eed3462-1cae-42ce-aea7-ce175618b8fa" contextRef="C_8abdad68-ec68-4b1c-a08b-9c7a8ad9e2f6" name="etnb:AccumulatedTaxLossCarryForward" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">18.5</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million for U.S. and Israeli tax purposes, respectively. </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_d61a43d4-833b-4bce-ada9-c4a680ea458e" contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698" name="us-gaap:OperatingLossCarryforwardsLimitationsOnUse"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Federal net operating losses generated after 2017 can be carried forward indefinitely but utilization will be limited to </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_f981b803-8be3-472b-978f-19640c5a146b" contextRef="C_85e3a5e5-8ff2-4682-901b-9d79336e863a" name="etnb:TaxableIncomeUtilizationPercentage" unitRef="U_pure" scale="-2" decimals="2" format="ixt:numdotdecimal">80</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">% of taxable income in the period that net operating losses are being utilized.</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> Carryforward tax losses in California will begin to expire in </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_f03728b9-f3a0-4411-853f-c58b61d7fe4b" contextRef="C_17d9d5b5-1459-459f-8bc2-52f76629e915" name="etnb:TaxCreditCarryforwardExpirationYear"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2041</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. Carryforward tax losses in Israel have no expiration date.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As of December 31, 2022 and 2021, the Company had federal research and development credit carryforwards of approximately </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_3923cb43-895e-47f8-8754-b43f58eb3457" contextRef="C_85e3a5e5-8ff2-4682-901b-9d79336e863a" name="etnb:DeferredTaxAssetsTaxCreditCarryforwardsResearchFederal" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">4.3</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> and $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_39c4a63c-7d1c-4a56-acd4-c5148de8b44b" contextRef="C_21f769c6-c78d-41d0-b871-ec3d93d7d343" name="etnb:DeferredTaxAssetsTaxCreditCarryforwardsResearchFederal" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">2.1</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million, respectively, which expire beginning in </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_bd5b0e30-ced2-4393-83fb-1b30c1833f73" contextRef="C_c6fb4616-5254-4cb5-bb2e-278e7e88bcc9" name="etnb:TaxCreditCarryforwardExpirationYear"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2040</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. As of </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31, 2022 and December 31, 2021, the Company had state research and development credit carryforwards of approximately </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_f6b723c3-4b0b-45df-aa4d-6357788a87cf" contextRef="C_85e3a5e5-8ff2-4682-901b-9d79336e863a" name="us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">1.8</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> and $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_6f08064f-20f2-450f-a9e2-4ecaca6e8cec" contextRef="C_21f769c6-c78d-41d0-b871-ec3d93d7d343" name="us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">1.1</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million, respectively, which will carry forward indefinitely.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Loss from Operations, Before Income Tax</span></p><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_b473e33d-3470-46ea-9f97-c44f10917a54" contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698" name="us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" escape="true"><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company recorded a loss from operations, before income tax for the periods presented as follows (in thousands):</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:70.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:57.78%;"></td>
        <td style="width:1.96%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:17.165%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:1.96%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:17.135%;"></td>
        <td style="width:1.0%;"></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Year Ended December 31,</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2022</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2021</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">United States</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_9633075e-6cc9-4027-8faf-5f07ef2997f2" contextRef="C_b88d9973-f0e9-45f8-b4fb-a6e4faea7667" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">101,938</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_4489adc4-7cd2-4d72-9fd3-b7a88bb526a7" contextRef="C_7c6e4cd6-6b45-4e07-9ce7-b8efe5b967e5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">91,141</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Lithuania</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_e3aa685f-404a-4a57-a481-0f9c9e73dcfa" contextRef="C_e52ac035-0be2-420f-b034-790f9ecc0826" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">7</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_701ae530-bbaf-4400-9efa-a4ec66bb6681" contextRef="C_9d22496e-a5ce-4a93-a7b9-674d6c8a803f" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" unitRef="U_USD" scale="3" decimals="-3">10</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Israel</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_7dac9011-f1d0-4013-b7bb-36f8fe4474a2" contextRef="C_50e7e18a-0655-4c7d-95a8-7ac3e1648249" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">62</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_fe0f9912-3bc5-42c3-bde1-22dc9baa5f91" contextRef="C_da14e69b-ecb1-4491-93da-01275cadc2ed" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" unitRef="U_USD" scale="3" decimals="-3">862</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:5.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Net loss before income tax</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_a63c2b44-66ca-490a-aece-f7db8b3094c9" contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">102,007</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_7f9b91d4-2cc4-46b4-85ab-358994d05e12" contextRef="C_7b31e452-ba3b-4180-9ddd-8faae2f90f0c" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">90,269</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
       </tr>
      </table></ix:nonNumeric></div><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Reconciliation of Income Tax (Expense) Benefit</span></p><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_63a28050-5c5b-475a-88a3-18753b1196ea" contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698" name="us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" escape="true"><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The reconciliation of income tax (expense) benefit based on the statutory tax rate to the effective tax rate for the periods presented is as follows (in thousands):</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:83.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:64.941%;"></td>
        <td style="width:1.837%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:14.007%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:1.208%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:14.007%;"></td>
        <td style="width:1.0%;"></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Year Ended December 31,</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2022</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2021</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Income tax benefit computed at statutory rates</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_c31d9355-1a30-4b09-ab8b-2e301e067e21" contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698" name="us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">21,429</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_9b1855e7-0699-43a6-a085-79d68217b1a9" contextRef="C_7b31e452-ba3b-4180-9ddd-8faae2f90f0c" name="us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">18,757</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Change in valuation allowance</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_537eb6a6-a7e5-4045-8211-8bb061eda495" contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698" name="us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">33,936</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_6b55e942-a21d-4134-b351-3f8f8cfeea3d" contextRef="C_7b31e452-ba3b-4180-9ddd-8faae2f90f0c" name="us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">20,111</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Foreign rate differential</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_b3d2a43b-81a9-4e36-b72a-35fb0c3ca2f3" contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698" name="us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_16d26989-5d15-454f-84ec-c7c6c77ff9ae" contextRef="C_7b31e452-ba3b-4180-9ddd-8faae2f90f0c" name="us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential" unitRef="U_USD" scale="3" decimals="-3" sign="-">19</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">State income taxes, net of federal benefit</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_80e11b62-db05-46b9-91b6-3ea3898ad939" contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698" name="us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">5,824</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">State deferred tax true-up due to change in apportionment</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_f2abfdbb-6bd3-405e-809c-059b439b683b" contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698" name="etnb:EffectiveIncomeTaxRateReconciliationStateDeferredTaxTrueUpDueToChangeInApportionment" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">6,517</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Change in Israel effective tax rate due to the 2019 reorganization</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2014;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_4e8ba513-6082-462d-91fa-7b68365cafce" contextRef="C_7b31e452-ba3b-4180-9ddd-8faae2f90f0c" name="etnb:IncomeTaxReconciliationChangeInEffectiveTaxRateDueToReorganization" unitRef="U_USD" scale="3" decimals="-3" sign="-">2</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Research and development credits, net of uncertain tax position</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_2025a814-3ddb-4280-8b29-8afb272d1298" contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698" name="us-gaap:IncomeTaxReconciliationNondeductibleExpenseResearchAndDevelopment" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">2,130</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_adc2dfa5-d9ae-4b03-bb93-46da20cbf4ca" contextRef="C_7b31e452-ba3b-4180-9ddd-8faae2f90f0c" name="us-gaap:IncomeTaxReconciliationNondeductibleExpenseResearchAndDevelopment" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,331</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Other</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_30bdb12f-3eaf-47d1-8fec-78ab107001dc" contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698" name="us-gaap:IncomeTaxReconciliationOtherAdjustments" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">1,984</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_015cd470-5b3b-4ed8-9806-7df40d881e0c" contextRef="C_7b31e452-ba3b-4180-9ddd-8faae2f90f0c" name="us-gaap:IncomeTaxReconciliationOtherAdjustments" unitRef="U_USD" scale="3" decimals="-3">191</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:5.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Income tax (expense) benefit</span></p></td>
        <td style="background-color:rgba(207,240,252,1);text-indent:5.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_4a862614-a5cf-4264-9911-16dc65e06b5f" contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698" name="us-gaap:IncomeTaxExpenseBenefit" unitRef="U_USD" scale="3" decimals="-3">19</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_fd7402c2-9bbe-4f9f-ae48-f7b93fe3c095" contextRef="C_7b31e452-ba3b-4180-9ddd-8faae2f90f0c" name="us-gaap:IncomeTaxExpenseBenefit" unitRef="U_USD" scale="3" decimals="-3" sign="-">147</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></ix:nonNumeric></div><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p><ix:exclude><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">91</span></p>
     <hr style="page-break-after:always;" /><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></ix:exclude><p style="text-indent:4.533%;font-size:10.0pt;margin-top:2.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Utilization of U.S. federal and state net operating losses and credit carryforwards may be subject to an annual limitation provided for in Section 382 of the Internal Revenue Code and similar state codes. Any annual limitation could result in a deferral of the utilization of the net operating loss and credit carryforwards.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Unrecognized Tax Benefits</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_daf4dc8f-b063-4f98-b38e-d989757edeaa" contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698" name="us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" escape="true"><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">A reconciliation of the unrecognized tax benefits for the year ended December 31, 2022 and 2021 is as follows (in thousands):</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:90.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:59.438%;"></td>
        <td style="width:1.418%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:16.875000000000004%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:1.431%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:16.837999999999997%;"></td>
        <td style="width:1.0%;"></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As of December 31,</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2022</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2021</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Balance beginning of year</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_85bdfa09-b011-4321-9948-d4cf1cc12aff" contextRef="C_21f769c6-c78d-41d0-b871-ec3d93d7d343" name="us-gaap:UnrecognizedTaxBenefits" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">851</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_fa2442a4-d7f3-44ae-a907-566077d26c9d" contextRef="C_19418b37-9af5-4eb2-b38a-a9070fc599d5" name="us-gaap:UnrecognizedTaxBenefits" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">329</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Decrease related to prior year positions</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_d310c51d-4889-42d2-a654-bb6f5f605f9e" contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">19</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_c805c37a-1bbc-4fd1-8753-257b15164b81" contextRef="C_7b31e452-ba3b-4180-9ddd-8faae2f90f0c" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">35</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Increase related to current year positions</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_ad159e97-7a89-4b73-bb80-8b4246e06691" contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">752</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_3725cb1b-bfd2-4965-b60f-4f8ff8e0c6de" contextRef="C_7b31e452-ba3b-4180-9ddd-8faae2f90f0c" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">557</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;Balance end of year</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_a24caedd-1ada-4ff0-9a22-a3c867c19bce" contextRef="C_85e3a5e5-8ff2-4682-901b-9d79336e863a" name="us-gaap:UnrecognizedTaxBenefits" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,584</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_f417cdbf-b023-4531-a127-373f86354d59" contextRef="C_21f769c6-c78d-41d0-b871-ec3d93d7d343" name="us-gaap:UnrecognizedTaxBenefits" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">851</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></ix:nonNumeric></div><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">During the year ended December 31, 2022 and 2021, the amount of gross unrecognized tax benefits increased by </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_025d4e6d-3aa6-40c0-a67d-c80372f7e393" contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698" name="us-gaap:UnrecognizedTaxBenefitsPeriodIncreaseDecrease" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">0.7</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> and </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_1b6e71cd-258c-41b0-9a9c-9ad1d40f959d" contextRef="C_7b31e452-ba3b-4180-9ddd-8faae2f90f0c" name="us-gaap:UnrecognizedTaxBenefitsPeriodIncreaseDecrease" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">0.5</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, respectively. If the total amount of unrecognized tax benefits was recognized, it would </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_580b5a69-d6e6-42ca-87d1-84b11e3ba06e" contextRef="C_85e3a5e5-8ff2-4682-901b-9d79336e863a" name="us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" unitRef="U_USD" scale="3" decimals="INF" format="ixt-sec:numwordsen">no</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">t have an impact to the effective tax rate as it would be offset by the reversal of related deferred tax assets which are subject to a full valuation allowance.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company recognizes interest and penalties related to uncertain tax positions as part of the income tax provision. As of December 31, 2022 and 2021, such interest and penalties were not material.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company is subject to taxation in the United States, California, Colorado, North Carolina and several foreign jurisdictions. To date, the Company has not been subject to any federal or state income tax audits. The Company is currently under examination by the Israeli tax authorities for 2018 and 2019. As of December 31, 2022, all tax years remain open to examination.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">On August 9, 2022 and August 16, 2022, the Creating Helpful Incentives to Produce Semiconductors (&#x201c;CHIPS&#x201d;) Act and the Inflation Reduction Act (&#x201c;IRA&#x201d;), respectively, were signed into law. The CHIPS Act and IRA contain among other things, some income tax provisions that establish a corporate alternative minimum tax and provide tax incentives for semiconductor manufacturing and research. The Company has evaluated the current legislation and at this time, does not anticipate either to have a material impact on its financial statements.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Tax Cuts and Jobs Act (&#x201c;TCJA&#x201d;) included a change in the treatment of research and development (&#x201c;R&amp;D&#x201d;) expenditures for tax purposes under Section 174. Effective for tax years beginning after December 31, 2021, specified R&amp;D expenditures must undergo a </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_3ceb63ea-3508-49db-98a8-ced42885516a" contextRef="C_dd9c4882-66d0-4386-bb9e-0f1c29a674cb" name="etnb:AmortizationPeriod" format="ixt-sec:durwordsen"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5-year</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> amortization period for domestic spend and a </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_939d8b67-e191-46a8-b86f-cc943be314ab" contextRef="C_cc8b62e3-7c1c-4b52-9dfb-ede005f6e5b4" name="etnb:AmortizationPeriod" format="ixt-sec:durwordsen"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">15-year</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> amortization period for foreign spend. Prior to the effective date (2021 tax year and prior), taxpayers were able to immediately expense R&amp;D costs under Section 174(a) or had the option to capitalize and amortize R&amp;D expenditures over a </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_9e710c9a-e162-4e63-9ce2-b5cc35930214" contextRef="C_302d3395-cf3f-4431-8710-ee66bc04c06d" name="etnb:AmortizationPeriod" format="ixt-sec:durwordsen"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5-year</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> recovery period under Section 174(b). The Company has evaluated the current legislation at this time and prepared the provision by following the treatment of R&amp;D expenditures for tax purposes under Section 174.</span></p></ix:continuation></div>
  <div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_958dcfd7-9392-4a9d-a62a-7601e603d03b" contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698" name="us-gaap:EarningsPerShareTextBlock" escape="true"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10. Net Loss Per Share</span></p><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_f5b34c47-599f-4c39-843e-856714774c61" contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698" name="us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" escape="true"><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The following outstanding potentially dilutive common stock equivalents have been excluded from the calculation of diluted net loss per share for the periods indicated due to their anti-dilutive effect:</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:83.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:55.149%;"></td>
        <td style="width:0.996%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:18.892999999999997%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:1.009%;"></td>
        <td style="width:1.0%;"></td>
        <td style="width:19.953000000000003%;"></td>
        <td style="width:1.0%;"></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Year Ended December 31,</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2022</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2021</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Stock options to purchase common stock</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_bdffbec8-ec37-4dc0-a3bd-6731737fc62c" contextRef="C_1987e38f-7346-406e-addf-f3687776929f" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" unitRef="U_shares" decimals="0" format="ixt:numdotdecimal">3,161,917</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_24abac54-d10e-4031-9ead-051e526446b1" contextRef="C_71719056-4c35-44bc-be7b-ed47745f7284" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" unitRef="U_shares" decimals="0" format="ixt:numdotdecimal">2,406,668</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Unvested restricted stock units</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_c3f189e8-44bf-453f-82d9-180a9e7a3d77" contextRef="C_3d0b52b1-23df-4031-9043-36966d3bfe8f" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" unitRef="U_shares" decimals="0" format="ixt:numdotdecimal">1,095,738</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_bd839aef-8499-4c9d-ae62-3e40aca7e67d" contextRef="C_2927c45f-85bc-4b1d-bb2a-c302c8ed2347" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" unitRef="U_shares" decimals="0" format="ixt:numdotdecimal">106,394</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Warrants to purchase common stock</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);top:-4.6899999999999995pt;white-space:pre-wrap;font-weight:normal;font-size:6.7pt;font-family:&quot;Times New Roman&quot;, serif;position:relative;min-width:fit-content;">1</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_590cb022-b1e5-419e-8da0-41c3c99bb51c" contextRef="C_04dfbd26-115a-4a0f-a7b5-f27eb17ef112" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" unitRef="U_shares" decimals="0" format="ixt:numdotdecimal">13,166,283</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_4483d3b1-4fde-425c-bc22-b781fd3b52c1" contextRef="C_b7499103-4103-44cf-b691-30ec371253b5" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" unitRef="U_shares" decimals="0" format="ixt:numdotdecimal">58,923</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:5.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_be001b23-0505-4a64-98ea-b9e913be8d64" contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" unitRef="U_shares" decimals="0" format="ixt:numdotdecimal">17,423,938</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_492cf17d-d8d1-4720-9aa9-dceec23d0569" contextRef="C_7b31e452-ba3b-4180-9ddd-8faae2f90f0c" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" unitRef="U_shares" decimals="0" format="ixt:numdotdecimal">2,571,985</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><p style="margin-left:9.067%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;vertical-align:super;font-size:5.36pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> The table above excludes pre-funded warrants issued in connection with the July 2022 public offering (see Note 7).</span></p></ix:nonNumeric></div></ix:nonNumeric></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">92</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_b162cc02-fa22-44c5-aac6-1ee53d5fa363" contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698" name="us-gaap:SubsequentEventsTextBlock" escape="true"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">11. Subsequent Events</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">2023 Loan Agreement</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In January 2023, the Company executed the 2023 Loan Agreement with the new lenders named therein. The 2023 Loan Agreement provides up to $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_250f3579-32aa-4067-b30a-c6c850e2392b" contextRef="C_2e474f95-87bf-4927-8cbe-0c9312719cd9" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">100.0</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million in aggregate principal in term loans, consisting of a first tranche of $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_3a81caaa-614d-4afe-9463-37608eef01b3" contextRef="C_9b3365b2-21c7-49a6-ad95-a43fd3b9d2c1" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">25.0</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million that was funded at closing, two subsequent tranches totaling $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_c8ae72d1-a08d-4c31-9a5d-d0fb52057a2d" contextRef="C_6cebf0eb-4166-4c8e-ac4c-8137ee3b770e" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">25.0</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million that may be funded upon the achievement of certain time-based, clinical and regulatory milestones, and a fourth tranche of up to $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_e1d0f6d1-65f0-4a0f-b8ff-8210c3a8fe5e" contextRef="C_f85e5250-59a9-43e3-a14f-d55368e20822" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">50.0</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million that may be funded upon discretionary approval by the lenders.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_00fd9a69-ea1e-4ce8-a7ed-1f0236dbca13" contextRef="C_c666f3b9-1ce5-4d4c-88e3-dbd7868d4edb" name="us-gaap:DebtInstrumentMaturityDateDescription"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The term loans under the 2023 Loan Agreement mature on </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_818878ce-e2f2-4cad-a293-90cc035a783d" contextRef="C_c666f3b9-1ce5-4d4c-88e3-dbd7868d4edb" name="us-gaap:DebtInstrumentMaturityDate" format="ixt:datemonthdayyearen"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">January 1, 2027</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. The maturity date may be extended to </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_38c8456c-2931-41c2-8f17-ce28f37db620" contextRef="C_5e92a8a9-dc98-44f0-9e1f-f9aa3e8099bf" name="us-gaap:DebtInstrumentMaturityDate" format="ixt:datemonthdayyearen"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">July 1, 2027</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, provided that the second and third tranches are funded and the Company achieves certain other financing milestones.</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> The term loans bear interest equal to the greater of (i) </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_ebd67b85-3c4d-4e59-8fd4-9daa4e1cd52d" contextRef="C_c666f3b9-1ce5-4d4c-88e3-dbd7868d4edb" name="us-gaap:DebtInstrumentInterestRateDuringPeriod" unitRef="U_pure" scale="-2" decimals="4" format="ixt:numdotdecimal">8.45</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">% and (ii) the sum of (a) the Prime Rate as reported in The Wall Street Journal plus (b) </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_4fd19ea5-c95f-44ce-bd71-4b84ce1a40ac" contextRef="C_c666f3b9-1ce5-4d4c-88e3-dbd7868d4edb" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" unitRef="U_pure" scale="-2" decimals="4" format="ixt:numdotdecimal">2.25</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%. </span><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Consecutive monthly payments of interest commence in February 2023 and consecutive monthly payments of principal commence in February 2025, or February 2026 provided that certain extension milestones are achieved.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">2021 Loan Agreement</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In January 2023, the first tranche of $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_ec1d53a3-ac20-4683-9cb9-ab7e91a74720" contextRef="C_46a37282-7c21-4f91-b5bc-d6bf1cfad31b" name="us-gaap:LineOfCreditFacilityAverageOutstandingAmount" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">25.0</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million that was funded pursuant to the 2023 Loan Agreement was primarily used to repay the Company&#x2019;s outstanding obligations under the 2021 Loan Agreement, including the total principal amount outstanding as of December 31, 2022 of $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_6b02aa1f-0ea5-46d2-b15a-be5ecdb3d257" contextRef="C_37523fff-f632-40a8-b39a-8f096f5c4549" name="us-gaap:DebtInstrumentAnnualPrincipalPayment" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">20.0</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million, the final payment fee of $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_c092b305-ae4f-462f-9e01-347412132d4c" contextRef="C_37523fff-f632-40a8-b39a-8f096f5c4549" name="etnb:DebtInstrumentFinalPaymentFee" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">1.0</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million and an early prepayment fee of $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_0626e92e-01c2-406c-afb5-45150d4651cc" contextRef="C_37523fff-f632-40a8-b39a-8f096f5c4549" name="etnb:DebtInstrumentEarlyPrepaymentFee" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">0.4</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million (see Note 6).</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">ATM Facility</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_6ed6bb53-49a7-4407-8cfa-543542aefddb" contextRef="C_3b993bd4-a1f0-42fb-959d-d02b87902727" name="us-gaap:SaleOfStockDescriptionOfTransaction"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In January and February 2023, the Company received aggregate proceeds of $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_5e35967c-2dbe-4613-bf07-12a501e39854" contextRef="C_3c40b2dc-88af-4c40-8a0c-0d6d05ae9073" name="us-gaap:ProceedsFromIssuanceOfCommonStock" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">13.4</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million, net of commissions from sales of </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_4062acbb-5208-4011-91d1-dd07822f6b73" contextRef="C_3c40b2dc-88af-4c40-8a0c-0d6d05ae9073" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" unitRef="U_shares" decimals="0" format="ixt:numdotdecimal">968,000</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> shares of its common stock pursuant to the ATM Facility (see Note 7).</span></ix:nonNumeric></span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">On </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><ix:nonNumeric id="F_9d2d50c2-71ba-4686-9667-01ed53611669" contextRef="C_6201b105-b38d-4bd4-81b7-a6dfd189c83e" name="us-gaap:SaleOfStockTransactionDate" format="ixt:datemonthdayyearen"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">February 15, 2023</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, the Company entered into Amendment No. 1 to the Sales Agreement with the Sales Agent, </span><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">pursuant to which the Company may offer and sell up to $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"><ix:nonFraction id="F_754f7ed1-f421-4d1a-b9ce-c78ddea47202" contextRef="C_8c46fb5d-0dfa-460a-9514-f05dd04eb080" name="etnb:MaximumAmountOfEquitySharesIssuable" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">150.0</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">shares of its common stock, from time to time, through the ATM Facility (see Note 7).</span><span style="color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Banking Relationship with SVB</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company has a banking relationship with SVB. On March 10, 2023, SVB was closed by the California Department of Financial Protection and Innovation, which appointed the Federal Deposit Insurance Corporation (&#34;FDIC&#34;) as receiver. On March 12, 2023, the Federal Reserve Board approved actions enabling the FDIC to complete its resolution of SVB in a manner that fully protects all depositors. Based on the foregoing and the Company&#x2019;s analysis of the components of its relationship with SVB, the Company does not expect these events to have a material impact on the Company&#x2019;s consolidated financial statements.</span></p></ix:nonNumeric></div>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">93</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;" id="item_9_changes_in_disagreements_with_acc"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Item 9. Changes in and Disagreements With Acco</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">untants on Accounting and Financial Disclosure.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">None.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;" id="item_9a_controls_procedures"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Item 9A. Controls</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> and Procedures.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Evaluation of Disclosure Controls and Procedures</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As of December 31, 2022, our management, with the participation and supervision of our principal executive officer and our principal financial officer, evaluated our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act). The term &#x201c;disclosure controls and procedures,&#x201d; as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act, means controls and other procedures of a company that are designed to ensure that information required to be disclosed by a company in the reports that it files or submits under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the SEC&#x2019;s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by a company in the reports that it files or submits under the Exchange Act is accumulated and communicated to the Company&#x2019;s management, including its principal executive and principal financial officers, as appropriate to allow timely decisions regarding required disclosure. Management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving their objectives and management necessarily applies its judgment in evaluating the cost benefit relationship of possible controls and procedures. Based on this evaluation, our principal executive officer and our principal financial officer concluded that our disclosure controls and procedures were effective as of December 31, 2022 to provide reasonable assurance that information we are required to disclose in reports that we file or submit under the Exchange Act is recorded, processed, summarized, and reported within the time periods specified in SEC rules and forms, and that such information is accumulated and communicated to our management, including our principal executive officer and our principal financial officer, as appropriate, to allow timely decisions regarding required disclosure.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Changes in Internal Control over Financial Reporting</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">There were no changes in our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) occurred during the quarter ended December 31, 2022 that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Management&#x2019;s Annual Report on Internal Control Over Financial Reporting</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Our management is responsible for establishing and maintaining adequate internal control over financial reporting (as defined in Rules 13a-15(f) under the Exchange Act). Internal control over financial reporting is a process designed under the supervision and with the participation of our management, including our principal executive officer and our principal financial officer, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles in the United States.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As of December 31, 2022, our management assessed the effectiveness of our internal control over financial reporting using the criteria set forth by the Committee of Sponsoring Organizations of the Treadway Commission in Internal Control-Integrated Framework (&#x201c;2013 Framework&#x201d;). Based on this assessment, our management concluded that our internal control over financial reporting was effective as of December 31, 2022.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">94</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Attestation Report of Registered Public Accounting Firm</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As an emerging growth company, we are not required to provide and this Annual Report on Form 10-K does not include an attestation report on our internal control over financial reporting issued by the Company&#x2019;s independent registered public accounting firm. Our auditors will not be required to formally opine on the effectiveness of our internal control over financial reporting pursuant to Section 404(b) of the Sarbanes-Oxley Act of 2002 until we are no longer an emerging growth company, as defined in the Jumpstart Our Business Startups Act of 2012, and are no longer a non-accelerated filer.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;" id="item_9b_or_information"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Item 9B. Other </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Information.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">None.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;" id="item_9c_disclosure_regarding"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Item 9C. Disclos</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">ure Regarding Foreign Jurisdictions that Prevent Inspections.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Not applicable.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">95</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;" id="part_iii"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">PART </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">III</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;" id="item_10_directors_executive_ficers_corpo"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Item 10. Directors, Executive Of</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">ficers and Corporate Governance.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The information required by this Item 10 is incorporated herein by reference to information in our proxy statement for our 2023 Annual Meeting of Stockholders (the &#x201c;2023 Proxy Statement&#x201d;), which we expect to be filed with the SEC within 120 days of the end of our fiscal year ended December 31, 2022, including under the heading &#x201c;Directors, Executive Officers and Corporate Governance.&#x201d;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We have adopted a written code of business conduct and ethics that applies to our directors, officers and employees, including our principal executive officer, principal financial officer, principal accounting officer or controller, or persons performing similar functions. A copy of the code is available on our website located at www.89bio.com, under &#x201c;Corporate Governance.&#x201d; We intend to disclose on our website any amendments to, or waivers from, the code of business conduct and ethics that are required to be disclosed pursuant to the disclosure requirements of Item 5.05 of Form 8-K within four business days following the date of the amendment or waiver.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;" id="item_11_executive_compensation"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Item 11. Executiv</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">e Compensation.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The information required by this Item 11 is incorporated herein by reference to information in our 2023 Proxy Statement, including under headings &#x201c;Executive Compensation&#x201d; and &#x201c;Directors, Executive Officers and Corporate Governance.&#x201d;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;" id="item_12_security_ownership_certain_benef"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Item 12. Security Ownership of Certain Beneficial Own</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">ers and Management and Related Stockholder Matters.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The information required by this Item 12 is incorporated herein by reference to information in our 2023 Proxy Statement, including under headings &#x201c;Security Ownership of Certain Beneficial Owners and Management&#x201d; and &#x201c;Executive Compensation-Securities Authorized for Issuance Under Equity Compensation Plans.&#x201d;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;" id="item_13_certain_relationships_related_tr"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Item 13. Certain Relationships and Related </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Transactions, and Director Independence.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The information required by this Item 13 is incorporated herein by reference to information in our 2023 Proxy Statement, including under headings &#x201c;Directors, Executive Officers and Corporate Governance&#x201d; and &#x201c;Certain Relationships and Related Party Transactions.&#x201d;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;" id="item_14_principal_accounting_fees_servic"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Item 14. Principal Accoun</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">tant Fees and Services.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The information required by this Item 14 is incorporated herein by reference to information in our 2023 Proxy Statement, including under the heading &#x201c;Ratification of Selection of Independent Registered Public Accounting Firm.&#x201d;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">96</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;" id="part_iv"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">PART</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> IV</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;" id="item_15_exhibits_financial_statement_sch"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Item 15. Exhibits, Financ</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">ial Statement Schedules.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">(a)</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The following documents are filed as a part of this report: </span></div></div>
  <div style="margin-left:9.065%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.989278055754109%;">(1)</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Financial Statements</span></div></div>
  <p style="margin-left:13.333%;text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">See Index to Consolidated Financial Statements at Part II Item 8 &#x201c;Financial Statements and Supplementary Data.&#x201d;</span></p>
  <div style="margin-left:9.065%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.989278055754109%;">(2)</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Financial Statement Schedules </span></div></div>
  <p style="margin-left:13.333%;text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The financial statement schedules are omitted as they are either not applicable or the information required is presented in the financial statements and notes thereto under Part II Item 8 &#x201c;Financial Statements and Supplementary Data.&#x201d;</span></p>
  <div style="margin-left:9.065%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.989278055754109%;">(3)</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Exhibits:</span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">97</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Exhibit Index</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="background-color:#ffffff;font-weight:bold;visibility:collapse;">
    <td style="width:8.697%;"></td>
    <td style="width:1.004%;"></td>
    <td style="width:90.299%;"></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Exhibit</span></p><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Number</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(255,255,255,0.01);padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Description</span></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:7.9pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2.1</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/0001785173/000119312519266760/d743471dex21.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Contribution and Exchange Agreement, dated as of September 17, 2019, by and among 89Bio Ltd., the Company and its shareholders (filed with the SEC as Exhibit 2.1 to the Company&#x2019;s Form S-1 filed on October 11, 2019)</span></a></p></td>
   </tr>
   <tr style="height:7.9pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:3.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:3.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:3.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3.1</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/0001785173/000119312519292680/d829788dex31.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Second Amended and Restated Certificate of Incorporation of the Company (filed with the SEC as Exhibit 3.1 to the Company&#x2019;s Current Report on Form 8-K filed on November 15, 2019)</span></a></p></td>
   </tr>
   <tr style="height:7.9pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:3.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:3.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:3.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3.2</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/0001785173/000119312519292680/d829788dex32.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Second Amended and Restated Bylaws of the Company (filed with the SEC as Exhibit 3.2 to the Company&#x2019;s Current Report on Form 8-K filed on November 15, 2019)</span></a></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:3.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:3.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:3.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4.1</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/0001785173/000119312519275407/d743471dex41.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Specimen common stock certificate of the Company (filed with the SEC as Exhibit 4.1 to the Company&#x2019;s Form S-1/A filed on October 28, 2019)</span></a></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:3.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:3.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:3.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;&#160;4.2*</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="etnb-ex4_2.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Description of Securities</span><span style="color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></a></p></td>
   </tr>
   <tr style="height:3.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:3.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:3.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:3.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4.3</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1785173/000119312520104858/d912211dex41.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Form of Warrant to Purchase Common Stock for Silicon Valley Bank (filed with SEC as Exhibit 4.1 to the Company&#x2019;s Current Report on Form 8-K filed on April 13, 2020)</span></a></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:3.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:3.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:3.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4.4</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/0001785173/000119312521182891/d127486dex41.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Form of Warrant to Purchase Common Stock for Silicon Valley Bank (filed with the SEC as Exhibit 4.1 to the Company&#x2019;s Current Report on Form 8-K filed on June 4, 2021)</span></a></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:3.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:3.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:3.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4.5</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1785173/000119312522186433/d376547dex41.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Form of Warrant (filed with the SEC as Exhibit 4.1 to the Company&#x2019;s Current Report on Form 8-K filed on July 1, 2022)</span></a></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:3.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:3.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:3.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4.6</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1785173/000119312522186433/d376547dex42.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Form of Pre-Funded Warrant (filed with the SEC as Exhibit 4.2 to the Company&#x2019;s Current Report on Form 8-K filed on July 1, 2022)</span></a></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:3.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:3.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:3.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4.7</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1785173/000119312523022818/d650071dex41.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Form of Warrant to Purchase Common Stock for K2 HealthVentures LLC (filed with the SEC as Exhibit 4.1 to the Company&#x2019;s Current Report on Form 8-K/A filed on February 2, 2023)</span></a></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:3.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:3.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:3.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10.1</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1785173/000119312521093314/d150630dex12.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Sales Agreement, dated March 25, 2021, by and among the Company, SVB Securities LLC and Cantor Fitzgerald &amp; Co. (filed with the SEC as Exhibit 1.2 to the Company&#x2019;s Form S-3 filed on March 25, 2021)</span></a></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:3.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:3.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:3.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10.2</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:3.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1785173/000119312523040497/d422452dex12.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Amendment No. 1 to Sales Agreement, dated February 15, 2023, by and among the Company, SVB Securities LLC and Cantor Fitzgerald &amp; Co. (filed with the SEC as Exhibit 1.2 to the Company&#x2019;s Current Report on Form 8-K filed on February 16, 2023)</span></a></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:3.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:3.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:3.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;&#160;10.3+</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1785173/000119312519266760/d743471dex101.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Form of Indemnification Agreement for directors and executive officers (filed with the SEC as Exhibit 10.1 to the Company&#x2019;s Form S-1 filed on October 11, 2019)</span></a></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:3.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:3.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:3.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;&#160;10.4+</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/0001785173/000119312519275407/d743471dex102.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Amended and Restated 2019 Equity Incentive Plan and form of agreements thereunder (filed with the SEC as Exhibit 10.2 to the Company&#x2019;s Form S-1/A filed on October 28, 2019)</span></a></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:3.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:3.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:3.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;&#160;10.5+</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1785173/000119312519275407/d743471dex103.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2019 Employee Stock Purchase Plan (filed with the SEC as Exhibit 10.3 to the Company&#x2019;s Form S-1/A filed on October 28, 2019)</span></a></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:3.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:3.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:3.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;&#160;10.6+</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1785173/000119312520132419/d898684dex101.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Executive Employment Offer Letter, dated April 15, 2020, by and between the Company and Rohan Palekar (filed with the SEC as Exhibit 10.1 to the Company&#x2019;s Current Report on Form 8-K filed on May 4, 2020)</span></a></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:3.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:3.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:3.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;&#160;10.7+</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1785173/000119312520132419/d898684dex103.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Executive Employment Offer Letter, dated April 15, 2020, by and between the Company and Hank Mansbach (filed with the SEC as Exhibit 10.3 to the Company&#x2019;s Current Report on Form 8-K filed on May 4, 2020)</span></a></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:3.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:3.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:3.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;&#160;10.8+</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1785173/000119312520132419/d898684dex104.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Executive Employment Offer Letter, dated April 15, 2020, by and between the Company and Quoc Le-Nguyen (filed with the SEC as Exhibit 10.4 to the Company&#x2019;s Current Report on Form 8-K filed on May 4, 2020)</span></a></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:3.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:3.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:3.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10.9+</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1785173/000119312520132419/d898684dex102.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Executive Employment Offer Letter, dated April 15, 2020, by and between the Company and Ryan Martins (filed with the SEC as Exhibit 10.2 to the Company&#x2019;s Current Report on Form 8-K filed on May 4, 2020)</span></a></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:3.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:3.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:3.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">98</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="background-color:#ffffff;font-weight:bold;visibility:collapse;">
    <td style="width:8.697%;"></td>
    <td style="width:1.004%;"></td>
    <td style="width:90.299%;"></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Exhibit</span></p><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Number</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid rgba(255,255,255,0.01);padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Description</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10.10+</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1785173/000119312519266760/d743471dex109.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Director Offer Letter, dated July 1, 2018, by and between 89Bio Ltd. and Michael Hayden (filed with the SEC as Exhibit 10.9 to the Company&#x2019;s Form S-1 filed on October 11, 2019)</span></a></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;&#160;10.11+</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1785173/000156459020053677/etnb-ex101_102.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Non-Employee Director Compensation Policy (filed with the SEC as Exhibit 10.1 to the Company&#x2019;s Quarterly Report on Form 10-Q filed on November 13, 2020)</span></a></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:3.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:3.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:3.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;&#160;10.12+</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1785173/000119312519266760/d743471dex1011.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Asset Transfer and License Agreement&#x2014;FGF21 by and among 89Bio Ltd., ratiopharm GmbH, Teva Branded Pharmaceutical Products R&amp;D, Inc. and Teva Pharmaceutical Industries Ltd, dated as of April 16, 2018 (filed with the SEC as Exhibit 10.11 to the Company&#x2019;s Form S-1 filed on October 11, 2019)</span></a></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:3.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:3.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:3.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;&#160;10.13+</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1785173/000119312519266760/d743471dex1013.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Sublicense Agreement by and between 89Bio Ltd. and ratiopharm GmbH, dated as of April 16, 2018 (filed with the SEC as Exhibit 10.13 to the Company&#x2019;s Form S-1 filed on October 11, 2019)</span></a></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:3.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:3.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:3.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;&#160;10.14+</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1785173/000119312519266760/d743471dex1014.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Master Services Agreement by and between 89Bio Ltd. and Biotechpharma UAB, dated as of May 7, 2018, as amended (filed with the SEC as Exhibit 10.14 to the Company&#x2019;s Form S-1 filed on October 11, 2019)</span></a></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:3.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:3.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:3.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10.15</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1785173/000156459020011636/etnb-ex1015_527.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Office Lease by and between 89bio, Inc. and King Family Irrevocable Trust, dated as of December 5, 2019 (filed with the SEC as Exhibit 10.15 to the Company&#x2019;s Annual Report on Form 10-K filed on March 18, 2020)</span></a><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:3.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:3.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:3.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10.16</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:3.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1785173/000156459021056616/etnb-ex101_191.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">First Amendment to Office Lease, dated as of July 27, 2021, by and between King Family Irrevocable Trust and the Company (filed with the SEC as Exhibit 10.1 to the Company&#x2019;s Quarterly Report on Form 10-Q filed on November 12, 2021)</span></a></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:3.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:3.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:3.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10.17</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:3.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1785173/000156459022037425/etnb-ex101_12.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Second Amendment to Office Lease, dated as of August 31, 2022, by and between King Family Irrevocable Trust and the Company (filed with the SEC as Exhibit 10.1 to the Company&#x2019;s Quarterly Report on Form 10-Q filed on November 10, 2022)</span></a></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:3.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:3.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:3.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10.18</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:3.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1785173/000119312523003660/d445245dex101.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Loan and Security Agreement, dated as of January 4, 2023, among the Company, 89bio Management, Inc., 89Bio Ltd., K2 HealthVentures LLC and Ankura Trust Company, LLC (filed with the SEC as Exhibit 10.1 to the Company&#x2019;s Current Report on Form 8-K filed January 6, 2023)</span></a></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:3.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:3.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:3.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">21.1+</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1785173/000119312519266760/d743471dex211.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">List of subsidiaries (filed with the SEC as Exhibit 21.1 to the Company&#x2019;s Form S-1 filed on October 11, 2019)</span></a></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:3.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:3.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:3.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">23.1*</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="etnb-ex23_1.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Consent of Independent Registered Public Accounting Firm</span></a></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:3.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:3.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:3.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">24.1*</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#power_of_attorney"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Power of Attorney</span></a></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:3.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:3.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:3.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">31.1*</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="etnb-ex31_1.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Certification of Principal Executive Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934</span></a></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:3.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:3.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:3.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">31.2*</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="etnb-ex31_2.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Certification of Principal Financial Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934</span></a></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:3.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:3.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:3.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:16.55pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">32.1#</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="etnb-ex32_1.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Certification of Principal Executive Officer and Principal Financial Officer Pursuant to 18 U.S.C. Section 1350</span></a></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:3.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:3.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:3.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">101.INS</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Inline XBRL Instance Document</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">101.SCH</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Inline XBRL Taxonomy Extension Schema Document</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">101.CAL</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Inline XBRL Taxonomy Extension Calculation Linkbase Document</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">101.DEF</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Inline XBRL Taxonomy Extension Definition Linkbase Document</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">101.LAB</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Inline XBRL Taxonomy Extension Label Linkbase Document</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">101.PRE</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Inline XBRL Taxonomy Extension Presentation Linkbase Document</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">104&#x202f;</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Cover Page Interactive Data File</span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;border-bottom:0.5pt solid;margin-right:73.333%;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">* Filed herewith.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">+ Indicates management contract or compensatory plan.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#134; Portions of the exhibit have been omitted for confidentiality purposes.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"># Furnished herewith and not deemed to be &#x201c;filed&#x201d; for purposes of Section 18 of the Exchange Act, and shall not be deemed to be incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">99</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;" id="item_16_form_10k_summary"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Item 16. Form </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10-K Summary.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">None.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">100</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;" id="signatures"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">SIGNAT</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">URES</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this Report to be signed on its behalf by the undersigned, thereunto duly authorized</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:48.996%;"></td>
    <td style="width:1.004%;"></td>
    <td style="width:3.996%;"></td>
    <td style="width:46.004%;"></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">89bio, Inc.</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:middle;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Date: March 14, 2023</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">By:</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.25pt solid rgba(0,0,0,1);padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">/s/ Rohan Palekar</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:middle;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Rohan Palekar</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Chief Executive Officer and Director</span></p><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">(principal executive officer)</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Date: March 14, 2023</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">By:</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">/s/ Ryan Martins</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:middle;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Ryan Martins</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Chief Financial Officer</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">(principal financial and accounting officer)</span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">101</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;" id="power_of_attorney"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">POWER OF </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">ATTORNEY</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below hereby constitutes and appoints Rohan Palekar, and Ryan Martins, and each of them, the true and lawful attorneys-in-fact and agents of the undersigned, with full power of substitution and resubstitution, for and in the name, place and stead of the undersigned, to sign in any and all capacities (including, without limitation, the capacities listed below), this Annual Report on Form 10-K, any and all amendments thereto, and to file the same, with all exhibits thereto, and all other documents in connection therewith, with the Securities and Exchange Commission, and hereby grants to such attorneys-in-fact and agents, and each of them, full power and authority to do and perform each and every act and anything necessary to be done to enable the registrant to comply with the provisions of the Securities Exchange Act and all the requirements of the Securities and Exchange Commission, as fully to all intents and purposes as the undersigned might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact and agents, or any of them, or their or his or her substitute, or substitutes, may lawfully do or cause to be done by virtue hereof.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, this Report has been signed below by the following persons on behalf of the Registrant in the capacities and on the dates indicated.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:31.987%;"></td>
    <td style="width:1.496%;"></td>
    <td style="width:35.021%;"></td>
    <td style="width:1.496%;"></td>
    <td style="width:30.0%;"></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.25pt solid rgba(0,0,0,1);padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Name</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.25pt solid rgba(255,255,255,0.01);padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.25pt solid rgba(0,0,0,1);padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Title</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.25pt solid rgba(255,255,255,0.01);padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.25pt solid rgba(0,0,0,1);padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Date</span></p></td>
   </tr>
   <tr style="height:2.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:2.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:2.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:2.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:2.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:2.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:2.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:2.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:2.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:2.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:2.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.25pt solid rgba(0,0,0,1);padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">/s/ Rohan Palekar</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.25pt solid rgba(255,255,255,0.01);padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Chief Executive Officer and Director</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">March 14, 2023</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Rohan Palekar</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">principal executive officer</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
   </tr>
   <tr style="height:2.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:2.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:2.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:2.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:2.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:2.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:2.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:2.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:2.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:2.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:2.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.25pt solid rgba(0,0,0,1);padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">/s/ Ryan Martins</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.25pt solid rgba(255,255,255,0.01);padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Chief Financial Officer</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">March 14, 2023</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Ryan Martins</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">principal financial and accounting officer</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
   </tr>
   <tr style="height:2.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:2.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:2.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:2.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:2.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:2.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:2.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:2.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:2.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:2.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:2.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.25pt solid rgba(0,0,0,1);padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">/s/ Steven Altschuler</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.25pt solid rgba(255,255,255,0.01);padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Director</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">March 14, 2023</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Steven Altschuler, M.D.</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
   </tr>
   <tr style="height:2.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:2.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:2.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:2.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:2.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:2.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:2.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:2.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:2.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:2.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:2.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.25pt solid rgba(0,0,0,1);padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">/s/ Derek DiRocco</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.25pt solid rgba(255,255,255,0.01);padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Director</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">March 14, 2023</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Derek DiRocco, Ph.D.</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
   </tr>
   <tr style="height:2.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:2.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:2.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:2.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:2.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:2.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:2.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:2.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:2.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:2.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:2.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.25pt solid rgba(0,0,0,1);padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">/s/ Gregory Grunberg</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.25pt solid rgba(255,255,255,0.01);padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Director</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">March 14, 2023</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Gregory Grunberg, M.D.</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
   </tr>
   <tr style="height:2.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:2.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:2.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:2.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:2.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:2.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:2.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:2.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:2.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:2.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:2.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.25pt solid rgba(0,0,0,1);padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">/s/ Michael Hayden</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.25pt solid rgba(255,255,255,0.01);padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Director</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">March 14, 2023</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Michael Hayden, M.B., Ch.B., Ph.D.</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
   </tr>
   <tr style="height:2.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:2.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:2.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:2.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:2.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:2.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:2.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:2.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:2.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:2.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:2.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.25pt solid rgba(0,0,0,1);padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">/s/ Kathleen D. LaPorte</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.25pt solid rgba(255,255,255,0.01);padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Director</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">March 14, 2023</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Kathleen D. LaPorte</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
   </tr>
   <tr style="height:2.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:2.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:2.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:2.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:2.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:2.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:2.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:2.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:2.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:2.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:2.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.25pt solid rgba(0,0,0,1);padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">/s/ Lota Zoth</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.25pt solid rgba(255,255,255,0.01);padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Director</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">March 14, 2023</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Lota Zoth, C.P.A.</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:2.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:2.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:2.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:2.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:2.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:2.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:2.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:2.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:2.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:2.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">/s/ Edward Morrow Atkinson III</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Director</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">March 14, 2023</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Edward Morrow Atkinson III</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:2.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">102</span></p>
  <hr style="page-break-after:always;" />
 </body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4
<SEQUENCE>2
<FILENAME>etnb-ex4_2.htm
<DESCRIPTION>EX-4.2
<TEXT>
<html>
 <head>
  <title>EX-4</title>
 </head>
 <body style="margin: auto!important;padding: 8px;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Exhibit 4.2</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">DESCRIPTION OF REGISTRANT&#x2019;S SECURITIES REGISTERED PURSUANT TO SECTION 12 OF THE SECURITIES EXCHANGE ACT OF 1934</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The following description of our capital stock is intended as a summary only and therefore is not a complete description of our capital stock. This description is based upon, and is qualified by reference to, our second amended and restated certificate of incorporation (the &#x201c;Amended Certificate&#x201d;), our second amended and restated bylaws (the &#x201c;Amended Bylaws&#x201d;) and applicable provisions of Delaware corporate law. You should read our Amended Certificate and Amended Bylaws, which are filed as exhibits to our Annual Report on Form 10-K, to which this exhibit is also appended.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Our authorized capital stock consists of 100,000,000 shares of common stock and 10,000,000 shares of preferred stock.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Common Stock</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Our Amended Certificate authorizes the issuance of up to 100,000,000 shares of our common stock. All outstanding shares of our common stock are validly issued, fully paid and nonassessable.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The holders of our common stock are entitled to one vote per share on all matters submitted to a vote of stockholders. A majority vote of the shares present in person or represented by proxy and entitled to vote on the subject matter is required for the holders of our common stock to take action on all matters (except for election of directors (as discussed below)), except as otherwise required by law, our Amended Certificate or our Amended Bylaws. Our Amended Certificate does not provide for cumulative voting in the election of directors. The holders of our common stock will receive ratably any dividends declared by our board of directors out of funds legally available therefor. In the event of our liquidation, dissolution or winding-up, the holders of our common stock will be entitled to share ratably in all assets remaining after payment of or provision for any liabilities.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Preferred Stock</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Under the terms of our Amended Certificate, our board of directors has the authority, without further action by our stockholders, to issue up to 10,000,000 shares of preferred stock in one or more series, to establish from time to time the number of shares to be included in each such series, to fix the dividend, voting and other rights, preferences and privileges of the shares of each wholly unissued series and any qualifications, limitations or restrictions thereon, and to increase or decrease the number of shares of any such series, but not below the number of shares of such series then outstanding.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Our board of directors may authorize the issuance of preferred stock with voting or conversion rights that could adversely affect the voting power or other rights of the holders of our common stock. The issuance of preferred stock, while providing flexibility in connection with possible acquisitions and other corporate purposes, could, among other things, have the effect of delaying, deferring or preventing a change in our control and may adversely affect the market price of our common stock and the voting and other rights of the holders of our common stock.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Anti-Takeover Effects of Our Amended Certificate, Amended Bylaws and Delaware Law</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Our Amended Certificate and our Amended Bylaws include a number of provisions that may have the effect of delaying, deferring or preventing another party from acquiring control of us and encouraging persons considering unsolicited tender offers or other unilateral takeover proposals to negotiate with our board of directors rather than pursue non-negotiated takeover attempts.</font></p>
  <div style="margin-left:3.333%;text-indent:0.0%;display:flex;margin-top:12.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:12.0pt;min-width:3.333%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Issuance of undesignated preferred stock: </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Under our Amended Certificate, our board of directors has the authority, without further action by the stockholders, to issue up to 10,000,000 shares of undesignated preferred stock with rights and preferences, including voting rights, designated from time to time by our board of directors. The existence of authorized but unissued shares of preferred stock enables our board of </font></div></div>
  <hr style="page-break-after:always;">
  <div style="margin-left:3.333%;text-indent:0;display:flex;margin-top:12.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:12.0pt;min-width:3.333%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;visibility:hidden;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;"></font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">directors to make it more difficult to attempt to obtain control of us by means of a merger, tender offer, proxy contest or otherwise.</font></div></div>
  <p style="margin-left:6.667%;text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <div style="margin-left:3.333%;text-indent:0.0%;display:flex;margin-top:0.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Classified board: </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Our Amended Certificate establishes a classified board of directors consisting of three classes of directors, with staggered three-year terms. Only one class of directors will be elected at each annual meeting of our stockholders, with the other classes continuing for the remainder of their respective three-year terms. This provision may have the effect of delaying a change in control of our board of directors.</font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <div style="margin-left:3.333%;text-indent:0.0%;display:flex;margin-top:0.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Election and removal of directors and board vacancies: </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Our Amended Bylaws provide that directors will be elected by a plurality vote. Our Amended Certificate and Amended Bylaws also provide that our board of directors has the right to increase or decrease the size of the board and to fill vacancies on the board. Directors may be removed only for cause by the affirmative vote of the holders of at least 66</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2044;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">% of the votes that all our stockholders would be entitled to cast in an annual election of directors. Only our board of directors is authorized to fill vacant directorships. In addition the number of directors constituting our board of directors may be set only by resolution adopted by a majority vote of the directors then in office. These provisions prevent stockholders from increasing the size of our board of directors and gaining control of our board of directors by filling the resulting vacancies with its own nominees.</font></div></div>
  <p style="margin-left:6.667%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <div style="margin-left:3.333%;text-indent:0.0%;display:flex;margin-top:12.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Requirements for advance notification of stockholder nominations and proposals: </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Our Amended Bylaws establish advance notice procedures with respect to stockholder proposals and the nomination of candidates for election as directors that specify certain requirements as to the timing, form and content of a stockholder&#x2019;s notice. Business that may be conducted at an annual meeting of stockholders will be limited to those matters properly brought before the meeting. These provisions may make it more difficult for our stockholders to bring matters before our annual meeting of stockholders or to nominate directors at annual meetings of stockholders.</font></div></div>
  <p style="margin-left:6.667%;text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <div style="margin-left:3.333%;text-indent:0.0%;display:flex;margin-top:12.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">No written consent of stockholders: </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Our Amended Certificate provides that all stockholder actions be taken by a vote of the stockholders at an annual or special meeting, and that stockholders may not take any action by written consent in lieu of a meeting. This limit may lengthen the amount of time required to take stockholder actions and would prevent the amendment of our Amended Bylaws or removal of directors by our stockholders without holding a meeting of stockholders</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">.</font></div></div>
  <p style="margin-left:6.667%;text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <div style="margin-left:3.333%;text-indent:0.0%;display:flex;margin-top:12.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">No stockholder ability to call special meetings: </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Our Amended Certificate and Amended Bylaws provide that only a majority of the members of our board of directors then in office may be able to call special meetings of stockholders and only those matters set forth in the notice of the special meeting may be considered or acted upon at a special meeting of stockholders.</font></div></div>
  <p style="margin-left:6.667%;text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <div style="margin-left:3.333%;text-indent:0.0%;display:flex;margin-top:12.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Amendments to certificate of incorporation and bylaws: </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Any amendment to our Amended Certificate will be required to be approved by a majority of our board of directors as well as, if required by law or the Amended Certificate, a majority of the outstanding shares entitled to vote on the amendment and a majority of the outstanding shares of each class entitled to vote thereon as a class, except that the amendment of provisions to board classification, stockholder action, certificate amendments, and liability of directors must be approved by not less than 66</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2044;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">% of the outstanding shares entitled to vote on the amendment, voting together as a single class. Any amendment to our Amended Bylaws must be approved by either a </font></div></div>
  <hr style="page-break-after:always;">
  <div style="margin-left:3.333%;text-indent:0;display:flex;margin-top:12.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;visibility:hidden;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;"></font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">majority of our board of directors or not less than 66</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#x2044;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.5pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">% of the outstanding shares entitled to vote on the amendment, voting together as a single class.</font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">These provisions are designed to enhance the likelihood of continued stability in the composition of our board of directors and its policies, to discourage certain types of transactions that may involve an actual or threatened acquisition of us and to reduce our vulnerability to an unsolicited acquisition proposal. We also designed these provisions to discourage certain tactics that may be used in proxy fights. However, these provisions could have the effect of discouraging others from making tender offers for our shares and, as a consequence, they may also reduce fluctuations in the market price of our shares that could result from actual or rumored takeover attempts.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Section 203 of the Delaware General Corporation Law</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We are subject to the provisions of Section 203 of the Delaware General Corporation Law. In general, Section 203 prohibits a publicly held Delaware corporation from engaging in a &#x201c;business combination&#x201d; with an &#x201c;interested stockholder&#x201d; for a three-year period following the time that this stockholder becomes an interested stockholder, unless the business combination is approved in a prescribed manner.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Choice of Forum</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Our Amended Certificate requires that the Court of Chancery of the State of Delaware be the exclusive forum for the following types of actions or proceedings under Delaware statutory or common law: (1) any derivative action or proceeding brought on our behalf; (2) any action asserting a breach of fiduciary duty owed by any director, officer or other employee to us or our stockholders; (3) any action asserting a claim against us or any director or officer or other employee arising pursuant to the Delaware General Corporation Law, our Amended Certificate or Amended Bylaws; or (4) any action asserting a claim against us or any director or officer or other employee that is governed by the internal affairs doctrine. This provision would not apply to claims brought to enforce a duty or liability created by the Securities Exchange Act of 1934, as amended, or any other claim for which the federal courts have exclusive jurisdiction. Our Amended Certificate provides further that the federal district courts of the United States will be the exclusive forum for resolving any complaint asserting a cause of action arising under the Securities Act, subject to and contingent upon a final adjudication in the State of Delaware of the enforceability of such exclusive forum provision. Although we believe these provisions benefit us by providing increased consistency in the application of Delaware law for the specified types of actions and proceedings, the provisions may have the effect of discouraging lawsuits against us or our directors or officers.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Transfer Agent and Registrar</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">American Stock Transfer and Trust Company, LLC serves as the transfer agent and registrar for our common stock.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Listing</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Our common stock is listed on The Nasdaq Global Market under the symbol &#x201c;ETNB.&#x201d;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
 </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23
<SEQUENCE>3
<FILENAME>etnb-ex23_1.htm
<DESCRIPTION>EX-23.1
<TEXT>
<html>
 <head>
  <title>EX-23</title>
 </head>
 <body style="margin: auto!important;padding: 8px;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Exhibit 23.1</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Consent of Independent Registered Public Accounting Firm</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">We consent to the incorporation by reference in the registration statements (No. 333-269471) on Form S-3 and (Nos.333-263838, 333-254683, 333-237263, 333-235577) on Form S-8 of our report dated March 14, 2023, with respect to the consolidated financial statements of 89bio, Inc.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">/s/ KPMG LLP</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">San Francisco, California<br>March 14, 2023</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
 </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31
<SEQUENCE>4
<FILENAME>etnb-ex31_1.htm
<DESCRIPTION>EX-31.1
<TEXT>
<html>
 <head>
  <title>EX-31</title>
 </head>
 <body style="margin: auto!important;padding: 8px;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Exhibit 31.1</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">CERTIFICATION PURSUANT TO</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">RULES 13a-14(a) AND 15d-14(a) UNDER THE SECURITIES EXCHANGE ACT OF 1934,</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">I, Rohan Palekar, certify that:</font></p>
  <div style="text-indent:0.0%;display:flex;margin-top:12.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.537%;">1.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">I have reviewed this Annual Report on Form 10-K of 89bio, Inc.;</font></div></div>
  <div style="text-indent:0.0%;display:flex;margin-top:12.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.537%;">2.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;</font></div></div>
  <div style="text-indent:0.0%;display:flex;margin-top:12.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.537%;">3.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;</font></div></div>
  <div style="text-indent:0.0%;display:flex;margin-top:12.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.537%;">4.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:12.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">(a)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:12.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">(b)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:12.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">(c)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:12.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">(d)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and</font></div></div>
  <div style="text-indent:0.0%;display:flex;margin-top:12.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.537%;">5.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:12.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">(a)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:12.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">(b)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.</font></div></div>
  <p style="text-indent:-4.749%;padding-left:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:44.999%;"></td>
    <td style="width:5.039%;"></td>
    <td style="width:3.998%;"></td>
    <td style="width:45.963%;"></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Date: March 14, 2023</font></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">By:</font></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.25pt solid rgba(0,0,0,1);padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">/s/ Rohan Palekar</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:middle;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Rohan Palekar</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Chief Executive Officer</font></p><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">(principal executive officer)</font></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
 </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31
<SEQUENCE>5
<FILENAME>etnb-ex31_2.htm
<DESCRIPTION>EX-31.2
<TEXT>
<html>
 <head>
  <title>EX-31</title>
 </head>
 <body style="margin: auto!important;padding: 8px;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Exhibit 31.2</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">CERTIFICATION PURSUANT TO</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">RULES 13a-14(a) AND 15d-14(a) UNDER THE SECURITIES EXCHANGE ACT OF 1934,</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">I, Ryan Martins, certify that:</font></p>
  <div style="text-indent:0.0%;display:flex;margin-top:12.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.537%;">1.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">I have reviewed this Annual Report on Form 10-K of 89bio, Inc.;</font></div></div>
  <div style="text-indent:0.0%;display:flex;margin-top:12.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.537%;">2.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;</font></div></div>
  <div style="text-indent:0.0%;display:flex;margin-top:12.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.537%;">3.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;</font></div></div>
  <div style="text-indent:0.0%;display:flex;margin-top:12.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.537%;">4.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:12.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">(a)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:12.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">(b)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:12.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">(c)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:12.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">(d)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and</font></div></div>
  <div style="text-indent:0.0%;display:flex;margin-top:12.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.537%;">5.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:12.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">(a)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:12.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">(b)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.</font></div></div>
  <p style="text-indent:-4.749%;padding-left:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:44.999%;"></td>
    <td style="width:5.039%;"></td>
    <td style="width:3.998%;"></td>
    <td style="width:45.963%;"></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Date: March 14, 2023</font></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">By:</font></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.25pt solid rgba(0,0,0,1);padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">/s/ Ryan Martins</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:middle;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Ryan Martins</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Chief Financial Officer</font></p><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">(principal financial and accounting officer)</font></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
 </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32
<SEQUENCE>6
<FILENAME>etnb-ex32_1.htm
<DESCRIPTION>EX-32.1
<TEXT>
<html>
 <head>
  <title>EX-32</title>
 </head>
 <body style="margin: auto!important;padding: 8px;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Exhibit 32.1</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">CERTIFICATION PURSUANT TO</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In connection with the Annual Report of 89bio, Inc. (the &#x201c;Company&#x201d;) on Form 10-K for the year ending December 31, 2022, as filed with the Securities and Exchange Commission on the date hereof (the &#x201c;Report&#x201d;), each of the undersigned officers of the Company hereby certifies, pursuant to 18 U.S.C. &#167; 1350, as adopted pursuant to &#167; 906 of the Sarbanes-Oxley Act of 2002, that to the best of his knowledge:</font></p>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:12.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">(1)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and</font></div></div>
  <div style="margin-left:4.528%;text-indent:0.0%;display:flex;margin-top:12.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">(2)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div></div>
  <p style="text-indent:-4.749%;padding-left:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:50.0%;"></td>
    <td style="width:5.0%;"></td>
    <td style="width:45.0%;"></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Date: March 14, 2023</font></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">By:</font></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.25pt solid rgba(0,0,0,1);padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">/s/ Rohan Palekar</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:middle;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Rohan Palekar</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Chief Executive Officer</font></p><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">(principal executive officer)</font></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:50.0%;"></td>
    <td style="width:5.0%;"></td>
    <td style="width:45.0%;"></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Date: March 14, 2023</font></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">By:</font></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.25pt solid rgba(0,0,0,1);padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">/s/ Ryan Martins</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:middle;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Ryan Martins</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Chief Financial Officer</font></p><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">(principal financial and accounting officer)</font></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The foregoing certification is being furnished solely to accompany the Report pursuant to 18 U.S.C. &#167; 1350, and is not being filed for purposes of Section 18 of the Securities Exchange Act of 1934, and is not to be incorporated by reference into any filing of the Company, whether made before or after the date hereof, regardless of any general incorporation language in such filing.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Note: A signed original of this written statement required by &#167; 906 has been provided to 89bio, Inc. and will be retained by 89bio, Inc. and furnished to the Securities and Exchange Commission or its staff upon request.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
 </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>img32108071_0.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img32108071_0.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 2-"MT# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M/]F75Q(]O>+M0.Y(20<C&>F>1]<5?)>-R>;6Q[71114%!1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%>;>)OBM!IUS)9Z-!'=RH=K3R$^6#Z #EOKD?C7(M\5?$Y?<
M)K91_=$ Q_C5JG)DN:1[O17B:?&#7U0!K33G(_B,;C/_ (]5FR^+NL2WUO'/
M8V'E/(JOL5PV"><98\T_9R%SH[KXC?\ (@ZI_NQ_^C%KY[KZ$^(W_(@ZI_NQ
M_P#HQ:^>ZTI;$U-SZFLO^/&W_P"N2_RJ>L^6XEL_#KW,$7FRPVAD2/.-[!,@
M?C7D)^+_ (A+Y%MIP'IY3_\ Q=8J#EL6Y);GMU%8_A?7%\1>'K;4@JI)("LB
M*>%<'!']?H:V*EJQ045Y?XP^)FH:-XAGTW3(+1H[?"O)*K,2V,G&".F<?A6S
M\/\ QCJ/BO[:M]:P1BW"8DA! );/!!)]*IP:5R>97L=O16?K6MV.@:<]]J$W
MEQ+P .6=NRJ.YKRC5?B]JL\K+IEI!:P]FE'F.?Z#Z8-$8.6P.21[/17@\'Q4
M\3PRAI)K:=?[DD  _P#'<&O1_!?CR#Q6\EI+;FVOHD\PJ#E'7(!(/;DC@^O>
MFZ;6H*:9V-%%>>>)OBI9Z7.]II,*WLZ'#2LV(E/MCEOPP/>I46]AMI;GH=%>
M#3_%/Q1*Y9+FWA']V.!2/_'LFK%E\6?$-O(#<K:W2=PT>P_@5Q_*K]E(GG1[
MC17->%?&NG>*HF2$&"\09DMI#DX]5/\ $/\ .*Z6H::W+3N?._Q!)/CO5<_\
M]%_] 6J&A^&]3\1RS1Z9 LK0J&<&15P#TZFK_P 0/^1[U7_KHO\ Z M=3\&?
M^0CJO_7*/^9KH;M"YA:\K'+7WP_\3Z? T\VENT:C),3K(0/HI)_2N>AFEMID
MF@D>*5#E71B&4^H(KZIKY\^(MA#IWC:]CMU"1R;9=HZ L,G]<G\:4)\VC'*-
MM4>G?#KQ?)XDTV2VO6!O[4#<W3S4/1OKV/X>M;/C'_D3=8_Z]7_E7DWPHE>/
MQJJ*3MDMY%;Z<'^8%>L^,O\ D3-8_P"O5_Y5G)6F7%WB?-U=-9> /$NHV4-Y
M:Z>'@F0/&WGQC(/L6S7,U](>#/\ D3-(_P"O5/Y5K.3BM#.,;GCG_"L_%O\
MT#%_\"(O_BJZKX?^"-=T7Q,+_4K58(4A< ^:K%B>,84FO5J*R=1M6-%!(*\E
M\?\ Q#G%S+H^B3&-(R4GN4/S,>ZJ>P'<_P"3VWCK6VT'PG=7,3;;B7$$)'4,
MW<>X&3^%?.U.G&^K%.5M!Z))/,$17DE<X"J"68G^9KJ[+X:>*+V(2&Q6W4\C
MSY I_+J/Q%>D?#SP?!HFE1:A<Q!M2N4#EF',2GHH]#CK^7:NWIRJZV0E#N>
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M=O D4:A8XU"JH[ # %55>EA4UK<\&^(^O2:SXIG@5R;6R8P1KGC</O'\3Q]
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M4&GN[@CYV$A10?\ 9 [?6N5\=_#N+0+'^U-+DE>T5@)HI#DQY. 0>XS@<_\
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M_P#?D_\ Q5>G>!O$%SXE\.+?7B1K.LK1MY8(4XP0<?0UB_\ "H?#O_/?4?\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MJ?RKYOK>M/&GB*QM(K6VU6:.")0J( N% [=*Z)Q<D8QE8^CZ*^=O^$^\4_\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 1RP17";)HDD3^
MZZ@C]:I_V%H^[=_95CGU^SI_A6A11<".*"*W39#$D:?W44 ?I4E%% !1110
M4444 4Y=)TV>4RRZ?:R2$Y+O"I)_'%6HXTB0)&BH@Z*HP!3J* "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** &20Q2X\R-'QTW*#3@ H 4  = *6B@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** &211RC$B*X]&&:<J*BA44*
MHZ # I:* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 5YAXVUZ\&LWFE@G[.FS'XHI_K7
MI]>/^-QGQA??]L__ $6M5#<B>QST<>.!5R*WSVHMXLXXK4@@SVK1LS2*J6WM
M3C:^U:\=KD=*>UM@=*5QV.>EMO:J4L1&1VKHYK? /%9=Q#UXIIB:&:3KMWH@
M86I/S=:]QKP"1=IKW^HF73"BBBH- HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ KR#QG_R.5]_VS_]%K7K]>0^,^/&=]_VS_\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M_3W%_P"ABO;ZB9I#8****@L**** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH *S]6TJ'5;)X'"@M_%CFM"B@#P[7=)&B:@;4-NYZU15RM>_P!%7SF?LSP9
M;@TIN37O%%'.')YG@32EJ(1EZ]]KQ+6#CQ)J?_7W+_Z&:I2N3*-B:V4<5LVR
M#BL:U8<5LVSCBA@C6MX0U/G@"BF03A>]1:IJ M+%[@KN(("ITW>O-264;E!S
M6/=)C-,?Q'YPS]DV_P#;3_ZU5)=2,O\ RQQ_P+_ZU4D0VB;2!_Q4FF?]?<7_
M *&*]KKPJTO3:ZE;7GE;O(E279NQNVD'&>W2NU_X6:?^@/\ ^3/_ -A2DFQP
M:6YZ!17GQ^)^!G^Q_P#R9_\ L*Z'P[XHCUZ)F:!;9AT4R[L_H*AQ:+4DSH**
M**104444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7A^N'
M'B/4_P#K[E_]#->X5X_XGT*\L]3OKZ5<0S7$CJ?8L2*N&Y$]C.MI@,5JP7&
M.:YV*3!SVJ]#<>]6T9IFY-J4=I$LDA.TL!QUKG-0OYKZZ,F\^7C 6I[^42VR
MKUPX/Z&J$:;CBA(&Q4B+=*M1VV1TJ:"#@<5HPV^>U%PL9PM>.E,>V]JW/LOM
M44EM[47'8YZ2$BBTNY[.Z26.0JJG) /6M.># /%9DT>#3$>M>%O$::]%.JIM
M:W"!CZYS_A70UY]\, !_:N!_SQ_]GKT&L9*S-8NZ"BBBD4%%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !7.^,-,O=4TH064/FOGIN"_S(KHJ*
M$[":N>.IX'\1!0#IW_D>/_XJG#P5XC'33_\ R/'_ /%5[!15\[)Y$>*:IH&K
M:5:K/?VOE1,X0-YBM\V"<<$^AJI;)DUZ-\2/^1>M_P#K[7_T!Z\\M>U4G=$-
M6=C4MH\XK6@AR!Q6?:]JV;;'%)C1(MKE>E5YX,#I6NC*(ZHW1!SBD58P;F+K
M61<Q]:W;G'-8UUWJD0SK/AD,'5?^V7_L]>@5P'PTZZK_ -LO_9Z[^HEN:0V"
MBBBI*"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M_P"8K_VR_P#9Z] K.6YK#8****DH**** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M#D_KM'XT_P"$_P#R)8_Z^9/Z5@?&AF_XDJ_P_OS^/R4TOW@-^X4/A+X?AO\
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M 4#L!3Z**Q- HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M^@<Z-;XP:S%-<66CQ.&:',TP'\)(PH^N,G\16Y\)-+>T\-3WLB[6O)LK[HO
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M^.1<22J9F'^\21^F*\O\%> [W7[Z*\OX9(=,5M[-("#-[+['N?ZU[LJA5"J
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH ***YSQ+XGAT:VPNV1G&.#G%-*XF['1T5X%<R_:KM[C&-
MYSBFJA:JY"/:'0>-./&5]_VS_P#1:U3MFZ50%N:#;&KL1?6YU%LXXK6@F"XK
MSUHRM26-T+"Z\]EW#&"/6E8:D>BR7(*]:SKB0<U6MKW[9;>=$KE.2>/N_7'\
MSBH);C/>DBFRO<OG-8URV35ZXEZ\UERON8U2(9[;H/\ R+NF?]>D7_H K0K/
MT'_D7=,_Z](O_0!6A6+-EL%%%% PHHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MTB+&@1%"J.  , 4ZB@!OEIOW[%W_ -['-.HHH :\:2##HK ?WAFG8P,"BB@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MMZ<&]/M*<?K18#6HJK::GI]__P >=];7'_7&57_D:M4 %%%% !1110 4444
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "O&/C%=&3Q#8VN?EBMM_XLQ_\
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MZE8_"WPS;6RI<6TMW+CYI))F7)]@I %>>?#WQ1I7A>>_GU&.X:6942(PH&P
M26SDC_9_*N[_ .%N>'/^>.H?]^E_^*K6?->R(CR[LYSQQ\-K;2M-DU71FD$4
M/,UN[;L+_>4]>.X-7_A-XFFN!+H-W(7\I/,MF8\A0<%/U!'XU;U#XI^'+W3;
MJU\F^/GPO'@Q+CD$?WO>N!^'4S0^/-,*D_,SH1Z@HU%FXOF#12T/H">>.VMY
M9YF"11(7=CV &2:^>=:U;4O''B=0@9C+)Y5K;YX12>/\2:]A^(MTUIX%U)D.
M&D58OP9@#^F:\Y^$=FEQXMEG< _9[9F3V8D+_(FIIZ)R'/5I'6Z7\(]&@M5_
MM&:>ZN"/G*/L0'V Y_,UF^(/A%$('GT&YD\U1G[/<,"&]E;C'X_F*]4HJ>>5
MRN5'.>!;2_L?!]C;:DCQW$>\;'.65=QVC\L?A7G7QB_Y&2Q_Z\Q_Z&U>T5XO
M\8O^1DL?^O,?^AM3IN\KBGI$P_#VB:UXT:VTY)F33[$$>8P^2(,23@=V))__
M %5Z,OPC\/BU\MIKUI<?ZWS #GZ8Q6E\-HHX_ >G,B*I?S&<@?>/F,,G\ !^
M%=91*;O9!&*MJ?-WB+0[SPCXA-J9CNCQ+;SI\I9<\,/0Y!_$5[SX6U@Z[X9L
M=1?'F2QXDQ_?4E6_4&O//C/$HNM'E ^9DE4GV!7'\S72?"EBW@E ?X;B0#]#
M_6JGK!,4=)6.F\0?\BWJG_7G+_Z :^<M)U6^TFXEDT]S'//$8-ZCY@&(SM]^
M,?C7T;X@_P"1;U3_ *\Y?_0#7AWPVBCE\>:<LB*X'F, PS@B-B#^!YHI_"PG
MNCJO#7PG%Q;+=^()IDDD&X6T1 *_[[<\^P_.H_&'PPM=.TF;4M&EF/V=2\L$
MI#90=2IQVZX->N5%<Q+-:S1.,JZ%2/8BH]I*]RN16/&?A/KLMGX@.D.Y-M>*
M2JD\+(HSD?4 C\J]KKYQ\$,5\;:01_S\ ?GQ7T9(XCC9V^ZH)-556HJ;T/'?
MBAXNFN=0DT&SE*6L'%P5/^L?^Z?8>GK]!4OA#X7)J-A%J.M2RQI,H>*WB.#M
M/0L??T'Y]JX?2XSKOBRU2X^;[9>*9?<,^6_F:^EP   !@#M3F^1)(45S.[.&
MN_A/X<G@*0"YMI,<.LN[GW!S7E.KZ5J?@GQ&L?G%)XB)(+B/@.O8C]01]:^C
MZ\T^,EDCZ1IU]@;XYS#GV92?_9*4)N]F$HJUT=CX4UY?$?AZVU  +*P*3(.B
MN.OX=_H15+XA_P#(AZK_ +B?^AK7*_!FY9K/5K4GY8Y(Y /=@P/_ *"*ZKXA
M_P#(AZK_ +B?^AK4VM.Q5[Q///@]_P C3>?]>3?^AI7M5>*_![_D:;S_ *\F
M_P#0TKUCQ#=M8>'-2NT.'BMI&0_[6TX_7%.I\0H?">,?$#Q;/X@UF2PMI&_L
MZW?9&B])7'!8^O/3V^M=1X<^$MK]CCN-=EE:=P&^SQ-M">Q/4GZ8_&N)^']D
ME_XXTV.0 HCF4@^J*6'Z@5]#U4WR^ZA17-JS@-2^$NA7%LPL9+BTGQ\K;]ZY
M]P>?R(KRU)-6\$>)V ;RKNU?# '*R+UP?52,?_KKZ1KQ[XR621ZKIEZ  TT+
MQM[[""/_ $.E3DV[,)Q25T>J:3J4.L:3:ZA;_P"KN(PX']T]Q^!R/PKBOBMX
MAFTS28-,M7*2WN[S&4\B,8R/Q)_('UJ?X2W+3^#6B8\073QK[ A6_FQKG?C+
M;2"^TN[P?*:)X\^A!S_7]*48KGL-OW;E?X?_  ^M-<L/[6U;>ULS%884;;OP
M<$DCG&<CC'2NLU7X6>'KNS=+"%[*YQ\DBRLZY[;@Q/'TQ5CX9:A!>>"K2"-A
MYMJ6CE3/*G<2#^((_6NOED2&)Y975(T!9F8X  ZDT2E+F!15CYMT?3K3_A*(
MM+UE94C,YMY3$X5D?.W.2#P#UKWGPYX6T[PO:S06!F83.&=IF#$X& . ./\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% '@EN,M6O;+TK(MSAJV+5NE;,
MP1L6T8XK4A@W#@5F6SCBM6"<*.M2RT1SP;1TK*N8QS6O/,&%9-RXYH0,Q;E<
M9JUX-&/&5C_VT_\ 1;57N6!!JQX-/_%96/\ VT_]%M3>Q*W/7:***R-@HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M<C%1M6[C&21_MKZ^X_*NWB\=^%YH]ZZS; >CY4_D1FLW!HI23-'7O^1>U/\
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MB6>G1XQ;Q!"1W;^(_B<G\:OT45S&Q\W>&_\ D>-+_P"PA'_Z&*^D:^;O#?\
MR/&E_P#80C_]#%?2-:U=T9T]CPSXC^*KO5M=N-*@E9;"UD,7EJ?]8XX)/KSP
M/I71Z#\(K7[''-K=S,UPX#&"$A53V)P23],5Y_XIMIM)\::BLB_,MVTR;NZE
MMRG\B*]VTCQ9HVLV,=S!?P(64%XI) KH>X(/\^E5)M17**-FW<Q1\+/"^/\
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M]A+<]BHHHK$W"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M=.N[;6IKB:,K"UJRJQ[G<O\ A2EL..YZ111161L%%%% !1110 4444 %%%%
M!7E'QHZZ)_VW_P#:=>KUY1\:.NB?]M__ &G5T_B1,_A-?X0?\BC<_P#7\_\
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ML<2G:92.I)[*.G'?/3%9/Q)N6N?'>H GY8MD:CT 0?U)KVOPK:I9>%-*@08
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MEV@*%8RQYSR2&.XG''# =/QY&;X<>+]#NS)HUQYN_<GFVESY+[,C&[)7KP<
MGI]*+0>S"\EN>V45XA:?$/Q;X=FCMM7@:9=J$1WT)CDV#(R&X))P?F8-R/KG
MKM-^+NAW7E)?V]U92-G>V!)&G7'(^8YX_AZGTYI.G)#4T>@T51TW6--UB'S=
M.OH+E0JLPC<$H&Z;AU4\'@X/!J]4%!1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MMJ7_ 'Z3_P"+K-QDW=EIQ1W]%5M/OH-3T^WOK8DPSQB1"1@X/K5FH*"BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MZLT45)04444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MLGK<V/\ W\?_ .)HN@LSD&;=77?#</\ \)%<90@?9&Y_X&E ^&^L>8I^TV.
M>?WC_P#Q->@:3I,.FVT8$:"8+M9U[TI25AQB[FC11169J%%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !117D&
MJ^,/$%W\2S8Z%,R+'*+)8)%+1OM;YV=1GC(;+#!"#MS51CS";L>OT445(PHH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M+B 2,X68 [AC[U3Z9H5YK()M1G'6GHB5=[H]PHHHK Z0HHHH **** "BBB@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M7/Z1XW\/:UL6VU*))VV#R)_W;[FZ* >&.>/E)_45T%0TUN7>X5X);_>KWNO
MH3AJJ!G4Z&U;=JVK;'%8-M)TK7MY<8JF2C>M@O>BY"X.*I1W.!UHDN,CDU)9
MA:]?7-GY26[[5E#!_?&/\37-8WR%S]X]36WXB?>UO_P+^E9D$>XU:,WN/A@W
M=JNQVWM4L$.<5I0VW'2AL:1G?9?:H9+;CI6_]FXZ57FMP.U*X6.149-:%O#G
M%4X!EJV+9>E-B18AM\@<5=6VR.E/MHQQ6I#;AATJ6RDC'>VP.E4)X,9XKI9X
M-HZ5E7,8YH3!HYB]B 49'>JT:9.*T=37:B_[U5K9,FJ(+,$&<<5H16WM26T>
M<5K009 XI-E)%'[+[5#);8'2M\6OR]*K3P  \4KCL<U/!UXK-ECP<8XKHKF+
M&:Q[E ,U2)9Z'\-@!X=N,?\ /VW_ * E=C7'_#?_ )%ZX_Z^V_\ 0$KL*REN
M;1V"BBBD,**** "BBB@ HHHH **** "BBB@ HHHH *\(\93W'B[XBMI]G%AX
MY!8Q94_PL=S-C/ )8Y'\(''6O7/%VM+H'AB]OO-\N?RS';D;23*PPN >#@\D
M<\ \&O-OA#HBW.K7.LS*VVT7RX25(!=@=Q!S@D+QCG[X/'%:0T3D1+5V/7[6
MVALK2&UMTV001K'&N2=JJ, 9//05+116984444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH *R-;\.6>OHJW4DZ!>GE,!_,&M
M>B@+7..'PVT<#'VF^_[^)_\ $TU_AGHD@P\UZPZX9D/_ +)79T4^9D\J//KC
MX0:#)"P@NKZ&7:=K%U8 ]B1MY'L"/K7)ZG\*-?L)/,TR:&^3< NQ_*DQCDD,
M< 9XX8GI[X]MHJE4D@<$?-=[%K>A2B+4;2>$Y95\^,X8@\E6_BZCD$CD58M=
M?A! EC=.<9'S #UKUKQ]HEUK$5DUNNY(1)Y@]CM_P->2SZ9;&9XFB*.#@E>,
M?ATK524EJ925F=#8:E;W./)G1SC.T'G'TZUL0W'O7G4NB/R8)5;J=K<'V'O^
ME/6]UO3&WN\Q3@MYG[Q<9Z9YQ^8HY4]@3/2_M/'6J\MQ[UQMMXP^7%U;D''W
MHCU/T/\ C6BFMV=R=L5PI;(&&RI.?3/6IY6AW(+BQNK+'VF,H3V/6DBFQ5N[
MN1+I8BW?,LC'&?4#M^%9HX44_4FYK0W'O5M;G ZUEVECJ%W&9+2RN9XP=I:*
M)F /ID#W%<W%K$L%_-)N+PR/ROMT!'OC%"5QW.W>YXZU4EN?>F6UIJ-_:I<V
MEC=3P2#*R1PLRGG!Y ]>*5M$UENNE7__ (#O_A2#4HSR[O?FFQN0<U>&BZU$
MRLNDWIP>0;5B"/?BH-4B6WU.2%/NJ2O3'(XIB+,$^ .:T(KCWK 1RIJRESCO
M2L.YO?:N.M0R7/O69]JXZU&]SGO18+EF><$'FLV5RS4/(6--C0S2; <'&2?0
M4Q'I_P -_P#D7;C_ *^V_P#0$KL*\C\.?$#1O"VGRV-RMU=.\QE#VRHR@$ 8
M.6!S\OZUZ7H6LV_B#1K?5+1)4@GW;5E ##:Q4YP2.H/>HG3G'5HZW1J0BG)6
M-&BBBLR HHHH **** "BBB@ HHHH *YGQOXEN/"ND6M_;P13[[M(I$DR,H58
MG!'0_+UY^AKIJX;XL6<ESX+,R,H6UN8YG#'D@Y3CWRX_#-5'5ZBEL3:)\3O#
M^KLL,\C:?.5&1<X$9."2 _3 QU;;G(P.U5/BCKZVGA.&WL[E2VIL &C).^$#
M+%6'&#E![AC^'B%=GIFA^'U^'>HZQJ-PLFHEMMO'#<#?"<D(&3CEB&)SGY!D
M8.:U<$G<SYFU8[GX2:/]B\.3:FSY?4).%!X5(RRCMUR7[GC'O7H->4^&_BO:
M6]O::?J6F_9H(HUB6:V8NJ@$!<HV6P%ZG<QXZ<\>C:3KFF:[;F?3+V*Y1?O!
M3ADY(&Y3RN<'&1S6<T[W9<6K61H4445!04444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 (P#*5/0C!KA?%7@Z2X ETFTWRL?F&]5_F17=T4T[":N>/+
MX(\1@#_B7<_]=X__ (JI%\&^)!_S#_\ R/'_ /%5Z[15<[)Y$>,S_#S6+C)?
M25#'/S+-&#D]^&Y_&L^;X7>(.L%H?H\T?\PW]*]VHI^TD'LT?/-SX0\7:045
MM+NV5LA?( G''LN<=>^._O5'3M<6"[C:]@\Z$$;]AP<=SCH3^5?2E9FJ^'M'
MUQ2-2T^"X8J%\QEQ( #D .,,!GT/<^M-5+[H3I]CBX/'OA>R\,7::5=RVEZ\
M4CPPRV[%A+MPN< KR0#U(]:\9KTSQAX>T;P)<:?JNF^;)>M=F2&UN6+1!5!.
M1MPWRL4QEN>^>:XOQ-KD?B'67OXM.@L590#'%U8Y)+,<#<Q)/..F/3-:0MT)
MEYFCX,\9W7A2^VL&FTV9LSP \@_WT]&_0C@]B/=M*U>PURQ%YIMRMQ 6*[E!
M!!'4$'!!^O8@]Z^8*V_#'B>^\+:F+JU.^)\+/;L<+*O]".<'M[@D%3A?5!&5
MM#Z2ZBOFOQ-J5W%XJU:))<)%>3(@VCA0Y '2OH31=:L?$&F1W]A+OB?@J>&C
M;NK#L1_@1D$&O)=<\*?:/$&I3^7GS+J5^GJY-7A>52?,CT\$J;D^=)G _P!K
M7W_/?_QQ?\*/[6OO^>__ (XO^%=?_P (=_TR_2C_ (0[_IE^E=O[KLCT>3#_
M ,J^Y'(_VO?_ //?_P <7_"D_M>^_P">_P#XXO\ A77_ /"'?],OTH_X0[_I
ME^E'[KL@Y,/_ "K[D<A_:U]_SW_\<7_"E36+]&++/@D8/R+_ (5UW_"'?],O
MTH_X0[_IE^E%Z?9 HX=:J*^Y'!U]$?#+_DGFE_\ ;7_T:]>9_P#"'?\ 3+]*
M];\%V?\ 9_A*QM<8V>9Q]9&/]:PQ<U*"2[G/CZBE327?_,WJ***\X\D****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M1_PO7_J7/_)[_P"UUX]11]7I]@YY'L/_  O7_J7/_)[_ .UT?\+U_P"I<_\
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MP_\ "]?^I<_\GO\ [71_PO7_ *ES_P GO_M=>/44?5Z?8.>1[#_PO7_J7/\
MR>_^UT?\+U_ZES_R>_\ M=>/44?5Z?8.>1[#_P +U_ZES_R>_P#M='_"]?\
MJ7/_ ">_^UUX]11]7I]@YY'L/_"]?^I<_P#)[_[71_PO7_J7/_)[_P"UUX]1
M1]7I]@YY'L/_  O7_J7/_)[_ .UT?\+U_P"I<_\ )[_[77CU%'U>GV#GD>P_
M\+U_ZES_ ,GO_M='_"]?^I<_\GO_ +77CU%'U>GV#GD>P_\ "]?^I<_\GO\
M[71_PO7_ *ES_P GO_M=>/44?5Z?8.>1[#_PO7_J7/\ R>_^UT?\+U_ZES_R
M>_\ M=>/44?5Z?8.>1[#_P +U_ZES_R>_P#M='_"]?\ J7/_ ">_^UUX]11]
M7I]@YY'L/_"]?^I<_P#)[_[71_PO7_J7/_)[_P"UUX]11]7I]@YY'L/_  O7
M_J7/_)[_ .UT?\+U_P"I<_\ )[_[77CU%'U>GV#GD>P_\+U_ZES_ ,GO_M='
M_"]?^I<_\GO_ +77CU%'U>GV#GD>P_\ "]?^I<_\GO\ [71_PO7_ *ES_P G
MO_M=>/44?5Z?8.>1[#_PO7_J7/\ R>_^UT?\+U_ZES_R>_\ M=>/44?5Z?8.
M>1[#_P +U_ZES_R>_P#M='_"]?\ J7/_ ">_^UUX]11]7I]@YY'L/_"]?^I<
M_P#)[_[71_PO7_J7/_)[_P"UUX]11]7I]@YY'L/_  O7_J7/_)[_ .UT?\+U
M_P"I<_\ )[_[77CU%'U>GV#GD>P_\+U_ZES_ ,GO_M='_"]?^I<_\GO_ +77
MCU%'U>GV#GD>P_\ "]?^I<_\GO\ [71_PO7_ *ES_P GO_M=>/44?5Z?8.>1
M[#_PO7_J7/\ R>_^UT?\+U_ZES_R>_\ M=>/44?5Z?8.>1[#_P +U_ZES_R>
M_P#M='_"]?\ J7/_ ">_^UUX]11]7I]@YY'L/_"]?^I<_P#)[_[71_PO7_J7
M/_)[_P"UUX]11]7I]@YY'L/_  O7_J7/_)[_ .UT?\+U_P"I<_\ )[_[77CU
M%'U>GV#GD>P_\+U_ZES_ ,GO_M='_"]?^I<_\GO_ +77CU%'U>GV#GD>P_\
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M#&LS>39:S;M+N5%27,3.S' "AP-Q^F>WJ*^7Z*AX2#V#VC/L&BOE/1_$NM:
MX.EZE<6RAB_EJV8RQ&"2ARI.,=1V'I7H6@_&N[A=8M>L4GB"@>?:#;)D Y)4
MG:Q)QT*@<\'I6$\+-;:EJ:/:J*S=&\0:3X@MC/I5]%=(OW@IPR<D#<IP5S@X
MR!G%:5<[36C+"BBBD 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MO=",2,BR#RY%<;3R.0?2@.8SJ*EVU<U+2KG2;E;>Z$8D9%D'ER*XVGD<@^E
M<QG45+MJWJ.EW&E77V:Z""38K_(X8889'(XZ4>0<QGT5+MJWJ.EW&E7?V:Z"
M"38K_(X8889'(XZ4>0<QGT5+MJWJ.EW&E7?V:Z""38K_ ".'&&&0<CCI1Y!S
M&?14NVK>HZ7<:5=_9KH()-JO\CAQAAD<CCI1Y!S&?14NVK>HZ7<:5=_9KH()
M-JO\CAQ@C(Y''2CR#F,^BI=M6]1TNXTJ[^S7002;5?Y'#C!&1R..E'D',9]%
M2[:MZCI=QI5W]FN@@DVJ_P CAAAAD<CCI1Y!S&?14NVK>HZ7<:5=_9KH()-J
MO\CAA@C(Y''2CR#F,^BI=M7-3TJZTB]:SO$59E 8A6##!&1R/:@.8SJ*EVU<
MU/2KK2+YK.\15F4!B%8,,$9'(]J YC.HJ7;5S4]*NM'OFL[Q%290&(5@PP1D
M<B@.8SJ*EVU<U/2KK1[YK.\14F4 D*P88(R.10',9U%2[:N:II-UH]\UG>(J
MSJ 2%8,,$9'(H#F,ZBI0F3BKFJ:3=:/?-9WJ*DZJ&(5@PP1D<CV-'D+G,ZBI
M0F3BKFJ:3=:/?-9WB*DZ@,0K!A@C(Y'L:/(.<SJ*E"9.*N:II-UH]\UE>(J3
MJ Q56##!&1R/8BCR#G,ZBI@F2 .IJWJFDW6CWS65XBI.H5BJL&&",CD>Q%'D
M/F,ZBI@F2 .IJWJFDW6CWSV5XBI.@!*JP88(R.1[$4>0<QG45,$R0!U-6]4T
MFZT>_>RO$5)T +*K!@ 1D<CV(H\@YC.HJ8(20!U-6]4TFZT:_>RO45)T +*K
M!@,C(Y'L11UL',9U%3!,D =35O5-)NM'OWLKU%2X0 LH<-C(R.1QT(H\@YC.
MHJ8(20!U-6]4TFZT>^>RO45+A "RAPV,C(Y''0T>0<QG45,$+$ =3Q5O5-)N
M]'OWLKU%2X0 LH<-C(R.1QT-'D',9U%3!,D =35O5-)NM'OWLKU%2X0 LH<-
MC(R.1QT-'D',9U%3!,D =35O4]*NM'OGLKU%2= "RA@V,C(Y''0T>0<QG45,
M$R0!U-6]3TJZT>_>RO4"7" %E#!L9 (Y''0BCR#F,ZBI@A8@#J>*MZII-WHU
M^]E>QB.= "RA@V,C(Y''0T>0<QG45,$+$ =3Q5O5-)N]'OGLKV,1W" %E#!L
M9&1R..AH\@YC.HJ8(68 =3Q5O5-)N]'OWLKV,1W" %E#!L9&1R..AH\@YC.H
MJ94+, .I.*MZGI5WH]\]E>QB.= "RA@V 1D<CCH:/(.8SJ*F5"S #J3BK>IZ
M5=Z/?/97L8CG0 LH8-C(R.1QT-'D',9U%3!"S #J>*MZGI5WH]\]E>QB.= "
MRA@V,C(Y''0T>0<QG45,$+, .IXJWJ>E7>CWSV5[&(YT +*&#8R,CD<=#1Y!
MS&=14RH68*.I.*MZGI5WH]\]E>QB.= "RA@V,C(Y''0T>0<QG45,L99@HZDX
MJWJ>E7>CWSV5[&(YT +*&#8R,CD>U'D+G1G45+MHVT[!SHBHJ7;1MHL'.B*B
MI=M&VBP<Z(J*EVT;:+!SHDT^_N]*OX;ZQG>"YA;='(G4'^H/0@\$'!KU[P?\
M7_M5S!I_B..*(O\ (M^AVKG  \Q>@R<Y88 R. ,D>.[:-M9SI1FM2E4L?7E%
M?/W@+XB3^%<V-^LMSI39943!>%NOR9(&">HR.N1W!]XL+^UU2PAOK&=)[:9=
MT<B]"/Z'L0>01@UYM6C*F]=C>$U+8LT445D6%%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MFCPP.5/0\=*74=*N]-:!;M0#-"LT>'#?(>G3I]*T3:_V)N74[".X:[M ]O\
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MB.O7_@[:K7;^O5N9#J6DW6DWQL[M568!6(5PP (R.1QT-&IZ5=Z7?FTO0!.
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ME/<'(I: "BBFNZ1KN=U4>K'% #J*16# %2"#T(I: "BFO(D8R[JH]6.*4$,
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M<>9IYN8R]P%\M3P''/)_V?>C1K?_ (/IJ"EKH4OLQT0$:E917/VRSWV^9?\
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MO]>6N@KOL5/LO]BDC4[&.X:ZM-]O^^_U>[[K\?R-'V7^Q21J=BEPUU:;[?\
M??ZO=]U^/Y&K=MI,]JMV)[.VN&-C]H4M< >4K8PPP>6Y^[UY%%MI,UJEV)[.
MVN";$3J6N /*5L888/+<_=]Q2LGU_KRUT"[[%0VO]BY&IV,=PUU:![?]]_J]
MWW7X_D:#:_V+E=3L8[AKJTWVY\[_ %>[[K\?R-6[;29K5+L3V=M<$V(G4M<
M>4K8PPP>6Y^[UY%%MI,UJEV)[.VN";$3J6N /*5L888/+<_=]Q3T[_UY:Z!=
M]BH;7^Q25U.QCN&NK4/;GSO]7N^Z_'\C0;7^Q=RZG8QW#75H'MSYW^KW?=?C
M^1JW;:3/:I=B>SMK@FQ$ZEK@#RE;&&&#RW/W?<46VDS6J78GL[:X8V(G4M<
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M!^[[]*+KO_7WA=]O^!_F4FM_[(\R/4+2*XDN+96A/FY\K=R&X/7'8^M#6_\
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MY;G[ON.*6#29[.*^6XL[:=OL0G5FN /)5B,,,'EN?N^XXHNN_P#7EJ%VNG_
MW*+V_P#9 F@U"SBN)KBV5H6\[/E;N0WRGKCL?6B2W_LCSH-0LXKB:XME:%O.
MSY6[D-\IZX['UJ]!I,]G%?+<65M.WV)9@S7 'DJQ&&&#RW/W?<<4L&E36<%_
M'<6-K<.;-9U=K@ PJ2,,,'D\CY3ST_$NN_\ 7WA=KI_P-RA);_V1YT&H6<5Q
M-<6RM"WG9\K=R&^4]<=CZTZ6V_L7[1;:C907$\\"M#()]WDYY##:<$X['VJY
M!I4UG!?QW%C:SN;-9U=K@ PJ2,,,'EN1\IYZ?B0:5-9P7\=Q8VMPYLUG5VN
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M;:G%<V=M-)'#&_F_:!F(,1@J ?FR"!WQD4)KO_6FVNWE_3+OM_P-_O*4]O\
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M117C'MA1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M&K=*6,J.\9I#C@J:M*#?J%%%%<9W!1110 4444 %%%% !1110 4444 %%%%
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ME <X*?[7'3V/'H0Z5+8V^HQW$%G,_P!G#AGEY0'."G^UQT]CQZ+G\^WZ>?\
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MGCACD\W[0,Q!B,%0#\V<@=\9%*-)FLK74H[BTMIGCAC?S?M S$&(PRX.&SD
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MZ_2A2ON_ZT\]O+^FG+LK?T]-B@=*FLK74X;BTMII8HXF\X7 )B#$8*X.&!!
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M-@T?3+?3[;>88%VJ7.2>^3^=7***&VW=@DDK(*BN;F&TMI+BXD6*&-2SNQP
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M\0+J*1B1X6<JIZ$D$#/MDU.'H*JI=T5B<0Z+CV9[OK'B72-!VC4;U(G896,
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MPY%8WKHTRNS81LA03TS_ )ZUSWQ;_P"1>LO^OL?^@-7H-<!\6T)\-V;CH+L
M_BC5%"3E74GU9IB(*&'<5T1!\(O^03J/_7=?_0:]&KS7X0SH;+4X,C>LB/CV
M((_I7I5+%_QI#P?\")P'Q;S_ ,(W9_W?M8S]=C?_ %Z\]\->%M3\2K<G3IX(
MO(V[_-=ESNSC& ?0UZO\1--?4O!]SY:[I+9A< #T7K_XZ37 ?#'6X=,U^6TN
M7$<5Z@16)P X/R@_7)'U(KKP\Y+#-PW1Q8F$7BDI[,F_X5=XE_Y_;+_O^_\
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MNSU[_D7=3_Z])?\ T TZ_P#O#]2</_NZ]#QCX<?\CU8?27_T6U>[UX1\./\
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M5_"__D<D_P"N$G]*[?XB>*+/3='N-*0B6]NHRA0'_5J>K-_05Q'PO_Y')/\
MKA)_2M:$6L--OJ8XB2>*@ET/;JY'Q9X#L_$C_:XI/LM^!@R!<K(!TW#^O\ZZ
MUF"J68@*!DD]J9!<074*S6\T<T3<J\;!E/T(KAA.4'S1/0J0C47+(\)OO#7B
M?PG,;I$GC1/^7FT<E<>Y'('U KI?"WQ/N/M,5GKNQXW(472C:5/^T!P1[C'X
MUZJ1D8/2O _'MG9V/C"\AL55(_E9D3HK%02!Z>OXUZ%*I'$WA46O<\VM3EA+
M3IRT['OE%9WA\R-X<TLS9\TVD1?/7.P9K1KS6K.QZD7=7"BBBD,\"_X5QXL_
MZ!7_ ),1?_%4?\*X\6?] K_R8B_^*KWVBO4_M:MV7X_YGE?V10[O\/\ (\"_
MX5QXL_Z!7_DQ%_\ %4?\*X\6?] K_P F(O\ XJO?:*/[6K=E^/\ F']D4.[_
M  _R/ O^%<>+/^@5_P"3$7_Q5'_"N/%G_0*_\F(O_BJ]]HH_M:MV7X_YA_9%
M#N_P_P CP+_A7'BS_H%?^3$7_P 51_PKCQ9_T"O_ "8B_P#BJ]]HH_M:MV7X
M_P"8?V10[O\ #_(\"_X5QXL_Z!7_ ),1?_%4?\*X\6?] K_R8B_^*KWVBC^U
MJW9?C_F']D4.[_#_ "/ O^%<>+/^@5_Y,1?_ !5'_"N/%G_0*_\ )B+_ .*K
MWVBC^UJW9?C_ )A_9%#N_P /\CPS4/$7ABX\%)IMMHWE:L((4-U]EB7+J5WG
M>#NYPW..<\UQ=%6M/TR]U:[6UL+66XF/\,:YP,@9)Z 9(Y/ KW(4XTD]=-]3
MP9U)5I+37;0JUJZ#INMZA?@Z'%<FYC_Y:P,4\O(/5\@+D CDC/2O1O#GPHMH
MXH[G7I&FF9<FTC;:B'GAF!RQY'3 !!^\*]'MK6WL[=;>U@B@A3.V.) JC)R<
M <=37G8C-(1O&FK_ )?\$]+#954E:51\OY_\ I:%#J]OI21ZW=P75Z&;=)"F
MT8SP.@R?? ^G&3I445X,I<S;/?C'E204444B@HHHH X_XA3(-,M+8AM\DQD!
M[852#_Z$/UKSWRZ[OX@.ADT] REP)"5SR =N#^A_*N+KWL%']PC\\SZHWCYK
MM;\D0>71Y=3T5UV/'YF0>71Y=3T46#F9!Y='EU/118.9D'EUFW"AIW(]<5LU
MDRX,KD<C<:J*/0RY^^WY%?91LJ:K5[I\UAY/G%"9HQ(NULX!Z9JM+V/7N]R.
M_P!+FTXP"9HV\Z(2KL;/!]?>K9MSH9Q=VUM=?:K;<F3G8&Z'IP:@O=/FL/)\
MXH3-&)%VMG /3-%[I\UAY/G%"9HQ(NULX!Z9J+)I*Y6JOH3^1_8AQ<V]K=BZ
MM\I\V[R\Y&1Z$&D^S_V*<75O:W?VF#*$/N\O.1GZ@_RJ;RCHNY;NUM[DW5OF
M/Y@?+ST;IUJU9Z9+9_:4GMK.=I+(S*7D^X/4<'G_ #D5#:M=O_@_B/T7]?<1
M6.DO:&Y6:"RNM]D9E+2_<'J./O#T_6GZ9I!M9)ENX+6=)++S]Q?+1(3]Y1QE
MAZ<?446.FRVJW FMK2<R6)G7S).8U]1QU_SD5+I-A+8S2--' Q:T^T+)O^>%
M<_>7_;[@9'U%1)Z/7^OO&EKM_7W#]/T,0D^?!8R?:+3?S*/W*87YQN;[YR20
M=J^A'(%:+3X].,/VJWLY!>0*,>8O[E2% <;G'S9;)!P.#@@ [=#3(#9*@FMK
M9BMN;L?O&/E+A!O7YOOG;G V_P"\. JV$<EN8VNH8)&CM_M2DS.3$@5%#+\_
M+X7H-N./F& %S<G=Z_U]YLHQZK^ON*]AH:PLPFBL)?/M=Q_? B%1M&\;FY?)
M.0=JY'!'(":=HJQY\V*PE^T6N\_O1^Y4;1O&YOOY)R#M7(X(Y"VK!);;8;F&
MWD9+;[2"TKDQ( BAD^?[^$Z#;CCYAP%+!);;8;F&WD9+;[2"TKDQ( BAD^?[
M^$Z#;CCYAP%3E+77^OO#ECV_K[BKIVBK'GS8K"7S[7<?WH_<J-HWC<WW\DY!
MVKGH1R!6AL(K#RC<PV4HO(0.)5_<@[5WC<X^?))(. ,'! !VZ=@DMML-S#;R
MLEM]I!,KDQ( BAD^?[^$Z#;CCYAP%2QCDMO+:ZA@D:.W%TK&9R8D"HH9?GY?
M"]!MQQ\PP K<GKK_ %]X*,>W]?<5K'0UA+B:*PE\ZVW$B92(5&T;QN;E\DY!
MVKUP1R%-/T18PWFQ6,GGVNX_O1^Y4;1O&YOOY)R#M7(.".0+5BDEML-U#;RL
MEL+D,TKDQ)A%#)\_W\)T&W''S#@*6*2VH4W4-O*R6XN0S2N3$@"*&3Y^7PG0
M;<<?,. HY2UU_K[PY8]OZT\BKI^B+&&\V*QE\^UW']Z/W*C:-XW-]_).0=JY
M!P1R!6BT^*P\K[3#92B\A XE4^2/E7>-SCY\DD@X P<$ ';IV*2VNTW4-O*T
M=N+@%I7)B0!%#)\_W\)T&W''S#@*EE');;#=0P2-%;BY!,SDQ(%10R?/R^%Z
M#;CCYA@!1R=W=_U]X*,?Z_X8KV.AK"7$T5A+YUMDD3 ^2HVC>-S<ODG(.U?0
MCD!+#1%B#>=%8R>?:[B?-'[E1M&\;FY?).0=JY!P1R!:L4EM0INH;>1H[<7(
M+2N3$@"*&3Y_OX3H-N./F' 4L4EM0INH;>1H[<7(+2N3$@"*&3Y_OX3H-N./
MF' 4<I:Z_P!?>+ECV_K3R*MAHBQ!O.BL9//M=Q/FC]RHVC>-S<ODG(.U<@X(
MY KQ6$6G^6+F&RE%Y"!Q*I\D?*N\;G'SY))!P!@X( .W2L4DM0INH8)&CMQ<
M@F5R8D 10R?/R^$Z#;CCYAP%2RCDMMANH8)'BMQ<@F9R8DVHH9/GY?"]!MQQ
M\PP HY.[U_K[QJ,?Z_X8K6&B"(2">"Q<S6^2?.4^2HVC>N6Y8Y)(.T>A'(4L
M=$6%7\Z&QE\ZV!)$H/DK\HWKN;ELDY!PH(.&'(%JQ22U"FZA@D:.W%R"97)B
M0!%#)\_+X3H-N./F' 4LDDM #=0V\K10"X!,KL8DPBAD^?EL)T&W''S#@*.4
MM=?Z^\.6/;^ON*FGZ*(TD\^"R?SK?G]ZI\E1M&]<MRQR20<*/4<A:\-C%8;!
M=064GVN(+Q,A\E?E7>NY^6).2#@#!P0 =NG9)): &ZBMY7B@%P"978Q)A%#)
M\W+83H-N./F' 5+..2UVF[B@D>& 7 )F<F)-J*&3Y^6PO0;<<?,, *<SUU_K
M[P2CV_K[BM8:*(ED\^"QD\ZWY/FJ?)4;1O7+<L<DD' 'J.0J:?HHB23SX+)_
M.M^3YJGR5&T;URW+$DD@X ]1R%MV226@!NHK>5XH!< F5V,2810R?/RV$Z#;
MCCYAP%+))+0?Z5%;RO% +@$RNQB3"*&3YN6PG0;<<?,. HY2UU_K[PM'MU_K
MH5-/T41))Y\%B_G6_)\U3Y*C:-ZY;EB220< >HY"UXK"*PV+=06<GVN(+Q,A
M\E?E7>NY_O$G)!P!@X(P=NG9)):#-U%;RM% )]QE=C$F$563YN7PG0;<<?,.
M K;)'ME#7,=O*T$(G#><[>4H"(&3Y^7^3H-N./F& %.9ZZ_U]X)1[=?ZZ%:P
MT41)+Y\%D_G6_)\U3Y*_*-ZY;ECDDYVJ/4<A2PT411R^?!9/YUN,GS5/DK\H
MWKEN6.23G:H]1R%M6(>V3-Q';3-%")]WFNQB4!%#)\_+_)T&W' W#@*60>U3
M-S';S-#")]WFNQB4!%#)\_+_ "=!MQ@#<, *.4M=?Z^\.6/;K_70JV&BB*.7
MSX+)_.@&3YJGR5^4;URW+'))SM4>HY"UX[".PVK=06;_ &N,+D2H?)7Y5WKN
M?EB3DC@#!P1@[=*R#VJ;KF.VF:&$3;O-=C$H"*&3Y^7^3H-N, ;AP%2S1[90
MUS';RM!$)]PF=C$H"(&3Y^6^3H-N./F& %?,[O\ K]1\L>W7^NA6L=%$4<WG
MP63F6 9/G*?)7Y1O7+<L<DG.U1_>'(4L=%$44WGP63F6 9/FJ?)7Y1O7+<L<
MDG.T#U'(6U9*]JF;F.WE:&$3[O-9C$H"*&3Y^7^3H-N.!N& %+-7M4S<QV\K
M0PB;=YK,8E 10R?/R_R=!MQP-PX"IREKK_7W_P!?FN6/;K_70J66B>5'+YL-
MBWFP#<?-4^4ORC>N6^\223G"C!&1SM@CT^.P"I<P6;F[C"9$JGR5^5=Z[GY8
MDY(X P<$8.W2LU>U3-S';RM#")]WFNQB4!%#)\_+_)T&W' W#@*EFCVR[KF.
MWE:"(3[O.=C$H"(&3Y^6PG0;<<?,, *^9ZZ_U]_]?F[1[=?ZZ%6ST0Q1RB:&
MQ;S81N/FJ?*7Y1O7+?>)))SA1@X(YVEEHACCE$L-BWFP#<?-4^4ORC>N6^\2
M23G"C! (YVV[-7M4)N8[>5H8A/N\UV,2@(H9/GY;Y.@VXX&X<!2R5[9";F.V
ME:&)9]WG.QB4!%#)\_+?)T&W' W#@*G*6NO]?>*T>W7^NA4LM$,4<HEAL6\V
M ;CYJGRE^4;URWWB22<X48.".=L$=A'8*J7,%FYNXPN1*I\E?E7>NY^6).2.
M ,'!&#MTK(/;(3<QVTK0PK/N\YV,2@(H9/GY;Y.@VXX&X<!4LU>V3=<QV\KP
M1"?=YSL8E 10R?/RV$Z#;CCYA@!7S/77^OO'RQ[=?ZZ%6ST0Q1S":&Q;S81O
M/FJ?*7Y1O7+?>)))SA1@X(YVEEHOEQ2B6&Q;S8!N/FJ?*7Y1O7+?>)))SA1@
MX(YVV[(/;(3<QV\K0Q+/N\YV,2@(H9/GY;Y.0-N.!N' 4L@]LA-S';RM#$L^
M[SF8Q* BAD^?EODY VXX&X<!4Y2UU_K[_P"OS.6/;K_70J66B^7%*)8;%O-A
M&X^:I\I?E&]<M]XDDG.%&#@CG;!'81V*A+F"S<W<83(E0^2ORKO7<_+$G)'
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ME?E7>NY^6).2. ,'!&#MT+0O:QM]HA@F:"-9BXE9C"H"*&3Y^6^3D+MQP-P
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MBBP7(=E&RIJ*+!<[_P"%@Q_:W_;'_P!GKT2O,?AI/(NM7=N&Q$]OO9<#EE8
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MU'_KNO\ Z#4OQ;_Y%ZR_Z^Q_Z U1?"+_ )!.H_\ 7=?_ $&M_P#F$^?ZG/\
M\QOR_0]&KC/BA>M:^#VB0X-S.D1QZ<L?_0:[.N!^+2,WAJT<=%NQG\4:N;#I
M.K&YU8IM496['*?#?5=&T:\OKO5+I8)3&L<.49L@DEN@/HM>B?\ "?\ A?\
MZ"R?]^G_ /B:\T\">$]/\4_;Q>3W$36_EE!"RC(;=G.0?05V7_"I-$_Y_=0_
M[[3_ .)KLQ"H.H^=NYQ85XA4E[-*Q>U7QKX6OM(O+0ZI&WG0.F/*?DD$?W:\
MV^'EPT'C>PP>)-Z-[@H?ZXKN_P#A4FB?\_NH?]]I_P#$UHZ)\.](T+5(]0AF
MNYIHL[!*Z[02,9P .QJ8U:%.G*,6W<J5+$5*D9325CK:^;].LTU'Q':V4C%8
M[BZ6)BO4 M@XKZ0KYX\/?\CIIO\ U_Q_^ABC NT9M?UN&8*\H)]_\CZ"MK>&
MTMHK>WC6.&)0B(O0 5+117GGI;'#_%;_ )%&/_K[3_T%JPOA#:027&IW;Q*T
M\0C2-SU4-NSCZX%;OQ6_Y%&/_K[3_P!!:LGX/?ZO6/K#_P"SUZ$?]T?]=CS9
MJ^-CZ?HSTZO//BY K:%83D?.ESL!]F4D_P#H(KT.N!^+?_(LVG_7XO\ Z ]<
MV%_C1.K%_P &1G?"*SMVCU&\:)3<*RQJYZJI!) KT^O-_A#_ ,@[4_\ KJG\
MC7I%5BW^^9."7[B)YM\7H5-AID^/G65T!]B ?Z58^$CD^'KU">%NB1^*+_A4
M?Q=_Y ^G_P#7P?\ T&G?"/\ Y 5__P!?/_LHK;_F$_KN<Z_WWY?H=GKW_(NZ
MG_UZ2_\ H!KQCX<?\CU8?27_ -%M7L^O?\B[J?\ UZ2_^@&O&/AQ_P CU8?2
M7_T6U&&_@U/ZZ#Q?\>GZ_J>[UX5\2?\ D>+W_<C_ /0!7NM>%?$G_D>+W_<C
M_P#0!4X#^*_0K,?X2]?\SUSPI9V]EX5TQ+>)8U>WCD;'\3,H))]\FMFLWP]_
MR+.E?]></_H K2KDF[R9V4U:"L>*?%.!(O& =0 9K9';W.2O\E%>F^"G,G@S
M2F/40!?R)']*\W^+'_(V6_\ UYI_Z&]>C>!O^1*TO_KD?_0C7;7_ -V@<&'_
M -ZF5_B+_P B'J7_ &R_]&I7$?"/_D/7W_7K_P"S"NW^(O\ R(FI?]LO_1J5
MQ'PC/_$_OAW^R_\ LRT4O]UGZ_Y!6_WR'I_F>OUB^+O^10U;_KU?^5;58OB[
M_D4-6_Z]7_E7'3^->IWU?@?H>5_"_P#Y')/^N$G]*]NKQ'X7_P#(Y)_UPD_I
M7MU=.._B_(Y,O_@_,^?-5M;SPGXO8A=LEO/YT#,.'7.5/T(X/XUZOH7Q!T36
M(T2:=;*Z/!BG.!GV;H?T/M6UK.@Z;KUL(-1MEE"_<?HR'V(Y%>;ZU\*+J /+
MH]T+A1R()L*_T#=#^E:>TI5TE4T:ZF?LJV'DW2UB^AZR"" 0<@]"*6O!O#WB
MS5O"FHBVG,K6J/LFM)<_+Z[<_=->[0S1W$$<T3!HY%#JP[@C(-<U>A*D]=4S
MJP^(C63MHT/HHHK Z HHHH **** "BBB@ HHHH **** "BBB@ HHHH *XKXH
M6-W?>&8$M+:6X=+M798D+$+L<9P.V2*[6BKISY)*2Z$58*I!P?4\_P#A7I]Y
M8Z;J!N[6:W\R5=@E0J6P.<9KT"BBG5J>TFY/J*E35."@N@5XSXW\#WUGK$MW
MI=E+<65PQ?; A8Q,>HP.W<?E7LU%51K2I2NB*]"-:/+(\Q^%FBZE8WU]=7EG
M/;1-$(U\Y"A8YSP#]*].HHJ:M1U)\S*HTE2@H(****S-0K'\4:&OB'0+C3]P
M21L-$YZ*XY'X=OQK8HIQDXM-$RBI)Q>S/GQ;+Q+X4U$R107=I.N5\Q$+*P^O
M(85UW@Z_\7:QXIM+B_EO6L8PYE+IY<1&T@<  $YQ7JM%=<\7SQUBK]SCIX+D
MDFINW80@,"" 0>"#WKR3Q7\-+NWN9+O0X_/MG)8VX.'C]AGJ/U^M>N45A2K2
MI.\3HK4(5E:1X7;>*/&6B1BV:2[54X"7-ON(_%AG]:G/B3QWK(\J!KT@_P#/
MM;;?_'@,C\Z]MHKH^MQWY%<YE@Y[>T=C@/A]X8UC2;Z[U+5OD>XCV!'DWN3D
M'+'GT]<UW]%%<U2HZDN9G72I*E'EB>$:#H6KQ>,[!I-,O$6.]1W9H6 50^22
M<8Q7N]%%77KNJTVMC/#X=44TG>X5QWQ,LKJ^\*K':6\L[K<HQ6)"Q PPS@?4
M5V-%9TY\DE+L:U(<\'%]3SKX4Z=>V,&J-=VD]N)&BV>;&5W8W9QGZBO1:**=
M6HZDW-]14::I04%T.(^*%C=WWANV2TMI9V2Z5F6)"Q VL,X';D56^%>GWECI
MNH&[M9K?S)5V>:A4M@'.,UZ!15^W?LO96,_JZ]M[6X5P7Q3L+R^T>R^R6LUP
M4G)81(6*C;U(%=[16=.?LYJ2Z&E6FJD'!]3A/A;87=CH=X+NUFMR]QE1*A4D
M;1S@UUVLQ//H>H11(7D>VD55'4DJ0!5VBG.HYSYQ4Z2A34#Q;X?:-J=MXSM)
MI].NX8HUDWO)"RA<HP&21ZFO::**JO6=67,T3AZ"HQY4[GB_Q#T?4[GQE<S6
M^G74T4B1['CA9@<* >0/6O6=#BD@T#3894*21VL2NK#E2$ (-7Z*=2NYPC"V
MPJ6'5.<II[A7DGQ0TK4+OQ+;SVUC<SQ?957?%$S#(9N,@=>17K=%31JNE+F1
M5>BJT.5LP_!UO-:>$=-@N(GBE6+YD<8*\D\CM6U)&DL;1R*&1P593T(/:G45
M$I<TG(TC'EBH]CP_Q1X"U/1;V2:P@ENK MNC>(%FC'HP'/'KTJ"V\3^-)(A8
MV]U?R<;0HAW/_P!];=WZU[O176L8W&TXIG$\"E)N$FCR;1/AS>SV]SJ>N!VG
M,3M%;%MSN^#@N?KV_/TJO\-M(U*U\6":YT^ZAB6%PSRPLH!..,D=:]AHJ7BY
MR4D^OX%K!0C*,H]/Q(+VW^UV-Q;;MOG1-'N],C&:\3.E^,O!UPYM4NXX\\O;
MCS(G]R,$?F,U[G16=&NZ=U:Z9I7PZJV=[-'B+>./&=VA@C>4.>,Q6HW?R_E5
MOPS\/M4U74%OM;CD@M=_F.LQ_>S'K@CJ,]R>:]CHK5XNRM3BD8K!7:=23E80
M *H   '  [4M%%<9W!1110 4444 %%%% !1110 4444 %%%% !1110!Y9X>^
M$O\ J[C7[CT;[) ?H<,__?0(7ZAJ])T_3++2;1;6PM8K>$?PQKC)P!DGJ3@#
MD\FK5%;UL35K/WV<]#"TJ"]Q?YA1116!T!1110 4444 %%%% '!^/K?;?6=S
MNSYD9CVXZ;3G.?\ @7Z5R%=SX_AD:"QF"_NT9T8YZ$@$?^@G\JX:OH,$[T(G
MYQGL.7'U++>S_!?J%%%%=1Y(4444 %%%% !60Z['9<YP<5KUES@K.X/]XFJB
M>CES]Z2(Z***L]8LWEA-8^3YVS]Z@D7:V?E-6C#_ &2"+RUBN/M$&Z+]Y]S/
M1N/Y5F59O+&:Q\KS2G[U!(NUL_*>E0^B;+3W:1::#^R,K>6L-P;B#=$1)]S/
M1N/Y4[RSHN]+RT@N#<P9C)<'9GHP]Z;Y0TC(N[:&X^T0;HCO^YGHW'\JL6NF
MRVOGK-;VLV^T,Z,\N-@[$8ZGVK-R5KM_\'\2U&^G](DM-,ELA<K/!9SF2R,R
MEY/N#/4<?>_SFJBI_9"L+NS@N#=6^8B6SLST8>] C&D _:[2&X-S!NB)?.S/
M1OK5BVTR6T-Q'/;VLQ>T,RL\WW!V(QU/M2;M=MZ/\?Q!13TM_7ZC[33);(72
M3P6<[/9&92\GW!GJ./O?YS266G26B7(FM[.<R6)G4R2<H,]1Q][V_6F6>GRV
MOGB:VM9B]F9D,DGW%(X(]3[?3I19Z?+:^>)K:UF+V9F0R2?<4C@CU/M]*ERW
MU_K[RE3\OZ^X?9:=):)<B:"SG,EB9U,DGW%SU''WO;]:K*G]CJZW=G!<&ZM\
MQ$MG9GHP]ZFM-/EM//$UM:S%[,S(9)/N*1P1ZGV^E):Z=);"=9K:VFWVAG1G
MEQL'8C'4^U/G5W=_U]X>S\B6TTV6R%TD\%G.SV1F4O)]P9ZCC[WM^M%EITEH
MET)K>SG,EB9U,DGW!G@CC[WM^HJ.TT^6T^T":VM9B]F9D,DGW%QU'J?;Z46F
MGR6@N%FMK68O:&9&DD^XI'4>I]J3EOK_ %]XO9^0^RTZ2T2Z$T%G.9+(SJ9)
M/N ]"./O>WZBJX0:,C+=VMO<F[MMT1WY\K/1OK4UIITEH)Q-;VDY>S,ZEY/]
M6#G!'J?;W'2BUTU[59UF@M)R]IYZEY<>6.Q&.I]O<4^97=W_ %]XN3R)+33)
M;);M)X+*<O9&92\GW!G@K@<M_G(IMGI\MFERLUM9W!ELC,K/)_JU/0C_ &O;
MW[4VUTZ2T6<306DY>S,ZEY?]6#G!'J?;W'2EM=.DM%G$T%I.7LS,I>7_ %8.
M<$>I]O<=*3EOK_7W@H>0MIITMFERLUM:7!DLC,K/)_JU/0C_ &O;W[57\O\
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M9Z,/>IK73WM$N5F@M)R]IYREY#^[!S@CU/M[CI1:Z?)9K<B:"TG+VGG*7?\
MU8/0CU/M[CI3YM7=_P!?>')IL+;:9+9+=+/;VL[&T\X%I/\ 5@YP1CJ?;W'2
MBVTR6R6Z6>WM9RUIYRLTG^K!S@CU/M[CI26VG26B7(F@M)RUIYREY/\ 5@YP
M1ZGV[9'2EMM-DLUNEG@M)RUIYH+R?ZL'."/4_P LCI2<M]?Z^\:CMH%MIDMD
MMTL]O:SDVGG!FD_U8.<$>I]O<=*KM"-&W)>6L%RUS;[HB'SY><X;Z_YZU8MM
M-DLUNEF@M)RUIYH+R?ZL'."/4_RR.E%MILEFMTLT%I.3:>:"TG^K!S@CU/\
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M2>$]:LHIX6TA+II4&V0./W1YZ>_3_P#7T]:HK59A42M9?C_F8/+*3=[O\/\
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M<5X=6<L15NMV?1TH0PU&ST2U.8\;7@NI9[)(H)1;6QE9GD *,QQD#N<#&/\
M:_$<C#ISVD%\DL=I,PMQ(',HS&,GD<?>[8Z\^O21[&XB_M$W8MKB=X!.9'DY
M3<3R..6/I[C\&)IDEE#?1RQVLK_9EE#-)S&#W''+=L>X_#V:4%3AR)]OGL>!
M7JNK-S:[_+?^OD)#ISVD%\DL=I,PMQ(',HS&,D9''WNV.O/Y59(_[+\ZWGAA
MG>:,%'!SY><\CCK_ "^O2VFF264-]'+':RO]F64,9.8P>XXZ]L>X_ 33);*&
M^BECM97^S+*&,G,8/<<=>V/<?AJI*^KO^NQEMLK;_+?RU/9AT%<UXZC\SP\Y
M\J)]IW;I&QLX/(]3VQ[UTHZ"N:\=1^9X><^5$^P[MTC8V<'D>I[8]Z\##?QH
M^I])B_X$_0\\CTY[2WOHY([29Q L@?S1F,$GD<<MVQUY]>E:6/\ LKSK:XAA
MGDFC!5P<^7UY''7_ #UZ6TTR2RAOHI8[65Q;K*',G,8/<<<GV]Q^ FF2V4%_
M%+':2O\ 9UE#F09C![CCKVQ[C\/?4EU=_P!=CYMZ;*V_RW\M1(]-DM(+^.2.
MTF<0"0/YHS&,D9'')[8Z\^O1(].DM+>_CDCM9G$"R;S*,Q@D\CCENV.O/KT<
MFF264-]%+':3.+=90YDYC![CCD^WN/P$TR2RAOHI8[29Q;K*',G,8/<<<GV]
MQ^"YO/M\]@LETMO\M_+^K"1:<]G!?I+#:7#BW$@8R_ZL'(R/5O;W''I7DB_L
MCS;>Y@M[AYXLHX;/EYR,CW]C_/I9CTV2QAOXY8;2=Q;+(&:3F,'/(]6]O<<>
MBQZ=)8PW\4L-I._V=9 S2<Q@YY'O[>XX]&I=W?\ 7835ME;?Y;Z?\$2+3GLX
M;^.6*TN'%N) YE_U8)(R/5O;]/0BTZ2SM[])8;2X80!]YE_U0.1D?[7M^GH1
MZ;)8PW\<L-I.XMED#-)S&#W'^U[>XX]"/39+&&_CEAM)W%LL@9I.8P>X_P!K
MV]QQZ'-?KV^>WF#273O\OB_KY!%ITEG!?I)#:7#" /O,O^J!R,C_ &O;K[>E
M:2+^R?-M[BWM[AYX@4</GR\Y&1[^Q_GTLQZ;)8PW\4L-I.XMUD#-)S&#W'^U
M[>XX]%CTZ2Q@OXI8+2=_LZR!VDYC!SR/?GI[CCT%+N[_ *[!)6V5M_EOH)%I
MLEG!J$<D-G<,L ?S/-_U8.1D?[7M^GH1:<]G;WZ20VEPP@#[S+_J@<C(_P!K
MV_3C@CTZ2QAOXI8+2=Q;K(&:3F,'/(]_;W''H1Z=)8PW\4T%I.XMUD#-)S&#
MGD>_M[CCT7-?KV_0&K=._P#[=_7R"+3I+2WOTDAM+AE@#[S+_J@<C(_VO;].
M.*TD8TGSK:X@M[B2:,%'#Y\K.1GZ^Q_GTLIILEC#?Q2PVD[BW60.TG,8/<>_
MM[CCT6/3I+&#4(98;2=Q;K(':3F,'/(]_;W''HT^[O\ TA-6V5M_UT_KL":9
M+8P:A%-;VL[K LF\R?ZL'."/4^WZ>B)IDME;ZA%-;VLSK LF\RX,8/0CU/M^
ME*FG26,&H12PVD[B!9 [2<Q@YY'J?;W''H)ITEC!J$4L-I.X@60.TG,8.>1Z
MGV]QQZ'-?KV_3S!JW3O^O]?(1-,ELK?4(IK>UF=8%D#F7F,'H1ZGV_2JTT/]
MD>=:7-O;SR31JR2;B?+SG!'O['\O2TFG26,&H130VD[B!9 [2<Q@YY'J?;W'
M'H1Z?)80:A#-!:3N(%D#M)S&#GE??GI[CCT%+SO_ $@:MLK;_J(NF2V,&HQ3
M6]K.Z0J_F&3F,'H5]3[>_2A-,ELK?4(YK>UG=85D#F3!C!Z%?4^WN.*$TZ2Q
MM]0BFM[6=UA5P[2<Q@YY7W]OIQZ":=)8V^H136]K.ZPJX=I.8P<\KZGV^G'H
M<WGV_3S!KR[_ *@FF2V5OJ$4UO:SND*OO,G,8/0KZGV]QQ5>: Z1YUI<V]O/
M+-&&20-GR\YP1[^Q_*K":=)8V^H136]K.ZPJXD:3F,'."OJ?;Z<>BII\MC;Z
MA%+;VD["%7$C/S&#G!7W]OIQZ"EW=_Z7F#3Z+O\ J(NF2V-OJ,4UO:SND*OO
M,O,8.<%?4^Q]1Q0FFRV5OJ$<UO:SLD*OO,G,8.<%?4^WN.*$TZ2RMM0BF@M9
MV6%7#F3!C!S@KZGV^G%"Z;)8V^HQ306L[+"KB0R8,8.<%?4^WTXHYO/M^GF#
M5NG1_J":;+96^H1S6]K,R0JX<R<Q@YP5]3[?3BJ\T)TCSK2YM[>>6:,%'#9\
MO.<$8[^Q_*K"Z;)8V^H1306L[+"KB0R8,8.<%?4^WTXI4TZ6PM]1BF@M)V6%
M7WM)S&#G!7CK[?3CT:EYW_I>8FGV[_J(NF2V-OJ,4UO:S,D2OYADYC!S@KZG
MV^G%":;+96VHQ36]K,R1*XD,G,8.<%?4^WN.*%TV2QM]0BF@M9V6)7#F3!C!
MS@KZGV^G'H)ILEE;:A%-!:SLL2N)#)@Q@YP5]3[?3CT7-Y]OT\P:\NC_ %!-
M,ELK?48IK>UF9(E?S#)S&#G!7U/M].*KSP_V1YUG<V]O/+,BE) V?+SG!'O[
M'\O2PFFR65OJ$4T%K.RQ*XD,F#&#G!7U/M]./14TZ2QM]1BE@M)V6)6#F3E
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M^:9/F3.<%?7Z?2FI=W?;]/,'#R_K4<-.ET^TU2WGMK2:1%3,IDYCR>"OK_\
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MGV68IY@QG:V0,^]-OK*73[IK>?;YB@$[6R.>:N,DTM2)1:;T*]%%%42%%%%
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MT@,EW;07!N8 T;;_ +F>AX_E5FVL);,7:2PVDV;7S0SR_='8KCJ?:ARZM_\
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MDBSL1'GN#W./\YZ4)T&C/<6EQ%;W,DT(*2*V?+SW!QUQ_G/2W%ITMC;WZ/\
M89C]E67<T@R@.<%01U[8]Q^'NVCUZ_\  /G.:71V)3974:7XNFM[F1+97\R6
M;+1@Y(*YZGMCW'?I4FA&CF>UN88+B2:$%)%;(CSW!QR<?YSTBG3^QFN+2XBM
M[F2:%2DBG(CSW!QUQ_G(XTM.T*[:6YL(EL;B::!&0M(,H&S@C(SGU';(_ <E
M%7D]/^&%9R:M_6_WW)M+\-W<US<V"1V<TCPHWF-)_J@Q/S 8SG';W%>EZ+HU
MKH>GK:VRY/620CEV]347A_0+;P_IX@AP\S<RRD<N?\/05=U"]CTZPFNI%+"-
M"P1>K$=A[UX^)Q,JTN6.WYGO83"QP\.>>_Y(9J>I0Z78374Q'[M"P3< 7QV&
M:\IUO4;A[^Y?4HX;B6YA4PE6X@4\C;D>G^<])?$%YJ<NH77V^T2Z>:("$Q@L
MMN#_ '>.3C_.>D$6B7ME;7Z-!;39MED#$\J#G[N1RWM[C\.W#4(45S2>K_X'
M]>9YV,Q,ZSM'1+_@[^O08FF2V4=]%(MG,PMA*':3F,'N./O=L>X_"K)&NE>?
M;7$,-P\T*E)%/^KSR"..N/\ .>A/;2Z,EQ#<6B3F:%2LH4XBSWR1UQ_/U'$R
M:?+8PW\3_8IB;59=Q?E >ZY'WNV.O(_#LYENW>__  #B<6M-K?AN/73)+**^
MBD6SE86RR[R_,8/<<=>V/<>G%:6,:4)[:>*&>2:)620'/EYYR..N/Y^HXCF
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MA;-:>%+"%G5R$8[D.006)'\ZE\3G;X6U0X_Y=9/_ $$UY!%XDU_PLD=A;:E
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M&XMX)YID4I+OSY6?IWK*U"T;3[UK5IX)BH!\R!]Z'(SP:-0M&T^]:U:>"8J
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M $!O_)J'_P"+H_X5;XS_ .@-_P"34/\ \71[6'=!ROL<AFC-=?\ \*M\9_\
M0&_\FH?_ (NC_A5OC/\ Z W_ )-0_P#Q='M8=T'*^QR&:,UU_P#PJWQG_P!
M;_R:A_\ BZ/^%6^,_P#H#?\ DU#_ /%T>UAW0<K['(9HS77_ /"K?&?_ $!O
M_)J'_P"+H_X5;XS_ .@-_P"34/\ \71[6'=!ROL<AFC-=?\ \*M\9_\ 0&_\
MFH?_ (NC_A5OC/\ Z W_ )-0_P#Q='M8=T'*^QR&:,UU_P#PJWQG_P! ;_R:
MA_\ BZ/^%6^,_P#H#?\ DU#_ /%T>UAW0<K['(9HS77_ /"K?&?_ $!O_)J'
M_P"+H_X5;XS_ .@-_P"34/\ \71[6'=!ROL<AFC-=?\ \*M\9_\ 0&_\FH?_
M (NC_A5OC/\ Z W_ )-0_P#Q='M8=T'*^QR&:,UU_P#PJWQG_P! ;_R:A_\
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M .@-_P"34/\ \71[6'=!ROL<AFC-=?\ \*M\9_\ 0&_\FH?_ (NC_A5OC/\
MZ W_ )-0_P#Q='M8=T'*^QR&:,UU_P#PJWQG_P! ;_R:A_\ BZ/^%6^,_P#H
M#?\ DU#_ /%T>UAW0<K['(9HS77_ /"K?&?_ $!O_)J'_P"+H_X5;XS_ .@-
M_P"34/\ \71[6'=!ROL<AFC-=?\ \*M\9_\ 0&_\FH?_ (NC_A5OC/\ Z W_
M )-0_P#Q='M8=T'*^QR&:,UU_P#PJWQG_P! ;_R:A_\ BZ/^%6^,_P#H#?\
MDU#_ /%T>UAW0<K['(9HS77_ /"K?&?_ $!O_)J'_P"+H_X5;XS_ .@-_P"3
M4/\ \71[6'=!ROL<AFC-=?\ \*M\9_\ 0&_\FH?_ (NC_A5OC/\ Z W_ )-0
M_P#Q='M8=T'*^QR&:,UU_P#PJWQG_P! ;_R:A_\ BZ/^%6^,_P#H#?\ DU#_
M /%T>UAW0<K['(9HS77_ /"K?&?_ $!O_)J'_P"+H_X5;XS_ .@-_P"34/\
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M /"K?&?_ $!O_)J'_P"+H_X5;XS_ .@-_P"34/\ \71[6'=!ROL<AFC-=?\
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M $!O_)J'_P"+H_X5;XS_ .@-_P"34/\ \71[6'=!ROL<AFC-=?\ \*M\9_\
M0&_\FH?_ (NC_A5OC/\ Z W_ )-0_P#Q='M8=T'*^QR&:,UU_P#PJWQG_P!
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M (NC_A5OC/\ Z W_ )-0_P#Q='M8=T'*^QR&:,UU_P#PJWQG_P! ;_R:A_\
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M .@-_P"34/\ \71[6'=!ROL<AFC-=?\ \*M\9_\ 0&_\FH?_ (NC_A5OC/\
MZ W_ )-0_P#Q='M8=T'*^QR&:,UU_P#PJWQG_P! ;_R:A_\ BZ/^%6^,_P#H
M#?\ DU#_ /%T>UAW0<K['(9HS77_ /"K?&?_ $!O_)J'_P"+H_X5;XS_ .@-
M_P"34/\ \71[6'=!ROL<AFC-=?\ \*M\9_\ 0&_\FH?_ (NC_A5OC/\ Z W_
M )-0_P#Q='M8=T'*^QR&:,UU_P#PJWQG_P! ;_R:A_\ BZ/^%6^,_P#H#?\
MDU#_ /%T>UAW0<K['(9HS77_ /"K?&?_ $!O_)J'_P"+H_X5;XS_ .@-_P"3
M4/\ \71[6'=!ROL<AFC-=?\ \*M\9_\ 0&_\FH?_ (NC_A5OC/\ Z W_ )-0
M_P#Q='M8=T'*^QR&:,UU_P#PJWQG_P! ;_R:A_\ BZ/^%6^,_P#H#?\ DU#_
M /%T>UAW0<K['(9HS77_ /"K?&?_ $!O_)J'_P"+H_X5;XS_ .@-_P"34/\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1156._BDU*6Q!_>1H'/7OU_+*_G[5,IQC:[
MW&HMWMT+5%%%4(**** "BBB@ HK'\2>([+POIL5]?-B.2XC@'!_B/S'@'HH9
ML=]N.I%;%.SM< HHHI %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MV(R>A/! ; Y.W'>O1J44Z?*NABI:W/IVBBBO--@HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "N-T_\ Y')_^N\W\FKLJXW3_P#D<G_Z[S?R:O*S'^)1_P 2.W"?!4]#LJ**
M*]4X@HHHH **** /'_CK_P P#_MX_P#:=>D>$O\ D3=#_P"P?;_^BUKS?XZ_
M\P#_ +>/_:=>D>$O^1-T/_L'V_\ Z+6NB?\ !C\R%\3-BBBBN<L**** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *XW3_ /D<G_Z[
MS?R:NRKC=/\ ^1R?_KO-_)J\K,?XE'_$CMPGP5/0[*BBBO5.(**** "BBB@#
MQ_XZ_P#, _[>/_:=>D>$O^1-T/\ [!]O_P"BUKS?XZ_\P#_MX_\ :=>D>$O^
M1-T/_L'V_P#Z+6NB?\&/S(7Q,V****YRPHHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ KC=/_Y')_\ KO-_)J[*L"UT.Y@\0-?L
M\)B,CO@$[L-G';WKSL=2G.=)Q5[239U8:<8QFF]T;]%%%>B<H4444 %%%% '
MC_QU_P"8!_V\?^TZ](\)?\B;H?\ V#[?_P!%K7-_$GP3J7C'^S/[/GM(OLOF
M[_M#LN=VS&,*?[IKK=#LI=,\/Z;83,C2VMK%"Y0DJ65 #C/;BMY23I174E+W
MF7Z***P*"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***#T- &)/XO\
M.VL[P3:Q:+*AVLOF9P?3BM*QU"SU*W\^QNH;F+.-\3AAGTX[U\QV=I-J-]%:
MPC=-,VU >['H*ZWX8ZV=*\5):2.5M[X>2P)X#_P'ZYX_X%6TJ5EH9J>I[Q11
M16)H%1SW$-K \]Q*D4*#+R2,%51[DU)7DWQ?UTF2UT.%^ //G /4]%!_4_B*
MJ,>9V%)V5SO!XT\-,X0:U9Y)QS)@?G6X"& (((/((KY;O+*:QDCCG&UWB24#
MT# ,/T(KZ0\,$MX3T8DY)L8"2?\ <%5."BM"8RN:M%%%9EA1110 4444 %%<
M%\1O%^I^&7T^/3O)'V@.SM(FX\;<8_,UM>!]<N_$/AF*_O1&)S(Z$QK@'!ZX
MJN5VN*ZO8Z.BBBI&%%%% !1110 45G:]?2Z9H&H7T*JTMO \B!QQD#(S7 ^
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MGR) <,&QZ?[OZU"LWJ4[VT-'_A-_#/\ T&K3_ONC_A-_#/\ T&K3_ONO.?\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MG_\ (^7O^Y%_Z *]G\+_ /(I:-_UXP?^BUHG\*"/Q,?X@UF/P_H=SJDT3RI
M%RB'!.6"C]36)X1\>0>++RXM4L9+:2&/S,LX8$9QZ#UI_P 2O^2?ZG_VR_\
M1J5PGP<_Y&&__P"O7_V=:2BG!L;;YK'LU4]5U!-*TJZU"5&=+>)I"J]3@=*N
M5A^,O^1,UC_KU?\ E4+<MF-X6^(MOXGU<Z<NGRV[F-G5C(&!QV/ K=\2^((/
M#.CMJ,\+S*'5 B$ DGW_ #KR'X4_\CLG_7O)_2O:=4TFQUJQ:RU" 3V[$$H6
M*\CH<@@BKFE&1$6VCPSQSXP@\6S63PVDEO\ 9U<$.P.=V/3Z5K>$/B-:^&M
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M6K):2/Y<D)8MY;$9!!/.#@]>_P!:Z'X0:O)<Z5>:7*Q86CJ\6>RMG(_ C/\
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M"#4.+6Y2:>PZBBBD,**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M(?KC;_[+7O5>!?$Z[2Z\<7:H<B!$BR/4#)_4D4J7Q#J;'KO@:9I_!&DNQR1
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MKU6O*_@O_JM:_P!Z'_V>O5**GQ,(?"<C\34#> K\D<JT1'_?Q1_6N*^#9/\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M.N=OW<X_SFG3FDK,)QOL:7P\T3^Q?"5L'7;<77^D2YZ_-]T?@N/QS754  #
MX%%9MW=RDK'@7Q/_ .1\O?\ <B_] %>S^%_^12T;_KQ@_P#1:UB^(?ASI7B+
M5WU*XN;N*5PJNL3+M.!@=0<<5U-E:1:?86UE#N\JWB6)-QR=J@ 9_*KE).*1
M,4TVRKKVFC6-!OM/R 9X612>@;^$_GBOGW0]5N_"7B1+HPD2V[M'-"W&1T93
M_GJ!7TG7,>)/ FC^)9/M%PCP7>,&> @%O3<#P?Y^]$)):,)1OJBFGQ2\+M:>
M<US.DF,^08&+?3(^7]:\]\1^)]5\>WILM/MY(["%6E\K/91DO(>GX?S-=3#\
M&K!9@9M6N7CS]U(U4_GS_*NUT[PUI6DZ7+I]C;"*&9"DK Y=\C&2QY/6G>$=
M4%I/<\@^%/\ R.R?]>\G]*]VKD?#GP]TSPUJAU"VN;N678442LN #UZ <UUU
M3.2;NAQ5D>8_&2PDET_3+]%)2"1XW([;@"/_ $$_G63\.?'.G:#ITVF:J[Q1
M^:98I0A8#( *D#GMGIW->NWME;:C9RVEW"LUO*NUT8<$5Y_=_!W2I9B]KJ%U
M A.=C /CZ'BJC*/+RR$T[W1T>B>.-'\0ZO)IVG-/(Z1&7S&CVH0"!@9YSSZ5
MP/QATN9-6L]4528)(?(9AT#J2>?J#^AKN?"W@33?"L\ES;RSSW,B>69)2,!<
M@D  >P]:Z&^L;74K.2TO8$GMY!AD<9!_SZU*DHRNAM-K4\V\ >/M*L]"ATG5
M9_LLMOE8Y&4E74DD<CH1G'/M6WK?Q/T'3;5OL,WV^Z(^2.,$*#ZLQ'3Z9-9U
M[\'M*FE+V=_=6RG^!@) /IT/YYJWI'PHT/3YEFNY)K]U.0DF%C_%1U_$XJGR
M7N)<VQX]K-Y?ZGJ+ZEJ(;SKL>:&*[0R_=&/8;<?A7T=HG_( T[_KUB_]!%87
MB/X?Z7XEOH;J>>YMVBA$(2 J%V@DC@@XZFNGMK=+2UAMX\^7$BQKD\X P*4Y
M*25@C%IE;6K-M1T+4+)/OSV\D:_4J0/UKY[\+:R?#7B:VOYHG*1,R31@8;:0
M0>O<=?PKZ2KCO$/PWT77KM[P&6SNI#EWAQM<^I4]_IBB$DM&$HMZHCN/BIX7
MAA#QSW$['_EG' 01_P!]8'ZUV@(901T/(KSJR^#^DP3K)=7]S<HISY8 0'V/
M4X^F*]&Q@8%3+E^R-7ZGS=XK_P"1VU;_ *_9/_0C7TC7$:A\+]'U+69M2ENK
MU6FE,KQJR[<DY./ESBNWJIR32L**:N>:?%?PQ+?6T6MVD9>2V3R[A5&28\Y#
M?@2<^Q]JY?P)X_\ ^$:1M/OXWET]VW*R<M$3UP.X/I7N?6N,UGX9>']6F:>-
M)+&9CDFW("D_[I&/RQ1&:MRR!Q=[HF/Q+\)B'S/[3)./N""3/T^[7F?CGQT_
MBEX[.SB>'3XVW!6^_*W0$@=/8?Y'5+\&;3?EM9G*^@A /YYKI]!\ :#H$JW$
M,#W%TO*S7!#%3[#  ^N,TTX1U0FI/1F=\-/"LN@Z5)>WL92]O,'8PYCC'0'T
M)ZG\/2NYHHK-N[N6E96/F[PW_P CQI?_ &$(_P#T,5](UQ%C\+]'L-:AU..Z
MO6:&83)&S+MW Y&?ESC-=O5U)*6Q,$UN%?-VK?\ (]WW_83D_P#1IKZ1KB+C
MX7Z/<ZY)JCW5Z'DG,[1AEV[BVXC[N<9HIR4=PDFSMZ\STWXMP"^GMM:LS JR
MLJ30 L  ?XE//XC\J],KD=<^'&@ZY</<F.2TN7.YY+=@ Q]2I!'Y8J8\O4;O
MT)S\0_"HA\W^UXR,9P(WS^6,UY)XY\2IXMU^)[*&3R(D$,((^9R3UQ[DX ]J
M[,?!FSWY.L3[/3R1G\\UU'A_P%H?AV5;BWA>>Z7I/<$,R_08 'UQFK3A'5$M
M2>C+GA'29-$\*Z?I\W$T<9:0>C,2Q'X$XK;HHK)NYH%9WB#_ )%O5/\ KSE_
M] -:-0W=M'>6<]K+GRYHVC?!P<$8/\Z$!X+\,_\ D?M/_P!V7_T6U?0%<=X?
M^'&E>'M8CU*WNKN66(,$65EP,@@YP!G@FNQJZDE)W1,$TM3P+XG?\CY??[D7
M_H"U[5X;_P"16TC_ *\H?_0!6#X@^'.E^(M7?4KBZNXI9 H=8F7:<# QD''
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M<_X6\(6/A.*Y2SFGE-P5+M,1_#G&, >IKH*)N[N@BK*QR7Q,_P"1 U'ZQ?\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@#YN\-_\CQI?_80C_P#0Q7TC6'!X
M.\/6NH+?0Z5 ERK[U<9X;U S@5N5<Y*1,8V"BBBH*"BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MP3_ZF:.3_<8&I::::N@::W"BBBF(**** "BBB@ HHHH **** "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M47AS_D.V_P#P+_T$UW=>-EN7T<32<ZE[WM^1Z&+Q52E-1CV.)_X1;4?^F/\
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MIB<=+&0]CAX/7=DT<,L/+VE62T-/PE;LEI/<,,"5@%]P/_U_I6QJ?_(*O/\
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MFL7+$4HQ=F]+^K%@FE2FVKV-/3O"PDC$M^[AFY$:GD?4TFK>&H[>U>XM&?\
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M/_7)OY&N(T'_ )#EK_O'^1KH=1\0V M98HG:5W0J-J\#(]37/: ,ZY:_4_\
MH)KRL?6IU,71Y'>S6WJCNPU.4*,^96T_0[ZBBBOH3R@KG?$VJ2VRI:0,4:1=
MSL.H'3 _6NBKC_%L++?Q38^1X]H/N"?\17G9I4G##-P.K!1C*LE(;H_A[[?
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10!E3>'K"XNFN'$FYFW, W!-:M%%9TZ-.FVX*U]RY5)2LI.]@HHHK0@****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH I3Z1875P;B:W#RG&26/./;.*N]***B-.$6W%)7W*<I-)-[!1115DA1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
(4 %%%% '_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>img32108071_1.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img32108071_1.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" /-#SP# 2(  A$! Q$!_\0
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M977:_;ZFK']F_P#3Q)26'_'S=_[_ /4U?H H_P!F_P#3Q)1_9O\ T\25>HH
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M4?V;_P!/$E7J* */]F_]/$E']F_]/$E7J* */]F_]/$E']F_]/$E7J* */\
M9O\ T\24?V;_ -/$E7J* */]F_\ 3Q)1_9O_ $\25>HH H_V;_T\24?V;_T\
M25>HH H_V;_T\24?V;_T\25>HH H_P!F_P#3Q)1_9O\ T\25>HH H_V;_P!/
M$E']F_\ 3Q)5ZB@"C_9O_3Q)1_9O_3Q)5ZB@"C_9O_3Q)1_9O_3Q)5ZB@"C_
M &;_ -/$E']F_P#3Q)5ZB@"C_9O_ $\24?V;_P!/$E7J* */]F_]/$E']F_]
M/$E7J* */]F_]/$E']F_]/$E7J* */\ 9O\ T\24?V;_ -/$E7J* */]F_\
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MV;_T\24?V;_T\25>HH H_P!F_P#3Q)1_9O\ T\25>HH H_V;_P!/$E']F_\
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MV;_T\24?V;_T\25>HH H_P!F_P#3Q)1_9O\ T\25>HH H_V;_P!/$E']F_\
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M_P!/$E7J* */]F_]/$E']F_]/$E7J* */]F_]/$E']F_]/$E7J* */\ 9O\
MT\24?V;_ -/$E7J* */]F_\ 3Q)1_9O_ $\25>HH H_V;_T\24?V;_T\25>H
MH H_V;_T\24?V;_T\25>HH H_P!F_P#3Q)1_9O\ T\25>HH H_V;_P!/$E']
MF_\ 3Q)5ZB@"C_9O_3Q)1_9O_3Q)5ZB@#)N[0V\&\3.W.,&IDT_<BG[1)R,U
M)J?_ !Y_\"%6H_\ 5)_NB@"G_9O_ $\24?V;_P!/$E7J* */]F_]/$E']F_]
M/$E7J* */]F_]/$E']F_]/$E7J* */\ 9O\ T\24?V;_ -/$E7J* */]F_\
M3Q)1_9O_ $\25>HH H_V;_T\24?V;_T\25>HH H_V;_T\24?V;_T\25>HH H
M_P!F_P#3Q)1_9O\ T\25>HH H_V;_P!/$E']F_\ 3Q)5ZB@"C_9O_3Q)1_9O
M_3Q)5ZB@"C_9O_3Q)1_9O_3Q)5ZB@"C_ &;_ -/$E']F_P#3Q)5ZB@"C_9O_
M $\24?V;_P!/$E7J* */]F_]/$E']F_]/$E7J* */]F_]/$E']F_]/$E7J*
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M24?V;_T\25>HH H_V;_T\24?V;_T\25>HH H_P!F_P#3Q)1_9O\ T\25>HH
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MJA8?\?-W_O\ ]35^@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M&R?ZI_\ =-5=,_X\_P#@1JU)_JG_ -TU5TS_ (\_^!&@"Y1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110!'<?\ 'M+_ +A_E4&F_P#'DGU/\ZGN
M/^/:7_</\J@TW_CR3ZG^= %NBBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@""\_X\Y?]VDL?^/*+Z?UI;S_ (\Y?]VDL?\ CRB^G]: +%%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% %>^_X\I?I_6EL_^/.+_=I+
M[_CRE^G]:6S_ ./.+_=H GHHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH J:E_QY/\ 4?SJ>W_X]HO]P?RJ#4O^/)_J/YU/;_\ 'M%_N#^5 $E%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% %/4_^//\ X$*M1_ZI
M/]T55U/_ (\_^!"K4?\ JD_W10 ZBBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@"CJO_'JO^^/Y&KU4=5_X]5_WQ_(U>H **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** *&I](?\ ?J_5#4^D/^_5^@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "J$/_(7G_W/\*OU0A_Y"\_^Y_A0
M!?HHHH H6'_'S=_[_P#4U?JA8?\ 'S=_[_\ 4U?H **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@!LG^J?_=-5=,_X\_^!&K4G^J?_=-5=,_X\_\
M@1H N4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 1W'_'M+_N'
M^50:;_QY)]3_ #J>X_X]I?\ </\ *H--_P"/)/J?YT 6Z*** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** (+S_CSE_P!VDL?^/*+Z?UI;S_CSE_W:
M2Q_X\HOI_6@"Q1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!7O
MO^/*7Z?UI;/_ (\XO]VDOO\ CRE^G]:6S_X\XO\ =H GHHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH J:E_P >3_4?SJ>W_P"/:+_<'\J@U+_C
MR?ZC^=3V_P#Q[1?[@_E0!)1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110!3U/\ X\_^!"K4?^J3_=%5=3_X\_\ @0JU'_JD_P!T4 .HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH HZK_ ,>J_P"^/Y&KU4=5_P"/
M5?\ ?'\C5Z@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH H:G
MTA_WZOU0U/I#_OU?H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M JA#_P A>?\ W/\ "K]4(?\ D+S_ .Y_A0!?HHHH H6'_'S=_P"__4U?JA8?
M\?-W_O\ ]35^@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** &R?Z
MI_\ =-5=,_X\_P#@1JU)_JG_ -TU5TS_ (\_^!&@"Y1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110!'<?\ 'M+_ +A_E4&F_P#'DGU/\ZGN/^/:
M7_</\J@TW_CR3ZG^= %NBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@""\_X\Y?]VDL?^/*+Z?UI;S_ (\Y?]VDL?\ CRB^G]: +%%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% %>^_X\I?I_6EL_^/.+_=I+[_CR
ME^G]:6S_ ./.+_=H GHHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH J:E_QY/\ 4?SJ>W_X]HO]P?RJ#4O^/)_J/YU/;_\ 'M%_N#^5 $E%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% %/4_^//\ X$*M1_ZI/]T5
M5U/_ (\_^!"K4?\ JD_W10 ZBBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@"CJO_'JO^^/Y&KU4=5_X]5_WQ_(U>H **** "BBB@ HHHH ****
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MBB@ HHHH **** "BBB@!LG^J?_=-5=,_X\_^!&K4G^J?_=-5=,_X\_\ @1H
MN4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 1W'_'M+_N'^50:
M;_QY)]3_ #J>X_X]I?\ </\ *H--_P"/)/J?YT 6Z*** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** (+S_CSE_P!VDL?^/*+Z?UI;S_CSE_W:2Q_X
M\HOI_6@"Q1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!7OO^/*
M7Z?UI;/_ (\XO]VDOO\ CRE^G]:6S_X\XO\ =H GHHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH J:E_P >3_4?SJ>W_P"/:+_<'\J@U+_CR?ZC
M^=3V_P#Q[1?[@_E0!)1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10!3U/\ X\_^!"K4?^J3_=%5=3_X\_\ @0JU'_JD_P!T4 .HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH HZK_ ,>J_P"^/Y&KU4=5_P"/5?\
M?'\C5Z@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH H:GTA_W
MZOU0U/I#_OU?H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ JA#
M_P A>?\ W/\ "K]4(?\ D+S_ .Y_A0!?HHHH H6'_'S=_P"__4U?JA8?\?-W
M_O\ ]35^@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** &R?ZI_\
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M2[G4+IL0VZ%V (!;T49(&2< #/)(KP'Q)XDO?$VI&[NSLC3*P0*<K$OH/4G
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M#W_,:_[8?^U*[*^%ITZ3DMSBP^,J5*RC+8]0HHHKS3U HHHH **** "BBB@
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M:*'4(I=.F?JSG?"#NP!O&#T.22H P<GUX'6_A]KNAV37DD<-S;HI:5[9RWE
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MXOV:B(V&CW$V<^8+F58BO3&-N_/?T_&O-=7U>]UW4I+^_EWS/P .%11T51V
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MO$O_ "*NL?\ 7E-_Z :^<J,)AX54W(,9B9T6E$]C_P"%MZ%_SY:G_P!^X_\
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M/-0^(]>@\.:+-J,Z^85(6.(.%,CGHHS^).,D $X.*\"UC6+W7=2DO[^7?,_
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M*J<;<9SEA_>_G531O'FDZWJD>GP1W44TH8QF5  Q R1P3S@$\\<?2N>^*_\
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MUU<_\M)IYG]V9W8_F22?QHH8;G7-+8K,,T^KR]E25Y?D>C7'Q61;AUM=&:2
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M%O(T,:/D<NH<L,=> Z?G]:].K)\-Z!;^&M%BTZ!O,*DO+,4"F5SU8X_ #.2
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M5MXZ\_?\OIS^&:]B3Y\+=]CQ(KDQEEW/2?B+_P B'J7_ &R_]&I7@<O^I?\
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M(U8*<=F%%%%0:!1110 4444 %%%% !1110!1U7_CU7_?'\C5ZJ.J_P#'JO\
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MJD[AG.1E>G7GCCE@ZJE9*YW1QM%QNW8D^+>K1QZ;9:3',XN)I?/D1'&/+4$
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M_K_N/_1C5](5\W^(?^1HUC_K_N/_ $8U&7_&_069?!'U/5/A+_R*MU_U^O\
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M'_7_ ''_ *,:C+_C?H+,O@CZGJGPE_Y%6Z_Z_7_] 2N\K@_A+_R*MU_U^O\
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M/J]/\SR<-&6*Q?M;:)W_ ,C:U[_D7=3_ .O27_T UX;7N6O?\B[J?_7I+_Z
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MJ+HVO6M](SB%&*S;6(RC#!) !W 9W8QR5%>WUCCZ/LZMULS?+J_M:-GNM/\
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M9/1G5Q#Q$ME?[V<+\5_^81_VV_\ 9*YCP+_R/&E_[TO_ **>NG^*_P#S"/\
MMM_[)7,>!?\ D>-+_P!Z7_T4].G_ +M\F1B?^1JO6/Y(]OK-\0_\BSJO_7G-
M_P"@&M*LWQ#_ ,BSJO\ UYS?^@&O.A\2/IZW\.7HSP&O>_#'_(IZ-_UXP?\
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M[P!7K@9]!71445,I.3YGN7""A%1CL%%%%24%>8-\'8P["'6W6('Y%>V#,%[
MD,,GWP/H*]/HK2G5G3^!V,JM&%6W.KGE_P#PI[_J._\ DI_]G1_PI[_J._\
MDI_]G7J%%:_7*W\WY&7U*A_+^+.,\)> CX6U:6^_M/[2'@,.SR-F,LISG<?[
MO3WKLZ**QG4E-\TMS>G3C3CRQ6@4445!84444 %%%% !1110 4444 1W'_'M
M+_N'^50:;_QY)]3_ #J>X_X]I?\ </\ *H--_P"/)/J?YT 6Z*** "BBB@ H
MHHH **** "BBB@ HHHH Y7Q-X"TOQ)=&]>26UO?+*>9%C:YQ\I=2/FQ[$$CC
M/ QQ%Q\)-96Y=;:^L)8!C8\K.C'CG*A6 YSW/]*]AHK>GB:L%9/0YZF%I5'>
M2U/';?X2:T]RBW-]I\4!SODC9Y&7CC"E5!YQW']*] \+>#K#PM"[0LUQ>2J!
M+<2  ]!E5 ^ZN1G')Z9)P,=%114Q%2HK2>@4L+2IN\5J%<+K_P +],U2X%QI
MTPTQSM#1QPAH2 ".$!&T].AQQTR2:[JBLX5)0=XNQK4IPJ*TU<\;D^$NNB:0
M17FG-$&(1FD=2RYX)&PX..V3]33[?X2:RURBW-]810'.]XF=V''&%*J#SCN/
MZ5[#171]=K=SF^H4+[''>&?AWIF@2"YN6&HWHP5DEB 2,ALAD3G#?=Y))XXQ
MDBNQHHKFG.4W>3N=,(1@K15D97B/1SK^@W.F"X^S^?L_>;-^W:X;ID>F.M>:
MQ?"#4Y;F>*XU.TBM<,(I8U:1VYXW(=H'')PQP>.>M>OT5I3KU*:Y8LSJ8>G4
MES36H4445B;GEGB'X7:G>ZK<7VGW]I)]IGDF=+@-%Y>YL@ @-NZGGCI[\=GX
M0\,GPKI<]D;S[5YMP9M_E;,955QC)S]W.?>N@HK:=>I./+)Z&$,/3A+GBM0K
MC_$OP\TO7W-S;L-/O#DM)%&"DA+9)=>,M][D$')YS@"NPHK.$Y0=XNQI.$9J
MTE='CUQ\)-96Y=;:^L)8!C8\K.C'CG*A6 YSW/\ 2F1_"773-&);S3EB+ .R
MR.Q5<\D#8,G';(^HKV2BNGZ[6[G-]0H7V.$T#X7Z9I=P;C49AJCC<$BDA"P@
M$ <H2VXCYNIQSTR :[NBBN>=24W>3N=-.G"FK15@KR*?X1:FMY"EOJ=I+:G'
MFRR*R.O/.U!N!XY&6&>G'6O7:*JG6G2OR/<BK0A5MSK8R?#6BGP]H%MI9N/M
M'DESYNS9G<[-TR>F['7M6G-#%<0R0S1I)%(I1T=0592,$$'J#3Z*S;;=V:J*
M2LCR'4?A)JB79&EWUI-;$9!NG:-UY/!VJP/&.>,G/ KN_!?AJ3PMHKVDUPDT
MTTWGR&-2%5BBJ5!/W@-O7 SZ"NCHK6>(J5(\LF8T\-3IRYHK4*\JU_X6ZG=Z
MI<WNGW]G+]JN)9G2X#1>7N;< " V[J1GCI[\>JT5-.K.F[Q956C"JK31SO@S
MPY+X8T,V<]PD\LLOG.44A48JH*@G[P!7K@9]!71445,I.3YGN7""A%1CL%%%
M%249OB#1X]?T*ZTR29H5G Q(HR5(8,#CN,@9'IW'6N!_X4]_U'?_ "4_^SKU
M"BM:=>I35HLQJ8>G5=YJYY?_ ,*>_P"H[_Y*?_9T?\*>_P"H[_Y*?_9UZA16
MGURM_-^1G]2H?R_BSA/#?PUCT#78-4?5'N&@#;(U@"#<RE<D[CD88\<<XY['
MNZ**QJ5)5'>3-J=*%-<L%9!1114&@4444 %%%% !1110 4444 07G_'G+_NT
MEC_QY1?3^M+>?\><O^[26/\ QY1?3^M %BBBB@ HHHH **** "BBB@ HHHH
M**** .5\3> M+\271O7DEM;WRRGF18VN<?*74CYL>Q!(XSP,<1<?"365N76V
MOK"6 8V/*SHQXYRH5@.<]S_2O8:*WIXFK!63T.>IA:51WDM3QVW^$FM/<HMS
M?:?% <[Y(V>1EXXPI50><=Q_2O0/"W@ZP\+0NT+-<7DJ@2W$@ /0950/NKD9
MQR>F2<#'1445,14J*TGH%+"TJ;O%:C)H8KB"2">-)8I%*/&ZAE92,$$'J"*X
M'6?A387]^USI]\U@LC%I(?)$B G'W!E=HZG'/7C &*]!HK.%2=-WB[&E2E"H
MK35SQ@?";Q#CFYTL'VFD_P#C=6+3X1ZM),RWFHV4$6WY7A#RMNXXVD+QUYS^
M'IZ_170\;6[G.L!0OL<SX8\#Z7X:02JOVN^X)NID&4.W:?+'\ .6[D\X).!7
M3445S2DY.\F=481@K15D97B/1SK^@W.F"X^S^?L_>;-^W:X;ID>F.M>:Q?"#
M4Y;F>*XU.TBM<,(I8U:1VYXW(=H'')PQP>.>M>OT5I3KU*:Y8LRJ8>G4ES36
MH4445B;GEGB'X7:G>ZK<7VGW]I)]IGDF=+@-%Y>YL@ @-NZGGCI[\=GX0\,G
MPKI<]D;S[5YMP9M_E;,955QC)S]W.?>N@HK:=>I./+)Z&$,/3A+GBM0KC_$O
MP\TO7W-S;L-/O#DM)%&"DA+9)=>,M][D$')YS@"NPHK.$Y0=XNQI.$9JTE='
MCUQ\)-96Y=;:^L)8!C8\K.C'CG*A6 YSW/\ 2F1_"773-&);S3EB+ .RR.Q5
M<\D#8,G';(^HKV2BNGZ[6[G-]0H7V.$T#X7Z9I=P;C49AJCC<$BDA"P@$ <H
M2VXCYNIQSTR :[NBBN>=24W>3N=-.G"FK15BKJ=F=1TF\L1)Y9N8'AW[=VW<
MI&<9&<9Z9KRS_A46I_VEY?\ :5I]@_Y[[6\WI_SSQCKQ]_IS[5Z[154Z\Z:M
M%D5</3JM.:*>DV/]F:-8Z>9/--K;QP^9MV[MJA<XR<9QTS2ZIIUOJ^F7.GW2
M[H9T*-P"5]&&01D'!!QP0#5NBL[N]S6RM8\<NOA+KB7+K9WNG30#&UYG>-CQ
MSE0K <Y[FO3?#6BCP[H%MI8G$_DESY@39NW.S=,G^]ZUK45K4KU*BM)F-+#T
MZ3O!!7CMW\(M8A9$L-0L;B,(,O/OA.[TV@/QTYS^'K[%12IUITOA956A"K;G
M6QE^'-'_ + T&VTPW'VCR-_[S9LW;F+=,GUQUK4HHK.3<G=FD8J*270****0
MS)\1>';+Q-IHL;YID19%E1X6VLK#(R,@@\$CD'KZX(\[U'X1WR3 Z7J-O+$S
M,2+H-&R+GY1E0VXXSDX7ITYX]:HK:G7J4](LPJX>G5UDCQD_";Q#CBZTS/\
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M2;RQ$GEFY@>'?MW;=RD9QD9QGIFO+/\ A46I_P!I>7_:5I]@_P">^UO-Z?\
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MH **** "BBB@ HHHH J:E_QY/]1_.I[?_CVB_P!P?RJ#4O\ CR?ZC^=3V_\
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M<_A7IM%=#S"NU:_X',LLPZ=[?B9&A^&M.T"+%K&7G.X-<RA3*02#MW # X'
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M<01SP2)+%(H=)$8,K*1D$$=013Z0PHHHH **** "BBB@ JA#_P A>?\ W/\
M"K]4(?\ D+S_ .Y_A0!?HHHH H6'_'S=_P"__4U?JA8?\?-W_O\ ]35^@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** &R?ZI_\ =-5=,_X\_P#@
M1JU)_JG_ -TU5TS_ (\_^!&@"Y1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110!'<?\ 'M+_ +A_E4&F_P#'DGU/\ZGN/^/:7_</\J@TW_CR3ZG^
M= %NBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@""\_X\Y?]VDL
M?^/*+Z?UI;S_ (\Y?]VDL?\ CRB^G]: +%%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% %>^_X\I?I_6EL_^/.+_=I+[_CRE^G]:6S_ ./.+_=H
M GHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH J:E_QY/\ 4?SJ
M>W_X]HO]P?RJ#4O^/)_J/YU/;_\ 'M%_N#^5 $E%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% %/4_^//\ X$*M1_ZI/]T55U/_ (\_^!"K4?\
MJD_W10 ZBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@"CJO_'JO
M^^/Y&KU4=5_X]5_WQ_(U>H **** "BBB@ HHHH **** "BBB@ HHHH ****
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M*]]_QY2_3^M+9_\ 'G%_NTE]_P >4OT_K2V?_'G%_NT 3T444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 5-2_X\G^H_G4]O_P >T7^X/Y5!J7_'
MD_U'\ZGM_P#CVB_W!_*@"2BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@"GJ?\ QY_\"%6H_P#5)_NBJNI_\>?_  (5:C_U2?[HH =1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M*=\/_P#/]JG_ '\C_P#B*/\ A3OA_P#Y_M4_[^1__$4W*#5A6EN9'_"Z9/\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110!'<?\>TO^X?Y5!IO_'DGU/\
MZGN/^/:7_</\J@TW_CR3ZG^= %NBBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@""\_X\Y?]VDL?^/*+Z?UI;S_CSE_W:2Q_X\HOI_6@"Q1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110!7OO\ CRE^G]:6S_X\XO\
M=I+[_CRE^G]:6S_X\XO]V@">BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@"IJ7_'D_U'\ZGM_^/:+_ '!_*H-2_P"/)_J/YU/;_P#'M%_N#^5
M$E%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% %/4_\ CS_X$*M1
M_P"J3_=%5=3_ .//_@0JU'_JD_W10 ZBBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@"CJO_ !ZK_OC^1J]5'5?^/5?]\?R-7J "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@"AJ?2'_?J_5#4^D/^_5^@ HHHH *
M*** "J%[KND:;.(+_5;&UF*AQ'/<(C%22,X)Z9!Y]C5^O+?B3X1UW7O$=O=:
M9IYN($M%C9_.C7Y@[G&&8'H1^=5%)O43=EH=U_PEGAO_ *&#2O\ P-C_ ,:/
M^$L\-_\ 0P:5_P"!L?\ C7BG_"MO%W_0'/\ X$P__%T?\*V\7?\ 0'/_ ($P
M_P#Q=7R1[D<S['M?_"6>&_\ H8-*_P# V/\ QJW8:OIFJ^9_9VHVEYY6/,^S
MSK)LSG&=I.,X/Y5X3_PK;Q=_T!S_ .!,/_Q=4[[P/XFL/+6XT2Z?S<X$""<<
M8Z[-VWKWQGGT-'LX]PYWV/H^BO"/"?Q&U72+Z.'4+MKW3YYE,SW3O(\2G@LC
M<G X.W!!V\8))KW2&:*X@CG@D26*10Z2(P964C(((Z@BHE%QW+4DQ]%%%2,*
M*** "J$/_(7G_P!S_"K]4(?^0O/_ +G^% %^BBB@"A8?\?-W_O\ ]35^J%A_
MQ\W?^_\ U-7Z "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ;)_J
MG_W3573/^//_ ($:M2?ZI_\ =-5=,_X\_P#@1H N4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 1W'_'M+_N'^50:;_P >2?4_SJ>X_P"/:7_<
M/\J@TW_CR3ZG^= %NBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@""\_P"/.7_=I+'_ (\HOI_6EO/^/.7_ ':2Q_X\HOI_6@"Q1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110!7OO^/*7Z?UI;/\ X\XO]VDOO^/*
M7Z?UI;/_ (\XO]V@">BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@"IJ7_'D_U'\ZGM_P#CVB_W!_*H-2_X\G^H_G4]O_Q[1?[@_E0!)1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110!3U/_CS_P"!"K4?^J3_ '15
M74_^//\ X$*M1_ZI/]T4 .HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH HZK_QZK_OC^1J]5'5?^/5?]\?R-7J "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@"AJ?2'_?J_5#4^D/\ OU?H **** "BBB@ HHHH
M **** "BBB@#Q[XL>%[6PDAUVR1(OM4QCN4!P&D(+!PN."0K;N>3@XR6-=7\
M*]2DU#P6D4H<FRG>V#O(6+K@..O0 .% YX4?09'QCU*V&EZ?I6[-T\_VG:"/
ME159<D9R,EN.,':WI5WX/QR)X1N6>-T62^=HV92 Z[$&1ZC((SZ@^E:OX-2%
M\1Z!1116184444 %4(?^0O/_ +G^%7ZH0_\ (7G_ -S_  H OT444 4+#_CY
MN_\ ?_J:OU0L/^/F[_W_ .IJ_0 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% #)>87Q_=-<E<:TUA+Y(\S&,_*V!772?ZI_]TUYWK'_'_P#\ %-*
MXF[(T?\ A)W_ .FW_?5'_"3O_P!-O^^JYZBJY41S,Z'_ (2=_P#IM_WU1_PD
M[_\ 3;_OJN>HHY4',SH?^$G?_IM_WU1_PD[_ /3;_OJN>HHY4',SH?\ A)W_
M .FW_?5'_"3O_P!-O^^JYZBCE0<S.A_X2=_^FW_?5'_"3O\ ]-O^^JYZBCE0
M<S.A_P"$G?\ Z;?]]4?\).__ $V_[ZKGJ*.5!S,Z'_A)W_Z;?]]4?\)._P#T
MV_[ZKGJ*.5!S,Z'_ (2=_P#IM_WU1_PD[_\ 3;_OJN>HHY4',SH?^$G?_IM_
MWU1_PD[_ /3;_OJN>HHY4',SH?\ A)W_ .FW_?5'_"3O_P!-O^^JYZBCE0<S
M.A_X2=_^FW_?5'_"3O\ ]-O^^JYZBCE0<S.A_P"$G?\ Z;?]]4?\).__ $V_
M[ZKGJ*.5!S,Z'_A)W_Z;?]]4?\)._P#TV_[ZKGJ2CE0<S.B_X2=_^FW_ 'U2
M?\)0_P#TV_[ZKGJ#3Y4',SH?^$H?_IM_WU2?\)2__3;_ +ZKG:2CE0<S.C_X
M2I_2;_OJD_X2I_2;_OJN<-(:.5!S,Z3_ (2M_2;_ +ZI/^$L;TF_[[KFJ2CE
M0<S.F_X2UO2;_OND_P"$M;TF_P"^ZYDTAHY4',SI_P#A+F_NS_\ ?=)_PES?
MW9_^^ZY@TAHY4',SJ/\ A+V_NS_]]TG_  F#?W9_^^ZY<TAHY4',SJ?^$P;^
M[/\ ]]TG_"8M_=G_ .^ZY6DHY4',SJ_^$R;^[/\ ]]TG_"9'^Y/_ -]URAI#
M1RH7,SK/^$S/]R?_ +[I/^$T/]R?_ONN3-(:.5!S,ZW_ (30_P!R?_OND_X3
M4_W)_P#ONN2-(:.5!S,Z[_A-C_<G_P"^Z3_A-C_<G_[[%<A24^5!S,[#_A-S
M_P \Y_\ OL4G_"<'_GG/_P!]BN/-(:.5!SL['_A.3_SSG_[[%)_PG/\ TSN/
M^^Q7&TE'*@YV=E_PG7_3.X_[[%'_  G?_3.X_P"^Q7&&D-+E0N=G9_\ "=_]
M,KC_ +[%'_">?],KC_OL5Q5)3Y4'.SM?^$]_Z97'_?8H_P"$^_Z97'_?8KB3
M2&CE0<[.V_X3[_IE<?\ ?8H_X3\?\\KC_OL5Q!I#1RH.=G=P>.!<W$=OY4X\
MUPF2XQR<5ISZXUE*8!YF%Y^5L#FO.M-_Y"MG_P!=T_\ 0A76ZM_R$9/H/Y4G
M%7*4G8U/^$G?_IM_WU1_PD[_ /3;_OJN>HI<J#F9T/\ PD[_ /3;_OJC_A)W
M_P"FW_?5<]11RH.9G0_\).__ $V_[ZH_X2=_^FW_ 'U7/44<J#F9T/\ PD[_
M /3;_OJC_A)W_P"FW_?5<]11RH.9G0_\).__ $V_[ZH_X2=_^FW_ 'U7/44<
MJ#F9T/\ PD[_ /3;_OJC_A)W_P"FW_?5<]11RH.9G0_\).__ $V_[ZH_X2=_
M^FW_ 'U7/44<J#F9T/\ PD[_ /3;_OJC_A)W_P"FW_?5<]11RH.9G0_\).__
M $V_[ZH_X2=_^FW_ 'U7/44<J#F9T/\ PD[_ /3;_OJC_A)W_P"FW_?5<]11
MRH.9G0_\).__ $V_[ZH_X2=_^FW_ 'U7/44<J#F9T/\ PD[_ /3;_OJC_A)W
M_P"FW_?5<]11RH.9G0_\).__ $V_[ZH_X2=_^FW_ 'U7/4E/E0<S.B_X2=_^
MFW_?5)_PE#_]-O\ OJN>H-'*@YF=#_PE#_\ 3;_OJD_X2E_2;_OJN=I*.5!S
M,Z/_ (2I_2;_ +ZI/^$J?TF_[ZKG#2&CE0<S.D_X2M_2;_OJD_X2QO2;_ONN
M:I*.5!S,Z;_A+6])O^^Z3_A+6])_^^ZYDTAHY4',SI_^$N;^[/\ ]]TG_"7-
M_=G_ .^ZY@TAHY4',SJ/^$O;^[/_ -]TG_"8-_=G_P"^ZY<TTT<J#F9U7_"8
M-_=G_P"^Z3_A,6_NS_\ ?=<K24<J#F9U?_"9-_=G_P"^Z3_A,S_<G_[[KE#2
M&CE0<S.L_P"$S/\ <G_[[I/^$T/]R?\ [[KDS2&CE0N9G6_\)H?[D_\ WW2?
M\)J?[D__ 'W7)&FFCE0<S.O_ .$V/]R?_OND_P"$V/\ SSG_ .^Q7(4E/E0<
MS.P_X3<_\\Y_^^Q2?\)P?^><_P#WV*X\TTT<J#F9V7_"<G_GG/\ ]]BD_P"$
MY_Z9W'_?8KC:2CE0<[.R_P"$Z_Z9W'_?8H_X3O\ Z9W'_?8KC#331RH7.SM/
M^$[_ .F5Q_WV*/\ A//^F5Q_WV*XJDHY4'.SM?\ A/?^F5Q_WV*/^$^_Z97'
M_?8KB32&CE0<[.V_X3[_ *97'_?8H_X3\?\ /*X_[[%<0:::.5!SL[ZU\:"^
MNHK7RYQYK;<EP16A-KSVDK0#S<)QPW%<!HG_ "&[/_KJ*Z;4O^0A-]1_*I<5
M<I2=C6_X2=_^FW_?5'_"3O\ ]-O^^JYZBCE0<S.A_P"$G?\ Z;?]]4?\).__
M $V_[ZKGJ*.5!S,Z'_A)W_Z;?]]4?\)._P#TV_[ZKGJ*.5!S,Z'_ (2=_P#I
MM_WU1_PD[_\ 3;_OJN>HHY4',SH?^$G?_IM_WU1_PD[_ /3;_OJN>HHY4',S
MH?\ A)W_ .FW_?5'_"3O_P!-O^^JYZBCE0<S.A_X2=_^FW_?5'_"3O\ ]-O^
M^JYZBCE0<S.A_P"$G?\ Z;?]]4?\).__ $V_[ZKGJ*.5!S,Z'_A)W_Z;?]]4
M?\)._P#TV_[ZKGJ*.5!S,Z'_ (2=_P#IM_WU1_PD[_\ 3;_OJN>HHY4',SH?
M^$G?_IM_WU1_PD[_ /3;_OJN>HHY4',SH?\ A)W_ .FW_?5'_"3O_P!-O^^J
MYZBCE0<S.A_X2=_^FW_?5'_"3O\ ]-O^^JYZDI\J#F9T7_"3O_TV_P"^J3_A
M*'_Z;?\ ?5<]2&CE0<S.B_X2A_\ IM_WU2?\)2_I-_WU7.TE'*@YF='_ ,)4
M_I-_WU2?\)4_I-_WU7.&FFCE0<S.E_X2M_2;_OJD_P"$L;TF_P"^ZYJDHY4'
M,SIO^$M;TF_[[I/^$M;TG_[[KF32&CE0<S.G_P"$N;^[/_WW2?\ "7-_=G_[
M[KF#2&CE0<S.H_X2]O[L_P#WW2?\)@W]V?\ [[KES331RH.9G5?\)@W]V?\
M[[I/^$Q;^[/_ -]URM)1RH.9G5_\)DW]V?\ [[I/^$S/]R?_ +[KE#2&CE0<
MS.L_X3,_W)_^^Z3_ (30_P!R?_ONN3-(:.5"YF=;_P )H?[D_P#WW2?\)J?[
MD_\ WW7)&FFCE0<S.O\ ^$V/]R?_ +[I/^$W/_/.?_OL5R%)3Y4',SL/^$W/
M_/.?_OL4G_"<'_GG/_WV*X\TTT<J#F9V7_"<G_GG/_WV*3_A.?\ IG<?]]BN
M-I*.5!SL[+_A.O\ IG<?]]BC_A._^F=Q_P!]BN,---'*A<[.T_X3O_IE<?\
M?8H_X3S_ *97'_?8KBJ2CE0<[.U_X3W_ *97'_?8H_X3[_IE<?\ ?8KB32&C
ME0<[.V_X3[_IE<?]]BC_ (3\?\\KC_OL5Q!IIHY4'.ST"R\8_P!I7D=GY<P\
MTXRS@CIG^E7I/$#VTC0CS<(<<-Q7"^'?^0_:?[Q_]!-;U]_Q_3?[YJ7%7*4G
M8V?^$G?_ *;?]]4?\).__3;_ +ZKGJ*.5!S,Z'_A)W_Z;?\ ?5'_  D[_P#3
M;_OJN>HHY4',SH?^$G?_ *;?]]4?\).__3;_ +ZKGJ*.5!S,Z'_A)W_Z;?\
M?5'_  D[_P#3;_OJN>HHY4',SH?^$G?_ *;?]]4?\).__3;_ +ZKGJ*.5!S,
MZ'_A)W_Z;?\ ?5'_  D[_P#3;_OJN>HHY4',SH?^$G?_ *;?]]4?\).__3;_
M +ZKGJ*.5!S,Z'_A)W_Z;?\ ?5'_  D[_P#3;_OJN>HHY4',SH?^$G?_ *;?
M]]4?\).__3;_ +ZKGJ*.5!S,Z'_A)W_Z;?\ ?5'_  D[_P#3;_OJN>HHY4',
MSH?^$G?_ *;?]]4?\).__3;_ +ZKGJ*.5!S,Z'_A)W_Z;?\ ?5'_  D[_P#3
M;_OJN>HHY4',SH?^$G?_ *;?]]4?\).__3;_ +ZKGJ2GRH.9G1?\).__ $V_
M[ZI/^$H?_IM_WU7/4AHY4',SHO\ A*'_ .FW_?5)_P )2_I-_P!]5SM)1RH.
M9G1_\)4_I-_WU2?\)4_I-_WU7.&FFCE0<S.E_P"$K;TF_P"^J3_A+&])O^^Z
MYJDHY4',SIO^$M;TF_[[I/\ A+6])_\ ONN9-(:.5!S,Z?\ X2YO[L__ 'W2
M?\)<W]V?_ONN8-(:.5!S,ZC_ (2]O[L__?=)_P )@W]V?_ONN7---'*@YF=5
M_P )@W]V?_OND_X3%O[L_P#WW7*TE'*@YF=7_P )DW]V?_OND_X3,_W)_P#O
MNN4-(:.5!S,ZS_A,S_<G_P"^Z3_A-#_<G_[[KDS2&CE0N9G6_P#":'^Y/_WW
M2?\ ":G^Y/\ ]]UR1IIHY4',SK_^$V/]R?\ [[%)_P )N?\ GG/_ -]BN0I*
M?*@YF=A_PFY_YYS_ /?8I/\ A.#_ ,\Y_P#OL5QYIIHY4',SL?\ A.3_ ,\Y
M_P#OL4?\)S_TSN/^^Q7&TE'*@YV=E_PG7_3.X_[[%'_"=_\ 3.X_[[%<8:::
M.5"YV=I_PG?_ $RN/^^Q1_PGG_3*X_[[%<524<J#G9VO_">_],KC_OL4?\)]
M_P!,KC_OL5Q)I#1RH.=G;?\ "??],KC_ +[%'_"?C_GE<?\ ?8KB#331RH.=
MGH5AXM_M:\6S\N8;P3EFR.!FK;^(GA=HAYOR$KPWI7%^%O\ D/P?[K?^@FM:
MZ_X^YO\ KHW\ZEQ5RE)V-S_A)W_Z;?\ ?5'_  D[_P#3;_OJN>HHY4',SH?^
M$G?_ *;?]]4?\).__3;_ +ZKGJ*.5!S,Z'_A)W_Z;?\ ?5'_  D[_P#3;_OJ
MN>HHY4',SH?^$G?_ *;?]]4?\).__3;_ +ZKGJ*.5!S,Z'_A)W_Z;?\ ?5'_
M  D[_P#3;_OJN>HHY4',SH?^$G?_ *;?]]4?\).__3;_ +ZKGJ*.5!S,Z'_A
M)W_Z;?\ ?5'_  D[_P#3;_OJN>HHY4',SH?^$G?_ *;?]]4?\).__3;_ +ZK
MGJ*.5!S,Z'_A)W_Z;?\ ?5'_  D[_P#3;_OJN>HHY4',SH?^$G?_ *;?]]4?
M\).__3;_ +ZKGJ*.5!S,Z'_A)W_Z;?\ ?5'_  D[_P#3;_OJN>HHY4',SH?^
M$G?_ *;?]]4?\).__3;_ +ZKGJ*.5!S,Z'_A)W_Z;?\ ?5'_  D[_P#3;_OJ
MN>I*?*@YF=%_PD[_ /3;_OJD_P"$H?\ Z;?]]5SU)1RH.9G1?\)0_P#TV_[Z
MI/\ A*7])O\ OJN=I*.5!S,Z/_A*G])O^^J3_A*W])O^^JYPTVCE0<S.E_X2
MMO2;_OJD_P"$L;TF_P"^ZYJDHY4',SIO^$M;TF_[[I/^$M;TG_[[KF3331RH
M.9G4?\)<W]V?_OND_P"$O;^[/_WW7+FD-'*@YF=3_P )>W]V?_OND_X3!O[L
M_P#WW7+&DHY4',SJO^$Q;^[/_P!]TG_"8M_=G_[[KE:0T<J#F9U?_"9-_=G_
M .^Z3_A,S_<G_P"^ZY0TTT<J#F9UO_"9G^Y/_P!]TG_":'^Y/_WW7)&D-'*A
M<S.N_P"$T/\ <G_[[I/^$U/]R?\ [[KD324<J#F9U_\ PFQ_N3_]]BD_X3<_
M\\Y_^^Q7(4AI\J#F9V'_  FY_P"><_\ WV*3_A.#_P \Y_\ OL5QYIM'*@YF
M=C_PG)_YYW'_ 'V*/^$Y_P"F=Q_WV*XVD-'*@YV=E_PG7_3.X_[[%'_"=_\
M3.X_[[%<8:;1RH7.SM/^$\_Z97'_ 'V*/^$\_P"F5Q_WV*XJD-'*@YV=K_PG
MO_3*X_[[%'_"??\ 3*X_[[%<2:::.5!SL[?_ (3[_IE<?]]BC_A/Q_SRN/\
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M:.5!S,ZK_A,F_NS_ /?='_"9G^Y/_P!]UR9I#1RH.9G6_P#"9G^Y/_WW2?\
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MX60O_/"Y_P"_@H_X60O_ #PN?^_@KSVBCZI2[!_;&+_F_!'H7_"R%_YX7/\
MW\%'_"R%_P">%S_W\%>>T4?5*78/[8Q?\WX(]"_X60O_ #PN?^_@H_X60O\
MSPN?^_@KSVBCZI2[!_;&+_F_!'H7_"R%_P">%S_W\%'_  LA?^>%S_W\%>>T
M4?5*78/[8Q?\WX(]"_X60O\ SPN?^_@H_P"%D+_SPN?^_@KSVBCZI2[!_;&+
M_F_!'H7_  LA?^>%S_W\%'_"R%_YX7/_ '\%>>T4?5*78/[8Q?\ -^"/0O\
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MTX_^?6Z_[^"O-*2CZK2[!_:>)[_@CTS_ (6G'_SZW7_?P4G_  M./_GUNO\
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MSSE0JD\9[C^E;G_"G?#_ /S_ &J?]_(__B*=%\(/#T<T;M=:E(JL&,;RIM<
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MUC_C_P#^ "JCN3+8SZ***H@**** "BBB@ HHHH **** "BBB@ HHHH ****
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M::: $I*6DI@(:0TII#0 AI#2FD- A#333C330 E)2TE "&FFG&FFF E)2TE
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M<]VI_/\ 0****[3Y\**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M_KJ*Z;4O^0A-]1_*I>Y:V*E%%%( HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHIK2(A 9U4GH"<9H =12*RL,J01Z@TM !24M)3 *0TM
M(: $I*6DH$(:::<::: $I*6DH 0TAI32&@!#2&AB%!)( '))[4W<I. 03]:
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M **** .AT;PTNH60NIYV17)"*@YP#@DGZ_RK1_X0ZT_Y^9OR%7_#7_(OVO\
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MU.C'#J@HHHK,L**** &R?ZI_]TUYWK'_ !__ / !7HDG^J?_ '37G>L?\?\
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M(:6D-,!#333C330 AI#2FD- &[X1_P"0Y_VR;^E:$W^ND_WC_.L_PC_R'/\
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M   # %>@>";IIM(D@=B?)DPN>RD9Q^>:'&P*5SE/$6CC1]1,<6XV\@WQ%CG
M[KGOC^6,U#H>DOK&HK;@E8U&Z1QV7_&NJ\>0AM/M9^Z2E!_P(9_]EH\!PH--
MNIP/G:;8?H%!'_H1IW]T5O>.BMK6RTFT*PI'!"@W,W3\2>_U-9O_  EVB>9L
M^UG_ 'O+;'\JS?'EW)%96MJN0DS,SD'KMQ@?F<_A7!&A1N#E8]CFAM=2L]DJ
MQSV\@R.X(]0?ZBO,/$.CMHVIF$$M XWQ,>N/0^X/]/6NK\!W1DTVXM2>()-R
MCT#9/\P3^--\?PJ=,M9S]Y)M@^A4D_\ H(I+1V!ZJYY^:2E-)6AF)2&EI#0
MTTE*:2F E(:6D- AII*4TE(!*0TM(:8#32&E-(: $-(:4TAH Z+P;_R&)?\
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M7^M*6PX[DGC'_CPM_P#KK_0UF>%+".[OIIIH]RP*I4,."QS_ "Q^HK3\8_\
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M;":8O#/+"I.=G# ?2E%V')7.>\%VS3>(HY1G; C.3]1M_K7<>()D@\/W[N0
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M_'W-_P!=&_G4O<M;$5%%%( HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M[;P?_P @F7_KN?\ T%:/%%_=6,5L;:8QEV;=@#GI1X/_ .03+_UW/_H*U7\9
M_P"IM/\ >;^E3U+Z'/RZUJ4H :]F&/[K;?Y52)+,68DD\DGO2451%PKT/P__
M ,@*U_W3_,UYY7H?A_\ Y 5K_NG^9J9%1.9\6?\ (:_[9+_6KOA"PCD6:]DC
MRZ/Y<>X=. 21^>/P-4O%G_(:_P"V2_UK2\'7:&WGLR3YBOYBY(Y! !Q],?K0
M]@7Q%_7-=&D^5&D/FRR GDX"@=SZ\_R//KCV/BJ_N+VW@DBML22JC%48<$XX
M^:MC7-"&KM%(D_E2Q@KRN0P/KZ8_J?;%73/#4&FR?:[N=9&C&X9&U4([DGK^
ME"M8;O<Z*O,M,8KJUFP(&)TR3Z;AG]*],5E=%=2"K#(([BO*&&01DC/H<'\Z
M(A(]8KR:1&CD>-\;T8HP!SA@<$?F*]&T35X]6L@VX"XC 69,8(/KCT.,C\NH
M-1:EX;LM2G,[&2*4CYC&1AOJ"*$[ U<\\K2\,LI\16+AEVY;G/7*,!C\Q7::
M=X>L-,D\V-6DE'1Y#G;].P_G7!7-SLU>:ZM&7B=I(FZK][(/N.E5>Y-K:GI=
M[+);V%Q-"F^6.)G1,?>(!(%<5_PFNI?\\+3_ +X;_P"*KL=.U"#4[1;B!A@_
M>7/*GT-8=[X+M9YB]K<&V4G)CV!E'LO(P/SJ%;J4[]#*_P"$VU+_ )X6G_?#
M?_%5G:MK]YJ\4<5P(DC1MP6-<9/3/)/J?SKH8? T*N3/?2.G81QA#^9)K)\5
M:79Z7-;):(4WH2^7))Z8/-4K7):=M2SX'_Y"-U_UR'\ZWO%D;R>'KC8I;:58
MX'0 C)K!\#_\A&Z_ZY#^==C->6\%S#;32!9)PWEANC8QD?7D4GN4MCR(UWG@
M:!DTRXF8$"27"^X Z_K^E3S^"]+FN&E5KB(,<^7&XV]<G&02,^F>.V*W;>WA
ML[9((4"11KA1GH/J:'*X1C9G,^.YE73K6 D;GE+@>R@@_P#H0JMX!D/^GQEN
M/W; ?]]9_I6/XIU5=3U4B%]UO -B$'ACW;\>GX"J_A_5?[)U:.=S^X<%)>,G
M:>X^A /YT[>Z*_O'7^.8G?0%=2 L4ZL^?0@J/U85YR:]E98+ZT*G;+;S)C@Y
M#*:YF3P'9-,62ZG2//W, D?C1&5@E&YG> ;9FO[JZYV)$(_J20?_ &6M[QG,
MD7AJ=&(!E=$7W.X-_)36II^G6VDV2V]LNV->69CRQ[DGUK@O%VNQZI=);6K;
MK: G+#H[=,CV'8^YI;L;TB<R:2E-)6AD)2&EI#0 AIM.--I@)2&EI#0(0TVG
M&FT@$I#2TAI@(:::<::: $-(:4TAH W?"/\ R'/^V3?TK0F_UTG^\?YUG^$?
M^0Y_VR;^E:$W^ND_WC_.H>Y:V&4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% 'H/AK_D7[7_@?_H9K,\3ZG>65["EM.T:M'D@ <G)K3\-?\B_:_\
M _\ T,U@^,?^0A;_ /7+^IJ>I;V,F75]1G^_>SX]%<J#^54J**H@*]#\/_\
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M4 %,FABN(9(9HTDBD4HZ.H964C!!!Z@BGUCCQ;X;(R/$.D_^!L?^- '$Z_\
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M% !1110 4444 6[35+ZPC:.UN6B5CDC:#S^(-)>:C>:AY?VN=I?+SMR O7V
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M#HZ,&5E(R"".H(I]04%%%% !1110 50A_P"0O/\ [G^%7ZH0_P#(7G_W/\*
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M% !1110 4444 %%%% !1110 4E+24P"D-+2&@!*2EI*!"&FFG&FF@!*2EI*
M$-(:4TAH 0TAI32&@!#333C330 E)2TE,!#2&E-(: $-(:4TAH$(:::<:::
M$I*6DH 0TTTXTTTP$I*6DH$(:::<:::0"4E+24P$-(:4TAH 0TTTXTTT ;/A
M;_D/P?[K?^@FM:Z_X^YO^NC?SK)\+?\ (?@_W6_]!-:UU_Q]S?\ 71OYU+W+
M6Q%1112 **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ I*6DI@%)2TE "4E+24"$--IQIM "4E+24 (:::<::: $-(:4TAH 0
MTE*:2@!*0TM(:8"&FFG&FF@!#2&E-(:!"&DI324 )2&EI#0 AIM.--I@)2&E
MI#0(0TVG&FT@$I#2TAI@(:::<::: $-(:4TAH W?"/\ R'/^V3?TK0F_UTG^
M\?YUG^$?^0Y_VR;^E:$W^ND_WC_.H>Y:V&4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4E+24P"DI:2@!*0TM(:!#3
M24II* $I#2TAH ::0TII#0 AI#2FD- "&DI324 )2&EI#3 ::0TII#0 AI#2
MFD- A#24II* $I#2TAH ::2E-)3 2D-+2&@0TTE*:2D E(:6D-,!II#2FD-
M"&D-*:0T =%X-_Y#$O\ U[G_ -"6N-KLO!O_ "&)?^O<_P#H2UQM=>$WE\OU
M/!SW:G\_T"BBBNT^?"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M@6;5+Z*V5ON*QR[\@':HRS8W#.!QGFM&OEJ^U*^U6X-UJ%W+=7##EY6SCDG
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M_JG_ -TUYWK'_'__ , %>B2?ZI_]TUYWK'_'_P#\ %5'<F6QGT4451 4444
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M444 %%%% !1110 $@#).!2 AAD$$>HKI_"%AYEQ+?2*"L8V1]_F/4^V!@?\
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M,:]3[<@\?[(KF+VZ>]O9KE\YD8G![#L/P&!1<;5D04E+24Q!24M)0 E)2TE
MA#3:<:;0 E)2TE "&FFG&K.G:?-J=\EK#P6Y+$<*!U)H IFD-==/X'DCMW>.
M_5G520K1;0>/7)_E7(FA.XVFA&8*,D@#WI,@\@Y%7](O_P"S=5M[H_<1OGXS
M\IX/'T-=+XXTW<L.IQ]AY4N,GCJI]!W'OD>E*^H6TN<52&EI#5"$---.---
M"&D-*:0T"$-)2FDH 2D-+2&@!#3:<:;3 2D-+2&@0AIM.--I )2&EI#3 0TT
MTXTTT (:0TII#0!N^$?^0Y_VR;^E:$W^ND_WC_.L_P (_P#(<_[9-_2M";_7
M2?[Q_G4/<M;#**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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ME,!*0TM(:!#324II*0"4AI:0TP&FD-*:0T (:0TII#0!T7@W_D,2_P#7N?\
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M7G\GP?\ #KRNR7.I1*S$K&DJ$(/090G ]R3[UZ!6./%OALC(\0Z3_P"!L?\
MC33:V$TGN<K_ ,*=\/\ _/\ :I_W\C_^(H_X4[X?_P"?[5/^_D?_ ,175?\
M"6>&_P#H8-*_\#8_\:/^$L\-_P#0P:5_X&Q_XU7-(7+$Y7_A3OA__G^U3_OY
M'_\ $4?\*=\/_P#/]JG_ '\C_P#B*ZK_ (2SPW_T,&E?^!L?^-'_  EGAO\
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M-(:!"&D-*:0T -I*6DH 0TAI32&F VDI:2@0AI#2FD-(!M)2TE,!#2&E-(:
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M)3F4JQ5@00<$'M6MI?AVYU2U-Q'+$B!BN&SD_P"<U5[$I7,8TAKIO^$+O/\
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MFF@!*2EI* $---.---,!*2EI* $---.---(0E)2TE,!#2&E-(: $---.---
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MAH$(:::<::: $I*6DH 0TTTXTTTP$I*6DH$(:::<:::0"4E+24P$-(:4TAH
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M%H.1\X ?)*]>.>*]\HHJ)2<MRE%(****D84444 -D_U3_P"Z:\[UC_C_ /\
M@ KT23_5/_NFO.]8_P"/_P#X *J.Y,MC/HHHJB HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ JSIQ']J6889!GC&/JP%5JL:>!_:=F68@"
MXC8D>S T,$=;XQW?V3!@X'V@9]QM;_ZU<57:>,D9M*@(SA;@$\]MK#^M<72C
ML5+<V/"__(=A_P!UOY&M#QE<R^;;VH<B$KYC*/XCGC/TQ^?T&,_PO_R'8?\
M=;^1JWXR_P"0A;_]<OZFC[0?9.;KLO!LK&RN8B20L@89/J/_ *U<;77^#/\
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MTUU,PDWE=H<# P/\:;V$EKH9O_"0ZM_S^O\ D/\ "D_X2+5O^?U_R'^%=/\
M\(MHW_/:3_OZ/\*3_A%M&_YZR?\ ?T?X4KH?+(Y@^(M6((^VR?D/\*R20BDD
M@*!R3T KO'\*Z,4;]_(O'WA*O'OR*Y?P]"DWB&RC?#IO+'@C.%)'TY H30FG
MU.HTV"/PQX>EN[D9GD 9E[YZ*G3\_3)[5PMQ/)<W$D\K%I)&+,2<\G^GM7I>
MKZ-'K"Q)+<2QI&2=J8P3ZFLK_A![+_GZN/T_PI)H;3V0[P/_ ,@>X_Z^3_Z
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MM)\/Z9=Z9#//,_F/DL!( !SC%-M=1)/H8W_"0ZM_S^O^0_PI/^$BU;_G]?\
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M_(HC_K@_]:)!$X&K\>NZG%$L:7CA% 51@< ?A5"NQM/#6DRV<,CSN7= S$2
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MEQI*4TE=IXP4E+24#"DI:2D,2@T4&F,::*#12&)11104CNOAA_R%;S_KFO\
MZ%7MM>)?##_D*WG_ %S7_P!"KVVO+Q7\1GTF7?[NOF%%%%<YW!1110 445YS
MX^\>:OX7UZ&RL(;%X9+59B9XW9MQ9P>0XXPH[>M-)MV0F['HU%>(_P#"X/$G
M_/KI7_?B3_XY1_PN#Q)_SZZ5_P!^)/\ XY5^SD3SH]NHKQ'_ (7!XD_Y]=*_
M[\2?_'*/^%P>)/\ GUTK_OQ)_P#'*/9R#G1J_&G_ %NA?[MQ_P"TJZ[X:_\
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M)EL9]%%%40%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
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M,\9:I'=74=E X9("3(5.1OZ8_#^OM52^\5ZI>QF,2) AZB$$$_B23^580 4
M   < #M0EK=@VK60&NM\"0!KF\N".414!QZG)_\ 017)&O0O"L2Z=X:-U."@
M<O.V1R%' _#"Y_&G+8([G+^+[CS_ !#,N05A58P0?;)_4FL&I;B=[JYEN)
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M/.[B9KFYEG88:1RY^I.:B-+2&K)&FD-*:0T (:0TII#0(0TE*:2@!*0TM(:
M&FDI324P$I#2TAH$--)2FDI )2&EI#3 ::0TII#0 AI#2FD- '1>#?\ D,2_
M]>Y_]"6N-KLO!O\ R&)?^O<_^A+7&UUX3>7R_4\'/=J?S_0****[3Y\****
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M6]W!'-$W577(_P#K&N0TGX<V%EJEQ<WA%S '_P!&A;H%_P!OU/;'3C/? T/
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MZYK_ .A5[;7B7PP_Y"MY_P!<U_\ 0J]MKR\5_$9])EW^[KYA1117.=P4444
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M_P"Z:\[UC_C_ /\ @ KT23_5/_NFO.]8_P"/_P#X *J.Y,MC/HHHJB HHHH
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MI>Y:V*E%%%( HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M(LQHFW=C/W5&?NCKZ5[=\-?^2?Z9_P!M?_1KU4U:"3%%WE<ZNBBBL30****
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M$D_U3_[IKSO6/^/_ /X *J.Y,MC/HHHJB HHHH **** "BBB@ HHHH ****
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MAH 0TAI32&@0AIIIQIIH 2DI:2@!#333C333 2DI:2@0AIIIQIII )24M)3
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M4O<M;$5%%%( HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "DI:2F 4E+24 )24M)0(0TVG&FT )24M)0 AIIIQIIH 0TAI32
M&@!#24II* $I#2TAI@(:::<::: $-(:4TAH$(:2E-)0 E(:6D- "&FTXTVF
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M$];_ ++/_/U;_P#?5']EG_GZM_\ OJO)**/J'][\ _M'^[^)ZW_99_Y^K?\
M[ZH_LL_\_5O_ -]5Y)11]0_O?@']H_W?Q/6_[+/_ #]6_P#WU1_99_Y^K?\
M[ZKR2BCZA_>_ /[1_N_B>M_V6?\ GZM_^^J/[+/_ #]6_P#WU7DE%'U#^]^
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M_K7_ +[I/^$;D_Y_K3_ONO(J0T?57_-^ ?7%_+^)Z]_PC4G_ #_6G_?9I/\
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M/^^S2?\ "+R_\_\ :?\ ?9KR TAH^JO^8/K:_E_$]?\ ^$6E_P"?^T_[[/\
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M  BTO_/_ &G_ 'V?\*3_ (1:7_G_ +3_ +[/^%>0FDI?5G_,'UI?R_B>O_\
M"*R_\_\ 9_\ ?9_PI/\ A%9O^?\ L_\ OL_X5Y :0T?5GW']:7\OXGMFD^'I
M+/5(+AKRV<(2=J,23P:T[K3C+=2/]HA7<V<%N17D/@7_ )'73/\ ?;_T!JT_
M$O\ R,NH_P#7=J4<+S3Y;]!SQ?)3YN7KW/1O[+/_ #]6_P#WU1_99_Y^K?\
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MN_B>M_V6?^?JW_[ZH_LL_P#/U;_]]5Y)11]0_O?@']H_W?Q/6_[+/_/U;_\
M?5)_91_Y^K?_ +ZKR6BCZC_>_ /[1_N_B>M?V4?^?JW_ .^J/[*/_/U;_P#?
M5>2TAH^H_P![\ _M'^[^)ZU_9)_Y^K?_ +ZI/[(;_GZM_P#OJO):2CZC_>_
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M]>_X1J3_ )_K3_OLTG_"-2?\_P!:?]]FO(:2E]5?\WX!]<7\OXGKW_",R_\
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M2Y=WW.S_ +)?_GX@_P"^J/[)?_GX@_[ZK@J*Z?[+_O\ X?\ !.3^UO[GX_\
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M?[);_GY@_P"^J/[);_GY@_[ZKSZBC^S/[_X?\$/[6_N?C_P#T'^R6_Y^8/\
MOJC^R6_Y^8/^^J\]I#1_9G]_\/\ @C_M7^Y^/_ /0_[);_GY@_[ZH_LEO^?F
M#_OJO/*2E_9O]_\ #_@A_:O]S\?^ >B?V2W_ #\P?]]4?V2W_/S!_P!]5YT:
M*/[-_O\ X?\ !#^U?[GX_P# /1?[);_GY@_[ZH_LEO\ GY@_[ZKSFDH_LW^]
M^'_!#^U?[GX_\ ]'_LEO^?F#_OJD_LEO^?F#_OJO.:2C^S?[WX?\$?\ :O\
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M><4E+^S_ .]^ ?VG_<_'_@'H_P#8$G_/W;?]]4G]@2?\_=M_WU7G%)1_9_\
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MYY24O[-_O_A_P0_M7^Y^/_ /1/[);_GY@_[ZH_LEO^?F#_OJO.C11_9O]_\
M#_@A_:O]S\?^ >B_V2W_ #\P?]]4?V2W_/S!_P!]5YR:2C^S?[WX?\$/[5_N
M?C_P#T?^R6_Y^8/^^J3^R6_Y^8/^^J\YI*/[-_O?A_P1_P!J_P!S\?\ @'HW
M]D-_S\P?]]4?V.__ #\P?]]5YQ2&C^SO[WX?\$/[4_N?C_P#T?\ L9_^?J#_
M +ZI/[&?_GZ@_P"^J\XHI?V=_>_#_@A_:?\ <_'_ (!Z-_8K_P#/U;_]]4?V
M(_\ S]6__?5><&D-']G?WOP'_:?]S\?^ >C_ -B/_P _5O\ ]]4G]AO_ ,_5
MO_WU7G!I#1_9W][\ _M/^Y^/_ /2/[#?_GZM_P#OJD_L*3_G[M_^^J\X-)1_
M9_\ >_ /[3_N?C_P#T?^PI/^?NW_ .^J/[!D_P"?NW_[ZKS@TAI?V?\ WOP#
M^TO[GX_\ ]'_ + D_P"?NV_[ZI/[ D_Y^[;_ +ZKSBDH_L_^]^ _[2_N?C_P
M#T?_ (1^3_G[MO\ OJC_ (1^3_G[MO\ OHUYN:*/J'][\ _M+^Y^/_ /1_\
MA'I/^?RV_P"^C2?\([+_ ,_EM_WT:\XI*/J'][\ _M+^Y^/_  #TC_A'9?\
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MW\)2RO(VD*"[%B$GE51GT4, ![#@5<))7N3*+>QYW_PN#Q)_SZZ5_P!^)/\
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M:2@8E(:6D-(8AI#2FD- P-)2FDI (:2E-)2&=7\./^1UM/\ <D_] -;NI_\
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MI:0T@$I*6DH&)2&EI#2&(:0TII#0,#24II*0"&DI324AG5_#C_D=;3_<D_\
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M ?RKQ$ LP !)/  J,&W[-W-\[BEB%;=H]<^'&@16&C_VO<*/M-R"49OX(_\
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M_P!4_P#NFO"?'_\ R,O_ &P3^M=F!_B_(X<P_@_,Y:BBBO8/#"BBB@ HHHH
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MJ[MXYX=)?RY%#*7FC0X//0L"*R-#T_\ M77K"PVDK/.B-C^Z3R?RS7U
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MW)/_ $ UNZG_ ,A6\_Z[O_Z$:POAQ_R.MI_N2?\ H!K=U/\ Y"MY_P!=W_\
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M_9?@*WDE!7R-/\Q@>QV;B*6-V2*R32<WTL>"UTG@%BGC?32.Y<?G&U<W71^
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M6M;%>-:3\6WTO1K'3_["67[+;QP>9]LV[MJA<X\LXSCIFKG_  NF3_H75_\
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MT2CRA&5PHHHJ2@HHHH ;)_JG_P!TUX3X_P#^1E_[8)_6O=I/]4_^Z:\)\?\
M_(R_]L$_K79@?XOR.',/X/S.6HHHKV#PPHHHH **** "BBB@ HHHH **** "
MBBB@!02""#@CH12N[RNSR,SNQRS,<DFFUZOX \*:'JGA=+N^L4GG>5P69FX
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M'_H1'X5B_&:PW6NEZB/X'>!N.N1N'_H+?G44/W=?E^1>(_>8?F]&<Y\*-/\
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MA"BBB@ HHHH **** "BBB@ HHHH ZCPWXWN_#.E75G:VT4CS2"19)"<(<8/
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M]*UQ\[J,5ZF.6PLY2?33_,EMKJ&\A\Z!P\>YDR/56*G]0:\1^(MC]B\973
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MTSVKN?B1KD>G:#_9D3 7-YA=HZK&#R?QQC\_2LG4/BP#&RZ=II#GI)</P/\
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M</-.-\K$J 2'ZJ>,_+@ \@"O*O'_ (7A\'ZS92Z9/*D-R'EAS*?,B=&!.T@
M@ ,F#DMP<GN?>J\^^,/_ "*5I_U_)_Z+DI0D^8))6/,-+TC7/'&MW!B;[1=.
M/-N+JX8JB^FX@'&<8"@=N!A3CU70_A3H>G(KZB7U.Y#!MTF8XP021A >01@$
M,6!QT )%5O@V2?"M^#VU%@/^_45>B43F[V01BK7&0PQ6\,<,,:1Q1J$1$4*J
MJ!@  = !3Z**S+"BBB@ HHHH ;)_JG_W37A/C_\ Y&7_ +8)_6O=I/\ 5/\
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M%_Y'73/]]O\ T!JT_$O_ ",NH_\ 7=J*7\9^GZCK?P%Z_H95%%%=9PA1110
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MR3_T UNZG_R%;S_KN_\ Z$:UPG\:7HC+&?P(^K_(JT445Z)Y8E%%% !1110
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MKU#R HHHH$%)2TE PHHHI %%%% '4^ /^1E_[8/_ $J.[_X_)_\ KHW\ZD\
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MRQ]#1\%^#Y/$-U]HN@Z:=$?F8<&4_P!T'^9KV*::STC33)(T=M:6Z8]%51P
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MAU_R,%Q_UZM_Z&E85<R_BR^7ZF.8?P:7_;WZ!1116AY(4444 %%%% !1110
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M"?2N81MDBMC.T@XI*2G"E&$/9K852M*I4]I+<]7_ .%F:+Y>XP7N[^[Y:_\
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M9QZ?%6<8WZ3&WKMG(_\ 937?Z1J<.LZ5!J$"LL<P)"MU!!((_,&N)A^%4*S
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ML--AN?-N%\LR2J%55/WNY)../QKS"BBG1HQI*T0K5YUI7D)2&EI#6IB%%%%
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M2D,0TAI32&D AI#2FD-(8AHH-% "4E+24AB&D-*:0TA@:::<:::!A2&EI#2
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MZ-_.IH?QY>B_4K$?P(>K_0AH-%!KM.$2BBB@ HHHH *2EI* "BBBD,2BBB@
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M98S^!'U?Y%6BBBO1/+$HHHH **** "DI:2@ HHHI#$HHHH *2EI* "DI:2@
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M*6DH&%%%%( HHHH ZGP!_P C+_VP?^E1W?\ Q^3_ /71OYU)X _Y&7_M@_\
M2H[O_C\G_P"NC?SJ:'\>7HOU*Q'\"'J_T(:#10:[3A$HHHH **** "DI:2@
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MY1R2[#YD>BT5YU_PN70?^@;J_P#W[B_^.5VFAZY8>(=+CU#3Y=\3<,AQOB;
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M,>E_]?<7_H8KLO''_(U7/^XG_H(I4_XR]/\ (=7^ _5?DSG****[#A"BBB@
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M?]O?H%%%%:'DA1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%%, I*6DH 3O11WHI#0E%%% Q****!B4E+24AA24M)04)24
MM)0,*2EI*!H2BBB@8E%%% Q*2EI*0PI*6DH*$-)2FDH&%)2TE PI*6DI#$H-
M%!IC&FB@T4AB4444%([KX8?\A6\_ZYK_ .A5[;7B7PP_Y"MY_P!<U_\ 0J]M
MKR\5_$9])EW^[KYA1117.=P4444 %>)?&#_D<+7_ *\$_P#1DE>VUXE\8/\
MD<+7_KP3_P!&25I2^(B>Q;TGX2_VIHUCJ']M^5]JMXY_+^R;MNY0V,[QG&:N
M?\*6_P"H_P#^2?\ ]G7?>$_^1-T/_L'V_P#Z+6MBAU)=PY$>4_\ "EO^H_\
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M+N)3^+@5GUL>$W$?B[26;H;N-?S8#^M14=H-^1I25ZD5YH]7^)\IC\&2J/\
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MMS1O^?"__P"^4_\ BJ/^%NZ-_P ^%_\ ]\I_\57)?\*L\1^EI_W^_P#K4?\
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MKH/^%<:__<MO^_O_ -:ML13PTIWJ/4QPM3%1IVI*Z.G_ .%HZ5_SY7OY+_\
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M DCU'-$HR^MIVT_X 1E'ZFXWUO\ J</7KOPB_P"0+J'_ %\#_P!!%>15Z/\
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M#%J]CJ !VS0F(\?Q*<_R;]*\ZJ\-+FI19&*CRUI+^M3WWPY_R3ZS_P"O(_\
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MD<AMHQ^=>5&NV$O:Q:DFCAG#V,DXR3]#WWX@Z,^O>$91:J99X&%Q$J<[\ Y
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MU2C_ "FGURO_ #,U-=\07OB&ZCGO3&#&FQ5C7  SGUZUE45?T66RAUJSDU%
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M*0PH-%!H 2DI:2D,****!B4AI:0T %%%% @-)2FDH&%%%%( HHHH Z[X=?\
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M4 %%%% !1110 4444 %%%% #9/\ 5/\ [IKPGQ__ ,C+_P!L$_K7NTG^J?\
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M--.GVDT1M^=JR1AMF>N/YX-<]7-AJ4J2<7MT.K%5H57&2WZA11172<@4444
M%(:6D- Q*2EI* $I#2TAI#$-(:4TAI#$-%!HH&)24M)2&(:0TII#2 0U[E\-
M]/BT#P2^IWA$7VD-<R,W\,:CY?T!/_ J\--=)J/CO7=3T1=(GFB6UVJC>7&%
M9U7H"?3@=,5SXBG*HE%;'5AJL:3<I;]#(UO4Y-9UJ\U&7.ZXE+@'^%>P_ 8'
MX50H-%;))*R.=MMW8E)2TE "&D-*:0TA@:::<:::!A2&EI#2 2DI:2@8E(:6
MD-(8AI#2FD- P-)2FDI (:0TII#2&=#X%_Y'73/]]O\ T!JT_$O_ ",NH_\
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M,/X-+_M[] HHHK0\D**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M<_E[MVW<H;&>,XS5RB["R,C_ (17P[_T -+_ / ./_"C_A%?#O\ T -+_P#
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MI*!B4&B@TAB&D-*:0T#$I*6DI !IIIQIII#-#0/^1CTO_K[B_P#0Q79>./\
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M***ZSA"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MBBB@ HHHH *2EI* "BBBD,2BBB@ I*6DH *2EI* "BBB@8E(:6D-( I*6DH
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M_P *OU0A_P"0O/\ [G^% %^BBB@"A8?\?-W_ +_]35^J%A_Q\W?^_P#U-7Z
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M51]?I]G_ %\P_LZKW7X_Y'@U%>\_\*Z\*?\ 0*_\F)?_ (JC_A77A3_H%?\
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M17_"L?!__0(_\F9O_BZ3_A6/@_\ Z!'_ ),S?_%T?7(=F/ZC4[H^=:2OHO\
MX5AX._Z _P#Y,S?_ !='_"L/!W_0'_\ )F;_ .+I?7(=F'U*IW1\YT&OHS_A
M6'@[_H#_ /DS-_\ %TG_  J_P=_T!_\ R9F_^+H^MP[,?U*IW1\YFD-?1O\
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M_P#)B7_XJC_A77A3_H%?^3$O_P 571]?I]G_ %\SF_LZKW7X_P"1X-17O/\
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MX5UX4_Z!7_DQ+_\ %4?7Z?9_U\P_LZKW7X_Y'@U%>\_\*Z\*?] K_P F)?\
MXJC_ (5UX4_Z!7_DQ+_\51]?I]G_ %\P_LZKW7X_Y'@U%>\_\*Z\*?\ 0*_\
MF)?_ (JC_A77A3_H%?\ DQ+_ /%4?7Z?9_U\P_LZKW7X_P"1X-2&O>O^%=>%
M/^@5_P"3$O\ \51_PKKPI_T"O_)B7_XJE]?I]G_7S#^SJO=?C_D>"4E>]_\
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MZ_3[/^OF<_\ 9U7NOQ_R/!J*]Y_X5UX4_P"@5_Y,2_\ Q5'_  KKPI_T"O\
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MV=5[K\?\CP:BO>?^%=>%/^@5_P"3$O\ \51_PKKPI_T"O_)B7_XJCZ_3[/\
MKYA_9U7NOQ_R/!J0U[U_PKKPI_T"O_)B7_XJC_A77A3_ *!7_DQ+_P#%4OK]
M/L_Z^8?V=5[K\?\ (\$I*][_ .%<^%/^@5_Y,2__ !5'_"N?"G_0*_\ )B7_
M .*H^OT^S_KYC_LZKW7]?(\#I#7OO_"N?"?_ $"O_)B7_P"*H_X5QX3_ .@5
M_P"3$O\ \51]?I]G_7S#^SJO=?U\CP$TAKW[_A7'A/\ Z!7_ ),2_P#Q5'_"
MM_"?_0)_\F)?_BJ7UZGV?]?,?]GU>Z_KY'@!HKW_ /X5OX3_ .@3_P"3$O\
M\51_PK?PE_T"?_)B7_XJCZ]3[/\ KYA_9]7NOZ^1\_TE?0/_  K;PE_T"?\
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MCZ_3[/\ KYA_9U7NOQ_R/!J*]Y_X5UX4_P"@5_Y,2_\ Q5'_  KKPI_T"O\
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M3_H%?^3$O_Q5'_"N?"G_ $"O_)B7_P"*H^OT^S_KYC_LZKW7]?(\#I#7OO\
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M_P#%T?7:?9A]0J=U_7R/G@TAKZ'_ .%9^$/^@1_Y,R__ !='_"LO"'_0(_\
M)F7_ .+I?7*?9C^HU.Z_KY'SP:::^B?^%9>#_P#H$?\ DS-_\71_PK'P?_T"
M/_)F;_XNCZY3[,/J-3NOZ^1\[4AKZ*_X5CX/_P"@1_Y,S?\ Q=)_PK'P?_T"
M/_)F;_XNCZY#LQ_4:G='SK25]%_\*P\'?] ?_P F9O\ XNC_ (5AX._Z _\
MY,S?_%TOKD.S#ZE4[H^<Z0U]&_\ "L/!W_0'_P#)F;_XND_X5?X._P"@/_Y,
MS?\ Q='UN'9C^I5.Z/G(TAKZ._X5?X._Z __ ),S?_%T?\*N\&_] ?\ \F9O
M_BZ/K<.S#ZE4[H^<325]'_\ "KO!O_0'_P#)F;_XNC_A5W@W_H#_ /DU-_\
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MD_\ BJ/[4H]G^'^8?V17[K\?\CQVBO8O^$'\.?\ 0._\CR?_ !5'_"#^'/\
MH'?^1Y/_ (JC^U*/9_A_F']D5^Z_'_(\=I*]C_X0?PY_T#O_ "/)_P#%4?\
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M/)_\52_M*EV?X?YA_95;NOQ_R/%:2O:_^$#\-?\ 0-_\CR?_ !5'_"!>&O\
MH&_^1Y/_ (JC^TJ79_A_F/\ LJMW7X_Y'B=(:]L_X0+PS_T#?_(\G_Q5'_"!
M>&?^@;_Y'D_^*H_M*EV?X?YA_95;NOQ_R/$J*]M_X0'PS_T#/_(\G_Q5'_"
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M_P"*H_M"EV?]?,/[,J]U^/\ D>%45[K_ ,*\\+?] O\ \F)?_BJ/^%>>%O\
MH%_^3$O_ ,51_:%+L_Z^8_[-J]U^/^1X325[O_PKSPM_T"__ "8E_P#BJ/\
MA7GA7_H%_P#DQ+_\52_M"EV?]?,/[-J]U^/^1X117N__  KOPK_T"_\ R8E_
M^*H_X5WX5_Z!?_DQ+_\ %4?VA2[/^OF']FU>Z_'_ "/!Z0U[Q_PKOPK_ - O
M_P F)?\ XJC_ (5WX5_Z!7_DQ+_\51_:%+L_Z^8?V;5[K\?\CP>BO>/^%=^%
M?^@5_P"3$O\ \51_PKOPK_T"O_)B7_XJC^T*79_U\P_LVKW7X_Y'@])7O/\
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MY'D_^*H_X07PW_T#O_(\G_Q5']IT>S_#_,/[)K=U^/\ D>,TAKV?_A!?#?\
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M=G_7S#^S*O=?C_D>%4&O=?\ A7GA;_H%_P#DQ+_\51_PKSPM_P! O_R8E_\
MBJ/[0I=G_7S'_9M7NOQ_R/":2O=_^%>>%O\ H%_^3$O_ ,51_P *\\*_] O_
M ,F)?_BJ7]H4NS_KYA_9M7NOQ_R/"**]W_X5WX5_Z!?_ ),2_P#Q5'_"N_"O
M_0+_ /)B7_XJC^T*79_U\Q_V;5[K\?\ (\'I#7O'_"N_"O\ T"__ "8E_P#B
MJ/\ A7?A7_H%?^3$O_Q5']H4NS_KYB_LVKW7X_Y'@]%>\?\ "N_"O_0*_P#)
MB7_XJC_A7?A7_H%?^3$O_P 51_:%+L_Z^8?V;5[K\?\ (\'-)7O/_"NO"O\
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M_P"3$O\ \51_PKWPM_T"_P#R8E_^*H^NT^S'_8N([K\?\CPJBO=/^%>^%O\
MH%_^3$O_ ,51_P *]\+?] O_ ,F)?_BJ/KM/LQ_V+7[K\?\ (\*HKW7_ (5Y
MX6_Z!?\ Y,2__%4?\*\\+?\ 0+_\F)?_ (JE]<I]F/\ L:OW7X_Y'A-)7N__
M  KSPM_T"_\ R8E_^*H_X5YX5_Z!?_DQ+_\ %4?7*?9A_8U?NOQ_R/"*2O=_
M^%=^%?\ H%_^3$O_ ,51_P *[\*_] O_ ,F)?_BJ/KE/LQ_V/7[K\?\ (\'-
M)7O/_"N_"O\ T"O_ "8E_P#BJ/\ A77A7_H%?^3$O_Q5'URGV8_[(K]U^/\
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M:IK>EZ+%YFI7]O:@JSJLC@,X49.U>K$9' !/(]:/:2#DB>;?\*6;_H8!_P"
M7_VRN\\)^&H?"NB#3XI?.D:1I9IMI7S&/ .TDXPH4<'MGO7)ZW\7M-MXY8M&
MMI;N?HDTR^7%RN=V/O'!P"I"YYYZ9W_ 7B>Y\5Z#->7D$,4\-RT#>3G:^%5@
M0#DCAP,9/3/? <N>VHERWT.IHHHK,L**** "J$/_ "%Y_P#<_P *OU0A_P"0
MO/\ [G^% %^BBB@"A8?\?-W_ +_]35^J%A_Q\W?^_P#U-7Z "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH ;)_JG_P!TU5TS_CS_ .!&K4G^J?\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 445#:7EK?VJ75G<PW-N^=DL+AT;!P<$<'D$4
M34444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 45#<WEK9^5]
MJN88/.D$,7FN%WN>BKGJQ[ <U-0 4444 %%%% !1110 4444 %%%% !1110
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M]&L=0,7E&ZMXYO+W;MFY0V,X&<9ZU<K$T"BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MN8.FUB /F (R,8#!3@C&9@[MOJ5)62[&Y??"#5+&%;O2M6CNKN%O,1#$8&!
M)!1MQ^;(&,[1SG(Q7H_A&+5X?"UE%KN\ZB@=9/,=7; =@F64D$[=O.23WYS6
M;X<^(FA^(/+A:7[#?-@?9[@@!F.T81^C99L <,<'Y:ZVIDY;,:2W04445!04
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M_P 3:7XFLVN--G+&/:)8G7:\1(SAA^8R,@D'!.*)N2T>P12->BBBL30****
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MV**Q_P#A(K?_ )XR_I_C1_PD5O\ \\9?T_QH_MG _P#/Q?B'U6M_*;%%8_\
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MY38HK'_X2*W_ .>,OZ?XT?\ "16__/&7]/\ &C^V<#_S\7XA]5K?RFQ16/\
M\)%;_P#/&7]/\:/^$BM_^>,OZ?XT?VS@?^?B_$/JM;^4V**Q_P#A(K?_ )XR
M_I_C1_PD5O\ \\9?T_QH_MG _P#/Q?B'U6M_*;%%8_\ PD5O_P \9?T_QH_X
M2*W_ .>,OZ?XT?VS@?\ GXOQ#ZK6_E-BBL?_ (2*W_YXR_I_C1_PD5O_ ,\9
M?T_QH_MG _\ /Q?B'U6M_*;%%8__  D5O_SQE_3_ !H_X2*W_P">,OZ?XT?V
MS@?^?B_$/JM;^4V**Q_^$BM_^>,OZ?XT?\)%;_\ /&7]/\:/[9P/_/Q?B'U6
MM_*;%%8__"16_P#SQE_3_&C_ (2*W_YXR_I_C1_;.!_Y^+\0^JUOY38HK'_X
M2*W_ .>,OZ?XT?\ "16__/&7]/\ &C^V<#_S\7XA]5K?RFQ16/\ \)%;_P#/
M&7]/\:/^$BM_^>,OZ?XT?VS@?^?B_$/JM;^4V**Q_P#A(K?_ )XR_I_C1_PD
M5O\ \\9?T_QH_MG _P#/Q?B'U6M_*;%%8_\ PD5O_P \9?T_QH_X2*W_ .>,
MOZ?XT?VS@?\ GXOQ#ZK6_E-BBL?_ (2*W_YXR_I_C1_PD5O_ ,\9?T_QH_MG
M _\ /Q?B'U6M_*;%%8__  D5O_SQE_3_ !H_X2*W_P">,OZ?XT?VS@?^?B_$
M/JM;^4V**Q_^$BM_^>,OZ?XT?\)%;_\ /&7]/\:/[9P/_/Q?B'U6M_*;%%8_
M_"16_P#SQE_3_&C_ (2*W_YXR_I_C1_;.!_Y^+\0^JUOY38HK'_X2*W_ .>,
MOZ?XT?\ "16__/&7]/\ &C^V<#_S\7XA]5K?RFQ16/\ \)%;_P#/&7]/\:/^
M$BM_^>,OZ?XT?VS@?^?B_$/JM;^4V**Q_P#A(K?_ )XR_I_C1_PD5O\ \\9?
MT_QH_MG _P#/Q?B'U6M_*;%%8_\ PD5O_P \9?T_QH_X2*W_ .>,OZ?XT?VS
M@?\ GXOQ#ZK6_E-BBL?_ (2*W_YXR_I_C1_PD5O_ ,\9?T_QH_MG _\ /Q?B
M'U6M_*;%%8__  D5O_SQE_3_ !H_X2*W_P">,OZ?XT?VS@?^?B_$/JM;^4V*
M*Q_^$BM_^>,OZ?XT?\)%;_\ /&7]/\:/[9P/_/Q?B'U6M_*;%%8__"16_P#S
MQE_3_&C_ (2*W_YXR_I_C1_;.!_Y^+\0^JUOY38HK'_X2*W_ .>,OZ?XT?\
M"16__/&7]/\ &C^V<#_S\7XA]5K?RFQ16/\ \)%;_P#/&7]/\:/^$BM_^>,O
MZ?XT?VS@?^?B_$/JM;^4V**Q_P#A(K?_ )XR_I_C1_PD5O\ \\9?T_QH_MG
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M !H_X2*W_P">,OZ?XT?VS@?^?B_$/JM;^4V**Q_^$BM_^>,OZ?XT?\)%;_\
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M\:/^$BM_^>,OZ?XT?VS@?^?B_$/JM;^4V**Q_P#A(K?_ )XR_I_C1_PD5O\
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M%2YUKR_JCEZ]9^!NHS+JNIZ9N)@> 7 4G@,K!<CZAOT%>35Z;\#_ /D;;_\
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M\:/^$BM_^>,OZ?XT?VS@?^?B_$/JM;^4V**Q_P#A(K?_ )XR_I_C1_PD5O\
M\\9?T_QH_MG _P#/Q?B'U6M_*;%%8_\ PD5O_P \9?T_QH_X2*W_ .>,OZ?X
MT?VS@?\ GXOQ#ZK6_E-BBL?_ (2*W_YXR_I_C1_PD5O_ ,\9?T_QH_MG _\
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M_MG _P#/Q?B'U6M_*;%%8_\ PD5O_P \9?T_QH_X2*W_ .>,OZ?XT?VS@?\
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MW_YXR_I_C1_;.!_Y^+\0^JUOY38HK'_X2*W_ .>,OZ?XT?\ "16__/&7]/\
M&C^V<#_S\7XA]5K?RFQ16/\ \)%;_P#/&7]/\:/^$BM_^>,OZ?XT?VS@?^?B
M_$/JM;^4V**Q_P#A(K?_ )XR_I_C1_PD5O\ \\9?T_QH_MG _P#/Q?B'U6M_
M*;%%8_\ PD5O_P \9?T_QH_X2*W_ .>,OZ?XT?VS@?\ GXOQ#ZK6_E-BBL?_
M (2*W_YXR_I_C1_PD5O_ ,\9?T_QH_MG _\ /Q?B'U6M_*;%%8__  D5O_SQ
ME_3_ !H_X2*W_P">,OZ?XT?VS@?^?B_$/JM;^4V**Q_^$BM_^>,OZ?XT?\)%
M;_\ /&7]/\:/[9P/_/Q?B'U6M_*;%%8__"16_P#SQE_3_&C_ (2*W_YXR_I_
MC1_;.!_Y^+\0^JUOY38HK'_X2*W_ .>,OZ?XT?\ "16__/&7]/\ &C^V<#_S
M\7XA]5K?RFQ16/\ \)%;_P#/&7]/\:/^$BM_^>,OZ?XT?VS@?^?B_$/JM;^4
MV**Q_P#A(K?_ )XR_I_C1_PD5O\ \\9?T_QH_MG _P#/Q?B'U6M_*;%%8_\
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MY38HK'_X2*W_ .>,OZ?XT?\ "16__/&7]/\ &C^V<#_S\7XA]5K?RFQ16/\
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M_P"$BM_^>,OZ?XT?\)%;_P#/&7]/\:/[9P/_ #\7XC^JUOY2#QN2/ VMX/\
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M "BBB@ HHHH **** "BBB@ KE_B-_P D^UG_ *XC_P!"%=17+_$;_DGVL_\
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M7]U_^^J/["LO[K_]]4?ZMXWO'[_^ 'U^EYG+45U/]A67]U_^^J/["LO[K_\
M?5'^K>-[Q^__ ( ?7Z7F<M174_V%9?W7_P"^J/["LO[K_P#?5'^K>-[Q^_\
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M5'^K>-[Q^_\ X ?7Z7F<M174_P!A67]U_P#OJC^PK+^Z_P#WU1_JWC>\?O\
M^ 'U^EYG+45U/]A67]U_^^J/["LO[K_]]4?ZMXWO'[_^ 'U^EYG+45U/]A67
M]U_^^J/["LO[K_\ ?5'^K>-[Q^__ ( ?7Z7F<M174_V%9?W7_P"^J/["LO[K
M_P#?5'^K>-[Q^_\ X ?7Z7F<M174_P!A67]U_P#OJC^PK+^Z_P#WU1_JWC>\
M?O\ ^ 'U^EYG+45U/]A67]U_^^J/["LO[K_]]4?ZMXWO'[_^ 'U^EYG+45U/
M]A67]U_^^J/["LO[K_\ ?5'^K>-[Q^__ ( ?7Z7F<M174_V%9?W7_P"^J/["
MLO[K_P#?5'^K>-[Q^_\ X ?7Z7F<M174_P!A67]U_P#OJC^PK+^Z_P#WU1_J
MWC>\?O\ ^ 'U^EYG+45U/]A67]U_^^J/["LO[K_]]4?ZMXWO'[_^ 'U^EYG+
M45U/]A67]U_^^J/["LO[K_\ ?5'^K>-[Q^__ ( ?7Z7F<M174_V%9?W7_P"^
MJ/["LO[K_P#?5'^K>-[Q^_\ X ?7Z7F<M174_P!A67]U_P#OJC^PK+^Z_P#W
MU1_JWC>\?O\ ^ 'U^EYG+45U/]A67]U_^^J/["LO[K_]]4?ZMXWO'[_^ 'U^
MEYG+45U/]A67]U_^^J/["LO[K_\ ?5'^K>-[Q^__ ( ?7Z7F<M174_V%9?W7
M_P"^J/["LO[K_P#?5'^K>-[Q^_\ X ?7Z7F<M174_P!A67]U_P#OJC^PK+^Z
M_P#WU1_JWC>\?O\ ^ 'U^EYG+45U/]A67]U_^^J/["LO[K_]]4?ZMXWO'[_^
M 'U^EYG+45U/]A67]U_^^J/["LO[K_\ ?5'^K>-[Q^__ ( ?7Z7F<M174_V%
M9?W7_P"^J/["LO[K_P#?5'^K>-[Q^_\ X ?7Z7F<M174_P!A67]U_P#OJC^P
MK+^Z_P#WU1_JWC>\?O\ ^ 'U^EYG+45U/]A67]U_^^J/["LO[K_]]4?ZMXWO
M'[_^ 'U^EYG+45U/]A67]U_^^J/["LO[K_\ ?5'^K>-[Q^__ ( ?7Z7F<M17
M4_V%9?W7_P"^J/["LO[K_P#?5'^K>-[Q^_\ X ?7Z7F<M174_P!A67]U_P#O
MJC^PK+^Z_P#WU1_JWC>\?O\ ^ 'U^EYG+45U/]A67]U_^^J/["LO[K_]]4?Z
MMXWO'[_^ 'U^EYG+45U/]A67]U_^^J/["LO[K_\ ?5'^K>-[Q^__ ( ?7Z7F
M<M174_V%9?W7_P"^J/["LO[K_P#?5'^K>-[Q^_\ X ?7Z7F<M174_P!A67]U
M_P#OJC^PK+^Z_P#WU1_JWC>\?O\ ^ 'U^EYG+45U/]A67]U_^^J/["LO[K_]
M]4?ZMXWO'[_^ 'U^EYG+45U/]A67]U_^^J/["LO[K_\ ?5'^K>-[Q^__ ( ?
M7Z7F<M174_V%9?W7_P"^J/["LO[K_P#?5'^K>-[Q^_\ X ?7Z7F<M174_P!A
M67]U_P#OJC^PK+^Z_P#WU1_JWC>\?O\ ^ 'U^EYG+45U/]A67]U_^^J/["LO
M[K_]]4?ZMXWO'[_^ 'U^EYG+45U/]A67]U_^^J/["LO[K_\ ?5'^K>-[Q^__
M ( ?7Z7F<M174_V%9?W7_P"^J/["LO[K_P#?5'^K>-[Q^_\ X ?7Z7F<M174
M_P!A67]U_P#OJC^PK+^Z_P#WU1_JWC>\?O\ ^ 'U^EYG+45U/]A67]U_^^J/
M["LO[K_]]4?ZMXWO'[_^ 'U^EYG+45U/]A67]U_^^J/["LO[K_\ ?5'^K>-[
MQ^__ ( ?7Z7F<M174_V%9?W7_P"^J/["LO[K_P#?5'^K>-[Q^_\ X ?7Z7F<
MM174_P!A67]U_P#OJC^PK+^Z_P#WU1_JWC>\?O\ ^ 'U^EYG+45U/]A67]U_
M^^J/["LO[K_]]4?ZMXWO'[_^ 'U^EYG+45U/]A67]U_^^J/["LO[K_\ ?5'^
MK>-[Q^__ ( ?7Z7F<M174_V%9?W7_P"^J/["LO[K_P#?5'^K>-[Q^_\ X ?7
MZ7F<M174_P!A67]U_P#OJC^PK+^Z_P#WU1_JWC>\?O\ ^ 'U^EYG+45U/]A6
M7]U_^^J/["LO[K_]]4?ZMXWO'[_^ 'U^EYG+45U/]A67]U_^^J/["LO[K_\
M?5'^K>-[Q^__ ( ?7Z7F<M174_V%9?W7_P"^J/["LO[K_P#?5'^K>-[Q^_\
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M]A67]U_^^J/]6\;WC]__   ^OTO,Y:BNI_L*R_NO_P!]4?V%9?W7_P"^J/\
M5O&]X_?_ , /K]+S.6HKJ?["LO[K_P#?5']A67]U_P#OJC_5O&]X_?\ \ /K
M]+S.6HKJ?["LO[K_ /?5']A67]U_^^J/]6\;WC]__ #Z_2\SEJ*ZG^PK+^Z_
M_?5']A67]U_^^J/]6\;WC]__   ^OTO,Y:BNI_L*R_NO_P!]4?V%9?W7_P"^
MJ/\ 5O&]X_?_ , /K]+S.6HKJ?["LO[K_P#?5']A67]U_P#OJC_5O&]X_?\
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M]A67]U_^^J/]6\;WC]__   ^OTO,Y:BNI_L*R_NO_P!]4?V%9?W7_P"^J/\
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MK)(_/ZU3VE24^[;^\****9F%%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M):XB>VO8K2TN+F.86TR-]E=SE2JNP8+Z8;=D<<G./FR>W^,'_(Y6W_8/C_\
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M'G)/T'85G*U]#1;:A1114C"BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *CG@AN8'@N(
MDEB<8>.10RL/0@]:DHH!.VJ.>B\"^%H+G[1'H5D) <C,>0#[*>/TKH  H
M X %+1244MD:3JU*GQR;]6%%%%,S"BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M,<O;6@(4D-P/,/)!4<X53SP>,GU.BG[20N1#(88K>".""-(HHU")&BA550,
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MG..X(Z]0<9.,$UPO_"E9,?\ (Q)G_KP/_P <KO/^$D_Z=/\ R)_]:C_A)/\
MIT_\B?\ UJ%Q!@%M4_"7^0/ U7]G\41>&?!>D^%#.]D)I9YN&FN"&<+Q\@P
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M[RQKO1V)&2R9'. ?NE>6).:V?^$D_P"G3_R)_P#6H_X23_IT_P#(G_UJ%G^
M3O[3\)?Y#^I5MN7\CB;7X+Q+<HUWKKRP#.](;41N>.,,68#G'8_UKT+0]#L?
M#VE1:?81E8DY9VY>1N[,>Y/^ &  *I_\))_TZ?\ D3_ZU'_"2?\ 3I_Y$_\
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M\B?_ %J/[>R__GY^$O\ (/J=;^7\4;M%87_"2?\ 3I_Y$_\ K4?\))_TZ?\
MD3_ZU']O9?\ \_/PE_D'U.M_+^*-VBL+_A)/^G3_ ,B?_6H_X23_ *=/_(G_
M -:C^WLO_P"?GX2_R#ZG6_E_%&[16%_PDG_3I_Y$_P#K4?\ "2?].G_D3_ZU
M']O9?_S\_"7^0?4ZW\OXHW:*PO\ A)/^G3_R)_\ 6H_X23_IT_\ (G_UJ/[>
MR_\ Y^?A+_(/J=;^7\4;M%87_"2?].G_ )$_^M1_PDG_ $Z?^1/_ *U']O9?
M_P _/PE_D'U.M_+^*-VBL+_A)/\ IT_\B?\ UJ/^$D_Z=/\ R)_]:C^WLO\
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M/_(G_P!:C_A)/^G3_P B?_6H_M[+_P#GY^$O\@^IUOY?Q1NT5A?\))_TZ?\
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M.G_D3_ZU']O9?_S\_"7^0?4ZW\OXHW:*PO\ A)/^G3_R)_\ 6H_X23_IT_\
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M //S\)?Y!]3K?R_BC=HK"_X23_IT_P#(G_UJ/^$D_P"G3_R)_P#6H_M[+_\
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M]:C_ (23_IT_\B?_ %J/[>R__GY^$O\ (/J=;^7\4;M%87_"2?\ 3I_Y$_\
MK4?\))_TZ?\ D3_ZU']O9?\ \_/PE_D'U.M_+^*-VBL+_A)/^G3_ ,B?_6H_
MX23_ *=/_(G_ -:C^WLO_P"?GX2_R#ZG6_E_%&[16%_PDG_3I_Y$_P#K4?\
M"2?].G_D3_ZU']O9?_S\_"7^0?4ZW\OXHW:*PO\ A)/^G3_R)_\ 6H_X23_I
MT_\ (G_UJ/[>R_\ Y^?A+_(/J=;^7\4;M%87_"2?].G_ )$_^M1_PDG_ $Z?
M^1/_ *U']O9?_P _/PE_D'U.M_+^*-VBL+_A)/\ IT_\B?\ UJ/^$D_Z=/\
MR)_]:C^WLO\ ^?GX2_R#ZG6_E_%&[16%_P ))_TZ?^1/_K4?\))_TZ?^1/\
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M .?GX2_R#ZG6_E_%&[16%_PDG_3I_P"1/_K4?\))_P!.G_D3_P"M1_;V7_\
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MZ=/_ ")_]:C_ (23_IT_\B?_ %J/[>R__GY^$O\ (/J=;^7\4;M%87_"2?\
M3I_Y$_\ K4?\))_TZ?\ D3_ZU']O9?\ \_/PE_D'U.M_+^*-VBL+_A)/^G3_
M ,B?_6H_X23_ *=/_(G_ -:C^WLO_P"?GX2_R#ZG6_E_%&[16%_PDG_3I_Y$
M_P#K4?\ "2?].G_D3_ZU']O9?_S\_"7^0?4ZW\OXHW:*PO\ A)/^G3_R)_\
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M^M1_PDG_ $Z?^1/_ *U']O9?_P _/PE_D'U.M_+^*-VBL+_A)/\ IT_\B?\
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M/_(G_P!:C_A)/^G3_P B?_6H_M[+_P#GY^$O\@^IUOY?Q1NT5A?\))_TZ?\
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M.G_D3_ZU']O9?_S\_"7^0?4ZW\OXHW:*PO\ A)/^G3_R)_\ 6H_X23_IT_\
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M]O\ &C^QM/\ ^??_ ,?;_&C_ %8Q?\T?O?\ D']H4NS_ *^9R=%=9_8VG_\
M/O\ ^/M_C1_8VG_\^_\ X^W^-'^K&+_FC][_ ,@_M"EV?]?,Y.BNL_L;3_\
MGW_\?;_&C^QM/_Y]_P#Q]O\ &C_5C%_S1^]_Y!_:%+L_Z^9R=%=9_8VG_P#/
MO_X^W^-']C:?_P ^_P#X^W^-'^K&+_FC][_R#^T*79_U\SDZ*ZS^QM/_ .??
M_P ?;_&C^QM/_P"??_Q]O\:/]6,7_-'[W_D']H4NS_KYG)T5UG]C:?\ \^__
M (^W^-']C:?_ ,^__C[?XT?ZL8O^:/WO_(/[0I=G_7S.3HKK/[&T_P#Y]_\
MQ]O\:/[&T_\ Y]__ !]O\:/]6,7_ #1^]_Y!_:%+L_Z^9R=%=9_8VG_\^_\
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M .??_P ?;_&C^QM/_P"??_Q]O\:/]6,7_-'[W_D']H4NS_KYG)T5UG]C:?\
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MI=G_ %\SDZ*ZS^QM/_Y]_P#Q]O\ &C^QM/\ ^??_ ,?;_&C_ %8Q?\T?O?\
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M_:%+L_Z^9R=%=9_8VG_\^_\ X^W^-']C:?\ \^__ (^W^-'^K&+_ )H_>_\
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M-'^K&+_FC][_ ,@_M"EV?]?,Y.BNL_L;3_\ GW_\?;_&C^QM/_Y]_P#Q]O\
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M_&C_ %8Q?\T?O?\ D']H4NS_ *^9R=%=9_8VG_\ /O\ ^/M_C1_8VG_\^_\
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M (^W^-'^K&+_ )H_>_\ (/[0I=G_ %\SDZ*ZS^QM/_Y]_P#Q]O\ &C^QM/\
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M ,^__C[?XT?ZL8O^:/WO_(/[0I=G_7S.3HKK/[&T_P#Y]_\ Q]O\:/[&T_\
MY]__ !]O\:/]6,7_ #1^]_Y!_:%+L_Z^9R=%=9_8VG_\^_\ X^W^-']C:?\
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M:?\ \^__ (^W^-'^K&+_ )H_>_\ (/[0I=G_ %\SDZ*ZS^QM/_Y]_P#Q]O\
M&C^QM/\ ^??_ ,?;_&C_ %8Q?\T?O?\ D']H4NS_ *^9R=%=9_8VG_\ /O\
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M]O\ &C^QM/\ ^??_ ,?;_&C_ %8Q?\T?O?\ D']H4NS_ *^9R=%=9_8VG_\
M/O\ ^/M_C1_8VG_\^_\ X^W^-'^K&+_FC][_ ,@_M"EV?]?,Y.BNL_L;3_\
MGW_\?;_&C^QM/_Y]_P#Q]O\ &C_5C%_S1^]_Y!_:%+L_Z^9R=%=9_8VG_P#/
MO_X^W^-']C:?_P ^_P#X^W^-'^K&+_FC][_R#^T*79_U\SDZ*ZS^QM/_ .??
M_P ?;_&C^QM/_P"??_Q]O\:/]6,7_-'[W_D']H4NS_KYG)T5UG]C:?\ \^__
M (^W^-']C:?_ ,^__C[?XT?ZL8O^:/WO_(/[0I=G_7S.3HKK/[&T_P#Y]_\
MQ]O\:/[&T_\ Y]__ !]O\:/]6,7_ #1^]_Y!_:%+L_Z^9R=%=9_8VG_\^_\
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M .??_P ?;_&C^QM/_P"??_Q]O\:/]6,7_-'[W_D']H4NS_KYG)T5UG]C:?\
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MI=G_ %\SDZ*ZS^QM/_Y]_P#Q]O\ &C^QM/\ ^??_ ,?;_&C_ %8Q?\T?O?\
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M_:%+L_Z^9R=%=9_8VG_\^_\ X^W^-']C:?\ \^__ (^W^-'^K&+_ )H_>_\
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MHKK/[&T__GW_ /'V_P :/[&T_P#Y]_\ Q]O\:/\ 5C%_S1^]_P"0?VA2[/\
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M)T5UG]C:?_S[_P#C[?XT?V-I_P#S[_\ C[?XT?ZL8O\ FC][_P @_M"EV?\
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M?VA2[/\ KYG)T5UG]C:?_P ^_P#X^W^-']C:?_S[_P#C[?XT?ZL8O^:/WO\
MR#^T*79_U\SDZ*ZS^QM/_P"??_Q]O\:/[&T__GW_ /'V_P :/]6,7_-'[W_D
M']H4NS_KYG)T5UG]C:?_ ,^__C[?XT?V-I__ #[_ /C[?XT?ZL8O^:/WO_(/
M[0I=G_7S.3HKK/[&T_\ Y]__ !]O\:/[&T__ )]__'V_QH_U8Q?\T?O?^0?V
MA2[/^OF<G176?V-I_P#S[_\ C[?XT?V-I_\ S[_^/M_C1_JQB_YH_>_\@_M"
MEV?]?,Y.N0^-7_'AX7_ZY3?RBKUO^QM/_P"??_Q]O\:\I^.B+''X=C0851<
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MBB@ HHHH **** "BBB@ HHHH *H0_P#(7G_W/\*OU0A_Y"\_^Y_A0!?HHHH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MVEZFRMJ&FV=VRC"FX@60CZ9!J]10U?<<9.+O%V,'6@UI;P6ULJPVI!'EQJ%
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M^W3_ //E)^O^%'VZ?_GRD_7_  H O451^W3_ //E)^O^%'VZ?_GRD_7_  H
MO451^W3_ //E)^O^%'VZ?_GRD_7_  H O451^W3_ //E)^O^%'VZ?_GRD_7_
M  H O451^W3_ //E)^O^%'VZ?_GRD_7_  H O451^W3_ //E)^O^%'VZ?_GR
MD_7_  H O451^W3_ //E)^O^%'VZ?_GRD_7_  H O451^W3_ //E)^O^%'VZ
M?_GRD_7_  H O451^W3_ //E)^O^%'VZ?_GRD_7_  H O451^W3_ //E)^O^
M%'VZ?_GRD_7_  H O451^W3_ //E)^O^%'VZ?_GRD_7_  H O451^W3_ //E
M)^O^%'VZ?_GRD_7_  H O451^W3_ //E)^O^%'VZ?_GRD_7_  H O451^W3_
M //E)^O^%'VZ?_GRD_7_  H O451^W3_ //E)^O^%'VZ?_GRD_7_  H O451
M^W3_ //E)^O^%'VZ?_GRD_7_  H O451^W3_ //E)^O^%'VZ?_GRD_7_  H
MO451^W3_ //E)^O^%'VZ?_GRD_7_  H O451^W3_ //E)^O^%'VZ?_GRD_7_
M  H O451^W3_ //E)^O^%'VZ?_GRD_7_  H O451^W3_ //E)^O^%'VZ?_GR
MD_7_  H O451^W3_ //E)^O^%'VZ?_GRD_7_  H O451^W3_ //E)^O^%'VZ
M?_GRD_7_  H O451^W3_ //E)^O^%'VZ?_GRD_7_  H O451^W3_ //E)^O^
M%'VZ?_GRD_7_  H O451^W3_ //E)^O^%'VZ?_GRD_7_  H O451^W3_ //E
M)^O^%'VZ?_GRD_7_  H O451^W3_ //E)^O^%'VZ?_GRD_7_  H O451^W3_
M //E)^O^%'VZ?_GRD_7_  H O451^W3_ //E)^O^%'VZ?_GRD_7_  H O451
M^W3_ //E)^O^%'VZ?_GRD_7_  H O451^W3_ //E)^O^%'VZ?_GRD_7_  H
MO451^W3_ //E)^O^%'VZ?_GRD_7_  H O451^W3_ //E)^O^%'VZ?_GRD_7_
M  H O451^W3_ //E)^O^%'VZ?_GRD_7_  H O451^W3_ //E)^O^%'VZ?_GR
MD_7_  H O451^W3_ //E)^O^%'VZ?_GRD_7_  H O451^W3_ //E)^O^%'VZ
M?_GRD_7_  H O451^W3_ //E)^O^%'VZ?_GRD_7_  H O451^W3_ //E)^O^
M%'VZ?_GRD_7_  H O451^W3_ //E)^O^%'VZ?_GRD_7_  H O451^W3_ //E
M)^O^%'VZ?_GRD_7_  H O451^W3_ //E)^O^%'VZ?_GRD_7_  H O451^W3_
M //E)^O^%'VZ?_GRD_7_  H O451^W3_ //E)^O^%'VZ?_GRD_7_  H O451
M^W3_ //E)^O^%'VZ?_GRD_7_  H O451^W3_ //E)^O^%'VZ?_GRD_7_  H
MO451^W3_ //E)^O^%'VZ?_GRD_7_  H O451^W3_ //E)^O^%'VZ?_GRD_7_
M  H O451^W3_ //E)^O^%'VZ?_GRD_7_  H O451^W3_ //E)^O^%'VZ?_GR
MD_7_  H O451^W3_ //E)^O^%'VZ?_GRD_7_  H O451^W3_ //E)^O^%'VZ
M?_GRD_7_  H O451^W3_ //E)^O^%'VZ?_GRD_7_  H O451^W3_ //E)^O^
M%'VZ?_GRD_7_  H O451^W3_ //E)^O^%'VZ?_GRD_7_  H O451^W3_ //E
M)^O^%'VZ?_GRD_7_  H O451^W3_ //E)^O^%'VZ?_GRD_7_  H O451^W3_
M //E)^O^%'VZ?_GRD_7_  H O451^W3_ //E)^O^%'VZ?_GRD_7_  H O451
M^W3_ //E)^O^%'VZ?_GRD_7_  H O451^W3_ //E)^O^%'VZ?_GRD_7_  H
MO451^W3_ //E)^O^%'VZ?_GRD_7_  H O451^W3_ //E)^O^%'VZ?_GRD_7_
M  H O451^W3_ //E)^O^%'VZ?_GRD_7_  H O451^W3_ //E)^O^%'VZ?_GR
MD_7_  H O451^W3_ //E)^O^%'VZ?_GRD_7_  H O451^W3_ //E)^O^%'VZ
M?_GRD_7_  H O451^W3_ //E)^O^%'VZ?_GRD_7_  H O451^W3_ //E)^O^
M%'VZ?_GRD_7_  H O451^W3_ //E)^O^%'VZ?_GRD_7_  H O451^W3_ //E
M)^O^%'VZ?_GRD_7_  H O451^W3_ //E)^O^%'VZ?_GRD_7_  H O451^W3_
M //E)^O^%'VZ?_GRD_7_  H O451^W3_ //E)^O^%'VZ?_GRD_7_  H O451
M^W3_ //E)^O^%'VZ?_GRD_7_  H O451^W3_ //E)^O^%'VZ?_GRD_7_  H
MO451^W3_ //E)^O^%'VZ?_GRD_7_  H O451^W3_ //E)^O^%'VZ?_GRD_7_
M  H O451^W3_ //E)^O^%'VZ?_GRD_7_  H O451^W3_ //E)^O^%'VZ?_GR
MD_7_  H O451^W3_ //E)^O^%'VZ?_GRD_7_  H O451^W3_ //E)^O^%'VZ
M?_GRD_7_  H O451^W3_ //E)^O^%'VZ?_GRD_7_  H O451^W3_ //E)^O^
M%'VZ?_GRD_7_  H O451^W3_ //E)^O^%'VZ?_GRD_7_  H O451^W3_ //E
M)^O^%'VZ?_GRD_7_  H O451^W3_ //E)^O^%'VZ?_GRD_7_  H O451^W3_
M //E)^O^%'VZ?_GRD_7_  H O451^W3_ //E)^O^%'VZ?_GRD_7_  H O451
M^W3_ //E)^O^%'VZ?_GRD_7_  H O451^W3_ //E)^O^%'VZ?_GRD_7_  H
MO451^W3_ //E)^O^%'VZ?_GRD_7_  H O451^W3_ //E)^O^%'VZ?_GRD_7_
M  H O451^W3_ //E)^O^%'VZ?_GRD_7_  H O451^W3_ //E)^O^%'VZ?_GR
MD_7_  H O451^W3_ //E)^O^%'VZ?_GRD_7_  H O451^W3_ //E)^O^%'VZ
M?_GRD_7_  H O451^W3_ //E)^O^%'VZ?_GRD_7_  H O451^W3_ //E)^O^
M%'VZ?_GRD_7_  H O451^W3_ //E)^O^%'VZ?_GRD_7_  H O451^W3_ //E
M)^O^%'VZ?_GRD_7_  H O451^W3_ //E)^O^%'VZ?_GRD_7_  H O451^W3_
M //E)^O^%'VZ?_GRD_7_  H O451^W3_ //E)^O^%'VZ?_GRD_7_  H O451
M^W3_ //E)^O^%'VZ?_GRD_7_  H O451^W3_ //E)^O^%'VZ?_GRD_7_  H
MO451^W3_ //E)^O^%'VZ?_GRD_7_  H O451^W3_ //E)^O^%'VZ?_GRD_7_
M  H O451^W3_ //E)^O^%'VZ?_GRD_7_  H O451^W3_ //E)^O^%'VZ?_GR
MD_7_  H O451^W3_ //E)^O^%'VZ?_GRD_7_  H O451^W3_ //E)^O^%'VZ
M?_GRD_7_  H O451^W3_ //E)^O^%'VZ?_GRD_7_  H O451^W3_ //E)^O^
M%'VZ?_GRD_7_  H O451^W3_ //E)^O^%'VZ?_GRD_7_  H O451^W3_ //E
M)^O^%'VZ?_GRD_7_  H O451^W3_ //E)^O^%'VZ?_GRD_7_  H O451^W3_
M //E)^O^%'VZ?_GRD_7_  H O451^W3_ //E)^O^%'VZ?_GRD_7_  H O451
M^W3_ //E)^O^%'VZ?_GRD_7_  H O451^W3_ //E)^O^%'VZ?_GRD_7_  H
MO451^W3_ //E)^O^%'VZ?_GRD_7_  H O451^W3_ //E)^O^%'VZ?_GRD_7_
M  H O451^W3_ //E)^O^%'VZ?_GRD_7_  H O451^W3_ //E)^O^%'VZ?_GR
MD_7_  H O451^W3_ //E)^O^%'VZ?_GRD_7_  H O451^W3_ //E)^O^%'VZ
M?_GRD_7_  H O451^W3_ //E)^O^%'VZ?_GRD_7_  H O451^W3_ //E)^O^
M%'VZ?_GRD_7_  H O451^W3_ //E)^O^%'VZ?_GRD_7_  H O451^W3_ //E
M)^O^%'VZ?_GRD_7_  H O451^W3_ //E)^O^%'VZ?_GRD_7_  H O451^W3_
M //E)^O^%'VZ?_GRD_7_  H O451^W3_ //E)^O^%'VZ?_GRD_7_  H O451
M^W3_ //E)^O^%'VZ?_GRD_7_  H O451^W3_ //E)^O^%'VZ?_GRD_7_  H
MO451^W3_ //E)^O^%'VZ?_GRD_7_  H O451^W3_ //E)^O^%'VZ?_GRD_7_
M  H O451^W3_ //E)^O^%'VZ?_GRD_7_  H O451^W3_ //E)^O^%'VZ?_GR
MD_7_  H O451^W3_ //E)^O^%'VZ?_GRD_7_  H O451^W3_ //E)^O^%'VZ
M?_GRD_7_  H O451^W3_ //E)^O^%'VZ?_GRD_7_  H O451^W3_ //E)^O^
M%'VZ?_GRD_7_  H O451^W3_ //E)^O^%'VZ?_GRD_7_  H O451^W3_ //E
M)^O^%'VZ?_GRD_7_  H O451^W3_ //E)^O^%'VZ?_GRD_7_  H O451^W3_
M //E)^O^%'VZ?_GRD_7_  H O451^W3_ //E)^O^%'VZ?_GRD_7_  H O451
M^W3_ //E)^O^%'VZ?_GRD_7_  H O451^W3_ //E)^O^%'VZ?_GRD_7_  H
MO451^W3_ //E)^O^%'VZ?_GRD_7_  H O451^W3_ //E)^O^%'VZ?_GRD_7_
M  H O451^W3_ //E)^O^%'VZ?_GRD_7_  H O451^W3_ //E)^O^%'VZ?_GR
MD_7_  H O451^W3_ //E)^O^%'VZ?_GRD_7_  H O451^W3_ //E)^O^%'VZ
M?_GRD_7_  H O451^W3_ //E)^O^%'VZ?_GRD_7_  H O451^W3_ //E)^O^
M%'VZ?_GRD_7_  H O451^W3_ //E)^O^%'VZ?_GRD_7_  H O451^W3_ //E
M)^O^%'VZ?_GRD_7_  H O451^W3_ //E)^O^%'VZ?_GRD_7_  H O451^W3_
M //E)^O^%'VZ?_GRD_7_  H O451^W3_ //E)^O^%'VZ?_GRD_7_  H O451
M^W3_ //E)^O^%'VZ?_GRD_7_  H O451^W3_ //E)^O^%'VZ?_GRD_7_  H
MO451^W3_ //E)^O^%'VZ?_GRD_7_  H O451^W3_ //E)^O^%'VZ?_GRD_7_
M  H O451^W3_ //E)^O^%'VZ?_GRD_7_  H O451^W3_ //E)^O^%'VZ?_GR
MD_7_  H O451^W3_ //E)^O^%'VZ?_GRD_7_  H O451^W3_ //E)^O^%'VZ
M?_GRD_7_  H O451^W3_ //E)^O^%'VZ?_GRD_7_  H O451^W3_ //E)^O^
M%'VZ?_GRD_7_  H O451^W3_ //E)^O^%'VZ?_GRD_7_  H O451^W3_ //E
M)^O^%'VZ?_GRD_7_  H O451^W3_ //E)^O^%'VZ?_GRD_7_  H O451^W3_
M //E)^O^%'VZ?_GRD_7_  H O451^W3_ //E)^O^%'VZ?_GRD_7_  H O451
M^W3_ //E)^O^%'VZ?_GRD_7_  H O451^W3_ //E)^O^%'VZ?_GRD_7_  H
MO451^W3_ //E)^O^%'VZ?_GRD_7_  H O451^W3_ //E)^O^%'VZ?_GRD_7_
M  H O451^W3_ //E)^O^%'VZ?_GRD_7_  H O451^W3_ //E)^O^%'VZ?_GR
MD_7_  H O451^W3_ //E)^O^%'VZ?_GRD_7_  H O451^W3_ //E)^O^%'VZ
M?_GRD_7_  H O451^W3_ //E)^O^%'VZ?_GRD_7_  H O451^W3_ //E)^O^
M%'VZ?_GRD_7_  H O451^W3_ //E)^O^%'VZ?_GRD_7_  H O451^W3_ //E
M)^O^%'VZ?_GRD_7_  H O451^W3_ //E)^O^%'VZ?_GRD_7_  H O451^W3_
M //E)^O^%'VZ?_GRD_7_  H O451^W3_ //E)^O^%'VZ?_GRD_7_  H O451
M^W3_ //E)^O^%'VZ?_GRD_7_  H O451^W3_ //E)^O^%'VZ?_GRD_7_  H
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M_GRD_7_"@"]15'[=/_SY2?K_ (4?;I_^?*3]?\* +U4(?^0O/_N?X4OVZ?\
MY\I/U_PIMIYCW\DSPO&&3N#[4 :%%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %,FF2")I9&"HH
MR33ZY_Q#<$R1VX/R@;S[GM7#F.,6#P\JUKOIZFU"E[6:B0W>N7$S$0'RH^V/
MO'\:IKJ%XK;A<RY]V)JM17YY5S#%59\\JCOZGMQHTXJR1OZ?KA=Q%=XYX$@X
M_.MRN$KJ]&N#<:>NXY9#L)]<=/TKZG(,UJ5Y/#UG=VNG^C/.QF'C!<\#0HHH
MKZ@\\**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH Y+Q[XVA\':4C(BS:A<9%O$W3CJS>PR/K^9'S]JWBK7=;G:6
M_P!4N9,_P!RJ+]%' KI/B_=R7'C^XA=B4MH8HT'H"N[^;&N#KR\15E*;71'W
MF3X"E1P\:C5Y25[^IT.A^-O$'A^X62SU&9HP1N@F8O&P],'I]1@U]$>$?%%K
MXMT./4+=?+D!V3PDY,;CJ/<<Y!KY6KU7X&W<BZ[JEF&/E26PE(]U8 ?^AFJP
MU62GRO9F.>8"E/#NM%6E'\?4]QHHHKTCXD**** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH *Y?7?^0F?]P5U%<]J%J+S7A;L[('3[
MRXR.">,\5X>?TY5<-&G'=R2^^YUX*2C-R?1,Q:*VI- L86VRZI<(V,X9X@<?
M]\U'>:,$@-U9SB6 (6*XW%AURI'7Z8Y_G\W5X?Q<$^5J36Z3U_%([XXVF][H
MR:Z/P[_QYR_]=/Z"N<KH_#O_ !YR_P#73^@I</?[]'T?Y!C?X+-BBBBOT$\4
M**** "BO']"\1:Q/\8Y;.74KE[62\NK<V[.3&$19-H"=%(V+R "><GDY]@IM
M6$G<**X;6]#\5S^/=/O;/4YCHQDC:6))S$D*I@LK*#\^[G!P>N#@ &NYH: *
M***0PHHHH **** "BBB@ HKP:\O?$NO?$.]TFSUV]@DEO;B&%1>211(L>_ P
MG ^5,<#D\GDDUH:G<>/O 44#W6J_:;.293YDDHN%=R"?+)D'F ;4).,#G@@D
MU?)YD\Q[316)I&K/XI\))J%B7L)KJ&18V=1(89 63=CHP##(SC(QD#I6/X!T
MCQ)I?]I_\)#=S3[I%2W\VZ,V0N[+KDG ;(ZX/'('%38=SLZ***0PHHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** /F[XL?\E&U+_=A_P#12UQ5=K\6/^2C:E_NP_\ HI:XJO&J_P 27J?I
M67_[I2_PK\@KTWX'_P#(VW__ %XM_P"C$KS*O3?@?_R-M_\ ]>+?^C$JJ'\1
M&6;?[E4]#WFBBBO7/SH**S?$5U/8^&=6N[:3R[B"SFEB? .UE0D'!X/([UXA
MX?\ B!K=AX@CFO-6FEM9IT:[2XS*HC+'<57JF 20$QR!P0,548MK0ER2/H&B
MBN:\=Z_+X=\*SW=K*D=Y(RPVY9"XW$\\=,A0Q&>,@9ST*2OH4]#I:*\3^'?C
M#6KSQK!:W.H37=OJ+R"59W+!"J.X,8SA.5Q@<8/3@8W_ (O:MJ6G+H\-C?W-
MHDQF>3[/*8V8KL"Y9<''S-QG'/L,5R.]B>96N>FT5X]I.B?$2+28-:TW6WNO
MM5NDD=O+>-*Q5]K?=F&P$ Y)SV(!.<'H/AWXSU'6KFYT768Y&U"W5I?/,8C)
M4, 4=0!A@6 &!TZX(RR<=+H%(]!HKS/XO:OJ6G)H\%C?W-HDQF>0V\IC9BNP
M+\RX./F;C./R%=SX;NY[_P +Z1>7+^9<7%E#+*^ -S,@).!P.3VI-:7'?6QI
MT45YM\6M<U32HM,MM/OIK6.Z$WG>2=K-M,97##YEZGH1G/.:$KNP-V5STFBO
M'M)T3XB1:3!K6FZX]U]JMTDCMY;QI6*OM;[LPV @').>Q )S@]'X \;7^NWM
MQHVKVNR_MH]_FJFS(4JK!U/1]QSP .2,+CEN.ET)2.^HKQ+QOJNNW'Q(FTJR
MUB\MD::WMH$BN7B12ZIR=G7YG))P3CZ 5I2:%\2O#EE-<VNL/?[N7C2<W+JJ
M@G*K,OX87DDC@]GR>8<QZW17GW@GX@RZM?QZ#K-L\6J*I03;<>:Z9+!EP/+;
M SZ$AON\ V/BMJ5]IOA6W:PNYK5YKQ(W>%RC%=CM@,.1RHZ$>G0D4N5WL/F5
MKG<T5XGH/AOQKXBT:#5+3Q/<I!,7"K+J5P&&URISC(ZJ>]=]X(\/Z_H1O_[<
MU5K_ ,[R_)S=2S;,;MWWQQG*].N/:AQMU$G<ZZBO![N]\2:]\0[W2;/7;V"2
M6]N(80+N2*)%CWX&$X'RIC@<GD\DFMT^ /'V#CQ5)_X-+G_"GR6W8<WD>MT4
M45!04444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MY.>P1G; YR!]#2LK"[G02ZQ:1^'GUN,O-9K:F[78N&>/9OX#8Y([''X5YO\
M#75=5NI]9UW6]6O9;&TMR9!*':(L3O9E X!4)]U1T<8QP#SMQXL6;X50:"\J
M-=_:_*9)'+N8$(D5Q_< 8H@!SPIQT^7T'3M)&B?""Z@DCV32:;///NB\MMSQ
MLV''7<H(7GGY1TZ4K607NSDK&VU[XJ7>I2W&HR:=I:!$%N%>2$G.57;E5<C&
M68G.2O ! #+]-:^%.HZ9Y&JG4+"5),6;;HXR P+@)E@I^92&'.2<C&0T/@+P
MWJ&NZ7=/8>*KG2S%/A[6 L<Y48<A9%QG!'3^#KQQT-[\*-1U(QF^\7W-T8\A
M#<0-)MSC.,RG&<#\A5-I.SV$DVKG2>/-0>+X?WM_IUXR%EA>*XMY<95I$Y5E
M/0@]NH->::)X7\3^/-)DEO\ 59VL80WV7[:[.DLH+$ #T&Y@9#DC[HSC"]_X
MZL8M+^%5QI\#.T5K#;0(7(+%5DC49QCG JU\,_\ DGVF?6;_ -'/4IVC=#:O
M(U_#>G7NE>'[6SU&^>]O$#&6=F9B2S%L9;D@9V@GL!P.E:M%%9EGS[#J\&@_
M%6ZU6YCED@M]2O"ZQ %CN\U1C) ZL.];'CGXD6WB'0UT[3+>[@C>0/<F=4RR
MKR% !;^+!SD'Y0.035'1[2VOOC+);7=O%<0/J5[OBE0.K8$Q&0>#R ?PKT/Q
MEX.T!O"6I30:5:VL]K;O<Q26D*Q-N120"0.5/0@^O8@$;-I-7,TFT[&SX.TK
M^Q?"6GV)NHKK:A?SH>4;>Q?Y3W'S8![]<#.*XWX0ZIJ.I?VQ]OO[J[\L0;//
MF:3;GS,XR>,X'Y4?!O4KB>PU/39&W06KQR19))7S-^X=< 93. !R6/>JGP4_
MYC?^[;_^U*EJRD-/8=XDU[7?%7C%O#?ARZ>TBM'<-/&\D>YU!W&1E&54'* 8
MP3@Y.5QGZI\,]3\)Z7=:OH^M,988R9A AM7\D<L0P<YQ@''&<<<@ W/!,L4?
MQ@U]7E13(;M$5F +MYRG ]3A6/T!KU6[NH;&RGN[E]D$$;2R-@G:JC).!R>!
MVH;Y=$"5]6<K\/?%LGBC2)4O-O\ :%FRI,5! D4CY7Z8!.&! [KG@$"O/)-0
M\7ZCX\U72]&U6^R]S<P[#,3'%%YA&[G.P* ,,N".@Y.#N_!>*14UJ4QN(V,"
MK(5.UB/,R ?49&1VR/6H?!$T47Q>U]9)$1I6NTC#, 7;SPV!ZG"DX] ?2G9)
ML6Z10\0>"]:\$*?$>GZR\\GF?Z5.J^5(-S @MECY@+XR#WQD$9(Z^X\:W=U\
M+)_$-F;>'44 B=5/F")S($)P>AVL& .<9&=PZZGQ&>&/P#JAGMOM"%8P$WE,
M,9%"MD?W6(;'?;CO7/?"[2X=0\!ZA::C:>9:75ZYVR*0)%V1C*GV93@CH5]1
M2O>-V.UG9&%H/@"_\6Z9I_B&?Q+<+<\B-IHFFDBV2,!MD,@/49'IFO0++1-8
M3P$VDW>H-)J_E2A;I;J7B0LS(?,X? ^4'V&,$<5PM_X'\1>"C>ZOX?U@&TAC
M,L@)VR%1NX9""C[5).3CG.%!QGMOA]XBO/$GAK[3?JGVF"8V[R+QYN%4[R!P
M"=W('&1D8S@$KO5;!'L<U\)?$]UJ;7^FW][)<R;5N8&F9Y'*_=?YB2 H_=X'
M'+,>>Q\3]<U5-:TG0M&N;N"XE7S&$,@C$K.VR-=^0>"KY!P/F!YQQF:HR^#_
M (R170=([2\=99!]H*J$ERKM(3Q@.&?'3Y1T[)X65?%WQ8O=:V(]I [3HXMR
M4<*!'#G=]U\!7&><H< =G97YA7TL>M:=;2V>F6EK/<M<S0PI&\[@YE8* 6.2
M>21GJ>M6:**R- HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@#YN^+'_ "4;4O\ =A_]%+7%5VOQ94CXC:B2."D)'_?M:XJO&J_Q)>I^E9?_
M +I2_P *_(*]-^!__(VW_P#UXM_Z,2O,J].^!ZG_ (2N_;' L2,_\#2JH?Q$
M99M_N53T/>****]<_.C'\6?\B;KG_8/N/_1;5X)I6D_VAX9\07<<>Z:P:TE&
MV+>Y0F57&>JKR')Z83GU'O?BS_D3=<_[!]Q_Z+:O.?@W#%<-XB@GC26*2*W1
MXW4,K*?.!!!Z@BM(NT6R)*[.Q^&VL?VMX,M5,>Q['_0VPN%(11M(Y/\ "5ST
MYSQC%<9XQ=/&?Q,T_P /PW7^C6^878%1M;EYMC 'YMJA<'HR$8').7X>U9_A
MMXHUFQU O*@A9 JJ )I%^:%F(W% P)'&<>8,CC(Z;X3:;<W$NJ>)+Y=TUVYC
MCE(*ER6W2MM "D%MO([JPX[NW*W(5[Z'+>%88K;XS+!!$D4,>I7R)&BA550L
MP  '0 =JWOC3_K="_P!VX_\ :58GAO\ Y+:W_84O_P"4U;?QI_UNA?[MQ_[2
MIKXT'V6:6D_$CP]HOA'1K9Y;BYNH;6&"6&"$Y1EC ));:I (QP3UK/\ A99Z
ME?Z_J7BBXAC2VNUE7>N0))6D#-L!S\H((R3UXY(.-2#P+I/B#X>Z4\=G##J;
M:9$\5PG[O,K1J<R8'S D<D@G!.,$U4^$FLW'EWOAV\_=M:#S((6B*N@+'S0W
MT9EX/.6/4#B=.5V'K=7*GQI_UNA?[MQ_[2KO_"'_ ").@_\ 8.M__1:UP'QI
M_P!;H7^[<?\ M*NFM=&O=<^'/ARVL-8GTJ5+2VD::$-EE\G&WAEXR0>O:A_"
M@7Q,[.O)OC3_ *W0O]VX_P#:5:Q^'OB(@C_A/M2'_ 9/_CM9/QI_UNA?[MQ_
M[2H@DI*P2^$Z?PUXL\/67@O2$N-;T]9+?3H1+$+A3(I6,9&P'=GC&,9SQ7#>
M H/[=^*%UK$'G1V\,MQ>#='G_6%E5&(.%.)">^=AQZC8T/X5Z+JOAS3+^:^U
M))KJTBG<1R1@!F0,<90\9->B:1HVG:#8BRTRV6W@W%RH)8LQZDDDDGH.3T '
M0"E=).P6;W/'/$W_ "6R/_L)V/\ *&O<J\-\3?\ );(_^PG8_P H:]RHGLAQ
MZGB/Q0D71_B%;:A:1)]H2""\/F$E7D1V"Y&>F(U&!CIZ\UU?QC_Y%2Q_[""?
M^BI*Y3QK)9^+/B;::?;"Y=%:/3[AHTPV5D;S"N0>%#-R1CY2>1R>K^,?_(J6
M/_803_T5)5]8D]&4O ?C?P[HO@VQT_4-0,-U$TQ=/(D;&Z5V'*J1T(KN=$\4
M:/XC:X72KLW!MPIE_=.FW=G'W@,_=/3TKA/ G@3PYK?@ZRU#4+!YKJ5I@[BY
ME3.V5U'"L . .U=[H?AO2/#D4T>DV:VXF8-(2[.S8Z99B3@<X&<#)]342Y>A
M4;GB]AJ-II'Q=GU"^E\JUAU*\,C[2VW/FJ. ">I%>H-\3?""J6.K$ #)_P!%
MF_\ B*\NL=,M-9^+L^GW\1EM9M2O!(@=DW8\UARI!Z@=Z]1B^&?A"*5)%TC<
M48,!)<S.IQZJSD$>Q!!JI\O4F-^AUM%%%9&@4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M&(N6(SD X7*CD'%>O44U-BY48OA;PW:^%=%73[:1Y69C+-*__+20@ D#^$8
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M) O&W&?G&>?6O2***;=Q)6"BBBD,**** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!
"_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>9
<FILENAME>img32108071_2.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img32108071_2.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" (Z VH# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M /GY^$O\A?4ZW\OXHW:*PO\ A)/^G3_R)_\ 6H_X23_IT_\ (G_UJ/[>R_\
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MG_[Y'^-<W]KX'_GZC3ZM6_E-:BLG_A(;3_GG/_WR/\:/^$AM/^><_P#WR/\
M&C^U\#_S]0?5JW\IK45D_P#"0VG_ #SG_P"^1_C2CQ!9GJDP^JC_ !H6;8'_
M )^H/JU7^4U:*R_[?L_27_OG_P"O1_;]GZ2_]\__ %Z?]JX+_GZOO%]6J_RL
MU**JV>H0WQ<1!_DQG<,=:M5V4JL*T%.F[I]3.47%VEN%%%%:$A1110 4444
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M_P"_8I#8VA&/LL/_ 'P*L44?5Z/\B^Y!SR[E;^SK/_GVB_[YH_LZS_Y]HO\
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MXYYZ'PS#<P^&[!;SS_M1A5IO/D9WWD<Y+$D?3M2:L@N:U%%%(84444 %%%%
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M )+2_P#Q-'_"RO"/_06_\EI?_B:\)HH_L^/\P?VF_P"7\3W;_A97A'_H+?\
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M *"W_DM+_P#$T?\ "RO"/_06_P#):7_XFNKHH]T-3E/^%E>$?^@M_P"2TO\
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M^:"BBB@ HHHH **** "BBB@#WGX=?\B'IO\ VU_]&O745R_PZ_Y$/3?^VO\
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M5@O]XAZGJ-%%%?,GU@4444 9^O?\B[J?_7I+_P"@&O#:]RU[_D7=3_Z])?\
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MO+_C#_S!?^V__M.NG!_QH_UT.7&_P)?+\SRZBBBO;/GPHHHH **** "BBB@
MK4\-?\C5H_\ U^P_^ABLNM3PU_R-6C_]?L/_ *&*F?PLNG\:/HVBBBOG3Z<K
MI_R$9ON_ZJ/IUZOU]O\ Z]6*KI_R$9ON_P"JCZ=>K]?;_P"O5B@ KPW7O^1B
MU/\ Z^Y?_0S7N5>&Z]_R,6I_]?<O_H9KU<J^.7H>/G'P1]3/HHHKVCP0HHHH
M **** "BBB@ KL?AM_R,5Q_UZ-_Z&E<=78_#;_D8KC_KT;_T-*YL9_ EZ'5@
MO]XAZGJ-%%%?,GU@4444 9^O?\B[J?\ UZ2_^@&O#:]RU[_D7=3_ .O27_T
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M!&1ST->?>(/".A:!=^'KK3+'R)WUFVC9O-=LJ23C#,1U KT:N4\<_P#,M_\
M8=M?_9J<6[BDM#JZ***DH\:^+7_(U6O_ %Y)_P"AO7!UWGQ:_P"1JM?^O)/_
M $-ZX.O>PW\*)\[BOXT@HHHK8YPHHHH **** "BBB@#J/AU_R/FF_P#;7_T4
M]>\UX-\.O^1\TW_MK_Z*>O>:\G'_ ,1>G^9[66_PGZ_H@HHHKA/0"BBB@#Y>
MHHHKZ0^5"BBB@ HHHH **** "BBB@#U'X/?\QK_MA_[4KU"O+_@]_P QK_MA
M_P"U*]0KQ,9_&E_70^@P7\"/S_,****YCJ"N7^(O_(AZE_VR_P#1J5U%<O\
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M_P A&;[O^JCZ=>K]?;_Z]6* "O#=>_Y&+4_^ON7_ -#->Y5X;KW_ ",6I_\
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M/'/_ #+?_8=M?_9JZNN4\<_\RW_V';7_ -FJH[B>QU=%%%2,\:^+7_(U6O\
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M +9?^C4KJ*Y?XB_\B'J7_;+_ -&I6M'^)'U1E7_A2]'^1X-1117OGS04444
M%%%% !1110 4444 >\_#K_D0]-_[:_\ HUZZBN7^'7_(AZ;_ -M?_1KUU%>!
M6_B2]6?2T/X4?1?D%%%%9&H5Y?\ &'_F"_\ ;?\ ]IUZA7E_QA_Y@O\ VW_]
MIUTX/^-'^NARXW^!+Y?F>74445[9\^%%%% !1110 4444 %:GAK_ )&K1_\
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M%>!6_B2]6?2T/X4?1?D%%%%9&H5Y?\8?^8+_ -M__:=>H5Y?\8?^8+_VW_\
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MN_ZJ/IUZOU]O_KU8JNG_ "$9ON_ZJ/IUZOU]O_KU8H *\-U[_D8M3_Z^Y?\
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M +:_^C7KJ*\"M_$EZL^EH?PH^B_(****R-0KR_XP_P#,%_[;_P#M.O4*\O\
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MG\"7H=6"_P!XAZGJ-%%%?,GU@4444 9^O?\ (NZG_P!>DO\ Z :\-KW+7O\
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M%% 'R]1117TA\J%%%% !1110 4444 %%%% 'J/P>_P"8U_VP_P#:E>H5Y?\
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MM?\ T:]=17+_  Z_Y$/3?^VO_HUZZBO K?Q)>K/I:'\*/HOR"BBBLC4*\O\
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M<M>_Y%W4_P#KTE_] ->&U[>5?!+U/!SCXX^@4445ZAXX4444 %%%% !1110
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MG\:/HVBBBOG3Z<KI_P A&;[O^JCZ=>K]?;_Z]6*KI_R$9ON_ZJ/IUZOU]O\
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M7SY]*%%%% !1110 4444 %%%% !1110 4444 %%%% !7*>.?^9;_ .P[:_\
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M9ON_ZJ/IUZOU]O\ Z]6*KI_R$9ON_P"JCZ=>K]?;_P"O5B@ KPW7O^1BU/\
MZ^Y?_0S7N5>&Z]_R,6I_]?<O_H9KU<J^.7H>/G'P1]3/HHHKVCP0HHHH ***
M* "BBB@ KL?AM_R,5Q_UZ-_Z&E<=78_#;_D8KC_KT;_T-*YL9_ EZ'5@O]XA
MZGJ-%%%?,GU@4444 9^O?\B[J?\ UZ2_^@&O#:]RU[_D7=3_ .O27_T UX;7
MMY5\$O4\'./CCZ!1117J'CA1110 4444 %%%% !7J/PV_P"1=N/^OMO_ $!*
M\NKU'X;?\B[<?]?;?^@)7!F/\#YGHY7_ +PO1G8T445\^?2A1110 4444 %%
M%% !1110 44A(523T')K*L_$FG:AY1M1>R)*0$D%A.$/ON*8Q[YQ18#6HJA>
MZS8V%PEO-)(UPZ[Q#!"\S[>FXJ@) SQDC%0R^(+$:=;7MLSW:W4@B@C@ WR.
M?X?F( (P<[B,8.:=F%S5HK*7Q!9'1I=382I'"S1R1,H\P2 [2F <%MW P><B
MM*)S+"DAC>,LH)1\;E]C@D9I6 ?7*>.?^9;_ .P[:_\ LU=77*>.?^9;_P"P
M[:_^S54=Q/8ZNBBBI&<;XM\!?\)3JL5]_:7V7RX!#L\C?G#,<YW#^]^E8/\
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MUEZGXFT71KE;?4=0BMYF7>$;.<=,\#V-8GB75[+4[FRT);^&&UO(Q<W4SR[
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M_D8KC_KT;_T-*YL9_ EZ'5@O]XAZGJ-%%%?,GU@4444 9^O?\B[J?_7I+_Z
M:\-KW+7O^1=U/_KTE_\ 0#7AM>WE7P2]3P<X^./H%%%%>H>.%%%% !1110 4
M444 %>H_#;_D7;C_ *^V_P#0$KRZO4?AM_R+MQ_U]M_Z E<&8_P/F>CE?^\+
MT9V-%%%?/GTH4444 %%%% !1110 4444 %%%% !1110 4444 %<IXY_YEO\
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MG_F6_P#L.VO_ +-51W$]CJZ***D84444 %%%% !1110 4444 %%%% !1110
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M8^;(. O;.X!?F*CG.< T:SXML]%U2TT^XAE,UR?W8&/FR#@+VSN 7YBHYSG
M-%F*Z.@HHHI#"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *\O\
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M10 4444 %%%% !1110 4444 %%%% !7*>.?^9;_[#MK_ .S5U=<IXY_YEO\
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M%>7_ !A_Y@O_ &W_ /:==.#_ (T?ZZ'+C?X$OE^9Y=1117MGSX4444 %%%%
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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D4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>10
<FILENAME>img32108071_3.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img32108071_3.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  G!"4# 2(  A$! Q$!_\0
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M<H% .<D'HQ']T<FE8#1HJLNHV+WS6*WENUV@RT E4R >I7.>XJC>ZO<IJ_\
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M1 6+$*H&23DGZD\T^E>P6.5T_3+JUO\ 1)9XF:=Q<3WCJIVK+(%)!/;^Z/\
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M.WKTK7\+V<UEHBQS1-!NFEDC@;&8D9R57C@8!'';I6S12;N"04444AA1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
64444 %%%% !1110 4444 %%%% '_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>11
<FILENAME>img32108071_4.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img32108071_4.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" '" V<# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M>A4;AZ$]13MU"Y?HHHI %%%(S*BEF8*JC)). !0 M%0VMU;WMLEQ:SQSP/\
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M\,57O_".AZE9V5K=66^*R0);@2,I1< 8R#DC '6CG0N5E#XCF=? >H^1NSA
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MAI>+;/*XNKE[E_,(.&;&0, <<4RR\.V5GJFH:C\\]Q?.K2&;#!0HP O' _\
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ME!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !69KFMV^A6<=Q/')*TLR0111 %G=CP!
MDCW_ "K3KC/&!W^+/"$+?ZHW<CD=MRA=O\S3BKL3V-;4_&6@:/?-97]_Y5PB
MAF3R9&P#TY"D5K6=Y;:A:1W5I,DT$@RDB'(->>WL.KS_ !)UR+1Y+))7L$5S
M=JQ7:0O3'?ZY%5]%U2RA^'5E:"74K5Q?&TVV$@,MQ*<G"L< *=P_+&3WKE5M
M!<VIZC17EVG3^(YX/%&CZ?<WRW4 A:V2]G5YH]W++OR1DCISQ[&I'\12:=X*
MUM[*75(]2M9(XYHM1E\UK<N<95CU!YQ[T<@<QZ/>74=E93W<H8QP1M(P49.%
M&3C\JRH/%.GSPZ3(JW &J9^S@QYQC^]C('6N-CM_$%O!>NT>J'2Y=+G\]M0N
MTF^?RR0R88D9]!ZTNG7MU;6/@"&"XECBG+K*B.0) ,8##OUHY0YCTRBO&UNM
M:7P.?$O]OZB;FUN]D<)E_=E=^,,.K=>_;BND\3ZAJ-YXSM]&@&H&V6S^T&*P
MN%ADD8L1DL2.!Z4<@<QZ!67=>(])LM9M](N+Q4OK@ QQ;6.<D@<@8&<=S57P
M@-8CT$1ZXL@N8Y&56E=6=H_X2Q4D9[?A7EVJZA'JPUK6DM[UKW[8DMC.ENS1
MI%%P#OZ#(R3[@41C=@Y61[%>ZM8Z=<V=O=3^7+>2>5 NTG>WIP..HZU2UCQ9
MHF@7*6^IWOD2NGF*OE.V5R1G*@]P:YCQ!J$>JWO@:_B^Y<70DQZ9VY'X'BN@
M\<_\B1JW_7 _S%*RTN%]RUHOB?1_$+3+I=Y]H,(!D_=.F,YQ]X#T-:]9?AK_
M )%71_\ KRA_] %<MXGN(=,UN6?1M6O%UR;:7T^!/M"2X4 ;DZ)P!SD<<T6N
M[(=[([>ZNH+*TENKF01P1(7=VZ*!UK-M_%.C76B3:Q#>;K" E9)?+<;2,=B,
M]QVKD_$FK7=Q;Z)I^NV4UO#/_I&HI;1F4$*?EC&,\$@$\\52\(PQ^(/!6O:-
M Y@DENV8/)&0H#%=H^OR]/I3Y=+L7-J=MH_B[0]?NWM=,OO/F1#(R^4ZX4$#
M.64#J15Z75K&'5X-*DGQ>SQF2.+:?F49R<XQV/>N7T?5]7T[Q;#X9U0V=RKV
MOFQ3VR%2H&>&!/\ LG]*35W6+XLZ"TC!5>SE12> 6^;CZT<NH7T.I&K6)UEM
M)$_^G+#YYBVG[F<9SC'7MFJLFO(/%4.A10-)(UN;B64-Q$N<#([DG^=8$$B/
M\8+ME8%8M*"R'/"G>IP?P-2>!P=4N]8\2R _Z?<&.W)[0Q_*/S[_ $I62U"Y
MTNF:M8ZS;/<6$_G1)(T3-M*X8=1R!ZU#H>MV^O6#74$<D1CE:&2*4 ,CJ>0<
M$CT/XUSOPP_Y%N[_ .O^7_V6G>#3L\3^+H4_U2WJN!VW,&W?R%#2U!/8[.BB
MBI*"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "F2N8X7=4+LJDA1U/M3Z*4DVK($9/]K7?_0*G_7_XFC^UKO\ Z!4_
MZ_\ Q-:U%>?]4Q7_ $$/_P !C_D;^TI_R?BS)_M:[_Z!4_Z__$T?VM=_] J?
M]?\ XFM:BCZIBO\ H(?_ (#'_(/:4_Y/Q9D_VM=_] J?]?\ XFC^UKO_ *!4
M_P"O_P 36M11]4Q7_00__ 8_Y![2G_)^+,G^UKO_ *!4_P"O_P 31_:UW_T"
MI_U_^)K6HH^J8K_H(?\ X#'_ "#VE/\ D_%F3_:UW_T"I_U_^)J6VU&XGN%C
MDL)8E.<NV<#CZ5HT54,-B8R3E7;7;ECK^ G4IM:0_%F!/$FH^);JTO)IEA@M
M8Y(8DF:,-N9PS_*1G&U1[?C6.-6NK'2M/U1YY)EDAN;52S9\U@6:!C[L(\9[
M[ZZV\TVPU'9]MLK>YV?<\Z)7V_3(ID.D6$%O]G2V0P"42I$_SJC#&-H.0N",
M@# ':O1NC"QSVAO=?VA::--=2RR:6\S7$C.<R# $6[URLA/U2NCO;N:U\ORK
M5Y]V<[<_+T]C4Z6\$<\DZ0QK-* )) H#.!TR>^,FI*RKQE.#4)<K[Z/\]"H-
M1=VKF3_:UW_T"I_U_P#B:/[6N_\ H%3_ *__ !-:U%</U3%?]!#_ / 8_P"1
MM[2G_)^+,G^UKO\ Z!4_Z_\ Q-']K7?_ $"I_P!?_B:UJ*/JF*_Z"'_X#'_(
M/:4_Y/Q9D_VM=_\ 0*G_ %_^)H_M:[_Z!4_Z_P#Q-:U%'U3%?]!#_P# 8_Y!
M[2G_ "?BS)_M:[_Z!4_Z_P#Q-']K7?\ T"I_U_\ B:UJ*/JF*_Z"'_X#'_(/
M:4_Y/Q9D_P!K7?\ T"I_U_\ B:O6=Q)<PEY;=H&#8VMU/OT%6**UHT*\)WJ5
M7)=K)?DB9S@U91M\V%5+V[FM?+\JU>?=G.W/R]/8U;HKHK0G.#C"7*^^C_,B
M+2=VKF3_ &M=_P#0*G_7_P")H_M:[_Z!4_Z__$UK45Q?5,5_T$/_ ,!C_D:^
MTI_R?BS)_M:[_P"@5/\ K_\ $UF3)%?3:]/?7EQ"]D^V+9<-&($$2L' ! ))
M+')SG&.U=35*[TC3=0E$MYI]K<2 ;0\L*L0/3)%=.&I5:=_:5'*_DE;[C.I*
M,OAC8P;GSM0MM'*O<)K4T4$KA)7585!#2,R@[<'YEY')(';C/O+Z\MY'M$N)
M=VD7,MY.=Q)> ,K*I]1Y<K#ZQ^U=0/#VCE8Q+IUM.T8VH]Q&)7 R2!N;)P,\
M#/%73:6QDFD-O$7F4)*Q09=1G 8]QR>#ZUU71E8R]+N9FTZ[U(![C[1<N\2!
MB?W8(1=O7 *J&_$U)_:UW_T"I_U_^)K3BBC@A2&&-8XD4*B(,!0.@ ["GUQX
MBC6J2O3JN*[63_-&T)0BK2C?[S)_M:[_ .@5/^O_ ,31_:UW_P! J?\ 7_XF
MM:BL/JF*_P"@A_\ @,?\B_:4_P"3\60VTSSVZR21-$QSE&ZCFIJ**[X)QBE)
MW??N8MIO0****H04444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 5S_BK1+G5H;"XL#&M]87:7$7F$A6 /S*3SU'\JZ"BFG8&KF%J?@W0-8OV
MO;^P\VX=0K/YTBY Z<*P%37'A?1KG28M+>PC6SB8/&D9*%&_O @YSR>:UZ*+
ML5D8$?@O0(K>Y@2Q*K<A/-/G/N8J<J<YSG)SGK5BS\,:/8Z?<V,-DI@NN9Q(
MQ<R?4DDG^E:]%%V%D8%EX+T*P,OD6C_O(F@(>>1@$88*C+<?AS5I/#FDQKIJ
MK:X&FDFT_>-^[SU[\_CFM6BB["R,;_A%=%_L1]'^Q_Z [^8T7FORV<YSG/7W
MI^K^&M)UQH7O[7?+",1RH[(ZCTRI!Q6M11=A9%&ST>QT_3&TZUA,=JP8%=[$
MG=U^8G.??-+9Z38V&E+IEM;JEDJ,@BR2,'.>3R<Y-7:*5QF!-X*\/W&EVVFS
M6&^TM69H8S-)\A8Y/.[/ZU/;>%]&M-%GT>"SV6$Y)DB\USN)QGDG(Z#O6Q13
MNQ61%;6\5G:PVT";(846.-<DX4# &3[41VMO%/+/'!&DTQ!DD50&? P,GOP!
M4M%(85D#PQHXTFYTO['_ *'<RF66/S&^9R0<YSD<@=#VK7HHN!CZ/X7T?099
M)M/LQ'-(,/*SL[$>F6)P*FUG0-+U^!(=3M%G6,Y0Y*LI]B""*TJ*=WN*R.;D
M\)6NG^'M0L/#\,5I<W<90S2,S$YX.6.3T)Q[UK:/IL>CZ-::?%@K;Q*F1_$>
MY_$Y/XU>HHNV%CG(/ ?AJUU"._ATW9<QR"57\^3A@<YQNQUI_A31+G2+6]EO
MVC:^OKI[F;RSE1D\*#QT'\ZZ"BCF8604444AA1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !6;!KUA<7OV1'E$AD>)2\+*KNF=RJQ&"1@]^
MQK2K TG0GBGDN;R28NE[<S6\)9=B;W?## R258]2<;CTIJPC7L;V+4+"VO(=
MPCN8EE0-P=K $9]\&K&1G&>:X4Z)JOV+2+<Z:@EM;:S43H(BR,A!D!<MD  <
M;1SD\U/-HMV]E<0#2S]L-P9)KL&(FZC\X-L!)R<KCA@!\N.E.R[A=G5W%[%;
M36D3[LW4IBC(Z9",_/MA#^E6,C'6N0DT61;#3U&F7%S#%J#7$MI-Y*D(8G7Y
M54[,;F!VY[FFQ:+<Q16GVO1_MMJJW(6QW1M]GWR;D&&8+PGRY!..W%%D%SL:
M*I:1;3V>C65M=2>9<10(DC9SE@ #SW^M7:D97O+Q+*(2/'/)D[0L,32'UZ*#
MZ4MK=P7MG%=V\@>"50Z-C&0?KTJMJZN]GY:6][,'.#]CF6.1??)9?YU@Q^'9
M[BVTN'4+.&5+?3KB%D(7:KLT?EC XSM4\@8R/I320CK<CGGIUI0<]*X#4=*F
MTNPMF%M%&)H;2.XWE2LLRR9;S,D!N^22,YZ]*Z/PFMLFB%+:,(!/+YFU%52Y
M8D[=I(VC.!R<  =J;6EP3-RBBBI&17-S#9VTMS<.(X8E+NQ[ 5#9:E;WYE6+
MS%DB($D<L;(RY&1P0."*74K:.[TRYMY89)DDC(,<; ,WT)( /XBN:;0[V[@O
M99X[B0W-Q9KY=R\>_P J*4,Q;9\HX+<#G ]3BFDA,Z[(/0B@$'H:X^30#8&6
M[M[*.%H;]IHWCP"D'E\A<<A=Q;Y1W.<5'X'6W6=R8HA=M90AGA2/:4&>259B
M7)/).,X''%.VEPN=K1114C&R2)%$\DC!40%F8G  '4U036["333J"R.;<2&(
M?NF#%]^S:%QG.[C&*OR,4C9E1G(!(1<9;V&2!^=<H++49_#UY:/ID\327SS%
M3)%O:-YB^4(<@.!CDD8/0TTA,Z2ROX+^%I(2PV.8W61"C*PZ@@_4?G5G-<7;
M^')[B<"]L3):+%=B);ID>3+F$KO()#-D28/. !DYIEUI4VE:'>2B 0>9I"13
MNK#+SY()8YY/S'YCQZFG9!=G; @]#FEKF_"*VR+J(BABCG:=6F\B-%BSL4 +
ML9AC R03G))[UTE)JPT%4)-7M(=0CLI/.221_+1VA<1L^-VT/C&<9[_K5^L&
MX%]=>(X?/TVX-C:N&@D1XMK.1@R-EPV%!(  /<^E"$RXFMVK:C'8M'=1S2LR
MH9+=U5MH).&(QT%:.1ZCTKG-8TN]U%-;D\G+FQDM+%-P^8LF6;KQEMJ\X^Y[
MU5N_#"I<7\EGI\2G_1GM2NT;75OG8<\' 7)[X[T[(+LZW(SC/-+7"H;>3QJT
MMS'$^S42(65$:7?Y04 DMNV#DX"\$ YQ7=4FK G<*BN+B*T@>>9ML:]3@GV
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MQQ]<&H=3D\0:=I5Y??VAIDGV:!YMG]GR#=M4G&?.XZ4DKNR&W979T%%>,_\
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MI/\ X_1]G\0?]!/3/_!=)_\ 'ZY+'8:U%>4?\+'\0?\ //3/_ >3_P".4?\
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MWM12W,,$D$<CA7G<QQC'WF"EL?DK'\*Y"8WQL[G;_:@U+SS]H.)C&(?.'^K
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MXT_Y<?\ MI_[+5+<E['*44451 5K>&O^1@M?^!_^@&LFM;PU_P C!:_\#_\
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M0]2_[9?^C4KP:NS ?PWZ_P"1Q9E_%7I^K"BBBNT\\*^H:^7J^H:\W,?L_/\
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M!#T7Y!1116)N%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MF929D !^8;< <8 49P*ZVBBANX6*FJ?\@F]_ZX/_ .@FJWB7_D5=8_Z\IO\
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MHVOG+Q+_ ,C5K'_7[-_Z&:G+_B9>9?!$RZ***]0\<*]E^$O_ "*MU_U^O_Z
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MI67X:_Y%71_^O*'_ - %:E?.S^)GT]/X$>#?$7_D?-2_[9?^BDKEZZCXB_\
M(^:E_P!LO_125R]>]1_AQ]$?.U_XLO5_F%%%%:&1WGPE_P"1JNO^O)__ $-*
M]EKQKX2_\C5=?]>3_P#H:5[+7C8W^*>[@/X)R_Q%_P"1#U+_ +9?^C4KP:O>
M?B+_ ,B'J7_;+_T:E>#5V8#^&_7_ ".+,OXJ]/U84445VGGA7U#7R]7U#7FY
MC]GY_H>KEGVOE^H5\Y>)?^1JUC_K]F_]#-?1M?.7B7_D:M8_Z_9O_0S4Y?\
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M*MK_ -?J?^@/7C5>S@?X1X6/_C!11176<04444 %%%% '>?"7_D:KK_KR?\
M]#2O9:\:^$O_ "-5U_UY/_Z&E>RUXV-_BGNX#^"%%%%<AVA1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% &3;_\ (VZC_P!>-K_Z,N*UJR;?
M_D;=1_Z\;7_T9<5K4V)!1112&%%%% %35/\ D$WO_7!__035;Q+_ ,BKK'_7
ME-_Z :LZI_R";W_K@_\ Z":K>)?^15UC_KRF_P#0#5P^)$3^%^A\Y4445]"?
M,!1110!]&^&O^15T?_KRA_\ 0!6I67X:_P"15T?_ *\H?_0!6I7SL_B9]/3^
M!'@WQ%_Y'S4O^V7_ **2N7KJ/B+_ ,CYJ7_;+_T4E<O7O4?X<?1'SM?^++U?
MYA1116AD=Y\)?^1JNO\ KR?_ -#2O9:\:^$O_(U77_7D_P#Z&E>RUXV-_BGN
MX#^"<O\ $7_D0]2_[9?^C4KP:O>?B+_R(>I?]LO_ $:E>#5V8#^&_7_(XLR_
MBKT_5A1117:>>%?4-?+U?4->;F/V?G^AZN6?:^7ZA7SEXE_Y&K6/^OV;_P!#
M-?1M?.7B7_D:M8_Z_9O_ $,U.7_$R\R^")ET445ZAXX5[+\)?^15NO\ K]?_
M - 2O&J]E^$O_(JW7_7Z_P#Z E<F-_A';@/XQV,G_(6M_P#KA+_Z%'7$_$__
M )A7_;;_ -DKMI/^0M;_ /7"7_T*.N)^)_\ S"O^VW_LE<6 _P!XC\_R9WYC
M_NTOE^://J***^C/EPK0T'_D8M,_Z^XO_0Q6?6AH/_(Q:9_U]Q?^ABHJ? _0
MNE\<?4]RHHHKY,^S/GVBBBOKSXD**** /8O _P#R)]A_VT_]&-705S_@?_D3
M[#_MI_Z,:N@KY;$?QI^K_,^OPW\"'HOR"BBBL3<**** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH R=7_Y">@_]?S?^DT]:U9.K_\ (3T'_K^;
M_P!)IZUJ;$9^M_\ ('G_ . _^A"N/KL-;_Y \_\ P'_T(5Q](84444 %%%%
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MKV6O&OA+_P C5=?]>3_^AI7LM>-C?XI[N _@A1117(=H4444 %%%% !1110
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M** "BBB@#Y]HHHKZ\^)"BBB@#V+P/_R)]A_VT_\ 1C5T%<_X'_Y$^P_[:?\
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MX'_Y$^P_[:?^C&KH*^6Q'\:?J_S/K\-_ AZ+\@HHHK$W"BBB@ HHHH ****
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MBBB@#)U?_D)Z#_U_-_Z33UK5DZO_ ,A/0?\ K^;_ -)IZUJ;$%%%%(84444
M%%%% !1110 4444 %%%% '!_%K_D5;7_ *_4_P#0'KQJO9?BU_R*MK_U^I_Z
M ]>-5[.!_A'A8_\ C!11176<04444 %%%% '>?"7_D:KK_KR?_T-*]EKQKX2
M_P#(U77_ %Y/_P"AI7LM>-C?XI[N _@A1117(=H4444 %%%% !1110 4444
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M&GZO\SZ_#?P(>B_(****Q-PHHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M^O&U_P#1EQ6M38D%%%%(84444 5-4_Y!-[_UP?\ ]!-6ZJ:I_P @F]_ZX/\
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M7B640D>.>3)VA88FD/KT4'TJQ61?6]RMG)&[:A>B5_\ EU>.&2,>QRO'XTT
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M/^03>_\ 7!__ $$U;JIJG_()O?\ K@__ *":MT %%%% !1110 4444 %%%%
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MBH;2Y6[M8[A%95D&0KC!'U]*FJ"PHHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@#)U?_ )">@_\ 7\W_ *33UK5DZO\ \A/0?^OYO_2:>M:F
MQ!1112&%%%% !1110 4444 %%%% !1110!P?Q:_Y%6U_Z_4_] >O&J]E^+7_
M "*MK_U^I_Z ]>-5[.!_A'A8_P#C!11176<04444 %%%% '>?"7_ )&JZ_Z\
MG_\ 0TKV6O&OA+_R-5U_UY/_ .AI7LM>-C?XI[N _@A1117(=H4444 %%%%
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M9/,_UZEG7.,?*-R'!YXYJLGAK5O[2OHSJ*QVLNGQVJ310*N,%_E #9& >O\
MM>U3Z=H>H6FOW$ES+%/8&QBMPJP*JN%+_)MR<8!'L<X[5>A.I;37IGS:_98_
M[1^U&W$22%DP K,^[ .T*PSQUP.]6]4TR:_N+*2*]DMUMY"[*A/[P$8P>?\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
MY^[\*6NI>(VU343'=0BW$,5K)%E4YR6SGD]>W>J\?@R"UU#4YK&=+6UO[,V[
M6R0_*C8P''/UXQW/-=116JK32M<R="FW>QQ=KX%N8SIMM=:W)<Z;82+-';&
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M95T#="58, ?KC%4Q'?:GJUA<3V#6<-GO<^9(K%V9=N!M)X&2<FHA&#C=^?\
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MK2,O&21\\K<=/8?J:5U&I?2UEV[?YA9RIV5[W?===_N+LAE@TYBTFZ9(B2^
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M G]:@\G5KM='ADTWR5LYXWF<RJ0=JE<J >G/?!Z<4HQIIM_JNW^8Y2JM)/\
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MQTMX!+*NYRTDD/S@>4^"<J-IS@=!UQWJ#2#J1CD2^DGEWV,$N98PN)6#[U&
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M6,Y"+L89 .749'"\]LU:U_29=6U6UB5(PGV2=3/)&6\EBT6&4]GX)'/8UO\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>12
<FILENAME>img32108071_5.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img32108071_5.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" >R#SP# 2(  A$! Q$!_\0
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110!F:'_QYR?\ 74_R%:=9FA_\><G_ %U/\A6G38EL
M%%%%(84444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 9LG_(P0_]<O\ &M*LV3_D8(?^N7^-:5-B04444AA1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 9FA_P#'G)_UU/\ (5IUF:'_ ,><G_74_P A6G38EL%%%%(84444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 9LG_(P0_P#7+_&M*LV3_D8(?^N7^-:5-B04444AA1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 9FA_\><G_
M %U/\A6G69H?_'G)_P!=3_(5ITV);!1112&%%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% &;)_R,$/_7+_
M !K2K-D_Y&"'_KE_C6E38D%%%%(84444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% &9H?\ QYR?]=3_ "%:=9FA_P#'
MG)_UU/\ (5ITV);!1112&%%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% &;)_R,$/\ UR_QK2K-D_Y&"'_K
ME_C6E38D%%%%(84444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% &9H?_'G)_P!=3_(5IUF:'_QYR?\ 74_R%:=-B6P4
M444AA1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110!FR?\C!#_UR_P :TJS9/^1@A_ZY?XUI4V)!1112&%%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110!F:'_ ,><G_74_P A6G69H?\ QYR?]=3_ "%:=-B6P4444AA1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110!FR?\C!#_ -<O\:TJS9/^1@A_ZY?XUI4V)!1112&%%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!F:'_QYR?\
M74_R%:=9FA_\><G_ %U/\A6G38EL%%%%(84444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 9LG_(P0_]<O\
M&M*LV3_D8(?^N7^-:5-B04444AA1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 9FA_P#'G)_UU/\ (5IUF:'_ ,><
MG_74_P A6G38EL%%%%(84444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 9LG_(P0_P#7+_&M*LV3_D8(?^N7
M^-:5-B04444AA1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 9FA_\><G_ %U/\A6G69H?_'G)_P!=3_(5ITV);!11
M12&%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 445RGQ$UZ30/"4TEOO6YNW%K%(N1Y98$EL@@@A5;!'1MO&*:5W8&[%#Q-\
M3].T&_>PM+5M0N8F"S%9 D:'G*[L$E@<9&,<GG((KC!\8/$6.;32R?:*0?\
ML]>?]!@5ZEX>^$:75E;WFL7T\1FA#FUACV/$QP0&9L\@=5VC![\<[<L(K4RO
M*6Q5M/C'JT<S->Z993Q;<*D)>)MV1R6);CKQC\:].\.>(['Q1IAO[ 3*BR-$
MZ3+M96&#@X)!X(/!/7UR!Y?J/P=U:VA#V&I6UZP5F='C,#$CH%Y8$GGJ5 X_
M#K/A19W=CX7NHKVSN;60WK,$N(6C8C9'SA@#CK^1J9J-KHJ/->S*GQ9U[4M)
ML].M-/N7MENS(TLD3%9/DV8 8'('S<XY. ,XR#YG9^,?$6GWD5W'K%[,T)W"
M.XN'DC?CHRDX(_7N"#@U[;XQ\'6WBZRAC>=K:ZMV)AG"[PH;&X%<C(.!W!!
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MHHH *H7NN:1ILX@O]4L;64KO$<]PB,5R1G!/3(/Y5?KYC\0_\C5K?_81N?\
MT:U7"/,R92L?2=CJ5CJ<+3:?>V]W$K;&>WE610V <$@GG!''O5FO)O@M_K==
M_P!VV_\ :M>LTI*SL-.ZN%%%%2,**** "BBB@ HHHH R?%(!\(ZT",@V$_\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** ,V3_ )&"'_KE_C6E6;)_R,$/_7+_ !K2
MIL2"BBBD,**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@#,T/_ (\Y/^NI_D*TZS-#_P"/.3_KJ?Y"M.FQ+8****0P
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M74KR66-Y/-%N7/DQD# VH3@8'&>O7))))Z[XPRR'Q;:1&1S$MBC+&6.U29)
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MJN05P?\ 6 \8%>SUYY\'#GPI?>VH/_Z*BKT.HF[R+BM I@AB6=YQ&@F=51I
MHW,H)(!/< LV![GUI]%048OBGQ):^%M&;4+F-Y69A%#$G_+20@D G^$8!))[
M#N< ^#Z_XMUGQ)+(U_=L()%56M(698/E.1\F3DYYR<GIS@ #H?BSJIO?%BV
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MAO+>$_:)%"YPQ!1"1SD89L'H'!'6N/\ "L<DOB_1EBC>1A?0L5122 '!)X[
M DGL 36<D=WJ-X5CCN+NZF9G*HK222-RS' R2>I/XU[)\/\ X?3^'[IM6U5H
MC>&/9# F&$(8#<2V/O\ 5?EXQGD[N!M0C82O)W/0Z\2\7_$Z]U:26ST25[33
MPR[;A"T<\N#G.<@HIXX^]@<GDJ.]^)NJG2_!5RB%Q)>L+1650P 8$L#GL45A
MD<Y(^H\$2.25UCAB>65R%2-%+,Y/0 #J344XIZLJ<NB&3RAYGFGD#2RL7=Y&
MRSL3DDD]23WJ:SO+FQD:>PNIK:1T*&6WE,;%20<;E(.,@?E7TOH>AV/A[2X]
M/T^+9$O+,W+2,>K,>Y/^ &  *XCXO:(+G1K;6(HB9K23RYF&T?NFZ$YY.'V@
M 'C>W'<4JB;M83@TKDGP_P#B#<>(+MM)U98A>"/?!.F%$P4#<I7/W^K?+P1N
MX7;SW6I7T6EZ7=ZA.KM%:P/.ZH 6*JI8@9(&<#UKYGTO4Y=&U6UU.$.SVLJR
M[$D*%P#DKN[!AD'KP3UKZ?FABN()()XTEBD4H\;J&5E(P00>H(J*D4F5!W1\
M_:U\0O$6KW,K)?S65L9-\4%LVSRP!@#> &;U.3@GG X Y,+&HP H]L5[QI/P
MJ\/:>QDNUFU"02;T\]L*H#$J-JX#<8#;L@XZ '%=E:6=K86R6UG;0VUNF=L4
M*!%7)R< <#DD_C5>TBMD+D;W9\O6=Y=:=,TUC<SVLK+L,D$AC8KD'&5(.,@?
ME7L/P[\?7&MW+:/K#J][M:2"X^5/- Y*%1CY@,D;1RH.<;<M@?%[2+*QU/3K
MVUA6&2[643+&JJK,K [S@9+$R')/7 K!^&P!^(.E$]C*1_WZ>J=I1N2KQE8^
M@Z\5\<_$._O-5FL-#U#R=-BPOGVK8:=N"6#XR ",#:<$9.2& 'I7CC4I=)\%
MZI=PA_-\H1(R2%&0R,$W@CD%=V[\.HZU\Y5%*-]65.5M!HC11A44#T K9TWQ
M/JVE:3>Z7;3A[*[MWMV@FRR1ALY9!D;6^9NG!SD@X%>G_#WP-IH\/0:EJVGP
M75U=@R(LZAU2)L;1M)*DD#=G (WX[&D\=_#W2WT>ZU;2X8K&XM8VGEC0$1R(
MJ\@*.%.%R,  G.>N1;G%NS)Y6E<\:KW_ .&/_)/=,_WI_P#T<]> 5[_\,?\
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MFMBN>3N[FJ5D%%%%(84444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110!FR?\C!#_UR_P :TJS9/^1@A_ZY?XUI4V)!1112
M&%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110!F:'_ ,><G_74_P A6G69H?\ QYR?]=3_ "%:=-B6P4444AA1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MBBB@ HHHH **** ,V3_D8(?^N7^-:59LG_(P0_\ 7+_&M*FQ(****0PHHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M ,S0_P#CSD_ZZG^0K3K,T/\ X\Y/^NI_D*TZ;$M@HHHI#"BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@#,T/\ X\Y/^NI_D*TZS-#_ ./.3_KJ?Y"M.FQ+8****0PHHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@#C?%_P\LO%-U'>Q7 L;T<2RK%O$R@8&X9'S#C#
M9Z<'/&/-[[X6>*;/RO)MK:]+YW?9K@#9C'7S-G7/;/0].*]ZHJU.2)<4SY]B
M^&OBZ2>.-M)\M78*9'N8MJ GJ<,3@=> 3[5U.B_!Z5;F*;6M0A:)),O;6P8^
M:F.!O.TKSUP#QT()R/6:*;J28E!%;3]/M-*L(;&Q@6"VA7:D:]OZDDY))Y))
M)YJS116984444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 9LG_(P0_\ 7+_&M*LV3_D8(?\ KE_C
M6E38D%%%%(84444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% &9H?_'G)_UU/\A6G69H?_'G)_UU/\A6G38EL%%%%(84
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 9LG_ ",$/_7+_&M*LV3_ )&"'_KE_C6E38D%%%%(84444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% &
M9H?_ !YR?]=3_(5IUF:'_P ><G_74_R%:=-B6P4444AA1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!FR?
M\C!#_P!<O\:TJS9/^1@A_P"N7^-:5-B04444AA1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 9FA_\><G_74_R%:=
M9FA_\><G_74_R%:=-B6P4444AA1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110!FR?\ (P0_]<O\:TJS9/\
MD8(?^N7^-:5-B04444AA1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 9FA_\ 'G)_UU/\A6G69H?_ !YR?]=3_(5I
MTV);!1112&%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% &;)_R,$/_ %R_QK2K-D_Y&"'_ *Y?XUI4V)!1
M112&%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110!F:'_QYR?]=3_(5IUF:'_QYR?]=3_(5ITV);!1112&%%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% &;)_P C!#_UR_QK2K-D_P"1@A_ZY?XUI4V)!1112&%%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!F:'_P >
M<G_74_R%:=9FA_\ 'G)_UU/\A6G38EL%%%%(84444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 9LG_(P0_\
M7+_&M*LV3_D8(?\ KE_C6E38D%%%%(84444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% &9H?_'G)_UU/\A6G69H?_'G
M)_UU/\A6G38EL%%%%(84444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 9LG_ ",$/_7+_&M*LV3_ )&"'_KE
M_C6E38D%%%%(84444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% &9H?_ !YR?]=3_(5IUF:'_P ><G_74_R%:=-B6P44
M44AA1110 4444 %%%% !1110 4444 9MUXAT2QN7MKO6-/MYTQNBFN41ER,C
M()R."#4/_"6>&_\ H8-*_P# V/\ QKSC7?A3K=]K^H7EI>:>8+FX>=?-=T8;
MR6(("D<$D9SSC/&<50_X4_XD_P"?K2O^_P#)_P#&ZT48]R+R['JW_"6>&_\
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M]V0,9^\=JDYY' P#G+Y;1NPOK9'?4445!04444 %%%% !1110 4444 %%%%
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M,**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M:Z:]AT?7)GN%G9(K:Y*Y=6X4*^.6!./F.3D\D@Y5.GI=.X*>MF=?\2R!\/\
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MKR:]OM;^)'BE[2VF<0.S/;P2[EA@10VUG"[@&(."W/+8!Q@"5&[\AN5CV?\
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MBN49VP,G !R> 3^%:5>+>+_A;_8VEW>I:?>275M%M+6TD.75. S;EX;!Y^Z
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MPO#/_/\ S?\ @'/_ /$5K[&K_*_N,O;TOYE]Z.GHKF/^%A>&?^?^;_P#G_\
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M =6. >!DG%))MV0VTE=EJBN8_P"%A>&?^?\ F_\  .?_ .(H_P"%A>&?^?\
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M% !15#5-:T[18!+J%TD(;E5P6=^0#M499L;AG XSS6/_ ,+"\,_\_P#-_P"
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M/_CSD_ZZG^0K3K,T/_CSD_ZZG^0K3IL2V"BBBD,**** "BBB@ HHHH ****
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MYIU@99%W<!#N'?'F< ]^1TJ]?:$Z<AW_ ($U&YU7P5IEW>-OG*-&SY)+;'9
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% %/4]5L-'LVN]1NXK: 9^:1L;C@G"CJS8!X&2
M<5YCXD^+S$2V_A^WV#E?MMP.?XAE$_[Y8%O<%:O_ !$\.#5_$5C/?^(M.TO3
M_LYC07<^&W@L69$) /6,$[@>GH,Z'A^#X>^&RLEGK.DR70_Y>KB^B>0=>ASA
M>&(^4#(ZYJURI7>I+NV<7I_@'Q3XMO#J&M3RVH?(,UZ"TN,L<+'P54-_"=H
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M=5XJ_P"1/UO_ *\)_P#T6U>3?"#_ )':?_L'2_\ HR*O6?%7_(GZW_UX3_\
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M&2I4#G)"'L*[WP/XEL-;\/V-NE\9=1@MU2XBF?\ ?%D"JSD$Y8$D'=_M<\Y
MIOW5H)+WF>?Z[XA\<^(-'GTN[\-2I!,5W-#I\X8;6##!)(Z@=JW?A'HVI:8-
M8GO["XM5F\E(_/0HS%=Y/RGG'SCG&.?8UZ-=7=M8VSW-W<16\"8W2S.$5<G
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M?C[4T;+&EL#Y43$, Q)P7QE6Q\O(P<BO5:*?M)!R(XWP%X,NO"1U0W5U#/\
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M6T*0H7(+%54 9QWXJS114E!1110 4444 %%%% !1110 4444 %%%% !1110
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MNNE6E;^MCM]'TR+1M(MM/B.Y85Y;GYF)RS8).,L2<9XSBN(^*'_'QH_^Y/\
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MN'D\V\GVF=U)V#&<*H]!D\]3GMP!R7Q(U'S]4MM/C?*6\9>0++D;VZ!E[$*
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MI83DBKO_ #W/"ISC6QGM)NRO?7RV+_Q*TW?:6FI1I\T3&&4K%DE3RI9NP!!
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M\66J7GA74HY&=52$S90@'*?.!]"5 /M6S6-XMNTLO"FI22*[*\)A 0 G,GR
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M>6/7UQT KK*\RK3=.;@^AZM*HJD%-=0KQKQI_P CGJG^_'_Z*2O9:\:\:?\
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M@!\V>2)LJYQ\JA@<,.23P1G;SD&N0EU"_N+=H+C4+V>%L;HYKEY%.#D<,3W
M-1112W$RPP122RMG;'&I9FP,G ')X!-<V'R]4I<]1['5B<R=:/LZ:M<(8I+B
M>."%=\LKA$7(&YB< 9/'4U[GI.GII6DVMC'L(@C"LR($#M_$V.Q)R3[FN2\&
M^#9]/N1JFJ*8[J,LL$"N#L!!4LQ4X)()P.@!R>?N]S7'F&)562C#9';EN%E1
MBYSW?Y!1117GGIGEGQ(20>)H7,;B(V:!7*G:2'DR ?49&?J/6LSP=)%%XOTV
M2:1(U#LH+M@;F1E4?4D@ =R:ZKXG6V;/3KPRX$<KP^7M^\77=G.>WEGCW]J\
M_L[F.RU"UO)E=X[:>.=E0 L0C!L#..>*]_#?O,'RKLT?.8K]WC>9]TSWRO.O
MBA_Q\:/_ +D_\XZ]%KSKXH?\?&C_ .Y/_..O+P/^\1_KH>MF'^[2^7YF'X'_
M .1PL/\ MI_Z+:O8:\>\#_\ (X6'_;3_ -%M7L-;YI_&7I^K,,H_@/U_1'CO
MC#P^F@ZN!!Q:76Z6%<*H3GYD '9<KC@<$#G!-<^2Q4+O8)N#% >"0" 2/49/
MYGUKV?Q9H[:WH$UO$N;F/]] ,]77/'4#D$KSP,Y[5XTZ/%(T<B,CJ2K*PP5(
MZ@CL:[\#7]K2Y9;K^D>;F.']C5YH[/\ IEW1/^1@TO\ Z_(?_0UKW.O"]$_Y
M&#2_^OR'_P!#6O=*XLT^./H=^3_PY>IX;_PCNLP_NFTF]!3Y3M@9AQQP0,$>
MXXH_L'6/^@3??^ S_P"%>Y44+-)_RH'E$/YF>&_V#K'_ $";[_P&?_"C^P=8
M_P"@3??^ S_X5[E13_M6?\J%_8\/YF8/@N"6W\)V<4\$D$BF3='*A5A^\;L>
M>>OXUO45P/C;Q%JVD:W%!8WGE0M;*Y3RT;YMS G)!/0#\JXH4Y8FJTMW=G?4
MJ0PM%.6J5D;WCC_D3[__ +9_^C%KQVMB^\5:UJ5G):7=[YD$F-R^4@S@@CD#
M/4"L>O<P="5"FXR[GSV.Q,<144X=K:_,]N\-?\BKH_\ UY0_^@"M2O&;;Q?K
MMG:PVL%]LAA18XU\E#A0, 9*YZ"N_P# VM7NMZ/<RW[K)+!=-"KA I9=B-SC
MC/S$< < =^3Y&)P=2DN>35KGMX7'4ZS5.*=['3T5XS>Z_J]IXAOVM]4NP(KV
MX5%:8N@&]AC:<K@#H,<8&.E)_P )EXFSG^VI?I]GA_\ B*M9;5:336IF\THQ
MDXR3T/4/$^J?V1X>N[E93'.4,<# *2)&X4@-P<?>(YX!X->)\*,= *LWU]=:
MG>M>7LS37#*$+L /E'0 #@#J<#N2>YKH/"'A236YTOKD;=-BDR0R@_:"IY0
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M_<3W.+EUAEG)8LF%Z,>6&XN,Y/0CM@=M6!X/\4)XLT9[];5K9XYFADC+[P&
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MR22>36[12C.4'>+L.<(S5I*YAV_@[0+6ZAN8M/42PL'0M([ ,.AP202.H]"
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M]Y?D%%%%><>F%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@#R;XT_P"MT+_=N?\ VE75_#'_ ))[IG^]/_Z.>N4^-/\
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M7HG@GP4O@^*]S?F\FNF3<PB\M55<X &2<Y9LG/IP,<^>?&#_ )'*V_[!\?\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!FR?\C!
M#_UR_P :TJS9/^1@A_ZY?XUI4V)!1112&%%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M6EM<YWX9>#;C0X9=6U*/R[RYC"10G(:*/.3NYQEB%XQD;>N20,CXT_ZW0O\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M?VOIG_01M/\ O^O^->5FF&G]0CW)_M*?\IZM_;&F?]!&T_[_ *_XT?VSI?\
MT$K/_O\ K_C7DIIC4_[.C_,+^TY_RGKG]LZ7_P!!*S_[_K_C1_;6E?\ 03LO
M^_Z_XUY :C-5_9L?YB?[4G_*CV+^V])_Z"EE_P"!"?XT?VYI/_04LO\ P(3_
M !KQHTPT_P"S(?S$_P!JS_E1[1_;FD?]!6Q_\"$_QI/[=T?_ *"MC_X$)_C7
MBAIC4_[+A_,Q?VM/^5'MW]O:/_T%K'_P(3_&C^WM'_Z"UC_X$I_C7AQI*?\
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M:Q_\"4_QKPVBC^RH?S,/[8G_ "H]R_M[1_\ H+6/_@2G^-']O:/_ -!:Q_\
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MS#^V)_RH]R_M[1_^@M8_^!*?XT?V]H__ $%K'_P)3_&O#:*/[*A_,P_MB?\
M*CW+^WM'_P"@M8_^!*?XT?V]H_\ T%K'_P "4_QKPVBC^RH?S,/[8G_*CW+^
MWM'_ .@M8_\ @2G^-']O:/\ ]!:Q_P# E/\ &O#:*/[*A_,P_MB?\J/<O[>T
M?_H+6/\ X$I_C1_;VC_]!:Q_\"4_QKPVBC^RH?S,/[8G_*CW+^WM'_Z"UC_X
M$I_C1_;VC_\ 06L?_ E/\:\-HH_LJ'\S#^V)_P J/<O[>T?_ *"UC_X$I_C1
M_;VC_P#06L?_  )3_&O#:*/[*A_,P_MB?\J/<O[>T?\ Z"UC_P"!*?XT?V]H
M_P#T%K'_ ,"4_P :\-HH_LJ'\S#^V)_RH]R_M[1_^@M8_P#@2G^-']O:/_T%
MK'_P)3_&O#:*/[*A_,P_MB?\J/<O[>T?_H+6/_@2G^-']O:/_P!!:Q_\"4_Q
MKPVBC^RH?S,/[8G_ "H]R_M[1_\ H+6/_@2G^-']O:/_ -!:Q_\  E/\:\-H
MH_LJ'\S#^V)_RH]R_M[1_P#H+6/_ ($I_C1_;VC_ /06L?\ P)3_ !KPVBC^
MRH?S,/[8G_*CW+^WM'_Z"UC_ .!*?XT?V]H__06L?_ E/\:\-HH_LJ'\S#^V
M)_RH]R_M[1_^@M8_^!*?XT?V]H__ $%K'_P)3_&O#:*/[*A_,P_MB?\ *CW+
M^WM'_P"@M8_^!*?XT?V]H_\ T%K'_P "4_QKPVBC^RH?S,/[8G_*CW+^WM'_
M .@M8_\ @2G^-']O:/\ ]!:Q_P# E/\ &O#:*/[*A_,P_MB?\J/<O[>T?_H+
M6/\ X$I_C1_;VC_]!:Q_\"4_QKPVBC^RH?S,/[8G_*CW+^W='_Z"MC_X$)_C
M2_V[I'_05L?_  (3_&O#Q3Q2_LN'\S*6;S_E1[;_ &YI'_04LO\ P(3_ !H_
MMO2?^@I9?^!"?XUXJM2"I_LR'\P_[6G_ "H]G_MK2O\ H)V7_?\ 7_&C^VM*
M_P"@G9_]_P!?\:\;%/%+^S8?S%?VI/\ E1[%_;.E_P#02L_^_P"O^-']L:9_
MT$K/_O\ K_C7D(IXI?V='^8:S.?\IZW_ &OIG_01M/\ O^O^-+_:^F_]!"T_
M[_+_ (UY,M/%3_9\>Y7]I3_E/5O[6TW_ *"%K_W^7_&E_M73O^?^U_[_ "_X
MUY8*>M+ZA'N/^T9?RGJ']J:?_P _]K_W^7_&C^T]/_Y_K;_O\O\ C7F0J1:7
MU&/<K^T)=CTK^T[#_G^MO^_J_P"-']I6/_/[;?\ ?U?\:\X%2"I>"CW']>EV
M/1/[1L?^?RW_ ._J_P"-']H67_/Y;_\ ?U?\:\^6GBE]3CW*^NR['?\ ]H67
M_/W;_P#?P?XT?;[/_G[@_P"_@KA!3Q4_55W']<EV.X^W6G_/U!_W\%+]MM/^
M?J'_ +^"N)%/%+ZLNY2Q<NQV?VVU_P"?F'_OX*7[9:_\_,/_ 'V*XX5(M+ZN
MNY7UI]CK?M=M_P _$7_?8H^U6_\ SWB_[[%<J*D%3[!=QK$OL=/]JM_^>\7_
M 'V*/M,'_/:/_OH5S8IXI>Q7<KV[['1?:(?^>T?_ 'T*//A_YZI_WT*P%J04
MO9+N/VS[&YYT7_/5/^^A1YT7_/1/^^A6,*>*GV:*]JS6\V/_ )Z+^=+YB?WU
M_.LP4]:7(/VC-#>G]Y?SI=Z_WA^=414@I<I2D6MR^H_.C(]14"T\5-BKDM%(
M.E+2&%%%% !1110!F:'_ ,><G_74_P A6G69H?\ QYR?]=3_ "%:=-B6P444
M4AA1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110!Y!XX_P"2M:-_O6W_ *-->OUY!XX_Y*UH
MW^];?^C37K]7/9$QW84445!04444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MP]E#L9O]AV7]U_\ OJD_L&R_NO\ ]]5IT4>TGW%[*'8R_P"P+'^[)_WU2?\
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M?Z%_SSG_ ._IKJ:*/K5;^9A]4H?R+[CEO^%?Z%_SSG_[^FC_ (5_H7_/.?\
M[^FNIHH^M5OYF'U2A_(ON.6_X5_H7_/.?_OZ:/\ A7^A?\\Y_P#OZ:ZFBCZU
M6_F8?5*'\B^XY;_A7^A?\\Y_^_IH_P"%?Z%_SSG_ ._IKJ:*/K5;^9A]4H?R
M+[CEO^%?Z%_SSG_[^FC_ (5_H7_/.?\ [^FNIHH^M5OYF'U2A_(ON.6_X5_H
M7_/.?_OZ:/\ A7^A?\\Y_P#OZ:ZFBCZU6_F8?5*'\B^XY;_A7^A?\\Y_^_IH
M_P"%?Z%_SSG_ ._IKJ:*/K5;^9A]4H?R+[CEO^%?Z%_SSG_[^FC_ (5_H7_/
M.?\ [^FNIHH^M5OYF'U2A_(ON.6_X5_H7_/.?_OZ:/\ A7^A?\\Y_P#OZ:ZF
MBCZU6_F8?5*'\B^XY;_A7^A?\\Y_^_IH_P"%?Z%_SSG_ ._IKJ:*/K5;^9A]
M4H?R+[CEO^%?Z%_SSG_[^FC_ (5_H7_/.?\ [^FNIHH^M5OYF'U2A_(ON.6_
MX5_H7_/.?_OZ:/\ A7^A?\\Y_P#OZ:ZFBCZU6_F8?5*'\B^XY;_A7^A?\\Y_
M^_IH_P"%?Z%_SSG_ ._IKJ:*/K5;^9A]4H?R+[CEO^%?Z%_SSG_[^FC_ (5_
MH7_/.?\ [^FNIHH^M5OYF'U2A_(ON.6_X5_H7_/.?_OZ:/\ A7^A?\\Y_P#O
MZ:ZFBCZU6_F8?5*'\B^XY;_A7^A?\\Y_^_IH_P"%?Z%_SSG_ ._IKJ:*/K5;
M^9A]4H?R+[CEO^%?Z%_SSG_[^FC_ (5_H7_/.?\ [^FNIHH^M5OYF'U2A_(O
MN.6_X5_H7_/.?_OZ:/\ A7^A?\\Y_P#OZ:ZFBCZU6_F8?5*'\B^XY;_A7^A?
M\\Y_^_IH_P"%?Z%_SSG_ ._IKJ:*/K5;^9A]4H?R+[CEO^%?Z%_SSG_[^FC_
M (5_H7_/.?\ [^FNIHH^M5OYF'U2A_(ON.6_X5_H7_/.?_OZ:/\ A7^A?\\Y
M_P#OZ:ZFBCZU6_F8?5*'\B^XY;_A7^A?\\Y_^_IH_P"%?Z%_SSG_ ._IKJ:*
M/K5;^9A]4H?R+[CEO^%?Z%_SSG_[^FC_ (5_H7_/.?\ [^FNIHH^M5OYF'U2
MA_(ON.6_X5_H7_/.?_OZ:/\ A7^A?\\Y_P#OZ:ZFBCZU6_F8?5*'\B^XY;_A
M7^A?\\Y_^_IH_P"%?Z%_SSG_ ._IKJ:*/K5;^9A]4H?R+[CEO^%?Z%_SSG_[
M^FC_ (5_H7_/.?\ [^FNIHH^M5OYF'U2A_(ON.6_X5_H7_/.?_OZ:/\ A7^A
M?\\Y_P#OZ:ZFBCZU6_F8?5*'\B^XY;_A7^A?\\Y_^_IH_P"%?Z%_SSG_ ._I
MKJ:*/K5;^9A]4H?R+[CEO^%?Z%_SSG_[^FC_ (5_H7_/.?\ [^FNIHH^M5OY
MF'U2A_(ON.6_X5_H7_/.?_OZ:/\ A7^A?\\Y_P#OZ:ZFBCZU6_F8?5*'\B^X
MY;_A7^A?\\Y_^_IH_P"%?Z%_SSG_ ._IKJ:*/K5;^9A]4H?R+[CEO^%?Z%_S
MSG_[^FC_ (5_H7_/.?\ [^FNIHH^M5OYF'U2A_(ON.6_X5_H7_/.?_OZ:/\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 >0>./\ DK6C?[UM_P"C37K]>0>./^2M:-_O6W_H
MTUZ_5SV1,=V%%%%04%%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% &;)_R,
M$/\ UR_QK2K-D_Y&"'_KE_C6E38D%%%%(84444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M1_9.I?\ /)O^_B_XT?VSBO\ H%E^/_R(?5:?_/Q?U\SJJ*Y7^R=2_P">3?\
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M]?,ZJBN5_LG4O^>3?]_%_P :/[)U+_GDW_?Q?\:/[9Q7_0++\?\ Y$/JM/\
MY^+^OF=517*_V3J7_/)O^_B_XT?V3J7_ #R;_OXO^-']LXK_ *!9?C_\B'U6
MG_S\7]?,ZJBN5_LG4O\ GDW_ '\7_&C^R=2_YY-_W\7_ !H_MG%?] LOQ_\
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MO^>3?]_%_P :/[9Q7_0++\?_ )$/JM/_ )^+^OF=517*_P!DZE_SR;_OXO\
MC1_9.I?\\F_[^+_C1_;.*_Z!9?C_ /(A]5I_\_%_7S.JHKE?[)U+_GDW_?Q?
M\:/[)U+_ )Y-_P!_%_QH_MG%?] LOQ_^1#ZK3_Y^+^OF=517*_V3J7_/)O\
MOXO^-']DZE_SR;_OXO\ C1_;.*_Z!9?C_P#(A]5I_P#/Q?U\SJJ*Y7^R=2_Y
MY-_W\7_&C^R=2_YY-_W\7_&C^V<5_P! LOQ_^1#ZK3_Y^+^OF=517*_V3J7_
M #R;_OXO^-']DZE_SR;_ +^+_C1_;.*_Z!9?C_\ (A]5I_\ /Q?U\SJJ*Y7^
MR=2_YY-_W\7_ !H_LG4O^>3?]_%_QH_MG%?] LOQ_P#D0^JT_P#GXOZ^9U5%
M<K_9.I?\\F_[^+_C1_9.I?\ /)O^_B_XT?VSBO\ H%E^/_R(?5:?_/Q?U\SJ
MJ*Y7^R=2_P">3?\ ?Q?\:/[)U+_GDW_?Q?\ &C^V<5_T"R_'_P"1#ZK3_P"?
MB_KYG545RO\ 9.I?\\F_[^+_ (T?V3J7_/)O^_B_XT?VSBO^@67X_P#R(?5:
M?_/Q?U\SJJ*Y7^R=2_YY-_W\7_&C^R=2_P">3?\ ?Q?\:/[9Q7_0++\?_D0^
MJT_^?B_KYG545RO]DZE_SR;_ +^+_C1_9.I?\\F_[^+_ (T?VSBO^@67X_\
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M;_OXO^-']LXK_H%E^/\ \B'U6G_S\7]?,ZJBN5_LG4O^>3?]_%_QH_LG4O\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M3?\ ?Q?\:/[)U+_GDW_?Q?\ &C^V<5_T"R_'_P"1#ZK3_P"?B_KYG545RO\
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M\:/[9Q7_ $"R_'_Y$/JM/_GXOZ^9U5%<K_9.I?\ /)O^_B_XT?V3J7_/)O\
MOXO^-']LXK_H%E^/_P B'U6G_P _%_7S.JHKE?[)U+_GDW_?Q?\ &NJKT,!C
M:N)YO:4G"UM^N_DMC&M2C3MRRN%%%%>B8!1110 4444 %%%% !1110 4444
M%%%% &;)_P C!#_UR_QK2K-D_P"1@A_ZY?XUI4V)!1112&%%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!F:'_P >
M<G_74_R%:=9FA_\ 'G)_UU/\A6G38EL%%%%(84444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 >0>./^2M:-_O6W_HTUZ_7D'CC_ )*UHW^];?\ HTUZ_5SV1,=V%%%%04%%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% &;)_R,$/_ %R_QK2K-D_Y&"'_
M *Y?XUI4V)!1112&%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% &;)_R,$/_7+_ !K2K-D_Y&"'_KE_C6E38D%%%%(84444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% &9H?\ QYR?
M]=3_ "%:=9FA_P#'G)_UU/\ (5ITV);!1112&%%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110!\_:[I]W\/O'"3V,?EQ1R&:P>1=R/&1ADY))P&*'G
M=T/&0:BU?Q+K_CN^L[!HU9BV(;2U4JK/S\QR3R!GDG  /3DGW1M5T6^N)-*:
M_P!/N)I-\+VAF1V; .Y2F<G@'(QV-36&DZ;I?F?V?I]I:>9C?]GA6/=C.,X
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M/<7-PQ$,*G:&"XW$M@@ 9'J22.,9(:5]$#=CI**\0'Q?\2XYMM)S_P!<)/\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M$OB&WMS"[6,;![N0 [50<[20006QM&#D9)Q\IK:FK+F9G-W=D<^R.AQ)&Z'
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M*NCC(8%P""#U%?0G_"+^'_\ H!:9_P" D?\ A6DI\I$8W/FBBOI?_A%_#_\
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MC%>KT442DY.[!*P5R'Q0_P"2>:E_OP?^CXZZ^N0^*'_)/-2_WX/_ $?'1'=
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M[:42^3YA3<PY4[ATPVT]#G&.]>D?\+I_Z@'_ ).?_85O--Z(RBTM6<E\2?\
MDH.J_6+_ -$I6G\(/^1VG_[!TO\ Z,BKE_$FL_\ "0^(+O5?L_V?[1L_=;]^
MW:BKUP,_=ST[U9\'^)?^$4UN34?LGVK?;-!Y?F;,99&SG!_N=,=Z;3Y+"37-
M<^CZ*Y_P?XIC\6Z/)?):O;-%.T$D;.&&0 V0>,C##L.<CW/05S-6-SD?B+XD
M_P"$?\,R)!+LOKW,$&UL,HQ\[C!!&!T(SAF3UKP"NT^)OB#^V?%#VD1S:Z=N
M@3CK)G]X>0#U 7'(^3(ZUB>%=%?7_$UC8"'S(6D#W .X 1*<ODKR,CY0>.6
MR,UT07+&[,9.[L>P_#'14TOPA!=-#LN=0_TB1CM)*?\ +/!'\.W# $G!=NF<
M5V$L4=Q"\,T:212*5='4%64\$$'J*?16#=W<U2MH>)Z[\)=8L9-VCNNI0,V
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MU&0<$9!QQ6LHJ3(C)I&UXZ\00^)?%$MY;#_18HU@@8H59T4DY()[LS8Z<8R
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 9LG_(P0_P#7+_&M
M*LV3_D8(?^N7^-:5-B04444AA1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!FR?\C!#_
M -<O\:TJS9/^1@A_ZY?XUI4V)!1112&%%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** ,S0_\
MCSD_ZZG^0K3K,T/_ (\Y/^NI_D*TZ;$M@HHHI#"BBB@ HHHH **** "BBB@
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M(7.W@XZG^(UX[X%N=$L/$::AKET(8;5=\*&%Y-\O0'"HW"\GJ"#M(SS7K/\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M2$8&W& 3@G;US@$UDVLL_BWQI9-J,/VF2\N(([E8E*[T 5&8[>GR*22,8Y/
MZ5[-/5,7.]FCZ0HIDTT=O#)--(D<4:EW=V 55 R22>@%>#^(O%VL^.M2_LJQ
MBE6QGD58+!0-TA7)#2'U_B(SM7:#_#N,1BY%-V/9I?$^@0S20RZYID<L;%'1
MKN,,K X((SP0:OVEW;7]LES9W$-Q ^=LL+AU;!P<$<'D$?A7E%K\&+E[=&N]
M;AAFYW)%;F11SQABRD\8[?XUQ*R:QX'\42>6Z0ZC:-L< [XY%(!P<=48;3C@
MC@\,.*4$]F3S-;H^DZ*AL[N"_L;>\MG\RWN(UEB?!&Y6&0<'D<'O7CGQ)\5Z
MM'XNET^RO;JS@LD5,03E/,9E#ECMP>C 8).-N1C)J8QYG8INRN>TT5S7P_EO
M)_ ^FS7\EQ)<2"1B]PS,[*9&*G+<D%<8]L8XKI:35F-!6'XQT:Y\0>%;W3+1
MH5GF\O89F*I\KJW) )[>E;E%).P'":'\*=#TU5DU OJ=RK!PTF8XP021A >0
M1@$,6!QT )%1>._ FD3^'[O4=.LH+.]M(O,!B_=HR)DL"H&"=I;!P#D*"<5Z
M!7G/Q=UV.VT.+1$V//>LLD@."4C1@P/7()<+@X((5^XJXN3D2TDCA_AC<S6_
MCVQCB?:MPDL4HP#N78SX]OF13QZ5[]7C?PC\/B[U.?79AF.S)A@Y_P"6K+\Q
MX/9&Q@C!WYZBN\^(&MOH?A"ZFAE\JZN"+>!OFSN;J05^Z0@<@YZ@?0NIK*R%
M#2)Y9\0/$\GBC7UL[$S26-L_E011D.)Y<E?,4+][.<+R>.F-Q%=[X7^%VF:2
MOVC5Q%J5V<$*R'R8OEP1M)P_)/+#LN ".?/OAY>Z1I/B!]5UBZB@BMH]D(.]
MG,KY (50<J%#@D\ LO<BN\'QCT C)L-5'L8XO_CE5)/X8BC;=G42^#_#4T,D
M3:#IJK(I4F.V1& (QPR@$'W!R*M:-H6F^'[1[72[<P0/(967S&?+$ 9RQ)Z*
M*SO#_C?0_$FV.TN?*NFSBUN,)(?O=!DAN%)^4G ZXKHJR=UHRU;<****0PHH
MKRCXG^-XGAD\/:7<OO#[;Z:-@%P,@PY[\_>P1C&TYRP#BKNPF[(Q_&WB:\\:
MZW'H.DVWG6L-P1"$VLUQ(,KY@;H$P6QSC!+$]EX?4;4Z9?7=I))YCVLC12-M
MP-RG#8YY7(."<$C!P,X'LWPX\$Q:391:SJ-LXU6528XYE -LAR.!V9AR2>0#
MMP/FSYMX9^U:_P#$+3YSY,=S/?B[D'(3AC*X'4] V/PR>];Q:5[;(R:[GT#I
MUC'IFEVEA"SM%:PI"C.06*JH )P!SQ5'7/"^C^(S;G5;0W'V?=Y6)G3;NQG[
MI&?NCK6O17/<V.1_X5CX0_Z!+?\ @7-_\76=K_@GP7H.A7FJ3:.SK;Q[E3[7
M.-['A5R&.,L0,XXSFN_KPCXD^+DU_519V<R/IED3LEC<E9G(&7]"!R >>-Q!
M(:M(<TGN1*R1B>&- E\4^(X[&!$BA+>=/L<CRH0PW;=VXD\@#.>2,\9->S>,
M[M?"_P /YXM.D2V:.*.SM0TC!@#A<(<[BP3<0<Y^7/.#2?#_ ,)GPQHI:Y3;
MJ5WAKD"3<J@$[%';@'G&>2>2 *S?B];33^#X)8X]R6]ZDDK;@-BE70'GK\SJ
M./6FY<TDN@)6B8'PD\-VUXUUK=W%#,L,@@MXW4-LD&UR^"."/DVD'NWM2_&8
MVWV_2 GD_:O*E\W&/,V979GOMSYF.V=V.],^&WB_0O#GA^ZM=5OC!-+>-*BB
M"1_E,:+G*J1U4UA:E=7?Q+\;1"SM&@0JL*G;N:*!6),DG.,C<3@'N%!)Y-:\
M]V3IRV1[/X6Q_P (CHN.GV"#_P!%K7F7CWX@OJTC:%H#M):NWE2SP@LURQ./
M+CQR5)XR/O\ 0?+]Z]XW\6V]G8CP9X<B\XB,64I4&38N-GDKG)9R."><=/O9
MV[?@+P#'X>C74M259-6=?E&<K; CD#U8C@M^ XR6A)+WF4]=$:'@OP5:^%+(
MN^R?4YEQ/< < ==B>BY_$D9/8#JJ**AN^K+2L>=?&.*(^&K"8QH9EO0BR%1N
M52CD@'L"57(]AZ5+\())7\(W*R2.ZI?.L89B0B[$.!Z#))^I--^,0SX3LO:_
M3_T7)2_![_D4KO\ Z_W_ /1<=7_R[(^V>@T445F6%%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M/RNQ=3QZJP/XU]*T54)<KN3*-SY2HKZMHK3VWD3[/S/E*BNI^(__ "4+5_\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH S9/\ D8(?^N7^-:59LG_(P0_]<O\ &M*FQ(****0PHHHH **** "BBB@
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M.0H"I@^^4;UXQ7=445+=W<:5E8^=/!\<^M^/M,>ZN<7,MW]JEEV#YW3,K<#
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MC_DK6C?[UM_Z-->OUY!XX_Y*UHW^];?^C37K]7/9$QW84445!04444 %%%%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M 4444 %%%% !1110 4444 ,FC:6"2-)7A9E*B1 "R$CJ-P(R.O((]JX'P_\
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MB_B#_H!:G_X"2?X5]+T52J-*Q+A=W/FC_A%_$'_0"U/_ ,!)/\*/^$7\0?\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110!FR?\C!#_UR_P :TJS9/^1@A_ZY?XUI4V)!
M1112&%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M+!)&D.G0LRE1)'"^Y"1U&YR,CW!'L:Y$ZM<3ZU_:M^D6H3M)YDBW8+)(>P8
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M3^5'TS_PF?AK_H.V'_?]:/\ A,_#7_0=L/\ O^M?,U%'U:/</[4J?RH^F?\
MA,_#7_0=L/\ O^M'_"9^&O\ H.V'_?\ 6OF:BCZM'N']J5/Y4?3/_"9^&O\
MH.V'_?\ 6C_A,_#7_0=L/^_ZU\S44?5H]P_M2I_*CZT5@RAE.01D$4M0VO\
MQYP?]<U_E4U<9[:"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHJK=:E8V4]
MO!=WMM;S7+;((Y951I6R!A03\QR1T]10!:HHHH **** "BBB@ HHHH ****
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M#)8@?D,X!) R,U5.-O>8IOHCJ?A=X6FU+6H]<+K'9V$I&5<AY)-OW1M(( #
MG/!!VX()Q[A5/2M-M]'TJUTZU&(;>,(I( +8ZL< #<3DDXY)-7*SE+F=RXJR
M"BBBI&%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110!FR?\C!#_P!<O\:TJS9/^1@A_P"N7^-:5-B04444
MAA1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 9FA_\><G_74_R%:=9FA_\><G_74_R%:=-B6P4444AA1110 4444
M%%%% !1110 4444 %%%% !1110 4444 9<OAK09YGFFT339)9&+.[VJ%F8\D
MDD<FF?\ "*^'?^@!I?\ X!Q_X5KT4[L+&1_PBOAW_H :7_X!Q_X4?\(KX=_Z
M &E_^ <?^%:]%%V*QD?\(KX=_P"@!I?_ (!Q_P"%6;+1=*TV8S6.F65K*R[2
M\$"HQ7@XR!TX'Y5>HHNQV"BBBD 4444 %%%% !1110 4444 >0>./^2M:-_O
M6W_HTUZ_7D'CC_DK6C?[UM_Z-->OU<]D3'=A1114%!1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %9'BK_D4-;_Z\)__ $6U:]9'BK_D4-;_ .O"?_T6U..Z
M(J? _0^8:***]0^3"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /J^U_P"/
M.#_KFO\ *IJAM?\ CS@_ZYK_ "J:O*/KEL%%%% PHHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MEBLY,*MDDI\I5!R,CHQSSN(SGT  'I_Q@DD3PC;*DCHKWR+(JL0'78YP?49
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M_P"N7^-:5-B04444AA1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHKBOB-XM'A_1S96DJ?VE>*44!R'AC((,@QT.>!R.>1G:132N[";L>
M*ZU<PWNOZE=VS[X+B[FFC?:1N5G+ X/(X/>H=/LAJ6IVFGF7R?M<Z0>9MW;=
M[!<XR,]>F:KUZ?\ ";PPTMT?$=QQ%%OBM4*L"SD89P> 5 ++WY)Z%>>F3Y8F
M*5V>O5\X>-KW[?XVUB?RO*(N3"5W9SY8$>>@Z[,X[9QS7T?7RWJ%_P#VKJ5U
MJ/E>5]KF>?R]V[9O8MC.!G&>N*RI;EU-CKOA19QW7C=)'9PUK;23H%(PQXCP
M>.F)">,<@5ZA>?$+PI8S+%+K,+LR;PUNCS+C)'WD!&>.F<_G7STKN@<*[*'7
M8X!P&7(;!]1E5/U J,NJG!8 ^YK25/F=V2IV5D?15E\0?"M_,T46LPHRJ6)N
M$>%<9 ^\X SSTSG\JZ*&:*Y@CG@E26&10Z2(P964C(((Z@CO7RK75^#?&U[X
M9U"&.:=Y-)=@DT,C,5B4MDN@&2",DD ?-R.N"(E2TT*53N>B_%VVFG\'121)
MN2WO$DE.0-JE60'GK\S*./6O(O#NIG1O$FG:AYWDQPW"&:0)OQ$3B3C!S\A8
M<#/IS7T=JNF6^LZ5=:==KF"XC*,0 2OHPR"-P."#C@@&O"=<^'?B'1)?EM'U
M"W9MJ36:,Y/7&Y!\RG R>JC(&XT4Y*W*PFG>Z/7O'NIQZ7X*U*1@C-/$;9$9
M]I8R?*<>I );'<*>G6OGJWMYKRYBM;9/,N)G6.),@;F8X R>!DD=:THO"GB"
M69(TT'40TC!06M'49)QRQ& /<G KT#POX+@\*Z?/XF\4PJ)K,&2&UWHVPK]U
MLYVLY.-HS@$C^+&UJT%N)WDSK_'?B@>&/#[R1$_;KG,-L%*Y1L']Y@YR%X['
MDJ#C.:\#MK:]U?44@MXY;N]N7.!G<\C'DDD_B22?4DU;\1:[<>(];GU.Y7RS
M)A4B#EA$@& H)_,XP"23@9KT?P9H6G^"]'_X23Q.JVMW(^RW\T%FB1A@ (!D
M2'YLXR0OI\PH2Y(^8/WF=KX1\.Q>&/#\-BO,[?O;E@Y8-*0 VW('R\ #@< 9
MYR:W:\_E^+_AZ.:1%M=2D56*B1(DVN >HRX.#[@'VK6T'XA^']?F\B.=[2X+
M;4ANP$,G( VD$J22V ,[C@\5DXRW9::V1U5%%%24%%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M%% !1110 4444 9LG_(P0_\ 7+_&M*LV3_D8(?\ KE_C6E38D%%%%(84444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M &9H?_'G)_UU/\A6G69H?_'G)_UU/\A6G38EL%%%%(84444 %%%% !1110 4
M444 %%%% !1110 4444 <QXP\$V7BVWC+2"UOHL".Z$>X[<\JPR-PZXYX//<
M@^>W7P=UQ+IUM+_3I;<8V22L\;GCG*A6 YSW->TT52FUL2XIGS1:>'+V]\4'
MP]$]N+P320EV=A'NC#%N<9Q\IQQZ5U/_  I_Q)_S]:5_W_D_^-UZ<GA3P[IN
MK2>(/LJP7:-)</<O</M4L&WL06V@89NV!69J7Q1\,:>&$5Q/?2+(8V2UBSC&
M<L&?:I7CJ"<Y&,CFM/:2?PD\B6YPG_"G_$G_ #]:5_W_ )/_ (W1_P *?\2?
M\_6E?]_Y/_C==K8_%CPS=B0W#7ECLQC[1!NWYST\LMTQWQU[UV%EJ-EJ432V
M%Y;W4:-L9X)5<!L X)!ZX(X]Z3G-;C48LH>%M%_X1[PS8Z67WO"A,A#9&]F+
M/@X'&YCCC.,9K8HHK(L**** "BBB@ HHHH **** "BBB@#R#QQ_R5K1O]ZV_
M]&FO7Z\@\<?\E:T;_>MO_1IKU^KGLB8[L****@H**** "BBB@ HHHH ****
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M8^(=+BU"PDW1/PRMPT;=U8=B/\",@@U>FFBMX))YY$BBC4N\CL%55 R22>@
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MH!#9)))*LN2>K;JZNO/O@]_R*5W_ -?[_P#HN.O0:QDK-FD=@HHHJ1A1110
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M* "BBB@ HHHH **** "BBB@ HHHH **** ,V3_D8(?\ KE_C6E6;)_R,$/\
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MO^12N_\ K^?_ -%QUZ#4R5G8:=U<****0PHHHH **** "BBB@ HHHH ****
M"BBB@ HHKR[XS7ES'9Z58I,RVMR96FB'20H4VY]0"2<=,X/4##BKNPF[*YZC
M17RO:7=QIEW%?64QM[J [HY4 RIQ^HQD$'@@D'BOJBJG#E%&5PHHHJ"@HHHH
M **** "BOFWQE>7&H>,-5DNYFF:*ZE@C+8^2-'8*H] !^I)/))KJ_@Y>7*>(
M+S3UF86;VK3M#_#Y@9%#>QP2..O&<X&-'3LKD*=W8]GHHHK,L**** "BBB@
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M",A1PW( ' R<I?#8;WN7?A?'/I/CO6=%%QYL,4,BR-L"^8\4JHK=R.&;C/\
M%WP*T/B-XCO[[4H_".A><]S+\MVL:89]P!5 Q/W=I)8],8YQN%9>D07/PO\
M#]SJ>HVMNVKWY%O9VI96:%5R69F!Y4_*2%]$R03\IX2&G^$M)'B_Q"7GO+]C
M]BBVEK@@DAY/G(!+ YW?W<?,=^*I[\PNECT;PCX<B\,>'X;%>9V_>W+!RP:4
M@!MN0/EX ' X SSDUNUQNB?$S0=;U2+3XTN[667B-KE457;LH(8\GMGKTZD
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M4 %%%% !1110!]7VO_'G!_US7^535#:_\><'_7-?Y5-7E'URV"BBB@84444
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M_P 57K/_  I[P_\ \_FI_P#?V/\ ^(H_X4]X?_Y_-3_[^Q__ !%'/ ?+(W?
M-[=:CX(TVYO9WGG975I'.68+(RC)[G ')Y/4Y-<;\6_#)(3Q':H@50L5YR%)
MY"H^,?,>=I.2<!,# ->BZ%HUOX?T:#2[6262"$L5:8@L=S%CG  ZL>U:-8J5
MI71=KJS/E$@$$$9!ZBNLMOB1XJMK![4:EYF518YI8D:2(+Z$CYB1P2^X_0\U
MZ%KWPGTG4IO/TR=M,D9LNBIYD1').%R"IR1T.T 8"UD?\*6X_P"1@_\ )/\
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MH6FL+RWNHE;8SP2JX#8!P2#UP1Q[U\QWU[<ZE?37MY,TUS,VZ21NI/\ 08X
M'   %>F?!8#S-=/?%O\ ^U:<J=E<%.[L>LU3OM6TW2S&-0U"TM#+GR_M$RQ[
M\8SC)&<9'YUYQ\0OB%<V=[-HNBSP@",I<W49)DCDS@HAZ*0!R>3EL#:5KR:6
M5I)))YI"SNQ=Y';)9B<DDGJ2>]$:;:NP<['TJ?%?AT#)U_2O_ R/_&M2&:*X
M@CG@D26&10Z2(P964C(((Z@CO7R_>Z9?Z88Q?V-S:&7/EB>)H]^,9QD<XR/S
MJ;1=<U'P_?K>:;<-$X8,Z9/ES 9X=<_,,$^XSD$'FFZ79B]IW/IVBLCPSX@M
M_$VAPZE OEELK+"7#&)QU4D?@1G!((.!G%<E\3_&-SHL,6CZ;)Y5W=1%YIER
M'BC)P-IQC+$,,@Y7;T!((R46W8MM)7.XOM6TW3#&-0U"TM#+GR_M$RQ[\8SC
M)&<9'YU7B\3:#--'#%K>FR2R,$1$NXRS,3@ #/))[5\V1Q76H7A6*.>ZNYV9
MRJ*TDDC<LQP,DGJ3^)JU)H.M10R32Z+J<44:EWDDLY%55 R225P !6OLEU9'
M.^Q].UB^)/"^F^*;%+;4$=6C;=%/$0)(^F<$@C!Q@@@CIW (XGX-7US+9ZI8
MR3,UK;&)H8STC+[]V/8[0<=,Y/<YO_&$ ^$K3(Z7Z?\ HN2HY6I6*O>-R#0_
MA[X*NKU;BQU5M66V8-)!]JBFC.<X#A%SCC.,X..<C(KTBOF?PP ?%NBY&?\
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M_GPG_P#1;5\S2+OC9< Y!'-*$.8<I6/JR::*V@DGGE2*&-2[R.P554#)))Z
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MX4444AA1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M5D>*O^10UO\ Z\)__1;5KUD>*O\ D4-;_P"O"?\ ]%M3CNB*GP/T/F&BBBO4
M/DPHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#ZOM?^/.#_ *YK_*IJAM?^
M/.#_ *YK_*IJ\H^N6P4444#"BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@#-D_Y&"'_KE_C6E6;)_R,$/_ %R_QK2I
ML2"BBBD,**** "BBB@ HHHH **** "BBB@#E]6)&K3JP .%9>1DKC&?;D,.?
M2J==5>V$-]&JR;E93E73&X>HY['O_B :S/\ A'I?*Q]L3S,?>\DXS]-W]:I,
MEHJ:22=6@50"<,S<C(7&,^_)4<>M=156RL(;&-ECW,S'+.^-Q]!QV';_ !)-
M6J3&D%%%%(84444 ?*$?^J3_ '16A9ZSJFG0F&QU*\MHBVXI!.R GIG /7@?
ME6?'_JD_W17J7PX\':%XA\/7%WJED9YTNVC5A/(F%"(<85@.I-=4FDKLYTKO
M0X7_ (2CQ!_T'=3_ / N3_&N[^%/B+5;[Q%>:?>WL]W$]H9P;B5Y&1D=5&W)
MP ?,.>.<#TKKO^%8^$/^@2W_ (%S?_%UKZ'X7T?PX;@Z5:&W^T;?-S,[[MN<
M?>)Q]X]*RE.+5DC11:9ROQA_Y%*T_P"OY/\ T7)7E/A?_D;=&_Z_H/\ T8M>
MK?&'_D4K3_K^3_T7)7E/A?\ Y&W1O^OZ#_T8M73^ F?Q'TO7S1XH_P"1MUG_
M *_I_P#T8U?2]?-'BC_D;=9_Z_I__1C5%+=E5-CK/AKX*MM=D?6-1*RV=M+Y
M:6V,^9( #E_]D9''<]>!AO7[G2K"[TEM+FM(FL&C$7D!=JJHZ  ?=Q@8QC&!
MC&*XKX/?\BE=_P#7\_\ Z+CKT&IFWS%16A\O:KITND:M=Z=-O+VTS1[FC*%P
M#PVT] PP1R>".37H?P;U()J&IZ6S3$RQ+<1KG]VNT[6.,\,=Z=!R%YZ"N8^(
MDT<_C[57BE210R)E&! 98U5AQW!!!]"#6M\'S_Q6=P/^H?)_Z,BK66L#..DC
MKOC#_P BE:?]?R?^BY*\5CCDED6.*-Y)'(5$C4LS$]  .23Z5[5\8?\ D4K3
M_K^3_P!%R5Y3X7_Y&W1O^OZ#_P!&+13^$)_$>R>%_AUI.C:7LU.UM=2OI2&E
MDFB$B(>RH&' 'KU/4XX U?[-TOP?H^KZAI>FQQD1R7<J(Q'F%5+!<G.U>N .
M!DX%;U8'C=+R3P3JXL94BE%N69G'!C',@Z'DH& ]R.1UK&[;U-;61\YR2232
M/++(\DCDL[NQ9F)ZDD]2?6O:_A/HEK:^&5U<*CW=ZSCS-OS(BL5V YZ94L<8
MSD9SM%>)5]"?#F2&7P#I;6]O]G0+(I3>7RPD8,V3_>8%L=LX[5M5V,J>YT&H
M:?::K836-] L]M,NUXV[_CU!!P01R" 1S7S9K^E/HFOWVFLK@6\S+'O8,S1]
M48D<9*E3VZ]!TKZ<KY\^) /_  L'5L]S%C_ORE12>MBJFQTOP;U+9?ZGI;-,
M?-B6XC7/[M=IVL<9X8[TZ#D+ST%4OC#'(/%5G*8W$;62JLA4[6(=\@'N1D9^
MH]:9\'R/^$RN1W_L^3_T9'7J7BGPM8^*M,-K=#RYTR;>Y5<M$Q_FIP,KWQV(
M!#;Y9W!*\3Q+P/XEM_"OB!K^Z@EFADMWA81$;ER58$ X!Y4#J.N>V#[EHWBC
M1?$!==+U".>1,[HR"CX&,G:P!*_,!G&,\9KQ;7?AUX@T6;]U:/J%NS826T0N
M>IQN0?,IP,GJHR!DUR)"NN" RGUY!JG%3U1*DXZ,^I;;3K&SFGFM;.W@EN&W
M3/%$JM*<DY8@<G)/7U-</\8?^12M/^OY/_1<E4OACXTO-3NIM'U>\\^41AK2
M20*&8*,,A.<L<88<$\.2>E7?C#_R*5I_U_)_Z+DK-)J=F6W>.AY3X7_Y&W1O
M^OZ#_P!&+7T'XECDF\*ZO%%&\LCV4RI&BEF8E#@ #DDU\^>%_P#D;=&_Z_H/
M_1BU]+U57="I['RE7L_@_P"(^A+HNGZ9?R265Q;0Q6P:52T<A V@AA]T< DM
M@#/4X)JEXK^%!GN)K[P\\4>[YC8,-JYP2?+;H,G&%. ,GD# 'F.HZ1J.D3>5
MJ-C<6K%F5?-C*ARIP=IZ,.1R,CD>M5[LT3K%GTK<6FFZW91?:;>TO[5L2Q^8
MBRH<CAAG(Z$\^AJY7S+H?B#4_#=X]UI=P(GDVB5&4,DH!R P_,9&" 3@C-?1
M^EZE;ZQI=MJ%HVZ"XC#KR"5]5."1D'((SP0164X.)I&5RW1114%'S[\2O^2@
M:G_VR_\ 125UGP6_YCG_ &P_]J5R?Q*_Y*!J?_;+_P!%)76?!;_F.?\ ;#_V
MI71+^&8KXSJ_B5_R3_4_^V7_ *-2OGVOH+XE?\D_U/\ [9?^C4KY]HI?"%3<
M^@/!O@2Q\,VL<TZ176JGYGN2N?*."-L>>0,$@G@MDYXP!R/Q;\/6MI'9ZQ9V
MMO!YDKQ7)C&UI7;YU8@#!/$F6ZG(Z]O6Z\^^,/\ R*5I_P!?R?\ HN2LH-N5
MS227*>-V%G)J.HVUE"4$MQ*L*%R0H9B ,XSQS7T-X7\(Z;X7LDCMXTEO-I$M
MXZ 229P2 ?X5X&%SC@=3DGP?PO\ \C;HW_7]!_Z,6OI>KJM[$TT>'?%/P]:Z
M+K5G<6%K;6MI=0D"*$;0)$.&.T#"C:R=.X/'<YWPV&?B!I?MYO\ Z*>NJ^-/
MWM#^EQ_[3KE?AK_R4#3/^VO_ **>J6L"7\9[9XH_Y%+6?^O&?_T6U?-%?2_B
MC_D4M9_Z\9__ $6U?-%*ELQU-SVKX>^!+&QTVVUF_2*[O;E$GA#+N2W4X92H
M/\?0ENW0=RVWX^\/Q:]X7NL0[[VUC::V9(R[[@,E% .3N VXYY(."0*TO"__
M "*6C?\ 7C!_Z+6M"\NX+"QN+RY?9;V\;2RO@G:JC).!R>!VK)R?-<T25K'R
MQ7O7PNU(:AX)@B+3/)92O;NTISG^-0IR?E"NH'3&,= *\%[5[3\&SGPI?>VH
M/_Z*BK:K\)E3W.7^,/\ R-MI_P!>*?\ HR2N2\/:%<^)-:@TRU;89,EYBA98
MD R6./R&< D@9&:ZWXP_\C;:?]>*?^C)*/@]_P C;=_]>+_^C(Z$[0N#5Y'I
M-MX#\-6VE)8'2;:=1&8VGEC!F;/5C( &!Y/(QCMC K$^(;0^&_AXNF:9;^1;
MS2):J(G*[%Y=B>[;MI!R>=Y))YSWU>:?&1+PZ-ILB2H+);AEEC(^9I"OR$<=
M !)GG^(<'ME'62N:2T1XXQ"J6/0#)KZ:\/Z':^'=%M].M53Y%!ED5<&63 W.
M>3R<>IP,#H!7S1%)#%*DES;_ &F!&#20;RGFJ.J[AR,CC(Z9KZKJZKV)IG.>
M-?#5OXDT">,VQEOH(WDLV1@K"3'"Y/&UB "#QT/! (^=:^K:^4$!"*#UQ3I/
M="J'O/PUNX=8\!)9W"O.MN\EI,MP ZNI^8+SG*['5<'TQC%>)ZIITND:M=Z=
M,7+VTK1;WC*%P#@/M/0,,,.O!')KU_X.$'PI?>VH/_Z+CKE?B[I2V?B:WU!
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MUXMK;_VA:Q"6.X<8<(A+,NX#)&TOA3QDYXZB7X:_\D_TS_MK_P"C7K5\4?\
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M'_V#[?\ ]%K7E?QA_P"1MM/^O%/_ $9)7JGA/_D3=#_[!]O_ .BUKROXP_\
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M "BBB@ HHHH **** "BBB@ HHHH **** /J^U_X\X/\ KFO\JFJ&U_X\X/\
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M !1110 4444 %%%% !1110 4444 %%%% !1110!FR?\ (P0_]<O\:TJS9/\
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M(..& P1[@X-;OEFC)7BSTKQQ\1M*?1;O2M)=;V>Y62VF?:PCB0C:Q!(&\G)
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MQ,PR.XRHXZ'H:^C(88K>".""-(HHU")&BA550,  #H *V;4-+&:3EK<^8_\
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MR3!/6Q-1114C"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"LCQ5_R*&M_]>$__ *+:M>LCQ5_R*&M_]>$__HMJ<=T14^!^A\PT445ZA\F%
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 ?5]K_ ,><'_7-?Y5-4-K_ ,><
M'_7-?Y5-7E'URV"BBB@84444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MCO@?04W_ (4LW_0P#_P"_P#ME;-P:U9G[R>AUG_"S/"/_06/_@+-_P#$4?\
M"S/"/_06/_@+-_\ $5R?_"EF_P"A@'_@%_\ ;*/^%+-_T, _\ O_ +94VI]Q
MWGV/4K6ZAO;."[MWWP3QK)&V",JPR#@\C@]ZFK*\-Z''X<T"UTJ*9YE@#$R.
M "S,Q9C@=!EC@<X&.3UK5K,L**** "BBB@ HHHH **** "BBB@#R#QQ_R5K1
MO]ZV_P#1IKU^O(/''_)6M&_WK;_T::]?JY[(F.["BBBH*"BBB@ HHHH ****
M "BBB@ HHHH **** .(M?ACI UN]U34G>_DN+J2X2%ALB3<^\ @'+D'(Y.T@
M\K7$>'/^2VR_]A"]_E+7MU>(^'/^2VR_]A"]_E+6D6VG<B2LT>W5633K*._D
MOTL[=;R1=KW"Q*)'''!;&2/E7\AZ59KG?&6D:QK.D0V^B:@;&Y6X$C2"=XLH
M%8$909/)''3BH1;-'Q!<6-KX>U"74QNL1;N)D#;2ZD8V@Y'S'.!R.2*\G^#M
MM,_B:^NE3,,5F8W?(^5G=2HQUY"-^7TJGXE\"^,HK>*>]FFUE8\@&*>2X>+)
M4<*XW<\?=!^[DX KIOA5XILY((_#ALHK6=(S*LZ.,73Y^8D'G?MP>,C"M]T
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M26X98%7<2BE0#N;()W%>J]OE%0W/AGQ;\.H1J=K<1Q1.VV62Q<NBG!"^8K*
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M[A1112&%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110!Y]\8O^1-@_Z_4_] >O"Z]T^,7_ ")L'_7ZG_H#UX77=A_@/G\R_C_(
M****W. **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@#J/AU_R/VD_]=&_] :OHVOG
M+X=?\C]I/_71O_0&KZ-KBQ/Q(]W*_P"$_7]$%%%%<YZ04444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110!FR?\C!#_ -<O\:TJS9/^1@A_ZY?X
MUI4V)!1112&%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110!F:'_QYR?\ 74_R%:=9FA_\><G_ %U/\A6G38EL%%%%
M(84444 %%%% !1110 4444 %%%% !1110 4444 %%%% %/4M5L-'LVN]1NXK
M:$9&Z1L;C@G"CJQP#P,DXK@M2^,6F0!ETW3;F[D60KF9A"C+S\P/S'GC *C@
M\XZ5PWBS4[_QCXSEM[+?=HLK6]C#"X=2HX+*1@8;&XL>@QDX45V6F_!JU$).
MJZK.\C*N%M%"!&Q\PW,&W#I@X7ITYXUY8I>\1S-[#K'XS63B0ZCHUQ!C'EBV
ME6;=USG<$QV]?P[]UHOB/2?$44TFE7BW A8+(-K(RDC(X8 X/.#T.#Z&N+N?
M@WI+6SK::I?QSG&UY]DBCGG*A5)XSW']*X2^LM<^''B=)89,$9\F?:?*N8^,
MJPS],KG(."#]UJ.6,OA%>2W/H.BJ>E:G;:SI5MJ-HVZ"XC#KR"5]5."1N!R"
M,\$$5<K(T"BBB@ HHHH **** "BBB@ HHHH \@\<?\E:T;_>MO\ T::]?KR#
MQQ_R5K1O]ZV_]&FO7ZN>R)CNPHHHJ"@HHHH **** "BBB@ HHHH **** "BB
MB@ KQ'PY_P EME_["%[_ "EKHM7^$C:QK-[J,^O$O<S/( ]KO**3\JY+\A1A
M1[#M5/\ X4JI7']O#'I]B_\ LZUCRI;D.[Z'K%8]CXJT/4=5GTNVU&(WT$C1
M/ X*,67=N"[@-^-K9VYQC/<5@^#? #^$-3GNDU<W$4T)C: 0>6I;<"&/S')
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M-C,&WLDBY89S]W'=N<8%7O"/P_N=*U8:YKNHM?:H%(3;([*AP5W%VY<[, 9
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M=R%!/[GDANO 4DYP.C9/"U3\$?$NPLM)ATK6RT"VD(2*Z"EPZ@D!"J+E<+M
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MHHH **** "BBB@ HHHH **** //OC%_R)L'_ %^I_P"@/7A=>Z?&+_D38/\
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M@CJ*?0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%4(M;TF>^-C#JEE)=AF0VZ7"&0,N=PV@YR,'([8
M-7Z "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M,S0_^/.3_KJ?Y"M.LS0_^/.3_KJ?Y"M.FQ+8****0PHHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** /!?A1]A/C2V-S_K?(D^R?>_UFWGIQ]SS.O'X
MXKWJO"/'N@W_ (:\6MK$ ;[-<77VJVN#A]DV=Y4C& 0P) .<J!R2&QOZ;\97
MW0QZKI"D?-YL]K+CUV[8V_ '+^I]JUG%RU1G%I:,]8KROXS_ &;R=&W>=]JW
M3>7C'E[/DW;N^[.S&.,;L]JGOOC+8QF+^S](N9P<^9]HE6';TQC:'SW],<=<
M\>>7^HZKXZ\3VWG+";VXV6T2Q1D(B@D]LMM&68DYP,]A1"#3NPE)-61[%\,<
M?\*]TS']Z;_T<]==5#1-+CT71++38]A%M"J,Z1A [8^9]O8L<D]>2>35^LV[
MLM;!1112&%%%% !1110 4444 %%%% 'D'CC_ )*UHW^];?\ HTUZ_7D'CC_D
MK6C?[UM_Z-->OU<]D3'=A1114%!1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% 'G7B/X?ZEXE\;KJ-Y=VITA?+3RLL)?*499/E ^\Q?G=D!L]@*]%HHIMMB2
ML%%%%(84444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5D>*O
M^10UO_KPG_\ 1;5KUD>*O^10UO\ Z\)__1;4X[HBI\#]#YAHHHKU#Y,****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH ^K[7_ (\X/^N:_P JFJ&U_P"/.#_K
MFO\ *IJ\H^N6P4444#"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M:EW=V"JJ@9))/0 5\W>*/$,_B?7IM1E&V/\ U=NFP*4A!)4'!//))Y/)..,
M>F?%?Q0]A8IH-KQ->1[YW!92D6[  QP=Q# \] 01\P->=^#/#<OB7Q#;VYA=
MK&-@]W( =JH.=I(((+8VC!R,DX^4UM35ES,SF[NR.?9'0XDC=#@, ZD$@@$'
MGL000>X(-=Y\(/\ D=I_^P=+_P"C(JS/B3_R4'5?K%_Z)2M/X0?\CM/_ -@Z
M7_T9%5R=X7)BK2/<*^7=$T74M<9(-*LI;IPHSY8 5>"1N8X5<[3C)&<8%?45
M,BAB@0I#$D:EF<JB@ LQ+,>.Y)))[DFL8SY324;GB9^#_B3=Q=:3M]?/D_\
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M()QG (P?QKZEHJ12V"#;W"BBBLRPHHJM?W]KI=C->WLZ06T*[GD;H/\ $D\
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MEA1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 9FA_\><G
M_74_R%:=9FA_\><G_74_R%:=-B6P4444AA1110 4444 %%%% !1110 4444
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M1Z917F?_  M6?_H$Q_\ ?\_X4?\ "U9_^@3'_P!_S_A1]5J]@_M?!_S?@_\
M(],HKS/_ (6K/_T"8_\ O^?\*/\ A:L__0)C_P"_Y_PH^JU>P?VO@_YOP?\
MD>F45YG_ ,+5G_Z!,?\ W_/^%'_"U9_^@3'_ -_S_A1]5J]@_M?!_P WX/\
MR/3**\S_ .%JS_\ 0)C_ ._Y_P */^%JS_\ 0)C_ ._Y_P */JM7L']KX/\
MF_!_Y'IE%>9_\+5G_P"@3'_W_/\ A1_PM6?_ *!,?_?\_P"%'U6KV#^U\'_-
M^#_R/3**\S_X6K/_ - F/_O^?\*/^%JS_P#0)C_[_G_"CZK5[!_:^#_F_!_Y
M'IE%>9_\+5G_ .@3'_W_ #_A1_PM6?\ Z!,?_?\ /^%'U6KV#^U\'_-^#_R/
M3**\S_X6K/\ ] F/_O\ G_"C_A:L_P#T"8_^_P"?\*/JM7L']KX/^;\'_D>F
M45YG_P +5G_Z!,?_ '_/^%'_  M6?_H$Q_\ ?\_X4?5:O8/[7P?\WX/_ "/3
M**\S_P"%JS_] F/_ +_G_"O0=+O#J&E6EZ4"&>%9"H.<9&<5%2C.FKR1T8?&
MT,0W&D[V\F6Z***R.L**** "BBB@ HHHH **** "BBB@ HHHH *R/%7_ "*&
MM_\ 7A/_ .BVK7K(\5?\BAK?_7A/_P"BVIQW1%3X'Z'S#1117J'R84444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110!]7VO_'G!_US7^535#:_\><'_7-?Y5-7
ME'URV"BBB@84444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%4-4UO2]%A\S4K^"U!1G59' 9PHRVU
M>K$9' !/(]: +]%<YIGCWPQJ]ZMI9ZJAG;&U98GBW$D  %U +$D8 Y-='1:P
M!15:]U&RTV%9K^\M[6)FV*\\JHI;!. 2>N >/:F6.K:;J9D&GZA:W9CQO^SS
M+)MSG&<$XS@_E0!<HHK(UOQ/H_APP#5;LV_VC=Y?[IWW;<9^Z#C[PZT :]%,
MAE6>".9 X610P#H48 C/*L 0?8@$4^@ HHK+E\2Z#!,\,NMZ;'+&Q1T>[C#*
MP."",\$&@#4HK(_X2KP[_P!!_2__  ,C_P :T;6[MKZW2XM+B*X@?.V6)PZM
M@X.".#R"*+ 34451O-:TK3IA#?:G9VLI7>$GG5"5Y&<$].#^5 %ZBBH;J[MK
M"V>YO+B*W@3&Z69PBKDX&2>!R0/QH FHJA9:WI.I3F"QU2RNI@N\QP7".P7(
M&< ],D?G5^@ HK.UG7=-\/VB76J7!@A>01*PC9\L03C"@GHIJQI]_;ZG80WM
MHSM;S#=&SQM&6'KA@#@]0<<C!'!HL!9HKB=6^(D6B^,1HE]IKQ6Q>,?;6F"K
MM<#Y\, -H8D$[N-K=QBNVIM-"O<****0PHHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** //OC%_P B;!_U^I_Z ]>%U[I\8O\
MD38/^OU/_0'KPNN[#_ ?/YE_'^04445N< 4444 %%%% !1110 4444 %%%%
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MI[B0R/R2!GL,DD #@#/  %7O$OB6_P#%.J&]O3L1<K!;J<I"OH/4GC+=_8
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M874FH6MG% CSJHA+JH4DD-N(X)Q@9Z9&<C-\#Z7YVH7'C7Q$Z1Z=;,\_GS*
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M*4=T-['(?!>*)KG6I3&AF1(560J-RJQ<D ^A*KD>P]*];KR;X+#]YKI]K?\
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MJ>K7%S:Z-?7%E%YUU%;R/#'M+;W"DJ,#DY..!S7CW_"0_$__ )Y:I_X*U_\
MC=5&-Q.5AWQ?OVG\3VMFMPCQ6UL"8UP3'([$MG'()41G![8/?GT;X?6<MCX$
MTF*9D9GB,P*$D;9&+KU'7:PS[YZUXOJ.D>*]7U"6_OM(U.:ZFQOD^PLN< *.
M H'0"MFSU;XD:?8V]G;6^JI;V\:Q1)_9@.U5& ,F/)X'>M7&\4D9J6MSW2N:
M\5^-M-\)I''<![B]E4M';1$9Q@X9B?NJ2,9Y/7 .#C9TC[;_ &-8_P!I?\?W
MV>/[3G;_ *S:-WW>.N>G'I7SU=Z)XJU&[EO+W2=6GN9FW22O:298_P#?/ [
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M.[""L@HHHJ"@HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* ,S0_\ CSD_ZZG^0K3K,T/_ (\Y/^NI_D*TZ;$M@HHHI#"BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ KY^G?XBBXD^T#Q)YVX^9Y*S;-V>=NSY<9Z;>
M/3BOH&BJC+E$U<^88&U<:UFV^W_VMYC_ .J#_:-^#OZ?-G&[/?KFMKS/'_IX
MI_[YN*Z;2D\,0?$A-6A\5)<3RWTNRV2QDVLTNY HD!*D9<?-T./0YKUZM)3M
MT,XQ/GOS/'_IXI_[YN*@T?P#XBU6=H(=+ELT3[TE[&T"#()'49/3'R@XR,XK
MZ+HJ?:OHBN1%32]-MM'TNVT^T7;!;H$7@ MZL< #).23CDDFK=%%9EA1110
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MS+")$NMY5F.U?E*#(R1GGIZ]*]#O]0M-+L)KZ^G2"VA7<\C=!V_$DX  Y)(
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M U?1M?.7PZ_Y'[2?^NC?^@-7T;7%B?B1[N5_PGZ_H@HHHKG/2"BBB@ HHHH
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %>^>&O^17TK_KTC_P#017@=>^>&O^17TK_KTC_]
M!%<6.^%'O9#_ !9^AJ4445YI]0%%%% !1110 4444 %%%% !1110 4444 %9
M'BK_ )%#6_\ KPG_ /1;5KUD>*O^10UO_KPG_P#1;4X[HBI\#]#YAHHHKU#Y
M,**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH ^K[7_CS@_ZYK_*IJAM?^/.#
M_KFO\JFKRCZY;!1110,**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M?K^B"BBBN<](**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
MS9/^1@A_ZY?XUI5FR?\ (P0_]<O\:TJ;$@HHHI#"BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH S-#_X\Y/\ KJ?Y
M"M.LS0_^/.3_ *ZG^0K3IL2V"BBBD,**** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HKSGQ[\19=#O'TC2$4WJ+^_GE0D1;ERH4="W(;)RHX&#DX\
MOFN/$/BKSD=M2U5$D$LD2AYDC9LX.P9"_P 0& .,@5I&FVKD.:6A]+45\T16
MGB/P]:SW$-MJ^E6[;?.E2.6W4\X7<V!W; SZ^]=YX,^)]P;YK/Q+=*\4S?NK
MLHJ"(]-K[0!M/][L>O'*CINUT"FNIZW1116984444 %%%% !1110 4444 %%
M%% 'D'CC_DK6C?[UM_Z-->OUY!XX_P"2M:-_O6W_ *-->OU<]D3'=A1114%!
M1110 4444 -D_P!4_P#NFOG&OHZ3_5/_ +IKYQKT,#]KY'S?$&]/Y_H%%%%=
MY\Z%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 5[YX:_Y%?2O^O2/_T$5X'7OGAK
M_D5]*_Z](_\ T$5Q8[X4>]D/\6?H:E%%%>:?4!1110 4444 %%%% !1110 4
M444 %%%% !61XJ_Y%#6_^O"?_P!%M6O61XJ_Y%#6_P#KPG_]%M3CNB*GP/T/
MF&BBBO4/DPHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#ZOM?\ CS@_ZYK_
M "J:H;7_ (\X/^N:_P JFKRCZY;!1110,**** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** ,S0_\ CSD_ZZG^0K3K,T/_ (\Y/^NI_D*TZ;$M@HHHI#"BBB@
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M_P#017%COA1[V0_Q9^AJ4445YI]0%%%% !1110 4444 %%%% !1110 4444
M%9'BK_D4-;_Z\)__ $6U:]9'BK_D4-;_ .O"?_T6U..Z(J? _0^8:***]0^3
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** /J^U_P"/.#_KFO\ *IJAM?\
MCS@_ZYK_ "J:O*/KEL%%%% PHHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MN@_MZC_*_P #W6BO"O\ A+_$'_05N/S%'_"7^(/^@K<?F*/J4^Z#^WJ/\K_
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110!F:'_ ,><G_74_P A6G69H?\ QYR?]=3_ "%:=-B6
MP4444AA1110 4444 %%%% !1110 4444 %%%% !1110 4444 </XY^'T7B4B
M_P!/,-MJ@(#M)D).O3YL D,!T.#P,'C!7RI_"GBO1M0BE32=1ANU7<DUHAD*
M Y4_/'D XR,9S@^AKZ"U+5+'1[-KO4+J*V@&?FD;&XX)PHZL< \#).*XJ3XO
M^'DFD1;74G56*B18DVN >HRX.#UY /L*TA*5K(B21YA?Z5XMU'RVU'3M=O#%
MGRS/!-*4SC.,@XS@?D*Z[PI\++][Z.\U\+:PV\RL+7Y)3< <\D$J%S@$<DC<
M,#@UOM\8O#X'%CJC>PCC_P#BZZO1O%.B>(&=-,U&*>1,[HB"CX&,MM8 E?F
MW8QDXS3E*26UA*,;[FO11161H%%%% !1110 4444 %%%% !1110!Y!XX_P"2
MM:-_O6W_ *-->OUY!XX_Y*UHW^];?^C37K]7/9$QW84445!04444 %%%% #9
M/]4_^Z:^<:^CI/\ 5/\ [IKYQKT,#]KY'S?$&]/Y_H%%%%=Y\Z%%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 5[YX:_Y%?2O^O2/_P!!%>!U[YX:_P"17TK_ *](
M_P#T$5Q8[X4>]D/\6?H:E%%%>:?4!1110 4444 %%%% !1110 4444 %%%%
M!61XJ_Y%#6_^O"?_ -%M6O61XJ_Y%#6_^O"?_P!%M3CNB*GP/T/F&BBBO4/D
MPHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@#ZOM?^/.#_KFO\JFJ&U_X\X/
M^N:_RJ:O*/KEL%%%% PHHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ KF_'W_(E:A_VS_P#1BUTE<WX^_P"1*U#_ +9_^C%K2E_$
MCZHYL9_NU3_"_P CQ.BBBO;/@@HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "M#0
MO^1ATS_K[B_]#%9]:&A?\C#IG_7W%_Z&*F7PLTI?Q(^J/H"BBBO"/T(****
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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ME&4.O3Y3D<L,;6SQP1] UM.3C9(SBD]6>:WOP;TQX5%CJMY#+NRS3JLH*X/
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5
MS?C[_D2M0_[9_P#HQ:Z2N;\??\B5J'_;/_T8M:4OXD?5'-C/]VJ?X7^1XG11
M17MGP04444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !6AH7_(PZ9_U]Q?^ABL^M#0O
M^1ATS_K[B_\ 0Q4R^%FE+^)'U1] 4445X1^A!1110 4444 %%%% !1110 44
M44 %%%% !1110!Y]\8O^1-@_Z_4_] >O"Z]T^,7_ ")L'_7ZG_H#UX77=A_@
M/G\R_C_(****W. **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#J/AU_R/VD_]=&_
M] :OHVOG+X=?\C]I/_71O_0&KZ-KBQ/Q(]W*_P"$_7]$%%%%<YZ04444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110!FR?\C!#_ -<O\:TJS9/^
M1@A_ZY?XUI4V)!1112&%%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MD3JUQ/K7]JWZ1:A.TGF2+=@LDA[!@".!Q\O3  QCBOH?_A%?#O\ T -+_P#
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M** "BBB@ HHHH **** "LCQ5_P BAK?_ %X3_P#HMJUZR/%7_(H:W_UX3_\
MHMJ<=T14^!^A\PT445ZA\F%%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?5
M]K_QYP?]<U_E4U0VO_'G!_US7^535Y1]<M@HHHH&%%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MRNW.W_9.\<=N<<8 2<9Z6!IQU/=**PO!FL3Z]X1T_4;D8GD1DD.1\[(Q0MP
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M9#_%GZ&I1117FGU 4444 %%%% !1110 4444 %%%% !1110 5D>*O^10UO\
MZ\)__1;5KUD>*O\ D4-;_P"O"?\ ]%M3CNB*GP/T/F&BBBO4/DPHHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@#ZOM?^/.#_ *YK_*IJAM?^/.#_ *YK_*IJ
M\H^N6P4444#"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "N;\??\B5J'_;/_T8M=)7-^/O^1*U#_MG_P"C%K2E_$CZHYL9_NU3
M_"_R/$Z***]L^""BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *T-"_Y&'3/^ON+_
M -#%9]:&A?\ (PZ9_P!?<7_H8J9?"S2E_$CZH^@****\(_0@HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH \^^,7_(FP?]?J?^@/7A=>Z?&+_D38/^OU/_
M $!Z\+KNP_P'S^9?Q_D%%%%;G %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!U'P
MZ_Y'[2?^NC?^@-7T;7SE\.O^1^TG_KHW_H#5]&UQ8GXD>[E?\)^OZ(****YS
MT@HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#-D_P"1@A_Z
MY?XUI5FR?\C!#_UR_P :TJ;$@HHHI#"BBB@ HHHH **** "BBB@ HHHH S-4
MU1K-E@@4&<@,2ZG:JY_#).#].I[ Y']IZAY6S[8^['W]B9_]!Q^E&I^7_:UU
MLQNW+OQZ[%_IBJM4D2V=#I>J->,T$Z@3@%@44[67/XX(R/KU'<#3KE=,\O\
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ME(R2%&0NP3>".05W;OPZCK42C:5BD]+GCGB;QSK.KZQ.]KJ]S#8I*XM1:.\
M,><*3C#$D 'YNA)QC.*]"^%FKZYK%C?R:I=/<VD'E06SOMW;@"7!(^8G!CY;
M.<]<YKQ.OH3PA90^%O -O)>#R=D#7EVQ@*.I(WG<HR2RKA?7Y1P.E:5$E&R(
M@VV4O&GQ#MO#,OV"SB2\U(KET+X2#(RI?'4G@[>#CG(R,^1W?C'Q+?3++/KM
M\'50G[F4PJ1DGE8]HSSUQG\JSM1U"YU74KC4+MMUQ<2&1\$D#/89). . ,\
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MAJ'DVL6[8GDQMC+%CR5)ZDUS]>P>!?!/AW6?!MC?W^G^==2F7>_G2+G$K*.
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MXW4,K*1@@@]01VK(_P"$0\,_]"[I'_@%'_\ $TX3Y584HW/FRO;_ (0_:/\
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MZGMHKF%[BWV^=$K@O'N&5W#J,CD9ZUG/XF5'8FHHHJ2CR;XT_P"MT+_=N/\
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M7H->??&'_D4K3_K^3_T7)6,/B1I+8\I\+_\ (VZ-_P!?T'_HQ:^EZ^:/"_\
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MAK_R3_3/^VO_ *->MJOPF=/<U/%7_(H:W_UX3_\ HMJ^::^EO%7_ ")^M_\
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M5?\ (H:W_P!>$_\ Z+:G'=$5/@?H?,-%%%>H?)A1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% 'U?:_\><'_ %S7^535#:_\><'_ %S7^535Y1]<M@HHHH&%
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %<WX^
M_P"1*U#_ +9_^C%KI*YOQ]_R)6H?]L__ $8M:4OXD?5'-C/]VJ?X7^1XG111
M7MGP04444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !6AH7_(PZ9_U]Q?\ H8K/K0T+
M_D8=,_Z^XO\ T,5,OA9I2_B1]4?0%%%%>$?H04444 %%%% !1110 4444 %%
M%% !1110 4444 >??&+_ )$V#_K]3_T!Z\+KW3XQ?\B;!_U^I_Z ]>%UW8?X
M#Y_,OX_R"BBBMS@"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ZCX=?\C]I/_71O
M_0&KZ-KYR^'7_(_:3_UT;_T!J^C:XL3\2/=RO^$_7]$%%%%<YZ04444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110!FR?\ (P0_]<O\:TJS9/\
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MG@6/?C.,[0,XR?S-:*=HV(<;NY=K.U_1XM?T*\TN9MJW$>%?D[&!RK8!&<,
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M?I-C:3,NPR6]ND;%<@XR .,@<>U:%5.7,*,;'D_QI/SZ$/:X_P#:5<K\-?\
MDH&E_P#;7_T4]>]W=G:ZA:O:WMM#<V[XW13('1L'(R#P>0#^%0Z?H^F:3YG]
MG:=:6?FX\S[/ L>_&<9V@9QD_G34[1L)QUN7:^4J^K:^4JJCU%4Z&C/H6I6^
MC6NKM;.]A<*S">,%E0ARA#G^$YQC/!R,$G(&:%"] !]*^@_AK_R3_3/^VO\
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M5M!'!!$D4,:A$C10JJH&  !T ':GU,G=W&E96/E($$9!R*^@?AJ<_#_3,?\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH *]\\-?\BOI7_7I'_Z"*\#KWSPU_R*^E?]>D?_ *"*XL=\*/>R
M'^+/T-2BBBO-/J HHHH **** "BBB@ HHHH **** "BBB@ K(\5?\BAK?_7A
M/_Z+:M>LCQ5_R*&M_P#7A/\ ^BVIQW1%3X'Z'S#1117J'R84444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110!]7VO_ !YP?]<U_E4U0VO_ !YP?]<U_E4U>4?7
M+8****!A1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !7-^/O^1*U#_MG_Z,6NDKF_'W_(E:A_VS_P#1BUI2_B1]4<V,_P!VJ?X7
M^1XG1117MGP04444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !6AH7_ ",.F?\ 7W%_
MZ&*SZT-"_P"1ATS_ *^XO_0Q4R^%FE+^)'U1] 4445X1^A!1110 4444 %%%
M% !1110 4444 %%%% !1110!Y]\8O^1-@_Z_4_\ 0'KPNO=/C%_R)L'_ %^I
M_P"@/7A==V'^ ^?S+^/\@HHHK<X HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** .H
M^'7_ "/VD_\ 71O_ $!J^C:^<OAU_P C]I/_ %T;_P! :OHVN+$_$CW<K_A/
MU_1!1117.>D%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 9
MLG_(P0_]<O\ &M*LV3_D8(?^N7^-:5-B04444AA1110 4444 %%%% !1110
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH S-#_X\Y/^NI_D
M*TZS-#_X\Y/^NI_D*TZ;$M@HHHI#"BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@#EOB%K;:'X/NI89O*NKDBV@8;L[F^\05QM8('(.1@@?0^3^!_!$GBR:
M9Y)VM;&V*!W6,DR$GE%/0':.3SC*\'-=]\8_^14L?^P@G_HJ2F_!O_D5=0_[
M"+?^BHJUB^6%T0U>5AES\&]):W<6FJ7\4YQM>;9(@YYRH52>,]Q^/2O/-.N;
MWP%XV!NE_>V<GEW,<+;A)$P!..1G*D, <<[<@$8KZ+KQ#XOD_P#":6X[#3HS
M_P"1):(2;=F*225T>WT5C>$0%\%Z$!T&GVX_\AK6S61H%%%% !1110 4444
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M\2/JCZ HHHKPC]""BBB@ HHHH **** "BBB@ HHHH **** "BBB@#S[XQ?\
M(FP?]?J?^@/7A=>Z?&+_ )$V#_K]3_T!Z\+KNP_P'S^9?Q_D%%%%;G %%%%
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M^AJ4445YI]0%%%% !1110 4444 %%%% !1110 4444 %9'BK_D4-;_Z\)_\
MT6U:]9'BK_D4-;_Z\)__ $6U..Z(J? _0^8:***]0^3"BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** /J^U_X\X/^N:_RJ:H;7_CS@_ZYK_*IJ\H^N6P4444
M#"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "N;
M\??\B5J'_;/_ -&+725S?C[_ )$K4/\ MG_Z,6M*7\2/JCFQG^[5/\+_ "/$
MZ***]L^""BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *T-"_Y&'3/^ON+_T,5GUH
M:%_R,.F?]?<7_H8J9?"S2E_$CZH^@****\(_0@HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH \^^,7_(FP?]?J?^@/7A=>Z?&+_D38/^OU/_0'KPNN[#_
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M6%E/>7+[+>WC:65MI.U5&2<#D\#M4U9WB"UFO?#>J6ELGF3SV<L<:9 W,R$
M9/ Y/>@#B_\ A<N@_P#0,U?_ +]Q?_'*/^%RZ#_T#=7_ ._<7_QRO*_^$9\0
M?] +5/\ P#D_^)H_X1GQ!_T M4_\ Y/_ (FM_9P,N>1ZI_PN70?^@;J__?N+
M_P".4?\ "Y=!_P"@;J__ '[B_P#CE>37.AZQ9V[7%UI-_!"F-TDMLZ*N3@9)
M&!R0*H4_9Q%SL^H=+U2SUK3HK_3YO.M92P1]C+G:Q4\, >H-&IZM8:-9M=ZC
M=Q6T R TC8W'!.U1U9L \#).*Y[X>D6/PYT^6\_T>-$FE=IOD"IYCL&)/1=N
M#GICFO&O%7B6Z\4:S)=SN_V=&9;6$C:(H\\<9/S$ %CDY/L !E&%W8T<K*YZ
MM<?%SPY!<O%'%?W"+C$T4*A6XSP&8-[<@=*9'\7_  Z\T:-;:C&K,%,C1)M0
M$]3AR<#V!/M7EOAWPCJ_BB1O[/@40(VV2XE;;&AP3C/4GIP <9&< YI?$7A'
M5_#$B_VA I@=ML=Q$VZ-S@'&>H/7@@9P<9 S6G)"]B.:6Y] Z1K.GZ]8B]TR
MY6X@W%"P!4AAU!! (/0\CH0>A%7Z^;O"GB:Z\+ZQ'=0NYMG95NH0-PDCSS@9
M'S 9P<C!]B0?H*_U2.UT"ZU:WV7445J]S'LD&V4!2PPPSP?7GK6<X<K+C*Z,
M;Q%X^T/PW=?9+F2:>[&TO!;(&9 02"Q)"CH.,Y^8'&#FN6L?C/;R3,-0T26"
M+;D-;W F8MQQAE08Z\Y_"O+#]LU?4SM'GWU[/G'RIYDKM^ &6/L.:]#\8_#7
M2_#WAJYU6ROKUI('3*3E&5@S!<#:JD'+ YYZ8QSD7R16C(YI/5'I/A_Q-I7B
M:T:?39R[1[1-"Z[7B)&0&'YC(R"0<$X-;%?/'P_U4Z1XUT^3+^7<O]DD"*"6
M$A 4<] 'V$D<X7OT/T/43CRLN+NADTT5O#)--(D<4:EW=V"JJ@9))/0 5YC?
M_&6"&^FCL='-U;*V(YWN3$9!Z[=AP,YQDYQC..@J?%/Q?%=*?#NGSI)&K_Z<
MP4$;E8%4#>H(RV!P0!GAA6/\./!W]OZB-2O$ADTNTD*O%)\WG2;<A<9Z#*L<
M\'@8.3BHQ27-(3D[V1[1I%__ &IHUCJ'EB/[5;QS[ VX+N4-C.!GKUP*N445
MD6%%%% !117C7C_QMJ%[X@&CZ%=7<45M)Y3_ &8-')-/DJ5!!W,HZ 8&3D\_
M*:J,>9V$W8]EHK(\+6=_8>&;"WU2XEGOA'NF>9]S!F);:6R<[<[<YYQ6O4C"
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BJFI:I8Z/9M=ZA=16T S\TC8W'!.%'5C@'@9)Q7"W_QAT>&.<6-A>7,R
M-MC\S;%'(,XSNR6 QR,KGID#LU%O83:6YZ+17G-C\8M'EC@%]I]Y;3.VV3R]
MLL<8SC.[(8C')PN>H /?T.&:*X@CG@D26&10Z2(P964C(((Z@CO0TUN":>P^
MBL[5]>TK08%FU2^BME;[BL<N_(!VJ,LV-PS@<9YKA;WXRZ<ENK6&DWDTQ;YD
MN76(!<'G*[^<XXQ^-"BWL#:6YZ717"Z3\5M U"6&"Z6>PE=5W/, 8@Y(&W<#
MG&2?F( P,G%=U0TUN":>P4444AA117#:G\5=!TS4[JP:VU"=[:0Q.\42;2RG
M# ;G!X.1T[<9&#32;V$VD=S17GG_  N/0/\ H'ZK_P!^XO\ XY1_PN/0/^@?
MJO\ W[B_^.4^2787,CT.BN,T+XE:1X@UFWTNUL]0CFGW;6F2,*-JECG#D]!Z
M5V=)IK<:=PHKC=6^)_AO2[A8$FEOV/WFLE5T7@$?,2 <Y_A)Z'.*Y^Q^,]N\
MS#4-$E@BVY#6]P)F+9'&&5!C&><_AZ-0D^@<R/4J*SM#URQ\0Z5%J%A(6B?A
MD;AXV[JP[$?X$9!!K1J1A17":_\ %31M*DDM["-M3G5597AD40')Y'F#/('/
M"D=!G.<,\.?%33M9NX[._M)-/N9I!'"%8S(Y)4*-P4$$DGJ, #KVJN65KV%S
M+8[ZBBF3316T$D\\J10QJ7>1V"JJ@9))/0 =ZD8^BO-#\6FN]7-AHOA^74#)
M)Y=L3<>4TW'7:4.T=3DG@#)QR!Z73::W$FGL%%>,?$?4]:T+QLS66MWL:311
M7,<*2L(XL?)C;DJP)C+'(P=Q!![^O:=?1ZGIEI?PJZQ74*3(K@!@&4$ X)&>
M:;C9)@G=V+-%%%2,**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@#,T/\ X\Y/^NI_D*TZS-#_ ./.3_KJ?Y"M.FQ+8****0PHHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH \@\<?\E:T;_>MO\ T::]?KR#QQ_R5K1O]ZV_]&FO7ZN>R)CN
MPHHHJ"@HHHH **** &R?ZI_]TU\XU]'2?ZI_]TU\XUZ&!^U\CYOB#>G\_P!
MHHHKO/G0HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "O?/#7_(KZ5_UZ1_\ H(KP
M.O?/#7_(KZ5_UZ1_^@BN+'?"CWLA_BS]#4HHHKS3Z@**** "BBB@ HHHH **
M** "BBB@ HHHH *R/%7_ "*&M_\ 7A/_ .BVK7K(\5?\BAK?_7A/_P"BVIQW
M1%3X'Z'S#1117J'R84444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!]7VO_'G
M!_US7^535#:_\><'_7-?Y5-7E'URV"BBB@84444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 5S?C[_D2M0_[9_P#HQ:Z2N;\??\B5
MJ'_;/_T8M:4OXD?5'-C/]VJ?X7^1XG1117MGP04444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !6AH7_(PZ9_U]Q?^ABL^M#0O^1ATS_K[B_\ 0Q4R^%FE+^)'U1]
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MYZY?XT_\P/\ [;_^TZF*7/8;?NW(/"GQ3NU>>/Q%/!);P6KRK*L06>>3>H5
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MFVV<(L:OD@J'=4)!!!# ,2#V(%>)Z!XMO_#.C7]GIDI@EN)HI$?8&2-0&WD
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M!!GH<9(R1A=78.5M#Z%HKYYCLO%?P_N(-1:VEL!+( 5\Q7BF*@_+($8@\%L
M\]2,$9%OPU>R^)/BI87ES<7,;O<R2Q8F+-$@#R"(,1]SJI  R"1QFG[/K<7/
MT/>Z*AN[J&QLI[RY?9!!&TLC;2=JJ,DX')X':O$]9\=^(/%VK0Z?HHN+2)IC
M]FBMG*32<<>8P/8;B0,*,\YVAJF,7(IRL>Y45X4/A#XB%EYP&GA_+W_9O-._
M.,[/N[<]OO8]\<U#X.\8ZKX?UVWL[VYE-@SI:SP7LK*MLH.W(W?ZO9SD<# P
M<8!%<G9D\W='O=%%>+>+/B/KL7B:^MM*O#:VEM(;<(8(V+,A(9B6#=6!QTXQ
MP#FIC%RV*;2/::*S?#UU-?>&=*N[B3S)Y[.&61\ ;F9 2<#@9)[5I5(PJCK.
MK6NA:3<:E>EQ! H+!%W,22  !ZDD#TYY('-7J\?^,&N--J-IHD3H8K=1<3;6
M#'S#D*",94A<GKR)!QP*J,>9V%)V5SE+>VUSXA^)Y29H9+YXC(6E8I'%&IX5
M1R0H+   $Y;)R237J>G?"GPW:V:QWL4U_/P6F>9X^< $*J$87() .3SU-97@
M?5/#W@_PE#+J=]!!?WKB6:-2)90K F+*Q@L%*88;NA<],XKHX_B1X2EFCB75
MP&=@H+6\JJ"3CDE< >YX%7)RV6Q*2ZE&]^$_ABZ\OR$N[+;G/D3EM^<=?,#=
M,<8QUYSQ7:S316T$D\\J10QJ7>1V"JJ@9))/0 =Z(9H[B&.:&1)(I%#HZ,"K
M*1D$$=0:@U*QBU32[O3YV=8KJ%X'*$!@K*5.,YYP:S;;W*LEL?/ADU#QYXSC
M$COYU[-M0,P;[/$"3M'W00BY/8M@GJ:]:M_A9X4BMTBFLY[EUSF62ZD5FYSS
ML*CCIP.U>1Z)=S>#O&5M<:E92B6RD99H,@,-R%21V/#9'.#QS@YKVF]^('A>
MRT\7?]K03[E!2"W;?*25) *#E<XQ\V #P2*UG?1+8B-NIY=\2/"=CX8U&SDT
MTNEM>(^+=B6\IDV@D,3D@[@<'H0><$ =]\*-3N-0\'M%<-O^Q7+6T;$DG8%5
MP"2>V\@8P  !VKSK4]1U?XF>)[:*UM!$5CVQP>:62%<_.[-C'4C) &0%&"<9
M]MT'2(M!T.STR%MRV\>TOR-['EFP2<98DXSQG%*;M%)[A'>Z-&BBBLC0*X2_
M^%&B:AJ-U?2WVIK)<S/,ZI)'M!9BQ RG3FN[HIIM;":3W///^%.:!_T$-5_[
M^1?_ !NN-\>>%- \)QV]O:76H7&H7&7"R31%8T!ZL @;GD#H.&.>,'VG5=2M
M]'TJYU&[;$-O&78 @%O11D@9)P ,\DBO O\ B:_$#QA_RU9[B3V<6L&[_@(V
MJ#[;C_M-SI!MZMZ$226B.F^%/A>:XU,>(;@3106V5MN %G9E96Z\X4'L.2>O
MRD5H?%?Q7- R>'K"XV>9'NO2F,[3]V/(.1D9+#'(*\X)!]'TK3+?1M*M=.M%
MQ#;QA%) !;U8X &XG))QR237SKXSNY[CQ7KD\[[Y$NI4!P!\J,54<>BJ!^%.
M/O2NP?NQL=QX%^&UIJFEPZOK?G-'-EH;528P4Y&YSPW/##:1P <D' VO$WPR
MT-?#UY-I%G/!>P1M-&(WDF,I4$^7M9CG=T&.<XZ\@^@PPQ6\$<$$:111J$2-
M%"JJ@8  '0 55U>_.E:+?ZB(O--I;R3^7NV[]JEL9P<9QUQ4.<F[E<JL>)_"
MW4+FT\;6]K$W[B]1XYD)."%1G4@9QN!7&3GAF]:])^)6MW>A^$R]BSQSW4RV
MXF1L-$"&8D<'DA2O8C=D'(KRSX;G'Q!TH>IE'_D%ZZSXTPR$Z',(G,:?:$:0
M*=JD^60">Q.TX'L?2KDESHB+]T;\,O!5C?::^M:M9Q7*O(5M(Y1N7:H*LQ7.
M&R21AAP4R.HKG_BEI5AI7BF.*PM(K:&6S21XXEVINW.N0O0<*.GUZDUVW@+Q
M+H>D^ +*+4-7LH)XA.[PM,OF >:[#"9W$D8P ,GM7 M#_P +$^(DK6\$UO;W
MLBM+D_-'"B*I8D @,0HQG(W,!D]:$WS-L&ERI(^@:\@\;^.Y==NAX<\.R!X)
MY!!)<(P'VEF.T(A/&PDX)_B_W?O7OB1XS2XCE\+:0&N+B9A#<R1$G!R/W2[?
MO,3PPZ8)7!).W6\!> (_#T::EJ2))JSK\J\%;8$<A3W8C@M^ XR6E)17,RF[
MZ(T?!?@JU\*69D<I/J<RXGN .%'78F>B_JQ&3T '5445#=]66E8\A^,UK E_
MI%XJ8N)HI8G?<>50J5&.G!D;\_I7;_#NYGN_ 6E27#[W5'C!P!A4D95''HJ@
M?A7'?&D?O-"/M<?^TJZWX:_\D_TS_MK_ .C7JW\"(7Q,ZNBBBLRPHHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** ,S0_\ CSD_ZZG^0K3K,T/_
M (\Y/^NI_D*TZ;$M@HHHI#"BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M5_R*&M_]>$__ *+:M>LCQ5_R*&M_]>$__HMJ<=T14^!^A\PT445ZA\F%%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 ?5]K_ ,><'_7-?Y5-4-K_ ,><'_7-
M?Y5-7E'URV"BBB@84444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 5S?C[_D2M0_[9_\ HQ:Z2N;\??\ (E:A_P!L_P#T8M:4OXD?
M5'-C/]VJ?X7^1XG1117MGP04444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !6AH7_(
MPZ9_U]Q?^ABL^M#0O^1ATS_K[B_]#%3+X6:4OXD?5'T!1117A'Z$%%%% !11
M10 4444 %%%% !1110 4444 %%%% 'GWQB_Y$V#_ *_4_P#0'KPNO=/C%_R)
ML'_7ZG_H#UX77=A_@/G\R_C_ ""BBBMS@"BBB@ HHHH **** "BBB@ HHHH
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M%SM."-RGJK8)P1@C/!I0ERNX25T>86GQDEAT^..YT@W%U&J(TOVD*)?E.]R
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M1U"W\J_N\!4<#=%%U /&5+'DC/9<X((K>\:ZX_A[PI>7T+HMT0(K?<P!WL<
M@$'<5&6QCD*?K6_7B'Q,\1MK^OQZ/8>=)#92-$8U1LRW&=I 7/S8QM'&<EL9
M!%)>_+4;]U$7PJT6/4_%+7<T.^#3XQ*,[2HE)Q'D'GL[ CH4'/K[I7.>!_#Y
M\-^%[:TE7;=R_O[D9Z2,!E>I'R@*N1P=N>]='2G*["*L@HHHJ2@HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** ,S0_P#CSD_ZZG^0K3K,T/\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !7-^/O^1*U#_MG_ .C%KI*YOQ]_R)6H?]L__1BUI2_B1]4<V,_W:I_A
M?Y'B=%%%>V?!!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *YOQ]_R)
M6H?]L_\ T8M=)7-^/O\ D2M0_P"V?_HQ:TI?Q(^J.;&?[M4_PO\ (\3HHHKV
MSX(**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ K0T+_D8=,_Z^XO_0Q6?6AH7_(P
MZ9_U]Q?^ABIE\+-*7\2/JCZ HHHKPC]""BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@#S[XQ?\B;!_U^I_Z ]>%U[I\8O^1-@_Z_4_] >O"Z[L/\!\_F7\
M?Y!1116YP!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 =1\.O^1^TG_KHW_H#5]&
MU\Y?#K_D?M)_ZZ-_Z U?1M<6)^)'NY7_  GZ_H@HHHKG/2"BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** ,V3_D8(?\ KE_C6E6;)_R,$/\
MUR_QK2IL2"BBBD,**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@#,T/_CSD_ZZG^0K3K,T/_CSD_ZZG^0K3IL2V"BB
MBD,**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** /(/''_)6M&_WK;_T::]?KR#QQ_R5K1O]
MZV_]&FO7ZN>R)CNPHHHJ"@HHHH **** &R?ZI_\ =-?.-?1TG^J?_=-?.->A
M@?M?(^;X@WI_/] HHHKO/G0HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "O?/#7_
M "*^E?\ 7I'_ .@BO Z]\\-?\BOI7_7I'_Z"*XL=\*/>R'^+/T-2BBBO-/J
MHHHH **** "BBB@ HHHH **** "BBB@ K(\5?\BAK?\ UX3_ /HMJUZR/%7_
M "*&M_\ 7A/_ .BVIQW1%3X'Z'S#1117J'R84444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110!]7VO_'G!_P!<U_E4U0VO_'G!_P!<U_E4U>4?7+8****!A111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7-^/O\
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M 4444 %%%% !1110 4444 %%%% !1110!Y!XX_Y*UHW^];?^C37K]>0>./\
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MUD>*O^10UO\ Z\)__1;4X[HBI\#]#YAHHHKU#Y,**** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH ^K[7_ (\X/^N:_P JFJ&U_P"/.#_KFO\ *IJ\H^N6P444
M4#"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M=\*/>R'^+/T-2BBBO-/J HHHH **** "BBB@ HHHH **** "BBB@ K(\5?\
M(H:W_P!>$_\ Z+:M>LCQ5_R*&M_]>$__ *+:G'=$5/@?H?,-%%%>H?)A1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% 'U?:_\><'_7-?Y5-4-K_QYP?]<U_E
M4U>4?7+8****!A1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MGI!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% &;)_R,$/\
MUR_QK2K-D_Y&"'_KE_C6E38D%%%%(84444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% &9H?_'G)_P!=3_(5IUF:'_QY
MR?\ 74_R%:=-B6P4444AA1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!Y!XX_Y*UHW^];?
M^C37K]>0>./^2M:-_O6W_HTUZ_5SV1,=V%%%%04%%%% !1110 V3_5/_ +IK
MYQKZ.D_U3_[IKYQKT,#]KY'S?$&]/Y_H%%%%=Y\Z%%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M[5/\+_(\3HHHKVSX(**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M %J:=?8?\NX_[Z_^M3]C/L+V]/N;E%81\0N/^7=?^^__ *U-/B-Q_P NR_\
M??\ ]:G["?8/K%/N;]%<\?$K_P#/LO\ WW_]:FGQ._\ SZK_ -]__6H^KU.P
MOK-/N='17-GQ2X_Y=%_[[_\ K4T^*G_Y]%_[[_\ K4_J]3L+ZU2[G345RY\6
MR#_ES7_OO_ZU-/BZ0?\ +FO_ '\_^M1]6J]@^MTNYU5%<H?&$@_Y<E_[^?\
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M\Z_X6;-_T"X_^_Q_PH_X6;-_T"X_^_Q_PH_L_$?R_B@_M+#?S?@ST6BO.O\
MA9LW_0+C_P"_Q_PH_P"%FS?] N/_ +_'_"C^S\1_+^*#^TL-_-^#/1:*\Z_X
M6;-_T"X_^_Q_PH_X6;-_T"X_^_Q_PH_L_$?R_B@_M+#?S?@ST6BO.O\ A9LW
M_0+C_P"_Q_PH_P"%FS?] N/_ +_'_"C^S\1_+^*#^TL-_-^#/1:*\Z_X6;-_
MT"X_^_Q_PH_X6;-_T"X_^_Q_PH_L_$?R_B@_M+#?S?@ST6BO.O\ A9LW_0+C
M_P"_Q_PH_P"%FS?] N/_ +_'_"C^S\1_+^*#^TL-_-^#/1:*\Z_X6;-_T"X_
M^_Q_PH_X6;-_T"X_^_Q_PH_L_$?R_B@_M+#?S?@ST6BO.O\ A9LW_0+C_P"_
MQ_PH_P"%FS?] N/_ +_'_"C^S\1_+^*#^TL-_-^#/1:*\Z_X6;-_T"X_^_Q_
MPH_X6;-_T"X_^_Q_PH_L_$?R_B@_M+#?S?@ST6BO.O\ A9LW_0+C_P"_Q_PH
M_P"%FS?] N/_ +_'_"C^S\1_+^*#^TL-_-^#/1:*\Z_X6;-_T"X_^_Q_PH_X
M6;-_T"X_^_Q_PH_L_$?R_B@_M+#?S?@ST6BO.O\ A9LW_0+C_P"_Q_PH_P"%
MFS?] N/_ +_'_"C^S\1_+^*#^TL-_-^#/1:*\Z_X6;-_T"X_^_Q_PH_X6;-_
MT"X_^_Q_PH_L_$?R_B@_M+#?S?@ST6BO.Q\3)C_S"X_^_P ?\*</B5,?^88G
M_?X_X4OJ&(_E_%!_:6&_F_!GH5%>??\ "R)O^@8G_?X_X4X?$:;_ *!J?]_3
M_A1]1K]OQ0_[1P_\WX,[^BN"'Q$E/_,-3_OZ?\*</B%*?^8<G_?T_P"%+ZC7
M[?B@_M##_P WX,[NBN%'Q E/_,.3_OZ?\*</'TI_YAZ?]_3_ (4OJ5?M^0_K
M]#^;\&=Q17$CQ[*?^8>G_?T_X4[_ (3J7_GP3_OZ?\*/J=;L/Z]0[_@SM**X
MP>.9#_RX)_W\/^%.'C>3_GQ3_OX?\*7U2MV']=H=_P SL:*Y >-9/^?%?^_G
M_P!:E'C.0_\ +DO_ '\_^M2^JU>P?7*/<ZZBN3_X3&3_ )\E_P"_G_UJ</%\
MA_Y<U_[^?_6H^JU>P_K='N=517+CQ;(?^7-?^^__ *U.'BMS_P NB_\ ??\
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M8'[7R/F^(-Z?S_0****[SYT**** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KWSPU_
MR*^E?]>D?_H(KP.O?/#7_(KZ5_UZ1_\ H(KBQWPH][(?XL_0U****\T^H"BB
MB@ HHHH **** "BBB@ HHHH **** "LCQ5_R*&M_]>$__HMJUZR/%7_(H:W_
M ->$_P#Z+:G'=$5/@?H?,-%%%>H?)A1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% 'U?:_\ 'G!_US7^535#:_\ 'G!_US7^535Y1]<M@HHHH&%%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %<WX^_Y$K4/^V?
M_HQ:Z2N;\??\B5J'_;/_ -&+6E+^)'U1S8S_ ':I_A?Y'B=%%%>V?!!1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %:&A?\ (PZ9_P!?<7_H8K/K0T+_ )&'3/\
MK[B_]#%3+X6:4OXD?5'T!1117A'Z$%%%% !1110 4444 %%%% !1110 4444
M %%%% 'GWQB_Y$V#_K]3_P! >O"Z]T^,7_(FP?\ 7ZG_ * ]>%UW8?X#Y_,O
MX_R"BBBMS@"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ZCX=?\ (_:3_P!=&_\
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M_P#017%COA1[V0_Q9^AJ4445YI]0%%%% !1110 4444 %%%% !1110 4444
M%9'BK_D4-;_Z\)__ $6U:]9'BK_D4-;_ .O"?_T6U..Z(J? _0^8:***]0^3
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** /J^U_P"/.#_KFO\ *IJAM?\
MCS@_ZYK_ "J:O*/KEL%%%% PHHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ KF_'W_(E:A_VS_\ 1BUTE<WX^_Y$K4/^V?\ Z,6M
M*7\2/JCFQG^[5/\ "_R/$Z***]L^""BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M*T-"_P"1ATS_ *^XO_0Q6?6AH7_(PZ9_U]Q?^ABIE\+-*7\2/JCZ HHHKPC]
M""BBB@ HHHH **** "BBB@ HHHH **** "BBB@#S[XQ?\B;!_P!?J?\ H#UX
M77NGQB_Y$V#_ *_4_P#0'KPNN[#_  'S^9?Q_D%%%%;G %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110!U'PZ_P"1^TG_ *Z-_P"@-7T;7SE\.O\ D?M)_P"NC?\
MH#5]&UQ8GXD>[E?\)^OZ(****YST@HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@#-D_Y&"'_KE_C6E6;)_R,$/_ %R_QK2IL2"BBBD,****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@#,T/\ X\Y/^NI_D*TZS-#_ ./.3_KJ?Y"M.FQ+8****0PHHHH **** "BB
MB@ HHHH **** "BBB@ HHHH \3^,,LI\6VD1E<Q+8HRQECM5C)("0.Q.%R?8
M>E=]\,3GX>Z8?]J?_P!'/7GWQ@/_ !6=N/\ J'Q_^C):]!^&(Q\/=,_WI_\
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M'(R*I--7Z(33VZG7_#GPRGAK0YM8U0?9[NXCW2"X"I]FA4D\GJ,C#-DC&%!
M*FNQT_6-,U;S/[.U&SO/*QYGV>=9-F<XSM)QG!_(UX=<7&I?$WQK%$LCI 6<
M0!HSMM8.I9@"?F( R<\L5&0,8D\5>#+[P*MEJ%MJDDOF2-']HA7R&B8KP 0Y
M;YEW\CTYZBDXW>KU!2LM%H>]45SO@CQ#_P ))X8M[N1MUU$?(N>/^6B@9/0#
MY@5;C@;L=JZ*LVK:&@4444@"FNZQHSNP55&2S'  IU5-5L1JFDWE@TAC%S"\
M1<#.W<,9Q0 ?VII__/\ VO\ W^7_ !H_M33_ /G_ +7_ +_+_C7G/_"F+?\
MZ#<O_@./_BJ/^%,6_P#T&Y?_  ''_P 55VCW)O+L9GC2Y@E^*FCS1SQO$K6V
M75P0,2'/->L_VII__/\ VO\ W^7_ !KSG_A3%O\ ]!N7_P !Q_\ %4?\*8M_
M^@W+_P" X_\ BJI\K2U$N9=#T;^U-/\ ^?\ M?\ O\O^-']J:?\ \_\ :_\
M?Y?\:\Y_X4Q;_P#0;E_\!Q_\51_PIBW_ .@W+_X#C_XJIM'N.\NQZ-_:FG_\
M_P#:_P#?Y?\ &C^U-/\ ^?\ M?\ O\O^-><_\*8M_P#H-R_^ X_^*H_X4Q;_
M /0;E_\  <?_ !5%H]PO+L>C?VII_P#S_P!K_P!_E_QH_M33_P#G_M?^_P O
M^-><_P#"F+?_ *#<O_@./_BJ/^%,6_\ T&Y?_ <?_%46CW"\NQZ))JFG^6W^
MG6O0_P#+9?\ &OGK>G]Y?SKT'_A3%O\ ]!N7_P !Q_\ %4?\*8M_^@W+_P"
MX_\ BJZ*%:-*_6YYV/P#QG+=VM?\3S[>G]Y?SHWI_>7\Z]!_X4Q;_P#0;E_\
M!Q_\51_PIBW_ .@W+_X#C_XJM_KD>QY_]@_W_P /^">?;T_O+^=&]/[R_G7H
M/_"F+?\ Z#<O_@./_BJ/^%,6_P#T&Y?_  ''_P 51]<CV#^P?[_X?\$\^WI_
M>7\Z-Z?WE_.O0?\ A3%O_P!!N7_P''_Q5'_"F+?_ *#<O_@./_BJ/KD>P?V#
M_?\ P_X)Y]O3^\OYT;T_O+^=>@_\*8M_^@W+_P" X_\ BJ/^%,6__0;E_P#
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M_P#A_P $\^WI_>7\Z-Z?WE_.O0?^%,6__0;E_P# <?\ Q5'_  IBW_Z#<O\
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M?_ <?_%4?\*8M_\ H-R_^ X_^*HM'N%Y=CT;^U-/_P"?^U_[_+_C1_:FG_\
M/_:_]_E_QKSG_A3%O_T&Y?\ P''_ ,51_P *8M_^@W+_ . X_P#BJ+1[A>78
M]&_M33_^?^U_[_+_ (T?VII__/\ VO\ W^7_ !KSG_A3%O\ ]!N7_P !Q_\
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M4?6(A_9?]X\;P?2C!]*]D_X4Q;_]!N7_ ,!Q_P#%4?\ "F+?_H-R_P#@./\
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M1]8B']E_WCQO!]*,'TKV3_A3%O\ ]!N7_P !Q_\ %4?\*8M_^@W+_P" X_\
MBJ/K$0_LO^\>-X/I1@^E>R?\*8M_^@W+_P" X_\ BJ/^%,6__0;E_P# <?\
MQ5'UB(?V7_>/&\'THP?2O9/^%,6__0;E_P# <?\ Q5'_  IBW_Z#<O\ X#C_
M .*H^L1#^R_[QXW@^E&#Z5[)_P *8M_^@W+_ . X_P#BJ/\ A3%O_P!!N7_P
M''_Q5'UB(?V7_>/&\'THP?2O9/\ A3%O_P!!N7_P''_Q5'_"F+?_ *#<O_@.
M/_BJ/K$0_LO^\>-X/I1@^E>R?\*8M_\ H-R_^ X_^*H_X4Q;_P#0;E_\!Q_\
M51]8B']E_P!X\;P?2C!]*]D_X4Q;_P#0;E_\!Q_\51_PIBW_ .@W+_X#C_XJ
MCZQ$/[+_ +QXW@^E&#Z5[)_PIBW_ .@W+_X#C_XJC_A3%O\ ]!N7_P !Q_\
M%4?6(A_9?]X]!M=3T\6D(-]; ^6O_+9?3ZU+_:FG_P#/_:_]_E_QKSG_ (4Q
M;_\ 0;E_\!Q_\51_PIBW_P"@W+_X#C_XJN6T>YZJ<NQZ-_:FG_\ /_:_]_E_
MQH_M33_^?^U_[_+_ (UYS_PIBW_Z#<O_ (#C_P"*H_X4Q;_]!N7_ ,!Q_P#%
M46CW'>78]&_M33_^?^U_[_+_ (T?VII__/\ VO\ W^7_ !KSG_A3%O\ ]!N7
M_P !Q_\ %4?\*8M_^@W+_P" X_\ BJ+1[A>78]&_M33_ /G_ +7_ +_+_C1_
M:FG_ //_ &O_ '^7_&O.?^%,6_\ T&Y?_ <?_%4?\*8M_P#H-R_^ X_^*HM'
MN%Y=CT;^U-/_ .?^U_[_ "_XT?VII_\ S_VO_?Y?\:\Y_P"%,6__ $&Y?_ <
M?_%4?\*8M_\ H-R_^ X_^*HM'N%Y=CT;^U-/_P"?^U_[_+_C1_:FG_\ /_:_
M]_E_QKSG_A3%O_T&Y?\ P''_ ,51_P *8M_^@W+_ . X_P#BJ+1[A>78]&_M
M33_^?^U_[_+_ (T?VII__/\ VO\ W^7_ !KSG_A3%O\ ]!N7_P !Q_\ %4?\
M*8M_^@W+_P" X_\ BJ+1[A>78]&_M33_ /G_ +7_ +_+_C1_:FG_ //_ &O_
M '^7_&O.?^%,6_\ T&Y?_ <?_%4?\*8M_P#H-R_^ X_^*HM'N%Y=CT;^U-/_
M .?^U_[_ "_XT?VII_\ S_VO_?Y?\:\Y_P"%,6__ $&Y?_ <?_%4?\*8M_\
MH-R_^ X_^*HM'N%Y=CT;^U-/_P"?^U_[_+_C1_:FG_\ /_:_]_E_QKSG_A3%
MO_T&Y?\ P''_ ,51_P *8M_^@W+_ . X_P#BJ+1[A>78]&_M33_^?^U_[_+_
M (T?VII__/\ VO\ W^7_ !KSG_A3%O\ ]!N7_P !Q_\ %4?\*8M_^@W+_P"
MX_\ BJ+1[A>78]&_M33_ /G_ +7_ +_+_C1_:FG_ //_ &O_ '^7_&O.?^%,
M6_\ T&Y?_ <?_%4?\*8M_P#H-R_^ X_^*HM'N%Y=CT;^U-/_ .?^U_[_ "_X
MT?VII_\ S_VO_?Y?\:\Y_P"%,6__ $&Y?_ <?_%4?\*8M_\ H-R_^ X_^*HM
M'N%Y=CT;^U-/_P"?^U_[_+_C1_:FG_\ /_:_]_E_QKSG_A3%O_T&Y?\ P''_
M ,51_P *8M_^@W+_ . X_P#BJ+1[A>78]&_M33_^?^U_[_+_ (T?VII__/\
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M .?^U_[_ "_XT?VII_\ S_VO_?Y?\:\Y_P"%,6__ $&Y?_ <?_%4?\*8M_\
MH-R_^ X_^*HM'N%Y=CT;^U-/_P"?^U_[_+_C1_:FG_\ /_:_]_E_QKSG_A3%
MO_T&Y?\ P''_ ,51_P *8M_^@W+_ . X_P#BJ+1[A>78]&_M33_^?^U_[_+_
M (T?VII__/\ VO\ W^7_ !KSG_A3%O\ ]!N7_P !Q_\ %4?\*8M_^@W+_P"
MX_\ BJ+1[A>78]&_M33_ /G_ +7_ +_+_C1_:FG_ //_ &O_ '^7_&O.?^%,
M6_\ T&Y?_ <?_%4?\*8M_P#H-R_^ X_^*HM'N%Y=CT;^U-/_ .?^U_[_ "_X
MT?VII_\ S_VO_?Y?\:\Y_P"%,6__ $&Y?_ <?_%4?\*8M_\ H-R_^ X_^*HM
M'N%Y=CT;^U-/_P"?^U_[_+_C1_:FG_\ /_:_]_E_QKSG_A3%O_T&Y?\ P''_
M ,51_P *8M_^@W+_ . X_P#BJ+1[A>78]&_M33_^?^U_[_+_ (T?VII__/\
MVO\ W^7_ !KSG_A3%O\ ]!N7_P !Q_\ %4?\*8M_^@W+_P" X_\ BJ+1[A>7
M8]&_M33_ /G_ +7_ +_+_C7.^.M0LI?!M^D=Y;NY\O"K*"3^\7WKF_\ A3%O
M_P!!N7_P''_Q5'_"F+?_ *#<O_@./_BJJ'+&2E?8SK0=2G*GW37WGGV]/[R_
MG1O3^\OYUZ#_ ,*8M_\ H-R_^ X_^*H_X4Q;_P#0;E_\!Q_\57;]<CV/"_L'
M^_\ A_P3S[>G]Y?SHWI_>7\Z]!_X4Q;_ /0;E_\  <?_ !5'_"F+?_H-R_\
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M_?\ P_X)Y]O3^\OYT;T_O+^=>@_\*8M_^@W+_P" X_\ BJ/^%,6__0;E_P#
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M_P#T&Y?_  ''_P 51:/<+R['HW]J:?\ \_\ :_\ ?Y?\:/[4T_\ Y_[7_O\
M+_C7G/\ PIBW_P"@W+_X#C_XJC_A3%O_ -!N7_P''_Q5%H]PO+L>C?VII_\
MS_VO_?Y?\:/[4T__ )_[7_O\O^-><_\ "F+?_H-R_P#@./\ XJC_ (4Q;_\
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M2'QUI4DKJB+(V68X ^1N]?0G]J:?_P _]K_W^7_&O.?^%,6__0;E_P# <?\
MQ5'_  IBW_Z#<O\ X#C_ .*K&I*,W>YVX:@Z$7%:GHW]J:?_ ,_]K_W^7_&C
M^U-/_P"?^U_[_+_C7G/_  IBW_Z#<O\ X#C_ .*H_P"%,6__ $&Y?_ <?_%5
MG:/<Z;R['HW]J:?_ ,_]K_W^7_&C^U-/_P"?^U_[_+_C7G/_  IBW_Z#<O\
MX#C_ .*H_P"%,6__ $&Y?_ <?_%46CW"\NQZ-_:FG_\ /_:_]_E_QH_M33_^
M?^U_[_+_ (UYS_PIBW_Z#<O_ (#C_P"*H_X4Q;_]!N7_ ,!Q_P#%46CW"\NQ
MZ-_:FG_\_P#:_P#?Y?\ &K2.KHKHP96&0P.017E__"F+?_H-R_\ @./_ (JO
M1],LAINE6=B',@MH$A#D8W;5 SC\*32Z,:;ZEJBBBI&%%%% !1110 4444 %
M%%% !1110!FR?\C!#_UR_P :TJS9/^1@A_ZY?XUI4V)!1112&%%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!F:'_
M ,><G_74_P A6G69H?\ QYR?]=3_ "%:=-B6P4444AA1110 4444 %%%% !1
M110 4444 %%%% !1110!Y?\ &>TD:QTB]#((8Y9(64D[BSJ&&/;$;9_"K'PA
MUM;G1KG1Y9<S6DADB0[1^Z;KC')P^XDD<;UY[#O-5TVWUC2KG3KI<PW$91B
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH S9/^1@A_P"N7^-:59LG_(P0_P#7+_&M*FQ(****0PHHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** ,S0_
M^/.3_KJ?Y"M.LS0_^/.3_KJ?Y"M.FQ+8****0PHHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH S9/\ D8(?
M^N7^-:59LG_(P0_]<O\ &M*FQ(****0PHHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** ,S0_\ CSD_ZZG^0K3K,T/_
M (\Y/^NI_D*TZ;$M@HHHI#"BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@#-D_Y&"'_ *Y?XUI5FR?\C!#_
M -<O\:TJ;$@HHHI#"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH S-#_X\Y/^NI_D*TZS-#_X\Y/^NI_D*TZ;$M@H
MHHI#"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@#-D_P"1@A_ZY?XUI5FR?\C!#_UR_P :TJ;$@HHHI#"B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH S-#_P"/.3_KJ?Y"M.LS0_\ CSD_ZZG^0K3IL2V"BBBD,**** "BBB@
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M_P"N7^-:5-B04444AA1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MCYHSG:< X8=5.".#@C-%F%T7**S=:U[3?#MFEWJEP8('D$2L(G?+$$XPH)Z
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MK,EO2Z.ST6\EU#0M.O9P@FN+:.5P@(4,R@G )/&3ZFKU9/A?_D4M&_Z\8/\
MT6M1:3XOT+7-2FT_3+\7-Q"K.P2)]NT$*2'(VL,D="<YR.*30S;HHK'TGQ3H
MFN7MS9Z;J$=Q/;_ZQ0K#(SC*D@!USW7(Y'J,H9L44R::*WADFFD2.*-2[N[
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M4 %%%% !1110 4444 %%%% !1110 4444 9LG_(P0_\ 7+_&M*LV3_D8(?\
MKE_C6E38D%%%%(84444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% &9H?_'G)_UU/\A6G69H?_'G)_UU/\A6G38EL%%%
M%(84444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M]M?:O/JDK2VT@FGSE09B-O+-QP3U[UZKXP_Y$G7O^P=<?^BVIR>S"*W1Y!X
M\&V'B[^T?MUS=P_9?+V?9V09W;LYW*W]T5Z_X8\,VGA339;&RGN9HY)C,6N&
M4L"55<#:H&/E':N#^"W_ #'/^V'_ +4KU:E4;YK!!*USRGX+?\QS_MA_[4JK
M\5_$,]YJD7ANQ,SK%M:XAB!)FE;!1-N,M@;2,$@EQQE15KX+?\QS_MA_[4KE
M_'<$-Y\4+^UGGCMX99[>.2:3&V-3%&"QR0, '/4=*NW[QD_8/1]-^%7ANTM%
MCO(9K^?@M+)*R<X&0%0@ 9!/.3SU-< 4F^&?Q$0"8?86VAIIHPQ>U=AN)"\Y
M4J>F,E,XP<':_P"%'Q_]!N+_ , !_P#'*DB^"42NJR:YF$D>8L=F$8KW .\@
M''?!^AJ5)=6-I]$:_P 8?^12M/\ K^3_ -%R5B>$?AC'JNG6^JZ]<W!,PCDA
M@CD'S1 #:'8@G!4* %(*J!R#PNW\8?\ D4K3_K^3_P!%R5U?A?\ Y%+1O^O&
M#_T6M*[4-!VO(\;\<>&#X+U^TO-.N ()I#/:*PW/ Z%3@Y!# $J03SV.<9/J
M.HZ%8?$#PUI5S?+-:M)$ETA@9"\>] 2FYE/R\C/ R5'I7(?&G[VA_2X_]IUZ
M!X3_ .1-T/\ [!]O_P"BUHDWRI@EJT>'> /#=KXMU5[.^GN(46T,^ZW*ABP9
M1CYE(Q\Q[5ZSIOA2'P-HNM76B27=[=R6Q>.*YVR;GC5RB@(JDY+8QU/&,5Y_
M\%_^1EF_[!S?^AQU[A14;O8()6/"/AWI6A>(-:O(->D>>[D7?;QR3,IF;),C
M%@0688!Z\@L<'&1Z59?#W1]*\0V6KZ7YMJUON#0%S(C@HZYRQW!OF'.2,+C'
M.:YWQ)\(XKZ[N+O1;F"U63!%E+&?+#9^;##.U<<A=IYXX! &3H_C#Q3X5UVU
MT;Q'\T$DD8D-]("T4;$Y<2@D$ MDY+#Y-H*\X;][6+$M-T>RT445D:'AD:R^
M(?C01*Z0O'J;$%$)!6W)P,$]2L0!/J2<=J]SKPSP]-%#\:)7EE2-?[3O$!=@
M 68R*!SW)( ]217N=:5.A$.IX9XPTV]UCXK7FGZ><7-QLC!+[!M,"[\G^[MW
M9'.1D8.<5V"?"#14TN>$W=T][)&H2Y8C;$XZE4&,@GJ&)..A!YK,_P";@/\
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M#)&&8 NVY&P/4X4GZ ^E-;2$]T>YUX?\'?\ D<)_^P=)_P"C(J]PKP_X._\
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M?Q,_Y)]J?UA_]')7 ^ O'FE^%M#N+*^@O))9+EI@8$4C!1!W8<_*:[[XF?\
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MM3^L/_HY*R?@[_R*=Y_U_O\ ^BXZUOB9_P D^U/ZP_\ HY*R?@[_ ,BG>?\
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M@@@@^H(!YR..01Q7$>+/ *IX0M-,\-Z<LD\=RCRR%D624*D@W.YQN.7/';/
M KT:BDI- U<XJV^'FD7FFZ)-J5F8M1M+>V6?8P(E,: %) <JPXP3U( &<"NU
MHHH;N%@HHHI#"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#-D
M_P"1@A_ZY?XUI5FR?\C!#_UR_P :TJ;$@HHHI#"BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH S-#_P"/.3_KJ?Y"
MM.LS0_\ CSD_ZZG^0K3IL2V"BBBD,**** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** ,#QM_R)VH_[B_^A"O#J][\2:=-JOA^
M[L;<H)IE 7><#A@?Z5YM_P *SU[^_9_]_3_A7H82I",&I/J?.9SA:U:M&5.+
M:M^K.-HKLO\ A6>O?W[/_OZ?\*/^%9Z]_?L_^_I_PKJ]O3_F/(_L_%?\^V<;
M179?\*SU[^_9_P#?T_X4?\*SU[^_9_\ ?T_X4>WI_P P?V?BO^?;.-HKLO\
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M]9W$=Q=W,,T"%>!$KABJJ"=H4<E3R.K=<GWBBBE*5QI6/GB";7?AKK\DLMI
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M-C9P6ELFR""-8HUR3M51@#)Y/ [U-4MW=QI604444AGG?QE_Y%"T_P"O]/\
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MX?=4*H!/&"H/)8X]9HI\[O<7*K6..L$E\>?#=+;4&N+:XN(D628QX+,I#+(
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M&5%#YS%C SR-N%'<KU7Q0\+W^O:=:7NGCS9+ 2%K95R\BMMR5]2-GW>^3CD
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
MS9/^1@A_ZY?XUI5FR?\ (P0_]<O\:TJ;$@HHHI#"BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH S-#_X\Y/\ KJ?Y
M"M.LS0_^/.3_ *ZG^0K3IL2V"BBBD,**** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH *I7.CZ7>7T5[=:;9SW<.WRIY8%:1-I
MR-K$9&"21CO5VB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K/ET'1Y]0&H3:38R
M7H97%R]NAD#+C:=Q&<C QZ8%:%% !1110 52N='TN\OHKVZTVSGNX=OE3RP*
MTB;3D;6(R,$DC'>KM% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% %*YT?2[R^BO;K3;.>[AV^
M5/+ K2)M.1M8C(P22,=ZNT44 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110!FR?\C!#_ -<O\:TJS9/^1@A_ZY?XUI4V)!11
M12&%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110!F:'_QYR?\ 74_R%:=9FA_\><G_ %U/\A6G38EL%%%%(84444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 9LG_(P0_]<O\ &M*LV3_D8(?^N7^-:5-B04444AA1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 9FA_P#'
MG)_UU/\ (5IUF:'_ ,><G_74_P A6G38EL%%%%(84444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 9LG_(P0
M_P#7+_&M*LV3_D8(?^N7^-:5-B04444AA1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 9FA_\><G_ %U/\A6G69H?
M_'G)_P!=3_(5ITV);!1112&%%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% &;)_R,$/_7+_ !K2K-D_Y&"'
M_KE_C6E38D%%%%(84444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% &9H?\ QYR?]=3_ "%:=9FA_P#'G)_UU/\ (5IT
MV);!1112&%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% &;)_R,$/\ UR_QK2K-D_Y&"'_KE_C6E38D%%%%
M(84444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% &9H?_'G)_P!=3_(5IUF:'_QYR?\ 74_R%:=-B6P4444AA1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110!FR?\C!#_UR_P :TJS9/^1@A_ZY?XUI4V)!1112&%%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!F:'_ ,><
MG_74_P A6G69H?\ QYR?]=3_ "%:=-B6P4444AA1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!FR?\C!#_
M -<O\:TJS9/^1@A_ZY?XUI4V)!1112&%%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110!F:'_QYR?\ 74_R%:=9FA_\
M><G_ %U/\A6G38EL%%%%(84444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 9LG_(P0_]<O\ &M*LV3_D8(?^
MN7^-:5-B04444AA1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 9FA_P#'G)_UU/\ (5IUF:'_ ,><G_74_P A6G38
MEL%%%%(84444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 9LG_(P0_P#7+_&M*LV3_D8(?^N7^-:5-B04444A
MA1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 9FA_\><G_ %U/\A6G69H?_'G)_P!=3_(5ITV);!1112&%%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% &;)_R,$/_7+_ !K2K-D_Y&"'_KE_C6E38D%%%%(84444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% &9H?\ QYR?
M]=3_ "%:=9FA_P#'G)_UU/\ (5ITV);!1112&%%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% &;)_R,$/\
MUR_QK2K-D_Y&"'_KE_C6E38D%%%%(84444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% &9H?_'G)_P!=3_(5IUF:'_QY
MR?\ 74_R%:=-B6P4444AA1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110!FR?\C!#_UR_P :TJS9/^1@A_ZY
M?XUI4V)!1112&%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110!F:'_ ,><G_74_P A6G63#IM[;J5BNU52<XV]ZD^R
M:E_S_#_OFF)&E16;]DU+_G^'_?-'V34O^?X?]\T!<TJ*S?LFI?\ /\/^^:/L
MFI?\_P /^^: N:5%9OV34O\ G^'_ 'S1]DU+_G^'_?- 7-*BLW[)J7_/\/\
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MTJ*S?LFI?\_P_P"^:/LFI?\ /\/^^: N:5%9OV34O^?X?]\T?9-2_P"?X?\
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M_?- 7-*BLW[)J7_/\/\ OFC[)J7_ #_#_OF@+FE16;]DU+_G^'_?-'V34O\
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ME16;]DU+_G^'_?-'V34O^?X?]\T!<TJ*S?LFI?\ /\/^^:/LFI?\_P /^^:
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M[YH^R:E_S_#_ +YH"YI45F_9-2_Y_A_WS1]DU+_G^'_?- 7-*BLW[)J7_/\
M#_OFC[)J7_/\/^^: N:5%9OV34O^?X?]\T?9-2_Y_A_WS0%PD_Y&"'_KE_C6
ME6=!87"WJW$\ZR%01TQ6C0P04444AA1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M/<X<<>MW5/C#'(L5OH.F2R7<S!%^U@?>)  5$8ER>1U&#CKTJ_X&\(7WV_\
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M43<0JC ?@#(Z"N^J9WZCC8****DH**** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "F30Q7$$D$\:2Q2
M*4>-U#*RD8((/4$4^B@"EI^CZ9I/F?V=IUI9^;CS/L\"Q[\9QG:!G&3^=7:*
M* *M]IMCJD"P:A96UW$K;Q'<1+(H;!&<$'G!/YU):6=K86J6UG;0VUNF=L4*
M!$7)R< <#DD_C4U% !1110 4444 %4M0T?3-6\O^TM.M+SR\[/M,"R;,XSC<
M#C.!^57:* "JM]IMCJD"P:A96UW$K;Q'<1+(H;!&<$'G!/YU:HH 9##%;P1P
M01I%#&H1(T4*JJ!@  = !VI]%% !56^TVQU2!8-0LK:[B5MXCN(ED4-@C."#
MS@G\ZM44 0VEG:V%LEM9VT-M;IG9%"@15R<G ' Y)-3444 4M/T?3-)\S^SM
M.M+/S<>9]G@6/?C.,[0,XR?SJ[110 R:&*X@D@GC26*12CQNH964C!!!Z@BH
M+'3;'2X&@T^RMK2)FWF.WB6-2V ,X '. .?:K5% !1110 4444 %%%% !111
M0 5GQ:#H\&H'4(=)L8[TLSFY2W02%FSN.X#.3DY/?)K0HH **** "BBB@ HH
MHH **** "BBB@"E?Z/IFJ^7_ &CIUI>>5GR_M$"R;,XSC<#C.!^56H88K>".
M""-(H8U")&BA550,  #H .U/HH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M8S7M[.L%M"NYY&Z ?U)/  Y).!2::W!-,LT5YX/C)X?Q_P >.J!O[OEQ9_\
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MH(R"#4N+6XTTS2HKC+OXFZ#8R:C%.EVLUC/]G,6Q"TS;F!*#=]T;223CJ.Y
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MW^V8@5\%=T1#*3ALD%E<8P,>7U^84XQN$I6/I6L?6O%.B>'BBZIJ$<$CXVQ
M%WP<X;:H+;?E(SC&1C-:5I=0WUG!=VS[X)XUEC;!&Y6&0<'D<'O7B^D:1I_B
M/XKZS:ZS))-$)KED1IRIE97VJF<[L*N2 ",!!V!%**ON-NQZCI'C'P_KMR;;
M3M2CDG'2-U:-FX)^4.!NP 2<9QWJWK6O:;X=LTN]4N#! \@B5A$[Y8@G&%!/
M136 OPQ\-P:A8WMG%<VDEI,LP6.=G$C*P8;M^XXRO8CJ?;&=\8O^13L_^O\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MS$,#*O"^47(P"0H\Q 0 >  .!Q3_  3XVTKP?I]U8ZAI-TM\;@B62")=Q
M63>X(*G>,  #TR237\-ZM<:[\8;#4[JW%O+<.[B( X5/LS[.3URFTYX!SD
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M[YDY+ %<*SG<"<\;SDGG-.V@M_'WQ9NQ<E)]-B$A*?:6(:&,"-3&RXP"[*^
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M;G_VG2C)N5@<5:YZU11161H%%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% %*WT?3+.^EO;;3K2
M"[FSYL\4"K(^3D[F R<D G/>KM%% !1110 52_L?3/[3_M/^SK3^T/\ GZ\A
M?-^[M^_C/3CKTXJ[10 4444 %%%% !4-W9VM_;/;7EM#<V[XWQ3('5L'(R#P
M>0#4U% %6QTVQTN!H-/LK:TB9MYCMXEC4M@#. !S@#GVJU110 4444 %%%%
M!6?%H.CP:@=0ATFQCO2S.;E+=!)N;.X[@,Y.3D]\FM"B@ HHHH *SY=!T>?4
M!J$VDV,EZ&5Q<O;H9 RXVG<1G(P,'M@5H44 %4K_ $?3-5\O^T=.M+SRL^7]
MH@639G&<;@<9P/RJ[10 R&&*W@C@@C2**-0B1HH554#   Z "GT44 %%%% !
M1110 5YQ\6_#^I:QI]A<V%L]PMJ9$ECA4M*-^P JH&2 5YQR,@XQDCT>BFG9
MW$U=6///^%A>(]W_ "(&I;?7=)G\O)I/A[X;U2#6=2\2ZS;FUN;X'RX <<2,
M)')7DKR% !.1ALCH:]$HI\VEDA6[A1114E&?%H.CP:@=0ATFQCO2S.;E+=!)
MN;.X[@,Y.3D]\FM"BB@ HHHH **** "BBB@"E<Z/IEY>Q7MUIUI/=PX\J>6!
M6D3!R-K$9&#R,=ZNT44 %%%% %*_T?3-5\O^T=.M+SRL^7]H@639G&<;@<9P
M/RJU##%;P1P01I%#&H1(T4*JJ!@  = !VI]% $-W9VM_;/;7EM#<V[XWQ3('
M5L'(R#P>0#4=CIMCI<+0Z?96UI$S;V2WB6-2V ,D #G '/M5JB@ IDT,5Q!)
M!/&DL4BE'C=0RLI&""#U!%/HH I6&CZ9I7F?V=IUI9^;CS/L\"Q[\9QG:!G&
M3^9J[110 4444 %%%% !1110!2N='TR\O8KVZTZTGNX<>5/+ K2)@Y&UB,C!
MY&.]7:** "BBB@ JEJ&CZ9JWE_VEIUI>>7G9]I@639G&<;@<9P/RJ[10 444
M4 %%%% !1110!GV.@Z/I<[3Z?I-C:3,NPR6]ND;%<@XR .,@<>U:%%% !111
M0 4444 %4K_1],U7R_[1TZTO/*SY?VB!9-F<9QN!QG _*KM% #(88K>".""-
M(H8U")&BA550,  #H .U/HHH *I7^CZ9JOE_VCIUI>>5GR_M$"R;,XSC<#C.
M!^57:* &0PQ6T$<$$210QJ$2-%"JJ@8  '0 =J)H8KB"2">-)8I%*/&ZAE92
M,$$'J"*?10!2L-'TS2O,_L[3K2S\W'F?9X%CWXSC.T#.,G\ZNT44 %%%% !1
M110 5@>-=*NM;\(7^GV2H]S($9%=MH8JZMC/J0N!GC.,D=:WZ*:=M0/)/#'B
M?Q%X=\.VNEIX)U.Y$)<^:XDC)W.S_=\HXQNQU[5/::7KGC3QW8Z[J6CRZ58V
M)3"R,5<F,[U&&&6R[==H&T$9R.?5**KF[(GE"BBBH*,^^T'1]4G$VH:38W<J
MKL#W%NDC!<DXR0>,D\>]:%%% !1110 4444 %%%% !1110 55OM-L=4@6#4+
M*VNXE;>([B)9%#8(S@@\X)_.K5% $-I9VMA:I;6=M#;6Z9VQ0H$1<G)P!P.2
M3^-3444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M3;W=M=^;]GN(IO*D,4GEN&V..JG'0CTKYJ-EJ%WJ4=K86>HQO):%K:"5RSM
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M(ELJMY0XQNRPP2.<#)QR<9&:-A\5_#5[=K!(;JS5L8FN8U$>20,$JQQUSDX
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M%&TGD2J$R>" 3P""&HW5Q.5G8]NKG-1\>>&-*O6M+K5HQ.F=ZQ1O*%()!4E
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ML9+*LTC<<CGC(.1@X.13LK7%?6QU^C:[IOB"TDNM+N?/ACD,3-Y;)A@ <88
M]&%:-<OX#F\/7&@RR^'+:6VMC<MYT4Q8LLNU<YRS?P[#P<<^N:SU^*_ALZ8U
MVWVM9 Y1;4QJ96QMRV Q4#YNK$9VMC.*.5WT'?34[BBN2T#XBZ'XBU%;"W%U
M!<R?ZI)XO]9A2QP5) P%/7';&:W-<URQ\/:5+J%_(5B3A47EY&[*H[D_XDX
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MF\_4\Y\1+:&]^*&A6EPF^">.VBD7)&5:=P1D<C@]JOE3E8F[M<Z__A:'@_\
MZ"LG_@'/_P#$5TVGZA::K80WUC.L]M,NY)%[]C[@@Y!!Y!!!YKFO^%8^$/\
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M/#_Q(T3Q'J\>FVL5Y%/(K%#-&NUB!DC*L<' )YXXZYQGKZ&FMP3N%%<GX_\
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MQ@]97C_Q)NH;+XEZ#=W#%8(!:RR,%+85;AB3@<G@'I71_P#"W/#GVOR?*O\
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MQO<(S8S:[1PH)ZD4HJ]PD['LU%>?Q_&#PZ\D:M:ZE&K, SM$A" GJ<.3@=>
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M&%%5[^_M=+L9KV]G6&VA7<\C= /ZD] !R2<"N$'QD\/X_P"/'5 W]WRXL_\
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MR*DFPDC VGE2!SWYXYZ/3]0M-5L(;ZQG2>VF7<DB]#_4$'((/(((->7>"/\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M"_LK[1HWLKJ(NT]PRI'([?((VW*Q)*A3@D\<8K0T'5Y_ACXKU'3M2M))K>8
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MDK+\3:&NI?"+0-11':YTZPMW78I8F-D0., X &%8M@X"'H"36I\8?^12M/\
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M)2X#''"MD 'GGCN,]+X;\9^'_%EW:Y@2#5XE8Q13H"RY4;_*?'(/([,0I)7
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MD7<P/\6X\<'"'\&OB7H+HSUJO&_A/?1:79^*M0G5VBM;:&=P@!8JHF8XSCG
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MP=/0 "W>&)T.#NR07.3GG)YSSUJ/X)7#20ZS%Y^]$\AM@?*JQ#@D#L3M'/?
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M>W=\?)*(HRIS@X!Z$@9VLP'6O1_%7_(GZW_UX3_^BVKD_@Y_R*E]_P!A!_\
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M^446-2?O-@J3T'4\94&UXZ_Y*YX<_P"W3_TH:J6DM!;Q&?\ "#?$;_H9D_\
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MP!P*Q_!?CS2])T4>&=>LY8HH3+')(Z>8IW,[.DD>,KC(7&&SWQ77:CX\DLO
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M#'L+2_Q%A@'<>#DC)&#T(KE+KQAX+\$7<UC8V?[W>PN18PK\C YVLS$ X+,
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M1%"MNYR&/ V').*F47=LJ+5K'#^ 8(K?XM:]%#$D444=TD:(H5543H  !T&
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M.N>U94G_ "<'#_O_ /MF:I)ILEV:1VGBHV'AOP?K%[:6JVDCVRP"2SC6-PQ
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M+LNIKJ14^56W_NHLI\Q &X97/;=GM5#P3XVTKP?I]U8ZAI-TM\;@B62")=Q
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MUDPNG@1 68DN608;DJ)#R,[MG Y%6M$K]R7JW8RO#WQ&\'Z-X8@TB33ISNA
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M5EQGJ!A%X'&1GK4_CZY^V?#&\NO)F@\Z."3RIUVR)F1#M8=F&<$>M/\ A?\
M\D\TW_?G_P#1\E1?W?F5]HY3PW#;>'/C-J&F@;ENEE2 11A%CW!9PN,\ *I7
MCT' [>M5Y))_R<'#_O\ _MF:];HGT")X_P#&?4M]]IVF(\JM#"URX)Q&V\[4
M/7DC8_4<!N.IJY%\3? L.CQZ0NDW!T]  +=X8G0X.[)!<Y.><GG//6KOQ?T2
MYU#1+74(%:2.Q,GGHJYQ&X&7)ST7:,\'ALG !J'3_C)IQL(/[2TV]%YM_>FU
M5&B)]5W.#@]<'IG&3C)I:Q5D+9F=\'DCU/2_$.G7,AFM98XDDA60[?G616(P
M>"0 ,C!X'I5CX:S2:#XNUCPQ=2/C),1E8Q[FC.,K&>[H0V0?NH.HY'8>#_&,
M?B^._DBL)[:.UFV*[G<L@.2.1T<#!9><;EY.:X+XG1W7AWQG9:]IDR6US=0-
MMD'SMYB#8S%6!7&QT ^AX!Y)>[:8;),=IUQ_PFOQA^T.T,EGIY:2$++D-'$V
M$9&4#=F1E?GC#$9( ![/Q%J_A3PKJO\ :M];1/K$L:E?)B#3,HRFX$X"\,1D
MD%@N.=H S/A%I26?A:74<)YE],<,K$_NXR4 (/ (;S.G8CGL.8UUW\+?%1M7
MUVT:_LY9&F@D$(R0%PFP;@I:,[5RW8;L9*FBUY6[!LKE+QYXP\/>++:W>QL;
MF/487VF>94&8L'*G:QS\Q!&1QSC&3GTR2[GO_A4]Y<OYEQ<:(997P!N9H,DX
M' Y/:O-O'?CQ/%=C!:V%C/#8PRK)++.HW^:0P5?E)4#:'/)R<=MISZ';_P#)
M'(O^Q?'_ *3T26B$MV9/P:_Y%74/^PBW_HJ*LKX*_P#'QK_^Y;?SEK5^#7_(
MJZA_V$6_]%15QW@OQ(O@'5=5M=:TZZ$LHC21(]I>-TW$#!(!!#D[@>PQD'(&
MK\R0;6-SQO\ \EC\/?[EI_Z425VOBBZ\,:-/;ZSK=O ][&I2U)BWRL5.\!1Z
M@@88X"ENHW'/F5[JUSXD^(.@ZZUDUM8S7D5M9ENLB1R@DGGKF3G' Z9)4FM+
MXC6L^G^.;#6M3MA?Z.QB0(\0VJJDEHN"-Q^\XW<'=CD*11R[(+[L@\:>//#7
MBK1#;1:?=C4(V#6TTR(/+.1N&5<G!4'C!&<'L".^^'-W/>^ =+EN'WNJR1 X
M PJ2,BCCT50/PK@_&7Q(@\1Z#+INEZ==)&^U[J2Y091 Z[<!&.,L5!)X' P2
MV1VWPO\ ^2>:;_OS_P#H^2E)6B-?$<I\#_\ CWU?_<MOY25#\9]2WWVG:8CR
MJT,+7+@G$;;SM0]>2-C]1P&XZFLOPIKR?#GQ%JVF7\,\]LI\DM'"%E9D/R,
MS !65F/?JN..O2_%"PD\0^$M+UZRCE:VBB,LD>P;EBE56WGG^':,XS]XG@ F
MJ^W<7V;$47Q-\"PZ/'I"Z3<'3T  MWAB=#@[LD%SDYYR><\]:C^"5PTD.LQ>
M?O1/(;8'RJL0X) [$[1SWP/2K>G_ !DTXV$']I:;>B\V_O3:JC1$^J[G!P>N
M#TSC)QD]/X/\8Q^+X[^2*PGMH[6;8KN=RR Y(Y'1P,%EYQN7DYJ7=)Z#6KW.
M%^#UK#>ZMJ]_=IY][;K$8YY6+,#)YF\Y/\1V]>O)YY.8OB_IEC8ZCI=Q:6D4
M$MVL[3M&NWS"&0@D#@G+MD]3GGH*J>&-6G^&>OZC8Z[9R$31)G[.H8N5)V,A
M9E!0AG]\X'!!%5?'?B.7Q>;?4;:PEATFR<VT<TN S2R*&8'!(Z(.!G'4GY@!
M=GSWZ$W7+8]ZHHHK U/&O@_IMC?:CJMQ=VD,\MH(&@:1=WEDLY) / .47!ZC
M''4U-\8+:&RU?2-0M$\B]G64R3Q$JQ,?E[#D?Q#=UZ\#G@8P? ?BA_"5Q=7E
MQI]Q-IET5AEFCC.5D4,RA6.%)PQRN<X(/;!NZ]J\_P 3O%.GZ?IEG)#;0@A9
M'4-(BL5\R1P&VA1@8&><=<L -VGSWZ&5URV-?XE6R:EHNB^,M.^TQ2/'$-R@
MATC<>9&Q*G"%6)&1U+CG@5>\5^,S/\,+&YADA^UZN@@E"?+MP")]J,"2H8%/
M;>#GIGN=?T>'7]"O-+G;:MPF%?D['!RK8!&<, <9YQ@UX%X>LKO6_$6D^'[Y
MW-M'<OFUN"R>4/O3(,#<I(C/'&&]"2:F-FM>A4M'ZGL_P^T1]#\'VL,\/E75
MP3<3KEL[F^Z"&^Z0@0$8X(/7J>HHHK-N[N6M#R7X'_\ 'OJ_^Y;?RDK9^,/_
M "*5I_U_)_Z+DKC/"FO)\.?$6K:9?PSSVRGR2T<(65F0_(P#, %968]^JXXZ
M]7\4;R/4? .EWT(98KFYBF0.!D!HG(SCOS6MO?3,[^[8Z+P7H^FP^"].,=A;
MJ;ZPB:Z/E@F8LF3O)^\,LW!X .!Q7'_"SR](\5>(-!9WFG3I,$"JRPN4)(SP
M29 0.>_/KWO@_P#Y$G0?^P=;_P#HM:\^\$?\EC\0_P"Y>?\ I1'4+9E/='+Z
M3XIT:+QW=>(M8@N+FVE>2>U5\-)&Y<&,D%L?*F0.3@A<= 1>\?>./#OBFQMQ
M86K1WR3+ON)XXPQB"O\ )N#$XW,#CIUJY?W=W\/?B?=:E/;&XM+]I&#8VEXI
M&5WV<XW(V!@]<?P[@1OW?QGTB.UD>VTN_>88VK<&.-#SSE@S$<9[?EUJ^J:1
M/2S9VWAF5Y_"FCS22M+))8PLTCMN+DH"23W)]:M:E?1:7I=WJ$ZNT5K"\[A
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M7?\ Z41UJ_!K_D5=0_["+?\ HJ*LGP1_R6/Q#_N7G_I1'0_M!V/6Z\^^,/\
MR*5K_P!?R?\ HN2O0:\^^,/_ "*5I_U_)_Z+DJ(?$ARV-KP7H^FP^"M.,=A;
MC[=81-=9C!,Y9,D.3]X99N#P <#BN \!7<&C_%'4M*B$R6T\US:PQ*Q*@QNS
M*6R><*C 'D_-[DU;T#XIV^C^&+73[[2[EKRUMTC@$8"I(@0>66+'*Y&,D!N/
MF'7 G^%=A?7VM:KXHN4\J*Z\Q%VIA)7>3>Y7)SA2N._7&<J:NS2=Q73M8WM8
M\1^$/!>K7,GV13JMPV^X%I"ID 89)9B0 #M!*YR20V.2:\V\:^+M)UC5+76M
M!MIK74;?+RS2HF79=IC. S D8/)'3 Y &+VG7X\">/=0G\26,MY<,)'BN8X5
M$CLS?ZU!O"*&&_.,D?=&/F!S?B'XO_X2UH9(+.2#3[=)$A>5?G=R%+Y()48^
M3@$GG)/S !QC9DMW1WWQE_Y%73_^PBO_ **EKK_"_P#R*6C?]>,'_HM:Y_XJ
MZ8^H>"WFC+YL9UN2BH6++AD/T #EB?13]1G^ /'MK?6^E>'I[><7ZQ&(2(BB
M(JBDKR6W9V*,\=<]JBUXEWM(Q-1LK;4?CNMI>0)/;R2*7C?D-MMMPR.XRHXZ
M'H:Z3XHZ-;R>"4FA2* :;)&8E2(<1G$?EK_='S*>/[@&/3!D_P"3@X?]_P#]
MLS78?$K_ ))_J?\ VR_]&I57]Y"Z,Y?6M?@/P2T_R/M$1NDBT]"N%.Z,D/G!
M^Z1$X]PP!')QM?"S3+"+P?::E':1+?3F99+C;EV E*XW'D#"+P.,C/6LG0M#
M/B'X)0V42(]R#/+;[E!/F+/(0 21M+#*YSP&-9'@WXC6_AC1FT;5=.NB;65Q
M&;=1O!+,761788(8G\\$#&26NFEW"]G=A\1(SX4\>6&OV=IY4+JMP_E2[//E
M5CYJ\9V[E* \8.X]235SXX?\>^D?[ES_ "CJA +KXD?$*VU'^S6CTFW98V=X
MMZ>5&2^R0D[2S%\%1G ?HP4DWOCA_P >^D?[ES_*.FMTA/9D/QIU0?;-/TY6
MF#00/=.N?W;;CM0XSRPV/VX#<=37J5EHFEZ=IK:=:6%O%:.NV2(1@B3*A3OS
M]XD  DY)[UPGQ>\/27^EP:O;P!VM R7.R,;O)/.XGKM4@\8.-Y/ !J*U^,MD
M-+0W>EW+:B(SN6':(6<=,,6W*#Q_"<9_BQDS9N*L.Z3=S+\'&7PU\6+S1! \
M=O<R30I%YQ*H@!EB<]=QV+CDY&\]\BF>&[FQTGXOZS+JS16BF2Z\E[I=H5VD
M#!@2/ERF_#<9#=?F&='X9:+>WFOZAXHU*S\D3;G@WPX#O*=[/'N.0 #@'G(<
MC/!KC[4%/$^M6-_H4GB.47,AD\I7AE+I(RF0>7G:K%CE<8R5].:W;)VL=+K=
MS;ZK\8]'ET&>*9LP>?+;. '*LS298<-^ZP#@G(&WVK?^,/\ R*5I_P!?R?\
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M<1+(H;!&<$'G!/YU:HH AM+.UL+5+:SMH;:W3.V*% B+DY. .!R2?QJ:BB@
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M\;J&5E(P00>H(JK8:/IFE>9_9VG6EGYN/,^SP+'OQG&=H&<9/YU=HH ****
M"BBB@ HHHH SXM!T>#4#J$.DV,=Z69S<I;H)"S9W'<!G)R<^N36A110 5Q7Q
M,\,R:_X?6XM(7EOK%B\<: DR(V Z@9 SP&Z$_+@=:[6BFG9W$U<R_#=Y=7_A
MRPN+Z&XBO#"%G6XB\MS(ORLQ7L"02.G!' K4HHI#"BBB@ KE_B%-?)X/NK?3
MK6[N+F[(MP+:#S2J'E]PP<*5#+G'5ATZCJ**:=F#.7^'VBOHG@ZTBGA\JZN,
MW$ZG=D,W0$-C:P0(",<$'ZGJ***&[NX+09-#%<0203QI+%(I1XW4,K*1@@@]
M014%CIMCI<#0:?96UI$S;S';Q+&I; &< #G '/M5JBD 4444 %%%% %+3]'T
MS2?,_L[3K2S\W'F?9X%CWXSC.T#.,G\ZNT44 %,FABN()()XTEBD4H\;J&5E
M(P00>H(I]% %*PT?3-*\S^SM.M+/S<>9]G@6/?C.,[0,XR?SJ[110 4444 ,
MFABN()()XTEBD4H\;J&5E(P00>H(J"QTVQTN!H-/LK:TB9MYCMXEC4M@#. !
MS@#GVJU10 4444 0W=G:W]L]M>6T-S;OC?%,@=6P<C(/!Y -1V.FV.EP-!I]
ME;6D3-O,=O$L:EL 9P .< <^U6J* "BBB@ HHHH I6^CZ99WTM[;:=:07<V?
M-GB@59'R<G<P&3D@$Y[U=HHH *JWVFV.J0+!J%E;7<2MO$=Q$LBAL$9P0><$
M_G5JB@"&TL[6PMDMK.VAMK=,[(H4"*N3DX X'))I\T,5Q!)!/&DL4BE'C=0R
MLI&""#U!%/HH JV.FV.EP-!I]E;6D3-O,=O$L:EL 9P .< <^U6J** *5SH^
MF7E[%>W6G6D]W#CRIY8%:1,'(VL1D8/(QWJ[110 4444 %%%% &?%H.CP:@=
M0ATFQCO2S.;E+=!(6;.X[@,Y.3GUR:T*** "BBB@ JE;Z/IEG?2WMMIUI!=S
M9\V>*!5D?)R=S 9.2 3GO5VB@ J&[M8;ZRGL[E-\$\;12+DC<K#!&1R.#VJ:
MB@#SSX<Z?JGAW5=9T&]MKHVJOYUO<F +"^/E+!N>64QG;DXVGH0<^AT44V[N
MXDK!1112&5;[3;'5(%@U"RMKN)6WB.XB610V",X(/.">?>BQTVQTN!H-/LK:
MTB9MYCMXEC4M@#. !S@#GVJU10 4444 %>:?%&VU?6KW2=%TVRNY(2_F2S?9
MRT"NQV(6=02NT;RWH&!Y[>ET4T[.XFKD-I:PV-G!:6R;(((UBC7).U5& ,GD
M\#O4U%%(92O]'TS5?+_M'3K2\\K/E_:(%DV9QG&X'&<#\JM0PQ6T$<$$210Q
MJ$2-%"JJ@8  '0 =J?10 4444 %4M/T?3-)\S^SM.M+/S<>9]G@6/?C.,[0,
MXR?SJ[10 55OM-L=4@6#4+*VNXE;>([B)9%#8(S@@\X)_.K5% $-I9VMA;);
M6=M#;6Z9V10H$5<G)P!P.231=V=K?VSVUY;0W-N^-\4R!U;!R,@\'D U-10!
M5L=-L=+A:'3[*VM(F;>R6\2QJ6P!D@ <X Y]JM444 %4KG1],O+V*]NM.M)[
MN''E3RP*TB8.1M8C(P>1CO5VB@ HHHH *I7.CZ9>7L5[=:=:3W<./*GE@5I$
MP<C:Q&1@\C'>KM% !1110!2T_1],TGS/[.TZTL_-QYGV>!8]^,XSM SC)_.K
MM%% !1110 52N='TR\O8KVZTZTGNX<>5/+ K2)@Y&UB,C!Y&.]7:* "F30Q7
M$$D$\:2Q2*4>-U#*RD8((/4$4^B@"K8Z;8Z7 T&GV5M:1,V\QV\2QJ6P!G
MYP!S[5:HHH **** *5OH^F6=]+>VVG6D%W-GS9XH%61\G)W,!DY(!.>]7:**
M ,^^T'1]4G6?4-)L;N55V"2XMTD8+DG&2#QDG\ZT*** &30Q7$$D$\:2Q2*4
M>-U#*RD8((/4$55L-'TS2O,_L[3K2S\W'F?9X%CWXSC.T#.,G\ZNT4 %%%%
M!1110 5GRZ#H\^H#4)M)L9+T,KBY>W0R!EQM.XC.1@8],"M"B@ HHHH *AN[
M.UO[9[:\MH;FW?&^*9 ZM@Y&0>#R :FHH AM+.UL+5+:SMH;:W3.V*% B+DY
M. .!R2?QJ:BB@ JE?Z/IFJ^7_:.G6EYY6?+^T0+)LSC.-P.,X'Y5=HH *9-#
M%<0203QI+%(I1XW4,K*1@@@]013Z* *MCIMCI<#0:?96UI$S;S';Q+&I; &<
M #G '/M5JBB@"EJ&CZ9JWE_VEIUI>>7G9]I@639G&<;@<9P/RJ[110!GRZ#H
M\^H#4)M)L9+T,KBY>W0R!EQM.XC.1@8],"M"BB@"K?:;8ZI L&H65M=Q*V\1
MW$2R*&P1G!!YP3^=3PPQ6\$<$$:10QJ$2-%"JJ@8  '0 =J?10 4444 ,FAB
MN()()XTEBD4H\;J&5E(P00>H(J"QTVQTN!H-/LK:TB9MYCMXEC4M@#. !S@#
MGVJU10!6U&YEL],N[J"V:YFAA>2.!2096"DA1@'DD8Z'K7GGPQ\/ZG'J>I^(
M-8CN(;N<M$$EC,1<LP=W*E1QG;@CC[PQTKTRBFG96%;6X4444AE+4-'TS5O+
M_M+3K2\\O.S[3 LFS.,XW XS@?E5VBB@ HHHH 9-#%<0203QI+%(I1XW4,K*
M1@@@]0156PT?3-*\S^SM.M+/S<>9]G@6/?C.,[0,XR?SJ[10 4444 5;[3;'
M5(%@U"RMKN)6WB.XB610V",X(/.">?>I+2SM;"U2VL[:&VMTSMBA0(BY.3@#
M@<DG\:FHH 9-#%<0203QI+%(I1XW4,K*1@@@]0156PT?3-*\S^SM.M+/S<>9
M]G@6/?C.,[0,XR?SJ[10 4444 %,FABN()()XTEBD4H\;J&5E(P00>H(I]%
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M5;RAQC=EA@G.<<G')QD9.5WL*Z.JHKC]$^)?A[6[Y+-'GM9I65(1<H )6.>
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M2Q:A;(<[I985*I@9Y",Q]N >M=[4M-;C33V"BN$OOBUX<LKZ:V"7EPL3;1/
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M -Y8X![D]37I3>);/Q3X UZ^LH;B*..VN(2LZJ&R(LY^4GCYA5.#6XE),O\
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M6(&2,JQP< GGCCKG&7RNUQ76QU]%9VN:W8^'M+EU"_DVQ)PJKRTC=E4=R?\
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M[[$#G;AB,\C!R"".W6K<;):$J5V;6C:[IOB"TDNM+N?/ACD,3-Y;)A@ <88
M]&%8G@GQLOC".]#6!LYK0H642^8K*^<$-A3G*MD8].3GB3P'-X>N-!EE\.6T
MMM;&Y;SHIBQ99=JYSEF_AV'@XY]<UYC\.O%FF>%?[:EU S%YDM_*BACW-)M,
M@;!.%&-P/)'MFERWO8=]CW:BN,T;XG:!K6JQ:?&MU;23<1/<JBH[=DR&/)[9
MX/3.2 =?7_%>G^'+O3H+\2@7SE%E7:$CP5!9RS# &X'// -3RN]AW1N45Q-C
M\4O#]_J\.G1)>J9YA#%,\(",Q.%/7< QP!D<9YQSC4\3^-=)\*&!+WSIIYN5
M@MPK.%Y^<Y( &1CKDGH#@X.5[!='145P5O\ %[PW-.L<D=_;QG.Z:2%65<#/
M(1BWMP#UKMOMEK]A^W?:8?LGE^=Y^\>7LQG=NZ;<<YZ8H::W!-/8GJM?W]KI
M=C->WTZ06T*[GD;H/\23@ #DD@"N*N?B]X:@N&CCCO[A!C;+'"H5\C/ =E;V
MY Z5OS:GH^O^"9]3GMWN=+DMGEDA=,.0F2PQGA@5."#U (/0T^5K<+KH7M&U
MW3?$%I)=:7<^?#'(8F;RV3#  XPP!Z,*T:Y3P3>>&AX;N;O0XWL;!)G>Y6Y<
MCRW"KDL68@#8%/!QCWS69<_%[PU!<-'''?W"#&V6.%0KY&> [*WMR!THY6WH
M%]-3OJ*HZ/JUKKFD6^I69?R)URH=<,I!(((]001QD<<$BKU2,**Y?Q%X_P!#
M\-7/V2YDEGNUV[X+90S1@@D%B2%';C.?F!Q@YK,LOBUX<N[V&W9+VV25MIGG
M1!&GH6(<D#MG&!G)P,D5RO<5T=W17GGQ4\3VMEHL^@(\XU"\B1_W8PJQ>8,[
MCD<,%=<#/?. ><SP!X\TK3M(TGPXUI>?:6F,(>-$\L&24D'.X''S#/'K1R.U
MQ<RO8]6KG?&?BA_">CPWZ62WADN!#Y9F\O&58YSM;^[TQWKHJ\^^,/\ R*5I
M_P!?R?\ HN2B*N[#D[([?3;Z+5-+M-0@5UBNH4G17 #!64, <9YP:M5YCHWQ
M0T#2?#FCV+I>W$L-A"DAAA "NJ!2OSE22,=0,<]:[3PUXITWQ59/<Z>[JT;;
M98)0!)'UP2 2,$#(()'4=00$XM FF;5%<?K?Q+\/:)?-9N]Q=S1L4F%J@81,
M,<$L0">2.,X((.#3-%^)V@:UJL6GQK=6TDW$3W*HJ.W9,ACR>V>#TZD OE=K
MA=;'9T50U?6=.T*Q^V:G=);P;@@9@268]  ,DGJ>!T!/0&N.B^,/AR29(VM]
M1C#, S-$A" GJ<.3@>P)]C246]@;2/0**KW]_:Z78S7M[.L-M"NYY&Z ?U)Z
M #DDX%<(/C)X?Q_QXZH&_N^7%G_T90HM[ VD>AUR>@^-EUKQ9JF@/8&"6R,A
M259=ZR*DFPDC VGE2!SWYXYW=(UK3M>L?MFF72W$&\H6 (*L.H((!!Z'D="#
MT(KS3P1_R6/Q#_N7?_I1'32T=Q-ZH] C\6Z'-KW]AQ7ZR:CO9/*1&(W*I9AN
M VY !SSU!'7BMJN&A?PA%\3FM$TV6#7P6D6X&X12.T6YL -C)1F))49()SDC
M.OK'C72=!UN'3-1,L320&X\\J/+51NX/.XD["  #DD =:&NPT^YT5%<%_P +
M<\.?:_)\J_\ +\S9Y_DKLQG&_&[=COTSCMGBNWM+J&^LH+RV??!/&LL;%2,J
MPR#@\C@]Z336X)I[$U%<9K?Q-T#0]5ET^5;JXDAXD>W5&1&[H26'([XX&<=0
M0+?AWQ_H7B2Z%I;22P7;;BD%R@5I  "2I!*GJ>,Y^4G&!FCE=KA=;'4445S_
M (XU*72?!>J7< ?S?*$2,DA1D+L$W@CD%=V[\.HZTDKC*_A_QBOB/Q!J5C96
M0-C9#'VX3JPD;.!A1V.'(8$\*,XSBNHKA/A/ID5IX/%ZNQI;Z9W9A& RJA*!
M">X!5B/3>?J=G6?&ND:!K<.EZB9H6E@,_G[1Y:J-W!YW$G80  <D@#K5-:V0
MD]+LZ*BO/YOC!X>CDD5+74I@C$!DB0!P.XW.#@^X!^E=OI^H6FJV$-]8SK/;
M3+N21>A_J"#D$'D$$&DXM;@FGL6:*P/#'C#3/%D=R;!;B-[8J)(YT 8!L[3P
M2,'##KGCITR:MXPTS1]?L-%G6XDO+TH$$2 J@=MBEB2."0>F3P>.F2SO8+HW
MZ*\0^*OB6TUS48-+M&F:/3Y9DN XQ&\ORJ,#/)4B1<D#J<9!KT7PSX^TSQ3J
M4EC96M[%)'"9BTZ(%P"!CY6//S"FX.UQ<RO8ZJBN'U#XK^&K&[,$;75XJ]9K
M9%,><D8!9AGIG(R"",$U=\.?$'1?$NH-8VPN+>XV[HTN55?-ZY"X8Y( SC@X
MY&<'"Y7:X[HZNBO)OBWXFM;B'_A&[=IS<13QRW>!B,KL8A#S\QRT;=".G.1B
MMGP3X]TN]CT?PY#:7J726RP[V1!'F./GD-G'RG''I3Y':XN97L=-'XMT.;7O
M[#BOUDU'>R>4B,1N52S#<!MR #GGJ".O%;5<-"_A"+XG-:)ILL&O@M(MP-PB
MD=HMS8 ;&2C,22HR03G)&=/PYXXTWQ+J%QI\%M?6MY A=X;N((V =K#@G!!(
M!!P>>^#@:[#3.FHK+\0:]9^&])?4;[>8U946.,KO=B>B@D9.,GKT!/:F6OB2
MQG\-+K]P)K&R*&0_:TVN%R0#@$YW<%<9SN&.M*S'<UZ*\\'QD\/X_P"/'5 W
M]WRXL_\ HRNTTC6M.UZQ^V:9=+<0;RA8 @JPZ@@@$'H>1T(/0BAQ:W$FF7ZR
MM;\2:1X<ABEU6\%NLS%8P$9V8CKA5!.!QDXP,CU%:M>3?&OC^Q/I<?\ M.G%
M7=@D[*YU7_"T/!__ $%9/_ .?_XBNFT^_M=4L(;ZQG6:VF7<DB]Q].H(/!!Y
M!!!KFO\ A6/A#_H$M_X%S?\ Q==%I>EV>BZ=%I^GPF&UBW;$+LV,L6/+$GJ3
MWH=N@*_4?J%_:Z7837U[.L-M"NYY&[#Z=23T ')) %5-$\1Z3XBAEETJ\6X6
M%@L@V,C*2,C*L <'G!Q@X/H:\^\:74WC?Q9;>$=,?9%:R,]S<E1(BN%Y;Y>1
ML!9>2,LVTXP#47P4Y?7/]VV_]JT^7W;BYM;'5ZAXX.E^.;;P]>:<(X+DH(KS
MS]Q;>,*=@4D9D!3D^_2NOKS#XPV BM]*UJ"7R+F*8VX>-=LAR"ZG>#D;2C8'
MJY/'?T/2;XZGH]C?F+RC=6\<QCW;MFY0<9P,XSUQ2:T3&GK8N4445(PHHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M'&,8QBIJYOP#8W6F^"--M;RW>WG4.S1OPRAI&89'8X(.#R.AYKI*S>Y:/)?
M'_)5_$O^_>?^E(KK_B5_R3_4_P#ME_Z-2N/\ ?\ )5_$O^_>?^E(KL/B5_R3
M_4_^V7_HU*M_$OD0OA9D?#/P]I4_@B.ZNK&WN9;V27S3/"C_ "K)M"#(^[F-
M6P<_-SZ8YKQ[=0:O\4M-TN43/;P2VUI-$[$*3(X9BN#QE74$\'Y?85W'PO\
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M@[L<A2*F*NRI.R(/&GCSPUXJT0VT6GW8U"-@UM-,B#RSD;AE7)P5!XP1G![
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MK:L?BM8:IKFG:;9:3?O]KD\MV?:&C]"%4MN4<ECD;0">:Q/CA_Q[Z1_N7/\
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M,6QVZ8SEA26DK#W5ROKOQ*\(:IX:N-+BTZ3(MV2S66"'9!)L*HP&X[<9Z@9
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M@ P/A[%'%\4_$,<4:1QQ?:XT1% 55%PH  '08 KL?AG_ ,D^TSZS?^CGKD/
M'_)5_$O^_>?^E(HZR#HCE])\4Z-%X[NO$6L07%S;2O)/:J^&DC<N#&2"V/E3
M(')P0N.@(O>/O''AWQ38VXL+5H[Y)EWW$\<88Q!7^3<&)QN8''3K5R_N[OX>
M_$^ZU*>V-Q:7[2,&QM+Q2,KOLYQN1L#!ZX_AW C?N_C/I$=K(]MI=^\PQM6X
M,<:'GG+!F(XSV_+K5=4TA=+-EKQ)*\_P5CFDE:622QLV:1VW%R6C))/<GUJ?
MX5Z;8Q>#K34H[2%;V<S+)/MR[ 2LH&>H&$7@<9&>M3^/KG[9\,;RZ\F:#SHX
M)/*G7;(F9$.UAV89P1ZUQ?@KXC6WAOP]%IFIZ?=-$C.]K+;H,NK.Q;(9AT?<
M 1], KDRDW'0>BEJ,CFM/#/QL,%K$]O9M<1V_DP'"DS1K@8SC;O<-CH,# X
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M/-4[W;L2MK7,;XVL4BT=AU5;@C_R'7?W'A?36\,WFAV5K;VD%Q"R K$& ?:
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M.H:3=+?&X(ED@B7<0  %DWN""IWC   ],DDU_#>K7&N_&&PU.ZMQ;RW#NXB
M.%3[,^SD]<IM.> <Y  .*VM:YG>]C>^)]E>V'B32?%*P>;8V9@$A5L%624N
MQQPK9 !YYX[C/2^&_&?A_P 67=KF!(-7B5C%%.@++E1O\I\<@\CLQ"DE<"JN
MN?$J#P[XFN=*U#2;KR8HU>*>%@6ER <A6VC;G<,ACROUQQ!O;7Q;\3M)O- T
MN6&-'BFN8VB1#E9B\DK;21T*\DY)P.I&4E=:CO9Z'N->??&'_D4K3_K^3_T7
M)7H->??&'_D4K3_K^3_T7)40^)#EL;7@O1]-A\%Z<8["W4WUA$UT?+!,Q9,G
M>3]X99N#P <#BN/^%GEZ1XJ\0:"SO-.G28(%5EA<H21G@DR @<]^?7O?!_\
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MS1Q1C<WDNK%LY&XE6 &<8V#GT3X*_P#'QK_^Y;?SEH^.'_'MI'^Y<_RCJ_\
MEX3]D?\ &R&5H=&E2-\*+A/,"G:K$1D GH"=I('?:?2K_CW7/#=[\/VMM/O+
M"5R8/LD$6"T6&!X0<QX3<.0,9QWQ6;\8))[36M"O&>*:!%=DMIH0T89&0L6.
M<L&!4%?1#ZUDM<:9HR_;Y_AC<Q10\%[VZG:(;OE&X2(5/7 R.N.]"6B!O5GI
MGP_CNHO FDB[+&0Q%E+/N_=EB8^<GC85P.PP.,5TM87A;Q38^*M,%S;$1W"
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M2VUP+AHQ]YE"L#M'<_-G'?!QDX!Y[PG\0/#U[H-EH&N6Z1Q10Q6ZR3@303;
M@4MQ\I)&>1M&W.ZNJ\8^,3X0;3GDTV2ZMKJ1DDE1]OE8V\#C!8@L0"1G:?<C
MS?QQXOTCQA;6D.FZ7=IJ0N$42RP1[Y$PX$:E69CEF!"^OO4Q5U9E2=G<T?C/
MJ6^^T[3$>56AA:Y<$XC;>=J'KR1L?J. W'4U<B^)O@6'1X](72;@Z>@ %N\,
M3H<'=D@N<G/.3SGGK4?C_P -WS^ -!F,+[]*M%BNX% ;RU,:AF)!Z*4P<9X.
M> ":MZ?\9-.-A!_:6FWHO-O[TVJHT1/JNYP<'K@],XR<9+WBK"ZE3X)7#20Z
MS%Y^]$\AM@?*JQ#@D#L3M'/? ]*;X(_Y+'XA_P!R[_\ 2B.NT\'^,8_%\=_)
M%83VT=K-L5W.Y9 <D<CHX&"R\XW+R<UQ7@C_ )+'XA_W+S_THCI-WN/L+)_R
M<'#_ +__ +9FHOB/!%=_$W0;6=-\,ZVT4BY(RK3LI&1R.":DD_Y.#A_W_P#V
MS-'C_P#Y*OX:_P!^S_\ 2DU2W^0NGS.Q\9Z#9S> =0L[:"WM8K:,W,2QP+M0
MH=YV@8P6&X9']X]>AY;P]X@AL_@K?R1_:8Y+/S;3?%\K"65@592#D &93G@C
M!QVSWOBC_D4M9_Z\9_\ T6U<+\+[+^T_A]KU@)?*-S=30^9MW;-T$8SC(SC/
M2H7PZE/<YCP%XQ\.^$K>Z;4+29M1E?:LT*J<0X7"_,PQ\P).!S\N<X&$N/$>
ME:S\3M%OM#0V,;W$"2@!8GDD:8[R=A.=P8 DG)Y!JSX.\8MX#EU'1=9TV? E
M\QEB"^;'+A0006"E2H4@@^XW!@1U]C\5K#5-<T[3;+2;]_M<GENS[0T?H0JE
MMRCDL<C: 3S5N]V[$K:UST"O/OC#+)'X2M%25T62_19%5B Z^7(<'U&0#CU
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M#/L=!T?2YVGT_2;&TE9=ADM[=(V*Y!QD <9 _*M"BB@ HHHH **** "BBB@
MHHHH *SXM!T>#4#J$.DV,=Z69S<I;H)"S9W'<!G)R<^N36A10 52U#1],U;R
M_P"TM.M+SR\[/M,"R;,XSC<#C.!^57:* "BBB@ JE_8^F?VG_:?]G6G]H?\
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M_P#'J5^]C'7CZ\5Z?133L)JY2M]'TRSOI;ZVTZS@NYMWFSQ0*LCY.3E@,G)
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M>([B)9%#8(S@@\X)_.K5% $-I9VMA;);6=M#;6Z9V10H$5<G)P!P.234U%%
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M#=V=K?VSVUY;0W-N^-\4R!U;!R,@\'D T6EG:V%JEM9VT-M;IG;%"@1%R<G
M' Y)/XU-10 52_L?3/[3_M/^SK3^T/\ GZ\A?-^[M^_C/3CKTXJ[10 4444
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M@HHHI#"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
3 **** "BBB@ HHHH **** /_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>13
<FILENAME>img32108071_6.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img32108071_6.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" >&#SP# 2(  A$! Q$!_\0
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 5UWC:&**WT7RXT3=:@MM4#)P*Y&NQ\=?\>^A_P#7
MH/Y+7/5_C4_G^1U4OX%3Y?F<=11170<H4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110!Z#\,/^8K_P!L?_9Z]!KS[X8?
M\Q7_ +8_^SUZ#7SF/_WB7R_)'U&7?[M'Y_FPHHHKC.X**** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@#Y]HHHKZ\^)"BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "NQ\=?\ 'OH?_7H/Y+7'5V/CK_CWT/\ Z]!_):YJO\:G\_R.JC_ J?+\
MSCJ***Z3E"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** /0?AA_S%?\ MC_[/7H->??##_F*_P#;'_V>O0:^<Q_^\2^7
MY(^HR[_=H_/\V%%%%<9W!1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 ?/M%%%?7GQ(4444 %%%% !1110 445HKX?UEUW+I5[@_],&_P
MJ9U(0^)V+A3G/2";]#.HK2/A[65&3I5[^$#'^E5+BRNK0@7-M-"3T$L97^=*
M-6$OA:8Y4JD?BBU\B"BBBK,PHHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M76H5*+Y:BL%%%%:&04444 %%%% !1110 4444 %%.1'ED6.-&=V("JHR23V
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MTL6H2[T0L-R#!P,U%;%TJ,N69=#!U:\7*"T//****Z3E"BBB@ HHHH ****
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MO8'J/QS7)',J+=G='9+*J\5=69YO76^!_#]AKDEZU\KN( @55;:#NW<G'/\
M#7/V-@9];M]/N T1>X6&0="OS8/XUZ]H?ARR\/\ G_8WF;S]N[S6!^[G&, >
MII8[%*$.2+U>UAY=A)3J<\E[JT:?H<;XU\,:9HVEP7=C')&[3"-@7+ @JQ[]
M^*X:O<=:T6UUVS2UNVE6-)!(#&0#D CN#ZFN#\7>$=/T/28[NTDN"YF$9$C
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MD$98;R"0/4#&?YC\ZYSQZJMX3N"0"5=",]CN _K1;ZC]K^(,]JI_=VEBR_\
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M '%[#Z^M9J.T4BR(Q5U(92.Q%-HKU8PC&*@EH>1.I*<W.3U/>-.NUU'2[:[
M&)XE<CT)'(KQC7M/&E:[>62_<CD^3G/RGE?T(KTGP!<^?X6CC_YX2O'^N[_V
M:N;^)5H(]5M+L8 FB*'ZJ>OY,/RKQL$W2Q+I^J^X]S'I5L)&KVL_O.)HHHKV
MSP HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M2V-"M5XYN0?_ !UO\:\__F.^9Z?_ #+_ )'F%%%%>Z?.A1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M8XB*2[?FS'+ZDI8:3D[VO^2/*;CQAKUU;2V\U_NBE4HZ^4@R",$9"U=^'_\
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MXO\ $-W?ZS<VR3R1VD#F)8U; 8@X)..O(/X5ZY7.S^(?"\5Q)'--;B5&*N#
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M %R7^0KC?%OC6>PNWT[3,)+'Q+.R@X/HH/'XFNRL/^0?;?\ 7)?Y"O'O%?\
MR-.H_P#77^@KQ,!2A5JVFKV1[^95ITJ-X.S;L=9X+\67VH:DVGZC*)C(I:*3
M: 01U' Y&,FND\66Z7/A;4$?^&+S!]5Y'\J\W\#_ /(X6'_;3_T6U>F^)/\
MD6M2_P"O=_Y5IBZ<:6)CR:;/\3/!595<++GUM=?@>1:#J:Z/K=M?O&9%B)W*
M#@D%2IQ^==[_ ,+*TS_GSN_R7_&O/]'TQ]8U6"PC=8VE)^9AD  $G]!77_\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M=3U'^?2NNK3J5<.X2^)G%1JTJ.*4X_"O^&/4?&.CW.M:'Y%H TT<HE5"0-V
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M-SFK6V.[,\5"4%3IRO?>QU_PV_Y&*X_Z]&_]#2NM\=_\BE=?[T?_ *$*\_\
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MF52"ELHA!![CD_J2/PKBP_[W&.735_Y'?BOW.!4.MDO\SFJ***]T^>"BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MR,=<UT?AWQ\+*TCL]4CDD6,!4FCP3M[!AWQZUT,GC[04B+K--(P&=BQ')_/
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M:_1B/Y8/YFO'_#>L_P!A:S'>,K/$5*2JO4J?3\0#^%=X/B/HV,^3>_3RU_\
MBJXL9AJBK.4(MI]OQ.[ XJDZ"C4DDUW_  #XAZA]ET)+13A[J3!'^RO)_7;^
M=>65N^*M?7Q!JBS1(\=O$@2-7QD]R2!T_P#K"L*O3P5%TJ23W9Y6/KJM6;B]
M%HCW/1=175='M;U2,R1C>!V8<,/SS7G_ (L\(7Z:I/?6,#W-O.YD98QN9&)R
M1CJ1G)XK'\/>)KSP_,WE 36SG+P,< GU!['_ #Z5W=K\0]%F7]\+BW8=GCW
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 ?/M%%%?7GQ(4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!U?@'5ET_73
M:R$"*\ CR>,.,[?YD?5A79>.=.^W^&I9%'[RU/GCZ ?-^A)_"O(U9D8,K%64
MY!!P0:TYO$FLW%N]O+J-PT3KM92W4>AKSJ^#G*LJM-I'IX?'0C0=&JFS+HHH
MKT3S HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *T="TTZOK5K98.
MR1_WG.,(.6_0&LZI[2\N+&X6>UF>&5>C(<&HJ*3@U'<NDXQFG/:Y[?JM_'I6
ME7%Z^-L*$A>F3T _$X%>&2RO/,\LK%Y'8LS'J2>2:N7VM:GJ42Q7E[--&#D(
MS<9]<50KDP6$=!-RW9V8_&+$-*.R"BBBNXX HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KL?'7_'OH?\ UZ#^2UQU
M=CXZ_P"/?0_^O0?R6N:K_&I_/\CJH_P*GR_,XZBBBNDY0HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH *VO"FK+H_B"">0A89/W,I/&%;'.?0$ _A6+145*:J0
M<'U-*51TYJ:Z'MWB/33JV@7=HHS(R;H_]X<@?CC'XUXCUK57Q-K:0B%=3N0@
M7:/GY ^O6LJN7!8>I03C)JQUX_%4\0XR@FF@HHHKM. **** "BBB@ HHHH *
M*** "BBB@ HHHH ]A\%Z8=-\-P!QB6X/GO\ CC'_ (Z!^.:X7QWJO]H>(&AC
M?,-H/*7'3=_$?SX_X#6:GB76HX!"FI7 C"[0 _('UZUEDDDDG)/4FO.P^#G"
MLZM1W?\ F>GB<="=!4:::7GY"4445Z)Y@4444 %%%% !1110 4444 %%%% !
M1110!Z#\,/\ F*_]L?\ V>O0:\^^&'_,5_[8_P#L]>@U\YC_ />)?+\D?49=
M_NT?G^;"BBBN,[@HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** /GVBBBOKSXD**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH *['QU_Q[Z'_UZ#^2UQU=CXZ_
MX]]#_P"O0?R6N:K_ !J?S_(ZJ/\  J?+\SCJ***Z3E"BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /0?AA_S%?^V/\
M[/7H->??##_F*_\ ;'_V>O0:^<Q_^\2^7Y(^HR[_ ':/S_-A1117&=P4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M=3_Y\+C_ +X->T_8K;_GD/S-'V*V_P">0_,T?VI4_E0?V13_ )F>+?V+J?\
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M/V*V_P">0_,T?8K;_GD/S-']J5/Y4']D4_YF>+?V+J?_ #X7'_?!H_L74_\
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M=3_Y\+C_ +X->T_8K;_GD/S-'V*V_P">0_,T?VI4_E0?V13_ )F>+?V+J?\
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M/V*V_P">0_,T?8K;_GD/S-']J5/Y4']D4_YF>+?V+J?_ #X7'_?!H_L74_\
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M;_GD/S-'V*V_YY#\S1_:E3^5!_9%/^9GBW]BZG_SX7'_ 'P:/[%U/_GPN/\
MO@U[3]BMO^>0_,T?8K;_ )Y#\S1_:E3^5!_9%/\ F9XM_8NI_P#/A<?]\&C^
MQ=3_ .?"X_[X->T_8K;_ )Y#\S1]BMO^>0_,T?VI4_E0?V13_F9XM_8NI_\
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MX7'_ 'P:/[%U/_GPN/\ O@U[3]BMO^>0_,T?8K;_ )Y#\S1_:E3^5!_9%/\
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M&*[LVS\0]6'_ "[V7_?#_P#Q5-/Q%U<?\NUC_P!\/_\ %5AG0]6_Z!=[_P"
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M\+V0?6<7W9T/_"R=8_Y]K'_OV_\ \51_PLG6/^?:Q_[]O_\ %5SW]@ZQ_P!
MF^_\!G_PH_L'6/\ H$WW_@,_^%'U?"]D'UG%]V=#_P +)UC_ )]K'_OV_P#\
M51_PLG6/^?:Q_P"_;_\ Q5<]_8.L?] F^_\  9_\*/[!UC_H$WW_ (#/_A1]
M7PO9!]9Q?=G0_P#"R=8_Y]K'_OV__P 51_PLG6/^?:Q_[]O_ /%5SW]@ZQ_T
M";[_ ,!G_P */[!UC_H$WW_@,_\ A1]7PO9!]9Q?=G0_\+)UC_GVL?\ OV__
M ,51_P +)UC_ )]K'_OV_P#\57/?V#K'_0)OO_ 9_P#"C^P=8_Z!-]_X#/\
MX4?5\+V0?6<7W9T/_"R=8_Y]K'_OV_\ \51_PLG6/^?:Q_[]O_\ %5SW]@ZQ
M_P! F^_\!G_PH_L'6/\ H$WW_@,_^%'U?"]D'UG%]V=#_P +)UC_ )]K'_OV
M_P#\51_PLG6/^?:Q_P"_;_\ Q5<]_8.L?] F^_\  9_\*/[!UC_H$WW_ (#/
M_A1]7PO9!]9Q?=G0_P#"R=8_Y]K'_OV__P 51_PLG6/^?:Q_[]O_ /%5SW]@
MZQ_T";[_ ,!G_P */[!UC_H$WW_@,_\ A1]7PO9!]9Q?=G0_\+)UC_GVL?\
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M-]_X#/\ X4?5\+V0?6<7W9T/_"R=8_Y]K'_OV_\ \51_PLG6/^?:Q_[]O_\
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M]V=#_P +)UC_ )]K'_OV_P#\51_PLG6/^?:Q_P"_;_\ Q5<]_8.L?] F^_\
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M_0)OO_ 9_P#"C^P=8_Z!-]_X#/\ X4?5\+V0?6<7W9T/_"R=8_Y]K'_OV_\
M\51_PLG6/^?:Q_[]O_\ %5SW]@ZQ_P! F^_\!G_PH_L'6/\ H$WW_@,_^%'U
M?"]D'UG%]V=#_P +)UC_ )]K'_OV_P#\51_PLG6/^?:Q_P"_;_\ Q5<]_8.L
M?] F^_\  9_\*/[!UC_H$WW_ (#/_A1]7PO9!]9Q?=G0_P#"R=8_Y]K'_OV_
M_P 51_PLG6/^?:Q_[]O_ /%5SW]@ZQ_T";[_ ,!G_P */[!UC_H$WW_@,_\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH <M+2
M+2T#"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M&4444""BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH <M+2+2T#"BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M_E70LOH2=E/\CFEF>(BKN'YGJO\ PL#PU_S_ $W_ (!S_P#Q%'_"P/#7_/\
M3?\ @'/_ /$5Y5!;W%U)Y=M;S3R ;BD,;.0/7 !XY'YU8_LC5?\ H$:C_P"
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MV5>96A&%1QB[I'K4)RG34I*S9!>WMOIUG+=W<HB@B7<[$$X'L!R3V ')/ K
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 ,HHHH$%%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 Y:6D6EH&%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 ,HJ$W=N#@RK2?;+?\ YZK0(GHJ#[9;_P#/5:/MEO\ \]5H GHJ#[9;
M_P#/5:/MEO\ \]5H GHJ#[9;_P#/5:/MEO\ \]5H GHJ#[9;_P#/5:/MEO\
M\]5H GHJ#[9;_P#/5:/MEO\ \]5H GHJ#[9;_P#/5:/MEO\ \]5H GHJ#[9;
M_P#/5:/MEO\ \]5H GHJ#[9;_P#/5:/MEO\ \]5H GHJ#[9;_P#/5:/MEO\
M\]5H GHJ#[9;_P#/5:/MEO\ \]5H GHJ#[9;_P#/5:/MEO\ \]5H GHJ#[9;
M_P#/5:/MEO\ \]5H GHJ#[9;_P#/5:/MEO\ \]5H GHJ#[9;_P#/5:/MEO\
M\]5H GHJ#[9;_P#/5:/MEO\ \]5H GHJ#[9;_P#/5:/MEO\ \]5H GHJ#[9;
M_P#/5:/MEO\ \]5H GHJ#[9;_P#/5:/MEO\ \]5H GHJ#[9;_P#/5:/MEO\
M\]5H GHJ#[9;_P#/5:/MEO\ \]5H GHJ#[9;_P#/5:/MEO\ \]5H GHJ#[9;
M_P#/5:/MEO\ \]5H GHJ#[9;_P#/5:/MEO\ \]5H GHJ#[9;_P#/5:/MEO\
M\]5H GHJ#[9;_P#/5:/MEO\ \]5H GHJ#[9;_P#/5:/MEO\ \]5H GHJ#[9;
M_P#/5:/MEO\ \]5H GHJ#[9;_P#/5:/MEO\ \]5H GHJ#[9;_P#/5:/MEO\
M\]5H GHJ#[9;_P#/5:/MEO\ \]5H GHJ#[9;_P#/5:/MEO\ \]5H GHJ#[9;
M_P#/5:/MEO\ \]5H GHJ#[9;_P#/5:/MEO\ \]5H GHJ#[9;_P#/5:/MEO\
M\]5H GHJ#[9;_P#/5:/MEO\ \]5H GHJ#[9;_P#/5:/MEO\ \]5H GHJ#[9;
M_P#/5:/MEO\ \]5H GHJ#[9;_P#/5:/MEO\ \]5H GHJ#[9;_P#/5:/MEO\
M\]5H GHJ#[9;_P#/5:/MEO\ \]5H GHJ#[9;_P#/5:/MEO\ \]5H GHJ#[9;
M_P#/5:/MEO\ \]5H GHJ#[9;_P#/5:/MEO\ \]5H GHJ#[9;_P#/5:/MEO\
M\]5H GHJ#[9;_P#/5:/MEO\ \]5H GHJ#[9;_P#/5:/MEO\ \]5H GHJ#[9;
M_P#/5:/MEO\ \]5H GHJ#[9;_P#/5:/MEO\ \]5H GHJ#[9;_P#/5:/MEO\
M\]5H GHJ#[9;_P#/5:/MEO\ \]5H GHJ#[9;_P#/5:/MEO\ \]5H GHJ#[9;
M_P#/5:/MEO\ \]5H GHJ#[9;_P#/5:/MEO\ \]5H GHJ#[9;_P#/5:/MEO\
M\]5H GHJ#[9;_P#/5:/MEO\ \]5H GHJ#[9;_P#/5:/MEO\ \]5H GHJ#[9;
M_P#/5:/MEO\ \]5H GHJ#[9;_P#/5:/MEO\ \]5H GHJ#[9;_P#/5:/MEO\
M\]5H GHJ#[9;_P#/5:/MEO\ \]5H GHJ#[9;_P#/5:/MEO\ \]5H GHJ#[9;
M_P#/5:/MEO\ \]5H GHJ#[9;_P#/5:/MEO\ \]5H GHJ#[9;_P#/5:/MEO\
M\]5H GHJ#[9;_P#/5:/MEO\ \]5H GHJ#[9;_P#/5:/MEO\ \]5H GHJ#[9;
M_P#/5:/MEO\ \]5H GHJ#[9;_P#/5:/MEO\ \]5H GHJ#[9;_P#/5:/MEO\
M\]5H GHJ#[9;_P#/5:/MEO\ \]5H GHJ#[9;_P#/5:/MEO\ \]5H GHJ#[9;
M_P#/5:/MEO\ \]5H GHJ#[9;_P#/5:/MEO\ \]5H GHJ#[9;_P#/5:/MEO\
M\]5H GHJ#[9;_P#/5:/MEO\ \]5H GHJ#[9;_P#/5:/MEO\ \]5H GHJ#[9;
M_P#/5:/MEO\ \]5H GHJ#[9;_P#/5:/MEO\ \]5H GHJ#[9;_P#/5:/MEO\
M\]5H GHJ#[9;_P#/5:/MEO\ \]5H GHJ#[9;_P#/5:/MEO\ \]5H GHJ#[9;
M_P#/5:/MEO\ \]5H GHJ#[9;_P#/5:/MEO\ \]5H GHJ#[9;_P#/5:/MEO\
M\]5H GHJ#[9;_P#/5:/MEO\ \]5H GHJ#[9;_P#/5:/MEO\ \]5H GHJ#[9;
M_P#/5:/MEO\ \]5H GHJ#[9;_P#/5:/MEO\ \]5H GHJ#[9;_P#/5:/MEO\
M\]5H GHJ#[9;_P#/5:/MEO\ \]5H GHJ#[9;_P#/5:/MEO\ \]5H GHJ#[9;
M_P#/5:/MEO\ \]5H GHJ#[9;_P#/5:/MEO\ \]5H GHJ#[9;_P#/5:/MEO\
M\]5H GHJ#[9;_P#/5:/MEO\ \]5H GHJ#[9;_P#/5:/MEO\ \]5H GHJ#[9;
M_P#/5:/MEO\ \]5H GHJ#[9;_P#/5:/MEO\ \]5H GHJ#[9;_P#/5:/MEO\
M\]5H GHJ#[9;_P#/5:/MEO\ \]5H GHJ#[9;_P#/5:/MEO\ \]5H GHJ#[9;
M_P#/5:/MEO\ \]5H GHJ#[9;_P#/5:/MEO\ \]5H GHJ#[9;_P#/5:/MEO\
M\]5H GHJ#[9;_P#/5:/MEO\ \]5H GHJ#[9;_P#/5:/MEO\ \]5H GHJ#[9;
M_P#/5:/MEO\ \]5H GHJ#[9;_P#/5:/MEO\ \]5H GHJ#[9;_P#/5:/MEO\
M\]5H GHJ#[9;_P#/5:/MEO\ \]5H GHJ#[9;_P#/5:/MEO\ \]5H GHJ#[9;
M_P#/5:/MEO\ \]5H GHJ#[9;_P#/5:/MEO\ \]5H GHJ#[9;_P#/5:/MEO\
M\]5H GHJ#[9;_P#/5:/MEO\ \]5H GHJ#[9;_P#/5:/MEO\ \]5H GHJ#[9;
M_P#/5:/MEO\ \]5H GHJ#[9;_P#/5:/MEO\ \]5H GHJ#[9;_P#/5:/MEO\
M\]5H GHJ#[9;_P#/5:/MEO\ \]5H GHJ#[9;_P#/5:/MEO\ \]5H GHJ#[9;
M_P#/5:/MEO\ \]5H GHJ#[9;_P#/5:/MEO\ \]5H GHJ#[9;_P#/5:/MEO\
M\]5H GHJ#[9;_P#/5:/MEO\ \]5H GHJ#[9;_P#/5:/MEO\ \]5H GHJ#[9;
M_P#/5:/MEO\ \]5H GHJ#[9;_P#/5:/MEO\ \]5H GHJ#[9;_P#/5:/MEO\
M\]5H GHJ#[9;_P#/5:/MEO\ \]5H GHJ#[9;_P#/5:/MEO\ \]5H GHJ#[9;
M_P#/5:/MEO\ \]5H GHJ#[9;_P#/5:/MEO\ \]5H GHJ#[9;_P#/5:/MEO\
M\]5H GHJ#[9;_P#/5:/MEO\ \]5H GHJ#[9;_P#/5:/MEO\ \]5H GHJ#[9;
M_P#/5:/MEO\ \]5H GHJ#[9;_P#/5:/MEO\ \]5H GHJ#[9;_P#/5:/MEO\
M\]5H GHJ#[9;_P#/5:/MEO\ \]5H GHJ#[9;_P#/5:/MEO\ \]5H GHJ#[9;
M_P#/5:/MEO\ \]5H GHJ#[9;_P#/5:/MEO\ \]5H GHJ#[9;_P#/5:/MEO\
M\]5H GHJ#[9;_P#/5:/MEO\ \]5H GHJ#[9;_P#/5:/MEO\ \]5H GHJ#[9;
M_P#/5:/MEO\ \]5H GHJ#[9;_P#/5:/MEO\ \]5H GHJ#[9;_P#/5:/MEO\
M\]5H GHJ#[9;_P#/5:/MEO\ \]5H GHJ#[9;_P#/5:/MEO\ \]5H GHJ#[9;
M_P#/5:/MEO\ \]5H GHJ#[9;_P#/5:/MEO\ \]5H GHJ#[9;_P#/5:/MEO\
M\]5H GHJ#[9;_P#/5:/MEO\ \]5H GHJ#[9;_P#/5:/MEO\ \]5H GHJ#[9;
M_P#/5:/MEO\ \]5H GHJ#[9;_P#/5:/MEO\ \]5H GHJ#[9;_P#/5:/MEO\
M\]5H GHJ#[9;_P#/5:/MEO\ \]5H GHJ#[9;_P#/5:/MEO\ \]5H GHJ#[9;
M_P#/5:/MEO\ \]5H GHJ#[9;_P#/5:/MEO\ \]5H GHJ#[9;_P#/5:/MEO\
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MH^SQ?\\Q4E% $?V>+_GF*/L\7_/,5)10!']GB_YYBC[/%_SS%244 1_9XO\
MGF*/L\7_ #S%244 1_9XO^>8H^SQ?\\Q4E% $?V>+_GF*/L\7_/,5)10!']G
MB_YYBC[/%_SS%244 1_9XO\ GF*/L\7_ #S%244 1_9XO^>8H^SQ?\\Q4E%
M$?V>+_GF*/L\7_/,5)10!']GB_YYBC[/%_SS%244 1_9XO\ GF*/L\7_ #S%
M244 1_9XO^>8H^SQ?\\Q4E% $?V>+_GF*/L\7_/,5)10!']GB_YYBC[/%_SS
M%244 1_9XO\ GF*/L\7_ #S%244 1_9XO^>8H^SQ?\\Q4E% $?V>+_GF*/L\
M7_/,5)10!']GB_YYBC[/%_SS%244 1_9XO\ GF*/L\7_ #S%244 1_9XO^>8
MH^SQ?\\Q4E% $?V>+_GF*/L\7_/,5)10!']GB_YYBC[/%_SS%244 1_9XO\
MGF*/L\7_ #S%244 1_9XO^>8H^SQ?\\Q4E% $?V>+_GF*/L\7_/,5)10!']G
MB_YYBC[/%_SS%244 1_9XO\ GF*/L\7_ #S%244 1_9XO^>8H^SQ?\\Q4E%
M$?V>+_GF*/L\7_/,5)10!']GB_YYBC[/%_SS%244 1_9XO\ GF*/L\7_ #S%
M244 1_9XO^>8H^SQ?\\Q4E% $?V>+_GF*/L\7_/,5)10!']GB_YYBC[/%_SS
M%244 1_9XO\ GF*/L\7_ #S%244 1_9XO^>8H^SQ?\\Q4E% $?V>+_GF*/L\
M7_/,5)10!']GB_YYBC[/%_SS%244 1_9XO\ GF*/L\7_ #S%244 1_9XO^>8
MH^SQ?\\Q4E% $?V>+_GF*/L\7_/,5)10!']GB_YYBC[/%_SS%244 1_9XO\
MGF*/L\7_ #S%244 1_9XO^>8H^SQ?\\Q4E% $?V>+_GF*/L\7_/,5)10!']G
MB_YYBC[/%_SS%244 1_9XO\ GF*/L\7_ #S%244 1_9XO^>8H^SQ?\\Q4E%
M$?V>+_GF*/L\7_/,5)10!']GB_YYBC[/%_SS%244 1_9XO\ GF*/L\7_ #S%
M244 1_9XO^>8H^SQ?\\Q4E% $?V>+_GF*/L\7_/,5)10!']GB_YYBC[/%_SS
M%244 1_9XO\ GF*/L\7_ #S%244 1_9XO^>8H^SQ?\\Q4E% $?V>+_GF*/L\
M7_/,5)10!']GB_YYBC[/%_SS%244 1_9XO\ GF*/L\7_ #S%244 1_9XO^>8
MH^SQ?\\Q4E% $?V>+_GF*/L\7_/,5)10!']GB_YYBC[/%_SS%244 1_9XO\
MGF*/L\7_ #S%244 1_9XO^>8H^SQ?\\Q4E% $?V>+_GF*/L\7_/,5)10!']G
MB_YYBC[/%_SS%244 1_9XO\ GF*/L\7_ #S%244 1_9XO^>8H^SQ?\\Q4E%
M$?V>+_GF*/L\7_/,5)10!']GB_YYBC[/%_SS%244 1_9XO\ GF*/L\7_ #S%
M244 1_9XO^>8H^SQ?\\Q4E% $?V>+_GF*/L\7_/,5)10!']GB_YYBC[/%_SS
M%244 1_9XO\ GF*/L\7_ #S%244 1_9XO^>8H^SQ?\\Q4E% $?V>+_GF*/L\
M7_/,5)10!']GB_YYBC[/%_SS%244 1_9XO\ GF*/L\7_ #S%244 1_9XO^>8
MH^SQ?\\Q4E% $?V>+_GF*/L\7_/,5)10!']GB_YYBC[/%_SS%244 1_9XO\
MGF*/L\7_ #S%244 1_9XO^>8H^SQ?\\Q4E% $?V>+_GF*/L\7_/,5)10!']G
MB_YYBC[/%_SS%244 1_9XO\ GF*/L\7_ #S%244 1_9XO^>8H^SQ?\\Q4E%
M$?V>+_GF*/L\7_/,5)10!']GB_YYBC[/%_SS%244 1_9XO\ GF*/L\7_ #S%
M244 1_9XO^>8H^SQ?\\Q4E% $?V>+_GF*/L\7_/,5)10!']GB_YYBC[/%_SS
M%244 1_9XO\ GF*/L\7_ #S%244 1_9XO^>8H^SQ?\\Q4E% $?V>+_GF*/L\
M7_/,5)10!']GB_YYBC[/%_SS%244 1_9XO\ GF*/L\7_ #S%244 1_9XO^>8
MH^SQ?\\Q4E% $?V>+_GF*/L\7_/,5)10!']GB_YYBC[/%_SS%244 1_9XO\
MGF*/L\7_ #S%244 1_9XO^>8H^SQ?\\Q4E% $?V>+_GF*/L\7_/,5)10!']G
MB_YYBC[/%_SS%244 1_9XO\ GF*/L\7_ #S%244 1_9XO^>8H^SQ?\\Q4E%
M$?V>+_GF*/L\7_/,5)10!']GB_YYBC[/%_SS%244 1_9XO\ GF*/L\7_ #S%
M244 1_9XO^>8H^SQ?\\Q4E% $?V>+_GF*/L\7_/,5)10!']GB_YYBC[/%_SS
M%244 1_9XO\ GF*/L\7_ #S%244 1_9XO^>8H^SQ?\\Q4E% $?V>+_GF*/L\
M7_/,5)10!']GB_YYBC[/%_SS%244 1_9XO\ GF*/L\7_ #S%244 1_9XO^>8
MH^SQ?\\Q4E% $?V>+_GF*/L\7_/,5)10!']GB_YYBC[/%_SS%244 1_9XO\
MGF*/L\7_ #S%244 1_9XO^>8H^SQ?\\Q4E% $?V>+_GF*/L\7_/,5)10!']G
MB_YYBC[/%_SS%244 1_9XO\ GF*/L\7_ #S%244 1_9XO^>8H^SQ?\\Q4E%
M$?V>+_GF*/L\7_/,5)10!']GB_YYBC[/%_SS%244 1_9XO\ GF*/L\7_ #S%
M244 1_9XO^>8H^SQ?\\Q4E% $?V>+_GF*/L\7_/,5)10!']GB_YYBC[/%_SS
M%244 1_9XO\ GF*/L\7_ #S%244 1_9XO^>8H^SQ?\\Q4E% $?V>+_GF*/L\
M7_/,5)10!']GB_YYBC[/%_SS%244 1_9XO\ GF*/L\7_ #S%244 1_9XO^>8
MH^SQ?\\Q4E% $?V>+_GF*/L\7_/,5)10!']GB_YYBC[/%_SS%244 1_9XO\
MGF*/L\7_ #S%244 1_9XO^>8H^SQ?\\Q4E% $?V>+_GF*/L\7_/,5)10!']G
MB_YYBC[/%_SS%244 1_9XO\ GF*/L\7_ #S%244 1_9XO^>8H^SQ?\\Q4E%
M$?V>+_GF*/L\7_/,5)10!']GB_YYBC[/%_SS%244 1_9XO\ GF*/L\7_ #S%
M244 1_9XO^>8H^SQ?\\Q4E% $?V>+_GF*/L\7_/,5)10!']GB_YYBC[/%_SS
M%244 2VD:1[]J@9Q5FH+?^+\*GI#"BBB@ HHHH **** "BBB@ HHHH ****
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M""21X3-,;A"1@L0NTAAS\K9R/3WKJ/#7AJQ\+:6;"P:9T>4RR23,&=V( R<
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MF"C@#)8D#@ GM4QBI-OH5)M*QL7_ ,0_%%]%/'+J\D,,K;ML"K$4&<@*Z@.
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MV-8O+1;J,.!C&&++AF/'4L<Y.>>:]N\/V]C:^'=.ATPEK(6Z&%RNTNI&=S#
M^9LY/ Y)I=7T'2M>MUAU2RBN57[C-D.G()VL,,N=HS@\XP:KGCV#E?<FTJ^.
MIZ/97YB\HW5O'-Y>[=LW*#C.!G&>N*MU#:6L-C9P6ELFR""-8HUR3M51@#)Y
M/ [U-6185@>-=6NM$\(:AJ%DRK<QJBHS+NVEG5<X]1NR,\9Z@]*WZY/XF?\
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M<R8$]NQRT3?U!YP>_L00*?C?PI;^(]#N3#:PG58XP;:;8-Y*DD1[LC@Y8<G
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MDLBD.$SMR"5)&>@.,XYQG&3UK:MA:E%<TUH84,92KR<8/4TJ***YSJ"BBB@
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MW/H6EQW%O%&\LLPB7S,[5X9B2!C/"XZCK[8JIX1\2W6O/>Q7<,*/;^6P:($
MA]PQ@D\C8><]^G'.JHS=/VO0Q=>"J^RZG3T445D;!1110 4444 %%%% !114
M-S>6MDBO=7,,",VU6E<*"<$X&>^ ?RH2OL#=M6345CV'BG1=2D,=M?+O!50L
MR-$6+< +O W'Z9[>HK8IRC*.DE8F,XR5XNX4444B@HJ.>>&VA::XECBB7&7D
M8*!DX')]ZR[;Q3HMW?-90WZF8-M^9&16.0N%8@*Q)(Q@G/:J4)-72)<XQ=FS
M8HHK-U37]+T8J+Z[6-VQB-59WP<X.U02!\IYQC(Q247)V0Y245=LTJ*YZ+QO
MX>FE2);YPSL%!>VE49/J2N /<\5IKK6E-(D:ZG9EW8*BB=<L3P !GDU3I36Z
M9"JTWM)?>7J***@T"BLO5?$6EZ++''?W)CDD!952)Y#CU(4''X]<'T-7[>X@
MNX1-;31S1,2 \;!E.#@\CT((_"FXR2NUH2I1;LGJ2T444B@HHK-U37]+T8JM
M]=K&[8Q&JL[X.<':H) ^4\XQD8II.3LA2DHJ[9I45S9\>>' /^/V;_P#F_\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !14-U=6]E;M<7=Q%;P+@-)*X11DX&2>.20
M/QKF?^%E>$_^@G)_X!S_ /Q%%FPN=917)_\ "RO"?_03D_\  .?_ .(H_P"%
ME>$_^@G)_P" <_\ \13LQ71UE%9.C^)M&U_<--OTF=<YC*LCX&,G:P!Q\PYQ
MC)Q6M2&%%%<Y)X]\+QW@M3K$)<LJ[T5FCYQ@^8!MQSR<X'.<8-%K@='1110
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M3A/,NU^UR,C$AM^"IYZ'9L! XR#UZG7\2QR2^%=8CAC>65[*94C12S,Q0X
MY)/I6<G>5RTK1/FF&>6UN8;F"0Q302++&X .UE((.#D'D#K71_\ "R/%W_0>
M?_P&@_\ B*R=!OUTSQ!IM\]P\$4%U&\LB9R(PPW].2"N00.H.*^G:UJ22>J(
M@F^I\\?\+(\7?]!Y_P#P&@_^(K!U'4[K5;Z6_P!0N?/N9<>9(55<X  X4 =
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MBC0G5;4>@ZV(A12<^IZ%139)$BC:21U1$!9F8X  ZDFN U?Q_.9)8M,CCB@
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M3VFOQ_K\ST>BBJVH7T&FV$]Y<-B*%=QY +'LHR0,DX '<D5XB5W9'O-I*[.
M\?:BT^KQV*R?N;9 S* P_>-SSV.%VX(Z;FYYP.,O WV&Y62-D81N&1U(93@Y
M!!Z'VK<\/V$VM>((4E*2DR&XNF=%(<!LOE>!\Q...F[.,"J'B3_C_P!9_P"N
M]Q_Z$U?1T4J:]BNBNSYBNW5?MWU=D>W5YM\01_Q/X#_TZK_Z$]>DUYO\0?\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MITV30LT<B9!VLI((R..HKZ+T30=.\/V2VUA;JGRA9)2!YDI&>7;')R3[#/
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@">
MW_B_"IZ@M_XOPJ>D,**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M5U8X+X*_\?&O_P"Y;?SEKUJL7PWX6TWPM8M;6"NS2-NEGEP9).N-Q  P,X
M Z]R2=JB3N[A%65B&[M8;ZRGL[E-\$\;12+DC<K#!&1R.#VKYQ\3>%[[POJ1
MLKT"2-P3#<*N$F7U'H1D97MGN""?I2J>IZ58:S9M::C:17,!R0LBYVG!&Y3U
M5L$\C!&:<)\HI1N>5>'_ (NW5M%';Z[:M>?.Q:[A*J^WJ!LP%)SQG*\8X)',
MVL?&*26*Z@TC33"64"&[GD!920,DQX(R.<?,1T)':MZY^$7AR>Y>6*;4+=&Q
MB&*92J\ <%E+>_)/6BV^$7AR"Y266;4+A%SF&690K<8Y*J&]^".E5>GN3:9Y
M7X=\.ZEXOUAH('8\^9=7<N6$8).68]68G.!G).>@!(^B[6UALK."TMTV001K
M'&N2<*HP!D\G@=ZATS2=/T:S6TTVTBMH!@E8UQN. -S'JS8 R3DG')JY4SGS
M%1C8\@\8>,_$?ASQ[>K;3G[($C\JWN(LQ.OE]1T/WV?D$$E<$D+@:EE\9=->
M)C?Z5>0R[L*MNZR@K@<DL4P<YXP?KZ=OK?AS2?$44,>JV:W"PL6C.]D921@\
MJ0<'N.AP/05R"_!S0 ,&_P!5/N9(O_C=-.#6HFI7T./\<?$,^)K5=.L;:6VL
M1()&>1\/-@<!E'  ))QELD*>,8KH/A#X>EB2?Q#,<1SQFWM@K@[E#_.Q&./F
M0 <]FXZ&MW3?A5X9L)C+-'<WQW*R+=2C:I!ST0*&!XR&R#CZY[:B4U:T047>
M[,CQ5_R)^M_]>$__ *+:OGOP[_R-6B?]A&V_]&K7TK=VL-]9SVERF^">-HI%
MR1N5A@C(Y'![5RFD_#30-(UL:I$+F9D8O#!.ZM'"V<@J-N25[;B<=>H!HA))
M-!*+;1V->%:/\3?$FC7+Q:F/MZAV\V&Y7RY$;+$@,!\OS'H00 N %KW6N9\0
M> ]!\1SR7-W!)%>R*JFYMY"KX4^ARI..,E2<<=AB8M+<<DWL8$/QCT1H8S/I
M^HI*5!=45&56QR 2P)&>^!]!7FOB_P 67'BK4DO)XA;00QA(X!*75.[,2<#)
M/< <!1VS7IO_  IW0,?\?VJ_]_(__C=;OA_P'H/AR>.YM+>26]C5E%S<2%GP
MQ]!A0<<9"@XX[G-J4(ZHEJ3W&^ O#LWAKPREK=<7<\C3SH'#!&( "@@=E5<]
M><X)&*Z>BBLV[NYHE8*Y/XF?\D^U/ZP_^CDKK*J:GIEGK.GRV%_#YUM+MWIN
M*YP0PY!!Z@4)V=Q/8\$^'/\ R4/1O]^;_P!$25]#5RGAOX>Z-X9OFO;=KFZN
M=NV.2Z*,8NH.W:HP2#@GKC@8R<]753DI.Z%%61\^?$G_ )*#JOUB_P#1*5ZI
M\+_^2>:;_OS_ /H^2E\1?#G1/$>H-?SR7EM<O_K7MY!^\P HR'# 8"]L=\YK
MI;"PM-+L8;*Q@2"VA7:D:#@=S]23DDGDDDFG*2<4A*+3;+-?/?Q'_P"2A:O_
M +T7_HF.OH2N1\0_#G1/$>HM?SO>6UU(<RO;RC]YA549#A@,!1TQWSFE"2B[
ML<E=!\,?^2>Z9_O3_P#HYZZZJ>EZ79Z-IT5AI\/DVL6XHFXMC+%CR23U)JY4
MMW=QK8^>?B-_R4/6?]^'_P!$1UZU\,_^2?:9]9O_ $<]+XD^'NC>)K];VX:Y
MM;G;MDDM2BF7H!NW*<D 8!X..#G QT&F:99Z/I\5A80^3;1;MB;BV,DL>22>
MI-7*2<4B5%IW.(^,7_(IV?\ U_I_Z+DKQ>)YHY1+ 95>'$OF1Y!CPP ;(^[\
MS* ?4CO7M'QB_P"13L_^O]/_ $7)7(_"#_D=I_\ L'2_^C(JN#M"Y,E>5B_I
M?QBO8+81:GIL=U(JG$T4GEEB%^7<N",EAR1@ 'A>,'"\6_$&_P#%5O%:+ +&
MR'S20)+O\UL\%FP,@<8&.O)SQCT;4?A3X<O[QKB/[79!LEHK:10F2220&5L=
M<8&  !@"GZ;\+/#5A,998[F^(96074H*J0<]%"A@>X;(X^N94H+6P[2V.0^$
M_AB:YU(>(9_.BM[8LMM@ +.Q5E;D\X4'L.2>ORD5[)3(88K:"."")(H8U")&
MBA550,  #H .U/J)2YG<M*RL?/GQ)_Y*#JOUB_\ 1*5ZI\+_ /DGFF_[\_\
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M;?\ 8/C_ /1DM=7\'/\ D5+[_L(/_P"BHZW?$W@72/%4\=Q>&YAND54$]O(
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MG*?\+I_Z@'_DY_\ 84?\+I_Z@'_DY_\ 85U?_"M?"/\ T"?_ "9E_P#BJ/\
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M !Q_SQU/_P #X_\ XY7KXVC&34>=126QXN!K2A&4^1R;>Z.E\<:3!<Z.^H+
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M^ND?_HF.O3=!_P"1=TS_ *](O_0!7F7BO_D<-6_ZZ1_^B8Z]-T'_ )%W3/\
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M%_Y EG_U^#_T7)7+>%="37M1E6:3;;6P1YE4D,^XG"@]A\IR>OIUR.I^(O\
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MI.6"A-;QU.TL[E;VQM[M%=$GC615< , PS@X[\UR'C_5_+BBTB(_-*!--Q_
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MFMZLL<45I QBMT<%]W*^H7)' &3DN.A%9,4%_P",O$33&(HC,OG$2';!$.,
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M0!/;_P 7X5/4%O\ Q?A4](84444 %%%% !1110 4444 %%%% !1110 4444
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M1$YSLX!Z'&3S@<8R1725CBZ\:EH4_AB;8+#3I\TZGQ2/#_$/_']K7_7Q<_\
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M%%%<AV!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MHVR*QS@$]%/:H11MU\X>)_\ D9-:_P"ORX_]#:NL_P"%3:]_S]Z;_P!_'_\
MB*/^%3:]_P _>F_]_'_^(K:/+'J9RN^A['17CG_"IM>_Y^]-_P"_C_\ Q%>K
M:/9R:?HEA92E#);VT<3%#E<JH!Q[<5G));,M-LNUXGXRUV[\7^)$TS2UFFMH
MG,4$*.I6:0$YE&.,8Z$D@*,\9-=Y\1+O6H=#6TTG3I;F.\WPW,D49E:-"/NA
M "?F&X;N@QCJ011^'?@X:9:KJ^I6NW49,^0LGWH8R/[N/E<\Y[@<<984XV2N
M)ZZ'4^'="@\.Z+#IT#>84RTDI4*9'/4G'Y#J0 !DXKR_XL,#XLME[BQ0_P#D
M23_"O9:YOQEX3B\4Z:BK)Y5[;[C;2,3LR<95AZ' YQD8SSR"1E:5V$E=61K:
M-J<>LZ+9ZC&$ N(E<JCAPC8^9<CJ5.0?<&O$+3_2OB6DEK_I"2:T94:'YPR>
M>6W CJ-O.>F.:TT\*_$"P!MK07R01,P06^HJD9&3RJ[Q@'KR >>178^"_A^?
M#MZ=1O[F*>[\LI''&F4BR>6#$9)*X' &,L.<U2M&^HM6=S1116184444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% $]O_%^
M%3U!;_Q?A4](84444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110!1HHHIB"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#R#Q/JD>IZ[=7:2[[9 (
MXF^7&Q>X(ZJ3N8'T;\*]1T:P_LO1K2SPH>.,;]K%@7/+$$\X+$G_  JC!X0T
M*VEAEALBKPNKH?/DX*G(_BYZ=ZW*[,3B(U(1IP6B.'"X:=.I.I4=VPHHHKC.
MX**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M<]=JD[5]. ,#(Z5TX6O&BW)J[MH<F+P\J\5!.ROJ7=/L8--L(+.W7$4*[1P
M6/=C@ 9)R2>Y)JS117,W=W9U))*R"BBB@84444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% $]O_ !?A4]06_P#%^%3TAA1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !115.^U;3=,,8U#4+2T,N?+%Q,L>_&,XR1G&1^8H N456LM0LM2
MA::QO+>ZB5MA>"574-@'&0>N"/SJS0 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@">W_B_"IZ@M_P"+
M\*GI#"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@!DTT5O!)//(D44:EWD=@JJH&223T %4+;Q#HE[<QVUIK&G
MSSR9V117*,S8&3@ Y/ )_"H_%'_(I:S_ ->,_P#Z+:O$OAM_R4'2OK+_ .B7
MJXQNFR7*SL?0=%%%04%%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %>8_$KQGJ^A:W9Z?I5Q]F_T?SY'V(_F;F*@893
MC&P\@\[O:O3JPM?\(:+XE(DU&US<+$8DN(V*.@/3IP<'D!@0"3QR<U%I/433
M:T.=^&/BC5O$46IIJDZ3FW:,QOY:HV&W9!V@#'RC'&>3STQW]9FC>'M)\/12
MQZ79K;B9@TAW,S,0,#)8DX'/'3D^IK3I2:;T!)I:F;=>(=$LKE[:[UC3[>>/
M&^*6Y1&7(R,@G(X(-7X9HKF".>"5)89%#I(C!E92,@@CJ".]> ?$K_DH&I_]
MLO\ T4E>U^%?^1/T3_KP@_\ 1:U4HV28E*[L:]>3_&G[VA_2X_\ :=>L5Y/\
M:?O:']+C_P!IT4_B03^$;\%?^/C7_P#<MOYRUZU7DOP5_P"/C7_]RV_G+7K5
M%3XF$=@HHHJ"@HHHH **** "BBB@ HHHH **** "BBB@"G?:MINF&,:AJ%I:
M&7/E_:)ECWXQG&2,XR/SI]CJ-CJ<+36%Y;W<2ML9X)5D4-@'!(/7!''O7F7Q
MI_Y@?_;?_P!IUJ?!W_D4[S_K_?\ ]%QU?+[O,3S>]8]"HHHJ"@HHHH ****
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MWTZQCTS2[33X6=HK6%(49R"Q55"@G&.>*LU,JC>@U!(****@H**** "BBB@
MHHHH **** "BBB@ HHHH **** ,LW4(."_Z&C[5#_?\ T-7?L\)_Y8Q_]\BC
M[/!_SQC_ .^10(I?:H?[_P"AH^U0_P!_]#5W[/!_SQC_ .^11]G@_P">,?\
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M'_WR* *7VJ'^_P#H:/M4/]_]#5W[/!_SQC_[Y%'V>#_GC'_WR* *7VJ'^_\
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M/^>,?_?(H I?:H?[_P"AH^U0_P!_]#5W[/!_SQC_ .^11]G@_P">,?\ WR*
M*7VJ'^_^AH^U0_W_ -#5W[/!_P \8_\ OD4?9X/^>,?_ 'R* *7VJ'^_^AH^
MU0_W_P!#5W[/!_SQC_[Y%'V>#_GC'_WR* *7VJ'^_P#H:/M4/]_]#5W[/!_S
MQC_[Y%'V>#_GC'_WR* *7VJ'^_\ H:/M4/\ ?_0U=^SP?\\8_P#OD4?9X/\
MGC'_ -\B@"E]JA_O_H:/M4/]_P#0U=^SP?\ /&/_ +Y%'V>#_GC'_P!\B@"E
M]JA_O_H:/M4/]_\ 0U=^SP?\\8_^^11]G@_YXQ_]\B@"E]JA_O\ Z&C[5#_?
M_0U=^SP?\\8_^^11]G@_YXQ_]\B@"E]JA_O_ *&C[5#_ '_T-7?L\'_/&/\
M[Y%'V>#_ )XQ_P#?(H I?:H?[_Z&C[5#_?\ T-7?L\'_ #QC_P"^11]G@_YX
MQ_\ ?(H I?:H?[_Z&C[5#_?_ $-7?L\'_/&/_OD4?9X/^>,?_?(H I?:H?[_
M .AH^U0_W_T-7?L\'_/&/_OD4?9X/^>,?_?(H I?:H?[_P"AH^U0_P!_]#5W
M[/!_SQC_ .^11]G@_P">,?\ WR* *7VJ'^_^AH^U0_W_ -#5W[/!_P \8_\
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MV>#_ )XQ_P#?(H I?:H?[_Z&C[5#_?\ T-7?L\'_ #QC_P"^11]G@_YXQ_\
M?(H I?:H?[_Z&C[5#_?_ $-7?L\'_/&/_OD4?9X/^>,?_?(H I?:H?[_ .AH
M^U0_W_T-7?L\'_/&/_OD4?9X/^>,?_?(H I?:H?[_P"AH^U0_P!_]#5W[/!_
MSQC_ .^11]G@_P">,?\ WR* *7VJ'^_^AH^U0_W_ -#5W[/!_P \8_\ OD4?
M9X/^>,?_ 'R* *7VJ'^_^AH^U0_W_P!#5W[/!_SQC_[Y%'V>#_GC'_WR* *7
MVJ'^_P#H:/M4/]_]#5W[/!_SQC_[Y%'V>#_GC'_WR* *7VJ'^_\ H:/M4/\
M?_0U=^SP?\\8_P#OD4?9X/\ GC'_ -\B@"E]JA_O_H:/M4/]_P#0U=^SP?\
M/&/_ +Y%'V>#_GC'_P!\B@"E]JA_O_H:/M4/]_\ 0U=^SP?\\8_^^11]G@_Y
MXQ_]\B@"E]JA_O\ Z&C[5#_?_0U=^SP?\\8_^^11]G@_YXQ_]\B@"E]JA_O_
M *&C[5#_ '_T-7?L\'_/&/\ [Y%'V>#_ )XQ_P#?(H I?:H?[_Z&C[5#_?\
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M )XQ_P#?(H I?:H?[_Z&C[5#_?\ T-7?L\'_ #QC_P"^11]G@_YXQ_\ ?(H
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M_H:/M4/]_P#0U=^SP?\ /&/_ +Y%'V>#_GC'_P!\B@"E]JA_O_H:/M4/]_\
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M_P!\B@"E]JA_O_H:/M4/]_\ 0U=^SP?\\8_^^11]G@_YXQ_]\B@"E]JA_O\
MZ&C[5#_?_0U=^SP?\\8_^^11]G@_YXQ_]\B@!EG*DH?8<XQVJU4<<:1YV(JY
MZX&*DH&%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M*$5E-?ZS8;(E\NW>:6';'T&%)&%X('&.*^D+2UAL;*"SMDV001K%&NXG:JC
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M;''+'D],?A5F/Q-JMO$D,6OW\4<8"+&E](H4#@  -P!Z5O?$K_DH&I_]LO\
MT4E>U^%?^1/T3_KP@_\ 1:UI*5DG8A1NVCC/A%JNIZI::J;V]N;NWC>/RI)W
M,F'(;> YR>@0XSQD' SS1^-/WM#^EQ_[3KUBO)_C3][0_I<?^TZSB[SN7)6B
M<=X4\83^$H-4^R6R2W5WY C:7F-%0R;L@$$GY@ ..I.>,&"ZF\4>+HWFG74]
M4@$@R(X6>)7"XX51M5L'L!U]ZT/A_P"$8O%>K3?:I=ME9!'GC4D/+NW;5![#
MY3D]<<#DY'OL44=O"D,,:1Q1J$1$4!54<  #H*N4E%Z+4F,6T?-NA>+-9T P
MG3=0D%NGW;=FWPD%MQ&P\#)ZD8/)P1FO?/#'B.U\4Z,NH6R/&0QCFB?K'( "
M1G^(8(((['L<@<%\8-#M(H;37(E2.YDF^S3[5YE^4E6)SC*A".F2".?E JC\
M&[WR];U*P\K)N+99C)N^[Y;8QC'.?-ZYXQ[TI6E'F0U=2L>R5YMXY^)1TJY?
M2M":*2[3<MQ<L-RPG!&U1T+@\G.0,8()R%[+Q1K7_"/>&K[5%C\QX4 C7&1O
M8A5R,CY=S#/.<9Q7SSI6G7?B+7K>Q25FN;R;YYG.YAU+N<D;B &8C.3CU-33
MBGJQSE;1%IKSQ/XDCNHO.U;4XG8//#'YDL8).1E!E5&1P, #''2H4M]?\-PO
M*D.JZ1%.RHSJDEL)& ) )XR<;L?C7TC86%KI=C#964"PVT*[4C7H!_4GJ2>2
M3DU++%'<0O#-&DD4BE71U!5E/!!!ZBG[3R%R>9Y/X+^)]PU\UEXENE>*9OW5
MV45!$>FUMH VG^]V/7CE?6Z^<?&6@'PWXFNK)5Q;.?.MN?\ EDQ.!U)X(*Y/
M)VY[UZ]\,M5.I^"K9'+F2R<VC,RA00H!0#'8(R#)YR#]23BK<R'%N]F5/BO?
M7FG^&+26RN[BUD-\JEX)6C8CRY#@E2..!Q[5F_"/4K_43K)OK^[NMGD;/M$[
M2;<^9G&XG&<#IZ5;^,7_ "*=G_U_I_Z+DK+^"W_,<_[8?^U*$OW8OMGJU<U\
M0+^ZTWP/J5U93O!.!&BR(<,H:15.#V.">1R.HYKI:Y'XG?\ )/=3_P!Z#_T<
ME9QW1;V/.OA]XBUJ?QSIMK<:M>W%O<>:DD<\[2*0(F8<,3@Y4<CGMT)KO/BI
MJ&HZ;X2CFT^XGM\W2+/- 2I6/#=6'*C<$&<CJ!WP?,/AS_R4/1O]^;_T1)7T
M-6D])$PUB?+5SJUYJFW[7J5S>>7G;Y]PTNS/7&2<9P/RI;;6[_38S#::M=VB
M,=YCANGC!/3. 1SP.?:O3OC3_P P/_MO_P"TZU/@[_R*=Y_U_O\ ^BXZOF]V
M]B.7WK'(?#;Q!K5_XVM+=M5OKRW9)//22=IE"!"03DG;\VP9XZXSS@^XT45C
M)W=S5*P5S_CA+QO!>J-873VUQ%$)A*DC1LJHP=L,O.2JD>^<'BN@IDT,5S!)
M!/$DL,BE'C=0RLI&""#U!':I0SPCP5XMU:'Q?IR7NJ:A=6UQ(+=XI)C*#O\
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M>L7?2YP?B;XG:OJTDL5A,VFV 8[/+.V9EX(+.#P<C.%QP2"6ZUE?V%XO\_\
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M+M(S;BQ/)))ZD^M?5=?,WB;_ )&S6O\ K_G_ /1C55.5]!35M2+_ (2S6?\
MH8]2_P#!A)_\57O?@.ZO;WP3IEQJ$DLEPZ-^\E'S.F]@A/KE=ISWZY.<UT=%
M9RE?H6HV"BBBH*"BBB@ HHHH **** "BBB@ HHHH **** "BBB@!E%%% @HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M%6.>FW/440U@PE\2/HRBBBL30\/^+Y_XK6W'_4.B_P#1DM=?\'O^12N_^O\
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MK7_7_/\ ^C&KZ9KYF\3?\C9K7_7_ #_^C&I4MPJ;'TS11161H%%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 RBBB@04444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%5/[
M4T_^T/L'V^U^V_\ /OYR^9TW?=SGIS].:MT6L%[A1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4453L-7TS5?,_L[4;2\\O&_[/.LFW.<9VDXS@_E0!<H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH <M+2+2T#"BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH \5\>ZCXA\/>/;F_M;N[M8KA$^
MSN&W1NJQ@$;3E3AF<X(X+9QR";5E\9;^.)A?:/;3R%LJT$S0@+@<$$/DYSSD
M?3U]7OM.L=3A6&_L[>[B5MZI/$L@#8(R 1UP3S[US:_#+P@HP-);\;N8_P#L
M]:*4;:HAQ=]&>4^+_'=]XL2."6WAM;&*3S4B7YFW;<99SUQEL8 X;G. :[WX
M6^$IM)MIM9OXGBN[E3#'#(CH\2!OFW X^\54CCH 0?F(KIM-\#^&M)G,UII$
M'F[E=7F+3%&4Y!4N3M.>XQV]!7042FK60*.MV4]6L3JFC7VGB7RC=6\D DV[
MMFY2N<9&<9Z9KYJDBO\ 0]6"2QO:ZA9RJVUP"8W4AE/<'L1U!&#R#7U#6/K7
MA;1/$)1M4T^.>1,;9 61\#.%W*0=OS$XSC)SBE"?*.4;GDLOQ<\3212((M,B
M+*562.!]R$]QN<C(]P1[5ZQ$)?$O@A!)(D$VIZ:-SHA*HTD?) SR 6Z9_&J-
MM\._"=K<I/'H\;.F<"6621#D8Y5F*GKW%=11)QZ($GU/F;4=-U/PKKJPW*>3
M>VLBS12 !E.#E77(P1D=QVP1D$5W=K\9[M+=%N]$AFFYW217!C4\\84JQ'&.
M_P"72O3]3T73-9B\O4K&"Y 5D4R("R!A@[6ZJ3@<@@\#TK!_X5EX0(Q_9+?^
M!4W_ ,75<\7\2)Y6MCR'5M9\1^,Y+BYF6::"VC\V2&W5EMX JL=Q!) ) ?EC
MD]!V%3_#C_DH6D?[TO\ Z)DKWB#2--M;.:SM]/M(;6?/FPQPJJ29&#N4#!R
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M9!(1TW98Y Z@=,\]0,=3\,_!$LUQ;>(]179;I^\LX64$RG'$AST4=5[D@-P
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MR2-S'+-C<<9)QGBK\T,5Q#)#-&DD4BE'1U!5E(P00>H-$I7E<$K*Q\S^'?\
MD:M$_P"PC;?^C5KZ;K"TWP;X?TC5GU.QTU(;MMWS[W(7=UVJ257T^4# ) X.
M*W:<Y<S%&-D>)?&#_D<+7_KP3_T9)74?!K_D5=0_["+?^BHJZ[6O"VB>(=AU
M33XYW3&) S(^!G WJ0V/F/&<9.:O6%A:Z780V-E"L-M"NU$7L/J>23U)/))R
M:'.\; HZW+->2_&K_CXT#_<N?YQ5ZU6;K&@:5X@MQ!JEE'<*OW6.5=,D$[7&
M&7.T9P1G'-*+L[C:NK'G'P6_UNN_[MO_ .U:Z7XFZ;I-YX9%QJ=W]C>VD#02
MI$LCNQ',:@D$[@,X!'*AB<*:Z+1] TK0+8P:791VZG[S#+._)(W,<LV-QQDG
M&>*\H^,5Q,_B:QMF?,,5F)$7 ^5G=@QSUY")^7UJE[T[HE^[$X&VT^ZU)VAM
M;*>[D5=YC@A:5@,@9P 3C)'YUOPIXZMX(X((O$T4,:A$C2.X554#   '  KT
MCX1Z;:VWAB:_CF26YNYB)@I_U03(5",D9Y+9P#AQZ UZ!52J:VL)0T/G)_$/
MB[1-0C-SJ6KV]RJ[UBO)'.5.5R4DR".O)'4>HKTGX??$"XU^Z;2=66(7@CW0
M3IA/."@;@5S]_JWRC!&[A=O._P"/X=.E\%:D^HQJZ11%X6*DE)ONQD8Y!W,!
MZ8)SP37CWP[\P^/M*$3HC[Y.70L"/+8L,9')&0#V/.#C!-)1;L&L78^AJ***
MQ- KR#XE^!Y8+BY\1Z:N^W?]Y>0JH!B..9!CJIZMW!);D$[?7Z*J,G%W0FKH
M^<_#OC;6_#2NEE.LUNR;1;W.YXD.<Y4!AM/)S@@'/.<#'4WWQDU*1HO[/TJT
M@ SY@N':;=TQC&S'?USD=,<^AZEX(\-:M,)KO2(/-W,[/"6A+LQR2Q0C<<]S
MGOZFJ1^&7A!A@Z2WX74P_P#9ZOG@]6B.62V9XK9VFK>,/$1BC9KK4+IC)+)(
M>%' +,?X5' X''  Z"OH#PUH%OX:T.#3;=O,*9:28H%,KGJQQ^ &<D  9.*O
M66G6.FQ-%86=O:QLV]D@B5 6P!D@#K@#GVJS4RGS:%1C8*^9O$W_ "-FM?\
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M1P 3U(JS7/\ C;_D4+[_ +9_^C%K2E!3G&+ZM&=:;A3E-=$V9/\ PL[2\?\
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M@ #:!3Q&%@J:K4G="PV+J2JNC65I'950U36].T5(FU"Y$(E8J@VLQ..O"@G
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M +9?^SUW]:XV,8UY**LM/R,L!.4\/&4G=Z_FPHHHKE.L**** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M.1^8K,\;?\BA??\ ;/\ ]&+6M!-5H7[K\S+$-.A-KL_R.)^'7_(WO_UX2_\
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M'E4<5"AB*KGU;_-GMM%>,?\ "9^(_P#H.R?]^(/_ (BO4/"U[>:AX;LKJ_\
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MQRW#QY8N&Y"@\8&""2#G/&, GKO$-_\ V9X>OKL3>1(D16*3;NVR-\J<8/\
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M-.,X5&_Q3)J***X#T HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** ,O5O#NDZ[-:RZG9K<M:L6B#.P49()RH.&!VC@@C\S3?%
M/_(H:U_UX3_^BVK6K)\4_P#(H:U_UX3_ /HMJ:$SQ/X<_P#)0=)_WI?_ $3)
M7T%7S[\.?^2@Z3_O2_\ HF2OH*KJ_$3#8Y/XE7/V?P)?@7/D23&.-,/M+Y=2
MRCURH;([C/;->??".V\WQ=/.UMOCALW(E*9$;EE Y[$KO'J1N]ZZKXQ#/A6Q
M]M07_P!%2UF?!CKKGI_H_P#[4IK2FP?Q'JU<K\1K%K_P-J BMTFFA"3INQE
MK NP)Z$)OZ<D9'>NJK)\4\>$=:/_ $X3_P#HMJS6Y3V/(_A/<P6_C0I*^V2X
MM)(81@G<V5<CV^5&//I4WQ<N?.\6P0K<^8D%HH:(/D1N68GCLQ78?4C;[5D_
M#G_DH.D?[TO_ *)DH^(PQ\0=7]VB_P#1,=;V_>&?V3U7X:6WV;P'8%K;R)96
MDD?*;2^9&"L?7*A<'TQVQ76UD^%_^11T7/7[!!_Z+6M:L'N:+8\6^+MBT'B>
MVO%MT2&YM0/,7 ,DBL0V>^0IC&3VP.W';_"ZY@G\"VL,+[GMI98YA@C:Y<OC
MW^5U/'K7-_&?[VACVN/_ &G6I\'?^15OO^P@W_HJ.M'K31*^(X?X7ZM%8>,;
M<2;!'?1-;AWD"A"<,O7J25"@>K#Z'TGXHR1IX OHWD17EDA6-68 N1*K$#U.
M%8X] ?2N=\8_#B_?5I-:\.,6EDD\^2W,VR192P.Z-B0.I+8)&,<9R ,>#P-X
MYUN9+76+BYBM P<O>7OGJ#G'RJ';YL$XZ#J,C--VDU*XE=*QK_!F.0+K4IC<
M1,8%60J=K$>9D ]R,C(]QZU@>-=>O/&?B=-+TE9I[6%S%;P1NK+-("<RC'&"
M.A)("C/RY:M3Q3J,'@OPS'X.TF:&>YFC?^T9R@W@.!D%0,98' R2515ZY#5-
MX-TJQ\'Z"WB_7C$7FC4V,:C=( P)^7G!=P?^ J#D@%@#KS!_=/0/#'ARU\+Z
M,MA;.\I9C)-*Y_UDA !('\(P  !V'<Y)V:\MNOC-$MPXM-#>6#C:\UT(V/'.
M5"L!SGN?Z5UOA/QKIWBN)TA5K>]B4-+;2$$XP,LI_B4$XSP>F0,C.;C+=EIK
M9'2U1UK4X]&T6\U&0(1;Q-(%=P@=@/E7)Z$G 'N:O5YE\8=6\JPL-(CDPTSF
M>8++@[%X4,O=222">,Q]^RBKNP-V1Q7@+3IM:\<61E>:7R9#>3RF0;_D.0S%
MN6R^T'O\Q^H^@J\X^$>B);Z/<:S+#B>Z<Q1.=I_=+UVXY&7R"">=B\=SZ/55
M'>0H+0R[KP[I-]K5MK%U9K+?6RA8I&=L* 21\N=I(+$@D9!P>PK'^)7_ "3_
M %/ZP_\ HU*ZRN3^)7_)/]3^L/\ Z-2E'=#>QY]\(?\ D<;C_L'R?^C(J]MK
MQ+X0_P#(XW'_ &#Y/_1D5>VU53XA0V.3^)5S]G\"7X%SY$DQCC3#[2^74LH]
M<J&R.XSVS7GWPCMO-\73SM;;XX;-R)2F1&Y90.>Q*[QZD;O>NJ^,0SX5L?;4
M%_\ 14M9GP8ZZYZ?Z/\ ^U*:TIL3^(]6KE?B-8M?^!M0$5NDTT(2=-V,H%8%
MV!/0A-_3DC([UU59/BGCPCK1_P"G"?\ ]%M6:W*>QY'\)[F"W\:%)7VR7%I)
M#",$[FRKD>WRHQY]*F^+ESYWBV"%;GS$@M%#1!\B-RS$\=F*[#ZD;?:LGX<_
M\E!TC_>E_P#1,E'Q&&/B#J_NT7_HF.M[?O#/[)ZK\-+;[-X#L"UMY$LK22/E
M-I?,C!6/KE0N#Z8[8KK:R?"__(HZ+GK]@@_]%K6M6#W-%L>+?%VQ:#Q/;7BV
MZ)#<VH'F+@&216(;/?(4QC)[8';CM_A=<P3^!;6&%]SVTLL<PP1M<N7Q[_*Z
MGCUKF_C/][0Q[7'_ +3K4^#O_(JWW_80;_T5'6CUIHE?$</\+]6BL/&-N)-@
MCOHFMP[R!0A.&7KU)*A0/5A]#Z3\49(T\ 7T;R(KRR0K&K, 7(E5B!ZG"L<>
M@/I7.^,?AQ?OJTFM>'&+2R2>?);F;9(LI8'=&Q('4EL$C&.,Y &/!X&\<ZW,
MEKK%Q<Q6@8.7O+WSU!SCY5#M\V"<=!U&1FF[2:E<2NE8U_@S'(%UJ4QN(F,"
MK(5.UB/,R >Y&1D>X]:P/&NO7GC/Q.FEZ2LT]K"YBMX(W5EFD!.91CC!'0DD
M!1GY<M6IXIU&#P7X9C\':3-#/<S1O_:,Y0;P' R"H&,L#@9)*HJ]<AJF\&Z5
M8^#]!;Q?KQB+S1J;&-1ND 8$_+S@NX/_  %0<D L =>8/[IZ!X8\.6OA?1EL
M+9WE+,9)I7/^LD( ) _A&   .P[G).S7EMU\9HEN'%IH;RP<;7FNA&QXYRH5
M@.<]S_2NM\)^-=.\5Q.D*M;WL2AI;:0@G&!EE/\ $H)QG@],@9&<W&6[+36R
M.EHHHJ1A1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 .6EI%I:!A1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MAR5UOP__ .1+LO\ KI/_ .CGKDOB-_R-,7_7E'_Z')76_#__ )$NR_ZZ3_\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M0O/"#+L4JHD'#@ \X#!A^'4]:\.TO_B;?$Z&:P_?)/K#749^YF/S3(6PV.B
MG'7CIGBE!O6XY=+'T+1116184444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% #EI:1:
M6@84444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MSI_PUN7.=3OXXE#$%+0%RRXX(=@,'/;:>![\=_9V=O86D5K:Q+%!$,*B]O\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110!R?C3P5_PE[V#?VA]D%H)!CR?,W[]O
M^T,8V_K7+?\ "F/^H_\ ^2?_ -G7JM%4IR2LA.*9Y5_PIC_J/_\ DG_]G5K3
M/A+_ &;JUE??VWYGV:=)MGV3&[:P.,[^,XZUZ713]I(7*@KD?%?P^T[Q//\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@!E%%% @HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH @NK*UOHUCN[:&X16WJLL8<!L$9 /?!/YTVUTZQL6D:TL[>W:0 .88E0MC
M.,X'.,G\S5FBG=VL+E5[VU"BBBD,**** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@!RTM(M+0,**** "BBB@ HHHH **** "BBB@ HHHH ****
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M:^MUN+2XBN('SMEB<.IP<'!''4$?A6+36YHFGL34444AA1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ,HJL;^W!Q
MO/Y&D_M"V_OG_ODT"+5%5?[0MO[Y_P"^31_:%M_?/_?)H M455_M"V_OG_OD
MT?VA;?WS_P!\F@"U157^T+;^^?\ ODT?VA;?WS_WR: +5%5?[0MO[Y_[Y-']
MH6W]\_\ ?)H M455_M"V_OG_ +Y-']H6W]\_]\F@"U157^T+;^^?^^31_:%M
M_?/_ 'R: +5%5?[0MO[Y_P"^31_:%M_?/_?)H M455_M"V_OG_ODT?VA;?WS
M_P!\F@"U157^T+;^^?\ ODT?VA;?WS_WR: +5%5?[0MO[Y_[Y-']H6W]\_\
M?)H M455_M"V_OG_ +Y-']H6W]\_]\F@"U157^T+;^^?^^31_:%M_?/_ 'R:
M +5%5?[0MO[Y_P"^31_:%M_?/_?)H M455_M"V_OG_ODT?VA;?WS_P!\F@"U
M157^T+;^^?\ ODT?VA;?WS_WR: +5%5?[0MO[Y_[Y-']H6W]\_\ ?)H M455
M_M"V_OG_ +Y-']H6W]\_]\F@"U157^T+;^^?^^31_:%M_?/_ 'R: +5%5?[0
MMO[Y_P"^31_:%M_?/_?)H M455_M"V_OG_ODT?VA;?WS_P!\F@"U157^T+;^
M^?\ ODT?VA;?WS_WR: +5%5?[0MO[Y_[Y-']H6W]\_\ ?)H M455_M"V_OG_
M +Y-']H6W]\_]\F@"U157^T+;^^?^^31_:%M_?/_ 'R: +5%5?[0MO[Y_P"^
M31_:%M_?/_?)H M455_M"V_OG_ODT?VA;?WS_P!\F@"U157^T+;^^?\ ODT?
MVA;?WS_WR: +5%5?[0MO[Y_[Y-']H6W]\_\ ?)H M455_M"V_OG_ +Y-']H6
MW]\_]\F@"U157^T+;^^?^^31_:%M_?/_ 'R: +5%5?[0MO[Y_P"^31_:%M_?
M/_?)H M455_M"V_OG_ODT?VA;?WS_P!\F@"U157^T+;^^?\ ODT?VA;?WS_W
MR: +5%5?[0MO[Y_[Y-']H6W]\_\ ?)H M455_M"V_OG_ +Y-']H6W]\_]\F@
M"U157^T+;^^?^^31_:%M_?/_ 'R: +5%5?[0MO[Y_P"^31_:%M_?/_?)H M4
M55_M"V_OG_ODT?VA;?WS_P!\F@"U157^T+;^^?\ ODT?VA;?WS_WR: +5%5?
M[0MO[Y_[Y-']H6W]\_\ ?)H M455_M"V_OG_ +Y-']H6W]\_]\F@"U157^T+
M;^^?^^31_:%M_?/_ 'R: +5%5?[0MO[Y_P"^31_:%M_?/_?)H M455_M"V_O
MG_ODT?VA;?WS_P!\F@"U157^T+;^^?\ ODT?VA;?WS_WR: +5%5?[0MO[Y_[
MY-']H6W]\_\ ?)H M455_M"V_OG_ +Y-']H6W]\_]\F@"U157^T+;^^?^^31
M_:%M_?/_ 'R: +5%5?[0MO[Y_P"^31_:%M_?/_?)H M455_M"V_OG_ODT?VA
M;?WS_P!\F@"U157^T+;^^?\ ODT?VA;?WS_WR: +5%5?[0MO[Y_[Y-']H6W]
M\_\ ?)H M455_M"V_OG_ +Y-']H6W]\_]\F@"U157^T+;^^?^^31_:%M_?/_
M 'R: +5%5?[0MO[Y_P"^31_:%M_?/_?)H M455_M"V_OG_ODT?VA;?WS_P!\
MF@"U157^T+;^^?\ ODT?VA;?WS_WR: +5%5?[0MO[Y_[Y-']H6W]\_\ ?)H
MM455_M"V_OG_ +Y-']H6W]\_]\F@"U157^T+;^^?^^31_:%M_?/_ 'R: +5%
M5?[0MO[Y_P"^31_:%M_?/_?)H M455_M"V_OG_ODT?VA;?WS_P!\F@"U157^
MT+;^^?\ ODT?VA;?WS_WR: +5%5?[0MO[Y_[Y-']H6W]\_\ ?)H M455_M"V
M_OG_ +Y-']H6W]\_]\F@"U157^T+;^^?^^31_:%M_?/_ 'R: +5%5?[0MO[Y
M_P"^31_:%M_?/_?)H M455_M"V_OG_ODT?VA;?WS_P!\F@"U157^T+;^^?\
MODT?VA;?WS_WR: +5%5?[0MO[Y_[Y-']H6W]\_\ ?)H M455_M"V_OG_ +Y-
M']H6W]\_]\F@"U157^T+;^^?^^31_:%M_?/_ 'R: +5%5?[0MO[Y_P"^31_:
M%M_?/_?)H M455_M"V_OG_ODT?VA;?WS_P!\F@"U157^T+;^^?\ ODT?VA;?
MWS_WR: +5%5?[0MO[Y_[Y-']H6W]\_\ ?)H M455_M"V_OG_ +Y-']H6W]\_
M]\F@"U157^T+;^^?^^31_:%M_?/_ 'R: +5%5?[0MO[Y_P"^31_:%M_?/_?)
MH M455_M"V_OG_ODT?VA;?WS_P!\F@"U157^T+;^^?\ ODT?VA;?WS_WR: +
M5%5?[0MO[Y_[Y-']H6W]\_\ ?)H M455_M"V_OG_ +Y-']H6W]\_]\F@"U15
M7^T+;^^?^^31_:%M_?/_ 'R: +5%5?[0MO[Y_P"^31_:%M_?/_?)H M455_M
M"V_OG_ODT?VA;?WS_P!\F@"U157^T+;^^?\ ODT?VA;?WS_WR: +5%5?[0MO
M[Y_[Y-']H6W]\_\ ?)H M455_M"V_OG_ +Y-']H6W]\_]\F@"U157^T+;^^?
M^^31_:%M_?/_ 'R: +5%5?[0MO[Y_P"^31_:%M_?/_?)H M455_M"V_OG_OD
MT?VA;?WS_P!\F@"U157^T+;^^?\ ODT?VA;?WS_WR: +5%5?[0MO[Y_[Y-']
MH6W]\_\ ?)H M455_M"V_OG_ +Y-']H6W]\_]\F@"U157^T+;^^?^^31_:%M
M_?/_ 'R: +5%5?[0MO[Y_P"^31_:%M_?/_?)H M455_M"V_OG_ODT?VA;?WS
M_P!\F@"U157^T+;^^?\ ODT?VA;?WS_WR: +5%5?[0MO[Y_[Y-']H6W]\_\
M?)H M455_M"V_OG_ +Y-']H6W]\_]\F@"U157^T+;^^?^^31_:%M_?/_ 'R:
M +5%5?[0MO[Y_P"^31_:%M_?/_?)H M455_M"V_OG_ODT?VA;?WS_P!\F@"U
M157^T+;^^?\ ODT?VA;?WS_WR: +5%5?[0MO[Y_[Y-']H6W]\_\ ?)H M455
M_M"V_OG_ +Y-']H6W]\_]\F@"U157^T+;^^?^^31_:%M_?/_ 'R: +5%5?[0
MMO[Y_P"^31_:%M_?/_?)H M455_M"V_OG_ODT?VA;?WS_P!\F@"U157^T+;^
M^?\ ODT?VA;?WS_WR: +5%5?[0MO[Y_[Y-']H6W]\_\ ?)H M455_M"V_OG_
M +Y-']H6W]\_]\F@"U157^T+;^^?^^31_:%M_?/_ 'R: +5%5?[0MO[Y_P"^
M31_:%M_?/_?)H M455_M"V_OG_ODT?VA;?WS_P!\F@"U157^T+;^^?\ ODT?
MVA;?WS_WR: +5%5?[0MO[Y_[Y-']H6W]\_\ ?)H M455_M"V_OG_ +Y-']H6
MW]\_]\F@"U157^T+;^^?^^31_:%M_?/_ 'R: +5%5?[0MO[Y_P"^31_:%M_?
M/_?)H M455_M"V_OG_ODT?VA;?WS_P!\F@"U157^T+;^^?\ ODT?VA;?WS_W
MR: +5%5?[0MO[Y_[Y-']H6W]\_\ ?)H M455_M"V_OG_ +Y-']H6W]\_]\F@
M"U157^T+;^^?^^31_:%M_?/_ 'R: +5%5?[0MO[Y_P"^31_:%M_?/_?)H M4
M55_M"V_OG_ODT?VA;?WS_P!\F@"U157^T+;^^?\ ODT?VA;?WS_WR: +5%5?
M[0MO[Y_[Y-']H6W]\_\ ?)H M455_M"V_OG_ +Y-']H6W]\_]\F@"U157^T+
M;^^?^^31_:%M_?/_ 'R: +5%5?[0MO[Y_P"^31_:%M_?/_?)H M455_M"V_O
MG_ODT?VA;?WS_P!\F@"U157^T+;^^?\ ODT?VA;?WS_WR: +5%5?[0MO[Y_[
MY-']H6W]\_\ ?)H M455_M"V_OG_ +Y-']H6W]\_]\F@"U157^T+;^^?^^31
M_:%M_?/_ 'R: +5%5?[0MO[Y_P"^31_:%M_?/_?)H M455_M"V_OG_ODT?VA
M;?WS_P!\F@"U157^T+;^^?\ ODT?VA;?WS_WR: +5%5?[0MO[Y_[Y-']H6W]
M\_\ ?)H M455_M"V_OG_ +Y-']H6W]\_]\F@"U157^T+;^^?^^31_:%M_?/_
M 'R: +5%5?[0MO[Y_P"^31_:%M_?/_?)H M455_M"V_OG_ODT?VA;?WS_P!\
MF@"U157^T+;^^?\ ODT?VA;?WS_WR: +5%5?[0MO[Y_[Y-']H6W]\_\ ?)H
MM455_M"V_OG_ +Y-']H6W]\_]\F@"U157^T+;^^?^^31_:%M_?/_ 'R: +5%
M5?[0MO[Y_P"^31_:%M_?/_?)H M455_M"V_OG_ODT?VA;?WS_P!\F@"U157^
MT+;^^?\ ODT?VA;?WS_WR: +5%5?[0MO[Y_[Y-']H6W]\_\ ?)H M455_M"V
M_OG_ +Y-']H6W]\_]\F@"U157^T+;^^?^^31_:%M_?/_ 'R: +5%5?[0MO[Y
M_P"^31_:%M_?/_?)H M455_M"V_OG_ODT?VA;?WS_P!\F@"U157^T+;^^?\
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M94E=%+X7:_\ VMX8%C*<W&F[83QUBQ^[/  & "N.3\F3UKQ[PS_R-FB_]?\
M!_Z,6I/"WB*;PSKD.HP_-%_J[A @8R0D@L%R1SP".1R!GC(,?AG_ )&S1?\
MK_@_]&+6RC:YG>]CZ9KE?B-JJZ7X)OAE/,NU^R1JZDAM^0PXZ'9O()XR!UZ'
MJJ\3^+NJ+>>);;3T*,MA#\QVD,LDF&()/!&U8R,>IY[#""O(TD[(Y'PY?66F
M>(["^U&"6:UMY?-9(C\VY02A'(Z.%.,]!WZ5ZQ_PN+P__P ^.J?]^X__ (NN
M<\#_  ZL?$7A[^TM2DO(3),RP^1(@5XQ@9P5)!W!QSCI72?\*>\/_P#/YJ?_
M ']C_P#B*UDX-ZD14DM#(\3_ !)T#Q!X;OM,6UU2-YD'EMLC #J0RY.\\9 S
MQG&<5YWH.JMHFOV.IJ7 MIE=Q&JLS)T=0#QDJ6';KU'6O6_^%/>'_P#G\U/_
M +^Q_P#Q%>6^*]"_X1SQ)=::K2O"A#0R2)M+HP!'L<<J2."5/3H'!QV0I<V[
M/I.BN2^&VL?VOX,M5:/8]B?L;87"L$5=I')_A*YZ<YXQBND34;*2_DL$O+=K
MR-=TENLJF1%XY*YR!\P_,>M8-6=C5.Y9KB=>^&&@ZI!(;"%-+NV92)8%)C
MP5\K(4 C^[CGGGD'MJ*$VM@:N?+VKZ7<Z-JMSIEZJ?:+=MKA&W*<@$$'T((/
M///(%>[_  \UV37O"4$DY=KBU8VLLCDGS"H!#9)))*LN2>K9KS;XM7,-QXU$
M<3[FM[2.*48(VMEGQSU^5U/'K7:?"".1/"%PSQNBO>NR%E(#C8@R/49!'U!]
M*VGK!-F<=)6-/XF?\D^U/ZP_^CDKR7X<_P#)0]&_WYO_ $1)7K7Q,_Y)]J?U
MA_\ 1R5Y+\.?^2AZ-_OS?^B)*4/@8Y?$CZ&HHHK$T/.OC+_R*NG_ /817_T5
M+7+_  ?_ .1PNO\ KP?_ -&1UU'QE_Y%73_^PBO_ **EKE_@_P#\CA=?]>#_
M /HR.MH_PV9OXSVVBBF3316\$D\\B111J7>1V"JJ@9))/0 5B:#Z*@M+RUU"
MU2ZLKF&YMWSMEA<.C8.#@C@\@C\*GH **** "N4^)7_)/]3_ .V7_HU*ZNN4
M^)7_ "3_ %/_ +9?^C4JH_$A2V/GVOI;PK_R)^B?]>$'_HM:^::^EO"O_(GZ
M)_UX0?\ HM:UJ[(SI[FO1116!J4-;U--%T2]U*0(PMH6D5'D"!V ^5=W8L<
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MLPX/"AL^G09!(KY]K>E>VIC.USV?X/7Z3>'KVQ-P[S6]SO\ +;)$<;J-N,\
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M/:[="ZU#3(Y)QUE1VC9^ /F*$;L!0!G..U5"=E9BE&^J/$/$GC/5O%45M'J
MMXX[=F94ME=%8G'+ LP)&#@]MQ]:[#X1>'7>XE\13!/)4/;VZO$2Q;C=(K'@
M #*9&<Y8<8Y[2W^'7A.UN4G31XV=,X6:621#D$<JS%3U[BNHHE-6M$%%WNPH
MHHK,L**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@"C1113$%%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!/;_ ,7X
M5/4%O_%^%3TAA1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@">W_B_"IZ@M_P"+\*GI#"BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MW#_Z&*]UU%.,TNEU^!\\J;A.FWUL_P 3V>O"Z]TKPNO/RK[?R_4]+./L?/\
M0]3\$?\ (HV?^_-_Z->L;XC?\PW_ +:_^R5L^"/^11L_]^;_ -&O6-\1O^8;
M_P!M?_9*PP_^^_-_J=&)_P!P^4?T.%KM? >MK%*='G9OWK%[;@D X)9<YX&!
MD< 9W<Y(KC[:QFO)9WB;BVMGG=./F4,@/)(Q@$G\,=ZC1WBD26-MLL;K(C8!
MVLIR#@\<$ UZU>G&O"5/J>-AZDL/.-3H_P CW.O%M5_Y#>I?]?D__HQJ]<TG
M44U72K>^1=HE3++R=K#AAD@9P01G'.,UY'JO_(;U+_K\G_\ 1C5YN6)JI),]
M7-FI4HM=_P!#TSP;_P BI9?\#_\ 0VK=K"\&_P#(J67_  /_ -#:MVN'$?QI
M^K_,]##?P(>B_(XWX@:FD5C#IB2?O9F$DB#:?W8Z9[C+8((Z[#S7GF1G&>3S
MBMCQ1?-?^);V0E]D3^1&KJ 5"<$<=06W,,\X;MT%JUT.2;P/>ZB!+O$ZRHHD
M0(T<>59CGG@/(2,Y.P8]_9P_+AZ$>;J_S_X!X6)4L5B)<O1/\/\ @AX+O_L7
MB.*-WQ%<J86W2[5#=5..A.1M'^^<>A]3KPV.62"5)H7V2QL'1L [6!R#@\=:
M]IT^^@U/3X+VV;,4R[AR"5/=3@D9!R".Q!KCS.E::FNIW935YJ;IOH5]>U)M
M(T.ZOD3?)&H"#&1N8A5)&1P"03SG&<5Y!<7$UW<27%S*TLTAW.[=2?\ /;H*
M]4\8JS^%;T(C.?D.%&3@.I)^@&3^%>3,H92IZ$8K?*XQY)2ZW.?-YR]I&'2Q
MT=MX'UNZM8IPMK")!GR[B1E=1VR IQ].O/.#Q6=J^A:CHA)O("(!_P O$?S1
M=AR?X>6 &X#)Z9KT+0O%MAJ=M&ES/';7@*1LDI$8E=@/]7ECD%L@#.?4<C/0
MU@\?7ISM-?(Z%EV&JPO3?S*&AQM#X?TV)XVC9+6)2C#!4A!P1V-<-\0?^0]!
M_P!>J_\ H35Z17F_Q!_Y#T'_ %ZK_P"A-6>7N^(OZFF9*V&MZ',V=E>:C=?9
M;&V>XFV&0HK*N%! )RQ ZL*T?^$4\1_] :;_ +_P_P#Q=7O /_(V-_UXR_\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH G
MM_XOPJ>H+?\ B_"IZ0PHHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M\ ]"AEOLJBGSWMY?\$*\+KW2O"ZVRK[?R_4PSC['S_0U;'Q)JVFV:6EI=^7
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MWC[3Y,98*S[0S=ESVR<#\:\6NJCJM3^(][#NFJ*<-(V/,/%UZM_XFN7384@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% $]O_%^%3U!;_P 7X5/2&%%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MZX./O9Z=J]/\1^'%\0);_P"E- \!;!V;@0<9XR.>!W]?PP?^%<_]17_R7_\
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M06!SN(!)^5>PQD]>#755S8S%N=3]W+0ZL%@U"E^]BKOYG/?\(1X>_P"?%_\
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MYYS]!K5RXC%3G4;A)V.O#82$*2C.*OU.4U+P/I/]FW)L;25;L1EH=MPYRXY
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M2J*R1+X'T[['H*W+!/,O")@P49\O'R#<"<C&6'IO/'6N=^(/_(>@_P"O5?\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% $]O_%^%3U!;_Q?A4](84444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110!1HHHIB"BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH GM_P"+\*GJ"W_B_"IZ0PHHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** &3316\$D\\B111J7>1V"
MJJ@9))/0 5E'Q9X<49/B#2@!W-Y'_C65\3!GX?:GGUA_]')7S_6D(<RN1*5F
M?5M%>>?"?Q#]OT1]'GDS<6/,6YLEH3TZDD[3QP  "@KT.H:L[%)W5PK*B\3:
M!/+'%#KFFR22,$1$NXR68G   /))K5KYF\,_\C9HO_7_  ?^C%JHQYKBE*Q]
M,T445!05G7.OZ-9W+VUUJ]A!.F-\4MRBLN1D9!.1P0?QJW=W4-C93W=R^R""
M-I9&P3M51DG Y/ [5\O7MV][?7-[.(UEN9GFD" A=SL6.,D\9/K5PAS$RE8^
MGK+4++4H6FL;RWNHE;8SP2!P&P#C(/7!'YU9KQ'X2ZQ]A\3R::T>Y-1CP&"Y
M*O&&89.>%P7[$YV].:]NI2CRNPXNZN%%%<A\0O%DOA?1HEL]GV^[9DA+ D1J
M!\SXQ@D94 'NV>0"*25W9 W8Z#5-:TS18?-U*^@ME*LZB1P&<*,G:O5CR. "
M>1ZU@'XG^#P,_P!JO_X!S_\ Q%>-:3HNM^+]3D%L);N?Y3/<SR$[!PH+NQR>
M!TY.%. <5TH^#_B//-UI6/\ KM)_\;K3DBMV1S-[(]ELM0LM2A:6QO+>ZB5M
MC/!*K@-@'!(/7!'YU9KYFN;+6O"6KP2W$$^G7T3;X9"!@D 9VL,JXPP! )'.
M#W%?3-3*-MBHRN0W5W;6-LUS=W$5O F-TLSA%7)P,D\=2!^-5[/6M*U&8PV.
MIV=S*%WE()U=@N0,X!Z<C\ZP?B9_R3[4_K#_ .CDKR7X<_\ )0]&_P!^;_T1
M)0HWBV#E9V/H:BBBH*(;J[MK&W>XN[B*W@3&Z25PBKDX&2>.I JO9ZUI6HSF
M"RU.RN9@N\QP3J[!<@9P#TR1^=<1\9?^15T__L(K_P"BI:Y?X/\ _(X77_7@
M_P#Z,CJU&\;DN6MCVVBBBH*"BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@#Q%/C)K\862>QTV2-<,Z)'(I8=P"7.#[X./0U[=7R;+_
M ,>C_P"X?Y5]95K4BE:Q$&WN%%%%9%A1110 4444 %%>6>+_ (D:WH'BF]TR
MTM]/>"'9L:6)RW**QR0X'4GM7HFB7LNHZ!IU].$$US:Q3.$!"AF4$X!)XR?4
MU3BTKB33T+]9VLZ[IOA^T2ZU.X,$+R")6\MGRQ!.,*">BFM&O/OB?X6U;Q$-
M*ETJW2X-L95D3S%1AOV$$;B!CY"#SGD<'G"BDWJ#VT.HT;Q7HGB">6'2[]9Y
M8E#LA1D.W.,@,!D>N.F1GJ*V:\M^&'A/6=(U>;4]1M/LT$MGLC61AO8LRM]T
M<K@+R&P<D<=<>I4Y))Z!%MK4****D84444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 5SVI>./#FD:C-87VHF&YAQO3R)&QD!AR%(/!'2NAKP
MKQ%X \32>)K^:#3O/AN[V62&2*1=I#%I!G)!7 X).!G@$Y&:@DWJ3)M;'MEA
M?VNJ6,-[93K/;3+N21>A']"#P0>01@U9K!\%Z5=:)X1T_3[U46YC5RZJVX*6
M=FQGU ;!QQG.">M;U)[E(**\>T?XJ>(-0UO3K*:VTP1W%U%#(4AD!VLX!QE^
M#@^]>PTY1<=Q)I[!7EGB[XDZUH/BF^TRUM]/>" IL:6-RWS1JQR0X'4GM7J=
M?/GQ)_Y*#JOUB_\ 1*55-)O4F;LM#VCPCK<OB/PO9:K-"D,LP=71"2NY'9"1
MGH#MSCG&<9/6MNN0^%__ "3S3?\ ?G_]'R5U]0]REL%%%%(84444 %%%% !1
M110 4444 %%%% !1110 45Y9XO\ B1K>@>*;W3+2WT]X(=FQI8G+<HK')#@=
M2>U>B:)>RZCH&G7TX037-K%,X0$*&903@$GC)]35.+2N)-/0OT445(PHHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH HT444Q!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M6)+N=Q ^4$M@D#@#->%^)_$5]XMUUISYLD6\QV5LJ<JA/R@*"<N>,XSD\#@
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MJ-W%;0#(#2-C<<$[5'5FP#P,DXKA;[XQ:/#'.+&PO+F9&VQ^9MBCD&<9W9+
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M,KHK1YXW'8,'!YP-W&1R<<MJ*>H)R:T.D\.^/=#\2W/V6UDE@NSN*07*!6<
M DJ02#U/&<\$XP,UT]?,&HV%]X?UJ6RN&\F]M)!\\,G0\,K*PYZ$$=",CH:^
M@_!VK3ZYX2T_4+D8GD0K(<CYV5BA;@ #.W. .,XJ9P2U0XROHS<K-UC7]*T"
M!9M4OHK96^XK9+OR =JC+-C<,X!QGFI]4U*WT?2[G4;MML%O&7;D MZ*,D#)
M. !GDD5\X:AJ.I^*==6>Z?S[ZZD6&) 0J@DX5%R<*N3QD]R22232A#F'*5CT
MZ\^,NG+;JUAI%Y-,6^9+ETB 7!YRI?G..,?C3],^,6F3A5U+3;FT=I N87$R
M*O'S,?E/KD!3P.,YQ4>G_!NP%FO]IZG=/<G!;[+M1%X&1\RDGG//&1C@57UO
MX/Q1V+2Z'?3R7$:D^1=%3YIXP P"A3C/4$$XY'6J_=[$^^>C:1K.GZ]8B]TR
MY6X@W%"P!4AAU!! (/0\CH0>A%7Z^:_#'BB^\,:B+VR(DB< 36[-A)E]/8\\
M-VSW!(/T=:74-]907EL^^">-98VP1N5AD'!Y'![U,X<K*C*YA^*/&6G^$FM!
M?6]W+]JW[#;JIQMVYSN8?WATSWJSX:\2V?BG3I;ZRAN(HHYC"1.JAB0 <C:3
MQ\PK@/C3][0_I<?^TZU_@]_R*5W_ -?S_P#HN.GRKDN+F?-8]!K(\1^(['PO
MI8O[\2LC2")$A7<SL<G R0.@)Y(Z>N!6O7GGQC_Y%2Q_[""?^BI*B*N[%-V1
MM^&?'FD^*;Z:RLX[J&XCC\W;<(!N7(!(*DC@E>N.O&><'B;QYI/A6]AL[R*[
MFGEC\W;;HIVKD@$EF Y(;IGISCC/F_P@_P"1VG_[!TO_ *,BKN?&?P\'BS4X
M+^/5#9RQP^2ZM!YJL Q((^9<'YFSUSQTQS;45*SV)3;C<\C\6ZS;^(/$]YJE
MK'+'#/LVK, &&U%4YP2.H]:]"T7XK:)INA:?8S6.IM+;6T<+LD<94E5 )&7'
M'%><>(]$;P[K]SI37(N3!M_>B/9NW*&^[DXZXZ]J[/2_A'+J>D66H#7TB%U
MDWE_8BVW<H;&?,&<9ZXK27+97(7-=V/1O"_B_3?%D5R]@EQ$]NRB2.= & ;.
M#P2,'![YXZ=,[]<IX)\%+X/BO<WYO);IDW,(O+557. !DG.6;)SZ<#'/5U@[
M7T-5>VH4444AA1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M/MD7J?RK0\M/[B_E1Y:?W%_*@#/^V1>I_*C[9%ZG\JT/+3^XOY4>6G]Q?RH
MS_MD7J?RH^V1>I_*M#RT_N+^5'EI_<7\J ,_[9%ZG\J/MD7J?RK0\M/[B_E1
MY:?W%_*@#/\ MD7J?RH^V1>I_*M#RT_N+^5'EI_<7\J ,_[9%ZG\J/MD7J?R
MK0\M/[B_E1Y:?W%_*@#/^V1>I_*C[9%ZG\JT/+3^XOY4>6G]Q?RH S_MD7J?
MRH^V1>I_*M#RT_N+^5'EI_<7\J ,_P"V1>I_*C[9%ZG\JT/+3^XOY4>6G]Q?
MRH S_MD7J?RH^V1>I_*M#RT_N+^5'EI_<7\J ,_[9%ZG\J/MD7J?RK0\M/[B
M_E1Y:?W%_*@#/^V1>I_*C[9%ZG\JT/+3^XOY4>6G]Q?RH S_ +9%ZG\J/MD7
MJ?RK0\M/[B_E1Y:?W%_*@#/^V1>I_*C[9%ZG\JT/+3^XOY4>6G]Q?RH S_MD
M7J?RH^V1>I_*M#RT_N+^5'EI_<7\J ,_[9%ZG\J/MD7J?RK0\M/[B_E1Y:?W
M%_*@#/\ MD7J?RH^V1>I_*M#RT_N+^5'EI_<7\J ,_[9%ZG\J/MD7J?RK0\M
M/[B_E1Y:?W%_*@#/^V1>I_*C[9%ZG\JT/+3^XOY4>6G]Q?RH S_MD7J?RH^V
M1>I_*M#RT_N+^5'EI_<7\J ,_P"V1>I_*C[9%ZG\JT/+3^XOY4>6G]Q?RH S
M_MD7J?RH^V1>I_*M#RT_N+^5'EI_<7\J ,_[9%ZG\J/MD7J?RK0\M/[B_E1Y
M:?W%_*@#/^V1>I_*C[9%ZG\JT/+3^XOY4>6G]Q?RH S_ +9%ZG\J/MD7J?RK
M0\M/[B_E1Y:?W%_*@#/^V1>I_*C[9%ZG\JT/+3^XOY4>6G]Q?RH S_MD7J?R
MH^V1>I_*M#RT_N+^5'EI_<7\J ,_[9%ZG\J/MD7J?RK0\M/[B_E1Y:?W%_*@
M#/\ MD7J?RH^V1>I_*M#RT_N+^5'EI_<7\J ,_[9%ZG\J/MD7J?RK0\M/[B_
ME1Y:?W%_*@#/^V1>I_*C[9%ZG\JT/+3^XOY4>6G]Q?RH S_MD7J?RH^V1>I_
M*M#RT_N+^5'EI_<7\J ,_P"V1>I_*C[9%ZG\JT/+3^XOY4>6G]Q?RH S_MD7
MJ?RH^V1>I_*M#RT_N+^5'EI_<7\J ,_[9%ZG\J/MD7J?RK0\M/[B_E1Y:?W%
M_*@#/^V1>I_*C[9%ZG\JT/+3^XOY4>6G]Q?RH S_ +9%ZG\J/MD7J?RK0\M/
M[B_E1Y:?W%_*@#/^V1>I_*C[9%ZG\JT/+3^XOY4>6G]Q?RH S_MD7J?RH^V1
M>I_*M#RT_N+^5'EI_<7\J ,_[9%ZG\J/MD7J?RK0\M/[B_E1Y:?W%_*@#/\
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MMD7J?RK0\M/[B_E1Y:?W%_*@#/\ MD7J?RH^V1>I_*M#RT_N+^5'EI_<7\J
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M/--_WY__ $?)77UG+=E+8\0^,#?\5G;KZ:?&?_(DO^%=7\'!_P 4I?>^H/\
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M;')?"#_D=I_^P=+_ .C(J]PKP_X0?\CM/_V#I?\ T9%7N%.I\0H;'S[\2O\
MDH&I_P#;+_T4E>U^%?\ D3]$_P"O"#_T6M>*?$K_ )*!J?\ VR_]%)7M?A7_
M )$_1/\ KP@_]%K53^%"C\3->BBBLC0**** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** &4444""BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M-KM:P,6=^"2C-P%P< E=V><$<&A*,=;@W)Z6)_A%X<#-/XAN8L[<P6FY>_\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 .6EI%I:!A1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M,=2;I5%:2-^BBBN([@HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 5Q6K_%'0=(U&6Q,-]=20L4
MD:")0J.&(*_.RDD8Z@$<]:[6OG+6+0W_ ,0+RQ601FZU9H-Y7=MWS;<XR,XS
MG&:N$4]R9-K8])_X7'H7_0-U;_OW%_\ '*/^%QZ%_P! W5_^_<7_ ,<K*_X4
MO-_T,<?_ ( '_P".T?\ "EYO^ACC_P#  _\ QVJM3%[QZG:74-]9P7=N^^">
M-98VP1N5AD'!Y'![U-5;3[*/3=-M;&%G:*VA2%&<@L0H &<=^*J>(M:C\/:#
M=ZI)"TP@48C4XW,S!0,]ADC)YP.QZ5D6:,LL=O"\TTB1Q1J7=W8!54<DDGH*
MX>7XM^&H[SR56^DAW*/M*P 1@'&3@D/@9Y^7/!P#QGSS4]4\3?$346AM[6:>
M"*0O%:P@".#*G&YS@9(5L%CU+ 8SBN8U*TDT^[O+*8H9;>1X7*$E2RD@XR!Q
MQ6T::ZF;GV/J6BBBL30P]?\ %^B^&V6/4;HBX>-I(X(T+NX'TX7)X!8@$@\\
M''/6_P 7?#LUPD<L&HVT9SF:6%2JX&>0C,W/3@'K7G&BVK^-O'ZM<1R^5=W+
M7%P"6D\N(9;86&"!@+&#QC*X'05UWC[P#HFD>&Y-5TN.2T>V==\?F/(LH=E3
M'S$E2"001[@@Y!&O+%:,B[>J/4X9HKB&.:&1)(I%#HZ,"K*1D$$=0:?7FOP=
MU&2;2=1TU@Y2VE65&:0D 2 Y4+_" 4)]RY_'O-8U:UT/2;C4KPOY$"@L$7<Q
M)(  'J20.>.>2!S6;5G8I.ZN8_B_QK9>$[=%9!=7TN#':J^T[<\LQP=HZXXY
M(XZ$BYX5U]O$V@Q:HUFUH)'=0AD$@.UB,@C'&01R <@\8P3X]X=TR\^('C26
M[U IL++<7K+&RH4&%$8QT) VC)SA2<DCGWB&&.WACAAC2.*-0B(B@*J@8  '
M0"JDE%6ZB3;U'T445!04444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% #EI:1:6@84444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MR (US),%9AR!\YPW0\<Y -=GX.\8RZA.NF:FQDNW+&&<(!OP"Q5@HP" #@X
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M<FK% BR%HY'B5UV\&-00&R!T0'KZGF#P=I,6I^(K:VDBADM84:66*3.&51@
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 .6EI%I:!A1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MDS;$SC7HSA3=VO\ A_T.!T?PMJNO6LES8FS6*.0Q'SY64DX!Z!#Q\P[UH_\
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M<.64E9-G>ZU.?-&+NTCS?P?_ ,CII'_727_T3)7LU>,^#_\ D=-(_P"NDO\
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M_!GZ/\C!^&7_ #%/^V7_ +/70^,I;2/PK?)=R(IEC*P*S$;Y@-R 8Y/S*#]
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M^^)O^LTGZ3?^TZ]!KS[XF_ZS2?I-_P"TZY\!_O$?G^1T9C_NTOE^:.A\$_\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %4]6L?[4T:^T_P SROM5O)!Y
MFW=MW*5SCC.,]*N44 >)?\*A\1_\_6E?]_Y/_C='_"H?$?\ S]:5_P!_I/\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@#D_$/Q#T?PWJITZZCNIIA&KL;<(P3.<*V6
M!#8P<8Z,#WK6\.^(K'Q/IAO[ 2K&LAB=)5VLK#!P<$CH0>">OKD5P/C3X;ZQ
MK/B6ZU:PGM9(KDQ9CD8HZ$!4/8@@ ;LYSU !(&>N\"^&KGPMH#V5W/%+/)<-
M,WE9VKD*H )P3PN>@ZX[9-M1Y=-R4W<Z:BBBH*"BBB@ HHHH **** "BBB@
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M4I!(+N_M+<C'EF)6FSUSD'9CMZ_A7=:'H=IH%BUK:&5E>0R.\K99F.!VP!P
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M!QST].E>@Z;?1:II=IJ$"NL5U"DZ*X 8*RA@#C/.#7SAXF_Y&S6O^O\ G_\
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MCUZUK_"O0UU3Q2;V>+?;Z>GF@G:5\TG" @\G^-@1T*#GUX;S99_WTTCRRO\
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M 4444 %%%% #****!!1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% %.YTK3KV<3W6GVL\H7:))859@,YQDCIDG\ZB.@:,PP=)L"/
M>V3_  K1HJE.2T3)<(MW:&111P1)%$BQQHH5$08"@<  =A3Z**DH**** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH <M+2+2T#"BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH \_P#BYI*W?AB+4@$$MA,,LS$'RW(4@ <$
MEO+//8'GL>1^$>I?9/%4UB\^R.]MR%CV9WR(=R\XXPOF=P.?7%>OZWI<>M:)
M>Z;+L N860.\8<(V/E?'<J<$=.0.E?..D7DFA^(;.\F6YA:TN5::- 5D 5OG
M3!QR1E2#CJ0:VAK%HSEI),]E^+%Y]G\$/!Y6\7=S%$6W8V8/F9Z<\QXQQUSV
MKRS1?#G]J>%_$&J_9II)K".,P-NVQ_>S*<G 8K&N<9Z-T)*UTOQAU**YUVQT
M] C-9PL[NL@)#2$?(1V("*WN''X]G\.-#2R\"1QW<6\:B7N)8I=KH4<!5&!Q
MM**IP<_>.?0"?+ &KR///A5J4MGXTBM%#M%?1/$ZB0A5*J7#D=&(VE1Z;SSV
M/I?Q&U9=)\%7O*>;>#[)&KJ2&W@[AQT.P.03QD#KT/A/^E:#K?\ RPDO--NO
M=HVEB?\  E=R^QQZ5Z'\7M<2Z?2M-MI=]NT7VTNNUHY V5C96')P _MAAU[.
M4;R3$G:+.>^&>G_VAXYM"5A>.U1[EUE&<@#:I48^\'=#VQC/4"O7O'-[#8^!
M]8EG5V22V:WP@!.9/W8ZGIEQGVSUKF_A!I+6N@7>IR!U:]E"H"P*F./(! '(
M.YG!S_=''KT7CVP_M'P-JT/F^5LA\_=MS_JF$F.O?9C/;.>:B;O,J*M$\.\)
MZ8=7\6:79;(71KA7D2891XT^=U(P<Y52,=#GFOI2OG'P1?'3O&VD3B+S=UP(
M-N[&/,_=YZ=MV<=\8XKZ.IU=Q4]@KR/XT1QK>:)((T$LD<ZM(%&YE4QX!/H-
MS8^I]:]<KR/XT21M>:)$LJ&6..=GC##<JL8]I([ [6QZX/I4T_B14]B3X+*-
MVN-W(MQ_Z,KK/B9_R3[4_K#_ .CDKD_@LP+ZZO<"W/Y^;_A76?$S_DGVI_6'
M_P!')3E_$$OA/(_A[''+\0-&26-'3S)&VNH(RL3LIY[@@$>A KZ(KYY^'/\
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M5[P3X*\.:[X0L-1O]*4W,GF*[)<3*&VR,H.-_4A03CC). .E=!_PK/PC_P!
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MJ?85ZM\%1^^UX_[-M_[5KS;5+*+3=8OK"!G>&UN9($9R"Q",5!. !GCTKO\
MX-WICUK4K#RLB>W68R;ON^6V,8QSGS.N>-OOQT3U@91^(]CKP_XO_P#(ZV__
M &#HO_1DM>X5X3\5[R.Z\;M$BN&M;:.!RP&">9,CGIB0>G(-94OB+GL<YX9.
M/%FB_P#7_;_^C%KU?Q[X_P!1\+ZU;Z?86MJ^ZW$[R3AFSEF4  $8QM//.<]L
M<^=_#VP34/'.F)+;O-%$YG;;G"%%+(Q(Z .$Z\$D#OBO4/&7P\7Q9JL&H)J;
M6DD<'D.K0>8K ,6!'S+@_,V>N>.F.;FUS*Y,4^70XG_A</B#_GSTS_OU)_\
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M: +M%4O[4@_NR?D/\:/[4@_NR?D/\: +M%4O[4@_NR?D/\:/[4@_NR?D/\:
M+M%4O[4@_NR?D/\ &C^U(/[LGY#_ !H NT52_M2#^[)^0_QH_M2#^[)^0_QH
M NT52_M2#^[)^0_QH_M2#^[)^0_QH NT52_M2#^[)^0_QH_M2#^[)^0_QH N
MT52_M2#^[)^0_P :/[4@_NR?D/\ &@"[15+^U(/[LGY#_&C^U(/[LGY#_&@"
M[15+^U(/[LGY#_&C^U(/[LGY#_&@"[15+^U(/[LGY#_&C^U(/[LGY#_&@"[1
M5+^U(/[LGY#_ !H_M2#^[)^0_P : +M%4O[4@_NR?D/\:/[4@_NR?D/\: +M
M%4O[4@_NR?D/\:/[4@_NR?D/\: +M%4O[4@_NR?D/\:/[4@_NR?D/\: +M%4
MO[4@_NR?D/\ &C^U(/[LGY#_ !H NT52_M2#^[)^0_QH_M2#^[)^0_QH NT5
M2_M2#^[)^0_QH_M2#^[)^0_QH NT52_M2#^[)^0_QH_M2#^[)^0_QH NT52_
MM2#^[)^0_P :/[4@_NR?D/\ &@"[15+^U(/[LGY#_&C^U(/[LGY#_&@"[15+
M^U(/[LGY#_&C^U(/[LGY#_&@"[15+^U(/[LGY#_&C^U(/[LGY#_&@"[15+^U
M(/[LGY#_ !H_M2#^[)^0_P : +M%4O[4@_NR?D/\:/[4@_NR?D/\: +M%4O[
M4@_NR?D/\:/[4@_NR?D/\: +M%4O[4@_NR?D/\:/[4@_NR?D/\: +M%4O[4@
M_NR?D/\ &C^U(/[LGY#_ !H NT52_M2#^[)^0_QH_M2#^[)^0_QH NT52_M2
M#^[)^0_QH_M2#^[)^0_QH NT52_M2#^[)^0_QH_M2#^[)^0_QH NT52_M2#^
M[)^0_P :/[4@_NR?D/\ &@"[15+^U(/[LGY#_&C^U(/[LGY#_&@"[15+^U(/
M[LGY#_&C^U(/[LGY#_&@"[15+^U(/[LGY#_&C^U(/[LGY#_&@"[15+^U(/[L
MGY#_ !H_M2#^[)^0_P : +M%4O[4@_NR?D/\:/[4@_NR?D/\: +M%4O[4@_N
MR?D/\:/[4@_NR?D/\: +M%4O[4@_NR?D/\:/[4@_NR?D/\: +M%4O[4@_NR?
MD/\ &C^U(/[LGY#_ !H NT52_M2#^[)^0_QH_M2#^[)^0_QH NT52_M2#^[)
M^0_QH_M2#^[)^0_QH NT52_M2#^[)^0_QH_M2#^[)^0_QH NT52_M2#^[)^0
M_P :/[4@_NR?D/\ &@"[15+^U(/[LGY#_&C^U(/[LGY#_&@"[15+^U(/[LGY
M#_&C^U(/[LGY#_&@"[15+^U(/[LGY#_&C^U(/[LGY#_&@"[15+^U(/[LGY#_
M !H_M2#^[)^0_P : +M%4O[4@_NR?D/\:/[4@_NR?D/\: +M%4O[4@_NR?D/
M\:/[4@_NR?D/\: +M%4O[4@_NR?D/\:/[4@_NR?D/\: +M%4O[4@_NR?D/\
M&C^U(/[LGY#_ !H NT52_M2#^[)^0_QH_M2#^[)^0_QH NT52_M2#^[)^0_Q
MH_M2#^[)^0_QH NT52_M2#^[)^0_QH_M2#^[)^0_QH NT52_M2#^[)^0_P :
M/[4@_NR?D/\ &@"[15+^U(/[LGY#_&C^U(/[LGY#_&@"[15+^U(/[LGY#_&C
M^U(/[LGY#_&@"[15+^U(/[LGY#_&C^U(/[LGY#_&@"[15+^U(/[LGY#_ !H_
MM2#^[)^0_P : +M%4O[4@_NR?D/\:/[4@_NR?D/\: +M%4O[4@_NR?D/\:/[
M4@_NR?D/\: +M%4O[4@_NR?D/\:/[4@_NR?D/\: +M%4O[4@_NR?D/\ &C^U
M(/[LGY#_ !H NT52_M2#^[)^0_QH_M2#^[)^0_QH NT52_M2#^[)^0_QH_M2
M#^[)^0_QH NT52_M2#^[)^0_QH_M2#^[)^0_QH NT52_M2#^[)^0_P :/[4@
M_NR?D/\ &@"[15+^U(/[LGY#_&C^U(/[LGY#_&@"[15+^U(/[LGY#_&C^U(/
M[LGY#_&@"[15+^U(/[LGY#_&C^U(/[LGY#_&@"[15+^U(/[LGY#_ !H_M2#^
M[)^0_P : +M%4O[4@_NR?D/\:/[4@_NR?D/\: +M%4O[4@_NR?D/\:/[4@_N
MR?D/\: +M%4O[4@_NR?D/\:/[4@_NR?D/\: +M%4O[4@_NR?D/\ &C^U(/[L
MGY#_ !H NT52_M2#^[)^0_QH_M2#^[)^0_QH NT52_M2#^[)^0_QH_M2#^[)
M^0_QH NT52_M2#^[)^0_QH_M2#^[)^0_QH NT52_M2#^[)^0_P :/[4@_NR?
MD/\ &@"[15+^U(/[LGY#_&C^U(/[LGY#_&@"[15+^U(/[LGY#_&C^U(/[LGY
M#_&@"[15+^U(/[LGY#_&C^U(/[LGY#_&@"[15+^U(/[LGY#_ !H_M2#^[)^0
M_P : +M%4O[4@_NR?D/\:/[4@_NR?D/\: +M%4O[4@_NR?D/\:/[4@_NR?D/
M\: +M%4O[4@_NR?D/\:/[4@_NR?D/\: +M%4O[4@_NR?D/\ &C^U(/[LGY#_
M !H NT52_M2#^[)^0_QH_M2#^[)^0_QH NT52_M2#^[)^0_QH_M2#^[)^0_Q
MH NT52_M2#^[)^0_QH_M2#^[)^0_QH NT52_M2#^[)^0_P :/[4@_NR?D/\
M&@"[15+^U(/[LGY#_&C^U(/[LGY#_&@"[15+^U(/[LGY#_&C^U(/[LGY#_&@
M"[15+^U(/[LGY#_&C^U(/[LGY#_&@"[15+^U(/[LGY#_ !H_M2#^[)^0_P :
M +M%4O[4@_NR?D/\:/[4@_NR?D/\: +M%4O[4@_NR?D/\:/[4@_NR?D/\: +
MM%4O[4@_NR?D/\:/[4@_NR?D/\: +M%4O[4@_NR?D/\ &C^U(/[LGY#_ !H
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M#USQR>BV%]XS\7117,LL\MU+YEW<'JL8^\<@$+P-J\8R5' KV'_A6/A#)/\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110!/;_P 7X5/4%O\ Q?A4](84444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MO#MOJ&I6\4$TQ8J(@P#)GY6VMR,]N2",'/. [.UQ7UL;=%%%(84444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% $]O_ !?A
M4]06_P#%^%3TAA1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MBL+QC/-;>%KN6WFDAE5HL/&Q5AF10>1[5PMAXKU*QM+U/M$\US.$6*69RXA
MW;B <_-R,<8[G.,%4<).M!SCWL.OC(4:BA/M<]7HKR'^Q-<\0-_:#V4]V7X$
MTQ5<J?F&W>1\GS9&WY>3BDTO6-2\/7<:KYZ1Q AK*8LBX;YB-I^Z3G.<9Y[@
MD';ZA=-0FFUT,/[2Y6G.#47U/7Z*K:??P:GI\%[;MF*9=P&02I[J<$C(.01G
M@@U9KSVK.S/3335T%%%% ',>.K_[+H/V9'Q+=.$^63:P0<L<=2. I'^WSZ'S
M?[+.;+[: AMO.-N6#<K(%#8(]U.1CT.<<9V_&NH"\\13*'S#:H(1B7<N1RQQ
MT4Y.T_[@SZ#I[G077X>+8M&_VJ&'[1L9!*ZR9+LB[>_+(",\'OW]BC-8:E"^
M\GKZ'AUJ;Q=:I;:*LO7^KB?#Z]6719K'Y UK*2%52/D<ELD]"2V_IV ^IZZO
M)_".IMIWB&V4R;;>Y/D2 AB"6^X0!WW;1DYP&;IUKUBN/'4O9UGV>IWY?5]I
M07=:'*>/=2^RZ1'8I)MEO&(*_-DQKC=@CCJ4!!ZAB,5SWA#PW%K$DUU>JQM(
MOD5 V/,<CG)!R,#!]\CG@BMSQ_I<EW86U]#'+(]HS*X7&%C8 LQ'4X*+TZ D
MGCD<SX7\1-H5\R3!GL;@@2@$DQ$9PZCH>OS#&2 ,?=P>J@I?5'[+XOQ.+$N/
MUU>V^&VG;^KG9MX%T I($M9HV8$!Q<R,5/J S$9'N,5GZ7X(GTSQ+;7RWD<E
MI;EW4%2)"2K*%(Z<!@=V>2/NBNIL-1L]4MA<65Q'/$< E3RIP#AAU4X(X.",
MU:K@^L5DG%MZ]STOJU%M345IV,B[\+Z/?7DUW<V9>>8@NWFN,X 4< X' '2H
M?^$-T#_GP_\ (TG_ ,56[14JO52LI/[RGAZ,G=Q5_1'B&B(MY>:9'.-ZS2PK
M(.FX,P!Z?6O4O^$-T#_GP_\ (TG_ ,57EWAO_C_T;_KO;_\ H2U[=7HYA5G"
M4>636AYF6T:<XRYHIZ]C-T_0-,TJX:>RMO*E9"A/F,W!(/0D^@K2HHKRY2E)
MWD[GKQA&"M%604445)04444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M5/4%O_%^%3TAA1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M0 >E97BB]?3_  W>SQ!M^P1J4<J5+D)N!'<;L_AVK7K \:D#PE>$_P!Z(?\
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M"/-W<-(C.QSM59&4*OH#M!/J?H,8/C__ )&:/_KSC_\ 0Y*ZGP'_ ,B?:?\
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M7_D"6?\ U^#_ -%R5G?#?_C]U?\ ZYV_\Y:T?B+_ ,@2S_Z_!_Z+DK.^&_\
MQ^ZO_P!<[?\ G+7I1_W%^O\ D>5+_D8+T_S-_P ;_P#(HWG^_#_Z-2N'\):=
M:ZKXB2VO(_,AC@>?83PY5D #>H^;..^,'(R#W'C?_D4;S_?A_P#1J5R/@'_D
M;&_Z\9?_ $.*GAY..#FUW_R%B8J6-II]O\ST^O._B#900:C:WD:[9;E&$F
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M2U[=7B/AO_C_ -&_Z[V__H2U[=7I9E\4?0\K*OAGZA1117FGJA1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4R66."%YI
MI$CBC4L[NP"JHY))/04^J^H64>HZ;=6,S.L5S"\+E" P# @XSWYH YW_ (61
MX3_Z"C?^ LW_ ,11_P +(\*?]!1O_ 6;_P"(KE_^%/2?]!]?_ +_ .V4?\*>
MD_Z#Z_\ @%_]LK2T.Y%Y'IEI=0WUG!=V[[X)XUEC;:1E6&0<'D<'O4U5-+LC
MIND65B9/--M D)DV[=VU0,XR<9QTS5NLRR*ZN8;*TFNKAMD,,;22-@G"@9)P
M.3P.U>$VPOO'OC1!<-+B>0L_S9^SP YV@A<# X!( +$9Y8UV7Q=U&XAL],TZ
M-ML%RTDLN"06\O9M'7!&7S@CJ%/:N(\.>+K[PO'<+86UH[7!4N\RNQP,X'#
M8&3VSS],:P3M=&<GK9GO5I:PV5G!:6Z;(((UCC7).%48 R>3P.]?.?BC_D/Z
M[_U^7/\ Z,:NN_X6QK__ #ZZ9_WZD_\ BZXF_G?4;N[N9@JR74CRN$& "Y).
M,]N:J$&MPE),^FJX+XC^$;C68HM5T^/S+NVC*2Q#):6,'(VC.,J2W&,G=UR
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M <,I4C<_0C@\!1UZ\<]C7;C:\*KBX=$<& P\Z,9*?5A1117$=X4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MNT445F6%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110!/;_P 7X5/4%O\ Q?A4](84444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110!1HHHIB"BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH *YCQIH=UJ]G;26,9EN('(\K>%W(V,D9XR" >
MHXW=3@5T]%73J2IS4X[HSJTHU8.$MF>1V>OZUX?:&VWR0H,R"UNHL;@V1G!
M8#//!'(^M79?'VM-"ZG[%%N4@2)$VY#CJ-S$9'N"*]/HKL>+I2?-*FK^IQ1P
M5:"Y856EZ?\ !/)K/1=<\17:2RBX9),,UW<YVJC9;*YQN'7"KP,C[H.:]0T^
MQATVP@L[<8CA0*"0 6/=C@ 9)R3QU)JS16%?$RK65K)=#HP^%C0N[W;W;"BB
MBN<Z0HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** )[?\ B_"IZ@M_XOPJ>D,**** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH HT444Q!1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 3V_\7X5/4%O_ !?A4](84444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110!DF[ )'EOQ2?;%_YYO6I1
M0(R_MB_\\WH^V+_SS>M2B@#+^V+_ ,\WH^V+_P \WK4HH R_MB_\\WH^V+_S
MS>M2B@#+^V+_ ,\WH^V+_P \WK4HH R_MB_\\WH^V+_SS>M2B@#+^V+_ ,\W
MH^V+_P \WK4HH R_MB_\\WH^V+_SS>M2B@#+^V+_ ,\WH^V+_P \WK4HH R_
MMB_\\WH^V+_SS>M2B@#+^V+_ ,\WH^V+_P \WK4HH R_MB_\\WH^V+_SS>M2
MB@#+^V+_ ,\WH^V+_P \WK4HH R_MB_\\WH^V+_SS>M2B@#+^V+_ ,\WH^V+
M_P \WK4HH R_MB_\\WH^V+_SS>M2B@#+^V+_ ,\WH^V+_P \WK4HH R_MB_\
M\WH^V+_SS>M2B@#+^V+_ ,\WH^V+_P \WK4HH R_MB_\\WH^V+_SS>M2B@#+
M^V+_ ,\WH^V+_P \WK4HH R_MB_\\WH^V+_SS>M2B@#+^V+_ ,\WH^V+_P \
MWK4HH R_MB_\\WH^V+_SS>M2B@#+^V+_ ,\WH^V+_P \WK4HH R_MB_\\WH^
MV+_SS>M2B@#+^V+_ ,\WH^V+_P \WK4HH R_MB_\\WH^V+_SS>M2B@#+^V+_
M ,\WH^V+_P \WK4HH R_MB_\\WH^V+_SS>M2B@#+^V+_ ,\WH^V+_P \WK4H
MH R_MB_\\WH^V+_SS>M2B@#+^V+_ ,\WH^V+_P \WK4HH R_MB_\\WH^V+_S
MS>M2B@#+^V+_ ,\WH^V+_P \WK4HH R_MB_\\WH^V+_SS>M2B@#+^V+_ ,\W
MH^V+_P \WK4HH R_MB_\\WH^V+_SS>M2B@#+^V+_ ,\WH^V+_P \WK4HH R_
MMB_\\WH^V+_SS>M2B@#+^V+_ ,\WH^V+_P \WK4HH R_MB_\\WH^V+_SS>M2
MB@#+^V+_ ,\WH^V+_P \WK4HH R_MB_\\WH^V+_SS>M2B@#+^V+_ ,\WH^V+
M_P \WK4HH R_MB_\\WH^V+_SS>M2B@#+^V+_ ,\WH^V+_P \WK4HH R_MB_\
M\WH^V+_SS>M2B@#+^V+_ ,\WH^V+_P \WK4HH R_MB_\\WH^V+_SS>M2B@#+
M^V+_ ,\WH^V+_P \WK4HH R_MB_\\WH^V+_SS>M2B@#+^V+_ ,\WH^V+_P \
MWK4HH R_MB_\\WH^V+_SS>M2B@#+^V+_ ,\WH^V+_P \WK4HH R_MB_\\WH^
MV+_SS>M2B@#+^V+_ ,\WH^V+_P \WK4HH R_MB_\\WH^V+_SS>M2B@#+^V+_
M ,\WH^V+_P \WK4HH R_MB_\\WH^V+_SS>M2B@#+^V+_ ,\WH^V+_P \WK4H
MH R_MB_\\WH^V+_SS>M2B@#+^V+_ ,\WH^V+_P \WK4HH R_MB_\\WH^V+_S
MS>M2B@#+^V+_ ,\WH^V+_P \WK4HH R_MB_\\WH^V+_SS>M2B@#+^V+_ ,\W
MH^V+_P \WK4HH R_MB_\\WH^V+_SS>M2B@#+^V+_ ,\WH^V+_P \WK4HH R_
MMB_\\WH^V+_SS>M2B@#+^V+_ ,\WH^V+_P \WK4HH R_MB_\\WH^V+_SS>M2
MB@#+^V+_ ,\WH^V+_P \WK4HH R_MB_\\WH^V+_SS>M2B@#+^V+_ ,\WH^V+
M_P \WK4HH R_MB_\\WH^V+_SS>M2B@#+^V+_ ,\WH^V+_P \WK4HH R_MB_\
M\WH^V+_SS>M2B@#+^V+_ ,\WH^V+_P \WK4HH R_MB_\\WH^V+_SS>M2B@#+
M^V+_ ,\WH^V+_P \WK4HH R_MB_\\WH^V+_SS>M2B@#+^V+_ ,\WH^V+_P \
MWK4HH R_MB_\\WH^V+_SS>M2B@#+^V+_ ,\WH^V+_P \WK4HH R_MB_\\WH^
MV+_SS>M2B@#+^V+_ ,\WH^V+_P \WK4HH R_MB_\\WH^V+_SS>M2B@#+^V+_
M ,\WH^V+_P \WK4HH R_MB_\\WH^V+_SS>M2B@#+^V+_ ,\WH^V+_P \WK4H
MH R_MB_\\WH^V+_SS>M2B@#+^V+_ ,\WH^V+_P \WK4HH R_MB_\\WH^V+_S
MS>M2B@#+^V+_ ,\WH^V+_P \WK4HH R_MB_\\WH^V+_SS>M2B@#+^V+_ ,\W
MH^V+_P \WK4HH R_MB_\\WH^V+_SS>M2B@#+^V+_ ,\WH^V+_P \WK4HH R_
MMB_\\WH^V+_SS>M2B@#+^V+_ ,\WH^V+_P \WK4HH R_MB_\\WH^V+_SS>M2
MB@#+^V+_ ,\WH^V+_P \WK4HH R_MB_\\WH^V+_SS>M2B@#+^V+_ ,\WH^V+
M_P \WK4HH R_MB_\\WH^V+_SS>M2B@#+^V+_ ,\WH^V+_P \WK4HH R_MB_\
M\WH^V+_SS>M2B@#+^V+_ ,\WH^V+_P \WK4HH R_MB_\\WH^V+_SS>M2B@#+
M^V+_ ,\WH^V+_P \WK4HH R_MB_\\WH^V+_SS>M2B@#+^V+_ ,\WH^V+_P \
MWK4HH R_MB_\\WH^V+_SS>M2B@#+^V+_ ,\WH^V+_P \WK4HH R_MB_\\WH^
MV+_SS>M2B@#+^V+_ ,\WH^V+_P \WK4HH R_MB_\\WH^V+_SS>M2B@#+^V+_
M ,\WH^V+_P \WK4HH R_MB_\\WH^V+_SS>M2B@#+^V+_ ,\WH^V+_P \WK4H
MH R_MB_\\WH^V+_SS>M2B@#+^V+_ ,\WH^V+_P \WK4HH R_MB_\\WH^V+_S
MS>M2B@#+^V+_ ,\WH^V+_P \WK4HH R_MB_\\WH^V+_SS>M2B@#+^V+_ ,\W
MH^V+_P \WK4HH R_MB_\\WH^V+_SS>M2B@#+^V+_ ,\WH^V+_P \WK4HH R_
MMB_\\WH^V+_SS>M2B@#+^V+_ ,\WH^V+_P \WK4HH R_MB_\\WH^V+_SS>M2
MB@#+^V+_ ,\WH^V+_P \WK4HH R_MB_\\WH^V+_SS>M2B@#+^V+_ ,\WH^V+
M_P \WK4HH R_MB_\\WH^V+_SS>M2B@#+^V+_ ,\WH^V+_P \WK4HH R_MB_\
M\WH^V+_SS>M2B@#+^V+_ ,\WH^V+_P \WK4HH R_MB_\\WH^V+_SS>M2B@#+
M^V+_ ,\WH^V+_P \WK4HH R_MB_\\WH^V+_SS>M2B@#+^V+_ ,\WH^V+_P \
MWK4HH R_MB_\\WH^V+_SS>M2B@#+^V+_ ,\WH^V+_P \WK4HH R_MB_\\WH^
MV+_SS>M2B@#+^V+_ ,\WH^V+_P \WK4HH R_MB_\\WH^V+_SS>M2B@#+^V+_
M ,\WH^V+_P \WK4HH R_MB_\\WH^V+_SS>M2B@#+^V+_ ,\WH^V+_P \WK4H
MH R_MB_\\WH^V+_SS>M2B@#+^V+_ ,\WH^V+_P \WK4HH R_MB_\\WH^V+_S
MS>M2B@#+^V+_ ,\WH^V+_P \WK4HH R_MB_\\WH^V+_SS>M2B@#+^V+_ ,\W
MH^V+_P \WK4HH R_MB_\\WH^V+_SS>M2B@#+^V+_ ,\WH^V+_P \WK4HH R_
MMB_\\WH^V+_SS>M2B@#+^V+_ ,\WH^V+_P \WK4HH R_MB_\\WH^V+_SS>M2
MB@#+^V+_ ,\WH^V+_P \WK4HH R_MB_\\WH^V+_SS>M2B@#+^V+_ ,\WH^V+
M_P \WK4HH KV,HE#D*1C'6K=(M+0,**** "BBB@ HHHH *3(]12&F&G839)N
M7U'YT;U_O#\ZKM3#3Y1.1:\Q/[Z_G1YD?]]?SJD:C-5R$\YH>;'_ ,]$_.CS
MHO\ GHG_ 'T*S#49I^S1+J,UO/A_YZI_WT*/M$/_ #VC_P"^A6*U,:G[)"]L
M^QN?:(/^>T?_ 'T*/M,'_/>/_OL5SYIAJO8KN3[=]CH_M5O_ ,]XO^^Q2?:[
M;_GXB_[[%<T:C-/V"[DO$/L=3]LMO^?B'_OL4GVVU_Y^8?\ OX*Y1JC-5]77
M<3Q+['7_ &VT_P"?J'_OX*3[=:?\_4'_ '\%<<:C-/ZLNY+Q<NQVOV^S_P"?
MN#_OX*/[0LO^?NW_ ._@_P :X<U&:KZJNY/UR78[O^T;+_G\M_\ OZO^-']H
MV/\ S^V__?U?\:X$U&U/ZG'N+Z[+L>@_VE8?\_MM_P!_5_QH_M.P_P"?ZV_[
M^K_C7G;5&:?U*/<GZ_+L>C_VII__ #_6O_?Y?\:/[5T[_G_M?^_R_P"->:-3
M#5?48]Q?VA+L>F_VKIW_ $$+7_O\O^-']K:;_P!!"T_[_+_C7EYJ-J?U"/<E
MYC+^4]4_M?3/^@C:?]_E_P :3^V-,_Z"-I_W_7_&O*349JEE\?YB?[2G_*>M
M?VSI?_02L_\ O^O^-)_;.E?]!*S_ ._Z_P"->1M49I_V='^87]J3_E1[!_;6
ME?\ 03LO^_Z_XTG]MZ3_ -!2R_\  A/\:\=-1FJ_LV'\Q/\ :L_Y4>S?VYI/
M_04LO_ A/\:/[=TC_H*V/_@0G^->+&HS3_LR'\Q/]K3_ )4>V?V[H_\ T%;'
M_P "$_QH_M[1_P#H+6/_ ($I_C7B!IE/^RX?S,7]KS_E1[E_;VC_ /06L?\
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MH_\ T%K'_P "4_QH_M[1_P#H+6/_ ($I_C7AM%']E0_F8?VQ/^5'N7]O:/\
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M]H__ $%K'_P)3_&C^WM'_P"@M8_^!*?XUX;11_94/YF']L3_ )4>Y?V]H_\
MT%K'_P "4_QH_M[1_P#H+6/_ ($I_C7AM%']E0_F8?VQ/^5'N7]O:/\ ]!:Q
M_P# E/\ &C^WM'_Z"UC_ .!*?XUX;11_94/YF']L3_E1[E_;VC_]!:Q_\"4_
MQH_M[1_^@M8_^!*?XUX;11_94/YF']L3_E1[E_;VC_\ 06L?_ E/\:/[>T?_
M *"UC_X$I_C7AM%']E0_F8?VQ/\ E1[E_;VC_P#06L?_  )3_&C^WM'_ .@M
M8_\ @2G^->&T4?V5#^9A_;$_Y4>Y?V]H_P#T%K'_ ,"4_P :/[>T?_H+6/\
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M_P "4_QH_M[1_P#H+6/_ ($I_C7AM%']E0_F8?VQ/^5'N7]O:/\ ]!:Q_P#
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MB+_OL4OVJW_Y[Q?]]BN76I!2]@NY2Q#['2?:8/\ GM'_ -]"E^T0_P#/:/\
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M\31_PK;1_P#GYOO^_B?_ !-=C11]<K_S,/J6'_D1QW_"MM'_ .?F^_[^)_\
M$T?\*VT?_GYOO^_B?_$UV-%'URO_ #,/J6'_ )$<=_PK;1_^?F^_[^)_\31_
MPK;1_P#GYOO^_B?_ !-=C11]<K_S,/J6'_D1QW_"MM'_ .?F^_[^)_\ $T?\
M*VT?_GYOO^_B?_$UV-%'URO_ #,/J6'_ )$<=_PK;1_^?F^_[^)_\31_PK;1
M_P#GYOO^_B?_ !-=C11]<K_S,/J6'_D1QW_"MM'_ .?F^_[^)_\ $T?\*VT?
M_GYOO^_B?_$UV-%'URO_ #,/J6'_ )$<=_PK;1_^?F^_[^)_\31_PK;1_P#G
MYOO^_B?_ !-=C11]<K_S,/J6'_D1QW_"MM'_ .?F^_[^)_\ $T?\*VT?_GYO
MO^_B?_$UV-%'URO_ #,/J6'_ )$<=_PK;1_^?F^_[^)_\31_PK;1_P#GYOO^
M_B?_ !-=C11]<K_S,/J6'_D1QW_"MM'_ .?F^_[^)_\ $T?\*VT?_GYOO^_B
M?_$UV-%'URO_ #,/J6'_ )$<=_PK;1_^?F^_[^)_\31_PK;1_P#GYOO^_B?_
M !-=C11]<K_S,/J6'_D1QW_"MM'_ .?F^_[^)_\ $T?\*VT?_GYOO^_B?_$U
MV-%'URO_ #,/J6'_ )$<=_PK;1_^?F^_[^)_\31_PK;1_P#GYOO^_B?_ !-=
MC11]<K_S,/J6'_D1QW_"MM'_ .?F^_[^)_\ $T?\*VT?_GYOO^_B?_$UV-%'
MURO_ #,/J6'_ )$<=_PK;1_^?F^_[^)_\31_PK;1_P#GYOO^_B?_ !-=C11]
M<K_S,/J6'_D1QW_"MM'_ .?F^_[^)_\ $T?\*VT?_GYOO^_B?_$UV-%'URO_
M #,/J6'_ )$<=_PK;1_^?F^_[^)_\31_PK;1_P#GYOO^_B?_ !-=C11]<K_S
M,/J6'_D1QW_"MM'_ .?F^_[^)_\ $T?\*VT?_GYOO^_B?_$UV-%'URO_ #,/
MJ6'_ )$<?_PK?1_^?F^_[[3_ .)I1\.=('_+S??]]I_\377T4?6Z_P#,P^I8
M?^1'(_\ "N]('_+Q??\ ?:?_ !-._P"%>Z2/^7B]_P"^T_\ B:ZRBE];K?S#
M^IT/Y4<I_P *_P!*'_+Q>_\ ?:__ !-*/ .E#_EXO/\ OM?_ (FNJHH^M5OY
M@^IT/Y4<N/ >EC_EO>?]]K_\32_\(+IG_/>\_P"^U_\ B:Z>BE]9K?S#^J4/
MY3F1X'TP?\M[O_OM?_B:=_PA.F_\][O_ +[7_P")KI**/K-7^8/JM'^4YP>"
M].'_ "WNO^^U_P#B:4>#=.'_ "VNO^^E_P#B:Z*BE]8J_P P_JU'^4Y[_A#M
M/'_+:Z_[Z7_XFG?\(CIX_P"6US_WTO\ \36_11]8J_S!]6I?RF"/"5@/^6US
M_P!]+_A2_P#"*6/_ #UN/^^E_P *W:*7MZG<?U>E_*8@\+V(_P"6MQ_WTO\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@!RTM(M+0,**** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MFOKG=Y40R0@R22< #ZD@>GK7F_PY_P"1IE_Z\I/_ $..NS\;?\BA??\ ;/\
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M366=A::.)8>-K377EL>.<J$8#G/<UZ#7@%98##TZW-SK:QKF.)J4.7V;WO\
MH>Q_\)39?\(Q_;_D7/V7?M\O:OF?ZSR\XW8Z\]>GOQ7*_P#"S[K_ * 4/_@<
M?_C57M&TJ36OA='80RI'+(SLK."1E;AFP<=,[<9YQG.#TK$_X5SKO_/73O\
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MY^)K+.PM-'$L/&UIKKRV/'.5",!SGN:ZVSUZVO?#[:U'',MNJ2.4<#?A"P/
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M$\$9Y&>QKR'1+!=4URRL7"%)I1O5F*[D +,,CG.T''OZ5ZAXV_Y%"^_[9_\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@!E%%% @HHHH **** "BBB@#/UW_D7M3_Z])?_ $ UXA7M^N_\
MB]J?_7I+_P"@&O$*]O*O@EZG@YO\<?0]K\-_\BMI'_7E#_Z *X3XC_\ (PV_
M_7HO_H;UW?AO_D5M(_Z\H?\ T 5PGQ'_ .1AM_\ KT7_ -#>N7 ?[R_F=>8?
M[JOD<U9:3)>66IW\1=FLUAW(.048R9. #R"%/4 #<:BM+J>QNX;NV;;-"X="
M2<$CL<$$@]",\@D5V?PVBCG;6HI462-XX5='&0P/F @CN*Y76M+DT;5[BQ?<
M5C;,;M_'&>5.<#)QP<#&01VKTX55*K.C+^M#RJE%PHTZ\?Z=]#V?3[Z#4]/@
MO;<YBF0, 2"5]5."1D'(([$&O!8/^/>/_<'\J[_X?:\L4K:+<.Y\UB]MP6 .
M"67.>!@9' &=W.2*X"W(-M$1T*#^588*BZ-6I!^7ZF^/K*M2IS7G]^A[GH7_
M "+VF?\ 7I%_Z *\B\0Q20^)-329-K_:7;&0?E8[E/'JI!_&O7="_P"1>TS_
M *](O_0!63XI\(IX@>.ZAN/(O(TV?-DI(O) (_AY/WAV)R#QCBPN(C1KRYMF
M=^+PTJ^'CR;HXSPAXH&@3/;7",]E<2JS,"/W)P06QC+9^3(SP%R 3P?2M+UG
M3M9A:73[I)@OWE&5=.2!N4X(S@XR.<9%>,7VGWFESK!?VLEM*WW0X&&X!.UA
MD-C(S@G&:@CDDAE66&22*5<[9(W*LN1@X8<C@D<5W5\%3K_O(/5_<>?A\?4P
M_P"[J+1?>>^UQ_Q'_P"1>M_^OM?_ $!ZD\)^+X]71+&^=4U$#"DX G &21_M
M8!)'L2.,@1_$?_D7K?\ Z^U_] >O-H4Y4L3&,M[GJ8BK&KA93AM8\ZTS_D.:
M7_U_VW_HU:]UKPK3/^0YI?\ U_VW_HU:]UK?-/XD?0Y\H_A2]0KPS6/^0]JG
M_7[/_P"C&KW.O#-8_P"0]JG_ %^S_P#HQJ>5_P 27H&;_P ./J>A?#;_ )%^
MZ_Z_&_\ 0$JC\3?^87_VU_\ 9*O?#;_D7[K_ *_&_P#0$JC\3?\ F%_]M?\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% #EI:1:6@84444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 RBBB@04444 %%%%
M !1110!GZ[_R+VI_]>DO_H!KQ"O;]=_Y%[4_^O27_P! ->(5[>5?!+U/!S?X
MX^A[7X;_ .16TC_KRA_] %<)\1_^1AM_^O1?_0WKN_#?_(K:1_UY0_\ H KA
M/B/_ ,C#;_\ 7HO_ *&]<N _WE_,Z\P_W5?(N?#'_CXU?_<@_G)6GX\T!+_3
MSJL7RW-G&2^ H\R+.3DG!^7EASW88R>,SX8_\?&K_P"Y!_.2O0ZG$U'3Q;G'
MI;\B\)2C5P:A+K?\SP2WF:VNH+E%1G@E25 XRNY6##/X@57MT,5M%&W54"G\
M!6QXBTG^Q->N+)?]5Q+!S_RS;..Y/!!7)Y.TGO677N4Y1FE4CU/GJD94VZ<N
MC/;]"_Y%[3/^O2+_ - %:%9^A?\ (O:9_P!>D7_H KQW2M<U+3)A<V=[*ID;
MS)59MZ3$D$E@>I. "WWL="*\"GA95Y3Y7L?1U,7'#QAS+1GMMS:V][;M;W4$
M4\+8+1RH&4X.1D'CJ ?PKRKQGX?M- O;3[$76"Y1L1.2VPIM!^8DDYW#KSG/
M/.!J6WQ+ND@1;K3(99N=SQ2F-3SQA2&(XQW_ "Z5RNK:S?ZW=BYOY59E4*D<
M8*QQCOM!)ZGDDDGWP !UX+"UZ52\M%^9QX[%X>K2M'5]--A-$N);7Q#I<L#[
M'-Y#'G /RNX1ASZJQ'XUZ!\2& \/VP/>[4#_ +X>N?\ AYIK7>MR:@2PBL@1
MD9 :1@1MZ8.%))&01E>QKO?$.CIKFC369">;C? [8^20=#G!P.Q(&<$^M+%5
MHQQ<7VW'@Z$Y8.4?YKV/&[":*VU.RN;ABL,%S%-(P!.%5PQ.!R>!T%>\5X'+
M$\$\L$@ DB=HW4$':RG!&1QP0:Z#0O&>HZ+;P696.YLHB<))D.JXX56SPH/J
M#QP,#&-\=A95[3IZG/E^+A0O"IH>N5X3J4T5SJU]<0-OAFN9)4;!&59R1P>1
MUK;USQIJ6LP36BK':V<I&4CSYA7'*L^>03Z <<'(SGGX()[JXCM[:%IIY3MC
MC3JQ_P \Y/ &2>*,#AI4$YU- Q^*CB'&%+4]+^&Z2+X?N2\;*K7;%"RD!AL0
M9'J,@CZ@U0^)O_,+_P"VO_LE=EI&FQZ1I-M81'<L*X+<_,Q.6;!)QDDG&>,X
MKC?B;_S"_P#MK_[)7'AYJIC.9=6_R9W8JFZ>!Y'T2_-'-^#?^1RTO_?D_P#1
M3U['7A6FW\VE:E!?VXC:: L5$@)4Y4J<X([$]ZZ3_A8VM?\ /#3_ /OT_P#\
M773C<)5K5.:&UCEP&,I4:3C/>YZC7F'Q'_Y&&W_Z]%_]#>M'P]XYU'4]?M-/
MN[:U\NY+KNB#*4(1GSR3D?*1CCKG/&#G?$?_ )&&W_Z]%_\ 0WK'!T9TL3RS
MWL;XVO"MA7*&UR/X<_\ (TR_]>4G_H<==GXV_P"10OO^V?\ Z,6N,^'/_(TR
M_P#7E)_Z''79^-O^10OO^V?_ *,6C$_[['U087_<)>DCRS1_^0]I?_7[!_Z,
M6O:=2T^#5=-N+&Y&8ID*D@ E3V89!&X'!!QP0#7BVC_\A[2_^OV#_P!&+7N=
M&:.U2+7864J]*2?<\*U.PDTO4[FQF(+P/M+<#<.H. 3C((.,\9JJSN[QJ518
MXHA&FT8)^=W)/OF0UZ'\1])W6\&L1]8L03Y/\+'Y#R>S'& ,G>.PKSRO2PU5
M5Z:F]U^9YF*HO#U)06S_ "/0/AE_S%/^V7_L]=_7 ?#+_F*?]LO_ &>N_KQ<
M?_O$OE^2/=R[_=H_/\V%%%<=\26/_".01ECLENU5USPXV.<$=QD X]A7/2I^
MTFH=SIK5/94W/L=C65K'AS2]<7-Y;#SPNU;B/Y9%'./F[@;B=IR,\XKS;2O&
MNM:8%C:X%Y!N!*W678+DE@KYSDYZMN P,# Q6G?_ !'OI[4QV5E%:2MD&5I/
M-(&#]T8 !S@Y.1QT-=?U#$0E[OWW.+^T<-.'O?=8Y"[@^R7US:E]Y@F>$OMV
M[BK%<XYQG%=S\,;B5GU:U+_N(_)E5,#AFWACGKR$7\OK7 R2'YY)9"QY9WD;
M))ZDDGJ?<UZ_X,TM]+\.0K,'6:X/VAT<$%-P&%P0"#@#(/0YKOS"2C049;L\
M_+8.6(<X[*YP'C;_ )&^^_[9_P#HM:V?AA_Q^ZS_ -<[?^<M8WC;_D;[[_MG
M_P"BUJCHNOZAX?FN9+ 6I^T*BN)XV?&W=C&&7^\:J=*57"1C'>R(IU8TL;*<
M]KO]3VVBO*?^%B^(?[FE_P#@/)_\<K8\,>-]1U/7H+#44M=EPK+&;>%E(<*6
MY+.>-JMVZXKRIX&M"+DUHCV(8^A.2C%ZOR-[QM_R*%]_VS_]&+7EFC_\A[2_
M^OV#_P!&+7J?C;_D4+[_ +9_^C%KRS1_^0]I?_7[!_Z,6N_ ?[M/Y_DCSLP_
MWN'R_-GM.I:?!JNFW%C<C,4R%20 2I[,,@C<#@@XX(!KQ34["32]3N;&8@O
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M.N<\!_\ (FV7^_-_Z->NCKRJ_P#%EZO\SU\/_!AZ+\CR[XC?\C+#_P!>:?\
MH;T?#G_D99O^O-__ $-*/B-_R,L/_7FG_H;T?#G_ )&6;_KS?_T-*]C_ )@?
MD>+_ ,S#YGJ-%%%>$?0'@%>N> _^1-LO]^;_ -&O7D=>N> _^1-LO]^;_P!&
MO7NYI_"7K^C/G\H_C/T_5&]=6T5Y:36LZ[H9HVCD4$C*D8(R.1P>U>$30O;7
M$UM*R-+!(T4AC)*[E)5L9QQD&O?*\I^(%@UIXE-UAS'>1JX9F!&]0%95 Y
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MGB91\<O0TJ***\4]X**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* '+2TBTM PHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M5W<J ,C)8\$GM6[112G.4Y<TGJ5"$81Y8JR,S6]!L=>MDAO%8,AS'+&0'3U
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** &4444"
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH <M+2+2T#"BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** &452.H@$CR7I/[2'_ #Q>
M@1>HJC_:0_YXO1_:0_YXO0!>HJC_ &D/^>+T?VD/^>+T 7J*H_VD/^>+T?VD
M/^>+T 7J*H_VD/\ GB]']I#_ )XO0!>HJC_:0_YXO1_:0_YXO0!>HJC_ &D/
M^>+T?VD/^>+T 7J*H_VD/^>+T?VD/^>+T 7J*H_VD/\ GB]']I#_ )XO0!>H
MJC_:0_YXO1_:0_YXO0!>HJC_ &D/^>+T?VD/^>+T 7J*H_VD/^>+T?VD/^>+
MT 7J*H_VD/\ GB]']I#_ )XO0!>HJC_:0_YXO1_:0_YXO0!>HJC_ &D/^>+T
M?VD/^>+T 7J*H_VD/^>+T?VD/^>+T 7J*H_VD/\ GB]']I#_ )XO0!>HJC_:
M0_YXO1_:0_YXO0!>HJC_ &D/^>+T?VD/^>+T 7J*H_VD/^>+T?VD/^>+T 7J
M*H_VD/\ GB]']I#_ )XO0!>HJC_:0_YXO1_:0_YXO0!>HJC_ &D/^>+T?VD/
M^>+T 7J*H_VD/^>+T?VD/^>+T 7J*H_VD/\ GB]']I#_ )XO0!>HJC_:0_YX
MO1_:0_YXO0!>HJC_ &D/^>+T?VD/^>+T 7J*H_VD/^>+T?VD/^>+T 7J*H_V
MD/\ GB]']I#_ )XO0!>HJC_:0_YXO1_:0_YXO0!>HJC_ &D/^>+T?VD/^>+T
M 7J*H_VD/^>+T?VD/^>+T 7J*H_VD/\ GB]']I#_ )XO0!>HJC_:0_YXO1_:
M0_YXO0!>HJC_ &D/^>+T?VD/^>+T 7J*H_VD/^>+T?VD/^>+T 7J*H_VD/\
MGB]']I#_ )XO0!>HJC_:0_YXO1_:0_YXO0!>HJC_ &D/^>+T?VD/^>+T 7J*
MH_VD/^>+T?VD/^>+T 7J*H_VD/\ GB]']I#_ )XO0!>HJC_:0_YXO1_:0_YX
MO0!>HJC_ &D/^>+T?VD/^>+T 7J*H_VD/^>+T?VD/^>+T 7J*H_VD/\ GB]'
M]I#_ )XO0!>HJC_:0_YXO1_:0_YXO0!>HJC_ &D/^>+T?VD/^>+T 7J*H_VD
M/^>+T?VD/^>+T 7J*H_VD/\ GB]']I#_ )XO0!>HJC_:0_YXO1_:0_YXO0!>
MHJC_ &D/^>+T?VD/^>+T 7J*H_VD/^>+T?VD/^>+T 7J*H_VD/\ GB]']I#_
M )XO0!>HJC_:0_YXO1_:0_YXO0!>HJC_ &D/^>+T?VD/^>+T 7J*H_VD/^>+
MT?VD/^>+T 7J*H_VD/\ GB]']I#_ )XO0!>HJC_:0_YXO1_:0_YXO0!>HJC_
M &D/^>+T?VD/^>+T 7J*H_VD/^>+T?VD/^>+T 7J*H_VD/\ GB]']I#_ )XO
M0!>HJC_:0_YXO1_:0_YXO0!>HJC_ &D/^>+T?VD/^>+T 7J*H_VD/^>+T?VD
M/^>+T 7J*H_VD/\ GB]']I#_ )XO0!>HJC_:0_YXO1_:0_YXO0!>HJC_ &D/
M^>+T?VD/^>+T 7J*H_VD/^>+T?VD/^>+T 7J*H_VD/\ GB]']I#_ )XO0!>H
MJC_:0_YXO1_:0_YXO0!>HJC_ &D/^>+T?VD/^>+T 7J*H_VD/^>+T?VD/^>+
MT 7J*H_VD/\ GB]']I#_ )XO0!>HJC_:0_YXO1_:0_YXO0!>HJC_ &D/^>+T
M?VD/^>+T 7J*H_VD/^>+T?VD/^>+T 7J*H_VD/\ GB]']I#_ )XO0!>HJC_:
M0_YXO1_:0_YXO0!>HJC_ &D/^>+T?VD/^>+T 7J*H_VD/^>+T?VD/^>+T 7J
M*H_VD/\ GB]']I#_ )XO0!>HJC_:0_YXO1_:0_YXO0!>HJC_ &D/^>+T?VD/
M^>+T 7J*H_VD/^>+T?VD/^>+T 7J*H_VD/\ GB]']I#_ )XO0!>HJC_:0_YX
MO1_:0_YXO0!>HJC_ &D/^>+T?VD/^>+T 7J*H_VD/^>+T?VD/^>+T 7J*H_V
MD/\ GB]']I#_ )XO0!>HJC_:0_YXO1_:0_YXO0!>HJC_ &D/^>+T?VD/^>+T
M 7J*H_VD/^>+T?VD/^>+T 7J*H_VD/\ GB]']I#_ )XO0!>HJC_:0_YXO1_:
M0_YXO0!>HJC_ &D/^>+T?VD/^>+T 7J*H_VD/^>+T?VD/^>+T 7J*H_VD/\
MGB]']I#_ )XO0!>HJC_:0_YXO1_:0_YXO0!>HJC_ &D/^>+T?VD/^>+T 7J*
MH_VD/^>+T?VD/^>+T 7J*H_VD/\ GB]']I#_ )XO0!>HJC_:0_YXO1_:0_YX
MO0!>HJC_ &D/^>+T?VD/^>+T 7J*H_VD/^>+T?VD/^>+T 7J*H_VD/\ GB]'
M]I#_ )XO0!>HJC_:0_YXO1_:0_YXO0!>HJC_ &D/^>+T?VD/^>+T 7J*H_VD
M/^>+T?VD/^>+T 7J*H_VD/\ GB]']I#_ )XO0!>HJC_:0_YXO1_:0_YXO0!>
MHJC_ &D/^>+T?VD/^>+T 7J*H_VD/^>+T?VD/^>+T 7J*H_VD/\ GB]']I#_
M )XO0!>HJC_:0_YXO1_:0_YXO0!>HJC_ &D/^>+T?VD/^>+T 7J*H_VD/^>+
MT?VD/^>+T 7J*H_VD/\ GB]']I#_ )XO0!>HJC_:0_YXO1_:0_YXO0!>HJC_
M &D/^>+T?VD/^>+T 7J*H_VD/^>+T?VD/^>+T 7J*H_VD/\ GB]']I#_ )XO
M0!>HJC_:0_YXO1_:0_YXO0!>HJC_ &D/^>+T?VD/^>+T 7J*H_VD/^>+T?VD
M/^>+T 7J*H_VD/\ GB]']I#_ )XO0!>HJC_:0_YXO1_:0_YXO0!>HJC_ &D/
M^>+T?VD/^>+T 7J*H_VD/^>+T?VD/^>+T 7J*H_VD/\ GB]']I#_ )XO0!>H
MJC_:0_YXO1_:0_YXO0!>HJC_ &D/^>+T?VD/^>+T 7J*H_VD/^>+T?VD/^>+
MT 7J*H_VD/\ GB]']I#_ )XO0!>HJC_:0_YXO1_:0_YXO0!>HJC_ &D/^>+T
M?VD/^>+T 7J*H_VD/^>+T?VD/^>+T 7J*H_VD/\ GB]']I#_ )XO0!>HJC_:
M0_YXO1_:0_YXO0!>HJC_ &D/^>+T?VD/^>+T 7J*H_VD/^>+T?VD/^>+T 7J
M*H_VD/\ GB]']I#_ )XO0!>HJC_:0_YXO1_:0_YXO0!>HJC_ &D/^>+T?VD/
M^>+T 7J*H_VD/^>+T?VD/^>+T 7J*H_VD/\ GB]']I#_ )XO0!>HJC_:0_YX
MO1_:0_YXO0!>HJC_ &D/^>+T?VD/^>+T 7J*H_VD/^>+T?VD/^>+T 7J*H_V
MD/\ GB]']I#_ )XO0!>HJC_:0_YXO1_:0_YXO0!>HJC_ &D/^>+T?VD/^>+T
M 7J*H_VD/^>+T?VD/^>+T 7J*H_VD/\ GB]']I#_ )XO0!>HJC_:0_YXO1_:
M0_YXO0!>HJC_ &D/^>+T?VD/^>+T 7J*H_VD/^>+T?VD/^>+T 7J*H_VD/\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@"C1113$%%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110!/;_Q?A4]06_\7X5/2&%%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 4:***8@HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** )[?\ B_"IZ@M_XOPJ>D,**** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MMU!$DL 7,D1(5]Q;HISC  [G/M4^PJ>S]K;0KZQ3]K[*_O'1T445D;!1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M6#XH\1#0+:(1HDEU<;O*5\X  Y8X'(!*\9&<]>*B\)^(KG78;A;J"))8 N9(
MB0K[BW13G& !W.?:M?85/9^UMH8_6*?M?97]XZ.BBBLC8**** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HIDTT5O#)--(
MD<4:EW=V 55 R22>@%<)K'Q4TVQN)+?3[22_>.389/,$<3#')5OF)YXZ 'D@
MXQEI-[";2W.^HKS&/XP*94$NAE8RP#LMUN(7N0-@R?;(^HKM_#WB73_$UD]S
M8LZF-MLD,H DC],@$C!Z@@_J" W%K<%),UZ**S-;U_3O#]DUS?W"H=I:.$$>
M9+C'"+GDY(]AGD@<U(S3HKS.X^+\2W#BVT5Y(.-KRW(1CQSE0K <Y[FI]/\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 3V_\7X5/4%O_ !?A4](84444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M"M<5=>([W4]&@L+EDGBC97CGR2YP&'S'^+AASP>.<YR.U^'W_(!G_P"OIO\
MT%:VJTI4L)R2[F%&M&MC>>/8V=9T.RURW6*[0AD.8Y4P'3.,@$@\' R/IW P
MS1/#]GH*3"U>:1IB"SRL"<#H. !W/;//TK*\>75S9Z/:/;7$T#F["EHG*DCR
MW.#CMP/RJA\/[Z\O+S51=7<\X2. J)968+DR9QD\9P/R%<BIU/JSGS>[?8['
M4I?6E#E]ZVYW-%87C&>:V\+74UO-)#*K18>-BK#,B@\CVKA+'Q7J5C9WJ"XG
MFN9PBQ2S2%Q"!NW, V?FY&.,=SG&"J.$G6@YQ[V*KXR%&HH3[7N>L45Y&=(\
M0^((UNI+6YO$W%D:=U &[#$H'(^4\?=XXP.E5[.^U/PW>36]M(UK)')^]@89
M0MP3E>G( ^8<X/!YS6RP'-I&:;['.\RY6G*#47U/9**H:/JL&LZ;'=PLFX@"
M6-6W>4^ 2IX'3/H,@@]#3]4U2TT>R:ZO)-J [54?>=NRJ.YX/Y$G !-</)+F
MY;:GH\\>7GOH7**\EOM=U?Q#?BV664+<,T<5G"V%*D<J<8W# R2W ^8\#BJ\
MO@[68HY'?1&\M%+':T;D@#LJL23[ 9KN^HJ/\2:3['G_ -HN5_94W)=SV*BO
M+-'\6:EI5[MO)I[FWWD30S'<ZG@'!;D$8^[G'7H3D>F6=Y;:A:1W5I,LL$@R
MKK^1'L0<@@\@C%<]?#3HOWMGU.G#8J%=/ET:Z$]%>>>-]1OK3Q$D=M>W,,9M
M$8I'*RC.]^< ]>!^59UUXIU:_M[2QLI+I D"(XBRTT[J 6;(RW\)X')&2<YP
M-88&<X1FGH_P,9YA3A.4&G=?B>J45XY-X8U7246Y?2W@6)@5DBVML(YW?(25
M QG)P!71^$?%4R7,>F:C*TJ3.1#<2R996/16+'D$\#OD@=",.I@K0<Z<E)(5
M/'IU%3J1<6]KGH%%%<MXI\5II:/963JVH$88C!$ (SD]MV.0/H3Q@'DITY5)
M<L=SLJU8TH.<WH=317DUOH^N>*FCN) ]Q 7<">YD^1#U;:#SC( ^48R,<8XA
MGT[6/"TH?;+9"27"RP2 )*4Y&=IY'4A6'(SQUKM^HQ;Y547-V.'^T))<[IOE
M[GK]%<[X5\2_VY#)%=&".^C8GRXR1OCXPP!],X/)['C<!6SJ%]#INGSWLY_=
MPH6(! +>BC) R3@#GJ17%.G*$^1K4[H583ASQ>A9HKR/4_$.K:_*(R)55D=!
M:6F]@ZG)(91S(=HQTQP< 9--_P"$/UNU/GKI+(8?WBO&\98%>05"MG/'&!FN
MWZARK]Y-1?8X7F/,W[*#DEU/7JY[QS(\?@^]*.REFB0E3C*M*@(^A!(([@US
MWA#Q#?KK::3?W$TR2[XT64;GCD7<QRQ.[& P(.<$*!@9JEXDL=>A&H7%XUQ_
M9AN25#W 9=IE^3Y=QXR5P,<<=,5-/"N-91G)*UGZE5<8IT'.$6[W7IZC_A]&
M@\22L$4-]C<9 YQO2O3*\;T>WU.YO6CTEI1<",EC'+Y9V9&><CN1Q75Z+IOB
MN'6;62\FN!;*Q,GFW'F+C!XVA^3V!['!P<5T8ZA&4W/F2TVZG+E^(E&FH<C>
MN_0Z?6=#LM<MUBNT(9#F.5,!TSC(!(/!P,CZ=P,,T3P_9Z"DPM7FD:8@L\K
MG Z#@ =SVSS]*RO'EU<V>CVCVUQ- YNPI:)RI(\MS@X[<#\JH?#^^O+R\U47
M5W/.$C@*B65F"Y,F<9/&<#\A7(J=3ZLY\WNWV.UU*7UI0Y?>MN=S16%XQGFM
MO"UW+;S20RJT6'C8JPS(H/(]JX6P\5ZE8VEZGVB>:YG"+%+,Y<0@;MQ .?FY
M&.,=SG&"J.$G6@YQ[V'7QD*-10GVN>KT5Y#_ &)KGB!O[0>RGNR_ FF*KE3\
MPV[R/D^;(V_+R<4FEZQJ7AZ[C5?/2.($-93%D7#?,1M/W2<YSC//<$@[?4+I
MJ$TVNAA_:7*TYP:B^IZ_15;3[^#4]/@O;=LQ3+N R"5/=3@D9!R",\$&K->>
MU9V9Z:::N@HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% $]O_ !?A4]06_P#%^%3TAA1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MG$<TI#<'D*I<C@@C(4C/;.:]4\1?\BSJO_7G-_Z :\T\*?\ (X:3_P!=)/\
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M1_\ HF.O7:\B\5_\CAJW_72/_P!$QTLM_C?(K-?X'S/3=!_Y%W3/^O2+_P!
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M>:&%BO4!F521GOS7N=>'Z/\ \A'2/^ONV_\ 1B5CE[:A4:[?YF^9).=)/O\
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MB_\ ($L_^OP?^BY*SOAO_P ?NK_]<[?^<M>E'_<7Z_Y'E2_Y&"]/\S?\;_\
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M='&58'@@@]17D=I:QVOBZWM$9G2#4%C5GQD[9  3[\5Z_7DR?\CW_P!Q4_\
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M&SA^V*#B8+\W( R?4X  )Y R!P3G(\>?\B?=_P#72#_T<E='7.>//^1/N_\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M*FZ+(Z\G (56!P,<\9.>!6IH?PZM= 5=:UV]WM8_Z3Y=MN\M-F3DG&Y^BM@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!/;_P 7
MX5/4%O\ Q?A4](84444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110!1HHHIB"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MA^C_ /(1TC_K[MO_ $8E>X5QMG\/;:TU.*?[?,UM \<D,6P!PR%6&Y^A&0>
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M@2"[U.9\XV&WB6,KUSG=NSV]/QKK-.TRSTFU-O8P+#$6+D DEF/<D\D]!SV
M'0"N:LL.HVIW;[G50>)E*]6R79%NBBBN4ZSD/B+_ ,@2S_Z_!_Z+DK.^&_\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MHH **** "BBB@ HHHH GM_XOPJ>H+?\ B_"IZ0PHHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@"C1113$%%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110!/;_P 7X5/4%O\ Q?A4](84
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!1HHHI
MB"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH GM_XOPJ>H+?^+\*GI#"BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MD_*M.B@#,^T2?\^\GY4?:)/^?>3\JTZ* ,S[1)_S[R?E1]HD_P"?>3\JTZ*
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M?E1]HD_Y]Y/RK3HH S/M$G_/O)^5'VB3_GWD_*M.B@#,^T2?\^\GY4?:)/\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 RBBB@04444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% #EI:1:6@84444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 RBBB@04444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% #EI
M:1:6@84444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M[$+V!(<9..^!]*['P'_R)ME_OS?^C7KS?Q'IW]E>(;VU5-L0DWQ 1>6NQOF
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MJ.'8]ZA5]K2C/N8WB776\/:?%=BU%P'F$14R;, JQST.?NXQ[UP7_"Q?$/\
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M!<\9[UWUJ>#I-1G'?U/-H5,=6BY0EMZ#=/\ B3:33LFH63VD?\,L;F8="3N
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MBL5-JCHOZZD3?$;6B/D@T\'WB<_^SULZ/\18;F>*VU2U%LS[5^TQOF/=@Y+
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% #EI:1:6@84444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MY/RX'6O+X99+>>.>)MDL3AT; .U@<@X/'45I2:Q>&Y7O^O1F5:+P>*YX[/\
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M!_?@/_D9*\EKW<L;=%I]SY[-DE6378]TTN].I:197QB\HW,"3&/=NV;E!QG
MSC/I7C>N_P#(PZG_ -?<O_H9KUOPR0WA71R.AL83_P"."O)-=_Y&'4_^ON7_
M -#-898K5)HZ,U=Z4&Q9]'%KX<TW58AB.Z>:.7G_ ):"1\'D]U'0# V>]/\
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MQ@D 'V/4=:XXU/9XIR\V=TJ7M<(H>2_(\CT74%TK6[*_<H$AE!=F4MM0@JY
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M<=?3K7//"X51;53\4=,,9BW))T]/1GJE>0>-O^1OOO\ MG_Z+6O7Z\@\;?\
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MG\KS3]H6(#=C'F?N\]#T#D^^.U=1\3P?M6CGL$N!^L5<?I) UW2R?^?Z ?\
MD1:]_#>]@[/L_P!3YS%>[CKKNOT/5/&W_(H7W_;/_P!&+7CD_P#Q[R?[A_E7
ML?C;_D4+[_MG_P"C%KR#I4Y9_!?K^B*S;^.O3]6>_P!%?/GGP_\ /5/^^A6E
MX?*S^(],2/$C?:HVVI\QP&!)P/0#/X5SRRQ1BWS_ (?\$Z89JY24>3?S_P"
M>XT445Y1[ 5X!7O]> 5[&5?;^7ZGB9Q]CY_H>N> _P#D3;+_ 'YO_1KUT=?/
MIFB4X,B CL6%)Y\/_/5/^^A3J9:IS<N??R_X)-/-'""CR;+O_P  ^@Z\0UW_
M )&'4_\ K[E_]#->P:'&T.@:;$\;1LEK$I1A@J0HX([5X_KO_(PZG_U]R_\
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MC#.J !\ L58 8! !P>A P>?O1CHR]@HT_A7Y%Y?.'UARJ?$_S)_B/_R+UO\
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MU2/&"#QUWASWX(Y[#FP]55\9SG7B:3H8+V?WE3P?8F^\4V2F'S(H6,\F'V[
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MS]=_Y%[4_P#KTE_] -4\14JSCSN]F2L-2HPE[-6NCQ"O:_#?_(K:1_UY0_\
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M5$MQM)@A7:C,"2"<DD]1P3C@'&1FJFEZ5=ZO>Q6UK#*P:15DE1-RQ _Q-R
M "<$C.,#FO2PE*6'IOVK_P" >7C*L<357LEK^9ZCX'%P/!]C]I\WS,R8\W.=
MGF-LZ]MNW';&,<5Y#7O5M;Q6EK%;0+MBA01HN2<*!@#)Y/%>"UAELN:527>W
MZG1FL>6%./:_Z'KG@/\ Y$VR_P!^;_T:]='7.> _^1-LO]^;_P!&O71UY5?^
M++U?YGKX?^##T7Y'BGB+3O[*\0WMHJ;(A)OB B\M=C?, HZ87.W(XRIZ=!9T
MSQ!'I_AC5]*9HA+>8\A&C<[]PVRY(X&$ QG'/KTK?^)=@J26&IJ$!?-K(2QW
M,>70 =,#$F3UY'7MP>*]VARXBA'FZ?H?/XCFPN)ER];_ (EBQLY-1O[>RB+!
MYY%CW*A<H"<%L=P!DGV!KW2**."%(88UCBC4*B(,!0.  !T%>8_#NP6ZUZ6\
M8(19Q94;B&#OD X'!&T2#GU'X>HUY^9U.:JH=CTLJI<M)S?7]#/UW_D7M3_Z
M])?_ $ UXA7M^N_\B]J?_7I+_P"@&O$*Z<J^"7J<N;_''T/:?"W_ "*&B_\
M7A!_Z+6M:O%+7Q-K]E:0VMOJ\L<$$:QQIY,)VJHP!DID\#O4O_"8>)?^@U-_
MX#P?_$5RO+:S=]#KCFE!)+4]FHKFO ^LW6LZ'(]X[2W%O<-"TK;09.%<'"@
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MT09K_'CZ+\V?0=%%%>$?0!1110 5X!7O]> 5[&5?;^7ZGB9Q]CY_H>N> _\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% #EI:1:6@84444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M .V.ISFNDHJH3E!WB[$SIPJ*TU=%#1]'M-#L1:68?9G<[.VYG; !8]@3@<
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M<C(VUD;! 8=B1D\$$>U:%%0I.+NBY14E9K0X^V^&^B1-)]HEO;R-T*&.:15
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@!RTM(M+0,**** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH 91110(**** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@!RTM(M+0,**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH 915$WLP)Q;'\Z3[=/_P ^Q_.@1?HJA]NG_P"?8_G1]NG_ .?8
M_G0!?HJA]NG_ .?8_G1]NG_Y]C^= %^BJ'VZ?_GV/YT?;I_^?8_G0!?HJA]N
MG_Y]C^='VZ?_ )]C^= %^BJ'VZ?_ )]C^='VZ?\ Y]C^= %^BJ'VZ?\ Y]C^
M='VZ?_GV/YT 7Z*H?;I_^?8_G1]NG_Y]C^= %^BJ'VZ?_GV/YT?;I_\ GV/Y
MT 7Z*H?;I_\ GV/YT?;I_P#GV/YT 7Z*H?;I_P#GV/YT?;I_^?8_G0!?HJA]
MNG_Y]C^='VZ?_GV/YT 7Z*H?;I_^?8_G1]NG_P"?8_G0!?HJA]NG_P"?8_G1
M]NG_ .?8_G0!?HJA]NG_ .?8_G1]NG_Y]C^= %^BJ'VZ?_GV/YT?;I_^?8_G
M0!?HJA]NG_Y]C^='VZ?_ )]C^= %^BJ'VZ?_ )]C^='VZ?\ Y]C^= %^BJ'V
MZ?\ Y]C^='VZ?_GV/YT 7Z*H?;I_^?8_G1]NG_Y]C^= %^BJ'VZ?_GV/YT?;
MI_\ GV/YT 7Z*H?;I_\ GV/YT?;I_P#GV/YT 7Z*H?;I_P#GV/YT?;I_^?8_
MG0!?HJA]NG_Y]C^='VZ?_GV/YT 7Z*H?;I_^?8_G1]NG_P"?8_G0!?HJA]NG
M_P"?8_G1]NG_ .?8_G0!?HJA]NG_ .?8_G1]NG_Y]C^= %^BJ'VZ?_GV/YT?
M;I_^?8_G0!?HJA]NG_Y]C^='VZ?_ )]C^= %^BJ'VZ?_ )]C^='VZ?\ Y]C^
M= %^BJ'VZ?\ Y]C^='VZ?_GV/YT 7Z*H?;I_^?8_G1]NG_Y]C^= %^BJ'VZ?
M_GV/YT?;I_\ GV/YT 7Z*H?;I_\ GV/YT?;I_P#GV/YT 7Z*H?;I_P#GV/YT
M?;I_^?8_G0!?HJA]NG_Y]C^='VZ?_GV/YT 7Z*H?;I_^?8_G1]NG_P"?8_G0
M!?HJA]NG_P"?8_G1]NG_ .?8_G0!?HJA]NG_ .?8_G1]NG_Y]C^= %^BJ'VZ
M?_GV/YT?;I_^?8_G0!?HJA]NG_Y]C^='VZ?_ )]C^= %^BJ'VZ?_ )]C^='V
MZ?\ Y]C^= %^BJ'VZ?\ Y]C^='VZ?_GV/YT 7Z*H?;I_^?8_G1]NG_Y]C^=
M%^BJ'VZ?_GV/YT?;I_\ GV/YT 7Z*H?;I_\ GV/YT?;I_P#GV/YT 7Z*H?;I
M_P#GV/YT?;I_^?8_G0!?HJA]NG_Y]C^='VZ?_GV/YT 7Z*H?;I_^?8_G1]NG
M_P"?8_G0!?HJA]NG_P"?8_G1]NG_ .?8_G0!?HJA]NG_ .?8_G1]NG_Y]C^=
M %^BJ'VZ?_GV/YT?;I_^?8_G0!?HJA]NG_Y]C^='VZ?_ )]C^= %^BJ'VZ?_
M )]C^='VZ?\ Y]C^= %^BJ'VZ?\ Y]C^='VZ?_GV/YT 7Z*H?;I_^?8_G1]N
MG_Y]C^= %^BJ'VZ?_GV/YT?;I_\ GV/YT 7Z*H?;I_\ GV/YT?;I_P#GV/YT
M 7Z*H?;I_P#GV/YT?;I_^?8_G0!?HJA]NG_Y]C^='VZ?_GV/YT 7Z*H?;I_^
M?8_G1]NG_P"?8_G0!?HJA]NG_P"?8_G1]NG_ .?8_G0!?HJA]NG_ .?8_G1]
MNG_Y]C^= %^BJ'VZ?_GV/YT?;I_^?8_G0!?HJA]NG_Y]C^='VZ?_ )]C^= %
M^BJ'VZ?_ )]C^='VZ?\ Y]C^= %^BJ'VZ?\ Y]C^='VZ?_GV/YT 7Z*H?;I_
M^?8_G1]NG_Y]C^= %^BJ'VZ?_GV/YT?;I_\ GV/YT 7Z*H?;I_\ GV/YT?;I
M_P#GV/YT 7Z*H?;I_P#GV/YT?;I_^?8_G0!?HJA]NG_Y]C^='VZ?_GV/YT 7
MZ*H?;I_^?8_G1]NG_P"?8_G0!?HJA]NG_P"?8_G1]NG_ .?8_G0!?HJA]NG_
M .?8_G1]NG_Y]C^= %^BJ'VZ?_GV/YT?;I_^?8_G0!?HJA]NG_Y]C^='VZ?_
M )]C^= %^BJ'VZ?_ )]C^='VZ?\ Y]C^= %^BJ'VZ?\ Y]C^='VZ?_GV/YT
M7Z*H?;I_^?8_G1]NG_Y]C^= %^BJ'VZ?_GV/YT?;I_\ GV/YT 7Z*H?;I_\
MGV/YT?;I_P#GV/YT 7Z*H?;I_P#GV/YT?;I_^?8_G0!?HJA]NG_Y]C^='VZ?
M_GV/YT 7Z*H?;I_^?8_G1]NG_P"?8_G0!?HJA]NG_P"?8_G1]NG_ .?8_G0!
M?HJA]NG_ .?8_G1]NG_Y]C^= %^BJ'VZ?_GV/YT?;I_^?8_G0!?HJA]NG_Y]
MC^='VZ?_ )]C^= %^BJ'VZ?_ )]C^='VZ?\ Y]C^= %^BJ'VZ?\ Y]C^='VZ
M?_GV/YT 7Z*H?;I_^?8_G1]NG_Y]C^= %^BJ'VZ?_GV/YT?;I_\ GV/YT 7Z
M*H?;I_\ GV/YT?;I_P#GV/YT 7Z*H?;I_P#GV/YT?;I_^?8_G0!?HJA]NG_Y
M]C^='VZ?_GV/YT 7Z*H?;I_^?8_G1]NG_P"?8_G0!?HJA]NG_P"?8_G1]NG_
M .?8_G0!?HJA]NG_ .?8_G1]NG_Y]C^= %^BJ'VZ?_GV/YT?;I_^?8_G0!?H
MJA]NG_Y]C^='VZ?_ )]C^= %^BJ'VZ?_ )]C^='VZ?\ Y]C^= %^BJ'VZ?\
MY]C^='VZ?_GV/YT 7Z*H?;I_^?8_G1]NG_Y]C^= %^BJ'VZ?_GV/YT?;I_\
MGV/YT 7Z*H?;I_\ GV/YT?;I_P#GV/YT 7Z*H?;I_P#GV/YT?;I_^?8_G0!?
MHJA]NG_Y]C^='VZ?_GV/YT 7Z*H?;I_^?8_G1]NG_P"?8_G0!?HJA]NG_P"?
M8_G1]NG_ .?8_G0!?HJA]NG_ .?8_G1]NG_Y]C^= %^BJ'VZ?_GV/YT?;I_^
M?8_G0!?HJA]NG_Y]C^='VZ?_ )]C^= %^BJ'VZ?_ )]C^='VZ?\ Y]C^= %^
MBJ'VZ?\ Y]C^='VZ?_GV/YT 7Z*H?;I_^?8_G1]NG_Y]C^= %^BJ'VZ?_GV/
MYT?;I_\ GV/YT 7Z*H?;I_\ GV/YT?;I_P#GV/YT 7Z*H?;I_P#GV/YT?;I_
M^?8_G0!?HJA]NG_Y]C^='VZ?_GV/YT 7Z*H?;I_^?8_G1]NG_P"?8_G0!?HJ
MA]NG_P"?8_G1]NG_ .?8_G0!?HJA]NG_ .?8_G1]NG_Y]C^= %^BJ'VZ?_GV
M/YT?;I_^?8_G0!?HJA]NG_Y]C^='VZ?_ )]C^= %^BJ'VZ?_ )]C^='VZ?\
MY]C^= %^BJ'VZ?\ Y]C^='VZ?_GV/YT 7Z*H?;I_^?8_G1]NG_Y]C^= %^BJ
M'VZ?_GV/YT?;I_\ GV/YT 7Z*H?;I_\ GV/YT?;I_P#GV/YT 7Z*H?;I_P#G
MV/YT?;I_^?8_G0!?HJA]NG_Y]C^='VZ?_GV/YT 7Z*H?;I_^?8_G1]NG_P"?
M8_G0!?HJA]NG_P"?8_G1]NG_ .?8_G0!?HJA]NG_ .?8_G1]NG_Y]C^= %^B
MJ'VZ?_GV/YT?;I_^?8_G0!?HJA]NG_Y]C^='VZ?_ )]C^= %^BJ'VZ?_ )]C
M^='VZ?\ Y]C^= %^BJ'VZ?\ Y]C^='VZ?_GV/YT 7Z*H?;I_^?8_G1]NG_Y]
MC^= %^BJ'VZ?_GV/YT?;I_\ GV/YT 7Z*H?;I_\ GV/YT?;I_P#GV/YT 7Z*
MH?;I_P#GV/YT?;I_^?8_G0!?HJA]NG_Y]C^='VZ?_GV/YT 7Z*H?;I_^?8_G
M1]NG_P"?8_G0!?HJA]NG_P"?8_G1]NG_ .?8_G0!?HJA]NG_ .?8_G1]NG_Y
M]C^= %^BJ'VZ?_GV/YT?;I_^?8_G0!?HJA]NG_Y]C^='VZ?_ )]C^= %^BJ'
MVZ?_ )]C^='VZ?\ Y]C^= %^BJ'VZ?\ Y]C^='VZ?_GV/YT 7Z*H?;I_^?8_
MG1]NG_Y]C^= %^BJ'VZ?_GV/YT?;I_\ GV/YT 7Z*H?;I_\ GV/YT?;I_P#G
MV/YT 7Z*H?;I_P#GV/YT?;I_^?8_G0!?HJA]NG_Y]C^='VZ?_GV/YT 7Z*H?
M;I_^?8_G1]NG_P"?8_G0!?HJA]NG_P"?8_G1]NG_ .?8_G0!?HJA]NG_ .?8
M_G1]NG_Y]C^= %^BJ'VZ?_GV/YT?;I_^?8_G0!?HJA]NG_Y]C^='VZ?_ )]C
M^= %^BJ'VZ?_ )]C^='VZ?\ Y]C^= %^BJ'VZ?\ Y]C^='VZ?_GV/YT 7Z*H
M?;I_^?8_G1]NG_Y]C^= %^BJ'VZ?_GV/YT?;I_\ GV/YT :*TM5K2=Y@^^/9
MC'XU9H&%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 4:***8@HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** )[?^+\*GJ"W_ (OP
MJ>D,**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
MHT444Q!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 3V_\7X5/4%O_%^%3TAA
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% %&BBB
MF(**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **S]6UJQT6
M!9;R4J7SY<:C+.0,X _J<#D9/-<;>_$*\:4?8+.".,,V3/ERPS\IX*[3C.1S
MUZ\<[TL-5JZP6ASUL71HZ3>IZ%17F\7Q!U5;A&FMK*2$9W(BLC'CC#%B!SCL
M?ZUU^@>)+77HV$:M#<Q@&2%R#V&2I[KGC/!]0,BJJX2K25Y+0FCC*-9\L7J;
M-%<C\1'9=!MD#$+)=JKJ#PPV.<'UY /U K.^&SL+C5H0Q\I5@<)GY0Q,@)QZ
MD*OY#TH6'O0=:X/$VQ"H6Z;G?T445S'4%%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !117G&M>--2&M2QV$PAM[6=HRAB4F4J=K!B
M<\;E;&W:<'UK:C0G6ERP,*^(A0CS3/1Z*JZ;<27>E6=S+M\R:!)'V#"Y*@G'
MM5JLFK.S-DTU=!1112&%%%% !116)XIU>[T72/M-G LDK2JFYU+)&#D[F (X
MXQU'+#Z&H0<Y**W9,YJ$7*6R-NBN5\)>*+C6I9[6_6!;E%\R,P(RADX!R"3@
M@D=^=W3@UU5.I3E3ERRW)I58U8J<'H%%%8_B76CH6E&XCB\R:1_*BS]U6()!
M;D''!Z=>!QU"A!SDHQW94YQA%RELC8HKE/"'B+4]<N+M+U+/RX40@PJR,"Q.
M."6R#@\Y&,=\\=73J4Y4Y.,MR:56-6"G'9A17)ZGX\L+23R[*)KU@V&8-L0=
M0<'!ST'08(.0:Y\?$#6]O,6GEO40OC_T.NB&!KS5TCGJ9AAX.SE]QZ917"Z9
M\0B3''JEHHSPT]OG );CY#D@ =2&)XX'.!9\4>+[K2KN*UTZ*V??"DXGD)=6
M5BPP%4C^Z#G/?IWJ7A*RFH-:LI8V@X.:EHCL:*\P_P"$^U_^[IG_ (#R?_'*
M/^$^U_\ NZ9_X#R?_'*T_L^OV_$R_M+#=_P9Z?17F'_"?:__ '=,_P# >3_X
MY6MX;\8:IJ>MPV5['9F*56 ,,;(RD G/+-D<$8XZ]>,&98&M&+DUHBH9A0G)
M13U?D=S16+XGUJ;0]+6X@@26223REWL0$)5B&('WAD#C(Z]17%?\)]K_ /=T
MS_P'D_\ CE32PE6K'F@M"ZV,HT9<LWJ>GT5YA_PGVO\ ]W3/_ >3_P".5=TK
MQWJDVIV]O>6]G)'/*D(\E6C*EG"[LEFS@$\8&?45<L!7BFVOQ,XYCAY-)/?R
M/0J***XSN"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH *;))'#$\LKJD:*69V. H'4D]A3JXKQ_JWEP1:3&?FE FFX_@!^4<
MCNP)X.1M]ZUHTG5J*"ZF->LJ--S?0ZNTU*PU N+*]MKDQX+B&57VYSC.#QG!
M_(U:KEO NFBTT4WC*PFO&W'<I7"*2%&">1U8' R&'H*B^(CLN@VR!B%DNU5U
M!X8;'.#Z\@'Z@5?L4ZWLHOK:Y'MVJ'M9+6U['745P'PV=A<:M"&/E*L#A,_*
M&)D!./4A5_(>E=_45J7LJCA>]BZ%7VU-5+6N%%%9^MZDVD:1-?+ )S$5_=E]
MN<L%ZX/3.>G:LXQ<FHK=FLI**<GLC0HKS#_A/O$&.5TS_P !Y/\ XY5RT^(=
M['"PO;&WGEW95H6,2@8'!!W<YSSG\*ZWE^([?BCB698;^;\&>AT5S.C>-K#4
MY([>Y0V=U(VU48[D8DG #X'. .H') &:Z:N:I3E3?+-69UTZL*D>:#N@HHHJ
M"PHHHH JW>I6&GE!>WMM;&3.P32JF[&,XR><9'YU8CDCFB26)U>-U#*ZG(8'
MH0>XKE_'FFK=Z*MZJN9K-LC:I8E&(## / 'RL3@X"GIDUG_#S47/VO39),JH
M$T*D,2!T?GH!G:<<<LQY[=*PZE0=6+VW1RO$N.(5&2T:T9W5%%%<QU!6!K7B
M[3M$N1;2)/<38RZ6X4F/I@-N88)!SC^61G<EECAB>65UCC12SNYP% Y))["O
M'K9)?$/B%0ZRA[VX+.OFAFC0G) 9NNU<XXZ* !VKKPE"-5R<]DCBQF(E248T
M_BDSV"WN(KNVBN(&W12H)$;!&5(R#@^U25QWBCQ#?>';BTL=,M+6*W$((:6%
MBF <!$"E0-H XY^\.G?;\.:S_;FD)<L%6=&,<RH"%#C!XSV((/?&<9.*RE0G
M&"J6T9M'$0E4=*_O(UJ***Q-PHKE/%GBJYT6XBL[&&(SL@E:2="R;22, !@<
MY'X>^>-/PQJ5WJ^AQ7MXMN)'=P#!D*0&(Z'.#D$8R>F>^!K*C.--5&M&8QKT
MY5'23U1L45#=W<%A:275U*(X8QEF/;_$]@!R:XS4_B"%:2/2[4-CA9Y\X)W<
M_(,$@CH<@\\CCETJ%2K\"N%;$4J*]]V.YHKS-O'^ME?EBT\-ZF%R/_0ZZ31/
M&UKJEVMI<6YM)I&(C)<.C=,#. 0QYXQCCKD@5I4P5:"NUH8T\?0J/E4M3J**
M\]U7QWJD.I7%O9V]G''!*\)\Y6D+%7*[LAEQD <8./4U2_X3[7_[NF?^ \G_
M ,<JHX"O))I$RS'#Q;BWMY'I]%>8?\)]K_\ =TS_ ,!Y/_CE'_"?:_\ W=,_
M\!Y/_CE/^SZ_;\1?VEAN_P"#/3Z*YKPAX@O-=BNQ>QP"2%E(:%2H(;/&"3R-
MIYSWZ<<UO%GBJ^T6]CL[*"WW-&LIEFW.""6!7:".> <Y]>.]8K#5'4]E;4W>
M*I*E[6_NG745YA_PGVO_ -W3/_ >3_XY1_PGVO\ ]W3/_ >3_P".5M_9]?M^
M)A_:6&[_ (,]/HKD?"GBN\UF_>QO8(!((FF$L.5& 4&W:2?[Q.<^G%==7-4I
M2I2Y9;G72JPJQYX;!11169H%%%% !1110 4444 %%%% !1110 4444 %%%%
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MLV,\C;SD9ZXZ\5<*,I6E;1NUR:E>$6XI^\E>QU=K>VM]$9;.YAN(PVTM#('
M/7&1WY'YU/7GG@>YBTNVU*_OI8X+1S''&[N/G=0[,H'4G!!P!SVZ&M[1?&5M
MK.JM9+;26X:/?"TKKER/O*0#P>I&"V0">,5=7#2A*2CJEU,Z.*C.$7+1RZ'2
MT445S'4%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 445SOBGQCI_A>)%F5KB\E4M%;QD XP<,Q_A7(QGD]< X.!*^P;
M'145X_<?%K66N':VL;"* XVI('D8<<Y8,H/.>PJ73_BUJ2WB_P!I6%K):G 8
M6P9'7D<C<Q!XSQQDXY%7[.1/.CUNBL_1=:LM?TR._L)-T;<,K<-&W=6'8C/\
MB,@@UH5!04444 %%9'B#Q)I_AJR6XOW<F1ML<,8!=_7 )' SDDG]2 ?-KCXM
M:R]P[6UC810'&U) \C#CG+!E!YSV%4H-["<DCV"BO'H/BUK27"-<6-A+ ,[H
MXP\;'CC#%F YQV/]:])\/>)=.\36;W%@[AHVVR0R@"2/K@D G@XR"#CKW! '
M%K<%),V***XBV^)VD3:[-I\T;0VPF\J&]\Q6C?&06;'W5) P03D$$[><))O8
M;=CK)]5TZUO(K.XO[6&ZEQY<,DRJ[Y.!A2<G)XJW7A7CRSN;WQQ/]E5)AJ2P
MO9,DBE9E:-44@YP 6!'./7IS7HWB3XAZ7H+FVMQ_:%X,AHX9 $C(;!5VYVG[
MW !/'.,BJ<=K$\W<Z^BJFEZE;ZOI=MJ%JV8;B,.H)!*^JG!(R#D$9X(-97BW
MQ5!X5TZ*=H?M-Q-)LB@$@0D#EF)Y. .X!Y*CC.:BW0JYNRRQP0O--(D<4:EG
M=V 55')))Z"HK+4++483-8W=O=1*VTO!('4-@'&0>O(_.N'\0>(;'Q=X U-=
M*?-TBK*]K*RI*L<<B,[XSRNWG()ZXZ\5C_#&[@T;3M8U34IXK:RD:**.21P-
M[HKLRJ.I.T@X Y[9P:KETN3?4]8HKD/#GQ!L?$>MR:=':RVV8]\#S.N92/O*
M5!X8=0 6R 3QBNOI--;E)W"BBBD 445S_C;5?[(\(W\Z2;)Y$\B$K+Y;;G^7
M*GKN4$MQS\O;K0E<"E'\1="FU^/28C<2&240I=(JF%F/3!#9()^7.,=^G-=;
M7BOPQT9-2\2F[FAWP6""09VD"4G"9!Y[,P(Z%1SZ^U54TD[(F+;5PHHHJ2@H
MKF/$GCK2?#KR6SLUS?JH/V:+^'()&YNBC@>IPP."#7!R?%G73+(8[/3EC+$H
MK1NQ5<\ G>,G'? ^@JE!L3DD>QT5Y-I_Q<O8Y#_:>FV\L19>;4F-D7^(X8MN
M..@RO3KSQZS2<6MP33V"BLK7?$>F>'+99M1GV&3<(HD7<\A R0!^0R< $C)&
M17FUU\6]5DE5K/3K*"/;\R3%I3NR>=P*\=.,?C346]@<DCUZBO(;7XMZM'*S
M7>G64\>WY4A+Q'=QR6);CKQC\:]/T;6;+7M-CO[&3?$_#*>&C;NK#L1_]<9!
M!H<6MP4DR_15:_O[72[&6]O9U@MH5W/(W0=A]23@ #DD@"O+=2^+UZ7']G:?
M;01!F&Z[8R%US\IPI4*<=1ENO7CE*+>P-I'K=%>9^'/BI]JO$MM=AMK=)&.V
M[A)6-.F X).!URV<#C( R:],H::W!-/8**AN[J&RLY[NX?9!!&TDC!2<*HR3
M@<G@=J\M@\;^)/$OBV"WT,M;69D7]RT*2;8PWS22$\]#R P[ ')R11;!NQZQ
M117+^*_&MKX6N+*"2W:YEG.Z14D ,40XW8ZDD]!P#M;D8I)7V&W8Z*ZNK>RM
MVN+NXBMX$QNDE<(JY.!DGCJ0*+6ZM[VW6XM+B*X@?.V2)PZM@X."..H(KSGQ
MWJUIXG\#V][I4JRI!<QS7,9=1) K*Z#>N<@[B!QG/49'-'@35K3PQX&GO=5E
M6)9[F2:VB#J9)U540[%SDG<".<8ZG YJN72Y/-J>F45S'A3QK:>*;B\@CMVM
MI8#NC5Y%)EC)QNQU!!ZCD#<O)S723316\,DTTB1Q1J7=W8!54#)))Z 4FK:,
MJ]Q]5/[5T[^T?[/^WVOV[_GV\Y?,Z;ONYSTY^E<GHGQ.TC5+MX+R-M-R6,<M
MQ(OEE1TW-_"Q&>.1QC<217"#3;W_ (6Q]G\C]]_:_P!HV[U_U7F>;NSG'W/F
MQU[=>*I0[DN78]RHKB-;^)^D:7=I;V<;:E@J9);>1?+"GD[6_B8#'' YQN!!
MKM(9H[B&.:&1)(I%#HZ,"K*>001U!J6FBKCZ***0!1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 3V_\
M%^%3U!;_ ,7X5/2&%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M1XZUV2-UTFTFV@IFZ*XS@]$SGCC)(QR"O."0>VBBC@A2&&-(XHU"HB* JJ.
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MF3&Z.2=59<C(R">."#7 :^^N:[KU]IB0SR10R8%JCJ45<!E+D8'S; XWG@G
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MBF12QSPI-#(DD4BAD=&!5E/(((ZBLGQ3J']G>';J17VRR+Y,6)-C;FXRIZY
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M.-XX*FWR.I[QS2Q]5+G5-\O<]@HKD?!/B![^ Z;>3/+=PJ7C=E)+Q# ^9N[
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M$7M_B2>23R2<FL[Q'H.D:YI[#5D58X%=UN=^QH..6#=,=\'*\#(.*LZ%I?\
M8FB6FF_:9;G[.FWS9>IYS@>BC. .P &3BL;QYX:G\2:&J6;?Z5;/YL<;.0LO
M!!7KM#>A/3D9 8FL%N:/8\A\06VE:;JQBT'4Y[N$*RO(5V[>-K*'&-^?FR0
MNU@,MDUG6OE37%O;W=U)!:;SND5#((MP +!,C/1<XYP.^ *]"O\ P-8^%?!V
MH:EJ"+J-^$5(QDI' 7Q'D#^(@N6R1_"N IYK+\#>'++Q5IVK6=S$D4]N(WM[
MQ =ZL^[(89PZCRQ@'IN;!&<C?F5KF?*[G=^#_#/ABT4:IH\YOY#D+<2R!FBW
M*,KM  4X/<;AN(/!Q77UYSX-\"7^A>*;F\NYW6"V&R!XF 6Z# YW#)("\':1
M][!!(7GT:L9;[FBV"BBBI&%>3?%?6FFU&VT6)D,,"B>;:P)\QLA01C*D+SUY
M$@XX%>K3316\$D\\B111J7>1V"JJ@9))/0 5\^W,DWB[QBYC:7=J%T%1C"&:
M.,G"DJO78@&>>BDD]ZTIK6Y,WI8]4^&NBMI7A=;F94$]^WGY"C<(\ ("P)R,
M98=,;R,9S78TR**."%(88TCBC4*B(H"JHX  '04^H;N[E)6"LCQ/KD?A[0+F
M_8H90-D"-CYY#]T8R,CN0#G /I6O7F?Q?N)E@TBV5\0.\LCI@<LH4*<]> [?
MG3BKNPF[(XSPIX<G\6:VT,D\JPJ#-=7)!9CD]-QR-[$G[WHQYQ@^QV_@WPU;
MVZPKH=A(JYP9X1*W)SRSY)Z]S[5QOP]U32O#OA>YNM5N;:UEN)_,3D--+",(
MIVKERH<2#IQ\QZ<UJ77Q7T"WN'BBM]0ND7&)88D"MQGC>RGVY Z54[MZ$QLE
MJ;EWX*\-7D ADT6SC0-N_P!'3R3G!'5,$CGITK>K'T?Q3HNO3RP:;?":6)0S
M(8V0XZ9&X#(]<=,C/45?U&]CTW3+N_F5VBMH7F<( 6*J"3C/?BH=]F7H>%^+
M];N?$GB>?RG:>".4P6<4+>8I4'&4VCDN1N[GD#) %>I:%X!T33=,BCO--M;R
M\:-?M$DZ^<I<9)VAA@#)(X ) &<D5Y)X0LI;WQ;I$$#(K)<I+\Y(&V,[V''?
M"G'OBOH:M*CM9(B&NIQ'C+P1IUUX>FETG38+>]M098UM8@GF ?>4JJ_,2 <#
M&<XY )SP/P\UAM*\6VT;2[+:]_T>4'<02?N<#ONP,D' 9NF<U[K7S@<^&O$>
M3_I1TR[S_<\WRG_'&=OOC/>B&J:82T:9ZO\ %6XFA\)1QQOM2>[2.48!W*%9
M@/;YE4\>E,^%>E"S\.2Z@P7S+Z4E65B?W:94 CH#N\P\=B.>P?\ %:":7PE%
M)&FY(;M'E.0-JE64'GK\S*./6LSX:^*+*VT.XT_4]0@MOLTNZ$W$B1J4?G:I
M)!)#!B<_WASV"^QH'VCF_B=96MEXP(MH$B^T6RW$H7HTC.X+8[$[1G'4Y/4F
MO7]!N9KSP[IEU</YD\UI%)(^ -S% 2<#@<FO'OB'J%OK7C%3IS&Y"6\5NK0D
M2"5LLWR;2=WWP/7((KNO$.N3>"_!.G6"R)_:S6R6\3*A= 450[Y..F>,]R."
M,T25TD">K9SGQ0\5)<R_V':2HUO P>ZD1SS(,_NSV(7@GK\V.A6NQ\">%SX;
MT8FY3;J%UAK@"3<%P3M4=N ><9Y)Y(Q7'?"_PJES+_;EW$C6\#%+6-T/,@Q^
M\'8A>0.OS9Z%:]:I2=ERH<5?5A7.>*_#6@ZS;?:M8=;5HE""]$HC**6'!)^4
M@G@;@<;CC!-='7$^/_!]WXD^Q7%A(OGP'RVCE<A2C$?,.<#'4X&2/7: 9CN-
M['DFJ+8VVHW$6D7L]S8NH E>,Q%P2&VD=6 PO) RPSC@&C2UL;K4;>+5[Z>V
MLE4@RI&92@!+;0.J@Y;D X)SCDFNT\4^$=-\(^$ QC^W:A=7 @^UOE/*'+_*
MF2.D>W/7YFYQ\M,\)^$++Q;X3E=@EG?6UT84NHE)WH K_.N[#']XPR,'"KU
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MF'_W#Y/]3C/!-M!=^*46XB618K=YT#= ZN@5OPW''O@]0*]4KS#P#_R-C?\
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M>)HXI/#&I^<NY$MWEQDCE!N'3W K5K*\3,B^%M5$DBQA[62,%C@;F4J!]22
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M/_K\'_HN2LGX>6T$^JW\\L2O+;1Q>2Q_@W^8&(]R% SUQD=S6M\1?^0)9_\
M7X/_ $7)6=\-_P#C]U?_ *YV_P#.6B#:P+MW'-)YA&_;_,] KS'QY!%#XDW1
MKAIH$DD.2<MDK^'"CI7IU>:_$#_D8H?^O1/_ $-ZRRY_O_D:9HO]G?JCN]#
M&@::!T%K%_Z"*\Z\;7(N/%5POE;#;QQP[LYWC&_/M_K",>WO7HVB?\@'3O\
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M$UZCXB_Y%G5?^O.;_P! ->:>%/\ D<-)_P"NDG_HF2G@VUAZC1..2EB:2?\
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M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH GM_XOPJ>H+?\
MB_"IZ0PHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MMJ5F]I=Q^9 Y!9=Q&<$$<CGJ!6%6O&6(]JMKK\#>CAY0PWL7O9_C<\X\ _\
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MJZBM]*9XY2P:41OQ-@  -D' PN/EQU-=>#KQHU.:78X\=AY5Z7)#>Y:\,?\
M(IZ-_P!>,'_H KB/'_\ R,T?_7G'_P"AR5Z/:VT-E:0VMNFR&&-8XUR3A0,
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M;2+36K/[-=JQ4'<C(V"C8(##L2 QZY'M7)2E[*JG+HSMK1]M1<8]4<=\-_\
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M;I>#9V443A2OF8RY4G)!<Y8C..,]AZ4>VPM+6G&[\P=#%U=*LTEY%^LKQ/\
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M#GHH&0>X;(./K4QK812]IRN_;H5*AC91]ES*W?K8SO >BW$#RZK<*T:2Q>7
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M>7_"+3%(U'5F"%@1:QD,=R\!W!'3!S'@]>#T[^H551ZV%!:!1114%!7-^.=
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** *-%%%,04444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110!Q'BWPI>W^HG4=.2.0NBB6$OM<L, ,"3MQMQD<8V]R:PK63Q;IS2PVRZ
MHH7$>#"TJ*%R $W J![KP>.N!7JE%=E/&2C!0FE)+N<-3 QE-U(2<6^QY7=R
M>+=4B6RNTU*2*1MI7[/Y:MD%<,54 K@G(;CUZ5L>&_!5S%>Q7VJ 1+"P>.W1
M\L7!X+$< # . 3G/.,$'O**)XV3BX0BHI]@A@(J:G4DY-=PHHHKC.X**** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "N:\:Z.^I:0+B"-Y+FT)=40%F=#C< ,\G@'H3
M\N!UKI:*NG4=.:G'=&=6G&K!PELSD_ 2WT6EW,%U:W,,:S;HC<!D)R!E0C $
M 8!ST)8]P:ZRBBBK4]I-S:M<*5/V<%!.]@HHHJ#0**** "BBB@ HHHH ****
M "BBB@#E?';:@VE0VUG:3SQ32?OC#&9",<J-H!."><CIM [T>!]%N=-L9[J[
M5XY;LJ5A8\JB@X)&,JQ+-D9Z;>AR*ZJBM_;R]E[)+0Y_J\?;>V;UM8Q_$>A#
MQ!906YG$!BF$H8Q[_P"%EQU']ZF>'/#J>'XK@>?Y\LS F3:5^4#@8R1P2QS[
M^U;=%1[:?)[.^A?L:?M/:V]X****S-0HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *\<T
MK1]4COM*=],O55;JW9BUNXV@2*23QP !7L=%=%'$.DI)+<YJ^&5:49-_"%%%
M%<YTA1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5Q
MGBSP#_PE&L1ZA_:0M2ENL.SR-^<,S9SN'][I79T4TVM4#5S/T/28M#T6TTV$
M[E@3!;D;V/+-@DXRQ)QGC.*T***0!1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 3V_\ %^%3U!;_ ,7X5/2&%%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 4:***8@HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M )[?^+\*GJ"W_B_"IZ0PHHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@#++70)Q;FDWW7_/N:TJ*!&;ONO^?<T;[K_GW-:5% &;ON
MO^?<T;[K_GW-:5% &;ONO^?<T;[K_GW-:5% &;ONO^?<T;[K_GW-:5% &;ON
MO^?<T;[K_GW-:5% &;ONO^?<T;[K_GW-:5% &;ONO^?<T;[K_GW-:5% &;ON
MO^?<T;[K_GW-:5% &;ONO^?<T;[K_GW-:5% &;ONO^?<T;[K_GW-:5% &;ON
MO^?<T;[K_GW-:5% &;ONO^?<T;[K_GW-:5% &;ONO^?<T;[K_GW-:5% &;ON
MO^?<T;[K_GW-:5% &;ONO^?<T;[K_GW-:5% &;ONO^?<T;[K_GW-:5% &;ON
MO^?<T;[K_GW-:5% &;ONO^?<T;[K_GW-:5% &;ONO^?<T;[K_GW-:5% &;ON
MO^?<T;[K_GW-:5% &;ONO^?<T;[K_GW-:5% &;ONO^?<T;[K_GW-:5% &;ON
MO^?<T;[K_GW-:5% &;ONO^?<T;[K_GW-:5% &;ONO^?<T;[K_GW-:5% &;ON
MO^?<T;[K_GW-:5% &;ONO^?<T;[K_GW-:5% &;ONO^?<T;[K_GW-:5% &;ON
MO^?<T;[K_GW-:5% &;ONO^?<T;[K_GW-:5% &;ONO^?<T;[K_GW-:5% &;ON
MO^?<T;[K_GW-:5% &;ONO^?<T;[K_GW-:5% &;ONO^?<T;[K_GW-:5% &;ON
MO^?<T;[K_GW-:5% &;ONO^?<T;[K_GW-:5% &;ONO^?<T;[K_GW-:5% &;ON
MO^?<T;[K_GW-:5% &;ONO^?<T;[K_GW-:5% &;ONO^?<T;[K_GW-:5% &;ON
MO^?<T;[K_GW-:5% &;ONO^?<T;[K_GW-:5% &;ONO^?<T;[K_GW-:5% &;ON
MO^?<T;[K_GW-:5% &;ONO^?<T;[K_GW-:5% &;ONO^?<T;[K_GW-:5% &;ON
MO^?<T;[K_GW-:5% &;ONO^?<T;[K_GW-:5% &;ONO^?<T;[K_GW-:5% &;ON
MO^?<T;[K_GW-:5% &;ONO^?<T;[K_GW-:5% &;ONO^?<T;[K_GW-:5% &;ON
MO^?<T;[K_GW-:5% &;ONO^?<T;[K_GW-:5% &;ONO^?<T;[K_GW-:5% &;ON
MO^?<T;[K_GW-:5% &;ONO^?<T;[K_GW-:5% &;ONO^?<T;[K_GW-:5% &;ON
MO^?<T;[K_GW-:5% &;ONO^?<T;[K_GW-:5% &;ONO^?<T;[K_GW-:5% &;ON
MO^?<T;[K_GW-:5% &;ONO^?<T;[K_GW-:5% &;ONO^?<T;[K_GW-:5% &;ON
MO^?<T;[K_GW-:5% &;ONO^?<T;[K_GW-:5% &;ONO^?<T;[K_GW-:5% &;ON
MO^?<T;[K_GW-:5% &;ONO^?<T;[K_GW-:5% &;ONO^?<T;[K_GW-:5% &;ON
MO^?<T;[K_GW-:5% &;ONO^?<T;[K_GW-:5% &;ONO^?<T;[K_GW-:5% &;ON
MO^?<T;[K_GW-:5% &;ONO^?<T;[K_GW-:5% &;ONO^?<T;[K_GW-:5% &;ON
MO^?<T;[K_GW-:5% &;ONO^?<T;[K_GW-:5% &;ONO^?<T;[K_GW-:5% &;ON
MO^?<T;[K_GW-:5% &;ONO^?<T;[K_GW-:5% &;ONO^?<T;[K_GW-:5% &;ON
MO^?<T;[K_GW-:5% &;ONO^?<T;[K_GW-:5% &;ONO^?<T;[K_GW-:5% &;ON
MO^?<T;[K_GW-:5% &;ONO^?<T;[K_GW-:5% &;ONO^?<T;[K_GW-:5% &;ON
MO^?<T;[K_GW-:5% &;ONO^?<T;[K_GW-:5% &;ONO^?<T;[K_GW-:5% &;ON
MO^?<T;[K_GW-:5% &;ONO^?<T;[K_GW-:5% &;ONO^?<T;[K_GW-:5% &;ON
MO^?<T;[K_GW-:5% &;ONO^?<T;[K_GW-:5% &;ONO^?<T;[K_GW-:5% &;ON
MO^?<T;[K_GW-:5% &;ONO^?<T;[K_GW-:5% &;ONO^?<T;[K_GW-:5% &;ON
MO^?<T;[K_GW-:5% &;ONO^?<T;[K_GW-:5% &;ONO^?<T;[K_GW-:5% &;ON
MO^?<T;[K_GW-:5% &;ONO^?<T;[K_GW-:5% &;ONO^?<T;[K_GW-:5% &;ON
MO^?<T;[K_GW-:5% &;ONO^?<T;[K_GW-:5% &;ONO^?<T;[K_GW-:5% &;ON
MO^?<T;[K_GW-:5% &;ONO^?<T;[K_GW-:5% &;ONO^?<T;[K_GW-:5% &;ON
MO^?<T;[K_GW-:5% &;ONO^?<T;[K_GW-:5% &;ONO^?<T;[K_GW-:5% &;ON
MO^?<T;[K_GW-:5% &;ONO^?<T;[K_GW-:5% &;ONO^?<T;[K_GW-:5% &;ON
MO^?<T;[K_GW-:5% &;ONO^?<T;[K_GW-:5% &;ONO^?<T;[K_GW-:5% &;ON
MO^?<T;[K_GW-:5% &;ONO^?<T;[K_GW-:5% &;ONO^?<T;[K_GW-:5% &;ON
MO^?<T;[K_GW-:5% &;ONO^?<T;[K_GW-:5% &;ONO^?<T;[K_GW-:5% &;ON
MO^?<T;[K_GW-:5% &;ONO^?<T;[K_GW-:5% &;ONO^?<T;[K_GW-:5% &;ON
MO^?<T;[K_GW-:5% &;ONO^?<T;[K_GW-:5% &;ONO^?<T;[K_GW-:5% &;ON
MO^?<T;[K_GW-:5% &;ONO^?<T;[K_GW-:5% &;ONO^?<T;[K_GW-:5% &;ON
MO^?<T;[K_GW-:5% &;ONO^?<T;[K_GW-:5% &;ONO^?<T;[K_GW-:5% &;ON
MO^?<T;[K_GW-:5% &;ONO^?<T;[K_GW-:5% &;ONO^?<T;[K_GW-:5% &;ON
MO^?<T;[K_GW-:5% &;ONO^?<T;[K_GW-:5% &;ONO^?<T;[K_GW-:5% &;ON
MO^?<T;[K_GW-:5% &;ONO^?<T;[K_GW-:5% &;ONO^?<T;[K_GW-:5% &;ON
MO^?<T;[K_GW-:5% &;ONO^?<T;[K_GW-:5% &;ONO^?<T;[K_GW-:5% &;ON
MO^?<T;[K_GW-:5% &;ONO^?<T;[K_GW-:5% &;ONO^?<T;[K_GW-:5% &;ON
MO^?<T;[K_GW-:5% &;ONO^?<T;[K_GW-:5% &;ONO^?<T;[K_GW-:5% &;ON
MO^?<T;[K_GW-:5% &;ONO^?<T;[K_GW-:5% &;ONO^?<T;[K_GW-:5% &;ON
MO^?<T;[K_GW-:5% &;ONO^?<T;[K_GW-:5% &;ONO^?<T;[K_GW-:5% &;ON
MO^?<T;[K_GW-:5% $%D92'\V/9TQ[U:I%I:!A1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% #****!!1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 .6EI%I:!A1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% #****!!1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1167KFOV6@6JS799F<XC
MACP7?ID@$@8&>3G]2 7&+D[16I,I**YI.R-2BLW0]<M=?T\W=JLJ*KF-TE4!
ME88.#@D="#P3U]<BM*B47%V>XXR4E>.P4444AA1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !114%W?6EA$);RZ@MHV;:'FD" GKC)[\'\J$K@W;<GH
MID4L<\22Q.LD;J&1T.0P/((/<4^@ HHHH **JP:G87-U):P7UM+<QYWPQRJS
MI@X.0#D8/%6J;36X)I[!1112 **@N[ZTL(A+>74%M&S;0\T@0$]<9/?@_E4D
M4L<\22Q.LD;J&1T.0P/((/<4[/<+K8?1112 **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MBB@ HHHH **** "BBB@ HHJG8ZMINJ>9_9^H6EWY>-_V>99-N<XS@G&<'\J
M+E%%% !115:]U&RTV%9K^\M[6)FV!YY512V"<9)ZX!_*@"S13(9HKB&.:&1)
M(I%#HZ,"K*1D$$=0:?0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% #EI:1:6@84444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 RBBB@04444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !115;4+Z#3-/GO;AL10H6/(!/H!D@9)P
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M**0PHHJE=ZQIEA.(+S4;.WE*AQ'-.J,5)(S@GID'\J:3>PFTMR[145M=6]Y
ML]K/%/"V=LD3AE.#@X(XZ@BI:0PHHJO=WUGI\2RWMU!;1LVT/-($!."<9/?
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MU</&%IPNS6M1Q,IWISLCSG_A8OB'^YI?_@/)_P#'*/\ A8OB'^YI?_@/)_\
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MM(HFEM_-\N6[+JJ*.!O7/502<DXX!(W<9\ODEE;S6+N[R9+[G/[PYW?,>_S
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M*^7YNW(#;,G'5L9.<'MDBKFC0:=>ZF(]7OIK:%@H64+NW'&T*6.=F/EP2",
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M<M+2+2T#"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** &4444""BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *XKXDW2
M)I-G:"=TEFG\SRU) D15(.<<$!F0X/?![<=K7GGQ._X^-(_W)_YQUU8))UXI
MG)CI..'DT5_AO96]QJMY=R+NFM(T$8(!"[]P+#C(.%(R#T9AWKTNN!^&;VIC
MU-$B<78,9ED)^5D.[8!SU!#YX[CKV[ZGCFW7E<67Q2P\;!1117(=AQGQ+_Y
M-E_U^K_Z+DKSRRO]0LOM$-C/)%]K,2MY&1*Q0MM52.>2_0<G '0D'T/XE_\
M(!LO^OU?_1<E8_PUM8)]5U"XEB5YK6.+R7/)3?Y@8CW(4#/7&1W->OAYQAA'
M*2OJ>+B:<JF-48NUT4(OA_KOV+S1#;1E58BW,WS\9P!@%><<?-WYQ6=I6K7O
MAG5II(%4R(QBN("WRR;205)&>0<X/..>H)!]KKRKXA010^)]\:X::W220Y)W
M-EES[<*.GI3PN*EB).E55TQ8O"1PT%5I-IIGI]K<PWMG!=V[;X9XUDC8J1E6
M&0<'D<'O7G_C*ZUN^\0OHEJD_P!G:)"L$+ ^<K94NV!D+EBA#';\H/>NVT$
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M,PA%34X]47EDY.G*$G?E=@HHHKSSTCR#QM_R-]]_VS_]%K7I/A;_ )%#1?\
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M6]CISK'<R#S9)2NXHF<  $;3N(8$\X Z<@CL:\1\2W;W'B+5;B54#+<.GR#
M(0[%/UVJ,^]<N"I1K56Y+1:G7CZTJ-%*+U>A8TGPMJ^N![FVA18I&9C<W#[5
MD?(SS@LQ))YQC(.3FIM3\'ZSHML+Z58I(X/WK2VTA)AVD8;D CUR!Q@DXKU;
M3=/@TK3;>QMAB*% H) !8]V. !DG))QR235JK>95.;1+E[$1RNERZM\W?S.8
M\!ZM/JOAYA<.\LMI,;<RR/N:0!58$G'4!P.<DXR22:X[Q7XR?6"T-G+)!IB
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MEU,/P1H,WAWPQ;V=Q-,\[GSI(Y&!$#,!F-<$C /H3DECWQ71445FW<H****
M.-^)FMII7A*:V6;9=7_[B-1M)*?\M"0?X=N5) ."Z],YKC_A!I/GZO>ZK)'E
M+:,11%HL@N_4J_8JHP0.<2=N]+XL:HUYXK6Q!<16$(7:R@#>X#LP(Y(*^6.>
MZGCN?3? VD?V-X/T^W>/9/(GGS9B\M][_-AAUW*"%YY^4=.E:_##U(WD=%11
M16184444 <G\2O\ DG^I_6'_ -&I7GWPA_Y'&X_[!\G_ *,BKT'XE?\ )/\
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M_$S6KQ[XQ6)CUG3=0\W(GMV@\O;]W8V[.<\Y\SI_L^_'L->4_&?[VA_2X_\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@!E%%% @HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "N.^(]L9-!@N5@1C!<#?*<9C1@1P3S@ML&![>G'8U%<6\5W:RVTR
M[HI4,;KDC*D8(R.1Q6E&I[.HI]C*M3]K3<.YYI\.[\6VNS6;% EW%Q\I+%TR
M0,C@#:7)SZ#GU]0KQ'5](O?#NI+;W#D./G@N(\J) "/F7N"#C(SD''4$$]1I
M?Q'N(O+BU.T690<-/"=KX"\?(>"2>N"HYZ<<^EB\,ZS]M1U3/+P6+C07L*VC
M1Z-17!W_ ,2HA&!IUA(SLK9:Y8*$;^$[5SN'J,KTZ\\9OAJ[U+Q%XUM+^\S<
M"S$C;@H"6ZNK  #W)QW8@<D[<CD6"JJ#G/1(['CZ3FH0U;[&W\2_^0#9?]?J
M_P#HN2LSX8?\?NL_]<[?^<M:?Q+_ .0#9?\ 7ZO_ *+DK,^&'_'[K/\ USM_
MYRUT1_W%^O\ D<\O^1@O3_,]&KR[XC?\C+#_ ->:?^AO7J->7?$;_D98?^O-
M/_0WK++OXZ^9KF?^[OU1Z#H7_(O:9_UZ1?\ H KR_P 9ZY+JNLW$,C%;*QE9
M(HF&,,N59SR<G.[![+V!+9]0T+_D7M,_Z](O_0!7D7B>REM_$.J6]RN#+,\@
M(!PR.2RD$@9X.#CC((SQ6N!C%XB5]];&.82DL-&VVE_N.KTGX<>;9B75[J6&
M9U!$-OMS%UR&8@ACC'0  YY;@UF^+_"=GX=T^TN;6YNI6EN1"RS%",;';C"C
MG*BNEMOB)I$MO*\\-S!+'&&$94-YK8.50@^HQEMO4>^.2\5^)G\1ND<$#QV%
ML1+M=07WGY=S$9P!OV@9_BYSD :47BY5DYW2Z]C.NL%&BU3LW;3JS;^&7^LU
M;Z0_^U*WO'G_ ")M[_OP_P#HU*P?AE_K-6^D/_M2M[QY_P B;>_[\/\ Z-2L
M<1_OOS7Z&^&_W#Y/]3C/AU_R-[_]>$O_ *,BKU:O*?AU_P C>_\ UX2_^C(J
M]6K/,/X[^1IEO^[+Y_F>??$W_6:3])O_ &G70^"?^10L?^VG_HQJY[XF_P"L
MTGZ3?^TZZ'P3_P BA8_]M/\ T8U:5/\ <8>O^9E2_P"1A/T_R.=^).I*S6FD
MB.0.A6[:3("D8= N.I[D],8'7)QS=GI_B6PM8=1L[6_BAF9'C:U;?YHQN4LB
M$DKC/WACG!ZUTOQ&TJ4RP:N)8_*"+;M&2 P.6((_O9ST'(QGD9Q@Z9XVU?2H
M!;B6":!$2.*.:, 1*HP -N">,=2>GUKJPZE]7C[))][G)B7%8F7MFUV:&)HW
MB;7[IFFMK^1EDR7O=T:Q[SR5#X^7CD(#C XZ"O1?"GA[_A'M+,<KI+=S-OG=
M%X!QPBG&2HYZ]R3@9P.*/Q&ULCY8=/\ KY3G_P!GKH?#OCN/5+Q+*_@CM9G5
M1'*KY263N,$?+GC R<],YQG'%0Q+A9Q2BNQT82>%52ZDW)]64/B:DA;2G$;&
M,"8,X4X!.S )]3@_D?2LGPIX4L/$5G<RW&H744\4NWRH'CX0J,,0RD\G<,]/
ME]C7>>*M'.M:#-!&I:XC_>P 'JX!XZ@<@E>>!G/:O,M \0W?AN\G>.W64.-D
MUO)^[)9<X!."5().>#U/&>E8>4ZF%<*;M)$8F,*>+52JKQD=C_PK'2_^@GJG
M_?47_P ;H_X5CI?_ $$]4_[ZB_\ C=3+\1]':&>0VU\K1[=L91-TN3SMPV..
MIW$>V:S=0^)3,"NF:?MRH(DNVZ-GD%%/(QWW#D]..<(QQLG;4Z)2P$5=V.YL
M+"VTRR2SLX_+@0DJNXMC))/))/4FK-5=,O1J6DV=\$V"Y@2;8&W;=R@XSWZU
M:K@E>^NYZ,;65M@KQSQE_P CEJG^_'_Z*2O8Z\<\9?\ (Y:I_OQ_^BDKT,L_
MC/T_R/-S;^ O7_,]-\+?\BAHO_7A!_Z+6N"^(W_(TQ?]>4?_ *')7>^%O^10
MT7_KP@_]%K7!?$;_ )&F+_KRC_\ 0Y*6 _WG[RLQ_P!U^XZWX?\ _(EV7_72
M?_T<]=-7,_#_ /Y$NR_ZZ3_^CGKIJY*W\27JSLH?PH^B_(\>3_DH/_<6/_HZ
MO8:\>3_DH/\ W%C_ .CJ]AKLS#['H<&6_P#+SU"BBBO./4/(/&W_ "-]]_VS
M_P#1:UZ3X6_Y%#1?^O"#_P!%K7FWC;_D;[[_ +9_^BUKTGPM_P BAHO_ %X0
M?^BUKT\;_ I>GZ(\G _[Q6]?U9K5A>+]672?#L[AG6:X_P!'A*,5(=@>0P'!
M #-V^[C.2*W:\T^(^H>=JMM8(^4MXR\@67(+MT#+V(4 @GG#]N_)A*7M:RCT
M.W&5O9492ZG-Z-8:I?7I_LB.8SQ+N,D;;-@/'WL@ G)XSD\^AKH/[&\<_P#/
M6^_\#Q_\772^ -.^Q^'OM+IB6[<R?-%M8(.%&>I'!8'_ &_Q/55VXC'R51QC
M%-+N<.&RZ+I*4I--ZZ,\FO\ P]XNGMB;V*[N(HLR!'N1*00#R%W$DX)' SSB
MJ_@R_73_ !5:.Y0).#;,S*6(#XV@8Z$NJ#)XQGZCV&O#]7LSI&O7EG _E_9I
MOW1BD8F-2 R?,>=P5EY]>YZUKAJ_UF,J4DEIT,<5A_JDH5H-O7J>X45P?B37
M;V[\ Z=J%I<2Q/<2HEU):AXPI"L& /WE'F* #GG@9.>:NF?$>>)8XM3M!,!P
MT\)VM@+Q\AX))Z\J.>G'/GQP=6<'**O9VL>E/&TH349.UU>_0]&KR#QEI-GH
M_B P6,9BAEA6?RQ]U"68$*.P^7..V<# P!U$_P 2[ 0N;;3[MY@1M68HBGGG
MY@6(XSV_+K7#2W%_XBUJ(3R^=>7<@C08.U?8 9(51DGK@ DYY-=F!H5:4W.>
MB.',,12JP5.&LKGIW@553P=8A>FZ4_B97)KHJHZ/ID>CZ1;6$1W"%?F;GYF)
MRS8).,L2<9XSBKU>;5DI5)275L]6C%PIQB]TD>,^,/\ D=-7_P"ND7_HF.O5
M/#W_ "+6E?\ 7G#_ .@"O*_&'_(Z:O\ ]=(O_1,=>J>'O^1:TK_KSA_] %=^
M+_W:E_70\[!_[U5_KJ:5%%%>8>J%%%<QXN\277AZ2P^SQ02K,SF19 <D*5X!
M!X."><'MQ5TZ<JDE".YG5JQI0<Y;(CUCP%IFH#?98T^?C_5)F,]!RF1C@'&T
MCDY.:X'5]'U'PUJ(#NT>6<6US#)M+J  2,'<IPV#^.,CD]U8?$32;EECNH;B
MT;R]S.RAX]W&5!4ECU/)4=.W2N1\7>([7Q%/92V]O-"MLC@F8J"2Q7(P"1QL
M'.>]>KA/K*GR33Y?,\C&_57#VE-KFZ6.]\':U-KFA":Y^:Y@D,,K[0H<@ A@
M ?[K+GISG  Q7E.O@3ZOK"KSNNKA?_'V%>H^!M*N-*\/D72M'+<S-.8G7#1C
M"J >>X4'L1NP1D5S'C[0KF'5)-7C5I+6<*)6SGRW "XQCA2 N#SSGID9C"3I
MPQ,HK9[%XR%2>%A-[JS9Z3%+'/"DT,B212*&1T8%64\@@CJ*?7FGA_Q\=-L8
MK+4+1YHH4VQRP8WX& JE3@<#/.>PX/)JUJOQ'66S:/2K6:&9U(\ZXVYC/&"%
M!8,>O7@''!Z5S/ UU/E2^9UK,*#AS.7RZF]X\<)X-O2QP-T(_.5!7'?#QT3Q
M2V^15+VLB(&(!9MR-@>IPI/T!KI/",MYXA\*:C%J5Q.ZW$TT*S8 ;8RC)0D8
M.&9P.H!&.@P//W@U'PYK,8G3R;VV=9!M8[7&>H(P2C8([9&0<'(KKPT+TZF&
MOJ<>*G:I3Q5O=/<*JZG>'3]*O+U8O-:W@>41[MN_:I.,\XSBN1B^)ECY*FXT
MR]$ISN6$HZCGCEF4GC';\^M87B?QF^NVS6-M;>19%E9C*07DQ@@$=%PP[$YP
M.1R*Y*>"K2FHRC9'95Q]",'*,KLR/#=F+[Q-ID!E\LBX64';G/E_O,?CLQ[9
MKUCQ)_R*VK_]>4W_ * :Y7X=Z+<1-+K$ZM'%-$([8$_ZQ202Y&.G"[3GGYCC
M&">J\2?\BMJ__7E-_P"@&M,;553$*W30RP%%T\,^;=W9Y;X/_P"1TTC_ *Z2
M_P#HF2O9J\9\'_\ (Z:1_P!=)?\ T3)7LU&9_P ;Y!E7\#YG/>.$D?P??".-
MG;,9(523@2*2>.P&2?0"O./#6CVNN:R+*[NY;96B9H_*9 SN"/E&X'/R[C@#
M/'M7L=S;Q7=K-;3KNAF0QNN2,J1@C(Y'%>,R)?>%O$6 -MS:N6C:1!B1#D!L
M9/RL,]#D<C((XUP$W*E.E%VENC+,(*-6%:2O'9G:_P#"L=+_ .@GJG_?47_Q
MNC_A6.E_]!/5/^^HO_C=/L/B/IT[11WMI<6KMNWNN)(TQG'(PQR,=%X)].:@
MG^)MKY2FTTNZ:3=AEN'2,!<'D%2^3G'''UK*V-O;4UO@+7]TZ30O#ECX>A=+
M0RO)( ))97RSX)(R!A1C<1P![YI?$NH/I?AR^NXF=95CVQNBABCL0JM@\$ D
M$^PZ'I57PAKT_B#29;BZCB2>&<POY60K?*K9 ))'# 8R>F>^*YOXDZENFL]*
M$?"@73.5[G<BA3G_ '\\=UP>M94Z4ZF(Y)[WU-JE:%+#<]/16T^9B^"-(34?
M$$)D1O(LP)^%.W<I&P;@1@Y^;WV$8QFO7:Y#X>:6]GHTU[-%LEO) 5R6!,2C
M"Y!X')<@CJ".?3KZ>.J^TK.VRT%E]+V=!7W>H4445QG:%>0>-O\ D;[[_MG_
M .BUKU^O(/&W_(WWW_;/_P!%K7I97_&?I^J/+S;^ O7]&>D^%O\ D4-%_P"O
M"#_T6M:U9/A;_D4-%_Z\(/\ T6M:U>?+XF>E'X487B_5ETGP[.X9UFN/]'A*
M,5(=@>0P'! #-V^[C.2*\MT:PU2^O3_9$<QGB7<9(VV; >/O9 !.3QG)Y]#7
M2?$?4/.U6VL$?*6\9>0++D%VZ!E[$* 03SA^W?H? &G?8_#WVETQ+=N9/FBV
ML$'"C/4C@L#_ +?XGU*4OJV%Y[:R/)K0^M8OV=](HYK^QO'/_/6^_P# \?\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ J&[M8;ZRGM+E-\$\;12)DC<K#!&1R.#VJ:B@#SW_A3V@_]
M!#5?^_D7_P ;H_X4]H/_ $$-5_[^1?\ QNO0J*KGEW%RHX3X@Z3:6?PR%L0\
M@TT6ZV[R-\P(*Q G& 259ATQSTZ5QOPCN?*\6SP-<[$FLW B+X$CAE(P.Y"[
MSZ@;O>O9-1LH]2TR[L)7=([F%X7:,@, P()&01GGTKYVFMM6\&>)(O/3R;ZT
MD65"K'9(,]01@LC<@].,@X.15PUBXDRT:9])5ROQ&OGL/ VH&*X2&:8) F[&
M7#, Z@'J2F_ISC)[5@VWQCTIK=#=Z7?QSG.Y82DB#GC#%E)XQV_/K7%^,?&-
MQXSO+6VMK26*VB=A#"KEWF=CA25'&[&  ,D%FY.:48.^HW)6-#X1VWG>+)YV
MMO,2"T8K*4R(W+*!@]B5WCU(W>]>V5R'P^\)2^%])E:\V?;[QE>4(21&H'RI
MUP2,L21_>QR #1\1]?U#P]X<@N-,E6*>:Z6$R% Q5=K,< \9^4#D'@GO@A2]
MZ6@+1'7T5YC\-_&&MZ]KMU9:G=+<1"V,JDQ*I5@RCC:!P=W.<]!C'.>N\;ZO
M=:'X/O\ 4+)T2YC"(CLNX*7D5,XZ9&[(SQG&01Q2<6G8:=U<Z"BO*]*^,2[0
MFL:6V0I)ELVSN;/ V,>!CON/(Z<\7Y?C%HHAD,.G:DTH4E%D6-59L< D.2!G
MO@_0T^278.9#?C%]F_L#3]WD_:_M7[O.-_E[&WX[XSLSCC.W/:L_X,$>9KH[
MXM__ &K7$Z[KFK>,];\UHI96^86UG I?RUZD* ,L<#).,G'8  >T^!O#K^&O
M#<=M,[FYG;[1.C8Q&[*H*#&>!M SDY.3T( N7NPLR5K*YTE%%%8EA1110 44
M44 %%%% !1110 56U"]CTW3;J^E5WCMH7F=4 +$*"2!D@9XJS7GOQ;UC['X>
M@TI8]S:A)EF*Y"I&58\YX;<4QP1@-TXIQ5W83=D>;>&-+D\6>+X(+XO*MQ*T
M]Y(L9PPY9\[<;0Q^7(Q@L,=A7T77EOP?T5XTOM;FBVB0"WMW)8$J#F0XZ%20
M@!YY5AQW]2JZCN["@M HHHK,H***Y;Q'X]TOPQJ:6%[;WDDKPK,&A1"N"S#'
M+ Y^4]O2FDWL#=AGQ*_Y)_J?UA_]&I7GWPA_Y'&X_P"P?)_Z,BK2\7?$?1]?
M\+WFF6MM?)/-Y>UI40*-KJQSAB>@/:N6\">(K3PQK\M_>QSR1/:M"!"H+;BR
M'N1Q\IK6,7R-&;:YCZ$KSCXQVT#:#IUVR9N([OR8WR>%=&9ACIR8U_+ZUKZ)
M\2-'U[6+?3+6VODFGW;6E1 HPI8YPQ/0>E;/BC1CX@\-7VF))LDF0&-BV!O4
MAER<'Y=RC.!G&<5FKQEJ6]5H>?\ P:N<2ZQ:O<]5BDC@+^F\.P7\4!/^[GM7
MJ]?.&E7^H^"_%"S26[QW-JQCGMG8J'4CE21U!!!!Y&0K<\5Z5#\8M%,4?GZ;
MJ22E07$:QLJMCD EP2,]\#Z"KG!MW1,9*UF3?%R^>W\+06L=PB-=72B2(XW2
M1J"QP#S@,(\D>P[UC_!JVS)K%VUMT$4<<Y3UW%U#?@A('^SGM7):_KFI>/O$
M-LL%FRN5$-O:1R%P#U8Y.!D]VP.%&>F:]E\'>&QX7\/1V+.DEP[F:XD3.UG.
M!QGL %7MG;G )-#]V%@6LKGEGQ8MH+?QKOB3;)<6D<TQR3N;+(#[?*BCCTKT
M7X:7/VGP)8!KGSY8FDC?+[BF'8JI],(5P/3';%4OB=X9N]=TFVN[!'FN;%G)
M@4\O&P&[:,9+ JN!D<;NIP*\Z\$^-I?"<TR/ UU97+(702$&,@\NHZ$[2<CC
M.%Y&*=N:&@MI'O\ 7BWQ=OGG\3VUFMPCPVUJ#Y:X)CD9B6SWR5$9P>V#WYZ&
MX^,>DK;N;72[^2<8VI-LC4\\Y8,Q'&>WY=:X#3-(U;Q]XDN9%;:\LAEN;ALL
MD"D\ 9.3@<*N>@QP 2%"+3NQR=]$>M_#6V^S>!+ FV\F28R2/E-I?+L%8^N5
M"X/ICMBNLJ&SM(;"R@L[9-D$$:Q1KN)VJHP!D\G@=ZBU34K?2-+N=0NFQ#;Q
MEV (!;'11D@9)P ,\DBLWJRUHCF/B!XR/AG3DM[&2$ZI<?<5N3%'SF3&,'D8
M . 3D\[2*Y3X7>#A/)'XAOHX7M4R+.(_,?,5L>9UP-I! !R<\\8!.#I]GJ'Q
M(\9R2W+7"VS,6FD4AA:P\E8P3@9_A'')RQ!PU>\111P0I##&D<4:A41% 55'
M   Z"K?NJW4A>\[GC7Q@DD/BFSB,CF);)65"QVJ2[Y('J<#/T'I7K.B:7'HN
MB66FQ%"+:%8RZ1A [8^9\#H6.2?<FO+/C#I]RFM6.I%<VLEN+<, ?E=69L$X
MP,AN.<G:WI71>'/B3H4?AW3XM6U!XK^.$1RAXY92Q7Y=Q<+R6 #'TSC)IM-Q
M5@3M)W/.[/\ T3XHI':?Z.D>MF%%A^0*GGE=H Z#;QCICBOH2O /"EK-XG^(
ML=U$H@!O&U*5=P?RU$F\CG&?F*KD#^+..*]_I5.@0"BBBLRPHHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** '+2TBTM PHHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MQ7*AMZ,C89&VE0P[$@,>H(]J@T+PW8>'HI!:>:\LH EFE?+.%+%<@848W$<
M>^:UZ*OVDN7DOH1[.'-SVU[A1114%F-JOA71]8=YKFU"7+J1Y\)V/D@ ,<<,
M0 ,;@<8]*Q?^%:Z3MQ]NU'/KOC_^(KLZ*VAB*L%:,G8QGAJ,W>44V<W9>!=!
MLUB,EJUW)'N^>Y?<'SG[R#"' .!\O8'KS72445$YRF[R=RX4X05H*QS>J>!]
M&U2>2X*S6UQ+)YDDEO)C<<8(VL"HSU. "3SGDYI)\-](65'-W?LJL"4+IAP#
MT.$S@^Q!KL:*N.)K15E)F<L+1D^9Q5RM8Z?::9;"WLK>."(8X0?>. ,D]2<
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MFUL)I,SM(T'2]!@:'3+**V5OOLHRS\DC<QR6QN.,GC/%:-%%(84444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 Y:6D6EH&%%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 ,HHHH$%%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 Y:6D6EH&%%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 ,HJF9;X$XMUQ]?_KTGG7W_/LOY_\ UZ!%VBJ7G7W_ #[+
M^?\ ]>CSK[_GV7\__KT 7:*I>=??\^R_G_\ 7H\Z^_Y]E_/_ .O0!=HJEYU]
M_P ^R_G_ /7H\Z^_Y]E_/_Z] %VBJ7G7W_/LOY__ %Z/.OO^?9?S_P#KT 7:
M*I>=??\ /LOY_P#UZ/.OO^?9?S_^O0!=HJEYU]_S[+^?_P!>CSK[_GV7\_\
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M /7H\Z^_Y]E_/_Z] %VBJ7G7W_/LOY__ %Z/.OO^?9?S_P#KT 7:*I>=??\
M/LOY_P#UZ/.OO^?9?S_^O0!=HJEYU]_S[+^?_P!>CSK[_GV7\_\ Z] %VBJ7
MG7W_ #[+^?\ ]>CSK[_GV7\__KT 7:*I>=??\^R_G_\ 7H\Z^_Y]E_/_ .O0
M!=HJEYU]_P ^R_G_ /7H\Z^_Y]E_/_Z] %VBJ7G7W_/LOY__ %Z/.OO^?9?S
M_P#KT 7:*I>=??\ /LOY_P#UZ/.OO^?9?S_^O0!=HJEYU]_S[+^?_P!>CSK[
M_GV7\_\ Z] %VBJ7G7W_ #[+^?\ ]>CSK[_GV7\__KT 7:*I>=??\^R_G_\
M7H\Z^_Y]E_/_ .O0!=HJEYU]_P ^R_G_ /7H\Z^_Y]E_/_Z] %VBJ7G7W_/L
MOY__ %Z/.OO^?9?S_P#KT 7:*I>=??\ /LOY_P#UZ/.OO^?9?S_^O0!=HJEY
MU]_S[+^?_P!>CSK[_GV7\_\ Z] %VBJ7G7W_ #[+^?\ ]>CSK[_GV7\__KT
M7:*I>=??\^R_G_\ 7H\Z^_Y]E_/_ .O0!=HJEYU]_P ^R_G_ /7H\Z^_Y]E_
M/_Z] %VBJ7G7W_/LOY__ %Z/.OO^?9?S_P#KT 7:*I>=??\ /LOY_P#UZ/.O
MO^?9?S_^O0!=HJEYU]_S[+^?_P!>CSK[_GV7\_\ Z] %VBJ7G7W_ #[+^?\
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M*I>=??\ /LOY_P#UZ/.OO^?9?S_^O0!=HJEYU]_S[+^?_P!>CSK[_GV7\_\
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M /7H\Z^_Y]E_/_Z] %VBJ7G7W_/LOY__ %Z/.OO^?9?S_P#KT 7:*I>=??\
M/LOY_P#UZ/.OO^?9?S_^O0!=HJEYU]_S[+^?_P!>CSK[_GV7\_\ Z] %VBJ7
MG7W_ #[+^?\ ]>CSK[_GV7\__KT 7:*I>=??\^R_G_\ 7H\Z^_Y]E_/_ .O0
M!=HJEYU]_P ^R_G_ /7H\Z^_Y]E_/_Z] %VBJ7G7W_/LOY__ %Z/.OO^?9?S
M_P#KT 7:*I>=??\ /LOY_P#UZ/.OO^?9?S_^O0!=HJEYU]_S[+^?_P!>CSK[
M_GV7\_\ Z] %VBJ7G7W_ #[+^?\ ]>CSK[_GV7\__KT 7:*I>=??\^R_G_\
M7H\Z^_Y]E_/_ .O0!=HJEYU]_P ^R_G_ /7H\Z^_Y]E_/_Z] %VBJ7G7W_/L
MOY__ %Z/.OO^?9?S_P#KT 7:*I>=??\ /LOY_P#UZ/.OO^?9?S_^O0!=HJEY
MU]_S[+^?_P!>CSK[_GV7\_\ Z] %VBJ7G7W_ #[+^?\ ]>CSK[_GV7\__KT
M7:*I>=??\^R_G_\ 7H\Z^_Y]E_/_ .O0!=HJEYU]_P ^R_G_ /7H\Z^_Y]E_
M/_Z] %VBJ7G7W_/LOY__ %Z/.OO^?9?S_P#KT 7:*I>=??\ /LOY_P#UZ/.O
MO^?9?S_^O0!=HJEYU]_S[+^?_P!>CSK[_GV7\_\ Z] %VBJ7G7W_ #[+^?\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M &#?>*M/BM-5.GW-I>7NFH[S6IGV-A "_8G@'&0"-WRD@YQ'HOC"PU/2-*O+
MMXK&;4Y)(K>W>7<6969< X']T<X'+ =2,^3^+ETR_P#$.H?\(W8ZC%?V[W3:
MBS2#R]JEQ*XY) ;)!R0,87;EJR_#4&FR:A:#Q+8ZI<:?/F&S$(;:YWD, !\S
M*&<G]V<AN,-NQ6O(K$<SN?0M_?VNEV$U]?3K!;0KN>1N@_Q)/  Y)( KFO\
MA9WA#_H+-_X"3?\ Q%'Q._Y)[J?^]!_Z.2L#P1X%\.:SX0L;^_T]I;J7S-[B
MXE7.)& X5@.@':I25KL;;O9'?:9K6F:U%YFFW\%R JNRQN"R!AD;EZJ3@\$
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M3W+KC$45LZLW..-X4<=>3VJ+XK:?<7O@TRVZ[A:7"W$H ).P*RDC [;@3G
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MC[3.D,.97R3][<"5!8A<\@5U'Q7L+B\\&&6!=RVEPMQ,,$G8%920 #TW G.
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M/&_Q*E\2+8-'I4,ZRL97(.]$ C QU;*HQ'0#@DY&Z8IJ]QMIVL6/C;]S1?\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M:H^^5EPNQWD;/\.?EP>-O(Y6M3XRVTC:/IET+IUBCN&B:W&=LC,N0QYQE0C
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M\G&,9_B&;XATVQUOXS3Z;?S&*VF>-'=652&^SJ5 )!&2VT=.<UU/_"FO#?\
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MO>W(2)(N'C5E<I,O<!BA(R.H3KD+6AXD\/C2/ GA;5;-X8YI 7EN8D\N9GE
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MF",C,/7_ *[)7%>'?"%]X[L;#4=:O3#I=I$+6S@@ W%$&PD9R$.Y1DD$M@C
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M-XCX!VA?E^0>_7FO//#_ (>UCXE6\U]K.ORM9PW2(T!3=O95&XJHPD9VL &
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M@2?EYXRM=;\8?^12M/\ K_3_ -%R4*_,F'1G4^$ACP9H0'_0/M__ $6M>>^
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MT(#_ *!]O_Z+6O/? 2J/BUXE(4 EKOG'_3PM=_X.EBF\%Z(T4B2*ME"A*,"
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M7/V8SE/WOE[]NUU;ID==N.O>M>BGS,5D<AX,\"1^$;B\G:\2\EG141S;A&C
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MPA;LJCJ< =B3R6/&<5D:?\.O['\7G7-,U7R(3*S&S^S_ "^6WWH\JRC;W7C
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M4L[G[98V]UY,T'G1K)Y4Z;9$R,[6'9AG!'K2<6MP33V)Z***0PHHHH ****
M"BBB@ HHHH **** "BBB@ HHJ@=;TM=8323?V_\ :#J6%N'!?@ D$=C@@@'D
MC)' . "_17'^+?B)IOA>8V:Q->7X4,T*.%6,''WVYVD@D@ $],X!!K$D^+4M
MA?1V^K^&+NR!3>P,O[W;S@A&5<@D8SD=_3%4H-BYDCTNBH;2ZAOK*"\MGWP3
MQK+&VTC<K#(.#R.#WJ:I&%%</XB^)ECH^IC2]/LWU2^$HB=(Y-J!B2-@(!+.
M#@;0.^,Y!%9\/Q;B@U-K/6M#N=."X#G>7>,G&-R%5(&TYXR>F <U7)(7,CTB
MBJVHWL>F:9=W\RNT5M"\SA "Q55).,]^*\N/QL*G!T",'WO_ /[7246]@;2W
M/6J*\_\ "?Q-_P"$GUZ/3/[&>'>C-YL4_G!,#.7&U=J]L^I48YKT"AIK<$[A
M1112&%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M_(DZ#_V#K?\ ]%K7GY_Y.#7_ 'O_ &SI*S;'M8Z?QSX^B\)>7:06XN+^6(R
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M72;B \T;NTBY4!]H*^6N3U8]""=O(KL_'-S):^"-8>*U>Y+V[1%$SD*_R,W
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M4@!BN0/EX ' X SSDUNT5-]+#MK<\5T'Q!?_  O-_I>O6,K129>V*$+&\J@
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M=.O-'*[V"ZM<ZNBO,+WXQ0Q75R++1GNK.*01K<M<&/>2"1E=AVYVL0"<D+G
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M-RSQNBR7SLC,I <;$&1ZC((SZ@CM7H%3)6=AIW04444AA1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@"E?Z1IFJF,ZCIUI>>5G
MR_M$"R;,XSC<#C.!^536EG:Z?:I:V5M#;6Z9VQ0H$1<G)P!P.23^-3T4 %9]
M]H6CZG.)]0TJQNY@NP27%NDC!<DXR0>,D\>]:%% #(88K:"."")(H8U")&BA
M550,  #H .U/HHH **** "BBB@"M?:;8ZG"L.H65O=Q*V]4N(ED4-@C(!!YP
M3S[U-##%;P1P01I%%&H1(T4*JJ!@  = !3Z* &30Q7$$D$\:2Q2*4>-U#*RD
M8((/4$5#8Z=8Z9"T.GV5O:1,V\I;Q+&I; &< #G 'Y59HH **** "LS_ (1S
M0OMOVW^Q=.^U>;YWG_94W^9G.[=C.[/.>N:TZ* "JM]IMCJD"P:A96UW$K;Q
M'<1+(H;!&<$'G!//O5JB@!D,,5O!'!!&D44:A$C10JJH&  !T %/HHH I7^D
M:9JOE_VCIUI>>7G9]H@63;G&<;@<9P/RJ[110 4444 %%%% !1110 4444 %
M4K_2-,U4QG4=.M+PQ9\O[1 LFS.,XW XS@?D*NT4 0VEG:V%JEM9VT-M;IG;
M%"@1%R<G ' Y)/XU-110 4444 %%%% !1110 4444 %9]]H6CZG.)]0TJQNY
M@NP27%NDC!<DXR0>,D\>]:%% #(88K:"."")(H8U")&BA550,  #H .U/HHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
..HHHH **** "BBB@#_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>14
<FILENAME>etnb-20221231_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- DFIN New ActiveDisclosure (SM) XBRL Linkbase Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date :2023-03-14T17:28:02.0204+00:00 -->
<!-- Copyright (c) 2023 Donnelly Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <link:roleRef roleURI="http://www.89bio.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets" xlink:href="etnb-20221231.xsd#Role_StatementConsolidatedBalanceSheets" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.89bio.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumLeasePaymentsUnderNoncancellableOperatingLeaseObligationsDetails2" xlink:href="etnb-20221231.xsd#DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumLeasePaymentsUnderNoncancellableOperatingLeaseObligationsDetails2" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.89bio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss" xlink:href="etnb-20221231.xsd#Role_StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.89bio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows" xlink:href="etnb-20221231.xsd#Role_StatementConsolidatedStatementsOfCashFlows" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureFairValueMeasurementsSummaryOfFinancialAssetsMeasuredAtFairValueOnRecurringBasisDetails" xlink:href="etnb-20221231.xsd#Role_DisclosureFairValueMeasurementsSummaryOfFinancialAssetsMeasuredAtFairValueOnRecurringBasisDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfContractualMaturitiesOfCashEquivalentsAndAvailableForSaleSecuritiesDetails" xlink:href="etnb-20221231.xsd#Role_DisclosureFairValueMeasurementsScheduleOfContractualMaturitiesOfCashEquivalentsAndAvailableForSaleSecuritiesDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureConsolidatedBalanceSheetComponentsScheduleOfPrepaidAndOtherCurrentAssetsDetails" xlink:href="etnb-20221231.xsd#Role_DisclosureConsolidatedBalanceSheetComponentsScheduleOfPrepaidAndOtherCurrentAssetsDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureConsolidatedBalanceSheetComponentsScheduleOfAccruedExpensesDetails" xlink:href="etnb-20221231.xsd#Role_DisclosureConsolidatedBalanceSheetComponentsScheduleOfAccruedExpensesDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumLeasePaymentsUnderNonCancellableOperatingLeaseObligationsDetails" xlink:href="etnb-20221231.xsd#Role_DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumLeasePaymentsUnderNonCancellableOperatingLeaseObligationsDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.89bio.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumAnnualPaymentsForOperatingLeasesDetails" xlink:href="etnb-20221231.xsd#DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumAnnualPaymentsForOperatingLeasesDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.89bio.com/20221231/taxonomy/role/DisclosureIncomeTaxesSummaryOfIncomeTaxExpenseBenefitDetails" xlink:href="etnb-20221231.xsd#DisclosureIncomeTaxesSummaryOfIncomeTaxExpenseBenefitDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesSummaryOfComponentsOfDeferredTaxAssetsDetails" xlink:href="etnb-20221231.xsd#Role_DisclosureIncomeTaxesSummaryOfComponentsOfDeferredTaxAssetsDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.89bio.com/20221231/taxonomy/role/DisclosureIncomeTaxesSummaryOfReconciliationOfIncomeTaxExpenseBenefitStatutoryTaxRateToEffectiveTaxRateDetails" xlink:href="etnb-20221231.xsd#DisclosureIncomeTaxesSummaryOfReconciliationOfIncomeTaxExpenseBenefitStatutoryTaxRateToEffectiveTaxRateDetails" xlink:type="simple"/>
  <link:calculationLink xlink:type="extended" xlink:role="http://www.89bio.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets">
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_Liabilities" order="0" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_AccountsPayableCurrent" order="0" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" order="0" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_LiabilitiesCurrent" order="0" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_AssetsCurrent" order="0" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_PreferredStockValue" order="0" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_CommitmentsAndContingencies" order="1" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent" order="1" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_RestrictedCashCurrent" order="1" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_LongTermDebtNoncurrent" order="1" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_PropertyPlantAndEquipmentNet" order="1" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_CommonStockValue" order="1" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_StockholdersEquity" order="2" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_AccruedLiabilitiesCurrent" order="2" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="etnb_ShortTermAvailableForSaleSecuritiesCurrent" order="2" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent" order="2" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset" order="2" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_AdditionalPaidInCapitalCommonStock" order="2" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="etnb_TermLoanCurrent" order="3" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" order="3" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Liabilities" xlink:to="etnb_OtherNonCurrentLiability" order="3" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_OtherAssetsNoncurrent" order="3" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" order="3" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit" order="4" weight="1.00" use="optional"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities" xlink:label="us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent" xlink:label="us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent" xlink:label="us-gaap_AccountsPayableCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent" xlink:label="us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets" xlink:label="us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValue" xlink:label="us-gaap_PreferredStockValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="us-gaap_CommitmentsAndContingencies"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashCurrent" xlink:label="us-gaap_RestrictedCashCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtNoncurrent" xlink:label="us-gaap_LongTermDebtNoncurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue" xlink:label="us-gaap_CommonStockValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="us-gaap_AccruedLiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_ShortTermAvailableForSaleSecuritiesCurrent" xlink:label="etnb_ShortTermAvailableForSaleSecuritiesCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalCommonStock" xlink:label="us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_TermLoanCurrent" xlink:label="etnb_TermLoanCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_OtherNonCurrentLiability" xlink:label="etnb_OtherNonCurrentLiability"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="us-gaap_OtherAssetsNoncurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit"/>
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://www.89bio.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumLeasePaymentsUnderNoncancellableOperatingLeaseObligationsDetails2">
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_OperatingLeaseLiability" order="0" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" order="1" weight="1" use="optional"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability" xlink:label="us-gaap_OperatingLeaseLiability"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://www.89bio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss">
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_ResearchAndDevelopmentExpense" order="0" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:to="us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" order="0" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" order="0" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_OperatingIncomeLoss" order="0" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="us-gaap_NetIncomeLoss" order="0" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_GeneralAndAdministrativeExpense" order="1" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:to="us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" order="1" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_IncomeTaxExpenseBenefit" order="1" weight="-1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_InterestExpense" order="1" weight="-1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="us-gaap_OtherComprehensiveIncomeLossNetOfTax" order="1" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_InterestAndOtherIncome" order="2" weight="1" use="optional"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpenses" xlink:label="us-gaap_OperatingExpenses"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="us-gaap_ResearchAndDevelopmentExpense"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:label="us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss" xlink:label="us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="us-gaap_GeneralAndAdministrativeExpense"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:label="us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="us-gaap_IncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense" xlink:label="us-gaap_InterestExpense"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestAndOtherIncome" xlink:label="us-gaap_InterestAndOtherIncome"/>
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://www.89bio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows">
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" order="0" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_ProceedsFromIssuanceOfOtherLongTermDebt" order="0" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities" order="0" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_ProfitLoss" order="0" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities" order="0" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="us-gaap_RestrictedCashCurrent" order="1" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="etnb_ProceedsFromIssuancePublicOffering" order="1" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities" order="1" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_ShareBasedCompensation" order="1" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="etnb_PaymentForPurchaseOfAvailableForSaleSecurities" order="1" weight="-1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="etnb_ProceedsFromIssuancePublicOfferingAtTheMarketOffering" order="2" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities" order="2" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" order="2" weight="-1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" order="2" weight="-1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_ProceedsFromWarrantExercises" order="3" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="etnb_AmortizationOfDebtIssuanceCostsAndAccretionOfFinalPaymentFee" order="3" weight="-1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" order="4" weight="-1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" order="4" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" order="5" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_Depreciation" order="5" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock" order="6" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="etnb_DeferredTaxAssets" order="6" weight="-1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" order="7" weight="-1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayable" order="8" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInAccruedLiabilities" order="9" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInOperatingLeaseLiability" order="10" weight="1" use="optional"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfOtherLongTermDebt" xlink:label="us-gaap_ProceedsFromIssuanceOfOtherLongTermDebt"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss" xlink:label="us-gaap_ProfitLoss"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities" xlink:label="us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashCurrent" xlink:label="us-gaap_RestrictedCashCurrent"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_ProceedsFromIssuancePublicOffering" xlink:label="etnb_ProceedsFromIssuancePublicOffering"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation" xlink:label="us-gaap_ShareBasedCompensation"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_PaymentForPurchaseOfAvailableForSaleSecurities" xlink:label="etnb_PaymentForPurchaseOfAvailableForSaleSecurities"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_ProceedsFromIssuancePublicOfferingAtTheMarketOffering" xlink:label="etnb_ProceedsFromIssuancePublicOfferingAtTheMarketOffering"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:label="us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromWarrantExercises" xlink:label="us-gaap_ProceedsFromWarrantExercises"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_AmortizationOfDebtIssuanceCostsAndAccretionOfFinalPaymentFee" xlink:label="etnb_AmortizationOfDebtIssuanceCostsAndAccretionOfFinalPaymentFee"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:label="us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:label="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:label="us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Depreciation" xlink:label="us-gaap_Depreciation"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_DeferredTaxAssets" xlink:label="etnb_DeferredTaxAssets"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayable" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:label="us-gaap_IncreaseDecreaseInOperatingLeaseLiability"/>
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureFairValueMeasurementsSummaryOfFinancialAssetsMeasuredAtFairValueOnRecurringBasisDetails">
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:to="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" order="0" weight="-1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:to="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" order="1" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtSecurities" order="2" weight="1.00" use="optional"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfContractualMaturitiesOfCashEquivalentsAndAvailableForSaleSecuritiesDetails">
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" order="0" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:to="etnb_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughTwoYearsFairValue" order="1" weight="1.00" use="optional"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughTwoYearsFairValue" xlink:label="etnb_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughTwoYearsFairValue"/>
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureConsolidatedBalanceSheetComponentsScheduleOfPrepaidAndOtherCurrentAssetsDetails">
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="etnb_PrepaidResearchAndDevelopmentCurrent" order="0" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="us-gaap_PrepaidTaxes" order="1" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="us-gaap_OtherPrepaidExpenseCurrent" order="2" weight="1.00" use="optional"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_PrepaidResearchAndDevelopmentCurrent" xlink:label="etnb_PrepaidResearchAndDevelopmentCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidTaxes" xlink:label="us-gaap_PrepaidTaxes"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherPrepaidExpenseCurrent" xlink:label="us-gaap_OtherPrepaidExpenseCurrent"/>
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureConsolidatedBalanceSheetComponentsScheduleOfAccruedExpensesDetails">
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AccruedLiabilitiesCurrent" xlink:to="etnb_AccruedResearchAndDevelopmentExpenseCurrent" order="0" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AccruedLiabilitiesCurrent" xlink:to="us-gaap_EmployeeRelatedLiabilitiesCurrent" order="1" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AccruedLiabilitiesCurrent" xlink:to="us-gaap_AccruedProfessionalFeesCurrent" order="2" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AccruedLiabilitiesCurrent" xlink:to="us-gaap_OtherAccruedLiabilitiesCurrent" order="3" weight="1.00" use="optional"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="us-gaap_AccruedLiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_AccruedResearchAndDevelopmentExpenseCurrent" xlink:label="etnb_AccruedResearchAndDevelopmentExpenseCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedProfessionalFeesCurrent" xlink:label="us-gaap_AccruedProfessionalFeesCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAccruedLiabilitiesCurrent" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent"/>
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumLeasePaymentsUnderNonCancellableOperatingLeaseObligationsDetails">
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" order="0" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" order="1" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" order="2" weight="1" use="optional"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://www.89bio.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumAnnualPaymentsForOperatingLeasesDetails">
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear" order="0" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" order="1" weight="1" use="optional"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears"/>
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://www.89bio.com/20221231/taxonomy/role/DisclosureIncomeTaxesSummaryOfIncomeTaxExpenseBenefitDetails">
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:to="us-gaap_CurrentFederalTaxExpenseBenefit" order="0" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredFederalIncomeTaxExpenseBenefit" order="0" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_CurrentIncomeTaxExpenseBenefit" order="0" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:to="us-gaap_CurrentStateAndLocalTaxExpenseBenefit" order="1" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredForeignIncomeTaxExpenseBenefit" order="1" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredIncomeTaxExpenseBenefit" order="1" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:to="us-gaap_CurrentForeignTaxExpenseBenefit" order="2" weight="1.00" use="optional"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:label="us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentFederalTaxExpenseBenefit" xlink:label="us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:label="us-gaap_DeferredFederalIncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="us-gaap_IncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:label="us-gaap_CurrentStateAndLocalTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:label="us-gaap_DeferredForeignIncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentForeignTaxExpenseBenefit" xlink:label="us-gaap_CurrentForeignTaxExpenseBenefit"/>
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesSummaryOfComponentsOfDeferredTaxAssetsDetails">
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsOther" order="0" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:to="us-gaap_DeferredIncomeTaxLiabilities" order="0" weight="-1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsNet" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance" order="0" weight="-1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredIncomeTaxLiabilities" xlink:to="etnb_DeferredTaxLiabilitiesRightsOfUseAssets" order="0" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" order="1" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:to="us-gaap_DeferredTaxAssetsNet" order="1" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsNet" xlink:to="us-gaap_DeferredTaxAssetsGross" order="1" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment" order="2" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" order="3" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="etnb_DeferredTaxAssetsLeaseLiability" order="4" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" order="5" weight="1" use="optional"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsGross" xlink:label="us-gaap_DeferredTaxAssetsGross"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOther" xlink:label="us-gaap_DeferredTaxAssetsOther"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:label="us-gaap_DeferredTaxAssetsLiabilitiesNet"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilities" xlink:label="us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsNet" xlink:label="us-gaap_DeferredTaxAssetsNet"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_DeferredTaxLiabilitiesRightsOfUseAssets" xlink:label="etnb_DeferredTaxLiabilitiesRightsOfUseAssets"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment" xlink:label="us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_DeferredTaxAssetsLeaseLiability" xlink:label="etnb_DeferredTaxAssetsLeaseLiability"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://www.89bio.com/20221231/taxonomy/role/DisclosureIncomeTaxesSummaryOfReconciliationOfIncomeTaxExpenseBenefitStatutoryTaxRateToEffectiveTaxRateDetails">
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" order="0" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" order="1" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" order="2" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="etnb_EffectiveIncomeTaxRateReconciliationStateDeferredTaxTrueUpDueToChangeInApportionment" order="3" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" order="4" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="etnb_IncomeTaxReconciliationChangeInEffectiveTaxRateDueToReorganization" order="5" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxReconciliationNondeductibleExpenseResearchAndDevelopment" order="6" weight="1.00" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxReconciliationOtherAdjustments" order="7" weight="1.00" use="optional"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="us-gaap_IncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:label="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:label="us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_EffectiveIncomeTaxRateReconciliationStateDeferredTaxTrueUpDueToChangeInApportionment" xlink:label="etnb_EffectiveIncomeTaxRateReconciliationStateDeferredTaxTrueUpDueToChangeInApportionment"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:label="us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_IncomeTaxReconciliationChangeInEffectiveTaxRateDueToReorganization" xlink:label="etnb_IncomeTaxReconciliationChangeInEffectiveTaxRateDueToReorganization"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpenseResearchAndDevelopment" xlink:label="us-gaap_IncomeTaxReconciliationNondeductibleExpenseResearchAndDevelopment"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:label="us-gaap_IncomeTaxReconciliationOtherAdjustments"/>
  </link:calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>15
<FILENAME>etnb-20221231_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- DFIN New ActiveDisclosure (SM) XBRL Linkbase Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date :2023-03-14T17:27:58.3731+00:00 -->
<!-- Copyright (c) 2023 Donnelly Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <link:roleRef roleURI="http://www.89bio.com/20221231/taxonomy/role/Role_DocumentDocumentAndEntityInformation" xlink:href="etnb-20221231.xsd#Role_DocumentDocumentAndEntityInformation" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.89bio.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets" xlink:href="etnb-20221231.xsd#Role_StatementConsolidatedBalanceSheets" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.89bio.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheetsParenthetical" xlink:href="etnb-20221231.xsd#Role_StatementConsolidatedBalanceSheetsParenthetical" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.89bio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss" xlink:href="etnb-20221231.xsd#Role_StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.89bio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfStockholdersEquityDeficit" xlink:href="etnb-20221231.xsd#Role_StatementConsolidatedStatementsOfStockholdersEquityDeficit" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.89bio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfStockholdersEquityParenthetical" xlink:href="etnb-20221231.xsd#Role_StatementConsolidatedStatementsOfStockholdersEquityParenthetical" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.89bio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows" xlink:href="etnb-20221231.xsd#Role_StatementConsolidatedStatementsOfCashFlows" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureOrganizationAndBasisOfPresentation" xlink:href="etnb-20221231.xsd#Role_DisclosureOrganizationAndBasisOfPresentation" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPolicies" xlink:href="etnb-20221231.xsd#Role_DisclosureSummaryOfSignificantAccountingPolicies" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureFairValueMeasurements" xlink:href="etnb-20221231.xsd#Role_DisclosureFairValueMeasurements" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureConsolidatedBalanceSheetComponents" xlink:href="etnb-20221231.xsd#Role_DisclosureConsolidatedBalanceSheetComponents" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureCommitmentsAndContingencies" xlink:href="etnb-20221231.xsd#Role_DisclosureCommitmentsAndContingencies" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureTermLoan" xlink:href="etnb-20221231.xsd#Role_DisclosureTermLoan" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.89bio.com/20221231/taxonomy/role/DisclosureStockholdersEquity1" xlink:href="etnb-20221231.xsd#DisclosureStockholdersEquity1" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureStockBasedCompensation" xlink:href="etnb-20221231.xsd#Role_DisclosureStockBasedCompensation" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxes" xlink:href="etnb-20221231.xsd#Role_DisclosureIncomeTaxes" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureNetLossPerShare" xlink:href="etnb-20221231.xsd#Role_DisclosureNetLossPerShare" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureSubsequentEvents" xlink:href="etnb-20221231.xsd#Role_DisclosureSubsequentEvents" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies" xlink:href="etnb-20221231.xsd#Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureFairValueMeasurementsTables" xlink:href="etnb-20221231.xsd#Role_DisclosureFairValueMeasurementsTables" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureConsolidatedBalanceSheetComponentsTables" xlink:href="etnb-20221231.xsd#Role_DisclosureConsolidatedBalanceSheetComponentsTables" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesTables" xlink:href="etnb-20221231.xsd#Role_DisclosureCommitmentsAndContingenciesTables" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureTermLoanTables" xlink:href="etnb-20221231.xsd#Role_DisclosureTermLoanTables" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureStockBasedCompensationTables" xlink:href="etnb-20221231.xsd#Role_DisclosureStockBasedCompensationTables" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.89bio.com/20221231/taxonomy/role/DisclosureStockholdersEquityTables" xlink:href="etnb-20221231.xsd#DisclosureStockholdersEquityTables" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesTables" xlink:href="etnb-20221231.xsd#Role_DisclosureIncomeTaxesTables" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureNetLossPerShareTables" xlink:href="etnb-20221231.xsd#Role_DisclosureNetLossPerShareTables" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureOrganizationAndBasisOfPresentationAdditionalInformationDetails" xlink:href="etnb-20221231.xsd#Role_DisclosureOrganizationAndBasisOfPresentationAdditionalInformationDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails" xlink:href="etnb-20221231.xsd#Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureFairValueMeasurementsSummaryOfFinancialAssetsMeasuredAtFairValueOnRecurringBasisDetails" xlink:href="etnb-20221231.xsd#Role_DisclosureFairValueMeasurementsSummaryOfFinancialAssetsMeasuredAtFairValueOnRecurringBasisDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfContractualMaturitiesOfCashEquivalentsAndAvailableForSaleSecuritiesDetails" xlink:href="etnb-20221231.xsd#Role_DisclosureFairValueMeasurementsScheduleOfContractualMaturitiesOfCashEquivalentsAndAvailableForSaleSecuritiesDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureConsolidatedBalanceSheetComponentsScheduleOfPrepaidAndOtherCurrentAssetsDetails" xlink:href="etnb-20221231.xsd#Role_DisclosureConsolidatedBalanceSheetComponentsScheduleOfPrepaidAndOtherCurrentAssetsDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureConsolidatedBalanceSheetComponentsScheduleOfAccruedExpensesDetails" xlink:href="etnb-20221231.xsd#Role_DisclosureConsolidatedBalanceSheetComponentsScheduleOfAccruedExpensesDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails" xlink:href="etnb-20221231.xsd#Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumLeasePaymentsUnderNonCancellableOperatingLeaseObligationsDetails" xlink:href="etnb-20221231.xsd#Role_DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumLeasePaymentsUnderNonCancellableOperatingLeaseObligationsDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.89bio.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumAnnualPaymentsForOperatingLeasesDetails" xlink:href="etnb-20221231.xsd#DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumAnnualPaymentsForOperatingLeasesDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureTermLoanAdditionalInformationDetails" xlink:href="etnb-20221231.xsd#Role_DisclosureTermLoanAdditionalInformationDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.89bio.com/20221231/taxonomy/role/DisclosureStockholdersEquityScheduleOfSharesOfCommonStockAvailableForFutureIssuanceDetails" xlink:href="etnb-20221231.xsd#DisclosureStockholdersEquityScheduleOfSharesOfCommonStockAvailableForFutureIssuanceDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.89bio.com/20221231/taxonomy/role/DisclosureStockholdersEquityAdditionalInformationDetails" xlink:href="etnb-20221231.xsd#DisclosureStockholdersEquityAdditionalInformationDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.89bio.com/20221231/taxonomy/role/DisclosureStockholdersEquityScheduleOfOutstandingWarrantsToPurchaseSharesOfCommonStockDetails" xlink:href="etnb-20221231.xsd#DisclosureStockholdersEquityScheduleOfOutstandingWarrantsToPurchaseSharesOfCommonStockDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails" xlink:href="etnb-20221231.xsd#Role_DisclosureStockBasedCompensationAdditionalInformationDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockOptionActivityDetails" xlink:href="etnb-20221231.xsd#Role_DisclosureStockBasedCompensationSummaryOfStockOptionActivityDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfEstimatedFairValueOfStockOptionsGrantedUsingBlackScholesOptionPricingModelDetails" xlink:href="etnb-20221231.xsd#Role_DisclosureStockBasedCompensationSummaryOfEstimatedFairValueOfStockOptionsGrantedUsingBlackScholesOptionPricingModelDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.89bio.com/20221231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfRestrictedStockUnitActivityDetails" xlink:href="etnb-20221231.xsd#DisclosureStockbasedCompensationSummaryOfRestrictedStockUnitActivityDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockBasedCompensationDetails" xlink:href="etnb-20221231.xsd#Role_DisclosureStockBasedCompensationSummaryOfStockBasedCompensationDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesSummaryOfStatutoryTaxRatesApplicableToIncomeOfCompanyAndSubsidiariesDetails" xlink:href="etnb-20221231.xsd#Role_DisclosureIncomeTaxesSummaryOfStatutoryTaxRatesApplicableToIncomeOfCompanyAndSubsidiariesDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.89bio.com/20221231/taxonomy/role/DisclosureIncomeTaxesSummaryOfIncomeTaxExpenseBenefitDetails" xlink:href="etnb-20221231.xsd#DisclosureIncomeTaxesSummaryOfIncomeTaxExpenseBenefitDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesSummaryOfComponentsOfDeferredTaxAssetsDetails" xlink:href="etnb-20221231.xsd#Role_DisclosureIncomeTaxesSummaryOfComponentsOfDeferredTaxAssetsDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetails" xlink:href="etnb-20221231.xsd#Role_DisclosureIncomeTaxesAdditionalInformationDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesSummaryOfLossFromOperationsBeforeTaxesOnIncomeDetails" xlink:href="etnb-20221231.xsd#Role_DisclosureIncomeTaxesSummaryOfLossFromOperationsBeforeTaxesOnIncomeDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.89bio.com/20221231/taxonomy/role/DisclosureIncomeTaxesSummaryOfReconciliationOfIncomeTaxExpenseBenefitStatutoryTaxRateToEffectiveTaxRateDetails" xlink:href="etnb-20221231.xsd#DisclosureIncomeTaxesSummaryOfReconciliationOfIncomeTaxExpenseBenefitStatutoryTaxRateToEffectiveTaxRateDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.89bio.com/20221231/taxonomy/role/DisclosureIncomeTaxesSummaryOfAReconciliationOfTheBeginningAndEndingAmountOfUnrecognizedTaxBenefitsDetails" xlink:href="etnb-20221231.xsd#DisclosureIncomeTaxesSummaryOfAReconciliationOfTheBeginningAndEndingAmountOfUnrecognizedTaxBenefitsDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureNetLossPerShareScheduleOfOutstandingPotentiallyDilutiveSecuritiesExcludedFromCalculationOfDilutedNetLossDetails" xlink:href="etnb-20221231.xsd#Role_DisclosureNetLossPerShareScheduleOfOutstandingPotentiallyDilutiveSecuritiesExcludedFromCalculationOfDilutedNetLossDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.89bio.com/20221231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails" xlink:href="etnb-20221231.xsd#DisclosureSubsequentEventsAdditionalInformationDetails" xlink:type="simple"/>
  <link:presentationLink xlink:role="http://www.89bio.com/20221231/taxonomy/role/Role_DocumentDocumentAndEntityInformation" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType" xlink:label="dei_DocumentType"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_IcfrAuditorAttestationFlag" xlink:label="dei_IcfrAuditorAttestationFlag"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorFirmId" xlink:label="dei_AuditorFirmId"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorName" xlink:label="dei_AuditorName"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorLocation" xlink:label="dei_AuditorLocation"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentType" order="49.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_AmendmentFlag" order="50.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentPeriodEndDate" order="51.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentFiscalYearFocus" order="52.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentFiscalPeriodFocus" order="53.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityRegistrantName" order="54.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityCentralIndexKey" order="55.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityCurrentReportingStatus" order="56.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityVoluntaryFilers" order="57.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityInteractiveDataCurrent" order="58.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_CurrentFiscalYearEndDate" order="59.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityFilerCategory" order="60.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityWellKnownSeasonedIssuer" order="61.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityPublicFloat" order="62.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityCommonStockSharesOutstanding" order="63.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_IcfrAuditorAttestationFlag" order="64.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityShellCompany" order="65.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntitySmallBusiness" order="66.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityEmergingGrowthCompany" order="67.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityExTransitionPeriod" order="68.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_Security12bTitle" order="69.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_TradingSymbol" order="70.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SecurityExchangeName" order="71.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityFileNumber" order="72.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityIncorporationStateCountryCode" order="73.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityTaxIdentificationNumber" order="74.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine1" order="75.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine2" order="76.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressCityOrTown" order="77.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressStateOrProvince" order="78.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressPostalZipCode" order="79.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_CityAreaCode" order="80.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_LocalPhoneNumber" order="81.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentAnnualReport" order="82.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentTransitionReport" order="83.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock" order="84.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_AuditorFirmId" order="85.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_AuditorName" order="86.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_AuditorLocation" order="87.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.89bio.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract" xlink:label="us-gaap_AssetsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="us-gaap_StockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValue" xlink:label="us-gaap_PreferredStockValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="us-gaap_AssetsCurrentAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="us-gaap_LiabilitiesCurrentAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent" xlink:label="us-gaap_AccountsPayableCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue" xlink:label="us-gaap_CommonStockValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashCurrent" xlink:label="us-gaap_RestrictedCashCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="us-gaap_AccruedLiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalCommonStock" xlink:label="us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtNoncurrent" xlink:label="us-gaap_LongTermDebtNoncurrent"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_ShortTermAvailableForSaleSecuritiesCurrent" xlink:label="etnb_ShortTermAvailableForSaleSecuritiesCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="us-gaap_OtherAssetsNoncurrent"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_OtherNonCurrentLiability" xlink:label="etnb_OtherNonCurrentLiability"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_TermLoanCurrent" xlink:label="etnb_TermLoanCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets" xlink:label="us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities" xlink:label="us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent" xlink:label="us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent" xlink:label="us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="us-gaap_CommitmentsAndContingencies"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_AssetsAbstract" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_PreferredStockValue" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_AssetsCurrentAbstract" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_AccountsPayableCurrent" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquityAbstract" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_CommonStockValue" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_RestrictedCashCurrent" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_AccruedLiabilitiesCurrent" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_AdditionalPaidInCapitalCommonStock" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentNet" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LongTermDebtNoncurrent" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="etnb_ShortTermAvailableForSaleSecuritiesCurrent" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_OtherAssetsNoncurrent" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="etnb_OtherNonCurrentLiability" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="etnb_TermLoanCurrent" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_Assets" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_Liabilities" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrent" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrent" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquity" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_CommitmentsAndContingencies" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquityAbstract" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.89bio.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheetsParenthetical" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="us-gaap_PreferredStockSharesAuthorized"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="us-gaap_PreferredStockSharesIssued"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="us-gaap_PreferredStockSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="us-gaap_CommonStockSharesAuthorized"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued" xlink:label="us-gaap_CommonStockSharesIssued"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_PreferredStockSharesAuthorized" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_PreferredStockSharesIssued" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_PreferredStockSharesOutstanding" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_CommonStockSharesAuthorized" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_CommonStockSharesIssued" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_CommonStockSharesOutstanding" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.89bio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementAbstract" xlink:label="us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="us-gaap_OperatingExpensesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossTaxAbstract" xlink:label="us-gaap_OtherComprehensiveIncomeLossTaxAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:label="us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="us-gaap_ResearchAndDevelopmentExpense"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss" xlink:label="us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:label="us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="us-gaap_GeneralAndAdministrativeExpense"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense" xlink:label="us-gaap_InterestExpense"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpenses" xlink:label="us-gaap_OperatingExpenses"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestAndOtherIncome" xlink:label="us-gaap_InterestAndOtherIncome"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="us-gaap_IncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic" xlink:label="us-gaap_EarningsPerShareBasic"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="us-gaap_EarningsPerShareDiluted"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_OperatingExpensesAbstract" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherComprehensiveIncomeLossTaxAbstract" xlink:to="us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_ResearchAndDevelopmentExpense" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_OperatingIncomeLoss" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherComprehensiveIncomeLossTaxAbstract" xlink:to="us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_GeneralAndAdministrativeExpense" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_InterestExpense" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherComprehensiveIncomeLossTaxAbstract" xlink:to="us-gaap_OtherComprehensiveIncomeLossNetOfTax" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_OperatingExpenses" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_InterestAndOtherIncome" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherComprehensiveIncomeLossTaxAbstract" xlink:to="us-gaap_ComprehensiveIncomeNetOfTax" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_IncomeTaxExpenseBenefit" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_NetIncomeLoss" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_OtherComprehensiveIncomeLossTaxAbstract" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_EarningsPerShareBasic" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_EarningsPerShareDiluted" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" order="10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" order="11" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.89bio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfStockholdersEquityDeficit" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IPOMember" xlink:label="us-gaap_IPOMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="us-gaap_TypeOfArrangementAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_ATMFacilityMember" xlink:label="etnb_ATMFacilityMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesOutstanding" xlink:label="us-gaap_SharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="us-gaap_AdditionalPaidInCapitalMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember" xlink:label="us-gaap_RetainedEarningsMember"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_StockAndWarrantsIssuedDuringPeriodValueNewIssues" xlink:label="etnb_StockAndWarrantsIssuedDuringPeriodValueNewIssues"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_StockAndWarrantsIssuedDuringPeriodSharesNewIssues" xlink:label="etnb_StockAndWarrantsIssuedDuringPeriodSharesNewIssues"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_StockIssuedDuringPeriodValueCashlessExerciseOfWarrants" xlink:label="etnb_StockIssuedDuringPeriodValueCashlessExerciseOfWarrants"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_StockIssuedDuringPeriodSharesCashlessExerciseOfWarrants" xlink:label="etnb_StockIssuedDuringPeriodSharesCashlessExerciseOfWarrants"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_StockIssuedDuringPeriodValueWarrantsExercised" xlink:label="etnb_StockIssuedDuringPeriodValueWarrantsExercised"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_StockIssuedDuringPeriodSharesWarrantsExercised" xlink:label="etnb_StockIssuedDuringPeriodSharesWarrantsExercised"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfWithholdingTaxes" xlink:label="etnb_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfWithholdingTaxes"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfWithholdingTaxes" xlink:label="etnb_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfWithholdingTaxes"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:label="us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:label="us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_IssuanceOfCommonStockWarrantInConnectionWithTermLoanFacility" xlink:label="etnb_IssuanceOfCommonStockWarrantInConnectionWithTermLoanFacility"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_IssuanceOfCommonStockWarrantsInConnectionWithDebtFinancing" xlink:label="etnb_IssuanceOfCommonStockWarrantsInConnectionWithDebtFinancing"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity_21"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesOutstanding" xlink:label="us-gaap_SharesOutstanding_22"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_IPOMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="us-gaap_StatementTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="etnb_ATMFacilityMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockholdersEquity" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_CommonStockMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SharesOutstanding" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_AdditionalPaidInCapitalMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_TypeOfArrangementAxis" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_RetainedEarningsMember" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="etnb_StockAndWarrantsIssuedDuringPeriodValueNewIssues" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="etnb_StockAndWarrantsIssuedDuringPeriodSharesNewIssues" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="etnb_StockIssuedDuringPeriodValueCashlessExerciseOfWarrants" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="etnb_StockIssuedDuringPeriodSharesCashlessExerciseOfWarrants" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="etnb_StockIssuedDuringPeriodValueWarrantsExercised" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="etnb_StockIssuedDuringPeriodSharesWarrantsExercised" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="etnb_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfWithholdingTaxes" order="10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="etnb_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfWithholdingTaxes" order="11" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" order="12" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" order="13" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" order="14" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" order="15" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="etnb_IssuanceOfCommonStockWarrantInConnectionWithTermLoanFacility" order="16" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" order="17" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="etnb_IssuanceOfCommonStockWarrantsInConnectionWithDebtFinancing" order="18" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetIncomeLoss" order="19" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OtherComprehensiveIncomeLossNetOfTax" order="20" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockholdersEquity_21" order="21" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SharesOutstanding_22" order="22" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.89bio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfStockholdersEquityParenthetical" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IPOMember" xlink:label="us-gaap_IPOMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="us-gaap_TypeOfArrangementAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_ConvertiblePreferredSharesMember" xlink:label="etnb_ConvertiblePreferredSharesMember"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_ATMFacilityMember" xlink:label="etnb_ATMFacilityMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_TemporaryEquityIssuanceCosts" xlink:label="etnb_TemporaryEquityIssuanceCosts"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_IPOMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="us-gaap_StatementTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="etnb_ConvertiblePreferredSharesMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="etnb_ATMFacilityMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="etnb_TemporaryEquityIssuanceCosts" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_TypeOfArrangementAxis" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.89bio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_ProceedsFromIssuancePublicOffering" xlink:label="etnb_ProceedsFromIssuancePublicOffering"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalCashFlowInformationAbstract" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestPaidNet" xlink:label="us-gaap_InterestPaidNet"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss" xlink:label="us-gaap_ProfitLoss"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities" xlink:label="us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation" xlink:label="us-gaap_ShareBasedCompensation"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:label="us-gaap_NoncashInvestingAndFinancingItemsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_RemeasurementOfLeaseLiabilityAndRightOfUseAssetInConnectionWithLeaseModification" xlink:label="etnb_RemeasurementOfLeaseLiabilityAndRightOfUseAssetInConnectionWithLeaseModification"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_ProceedsFromIssuancePublicOfferingAtTheMarketOffering" xlink:label="etnb_ProceedsFromIssuancePublicOfferingAtTheMarketOffering"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeasePaymentsUse" xlink:label="us-gaap_OperatingLeasePaymentsUse"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_PaymentForPurchaseOfAvailableForSaleSecurities" xlink:label="etnb_PaymentForPurchaseOfAvailableForSaleSecurities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:label="us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashCurrent" xlink:label="us-gaap_RestrictedCashCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayable" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_IssuanceOfCommonStockWarrantInConnectionWithTermLoanFacility" xlink:label="etnb_IssuanceOfCommonStockWarrantInConnectionWithTermLoanFacility"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromWarrantExercises" xlink:label="us-gaap_ProceedsFromWarrantExercises"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_AmortizationOfDebtIssuanceCostsAndAccretionOfFinalPaymentFee" xlink:label="etnb_AmortizationOfDebtIssuanceCostsAndAccretionOfFinalPaymentFee"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:label="us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:label="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:label="us-gaap_IncreaseDecreaseInOperatingLeaseLiability"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_4"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Depreciation" xlink:label="us-gaap_Depreciation"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:label="us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_5"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_DeferredTaxAssets" xlink:label="etnb_DeferredTaxAssets"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfOtherLongTermDebt" xlink:label="us-gaap_ProceedsFromIssuanceOfOtherLongTermDebt"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="etnb_ProceedsFromIssuancePublicOffering" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_StatementTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="us-gaap_InterestPaidNet" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_ProfitLoss" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_ShareBasedCompensation" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:to="etnb_RemeasurementOfLeaseLiabilityAndRightOfUseAssetInConnectionWithLeaseModification" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="etnb_ProceedsFromIssuancePublicOfferingAtTheMarketOffering" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="us-gaap_OperatingLeasePaymentsUse" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="etnb_PaymentForPurchaseOfAvailableForSaleSecurities" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" xlink:to="us-gaap_RestrictedCashCurrent" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayable" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:to="etnb_IssuanceOfCommonStockWarrantInConnectionWithTermLoanFacility" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromWarrantExercises" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="etnb_AmortizationOfDebtIssuanceCostsAndAccretionOfFinalPaymentFee" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInAccruedLiabilities" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingLeaseLiability" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_4" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_Depreciation" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_5" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="etnb_DeferredTaxAssets" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromIssuanceOfOtherLongTermDebt" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SupplementalCashFlowInformationAbstract" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NoncashInvestingAndFinancingItemsAbstract" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureOrganizationAndBasisOfPresentation" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPolicies" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_SignificantAccountingPoliciesTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureFairValueMeasurements" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresTextBlock" xlink:label="us-gaap_FairValueDisclosuresTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="us-gaap_FairValueDisclosuresTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureConsolidatedBalanceSheetComponents" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:label="us-gaap_BalanceSheetRelatedDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalBalanceSheetDisclosuresTextBlock" xlink:label="us-gaap_SupplementalBalanceSheetDisclosuresTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:to="us-gaap_SupplementalBalanceSheetDisclosuresTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureCommitmentsAndContingencies" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureTermLoan" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtTextBlock" xlink:label="us-gaap_LongTermDebtTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="us-gaap_LongTermDebtTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.89bio.com/20221231/taxonomy/role/DisclosureStockholdersEquity1" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract" xlink:label="us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityAbstract" xlink:to="us-gaap_StockholdersEquityNoteDisclosureTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureStockBasedCompensation" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxes" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeTaxDisclosureTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureNetLossPerShare" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareTextBlock" xlink:label="us-gaap_EarningsPerShareTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_EarningsPerShareTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureSubsequentEvents" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="us-gaap_SubsequentEventsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsTextBlock" xlink:label="us-gaap_SubsequentEventsTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventsAbstract" xlink:to="us-gaap_SubsequentEventsTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:label="us-gaap_PriorPeriodReclassificationAdjustmentDescription"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConsolidationPolicyTextBlock" xlink:label="us-gaap_ConsolidationPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UseOfEstimates" xlink:label="us-gaap_UseOfEstimates"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:label="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:label="us-gaap_FairValueMeasurementPolicyPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskCreditRisk" xlink:label="us-gaap_ConcentrationRiskCreditRisk"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_OtherRisksAndUncertaintiesPolicyTextBlock" xlink:label="etnb_OtherRisksAndUncertaintiesPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:label="us-gaap_SegmentReportingPolicyPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:label="us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentPolicyTextBlock" xlink:label="us-gaap_InvestmentPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeasesPolicyTextBlock" xlink:label="us-gaap_LesseeLeasesPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:label="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_AccruedResearchAndDevelopmentExpensesPolicyTextBlock" xlink:label="etnb_AccruedResearchAndDevelopmentExpensesPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_WarrantsToPurchaseCommonStockPolicyTextBlock" xlink:label="etnb_WarrantsToPurchaseCommonStockPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:label="us-gaap_ResearchAndDevelopmentExpensePolicy"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:label="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxPolicyTextBlock" xlink:label="us-gaap_IncomeTaxPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:label="us-gaap_ComprehensiveIncomePolicyPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_PriorPeriodReclassificationAdjustmentDescription" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ConsolidationPolicyTextBlock" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_UseOfEstimates" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_FairValueMeasurementPolicyPolicyTextBlock" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ConcentrationRiskCreditRisk" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="etnb_OtherRisksAndUncertaintiesPolicyTextBlock" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_SegmentReportingPolicyPolicyTextBlock" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_InvestmentPolicyTextBlock" order="10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_LesseeLeasesPolicyTextBlock" order="11" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" order="12" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" order="13" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="etnb_AccruedResearchAndDevelopmentExpensesPolicyTextBlock" order="14" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="etnb_WarrantsToPurchaseCommonStockPolicyTextBlock" order="15" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ResearchAndDevelopmentExpensePolicy" order="16" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" order="17" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_IncomeTaxPolicyTextBlock" order="18" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_EarningsPerSharePolicyTextBlock" order="19" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" order="20" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" order="21" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureFairValueMeasurementsTables" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:label="us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:label="us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureConsolidatedBalanceSheetComponentsTables" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:label="us-gaap_BalanceSheetRelatedDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_ScheduleOfPrepaidAndOtherCurrentAssetsTableTextBlock" xlink:label="etnb_ScheduleOfPrepaidAndOtherCurrentAssetsTableTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:label="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:to="etnb_ScheduleOfPrepaidAndOtherCurrentAssetsTableTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:to="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesTables" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock" xlink:label="us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureTermLoanTables" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:label="us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureStockBasedCompensationTables" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.89bio.com/20221231/taxonomy/role/DisclosureStockholdersEquityTables" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract" xlink:label="us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_ScheduleOfCommonStockReservedForIssuanceTableTextBlock" xlink:label="etnb_ScheduleOfCommonStockReservedForIssuanceTableTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:label="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityAbstract" xlink:to="etnb_ScheduleOfCommonStockReservedForIssuanceTableTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityAbstract" xlink:to="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesTables" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_ScheduleOfEffectiveIncomeTaxRateOfCompanyAndSubsidiariesTableTextBlock" xlink:label="etnb_ScheduleOfEffectiveIncomeTaxRateOfCompanyAndSubsidiariesTableTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:label="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_SummaryOfAvailableCarryforwardTaxLossesAndCredits" xlink:label="etnb_SummaryOfAvailableCarryforwardTaxLossesAndCredits"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:label="us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:label="us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="etnb_ScheduleOfEffectiveIncomeTaxRateOfCompanyAndSubsidiariesTableTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="etnb_SummaryOfAvailableCarryforwardTaxLossesAndCredits" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureNetLossPerShareTables" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureOrganizationAndBasisOfPresentationAdditionalInformationDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:label="us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_UnderwrittenPublicOfferingMember" xlink:label="etnb_UnderwrittenPublicOfferingMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="us-gaap_TypeOfArrangementAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember" xlink:label="srt_RangeMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockLineItems" xlink:label="us-gaap_SubsidiarySaleOfStockLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationDateOfIncorporation" xlink:label="dei_EntityIncorporationDateOfIncorporation"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_ATMFacilityMember" xlink:label="etnb_ATMFacilityMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsAndShortTermInvestments" xlink:label="us-gaap_CashCashEquivalentsAndShortTermInvestments"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_SVBLeerinkLLCAndCantorFitzgeraldCoMember" xlink:label="etnb_SVBLeerinkLLCAndCantorFitzgeraldCoMember"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="etnb_UnderwrittenPublicOfferingMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="dei_EntityIncorporationDateOfIncorporation" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="etnb_ATMFacilityMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_CommonStockMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="us-gaap_CashCashEquivalentsAndShortTermInvestments" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="etnb_SVBLeerinkLLCAndCantorFitzgeraldCoMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="us-gaap_TypeOfArrangementAxis" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="srt_RangeAxis" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="us-gaap_SubsidiarySaleOfStockLineItems" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember" xlink:label="srt_RangeMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfAdoptionMember" xlink:label="us-gaap_TypeOfAdoptionMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingStandardsUpdate201602Member" xlink:label="us-gaap_AccountingStandardsUpdate201602Member"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:label="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_SummaryOfSignificantAccountingPoliciesTable" xlink:label="etnb_SummaryOfSignificantAccountingPoliciesTable"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_SummaryOfSignificantAccountingPoliciesLineItems" xlink:label="etnb_SummaryOfSignificantAccountingPoliciesLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfOperatingSegments" xlink:label="us-gaap_NumberOfOperatingSegments"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseholdImprovementsMember" xlink:label="us-gaap_LeaseholdImprovementsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives" xlink:label="us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted" xlink:label="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdoptionDate" xlink:label="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdoptionDate"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherThanTemporaryImpairmentLossDebtSecuritiesPortionRecognizedInEarnings" xlink:label="us-gaap_OtherThanTemporaryImpairmentLossDebtSecuritiesPortionRecognizedInEarnings"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RealizedInvestmentGainsLosses" xlink:label="us-gaap_RealizedInvestmentGainsLosses"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TypeOfAdoptionMember" xlink:to="us-gaap_AccountingStandardsUpdate201602Member" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:to="us-gaap_TypeOfAdoptionMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="etnb_SummaryOfSignificantAccountingPoliciesTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="etnb_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_NumberOfOperatingSegments" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="etnb_SummaryOfSignificantAccountingPoliciesTable" xlink:to="srt_RangeAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_LeaseholdImprovementsMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="etnb_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentUsefulLife" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="etnb_SummaryOfSignificantAccountingPoliciesTable" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="etnb_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="etnb_SummaryOfSignificantAccountingPoliciesTable" xlink:to="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="etnb_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="etnb_SummaryOfSignificantAccountingPoliciesTable" xlink:to="etnb_SummaryOfSignificantAccountingPoliciesLineItems" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="etnb_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdoptionDate" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="etnb_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="etnb_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="etnb_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="etnb_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_OtherThanTemporaryImpairmentLossDebtSecuritiesPortionRecognizedInEarnings" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="etnb_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_RealizedInvestmentGainsLosses" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureFairValueMeasurementsSummaryOfFinancialAssetsMeasuredAtFairValueOnRecurringBasisDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MoneyMarketFundsMember" xlink:label="us-gaap_MoneyMarketFundsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis" xlink:label="us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:label="us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="us-gaap_FinancialInstrumentAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="us-gaap_FairValueInputsLevel1Member"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsRecurringMember" xlink:label="us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialPaperMember" xlink:label="us-gaap_CommercialPaperMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="us-gaap_FairValueInputsLevel2Member"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USGovernmentAgenciesShorttermDebtSecuritiesMember" xlink:label="us-gaap_USGovernmentAgenciesShorttermDebtSecuritiesMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateDebtSecuritiesMember" xlink:label="us-gaap_CorporateDebtSecuritiesMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AgencySecuritiesMember" xlink:label="us-gaap_AgencySecuritiesMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USTreasuryBillSecuritiesMember" xlink:label="us-gaap_USTreasuryBillSecuritiesMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignGovernmentDebtSecuritiesMember" xlink:label="us-gaap_ForeignGovernmentDebtSecuritiesMember"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_AgencyDiscountSecuritiesMember" xlink:label="etnb_AgencyDiscountSecuritiesMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashEquivalentsMember" xlink:label="us-gaap_CashEquivalentsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermInvestmentsMember" xlink:label="us-gaap_ShortTermInvestmentsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MunicipalBondsMember" xlink:label="us-gaap_MunicipalBondsMember"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="us-gaap_MoneyMarketFundsMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_FairValueByMeasurementFrequencyAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="us-gaap_FairValueMeasurementFrequencyDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FinancialInstrumentAxis" xlink:to="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueInputsLevel1Member" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueMeasurementFrequencyDomain" xlink:to="us-gaap_FairValueMeasurementsRecurringMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="us-gaap_CommercialPaperMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_FairValueByFairValueHierarchyLevelAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueInputsLevel2Member" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="us-gaap_USGovernmentAgenciesShorttermDebtSecuritiesMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_FinancialInstrumentAxis" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="us-gaap_CorporateDebtSecuritiesMember" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtSecurities" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="us-gaap_AgencySecuritiesMember" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="us-gaap_USTreasuryBillSecuritiesMember" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="us-gaap_ForeignGovernmentDebtSecuritiesMember" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="etnb_AgencyDiscountSecuritiesMember" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="us-gaap_CashEquivalentsMember" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="us-gaap_ShortTermInvestmentsMember" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="us-gaap_MunicipalBondsMember" order="10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfContractualMaturitiesOfCashEquivalentsAndAvailableForSaleSecuritiesDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughTwoYearsFairValue" xlink:label="etnb_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughTwoYearsFairValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="etnb_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughTwoYearsFairValue" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtSecurities" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureConsolidatedBalanceSheetComponentsScheduleOfPrepaidAndOtherCurrentAssetsDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_PrepaidResearchAndDevelopmentCurrent" xlink:label="etnb_PrepaidResearchAndDevelopmentCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidTaxes" xlink:label="us-gaap_PrepaidTaxes"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherPrepaidExpenseCurrent" xlink:label="us-gaap_OtherPrepaidExpenseCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract" xlink:to="etnb_PrepaidResearchAndDevelopmentCurrent" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract" xlink:to="us-gaap_PrepaidTaxes" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract" xlink:to="us-gaap_OtherPrepaidExpenseCurrent" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureConsolidatedBalanceSheetComponentsScheduleOfAccruedExpensesDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="us-gaap_PayablesAndAccrualsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_AccruedResearchAndDevelopmentExpenseCurrent" xlink:label="etnb_AccruedResearchAndDevelopmentExpenseCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedProfessionalFeesCurrent" xlink:label="us-gaap_AccruedProfessionalFeesCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAccruedLiabilitiesCurrent" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="us-gaap_AccruedLiabilitiesCurrent"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PayablesAndAccrualsAbstract" xlink:to="etnb_AccruedResearchAndDevelopmentExpenseCurrent" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PayablesAndAccrualsAbstract" xlink:to="us-gaap_EmployeeRelatedLiabilitiesCurrent" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PayablesAndAccrualsAbstract" xlink:to="us-gaap_AccruedProfessionalFeesCurrent" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PayablesAndAccrualsAbstract" xlink:to="us-gaap_OtherAccruedLiabilitiesCurrent" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PayablesAndAccrualsAbstract" xlink:to="us-gaap_AccruedLiabilitiesCurrent" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="us-gaap_TypeOfArrangementAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain" xlink:label="srt_SegmentGeographicalDomain"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_SanFranciscoOfficeMember" xlink:label="etnb_SanFranciscoOfficeMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain" xlink:label="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_TevasGlycoPEGylatedFGF21ProgramMember" xlink:label="etnb_TevasGlycoPEGylatedFGF21ProgramMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="us-gaap_IncomeStatementLocationAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="us-gaap_IncomeStatementLocationDomain"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_TevaAgreementMember" xlink:label="etnb_TevaAgreementMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis" xlink:label="srt_StatementGeographicalAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesLineItems" xlink:label="us-gaap_LossContingenciesLineItems"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_OperatingLeaseExpirationMonthAndYear" xlink:label="etnb_OperatingLeaseExpirationMonthAndYear"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesTable" xlink:label="us-gaap_LossContingenciesTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis" xlink:label="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_TevasDevelopmentProgramMember" xlink:label="etnb_TevasDevelopmentProgramMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseAndRentalExpense" xlink:label="us-gaap_LeaseAndRentalExpense"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableLeasePayment" xlink:label="us-gaap_VariableLeasePayment"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermLeaseCost" xlink:label="us-gaap_ShortTermLeaseCost"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseRemainingLeaseTerm" xlink:label="us-gaap_LesseeOperatingLeaseRemainingLeaseTerm"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseDiscountRate" xlink:label="us-gaap_LesseeOperatingLeaseDiscountRate"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_AssetTransferAndLicenseAgreementInitialNonrefundableUpfrontPayment" xlink:label="etnb_AssetTransferAndLicenseAgreementInitialNonrefundableUpfrontPayment"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_ObligationToPaymentUponMaximumAchievementOfCertainClinicalAndCommercialMilestones" xlink:label="etnb_ObligationToPaymentUponMaximumAchievementOfCertainClinicalAndCommercialMilestones"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_AssetTransferAndLicenseAgreementTerminationPeriodAfterWrittenNotice" xlink:label="etnb_AssetTransferAndLicenseAgreementTerminationPeriodAfterWrittenNotice"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_AssetTransferAndLicenseAgreementTerminationPeriodNoticeOfFailure" xlink:label="etnb_AssetTransferAndLicenseAgreementTerminationPeriodNoticeOfFailure"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_AssetTransferAndLicenseAgreementTerminationNoticePeriodIfBankruptcyPetitionFiled" xlink:label="etnb_AssetTransferAndLicenseAgreementTerminationNoticePeriodIfBankruptcyPetitionFiled"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_MilestonePayment" xlink:label="etnb_MilestonePayment"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_SegmentGeographicalDomain" xlink:to="etnb_SanFranciscoOfficeMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain" xlink:to="etnb_TevasGlycoPEGylatedFGF21ProgramMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="etnb_TevaAgreementMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_StatementGeographicalAxis" xlink:to="srt_SegmentGeographicalDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="etnb_OperatingLeaseExpirationMonthAndYear" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_LossContingenciesTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LossContingenciesTable" xlink:to="srt_StatementGeographicalAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis" xlink:to="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_ResearchAndDevelopmentExpenseMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain" xlink:to="etnb_TevasDevelopmentProgramMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LossContingenciesTable" xlink:to="us-gaap_TypeOfArrangementAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LossContingenciesTable" xlink:to="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="us-gaap_LeaseAndRentalExpense" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LossContingenciesTable" xlink:to="us-gaap_IncomeStatementLocationAxis" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="us-gaap_VariableLeasePayment" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LossContingenciesTable" xlink:to="us-gaap_LossContingenciesLineItems" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="us-gaap_ShortTermLeaseCost" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="us-gaap_LesseeOperatingLeaseRemainingLeaseTerm" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="us-gaap_LesseeOperatingLeaseDiscountRate" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="etnb_AssetTransferAndLicenseAgreementInitialNonrefundableUpfrontPayment" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="etnb_ObligationToPaymentUponMaximumAchievementOfCertainClinicalAndCommercialMilestones" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="etnb_AssetTransferAndLicenseAgreementTerminationPeriodAfterWrittenNotice" order="10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="etnb_AssetTransferAndLicenseAgreementTerminationPeriodNoticeOfFailure" order="11" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="etnb_AssetTransferAndLicenseAgreementTerminationNoticePeriodIfBankruptcyPetitionFiled" order="12" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="etnb_MilestonePayment" order="13" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumLeasePaymentsUnderNonCancellableOperatingLeaseObligationsDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability" xlink:label="us-gaap_OperatingLeaseLiability"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_OperatingLeaseLiability" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.89bio.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumAnnualPaymentsForOperatingLeasesDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDue"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDue" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureTermLoanAdditionalInformationDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable" xlink:label="us-gaap_DebtInstrumentTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="us-gaap_TypeOfArrangementAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateAxis" xlink:label="us-gaap_VariableRateAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateDomain" xlink:label="us-gaap_VariableRateDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember" xlink:label="srt_RangeMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationTechniqueDomain" xlink:label="us-gaap_ValuationTechniqueDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationTechniqueOptionPricingModelMember" xlink:label="us-gaap_ValuationTechniqueOptionPricingModelMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain" xlink:label="us-gaap_BalanceSheetLocationDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsMember" xlink:label="us-gaap_OtherAssetsMember"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_LoanAndSecurityAgreementMember" xlink:label="etnb_LoanAndSecurityAgreementMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrimeRateMember" xlink:label="us-gaap_PrimeRateMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis" xlink:label="us-gaap_DebtInstrumentAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="us-gaap_DebtInstrumentNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputTypeDomain" xlink:label="us-gaap_MeasurementInputTypeDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputRiskFreeInterestRateMember" xlink:label="us-gaap_MeasurementInputRiskFreeInterestRateMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputTypeAxis" xlink:label="us-gaap_MeasurementInputTypeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_TermALoanFacilityMember" xlink:label="etnb_TermALoanFacilityMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationTechniqueAxis" xlink:label="us-gaap_ValuationTechniqueAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis" xlink:label="us-gaap_BalanceSheetLocationAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:label="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_TwentyTwentyThreeLoanAgreementMember" xlink:label="etnb_TwentyTwentyThreeLoanAgreementMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputExpectedDividendPaymentMember" xlink:label="us-gaap_MeasurementInputExpectedDividendPaymentMember"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_TermBLoanFacilityMember" xlink:label="etnb_TermBLoanFacilityMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromLinesOfCredit" xlink:label="us-gaap_ProceedsFromLinesOfCredit"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputPriceVolatilityMember" xlink:label="us-gaap_MeasurementInputPriceVolatilityMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityDescription" xlink:label="us-gaap_LineOfCreditFacilityDescription"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputExpectedTermMember" xlink:label="us-gaap_MeasurementInputExpectedTermMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantsAndRightsOutstandingMaturityDate" xlink:label="us-gaap_WarrantsAndRightsOutstandingMaturityDate"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredFinanceCostsGross" xlink:label="us-gaap_DeferredFinanceCostsGross"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_LineOfCreditFacilityIncreaseInBorrowingCapacity" xlink:label="etnb_LineOfCreditFacilityIncreaseInBorrowingCapacity"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityExpirationDate1" xlink:label="us-gaap_LineOfCreditFacilityExpirationDate1"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_NetCashProceedsFromSaleOfEquitySecurities" xlink:label="etnb_NetCashProceedsFromSaleOfEquitySecurities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:label="us-gaap_DebtInstrumentInterestRateDuringPeriod"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_PrepaymentFeePercentage" xlink:label="etnb_PrepaymentFeePercentage"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:label="us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_PercentageOfFeeOnLoan" xlink:label="etnb_PercentageOfFeeOnLoan"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentMeasurementInput" xlink:label="us-gaap_DebtInstrumentMeasurementInput"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_FairValueOfWarrantsAssumptionsDividends" xlink:label="etnb_FairValueOfWarrantsAssumptionsDividends"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTerm" xlink:label="us-gaap_DebtInstrumentTerm"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsGross" xlink:label="us-gaap_DeferredTaxAssetsGross"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityInterestRateDescription" xlink:label="us-gaap_LineOfCreditFacilityInterestRateDescription"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtNoncurrent" xlink:label="us-gaap_LongTermDebtNoncurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentCarryingAmount" xlink:label="us-gaap_DebtInstrumentCarryingAmount"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentUnamortizedDiscount" xlink:label="us-gaap_DebtInstrumentUnamortizedDiscount"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_OtherNonCurrentLiability" xlink:label="etnb_OtherNonCurrentLiability"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_TypeOfArrangementAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_VariableRateAxis" xlink:to="us-gaap_VariableRateDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ValuationTechniqueDomain" xlink:to="us-gaap_ValuationTechniqueOptionPricingModelMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BalanceSheetLocationDomain" xlink:to="us-gaap_OtherAssetsMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="etnb_LoanAndSecurityAgreementMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_VariableRateDomain" xlink:to="us-gaap_PrimeRateMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentNameDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_MeasurementInputTypeDomain" xlink:to="us-gaap_MeasurementInputRiskFreeInterestRateMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_MeasurementInputTypeAxis" xlink:to="us-gaap_MeasurementInputTypeDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="us-gaap_DebtInstrumentTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="etnb_TermALoanFacilityMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ValuationTechniqueAxis" xlink:to="us-gaap_ValuationTechniqueDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BalanceSheetLocationAxis" xlink:to="us-gaap_BalanceSheetLocationDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_DebtInstrumentAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="etnb_TwentyTwentyThreeLoanAgreementMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_MeasurementInputTypeDomain" xlink:to="us-gaap_MeasurementInputExpectedDividendPaymentMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="etnb_TermBLoanFacilityMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_ProceedsFromLinesOfCredit" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_BalanceSheetLocationAxis" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_MeasurementInputTypeDomain" xlink:to="us-gaap_MeasurementInputPriceVolatilityMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_LineOfCreditFacilityDescription" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="srt_RangeAxis" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_MeasurementInputTypeDomain" xlink:to="us-gaap_MeasurementInputExpectedTermMember" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_VariableRateAxis" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_ValuationTechniqueAxis" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_WarrantsAndRightsOutstandingMaturityDate" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_MeasurementInputTypeAxis" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DeferredFinanceCostsGross" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_DebtInstrumentLineItems" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="etnb_LineOfCreditFacilityIncreaseInBorrowingCapacity" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_LineOfCreditFacilityExpirationDate1" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="etnb_NetCashProceedsFromSaleOfEquitySecurities" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentInterestRateDuringPeriod" order="10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="etnb_PrepaymentFeePercentage" order="11" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" order="12" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="etnb_PercentageOfFeeOnLoan" order="13" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentMeasurementInput" order="14" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="etnb_FairValueOfWarrantsAssumptionsDividends" order="15" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentTerm" order="16" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DeferredTaxAssetsGross" order="17" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_LineOfCreditFacilityInterestRateDescription" order="18" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_LongTermDebtNoncurrent" order="19" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentCarryingAmount" order="20" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentUnamortizedDiscount" order="21" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="etnb_OtherNonCurrentLiability" order="22" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.89bio.com/20221231/taxonomy/role/DisclosureStockholdersEquityScheduleOfSharesOfCommonStockAvailableForFutureIssuanceDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_EquityIncentivePlanMember" xlink:label="etnb_EquityIncentivePlanMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract" xlink:label="us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfStockByClassTable" xlink:label="us-gaap_ScheduleOfStockByClassTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockLineItems" xlink:label="us-gaap_ClassOfStockLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:label="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockMember" xlink:label="us-gaap_EmployeeStockMember"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_ExerciseOfWarrantsAndPreFundedWarrantsMember" xlink:label="etnb_ExerciseOfWarrantsAndPreFundedWarrantsMember"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="etnb_EquityIncentivePlanMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityAbstract" xlink:to="us-gaap_ScheduleOfStockByClassTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_EmployeeStockMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="us-gaap_ClassOfStockLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="etnb_ExerciseOfWarrantsAndPreFundedWarrantsMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.89bio.com/20221231/taxonomy/role/DisclosureStockholdersEquityAdditionalInformationDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="us-gaap_SubsequentEventTypeDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember" xlink:label="us-gaap_SubsequentEventMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:label="us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IPOMember" xlink:label="us-gaap_IPOMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="us-gaap_TypeOfArrangementAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember" xlink:label="srt_RangeMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockLineItems" xlink:label="us-gaap_SubsidiarySaleOfStockLineItems"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_MaximumAmountOfEquitySharesIssuable" xlink:label="etnb_MaximumAmountOfEquitySharesIssuable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract" xlink:label="us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_ATMFacilityMember" xlink:label="etnb_ATMFacilityMember"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_PreFundedWarrantsMember" xlink:label="etnb_PreFundedWarrantsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="us-gaap_SubsequentEventTypeAxis"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_SellingCommissionPerSharesSoldPercentage" xlink:label="etnb_SellingCommissionPerSharesSoldPercentage"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_SVBLeerinkLLCAndCantorFitzgeraldCoMember" xlink:label="etnb_SVBLeerinkLLCAndCantorFitzgeraldCoMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantMember" xlink:label="us-gaap_WarrantMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockDescriptionOfTransaction" xlink:label="us-gaap_SaleOfStockDescriptionOfTransaction"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_NumberOfPrefundedWarrantsIssuedDuringPeriod" xlink:label="etnb_NumberOfPrefundedWarrantsIssuedDuringPeriod"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_CommonStockAndWarrantsCombinedOfferingPricePerShare" xlink:label="etnb_CommonStockAndWarrantsCombinedOfferingPricePerShare"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_PrefundedAndCommonStockWarrants" xlink:label="etnb_PrefundedAndCommonStockWarrants"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_UnderwritingDiscountsAndCommissions" xlink:label="etnb_UnderwritingDiscountsAndCommissions"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfStockIssuanceCosts" xlink:label="us-gaap_PaymentsOfStockIssuanceCosts"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_BeneficialOwnershipLimitationOnExerciseOfWarrant" xlink:label="etnb_BeneficialOwnershipLimitationOnExerciseOfWarrant"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_SaleOfStockPercentageOfBeneficialOwnershipLimitationBeforeTransaction" xlink:label="etnb_SaleOfStockPercentageOfBeneficialOwnershipLimitationBeforeTransaction"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTypeDomain" xlink:to="us-gaap_SubsequentEventMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_IPOMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="etnb_MaximumAmountOfEquitySharesIssuable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityAbstract" xlink:to="us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="etnb_ATMFacilityMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain" xlink:to="etnb_PreFundedWarrantsMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="us-gaap_TypeOfArrangementAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="etnb_SellingCommissionPerSharesSoldPercentage" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="etnb_SVBLeerinkLLCAndCantorFitzgeraldCoMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_WarrantMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="srt_RangeAxis" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="us-gaap_SaleOfStockDescriptionOfTransaction" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="us-gaap_SubsequentEventTypeAxis" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="us-gaap_SubsidiarySaleOfStockLineItems" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="etnb_NumberOfPrefundedWarrantsIssuedDuringPeriod" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="etnb_CommonStockAndWarrantsCombinedOfferingPricePerShare" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="etnb_PrefundedAndCommonStockWarrants" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="etnb_UnderwritingDiscountsAndCommissions" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="us-gaap_PaymentsOfStockIssuanceCosts" order="10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare" order="11" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="etnb_BeneficialOwnershipLimitationOnExerciseOfWarrant" order="12" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="etnb_SaleOfStockPercentageOfBeneficialOwnershipLimitationBeforeTransaction" order="13" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.89bio.com/20221231/taxonomy/role/DisclosureStockholdersEquityScheduleOfOutstandingWarrantsToPurchaseSharesOfCommonStockDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightTable" xlink:label="us-gaap_ClassOfWarrantOrRightTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="us-gaap_ClassOfWarrantOrRightAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightLineItems" xlink:label="us-gaap_ClassOfWarrantOrRightLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract" xlink:label="us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_WarrantTermLoanMember" xlink:label="etnb_WarrantTermLoanMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_WarrantTermLoanOneMember" xlink:label="etnb_WarrantTermLoanOneMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantsAndRightsOutstandingMaturityDate" xlink:label="us-gaap_WarrantsAndRightsOutstandingMaturityDate"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_WarrantPublicOfferingsMember" xlink:label="etnb_WarrantPublicOfferingsMember"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_WarrantsAndRightsOutstandingMaturityDateDescription" xlink:label="etnb_WarrantsAndRightsOutstandingMaturityDateDescription"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_PreFundedWarrantsMember" xlink:label="etnb_PreFundedWarrantsMember"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightTable" xlink:to="us-gaap_ClassOfWarrantOrRightAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightOutstanding" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityAbstract" xlink:to="us-gaap_ClassOfWarrantOrRightTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightDomain" xlink:to="etnb_WarrantTermLoanMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="us-gaap_ClassOfWarrantOrRightDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightTable" xlink:to="us-gaap_ClassOfWarrantOrRightLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightDomain" xlink:to="etnb_WarrantTermLoanOneMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="us-gaap_WarrantsAndRightsOutstandingMaturityDate" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightDomain" xlink:to="etnb_WarrantPublicOfferingsMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="etnb_WarrantsAndRightsOutstandingMaturityDateDescription" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightDomain" xlink:to="etnb_PreFundedWarrantsMember" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain" xlink:label="us-gaap_PlanNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_TwoThousandAndNineteenEquityIncentivePlanMember" xlink:label="etnb_TwoThousandAndNineteenEquityIncentivePlanMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockMember" xlink:label="us-gaap_EmployeeStockMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember" xlink:label="srt_RangeMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_ServiceBasedRSUsMember" xlink:label="etnb_ServiceBasedRSUsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_NumberOfSharesIssuableUnderShareBasedPaymentArrangement" xlink:label="etnb_NumberOfSharesIssuableUnderShareBasedPaymentArrangement"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedPaymentArrangementEmployeeMember" xlink:label="us-gaap_ShareBasedPaymentArrangementEmployeeMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameAxis" xlink:label="us-gaap_PlanNameAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualAxis" xlink:label="srt_TitleOfIndividualAxis"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_TwoThousandAndTwentyEquityIncentivePlanMember" xlink:label="etnb_TwoThousandAndTwentyEquityIncentivePlanMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_PeriodForIncreaseInNumberOfSharesOfCommonStockReservedForIssuance" xlink:label="etnb_PeriodForIncreaseInNumberOfSharesOfCommonStockReservedForIssuance"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ExecutiveOfficerMember" xlink:label="srt_ExecutiveOfficerMember"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_PerformanceRSUsMember" xlink:label="etnb_PerformanceRSUsMember"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_PercentageOfIncreaseInNumberOfSharesOfCapitalStockIssuedAndOutstanding" xlink:label="etnb_PercentageOfIncreaseInNumberOfSharesOfCapitalStockIssuedAndOutstanding"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAward" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAward"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_ShareBasedCompensationArrangementByShareBasedPaymentAwardRemainingOptionsVestingPeriod" xlink:label="etnb_ShareBasedCompensationArrangementByShareBasedPaymentAwardRemainingOptionsVestingPeriod"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_ShareBasedCompensationArrangementByShareBasedPaymentFirstOfferingPeriodCommencementDate" xlink:label="etnb_ShareBasedCompensationArrangementByShareBasedPaymentFirstOfferingPeriodCommencementDate"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantDateFairValue" xlink:label="etnb_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantDateFairValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_ShareBasedCompensationArrangementByShareBasedPaymentAwardAnniversary" xlink:label="etnb_ShareBasedCompensationArrangementByShareBasedPaymentAwardAnniversary"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameDomain" xlink:to="etnb_TwoThousandAndNineteenEquityIncentivePlanMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_EmployeeStockMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="etnb_ServiceBasedRSUsMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="etnb_NumberOfSharesIssuableUnderShareBasedPaymentArrangement" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="srt_RangeAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="us-gaap_ShareBasedPaymentArrangementEmployeeMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_TitleOfIndividualAxis" xlink:to="srt_TitleOfIndividualWithRelationshipToEntityDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameDomain" xlink:to="etnb_TwoThousandAndTwentyEquityIncentivePlanMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_RestrictedStockUnitsRSUMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="etnb_PeriodForIncreaseInNumberOfSharesOfCommonStockReservedForIssuance" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_PlanNameAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="srt_ExecutiveOfficerMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="etnb_PerformanceRSUsMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="etnb_PercentageOfIncreaseInNumberOfSharesOfCapitalStockIssuedAndOutstanding" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_AwardTypeAxis" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="srt_TitleOfIndividualAxis" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAward" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="etnb_ShareBasedCompensationArrangementByShareBasedPaymentAwardRemainingOptionsVestingPeriod" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="etnb_ShareBasedCompensationArrangementByShareBasedPaymentFirstOfferingPeriodCommencementDate" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" order="10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" order="11" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" order="12" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" order="13" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" order="14" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" order="15" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="etnb_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantDateFairValue" order="16" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense" order="17" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription" order="18" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" order="19" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" order="20" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" order="21" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="etnb_ShareBasedCompensationArrangementByShareBasedPaymentAwardAnniversary" order="22" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockOptionActivityDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain" xlink:label="us-gaap_PlanNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_TwoThousandAndNineteenEquityIncentivePlanMember" xlink:label="etnb_TwoThousandAndNineteenEquityIncentivePlanMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameAxis" xlink:label="us-gaap_PlanNameAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_5"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_12"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract" xlink:label="etnb_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract" xlink:label="etnb_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameDomain" xlink:to="etnb_TwoThousandAndNineteenEquityIncentivePlanMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_PlanNameAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_5" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" order="10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" order="11" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_12" order="12" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" order="13" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="etnb_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract" order="14" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" order="15" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" order="16" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="etnb_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract" order="17" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" order="18" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" order="19" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfEstimatedFairValueOfStockOptionsGrantedUsingBlackScholesOptionPricingModelDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember" xlink:label="srt_RangeMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="srt_RangeAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.89bio.com/20221231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfRestrictedStockUnitActivityDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_4"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_4"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_RestrictedStockUnitsRSUMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_AwardTypeAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_4" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_4" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockBasedCompensationDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="us-gaap_IncomeStatementLocationAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="us-gaap_IncomeStatementLocationDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpenseMember" xlink:label="us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:to="us-gaap_IncomeStatementLocationAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_ResearchAndDevelopmentExpenseMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_GeneralAndAdministrativeExpenseMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesSummaryOfStatutoryTaxRatesApplicableToIncomeOfCompanyAndSubsidiariesDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_IncomeTaxDisclosureTable" xlink:label="etnb_IncomeTaxDisclosureTable"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_IncomeTaxDisclosureLineItems" xlink:label="etnb_IncomeTaxDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesDomain" xlink:label="srt_ConsolidatedEntitiesDomain"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_EightyNineBioLtdMember" xlink:label="etnb_EightyNineBioLtdMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesAxis" xlink:label="srt_ConsolidatedEntitiesAxis"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_EightyNineBioManagementIncorporationMember" xlink:label="etnb_EightyNineBioManagementIncorporationMember"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_UABEightyNineBioLithuaniaMember" xlink:label="etnb_UABEightyNineBioLithuaniaMember"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="etnb_IncomeTaxDisclosureTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="etnb_IncomeTaxDisclosureLineItems" xlink:to="us-gaap_EffectiveIncomeTaxRateContinuingOperations" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ConsolidatedEntitiesDomain" xlink:to="etnb_EightyNineBioLtdMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="etnb_IncomeTaxDisclosureTable" xlink:to="srt_ConsolidatedEntitiesAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ConsolidatedEntitiesDomain" xlink:to="etnb_EightyNineBioManagementIncorporationMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="etnb_IncomeTaxDisclosureTable" xlink:to="etnb_IncomeTaxDisclosureLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ConsolidatedEntitiesDomain" xlink:to="etnb_UABEightyNineBioLithuaniaMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.89bio.com/20221231/taxonomy/role/DisclosureIncomeTaxesSummaryOfIncomeTaxExpenseBenefitDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:label="us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentFederalTaxExpenseBenefit" xlink:label="us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:label="us-gaap_CurrentStateAndLocalTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentForeignTaxExpenseBenefit" xlink:label="us-gaap_CurrentForeignTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:label="us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:label="us-gaap_DeferredFederalIncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:label="us-gaap_DeferredForeignIncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_CurrentFederalTaxExpenseBenefit" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_CurrentStateAndLocalTaxExpenseBenefit" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_CurrentForeignTaxExpenseBenefit" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_CurrentIncomeTaxExpenseBenefit" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_DeferredFederalIncomeTaxExpenseBenefit" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_DeferredForeignIncomeTaxExpenseBenefit" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_DeferredIncomeTaxExpenseBenefit" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeTaxExpenseBenefit" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesSummaryOfComponentsOfDeferredTaxAssetsDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain" xlink:label="srt_SegmentGeographicalDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_US" xlink:label="country_US"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_IncomeTaxDisclosureTable" xlink:label="etnb_IncomeTaxDisclosureTable"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_IncomeTaxDisclosureLineItems" xlink:label="etnb_IncomeTaxDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis" xlink:label="srt_StatementGeographicalAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_IL" xlink:label="country_IL"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment" xlink:label="us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_DeferredTaxAssetsLeaseLiability" xlink:label="etnb_DeferredTaxAssetsLeaseLiability"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOther" xlink:label="us-gaap_DeferredTaxAssetsOther"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsGross" xlink:label="us-gaap_DeferredTaxAssetsGross"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsNet" xlink:label="us-gaap_DeferredTaxAssetsNet"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_DeferredTaxLiabilitiesRightsOfUseAssets" xlink:label="etnb_DeferredTaxLiabilitiesRightsOfUseAssets"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilities" xlink:label="us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:label="us-gaap_DeferredTaxAssetsLiabilitiesNet"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_SegmentGeographicalDomain" xlink:to="country_US" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="etnb_IncomeTaxDisclosureTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="etnb_IncomeTaxDisclosureLineItems" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="etnb_IncomeTaxDisclosureTable" xlink:to="srt_StatementGeographicalAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_StatementGeographicalAxis" xlink:to="srt_SegmentGeographicalDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_SegmentGeographicalDomain" xlink:to="country_IL" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="etnb_IncomeTaxDisclosureLineItems" xlink:to="us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="etnb_IncomeTaxDisclosureTable" xlink:to="etnb_IncomeTaxDisclosureLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="etnb_IncomeTaxDisclosureLineItems" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="etnb_IncomeTaxDisclosureLineItems" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="etnb_IncomeTaxDisclosureLineItems" xlink:to="etnb_DeferredTaxAssetsLeaseLiability" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="etnb_IncomeTaxDisclosureLineItems" xlink:to="us-gaap_DeferredTaxAssetsOther" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="etnb_IncomeTaxDisclosureLineItems" xlink:to="us-gaap_DeferredTaxAssetsGross" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="etnb_IncomeTaxDisclosureLineItems" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="etnb_IncomeTaxDisclosureLineItems" xlink:to="us-gaap_DeferredTaxAssetsNet" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="etnb_IncomeTaxDisclosureLineItems" xlink:to="etnb_DeferredTaxLiabilitiesRightsOfUseAssets" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="etnb_IncomeTaxDisclosureLineItems" xlink:to="us-gaap_DeferredIncomeTaxLiabilities" order="10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="etnb_IncomeTaxDisclosureLineItems" xlink:to="us-gaap_DeferredTaxAssetsLiabilitiesNet" order="11" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:label="us-gaap_IncomeTaxAuthorityDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DomesticCountryMember" xlink:label="us-gaap_DomesticCountryMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain" xlink:label="srt_SegmentGeographicalDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_IL" xlink:label="country_IL"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_IncomeTaxDisclosureTable" xlink:label="etnb_IncomeTaxDisclosureTable"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_IncomeTaxDisclosureLineItems" xlink:label="etnb_IncomeTaxDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="us-gaap_IncomeStatementLocationAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="us-gaap_IncomeStatementLocationDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis" xlink:label="srt_StatementGeographicalAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxCreditCarryforwardAxis" xlink:label="us-gaap_TaxCreditCarryforwardAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxCreditCarryforwardNameDomain" xlink:label="us-gaap_TaxCreditCarryforwardNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchMember" xlink:label="us-gaap_ResearchMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityAxis" xlink:label="us-gaap_IncomeTaxAuthorityAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StateAndLocalJurisdictionMember" xlink:label="us-gaap_StateAndLocalJurisdictionMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_US" xlink:label="country_US"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:label="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCountryMember" xlink:label="us-gaap_ForeignCountryMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_CA" xlink:label="stpr_CA"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_AccumulatedTaxLossCarryForward" xlink:label="etnb_AccumulatedTaxLossCarryForward"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLossCarryforwardsLimitationsOnUse" xlink:label="us-gaap_OperatingLossCarryforwardsLimitationsOnUse"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_TaxableIncomeUtilizationPercentage" xlink:label="etnb_TaxableIncomeUtilizationPercentage"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_TaxCreditCarryforwardExpirationYear" xlink:label="etnb_TaxCreditCarryforwardExpirationYear"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_DeferredTaxAssetsTaxCreditCarryforwardsResearchFederal" xlink:label="etnb_DeferredTaxAssetsTaxCreditCarryforwardsResearchFederal"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:label="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease" xlink:label="us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:label="us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_AmortizationPeriod" xlink:label="etnb_AmortizationPeriod"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxAuthorityDomain" xlink:to="us-gaap_DomesticCountryMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_SegmentGeographicalDomain" xlink:to="country_IL" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="etnb_IncomeTaxDisclosureTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="etnb_IncomeTaxDisclosureLineItems" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="etnb_IncomeTaxDisclosureTable" xlink:to="srt_StatementGeographicalAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_StatementGeographicalAxis" xlink:to="srt_SegmentGeographicalDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TaxCreditCarryforwardAxis" xlink:to="us-gaap_TaxCreditCarryforwardNameDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TaxCreditCarryforwardNameDomain" xlink:to="us-gaap_ResearchMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_ResearchAndDevelopmentExpenseMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxAuthorityAxis" xlink:to="us-gaap_IncomeTaxAuthorityDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxAuthorityDomain" xlink:to="us-gaap_StateAndLocalJurisdictionMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_SegmentGeographicalDomain" xlink:to="country_US" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="etnb_IncomeTaxDisclosureLineItems" xlink:to="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="etnb_IncomeTaxDisclosureTable" xlink:to="us-gaap_IncomeTaxAuthorityAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxAuthorityDomain" xlink:to="us-gaap_ForeignCountryMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_SegmentGeographicalDomain" xlink:to="stpr_CA" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="etnb_IncomeTaxDisclosureLineItems" xlink:to="etnb_AccumulatedTaxLossCarryForward" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="etnb_IncomeTaxDisclosureTable" xlink:to="us-gaap_IncomeStatementLocationAxis" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="etnb_IncomeTaxDisclosureLineItems" xlink:to="us-gaap_OperatingLossCarryforwardsLimitationsOnUse" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="etnb_IncomeTaxDisclosureTable" xlink:to="us-gaap_TaxCreditCarryforwardAxis" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="etnb_IncomeTaxDisclosureLineItems" xlink:to="etnb_TaxableIncomeUtilizationPercentage" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="etnb_IncomeTaxDisclosureTable" xlink:to="etnb_IncomeTaxDisclosureLineItems" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="etnb_IncomeTaxDisclosureLineItems" xlink:to="etnb_TaxCreditCarryforwardExpirationYear" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="etnb_IncomeTaxDisclosureLineItems" xlink:to="etnb_DeferredTaxAssetsTaxCreditCarryforwardsResearchFederal" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="etnb_IncomeTaxDisclosureLineItems" xlink:to="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="etnb_IncomeTaxDisclosureLineItems" xlink:to="us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="etnb_IncomeTaxDisclosureLineItems" xlink:to="us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="etnb_IncomeTaxDisclosureLineItems" xlink:to="etnb_AmortizationPeriod" order="10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesSummaryOfLossFromOperationsBeforeTaxesOnIncomeDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain" xlink:label="srt_SegmentGeographicalDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_US" xlink:label="country_US"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_IncomeTaxDisclosureTable" xlink:label="etnb_IncomeTaxDisclosureTable"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_IncomeTaxDisclosureLineItems" xlink:label="etnb_IncomeTaxDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis" xlink:label="srt_StatementGeographicalAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_LT" xlink:label="country_LT"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_IL" xlink:label="country_IL"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_SegmentGeographicalDomain" xlink:to="country_US" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="etnb_IncomeTaxDisclosureTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="etnb_IncomeTaxDisclosureLineItems" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="etnb_IncomeTaxDisclosureTable" xlink:to="srt_StatementGeographicalAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_StatementGeographicalAxis" xlink:to="srt_SegmentGeographicalDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_SegmentGeographicalDomain" xlink:to="country_LT" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="etnb_IncomeTaxDisclosureTable" xlink:to="etnb_IncomeTaxDisclosureLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_SegmentGeographicalDomain" xlink:to="country_IL" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.89bio.com/20221231/taxonomy/role/DisclosureIncomeTaxesSummaryOfReconciliationOfIncomeTaxExpenseBenefitStatutoryTaxRateToEffectiveTaxRateDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:label="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:label="us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:label="us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_EffectiveIncomeTaxRateReconciliationStateDeferredTaxTrueUpDueToChangeInApportionment" xlink:label="etnb_EffectiveIncomeTaxRateReconciliationStateDeferredTaxTrueUpDueToChangeInApportionment"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_IncomeTaxReconciliationChangeInEffectiveTaxRateDueToReorganization" xlink:label="etnb_IncomeTaxReconciliationChangeInEffectiveTaxRateDueToReorganization"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpenseResearchAndDevelopment" xlink:label="us-gaap_IncomeTaxReconciliationNondeductibleExpenseResearchAndDevelopment"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:label="us-gaap_IncomeTaxReconciliationOtherAdjustments"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="etnb_EffectiveIncomeTaxRateReconciliationStateDeferredTaxTrueUpDueToChangeInApportionment" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="etnb_IncomeTaxReconciliationChangeInEffectiveTaxRateDueToReorganization" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeTaxReconciliationNondeductibleExpenseResearchAndDevelopment" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeTaxReconciliationOtherAdjustments" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeTaxExpenseBenefit" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.89bio.com/20221231/taxonomy/role/DisclosureIncomeTaxesSummaryOfAReconciliationOfTheBeginningAndEndingAmountOfUnrecognizedTaxBenefitsDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefits" xlink:label="us-gaap_UnrecognizedTaxBenefits"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefits" xlink:label="us-gaap_UnrecognizedTaxBenefits_3"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_UnrecognizedTaxBenefits" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_UnrecognizedTaxBenefits_3" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureNetLossPerShareScheduleOfOutstandingPotentiallyDilutiveSecuritiesExcludedFromCalculationOfDilutedNetLossDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="us-gaap_EmployeeStockOptionMember"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_UnvestedRestrictedStockUnitsMember" xlink:label="etnb_UnvestedRestrictedStockUnitsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantMember" xlink:label="us-gaap_WarrantMember"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="us-gaap_AntidilutiveSecuritiesNameDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="us-gaap_EmployeeStockOptionMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="etnb_UnvestedRestrictedStockUnitsMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="us-gaap_WarrantMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.89bio.com/20221231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="us-gaap_SubsequentEventTypeDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember" xlink:label="us-gaap_SubsequentEventMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IPOMember" xlink:label="us-gaap_IPOMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="us-gaap_TypeOfArrangementAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember" xlink:label="srt_RangeMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventLineItems" xlink:label="us-gaap_SubsequentEventLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:label="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="us-gaap_SubsequentEventsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTable" xlink:label="us-gaap_SubsequentEventTable"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_TwoThousandAndTwentyThreeLoanAgreementMember" xlink:label="etnb_TwoThousandAndTwentyThreeLoanAgreementMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis" xlink:label="us-gaap_DebtInstrumentAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="us-gaap_DebtInstrumentNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_TrancheOneMember" xlink:label="etnb_TrancheOneMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="us-gaap_SubsequentEventTypeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentMaturityDateDescription" xlink:label="us-gaap_DebtInstrumentMaturityDateDescription"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_TwoThousandAndTwentyOneLoanAgreementMember" xlink:label="etnb_TwoThousandAndTwentyOneLoanAgreementMember"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_TrancheTwoAndThreeMember" xlink:label="etnb_TrancheTwoAndThreeMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentMaturityDate" xlink:label="us-gaap_DebtInstrumentMaturityDate"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_ATMFacilityMember" xlink:label="etnb_ATMFacilityMember"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_TrancheFourMember" xlink:label="etnb_TrancheFourMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:label="us-gaap_DebtInstrumentInterestRateDuringPeriod"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_SVBLeerinkLLCAndCantorFitzgeraldCoMember" xlink:label="etnb_SVBLeerinkLLCAndCantorFitzgeraldCoMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:label="us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityAverageOutstandingAmount" xlink:label="us-gaap_LineOfCreditFacilityAverageOutstandingAmount"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAnnualPrincipalPayment" xlink:label="us-gaap_DebtInstrumentAnnualPrincipalPayment"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_DebtInstrumentFinalPaymentFee" xlink:label="etnb_DebtInstrumentFinalPaymentFee"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_DebtInstrumentEarlyPrepaymentFee" xlink:label="etnb_DebtInstrumentEarlyPrepaymentFee"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_MaximumAmountOfEquitySharesIssuable" xlink:label="etnb_MaximumAmountOfEquitySharesIssuable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockDescriptionOfTransaction" xlink:label="us-gaap_SaleOfStockDescriptionOfTransaction"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockTransactionDate" xlink:label="us-gaap_SaleOfStockTransactionDate"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTypeDomain" xlink:to="us-gaap_SubsequentEventMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_IPOMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventsAbstract" xlink:to="us-gaap_SubsequentEventTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="etnb_TwoThousandAndTwentyThreeLoanAgreementMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentNameDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTable" xlink:to="us-gaap_DebtInstrumentAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="etnb_TrancheOneMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_DebtInstrumentMaturityDateDescription" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="etnb_TwoThousandAndTwentyOneLoanAgreementMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTable" xlink:to="us-gaap_SubsequentEventTypeAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="etnb_TrancheTwoAndThreeMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_DebtInstrumentMaturityDate" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="etnb_ATMFacilityMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTable" xlink:to="us-gaap_TypeOfArrangementAxis" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="etnb_TrancheFourMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_DebtInstrumentInterestRateDuringPeriod" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="etnb_SVBLeerinkLLCAndCantorFitzgeraldCoMember" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTable" xlink:to="srt_RangeAxis" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_LineOfCreditFacilityAverageOutstandingAmount" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTable" xlink:to="us-gaap_SubsequentEventLineItems" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_DebtInstrumentAnnualPrincipalPayment" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="etnb_DebtInstrumentFinalPaymentFee" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="etnb_DebtInstrumentEarlyPrepaymentFee" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="etnb_MaximumAmountOfEquitySharesIssuable" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_SaleOfStockDescriptionOfTransaction" order="10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_SaleOfStockTransactionDate" order="11" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock" order="12" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues" order="13" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>16
<FILENAME>etnb-20221231_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- DFIN New ActiveDisclosure (SM) XBRL Linkbase Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date :2023-03-14T17:28:01.8663+00:00 -->
<!-- Copyright (c) 2023 Donnelly Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" xlink:type="simple"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:title="labelLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_PrepaymentFeePercentage" xlink:label="etnb_PrepaymentFeePercentage"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="us-gaap_FairValueInputsLevel1Member"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:label="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DomesticCountryMember" xlink:label="us-gaap_DomesticCountryMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpenseResearchAndDevelopment" xlink:label="us-gaap_IncomeTaxReconciliationNondeductibleExpenseResearchAndDevelopment"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:label="us-gaap_ResearchAndDevelopmentExpensePolicy"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseDiscountRate" xlink:label="us-gaap_LesseeOperatingLeaseDiscountRate"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_BeneficialOwnershipLimitationOnExerciseOfWarrant" xlink:label="etnb_BeneficialOwnershipLimitationOnExerciseOfWarrant"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="us-gaap_SubsequentEventTypeDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ExecutiveOfficerMember" xlink:label="srt_ExecutiveOfficerMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable" xlink:label="us-gaap_DebtInstrumentTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedPaymentArrangementEmployeeMember" xlink:label="us-gaap_ShareBasedPaymentArrangementEmployeeMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_UnderwrittenPublicOfferingMember" xlink:label="etnb_UnderwrittenPublicOfferingMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:label="us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:label="us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_AccumulatedTaxLossCarryForward" xlink:label="etnb_AccumulatedTaxLossCarryForward"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfOperatingSegments" xlink:label="us-gaap_NumberOfOperatingSegments"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="us-gaap_PreferredStockSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_ProceedsFromIssuancePublicOffering" xlink:label="etnb_ProceedsFromIssuancePublicOffering"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:label="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorFirmId" xlink:label="dei_AuditorFirmId"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_TwoThousandAndTwentyThreeLoanAgreementMember" xlink:label="etnb_TwoThousandAndTwentyThreeLoanAgreementMember"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_AssetTransferAndLicenseAgreementTerminationPeriodAfterWrittenNotice" xlink:label="etnb_AssetTransferAndLicenseAgreementTerminationPeriodAfterWrittenNotice"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:label="us-gaap_IncomeTaxAuthorityDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockMember" xlink:label="us-gaap_EmployeeStockMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="us-gaap_EmployeeStockOptionMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_PercentageOfIncreaseInNumberOfSharesOfCapitalStockIssuedAndOutstanding" xlink:label="etnb_PercentageOfIncreaseInNumberOfSharesOfCapitalStockIssuedAndOutstanding"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain" xlink:label="us-gaap_PlanNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:label="us-gaap_PriorPeriodReclassificationAdjustmentDescription"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_ATMFacilityMember" xlink:label="etnb_ATMFacilityMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:label="us-gaap_DeferredForeignIncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted" xlink:label="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementAbstract" xlink:label="us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:label="us-gaap_IncomeTaxReconciliationOtherAdjustments"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:label="us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent" xlink:label="us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:label="us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_IssuanceOfCommonStockWarrantsInConnectionWithDebtFinancing" xlink:label="etnb_IssuanceOfCommonStockWarrantsInConnectionWithDebtFinancing"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsRecurringMember" xlink:label="us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense" xlink:label="us-gaap_InterestExpense"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermLeaseCost" xlink:label="us-gaap_ShortTermLeaseCost"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxPolicyTextBlock" xlink:label="us-gaap_IncomeTaxPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="us-gaap_PreferredStockSharesAuthorized"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityDescription" xlink:label="us-gaap_LineOfCreditFacilityDescription"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_LineOfCreditFacilityIncreaseInBorrowingCapacity" xlink:label="etnb_LineOfCreditFacilityIncreaseInBorrowingCapacity"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:label="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_AmortizationPeriod" xlink:label="etnb_AmortizationPeriod"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateAxis" xlink:label="us-gaap_VariableRateAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="us-gaap_TypeOfArrangementAxis"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_NetCashProceedsFromSaleOfEquitySecurities" xlink:label="etnb_NetCashProceedsFromSaleOfEquitySecurities"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_ConvertiblePreferredSharesMember" xlink:label="etnb_ConvertiblePreferredSharesMember"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_EightyNineBioLtdMember" xlink:label="etnb_EightyNineBioLtdMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AgencySecuritiesMember" xlink:label="us-gaap_AgencySecuritiesMember"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_IssuanceOfCommonStockWarrantInConnectionWithTermLoanFacility" xlink:label="etnb_IssuanceOfCommonStockWarrantInConnectionWithTermLoanFacility"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent" xlink:label="us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_TrancheOneMember" xlink:label="etnb_TrancheOneMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities" xlink:label="us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfStockIssuanceCosts" xlink:label="us-gaap_PaymentsOfStockIssuanceCosts"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_ExerciseOfWarrantsAndPreFundedWarrantsMember" xlink:label="etnb_ExerciseOfWarrantsAndPreFundedWarrantsMember"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_SVBLeerinkLLCAndCantorFitzgeraldCoMember" xlink:label="etnb_SVBLeerinkLLCAndCantorFitzgeraldCoMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_DeferredTaxLiabilitiesRightsOfUseAssets" xlink:label="etnb_DeferredTaxLiabilitiesRightsOfUseAssets"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_ServiceBasedRSUsMember" xlink:label="etnb_ServiceBasedRSUsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockTransactionDate" xlink:label="us-gaap_SaleOfStockTransactionDate"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventLineItems" xlink:label="us-gaap_SubsequentEventLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities" xlink:label="us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets" xlink:label="us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingStandardsUpdate201602Member" xlink:label="us-gaap_AccountingStandardsUpdate201602Member"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StateAndLocalJurisdictionMember" xlink:label="us-gaap_StateAndLocalJurisdictionMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtNoncurrent" xlink:label="us-gaap_LongTermDebtNoncurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="us-gaap_EarningsPerShareDiluted"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_ScheduleOfPrepaidAndOtherCurrentAssetsTableTextBlock" xlink:label="etnb_ScheduleOfPrepaidAndOtherCurrentAssetsTableTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_PeriodForIncreaseInNumberOfSharesOfCommonStockReservedForIssuance" xlink:label="etnb_PeriodForIncreaseInNumberOfSharesOfCommonStockReservedForIssuance"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_TaxCreditCarryforwardExpirationYear" xlink:label="etnb_TaxCreditCarryforwardExpirationYear"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentMaturityDateDescription" xlink:label="us-gaap_DebtInstrumentMaturityDateDescription"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightTable" xlink:label="us-gaap_ClassOfWarrantOrRightTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:label="us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValue" xlink:label="us-gaap_PreferredStockValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeasePaymentsUse" xlink:label="us-gaap_OperatingLeasePaymentsUse"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability" xlink:label="us-gaap_OperatingLeaseLiability"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_CA" xlink:label="stpr_CA"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignGovernmentDebtSecuritiesMember" xlink:label="us-gaap_ForeignGovernmentDebtSecuritiesMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_IncomeTaxReconciliationChangeInEffectiveTaxRateDueToReorganization" xlink:label="etnb_IncomeTaxReconciliationChangeInEffectiveTaxRateDueToReorganization"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:label="us-gaap_BalanceSheetRelatedDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationTechniqueDomain" xlink:label="us-gaap_ValuationTechniqueDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_ProceedsFromIssuancePublicOfferingAtTheMarketOffering" xlink:label="etnb_ProceedsFromIssuancePublicOfferingAtTheMarketOffering"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightLineItems" xlink:label="us-gaap_ClassOfWarrantOrRightLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain" xlink:label="srt_SegmentGeographicalDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember" xlink:label="srt_RangeMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_StockIssuedDuringPeriodValueWarrantsExercised" xlink:label="etnb_StockIssuedDuringPeriodValueWarrantsExercised"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorLocation" xlink:label="dei_AuditorLocation"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="us-gaap_SubsequentEventsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresTextBlock" xlink:label="us-gaap_FairValueDisclosuresTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_TaxableIncomeUtilizationPercentage" xlink:label="etnb_TaxableIncomeUtilizationPercentage"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossTaxAbstract" xlink:label="us-gaap_OtherComprehensiveIncomeLossTaxAbstract"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_SanFranciscoOfficeMember" xlink:label="etnb_SanFranciscoOfficeMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:label="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_PaymentForPurchaseOfAvailableForSaleSecurities" xlink:label="etnb_PaymentForPurchaseOfAvailableForSaleSecurities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidTaxes" xlink:label="us-gaap_PrepaidTaxes"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputExpectedDividendPaymentMember" xlink:label="us-gaap_MeasurementInputExpectedDividendPaymentMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskCreditRisk" xlink:label="us-gaap_ConcentrationRiskCreditRisk"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:label="us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:label="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:label="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_AccruedResearchAndDevelopmentExpenseCurrent" xlink:label="etnb_AccruedResearchAndDevelopmentExpenseCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsAndShortTermInvestments" xlink:label="us-gaap_CashCashEquivalentsAndShortTermInvestments"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalBalanceSheetDisclosuresTextBlock" xlink:label="us-gaap_SupplementalBalanceSheetDisclosuresTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsTextBlock" xlink:label="us-gaap_SubsequentEventsTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashEquivalentsMember" xlink:label="us-gaap_CashEquivalentsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:label="us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateDebtSecuritiesMember" xlink:label="us-gaap_CorporateDebtSecuritiesMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpenseMember" xlink:label="us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain" xlink:label="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_StockIssuedDuringPeriodValueCashlessExerciseOfWarrants" xlink:label="etnb_StockIssuedDuringPeriodValueCashlessExerciseOfWarrants"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialPaperMember" xlink:label="us-gaap_CommercialPaperMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Depreciation" xlink:label="us-gaap_Depreciation"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_SellingCommissionPerSharesSoldPercentage" xlink:label="etnb_SellingCommissionPerSharesSoldPercentage"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="us-gaap_OtherAssetsNoncurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_CommonStockAndWarrantsCombinedOfferingPricePerShare" xlink:label="etnb_CommonStockAndWarrantsCombinedOfferingPricePerShare"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromLinesOfCredit" xlink:label="us-gaap_ProceedsFromLinesOfCredit"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalCashFlowInformationAbstract" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_PrefundedAndCommonStockWarrants" xlink:label="etnb_PrefundedAndCommonStockWarrants"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentPolicyTextBlock" xlink:label="us-gaap_InvestmentPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockLineItems" xlink:label="us-gaap_SubsidiarySaleOfStockLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="us-gaap_IncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:label="us-gaap_IncreaseDecreaseInOperatingLeaseLiability"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_EightyNineBioManagementIncorporationMember" xlink:label="etnb_EightyNineBioManagementIncorporationMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="us-gaap_PreferredStockSharesIssued"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain" xlink:label="us-gaap_BalanceSheetLocationDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAccruedLiabilitiesCurrent" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_ShareBasedCompensationArrangementByShareBasedPaymentFirstOfferingPeriodCommencementDate" xlink:label="etnb_ShareBasedCompensationArrangementByShareBasedPaymentFirstOfferingPeriodCommencementDate"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdoptionDate" xlink:label="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdoptionDate"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USTreasuryBillSecuritiesMember" xlink:label="us-gaap_USTreasuryBillSecuritiesMember"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_WarrantTermLoanMember" xlink:label="etnb_WarrantTermLoanMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughTwoYearsFairValue" xlink:label="etnb_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughTwoYearsFairValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:label="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_MaximumAmountOfEquitySharesIssuable" xlink:label="etnb_MaximumAmountOfEquitySharesIssuable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorName" xlink:label="dei_AuditorName"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract" xlink:label="us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock" xlink:label="us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss" xlink:label="us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalCommonStock" xlink:label="us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAward" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAward"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedProfessionalFeesCurrent" xlink:label="us-gaap_AccruedProfessionalFeesCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantDateFairValue" xlink:label="etnb_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantDateFairValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpenses" xlink:label="us-gaap_OperatingExpenses"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_TevasDevelopmentProgramMember" xlink:label="etnb_TevasDevelopmentProgramMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:label="us-gaap_CurrentStateAndLocalTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_IcfrAuditorAttestationFlag" xlink:label="dei_IcfrAuditorAttestationFlag"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrimeRateMember" xlink:label="us-gaap_PrimeRateMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockDescriptionOfTransaction" xlink:label="us-gaap_SaleOfStockDescriptionOfTransaction"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsMember" xlink:label="us-gaap_OtherAssetsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_UnderwritingDiscountsAndCommissions" xlink:label="etnb_UnderwritingDiscountsAndCommissions"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_RemeasurementOfLeaseLiabilityAndRightOfUseAssetInConnectionWithLeaseModification" xlink:label="etnb_RemeasurementOfLeaseLiabilityAndRightOfUseAssetInConnectionWithLeaseModification"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_IncomeTaxDisclosureLineItems" xlink:label="etnb_IncomeTaxDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermInvestmentsMember" xlink:label="us-gaap_ShortTermInvestmentsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_EffectiveIncomeTaxRateReconciliationStateDeferredTaxTrueUpDueToChangeInApportionment" xlink:label="etnb_EffectiveIncomeTaxRateReconciliationStateDeferredTaxTrueUpDueToChangeInApportionment"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="us-gaap_IncomeStatementLocationAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue" xlink:label="us-gaap_CommonStockValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:label="us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:label="us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_TwoThousandAndTwentyEquityIncentivePlanMember" xlink:label="etnb_TwoThousandAndTwentyEquityIncentivePlanMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesDomain" xlink:label="srt_ConsolidatedEntitiesDomain"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_FairValueOfWarrantsAssumptionsDividends" xlink:label="etnb_FairValueOfWarrantsAssumptionsDividends"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfAdoptionMember" xlink:label="us-gaap_TypeOfAdoptionMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromWarrantExercises" xlink:label="us-gaap_ProceedsFromWarrantExercises"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredFinanceCostsGross" xlink:label="us-gaap_DeferredFinanceCostsGross"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_ScheduleOfCommonStockReservedForIssuanceTableTextBlock" xlink:label="etnb_ScheduleOfCommonStockReservedForIssuanceTableTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_MilestonePayment" xlink:label="etnb_MilestonePayment"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="us-gaap_OperatingExpensesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract" xlink:label="etnb_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputPriceVolatilityMember" xlink:label="us-gaap_MeasurementInputPriceVolatilityMember"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract" xlink:label="etnb_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentFederalTaxExpenseBenefit" xlink:label="us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_WarrantsAndRightsOutstandingMaturityDateDescription" xlink:label="etnb_WarrantsAndRightsOutstandingMaturityDateDescription"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfStockByClassTable" xlink:label="us-gaap_ScheduleOfStockByClassTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:label="us-gaap_DeferredFederalIncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_TwoThousandAndNineteenEquityIncentivePlanMember" xlink:label="etnb_TwoThousandAndNineteenEquityIncentivePlanMember"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_IncomeTaxDisclosureTable" xlink:label="etnb_IncomeTaxDisclosureTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchMember" xlink:label="us-gaap_ResearchMember"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_OtherRisksAndUncertaintiesPolicyTextBlock" xlink:label="etnb_OtherRisksAndUncertaintiesPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseAndRentalExpense" xlink:label="us-gaap_LeaseAndRentalExpense"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:label="us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_ScheduleOfEffectiveIncomeTaxRateOfCompanyAndSubsidiariesTableTextBlock" xlink:label="etnb_ScheduleOfEffectiveIncomeTaxRateOfCompanyAndSubsidiariesTableTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_AssetTransferAndLicenseAgreementInitialNonrefundableUpfrontPayment" xlink:label="etnb_AssetTransferAndLicenseAgreementInitialNonrefundableUpfrontPayment"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityInterestRateDescription" xlink:label="us-gaap_LineOfCreditFacilityInterestRateDescription"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_WarrantTermLoanOneMember" xlink:label="etnb_WarrantTermLoanOneMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationTechniqueOptionPricingModelMember" xlink:label="us-gaap_ValuationTechniqueOptionPricingModelMember"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfWithholdingTaxes" xlink:label="etnb_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfWithholdingTaxes"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment" xlink:label="us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:label="us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="us-gaap_AdditionalPaidInCapitalMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:label="us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityExpirationDate1" xlink:label="us-gaap_LineOfCreditFacilityExpirationDate1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:label="us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:label="us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareTextBlock" xlink:label="us-gaap_EarningsPerShareTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentMaturityDate" xlink:label="us-gaap_DebtInstrumentMaturityDate"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation" xlink:label="us-gaap_ShareBasedCompensation"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_PrepaidResearchAndDevelopmentCurrent" xlink:label="etnb_PrepaidResearchAndDevelopmentCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentUnamortizedDiscount" xlink:label="us-gaap_DebtInstrumentUnamortizedDiscount"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_ShareBasedCompensationArrangementByShareBasedPaymentAwardRemainingOptionsVestingPeriod" xlink:label="etnb_ShareBasedCompensationArrangementByShareBasedPaymentAwardRemainingOptionsVestingPeriod"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:label="us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayable" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_StockIssuedDuringPeriodSharesWarrantsExercised" xlink:label="etnb_StockIssuedDuringPeriodSharesWarrantsExercised"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:label="us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:label="us-gaap_FairValueMeasurementPolicyPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_WarrantsToPurchaseCommonStockPolicyTextBlock" xlink:label="etnb_WarrantsToPurchaseCommonStockPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_PreFundedWarrantsMember" xlink:label="etnb_PreFundedWarrantsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis" xlink:label="srt_StatementGeographicalAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType" xlink:label="dei_DocumentType"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestPaidNet" xlink:label="us-gaap_InterestPaidNet"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_UnvestedRestrictedStockUnitsMember" xlink:label="etnb_UnvestedRestrictedStockUnitsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_US" xlink:label="country_US"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_LT" xlink:label="country_LT"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_StockIssuedDuringPeriodSharesCashlessExerciseOfWarrants" xlink:label="etnb_StockIssuedDuringPeriodSharesCashlessExerciseOfWarrants"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:label="us-gaap_DebtInstrumentInterestRateDuringPeriod"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesLineItems" xlink:label="us-gaap_LossContingenciesLineItems"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_TwoThousandAndTwentyOneLoanAgreementMember" xlink:label="etnb_TwoThousandAndTwentyOneLoanAgreementMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockLineItems" xlink:label="us-gaap_ClassOfStockLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_DeferredTaxAssetsLeaseLiability" xlink:label="etnb_DeferredTaxAssetsLeaseLiability"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_DebtInstrumentEarlyPrepaymentFee" xlink:label="etnb_DebtInstrumentEarlyPrepaymentFee"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_TermLoanCurrent" xlink:label="etnb_TermLoanCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputExpectedTermMember" xlink:label="us-gaap_MeasurementInputExpectedTermMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:label="us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_NumberOfSharesIssuableUnderShareBasedPaymentArrangement" xlink:label="etnb_NumberOfSharesIssuableUnderShareBasedPaymentArrangement"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConsolidationPolicyTextBlock" xlink:label="us-gaap_ConsolidationPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantMember" xlink:label="us-gaap_WarrantMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="us-gaap_CommonStockSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:label="us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="us-gaap_FairValueInputsLevel2Member"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="us-gaap_CommitmentsAndContingencies"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued" xlink:label="us-gaap_CommonStockSharesIssued"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_TevaAgreementMember" xlink:label="etnb_TevaAgreementMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateDomain" xlink:label="us-gaap_VariableRateDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_NumberOfPrefundedWarrantsIssuedDuringPeriod" xlink:label="etnb_NumberOfPrefundedWarrantsIssuedDuringPeriod"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashCurrent" xlink:label="us-gaap_RestrictedCashCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeasesPolicyTextBlock" xlink:label="us-gaap_LesseeLeasesPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:label="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxCreditCarryforwardAxis" xlink:label="us-gaap_TaxCreditCarryforwardAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="us-gaap_AccruedLiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis" xlink:label="us-gaap_DebtInstrumentAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="us-gaap_StockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableLeasePayment" xlink:label="us-gaap_VariableLeasePayment"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentForeignTaxExpenseBenefit" xlink:label="us-gaap_CurrentForeignTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:label="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_OtherNonCurrentLiability" xlink:label="etnb_OtherNonCurrentLiability"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember" xlink:label="us-gaap_SubsequentEventMember"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_AssetTransferAndLicenseAgreementTerminationPeriodNoticeOfFailure" xlink:label="etnb_AssetTransferAndLicenseAgreementTerminationPeriodNoticeOfFailure"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RealizedInvestmentGainsLosses" xlink:label="us-gaap_RealizedInvestmentGainsLosses"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsGross" xlink:label="us-gaap_DeferredTaxAssetsGross"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesTable" xlink:label="us-gaap_LossContingenciesTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:label="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_AgencyDiscountSecuritiesMember" xlink:label="etnb_AgencyDiscountSecuritiesMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="us-gaap_ResearchAndDevelopmentExpense"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:label="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantsAndRightsOutstandingMaturityDate" xlink:label="us-gaap_WarrantsAndRightsOutstandingMaturityDate"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_ObligationToPaymentUponMaximumAchievementOfCertainClinicalAndCommercialMilestones" xlink:label="etnb_ObligationToPaymentUponMaximumAchievementOfCertainClinicalAndCommercialMilestones"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_TermBLoanFacilityMember" xlink:label="etnb_TermBLoanFacilityMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis" xlink:label="us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_LoanAndSecurityAgreementMember" xlink:label="etnb_LoanAndSecurityAgreementMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTable" xlink:label="us-gaap_SubsequentEventTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="us-gaap_GeneralAndAdministrativeExpense"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_ShortTermAvailableForSaleSecuritiesCurrent" xlink:label="etnb_ShortTermAvailableForSaleSecuritiesCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputTypeDomain" xlink:label="us-gaap_MeasurementInputTypeDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_EquityIncentivePlanMember" xlink:label="etnb_EquityIncentivePlanMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember" xlink:label="us-gaap_RetainedEarningsMember"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_TwentyTwentyThreeLoanAgreementMember" xlink:label="etnb_TwentyTwentyThreeLoanAgreementMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxCreditCarryforwardNameDomain" xlink:label="us-gaap_TaxCreditCarryforwardNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_AssetTransferAndLicenseAgreementTerminationNoticePeriodIfBankruptcyPetitionFiled" xlink:label="etnb_AssetTransferAndLicenseAgreementTerminationNoticePeriodIfBankruptcyPetitionFiled"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MoneyMarketFundsMember" xlink:label="us-gaap_MoneyMarketFundsMember"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_ShareBasedCompensationArrangementByShareBasedPaymentAwardAnniversary" xlink:label="etnb_ShareBasedCompensationArrangementByShareBasedPaymentAwardAnniversary"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputTypeAxis" xlink:label="us-gaap_MeasurementInputTypeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis" xlink:label="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_StockAndWarrantsIssuedDuringPeriodSharesNewIssues" xlink:label="etnb_StockAndWarrantsIssuedDuringPeriodSharesNewIssues"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLossCarryforwardsLimitationsOnUse" xlink:label="us-gaap_OperatingLossCarryforwardsLimitationsOnUse"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseholdImprovementsMember" xlink:label="us-gaap_LeaseholdImprovementsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_SummaryOfSignificantAccountingPoliciesLineItems" xlink:label="etnb_SummaryOfSignificantAccountingPoliciesLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefits" xlink:label="us-gaap_UnrecognizedTaxBenefits"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IPOMember" xlink:label="us-gaap_IPOMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesAxis" xlink:label="srt_ConsolidatedEntitiesAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MunicipalBondsMember" xlink:label="us-gaap_MunicipalBondsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease" xlink:label="us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="us-gaap_IncomeStatementLocationDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputRiskFreeInterestRateMember" xlink:label="us-gaap_MeasurementInputRiskFreeInterestRateMember"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_UABEightyNineBioLithuaniaMember" xlink:label="etnb_UABEightyNineBioLithuaniaMember"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_TrancheTwoAndThreeMember" xlink:label="etnb_TrancheTwoAndThreeMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesOutstanding" xlink:label="us-gaap_SharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationDateOfIncorporation" xlink:label="dei_EntityIncorporationDateOfIncorporation"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="us-gaap_DebtInstrumentNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="us-gaap_ClassOfWarrantOrRightAxis"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_TermALoanFacilityMember" xlink:label="etnb_TermALoanFacilityMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestAndOtherIncome" xlink:label="us-gaap_InterestAndOtherIncome"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic" xlink:label="us-gaap_EarningsPerShareBasic"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherPrepaidExpenseCurrent" xlink:label="us-gaap_OtherPrepaidExpenseCurrent"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_TemporaryEquityIssuanceCosts" xlink:label="etnb_TemporaryEquityIssuanceCosts"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract" xlink:label="us-gaap_AssetsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAnnualPrincipalPayment" xlink:label="us-gaap_DebtInstrumentAnnualPrincipalPayment"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:label="us-gaap_DeferredTaxAssetsLiabilitiesNet"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherThanTemporaryImpairmentLossDebtSecuritiesPortionRecognizedInEarnings" xlink:label="us-gaap_OtherThanTemporaryImpairmentLossDebtSecuritiesPortionRecognizedInEarnings"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="us-gaap_FinancialInstrumentAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityAxis" xlink:label="us-gaap_IncomeTaxAuthorityAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationTechniqueAxis" xlink:label="us-gaap_ValuationTechniqueAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsNet" xlink:label="us-gaap_DeferredTaxAssetsNet"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss" xlink:label="us-gaap_ProfitLoss"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_DebtInstrumentFinalPaymentFee" xlink:label="etnb_DebtInstrumentFinalPaymentFee"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="us-gaap_AssetsCurrentAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_AmortizationOfDebtIssuanceCostsAndAccretionOfFinalPaymentFee" xlink:label="etnb_AmortizationOfDebtIssuanceCostsAndAccretionOfFinalPaymentFee"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="us-gaap_PayablesAndAccrualsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:label="us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_WarrantPublicOfferingsMember" xlink:label="etnb_WarrantPublicOfferingsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfWithholdingTaxes" xlink:label="etnb_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfWithholdingTaxes"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_TevasGlycoPEGylatedFGF21ProgramMember" xlink:label="etnb_TevasGlycoPEGylatedFGF21ProgramMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseRemainingLeaseTerm" xlink:label="us-gaap_LesseeOperatingLeaseRemainingLeaseTerm"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_SummaryOfAvailableCarryforwardTaxLossesAndCredits" xlink:label="etnb_SummaryOfAvailableCarryforwardTaxLossesAndCredits"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfOtherLongTermDebt" xlink:label="us-gaap_ProceedsFromIssuanceOfOtherLongTermDebt"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="us-gaap_LiabilitiesCurrentAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_PerformanceRSUsMember" xlink:label="etnb_PerformanceRSUsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:label="us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UseOfEstimates" xlink:label="us-gaap_UseOfEstimates"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:label="us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilities" xlink:label="us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentMeasurementInput" xlink:label="us-gaap_DebtInstrumentMeasurementInput"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:label="us-gaap_SegmentReportingPolicyPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_OperatingLeaseExpirationMonthAndYear" xlink:label="etnb_OperatingLeaseExpirationMonthAndYear"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_SummaryOfSignificantAccountingPoliciesTable" xlink:label="etnb_SummaryOfSignificantAccountingPoliciesTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCountryMember" xlink:label="us-gaap_ForeignCountryMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USGovernmentAgenciesShorttermDebtSecuritiesMember" xlink:label="us-gaap_USGovernmentAgenciesShorttermDebtSecuritiesMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentCarryingAmount" xlink:label="us-gaap_DebtInstrumentCarryingAmount"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="us-gaap_CommonStockSharesAuthorized"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_DeferredTaxAssets" xlink:label="etnb_DeferredTaxAssets"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="us-gaap_SubsequentEventTypeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOther" xlink:label="us-gaap_DeferredTaxAssetsOther"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:label="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_SaleOfStockPercentageOfBeneficialOwnershipLimitationBeforeTransaction" xlink:label="etnb_SaleOfStockPercentageOfBeneficialOwnershipLimitationBeforeTransaction"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis" xlink:label="us-gaap_BalanceSheetLocationAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityAverageOutstandingAmount" xlink:label="us-gaap_LineOfCreditFacilityAverageOutstandingAmount"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent" xlink:label="us-gaap_AccountsPayableCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_StockAndWarrantsIssuedDuringPeriodValueNewIssues" xlink:label="etnb_StockAndWarrantsIssuedDuringPeriodValueNewIssues"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameAxis" xlink:label="us-gaap_PlanNameAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualAxis" xlink:label="srt_TitleOfIndividualAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:label="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTerm" xlink:label="us-gaap_DebtInstrumentTerm"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:label="us-gaap_ComprehensiveIncomePolicyPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_DeferredTaxAssetsTaxCreditCarryforwardsResearchFederal" xlink:label="etnb_DeferredTaxAssetsTaxCreditCarryforwardsResearchFederal"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_TrancheFourMember" xlink:label="etnb_TrancheFourMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives" xlink:label="us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtTextBlock" xlink:label="us-gaap_LongTermDebtTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_PercentageOfFeeOnLoan" xlink:label="etnb_PercentageOfFeeOnLoan"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_AccruedResearchAndDevelopmentExpensesPolicyTextBlock" xlink:label="etnb_AccruedResearchAndDevelopmentExpensesPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_IL" xlink:label="country_IL"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:label="us-gaap_NoncashInvestingAndFinancingItemsAbstract"/>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, City or Town</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, City or Town</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary of Reconciliation of Income Tax (Expense) Benefit Statutory Tax Rate to Effective Tax Rate</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityExTransitionPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Ex Transition Period</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityExTransitionPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Ex Transition Period</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueDisclosuresAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value Disclosures [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_PrepaymentFeePercentage_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Prepayment fee percentage</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_PrepaymentFeePercentage_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Prepayment Fee Percentage</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_PrepaymentFeePercentage_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Prepayment fee percentage.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EarningsPerShareAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Earnings Per Share [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueInputsLevel1Member_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Level 1</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueInputsLevel1Member_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value, Inputs, Level 1 [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Accrued Expenses</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Accrued Liabilities [Table Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DomesticCountryMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Federal</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DomesticCountryMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Domestic Tax Authority [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxReconciliationNondeductibleExpenseResearchAndDevelopment_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Research and development credits, net of uncertain tax position</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxReconciliationNondeductibleExpenseResearchAndDevelopment_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Effective Income Tax Rate Reconciliation, Nondeductible Expense, Research and Development, Amount</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Issuance of common stock</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Stock Issued During Period, Value, New Issues</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ResearchAndDevelopmentExpensePolicy_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Research and Development Expenses</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ResearchAndDevelopmentExpensePolicy_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Research and Development Expense, Policy [Policy Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cash flows from financing activities:</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Net Cash Provided by (Used in) Financing Activities [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Expected dividend</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseDiscountRate_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Incremental borrowing rate used to determine operating lease liability</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseDiscountRate_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lessee, Operating Lease, Discount Rate</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_AmendmentFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amendment Flag</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_AmendmentFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Amendment Flag</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Estimated total grant date fair value of options vested</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested in Period, Fair Value</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_BeneficialOwnershipLimitationOnExerciseOfWarrant_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Beneficial ownership limitation on exercise of warrant.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_BeneficialOwnershipLimitationOnExerciseOfWarrant_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Beneficial Ownership Limitation On Exercise Of Warrant</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_BeneficialOwnershipLimitationOnExerciseOfWarrant_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Percentage of ownership limitation</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SubsequentEventTypeDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Subsequent Event Type [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_ExecutiveOfficerMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Executive Officer</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_ExecutiveOfficerMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Executive Officer [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Operating lease right-of-use asset</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Lease, Right-of-Use Asset</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentTable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Debt Instrument [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Long-Term Debt Instruments [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedPaymentArrangementEmployeeMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Employee</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedPaymentArrangementEmployeeMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Payment Arrangement, Employee [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Less: imputed interest</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lessee, Operating Lease, Liability, Undiscounted Excess Amount</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_UnderwrittenPublicOfferingMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Underwritten public offering</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_UnderwrittenPublicOfferingMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Underwritten Public Offering [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_UnderwrittenPublicOfferingMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Underwritten Public Offering [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Basic and Diluted Net Loss per Share</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Earnings Per Share, Policy [Policy Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StatementTable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Statement [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StatementTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Statement [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Operating lease liability, non-current</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Lease, Liability, Noncurrent</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Unrecognized tax benefits impact effective tax rate</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Unrecognized Tax Benefits that Would Impact Effective Tax Rate</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Issuance of common stock upon ESPP purchase, Shares</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Stock Issued During Period, Shares, Employee Stock Purchase Plans</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_AccumulatedTaxLossCarryForward_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accumulated tax loss carryforward</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_AccumulatedTaxLossCarryForward_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accumulated Tax Loss Carry Forward</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_AccumulatedTaxLossCarryForward_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Accumulated tax loss carry forward.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NumberOfOperatingSegments_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Number of operating segments</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NumberOfOperatingSegments_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Number of Operating Segments</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Preferred Stock, Shares Outstanding, Ending Balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Preferred Stock, Shares Outstanding, Beginning Balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Preferred stock, shares outstanding</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Preferred Stock, Shares Outstanding</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_ProceedsFromIssuancePublicOffering_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Proceeds from issuance of common stock and warrants in public offering, net of issuance costs</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_ProceedsFromIssuancePublicOffering_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Proceeds From Issuance Public Offering</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_ProceedsFromIssuancePublicOffering_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Proceeds from issuance public offering.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Total available for future issuance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock, Capital Shares Reserved for Future Issuance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_AuditorFirmId_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Auditor Firm ID</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_AuditorFirmId_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Auditor Firm ID</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Weighted Average Grant Date Fair Value Outstanding, Ending Balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted Average Grant Date Fair Value Outstanding, Beginning Balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value, Beginning Balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted Average Grant Date Fair Value Outstanding, Vested/Released</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_TwoThousandAndTwentyThreeLoanAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2023 Loan Agreement</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_TwoThousandAndTwentyThreeLoanAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Two Thousand and Twenty Three Loan Agreement [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_TwoThousandAndTwentyThreeLoanAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Two thousand and twenty three loan agreement.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_AssetTransferAndLicenseAgreementTerminationPeriodAfterWrittenNotice_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Asset transfer and license agreement, termination period after written notice</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_AssetTransferAndLicenseAgreementTerminationPeriodAfterWrittenNotice_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Asset Transfer And License Agreement Termination Period After Written Notice</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_AssetTransferAndLicenseAgreementTerminationPeriodAfterWrittenNotice_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Asset transfer and license agreement termination period after written notice.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxAuthorityDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Income Tax Authority [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EmployeeStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Employee Stock Purchase Plan</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EmployeeStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">ESPP Purchases</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EmployeeStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Employee Stock [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Employee-related Liabilities, Current, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accrued employee and related expenses</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Employee-related Liabilities, Current</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EmployeeStockOptionMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stock Options to Purchase Common Stock</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EmployeeStockOptionMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Payment Arrangement, Option [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total liabilities and stockholders&#8217; equity</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Liabilities and Equity</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_PercentageOfIncreaseInNumberOfSharesOfCapitalStockIssuedAndOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Percentage of increase in number of shares of capital stock issued and outstanding</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_PercentageOfIncreaseInNumberOfSharesOfCapitalStockIssuedAndOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Percentage Of Increase In Number Of Shares Of Capital Stock Issued And Outstanding</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_PercentageOfIncreaseInNumberOfSharesOfCapitalStockIssuedAndOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Percentage of increase in number of shares of capital stock reserved for issuance.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PlanNameDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Plan Name</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PlanNameDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Plan Name [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PriorPeriodReclassificationAdjustmentDescription_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Reclassification</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PriorPeriodReclassificationAdjustmentDescription_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Reclassification, Comparability Adjustment [Policy Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_ATMFacilityMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">A T M Facility</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_ATMFacilityMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">A T M Facility [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_ATMFacilityMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">ATM facility.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredForeignIncomeTaxExpenseBenefit_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Foreign</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredForeignIncomeTaxExpenseBenefit_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Foreign</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredForeignIncomeTaxExpenseBenefit_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Foreign Income Tax Expense (Benefit)</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Change in accounting principle, accounting standards update, adopted [true false]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Change in Accounting Principle, Accounting Standards Update, Adopted [true false]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Incorporation, State or Country Code</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Incorporation, State or Country Code</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeStatementAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Income Statement [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxReconciliationOtherAdjustments_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxReconciliationOtherAdjustments_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Effective Income Tax Rate Reconciliation, Other Adjustments, Amount</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Subsidiary Or Equity Method Investee Sale Of Stock By Subsidiary Or Equity Investee [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Subsidiary or Equity Method Investee, Sale of Stock by Subsidiary or Equity Investee [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Organization and Basis of Presentation</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Sale of Stock</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Sale of Stock [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilitiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total current liabilities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilitiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Liabilities, Current</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Issuance of common stock upon ESPP purchase</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Stock Issued During Period, Value, Employee Stock Purchase Plan</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2025</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lessee, Operating Lease, Liability, to be Paid, Year Three</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_IssuanceOfCommonStockWarrantsInConnectionWithDebtFinancing_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Issuance Of Common Stock Warrants In Connection With Debt Financing</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_IssuanceOfCommonStockWarrantsInConnectionWithDebtFinancing_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Issuance Of Common Stock Warrants In Connection With Debt Financing</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_IssuanceOfCommonStockWarrantsInConnectionWithDebtFinancing_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Issuance of common stock warrant in connection with debt financing.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueMeasurementsRecurringMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Recurring</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueMeasurementsRecurringMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value, Recurring [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InterestExpense_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Interest expense</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InterestExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Interest expense</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InterestExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Interest Expense</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InterestExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Interest Expense, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShortTermLeaseCost_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Short-term lease costs</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShortTermLeaseCost_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Short-Term Lease, Cost</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Income Taxes</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Income Tax, Policy [Policy Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockSharesAuthorized_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Preferred stock, shares authorized</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockSharesAuthorized_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Preferred Stock, Shares Authorized</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LineOfCreditFacilityDescription_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Line of credit facility, description</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LineOfCreditFacilityDescription_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Line of Credit Facility, Description</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_LineOfCreditFacilityIncreaseInBorrowingCapacity_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Line of credit facility maximum borrowing capacity</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_LineOfCreditFacilityIncreaseInBorrowingCapacity_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Line Of Credit Facility Increase In Borrowing Capacity</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_LineOfCreditFacilityIncreaseInBorrowingCapacity_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Line of credit facility increase in borrowing capacity.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule Of Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary of Income Tax (Expense) Benefit</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_AmortizationPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amortization period</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_AmortizationPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Amortization Period</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_AmortizationPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Amortization period</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_VariableRateAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Variable Rate</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_VariableRateAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Variable Rate [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntitySmallBusiness_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Small Business</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntitySmallBusiness_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Small Business</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total cash and cash equivalents, and restricted cash</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Cash and cash equivalents, and restricted cash at beginning of period</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Cash and cash equivalents, and restricted cash at end of period</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TypeOfArrangementAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Collaborative Arrangement and Arrangement Other than Collaborative</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TypeOfArrangementAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Collaborative Arrangement and Arrangement Other than Collaborative [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_NetCashProceedsFromSaleOfEquitySecurities_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Proceeds from sale of available-for-sale securities, equity</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_NetCashProceedsFromSaleOfEquitySecurities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Net Cash Proceeds From Sale Of Equity Securities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_NetCashProceedsFromSaleOfEquitySecurities_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Net cash proceeds from sale of equity securities.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_ConvertiblePreferredSharesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Convertible Preferred Shares</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_ConvertiblePreferredSharesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Convertible Preferred Shares [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_ConvertiblePreferredSharesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Convertible preferred shares.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_EightyNineBioLtdMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">89Bio Ltd</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_EightyNineBioLtdMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Eighty Nine Bio Ltd [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_EightyNineBioLtdMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">89Bio Ltd.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AgencySecuritiesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Agency bonds</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AgencySecuritiesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Agency Securities [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_IssuanceOfCommonStockWarrantInConnectionWithTermLoanFacility_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Issuance of common stock warrant in connection with term loan facility</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_IssuanceOfCommonStockWarrantInConnectionWithTermLoanFacility_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Issuance Of Common Stock Warrant In Connection With Term Loan Facility</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_IssuanceOfCommonStockWarrantInConnectionWithTermLoanFacility_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Issuance of common stock warrant in connection with term loan facility.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AssetsCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total current assets</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AssetsCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Assets, Current</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted-average shares used to compute net loss per share, basic</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Weighted Average Number of Shares Outstanding, Basic, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_TrancheOneMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Tranche one</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_TrancheOneMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Tranche One [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_TrancheOneMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Tranche one.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_CityAreaCode_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">City Area Code</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_CityAreaCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label">City Area Code</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Aggregate Intrinsic Value</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Aggregate Intrinsic Value Outstanding</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Aggregate Intrinsic Value Outstanding</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Cancelled and forfeited</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Cancelled shares</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Payment Arrangement [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_Liabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total liabilities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_Liabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Liabilities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Period End Date</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Document Period End Date</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PaymentsOfStockIssuanceCosts_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other offering costs</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PaymentsOfStockIssuanceCosts_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Payments of Stock Issuance Costs</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_ExerciseOfWarrantsAndPreFundedWarrantsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Exercise of warrants and pre-funded warrants member.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_ExerciseOfWarrantsAndPreFundedWarrantsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Exercise Of Warrants And Pre Funded Warrants [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_ExerciseOfWarrantsAndPreFundedWarrantsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Exercise of Warrants and Pre-funded Warrants</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_SVBLeerinkLLCAndCantorFitzgeraldCoMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">SVB Leerink LLC</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_SVBLeerinkLLCAndCantorFitzgeraldCoMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">S V B Leerink L L C And Cantor Fitzgerald Co [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_SVBLeerinkLLCAndCantorFitzgeraldCoMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Svb leerink llc and cantor fitzgerald &amp; co.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stock-based compensation</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-Based Compensation Cost</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted average fair value options granted</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_DeferredTaxLiabilitiesRightsOfUseAssets_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Operating lease right-of-use asset</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_DeferredTaxLiabilitiesRightsOfUseAssets_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Operating lease right-of-use asset</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_DeferredTaxLiabilitiesRightsOfUseAssets_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Liabilities Rights Of Use Assets</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_DeferredTaxLiabilitiesRightsOfUseAssets_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Deferred tax liabilities rights of use assets.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Short-term investments, Amortized Cost</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Securities, Available-for-Sale, Amortized Cost</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_RangeAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Statistical Measurement</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_RangeAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Statistical Measurement [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_ServiceBasedRSUsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Service-based RSUs</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_ServiceBasedRSUsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Service Based R S Us [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_ServiceBasedRSUsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Service-based RSUs member.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SaleOfStockTransactionDate_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Sales Agreement transaction date</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SaleOfStockTransactionDate_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Sale of Stock, Transaction Date</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SubsequentEventLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Subsequent Event [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Proceeds from Sale and Maturity of Debt Securities, Available-for-Sale, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Proceeds from sales and maturities of available-for-sale securities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Proceeds from Sale and Maturity of Debt Securities, Available-for-Sale</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_Assets_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total assets</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_Assets_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Assets</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccountingStandardsUpdate201602Member_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">ASC 842</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccountingStandardsUpdate201602Member_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accounting Standards Update 2016-02 [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StateAndLocalJurisdictionMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">State</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StateAndLocalJurisdictionMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">State and Local Jurisdiction [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LongTermDebtNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Term loan, non-current, net</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LongTermDebtNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Term loan, non-current, net</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LongTermDebtNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Long-Term Debt, Excluding Current Maturities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EarningsPerShareDiluted_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Net loss per share, diluted</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EarningsPerShareDiluted_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Earnings Per Share, Diluted</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EarningsPerShareDiluted_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Earnings Per Share, Diluted, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Outstanding Potentially Dilutive Securities Excluded From Calculation of Diluted Net Loss</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_ScheduleOfPrepaidAndOtherCurrentAssetsTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Prepaid and Other Current Assets</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_ScheduleOfPrepaidAndOtherCurrentAssetsTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule Of Prepaid And Other Current Assets Table [Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_ScheduleOfPrepaidAndOtherCurrentAssetsTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Schedule of prepaid and other current assets.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Postal Zip Code</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Postal Zip Code</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Fiscal Period Focus</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Document Fiscal Period Focus</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_PeriodForIncreaseInNumberOfSharesOfCommonStockReservedForIssuance_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Period for increase in number of shares of common stock reserved for issuance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_PeriodForIncreaseInNumberOfSharesOfCommonStockReservedForIssuance_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Period For Increase In Number Of Shares Of Common Stock Reserved For Issuance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_PeriodForIncreaseInNumberOfSharesOfCommonStockReservedForIssuance_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Period for increase in number of shares of common stock reserved for issuance.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_TaxCreditCarryforwardExpirationYear_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Carryforward tax losses expiration year</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_TaxCreditCarryforwardExpirationYear_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Tax Credit Carryforward Expiration Year</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_TaxCreditCarryforwardExpirationYear_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Tax credit carryforward expiration year.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentMaturityDateDescription_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Debt instrument, maturity date, description</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentMaturityDateDescription_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument, Maturity Date, Description</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ClassOfWarrantOrRightTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Class of Warrant or Right [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CurrentIncomeTaxExpenseBenefit_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel">Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CurrentIncomeTaxExpenseBenefit_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CurrentIncomeTaxExpenseBenefit_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Current Income Tax Expense (Benefit)</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Less: valuation allowance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Deferred tax assets, valuation allowance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets, Valuation Allowance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Preferred stock, $0.001 par value, 10,000,000 shares authorized as of December 31, 2022 and 2021; no shares issued and outstanding as of December 31, 2022 and 2021</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Preferred Stock, Value, Issued</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">APIC, Share-Based Payment Arrangement, Increase for Cost Recognition, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stock-based compensation</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">APIC, Share-Based Payment Arrangement, Increase for Cost Recognition</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeasePaymentsUse_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Cash paid for operating leases</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeasePaymentsUse_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cash paid for operating leases</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeasePaymentsUse_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Lease, Payments, Use</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Present value of operating lease liability</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Lease, Liability</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Operating Lease, Liability, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Net cash provided by financing activities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted Average Grant Date Fair Value</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Present value of operating lease liability</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDue_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total future minimum annual payments</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Leases, Future Minimum Payments Due</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="stpr_CA_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">California</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="stpr_CA_lbl" xlink:role="http://www.xbrl.org/2003/role/label">CALIFORNIA</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StatementOfFinancialPositionAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Statement of Financial Position [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ForeignGovernmentDebtSecuritiesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Non-US debt securities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ForeignGovernmentDebtSecuritiesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Security, Government, Non-US [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityFileNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity File Number</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityFileNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Securities Act File Number</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_IncomeTaxReconciliationChangeInEffectiveTaxRateDueToReorganization_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Change in Israel effective tax rate due to the 2019 reorganization</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_IncomeTaxReconciliationChangeInEffectiveTaxRateDueToReorganization_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Income Tax Reconciliation Change In Effective Tax Rate Due To Reorganization</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_IncomeTaxReconciliationChangeInEffectiveTaxRateDueToReorganization_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Income tax reconciliation change in effective tax rate due to reorganization.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StatementOfCashFlowsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Statement of Cash Flows [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BalanceSheetRelatedDisclosuresAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Balance Sheet Related Disclosures [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ValuationTechniqueDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Valuation Approach and Technique</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ValuationTechniqueDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Valuation Approach and Technique [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Warrants to purchase shares of common stock</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Warrants to purchase common stock</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Class of Warrant or Right, Number of Securities Called by Warrants or Rights</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_ProceedsFromIssuancePublicOfferingAtTheMarketOffering_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Proceeds from issuance public offering at the market offering.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_ProceedsFromIssuancePublicOfferingAtTheMarketOffering_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Proceeds From Issuance Public Offering At The Market Offering</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_ProceedsFromIssuancePublicOfferingAtTheMarketOffering_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Proceeds from issuance of common stock in at-the-market public offering, net of issuance costs</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ClassOfWarrantOrRightLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Class Of Warrant Or Right [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ClassOfWarrantOrRightLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Class of Warrant or Right [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_SegmentGeographicalDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Geographical</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_SegmentGeographicalDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Geographical [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_RangeMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Statistical Measurement</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_RangeMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Statistical Measurement [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SubsidiarySaleOfStockAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Sale of Stock</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SubsidiarySaleOfStockAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Sale of Stock [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Percent of purchase shares of common stock</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Purchase Price of Common Stock, Percent</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_StockIssuedDuringPeriodValueWarrantsExercised_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Stock Issued During Period Value Warrants Exercised</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_StockIssuedDuringPeriodValueWarrantsExercised_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Stock Issued During Period Value Warrants Exercised</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_StockIssuedDuringPeriodValueWarrantsExercised_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Issuance of common stock upon exercise of warrants</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_AuditorLocation_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Auditor Location</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_AuditorLocation_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Auditor Location</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ClassOfStockDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Class of Stock</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ClassOfStockDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Class of Stock [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SubsequentEventsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Subsequent Events [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueDisclosuresTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fair Value Measurements</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueDisclosuresTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value Disclosures [Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_TaxableIncomeUtilizationPercentage_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Taxable income utilization percentage</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_TaxableIncomeUtilizationPercentage_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Taxable Income Utilization Percentage</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_TaxableIncomeUtilizationPercentage_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Taxable income utilization percentage.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted Average Remaining Contractual Term (In years), Exercisable as of December 31, 2022</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Proceeds from issuance of common stock, net of commissions and offering expenses</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Proceeds from issuance of common stock, net of underwriters discount and commissions</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Proceeds from issuance of common stock upon ESPP purchases</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherComprehensiveIncomeLossTaxAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other comprehensive (loss) income:</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherComprehensiveIncomeLossTaxAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Other Comprehensive Income (Loss), Tax [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_SanFranciscoOfficeMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">San Francisco Office</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_SanFranciscoOfficeMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">San Francisco Office [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_SanFranciscoOfficeMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">San Francisco office.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefit_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel">Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefit_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefit_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefit_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Income Tax Expense (Benefit)</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">State research and development credit carryforwards</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets, Tax Credit Carryforwards, Research</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_PaymentForPurchaseOfAvailableForSaleSecurities_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Purchases of available-for-sale securities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_PaymentForPurchaseOfAvailableForSaleSecurities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Payment For Purchase Of Available For Sale Securities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_PaymentForPurchaseOfAvailableForSaleSecurities_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Payment for purchases of available for sale securities.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PrepaidTaxes_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Prepaid taxes</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PrepaidTaxes_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Prepaid Taxes</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_MeasurementInputExpectedDividendPaymentMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Measurement Input, Expected Dividend Payment</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_MeasurementInputExpectedDividendPaymentMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Measurement Input, Expected Dividend Payment [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ConcentrationRiskCreditRisk_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Concentrations of Credit Risk</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ConcentrationRiskCreditRisk_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Concentration Risk, Credit Risk, Policy [Policy Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Antidilutive Securities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Antidilutive Securities [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Proceeds from issuance of common stock upon exercise of stock options</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Proceeds, Issuance of Shares, Share-Based Payment Arrangement, Including Option Exercised, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Proceeds, Issuance of Shares, Share-Based Payment Arrangement, Including Option Exercised</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Line of credit facility, maximum borrowing capacity</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Line of Credit Facility, Maximum Borrowing Capacity</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Outstanding Warrants to Purchase Shares of Common Stock</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Preferred stock, par value</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Preferred Stock, Par or Stated Value Per Share</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Short-term investments, Gross Unrealized Holding Gains</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Gain, before Tax</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_AccruedResearchAndDevelopmentExpenseCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accrued research and development expenses</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_AccruedResearchAndDevelopmentExpenseCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accrued Research And Development Expense Current</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_AccruedResearchAndDevelopmentExpenseCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Accrued research and development expense current.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashCashEquivalentsAndShortTermInvestments_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Cash, Cash Equivalents, and Short-Term Investments, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashCashEquivalentsAndShortTermInvestments_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cash and cash equivalents and short term available-for-sale securities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashCashEquivalentsAndShortTermInvestments_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cash, Cash Equivalents, and Short-Term Investments</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SupplementalBalanceSheetDisclosuresTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Consolidated Balance Sheet Components</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SupplementalBalanceSheetDisclosuresTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Supplemental Balance Sheet Disclosures [Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SubsequentEventsTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Subsequent Events</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SubsequentEventsTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Subsequent Events [Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted-average shares used to compute net loss per share, diluted</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Weighted Average Number of Shares Outstanding, Diluted, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashEquivalentsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cash equivalents</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashEquivalentsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cash Equivalents [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">State income taxes, net of federal benefit</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Total Unrecognised expense</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CorporateDebtSecuritiesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Corporate debt securities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CorporateDebtSecuritiesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Corporate Debt Securities [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_GeneralAndAdministrativeExpenseMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">General and Administrative</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_GeneralAndAdministrativeExpenseMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">General and Administrative Expense [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Research and Development Arrangement, Contract to Perform for Others, Type</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Research and Development Arrangement, Contract to Perform for Others, Type [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_StockIssuedDuringPeriodValueCashlessExerciseOfWarrants_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Stock Issued During Period Value Cashless Exercise Of Warrants.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_StockIssuedDuringPeriodValueCashlessExerciseOfWarrants_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Stock Issued During Period Value Cashless Exercise Of Warrants</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_StockIssuedDuringPeriodValueCashlessExerciseOfWarrants_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Issuance of common stock upon cashless exercise of warrants</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Unrecognized stock option granted under plan</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommercialPaperMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Commercial Paper</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommercialPaperMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Commercial Paper [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Current Fiscal Year End Date</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Current Fiscal Year End Date</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_Depreciation_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Depreciation, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_Depreciation_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Depreciation</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_Depreciation_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Depreciation</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_SellingCommissionPerSharesSoldPercentage_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Selling commission per shares sold percentage</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_SellingCommissionPerSharesSoldPercentage_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Selling Commission Per Shares Sold Percentage</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_SellingCommissionPerSharesSoldPercentage_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Selling commission per shares sold percentage.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Financial Instruments [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherAssetsNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other assets</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherAssetsNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Other Assets, Noncurrent</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line One</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line One</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_CommonStockAndWarrantsCombinedOfferingPricePerShare_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Common stock and warrants combined offering price per share.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_CommonStockAndWarrantsCombinedOfferingPricePerShare_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock And Warrants Combined Offering Price Per Share</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_CommonStockAndWarrantsCombinedOfferingPricePerShare_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Offering price per share</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentAnnualReport_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Annual Report</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentAnnualReport_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Document Annual Report</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromLinesOfCredit_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Line of credit facility fully drawn amount</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromLinesOfCredit_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Proceeds from Lines of Credit</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromLinesOfCredit_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Proceeds from Lines of Credit, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Supplemental disclosures of cash information:</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Supplemental Cash Flow Information [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_PrefundedAndCommonStockWarrants_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Prefunded and common stock warrants.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_PrefundedAndCommonStockWarrants_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Prefunded And Common Stock Warrants</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_PrefundedAndCommonStockWarrants_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Combined price of prefunded and common stock warrant</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InvestmentPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Investments</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InvestmentPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Investment, Policy [Policy Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SubsidiarySaleOfStockLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Subsidiary Sale Of Stock [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SubsidiarySaleOfStockLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Subsidiary, Sale of Stock [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxExpenseBenefit_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel">Income tax (expense) benefit</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxExpenseBenefit_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Income tax (expense) benefit</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxExpenseBenefit_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Income Tax Expense (Benefit), Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxExpenseBenefit_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Income Tax Expense (Benefit)</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInOperatingLeaseLiability_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Operating lease liability</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInOperatingLeaseLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Operating lease liability</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInOperatingLeaseLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Increase (Decrease) in Operating Lease Liability</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_EightyNineBioManagementIncorporationMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">89bio Management, Inc.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_EightyNineBioManagementIncorporationMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Eighty Nine Bio Management Incorporation [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_EightyNineBioManagementIncorporationMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Eighty Nine Bio Management, Inc.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Change in valuation allowance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Income Taxes</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Income Tax Disclosure [Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockSharesIssued_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Preferred stock, shares issued</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockSharesIssued_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Preferred Stock, Shares Issued</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BalanceSheetLocationDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Balance Sheet Location</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BalanceSheetLocationDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Balance Sheet Location [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accrued other expenses</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Other Accrued Liabilities, Current</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Payments to Acquire Property, Plant, and Equipment, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Purchases of property and equipment</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Payments to Acquire Property, Plant, and Equipment</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxDisclosureAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Income Tax Disclosure [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_ShareBasedCompensationArrangementByShareBasedPaymentFirstOfferingPeriodCommencementDate_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Commencement date of first six month offering period</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_ShareBasedCompensationArrangementByShareBasedPaymentFirstOfferingPeriodCommencementDate_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment First Offering Period Commencement Date</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_ShareBasedCompensationArrangementByShareBasedPaymentFirstOfferingPeriodCommencementDate_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Share based compensation arrangement by share based payment first offering period commencement date.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdoptionDate_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Change in accounting principle, accounting standards update, adoption date</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdoptionDate_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Change in Accounting Principle, Accounting Standards Update, Adoption Date</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_USTreasuryBillSecuritiesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">U.S. treasury bills</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_USTreasuryBillSecuritiesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">US Treasury Bill Securities [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_WarrantTermLoanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Warrant term loan member.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_WarrantTermLoanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Warrant Term Loan [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_WarrantTermLoanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Warrants Term Loan</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Shares issued and sold</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Issuance of common stock, shares</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Stock Issued During Period, Shares, New Issues</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughTwoYearsFairValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">After one year through two years</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughTwoYearsFairValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Available For Sale Securities Debt Maturities After One Through Two Years Fair Value</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughTwoYearsFairValue_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Available for sale securities debt maturities after one through two years fair value.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fair Value Hierarchy and NAV</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stock-Based Compensation</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Payment Arrangement [Policy Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_MaximumAmountOfEquitySharesIssuable_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Maximum amount of equity shares issuable.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_MaximumAmountOfEquitySharesIssuable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Maximum Amount Of Equity Shares Issuable</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_MaximumAmountOfEquitySharesIssuable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Maximum amount of equity shares issuable</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_AuditorName_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Auditor Name</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_AuditorName_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Auditor Name</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EquityAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Equity [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Future Minimum Lease Payments Under Non-cancellable Operating Lease Obligations</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Future Minimum Rental Payments for Operating Leases [Table Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted Average Exercise Price, Cancelled and forfeited</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingIncomeLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Operating Income (Loss), Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingIncomeLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Loss from operations</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingIncomeLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Income (Loss)</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdditionalPaidInCapitalCommonStock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Additional paid-in capital</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdditionalPaidInCapitalCommonStock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Additional Paid in Capital, Common Stock</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAward_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Terms of award</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAward_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Terms of Award</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccruedProfessionalFeesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accrued professional and legal fees</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccruedProfessionalFeesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accrued Professional Fees, Current</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ClassOfWarrantOrRightDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Class of Warrant or Right [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityFilerCategory_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Filer Category</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityFilerCategory_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Filer Category</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantDateFairValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Total grant date fair value</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantDateFairValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Sharebased Compensation Arrangement By Sharebased Payment Award Options Grant Date Fair Value</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantDateFairValue_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Sharebased compensation arrangement by sharebased payment award options grant date fair value.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingExpenses_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total operating expenses</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingExpenses_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Expenses</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityCurrentReportingStatus_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Current Reporting Status</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityCurrentReportingStatus_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Current Reporting Status</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_TevasDevelopmentProgramMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Teva's Development Program</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_TevasDevelopmentProgramMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Tevas Development Program [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_TevasDevelopmentProgramMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Tevas development program.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CurrentStateAndLocalTaxExpenseBenefit_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">State</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CurrentStateAndLocalTaxExpenseBenefit_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">State</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CurrentStateAndLocalTaxExpenseBenefit_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Current State and Local Tax Expense (Benefit)</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_IcfrAuditorAttestationFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">ICFR Auditor Attestation Flag</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_IcfrAuditorAttestationFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/label">ICFR Auditor Attestation Flag</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Aggregate Intrinsic Value, Exercisable as of December 31, 2022</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PrimeRateMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Prime Rate</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PrimeRateMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Prime Rate [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SaleOfStockDescriptionOfTransaction_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">ATM Facility description</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SaleOfStockDescriptionOfTransaction_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Public offering description</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SaleOfStockDescriptionOfTransaction_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Sale of Stock, Description of Transaction</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherAssetsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other Assets</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherAssetsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Other Assets [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stockholders' Equity</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Stockholders' Equity Note Disclosure [Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_UnderwritingDiscountsAndCommissions_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Underwriting discounts and commissions.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_UnderwritingDiscountsAndCommissions_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Underwriting Discounts And Commissions</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_UnderwritingDiscountsAndCommissions_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Underwriting discounts and commissions</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockholdersEquity_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total stockholders&#8217; equity</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockholdersEquity_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Beginning balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockholdersEquity_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Ending balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockholdersEquity_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Stockholders' Equity Attributable to Parent</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_RemeasurementOfLeaseLiabilityAndRightOfUseAssetInConnectionWithLeaseModification_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Remeasurement of lease liability and right of use asset in connection with lease modification.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_RemeasurementOfLeaseLiabilityAndRightOfUseAssetInConnectionWithLeaseModification_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Remeasurement Of Lease Liability And Right Of Use Asset In Connection With Lease Modification</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_RemeasurementOfLeaseLiabilityAndRightOfUseAssetInConnectionWithLeaseModification_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Remeasurement of lease liability and right of use asset in connection with lease modification</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_IncomeTaxDisclosureLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Income Tax Disclosure [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_IncomeTaxDisclosureLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Income Tax Disclosure [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_IncomeTaxDisclosureLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Income Tax.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accumulated Other Comprehensive Loss</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">AOCI Attributable to Parent [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShortTermInvestmentsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Short-term available for sale securities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShortTermInvestmentsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Short-Term Investments [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Documents Incorporated by Reference</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Documents Incorporated by Reference [Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Tax Identification Number</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Tax Identification Number</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_EffectiveIncomeTaxRateReconciliationStateDeferredTaxTrueUpDueToChangeInApportionment_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">State deferred tax true-up due to change in apportionment</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_EffectiveIncomeTaxRateReconciliationStateDeferredTaxTrueUpDueToChangeInApportionment_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Effective Income Tax Rate Reconciliation State Deferred Tax True-up Due To Change In Apportionment</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_EffectiveIncomeTaxRateReconciliationStateDeferredTaxTrueUpDueToChangeInApportionment_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Effective income tax rate reconciliation state deferred tax true-up due to change in apportionment.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeStatementLocationAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Income Statement Location</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeStatementLocationAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Income Statement Location [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Cancelled / forfeited</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common stock, $0.001 par value, 100,000,000 shares authorized as of December 31, 2022 and 2021; 50,560,590 and 20,317,204 shares issued and outstanding as of December 31, 2022 and 2021, respectively</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock, Value, Issued</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Retained Earnings (Accumulated Deficit), Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accumulated deficit</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Retained Earnings (Accumulated Deficit)</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Unrealized loss on available-for-sale securities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_lbl" xlink:role="http://www.xbrl.org/2003/role/label">OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Foreign rate differential</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StatementEquityComponentsAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Equity Components</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StatementEquityComponentsAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Equity Components [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_TwoThousandAndTwentyEquityIncentivePlanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2020 Plan</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_TwoThousandAndTwentyEquityIncentivePlanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Two Thousand And Twenty Equity Incentive Plan [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_TwoThousandAndTwentyEquityIncentivePlanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Two thousand and twenty equity incentive plan.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_ConsolidatedEntitiesDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Consolidated Entities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_ConsolidatedEntitiesDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Consolidated Entities [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_FairValueOfWarrantsAssumptionsDividends_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fair value of warrant assumptions, dividends</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_FairValueOfWarrantsAssumptionsDividends_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value Of Warrants Assumptions Dividends</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_FairValueOfWarrantsAssumptionsDividends_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Fair value of warrant assumptions, dividends.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TypeOfAdoptionMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accounting Standards Update [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromWarrantExercises_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Proceeds from issuance of common stock upon exercise of warrants</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromWarrantExercises_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Proceeds from Warrant Exercises</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredFinanceCostsGross_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Debt issuance costs, gross</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredFinanceCostsGross_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Issuance Costs, Gross</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_ScheduleOfCommonStockReservedForIssuanceTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Schedule of common stock reserved for issuance.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_ScheduleOfCommonStockReservedForIssuanceTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule Of Common Stock Reserved For Issuance Table [Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_ScheduleOfCommonStockReservedForIssuanceTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Shares of Common Stock Available for Future Issuance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Emerging Growth Company</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Emerging Growth Company</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_MilestonePayment_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Milestone payments</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_MilestonePayment_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Milestone Payment</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_MilestonePayment_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Milestone payment.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingExpensesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Operating expenses:</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingExpensesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Expenses [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Aggregate Intrinsic Value</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Options Aggregate Intrinsic Value [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Share based compensation arrangement by share based payment award options aggregate intrinsic value.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_MeasurementInputPriceVolatilityMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Measurement Input, Price Volatility</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_MeasurementInputPriceVolatilityMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Measurement Input, Price Volatility [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted Average Remaining Contractual Term (In years)</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Options Weighted Average Remaining Contractual Term [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Share based compensation arrangement by share based payment award options weighted average remaining contractual term.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CurrentFederalTaxExpenseBenefit_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Federal</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CurrentFederalTaxExpenseBenefit_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Federal</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CurrentFederalTaxExpenseBenefit_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Current Federal Tax Expense (Benefit)</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_WarrantsAndRightsOutstandingMaturityDateDescription_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Warrants and rights outstanding maturity date description.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_WarrantsAndRightsOutstandingMaturityDateDescription_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Warrants And Rights Outstanding Maturity Date Description</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_WarrantsAndRightsOutstandingMaturityDateDescription_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Expiration Date</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfStockByClassTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Stock by Class [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Expected term (years)</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityVoluntaryFilers_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Voluntary Filers</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityVoluntaryFilers_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Voluntary Filers</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredFederalIncomeTaxExpenseBenefit_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Federal</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredFederalIncomeTaxExpenseBenefit_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Federal</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredFederalIncomeTaxExpenseBenefit_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Federal Income Tax Expense (Benefit)</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Expected volatility, maximum</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_TwoThousandAndNineteenEquityIncentivePlanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2019 Plan</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_TwoThousandAndNineteenEquityIncentivePlanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Two Thousand And Nineteen Equity Incentive Plan [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_TwoThousandAndNineteenEquityIncentivePlanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">2019 equity incentive plan.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_IncomeTaxDisclosureTable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Income Tax Disclosure [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_IncomeTaxDisclosureTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Income Tax Disclosure [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_IncomeTaxDisclosureTable_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Income Tax.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ResearchMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Research and Development Credit Carryforwards</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ResearchMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Research Tax Credit Carryforward [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_OtherRisksAndUncertaintiesPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other Risks and Uncertainties</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_OtherRisksAndUncertaintiesPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Other Risks And Uncertainties Policy [Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_OtherRisksAndUncertaintiesPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Other risks and uncertainties.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentTransitionReport_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Transition Report</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentTransitionReport_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Document Transition Report</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LeaseAndRentalExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Operating leases, rent expense</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LeaseAndRentalExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Leases, Rent Expense</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary of Loss from Operations Before Taxes on Income</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Income before Income Tax, Domestic and Foreign [Table Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted Average Grant Date Fair Value Outstanding, Granted</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_ScheduleOfEffectiveIncomeTaxRateOfCompanyAndSubsidiariesTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary of Statutory Tax Rates Applicable to Income of Company and Subsidiaries</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_ScheduleOfEffectiveIncomeTaxRateOfCompanyAndSubsidiariesTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule Of Effective Income Tax Rate Of Company And Subsidiaries Table [Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_ScheduleOfEffectiveIncomeTaxRateOfCompanyAndSubsidiariesTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Schedule of effective income tax rate of company and subsidiaries.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_AssetTransferAndLicenseAgreementInitialNonrefundableUpfrontPayment_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Nonrefundable upfront payment</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_AssetTransferAndLicenseAgreementInitialNonrefundableUpfrontPayment_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Asset Transfer And License Agreement Initial Nonrefundable Upfront Payment</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_AssetTransferAndLicenseAgreementInitialNonrefundableUpfrontPayment_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Asset transfer and license agreements initial nonrefundable upfront payment.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LineOfCreditFacilityInterestRateDescription_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Line of credit facility, interest rate description</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LineOfCreditFacilityInterestRateDescription_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Line of Credit Facility, Interest Rate Description</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_WarrantTermLoanOneMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Warrant term loan one member.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_WarrantTermLoanOneMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Warrant Term Loan One [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_WarrantTermLoanOneMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Warrants Term Loan</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Commitments and Contingencies</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Commitments and Contingencies Disclosure [Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted Average Exercise Price, Exercised</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Accumulated Other Comprehensive Income (Loss), Net of Tax, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accumulated other comprehensive loss</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Common Stock, Shares Outstanding</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Common Stock, Shares Outstanding</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTax_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Other comprehensive loss</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTax_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total other comprehensive loss</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTax_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetIncomeLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Net loss</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetIncomeLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Net loss</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetIncomeLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Net Income (Loss) Attributable to Parent</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ValuationTechniqueOptionPricingModelMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Valuation Technique, Option Pricing Model</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ValuationTechniqueOptionPricingModelMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Valuation Technique, Option Pricing Model [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfWithholdingTaxes_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Stock Issued During Period Value Restricted Stock Award Net Of Withholding Taxes.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfWithholdingTaxes_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Stock Issued During Period Value Restricted Stock Award Net Of Withholding Taxes</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfWithholdingTaxes_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Issuance of common stock upon vesting of restricted stock units, net of withholding taxes</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Operating lease liability, current</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Lease, Liability, Current</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Research and development expenses</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets, in Process Research and Development</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary of Financial Assets Measured at Fair Value on Recurring Basis</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdditionalPaidInCapitalMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Additional Paid-in Capital</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdditionalPaidInCapitalMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Additional Paid-in Capital [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Collaborative Arrangement and Arrangement Other than Collaborative</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Collaborative Arrangement and Arrangement Other than Collaborative [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Payment of withholding taxes related to restricted stock units</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Payment of withholding taxes related to restricted stock units</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Payment, Tax Withholding, Share-Based Payment Arrangement</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LineOfCreditFacilityExpirationDate1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Credit facility maturity date</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LineOfCreditFacilityExpirationDate1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Line of Credit Facility, Expiration Date</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Deferred Tax Assets, Operating Loss Carryforwards, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Net operating loss carryforwards</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets, Operating Loss Carryforwards</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Repayment of Principal Amount</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Maturities of Long-Term Debt [Table Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityRegistrantName_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Registrant Name</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityRegistrantName_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Registrant Name</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Foreign currency translation adjustments</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Cash and Cash Equivalents, at Carrying Value, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cash and cash equivalents</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cash and Cash Equivalents, at Carrying Value</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EarningsPerShareTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Net Loss Per Share</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EarningsPerShareTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Earnings Per Share [Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary of Estimated Fair Value of Stock Options Granted Using Black-Scholes Option-Pricing Model</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StatementClassOfStockAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Class of Stock</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StatementClassOfStockAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Class of Stock [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentMaturityDate_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Debt instrument, maturity date</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentMaturityDate_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument, Maturity Date</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensation_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Share-Based Payment Arrangement, Noncash Expense, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensation_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stock-based compensation</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensation_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Payment Arrangement, Noncash Expense</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_PrepaidResearchAndDevelopmentCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Prepaid research and development</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_PrepaidResearchAndDevelopmentCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Prepaid Research And Development Current</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_PrepaidResearchAndDevelopmentCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Research and development expense prepaid current.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Property, Plant and Equipment, Net, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Property and equipment, net</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Property, Plant and Equipment, Net</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentUnamortizedDiscount_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Unamortized debt discount</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentUnamortizedDiscount_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Unamortized debt discount</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentUnamortizedDiscount_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Debt Instrument, Unamortized Discount, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentUnamortizedDiscount_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument, Unamortized Discount</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Award Type</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Award Type [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StatementLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Statement [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StatementLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Statement [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_Security12bTitle_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Title of 12(b) Security</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_Security12bTitle_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Title of 12(b) Security</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_ShareBasedCompensationArrangementByShareBasedPaymentAwardRemainingOptionsVestingPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Remaining option vesting period</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_ShareBasedCompensationArrangementByShareBasedPaymentAwardRemainingOptionsVestingPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Remaining Options Vesting Period</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_ShareBasedCompensationArrangementByShareBasedPaymentAwardRemainingOptionsVestingPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Share based compensation arrangement by share based payment award remaining options vesting period.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Current:</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Current Income Tax Expense (Benefit), Continuing Operations [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Increase (Decrease) in Accounts Payable, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accounts payable</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Increase (Decrease) in Accounts Payable</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common Stock</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_StockIssuedDuringPeriodSharesWarrantsExercised_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Stock Issued During Period Shares Warrants Exercised.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_StockIssuedDuringPeriodSharesWarrantsExercised_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Stock Issued During Period Shares Warrants Exercised</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_StockIssuedDuringPeriodSharesWarrantsExercised_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Issuance of common stock upon exercise of warrants</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Expiration period</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cash and Cash Equivalents</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cash and Cash Equivalents, Restricted Cash and Cash Equivalents, Policy [Policy Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cash flows from operating activities:</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Net Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EquityComponentDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Equity Component</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EquityComponentDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Equity Component [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueMeasurementPolicyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fair Value Measurements</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueMeasurementPolicyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value Measurement, Policy [Policy Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Net loss before income tax</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Net loss before income tax</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_WarrantsToPurchaseCommonStockPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Warrants to purchase common stock.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_WarrantsToPurchaseCommonStockPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Warrants To Purchase Common Stock Policy [Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_WarrantsToPurchaseCommonStockPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Warrants To Purchase Common Stock</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, State or Province</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, State or Province</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_PreFundedWarrantsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Pre-funded warrants.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_PreFundedWarrantsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Pre Funded Warrants [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_PreFundedWarrantsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre-funded Warrants</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_StatementGeographicalAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Geographical</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_StatementGeographicalAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Geographical [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Within one year</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Net change in cash and cash equivalents, and restricted cash</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentType_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Type</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentType_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Document Type</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InterestPaidNet_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cash paid for interest</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InterestPaidNet_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Interest Paid, Excluding Capitalized Interest, Operating Activities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_UnvestedRestrictedStockUnitsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Unvested Restricted Stock Units</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_UnvestedRestrictedStockUnitsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Unvested Restricted Stock Units [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_UnvestedRestrictedStockUnitsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Unvested restricted stock units.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="country_US_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">United States</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="country_US_lbl" xlink:role="http://www.xbrl.org/2003/role/label">UNITED STATES</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityShellCompany_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Shell Company</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityShellCompany_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Shell Company</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Shares of Common Stock Underlying Warrants</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Class of Warrant or Right, Outstanding</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="country_LT_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">LITHUANIA</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="country_LT_lbl" xlink:role="http://www.xbrl.org/2003/role/label">LITHUANIA</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Share base compensation expense</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Total stock-based compensation</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Payment Arrangement, Expense</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accrued expenses</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Accrued Liabilities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_StockIssuedDuringPeriodSharesCashlessExerciseOfWarrants_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Stock Issued During Period Shares Cashless Exercise Of Warrants.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_StockIssuedDuringPeriodSharesCashlessExerciseOfWarrants_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Stock Issued During Period Shares Cashless Exercise Of Warrants</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_StockIssuedDuringPeriodSharesCashlessExerciseOfWarrants_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Issuance of common stock upon cashless exercise of warrants, shares</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value, Recurring and Nonrecurring [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentInterestRateDuringPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Debt instrument, interest rate</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentInterestRateDuringPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument, Interest Rate During Period</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LossContingenciesLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Loss Contingencies [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LossContingenciesLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Loss Contingencies [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_TwoThousandAndTwentyOneLoanAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2021 Loan Agreement</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_TwoThousandAndTwentyOneLoanAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Two Thousand and Twenty One Loan Agreement [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_TwoThousandAndTwentyOneLoanAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Two thousand and twenty one loan agreement.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_SecurityExchangeName_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security Exchange Name</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_SecurityExchangeName_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Security Exchange Name</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ClassOfStockLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Class Of Stock [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ClassOfStockLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Class of Stock [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_DeferredTaxAssetsLeaseLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Operating Lease Liability</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_DeferredTaxAssetsLeaseLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets Lease Liability</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_DeferredTaxAssetsLeaseLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Deferred tax assets lease liability.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary of Significant Accounting Policies</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Significant Accounting Policies [Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Net cash used in operating activities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_DebtInstrumentEarlyPrepaymentFee_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Debt instrument, early prepayment fee</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_DebtInstrumentEarlyPrepaymentFee_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument, Early Prepayment Fee</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_DebtInstrumentEarlyPrepaymentFee_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Debt instrument, early prepayment fee.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Unrecognized weighted average period</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Weighted Average Remaining Contractual Term (In years), Outstanding</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_TermLoanCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Term loan, current</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_TermLoanCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Term Loan Current</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_TermLoanCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Term loan current.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_MeasurementInputExpectedTermMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Measurement Input, Expected Term</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_MeasurementInputExpectedTermMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Measurement Input, Expected Term [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RestrictedStockUnitsRSUMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Restricted Stock Units (RSUs)</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RestrictedStockUnitsRSUMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Restricted Stock Units (RSUs) [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary of a Reconciliation of The Unrecognized Tax Benefits</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Unrecognized Tax Benefits Roll Forward [Table Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_NumberOfSharesIssuableUnderShareBasedPaymentArrangement_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Number of common shares issuable under the plan (in shares)</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_NumberOfSharesIssuableUnderShareBasedPaymentArrangement_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Number Of Shares Issuable Under Share Based Payment Arrangement</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_NumberOfSharesIssuableUnderShareBasedPaymentArrangement_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Number of shares issuable under share-based payment arrangement.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ConsolidationPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Principles of Consolidation</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ConsolidationPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Consolidation, Policy [Policy Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_WarrantMember_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Warrants to Purchase Common Stock</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_WarrantMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Warrants</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_WarrantMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Warrant [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary of Restricted Stock Unit Activity</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Payment Arrangement, Restricted Stock Unit, Activity [Table Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary of Stock Option Activity</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Payment Arrangement, Option, Activity [Table Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Recent Accounting Pronouncements</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">New Accounting Pronouncements, Policy [Policy Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Common Stock, Shares, Outstanding, Ending Balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Common Stock, Shares, Outstanding, Beginning Balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common stock, shares outstanding</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock, Shares, Outstanding</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Net (accretion) amortization on available-for-sale securities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accretion (Amortization) of Discounts and Premiums, Investments</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueInputsLevel2Member_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Level 2</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueInputsLevel2Member_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value, Inputs, Level 2 [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecurities_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total cash equivalents and available-for-sale securities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecurities_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Short-term investments, Aggregated Fair Value</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecurities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Securities, Available-for-Sale</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cash flows from investing activities:</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Net Cash Provided by (Used in) Investing Activities [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Increase related to current year positions</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommitmentsAndContingencies_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Commitments and contingencies (Note 5)</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommitmentsAndContingencies_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Commitments and Contingencies</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockSharesIssued_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common stock, shares issued</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockSharesIssued_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock, Shares, Issued</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_TevaAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Teva Agreements</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_TevaAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Teva Agreement [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_TevaAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Teva agreement.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_VariableRateDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Variable Rate</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_VariableRateDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Variable Rate [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_MinimumMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Minimum</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_MinimumMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Minimum [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">RSUs description</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Description</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_NumberOfPrefundedWarrantsIssuedDuringPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Number of prefunded warrants issued during period.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_NumberOfPrefundedWarrantsIssuedDuringPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Number Of Prefunded Warrants Issued During Period</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_NumberOfPrefundedWarrantsIssuedDuringPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Number of prefunded warrants issued during period</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RestrictedCashCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Restricted cash</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RestrictedCashCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Restricted Cash, Current</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Risk-free interest rate, maximum</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeLeasesPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Leases</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeLeasesPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lessee, Leases [Policy Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted Average Exercise Price, Exercisable as of December 31, 2022</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accounting Standards Update [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TaxCreditCarryforwardAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Tax Credit Carryforward [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccruedLiabilitiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total accrued expenses</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccruedLiabilitiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accrued expenses</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccruedLiabilitiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accrued Liabilities, Current</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Debt Instrument</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockholdersEquityAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stockholders&#8217; equity:</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockholdersEquityAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Stockholders' Equity Attributable to Parent [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_VariableLeasePayment_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Variable lease payments</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_VariableLeasePayment_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Variable Lease, Payment</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressAddressLine2_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address Address Line Two</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressAddressLine2_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line Two</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CurrentForeignTaxExpenseBenefit_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Foreign</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CurrentForeignTaxExpenseBenefit_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Foreign</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CurrentForeignTaxExpenseBenefit_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Current Foreign Tax Expense (Benefit)</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Foreign Currencies</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Foreign Currency Transactions and Translations Policy [Policy Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted Average Grant Date Fair Value Outstanding, Cancelled/Forfeited</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AwardTypeAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Award Type</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AwardTypeAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Award Type [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_OtherNonCurrentLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other non-current liability</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_OtherNonCurrentLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Other Non Current Liability</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_OtherNonCurrentLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Other non-current liability</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SubsequentEventMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Subsequent Event</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SubsequentEventMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Subsequent Event [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_AssetTransferAndLicenseAgreementTerminationPeriodNoticeOfFailure_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Asset transfer and license agreement, termination period notice of breach</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_AssetTransferAndLicenseAgreementTerminationPeriodNoticeOfFailure_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Asset Transfer And License Agreement Termination Period Notice Of Failure</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_AssetTransferAndLicenseAgreementTerminationPeriodNoticeOfFailure_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Asset transfer and license agreement termination period notice of failure.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RealizedInvestmentGainsLosses_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Realized gains or losses on investments</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RealizedInvestmentGainsLosses_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Realized Investment Gains (Losses)</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RealizedInvestmentGainsLosses_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Realized Investment Gains (Losses), Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsGross_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Gross deferred tax assets</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsGross_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Deferred tax assets</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsGross_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets, Gross</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LossContingenciesTable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Loss Contingencies [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LossContingenciesTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Loss Contingencies [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Impairment of Long-Lived Assets</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2022</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Leases, Future Minimum Payments, Remainder of Fiscal Year</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_AgencyDiscountSecuritiesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Agency discount securities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_AgencyDiscountSecuritiesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Agency Discount Securities [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_AgencyDiscountSecuritiesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Agency discount securities.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ResearchAndDevelopmentExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Research and Development Expense, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ResearchAndDevelopmentExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Research and development</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ResearchAndDevelopmentExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Research and Development Expense</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total undiscounted future minimum lease payments</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lessee, Operating Lease, Liability, to be Paid</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Central Index Key</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Central Index Key</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Deferred tax assets, change in valuation allowance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_WarrantsAndRightsOutstandingMaturityDate_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Warrant expiration date</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_WarrantsAndRightsOutstandingMaturityDate_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Warrants and Rights Outstanding, Maturity Date</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_ObligationToPaymentUponMaximumAchievementOfCertainClinicalAndCommercialMilestones_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Payment upon achievement of certain clinical and commercial milestones</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_ObligationToPaymentUponMaximumAchievementOfCertainClinicalAndCommercialMilestones_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Obligation To Payment Upon Maximum Achievement Of Certain Clinical And Commercial Milestones</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_ObligationToPaymentUponMaximumAchievementOfCertainClinicalAndCommercialMilestones_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Obligation to payment upon maximum achievement of certain clinical and commercial milestones.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2023</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Leases, Future Minimum Payments, Due in Two Years</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccountingPoliciesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accounting Policies [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Estimated total grant date fair value of options vested</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested, Weighted Average Grant Date Fair Value</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_TermBLoanFacilityMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Term B Loan Facility</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_TermBLoanFacilityMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Term B Loan Facility [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_TermBLoanFacilityMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Term b loan facility.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueByMeasurementFrequencyAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Measurement Frequency</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueByMeasurementFrequencyAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Measurement Frequency [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Number of shares of common stock available for issuance under ESPP</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stock-Based Compensation</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Payment Arrangement [Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_LoanAndSecurityAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Loan Agreement</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_LoanAndSecurityAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Loan And Security Agreement [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_LoanAndSecurityAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Loan and security agreement.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SubsequentEventTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Subsequent Event [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_GeneralAndAdministrativeExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">General and Administrative Expense, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_GeneralAndAdministrativeExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">General and administrative</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_GeneralAndAdministrativeExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/label">General and Administrative Expense</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_ShortTermAvailableForSaleSecuritiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Short-term available-for-sale securities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_ShortTermAvailableForSaleSecuritiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Short Term Available For Sale Securities Current</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_ShortTermAvailableForSaleSecuritiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Short term available for sale securities current.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_MeasurementInputTypeDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Measurement Input Type</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_MeasurementInputTypeDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Measurement Input Type [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Weighted Average Exercise Price Outstanding, Beginning Balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Weighted Average Exercise Price Outstanding, Ending Balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Research and Development</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Research and Development Expenses</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Research and Development Expense [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Risk-free interest rate, minimum</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_EquityIncentivePlanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Equity incentive plan member.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_EquityIncentivePlanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Equity Incentive Plan [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_EquityIncentivePlanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Equity Incentive Plan</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Adjustments to reconcile net loss to net cash used in operating activities:</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RetainedEarningsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Accumulated Deficit</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RetainedEarningsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Retained Earnings</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RetainedEarningsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Retained Earnings [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_TwentyTwentyThreeLoanAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2023 Loan Agreement</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_TwentyTwentyThreeLoanAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Twenty Twenty Three Loan Agreement [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_TwentyTwentyThreeLoanAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Twenty twenty three loan agreement.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TaxCreditCarryforwardNameDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Tax Credit Carryforward, Name [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_AssetTransferAndLicenseAgreementTerminationNoticePeriodIfBankruptcyPetitionFiled_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Asset transfer and license agreement termination notice period if bankruptcy petition filed</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_AssetTransferAndLicenseAgreementTerminationNoticePeriodIfBankruptcyPetitionFiled_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Asset Transfer And License Agreement Termination Notice Period If Bankruptcy Petition Filed</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_AssetTransferAndLicenseAgreementTerminationNoticePeriodIfBankruptcyPetitionFiled_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Asset transfer and license agreement termination notice period if bankruptcy petition filed.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_MoneyMarketFundsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Money Market Funds</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_MoneyMarketFundsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Money Market Funds [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_ShareBasedCompensationArrangementByShareBasedPaymentAwardAnniversary_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Anniversary period</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_ShareBasedCompensationArrangementByShareBasedPaymentAwardAnniversary_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Anniversary</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_ShareBasedCompensationArrangementByShareBasedPaymentAwardAnniversary_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Period of share based compensation arrangement by share based payment award anniversary.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_MeasurementInputTypeAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Measurement Input Type</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_MeasurementInputTypeAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Measurement Input Type [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Effective Income Tax Rate Reconciliation, Percent, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Effective income tax rate</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Effective Income Tax Rate Reconciliation, Percent</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Research and Development Arrangement, Contract to Perform for Others, Type</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Research and Development Arrangement, Contract to Perform for Others, Type [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_StockAndWarrantsIssuedDuringPeriodSharesNewIssues_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Stock And Warrants Issued During Period Shares New Issues.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_StockAndWarrantsIssuedDuringPeriodSharesNewIssues_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Stock And Warrants Issued During Period Shares New Issues</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_StockAndWarrantsIssuedDuringPeriodSharesNewIssues_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Issuance of common stock and warrants, shares</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Percentage of option vesting</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights, Percentage</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Interactive Data Current</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Interactive Data Current</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityPublicFloat_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Public Float</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityPublicFloat_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Public Float</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLossCarryforwardsLimitationsOnUse_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Operating loss carryforwards limitations on use</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLossCarryforwardsLimitationsOnUse_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Loss Carryforwards, Limitations on Use</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2023</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lessee, Operating Lease, Liability, to be Paid, Year One</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LeaseholdImprovementsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Leasehold Improvements</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LeaseholdImprovementsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Leasehold Improvements [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Deferred:</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Income Tax Expense (Benefit), Continuing Operations [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_LocalPhoneNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Local Phone Number</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_LocalPhoneNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Local Phone Number</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_SummaryOfSignificantAccountingPoliciesLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary Of Significant Accounting Policies [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_SummaryOfSignificantAccountingPoliciesLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Summary Of Significant Accounting Policies [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_SummaryOfSignificantAccountingPoliciesLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_UnrecognizedTaxBenefits_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Balance, end of year</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_UnrecognizedTaxBenefits_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Balance, beginning of year</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_UnrecognizedTaxBenefits_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Unrecognized Tax Benefits</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_UnrecognizedTaxBenefits_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Unrecognized Tax Benefits</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Vesting period</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtDisclosureAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Disclosure [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Basis of Presentation</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Basis of Accounting, Policy [Policy Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Exercisable as of December 31, 2022</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IPOMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Public Offerings</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IPOMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">IPO [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_ConsolidatedEntitiesAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Consolidated Entities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_ConsolidatedEntitiesAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Consolidated Entities [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_MunicipalBondsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Municipal Bonds</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_MunicipalBondsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Municipal Bonds [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Shares granted</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Granted</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Unrecognized Tax Benefits, Period Increase (Decrease), Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Increase in unrecognized tax benefits</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Unrecognized Tax Benefits, Period Increase (Decrease)</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeStatementLocationDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Income Statement Location</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeStatementLocationDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Income Statement Location [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_MeasurementInputRiskFreeInterestRateMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Measurement Input, Risk Free Interest Rate</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_MeasurementInputRiskFreeInterestRateMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Measurement Input, Risk Free Interest Rate [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_UABEightyNineBioLithuaniaMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">UAB 89bio Lithuania</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_UABEightyNineBioLithuaniaMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">U A B Eighty Nine Bio Lithuania [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_UABEightyNineBioLithuaniaMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">UAB Eighty Nine Bio Lithuania.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_TrancheTwoAndThreeMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Tranche two and three</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_TrancheTwoAndThreeMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Tranche Two And Three [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_TrancheTwoAndThreeMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Tranche two and three.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Outstanding, Ending Balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Outstanding, Beginning Balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Outstanding, Ending Balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Beginning balance, shares</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Ending balance, shares</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Shares, Outstanding</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Prepaid and other current assets</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Increase (Decrease) in Prepaid Expense and Other Assets</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule Of Share Based Compensation Arrangements By Share Based Payment Award [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityIncorporationDateOfIncorporation_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Date of incorporation</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityIncorporationDateOfIncorporation_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Incorporation, Date of Incorporation</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Outstanding</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Outstanding, Beginning Balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Outstanding, Ending Balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentNameDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Debt Instrument, Name</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentNameDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument, Name [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentFiscalYearFocus_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Fiscal Year Focus</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentFiscalYearFocus_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Document Fiscal Year Focus</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Prepaid Expense and Other Assets, Current [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ClassOfWarrantOrRightAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Class of Warrant or Right [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_TermALoanFacilityMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Term A Loan Facility</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_TermALoanFacilityMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Term A Loan Facility [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_TermALoanFacilityMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Term A loan facility.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2024</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lessee, Operating Lease, Liability, to be Paid, Year Two</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InterestAndOtherIncome_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Interest income and other, net</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InterestAndOtherIncome_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Interest and Other Income</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EarningsPerShareBasic_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Net loss per share, basic</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EarningsPerShareBasic_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Earnings Per Share, Basic</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EarningsPerShareBasic_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Earnings Per Share, Basic, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherPrepaidExpenseCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Prepaid other</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherPrepaidExpenseCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Other Prepaid Expense, Current</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_TemporaryEquityIssuanceCosts_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Temporary equity, issuance costs</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_TemporaryEquityIssuanceCosts_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Temporary Equity Issuance Costs</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_TemporaryEquityIssuanceCosts_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Temporary equity, issuance costs.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted Average Exercise Price</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AssetsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Assets</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AssetsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Assets [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Increase (Decrease) in Accrued Liabilities, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accrued expenses</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Increase (Decrease) in Accrued Liabilities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentAnnualPrincipalPayment_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Total principal amount outstanding</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentAnnualPrincipalPayment_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument, Annual Principal Payment</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsLiabilitiesNet_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Net deferred tax assets</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsLiabilitiesNet_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets, Net</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Components of cash and cash equivalents, and restricted cash:</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Expected volatility, minimum</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherThanTemporaryImpairmentLossDebtSecuritiesPortionRecognizedInEarnings_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other-than-temporary losses</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherThanTemporaryImpairmentLossDebtSecuritiesPortionRecognizedInEarnings_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Other-than-temporary Impairment Loss, Debt Securities, Portion Recognized in Earnings</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total prepaid and other current assets</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Prepaid and other current assets</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Prepaid Expense and Other Assets, Current</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FinancialInstrumentAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Financial Instrument [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Long-Lived Tangible Asset</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Long-Lived Tangible Asset [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Number of Options</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Liabilities and stockholders&#8217; equity</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Liabilities and Equity [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Property and Equipment, Net</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Property, Plant and Equipment, Policy [Policy Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Antidilutive Securities, Name</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Antidilutive Securities, Name [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxAuthorityAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Income Tax Authority [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ValuationTechniqueAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Valuation Approach and Technique</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ValuationTechniqueAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Valuation Approach and Technique [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsNet_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total deferred tax assets</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsNet_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets, Net of Valuation Allowance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProfitLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Net Income (Loss), Including Portion Attributable to Noncontrolling Interest, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProfitLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Net loss</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProfitLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Net Income (Loss), Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_DebtInstrumentFinalPaymentFee_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Debt instrument, final payment fee</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_DebtInstrumentFinalPaymentFee_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument, Final Payment Fee</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_DebtInstrumentFinalPaymentFee_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Debt instrument, final payment fee.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AssetsCurrentAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Current assets:</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AssetsCurrentAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Assets, Current [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Warrant exercise price</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Class of Warrant or Right, Exercise Price of Warrants or Rights</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary of Components of Deferred Tax Assets</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Deferred Tax Assets and Liabilities [Table Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_AmortizationOfDebtIssuanceCostsAndAccretionOfFinalPaymentFee_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Amortization of debt issuance costs and accretion of final payment fee</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_AmortizationOfDebtIssuanceCostsAndAccretionOfFinalPaymentFee_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Amortization Of Debt Issuance Costs And Accretion Of Final Payment Fee</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_AmortizationOfDebtIssuanceCostsAndAccretionOfFinalPaymentFee_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Amortization of debt issuance costs and accretion of final payment fee.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fair Value Hierarchy and NAV</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Decrease related to prior year positions</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PayablesAndAccrualsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Payables and Accruals [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueMeasurementFrequencyDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Measurement Frequency</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueMeasurementFrequencyDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Measurement Frequency [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_WarrantPublicOfferingsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Warrant public offerings member.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_WarrantPublicOfferingsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Warrant Public Offerings [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_WarrantPublicOfferingsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Warrants Public Offerings</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Changes in operating assets and liabilities:</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Increase (Decrease) in Operating Capital [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfWithholdingTaxes_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Stock Issued During Period Shares Restricted Stock Award Net Of Withholding Taxes.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfWithholdingTaxes_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Stock Issued During Period Shares Restricted Stock Award Net Of Withholding Taxes</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfWithholdingTaxes_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Issuance of common stock upon vesting of restricted stock units, net of withholding taxes, shares</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_TevasGlycoPEGylatedFGF21ProgramMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Teva's GlycoPEGylated FGF21 Program</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_TevasGlycoPEGylatedFGF21ProgramMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Tevas Glyco P E Gylated F G F21 Program [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_TevasGlycoPEGylatedFGF21ProgramMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Tevas glycoPEGylated FGF21 program.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseRemainingLeaseTerm_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Remaining lease term</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseRemainingLeaseTerm_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lessee, Operating Lease, Remaining Lease Term</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_CoverAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cover [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_SummaryOfAvailableCarryforwardTaxLossesAndCredits_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary Of Available Carryforward Tax Losses And Credits</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_SummaryOfAvailableCarryforwardTaxLossesAndCredits_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Summary Of Available Carryforward Tax Losses And Credits</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_SummaryOfAvailableCarryforwardTaxLossesAndCredits_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Summary of available carryforward tax losses and credits.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Vested / released</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromIssuanceOfOtherLongTermDebt_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Proceeds from term loan facility, net of issuance costs</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromIssuanceOfOtherLongTermDebt_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Proceeds from Issuance of Other Long-Term Debt</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilitiesCurrentAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Current liabilities:</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilitiesCurrentAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Liabilities, Current [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_MaximumMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Maximum</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_MaximumMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Maximum [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_PerformanceRSUsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Performance RSUs</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_PerformanceRSUsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Performance R S Us [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_PerformanceRSUsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Performance RSUs.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary of Stock-Based Compensation</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Net cash (used in) provided by investing activities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule Of Antidilutive Securities Excluded From Computation Of Earnings Per Share [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Exercised</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Issuance of common stock upon exercise of stock options, shares</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Contractual Maturities of Cash Equivalents and Available-for-Sale Securities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Investments Classified by Contractual Maturity Date [Table Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_UseOfEstimates_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Use of Estimates</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_UseOfEstimates_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Use of Estimates, Policy [Policy Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Debt instrument, basis spread on variable rate</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument, Basis Spread on Variable Rate</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredIncomeTaxLiabilities_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel">Total deferred tax liabilities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredIncomeTaxLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total deferred tax liabilities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredIncomeTaxLiabilities_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Total deferred tax liabilities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredIncomeTaxLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Total deferred tax liabilities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredIncomeTaxLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Liabilities, Gross</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentMeasurementInput_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fair measurement input</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentMeasurementInput_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument, Measurement Input</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Issuance of common stock upon exercise of stock options</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Stock Issued During Period, Value, Stock Options Exercised</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SegmentReportingPolicyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Segment Reporting</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SegmentReportingPolicyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Segment Reporting, Policy [Policy Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_OperatingLeaseExpirationMonthAndYear_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Operating lease expiration month and year.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_OperatingLeaseExpirationMonthAndYear_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Lease Expiration Month And Year</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_OperatingLeaseExpirationMonthAndYear_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Operating lease expiration month and year</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_SummaryOfSignificantAccountingPoliciesTable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary Of Significant Accounting Policies [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_SummaryOfSignificantAccountingPoliciesTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Summary Of Significant Accounting Policies [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_SummaryOfSignificantAccountingPoliciesTable_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Information related to various accounting policies of the entity.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLife_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Property and equipment, estimated useful lives</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLife_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Property, Plant and Equipment, Useful Life</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ForeignCountryMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Foreign</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ForeignCountryMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Foreign Tax Authority [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_USGovernmentAgenciesShorttermDebtSecuritiesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">U.S. government bonds</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_USGovernmentAgenciesShorttermDebtSecuritiesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">US Government Agencies Short-Term Debt Securities [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentCarryingAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Outstanding principal amount</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentCarryingAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total principal repayments</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentCarryingAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Long-Term Debt, Gross</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockSharesAuthorized_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common stock, shares authorized</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockSharesAuthorized_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock, Shares Authorized</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_TradingSymbol_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Trading Symbol</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_TradingSymbol_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Trading Symbol</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_DeferredTaxAssets_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Deferred tax assets</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_DeferredTaxAssets_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_DeferredTaxAssets_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Deferred tax assets.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Title of Individual</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Title of Individual [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SubsequentEventTypeAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Subsequent Event Type [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsOther_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsOther_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets, Other</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Non-cash operating lease expense</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Lease, Right-of-Use Asset, Amortization Expense</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_SaleOfStockPercentageOfBeneficialOwnershipLimitationBeforeTransaction_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Sale of stock percentage of beneficial ownership limitation before transaction.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_SaleOfStockPercentageOfBeneficialOwnershipLimitationBeforeTransaction_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Sale Of Stock Percentage Of Beneficial Ownership Limitation Before Transaction</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_SaleOfStockPercentageOfBeneficialOwnershipLimitationBeforeTransaction_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Percentage of ownership prior to issuance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BalanceSheetLocationAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Balance Sheet Location</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BalanceSheetLocationAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Balance Sheet Location [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Comprehensive loss</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LineOfCreditFacilityAverageOutstandingAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Loan Agreement funded outstanding amount</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LineOfCreditFacilityAverageOutstandingAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Line of Credit Facility, Average Outstanding Amount</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccountsPayableCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Accounts Payable, Current, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccountsPayableCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accounts payable</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccountsPayableCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accounts Payable, Current</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Short-term investments, Gross Unrealized Holding Losses</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_StockAndWarrantsIssuedDuringPeriodValueNewIssues_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Stock And Warrants Issued During Period Value New Issues.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_StockAndWarrantsIssuedDuringPeriodValueNewIssues_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Stock And Warrants Issued During Period Value New Issues</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_StockAndWarrantsIssuedDuringPeriodValueNewIssues_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Issuance of common stock and warrants</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PlanNameAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Plan Name</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PlanNameAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Plan Name [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_TitleOfIndividualAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Title of Individual</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_TitleOfIndividualAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Title of Individual [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Income tax benefit computed at statutory rates</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Long-Lived Tangible Asset</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Long-Lived Tangible Asset [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentTerm_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fair measurement input</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentTerm_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument, Term</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common stock, par value</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock, Par or Stated Value Per Share</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Well-known Seasoned Issuer</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Well-known Seasoned Issuer</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Comprehensive Loss</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Comprehensive Income, Policy [Policy Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_DeferredTaxAssetsTaxCreditCarryforwardsResearchFederal_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Federal research and development credit carryforwards</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_DeferredTaxAssetsTaxCreditCarryforwardsResearchFederal_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets Tax Credit Carryforwards Research Federal</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_DeferredTaxAssetsTaxCreditCarryforwardsResearchFederal_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Deferred tax assets tax credit carryforwards research, federal.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Granted</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_TrancheFourMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Tranche Four</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_TrancheFourMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Tranche Four [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_TrancheFourMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Tranche four.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Leasehold improvements amortization, description</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Property, Plant and Equipment, Estimated Useful Lives</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Weighted Average Exercise Price, Granted</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Issuance of common stock, weighted average price per share</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LongTermDebtTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Term Loan</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LongTermDebtTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Long-Term Debt [Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_PercentageOfFeeOnLoan_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Percentage of fee on loan</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_PercentageOfFeeOnLoan_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Percentage Of Fee On Loan</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_PercentageOfFeeOnLoan_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Percentage of fee on loan.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Debt Instrument [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Antidilutive common stock equivalents excluded from calculation of diluted net loss per share</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_AccruedResearchAndDevelopmentExpensesPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accrued Research and Development Expenses</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_AccruedResearchAndDevelopmentExpensesPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accrued Research And Development Expenses Policy [Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="etnb_AccruedResearchAndDevelopmentExpensesPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Accrued research and development expenses.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="country_IL_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Israel</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="country_IL_lbl" xlink:role="http://www.xbrl.org/2003/role/label">ISRAEL</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NoncashInvestingAndFinancingItemsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Supplemental disclosures of noncash information:</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NoncashInvestingAndFinancingItemsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Noncash Investing and Financing Items [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:to="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="us-gaap_FairValueDisclosuresAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="etnb_PrepaymentFeePercentage" xlink:to="etnb_PrepaymentFeePercentage_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_EarningsPerShareAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueInputsLevel1Member" xlink:to="us-gaap_FairValueInputsLevel1Member_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:to="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DomesticCountryMember" xlink:to="us-gaap_DomesticCountryMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationNondeductibleExpenseResearchAndDevelopment" xlink:to="us-gaap_IncomeTaxReconciliationNondeductibleExpenseResearchAndDevelopment_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:to="us-gaap_ResearchAndDevelopmentExpensePolicy_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseDiscountRate" xlink:to="us-gaap_LesseeOperatingLeaseDiscountRate_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="etnb_BeneficialOwnershipLimitationOnExerciseOfWarrant" xlink:to="etnb_BeneficialOwnershipLimitationOnExerciseOfWarrant_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventTypeDomain" xlink:to="us-gaap_SubsequentEventTypeDomain_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ExecutiveOfficerMember" xlink:to="srt_ExecutiveOfficerMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_DebtInstrumentTable_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedPaymentArrangementEmployeeMember" xlink:to="us-gaap_ShareBasedPaymentArrangementEmployeeMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="etnb_UnderwrittenPublicOfferingMember" xlink:to="etnb_UnderwrittenPublicOfferingMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerSharePolicyTextBlock" xlink:to="us-gaap_EarningsPerSharePolicyTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementTable_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:to="us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:to="us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="etnb_AccumulatedTaxLossCarryForward" xlink:to="etnb_AccumulatedTaxLossCarryForward_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NumberOfOperatingSegments" xlink:to="us-gaap_NumberOfOperatingSegments_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesOutstanding" xlink:to="us-gaap_PreferredStockSharesOutstanding_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="etnb_ProceedsFromIssuancePublicOffering" xlink:to="etnb_ProceedsFromIssuancePublicOffering_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:to="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditorFirmId" xlink:to="dei_AuditorFirmId_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="etnb_TwoThousandAndTwentyThreeLoanAgreementMember" xlink:to="etnb_TwoThousandAndTwentyThreeLoanAgreementMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="etnb_AssetTransferAndLicenseAgreementTerminationPeriodAfterWrittenNotice" xlink:to="etnb_AssetTransferAndLicenseAgreementTerminationPeriodAfterWrittenNotice_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxAuthorityDomain" xlink:to="us-gaap_IncomeTaxAuthorityDomain_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeStockMember" xlink:to="us-gaap_EmployeeStockMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:to="us-gaap_EmployeeRelatedLiabilitiesCurrent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeStockOptionMember" xlink:to="us-gaap_EmployeeStockOptionMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="etnb_PercentageOfIncreaseInNumberOfSharesOfCapitalStockIssuedAndOutstanding" xlink:to="etnb_PercentageOfIncreaseInNumberOfSharesOfCapitalStockIssuedAndOutstanding_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PlanNameDomain" xlink:to="us-gaap_PlanNameDomain_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:to="us-gaap_PriorPeriodReclassificationAdjustmentDescription_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="etnb_ATMFacilityMember" xlink:to="etnb_ATMFacilityMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredForeignIncomeTaxExpenseBenefit_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted" xlink:to="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_IncomeStatementAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:to="us-gaap_IncomeTaxReconciliationOtherAdjustments_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:to="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:to="us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="etnb_IssuanceOfCommonStockWarrantsInConnectionWithDebtFinancing" xlink:to="etnb_IssuanceOfCommonStockWarrantsInConnectionWithDebtFinancing_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementsRecurringMember" xlink:to="us-gaap_FairValueMeasurementsRecurringMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestExpense" xlink:to="us-gaap_InterestExpense_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShortTermLeaseCost" xlink:to="us-gaap_ShortTermLeaseCost_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxPolicyTextBlock" xlink:to="us-gaap_IncomeTaxPolicyTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesAuthorized" xlink:to="us-gaap_PreferredStockSharesAuthorized_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LineOfCreditFacilityDescription" xlink:to="us-gaap_LineOfCreditFacilityDescription_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="etnb_LineOfCreditFacilityIncreaseInBorrowingCapacity" xlink:to="etnb_LineOfCreditFacilityIncreaseInBorrowingCapacity_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:to="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:to="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="etnb_AmortizationPeriod" xlink:to="etnb_AmortizationPeriod_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_VariableRateAxis" xlink:to="us-gaap_VariableRateAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_TypeOfArrangementAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="etnb_NetCashProceedsFromSaleOfEquitySecurities" xlink:to="etnb_NetCashProceedsFromSaleOfEquitySecurities_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="etnb_ConvertiblePreferredSharesMember" xlink:to="etnb_ConvertiblePreferredSharesMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="etnb_EightyNineBioLtdMember" xlink:to="etnb_EightyNineBioLtdMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AgencySecuritiesMember" xlink:to="us-gaap_AgencySecuritiesMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="etnb_IssuanceOfCommonStockWarrantInConnectionWithTermLoanFacility" xlink:to="etnb_IssuanceOfCommonStockWarrantInConnectionWithTermLoanFacility_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AssetsCurrent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="etnb_TrancheOneMember" xlink:to="etnb_TrancheOneMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_Liabilities_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsOfStockIssuanceCosts" xlink:to="us-gaap_PaymentsOfStockIssuanceCosts_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="etnb_ExerciseOfWarrantsAndPreFundedWarrantsMember" xlink:to="etnb_ExerciseOfWarrantsAndPreFundedWarrantsMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="etnb_SVBLeerinkLLCAndCantorFitzgeraldCoMember" xlink:to="etnb_SVBLeerinkLLCAndCantorFitzgeraldCoMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="etnb_DeferredTaxLiabilitiesRightsOfUseAssets" xlink:to="etnb_DeferredTaxLiabilitiesRightsOfUseAssets_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:to="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_RangeAxis" xlink:to="srt_RangeAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="etnb_ServiceBasedRSUsMember" xlink:to="etnb_ServiceBasedRSUsMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockTransactionDate" xlink:to="us-gaap_SaleOfStockTransactionDate_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_SubsequentEventLineItems_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities" xlink:to="us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Assets_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountingStandardsUpdate201602Member" xlink:to="us-gaap_AccountingStandardsUpdate201602Member_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StateAndLocalJurisdictionMember" xlink:to="us-gaap_StateAndLocalJurisdictionMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtNoncurrent" xlink:to="us-gaap_LongTermDebtNoncurrent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareDiluted" xlink:to="us-gaap_EarningsPerShareDiluted_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:to="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="etnb_ScheduleOfPrepaidAndOtherCurrentAssetsTableTextBlock" xlink:to="etnb_ScheduleOfPrepaidAndOtherCurrentAssetsTableTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="etnb_PeriodForIncreaseInNumberOfSharesOfCommonStockReservedForIssuance" xlink:to="etnb_PeriodForIncreaseInNumberOfSharesOfCommonStockReservedForIssuance_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="etnb_TaxCreditCarryforwardExpirationYear" xlink:to="etnb_TaxCreditCarryforwardExpirationYear_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentMaturityDateDescription" xlink:to="us-gaap_DebtInstrumentMaturityDateDescription_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightTable" xlink:to="us-gaap_ClassOfWarrantOrRightTable_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:to="us-gaap_CurrentIncomeTaxExpenseBenefit_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockValue" xlink:to="us-gaap_PreferredStockValue_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasePaymentsUse" xlink:to="us-gaap_OperatingLeasePaymentsUse_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiability" xlink:to="us-gaap_OperatingLeaseLiability_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDue_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="stpr_CA" xlink:to="stpr_CA_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_StatementOfFinancialPositionAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ForeignGovernmentDebtSecuritiesMember" xlink:to="us-gaap_ForeignGovernmentDebtSecuritiesMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="etnb_IncomeTaxReconciliationChangeInEffectiveTaxRateDueToReorganization" xlink:to="etnb_IncomeTaxReconciliationChangeInEffectiveTaxRateDueToReorganization_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_StatementOfCashFlowsAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:to="us-gaap_BalanceSheetRelatedDisclosuresAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ValuationTechniqueDomain" xlink:to="us-gaap_ValuationTechniqueDomain_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="etnb_ProceedsFromIssuancePublicOfferingAtTheMarketOffering" xlink:to="etnb_ProceedsFromIssuancePublicOfferingAtTheMarketOffering_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightLineItems_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_SegmentGeographicalDomain" xlink:to="srt_SegmentGeographicalDomain_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_RangeMember" xlink:to="srt_RangeMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="us-gaap_StatementOfStockholdersEquityAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SubsidiarySaleOfStockAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="etnb_StockIssuedDuringPeriodValueWarrantsExercised" xlink:to="etnb_StockIssuedDuringPeriodValueWarrantsExercised_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditorLocation" xlink:to="dei_AuditorLocation_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_ClassOfStockDomain_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsAbstract" xlink:to="us-gaap_SubsequentEventsAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueDisclosuresTextBlock" xlink:to="us-gaap_FairValueDisclosuresTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="etnb_TaxableIncomeUtilizationPercentage" xlink:to="etnb_TaxableIncomeUtilizationPercentage_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeLossTaxAbstract" xlink:to="us-gaap_OtherComprehensiveIncomeLossTaxAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="etnb_SanFranciscoOfficeMember" xlink:to="etnb_SanFranciscoOfficeMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredIncomeTaxExpenseBenefit_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:to="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="etnb_PaymentForPurchaseOfAvailableForSaleSecurities" xlink:to="etnb_PaymentForPurchaseOfAvailableForSaleSecurities_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrepaidTaxes" xlink:to="us-gaap_PrepaidTaxes_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MeasurementInputExpectedDividendPaymentMember" xlink:to="us-gaap_MeasurementInputExpectedDividendPaymentMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskCreditRisk" xlink:to="us-gaap_ConcentrationRiskCreditRisk_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:to="us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:to="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:to="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:to="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="etnb_AccruedResearchAndDevelopmentExpenseCurrent" xlink:to="etnb_AccruedResearchAndDevelopmentExpenseCurrent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsAndShortTermInvestments" xlink:to="us-gaap_CashCashEquivalentsAndShortTermInvestments_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SupplementalBalanceSheetDisclosuresTextBlock" xlink:to="us-gaap_SupplementalBalanceSheetDisclosuresTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsTextBlock" xlink:to="us-gaap_SubsequentEventsTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashEquivalentsMember" xlink:to="us-gaap_CashEquivalentsMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:to="us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CorporateDebtSecuritiesMember" xlink:to="us-gaap_CorporateDebtSecuritiesMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GeneralAndAdministrativeExpenseMember" xlink:to="us-gaap_GeneralAndAdministrativeExpenseMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain" xlink:to="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="etnb_StockIssuedDuringPeriodValueCashlessExerciseOfWarrants" xlink:to="etnb_StockIssuedDuringPeriodValueCashlessExerciseOfWarrants_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommercialPaperMember" xlink:to="us-gaap_CommercialPaperMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Depreciation" xlink:to="us-gaap_Depreciation_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="etnb_SellingCommissionPerSharesSoldPercentage" xlink:to="etnb_SellingCommissionPerSharesSoldPercentage_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAssetsNoncurrent" xlink:to="us-gaap_OtherAssetsNoncurrent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="etnb_CommonStockAndWarrantsCombinedOfferingPricePerShare" xlink:to="etnb_CommonStockAndWarrantsCombinedOfferingPricePerShare_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromLinesOfCredit" xlink:to="us-gaap_ProceedsFromLinesOfCredit_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="us-gaap_SupplementalCashFlowInformationAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="etnb_PrefundedAndCommonStockWarrants" xlink:to="etnb_PrefundedAndCommonStockWarrants_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentPolicyTextBlock" xlink:to="us-gaap_InvestmentPolicyTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="us-gaap_SubsidiarySaleOfStockLineItems_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxExpenseBenefit_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:to="us-gaap_IncreaseDecreaseInOperatingLeaseLiability_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="etnb_EightyNineBioManagementIncorporationMember" xlink:to="etnb_EightyNineBioManagementIncorporationMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="us-gaap_IncomeTaxDisclosureTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesIssued" xlink:to="us-gaap_PreferredStockSharesIssued_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BalanceSheetLocationDomain" xlink:to="us-gaap_BalanceSheetLocationDomain_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAccruedLiabilitiesCurrent" xlink:to="us-gaap_OtherAccruedLiabilitiesCurrent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeTaxDisclosureAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="etnb_ShareBasedCompensationArrangementByShareBasedPaymentFirstOfferingPeriodCommencementDate" xlink:to="etnb_ShareBasedCompensationArrangementByShareBasedPaymentFirstOfferingPeriodCommencementDate_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdoptionDate" xlink:to="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdoptionDate_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_USTreasuryBillSecuritiesMember" xlink:to="us-gaap_USTreasuryBillSecuritiesMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="etnb_WarrantTermLoanMember" xlink:to="etnb_WarrantTermLoanMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="etnb_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughTwoYearsFairValue" xlink:to="etnb_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughTwoYearsFairValue_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueByFairValueHierarchyLevelAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:to="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="etnb_MaximumAmountOfEquitySharesIssuable" xlink:to="etnb_MaximumAmountOfEquitySharesIssuable_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditorName" xlink:to="dei_AuditorName_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityAbstract" xlink:to="us-gaap_EquityAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock" xlink:to="us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_OperatingIncomeLoss_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapitalCommonStock" xlink:to="us-gaap_AdditionalPaidInCapitalCommonStock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAward_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedProfessionalFeesCurrent" xlink:to="us-gaap_AccruedProfessionalFeesCurrent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightDomain" xlink:to="us-gaap_ClassOfWarrantOrRightDomain_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="etnb_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantDateFairValue" xlink:to="etnb_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantDateFairValue_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_OperatingExpenses_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="etnb_TevasDevelopmentProgramMember" xlink:to="etnb_TevasDevelopmentProgramMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:to="us-gaap_CurrentStateAndLocalTaxExpenseBenefit_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_IcfrAuditorAttestationFlag" xlink:to="dei_IcfrAuditorAttestationFlag_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrimeRateMember" xlink:to="us-gaap_PrimeRateMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockDescriptionOfTransaction" xlink:to="us-gaap_SaleOfStockDescriptionOfTransaction_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAssetsMember" xlink:to="us-gaap_OtherAssetsMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="etnb_UnderwritingDiscountsAndCommissions" xlink:to="etnb_UnderwritingDiscountsAndCommissions_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="etnb_RemeasurementOfLeaseLiabilityAndRightOfUseAssetInConnectionWithLeaseModification" xlink:to="etnb_RemeasurementOfLeaseLiabilityAndRightOfUseAssetInConnectionWithLeaseModification_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="etnb_IncomeTaxDisclosureLineItems" xlink:to="etnb_IncomeTaxDisclosureLineItems_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShortTermInvestmentsMember" xlink:to="us-gaap_ShortTermInvestmentsMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="etnb_EffectiveIncomeTaxRateReconciliationStateDeferredTaxTrueUpDueToChangeInApportionment" xlink:to="etnb_EffectiveIncomeTaxRateReconciliationStateDeferredTaxTrueUpDueToChangeInApportionment_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockValue" xlink:to="us-gaap_CommonStockValue_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:to="us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:to="us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_StatementEquityComponentsAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="etnb_TwoThousandAndTwentyEquityIncentivePlanMember" xlink:to="etnb_TwoThousandAndTwentyEquityIncentivePlanMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ConsolidatedEntitiesDomain" xlink:to="srt_ConsolidatedEntitiesDomain_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="etnb_FairValueOfWarrantsAssumptionsDividends" xlink:to="etnb_FairValueOfWarrantsAssumptionsDividends_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TypeOfAdoptionMember" xlink:to="us-gaap_TypeOfAdoptionMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromWarrantExercises" xlink:to="us-gaap_ProceedsFromWarrantExercises_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredFinanceCostsGross" xlink:to="us-gaap_DeferredFinanceCostsGross_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="etnb_ScheduleOfCommonStockReservedForIssuanceTableTextBlock" xlink:to="etnb_ScheduleOfCommonStockReservedForIssuanceTableTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="etnb_MilestonePayment" xlink:to="etnb_MilestonePayment_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_OperatingExpensesAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="etnb_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract" xlink:to="etnb_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MeasurementInputPriceVolatilityMember" xlink:to="us-gaap_MeasurementInputPriceVolatilityMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="etnb_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract" xlink:to="etnb_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CurrentFederalTaxExpenseBenefit" xlink:to="us-gaap_CurrentFederalTaxExpenseBenefit_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="etnb_WarrantsAndRightsOutstandingMaturityDateDescription" xlink:to="etnb_WarrantsAndRightsOutstandingMaturityDateDescription_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="us-gaap_ScheduleOfStockByClassTable_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredFederalIncomeTaxExpenseBenefit_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="etnb_TwoThousandAndNineteenEquityIncentivePlanMember" xlink:to="etnb_TwoThousandAndNineteenEquityIncentivePlanMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="etnb_IncomeTaxDisclosureTable" xlink:to="etnb_IncomeTaxDisclosureTable_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchMember" xlink:to="us-gaap_ResearchMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="etnb_OtherRisksAndUncertaintiesPolicyTextBlock" xlink:to="etnb_OtherRisksAndUncertaintiesPolicyTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseAndRentalExpense" xlink:to="us-gaap_LeaseAndRentalExpense_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:to="us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="etnb_ScheduleOfEffectiveIncomeTaxRateOfCompanyAndSubsidiariesTableTextBlock" xlink:to="etnb_ScheduleOfEffectiveIncomeTaxRateOfCompanyAndSubsidiariesTableTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="etnb_AssetTransferAndLicenseAgreementInitialNonrefundableUpfrontPayment" xlink:to="etnb_AssetTransferAndLicenseAgreementInitialNonrefundableUpfrontPayment_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LineOfCreditFacilityInterestRateDescription" xlink:to="us-gaap_LineOfCreditFacilityInterestRateDescription_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="etnb_WarrantTermLoanOneMember" xlink:to="etnb_WarrantTermLoanOneMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:to="us-gaap_OtherComprehensiveIncomeLossNetOfTax_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ValuationTechniqueOptionPricingModelMember" xlink:to="us-gaap_ValuationTechniqueOptionPricingModelMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="etnb_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfWithholdingTaxes" xlink:to="etnb_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfWithholdingTaxes_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment" xlink:to="us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:to="us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapitalMember" xlink:to="us-gaap_AdditionalPaidInCapitalMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:to="us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LineOfCreditFacilityExpirationDate1" xlink:to="us-gaap_LineOfCreditFacilityExpirationDate1_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:to="us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:to="us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareTextBlock" xlink:to="us-gaap_EarningsPerShareTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_StatementClassOfStockAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentMaturityDate" xlink:to="us-gaap_DebtInstrumentMaturityDate_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensation" xlink:to="us-gaap_ShareBasedCompensation_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="etnb_PrepaidResearchAndDevelopmentCurrent" xlink:to="etnb_PrepaidResearchAndDevelopmentCurrent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentNet" xlink:to="us-gaap_PropertyPlantAndEquipmentNet_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentUnamortizedDiscount" xlink:to="us-gaap_DebtInstrumentUnamortizedDiscount_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementLineItems_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="etnb_ShareBasedCompensationArrangementByShareBasedPaymentAwardRemainingOptionsVestingPeriod" xlink:to="etnb_ShareBasedCompensationArrangementByShareBasedPaymentAwardRemainingOptionsVestingPeriod_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsPayable" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayable_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockMember" xlink:to="us-gaap_CommonStockMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="etnb_StockIssuedDuringPeriodSharesWarrantsExercised" xlink:to="etnb_StockIssuedDuringPeriodSharesWarrantsExercised_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:to="us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_EquityComponentDomain_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:to="us-gaap_FairValueMeasurementPolicyPolicyTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="etnb_WarrantsToPurchaseCommonStockPolicyTextBlock" xlink:to="etnb_WarrantsToPurchaseCommonStockPolicyTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="etnb_PreFundedWarrantsMember" xlink:to="etnb_PreFundedWarrantsMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_StatementGeographicalAxis" xlink:to="srt_StatementGeographicalAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestPaidNet" xlink:to="us-gaap_InterestPaidNet_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="etnb_UnvestedRestrictedStockUnitsMember" xlink:to="etnb_UnvestedRestrictedStockUnitsMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="country_US" xlink:to="country_US_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightOutstanding" xlink:to="us-gaap_ClassOfWarrantOrRightOutstanding_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="country_LT" xlink:to="country_LT_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AllocatedShareBasedCompensationExpense" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="etnb_StockIssuedDuringPeriodSharesCashlessExerciseOfWarrants" xlink:to="etnb_StockIssuedDuringPeriodSharesCashlessExerciseOfWarrants_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:to="us-gaap_DebtInstrumentInterestRateDuringPeriod_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="us-gaap_LossContingenciesLineItems_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="etnb_TwoThousandAndTwentyOneLoanAgreementMember" xlink:to="etnb_TwoThousandAndTwentyOneLoanAgreementMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ClassOfStockLineItems_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="etnb_DeferredTaxAssetsLeaseLiability" xlink:to="etnb_DeferredTaxAssetsLeaseLiability_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="us-gaap_SignificantAccountingPoliciesTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="etnb_DebtInstrumentEarlyPrepaymentFee" xlink:to="etnb_DebtInstrumentEarlyPrepaymentFee_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="etnb_TermLoanCurrent" xlink:to="etnb_TermLoanCurrent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MeasurementInputExpectedTermMember" xlink:to="us-gaap_MeasurementInputExpectedTermMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestrictedStockUnitsRSUMember" xlink:to="us-gaap_RestrictedStockUnitsRSUMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:to="us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="etnb_NumberOfSharesIssuableUnderShareBasedPaymentArrangement" xlink:to="etnb_NumberOfSharesIssuableUnderShareBasedPaymentArrangement_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConsolidationPolicyTextBlock" xlink:to="us-gaap_ConsolidationPolicyTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WarrantMember" xlink:to="us-gaap_WarrantMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesOutstanding" xlink:to="us-gaap_CommonStockSharesOutstanding_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:to="us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueInputsLevel2Member" xlink:to="us-gaap_FairValueInputsLevel2Member_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtSecurities_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:to="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingencies" xlink:to="us-gaap_CommitmentsAndContingencies_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesIssued" xlink:to="us-gaap_CommonStockSharesIssued_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="etnb_TevaAgreementMember" xlink:to="etnb_TevaAgreementMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_VariableRateDomain" xlink:to="us-gaap_VariableRateDomain_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_MinimumMember" xlink:to="srt_MinimumMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="etnb_NumberOfPrefundedWarrantsIssuedDuringPeriod" xlink:to="etnb_NumberOfPrefundedWarrantsIssuedDuringPeriod_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestrictedCashCurrent" xlink:to="us-gaap_RestrictedCashCurrent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeLeasesPolicyTextBlock" xlink:to="us-gaap_LesseeLeasesPolicyTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:to="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TaxCreditCarryforwardAxis" xlink:to="us-gaap_TaxCreditCarryforwardAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedLiabilitiesCurrent" xlink:to="us-gaap_AccruedLiabilitiesCurrent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquityAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_VariableLeasePayment" xlink:to="us-gaap_VariableLeasePayment_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CurrentForeignTaxExpenseBenefit" xlink:to="us-gaap_CurrentForeignTaxExpenseBenefit_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:to="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_AwardTypeAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="etnb_OtherNonCurrentLiability" xlink:to="etnb_OtherNonCurrentLiability_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventMember" xlink:to="us-gaap_SubsequentEventMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="etnb_AssetTransferAndLicenseAgreementTerminationPeriodNoticeOfFailure" xlink:to="etnb_AssetTransferAndLicenseAgreementTerminationPeriodNoticeOfFailure_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RealizedInvestmentGainsLosses" xlink:to="us-gaap_RealizedInvestmentGainsLosses_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsGross_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LossContingenciesTable" xlink:to="us-gaap_LossContingenciesTable_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:to="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="etnb_AgencyDiscountSecuritiesMember" xlink:to="etnb_AgencyDiscountSecuritiesMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpense" xlink:to="us-gaap_ResearchAndDevelopmentExpense_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:to="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WarrantsAndRightsOutstandingMaturityDate" xlink:to="us-gaap_WarrantsAndRightsOutstandingMaturityDate_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="etnb_ObligationToPaymentUponMaximumAchievementOfCertainClinicalAndCommercialMilestones" xlink:to="etnb_ObligationToPaymentUponMaximumAchievementOfCertainClinicalAndCommercialMilestones_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_AccountingPoliciesAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="etnb_TermBLoanFacilityMember" xlink:to="etnb_TermBLoanFacilityMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="us-gaap_FairValueByMeasurementFrequencyAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:to="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="etnb_LoanAndSecurityAgreementMember" xlink:to="etnb_LoanAndSecurityAgreementMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventTable" xlink:to="us-gaap_SubsequentEventTable_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GeneralAndAdministrativeExpense" xlink:to="us-gaap_GeneralAndAdministrativeExpense_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="etnb_ShortTermAvailableForSaleSecuritiesCurrent" xlink:to="etnb_ShortTermAvailableForSaleSecuritiesCurrent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MeasurementInputTypeDomain" xlink:to="us-gaap_MeasurementInputTypeDomain_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpenseMember" xlink:to="us-gaap_ResearchAndDevelopmentExpenseMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="etnb_EquityIncentivePlanMember" xlink:to="etnb_EquityIncentivePlanMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsMember" xlink:to="us-gaap_RetainedEarningsMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="etnb_TwentyTwentyThreeLoanAgreementMember" xlink:to="etnb_TwentyTwentyThreeLoanAgreementMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TaxCreditCarryforwardNameDomain" xlink:to="us-gaap_TaxCreditCarryforwardNameDomain_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="etnb_AssetTransferAndLicenseAgreementTerminationNoticePeriodIfBankruptcyPetitionFiled" xlink:to="etnb_AssetTransferAndLicenseAgreementTerminationNoticePeriodIfBankruptcyPetitionFiled_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MoneyMarketFundsMember" xlink:to="us-gaap_MoneyMarketFundsMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="etnb_ShareBasedCompensationArrangementByShareBasedPaymentAwardAnniversary" xlink:to="etnb_ShareBasedCompensationArrangementByShareBasedPaymentAwardAnniversary_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MeasurementInputTypeAxis" xlink:to="us-gaap_MeasurementInputTypeAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="us-gaap_EffectiveIncomeTaxRateContinuingOperations_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis" xlink:to="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="etnb_StockAndWarrantsIssuedDuringPeriodSharesNewIssues" xlink:to="etnb_StockAndWarrantsIssuedDuringPeriodSharesNewIssues_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLossCarryforwardsLimitationsOnUse" xlink:to="us-gaap_OperatingLossCarryforwardsLimitationsOnUse_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseholdImprovementsMember" xlink:to="us-gaap_LeaseholdImprovementsMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="etnb_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="etnb_SummaryOfSignificantAccountingPoliciesLineItems_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnrecognizedTaxBenefits" xlink:to="us-gaap_UnrecognizedTaxBenefits_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="us-gaap_DebtDisclosureAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IPOMember" xlink:to="us-gaap_IPOMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MunicipalBondsMember" xlink:to="us-gaap_MunicipalBondsMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease" xlink:to="us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_IncomeStatementLocationDomain_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MeasurementInputRiskFreeInterestRateMember" xlink:to="us-gaap_MeasurementInputRiskFreeInterestRateMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="etnb_UABEightyNineBioLithuaniaMember" xlink:to="etnb_UABEightyNineBioLithuaniaMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="etnb_TrancheTwoAndThreeMember" xlink:to="etnb_TrancheTwoAndThreeMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesOutstanding" xlink:to="us-gaap_SharesOutstanding_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:to="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationDateOfIncorporation" xlink:to="dei_EntityIncorporationDateOfIncorporation_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="us-gaap_DebtInstrumentNameDomain_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="us-gaap_ClassOfWarrantOrRightAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="etnb_TermALoanFacilityMember" xlink:to="etnb_TermALoanFacilityMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestAndOtherIncome" xlink:to="us-gaap_InterestAndOtherIncome_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareBasic" xlink:to="us-gaap_EarningsPerShareBasic_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherPrepaidExpenseCurrent" xlink:to="us-gaap_OtherPrepaidExpenseCurrent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="etnb_TemporaryEquityIssuanceCosts" xlink:to="etnb_TemporaryEquityIssuanceCosts_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_AssetsAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:to="us-gaap_IncreaseDecreaseInAccruedLiabilities_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentAnnualPrincipalPayment" xlink:to="us-gaap_DebtInstrumentAnnualPrincipalPayment_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:to="us-gaap_DeferredTaxAssetsLiabilitiesNet_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherThanTemporaryImpairmentLossDebtSecuritiesPortionRecognizedInEarnings" xlink:to="us-gaap_OtherThanTemporaryImpairmentLossDebtSecuritiesPortionRecognizedInEarnings_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinancialInstrumentAxis" xlink:to="us-gaap_FinancialInstrumentAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="us-gaap_AntidilutiveSecuritiesNameDomain_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxAuthorityAxis" xlink:to="us-gaap_IncomeTaxAuthorityAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ValuationTechniqueAxis" xlink:to="us-gaap_ValuationTechniqueAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsNet" xlink:to="us-gaap_DeferredTaxAssetsNet_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProfitLoss" xlink:to="us-gaap_ProfitLoss_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="etnb_DebtInstrumentFinalPaymentFee" xlink:to="etnb_DebtInstrumentFinalPaymentFee_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrentAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:to="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="etnb_AmortizationOfDebtIssuanceCostsAndAccretionOfFinalPaymentFee" xlink:to="etnb_AmortizationOfDebtIssuanceCostsAndAccretionOfFinalPaymentFee_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:to="us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PayablesAndAccrualsAbstract" xlink:to="us-gaap_PayablesAndAccrualsAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementFrequencyDomain" xlink:to="us-gaap_FairValueMeasurementFrequencyDomain_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="etnb_WarrantPublicOfferingsMember" xlink:to="etnb_WarrantPublicOfferingsMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="etnb_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfWithholdingTaxes" xlink:to="etnb_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfWithholdingTaxes_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="etnb_TevasGlycoPEGylatedFGF21ProgramMember" xlink:to="etnb_TevasGlycoPEGylatedFGF21ProgramMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseRemainingLeaseTerm" xlink:to="us-gaap_LesseeOperatingLeaseRemainingLeaseTerm_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="etnb_SummaryOfAvailableCarryforwardTaxLossesAndCredits" xlink:to="etnb_SummaryOfAvailableCarryforwardTaxLossesAndCredits_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfOtherLongTermDebt" xlink:to="us-gaap_ProceedsFromIssuanceOfOtherLongTermDebt_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_MaximumMember" xlink:to="srt_MaximumMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="etnb_PerformanceRSUsMember" xlink:to="etnb_PerformanceRSUsMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:to="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:to="us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UseOfEstimates" xlink:to="us-gaap_UseOfEstimates_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:to="us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredIncomeTaxLiabilities" xlink:to="us-gaap_DeferredIncomeTaxLiabilities_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentMeasurementInput" xlink:to="us-gaap_DebtInstrumentMeasurementInput_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:to="us-gaap_SegmentReportingPolicyPolicyTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="etnb_OperatingLeaseExpirationMonthAndYear" xlink:to="etnb_OperatingLeaseExpirationMonthAndYear_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="etnb_SummaryOfSignificantAccountingPoliciesTable" xlink:to="etnb_SummaryOfSignificantAccountingPoliciesTable_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:to="us-gaap_PropertyPlantAndEquipmentUsefulLife_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ForeignCountryMember" xlink:to="us-gaap_ForeignCountryMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_USGovernmentAgenciesShorttermDebtSecuritiesMember" xlink:to="us-gaap_USGovernmentAgenciesShorttermDebtSecuritiesMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentCarryingAmount" xlink:to="us-gaap_DebtInstrumentCarryingAmount_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesAuthorized" xlink:to="us-gaap_CommonStockSharesAuthorized_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="etnb_DeferredTaxAssets" xlink:to="etnb_DeferredTaxAssets_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="srt_TitleOfIndividualWithRelationshipToEntityDomain_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsOther" xlink:to="us-gaap_DeferredTaxAssetsOther_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:to="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="etnb_SaleOfStockPercentageOfBeneficialOwnershipLimitationBeforeTransaction" xlink:to="etnb_SaleOfStockPercentageOfBeneficialOwnershipLimitationBeforeTransaction_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BalanceSheetLocationAxis" xlink:to="us-gaap_BalanceSheetLocationAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="us-gaap_ComprehensiveIncomeNetOfTax_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LineOfCreditFacilityAverageOutstandingAmount" xlink:to="us-gaap_LineOfCreditFacilityAverageOutstandingAmount_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableCurrent" xlink:to="us-gaap_AccountsPayableCurrent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:to="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="etnb_StockAndWarrantsIssuedDuringPeriodValueNewIssues" xlink:to="etnb_StockAndWarrantsIssuedDuringPeriodValueNewIssues_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_TitleOfIndividualAxis" xlink:to="srt_TitleOfIndividualAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:to="us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentTerm" xlink:to="us-gaap_DebtInstrumentTerm_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:to="us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="etnb_DeferredTaxAssetsTaxCreditCarryforwardsResearchFederal" xlink:to="etnb_DeferredTaxAssetsTaxCreditCarryforwardsResearchFederal_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="etnb_TrancheFourMember" xlink:to="etnb_TrancheFourMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives" xlink:to="us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtTextBlock" xlink:to="us-gaap_LongTermDebtTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="etnb_PercentageOfFeeOnLoan" xlink:to="etnb_PercentageOfFeeOnLoan_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentLineItems_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="etnb_AccruedResearchAndDevelopmentExpensesPolicyTextBlock" xlink:to="etnb_AccruedResearchAndDevelopmentExpensesPolicyTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="country_IL" xlink:to="country_IL_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:to="us-gaap_NoncashInvestingAndFinancingItemsAbstract_lbl"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>17
<FILENAME>etnb-20221231.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- DFIN New ActiveDisclosure (SM) XBRL Schema Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date :2023-03-14T17:27:58.5756+00:00 -->
<!-- Copyright (c) 2023 Donnelly Financial Solutions, Inc. All Rights Reserved. -->
<xsd:schema targetNamespace="http://www.89bio.com/20221231" attributeFormDefault="unqualified" elementFormDefault="qualified" xmlns:country="http://xbrl.sec.gov/country/2022" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:etnb="http://www.89bio.com/20221231" xmlns:enum2="http://xbrl.org/2020/extensible-enumerations-2.0" xmlns:srt="http://fasb.org/srt/2022" xmlns:stpr="http://xbrl.sec.gov/stpr/2022" xmlns:us-gaap="http://fasb.org/us-gaap/2022" xmlns:xlink="http://www.w3.org/1999/xlink">
  <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/instance"/>
  <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/linkbase"/>
  <xsd:import schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" namespace="http://xbrl.org/2005/xbrldt"/>
  <xsd:import schemaLocation="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd" namespace="http://xbrl.sec.gov/stpr/2022"/>
  <xsd:import schemaLocation="https://xbrl.sec.gov/dei/2022/dei-2022.xsd" namespace="http://xbrl.sec.gov/dei/2022"/>
  <xsd:import schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd" namespace="http://fasb.org/us-gaap/2022"/>
  <xsd:import schemaLocation="https://xbrl.sec.gov/country/2022/country-2022.xsd" namespace="http://xbrl.sec.gov/country/2022"/>
  <xsd:import schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd" namespace="http://www.xbrl.org/dtr/type/2020-01-21"/>
  <xsd:import schemaLocation="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd" namespace="http://fasb.org/srt/2022"/>
  <xsd:annotation>
    <xsd:appinfo>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="etnb-20221231_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:title="Labels link" xlink:type="simple"/>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="etnb-20221231_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:title="Presentation link" xlink:type="simple"/>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="etnb-20221231_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:title="Definition link" xlink:type="simple"/>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="etnb-20221231_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:title="Calculation link" xlink:type="simple"/>
      <link:roleType roleURI="http://www.89bio.com/20221231/taxonomy/role/Role_DocumentDocumentAndEntityInformation" id="Role_DocumentDocumentAndEntityInformation">
        <link:definition>100000 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.89bio.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets" id="Role_StatementConsolidatedBalanceSheets">
        <link:definition>100010 - Statement - Consolidated Balance Sheets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.89bio.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumLeasePaymentsUnderNoncancellableOperatingLeaseObligationsDetails2" id="DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumLeasePaymentsUnderNoncancellableOperatingLeaseObligationsDetails2">
        <link:definition>100020 - Disclosure - Commitments and Contingencies - Schedule of Future Minimum Lease Payments Under Non-cancellable Operating Lease Obligations (Details) 2</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.89bio.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheetsParenthetical" id="Role_StatementConsolidatedBalanceSheetsParenthetical">
        <link:definition>100030 - Statement - Consolidated Balance Sheets (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.89bio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss" id="Role_StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss">
        <link:definition>100040 - Statement - Consolidated Statements of Operations and Comprehensive Loss</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.89bio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfStockholdersEquityDeficit" id="Role_StatementConsolidatedStatementsOfStockholdersEquityDeficit">
        <link:definition>100050 - Statement - Consolidated Statements of Stockholders' Equity (Deficit)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.89bio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfStockholdersEquityParenthetical" id="Role_StatementConsolidatedStatementsOfStockholdersEquityParenthetical">
        <link:definition>100060 - Statement - Consolidated Statements of Stockholders' Equity (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.89bio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows" id="Role_StatementConsolidatedStatementsOfCashFlows">
        <link:definition>100070 - Statement - Consolidated Statements of Cash Flows</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureOrganizationAndBasisOfPresentation" id="Role_DisclosureOrganizationAndBasisOfPresentation">
        <link:definition>100080 - Disclosure - Organization and Basis of Presentation</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPolicies" id="Role_DisclosureSummaryOfSignificantAccountingPolicies">
        <link:definition>100090 - Disclosure - Summary of Significant Accounting Policies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureFairValueMeasurements" id="Role_DisclosureFairValueMeasurements">
        <link:definition>100100 - Disclosure - Fair Value Measurements</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureConsolidatedBalanceSheetComponents" id="Role_DisclosureConsolidatedBalanceSheetComponents">
        <link:definition>100110 - Disclosure - Consolidated Balance Sheet Components</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureCommitmentsAndContingencies" id="Role_DisclosureCommitmentsAndContingencies">
        <link:definition>100120 - Disclosure - Commitments and Contingencies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureTermLoan" id="Role_DisclosureTermLoan">
        <link:definition>100130 - Disclosure - Term Loan</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.89bio.com/20221231/taxonomy/role/DisclosureStockholdersEquity1" id="DisclosureStockholdersEquity1">
        <link:definition>100140 - Disclosure - Stockholders' Equity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureStockBasedCompensation" id="Role_DisclosureStockBasedCompensation">
        <link:definition>100150 - Disclosure - Stock-Based Compensation</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxes" id="Role_DisclosureIncomeTaxes">
        <link:definition>100160 - Disclosure - Income Taxes</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureNetLossPerShare" id="Role_DisclosureNetLossPerShare">
        <link:definition>100170 - Disclosure - Net Loss Per Share</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureSubsequentEvents" id="Role_DisclosureSubsequentEvents">
        <link:definition>100180 - Disclosure - Subsequent Events</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies" id="Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies">
        <link:definition>100190 - Disclosure - Summary of Significant Accounting Policies (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureFairValueMeasurementsTables" id="Role_DisclosureFairValueMeasurementsTables">
        <link:definition>100200 - Disclosure - Fair Value Measurements (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureConsolidatedBalanceSheetComponentsTables" id="Role_DisclosureConsolidatedBalanceSheetComponentsTables">
        <link:definition>100210 - Disclosure - Consolidated Balance Sheet Components (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesTables" id="Role_DisclosureCommitmentsAndContingenciesTables">
        <link:definition>100220 - Disclosure - Commitments and Contingencies (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureTermLoanTables" id="Role_DisclosureTermLoanTables">
        <link:definition>100230 - Disclosure - Term Loan (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureStockBasedCompensationTables" id="Role_DisclosureStockBasedCompensationTables">
        <link:definition>100240 - Disclosure - Stock-Based Compensation (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.89bio.com/20221231/taxonomy/role/DisclosureStockholdersEquityTables" id="DisclosureStockholdersEquityTables">
        <link:definition>100250 - Disclosure - Stockholders' Equity (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesTables" id="Role_DisclosureIncomeTaxesTables">
        <link:definition>100260 - Disclosure - Income Taxes (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureNetLossPerShareTables" id="Role_DisclosureNetLossPerShareTables">
        <link:definition>100270 - Disclosure - Net Loss Per Share (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureOrganizationAndBasisOfPresentationAdditionalInformationDetails" id="Role_DisclosureOrganizationAndBasisOfPresentationAdditionalInformationDetails">
        <link:definition>100280 - Disclosure - Organization and Basis of Presentation - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails" id="Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails">
        <link:definition>100290 - Disclosure - Summary of Significant Accounting Policies - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureFairValueMeasurementsSummaryOfFinancialAssetsMeasuredAtFairValueOnRecurringBasisDetails" id="Role_DisclosureFairValueMeasurementsSummaryOfFinancialAssetsMeasuredAtFairValueOnRecurringBasisDetails">
        <link:definition>100300 - Disclosure - Fair Value Measurements - Summary of Financial Assets Measured at Fair Value on Recurring Basis (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfContractualMaturitiesOfCashEquivalentsAndAvailableForSaleSecuritiesDetails" id="Role_DisclosureFairValueMeasurementsScheduleOfContractualMaturitiesOfCashEquivalentsAndAvailableForSaleSecuritiesDetails">
        <link:definition>100310 - Disclosure - Fair Value Measurements - Schedule of Contractual Maturities of Cash Equivalents and Available-for-Sale Securities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureConsolidatedBalanceSheetComponentsScheduleOfPrepaidAndOtherCurrentAssetsDetails" id="Role_DisclosureConsolidatedBalanceSheetComponentsScheduleOfPrepaidAndOtherCurrentAssetsDetails">
        <link:definition>100320 - Disclosure - Consolidated Balance Sheet Components - Schedule of Prepaid and Other Current Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureConsolidatedBalanceSheetComponentsScheduleOfAccruedExpensesDetails" id="Role_DisclosureConsolidatedBalanceSheetComponentsScheduleOfAccruedExpensesDetails">
        <link:definition>100330 - Disclosure - Consolidated Balance Sheet Components - Schedule of Accrued Expenses (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails" id="Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails">
        <link:definition>100340 - Disclosure - Commitments and Contingencies - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumLeasePaymentsUnderNonCancellableOperatingLeaseObligationsDetails" id="Role_DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumLeasePaymentsUnderNonCancellableOperatingLeaseObligationsDetails">
        <link:definition>100350 - Disclosure - Commitments and Contingencies - Schedule of Future Minimum Lease Payments Under Non-cancellable Operating Lease Obligations (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.89bio.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumAnnualPaymentsForOperatingLeasesDetails" id="DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumAnnualPaymentsForOperatingLeasesDetails">
        <link:definition>100360 - Disclosure - Commitments and Contingencies - Schedule of Future Minimum Annual Payments for Operating Leases (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureTermLoanAdditionalInformationDetails" id="Role_DisclosureTermLoanAdditionalInformationDetails">
        <link:definition>100370 - Disclosure - Term Loan - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.89bio.com/20221231/taxonomy/role/DisclosureStockholdersEquityScheduleOfSharesOfCommonStockAvailableForFutureIssuanceDetails" id="DisclosureStockholdersEquityScheduleOfSharesOfCommonStockAvailableForFutureIssuanceDetails">
        <link:definition>100380 - Disclosure - Stockholders' Equity - Schedule of Shares of Common Stock Available for Future Issuance (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.89bio.com/20221231/taxonomy/role/DisclosureStockholdersEquityAdditionalInformationDetails" id="DisclosureStockholdersEquityAdditionalInformationDetails">
        <link:definition>100390 - Disclosure - Stockholders' Equity - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.89bio.com/20221231/taxonomy/role/DisclosureStockholdersEquityScheduleOfOutstandingWarrantsToPurchaseSharesOfCommonStockDetails" id="DisclosureStockholdersEquityScheduleOfOutstandingWarrantsToPurchaseSharesOfCommonStockDetails">
        <link:definition>100400 - Disclosure - Stockholders' Equity - Schedule of Outstanding Warrants to Purchase Shares of Common Stock (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails" id="Role_DisclosureStockBasedCompensationAdditionalInformationDetails">
        <link:definition>100410 - Disclosure - Stock-Based Compensation - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockOptionActivityDetails" id="Role_DisclosureStockBasedCompensationSummaryOfStockOptionActivityDetails">
        <link:definition>100420 - Disclosure - Stock-Based Compensation - Summary of Stock Option Activity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfEstimatedFairValueOfStockOptionsGrantedUsingBlackScholesOptionPricingModelDetails" id="Role_DisclosureStockBasedCompensationSummaryOfEstimatedFairValueOfStockOptionsGrantedUsingBlackScholesOptionPricingModelDetails">
        <link:definition>100430 - Disclosure - Stock-Based Compensation - Summary of Estimated Fair Value of Stock Options Granted Using Black-Scholes Option-Pricing Model (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.89bio.com/20221231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfRestrictedStockUnitActivityDetails" id="DisclosureStockbasedCompensationSummaryOfRestrictedStockUnitActivityDetails">
        <link:definition>100440 - Disclosure - Stock-Based Compensation - Summary of Restricted Stock Unit Activity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockBasedCompensationDetails" id="Role_DisclosureStockBasedCompensationSummaryOfStockBasedCompensationDetails">
        <link:definition>100450 - Disclosure - Stock-Based Compensation - Summary of Stock-Based Compensation (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesSummaryOfStatutoryTaxRatesApplicableToIncomeOfCompanyAndSubsidiariesDetails" id="Role_DisclosureIncomeTaxesSummaryOfStatutoryTaxRatesApplicableToIncomeOfCompanyAndSubsidiariesDetails">
        <link:definition>100460 - Disclosure - Income Taxes - Summary of Statutory Tax Rates Applicable to Income of Company and Subsidiaries (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.89bio.com/20221231/taxonomy/role/DisclosureIncomeTaxesSummaryOfIncomeTaxExpenseBenefitDetails" id="DisclosureIncomeTaxesSummaryOfIncomeTaxExpenseBenefitDetails">
        <link:definition>100470 - Disclosure - Income Taxes - Summary of Income Tax (Expense) Benefit (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesSummaryOfComponentsOfDeferredTaxAssetsDetails" id="Role_DisclosureIncomeTaxesSummaryOfComponentsOfDeferredTaxAssetsDetails">
        <link:definition>100480 - Disclosure - Income Taxes - Summary of Components of Deferred Tax Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetails" id="Role_DisclosureIncomeTaxesAdditionalInformationDetails">
        <link:definition>100490 - Disclosure - Income Taxes - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesSummaryOfLossFromOperationsBeforeTaxesOnIncomeDetails" id="Role_DisclosureIncomeTaxesSummaryOfLossFromOperationsBeforeTaxesOnIncomeDetails">
        <link:definition>100500 - Disclosure - Income Taxes - Summary of Loss from Operations Before Taxes on Income (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.89bio.com/20221231/taxonomy/role/DisclosureIncomeTaxesSummaryOfReconciliationOfIncomeTaxExpenseBenefitStatutoryTaxRateToEffectiveTaxRateDetails" id="DisclosureIncomeTaxesSummaryOfReconciliationOfIncomeTaxExpenseBenefitStatutoryTaxRateToEffectiveTaxRateDetails">
        <link:definition>100510 - Disclosure - Income Taxes - Summary of Reconciliation of Income Tax (Expense) Benefit Statutory Tax Rate to Effective Tax Rate (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.89bio.com/20221231/taxonomy/role/DisclosureIncomeTaxesSummaryOfAReconciliationOfTheBeginningAndEndingAmountOfUnrecognizedTaxBenefitsDetails" id="DisclosureIncomeTaxesSummaryOfAReconciliationOfTheBeginningAndEndingAmountOfUnrecognizedTaxBenefitsDetails">
        <link:definition>100520 - Disclosure - Income Taxes - Summary of a Reconciliation of The Beginning And Ending Amount of Unrecognized Tax Benefits (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureNetLossPerShareScheduleOfOutstandingPotentiallyDilutiveSecuritiesExcludedFromCalculationOfDilutedNetLossDetails" id="Role_DisclosureNetLossPerShareScheduleOfOutstandingPotentiallyDilutiveSecuritiesExcludedFromCalculationOfDilutedNetLossDetails">
        <link:definition>100530 - Disclosure - Net Loss Per Share - Schedule of Outstanding Potentially Dilutive Securities Excluded From Calculation of Diluted Net Loss (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.89bio.com/20221231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails" id="DisclosureSubsequentEventsAdditionalInformationDetails">
        <link:definition>100540 - Disclosure - Subsequent Events - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xsd:appinfo>
  </xsd:annotation>
  <xsd:element id="etnb_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="etnb_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="etnb_AccruedResearchAndDevelopmentExpenseCurrent" name="AccruedResearchAndDevelopmentExpenseCurrent" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="etnb_AccumulatedTaxLossCarryForward" name="AccumulatedTaxLossCarryForward" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="etnb_AmortizationOfDebtIssuanceCostsAndAccretionOfFinalPaymentFee" name="AmortizationOfDebtIssuanceCostsAndAccretionOfFinalPaymentFee" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="etnb_AmortizationPeriod" name="AmortizationPeriod" type="xbrli:durationItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="etnb_AssetTransferAndLicenseAgreementInitialNonrefundableUpfrontPayment" name="AssetTransferAndLicenseAgreementInitialNonrefundableUpfrontPayment" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="etnb_AssetTransferAndLicenseAgreementTerminationNoticePeriodIfBankruptcyPetitionFiled" name="AssetTransferAndLicenseAgreementTerminationNoticePeriodIfBankruptcyPetitionFiled" type="xbrli:durationItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="etnb_AssetTransferAndLicenseAgreementTerminationPeriodAfterWrittenNotice" name="AssetTransferAndLicenseAgreementTerminationPeriodAfterWrittenNotice" type="xbrli:durationItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="etnb_AssetTransferAndLicenseAgreementTerminationPeriodNoticeOfFailure" name="AssetTransferAndLicenseAgreementTerminationPeriodNoticeOfFailure" type="xbrli:durationItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="etnb_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughTwoYearsFairValue" name="AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughTwoYearsFairValue" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="etnb_BeneficialOwnershipLimitationOnExerciseOfWarrant" name="BeneficialOwnershipLimitationOnExerciseOfWarrant" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="etnb_CommonStockAndWarrantsCombinedOfferingPricePerShare" name="CommonStockAndWarrantsCombinedOfferingPricePerShare" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false"/>
  <xsd:element id="etnb_DebtInstrumentEarlyPrepaymentFee" name="DebtInstrumentEarlyPrepaymentFee" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="etnb_DebtInstrumentFinalPaymentFee" name="DebtInstrumentFinalPaymentFee" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="etnb_DeferredTaxAssets" name="DeferredTaxAssets" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="etnb_DeferredTaxAssetsLeaseLiability" name="DeferredTaxAssetsLeaseLiability" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="etnb_DeferredTaxAssetsTaxCreditCarryforwardsResearchFederal" name="DeferredTaxAssetsTaxCreditCarryforwardsResearchFederal" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="etnb_DeferredTaxLiabilitiesRightsOfUseAssets" name="DeferredTaxLiabilitiesRightsOfUseAssets" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="etnb_EffectiveIncomeTaxRateReconciliationStateDeferredTaxTrueUpDueToChangeInApportionment" name="EffectiveIncomeTaxRateReconciliationStateDeferredTaxTrueUpDueToChangeInApportionment" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="etnb_FairValueOfWarrantsAssumptionsDividends" name="FairValueOfWarrantsAssumptionsDividends" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="etnb_IncomeTaxReconciliationChangeInEffectiveTaxRateDueToReorganization" name="IncomeTaxReconciliationChangeInEffectiveTaxRateDueToReorganization" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="etnb_IssuanceOfCommonStockWarrantInConnectionWithTermLoanFacility" name="IssuanceOfCommonStockWarrantInConnectionWithTermLoanFacility" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="etnb_IssuanceOfCommonStockWarrantsInConnectionWithDebtFinancing" name="IssuanceOfCommonStockWarrantsInConnectionWithDebtFinancing" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="etnb_LineOfCreditFacilityIncreaseInBorrowingCapacity" name="LineOfCreditFacilityIncreaseInBorrowingCapacity" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="etnb_MaximumAmountOfEquitySharesIssuable" name="MaximumAmountOfEquitySharesIssuable" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="etnb_MilestonePayment" name="MilestonePayment" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="etnb_NetCashProceedsFromSaleOfEquitySecurities" name="NetCashProceedsFromSaleOfEquitySecurities" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="etnb_NumberOfPrefundedWarrantsIssuedDuringPeriod" name="NumberOfPrefundedWarrantsIssuedDuringPeriod" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="etnb_NumberOfSharesIssuableUnderShareBasedPaymentArrangement" name="NumberOfSharesIssuableUnderShareBasedPaymentArrangement" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="etnb_ObligationToPaymentUponMaximumAchievementOfCertainClinicalAndCommercialMilestones" name="ObligationToPaymentUponMaximumAchievementOfCertainClinicalAndCommercialMilestones" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="etnb_OperatingLeaseExpirationMonthAndYear" name="OperatingLeaseExpirationMonthAndYear" type="xbrli:gYearMonthItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="etnb_OtherNonCurrentLiability" name="OtherNonCurrentLiability" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="etnb_PaymentForPurchaseOfAvailableForSaleSecurities" name="PaymentForPurchaseOfAvailableForSaleSecurities" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="etnb_PercentageOfFeeOnLoan" name="PercentageOfFeeOnLoan" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="etnb_PercentageOfIncreaseInNumberOfSharesOfCapitalStockIssuedAndOutstanding" name="PercentageOfIncreaseInNumberOfSharesOfCapitalStockIssuedAndOutstanding" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="etnb_PeriodForIncreaseInNumberOfSharesOfCommonStockReservedForIssuance" name="PeriodForIncreaseInNumberOfSharesOfCommonStockReservedForIssuance" type="xbrli:durationItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="etnb_PrefundedAndCommonStockWarrants" name="PrefundedAndCommonStockWarrants" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false"/>
  <xsd:element id="etnb_PrepaidResearchAndDevelopmentCurrent" name="PrepaidResearchAndDevelopmentCurrent" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="etnb_PrepaymentFeePercentage" name="PrepaymentFeePercentage" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="etnb_ProceedsFromIssuancePublicOffering" name="ProceedsFromIssuancePublicOffering" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="etnb_ProceedsFromIssuancePublicOfferingAtTheMarketOffering" name="ProceedsFromIssuancePublicOfferingAtTheMarketOffering" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="etnb_RemeasurementOfLeaseLiabilityAndRightOfUseAssetInConnectionWithLeaseModification" name="RemeasurementOfLeaseLiabilityAndRightOfUseAssetInConnectionWithLeaseModification" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="etnb_SaleOfStockPercentageOfBeneficialOwnershipLimitationBeforeTransaction" name="SaleOfStockPercentageOfBeneficialOwnershipLimitationBeforeTransaction" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="etnb_SellingCommissionPerSharesSoldPercentage" name="SellingCommissionPerSharesSoldPercentage" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false"/>
  <xsd:element id="etnb_ShareBasedCompensationArrangementByShareBasedPaymentAwardAnniversary" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardAnniversary" type="xbrli:durationItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="etnb_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantDateFairValue" name="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantDateFairValue" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="etnb_ShareBasedCompensationArrangementByShareBasedPaymentAwardRemainingOptionsVestingPeriod" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardRemainingOptionsVestingPeriod" type="xbrli:durationItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="etnb_ShareBasedCompensationArrangementByShareBasedPaymentFirstOfferingPeriodCommencementDate" name="ShareBasedCompensationArrangementByShareBasedPaymentFirstOfferingPeriodCommencementDate" type="xbrli:dateItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="etnb_ShortTermAvailableForSaleSecuritiesCurrent" name="ShortTermAvailableForSaleSecuritiesCurrent" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="etnb_StockAndWarrantsIssuedDuringPeriodSharesNewIssues" name="StockAndWarrantsIssuedDuringPeriodSharesNewIssues" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="etnb_StockAndWarrantsIssuedDuringPeriodValueNewIssues" name="StockAndWarrantsIssuedDuringPeriodValueNewIssues" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="etnb_StockIssuedDuringPeriodSharesCashlessExerciseOfWarrants" name="StockIssuedDuringPeriodSharesCashlessExerciseOfWarrants" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="etnb_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfWithholdingTaxes" name="StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfWithholdingTaxes" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="etnb_StockIssuedDuringPeriodSharesWarrantsExercised" name="StockIssuedDuringPeriodSharesWarrantsExercised" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="etnb_StockIssuedDuringPeriodValueCashlessExerciseOfWarrants" name="StockIssuedDuringPeriodValueCashlessExerciseOfWarrants" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="etnb_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfWithholdingTaxes" name="StockIssuedDuringPeriodValueRestrictedStockAwardNetOfWithholdingTaxes" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="etnb_StockIssuedDuringPeriodValueWarrantsExercised" name="StockIssuedDuringPeriodValueWarrantsExercised" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="etnb_TaxableIncomeUtilizationPercentage" name="TaxableIncomeUtilizationPercentage" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false"/>
  <xsd:element id="etnb_TaxCreditCarryforwardExpirationYear" name="TaxCreditCarryforwardExpirationYear" type="xbrli:gYearItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="etnb_TemporaryEquityIssuanceCosts" name="TemporaryEquityIssuanceCosts" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="etnb_TermLoanCurrent" name="TermLoanCurrent" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="etnb_UnderwritingDiscountsAndCommissions" name="UnderwritingDiscountsAndCommissions" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="etnb_WarrantsAndRightsOutstandingMaturityDateDescription" name="WarrantsAndRightsOutstandingMaturityDateDescription" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="etnb_IncomeTaxDisclosureLineItems" name="IncomeTaxDisclosureLineItems" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="etnb_SummaryOfSignificantAccountingPoliciesLineItems" name="SummaryOfSignificantAccountingPoliciesLineItems" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="etnb_AgencyDiscountSecuritiesMember" name="AgencyDiscountSecuritiesMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="etnb_ATMFacilityMember" name="ATMFacilityMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="etnb_ConvertiblePreferredSharesMember" name="ConvertiblePreferredSharesMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="etnb_EightyNineBioLtdMember" name="EightyNineBioLtdMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="etnb_EightyNineBioManagementIncorporationMember" name="EightyNineBioManagementIncorporationMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="etnb_EquityIncentivePlanMember" name="EquityIncentivePlanMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="etnb_ExerciseOfWarrantsAndPreFundedWarrantsMember" name="ExerciseOfWarrantsAndPreFundedWarrantsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="etnb_LoanAndSecurityAgreementMember" name="LoanAndSecurityAgreementMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="etnb_PerformanceRSUsMember" name="PerformanceRSUsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="etnb_PreFundedWarrantsMember" name="PreFundedWarrantsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="etnb_SanFranciscoOfficeMember" name="SanFranciscoOfficeMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="etnb_ServiceBasedRSUsMember" name="ServiceBasedRSUsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="etnb_SVBLeerinkLLCAndCantorFitzgeraldCoMember" name="SVBLeerinkLLCAndCantorFitzgeraldCoMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="etnb_TermALoanFacilityMember" name="TermALoanFacilityMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="etnb_TermBLoanFacilityMember" name="TermBLoanFacilityMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="etnb_TevaAgreementMember" name="TevaAgreementMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="etnb_TevasDevelopmentProgramMember" name="TevasDevelopmentProgramMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="etnb_TevasGlycoPEGylatedFGF21ProgramMember" name="TevasGlycoPEGylatedFGF21ProgramMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="etnb_TrancheFourMember" name="TrancheFourMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="etnb_TrancheOneMember" name="TrancheOneMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="etnb_TrancheTwoAndThreeMember" name="TrancheTwoAndThreeMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="etnb_TwentyTwentyThreeLoanAgreementMember" name="TwentyTwentyThreeLoanAgreementMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="etnb_TwoThousandAndNineteenEquityIncentivePlanMember" name="TwoThousandAndNineteenEquityIncentivePlanMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="etnb_TwoThousandAndTwentyEquityIncentivePlanMember" name="TwoThousandAndTwentyEquityIncentivePlanMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="etnb_TwoThousandAndTwentyOneLoanAgreementMember" name="TwoThousandAndTwentyOneLoanAgreementMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="etnb_TwoThousandAndTwentyThreeLoanAgreementMember" name="TwoThousandAndTwentyThreeLoanAgreementMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="etnb_UABEightyNineBioLithuaniaMember" name="UABEightyNineBioLithuaniaMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="etnb_UnderwrittenPublicOfferingMember" name="UnderwrittenPublicOfferingMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="etnb_UnvestedRestrictedStockUnitsMember" name="UnvestedRestrictedStockUnitsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="etnb_WarrantPublicOfferingsMember" name="WarrantPublicOfferingsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="etnb_WarrantTermLoanMember" name="WarrantTermLoanMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="etnb_WarrantTermLoanOneMember" name="WarrantTermLoanOneMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="etnb_IncomeTaxDisclosureTable" name="IncomeTaxDisclosureTable" type="xbrli:stringItemType" substitutionGroup="xbrldt:hypercubeItem" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="etnb_SummaryOfSignificantAccountingPoliciesTable" name="SummaryOfSignificantAccountingPoliciesTable" type="xbrli:stringItemType" substitutionGroup="xbrldt:hypercubeItem" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="etnb_AccruedResearchAndDevelopmentExpensesPolicyTextBlock" name="AccruedResearchAndDevelopmentExpensesPolicyTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="etnb_OtherRisksAndUncertaintiesPolicyTextBlock" name="OtherRisksAndUncertaintiesPolicyTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="etnb_ScheduleOfCommonStockReservedForIssuanceTableTextBlock" name="ScheduleOfCommonStockReservedForIssuanceTableTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="etnb_ScheduleOfEffectiveIncomeTaxRateOfCompanyAndSubsidiariesTableTextBlock" name="ScheduleOfEffectiveIncomeTaxRateOfCompanyAndSubsidiariesTableTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="etnb_ScheduleOfPrepaidAndOtherCurrentAssetsTableTextBlock" name="ScheduleOfPrepaidAndOtherCurrentAssetsTableTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="etnb_SummaryOfAvailableCarryforwardTaxLossesAndCredits" name="SummaryOfAvailableCarryforwardTaxLossesAndCredits" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="etnb_WarrantsToPurchaseCommonStockPolicyTextBlock" name="WarrantsToPurchaseCommonStockPolicyTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>18
<FILENAME>etnb-20221231_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- DFIN New ActiveDisclosure (SM) XBRL Linkbase Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date :2023-03-14T17:27:58.3955+00:00 -->
<!-- Copyright (c) 2023 Donnelly Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" xlink:type="simple"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" xlink:type="simple"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" xlink:type="simple"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" xlink:type="simple"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.89bio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfStockholdersEquityDeficit" xlink:href="etnb-20221231.xsd#Role_StatementConsolidatedStatementsOfStockholdersEquityDeficit" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.89bio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfStockholdersEquityParenthetical" xlink:href="etnb-20221231.xsd#Role_StatementConsolidatedStatementsOfStockholdersEquityParenthetical" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.89bio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows" xlink:href="etnb-20221231.xsd#Role_StatementConsolidatedStatementsOfCashFlows" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureOrganizationAndBasisOfPresentationAdditionalInformationDetails" xlink:href="etnb-20221231.xsd#Role_DisclosureOrganizationAndBasisOfPresentationAdditionalInformationDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails" xlink:href="etnb-20221231.xsd#Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureFairValueMeasurementsSummaryOfFinancialAssetsMeasuredAtFairValueOnRecurringBasisDetails" xlink:href="etnb-20221231.xsd#Role_DisclosureFairValueMeasurementsSummaryOfFinancialAssetsMeasuredAtFairValueOnRecurringBasisDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails" xlink:href="etnb-20221231.xsd#Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureTermLoanAdditionalInformationDetails" xlink:href="etnb-20221231.xsd#Role_DisclosureTermLoanAdditionalInformationDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.89bio.com/20221231/taxonomy/role/DisclosureStockholdersEquityScheduleOfSharesOfCommonStockAvailableForFutureIssuanceDetails" xlink:href="etnb-20221231.xsd#DisclosureStockholdersEquityScheduleOfSharesOfCommonStockAvailableForFutureIssuanceDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.89bio.com/20221231/taxonomy/role/DisclosureStockholdersEquityAdditionalInformationDetails" xlink:href="etnb-20221231.xsd#DisclosureStockholdersEquityAdditionalInformationDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.89bio.com/20221231/taxonomy/role/DisclosureStockholdersEquityScheduleOfOutstandingWarrantsToPurchaseSharesOfCommonStockDetails" xlink:href="etnb-20221231.xsd#DisclosureStockholdersEquityScheduleOfOutstandingWarrantsToPurchaseSharesOfCommonStockDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails" xlink:href="etnb-20221231.xsd#Role_DisclosureStockBasedCompensationAdditionalInformationDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockOptionActivityDetails" xlink:href="etnb-20221231.xsd#Role_DisclosureStockBasedCompensationSummaryOfStockOptionActivityDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfEstimatedFairValueOfStockOptionsGrantedUsingBlackScholesOptionPricingModelDetails" xlink:href="etnb-20221231.xsd#Role_DisclosureStockBasedCompensationSummaryOfEstimatedFairValueOfStockOptionsGrantedUsingBlackScholesOptionPricingModelDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.89bio.com/20221231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfRestrictedStockUnitActivityDetails" xlink:href="etnb-20221231.xsd#DisclosureStockbasedCompensationSummaryOfRestrictedStockUnitActivityDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockBasedCompensationDetails" xlink:href="etnb-20221231.xsd#Role_DisclosureStockBasedCompensationSummaryOfStockBasedCompensationDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesSummaryOfStatutoryTaxRatesApplicableToIncomeOfCompanyAndSubsidiariesDetails" xlink:href="etnb-20221231.xsd#Role_DisclosureIncomeTaxesSummaryOfStatutoryTaxRatesApplicableToIncomeOfCompanyAndSubsidiariesDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesSummaryOfComponentsOfDeferredTaxAssetsDetails" xlink:href="etnb-20221231.xsd#Role_DisclosureIncomeTaxesSummaryOfComponentsOfDeferredTaxAssetsDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetails" xlink:href="etnb-20221231.xsd#Role_DisclosureIncomeTaxesAdditionalInformationDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesSummaryOfLossFromOperationsBeforeTaxesOnIncomeDetails" xlink:href="etnb-20221231.xsd#Role_DisclosureIncomeTaxesSummaryOfLossFromOperationsBeforeTaxesOnIncomeDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureNetLossPerShareScheduleOfOutstandingPotentiallyDilutiveSecuritiesExcludedFromCalculationOfDilutedNetLossDetails" xlink:href="etnb-20221231.xsd#Role_DisclosureNetLossPerShareScheduleOfOutstandingPotentiallyDilutiveSecuritiesExcludedFromCalculationOfDilutedNetLossDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.89bio.com/20221231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails" xlink:href="etnb-20221231.xsd#DisclosureSubsequentEventsAdditionalInformationDetails" xlink:type="simple"/>
  <link:definitionLink xlink:type="extended" xlink:role="http://www.89bio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfStockholdersEquityDeficit">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IPOMember" xlink:label="us-gaap_IPOMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="us-gaap_TypeOfArrangementAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember_default"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain_default"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain_default"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_ATMFacilityMember" xlink:label="etnb_ATMFacilityMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesOutstanding" xlink:label="us-gaap_SharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="us-gaap_AdditionalPaidInCapitalMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember" xlink:label="us-gaap_RetainedEarningsMember"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_StockAndWarrantsIssuedDuringPeriodValueNewIssues" xlink:label="etnb_StockAndWarrantsIssuedDuringPeriodValueNewIssues"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_StockAndWarrantsIssuedDuringPeriodSharesNewIssues" xlink:label="etnb_StockAndWarrantsIssuedDuringPeriodSharesNewIssues"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_StockIssuedDuringPeriodValueCashlessExerciseOfWarrants" xlink:label="etnb_StockIssuedDuringPeriodValueCashlessExerciseOfWarrants"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_StockIssuedDuringPeriodSharesCashlessExerciseOfWarrants" xlink:label="etnb_StockIssuedDuringPeriodSharesCashlessExerciseOfWarrants"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_StockIssuedDuringPeriodValueWarrantsExercised" xlink:label="etnb_StockIssuedDuringPeriodValueWarrantsExercised"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_StockIssuedDuringPeriodSharesWarrantsExercised" xlink:label="etnb_StockIssuedDuringPeriodSharesWarrantsExercised"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfWithholdingTaxes" xlink:label="etnb_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfWithholdingTaxes"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfWithholdingTaxes" xlink:label="etnb_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfWithholdingTaxes"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:label="us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:label="us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_IssuanceOfCommonStockWarrantInConnectionWithTermLoanFacility" xlink:label="etnb_IssuanceOfCommonStockWarrantInConnectionWithTermLoanFacility"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_IssuanceOfCommonStockWarrantsInConnectionWithDebtFinancing" xlink:label="etnb_IssuanceOfCommonStockWarrantsInConnectionWithDebtFinancing"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementEquityComponentsAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_IPOMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="etnb_ATMFacilityMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockholdersEquity" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_CommonStockMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SharesOutstanding" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_AdditionalPaidInCapitalMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_TypeOfArrangementAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_RetainedEarningsMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="etnb_StockAndWarrantsIssuedDuringPeriodValueNewIssues" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="etnb_StockAndWarrantsIssuedDuringPeriodSharesNewIssues" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="etnb_StockIssuedDuringPeriodValueCashlessExerciseOfWarrants" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="etnb_StockIssuedDuringPeriodSharesCashlessExerciseOfWarrants" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="8" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="etnb_StockIssuedDuringPeriodValueWarrantsExercised" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="9" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="etnb_StockIssuedDuringPeriodSharesWarrantsExercised" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="etnb_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfWithholdingTaxes" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="11" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="etnb_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfWithholdingTaxes" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="12" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="13" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="14" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="15" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="16" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="etnb_IssuanceOfCommonStockWarrantInConnectionWithTermLoanFacility" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="17" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="18" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="etnb_IssuanceOfCommonStockWarrantsInConnectionWithDebtFinancing" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="19" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetIncomeLoss" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="20" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OtherComprehensiveIncomeLossNetOfTax" priority="2" use="optional"/>
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://www.89bio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfStockholdersEquityParenthetical">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IPOMember" xlink:label="us-gaap_IPOMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="us-gaap_TypeOfArrangementAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_ConvertiblePreferredSharesMember" xlink:label="etnb_ConvertiblePreferredSharesMember"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_ATMFacilityMember" xlink:label="etnb_ATMFacilityMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain_default"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_TemporaryEquityIssuanceCosts" xlink:label="etnb_TemporaryEquityIssuanceCosts"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementClassOfStockAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_IPOMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="etnb_ConvertiblePreferredSharesMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="etnb_ATMFacilityMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="etnb_TemporaryEquityIssuanceCosts" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_TypeOfArrangementAxis" priority="2" use="optional"/>
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://www.89bio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_ProceedsFromIssuancePublicOffering" xlink:label="etnb_ProceedsFromIssuancePublicOffering"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalCashFlowInformationAbstract" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestPaidNet" xlink:label="us-gaap_InterestPaidNet"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss" xlink:label="us-gaap_ProfitLoss"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities" xlink:label="us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation" xlink:label="us-gaap_ShareBasedCompensation"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:label="us-gaap_NoncashInvestingAndFinancingItemsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_RemeasurementOfLeaseLiabilityAndRightOfUseAssetInConnectionWithLeaseModification" xlink:label="etnb_RemeasurementOfLeaseLiabilityAndRightOfUseAssetInConnectionWithLeaseModification"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_ProceedsFromIssuancePublicOfferingAtTheMarketOffering" xlink:label="etnb_ProceedsFromIssuancePublicOfferingAtTheMarketOffering"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeasePaymentsUse" xlink:label="us-gaap_OperatingLeasePaymentsUse"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_PaymentForPurchaseOfAvailableForSaleSecurities" xlink:label="etnb_PaymentForPurchaseOfAvailableForSaleSecurities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:label="us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashCurrent" xlink:label="us-gaap_RestrictedCashCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayable" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_IssuanceOfCommonStockWarrantInConnectionWithTermLoanFacility" xlink:label="etnb_IssuanceOfCommonStockWarrantInConnectionWithTermLoanFacility"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromWarrantExercises" xlink:label="us-gaap_ProceedsFromWarrantExercises"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_AmortizationOfDebtIssuanceCostsAndAccretionOfFinalPaymentFee" xlink:label="etnb_AmortizationOfDebtIssuanceCostsAndAccretionOfFinalPaymentFee"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:label="us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:label="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:label="us-gaap_IncreaseDecreaseInOperatingLeaseLiability"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Depreciation" xlink:label="us-gaap_Depreciation"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:label="us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_DeferredTaxAssets" xlink:label="etnb_DeferredTaxAssets"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfOtherLongTermDebt" xlink:label="us-gaap_ProceedsFromIssuanceOfOtherLongTermDebt"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="etnb_ProceedsFromIssuancePublicOffering" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="us-gaap_InterestPaidNet" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_ProfitLoss" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_ShareBasedCompensation" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:to="etnb_RemeasurementOfLeaseLiabilityAndRightOfUseAssetInConnectionWithLeaseModification" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="etnb_ProceedsFromIssuancePublicOfferingAtTheMarketOffering" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="us-gaap_OperatingLeasePaymentsUse" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="etnb_PaymentForPurchaseOfAvailableForSaleSecurities" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" xlink:to="us-gaap_RestrictedCashCurrent" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:to="etnb_IssuanceOfCommonStockWarrantInConnectionWithTermLoanFacility" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromWarrantExercises" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="etnb_AmortizationOfDebtIssuanceCostsAndAccretionOfFinalPaymentFee" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInAccruedLiabilities" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingLeaseLiability" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_Depreciation" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="etnb_DeferredTaxAssets" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromIssuanceOfOtherLongTermDebt" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SupplementalCashFlowInformationAbstract" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="8" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NoncashInvestingAndFinancingItemsAbstract" priority="2" use="optional"/>
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureOrganizationAndBasisOfPresentationAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockLineItems" xlink:label="us-gaap_SubsidiarySaleOfStockLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:label="us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_UnderwrittenPublicOfferingMember" xlink:label="etnb_UnderwrittenPublicOfferingMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="us-gaap_TypeOfArrangementAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember" xlink:label="srt_RangeMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember" xlink:label="srt_RangeMember_default"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationDateOfIncorporation" xlink:label="dei_EntityIncorporationDateOfIncorporation"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_ATMFacilityMember" xlink:label="etnb_ATMFacilityMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsAndShortTermInvestments" xlink:label="us-gaap_CashCashEquivalentsAndShortTermInvestments"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_SVBLeerinkLLCAndCantorFitzgeraldCoMember" xlink:label="etnb_SVBLeerinkLLCAndCantorFitzgeraldCoMember"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="etnb_UnderwrittenPublicOfferingMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="dei_EntityIncorporationDateOfIncorporation" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="etnb_ATMFacilityMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_CommonStockMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="us-gaap_StatementEquityComponentsAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="us-gaap_CashCashEquivalentsAndShortTermInvestments" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="etnb_SVBLeerinkLLCAndCantorFitzgeraldCoMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="us-gaap_TypeOfArrangementAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="srt_RangeAxis" priority="2" use="optional"/>
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_SummaryOfSignificantAccountingPoliciesLineItems" xlink:label="etnb_SummaryOfSignificantAccountingPoliciesLineItems"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_SummaryOfSignificantAccountingPoliciesTable" xlink:label="etnb_SummaryOfSignificantAccountingPoliciesTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember" xlink:label="srt_RangeMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfAdoptionMember" xlink:label="us-gaap_TypeOfAdoptionMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingStandardsUpdate201602Member" xlink:label="us-gaap_AccountingStandardsUpdate201602Member"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:label="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfAdoptionMember" xlink:label="us-gaap_TypeOfAdoptionMember_default"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfOperatingSegments" xlink:label="us-gaap_NumberOfOperatingSegments"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain_default"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseholdImprovementsMember" xlink:label="us-gaap_LeaseholdImprovementsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives" xlink:label="us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted" xlink:label="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdoptionDate" xlink:label="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdoptionDate"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherThanTemporaryImpairmentLossDebtSecuritiesPortionRecognizedInEarnings" xlink:label="us-gaap_OtherThanTemporaryImpairmentLossDebtSecuritiesPortionRecognizedInEarnings"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RealizedInvestmentGainsLosses" xlink:label="us-gaap_RealizedInvestmentGainsLosses"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="etnb_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="etnb_SummaryOfSignificantAccountingPoliciesTable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TypeOfAdoptionMember" xlink:to="us-gaap_AccountingStandardsUpdate201602Member" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:to="us-gaap_TypeOfAdoptionMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:to="us-gaap_TypeOfAdoptionMember_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="etnb_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_NumberOfOperatingSegments" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="etnb_SummaryOfSignificantAccountingPoliciesTable" xlink:to="srt_RangeAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_LeaseholdImprovementsMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="etnb_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentUsefulLife" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="etnb_SummaryOfSignificantAccountingPoliciesTable" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="etnb_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="etnb_SummaryOfSignificantAccountingPoliciesTable" xlink:to="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="etnb_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="etnb_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdoptionDate" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="etnb_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="etnb_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="etnb_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="8" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="etnb_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_OtherThanTemporaryImpairmentLossDebtSecuritiesPortionRecognizedInEarnings" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="9" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="etnb_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_RealizedInvestmentGainsLosses" priority="2" use="optional"/>
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureFairValueMeasurementsSummaryOfFinancialAssetsMeasuredAtFairValueOnRecurringBasisDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MoneyMarketFundsMember" xlink:label="us-gaap_MoneyMarketFundsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_default"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis" xlink:label="us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:label="us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:label="us-gaap_FairValueMeasurementFrequencyDomain_default"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="us-gaap_FinancialInstrumentAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_default"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="us-gaap_FairValueInputsLevel1Member"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsRecurringMember" xlink:label="us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialPaperMember" xlink:label="us-gaap_CommercialPaperMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="us-gaap_FairValueInputsLevel2Member"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USGovernmentAgenciesShorttermDebtSecuritiesMember" xlink:label="us-gaap_USGovernmentAgenciesShorttermDebtSecuritiesMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateDebtSecuritiesMember" xlink:label="us-gaap_CorporateDebtSecuritiesMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AgencySecuritiesMember" xlink:label="us-gaap_AgencySecuritiesMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USTreasuryBillSecuritiesMember" xlink:label="us-gaap_USTreasuryBillSecuritiesMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignGovernmentDebtSecuritiesMember" xlink:label="us-gaap_ForeignGovernmentDebtSecuritiesMember"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_AgencyDiscountSecuritiesMember" xlink:label="etnb_AgencyDiscountSecuritiesMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashEquivalentsMember" xlink:label="us-gaap_CashEquivalentsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermInvestmentsMember" xlink:label="us-gaap_ShortTermInvestmentsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MunicipalBondsMember" xlink:label="us-gaap_MunicipalBondsMember"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="us-gaap_MoneyMarketFundsMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_FairValueByMeasurementFrequencyAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="us-gaap_FairValueMeasurementFrequencyDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="us-gaap_FairValueMeasurementFrequencyDomain_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_FinancialInstrumentAxis" xlink:to="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_FinancialInstrumentAxis" xlink:to="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueInputsLevel1Member" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueMeasurementFrequencyDomain" xlink:to="us-gaap_FairValueMeasurementsRecurringMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="us-gaap_CommercialPaperMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_FairValueByFairValueHierarchyLevelAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueInputsLevel2Member" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="us-gaap_USGovernmentAgenciesShorttermDebtSecuritiesMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_FinancialInstrumentAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="us-gaap_CorporateDebtSecuritiesMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtSecurities" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="us-gaap_AgencySecuritiesMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="us-gaap_USTreasuryBillSecuritiesMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="us-gaap_ForeignGovernmentDebtSecuritiesMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="etnb_AgencyDiscountSecuritiesMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="8" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="us-gaap_CashEquivalentsMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="9" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="us-gaap_ShortTermInvestmentsMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="us-gaap_MunicipalBondsMember" priority="2" use="optional"/>
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesLineItems" xlink:label="us-gaap_LossContingenciesLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesTable" xlink:label="us-gaap_LossContingenciesTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="us-gaap_TypeOfArrangementAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain" xlink:label="srt_SegmentGeographicalDomain"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_SanFranciscoOfficeMember" xlink:label="etnb_SanFranciscoOfficeMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain" xlink:label="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_TevasGlycoPEGylatedFGF21ProgramMember" xlink:label="etnb_TevasGlycoPEGylatedFGF21ProgramMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="us-gaap_IncomeStatementLocationAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="us-gaap_IncomeStatementLocationDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="us-gaap_IncomeStatementLocationDomain_default"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_TevaAgreementMember" xlink:label="etnb_TevaAgreementMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis" xlink:label="srt_StatementGeographicalAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain" xlink:label="srt_SegmentGeographicalDomain_default"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_OperatingLeaseExpirationMonthAndYear" xlink:label="etnb_OperatingLeaseExpirationMonthAndYear"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis" xlink:label="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain" xlink:label="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_default"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_TevasDevelopmentProgramMember" xlink:label="etnb_TevasDevelopmentProgramMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseAndRentalExpense" xlink:label="us-gaap_LeaseAndRentalExpense"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableLeasePayment" xlink:label="us-gaap_VariableLeasePayment"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermLeaseCost" xlink:label="us-gaap_ShortTermLeaseCost"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseRemainingLeaseTerm" xlink:label="us-gaap_LesseeOperatingLeaseRemainingLeaseTerm"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseDiscountRate" xlink:label="us-gaap_LesseeOperatingLeaseDiscountRate"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_AssetTransferAndLicenseAgreementInitialNonrefundableUpfrontPayment" xlink:label="etnb_AssetTransferAndLicenseAgreementInitialNonrefundableUpfrontPayment"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_ObligationToPaymentUponMaximumAchievementOfCertainClinicalAndCommercialMilestones" xlink:label="etnb_ObligationToPaymentUponMaximumAchievementOfCertainClinicalAndCommercialMilestones"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_AssetTransferAndLicenseAgreementTerminationPeriodAfterWrittenNotice" xlink:label="etnb_AssetTransferAndLicenseAgreementTerminationPeriodAfterWrittenNotice"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_AssetTransferAndLicenseAgreementTerminationPeriodNoticeOfFailure" xlink:label="etnb_AssetTransferAndLicenseAgreementTerminationPeriodNoticeOfFailure"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_AssetTransferAndLicenseAgreementTerminationNoticePeriodIfBankruptcyPetitionFiled" xlink:label="etnb_AssetTransferAndLicenseAgreementTerminationNoticePeriodIfBankruptcyPetitionFiled"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_MilestonePayment" xlink:label="etnb_MilestonePayment"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="us-gaap_LossContingenciesTable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_SegmentGeographicalDomain" xlink:to="etnb_SanFranciscoOfficeMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain" xlink:to="etnb_TevasGlycoPEGylatedFGF21ProgramMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationDomain_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="etnb_TevaAgreementMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_StatementGeographicalAxis" xlink:to="srt_SegmentGeographicalDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_StatementGeographicalAxis" xlink:to="srt_SegmentGeographicalDomain_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="etnb_OperatingLeaseExpirationMonthAndYear" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_LossContingenciesTable" xlink:to="srt_StatementGeographicalAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis" xlink:to="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis" xlink:to="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_ResearchAndDevelopmentExpenseMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain" xlink:to="etnb_TevasDevelopmentProgramMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_LossContingenciesTable" xlink:to="us-gaap_TypeOfArrangementAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_LossContingenciesTable" xlink:to="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="us-gaap_LeaseAndRentalExpense" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_LossContingenciesTable" xlink:to="us-gaap_IncomeStatementLocationAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="us-gaap_VariableLeasePayment" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="us-gaap_ShortTermLeaseCost" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="us-gaap_LesseeOperatingLeaseRemainingLeaseTerm" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="us-gaap_LesseeOperatingLeaseDiscountRate" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="8" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="etnb_AssetTransferAndLicenseAgreementInitialNonrefundableUpfrontPayment" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="9" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="etnb_ObligationToPaymentUponMaximumAchievementOfCertainClinicalAndCommercialMilestones" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="etnb_AssetTransferAndLicenseAgreementTerminationPeriodAfterWrittenNotice" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="11" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="etnb_AssetTransferAndLicenseAgreementTerminationPeriodNoticeOfFailure" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="12" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="etnb_AssetTransferAndLicenseAgreementTerminationNoticePeriodIfBankruptcyPetitionFiled" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="13" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LossContingenciesLineItems" xlink:to="etnb_MilestonePayment" priority="2" use="optional"/>
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureTermLoanAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable" xlink:label="us-gaap_DebtInstrumentTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="us-gaap_TypeOfArrangementAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateAxis" xlink:label="us-gaap_VariableRateAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateDomain" xlink:label="us-gaap_VariableRateDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateDomain" xlink:label="us-gaap_VariableRateDomain_default"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember" xlink:label="srt_RangeMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationTechniqueDomain" xlink:label="us-gaap_ValuationTechniqueDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationTechniqueOptionPricingModelMember" xlink:label="us-gaap_ValuationTechniqueOptionPricingModelMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain" xlink:label="us-gaap_BalanceSheetLocationDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsMember" xlink:label="us-gaap_OtherAssetsMember"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_LoanAndSecurityAgreementMember" xlink:label="etnb_LoanAndSecurityAgreementMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrimeRateMember" xlink:label="us-gaap_PrimeRateMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis" xlink:label="us-gaap_DebtInstrumentAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="us-gaap_DebtInstrumentNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="us-gaap_DebtInstrumentNameDomain_default"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputTypeDomain" xlink:label="us-gaap_MeasurementInputTypeDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputRiskFreeInterestRateMember" xlink:label="us-gaap_MeasurementInputRiskFreeInterestRateMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputTypeAxis" xlink:label="us-gaap_MeasurementInputTypeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputTypeDomain" xlink:label="us-gaap_MeasurementInputTypeDomain_default"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_TermALoanFacilityMember" xlink:label="etnb_TermALoanFacilityMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationTechniqueAxis" xlink:label="us-gaap_ValuationTechniqueAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationTechniqueDomain" xlink:label="us-gaap_ValuationTechniqueDomain_default"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis" xlink:label="us-gaap_BalanceSheetLocationAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain" xlink:label="us-gaap_BalanceSheetLocationDomain_default"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:label="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_TwentyTwentyThreeLoanAgreementMember" xlink:label="etnb_TwentyTwentyThreeLoanAgreementMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputExpectedDividendPaymentMember" xlink:label="us-gaap_MeasurementInputExpectedDividendPaymentMember"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_TermBLoanFacilityMember" xlink:label="etnb_TermBLoanFacilityMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromLinesOfCredit" xlink:label="us-gaap_ProceedsFromLinesOfCredit"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputPriceVolatilityMember" xlink:label="us-gaap_MeasurementInputPriceVolatilityMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityDescription" xlink:label="us-gaap_LineOfCreditFacilityDescription"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputExpectedTermMember" xlink:label="us-gaap_MeasurementInputExpectedTermMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantsAndRightsOutstandingMaturityDate" xlink:label="us-gaap_WarrantsAndRightsOutstandingMaturityDate"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredFinanceCostsGross" xlink:label="us-gaap_DeferredFinanceCostsGross"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_LineOfCreditFacilityIncreaseInBorrowingCapacity" xlink:label="etnb_LineOfCreditFacilityIncreaseInBorrowingCapacity"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityExpirationDate1" xlink:label="us-gaap_LineOfCreditFacilityExpirationDate1"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_NetCashProceedsFromSaleOfEquitySecurities" xlink:label="etnb_NetCashProceedsFromSaleOfEquitySecurities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:label="us-gaap_DebtInstrumentInterestRateDuringPeriod"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_PrepaymentFeePercentage" xlink:label="etnb_PrepaymentFeePercentage"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:label="us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_PercentageOfFeeOnLoan" xlink:label="etnb_PercentageOfFeeOnLoan"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentMeasurementInput" xlink:label="us-gaap_DebtInstrumentMeasurementInput"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_FairValueOfWarrantsAssumptionsDividends" xlink:label="etnb_FairValueOfWarrantsAssumptionsDividends"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTerm" xlink:label="us-gaap_DebtInstrumentTerm"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsGross" xlink:label="us-gaap_DeferredTaxAssetsGross"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityInterestRateDescription" xlink:label="us-gaap_LineOfCreditFacilityInterestRateDescription"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtNoncurrent" xlink:label="us-gaap_LongTermDebtNoncurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentCarryingAmount" xlink:label="us-gaap_DebtInstrumentCarryingAmount"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentUnamortizedDiscount" xlink:label="us-gaap_DebtInstrumentUnamortizedDiscount"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_OtherNonCurrentLiability" xlink:label="etnb_OtherNonCurrentLiability"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentTable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_TypeOfArrangementAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_VariableRateAxis" xlink:to="us-gaap_VariableRateDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_VariableRateAxis" xlink:to="us-gaap_VariableRateDomain_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ValuationTechniqueDomain" xlink:to="us-gaap_ValuationTechniqueOptionPricingModelMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BalanceSheetLocationDomain" xlink:to="us-gaap_OtherAssetsMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="etnb_LoanAndSecurityAgreementMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_VariableRateDomain" xlink:to="us-gaap_PrimeRateMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentNameDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentNameDomain_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_MeasurementInputTypeDomain" xlink:to="us-gaap_MeasurementInputRiskFreeInterestRateMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_MeasurementInputTypeAxis" xlink:to="us-gaap_MeasurementInputTypeDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_MeasurementInputTypeAxis" xlink:to="us-gaap_MeasurementInputTypeDomain_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="etnb_TermALoanFacilityMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_ValuationTechniqueAxis" xlink:to="us-gaap_ValuationTechniqueDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_ValuationTechniqueAxis" xlink:to="us-gaap_ValuationTechniqueDomain_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_BalanceSheetLocationAxis" xlink:to="us-gaap_BalanceSheetLocationDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_BalanceSheetLocationAxis" xlink:to="us-gaap_BalanceSheetLocationDomain_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_DebtInstrumentAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="etnb_TwentyTwentyThreeLoanAgreementMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_MeasurementInputTypeDomain" xlink:to="us-gaap_MeasurementInputExpectedDividendPaymentMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="etnb_TermBLoanFacilityMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_ProceedsFromLinesOfCredit" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_BalanceSheetLocationAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_MeasurementInputTypeDomain" xlink:to="us-gaap_MeasurementInputPriceVolatilityMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_LineOfCreditFacilityDescription" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="srt_RangeAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_MeasurementInputTypeDomain" xlink:to="us-gaap_MeasurementInputExpectedTermMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_VariableRateAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_ValuationTechniqueAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_WarrantsAndRightsOutstandingMaturityDate" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_MeasurementInputTypeAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DeferredFinanceCostsGross" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="etnb_LineOfCreditFacilityIncreaseInBorrowingCapacity" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="8" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_LineOfCreditFacilityExpirationDate1" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="9" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="etnb_NetCashProceedsFromSaleOfEquitySecurities" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentInterestRateDuringPeriod" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="11" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="etnb_PrepaymentFeePercentage" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="12" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="13" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="etnb_PercentageOfFeeOnLoan" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="14" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentMeasurementInput" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="15" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="etnb_FairValueOfWarrantsAssumptionsDividends" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="16" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentTerm" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="17" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DeferredTaxAssetsGross" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="18" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_LineOfCreditFacilityInterestRateDescription" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="19" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_LongTermDebtNoncurrent" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="20" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentCarryingAmount" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="21" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentUnamortizedDiscount" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="22" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="etnb_OtherNonCurrentLiability" priority="2" use="optional"/>
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://www.89bio.com/20221231/taxonomy/role/DisclosureStockholdersEquityScheduleOfSharesOfCommonStockAvailableForFutureIssuanceDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockLineItems" xlink:label="us-gaap_ClassOfStockLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfStockByClassTable" xlink:label="us-gaap_ScheduleOfStockByClassTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_EquityIncentivePlanMember" xlink:label="etnb_EquityIncentivePlanMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:label="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockMember" xlink:label="us-gaap_EmployeeStockMember"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_ExerciseOfWarrantsAndPreFundedWarrantsMember" xlink:label="etnb_ExerciseOfWarrantsAndPreFundedWarrantsMember"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ScheduleOfStockByClassTable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="etnb_EquityIncentivePlanMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_EmployeeStockMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="etnb_ExerciseOfWarrantsAndPreFundedWarrantsMember" priority="2" use="optional"/>
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://www.89bio.com/20221231/taxonomy/role/DisclosureStockholdersEquityAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockLineItems" xlink:label="us-gaap_SubsidiarySaleOfStockLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:label="us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="us-gaap_SubsequentEventTypeDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember" xlink:label="us-gaap_SubsequentEventMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IPOMember" xlink:label="us-gaap_IPOMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="us-gaap_TypeOfArrangementAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember" xlink:label="srt_RangeMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_MaximumAmountOfEquitySharesIssuable" xlink:label="etnb_MaximumAmountOfEquitySharesIssuable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_ATMFacilityMember" xlink:label="etnb_ATMFacilityMember"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_PreFundedWarrantsMember" xlink:label="etnb_PreFundedWarrantsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="us-gaap_SubsequentEventTypeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="us-gaap_SubsequentEventTypeDomain_default"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_SellingCommissionPerSharesSoldPercentage" xlink:label="etnb_SellingCommissionPerSharesSoldPercentage"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_SVBLeerinkLLCAndCantorFitzgeraldCoMember" xlink:label="etnb_SVBLeerinkLLCAndCantorFitzgeraldCoMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantMember" xlink:label="us-gaap_WarrantMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockDescriptionOfTransaction" xlink:label="us-gaap_SaleOfStockDescriptionOfTransaction"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_NumberOfPrefundedWarrantsIssuedDuringPeriod" xlink:label="etnb_NumberOfPrefundedWarrantsIssuedDuringPeriod"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_CommonStockAndWarrantsCombinedOfferingPricePerShare" xlink:label="etnb_CommonStockAndWarrantsCombinedOfferingPricePerShare"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_PrefundedAndCommonStockWarrants" xlink:label="etnb_PrefundedAndCommonStockWarrants"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_UnderwritingDiscountsAndCommissions" xlink:label="etnb_UnderwritingDiscountsAndCommissions"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfStockIssuanceCosts" xlink:label="us-gaap_PaymentsOfStockIssuanceCosts"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_BeneficialOwnershipLimitationOnExerciseOfWarrant" xlink:label="etnb_BeneficialOwnershipLimitationOnExerciseOfWarrant"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_SaleOfStockPercentageOfBeneficialOwnershipLimitationBeforeTransaction" xlink:label="etnb_SaleOfStockPercentageOfBeneficialOwnershipLimitationBeforeTransaction"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventTypeDomain" xlink:to="us-gaap_SubsequentEventMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_IPOMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="etnb_MaximumAmountOfEquitySharesIssuable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="etnb_ATMFacilityMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="etnb_PreFundedWarrantsMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeDomain_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="us-gaap_TypeOfArrangementAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="etnb_SellingCommissionPerSharesSoldPercentage" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="etnb_SVBLeerinkLLCAndCantorFitzgeraldCoMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_WarrantMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="srt_RangeAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="us-gaap_StatementEquityComponentsAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="us-gaap_SaleOfStockDescriptionOfTransaction" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="us-gaap_SubsequentEventTypeAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="etnb_NumberOfPrefundedWarrantsIssuedDuringPeriod" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="etnb_CommonStockAndWarrantsCombinedOfferingPricePerShare" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="8" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="etnb_PrefundedAndCommonStockWarrants" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="9" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="etnb_UnderwritingDiscountsAndCommissions" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="us-gaap_PaymentsOfStockIssuanceCosts" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="11" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="12" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="etnb_BeneficialOwnershipLimitationOnExerciseOfWarrant" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="13" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="etnb_SaleOfStockPercentageOfBeneficialOwnershipLimitationBeforeTransaction" priority="2" use="optional"/>
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://www.89bio.com/20221231/taxonomy/role/DisclosureStockholdersEquityScheduleOfOutstandingWarrantsToPurchaseSharesOfCommonStockDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightLineItems" xlink:label="us-gaap_ClassOfWarrantOrRightLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightTable" xlink:label="us-gaap_ClassOfWarrantOrRightTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="us-gaap_ClassOfWarrantOrRightAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_WarrantTermLoanMember" xlink:label="etnb_WarrantTermLoanMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="us-gaap_ClassOfWarrantOrRightDomain_default"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_WarrantTermLoanOneMember" xlink:label="etnb_WarrantTermLoanOneMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantsAndRightsOutstandingMaturityDate" xlink:label="us-gaap_WarrantsAndRightsOutstandingMaturityDate"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_WarrantPublicOfferingsMember" xlink:label="etnb_WarrantPublicOfferingsMember"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_WarrantsAndRightsOutstandingMaturityDateDescription" xlink:label="etnb_WarrantsAndRightsOutstandingMaturityDateDescription"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_PreFundedWarrantsMember" xlink:label="etnb_PreFundedWarrantsMember"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightTable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ClassOfWarrantOrRightTable" xlink:to="us-gaap_ClassOfWarrantOrRightAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightOutstanding" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfWarrantOrRightDomain" xlink:to="etnb_WarrantTermLoanMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="us-gaap_ClassOfWarrantOrRightDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="us-gaap_ClassOfWarrantOrRightDomain_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfWarrantOrRightDomain" xlink:to="etnb_WarrantTermLoanOneMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="us-gaap_WarrantsAndRightsOutstandingMaturityDate" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfWarrantOrRightDomain" xlink:to="etnb_WarrantPublicOfferingsMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="etnb_WarrantsAndRightsOutstandingMaturityDateDescription" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfWarrantOrRightDomain" xlink:to="etnb_PreFundedWarrantsMember" priority="2" use="optional"/>
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain" xlink:label="us-gaap_PlanNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_TwoThousandAndNineteenEquityIncentivePlanMember" xlink:label="etnb_TwoThousandAndNineteenEquityIncentivePlanMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockMember" xlink:label="us-gaap_EmployeeStockMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember" xlink:label="srt_RangeMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_ServiceBasedRSUsMember" xlink:label="etnb_ServiceBasedRSUsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_default"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_NumberOfSharesIssuableUnderShareBasedPaymentArrangement" xlink:label="etnb_NumberOfSharesIssuableUnderShareBasedPaymentArrangement"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedPaymentArrangementEmployeeMember" xlink:label="us-gaap_ShareBasedPaymentArrangementEmployeeMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameAxis" xlink:label="us-gaap_PlanNameAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain" xlink:label="us-gaap_PlanNameDomain_default"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualAxis" xlink:label="srt_TitleOfIndividualAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain_default"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_TwoThousandAndTwentyEquityIncentivePlanMember" xlink:label="etnb_TwoThousandAndTwentyEquityIncentivePlanMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_PeriodForIncreaseInNumberOfSharesOfCommonStockReservedForIssuance" xlink:label="etnb_PeriodForIncreaseInNumberOfSharesOfCommonStockReservedForIssuance"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ExecutiveOfficerMember" xlink:label="srt_ExecutiveOfficerMember"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_PerformanceRSUsMember" xlink:label="etnb_PerformanceRSUsMember"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_PercentageOfIncreaseInNumberOfSharesOfCapitalStockIssuedAndOutstanding" xlink:label="etnb_PercentageOfIncreaseInNumberOfSharesOfCapitalStockIssuedAndOutstanding"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAward" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAward"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_ShareBasedCompensationArrangementByShareBasedPaymentAwardRemainingOptionsVestingPeriod" xlink:label="etnb_ShareBasedCompensationArrangementByShareBasedPaymentAwardRemainingOptionsVestingPeriod"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_ShareBasedCompensationArrangementByShareBasedPaymentFirstOfferingPeriodCommencementDate" xlink:label="etnb_ShareBasedCompensationArrangementByShareBasedPaymentFirstOfferingPeriodCommencementDate"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantDateFairValue" xlink:label="etnb_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantDateFairValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_ShareBasedCompensationArrangementByShareBasedPaymentAwardAnniversary" xlink:label="etnb_ShareBasedCompensationArrangementByShareBasedPaymentAwardAnniversary"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PlanNameDomain" xlink:to="etnb_TwoThousandAndNineteenEquityIncentivePlanMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_EmployeeStockMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="etnb_ServiceBasedRSUsMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="etnb_NumberOfSharesIssuableUnderShareBasedPaymentArrangement" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="srt_RangeAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="us-gaap_ShareBasedPaymentArrangementEmployeeMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_TitleOfIndividualAxis" xlink:to="srt_TitleOfIndividualWithRelationshipToEntityDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_TitleOfIndividualAxis" xlink:to="srt_TitleOfIndividualWithRelationshipToEntityDomain_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PlanNameDomain" xlink:to="etnb_TwoThousandAndTwentyEquityIncentivePlanMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_RestrictedStockUnitsRSUMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="etnb_PeriodForIncreaseInNumberOfSharesOfCommonStockReservedForIssuance" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_PlanNameAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="srt_ExecutiveOfficerMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="etnb_PerformanceRSUsMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="etnb_PercentageOfIncreaseInNumberOfSharesOfCapitalStockIssuedAndOutstanding" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_AwardTypeAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="srt_TitleOfIndividualAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAward" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="etnb_ShareBasedCompensationArrangementByShareBasedPaymentAwardRemainingOptionsVestingPeriod" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="8" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="9" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="etnb_ShareBasedCompensationArrangementByShareBasedPaymentFirstOfferingPeriodCommencementDate" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="11" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="12" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="13" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="14" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="15" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="16" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="etnb_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantDateFairValue" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="17" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="18" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="19" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="20" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="21" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="22" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="etnb_ShareBasedCompensationArrangementByShareBasedPaymentAwardAnniversary" priority="2" use="optional"/>
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockOptionActivityDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain" xlink:label="us-gaap_PlanNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_TwoThousandAndNineteenEquityIncentivePlanMember" xlink:label="etnb_TwoThousandAndNineteenEquityIncentivePlanMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameAxis" xlink:label="us-gaap_PlanNameAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract" xlink:label="etnb_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract" xlink:label="etnb_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PlanNameDomain" xlink:to="etnb_TwoThousandAndNineteenEquityIncentivePlanMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_PlanNameAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="8" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="9" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="11" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="13" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="14" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="etnb_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="15" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="16" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="17" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="etnb_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="18" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="19" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" priority="2" use="optional"/>
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfEstimatedFairValueOfStockOptionsGrantedUsingBlackScholesOptionPricingModelDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember" xlink:label="srt_RangeMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="srt_RangeAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" priority="2" use="optional"/>
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://www.89bio.com/20221231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfRestrictedStockUnitActivityDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_RestrictedStockUnitsRSUMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_AwardTypeAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" priority="2" use="optional"/>
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockBasedCompensationDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="us-gaap_IncomeStatementLocationAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="us-gaap_IncomeStatementLocationDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpenseMember" xlink:label="us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:to="us-gaap_IncomeStatementLocationAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_ResearchAndDevelopmentExpenseMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_GeneralAndAdministrativeExpenseMember" priority="2" use="optional"/>
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesSummaryOfStatutoryTaxRatesApplicableToIncomeOfCompanyAndSubsidiariesDetails">
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_IncomeTaxDisclosureLineItems" xlink:label="etnb_IncomeTaxDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_IncomeTaxDisclosureTable" xlink:label="etnb_IncomeTaxDisclosureTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesDomain" xlink:label="srt_ConsolidatedEntitiesDomain"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_EightyNineBioLtdMember" xlink:label="etnb_EightyNineBioLtdMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesAxis" xlink:label="srt_ConsolidatedEntitiesAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesDomain" xlink:label="srt_ConsolidatedEntitiesDomain_default"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_EightyNineBioManagementIncorporationMember" xlink:label="etnb_EightyNineBioManagementIncorporationMember"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_UABEightyNineBioLithuaniaMember" xlink:label="etnb_UABEightyNineBioLithuaniaMember"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="etnb_IncomeTaxDisclosureLineItems" xlink:to="etnb_IncomeTaxDisclosureTable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="etnb_IncomeTaxDisclosureLineItems" xlink:to="us-gaap_EffectiveIncomeTaxRateContinuingOperations" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ConsolidatedEntitiesDomain" xlink:to="etnb_EightyNineBioLtdMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="etnb_IncomeTaxDisclosureTable" xlink:to="srt_ConsolidatedEntitiesAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ConsolidatedEntitiesDomain" xlink:to="etnb_EightyNineBioManagementIncorporationMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ConsolidatedEntitiesDomain" xlink:to="etnb_UABEightyNineBioLithuaniaMember" priority="2" use="optional"/>
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesSummaryOfComponentsOfDeferredTaxAssetsDetails">
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_IncomeTaxDisclosureLineItems" xlink:label="etnb_IncomeTaxDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_IncomeTaxDisclosureTable" xlink:label="etnb_IncomeTaxDisclosureTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain" xlink:label="srt_SegmentGeographicalDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_US" xlink:label="country_US"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis" xlink:label="srt_StatementGeographicalAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_IL" xlink:label="country_IL"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment" xlink:label="us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_DeferredTaxAssetsLeaseLiability" xlink:label="etnb_DeferredTaxAssetsLeaseLiability"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOther" xlink:label="us-gaap_DeferredTaxAssetsOther"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsGross" xlink:label="us-gaap_DeferredTaxAssetsGross"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsNet" xlink:label="us-gaap_DeferredTaxAssetsNet"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_DeferredTaxLiabilitiesRightsOfUseAssets" xlink:label="etnb_DeferredTaxLiabilitiesRightsOfUseAssets"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilities" xlink:label="us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:label="us-gaap_DeferredTaxAssetsLiabilitiesNet"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="etnb_IncomeTaxDisclosureLineItems" xlink:to="etnb_IncomeTaxDisclosureTable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_SegmentGeographicalDomain" xlink:to="country_US" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="etnb_IncomeTaxDisclosureLineItems" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="etnb_IncomeTaxDisclosureTable" xlink:to="srt_StatementGeographicalAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_StatementGeographicalAxis" xlink:to="srt_SegmentGeographicalDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_SegmentGeographicalDomain" xlink:to="country_IL" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="etnb_IncomeTaxDisclosureLineItems" xlink:to="us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="etnb_IncomeTaxDisclosureLineItems" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="etnb_IncomeTaxDisclosureLineItems" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="etnb_IncomeTaxDisclosureLineItems" xlink:to="etnb_DeferredTaxAssetsLeaseLiability" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="etnb_IncomeTaxDisclosureLineItems" xlink:to="us-gaap_DeferredTaxAssetsOther" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="etnb_IncomeTaxDisclosureLineItems" xlink:to="us-gaap_DeferredTaxAssetsGross" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="etnb_IncomeTaxDisclosureLineItems" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="8" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="etnb_IncomeTaxDisclosureLineItems" xlink:to="us-gaap_DeferredTaxAssetsNet" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="9" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="etnb_IncomeTaxDisclosureLineItems" xlink:to="etnb_DeferredTaxLiabilitiesRightsOfUseAssets" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="etnb_IncomeTaxDisclosureLineItems" xlink:to="us-gaap_DeferredIncomeTaxLiabilities" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="11" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="etnb_IncomeTaxDisclosureLineItems" xlink:to="us-gaap_DeferredTaxAssetsLiabilitiesNet" priority="2" use="optional"/>
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_IncomeTaxDisclosureLineItems" xlink:label="etnb_IncomeTaxDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_IncomeTaxDisclosureTable" xlink:label="etnb_IncomeTaxDisclosureTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:label="us-gaap_IncomeTaxAuthorityDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DomesticCountryMember" xlink:label="us-gaap_DomesticCountryMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain" xlink:label="srt_SegmentGeographicalDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_IL" xlink:label="country_IL"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="us-gaap_IncomeStatementLocationAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="us-gaap_IncomeStatementLocationDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis" xlink:label="srt_StatementGeographicalAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxCreditCarryforwardAxis" xlink:label="us-gaap_TaxCreditCarryforwardAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxCreditCarryforwardNameDomain" xlink:label="us-gaap_TaxCreditCarryforwardNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxCreditCarryforwardNameDomain" xlink:label="us-gaap_TaxCreditCarryforwardNameDomain_default"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchMember" xlink:label="us-gaap_ResearchMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityAxis" xlink:label="us-gaap_IncomeTaxAuthorityAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:label="us-gaap_IncomeTaxAuthorityDomain_default"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StateAndLocalJurisdictionMember" xlink:label="us-gaap_StateAndLocalJurisdictionMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_US" xlink:label="country_US"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:label="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCountryMember" xlink:label="us-gaap_ForeignCountryMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_CA" xlink:label="stpr_CA"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_AccumulatedTaxLossCarryForward" xlink:label="etnb_AccumulatedTaxLossCarryForward"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLossCarryforwardsLimitationsOnUse" xlink:label="us-gaap_OperatingLossCarryforwardsLimitationsOnUse"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_TaxableIncomeUtilizationPercentage" xlink:label="etnb_TaxableIncomeUtilizationPercentage"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_TaxCreditCarryforwardExpirationYear" xlink:label="etnb_TaxCreditCarryforwardExpirationYear"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_DeferredTaxAssetsTaxCreditCarryforwardsResearchFederal" xlink:label="etnb_DeferredTaxAssetsTaxCreditCarryforwardsResearchFederal"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:label="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease" xlink:label="us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:label="us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_AmortizationPeriod" xlink:label="etnb_AmortizationPeriod"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="etnb_IncomeTaxDisclosureLineItems" xlink:to="etnb_IncomeTaxDisclosureTable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeTaxAuthorityDomain" xlink:to="us-gaap_DomesticCountryMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_SegmentGeographicalDomain" xlink:to="country_IL" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="etnb_IncomeTaxDisclosureLineItems" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="etnb_IncomeTaxDisclosureTable" xlink:to="srt_StatementGeographicalAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_StatementGeographicalAxis" xlink:to="srt_SegmentGeographicalDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_TaxCreditCarryforwardAxis" xlink:to="us-gaap_TaxCreditCarryforwardNameDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_TaxCreditCarryforwardAxis" xlink:to="us-gaap_TaxCreditCarryforwardNameDomain_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TaxCreditCarryforwardNameDomain" xlink:to="us-gaap_ResearchMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_ResearchAndDevelopmentExpenseMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_IncomeTaxAuthorityAxis" xlink:to="us-gaap_IncomeTaxAuthorityDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_IncomeTaxAuthorityAxis" xlink:to="us-gaap_IncomeTaxAuthorityDomain_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeTaxAuthorityDomain" xlink:to="us-gaap_StateAndLocalJurisdictionMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_SegmentGeographicalDomain" xlink:to="country_US" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="etnb_IncomeTaxDisclosureLineItems" xlink:to="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="etnb_IncomeTaxDisclosureTable" xlink:to="us-gaap_IncomeTaxAuthorityAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeTaxAuthorityDomain" xlink:to="us-gaap_ForeignCountryMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_SegmentGeographicalDomain" xlink:to="stpr_CA" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="etnb_IncomeTaxDisclosureLineItems" xlink:to="etnb_AccumulatedTaxLossCarryForward" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="etnb_IncomeTaxDisclosureTable" xlink:to="us-gaap_IncomeStatementLocationAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="etnb_IncomeTaxDisclosureLineItems" xlink:to="us-gaap_OperatingLossCarryforwardsLimitationsOnUse" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="etnb_IncomeTaxDisclosureTable" xlink:to="us-gaap_TaxCreditCarryforwardAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="etnb_IncomeTaxDisclosureLineItems" xlink:to="etnb_TaxableIncomeUtilizationPercentage" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="etnb_IncomeTaxDisclosureLineItems" xlink:to="etnb_TaxCreditCarryforwardExpirationYear" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="etnb_IncomeTaxDisclosureLineItems" xlink:to="etnb_DeferredTaxAssetsTaxCreditCarryforwardsResearchFederal" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="etnb_IncomeTaxDisclosureLineItems" xlink:to="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="8" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="etnb_IncomeTaxDisclosureLineItems" xlink:to="us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="9" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="etnb_IncomeTaxDisclosureLineItems" xlink:to="us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="etnb_IncomeTaxDisclosureLineItems" xlink:to="etnb_AmortizationPeriod" priority="2" use="optional"/>
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesSummaryOfLossFromOperationsBeforeTaxesOnIncomeDetails">
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_IncomeTaxDisclosureLineItems" xlink:label="etnb_IncomeTaxDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_IncomeTaxDisclosureTable" xlink:label="etnb_IncomeTaxDisclosureTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain" xlink:label="srt_SegmentGeographicalDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_US" xlink:label="country_US"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis" xlink:label="srt_StatementGeographicalAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_LT" xlink:label="country_LT"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_IL" xlink:label="country_IL"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="etnb_IncomeTaxDisclosureLineItems" xlink:to="etnb_IncomeTaxDisclosureTable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_SegmentGeographicalDomain" xlink:to="country_US" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="etnb_IncomeTaxDisclosureLineItems" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="etnb_IncomeTaxDisclosureTable" xlink:to="srt_StatementGeographicalAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_StatementGeographicalAxis" xlink:to="srt_SegmentGeographicalDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_SegmentGeographicalDomain" xlink:to="country_LT" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_SegmentGeographicalDomain" xlink:to="country_IL" priority="2" use="optional"/>
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureNetLossPerShareScheduleOfOutstandingPotentiallyDilutiveSecuritiesExcludedFromCalculationOfDilutedNetLossDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain_default"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="us-gaap_EmployeeStockOptionMember"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_UnvestedRestrictedStockUnitsMember" xlink:label="etnb_UnvestedRestrictedStockUnitsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantMember" xlink:label="us-gaap_WarrantMember"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="us-gaap_AntidilutiveSecuritiesNameDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="us-gaap_AntidilutiveSecuritiesNameDomain_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="us-gaap_EmployeeStockOptionMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="etnb_UnvestedRestrictedStockUnitsMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="us-gaap_WarrantMember" priority="2" use="optional"/>
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://www.89bio.com/20221231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventLineItems" xlink:label="us-gaap_SubsequentEventLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTable" xlink:label="us-gaap_SubsequentEventTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="us-gaap_SubsequentEventTypeDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember" xlink:label="us-gaap_SubsequentEventMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IPOMember" xlink:label="us-gaap_IPOMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="us-gaap_TypeOfArrangementAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember" xlink:label="srt_RangeMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:label="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_TwoThousandAndTwentyThreeLoanAgreementMember" xlink:label="etnb_TwoThousandAndTwentyThreeLoanAgreementMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis" xlink:label="us-gaap_DebtInstrumentAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="us-gaap_DebtInstrumentNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_TrancheOneMember" xlink:label="etnb_TrancheOneMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="us-gaap_SubsequentEventTypeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentMaturityDateDescription" xlink:label="us-gaap_DebtInstrumentMaturityDateDescription"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_TwoThousandAndTwentyOneLoanAgreementMember" xlink:label="etnb_TwoThousandAndTwentyOneLoanAgreementMember"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_TrancheTwoAndThreeMember" xlink:label="etnb_TrancheTwoAndThreeMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentMaturityDate" xlink:label="us-gaap_DebtInstrumentMaturityDate"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_ATMFacilityMember" xlink:label="etnb_ATMFacilityMember"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_TrancheFourMember" xlink:label="etnb_TrancheFourMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:label="us-gaap_DebtInstrumentInterestRateDuringPeriod"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_SVBLeerinkLLCAndCantorFitzgeraldCoMember" xlink:label="etnb_SVBLeerinkLLCAndCantorFitzgeraldCoMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:label="us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityAverageOutstandingAmount" xlink:label="us-gaap_LineOfCreditFacilityAverageOutstandingAmount"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAnnualPrincipalPayment" xlink:label="us-gaap_DebtInstrumentAnnualPrincipalPayment"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_DebtInstrumentFinalPaymentFee" xlink:label="etnb_DebtInstrumentFinalPaymentFee"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_DebtInstrumentEarlyPrepaymentFee" xlink:label="etnb_DebtInstrumentEarlyPrepaymentFee"/>
    <link:loc xlink:type="locator" xlink:href="etnb-20221231.xsd#etnb_MaximumAmountOfEquitySharesIssuable" xlink:label="etnb_MaximumAmountOfEquitySharesIssuable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockDescriptionOfTransaction" xlink:label="us-gaap_SaleOfStockDescriptionOfTransaction"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockTransactionDate" xlink:label="us-gaap_SaleOfStockTransactionDate"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_SubsequentEventTable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventTypeDomain" xlink:to="us-gaap_SubsequentEventMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_IPOMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="etnb_TwoThousandAndTwentyThreeLoanAgreementMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentNameDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_SubsequentEventTable" xlink:to="us-gaap_DebtInstrumentAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="etnb_TrancheOneMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_DebtInstrumentMaturityDateDescription" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="etnb_TwoThousandAndTwentyOneLoanAgreementMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_SubsequentEventTable" xlink:to="us-gaap_SubsequentEventTypeAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="etnb_TrancheTwoAndThreeMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_DebtInstrumentMaturityDate" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="etnb_ATMFacilityMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_SubsequentEventTable" xlink:to="us-gaap_TypeOfArrangementAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="etnb_TrancheFourMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_DebtInstrumentInterestRateDuringPeriod" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="etnb_SVBLeerinkLLCAndCantorFitzgeraldCoMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_SubsequentEventTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_SubsequentEventTable" xlink:to="srt_RangeAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_LineOfCreditFacilityAverageOutstandingAmount" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_DebtInstrumentAnnualPrincipalPayment" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="etnb_DebtInstrumentFinalPaymentFee" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="8" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="etnb_DebtInstrumentEarlyPrepaymentFee" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="9" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="etnb_MaximumAmountOfEquitySharesIssuable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_SaleOfStockDescriptionOfTransaction" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="11" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_SaleOfStockTransactionDate" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="12" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="13" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues" priority="2" use="optional"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139683191495680">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Document and Entity Information - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Mar. 03, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-K<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Dec. 31,  2022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">FY<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">89bio, Inc.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001785173<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityVoluntaryFilers', window );">Entity Voluntary Filers</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Non-accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityWellKnownSeasonedIssuer', window );">Entity Well-known Seasoned Issuer</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityPublicFloat', window );">Entity Public Float</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 30.4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">52,230,621<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_IcfrAuditorAttestationFlag', window );">ICFR Auditor Attestation Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityExTransitionPeriod', window );">Entity Ex Transition Period</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common stock, par value $0.001 per share<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">ETNB<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-39122<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">36-4946844<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">142 Sansome Street<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address Address Line Two</a></td>
<td class="text">Second Floor<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">San Francisco<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">94104<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">415<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">432-9270<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentAnnualReport', window );">Document Annual Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentsIncorporatedByReferenceTextBlock', window );">Documents Incorporated by Reference</a></td>
<td class="text"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Portions of the Registrant&#8217;s definitive proxy statement relating to its 2023 Annual Meeting of Stockholders, to be held on or about May 31, 2023, are incorporated by reference into Part III of this Annual Report on Form 10-K where indicated. Such proxy statement will be filed with the U.S. Securities and Exchange Commission within 120 days after the end of the fiscal year to which this report relates.</span></p><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorFirmId', window );">Auditor Firm ID</a></td>
<td class="text">185<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorName', window );">Auditor Name</a></td>
<td class="text">KPMG LLP<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorLocation', window );">Auditor Location</a></td>
<td class="text">San Francisco, California, USA<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorFirmId">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>PCAOB issued Audit Firm Identifier</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorFirmId</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:nonemptySequenceNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorLocation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorLocation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentAnnualReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an annual report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentAnnualReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentsIncorporatedByReferenceTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Documents incorporated by reference.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentsIncorporatedByReferenceTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityExTransitionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 7A<br> -Section B<br> -Subsection 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityExTransitionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityPublicFloat">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityPublicFloat</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityVoluntaryFilers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityVoluntaryFilers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityWellKnownSeasonedIssuer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityWellKnownSeasonedIssuer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_IcfrAuditorAttestationFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_IcfrAuditorAttestationFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139683194195552">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Balance Sheets - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 55,255<span></span>
</td>
<td class="nump">$ 52,432<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashCurrent', window );">Restricted cash</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">25<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_etnb_ShortTermAvailableForSaleSecuritiesCurrent', window );">Short-term available-for-sale securities</a></td>
<td class="nump">132,905<span></span>
</td>
<td class="nump">98,288<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid and other current assets</a></td>
<td class="nump">7,920<span></span>
</td>
<td class="nump">11,237<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">196,080<span></span>
</td>
<td class="nump">161,982<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use asset</a></td>
<td class="nump">363<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">92<span></span>
</td>
<td class="nump">150<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other assets</a></td>
<td class="nump">289<span></span>
</td>
<td class="nump">290<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">196,824<span></span>
</td>
<td class="nump">162,422<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">12,502<span></span>
</td>
<td class="nump">6,843<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued expenses</a></td>
<td class="nump">11,944<span></span>
</td>
<td class="nump">10,194<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Operating lease liability, current</a></td>
<td class="nump">168<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_etnb_TermLoanCurrent', window );">Term loan, current</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,500<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">24,614<span></span>
</td>
<td class="nump">19,537<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Operating lease liability, non-current</a></td>
<td class="nump">186<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Term loan, non-current, net</a></td>
<td class="nump">19,691<span></span>
</td>
<td class="nump">16,898<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_etnb_OtherNonCurrentLiability', window );">Other non-current liability</a></td>
<td class="nump">501<span></span>
</td>
<td class="nump">30<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">44,992<span></span>
</td>
<td class="nump">36,465<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and contingencies (Note 5)</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders&#8217; equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock, $0.001 par value, 10,000,000 shares authorized as of December 31, 2022 and 2021; no shares issued and outstanding as of December 31, 2022 and 2021</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, $0.001 par value, 100,000,000 shares authorized as of December 31, 2022 and 2021; 50,560,590 and 20,317,204 shares issued and outstanding as of December 31, 2022 and 2021, respectively</a></td>
<td class="nump">51<span></span>
</td>
<td class="nump">20<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapitalCommonStock', window );">Additional paid-in capital</a></td>
<td class="nump">467,374<span></span>
</td>
<td class="nump">339,218<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive loss</a></td>
<td class="num">(350)<span></span>
</td>
<td class="num">(64)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">(315,243)<span></span>
</td>
<td class="num">(213,217)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total stockholders&#8217; equity</a></td>
<td class="nump">151,832<span></span>
</td>
<td class="nump">125,957<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and stockholders&#8217; equity</a></td>
<td class="nump">$ 196,824<span></span>
</td>
<td class="nump">$ 162,422<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_etnb_OtherNonCurrentLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Other non-current liability</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">etnb_OtherNonCurrentLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>etnb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_etnb_ShortTermAvailableForSaleSecuritiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Short term available for sale securities current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">etnb_ShortTermAvailableForSaleSecuritiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>etnb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_etnb_TermLoanCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Term loan current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">etnb_TermLoanCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>etnb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapitalCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapitalCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.(a),19)<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6904-107765<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=SL98516268-108586<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI https://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139683191402448">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Balance Sheets (Parenthetical) - $ / shares<br></strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized</a></td>
<td class="nump">10,000,000<span></span>
</td>
<td class="nump">10,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, shares issued</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, shares outstanding</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized</a></td>
<td class="nump">100,000,000<span></span>
</td>
<td class="nump">100,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued</a></td>
<td class="nump">50,560,590<span></span>
</td>
<td class="nump">20,317,204<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding</a></td>
<td class="nump">50,560,590<span></span>
</td>
<td class="nump">20,317,204<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139683191514624">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Operations and Comprehensive Loss - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="nump">$ 80,796<span></span>
</td>
<td class="nump">$ 70,330<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative</a></td>
<td class="nump">21,453<span></span>
</td>
<td class="nump">19,413<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Total operating expenses</a></td>
<td class="nump">102,249<span></span>
</td>
<td class="nump">89,743<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Loss from operations</a></td>
<td class="num">(102,249)<span></span>
</td>
<td class="num">(89,743)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="num">(1,922)<span></span>
</td>
<td class="num">(674)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestAndOtherIncome', window );">Interest income and other, net</a></td>
<td class="nump">2,164<span></span>
</td>
<td class="nump">148<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Net loss before income tax</a></td>
<td class="num">(102,007)<span></span>
</td>
<td class="num">(90,269)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax (expense) benefit</a></td>
<td class="num">(19)<span></span>
</td>
<td class="nump">147<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(102,026)<span></span>
</td>
<td class="num">(90,122)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossTaxAbstract', window );"><strong>Other comprehensive (loss) income:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax', window );">Unrealized loss on available-for-sale securities</a></td>
<td class="num">(299)<span></span>
</td>
<td class="num">(71)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax', window );">Foreign currency translation adjustments</a></td>
<td class="nump">13<span></span>
</td>
<td class="nump">17<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Total other comprehensive loss</a></td>
<td class="num">(286)<span></span>
</td>
<td class="num">(54)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive loss</a></td>
<td class="num">$ (102,312)<span></span>
</td>
<td class="num">$ (90,176)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Net loss per share, basic</a></td>
<td class="num">$ (2.93)<span></span>
</td>
<td class="num">$ (4.48)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Net loss per share, diluted</a></td>
<td class="num">$ (2.93)<span></span>
</td>
<td class="num">$ (4.48)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted-average shares used to compute net loss per share, basic</a></td>
<td class="nump">34,806,349<span></span>
</td>
<td class="nump">20,098,340<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted-average shares used to compute net loss per share, diluted</a></td>
<td class="nump">34,806,349<span></span>
</td>
<td class="nump">20,098,340<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e557-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126941158&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestAndOtherIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of interest income and other income recognized during the period. Included in this element is interest derived from investments in debt securities, cash and cash equivalents, and other investments which reflect the time value of money or transactions in which the payments are for the use or forbearance of money and other income from ancillary business-related activities (that is, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestAndOtherIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and adjustment, of unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale) and unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossTaxAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossTaxAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 730<br> -Section 25<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6472174&amp;loc=d3e58812-109433<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139683190431200">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Statements of Stockholders' Equity (Deficit) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>A T M Facility</div></th>
<th class="th"><div>Public Offerings</div></th>
<th class="th"><div>Common Stock</div></th>
<th class="th">
<div>Common Stock </div>
<div>A T M Facility</div>
</th>
<th class="th">
<div>Common Stock </div>
<div>Public Offerings</div>
</th>
<th class="th"><div>Additional Paid-in Capital</div></th>
<th class="th">
<div>Additional Paid-in Capital </div>
<div>A T M Facility</div>
</th>
<th class="th">
<div>Additional Paid-in Capital </div>
<div>Public Offerings</div>
</th>
<th class="th"><div>Accumulated Other Comprehensive Loss</div></th>
<th class="th"><div>Accumulated Deficit</div></th>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance at Dec. 31, 2020</a></td>
<td class="nump">$ 202,961<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 326,046<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (10)<span></span>
</td>
<td class="num">$ (123,095)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance, shares at Dec. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19,931,660<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,289<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,289<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of common stock, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">186,546<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Issuance of common stock upon exercise of stock options</a></td>
<td class="nump">487<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">487<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Issuance of common stock upon exercise of stock options, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">188,286<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan', window );">Issuance of common stock upon ESPP purchase</a></td>
<td class="nump">144<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">144<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans', window );">Issuance of common stock upon ESPP purchase, Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,712<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_etnb_IssuanceOfCommonStockWarrantInConnectionWithTermLoanFacility', window );">Issuance of common stock warrant in connection with term loan facility</a></td>
<td class="nump">574<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">574<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation</a></td>
<td class="nump">8,678<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,678<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(90,122)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(90,122)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive loss</a></td>
<td class="num">(54)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(54)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Dec. 31, 2021</a></td>
<td class="nump">125,957<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">339,218<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(64)<span></span>
</td>
<td class="num">(213,217)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance, shares at Dec. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20,317,204<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 28,453<span></span>
</td>
<td class="nump">$ 88,239<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4<span></span>
</td>
<td class="nump">$ 20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 28,449<span></span>
</td>
<td class="nump">$ 88,219<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of common stock, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,948,611<span></span>
</td>
<td class="nump">18,675,466<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_etnb_StockIssuedDuringPeriodValueCashlessExerciseOfWarrants', window );">Issuance of common stock upon cashless exercise of warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_etnb_StockIssuedDuringPeriodSharesCashlessExerciseOfWarrants', window );">Issuance of common stock upon cashless exercise of warrants, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,143,682<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_etnb_StockIssuedDuringPeriodValueWarrantsExercised', window );">Issuance of common stock upon exercise of warrants</a></td>
<td class="nump">1,082<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,078<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_etnb_StockIssuedDuringPeriodSharesWarrantsExercised', window );">Issuance of common stock upon exercise of warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,202,499<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_etnb_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfWithholdingTaxes', window );">Issuance of common stock upon vesting of restricted stock units, net of withholding taxes</a></td>
<td class="num">(298)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(298)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_etnb_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfWithholdingTaxes', window );">Issuance of common stock upon vesting of restricted stock units, net of withholding taxes, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">103,703<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Issuance of common stock upon exercise of stock options</a></td>
<td class="nump">305<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">305<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Issuance of common stock upon exercise of stock options, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">151,061<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan', window );">Issuance of common stock upon ESPP purchase</a></td>
<td class="nump">50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans', window );">Issuance of common stock upon ESPP purchase, Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18,364<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation</a></td>
<td class="nump">10,356<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,356<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(102,026)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(102,026)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive loss</a></td>
<td class="num">(286)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(286)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Dec. 31, 2022</a></td>
<td class="nump">$ 151,832<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 51<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 467,374<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (350)<span></span>
</td>
<td class="num">$ (315,243)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance, shares at Dec. 31, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50,560,590<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_etnb_IssuanceOfCommonStockWarrantInConnectionWithTermLoanFacility">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Issuance of common stock warrant in connection with term loan facility.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">etnb_IssuanceOfCommonStockWarrantInConnectionWithTermLoanFacility</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>etnb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_etnb_StockIssuedDuringPeriodSharesCashlessExerciseOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Stock Issued During Period Shares Cashless Exercise Of Warrants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">etnb_StockIssuedDuringPeriodSharesCashlessExerciseOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>etnb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_etnb_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfWithholdingTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Stock Issued During Period Shares Restricted Stock Award Net Of Withholding Taxes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">etnb_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfWithholdingTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>etnb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_etnb_StockIssuedDuringPeriodSharesWarrantsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Stock Issued During Period Shares Warrants Exercised.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">etnb_StockIssuedDuringPeriodSharesWarrantsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>etnb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_etnb_StockIssuedDuringPeriodValueCashlessExerciseOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Stock Issued During Period Value Cashless Exercise Of Warrants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">etnb_StockIssuedDuringPeriodValueCashlessExerciseOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>etnb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_etnb_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfWithholdingTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Stock Issued During Period Value Restricted Stock Award Net Of Withholding Taxes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">etnb_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfWithholdingTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>etnb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_etnb_StockIssuedDuringPeriodValueWarrantsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Stock Issued During Period Value Warrants Exercised</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">etnb_StockIssuedDuringPeriodValueWarrantsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>etnb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126964447&amp;loc=d3e11149-113907<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=126964447&amp;loc=d3e11178-113907<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 35<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126961718&amp;loc=d3e4534-113899<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued which are neither cancelled nor held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period as a result of an employee stock purchase plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate change in value for stock issued during the period as a result of employee stock purchase plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued as a result of the exercise of stock options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI https://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139683197636736">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Cash Flows - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash flows from operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net loss</a></td>
<td class="num">$ (102,026)<span></span>
</td>
<td class="num">$ (90,122)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net loss to net cash used in operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation</a></td>
<td class="nump">10,356<span></span>
</td>
<td class="nump">8,678<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments', window );">Net (accretion) amortization on available-for-sale securities</a></td>
<td class="num">(980)<span></span>
</td>
<td class="nump">865<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_etnb_AmortizationOfDebtIssuanceCostsAndAccretionOfFinalPaymentFee', window );">Amortization of debt issuance costs and accretion of final payment fee</a></td>
<td class="nump">764<span></span>
</td>
<td class="nump">617<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense', window );">Non-cash operating lease expense</a></td>
<td class="nump">175<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation</a></td>
<td class="nump">65<span></span>
</td>
<td class="nump">79<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_etnb_DeferredTaxAssets', window );">Deferred tax assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(150)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in operating assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets', window );">Prepaid and other current assets</a></td>
<td class="nump">3,331<span></span>
</td>
<td class="num">(5,672)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayable', window );">Accounts payable</a></td>
<td class="nump">5,659<span></span>
</td>
<td class="nump">4,778<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedLiabilities', window );">Accrued expenses</a></td>
<td class="nump">1,750<span></span>
</td>
<td class="nump">4,146<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingLeaseLiability', window );">Operating lease liability</a></td>
<td class="num">(184)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash used in operating activities</a></td>
<td class="num">(81,090)<span></span>
</td>
<td class="num">(76,781)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Cash flows from investing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities', window );">Proceeds from sales and maturities of available-for-sale securities</a></td>
<td class="nump">118,760<span></span>
</td>
<td class="nump">148,422<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_etnb_PaymentForPurchaseOfAvailableForSaleSecurities', window );">Purchases of available-for-sale securities</a></td>
<td class="num">(152,696)<span></span>
</td>
<td class="num">(141,200)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchases of property and equipment</a></td>
<td class="num">(7)<span></span>
</td>
<td class="num">(63)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash (used in) provided by investing activities</a></td>
<td class="num">(33,943)<span></span>
</td>
<td class="nump">7,159<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash flows from financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_etnb_ProceedsFromIssuancePublicOffering', window );">Proceeds from issuance of common stock and warrants in public offering, net of issuance costs</a></td>
<td class="nump">88,239<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_etnb_ProceedsFromIssuancePublicOfferingAtTheMarketOffering', window );">Proceeds from issuance of common stock in at-the-market public offering, net of issuance costs</a></td>
<td class="nump">28,453<span></span>
</td>
<td class="nump">3,289<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromWarrantExercises', window );">Proceeds from issuance of common stock upon exercise of warrants</a></td>
<td class="nump">1,082<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions', window );">Proceeds from issuance of common stock upon exercise of stock options</a></td>
<td class="nump">305<span></span>
</td>
<td class="nump">487<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from issuance of common stock upon ESPP purchases</a></td>
<td class="nump">50<span></span>
</td>
<td class="nump">144<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Payment of withholding taxes related to restricted stock units</a></td>
<td class="num">(298)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfOtherLongTermDebt', window );">Proceeds from term loan facility, net of issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19,951<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash provided by financing activities</a></td>
<td class="nump">117,831<span></span>
</td>
<td class="nump">23,871<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Net change in cash and cash equivalents, and restricted cash</a></td>
<td class="nump">2,798<span></span>
</td>
<td class="num">(45,751)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents, and restricted cash at beginning of period</a></td>
<td class="nump">52,457<span></span>
</td>
<td class="nump">98,208<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents, and restricted cash at end of period</a></td>
<td class="nump">55,255<span></span>
</td>
<td class="nump">52,457<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract', window );"><strong>Components of cash and cash equivalents, and restricted cash:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">55,255<span></span>
</td>
<td class="nump">52,432<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashCurrent', window );">Restricted cash</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">25<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Total cash and cash equivalents, and restricted cash</a></td>
<td class="nump">55,255<span></span>
</td>
<td class="nump">52,457<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowInformationAbstract', window );"><strong>Supplemental disclosures of cash information:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestPaidNet', window );">Cash paid for interest</a></td>
<td class="nump">1,076<span></span>
</td>
<td class="nump">16<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeasePaymentsUse', window );">Cash paid for operating leases</a></td>
<td class="nump">234<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoncashInvestingAndFinancingItemsAbstract', window );"><strong>Supplemental disclosures of noncash information:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_etnb_RemeasurementOfLeaseLiabilityAndRightOfUseAssetInConnectionWithLeaseModification', window );">Remeasurement of lease liability and right of use asset in connection with lease modification</a></td>
<td class="nump">$ 338<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_etnb_IssuanceOfCommonStockWarrantInConnectionWithTermLoanFacility', window );">Issuance of common stock warrant in connection with term loan facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 574<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_etnb_AmortizationOfDebtIssuanceCostsAndAccretionOfFinalPaymentFee">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amortization of debt issuance costs and accretion of final payment fee.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">etnb_AmortizationOfDebtIssuanceCostsAndAccretionOfFinalPaymentFee</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>etnb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_etnb_DeferredTaxAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">etnb_DeferredTaxAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>etnb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_etnb_IssuanceOfCommonStockWarrantInConnectionWithTermLoanFacility">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Issuance of common stock warrant in connection with term loan facility.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">etnb_IssuanceOfCommonStockWarrantInConnectionWithTermLoanFacility</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>etnb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_etnb_PaymentForPurchaseOfAvailableForSaleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Payment for purchases of available for sale securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">etnb_PaymentForPurchaseOfAvailableForSaleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>etnb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_etnb_ProceedsFromIssuancePublicOffering">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Proceeds from issuance public offering.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">etnb_ProceedsFromIssuancePublicOffering</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>etnb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_etnb_ProceedsFromIssuancePublicOfferingAtTheMarketOffering">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Proceeds from issuance public offering at the market offering.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">etnb_ProceedsFromIssuancePublicOfferingAtTheMarketOffering</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>etnb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_etnb_RemeasurementOfLeaseLiabilityAndRightOfUseAssetInConnectionWithLeaseModification">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Remeasurement of lease liability and right of use asset in connection with lease modification.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">etnb_RemeasurementOfLeaseLiabilityAndRightOfUseAssetInConnectionWithLeaseModification</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>etnb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The sum of the periodic adjustments of the differences between securities' face values and purchase prices that are charged against earnings. This is called accretion if the security was purchased at a discount and amortization if it was purchased at premium. As a noncash item, this element is an adjustment to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in obligation for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in prepaid expenses, and assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4297-108586<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3367-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncashInvestingAndFinancingItemsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncashInvestingAndFinancingItemsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasePaymentsUse">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow from operating lease to bring another asset to condition and location necessary for its intended use.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918643-209977<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasePaymentsUse</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense for right-of-use asset from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the additional capital contribution to the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfOtherLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from issuance of long-term debt classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfOtherLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from issuance of shares under share-based payment arrangement. Includes, but is not limited to, option exercised.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=SL79508275-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from sale, maturity, prepayment and call of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3151-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3179-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26853-111562<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromWarrantExercises">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from holders exercising their stock warrants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromWarrantExercises</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=SL98516268-108586<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139683194956304">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Organization and Basis of Presentation<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock', window );">Organization and Basis of Presentation</a></td>
<td class="text"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1. Organization and Basis of Presentation</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Description of Business</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">89bio, Inc. (&#8220;89bio&#8221; or the &#8220;Company&#8221;) is a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of liver and cardio-metabolic diseases. The Company&#8217;s lead product candidate, pegozafermin (previously BIO89-100), a specifically engineered glycoPEGylated analog of fibroblast growth factor 21, is currently being developed for the treatment of nonalcoholic steatohepatitis and for the treatment of severe hypertriglyceridemia.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">89bio, Inc. was formed as a Delaware corporation in </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="-sec-ix-hidden:F_334737a3-eb1d-48a1-9363-2f3248ac80ff;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">June 2019</span></span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> to carry on the business of 89Bio Ltd., which was incorporated in Israel in January 2018.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Liquidity</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The accompanying consolidated financial statements have been prepared assuming the Company will continue as a going concern, which contemplates the realization of assets and liquidation of liabilities in the normal course of business. To date, the Company has not generated revenues from its activities and has incurred substantial operating losses. Management expects the Company to continue to generate substantial operating losses for the foreseeable future until it completes development of its products and seeks regulatory approvals to market such products. The Company had cash and cash equivalents and short-term available-for-sale securities of </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">188.2</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> as of December 31, 2022.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company expects that its cash and cash equivalents and short-term available-for-sale securities as of December 31, 2022</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, together with proceeds received in January and February 2023 from its ATM Facility (see Note 7 and Note 11), and proceeds available from the 2023 Loan Agreement (see Note 6 and Note 11), will be sufficient to fund operating expenses and capital expenditure requirements for a period of at least one year from the date these audited consolidated financial statements are filed with the Securities and Exchange Commission.</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -URI https://asc.fasb.org/topic&amp;trid=2122149<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -URI https://asc.fasb.org/topic&amp;trid=2197479<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139683199561568">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">Summary of Significant Accounting Policies</a></td>
<td class="text"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2. Summary of Significant Accounting Policie</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">s</span></p><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Basis of Presentation</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States (&#8220;U.S. GAAP&#8221;).</span></p></div><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Reclassification</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Certain prior year amounts in the Company&#8217;s consolidated statements of operations and comprehensive loss have been reclassified to conform to the current year presentation. Specifically, interest expense is disclosed separately on the Company&#8217;s consolidated statements of operations and comprehensive loss, which had no impact on reported net loss, comprehensive loss, or loss per share.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p></div><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Principles of Consolidation</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The accompanying consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries. All intercompany balances and transactions have been eliminated in consolidation.</span></p></div><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Use of Estimates</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the consolidated financial statements and the reported amounts of expenses during the reporting period. Significant estimates and assumptions made in the accompanying consolidated financial statements include but are not limited to accrued research and development expenses and to the fair value of stock options. The Company evaluates its estimates and assumptions on an ongoing basis using historical experience and other factors and adjusts those estimates and assumptions when facts and circumstances dictate. Actual results could differ from those estimates.</span></p></div><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Foreign Currencies</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Certain transactions during the year ended December 31, 2022 and 2021</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> were denominated in currencies other than the U.S. dollar. Gains and losses from foreign currency transactions were not material for all periods presented and are reflected in the consolidated statements of operations and comprehensive loss as a component of interest income and other, net. The Company&#8217;s subsidiary in Lithuania uses the Euro as its functional currency for financial reporting. The re-measurement from Euros to U.S. dollars results in translation gain and loss adjustments, which are reflected as a component of comprehensive loss as foreign currency translation adjustments.</span></p></div><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Fair Value Measurements</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Financial assets and liabilities are recorded at fair value on a recurring basis in the consolidated balance sheets. The carrying values of Company&#8217;s financial assets and liabilities, including cash and cash equivalents, restricted cash, prepaid and other current assets, accounts payable, and accrued expenses approximate to their fair value due to the short-term nature of these instruments. The fair value of the Company&#8217;s term loan approximates its carrying value, or amortized cost, due to the prevailing market rates of interest rates it bears. Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability (an exit price) in an orderly transaction between market participants at the reporting date. Assets and liabilities recorded at fair value are categorized based upon the level of judgment associated with the inputs used to measure their fair value. Hierarchical levels are directly related to the amount of subjectivity with the inputs to the valuation of these assets or liabilities as follows:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Level 1</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;Observable inputs such as unadjusted, quoted prices in active markets for identical assets or liabilities at the measurement date;</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Level 2</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;Inputs (other than quoted prices included in Level 1) are either directly or indirectly observable inputs for similar assets or liabilities. These include quoted prices for identical or similar assets or liabilities in active markets and quoted prices for identical or similar assets or liabilities in markets that are not active; and</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Level 3</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.</span></p></div><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Concentrations of Credit Risk</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Financial instruments that potentially subject the Company to a concentration of credit risk consist primarily of cash and cash equivalents and short-term available-for-sale securities. Bank deposits are held by accredited financial institutions and these deposits may at times be in excess of insured limits. The Company limits its credit risk associated with cash and cash equivalents by placing them with financial institutions that it believes are of high quality. The Company has not experienced any losses on its deposits of cash or cash equivalents. The Company </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">limits amounts invested in available-for-sale securities by credit rating, maturity, industry group, investment type and issuer, except for securities issued by the U.S. government. The Company is not exposed to any significant concentrations of credit risk from these financial instruments.</span></p></div><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Other Risks and Uncertainties</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company&#8217;s future results of operations involve a number of other risks and uncertainties. Factors that could affect the Company&#8217;s future operating results and cause actual results to vary materially from expectations include, but are not limited to, the Company&#8217;s early stages of clinical drug development; the Company&#8217;s ability to advance product candidates into, and successfully complete, clinical trials on the timelines it projects; the Company&#8217;s ability to adequately demonstrate sufficient safety and efficacy of its product candidates; the Company&#8217;s ability to enroll patients in its ongoing and future clinical trials; the Company&#8217;s ability to successfully manufacture and supply its product candidates for clinical trials; the Company&#8217;s ability to obtain additional capital to finance its operations; uncertainties related to the projections of the size of patient populations suffering from the diseases the Company is targeting; the Company&#8217;s ability to obtain, maintain, and protect its intellectual property rights; developments relating to the Company&#8217;s competitors and its industry, including competing product candidates and therapies; general economic and market conditions; and other risks and uncertainties.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company&#8217;s product candidates will require approvals from the U.S. Food and Drug Administration and comparable foreign regulatory agencies prior to commercial sales in their respective jurisdictions. There can be no assurance that any product candidates will receive the necessary approvals. If the Company is denied approval, approval is delayed or the Company is unable to maintain approval for any product candidate, it could have a materially adverse impact on the Company.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The ongoing COVID-19 pandemic has disrupted and may continue to disrupt the Company&#8217;s business and delay its preclinical and clinical programs and timelines. The extent to which the COVID-19 pandemic may impact the Company&#8217;s future operating results and financial condition is uncertain.</span></p></div><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Segment Reporting</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company has </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">one</span><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> operating segment. The Company&#8217;s chief operating decision maker, its Chief Executive Officer, manages the Company&#8217;s operations on a consolidated basis for the purposes of allocating resources and evaluating financial performance.</span></p></div><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Cash and Cash Equivalents</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company considers all highly liquid investments purchased with original maturities of three months or less from the purchase date to be cash equivalents. Cash equivalents consist primarily of amounts invested in money market funds and commercial paper that are stated at fair value.</span></p></div><div style="font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Investments</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Investments have been classified as available-for-sale and are carried at estimated fair value as determined based upon quoted market prices or pricing models for similar securities. Management determines the appropriate classification of its available-for-sale investments in debt securities at the time of purchase. Generally, investments with original maturities beyond three months at the date of purchase are classified as short-term because it is management&#8217;s intent to use the investments to fund current operations or to make them available for current operations.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Unrealized gains and losses are excluded from net loss and are reported as a component of comprehensive loss. The Company periodically evaluates whether declines in fair values of its available-for-sale securities below their book value are other-than-temporary. This evaluation consists of several qualitative and quantitative factors regarding the severity and duration of the unrealized loss as well as the Company&#8217;s ability and intent to hold the available-for-sale security until a forecasted recovery occurs. Additionally, the Company assesses whether it has plans to sell the security or it is more likely than not it will be required to sell any available-for-sale securities before recovery of its amortized cost basis. Realized gains and losses and declines in fair value judged to be other than temporary, if any, on available-for-sale securities are included in interest income and other, net. The cost of investments sold is based on the specific-identification method. The Company has </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">no</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">t experienced any material realized gains or losses or other-than-temporary losses in the periods presented.</span></p></div><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Leases</span><span style="color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company is a lessee in noncancellable operating leases for office space. Beginning in 2022, the Company accounts for leases in accordance with Accounting Standards Update (&#8220;ASU&#8221;) 2016-02,</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> Leases</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> (</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Topic 842</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">). The Company determines if an arrangement is a lease or contains an embedded lease at inception. The Company accounts for a contract as a lease when it has the right to control the asset for a period of time while obtaining substantially all of the asset&#8217;s economic benefits. For arrangements that meet the definition of a lease, the Company determines the initial classification and measurement of its right-of-use (&#8220;ROU&#8221;) asset and lease liability at the lease commencement date and thereafter if modified. Operating lease ROU assets represent the Company&#8217;s right to use an underlying asset for the lease term and lease liabilities represent the Company&#8217;s obligation to make the contractual lease payments over the lease term. The ROU asset is initially measured at cost, which comprises the initial amount of the lease liability adjusted for lease payments made at or before the lease commencement date, plus any initial direct costs incurred less any lease incentives received. The operating lease liability is initially measured at the present value of the unpaid lease payments at the lease commencement date. The lease liability is subsequently measured at amortized cost using the effective-interest method. The lease term includes any renewal options that the Company is reasonably assured to exercise. The present value of lease payments is determined by using the interest rate implicit in the lease, if that rate is readily determinable, otherwise, the Company uses its estimated collateralized incremental borrowing rate for the lease term. The Company has elected not to record leases with an original term of twelve months or less on its consolidated balance sheets and recognizes those lease payments in operating expenses in the consolidated statements of operations and comprehensive loss. The Company&#8217;s short-term lease is not material.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In addition, the Company&#8217;s leases may require it to pay additional costs, such as utilities, maintenance, and other operating costs, which are generally referred to as non-lease components and vary based on future outcomes. The Company has elected to not separate lease and non-lease components. Only the fixed costs for lease components and their associated non-lease components are accounted for as a single lease component and recognized as part of a ROU </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">asset and lease liability. Any variable expenses are recognized in operating expenses as incurred. Rent expense for an operating lease liability is recognized on a straight-line basis over the lease term and is included in operating expenses in the consolidated statements of operations and comprehensive loss.</span></p></div><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Property and Equipment, Net</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Property and equipment are stated at cost, less accumulated depreciation. Depreciation is calculated on a straight-line basis over the estimated useful lives of the related assets, generally ranging from </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="-sec-ix-hidden:F_4640215a-3a60-4f28-a85d-e6242af9c877;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">three</span></span></span><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> to </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">seven years</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Leasehold improvements are amortized on a straight-line basis over the shorter of the assets&#8217; estimated useful life or the remaining term of the lease.</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Upon retirement or sale of the assets, the cost and related accumulated depreciation and amortization are removed from the consolidated balance sheets and the resulting gains or losses are recorded in the consolidated statements of operations and comprehensive loss. </span><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Maintenance and repair costs are expensed as incurred.</span></p></div><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Impairment of Long-Lived Assets</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company periodically evaluates its long-lived assets, including property and equipment, for impairment whenever events or changes in business circumstances indicate that the carrying amount of the assets or group of assets may not be fully recoverable. If indicators of impairment exist and the undiscounted future cash flows that the assets are expected to generate are less than the carrying value of the assets, then the Company will reduce the carrying amount of the assets through an impairment charge, to their estimated fair values based on a discounted cash flow approach or, when available and appropriate, to comparable market values. There were no such indicators for the periods presented.</span></p></div><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Accrued Research and Development Expenses</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company estimates preclinical and clinical study and research expenses based on the services performed, pursuant to contracts with research institutions that conduct and manage preclinical and clinical studies and research services on its behalf. The Company records the costs of research and development activities based upon the estimated services provided but not yet invoiced and includes these costs in accrued expenses in the consolidated balance sheets. These costs are a component of the Company&#8217;s research and development expenses.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company accrues for these costs based on factors such as estimates of the work completed in accordance with agreements established with its third-party service providers. The Company makes judgments and estimates in determining the accrued expenses balance. As actual costs become known, the Company adjusts its accrued expenses. The Company has not experienced any material differences between accrued costs and actual costs incurred. However, the status and timing of actual services performed may vary from the Company&#8217;s estimates, resulting in adjustments to expense in future periods. Changes in these estimates that result in material changes to the Company&#8217;s accrued expenses could materially affect the Company&#8217;s results of operations. Contingent milestone payments, if any, are expensed when the milestone results are probable and estimable, which is generally upon achievement of the milestone.</span></p></div><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Warrants to Purchase Common Stock</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company classifies warrants indexed to its common stock and meeting the requirements for equity classification within stockholders&#8217; equity. This assessment is conducted at the time of warrant issuance and as of each reporting period that the warrants remain outstanding.</span></p></div><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Research and Development Expenses</span><span style="color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Research and development expenses consist primarily of costs incurred for the development of the Company&#8217;s lead product candidate, pegozafermin. Research and development expenses consist primarily of external costs related to preclinical and clinical development and related supplies and personnel costs. Personnel costs consist of salaries, employee benefits and stock-based compensation for individuals involved in research and development efforts. Payments associated with agreements to acquire licenses to develop, use, manufacture and commercialize products and purchases of pegozafermin from contract manufacturing organizations that have not reached technological feasibility and do not have alternate future commercial use are expensed as incurred.</span></p></div><div style="font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Stock-Based Compensation</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company provides equity awards in the form of stock options and restricted stock units. The Company measures its equity awards made to employees, directors, and</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">non-employee service providers based on estimated fair values and recognizes stock-based compensation over the requisite service period. The Company accounts for forfeitures as they occur.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company estimates the fair value of stock option awards on the date of grant using a</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Black-Scholes option pricing model. The Company recognizes compensation for the value of stock options awards, which have graded vesting, using the straight-line method over the requisite service period of each award.</span><span style="color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Black-Scholes option pricing model requires a number of assumptions, of which the most significant are expected volatility, expected option term (the time from the grant date until the options are exercised or expire), risk-free rate, and expected dividend rate. These assumptions include:</span></p><div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#8226;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Expected volatility&#8212;Since the Company has limited trading history for its common stock, expected volatility is estimated based on weighting the Company&#8217;s volatility and the volatility of comparable publicly traded biotechnology companies during the equivalent period of the calculated expected term of the options granted. The comparable companies were chosen based on their similar size, stage in the life cycle, or area of specialty. There is a degree of uncertainty in determining a comparable peer group as each of the peers are engaged in varied research and development activities, the timing and progress of which differ within the peer group. </span></div></div><div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#8226;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Expected term&#8212;The expected term of options granted to employees and directors is determined using the &#8220;simplified&#8221; method. Under this approach, the expected term is presumed to be the midpoint between the weighted-average vesting term and the contractual term of the option. The simplified method makes the assumption that the employee will exercise stock options evenly over the period when the stock options are vested and ending on the date when the stock options would expire. The expected option term for options granted to non-employees is estimated on a grant-by-grant basis.</span></div></div><div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#8226;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Risk-free interest rate&#8212;The risk-free interest rate is based on the U.S. Treasury zero coupon bonds in effect on the grant date for periods with an equivalent expected term as the option.</span></div></div><div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#8226;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Expected dividend&#8212;The Company has never paid dividends and has no foreseeable plans to pay dividends on its shares of common stock. Therefore, an expected dividend of zero is used.</span></div></div><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The fair value of restricted stock units is based on the fair value of the Company&#8217;s common stock on the date of grant. The grant date fair value of restricted stock units with service vesting conditions is recognized over the requisite service period on a straight-line basis. For restricted stock units with performance vesting conditions, the Company evaluates the probability of achieving the performance condition at each reporting date and recognizes expense for such performance awards over the requisite service period using the accelerated attribution method.</span></p></div><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Income Taxes</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Income taxes are accounted for under the asset and liability method. Under this method, deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the consolidated financial statements carrying amounts of existing assets and liabilities and their respective tax bases and operating loss and tax credit carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates applied to taxable income in the years in which those temporary differences are expected to be realized. The effect on deferred tax assets and liabilities of a change in tax rates is recognized as income or loss in the period that includes the enactment date. A valuation allowance is established when necessary to reduce deferred tax assets to the amount expected to be realized. Interest and penalties related to unrecognized tax benefits are included within the provision of income tax.</span><span style="color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p></div><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Basic and Diluted Net Loss per Share</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Basic loss per share is computed by dividing net loss by the weighted-average number of shares of common stock outstanding during the period. Diluted loss per share is computed by dividing net loss by the weighted-average number of shares of common stock outstanding together with the number of additional shares of common stock that would have been outstanding if all potentially dilutive shares of common stock had been issued. Since the Company is in a loss position for the periods presented, basic net loss per share is the same as diluted net loss per share since the effects of potentially dilutive securities are antidilutive. </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Shares of the Company&#8217;s common stock underlying pre-funded warrants exercisable for nominal consideration are included in the computation of basic and diluted net loss per share, even if antidilutive.</span></p></div><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Comprehensive Loss</span><span style="color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company&#8217;s comprehensive loss is comprised of net loss and changes in unrealized gains or losses on available-for-sale securities and foreign currency translation adjustments.</span></p></div><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Recently Adopted Accounting Standards</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> &#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In February 2016, the Financial Accounting Standards Board (&#8220;FASB&#8221;) issued ASU 2016-02,</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> Leases</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> (</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Topic 842</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">), or Accounting Standards Codification (&#8220;ASC&#8221;) 842, which requires lessees to recognize leases on the balance sheet and disclose key information about leasing arrangements. ASC 842 establishes a ROU model that requires a lessee to recognize a ROU asset and lease liability on the balance sheet for all leases with a term longer than 12 months. Leases are classified as finance or operating, with classification affecting the pattern and classification of expense recognition in the income statement.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">On</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> January 1, 2022</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, the Company adopted </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">ASC 842</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> using the modified retrospective transition method and elected the practical expedients to not reassess whether any expired or existing contracts are or contain leases, carry forward its historical lease classification and not reassess initial direct costs for existing leases. Upon adoption of ASC 842, the Company recorded an operating ROU asset of $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">0.2</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million and an operating lease liability of $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">0.2</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million on its consolidated balance sheet. There was </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">no</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> adjustment to the opening balance of accumulated deficit as a result of adoption. Results for the year ended December 31, 2022 are presented under ASC 842. Prior period amounts preceding January 1, 2022 continue to be reported in accordance with the Company&#8217;s historical accounting under the previous lease guidance, ASC 840.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Recent Accounting Pronouncements</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In June 2016, the FASB issued ASU 2016-13, </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Financial Instruments&#8212;Credit Losses (Topic 326)</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">: </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Measurement of Credit Losses on Financial Instruments </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(&#8220;ASU 2016-13&#8221;), which replaces the existing incurred loss impairment model with an expected credit loss model and requires a financial asset measured at amortized cost to be presented at the net amount expected to be collected. As an emerging growth company, ASU 2016-13 is effective for the Company for the year ending December 31, 2023 and interim periods within that fiscal year and must be adopted using a modified retrospective approach, with certain exceptions. The Company is evaluating the impact of this standard and </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">does not expect the adoption of ASU 2016-13 to have a material impact on the Company&#8217;s consolidated financial statements and related disclosures.</span></p></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126899994&amp;loc=d3e18726-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI https://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139683194903488">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresTextBlock', window );">Fair Value Measurements</a></td>
<td class="text"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3. Fair Value Measurements</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><div style="font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;"><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The following table presents the Company&#8217;s financial assets measured at fair value on a recurring basis by level within the fair value hierarchy as of </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31, 2022 (in thousands):</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:90.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:45.662%;"/>
        <td style="width:0.122%;"/>
        <td style="width:10.9%;"/>
        <td style="width:0.122%;"/>
        <td style="width:1.0%;"/>
        <td style="width:8.655%;"/>
        <td style="width:1.0%;"/>
        <td style="width:0.081%;"/>
        <td style="width:1.0%;"/>
        <td style="width:8.384%;"/>
        <td style="width:1.0%;"/>
        <td style="width:0.108%;"/>
        <td style="width:1.0%;"/>
        <td style="width:9.225%;"/>
        <td style="width:1.0%;"/>
        <td style="width:0.081%;"/>
        <td style="width:1.0%;"/>
        <td style="width:8.655%;"/>
        <td style="width:1.0%;"/>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Valuation</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Amortized</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Unrealized</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Unrealized</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Fair</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Hierarchy</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Cost</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Gains</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Losses</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Value</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Money market funds</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Level 1</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">18,224</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">18,224</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Commercial paper</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Level 2</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">104,279</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">84</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">104,196</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">U.S. government bonds</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Level 2</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">18,225</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">109</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">18,117</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Agency bonds</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Level 2</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">13,986</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">78</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">13,908</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Corporate debt securities</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Level 2</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10,488</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">62</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10,426</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">U.S. treasury bills</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Level 2</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">7,414</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">21</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">7,394</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Agency discount securities</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Level 2</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5,216</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">9</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5,225</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Non-U.S. debt securities</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Level 2</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3,975</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">20</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3,955</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:5.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total cash equivalents and available-for-<br/>&#160;&#160;&#160;sale securities</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">181,807</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">12</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">374</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">181,445</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Classified as:</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Cash equivalents</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">48,540</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Short-term available-for-sale securities</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">132,905</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:5.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total cash equivalents and available-for-<br/>&#160;&#160;&#160;sale securities</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">181,445</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></div><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><p style="text-indent:4.533%;font-size:10.0pt;margin-top:2.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The following table summarizes the Company&#8217;s cash equivalents and available-for-sale securities by contractual maturity as of </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31, 2022 (in thousands):</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:90.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:77.695%;"/>
        <td style="width:2.196%;"/>
        <td style="width:1.0%;"/>
        <td style="width:18.109%;"/>
        <td style="width:1.0%;"/>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Within one year</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">175,243</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">After one year through two years</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">6,202</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:5.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total cash equivalents and available-for-sale securities</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">181,445</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></div><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><p style="text-indent:4.533%;font-size:10.0pt;margin-top:2.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The following table presents the Company&#8217;s financial assets measured at fair value on a recurring basis by level within the fair value hierarchy as of </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31, 2021 (in thousands):</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:90.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:45.662%;"/>
        <td style="width:0.122%;"/>
        <td style="width:10.9%;"/>
        <td style="width:0.122%;"/>
        <td style="width:1.0%;"/>
        <td style="width:8.655%;"/>
        <td style="width:1.0%;"/>
        <td style="width:0.081%;"/>
        <td style="width:1.0%;"/>
        <td style="width:8.384%;"/>
        <td style="width:1.0%;"/>
        <td style="width:0.108%;"/>
        <td style="width:1.0%;"/>
        <td style="width:9.225%;"/>
        <td style="width:1.0%;"/>
        <td style="width:0.081%;"/>
        <td style="width:1.0%;"/>
        <td style="width:8.655%;"/>
        <td style="width:1.0%;"/>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Valuation</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Amortized</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Unrealized</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Unrealized</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Fair</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Hierarchy</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Cost</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Gains</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Losses</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Value</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Money market funds</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Level 1</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">21,477</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">21,477</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Commercial paper</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Level 2</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">59,647</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">59,637</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">U.S. government bonds</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Level 2</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">21,662</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">42</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">21,620</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Corporate debt securities</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Level 2</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">8,776</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">8,776</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Agency bonds</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Level 2</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">7,747</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">7</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">7,741</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Municipal bonds</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Level 2</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4,251</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4,247</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Non-U.S. debt securities</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Level 2</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2,506</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2,505</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:5.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total cash equivalents and available-for-<br/>&#160;&#160;&#160;sale securities</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">126,066</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">65</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">126,003</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Classified as:</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Cash equivalents</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">27,715</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Short-term available-for-sale securities</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">98,288</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:5.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total cash equivalents and available-for-<br/>&#160;&#160;&#160;sale securities</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">126,003</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></div><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><p style="text-indent:4.533%;font-size:10.0pt;margin-top:2.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The following table summarizes the Company&#8217;s cash equivalents and available-for-sale securities by contractual maturity as of </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31, 2021 (in thousands):</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:90.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:77.695%;"/>
        <td style="width:2.196%;"/>
        <td style="width:1.0%;"/>
        <td style="width:18.109%;"/>
        <td style="width:1.0%;"/>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Within one year</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">120,726</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">After one year through two years</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5,277</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:5.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total cash equivalents and available-for-sale securities</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">126,003</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139683296652736">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Balance Sheet Components<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BalanceSheetRelatedDisclosuresAbstract', window );"><strong>Balance Sheet Related Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock', window );">Consolidated Balance Sheet Components</a></td>
<td class="text"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4. Consolidated Balance Sheet Components</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Prepaid and other current assets consist of the following as of the periods presented (in thousands):</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:70.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:65.777%;"/>
        <td style="width:1.589%;"/>
        <td style="width:1.0%;"/>
        <td style="width:13.515%;"/>
        <td style="width:1.0%;"/>
        <td style="width:1.589%;"/>
        <td style="width:1.0%;"/>
        <td style="width:13.530000000000001%;"/>
        <td style="width:1.0%;"/>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As of December 31,</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2022</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2021</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Prepaid research and development</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5,727</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">7,895</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Prepaid taxes</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">646</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">836</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Prepaid other</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1,547</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2,506</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:5.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total prepaid and other current assets</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">7,920</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">11,237</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></div><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Accrued expenses consist of the following as of the periods presented (in thousands):</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:70.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:65.777%;"/>
        <td style="width:1.589%;"/>
        <td style="width:1.0%;"/>
        <td style="width:13.515%;"/>
        <td style="width:1.0%;"/>
        <td style="width:1.589%;"/>
        <td style="width:1.0%;"/>
        <td style="width:13.530000000000001%;"/>
        <td style="width:1.0%;"/>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As of December 31,</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2022</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2021</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Accrued research and development expenses</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">6,499</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">6,195</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Accrued employee and related expenses</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4,165</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3,168</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Accrued professional and legal fees</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1,052</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">495</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Accrued other expenses</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">228</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">336</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:5.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total accrued expenses</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">11,944</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10,194</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetRelatedDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetRelatedDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for supplemental balance sheet disclosures, including descriptions and amounts for assets, liabilities, and equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -URI https://asc.fasb.org/topic&amp;trid=2122208<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalBalanceSheetDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139683195183424">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">Commitments and Contingencies</a></td>
<td class="text"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:8.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5. Commitments and Contingencies</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Leases</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">On January 1, 2022, the Company adopted ASC 842 (see Note 2), and the following disclosures as of and for the year ended December 31, 2022 are presented under ASC 842, while prior period amounts have not been adjusted and continue to be reported in accordance with the historical accounting under ASC 840. Upon adoption, the Company recorded an operating lease ROU asset and lease liability for its lease in San Francisco, which was due to expire in </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">January 2023</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. Effective August 31, 2022, the Company amended the lease to extend the expiration date of the lease to </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">January 2025</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, with one option to renew for an additional year that is not reasonably certain to be exercised. The amendment resulted in the remeasurement of the lease liability and ROU asset as of the modification date to reflect the extended term and the Company recorded an incremental ROU asset and lease liability of $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">0.3</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">For the year ended December 31, 2022, the Company incurred </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">0.2</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> in rent expense. For the year ended December 31, 2022, variable lease payments and short-term lease costs were </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="-sec-ix-hidden:F_4a26968b-e9d0-4e69-8f86-01a61afe4e4c;"><span style="-sec-ix-hidden:F_104effa9-00d2-42bf-9012-ca94303c5178;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">immaterial</span></span></span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. As of </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31, 2022, the remaining lease term was </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2.0</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> years and the Company&#8217;s incremental borrowing rate used to determine the operating lease liability was </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">6.5</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As of </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31, 2022, the undiscounted future minimum lease payments due under the Company&#8217;s non-cancellable operating lease are as follows (in thousands):</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:70.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:69.795%;"/>
        <td style="width:2.701%;"/>
        <td style="width:1.0%;"/>
        <td style="width:25.503%;"/>
        <td style="width:1.0%;"/>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2023</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">185</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2024</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">185</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2025</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">7</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total undiscounted future minimum lease payments</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">377</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Less: imputed interest</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">23</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:5.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Present value of operating lease liability</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">354</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></div><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In accordance with ASC 840, rent expense for the year ended December 31, 2021 was $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">0.3</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million. </span><span style="font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The total future minimum annual payments for operating leases in effect as of December 31, 2021 were as follows (in thousands):</span></span></p><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:70.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:70.024%;"/>
        <td style="width:2.946%;"/>
        <td style="width:1.0%;"/>
        <td style="width:25.03%;"/>
        <td style="width:1.0%;"/>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2022</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">212</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2023</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">7</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:5.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total future minimum annual payments</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">219</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></div><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Asset Transfer and License Agreement with Teva Pharmaceutical Industries Ltd</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In April 2018, the Company concurrently entered into two Asset Transfer and License Agreements (the &#8220;Teva Agreements&#8221;) with Teva Pharmaceutical Industries Ltd (&#8220;Teva&#8221;) under which it acquired certain patents and intellectual property relating to two programs: (1) Teva&#8217;s glycoPEGylated FGF21 </span><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">fibroblast growth factor 21 (&#8220;</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">FGF21&#8221;) program, including the compound TEV-47948 (pegozafermin), a glycoPEGylated long-acting FGF21 and (2) Teva&#8217;s development program of small molecule inhibitors of fatty acid synthase. Pursuant to the Teva Agreements, the Company paid Teva an initial nonrefundable upfront payment of $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">6.0</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">and the Company</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">could </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">be obligated to pay Teva up to $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">67.5</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million under each program, for a total of $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">135.0</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million, upon the achievement of certain clinical development and commercial milestones. In addition, the Company is obligated to pay Teva tiered royalties at percentages in the low-to-mid single-digits on worldwide net sales on all products containing the Teva compounds.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Teva Agreements can be terminated (i) by the Company without cause upon </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">120 days</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8217; written notice to Teva, (ii) by either party, if the other party materially breaches any of its obligations under the Teva Agreements and fails to cure such breach within </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">60 days</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> after receiving notice thereof, or (iii) by either party, if a bankruptcy petition is filed against the other party and is not dismissed within </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">60 days</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. In addition, Teva can also terminate the agreement related to the Company&#8217;s glycoPEGylated FGF21 program in the event the Company, or any of its affiliates or sublicensees, challenges any of the Teva patents licensed to the Company, and the challenge is not withdrawn within 30 days of written notice from Teva.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">During the year ended December 31, 2022 and 2021</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">no</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">ne of the development and commercial milestones were met and accordingly, there were </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">no</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> milestone payments related to the Teva Agreements.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI https://asc.fasb.org/topic&amp;trid=2144648<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 440<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6491277&amp;loc=d3e6429-115629<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI https://asc.fasb.org/topic&amp;trid=2127136<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139683195183424">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Term Loan<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtTextBlock', window );">Term Loan</a></td>
<td class="text"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">6. Term Loan</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Loan and Security Agreement</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In April 2020, the Company entered into a Loan and Security Agreement, (the &#8220;Loan Agreement&#8221;) with the lenders referred to therein, and Silicon Valley Bank (&#8220;SVB&#8221;), as collateral agent. The Loan Agreement provided for (i) a secured term A loan facility (the &#8220;Term A Loan Facility&#8221;) of up to $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10.0</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million and (ii) a secured term B loan facility (the &#8220;Term B Loan Facility&#8221;) of up to $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5.0</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million that became available upon the satisfaction of certain milestones, each of which was available to be drawn through May 31, 2021. The term loan is secured by certain assets of the Borrowers (as defined in the Loan Agreement), including substantially all of the assets of the Company, excluding the Company&#8217;s intellectual property. The term loan contains customary representations, warranties, affirmative covenants and also certain restrictive covenants.</span></span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In April 2020, in connection with the execution of the Loan Agreement, the Company issued SVB a warrant to purchase </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">25,000</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> shares of the Company&#8217;s common stock with a warrant exercise price of $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">22.06</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> per share that is immediately exercisable and expires on </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">June 30, 2025</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, as amended. The fair value of the warrant at the issuance date was determined by using the Black-Scholes option-pricing model and the fair value allocated to the warrant of $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">0.6</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million met the requirements for equity classification within additional paid-in capital. Additionally, the Company incurred $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">0.2</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million in closing costs, which together with the value of the warrants, were recorded as debt issuance costs.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In May 2021, the parties further amended the Loan Agreement (as amended, the &#8220;2021 Loan Agreement&#8221;). The 2021 Loan Agreement increased the Term A Loan Facility to up to $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">20.0</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million, which was fully drawn as of December 2021. The Term B Loan Facility of up to $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5.0</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million was available to be drawn upon on achievement of certain additional milestones, on or before September 30, 2022, which expired unused.</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> The 2021 Loan Agreement provided for interest-only payments until October 1, 2022, which could be extended to April 1, 2023, if on or before September 30, 2022, the Company received net cash proceeds of at least $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">75.0</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million from the sale of its equity securities. In July 2022, the Company met the net cash proceeds requirement (see Note 7) and on September 1, 2022, the interest-only period was extended to April 1, 2023. Consecutive monthly payments of principal and interest commence on April 1, 2023 and continue through </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">September 1, 2024</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, the maturity date of the term loan. The term loan bears interest at the greater of (i) </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4.25</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">% and (ii) the sum of (a) the Prime Rate as reported in The Wall Street Journal plus (b) </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.00</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%. The interest rate on the term loan was </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4.25</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">% at inception and </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">8.50</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">% as of December 31, 2022. In addition, a final payment fee of </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5.0</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">% of the principal amount of the loan is due when the term loan becomes due or upon prepayment of the term loan. If the Company elects to prepay the loan, there is also a prepayment fee of between </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.0</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">% and </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3.0</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">% of the principal amount of the term loan depending on the timing of prepayment.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In May 2021, in connection with the execution of the 2021 Loan Agreement, the Company issued SVB a warrant to purchase </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">33,923</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> shares of the Company&#8217;s common stock with a warrant exercise price of $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">19.12</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> per share that is immediately exercisable and expires on </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">May 28, 2031</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company determined the fair value of the</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">warrant </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">at the issuance date by using the Black-Scholes option-pricing model with the following assumptions: risk-free interest rate of </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.6</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%, </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">no</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> dividends, expected volatility of </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">98.6</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">% and expected term of </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10.0</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> years. Upon issuance, the fair value of the warrant of $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">0.6</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million was recorded as a debt issuance cost and met the requirements for equity classification within additional paid-in capital in the consolidated balance sheets. In addition, closing costs incurred were not material. In connection with Term B Loan Facility, if funded, the Company was to issue an additional warrant to purchase </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">11,305</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> shares of the Company&#8217;s common stock with the exercise price at the Company&#8217;s stock price at the time of issuance. However, the Term Loan B Facility expired unused and therefore no additional warrant was issued.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The 2021 Loan Agreement was accounted for as a modification to a credit facility. The related debt issuance costs incurred in May 2021, including the fair value of the warrant, together with the remaining unamortized debt issuance costs related to the Loan Agreement of $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">0.4</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million were recorded as deferred assets and recognized on a straight-line basis as interest expense over the availability of the draw period. </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As of December 31, 2021, all amounts were drawn under the Term Loan A Facility such that all debt issuance costs were recorded as a debt discount.</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> The carrying value of the debt discount, together with the final payment fee, are recognized using the effective interest method.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In September 2022, the parties agreed the extension of the interest-only period was met as a result of the July 2022 public offering (see Note 7), which was accounted for as a debt modification. A new effective interest rate equating to the revised cash flows of the carrying amount of the original debt was applied prospectively. The Company did not incur any costs in relation to the extension.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In January 2023, the Company executed a loan and security agreement with new lenders (the &#8220;2023 Loan Agreement</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8221;</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">) and repaid its outstanding obligations under the 2021 Loan Agreement (see Note 11). As the Company had the intent and ability to refinance amounts due under the 2021 Loan Agreement pursuant to the terms of the 2023 Loan Agreement, as of December 31, 2022, the current portion of the outstanding principal obligation under the 2021 Loan Agreement was classified as long-term. As of December 31, 2022, the Company&#8217;s total obligations under the 2021 Loan Agreement were $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">19.7</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million classified as term loan, non-current, net and $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">0.5</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million classified as other non-current liability related to the final payment fee. The term loan, non-current, net is comprised of the outstanding principal amount of $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">20.0</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million net of $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">0.3</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million of unamortized debt discount.</span></span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for long-term debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -URI https://asc.fasb.org/topic&amp;trid=2208564<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139683195799920">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">Stockholders' Equity</a></td>
<td class="text"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">7. Stockholders&#8217; Equity</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As of </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31, 2022, the Company&#8217;s shares of common stock available for future issuance were as follows:</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:79.712%;"/>
        <td style="width:1.464%;"/>
        <td style="width:1.0%;"/>
        <td style="width:16.823999999999998%;"/>
        <td style="width:1.0%;"/>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Shares available for future grant under the equity incentive plan</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">241,635</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Shares available for future issuance under the employee stock purchase plan</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">729,218</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Shares available for future issuance upon the exercise of warrants and pre-funded warrants</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">13,966,283</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:5.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total available for future issuance</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">14,937,136</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></div><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:8.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Public Offerings</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">At-the-Market Offerings</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In March 2021, the Company entered into a sales agreement (as amended, the &#8220;Sales Agreement&#8221;) with SVB Securities LLC and Cantor Fitzgerald &amp; Co. (the &#8220;Sales Agents&#8221;) pursuant to which the Company may offer and sell up to $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">75.0</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million of shares of its common stock, from time to time, in &#8220;at-the-market&#8221; offerings (the &#8220;ATM Facility&#8221;). The Sales Agents are entitled to compensation at a commission equal to </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3.0</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">% of the aggregate gross sales price per share sold under the Sales Agreement. Pursuant to the ATM Facility, in 2021, the Company received aggregate proceeds of $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3.3</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million, net of commissions and offering expenses from sales of </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">186,546</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> shares of its common stock and, in 2022, received aggregate proceeds of $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">28.5</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million, net of commissions from the sales of </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3,948,611</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> shares of its common stock.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">July 2022 Public Offering</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In July 2022, the Company completed an underwritten public offering of its common stock, warrants to purchase shares of its common stock and pre-funded warrants to purchase shares of its common stock. The Company sold </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">18,675,466</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> shares of its common stock with accompanying warrants to purchase up to </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">9,337,733</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> shares of its common stock at a combined public offering price of $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3.55</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> per share. The Company also sold </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">7,944,252</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> pre-funded warrants to purchase shares of its common stock with accompanying warrants to purchase up to </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3,972,126</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> shares of its common stock at a combined public offering price of $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3.549</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> per pre-funded warrant, which represents the per share public offering price for the common stock less $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">0.001</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> per share, the exercise price for each pre-funded warrant. The Company raised net proceeds of $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">88.2</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million, after deducting underwriting discounts and commissions of $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5.7</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million and other offering costs of $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">0.6</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million. </span></span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"/></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The exercise of the outstanding warrants is subject to a beneficial ownership limitation of </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">9.99</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%, or at the election of the holder prior to the issuance of the warrant, </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4.99</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%. The exercise of the outstanding pre-funded warrants is subject to a beneficial ownership limitation of </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">9.99</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%, or at the election of the holder prior to the issuance of the pre-funded warrant, </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4.99</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%, which a holder may increase or decrease from time to time but shall not exceed </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">19.99</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%. The exercise price and number of shares of common stock issuable upon the exercise of the warrants and pre-funded warrants are subject to adjustment in the event of any stock dividends, stock splits, reverse stock split, recapitalization, or reorganization or similar transaction, as described in the agreements. Under certain circumstances, the warrants and pre-funded warrants may be exercisable on a &#8220;cashless&#8221; basis. The warrants and pre-funded warrants were classified as a component of stockholders&#8217; equity and additional paid-in capital because such warrants and pre-funded warrants (i) are freestanding financial instruments that are legally detachable and separately exercisable from the equity instruments, (ii) are immediately exercisable, (iii) do not embody an obligation for the Company to repurchase its shares, (iv) permit the holders to receive a fixed number of common shares upon exercise, (v) are indexed to the Company&#8217;s common stock and (vi) meet the equity classification criteria. In addition, the warrants and pre-funded warrants do not provide any guarantee of value or return.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Common Stock Warrants</span></p><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As of </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31, 2022, the Company&#8217;s outstanding warrants to purchase shares of its common stock were as follows:</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:57.363%;"/>
        <td style="width:0.996%;"/>
        <td style="width:1.0%;"/>
        <td style="width:10.953999999999999%;"/>
        <td style="width:1.0%;"/>
        <td style="width:1.384%;"/>
        <td style="width:1.0%;"/>
        <td style="width:11.152000000000001%;"/>
        <td style="width:1.0%;"/>
        <td style="width:1.384%;"/>
        <td style="width:12.766%;"/>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Shares of<br/>Common Stock<br/>Underlying<br/>Warrants</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Exercise Price<br/>Per Share</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Expiration<br/>Date</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Warrant issued with term loan</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">25,000</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">22.06</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">June 30, 2025</span></span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Warrant issued with term loan</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">33,923</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">19.12</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">May 28, 2031</span></span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Warrants issued in public offering</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">13,107,360</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5.325</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">July 1, 2024</span></span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Pre-funded warrants issued in public offering</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">800,000</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">0.001</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Do not expire</span></span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:5.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total outstanding</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">13,966,283</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);text-indent:25.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="margin-left:25.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
       </tr>
      </table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -URI https://asc.fasb.org/topic&amp;trid=2208762<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496171-112644<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496171-112644<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496189-112644<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496189-112644<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496171-112644<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496189-112644<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 16<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496180-112644<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(e)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126731327&amp;loc=SL126733271-114008<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139683195071680">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-Based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock', window );">Stock-Based Compensation</a></td>
<td class="text"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">8</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. Stock-Based Compensation </span><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Equity Incentive Plan</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In September 2019, the Company&#8217;s board of directors adopted the 2019 Equity Incentive Plan (the &#8220;2019 Plan&#8221;), which also became effective in September 2019. The Company initially reserved </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2,844,193</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> shares of common stock for issuance under the 2019 Plan. In addition, the number of shares of common stock reserved for issuance under the 2019 Plan will automatically increase on the first day of January for a period of up to </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">ten years</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> in an amount equal to </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">% of the total number of shares of the Company&#8217;s capital stock outstanding on the immediately preceding December 31, or a lesser number of shares determined by the Company&#8217;s board of directors.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The board of directors determines the period over which options become exercisable and options generally vest over a </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">four-year</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> period, with </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">25</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">% of options vesting on the first anniversary of employment, and thereafter, the remaining options vesting quarterly, over the following </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">36-month</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> period. The options expire within </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">ten years</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> from </span></span><span style=""/></p><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">the </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">date of grant. The exercise price of awards granted will not be less than the estimated fair value of the shares on the date of grant. The 2019 Plan also permits the board of directors to grant restricted stock units, which are subject to continued service conditions.</span></p></div><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Employee Stock Purchase Plan</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In October 2019, the Company&#8217;s board of directors adopted the 2019 Employee Stock Purchase Plan (&#8220;ESPP&#8221;), which became effective in November 2019. The Company initially reserved </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">225,188</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> shares of common stock for purchase under the ESPP. The number of shares of common stock reserved for issuance under the ESPP will automatically increase on the first day of January for a period of up to </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">ten years</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> in an amount equal to </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">% of the total number of shares of the Company&#8217;s common stock outstanding on the immediately preceding December 31, or a lesser number of shares determined by the Company&#8217;s board of directors. Purchases are accomplished through the participation of discrete offering periods and each offering is expected to be six months in duration. For each offering period, ESPP participants will purchase shares of common stock at a price per share equal to </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">85</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">% of the lesser of the fair market value of the Company&#8217;s common stock on (1) the first trading day of the applicable offering period or (2) the last trading day of the applicable offering period.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Stock Options</span></p><div style="font-size:11.0pt;font-family:&quot;Calibri&quot;, sans-serif;"><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The following table summarizes stock option activity for the year ended </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31, 2022:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:95.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:55.851%;"/>
        <td style="width:0.081%;"/>
        <td style="width:1.0%;"/>
        <td style="width:10.520999999999999%;"/>
        <td style="width:1.0%;"/>
        <td style="width:0.081%;"/>
        <td style="width:1.0%;"/>
        <td style="width:7.231%;"/>
        <td style="width:1.0%;"/>
        <td style="width:0.081%;"/>
        <td style="width:1.0%;"/>
        <td style="width:8.775%;"/>
        <td style="width:1.0%;"/>
        <td style="width:0.269%;"/>
        <td style="width:1.0%;"/>
        <td style="width:9.112%;"/>
        <td style="width:1.0%;"/>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Weighted</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Weighted</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Average</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Average</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Remaining</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Aggregate</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Number of</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Exercise</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Contractual</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Intrinsic</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Options</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Price</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Term</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Value</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(In years)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(In thousands)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Balance outstanding as of December 31, 2021</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2,406,668</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">16.46</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">8.1</span></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">9,970</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Granted</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1,149,816</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4.48</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Exercised</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">151,061</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2.09</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Cancelled and forfeited</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">243,506</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">16.34</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:11.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:11.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Balance outstanding as of December 31, 2022</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3,161,917</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">12.80</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">7.9</span></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">16,612</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Exercisable as of December 31, 2022</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1,460,685</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">14.60</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">7.0</span></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">7,320</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></div><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The fair value of stock options granted for the periods presented was estimated at the date of grant using a Black-Scholes option-pricing model with the following assumptions:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:90.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:59.283%;"/>
        <td style="width:1.994%;"/>
        <td style="width:18.364%;"/>
        <td style="width:1.994%;"/>
        <td style="width:18.364%;"/>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="3" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Year Ended December 31,</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2022</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2021</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Expected term (years)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5.5</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">-</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">6.3</span></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5.5</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">-</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">6.1</span></span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Expected volatility</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">89.9</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">-</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">91.0</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">86.9</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">-</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">91.9</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Risk-free interest rate</span></p></td>
        <td style="background-color:rgba(207,240,252,1);text-indent:5.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.6</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">-</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3.9</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">0.7</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">-</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.3</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Expected dividend</span></p></td>
        <td style="background-color:rgba(255,255,255,1);text-indent:15.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:15.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
       </tr>
      </table><p style="text-indent:4.533%;font-size:10.0pt;margin-top:2.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></div><p style="text-indent:4.533%;font-size:10.0pt;margin-top:2.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The weighted-average grant date fair value of stock options that were granted during the year ended December 31, 2022 and 2021 was </span><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3.38</span><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> and $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">16.18</span><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> per share, respectively. As of </span><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31, 2022, there was </span><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">12.2</span><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million</span><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> of unrecognized stock-based compensation related to stock options granted under the 2019 Plan, which is expected to be recognized over a weighted-average period of </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2.2</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> years.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Restricted Stock Units (&#8220;RSUs&#8221;)</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company has granted certain employees service-based RSUs that generally vest annually over a </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="-sec-ix-hidden:F_79bc5d0a-fb68-4600-adad-d1cd8af005e1;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">two</span></span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> or </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">three-year</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> period. The restrictions lapse over time for these service-based RSUs. In the event of termination of the holder&#8217;s continuous service to the Company, any unvested portion of the service-based RSUs are cancelled. For the year ended </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31, 2022 and 2021, the Company recognized expense of </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.2</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> and $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">0.3</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million, respectively, related to the service-based RSUs.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In February 2021, the Company granted performance-based RSUs that vest as to </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="-sec-ix-hidden:F_f41dc902-b0a0-44c4-a2f2-3886c58e26bf;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">one-third</span></span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> on each </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">one-year </span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">anniversary date, subject to achievement of a development milestone and continued service to the Company. In February 2022, a portion of the performance-based RSUs vested upon achievement of the development milestone and satisfaction of the continued service condition. </span></span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"/></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In February and September 2022, the Company granted performance-based RSUs that vest during the applicable performance period, subject to the achievement of certain corporate or department targets and continued service to the Company. In September 2022, a portion of the performance-based RSUs that were granted in February 2022 vested upon achievement of specific targets and satisfaction of the continued service condition. </span></span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"/></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As of December 31, 2022, it was probable that the remaining performance conditions would be met for the Company&#8217;s performance-based RSUs and expense was recognized using the accelerated attribution method. For the year ended December 31, 2022 and 2021, the Company recognized expense of </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.5</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> and $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">0.8</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million, respectively, related to performance-based RSUs.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The following table summarizes RSU activity for the year ended </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31, 2022:</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:90.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:53.677%;"/>
        <td style="width:1.783%;"/>
        <td style="width:1.0%;"/>
        <td style="width:19.008%;"/>
        <td style="width:1.0%;"/>
        <td style="width:2.253%;"/>
        <td style="width:1.0%;"/>
        <td style="width:19.279999999999998%;"/>
        <td style="width:1.0%;"/>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Number of<br/>RSUs</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Weighted Average<br/>Fair Value at <br/>Date of Grant per Unit</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Balance outstanding as of December 31, 2021</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">106,394</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">23.10</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Granted</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1,224,391</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4.61</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Vested / released</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">103,703</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">8.61</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Cancelled / forfeited</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">131,344</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5.53</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:5.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Balance outstanding as of December 31, 2022</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1,095,738</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5.77</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></div><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:2.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As of December 31, 2022, there was $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3.9</span><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million of total unrecognized expense related to RSUs, which is expected to be recognized over a weighted-average period of </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.4</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> years.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:2.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><p style="text-indent:4.533%;font-size:10.0pt;margin-top:2.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company recorded stock-based compensation for the periods indicated as follows (in thousands):</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:90.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:66.521%;"/>
        <td style="width:1.603%;"/>
        <td style="width:1.0%;"/>
        <td style="width:13.025%;"/>
        <td style="width:1.0%;"/>
        <td style="width:1.603%;"/>
        <td style="width:1.0%;"/>
        <td style="width:13.249%;"/>
        <td style="width:1.0%;"/>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Year Ended December 31,</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2022</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2021</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Research and development</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4,094</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2,966</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">General and administrative</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">6,262</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5,712</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:5.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total stock-based compensation</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10,356</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">8,678</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -URI https://asc.fasb.org/topic&amp;trid=2228938<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (l)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139683195097616">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">Income Taxes</a></td>
<td class="text"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">9</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. Income Taxes</span><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Tax Rates Applicable to the Income of the Company and its Subsidiaries</span></p><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company is taxed according to U.S. federal and state tax laws and Israeli tax laws. The statutory tax rates applicable to the income of the Company and its subsidiaries for the periods presented are as follows:</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:70.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:60.742%;"/>
        <td style="width:1.438%;"/>
        <td style="width:1.0%;"/>
        <td style="width:16.341%;"/>
        <td style="width:1.0%;"/>
        <td style="width:1.438%;"/>
        <td style="width:1.0%;"/>
        <td style="width:16.04%;"/>
        <td style="width:1.0%;"/>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Year Ended December 31,</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2022</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2021</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">89bio, Inc.</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">21</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">21</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">89Bio Ltd.</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">23</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">23</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">89bio Management, Inc.</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">21</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">21</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">UAB 89bio Lithuania</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">15</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">15</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
       </tr>
      </table></div><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The income tax (expense) benefit for the periods presented is comprised of (in thousands):</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:70.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:59.085%;"/>
        <td style="width:1.409%;"/>
        <td style="width:1.0%;"/>
        <td style="width:17.119999999999997%;"/>
        <td style="width:1.0%;"/>
        <td style="width:1.409%;"/>
        <td style="width:1.0%;"/>
        <td style="width:16.978%;"/>
        <td style="width:1.0%;"/>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Year Ended December 31,</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2022</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2021</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Current:</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:5.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Federal</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:5.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">State</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:5.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Foreign</span></p></td>
        <td style="background-color:rgba(255,255,255,1);text-indent:5.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">16</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:5.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total</span></p></td>
        <td style="background-color:rgba(207,240,252,1);text-indent:15.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:15.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">19</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Deferred:</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:5.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Federal</span></p></td>
        <td style="background-color:rgba(207,240,252,1);text-indent:5.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">150</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:5.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">State</span></p></td>
        <td style="background-color:rgba(255,255,255,1);text-indent:5.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:5.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Foreign</span></p></td>
        <td style="background-color:rgba(207,240,252,1);text-indent:5.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:5.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total</span></p></td>
        <td style="background-color:rgba(255,255,255,1);text-indent:15.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:15.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">150</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:5.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Income tax (expense) benefit</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">19</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">147</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></div><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Deferred Income Taxes</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Deferred income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. </span><span style="font-size:12.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Significant components of the Company&#8217;s deferred tax assets for the periods presented are as follows (in thousands):</span></span></p><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:70.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:58.709%;"/>
        <td style="width:1.422%;"/>
        <td style="width:1.0%;"/>
        <td style="width:17.192%;"/>
        <td style="width:1.0%;"/>
        <td style="width:1.422%;"/>
        <td style="width:1.0%;"/>
        <td style="width:17.253%;"/>
        <td style="width:1.0%;"/>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As of December 31,</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2022</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2021</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">U.S. net operating loss carryforwards</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">45,002</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">29,094</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Research and development expenses</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">18,927</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">6,529</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Israel net operating loss carryforwards</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">7,385</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4,262</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Stock-based compensation</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4,328</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1,969</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Accrued expenses</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">317</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">220</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Operating Lease Liability</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">98</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Other</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">244</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">191</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Gross deferred tax assets</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">76,301</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">42,265</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Less: valuation allowance</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">75,982</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">42,046</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;Total deferred tax assets</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">319</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">219</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">  &#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Operating lease right-of-use asset</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">100</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total deferred tax liabilities</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">100</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;Net deferred tax assets</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">219</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">219</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></div><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As of December 31, 2022 and 2021, the Company recorded a valuation allowance of </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">76.0</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> and $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">42.0</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million, </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">respectively, in respect of deferred tax assets resulting from tax loss carryforwards and other temporary differences. Realization of deferred tax assets is dependent upon future earnings, if any, the time and amount of</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">which </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">are uncertain. The Company regularly assesses the likelihood that its deferred tax assets will be recovered from future taxable income and, to the extent it believes based upon the weight of available evidence that it is more likely than not that all or a portion of deferred tax assets will not be realized, a valuation allowance is established through an adjustment to income tax expense. The valuation allowance increased by </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">34.0</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> in 2022, which primarily relates to significant taxable losses. The Company continues to record a partial valuation allowance against the deferred tax assets in Israel due to achievement of recent profitability and the expectation of future profitability in the jurisdiction.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Available Carryforward Tax Losses and Credits</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As of December 31, 2022, the Company had an accumulated tax loss carryforward of approximately </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">160.9</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">169.8</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, and </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">32.1</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> for Federal, State and Israeli tax purposes, respectively. As of December 31, 2021</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, the Company had an accumulated tax loss carryforward of approximately $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">138.5</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million and $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">18.5</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million for U.S. and Israeli tax purposes, respectively. </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Federal net operating losses generated after 2017 can be carried forward indefinitely but utilization will be limited to </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">80</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">% of taxable income in the period that net operating losses are being utilized.</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> Carryforward tax losses in California will begin to expire in </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2041</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. Carryforward tax losses in Israel have no expiration date.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As of December 31, 2022 and 2021, the Company had federal research and development credit carryforwards of approximately </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4.3</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> and $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2.1</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million, respectively, which expire beginning in </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2040</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. As of </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31, 2022 and December 31, 2021, the Company had state research and development credit carryforwards of approximately </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.8</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> and $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.1</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million, respectively, which will carry forward indefinitely.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Loss from Operations, Before Income Tax</span></p><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company recorded a loss from operations, before income tax for the periods presented as follows (in thousands):</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:70.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:57.78%;"/>
        <td style="width:1.96%;"/>
        <td style="width:1.0%;"/>
        <td style="width:17.165%;"/>
        <td style="width:1.0%;"/>
        <td style="width:1.96%;"/>
        <td style="width:1.0%;"/>
        <td style="width:17.135%;"/>
        <td style="width:1.0%;"/>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Year Ended December 31,</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2022</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2021</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">United States</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">101,938</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">91,141</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Lithuania</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">7</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Israel</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">62</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">862</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:5.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Net loss before income tax</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">102,007</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">90,269</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
       </tr>
      </table></div><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Reconciliation of Income Tax (Expense) Benefit</span></p><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The reconciliation of income tax (expense) benefit based on the statutory tax rate to the effective tax rate for the periods presented is as follows (in thousands):</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:83.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:64.941%;"/>
        <td style="width:1.837%;"/>
        <td style="width:1.0%;"/>
        <td style="width:14.007%;"/>
        <td style="width:1.0%;"/>
        <td style="width:1.208%;"/>
        <td style="width:1.0%;"/>
        <td style="width:14.007%;"/>
        <td style="width:1.0%;"/>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Year Ended December 31,</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2022</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2021</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Income tax benefit computed at statutory rates</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">21,429</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">18,757</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Change in valuation allowance</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">33,936</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">20,111</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Foreign rate differential</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">19</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">State income taxes, net of federal benefit</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5,824</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">State deferred tax true-up due to change in apportionment</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">6,517</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Change in Israel effective tax rate due to the 2019 reorganization</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Research and development credits, net of uncertain tax position</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2,130</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1,331</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Other</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1,984</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">191</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:5.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Income tax (expense) benefit</span></p></td>
        <td style="background-color:rgba(207,240,252,1);text-indent:5.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">19</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">147</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></div><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:2.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Utilization of U.S. federal and state net operating losses and credit carryforwards may be subject to an annual limitation provided for in Section 382 of the Internal Revenue Code and similar state codes. Any annual limitation could result in a deferral of the utilization of the net operating loss and credit carryforwards.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Unrecognized Tax Benefits</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">A reconciliation of the unrecognized tax benefits for the year ended December 31, 2022 and 2021 is as follows (in thousands):</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:90.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:59.438%;"/>
        <td style="width:1.418%;"/>
        <td style="width:1.0%;"/>
        <td style="width:16.875000000000004%;"/>
        <td style="width:1.0%;"/>
        <td style="width:1.431%;"/>
        <td style="width:1.0%;"/>
        <td style="width:16.837999999999997%;"/>
        <td style="width:1.0%;"/>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As of December 31,</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2022</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2021</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Balance beginning of year</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">851</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">329</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Decrease related to prior year positions</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">19</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">35</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Increase related to current year positions</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">752</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">557</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;Balance end of year</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1,584</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">851</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table></div><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">During the year ended December 31, 2022 and 2021, the amount of gross unrecognized tax benefits increased by </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">0.7</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> and </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">0.5</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, respectively. If the total amount of unrecognized tax benefits was recognized, it would </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">no</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">t have an impact to the effective tax rate as it would be offset by the reversal of related deferred tax assets which are subject to a full valuation allowance.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company recognizes interest and penalties related to uncertain tax positions as part of the income tax provision. As of December 31, 2022 and 2021, such interest and penalties were not material.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company is subject to taxation in the United States, California, Colorado, North Carolina and several foreign jurisdictions. To date, the Company has not been subject to any federal or state income tax audits. The Company is currently under examination by the Israeli tax authorities for 2018 and 2019. As of December 31, 2022, all tax years remain open to examination.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">On August 9, 2022 and August 16, 2022, the Creating Helpful Incentives to Produce Semiconductors (&#8220;CHIPS&#8221;) Act and the Inflation Reduction Act (&#8220;IRA&#8221;), respectively, were signed into law. The CHIPS Act and IRA contain among other things, some income tax provisions that establish a corporate alternative minimum tax and provide tax incentives for semiconductor manufacturing and research. The Company has evaluated the current legislation and at this time, does not anticipate either to have a material impact on its financial statements.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Tax Cuts and Jobs Act (&#8220;TCJA&#8221;) included a change in the treatment of research and development (&#8220;R&amp;D&#8221;) expenditures for tax purposes under Section 174. Effective for tax years beginning after December 31, 2021, specified R&amp;D expenditures must undergo a </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5-year</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> amortization period for domestic spend and a </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">15-year</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> amortization period for foreign spend. Prior to the effective date (2021 tax year and prior), taxpayers were able to immediately expense R&amp;D costs under Section 174(a) or had the option to capitalize and amortize R&amp;D expenditures over a </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5-year</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> recovery period under Section 174(b). The Company has evaluated the current legislation at this time and prepared the provision by following the treatment of R&amp;D expenditures for tax purposes under Section 174.</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32857-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330215-122817<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32809-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.5.Q1)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32705-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6424409&amp;loc=d3e44925-109338<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -URI https://asc.fasb.org/topic&amp;trid=2144680<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6424122&amp;loc=d3e41874-109331<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139683194939424">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Loss Per Share<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">Net Loss Per Share</a></td>
<td class="text"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10. Net Loss Per Share</span></p><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The following outstanding potentially dilutive common stock equivalents have been excluded from the calculation of diluted net loss per share for the periods indicated due to their anti-dilutive effect:</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:83.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:55.149%;"/>
        <td style="width:0.996%;"/>
        <td style="width:1.0%;"/>
        <td style="width:18.892999999999997%;"/>
        <td style="width:1.0%;"/>
        <td style="width:1.009%;"/>
        <td style="width:1.0%;"/>
        <td style="width:19.953000000000003%;"/>
        <td style="width:1.0%;"/>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Year Ended December 31,</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2022</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2021</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Stock options to purchase common stock</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3,161,917</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2,406,668</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Unvested restricted stock units</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1,095,738</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">106,394</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Warrants to purchase common stock</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);top:-4.6899999999999995pt;white-space:pre-wrap;font-weight:normal;font-size:6.7pt;font-family:&quot;Times New Roman&quot;, serif;position:relative;min-width:fit-content;">1</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">13,166,283</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">58,923</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:5.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">17,423,938</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2,571,985</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><p style="margin-left:9.067%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;vertical-align:super;font-size:5.36pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> The table above excludes pre-funded warrants issued in connection with the July 2022 public offering (see Note 7).</span></p></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=109243012&amp;loc=SL65017193-207537<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -URI https://asc.fasb.org/topic&amp;trid=2144383<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139683194934608">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Subsequent Events<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventsAbstract', window );"><strong>Subsequent Events [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventsTextBlock', window );">Subsequent Events</a></td>
<td class="text"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">11. Subsequent Events</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">2023 Loan Agreement</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In January 2023, the Company executed the 2023 Loan Agreement with the new lenders named therein. The 2023 Loan Agreement provides up to $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">100.0</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million in aggregate principal in term loans, consisting of a first tranche of $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">25.0</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million that was funded at closing, two subsequent tranches totaling $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">25.0</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million that may be funded upon the achievement of certain time-based, clinical and regulatory milestones, and a fourth tranche of up to $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">50.0</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million that may be funded upon discretionary approval by the lenders.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The term loans under the 2023 Loan Agreement mature on </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">January 1, 2027</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. The maturity date may be extended to </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">July 1, 2027</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, provided that the second and third tranches are funded and the Company achieves certain other financing milestones.</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> The term loans bear interest equal to the greater of (i) </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">8.45</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">% and (ii) the sum of (a) the Prime Rate as reported in The Wall Street Journal plus (b) </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2.25</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%. </span><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Consecutive monthly payments of interest commence in February 2023 and consecutive monthly payments of principal commence in February 2025, or February 2026 provided that certain extension milestones are achieved.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">2021 Loan Agreement</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In January 2023, the first tranche of $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">25.0</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million that was funded pursuant to the 2023 Loan Agreement was primarily used to repay the Company&#8217;s outstanding obligations under the 2021 Loan Agreement, including the total principal amount outstanding as of December 31, 2022 of $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">20.0</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million, the final payment fee of $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.0</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million and an early prepayment fee of $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">0.4</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million (see Note 6).</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">ATM Facility</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In January and February 2023, the Company received aggregate proceeds of $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">13.4</span><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million, net of commissions from sales of </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">968,000</span><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> shares of its common stock pursuant to the ATM Facility (see Note 7).</span></span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">On </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">February 15, 2023</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, the Company entered into Amendment No. 1 to the Sales Agreement with the Sales Agent, </span><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">pursuant to which the Company may offer and sell up to $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">150.0</span><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">shares of its common stock, from time to time, through the ATM Facility (see Note 7).</span><span style="color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Banking Relationship with SVB</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company has a banking relationship with SVB. On March 10, 2023, SVB was closed by the California Department of Financial Protection and Innovation, which appointed the Federal Deposit Insurance Corporation ("FDIC") as receiver. On March 12, 2023, the Federal Reserve Board approved actions enabling the FDIC to complete its resolution of SVB in a manner that fully protects all depositors. Based on the foregoing and the Company&#8217;s analysis of the components of its relationship with SVB, the Company does not expect these events to have a material impact on the Company&#8217;s consolidated financial statements.</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 855<br> -URI https://asc.fasb.org/topic&amp;trid=2122774<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 855<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6842918&amp;loc=SL6314017-165662<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139683197595392">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Policies)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Basis of Presentation</a></td>
<td class="text"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Basis of Presentation</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States (&#8220;U.S. GAAP&#8221;).</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PriorPeriodReclassificationAdjustmentDescription', window );">Reclassification</a></td>
<td class="text"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Reclassification</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Certain prior year amounts in the Company&#8217;s consolidated statements of operations and comprehensive loss have been reclassified to conform to the current year presentation. Specifically, interest expense is disclosed separately on the Company&#8217;s consolidated statements of operations and comprehensive loss, which had no impact on reported net loss, comprehensive loss, or loss per share.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConsolidationPolicyTextBlock', window );">Principles of Consolidation</a></td>
<td class="text"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Principles of Consolidation</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The accompanying consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries. All intercompany balances and transactions have been eliminated in consolidation.</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates</a></td>
<td class="text"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Use of Estimates</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the consolidated financial statements and the reported amounts of expenses during the reporting period. Significant estimates and assumptions made in the accompanying consolidated financial statements include but are not limited to accrued research and development expenses and to the fair value of stock options. The Company evaluates its estimates and assumptions on an ongoing basis using historical experience and other factors and adjusts those estimates and assumptions when facts and circumstances dictate. Actual results could differ from those estimates.</span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock', window );">Foreign Currencies</a></td>
<td class="text"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Foreign Currencies</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Certain transactions during the year ended December 31, 2022 and 2021</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> were denominated in currencies other than the U.S. dollar. Gains and losses from foreign currency transactions were not material for all periods presented and are reflected in the consolidated statements of operations and comprehensive loss as a component of interest income and other, net. The Company&#8217;s subsidiary in Lithuania uses the Euro as its functional currency for financial reporting. The re-measurement from Euros to U.S. dollars results in translation gain and loss adjustments, which are reflected as a component of comprehensive loss as foreign currency translation adjustments.</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementPolicyPolicyTextBlock', window );">Fair Value Measurements</a></td>
<td class="text"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Fair Value Measurements</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Financial assets and liabilities are recorded at fair value on a recurring basis in the consolidated balance sheets. The carrying values of Company&#8217;s financial assets and liabilities, including cash and cash equivalents, restricted cash, prepaid and other current assets, accounts payable, and accrued expenses approximate to their fair value due to the short-term nature of these instruments. The fair value of the Company&#8217;s term loan approximates its carrying value, or amortized cost, due to the prevailing market rates of interest rates it bears. Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability (an exit price) in an orderly transaction between market participants at the reporting date. Assets and liabilities recorded at fair value are categorized based upon the level of judgment associated with the inputs used to measure their fair value. Hierarchical levels are directly related to the amount of subjectivity with the inputs to the valuation of these assets or liabilities as follows:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Level 1</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;Observable inputs such as unadjusted, quoted prices in active markets for identical assets or liabilities at the measurement date;</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Level 2</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;Inputs (other than quoted prices included in Level 1) are either directly or indirectly observable inputs for similar assets or liabilities. These include quoted prices for identical or similar assets or liabilities in active markets and quoted prices for identical or similar assets or liabilities in markets that are not active; and</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Level 3</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.</span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskCreditRisk', window );">Concentrations of Credit Risk</a></td>
<td class="text"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Concentrations of Credit Risk</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Financial instruments that potentially subject the Company to a concentration of credit risk consist primarily of cash and cash equivalents and short-term available-for-sale securities. Bank deposits are held by accredited financial institutions and these deposits may at times be in excess of insured limits. The Company limits its credit risk associated with cash and cash equivalents by placing them with financial institutions that it believes are of high quality. The Company has not experienced any losses on its deposits of cash or cash equivalents. The Company </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">limits amounts invested in available-for-sale securities by credit rating, maturity, industry group, investment type and issuer, except for securities issued by the U.S. government. The Company is not exposed to any significant concentrations of credit risk from these financial instruments.</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_etnb_OtherRisksAndUncertaintiesPolicyTextBlock', window );">Other Risks and Uncertainties</a></td>
<td class="text"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Other Risks and Uncertainties</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company&#8217;s future results of operations involve a number of other risks and uncertainties. Factors that could affect the Company&#8217;s future operating results and cause actual results to vary materially from expectations include, but are not limited to, the Company&#8217;s early stages of clinical drug development; the Company&#8217;s ability to advance product candidates into, and successfully complete, clinical trials on the timelines it projects; the Company&#8217;s ability to adequately demonstrate sufficient safety and efficacy of its product candidates; the Company&#8217;s ability to enroll patients in its ongoing and future clinical trials; the Company&#8217;s ability to successfully manufacture and supply its product candidates for clinical trials; the Company&#8217;s ability to obtain additional capital to finance its operations; uncertainties related to the projections of the size of patient populations suffering from the diseases the Company is targeting; the Company&#8217;s ability to obtain, maintain, and protect its intellectual property rights; developments relating to the Company&#8217;s competitors and its industry, including competing product candidates and therapies; general economic and market conditions; and other risks and uncertainties.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company&#8217;s product candidates will require approvals from the U.S. Food and Drug Administration and comparable foreign regulatory agencies prior to commercial sales in their respective jurisdictions. There can be no assurance that any product candidates will receive the necessary approvals. If the Company is denied approval, approval is delayed or the Company is unable to maintain approval for any product candidate, it could have a materially adverse impact on the Company.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The ongoing COVID-19 pandemic has disrupted and may continue to disrupt the Company&#8217;s business and delay its preclinical and clinical programs and timelines. The extent to which the COVID-19 pandemic may impact the Company&#8217;s future operating results and financial condition is uncertain.</span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingPolicyPolicyTextBlock', window );">Segment Reporting</a></td>
<td class="text"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Segment Reporting</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company has </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">one</span><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> operating segment. The Company&#8217;s chief operating decision maker, its Chief Executive Officer, manages the Company&#8217;s operations on a consolidated basis for the purposes of allocating resources and evaluating financial performance.</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy', window );">Cash and Cash Equivalents</a></td>
<td class="text"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Cash and Cash Equivalents</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company considers all highly liquid investments purchased with original maturities of three months or less from the purchase date to be cash equivalents. Cash equivalents consist primarily of amounts invested in money market funds and commercial paper that are stated at fair value.</span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentPolicyTextBlock', window );">Investments</a></td>
<td class="text"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Investments</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Investments have been classified as available-for-sale and are carried at estimated fair value as determined based upon quoted market prices or pricing models for similar securities. Management determines the appropriate classification of its available-for-sale investments in debt securities at the time of purchase. Generally, investments with original maturities beyond three months at the date of purchase are classified as short-term because it is management&#8217;s intent to use the investments to fund current operations or to make them available for current operations.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Unrealized gains and losses are excluded from net loss and are reported as a component of comprehensive loss. The Company periodically evaluates whether declines in fair values of its available-for-sale securities below their book value are other-than-temporary. This evaluation consists of several qualitative and quantitative factors regarding the severity and duration of the unrealized loss as well as the Company&#8217;s ability and intent to hold the available-for-sale security until a forecasted recovery occurs. Additionally, the Company assesses whether it has plans to sell the security or it is more likely than not it will be required to sell any available-for-sale securities before recovery of its amortized cost basis. Realized gains and losses and declines in fair value judged to be other than temporary, if any, on available-for-sale securities are included in interest income and other, net. The cost of investments sold is based on the specific-identification method. The Company has </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">no</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">t experienced any material realized gains or losses or other-than-temporary losses in the periods presented.</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeasesPolicyTextBlock', window );">Leases</a></td>
<td class="text"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Leases</span><span style="color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company is a lessee in noncancellable operating leases for office space. Beginning in 2022, the Company accounts for leases in accordance with Accounting Standards Update (&#8220;ASU&#8221;) 2016-02,</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> Leases</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> (</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Topic 842</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">). The Company determines if an arrangement is a lease or contains an embedded lease at inception. The Company accounts for a contract as a lease when it has the right to control the asset for a period of time while obtaining substantially all of the asset&#8217;s economic benefits. For arrangements that meet the definition of a lease, the Company determines the initial classification and measurement of its right-of-use (&#8220;ROU&#8221;) asset and lease liability at the lease commencement date and thereafter if modified. Operating lease ROU assets represent the Company&#8217;s right to use an underlying asset for the lease term and lease liabilities represent the Company&#8217;s obligation to make the contractual lease payments over the lease term. The ROU asset is initially measured at cost, which comprises the initial amount of the lease liability adjusted for lease payments made at or before the lease commencement date, plus any initial direct costs incurred less any lease incentives received. The operating lease liability is initially measured at the present value of the unpaid lease payments at the lease commencement date. The lease liability is subsequently measured at amortized cost using the effective-interest method. The lease term includes any renewal options that the Company is reasonably assured to exercise. The present value of lease payments is determined by using the interest rate implicit in the lease, if that rate is readily determinable, otherwise, the Company uses its estimated collateralized incremental borrowing rate for the lease term. The Company has elected not to record leases with an original term of twelve months or less on its consolidated balance sheets and recognizes those lease payments in operating expenses in the consolidated statements of operations and comprehensive loss. The Company&#8217;s short-term lease is not material.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In addition, the Company&#8217;s leases may require it to pay additional costs, such as utilities, maintenance, and other operating costs, which are generally referred to as non-lease components and vary based on future outcomes. The Company has elected to not separate lease and non-lease components. Only the fixed costs for lease components and their associated non-lease components are accounted for as a single lease component and recognized as part of a ROU </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">asset and lease liability. Any variable expenses are recognized in operating expenses as incurred. Rent expense for an operating lease liability is recognized on a straight-line basis over the lease term and is included in operating expenses in the consolidated statements of operations and comprehensive loss.</span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock', window );">Property and Equipment, Net</a></td>
<td class="text"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Property and Equipment, Net</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Property and equipment are stated at cost, less accumulated depreciation. Depreciation is calculated on a straight-line basis over the estimated useful lives of the related assets, generally ranging from </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="-sec-ix-hidden:F_4640215a-3a60-4f28-a85d-e6242af9c877;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">three</span></span></span><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> to </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">seven years</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">. </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Leasehold improvements are amortized on a straight-line basis over the shorter of the assets&#8217; estimated useful life or the remaining term of the lease.</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Upon retirement or sale of the assets, the cost and related accumulated depreciation and amortization are removed from the consolidated balance sheets and the resulting gains or losses are recorded in the consolidated statements of operations and comprehensive loss. </span><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Maintenance and repair costs are expensed as incurred.</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock', window );">Impairment of Long-Lived Assets</a></td>
<td class="text"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Impairment of Long-Lived Assets</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company periodically evaluates its long-lived assets, including property and equipment, for impairment whenever events or changes in business circumstances indicate that the carrying amount of the assets or group of assets may not be fully recoverable. If indicators of impairment exist and the undiscounted future cash flows that the assets are expected to generate are less than the carrying value of the assets, then the Company will reduce the carrying amount of the assets through an impairment charge, to their estimated fair values based on a discounted cash flow approach or, when available and appropriate, to comparable market values. There were no such indicators for the periods presented.</span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_etnb_AccruedResearchAndDevelopmentExpensesPolicyTextBlock', window );">Accrued Research and Development Expenses</a></td>
<td class="text"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Accrued Research and Development Expenses</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company estimates preclinical and clinical study and research expenses based on the services performed, pursuant to contracts with research institutions that conduct and manage preclinical and clinical studies and research services on its behalf. The Company records the costs of research and development activities based upon the estimated services provided but not yet invoiced and includes these costs in accrued expenses in the consolidated balance sheets. These costs are a component of the Company&#8217;s research and development expenses.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company accrues for these costs based on factors such as estimates of the work completed in accordance with agreements established with its third-party service providers. The Company makes judgments and estimates in determining the accrued expenses balance. As actual costs become known, the Company adjusts its accrued expenses. The Company has not experienced any material differences between accrued costs and actual costs incurred. However, the status and timing of actual services performed may vary from the Company&#8217;s estimates, resulting in adjustments to expense in future periods. Changes in these estimates that result in material changes to the Company&#8217;s accrued expenses could materially affect the Company&#8217;s results of operations. Contingent milestone payments, if any, are expensed when the milestone results are probable and estimable, which is generally upon achievement of the milestone.</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_etnb_WarrantsToPurchaseCommonStockPolicyTextBlock', window );">Warrants To Purchase Common Stock</a></td>
<td class="text"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Warrants to Purchase Common Stock</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company classifies warrants indexed to its common stock and meeting the requirements for equity classification within stockholders&#8217; equity. This assessment is conducted at the time of warrant issuance and as of each reporting period that the warrants remain outstanding.</span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpensePolicy', window );">Research and Development Expenses</a></td>
<td class="text"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Research and Development Expenses</span><span style="color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Research and development expenses consist primarily of costs incurred for the development of the Company&#8217;s lead product candidate, pegozafermin. Research and development expenses consist primarily of external costs related to preclinical and clinical development and related supplies and personnel costs. Personnel costs consist of salaries, employee benefits and stock-based compensation for individuals involved in research and development efforts. Payments associated with agreements to acquire licenses to develop, use, manufacture and commercialize products and purchases of pegozafermin from contract manufacturing organizations that have not reached technological feasibility and do not have alternate future commercial use are expensed as incurred.</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy', window );">Stock-Based Compensation</a></td>
<td class="text"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Stock-Based Compensation</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company provides equity awards in the form of stock options and restricted stock units. The Company measures its equity awards made to employees, directors, and</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">non-employee service providers based on estimated fair values and recognizes stock-based compensation over the requisite service period. The Company accounts for forfeitures as they occur.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company estimates the fair value of stock option awards on the date of grant using a</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Black-Scholes option pricing model. The Company recognizes compensation for the value of stock options awards, which have graded vesting, using the straight-line method over the requisite service period of each award.</span><span style="color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Black-Scholes option pricing model requires a number of assumptions, of which the most significant are expected volatility, expected option term (the time from the grant date until the options are exercised or expire), risk-free rate, and expected dividend rate. These assumptions include:</span></p><div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#8226;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Expected volatility&#8212;Since the Company has limited trading history for its common stock, expected volatility is estimated based on weighting the Company&#8217;s volatility and the volatility of comparable publicly traded biotechnology companies during the equivalent period of the calculated expected term of the options granted. The comparable companies were chosen based on their similar size, stage in the life cycle, or area of specialty. There is a degree of uncertainty in determining a comparable peer group as each of the peers are engaged in varied research and development activities, the timing and progress of which differ within the peer group. </span></div></div><div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#8226;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Expected term&#8212;The expected term of options granted to employees and directors is determined using the &#8220;simplified&#8221; method. Under this approach, the expected term is presumed to be the midpoint between the weighted-average vesting term and the contractual term of the option. The simplified method makes the assumption that the employee will exercise stock options evenly over the period when the stock options are vested and ending on the date when the stock options would expire. The expected option term for options granted to non-employees is estimated on a grant-by-grant basis.</span></div></div><div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#8226;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Risk-free interest rate&#8212;The risk-free interest rate is based on the U.S. Treasury zero coupon bonds in effect on the grant date for periods with an equivalent expected term as the option.</span></div></div><div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#8226;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Expected dividend&#8212;The Company has never paid dividends and has no foreseeable plans to pay dividends on its shares of common stock. Therefore, an expected dividend of zero is used.</span></div></div><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The fair value of restricted stock units is based on the fair value of the Company&#8217;s common stock on the date of grant. The grant date fair value of restricted stock units with service vesting conditions is recognized over the requisite service period on a straight-line basis. For restricted stock units with performance vesting conditions, the Company evaluates the probability of achieving the performance condition at each reporting date and recognizes expense for such performance awards over the requisite service period using the accelerated attribution method.</span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxPolicyTextBlock', window );">Income Taxes</a></td>
<td class="text"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Income Taxes</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Income taxes are accounted for under the asset and liability method. Under this method, deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the consolidated financial statements carrying amounts of existing assets and liabilities and their respective tax bases and operating loss and tax credit carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates applied to taxable income in the years in which those temporary differences are expected to be realized. The effect on deferred tax assets and liabilities of a change in tax rates is recognized as income or loss in the period that includes the enactment date. A valuation allowance is established when necessary to reduce deferred tax assets to the amount expected to be realized. Interest and penalties related to unrecognized tax benefits are included within the provision of income tax.</span><span style="color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerSharePolicyTextBlock', window );">Basic and Diluted Net Loss per Share</a></td>
<td class="text"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Basic and Diluted Net Loss per Share</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Basic loss per share is computed by dividing net loss by the weighted-average number of shares of common stock outstanding during the period. Diluted loss per share is computed by dividing net loss by the weighted-average number of shares of common stock outstanding together with the number of additional shares of common stock that would have been outstanding if all potentially dilutive shares of common stock had been issued. Since the Company is in a loss position for the periods presented, basic net loss per share is the same as diluted net loss per share since the effects of potentially dilutive securities are antidilutive. </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Shares of the Company&#8217;s common stock underlying pre-funded warrants exercisable for nominal consideration are included in the computation of basic and diluted net loss per share, even if antidilutive.</span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock', window );">Comprehensive Loss</a></td>
<td class="text"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Comprehensive Loss</span><span style="color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company&#8217;s comprehensive loss is comprised of net loss and changes in unrealized gains or losses on available-for-sale securities and foreign currency translation adjustments.</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recent Accounting Pronouncements</a></td>
<td class="text"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Recently Adopted Accounting Standards</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:6.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> &#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In February 2016, the Financial Accounting Standards Board (&#8220;FASB&#8221;) issued ASU 2016-02,</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> Leases</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> (</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Topic 842</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">), or Accounting Standards Codification (&#8220;ASC&#8221;) 842, which requires lessees to recognize leases on the balance sheet and disclose key information about leasing arrangements. ASC 842 establishes a ROU model that requires a lessee to recognize a ROU asset and lease liability on the balance sheet for all leases with a term longer than 12 months. Leases are classified as finance or operating, with classification affecting the pattern and classification of expense recognition in the income statement.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">On</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> January 1, 2022</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">, the Company adopted </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">ASC 842</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> using the modified retrospective transition method and elected the practical expedients to not reassess whether any expired or existing contracts are or contain leases, carry forward its historical lease classification and not reassess initial direct costs for existing leases. Upon adoption of ASC 842, the Company recorded an operating ROU asset of $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">0.2</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million and an operating lease liability of $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">0.2</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million on its consolidated balance sheet. There was </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">no</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> adjustment to the opening balance of accumulated deficit as a result of adoption. Results for the year ended December 31, 2022 are presented under ASC 842. Prior period amounts preceding January 1, 2022 continue to be reported in accordance with the Company&#8217;s historical accounting under the previous lease guidance, ASC 840.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Recent Accounting Pronouncements</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">In June 2016, the FASB issued ASU 2016-13, </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Financial Instruments&#8212;Credit Losses (Topic 326)</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">: </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Measurement of Credit Losses on Financial Instruments </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(&#8220;ASU 2016-13&#8221;), which replaces the existing incurred loss impairment model with an expected credit loss model and requires a financial asset measured at amortized cost to be presented at the net amount expected to be collected. As an emerging growth company, ASU 2016-13 is effective for the Company for the year ending December 31, 2023 and interim periods within that fiscal year and must be adopted using a modified retrospective approach, with certain exceptions. The Company is evaluating the impact of this standard and </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">does not expect the adoption of ASU 2016-13 to have a material impact on the Company&#8217;s consolidated financial statements and related disclosures.</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_etnb_AccruedResearchAndDevelopmentExpensesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accrued research and development expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">etnb_AccruedResearchAndDevelopmentExpensesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>etnb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_etnb_OtherRisksAndUncertaintiesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Other risks and uncertainties.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">etnb_OtherRisksAndUncertaintiesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>etnb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_etnb_WarrantsToPurchaseCommonStockPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Warrants to purchase common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">etnb_WarrantsToPurchaseCommonStockPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>etnb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Entity's cash and cash equivalents accounting policy with respect to restricted balances. Restrictions may include legally restricted deposits held as compensating balances against short-term borrowing arrangements, contracts entered into with others, or company statements of intention with regard to particular deposits; however, time deposits and short-term certificates of deposit are not generally included in legally restricted deposits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(1)(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4273-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomePolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskCreditRisk">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for credit risk.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 825<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126941378&amp;loc=d3e61044-112788<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskCreditRisk</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126899994&amp;loc=d3e18823-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=d3e5614-111684<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerSharePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerSharePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -URI https://asc.fasb.org/topic&amp;trid=2175825<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 05<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=109226317&amp;loc=d3e202-110218<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.CC)<br> -URI https://asc.fasb.org/extlink&amp;oid=27011434&amp;loc=d3e125687-122742<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e32247-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32847-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32840-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL116659661-227067<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e32280-109318<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32809-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for investment in financial asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(3)(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeasesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for leasing arrangement entered into by lessee.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918666-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeasesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PriorPeriodReclassificationAdjustmentDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for reclassification affecting comparability of financial statement. Excludes amendment to accounting standards, other change in accounting principle, and correction of error.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429488&amp;loc=d3e326-107755<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PriorPeriodReclassificationAdjustmentDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126982197&amp;loc=d3e99779-112916<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=126982197&amp;loc=d3e99893-112916<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpensePolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpensePolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for segment reporting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8864-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8864-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8864-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8864-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8864-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8864-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -URI https://asc.fasb.org/topic&amp;trid=2228938<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.2.Q6)<br> -URI https://asc.fasb.org/extlink&amp;oid=122041274&amp;loc=d3e301413-122809<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6191-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6161-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6143-108592<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6061-108592<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6132-108592<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139683194873184">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock', window );">Summary of Financial Assets Measured at Fair Value on Recurring Basis</a></td>
<td class="text"><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The following table presents the Company&#8217;s financial assets measured at fair value on a recurring basis by level within the fair value hierarchy as of </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31, 2022 (in thousands):</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:90.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:45.662%;"/>
        <td style="width:0.122%;"/>
        <td style="width:10.9%;"/>
        <td style="width:0.122%;"/>
        <td style="width:1.0%;"/>
        <td style="width:8.655%;"/>
        <td style="width:1.0%;"/>
        <td style="width:0.081%;"/>
        <td style="width:1.0%;"/>
        <td style="width:8.384%;"/>
        <td style="width:1.0%;"/>
        <td style="width:0.108%;"/>
        <td style="width:1.0%;"/>
        <td style="width:9.225%;"/>
        <td style="width:1.0%;"/>
        <td style="width:0.081%;"/>
        <td style="width:1.0%;"/>
        <td style="width:8.655%;"/>
        <td style="width:1.0%;"/>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Valuation</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Amortized</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Unrealized</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Unrealized</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Fair</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Hierarchy</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Cost</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Gains</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Losses</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Value</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Money market funds</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Level 1</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">18,224</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">18,224</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Commercial paper</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Level 2</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">104,279</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">84</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">104,196</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">U.S. government bonds</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Level 2</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">18,225</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">109</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">18,117</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Agency bonds</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Level 2</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">13,986</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">78</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">13,908</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Corporate debt securities</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Level 2</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10,488</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">62</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10,426</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">U.S. treasury bills</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Level 2</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">7,414</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">21</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">7,394</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Agency discount securities</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Level 2</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5,216</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">9</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5,225</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Non-U.S. debt securities</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Level 2</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3,975</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">20</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3,955</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:5.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total cash equivalents and available-for-<br/>&#160;&#160;&#160;sale securities</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">181,807</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">12</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">374</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">181,445</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Classified as:</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Cash equivalents</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">48,540</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Short-term available-for-sale securities</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">132,905</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:5.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total cash equivalents and available-for-<br/>&#160;&#160;&#160;sale securities</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">181,445</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:2.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The following table presents the Company&#8217;s financial assets measured at fair value on a recurring basis by level within the fair value hierarchy as of </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31, 2021 (in thousands):</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:90.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:45.662%;"/>
        <td style="width:0.122%;"/>
        <td style="width:10.9%;"/>
        <td style="width:0.122%;"/>
        <td style="width:1.0%;"/>
        <td style="width:8.655%;"/>
        <td style="width:1.0%;"/>
        <td style="width:0.081%;"/>
        <td style="width:1.0%;"/>
        <td style="width:8.384%;"/>
        <td style="width:1.0%;"/>
        <td style="width:0.108%;"/>
        <td style="width:1.0%;"/>
        <td style="width:9.225%;"/>
        <td style="width:1.0%;"/>
        <td style="width:0.081%;"/>
        <td style="width:1.0%;"/>
        <td style="width:8.655%;"/>
        <td style="width:1.0%;"/>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Valuation</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Amortized</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Unrealized</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Unrealized</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Fair</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Hierarchy</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Cost</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Gains</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Losses</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Value</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Money market funds</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Level 1</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">21,477</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">21,477</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Commercial paper</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Level 2</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">59,647</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">59,637</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">U.S. government bonds</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Level 2</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">21,662</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">42</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">21,620</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Corporate debt securities</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Level 2</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">8,776</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">8,776</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Agency bonds</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Level 2</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">7,747</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">7</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">7,741</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Municipal bonds</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Level 2</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4,251</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4,247</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Non-U.S. debt securities</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Level 2</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2,506</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2,505</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:5.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total cash equivalents and available-for-<br/>&#160;&#160;&#160;sale securities</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">126,066</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">65</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">126,003</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Classified as:</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Cash equivalents</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">27,715</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Short-term available-for-sale securities</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">98,288</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:5.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total cash equivalents and available-for-<br/>&#160;&#160;&#160;sale securities</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">126,003</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock', window );">Schedule of Contractual Maturities of Cash Equivalents and Available-for-Sale Securities</a></td>
<td class="text"><p style="text-indent:4.533%;font-size:10.0pt;margin-top:2.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The following table summarizes the Company&#8217;s cash equivalents and available-for-sale securities by contractual maturity as of </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31, 2022 (in thousands):</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:90.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:77.695%;"/>
        <td style="width:2.196%;"/>
        <td style="width:1.0%;"/>
        <td style="width:18.109%;"/>
        <td style="width:1.0%;"/>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Within one year</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">175,243</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">After one year through two years</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">6,202</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:5.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total cash equivalents and available-for-sale securities</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">181,445</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:2.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The following table summarizes the Company&#8217;s cash equivalents and available-for-sale securities by contractual maturity as of </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31, 2021 (in thousands):</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:90.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:77.695%;"/>
        <td style="width:2.196%;"/>
        <td style="width:1.0%;"/>
        <td style="width:18.109%;"/>
        <td style="width:1.0%;"/>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Within one year</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">120,726</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">After one year through two years</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5,277</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:5.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total cash equivalents and available-for-sale securities</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">126,003</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of maturities of an entity's investments as well as any other information pertinent to the investments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139683195133504">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Balance Sheet Components (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BalanceSheetRelatedDisclosuresAbstract', window );"><strong>Balance Sheet Related Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_etnb_ScheduleOfPrepaidAndOtherCurrentAssetsTableTextBlock', window );">Schedule of Prepaid and Other Current Assets</a></td>
<td class="text"><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Prepaid and other current assets consist of the following as of the periods presented (in thousands):</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:70.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:65.777%;"/>
        <td style="width:1.589%;"/>
        <td style="width:1.0%;"/>
        <td style="width:13.515%;"/>
        <td style="width:1.0%;"/>
        <td style="width:1.589%;"/>
        <td style="width:1.0%;"/>
        <td style="width:13.530000000000001%;"/>
        <td style="width:1.0%;"/>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As of December 31,</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2022</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2021</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Prepaid research and development</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5,727</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">7,895</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Prepaid taxes</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">646</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">836</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Prepaid other</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1,547</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2,506</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:5.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total prepaid and other current assets</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">7,920</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">11,237</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock', window );">Schedule of Accrued Expenses</a></td>
<td class="text"><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Accrued expenses consist of the following as of the periods presented (in thousands):</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:70.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:65.777%;"/>
        <td style="width:1.589%;"/>
        <td style="width:1.0%;"/>
        <td style="width:13.515%;"/>
        <td style="width:1.0%;"/>
        <td style="width:1.589%;"/>
        <td style="width:1.0%;"/>
        <td style="width:13.530000000000001%;"/>
        <td style="width:1.0%;"/>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As of December 31,</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2022</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2021</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Accrued research and development expenses</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">6,499</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">6,195</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Accrued employee and related expenses</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4,165</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3,168</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Accrued professional and legal fees</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1,052</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">495</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Accrued other expenses</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">228</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">336</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:5.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total accrued expenses</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">11,944</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10,194</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_etnb_ScheduleOfPrepaidAndOtherCurrentAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Schedule of prepaid and other current assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">etnb_ScheduleOfPrepaidAndOtherCurrentAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>etnb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetRelatedDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetRelatedDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accrued liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139683194961568">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock', window );">Schedule of Future Minimum Lease Payments Under Non-cancellable Operating Lease Obligations</a></td>
<td class="text"><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As of </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31, 2022, the undiscounted future minimum lease payments due under the Company&#8217;s non-cancellable operating lease are as follows (in thousands):</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:70.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:69.795%;"/>
        <td style="width:2.701%;"/>
        <td style="width:1.0%;"/>
        <td style="width:25.503%;"/>
        <td style="width:1.0%;"/>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2023</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">185</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2024</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">185</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2025</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">7</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total undiscounted future minimum lease payments</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">377</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Less: imputed interest</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">23</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:5.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Present value of operating lease liability</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">354</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The total future minimum annual payments for operating leases in effect as of December 31, 2021 were as follows (in thousands):</span><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:70.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:70.024%;"/>
        <td style="width:2.946%;"/>
        <td style="width:1.0%;"/>
        <td style="width:25.03%;"/>
        <td style="width:1.0%;"/>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2022</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">212</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2023</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">7</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:5.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total future minimum annual payments</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">219</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of future minimum payments required in the aggregate and for each of the five succeeding fiscal years for operating leases having initial or remaining noncancelable lease terms in excess of one year and the total minimum rentals to be received in the future under noncancelable subleases as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=123406913&amp;loc=d3e41502-112717<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139683121645728">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-Based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock', window );">Summary of Stock Option Activity</a></td>
<td class="text"><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The following table summarizes stock option activity for the year ended </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31, 2022:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:95.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:55.851%;"/>
        <td style="width:0.081%;"/>
        <td style="width:1.0%;"/>
        <td style="width:10.520999999999999%;"/>
        <td style="width:1.0%;"/>
        <td style="width:0.081%;"/>
        <td style="width:1.0%;"/>
        <td style="width:7.231%;"/>
        <td style="width:1.0%;"/>
        <td style="width:0.081%;"/>
        <td style="width:1.0%;"/>
        <td style="width:8.775%;"/>
        <td style="width:1.0%;"/>
        <td style="width:0.269%;"/>
        <td style="width:1.0%;"/>
        <td style="width:9.112%;"/>
        <td style="width:1.0%;"/>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Weighted</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Weighted</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Average</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Average</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Remaining</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Aggregate</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Number of</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Exercise</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Contractual</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Intrinsic</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Options</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Price</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Term</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Value</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(In years)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(In thousands)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Balance outstanding as of December 31, 2021</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2,406,668</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">16.46</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">8.1</span></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">9,970</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Granted</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1,149,816</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4.48</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Exercised</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">151,061</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2.09</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Cancelled and forfeited</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">243,506</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">16.34</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:11.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:11.0pt;font-family:&quot;Calibri&quot;, sans-serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Balance outstanding as of December 31, 2022</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3,161,917</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">12.80</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">7.9</span></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">16,612</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Exercisable as of December 31, 2022</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1,460,685</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">14.60</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">7.0</span></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">7,320</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock', window );">Summary of Estimated Fair Value of Stock Options Granted Using Black-Scholes Option-Pricing Model</a></td>
<td class="text"><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The fair value of stock options granted for the periods presented was estimated at the date of grant using a Black-Scholes option-pricing model with the following assumptions:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:90.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:59.283%;"/>
        <td style="width:1.994%;"/>
        <td style="width:18.364%;"/>
        <td style="width:1.994%;"/>
        <td style="width:18.364%;"/>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="3" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Year Ended December 31,</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2022</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2021</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Expected term (years)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5.5</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">-</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">6.3</span></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5.5</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">-</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">6.1</span></span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Expected volatility</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">89.9</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">-</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">91.0</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">86.9</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">-</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">91.9</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Risk-free interest rate</span></p></td>
        <td style="background-color:rgba(207,240,252,1);text-indent:5.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.6</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">-</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3.9</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">0.7</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">-</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1.3</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Expected dividend</span></p></td>
        <td style="background-color:rgba(255,255,255,1);text-indent:15.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:15.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
       </tr>
      </table><p style="text-indent:4.533%;font-size:10.0pt;margin-top:2.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock', window );">Summary of Restricted Stock Unit Activity</a></td>
<td class="text"><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The following table summarizes RSU activity for the year ended </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31, 2022:</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:90.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:53.677%;"/>
        <td style="width:1.783%;"/>
        <td style="width:1.0%;"/>
        <td style="width:19.008%;"/>
        <td style="width:1.0%;"/>
        <td style="width:2.253%;"/>
        <td style="width:1.0%;"/>
        <td style="width:19.279999999999998%;"/>
        <td style="width:1.0%;"/>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Number of<br/>RSUs</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Weighted Average<br/>Fair Value at <br/>Date of Grant per Unit</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Balance outstanding as of December 31, 2021</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">106,394</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">23.10</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Granted</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1,224,391</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4.61</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Vested / released</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">103,703</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">8.61</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Cancelled / forfeited</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">131,344</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5.53</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:5.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Balance outstanding as of December 31, 2022</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1,095,738</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5.77</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock', window );">Summary of Stock-Based Compensation</a></td>
<td class="text"><p style="text-indent:4.533%;font-size:10.0pt;margin-top:2.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company recorded stock-based compensation for the periods indicated as follows (in thousands):</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:90.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:66.521%;"/>
        <td style="width:1.603%;"/>
        <td style="width:1.0%;"/>
        <td style="width:13.025%;"/>
        <td style="width:1.0%;"/>
        <td style="width:1.603%;"/>
        <td style="width:1.0%;"/>
        <td style="width:13.249%;"/>
        <td style="width:1.0%;"/>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Year Ended December 31,</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2022</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2021</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Research and development</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4,094</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2,966</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">General and administrative</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">6,262</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5,712</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:5.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total stock-based compensation</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10,356</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">8,678</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the number and weighted-average grant date fair value for restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock units that were granted, vested, or forfeited during the year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139683195133632">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_etnb_ScheduleOfCommonStockReservedForIssuanceTableTextBlock', window );">Schedule of Shares of Common Stock Available for Future Issuance</a></td>
<td class="text"><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As of </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31, 2022, the Company&#8217;s shares of common stock available for future issuance were as follows:</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:79.712%;"/>
        <td style="width:1.464%;"/>
        <td style="width:1.0%;"/>
        <td style="width:16.823999999999998%;"/>
        <td style="width:1.0%;"/>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Shares available for future grant under the equity incentive plan</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">241,635</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Shares available for future issuance under the employee stock purchase plan</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">729,218</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Shares available for future issuance upon the exercise of warrants and pre-funded warrants</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">13,966,283</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:5.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total available for future issuance</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">14,937,136</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock', window );">Schedule of Outstanding Warrants to Purchase Shares of Common Stock</a></td>
<td class="text"><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As of </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">December 31, 2022, the Company&#8217;s outstanding warrants to purchase shares of its common stock were as follows:</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:57.363%;"/>
        <td style="width:0.996%;"/>
        <td style="width:1.0%;"/>
        <td style="width:10.953999999999999%;"/>
        <td style="width:1.0%;"/>
        <td style="width:1.384%;"/>
        <td style="width:1.0%;"/>
        <td style="width:11.152000000000001%;"/>
        <td style="width:1.0%;"/>
        <td style="width:1.384%;"/>
        <td style="width:12.766%;"/>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Shares of<br/>Common Stock<br/>Underlying<br/>Warrants</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Exercise Price<br/>Per Share</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Expiration<br/>Date</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Warrant issued with term loan</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">25,000</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">22.06</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">June 30, 2025</span></span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Warrant issued with term loan</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">33,923</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">19.12</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">May 28, 2031</span></span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Warrants issued in public offering</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">13,107,360</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5.325</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">July 1, 2024</span></span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Pre-funded warrants issued in public offering</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">800,000</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">0.001</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Do not expire</span></span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:5.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total outstanding</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">13,966,283</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);text-indent:25.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="margin-left:25.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> &#160;</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_etnb_ScheduleOfCommonStockReservedForIssuanceTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Schedule of common stock reserved for issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">etnb_ScheduleOfCommonStockReservedForIssuanceTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>etnb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5047-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 50<br> -Section S99<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6784392&amp;loc=d3e188667-122775<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139683190551008">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_etnb_ScheduleOfEffectiveIncomeTaxRateOfCompanyAndSubsidiariesTableTextBlock', window );">Summary of Statutory Tax Rates Applicable to Income of Company and Subsidiaries</a></td>
<td class="text"><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company is taxed according to U.S. federal and state tax laws and Israeli tax laws. The statutory tax rates applicable to the income of the Company and its subsidiaries for the periods presented are as follows:</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:70.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:60.742%;"/>
        <td style="width:1.438%;"/>
        <td style="width:1.0%;"/>
        <td style="width:16.341%;"/>
        <td style="width:1.0%;"/>
        <td style="width:1.438%;"/>
        <td style="width:1.0%;"/>
        <td style="width:16.04%;"/>
        <td style="width:1.0%;"/>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Year Ended December 31,</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2022</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2021</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">89bio, Inc.</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">21</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">21</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">89Bio Ltd.</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">23</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">23</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">89bio Management, Inc.</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">21</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">21</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">UAB 89bio Lithuania</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">15</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">15</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock', window );">Summary of Income Tax (Expense) Benefit</a></td>
<td class="text"><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The income tax (expense) benefit for the periods presented is comprised of (in thousands):</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:70.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:59.085%;"/>
        <td style="width:1.409%;"/>
        <td style="width:1.0%;"/>
        <td style="width:17.119999999999997%;"/>
        <td style="width:1.0%;"/>
        <td style="width:1.409%;"/>
        <td style="width:1.0%;"/>
        <td style="width:16.978%;"/>
        <td style="width:1.0%;"/>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Year Ended December 31,</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2022</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2021</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Current:</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:5.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Federal</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:5.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">State</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:5.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Foreign</span></p></td>
        <td style="background-color:rgba(255,255,255,1);text-indent:5.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">16</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:5.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total</span></p></td>
        <td style="background-color:rgba(207,240,252,1);text-indent:15.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:15.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">19</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Deferred:</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:5.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Federal</span></p></td>
        <td style="background-color:rgba(207,240,252,1);text-indent:5.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">150</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:5.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">State</span></p></td>
        <td style="background-color:rgba(255,255,255,1);text-indent:5.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:5.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Foreign</span></p></td>
        <td style="background-color:rgba(207,240,252,1);text-indent:5.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:5.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total</span></p></td>
        <td style="background-color:rgba(255,255,255,1);text-indent:15.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:15.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">150</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:5.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Income tax (expense) benefit</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">19</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">147</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock', window );">Summary of Components of Deferred Tax Assets</a></td>
<td class="text"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Significant components of the Company&#8217;s deferred tax assets for the periods presented are as follows (in thousands):</span><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:70.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:58.709%;"/>
        <td style="width:1.422%;"/>
        <td style="width:1.0%;"/>
        <td style="width:17.192%;"/>
        <td style="width:1.0%;"/>
        <td style="width:1.422%;"/>
        <td style="width:1.0%;"/>
        <td style="width:17.253%;"/>
        <td style="width:1.0%;"/>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As of December 31,</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2022</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2021</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">U.S. net operating loss carryforwards</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">45,002</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">29,094</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Research and development expenses</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">18,927</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">6,529</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Israel net operating loss carryforwards</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">7,385</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4,262</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Stock-based compensation</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">4,328</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1,969</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Accrued expenses</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">317</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">220</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Operating Lease Liability</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">98</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Other</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">244</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">191</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Gross deferred tax assets</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">76,301</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">42,265</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Less: valuation allowance</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">75,982</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">42,046</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;Total deferred tax assets</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">319</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">219</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">  &#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Operating lease right-of-use asset</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">100</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total deferred tax liabilities</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">100</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;Net deferred tax assets</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">219</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">219</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock', window );">Summary of Loss from Operations Before Taxes on Income</a></td>
<td class="text"><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company recorded a loss from operations, before income tax for the periods presented as follows (in thousands):</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:70.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:57.78%;"/>
        <td style="width:1.96%;"/>
        <td style="width:1.0%;"/>
        <td style="width:17.165%;"/>
        <td style="width:1.0%;"/>
        <td style="width:1.96%;"/>
        <td style="width:1.0%;"/>
        <td style="width:17.135%;"/>
        <td style="width:1.0%;"/>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Year Ended December 31,</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2022</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2021</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">United States</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">101,938</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">91,141</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Lithuania</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">7</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">10</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Israel</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">62</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">862</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:5.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Net loss before income tax</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">102,007</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">90,269</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock', window );">Summary of Reconciliation of Income Tax (Expense) Benefit Statutory Tax Rate to Effective Tax Rate</a></td>
<td class="text"><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The reconciliation of income tax (expense) benefit based on the statutory tax rate to the effective tax rate for the periods presented is as follows (in thousands):</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:83.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:64.941%;"/>
        <td style="width:1.837%;"/>
        <td style="width:1.0%;"/>
        <td style="width:14.007%;"/>
        <td style="width:1.0%;"/>
        <td style="width:1.208%;"/>
        <td style="width:1.0%;"/>
        <td style="width:14.007%;"/>
        <td style="width:1.0%;"/>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Year Ended December 31,</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2022</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2021</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Income tax benefit computed at statutory rates</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">21,429</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">18,757</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Change in valuation allowance</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">33,936</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">20,111</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Foreign rate differential</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">19</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">State income taxes, net of federal benefit</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5,824</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">State deferred tax true-up due to change in apportionment</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">6,517</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Change in Israel effective tax rate due to the 2019 reorganization</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#8212;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Research and development credits, net of uncertain tax position</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2,130</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1,331</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Other</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1,984</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">191</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:5.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Income tax (expense) benefit</span></p></td>
        <td style="background-color:rgba(207,240,252,1);text-indent:5.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">19</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">147</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock', window );">Summary of a Reconciliation of The Unrecognized Tax Benefits</a></td>
<td class="text"><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">A reconciliation of the unrecognized tax benefits for the year ended December 31, 2022 and 2021 is as follows (in thousands):</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:90.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:59.438%;"/>
        <td style="width:1.418%;"/>
        <td style="width:1.0%;"/>
        <td style="width:16.875000000000004%;"/>
        <td style="width:1.0%;"/>
        <td style="width:1.431%;"/>
        <td style="width:1.0%;"/>
        <td style="width:16.837999999999997%;"/>
        <td style="width:1.0%;"/>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As of December 31,</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2022</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2021</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Balance beginning of year</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">851</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">329</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Decrease related to prior year positions</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">19</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">(</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">35</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">)</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Increase related to current year positions</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">752</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">557</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;Balance end of year</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1,584</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">851</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_etnb_ScheduleOfEffectiveIncomeTaxRateOfCompanyAndSubsidiariesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Schedule of effective income tax rate of company and subsidiaries.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">etnb_ScheduleOfEffectiveIncomeTaxRateOfCompanyAndSubsidiariesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>etnb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of income before income tax between domestic and foreign jurisdictions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the change in unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 55<br> -Paragraph 217<br> -URI https://asc.fasb.org/extlink&amp;oid=126976462&amp;loc=d3e36027-109320<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139683194961568">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Loss Per Share (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock', window );">Schedule of Outstanding Potentially Dilutive Securities Excluded From Calculation of Diluted Net Loss</a></td>
<td class="text"><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The following outstanding potentially dilutive common stock equivalents have been excluded from the calculation of diluted net loss per share for the periods indicated due to their anti-dilutive effect:</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:83.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:55.149%;"/>
        <td style="width:0.996%;"/>
        <td style="width:1.0%;"/>
        <td style="width:18.892999999999997%;"/>
        <td style="width:1.0%;"/>
        <td style="width:1.009%;"/>
        <td style="width:1.0%;"/>
        <td style="width:19.953000000000003%;"/>
        <td style="width:1.0%;"/>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Year Ended December 31,</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2022</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2021</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Stock options to purchase common stock</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">3,161,917</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2,406,668</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Unvested restricted stock units</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1,095,738</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">106,394</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Warrants to purchase common stock</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);top:-4.6899999999999995pt;white-space:pre-wrap;font-weight:normal;font-size:6.7pt;font-family:&quot;Times New Roman&quot;, serif;position:relative;min-width:fit-content;">1</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">13,166,283</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">58,923</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:5.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Total</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">17,423,938</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2,571,985</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">&#160;</span></p></td>
       </tr>
      </table><p style="margin-left:9.067%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;vertical-align:super;font-size:5.36pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">1</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> The table above excludes pre-funded warrants issued in connection with the July 2022 public offering (see Note 7).</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139683194958464">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Organization and Basis of Presentation - Additional Information (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary Sale Of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationDateOfIncorporation', window );">Date of incorporation</a></td>
<td class="text">Jun. 30,  2019<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsAndShortTermInvestments', window );">Cash and cash equivalents and short term available-for-sale securities</a></td>
<td class="nump">$ 188.2<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationDateOfIncorporation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Date when an entity was incorporated</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationDateOfIncorporation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsAndShortTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash includes currency on hand as well as demand deposits with banks or financial institutions. It also includes other kinds of accounts that have the general characteristics of demand deposits in that the customer may deposit additional funds at any time and effectively may withdraw funds at any time without prior notice or penalty. Cash equivalents, excluding items classified as marketable securities, include short-term, highly liquid Investments that are both readily convertible to known amounts of cash, and so near their maturity that they present minimal risk of changes in value because of changes in interest rates. Generally, only investments with original maturities of three months or less qualify under that definition. Original maturity means original maturity to the entity holding the investment. For example, both a three-month US Treasury bill and a three-year Treasury note purchased three months from maturity qualify as cash equivalents. However, a Treasury note purchased three years ago does not become a cash equivalent when its remaining maturity is three months. Short-term investments, exclusive of cash equivalents, generally consist of marketable securities intended to be sold within one year (or the normal operating cycle if longer) and may include trading securities, available-for-sale securities, or held-to-maturity securities (if maturing within one year), as applicable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsAndShortTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139683121693984">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Additional Information (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($) </div>
<div>Segment</div>
</th>
<th class="th">
<div>Aug. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jan. 01, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_etnb_SummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Summary Of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfOperatingSegments', window );">Number of operating segments | Segment</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use asset</a></td>
<td class="nump">$ 363,000<span></span>
</td>
<td class="nump">$ 300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Operating lease liability, current</a></td>
<td class="nump">168,000<span></span>
</td>
<td class="nump">$ 300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">(315,243,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (213,217,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherThanTemporaryImpairmentLossDebtSecuritiesPortionRecognizedInEarnings', window );">Other-than-temporary losses</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RealizedInvestmentGainsLosses', window );">Realized gains or losses on investments</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201602Member', window );">ASC 842</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_etnb_SummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Summary Of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted', window );">Change in accounting principle, accounting standards update, adopted [true false]</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdoptionDate', window );">Change in accounting principle, accounting standards update, adoption date</a></td>
<td class="text">Jan.  01,  2022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use asset</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Operating lease liability, current</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember', window );">Leasehold Improvements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_etnb_SummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Summary Of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives', window );">Leasehold improvements amortization, description</a></td>
<td class="text">Leasehold improvements are amortized on a straight-line basis over the shorter of the assets&#8217; estimated useful life or the remaining term of the lease.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_etnb_SummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Summary Of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property and equipment, estimated useful lives</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_etnb_SummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Summary Of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property and equipment, estimated useful lives</a></td>
<td class="text">7 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_etnb_SummaryOfSignificantAccountingPoliciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">etnb_SummaryOfSignificantAccountingPoliciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>etnb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates (true false) whether accounting standards update was adopted.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 10<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128293352&amp;loc=SL126838806-209984<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 20<br> -Section 65<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=121483254&amp;loc=SL120254523-199619<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 10<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=128293352&amp;loc=SL126838806-209984<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 10<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128293352&amp;loc=SL126838806-209984<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126986314&amp;loc=SL124402458-218513<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=120154821&amp;loc=SL120154904-197079<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=120154821&amp;loc=SL120154904-197079<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983955&amp;loc=SL122642865-165497<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983955&amp;loc=SL122642865-165497<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983955&amp;loc=SL120254526-165497<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126983955&amp;loc=SL120254526-165497<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL120254519-210437<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128293352&amp;loc=SL120154346-209984<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=125980421&amp;loc=SL122150809-237846<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126986314&amp;loc=SL124402458-218513<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 65<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092918&amp;loc=SL128093175-196984<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 65<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092918&amp;loc=SL128093175-196984<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL126732908-238011<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983955&amp;loc=SL121967933-165497<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL120320025-210437<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=125980421&amp;loc=SL125981372-237846<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983955&amp;loc=SL121967933-165497<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL120320025-210437<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 832<br> -SubTopic 10<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128342835&amp;loc=SL128342857-244232<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdoptionDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Date accounting standards update was adopted, in YYYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126986314&amp;loc=SL124402458-218513<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983955&amp;loc=SL122642865-165497<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 832<br> -SubTopic 10<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128342835&amp;loc=SL128342857-244232<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983955&amp;loc=SL120254526-165497<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126986314&amp;loc=SL124402458-218513<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 65<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092918&amp;loc=SL128093175-196984<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL120320025-210437<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL120320025-210437<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=120154821&amp;loc=SL120154904-197079<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983955&amp;loc=SL122642865-165497<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983955&amp;loc=SL121967933-165497<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=125980421&amp;loc=SL122150809-237846<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 10<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=128293352&amp;loc=SL126838806-209984<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 10<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128293352&amp;loc=SL126838806-209984<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 65<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092918&amp;loc=SL128093175-196984<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL126732908-238011<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128293352&amp;loc=SL120154346-209984<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 65<br> -Paragraph 3<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092918&amp;loc=SL128093175-196984<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=125980421&amp;loc=SL125981372-237846<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 20<br> -Section 65<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=121483254&amp;loc=SL120254523-199619<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=120154821&amp;loc=SL120154904-197079<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983955&amp;loc=SL121967933-165497<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL120254519-210437<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126983955&amp;loc=SL120254526-165497<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 10<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128293352&amp;loc=SL126838806-209984<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdoptionDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfOperatingSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8672-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfOperatingSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherThanTemporaryImpairmentLossDebtSecuritiesPortionRecognizedInEarnings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of other-than-temporary impairment (OTTI) on investment in debt security, recognized in earnings.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8A<br> -URI https://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=SL6284422-111562<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherThanTemporaryImpairmentLossDebtSecuritiesPortionRecognizedInEarnings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Describes the periods of time over which an entity anticipates to receive utility from its property, plant and equipment (that is, the periods of time over which an entity allocates the initial cost of its property, plant and equipment).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 35<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126905813&amp;loc=d3e1205-110223<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RealizedInvestmentGainsLosses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of realized gain (loss) on investment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04.3(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RealizedInvestmentGainsLosses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201602Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201602Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139683190563392">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value Measurements - Summary of Financial Assets Measured at Fair Value on Recurring Basis (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Short-term investments, Aggregated Fair Value</a></td>
<td class="nump">$ 181,445<span></span>
</td>
<td class="nump">$ 126,003<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Short-term investments, Amortized Cost</a></td>
<td class="nump">181,807<span></span>
</td>
<td class="nump">126,066<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Short-term investments, Gross Unrealized Holding Gains</a></td>
<td class="nump">12<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Short-term investments, Gross Unrealized Holding Losses</a></td>
<td class="num">(374)<span></span>
</td>
<td class="num">(65)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Short-term investments, Aggregated Fair Value</a></td>
<td class="nump">181,445<span></span>
</td>
<td class="nump">126,003<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Short-term investments, Aggregated Fair Value</a></td>
<td class="nump">48,540<span></span>
</td>
<td class="nump">27,715<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Short-term available for sale securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Short-term investments, Aggregated Fair Value</a></td>
<td class="nump">132,905<span></span>
</td>
<td class="nump">98,288<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level 1 | Money Market Funds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Short-term investments, Amortized Cost</a></td>
<td class="nump">18,224<span></span>
</td>
<td class="nump">21,477<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Short-term investments, Aggregated Fair Value</a></td>
<td class="nump">18,224<span></span>
</td>
<td class="nump">21,477<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level 2 | Commercial Paper</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Short-term investments, Amortized Cost</a></td>
<td class="nump">104,279<span></span>
</td>
<td class="nump">59,647<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Short-term investments, Gross Unrealized Holding Gains</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Short-term investments, Gross Unrealized Holding Losses</a></td>
<td class="num">(84)<span></span>
</td>
<td class="num">(10)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Short-term investments, Aggregated Fair Value</a></td>
<td class="nump">104,196<span></span>
</td>
<td class="nump">59,637<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level 2 | U.S. government bonds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Short-term investments, Amortized Cost</a></td>
<td class="nump">18,225<span></span>
</td>
<td class="nump">21,662<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Short-term investments, Gross Unrealized Holding Gains</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Short-term investments, Gross Unrealized Holding Losses</a></td>
<td class="num">(109)<span></span>
</td>
<td class="num">(42)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Short-term investments, Aggregated Fair Value</a></td>
<td class="nump">18,117<span></span>
</td>
<td class="nump">21,620<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level 2 | Corporate debt securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Short-term investments, Amortized Cost</a></td>
<td class="nump">10,488<span></span>
</td>
<td class="nump">8,776<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Short-term investments, Gross Unrealized Holding Gains</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Short-term investments, Gross Unrealized Holding Losses</a></td>
<td class="num">(62)<span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Short-term investments, Aggregated Fair Value</a></td>
<td class="nump">10,426<span></span>
</td>
<td class="nump">8,776<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level 2 | Agency bonds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Short-term investments, Amortized Cost</a></td>
<td class="nump">13,986<span></span>
</td>
<td class="nump">7,747<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Short-term investments, Gross Unrealized Holding Gains</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Short-term investments, Gross Unrealized Holding Losses</a></td>
<td class="num">(78)<span></span>
</td>
<td class="num">(7)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Short-term investments, Aggregated Fair Value</a></td>
<td class="nump">13,908<span></span>
</td>
<td class="nump">7,741<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level 2 | U.S. treasury bills</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Short-term investments, Amortized Cost</a></td>
<td class="nump">7,414<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Short-term investments, Gross Unrealized Holding Gains</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Short-term investments, Gross Unrealized Holding Losses</a></td>
<td class="num">(21)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Short-term investments, Aggregated Fair Value</a></td>
<td class="nump">7,394<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level 2 | Non-US debt securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Short-term investments, Amortized Cost</a></td>
<td class="nump">3,975<span></span>
</td>
<td class="nump">2,506<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Short-term investments, Gross Unrealized Holding Losses</a></td>
<td class="num">(20)<span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Short-term investments, Aggregated Fair Value</a></td>
<td class="nump">3,955<span></span>
</td>
<td class="nump">2,505<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level 2 | Agency discount securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Short-term investments, Amortized Cost</a></td>
<td class="nump">5,216<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Short-term investments, Gross Unrealized Holding Gains</a></td>
<td class="nump">9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Short-term investments, Aggregated Fair Value</a></td>
<td class="nump">$ 5,225<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level 2 | Municipal Bonds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Short-term investments, Amortized Cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,251<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Short-term investments, Gross Unrealized Holding Losses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Short-term investments, Aggregated Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,247<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of unrealized gain in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of unrealized loss in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27161-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(6))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26610-111562<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aa)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CashEquivalentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CashEquivalentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_ShortTermInvestmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_ShortTermInvestmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_MoneyMarketFundsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_MoneyMarketFundsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialPaperMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CommercialPaperMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesShorttermDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesShorttermDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_AgencySecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_AgencySecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USTreasuryBillSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USTreasuryBillSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_ForeignGovernmentDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_ForeignGovernmentDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=etnb_AgencyDiscountSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=etnb_AgencyDiscountSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_MunicipalBondsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_MunicipalBondsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139683120694800">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value Measurements - Schedule of Contractual Maturities of Cash Equivalents and Available-for-Sale Securities (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue', window );">Within one year</a></td>
<td class="nump">$ 175,243<span></span>
</td>
<td class="nump">$ 120,726<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_etnb_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughTwoYearsFairValue', window );">After one year through two years</a></td>
<td class="nump">6,202<span></span>
</td>
<td class="nump">5,277<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Total cash equivalents and available-for-sale securities</a></td>
<td class="nump">$ 181,445<span></span>
</td>
<td class="nump">$ 126,003<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_etnb_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughTwoYearsFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Available for sale securities debt maturities after one through two years fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">etnb_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughTwoYearsFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>etnb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 3A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126980459&amp;loc=SL120269850-112803<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27198-111563<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(6))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26610-111562<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aa)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139683120719168">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Balance Sheet Components - Schedule of Prepaid and Other Current Assets (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract', window );"><strong>Prepaid Expense and Other Assets, Current [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_etnb_PrepaidResearchAndDevelopmentCurrent', window );">Prepaid research and development</a></td>
<td class="nump">$ 5,727<span></span>
</td>
<td class="nump">$ 7,895<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidTaxes', window );">Prepaid taxes</a></td>
<td class="nump">646<span></span>
</td>
<td class="nump">836<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherPrepaidExpenseCurrent', window );">Prepaid other</a></td>
<td class="nump">1,547<span></span>
</td>
<td class="nump">2,506<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Total prepaid and other current assets</a></td>
<td class="nump">$ 7,920<span></span>
</td>
<td class="nump">$ 11,237<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_etnb_PrepaidResearchAndDevelopmentCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Research and development expense prepaid current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">etnb_PrepaidResearchAndDevelopmentCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>etnb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherPrepaidExpenseCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for other costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6387103&amp;loc=d3e6435-108320<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(7))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherPrepaidExpenseCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for income and other taxes that provide economic benefits within a future period of one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6387103&amp;loc=d3e6435-108320<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (g)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section 05<br> -Paragraph 5<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126905020&amp;loc=d3e5879-108316<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139683190440336">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Balance Sheet Components - Schedule of Accrued Expenses (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_etnb_AccruedResearchAndDevelopmentExpenseCurrent', window );">Accrued research and development expenses</a></td>
<td class="nump">$ 6,499<span></span>
</td>
<td class="nump">$ 6,195<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeRelatedLiabilitiesCurrent', window );">Accrued employee and related expenses</a></td>
<td class="nump">4,165<span></span>
</td>
<td class="nump">3,168<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedProfessionalFeesCurrent', window );">Accrued professional and legal fees</a></td>
<td class="nump">1,052<span></span>
</td>
<td class="nump">495<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAccruedLiabilitiesCurrent', window );">Accrued other expenses</a></td>
<td class="nump">228<span></span>
</td>
<td class="nump">336<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Total accrued expenses</a></td>
<td class="nump">$ 11,944<span></span>
</td>
<td class="nump">$ 10,194<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_etnb_AccruedResearchAndDevelopmentExpenseCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accrued research and development expense current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">etnb_AccruedResearchAndDevelopmentExpenseCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>etnb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedProfessionalFeesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedProfessionalFeesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeRelatedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeRelatedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139683190402304">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies - Additional Information (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Aug. 31, 2022</div></th>
<th class="th"><div>Jan. 01, 2022</div></th>
<th class="th"><div>Apr. 30, 2018</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use asset</a></td>
<td class="nump">$ 300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 363,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Operating lease liability, current</a></td>
<td class="nump">$ 300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">168,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeaseAndRentalExpense', window );">Operating leases, rent expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200,000<span></span>
</td>
<td class="nump">$ 300,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_VariableLeasePayment', window );">Variable lease payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermLeaseCost', window );">Short-term lease costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm', window );">Remaining lease term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseDiscountRate', window );">Incremental borrowing rate used to determine operating lease liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=etnb_TevaAgreementMember', window );">Teva Agreements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_etnb_AssetTransferAndLicenseAgreementInitialNonrefundableUpfrontPayment', window );">Nonrefundable upfront payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_etnb_ObligationToPaymentUponMaximumAchievementOfCertainClinicalAndCommercialMilestones', window );">Payment upon achievement of certain clinical and commercial milestones</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">135,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_etnb_AssetTransferAndLicenseAgreementTerminationPeriodAfterWrittenNotice', window );">Asset transfer and license agreement, termination period after written notice</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">120 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_etnb_AssetTransferAndLicenseAgreementTerminationPeriodNoticeOfFailure', window );">Asset transfer and license agreement, termination period notice of breach</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">60 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_etnb_AssetTransferAndLicenseAgreementTerminationNoticePeriodIfBankruptcyPetitionFiled', window );">Asset transfer and license agreement termination notice period if bankruptcy petition filed</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">60 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_etnb_MilestonePayment', window );">Milestone payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=etnb_TevaAgreementMember', window );">Teva Agreements | Research and Development Expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_etnb_MilestonePayment', window );">Milestone payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=etnb_TevaAgreementMember', window );">Teva Agreements | Teva's GlycoPEGylated FGF21 Program</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_etnb_ObligationToPaymentUponMaximumAchievementOfCertainClinicalAndCommercialMilestones', window );">Payment upon achievement of certain clinical and commercial milestones</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">67,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=etnb_TevaAgreementMember', window );">Teva Agreements | Teva's Development Program</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_etnb_ObligationToPaymentUponMaximumAchievementOfCertainClinicalAndCommercialMilestones', window );">Payment upon achievement of certain clinical and commercial milestones</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 67,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=etnb_SanFranciscoOfficeMember', window );">San Francisco Office</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_etnb_OperatingLeaseExpirationMonthAndYear', window );">Operating lease expiration month and year</a></td>
<td class="text">2025-01<span></span>
</td>
<td class="text">2023-01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_etnb_AssetTransferAndLicenseAgreementInitialNonrefundableUpfrontPayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Asset transfer and license agreements initial nonrefundable upfront payment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">etnb_AssetTransferAndLicenseAgreementInitialNonrefundableUpfrontPayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>etnb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_etnb_AssetTransferAndLicenseAgreementTerminationNoticePeriodIfBankruptcyPetitionFiled">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Asset transfer and license agreement termination notice period if bankruptcy petition filed.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">etnb_AssetTransferAndLicenseAgreementTerminationNoticePeriodIfBankruptcyPetitionFiled</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>etnb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_etnb_AssetTransferAndLicenseAgreementTerminationPeriodAfterWrittenNotice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Asset transfer and license agreement termination period after written notice.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">etnb_AssetTransferAndLicenseAgreementTerminationPeriodAfterWrittenNotice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>etnb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_etnb_AssetTransferAndLicenseAgreementTerminationPeriodNoticeOfFailure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Asset transfer and license agreement termination period notice of failure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">etnb_AssetTransferAndLicenseAgreementTerminationPeriodNoticeOfFailure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>etnb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_etnb_MilestonePayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Milestone payment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">etnb_MilestonePayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>etnb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_etnb_ObligationToPaymentUponMaximumAchievementOfCertainClinicalAndCommercialMilestones">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Obligation to payment upon maximum achievement of certain clinical and commercial milestones.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">etnb_ObligationToPaymentUponMaximumAchievementOfCertainClinicalAndCommercialMilestones</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>etnb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_etnb_OperatingLeaseExpirationMonthAndYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Operating lease expiration month and year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">etnb_OperatingLeaseExpirationMonthAndYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>etnb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearMonthItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseAndRentalExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of rent expense incurred for leased assets, including but not limited to, furniture and equipment, that is not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseAndRentalExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseDiscountRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Discount rate used by lessee to determine present value of operating lease payments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918673-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseDiscountRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Remaining lease term of operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918673-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseRemainingLeaseTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of short-term lease cost, excluding expense for lease with term of one month or less.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableLeasePayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for variable lease payment excluded from lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918643-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableLeasePayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=etnb_TevaAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=etnb_TevaAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=etnb_TevasGlycoPEGylatedFGF21ProgramMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=etnb_TevasGlycoPEGylatedFGF21ProgramMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=etnb_TevasDevelopmentProgramMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=etnb_TevasDevelopmentProgramMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=etnb_SanFranciscoOfficeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=etnb_SanFranciscoOfficeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139683190440080">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Commitments and Contingencies - Schedule of Future Minimum Lease Payments Under Non-cancellable Operating Lease Obligations (Details)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths', window );">2023</a></td>
<td class="nump">$ 185<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo', window );">2024</a></td>
<td class="nump">185<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree', window );">2025</a></td>
<td class="nump">7<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue', window );">Total undiscounted future minimum lease payments</a></td>
<td class="nump">377<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount', window );">Less: imputed interest</a></td>
<td class="num">(23)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Present value of operating lease liability</a></td>
<td class="nump">$ 354<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139683191248608">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Commitments and Contingencies - Schedule of Future Minimum Annual Payments for Operating Leases (Details)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear', window );">2022</a></td>
<td class="nump">$ 212<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears', window );">2023</a></td>
<td class="nump">7<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDue', window );">Total future minimum annual payments</a></td>
<td class="nump">$ 219<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of required minimum rental payments for leases having an initial or remaining non-cancelable letter-terms in excess of one year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123406913&amp;loc=d3e41502-112717<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 10<br> -Section 55<br> -Paragraph 40<br> -Subparagraph (Note 3)<br> -URI https://asc.fasb.org/extlink&amp;oid=123403562&amp;loc=d3e38371-112697<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesFutureMinimumPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the second fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123406913&amp;loc=d3e41502-112717<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 10<br> -Section 55<br> -Paragraph 40<br> -Subparagraph (Note 3)<br> -URI https://asc.fasb.org/extlink&amp;oid=123403562&amp;loc=d3e38371-112697<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the remainder of the fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139683190177056">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Term Loan - Additional Information (Details)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="2">1 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>May 31, 2021 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Apr. 30, 2020 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_etnb_PercentageOfFeeOnLoan', window );">Percentage of fee on loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsGross', window );">Deferred tax assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 76,301<span></span>
</td>
<td class="nump">$ 42,265<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Term loan, non-current, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19,691<span></span>
</td>
<td class="nump">16,898<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_etnb_OtherNonCurrentLiability', window );">Other non-current liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 501<span></span>
</td>
<td class="nump">$ 30<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=etnb_TermALoanFacilityMember', window );">Term A Loan Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityDescription', window );">Line of credit facility, description</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">As of December 31, 2021, all amounts were drawn under the Term Loan A Facility such that all debt issuance costs were recorded as a debt discount.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=etnb_LoanAndSecurityAgreementMember', window );">Loan Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityDescription', window );">Line of credit facility, description</a></td>
<td class="text">In May 2021, the parties further amended the Loan Agreement (as amended, the &#8220;2021 Loan Agreement&#8221;). The 2021 Loan Agreement increased the Term A Loan Facility to up to $20.0 million, which was fully drawn as of December 2021. The Term B Loan Facility of up to $5.0 million was available to be drawn upon on achievement of certain additional milestones, on or before September 30, 2022, which expired unused.<span></span>
</td>
<td class="text">In April 2020, the Company entered into a Loan and Security Agreement, (the &#8220;Loan Agreement&#8221;) with the lenders referred to therein, and Silicon Valley Bank (&#8220;SVB&#8221;), as collateral agent. The Loan Agreement provided for (i) a secured term A loan facility (the &#8220;Term A Loan Facility&#8221;) of up to $10.0 million and (ii) a secured term B loan facility (the &#8220;Term B Loan Facility&#8221;) of up to $5.0 million that became available upon the satisfaction of certain milestones, each of which was available to be drawn through May 31, 2021. The term loan is secured by certain assets of the Borrowers (as defined in the Loan Agreement), including substantially all of the assets of the Company, excluding the Company&#8217;s intellectual property. The term loan contains customary representations, warranties, affirmative covenants and also certain restrictive covenants.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Warrants to purchase common stock | shares</a></td>
<td class="nump">33,923<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrant exercise price | $ / shares</a></td>
<td class="nump">$ 19.12<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMaturityDate', window );">Warrant expiration date</a></td>
<td class="text">May 28,  2031<span></span>
</td>
<td class="text">Jun. 30,  2025<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredFinanceCostsGross', window );">Debt issuance costs, gross</a></td>
<td class="nump">$ 600<span></span>
</td>
<td class="nump">$ 600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_etnb_NetCashProceedsFromSaleOfEquitySecurities', window );">Proceeds from sale of available-for-sale securities, equity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 75,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateDuringPeriod', window );">Debt instrument, interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.25%<span></span>
</td>
<td class="nump">8.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsGross', window );">Deferred tax assets</a></td>
<td class="nump">400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Term loan, non-current, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 19,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Outstanding principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscount', window );">Unamortized debt discount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_etnb_OtherNonCurrentLiability', window );">Other non-current liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=etnb_LoanAndSecurityAgreementMember', window );">Loan Agreement | Measurement Input, Expected Dividend Payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_etnb_FairValueOfWarrantsAssumptionsDividends', window );">Fair value of warrant assumptions, dividends</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=etnb_LoanAndSecurityAgreementMember', window );">Loan Agreement | Valuation Technique, Option Pricing Model | Measurement Input, Risk Free Interest Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentMeasurementInput', window );">Fair measurement input</a></td>
<td class="nump">0.016<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=etnb_LoanAndSecurityAgreementMember', window );">Loan Agreement | Valuation Technique, Option Pricing Model | Measurement Input, Price Volatility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentMeasurementInput', window );">Fair measurement input</a></td>
<td class="nump">0.986<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=etnb_LoanAndSecurityAgreementMember', window );">Loan Agreement | Valuation Technique, Option Pricing Model | Measurement Input, Expected Term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentTerm', window );">Fair measurement input</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=etnb_LoanAndSecurityAgreementMember', window );">Loan Agreement | Prime Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Debt instrument, basis spread on variable rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=etnb_LoanAndSecurityAgreementMember', window );">Loan Agreement | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_etnb_PrepaymentFeePercentage', window );">Prepayment fee percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=etnb_LoanAndSecurityAgreementMember', window );">Loan Agreement | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateDuringPeriod', window );">Debt instrument, interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_etnb_PrepaymentFeePercentage', window );">Prepayment fee percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=etnb_LoanAndSecurityAgreementMember', window );">Loan Agreement | Other Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredFinanceCostsGross', window );">Debt issuance costs, gross</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=etnb_LoanAndSecurityAgreementMember', window );">Loan Agreement | Term A Loan Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Line of credit facility, maximum borrowing capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromLinesOfCredit', window );">Line of credit facility fully drawn amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Warrants to purchase common stock | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrant exercise price | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 22.06<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityExpirationDate1', window );">Credit facility maturity date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Sep.  01,  2024<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=etnb_LoanAndSecurityAgreementMember', window );">Loan Agreement | Term B Loan Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Line of credit facility, maximum borrowing capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Warrants to purchase common stock | shares</a></td>
<td class="nump">11,305<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_etnb_LineOfCreditFacilityIncreaseInBorrowingCapacity', window );">Line of credit facility maximum borrowing capacity</a></td>
<td class="nump">$ 5,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=etnb_TwentyTwentyThreeLoanAgreementMember', window );">2023 Loan Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityDescription', window );">Line of credit facility, description</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">In January 2023, the Company executed a loan and security agreement with new lenders (the &#8220;2023 Loan Agreement&#8221;) and repaid its outstanding obligations under the 2021 Loan Agreement (see Note 11). As the Company had the intent and ability to refinance amounts due under the 2021 Loan Agreement pursuant to the terms of the 2023 Loan Agreement, as of December 31, 2022, the current portion of the outstanding principal obligation under the 2021 Loan Agreement was classified as long-term. As of December 31, 2022, the Company&#8217;s total obligations under the 2021 Loan Agreement were $19.7 million classified as term loan, non-current, net and $0.5 million classified as other non-current liability related to the final payment fee. The term loan, non-current, net is comprised of the outstanding principal amount of $20.0 million net of $0.3 million of unamortized debt discount.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_etnb_FairValueOfWarrantsAssumptionsDividends">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of warrant assumptions, dividends.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">etnb_FairValueOfWarrantsAssumptionsDividends</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>etnb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_etnb_LineOfCreditFacilityIncreaseInBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line of credit facility increase in borrowing capacity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">etnb_LineOfCreditFacilityIncreaseInBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>etnb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_etnb_NetCashProceedsFromSaleOfEquitySecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Net cash proceeds from sale of equity securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">etnb_NetCashProceedsFromSaleOfEquitySecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>etnb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_etnb_OtherNonCurrentLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Other non-current liability</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">etnb_OtherNonCurrentLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>etnb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_etnb_PercentageOfFeeOnLoan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of fee on loan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">etnb_PercentageOfFeeOnLoan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>etnb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_etnb_PrepaymentFeePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Prepayment fee percentage.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">etnb_PrepaymentFeePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>etnb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage points added to the reference rate to compute the variable rate on the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentBasisSpreadOnVariableRate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average effective interest rate during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495355-112611<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentMeasurementInput">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of input used to measure debt instrument, including, but not limited to, convertible and non-convertible debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentMeasurementInput</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentUnamortizedDiscount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt discount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28541-108399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentUnamortizedDiscount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFinanceCostsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFinanceCostsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Description of the terms of a credit facility arrangement. Terms typically include interest rate, collateral required, guarantees required, repayment requirements, and restrictions on use of assets and activities of the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityExpirationDate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Date the credit facility terminates, in YYYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityExpirationDate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromLinesOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from contractual arrangement with the lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(f))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromLinesOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsAndRightsOutstandingMaturityDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Expiration date of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in YYYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsAndRightsOutstandingMaturityDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=etnb_TermALoanFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=etnb_TermALoanFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=etnb_LoanAndSecurityAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=etnb_LoanAndSecurityAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedDividendPaymentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedDividendPaymentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationTechniqueAxis=us-gaap_ValuationTechniqueOptionPricingModelMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationTechniqueAxis=us-gaap_ValuationTechniqueOptionPricingModelMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputRiskFreeInterestRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputRiskFreeInterestRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputPriceVolatilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputPriceVolatilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedTermMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedTermMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=us-gaap_PrimeRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=us-gaap_PrimeRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=etnb_TermBLoanFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=etnb_TermBLoanFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=etnb_TwentyTwentyThreeLoanAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=etnb_TwentyTwentyThreeLoanAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139683190076864">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Stockholders' Equity - Schedule of Shares of Common Stock Available for Future Issuance (Details)<br></strong></div></th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class Of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Total available for future issuance</a></td>
<td class="nump">14,937,136<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=etnb_EquityIncentivePlanMember', window );">Equity Incentive Plan</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class Of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Total available for future issuance</a></td>
<td class="nump">241,635<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_EmployeeStockMember', window );">Employee Stock Purchase Plan</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class Of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Total available for future issuance</a></td>
<td class="nump">729,218<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=etnb_ExerciseOfWarrantsAndPreFundedWarrantsMember', window );">Exercise of Warrants and Pre-funded Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class Of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Total available for future issuance</a></td>
<td class="nump">13,966,283<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate number of common shares reserved for future issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockCapitalSharesReservedForFutureIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=etnb_EquityIncentivePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=etnb_EquityIncentivePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_EmployeeStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_EmployeeStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=etnb_ExerciseOfWarrantsAndPreFundedWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=etnb_ExerciseOfWarrantsAndPreFundedWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139683189847984">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity - Additional Information (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">1 Months Ended</th>
<th class="th" colspan="1">2 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Feb. 15, 2023</div></th>
<th class="th"><div>Jul. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Feb. 28, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary Sale Of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from issuance of common stock, net of commissions and offering expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 50<span></span>
</td>
<td class="nump">$ 144<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=etnb_PreFundedWarrantsMember', window );">Pre-funded Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary Sale Of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_etnb_BeneficialOwnershipLimitationOnExerciseOfWarrant', window );">Percentage of ownership limitation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9.99%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_etnb_SaleOfStockPercentageOfBeneficialOwnershipLimitationBeforeTransaction', window );">Percentage of ownership prior to issuance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.99%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember', window );">Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary Sale Of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_etnb_BeneficialOwnershipLimitationOnExerciseOfWarrant', window );">Percentage of ownership limitation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9.99%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_etnb_SaleOfStockPercentageOfBeneficialOwnershipLimitationBeforeTransaction', window );">Percentage of ownership prior to issuance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.99%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | Pre-funded Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary Sale Of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_etnb_BeneficialOwnershipLimitationOnExerciseOfWarrant', window );">Percentage of ownership limitation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19.99%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary Sale Of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_etnb_BeneficialOwnershipLimitationOnExerciseOfWarrant', window );">Percentage of ownership limitation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19.99%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=etnb_ATMFacilityMember', window );">A T M Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary Sale Of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockDescriptionOfTransaction', window );">Public offering description</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">In January and February 2023, the Company received aggregate proceeds of $13.4 million, net of commissions from sales of 968,000 shares of its common stock pursuant to the ATM Facility (see Note 7).<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=etnb_ATMFacilityMember', window );">A T M Facility | Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary Sale Of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from issuance of common stock, net of commissions and offering expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 13,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Shares issued and sold</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">968,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember', window );">Public Offerings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary Sale Of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from issuance of common stock, net of commissions and offering expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 88,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockDescriptionOfTransaction', window );">Public offering description</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">In July 2022, the Company completed an underwritten public offering of its common stock, warrants to purchase shares of its common stock and pre-funded warrants to purchase shares of its common stock. The Company sold 18,675,466 shares of its common stock with accompanying warrants to purchase up to 9,337,733 shares of its common stock at a combined public offering price of $3.55 per share. The Company also sold 7,944,252 pre-funded warrants to purchase shares of its common stock with accompanying warrants to purchase up to 3,972,126 shares of its common stock at a combined public offering price of $3.549 per pre-funded warrant, which represents the per share public offering price for the common stock less $0.001 per share, the exercise price for each pre-funded warrant. The Company raised net proceeds of $88.2 million, after deducting underwriting discounts and commissions of $5.7 million and other offering costs of $0.6 million. <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Shares issued and sold</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18,675,466<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_etnb_CommonStockAndWarrantsCombinedOfferingPricePerShare', window );">Offering price per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3.55<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_etnb_UnderwritingDiscountsAndCommissions', window );">Underwriting discounts and commissions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfStockIssuanceCosts', window );">Other offering costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember', window );">Public Offerings | Pre-funded Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary Sale Of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_etnb_NumberOfPrefundedWarrantsIssuedDuringPeriod', window );">Number of prefunded warrants issued during period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,944,252<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_etnb_PrefundedAndCommonStockWarrants', window );">Combined price of prefunded and common stock warrant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3.549<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember', window );">Public Offerings | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary Sale Of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Warrants to purchase shares of common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,337,733<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember', window );">Public Offerings | Maximum | Pre-funded Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary Sale Of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Warrants to purchase shares of common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,972,126<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember', window );">Public Offerings | A T M Facility | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary Sale Of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_etnb_MaximumAmountOfEquitySharesIssuable', window );">Maximum amount of equity shares issuable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 75,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember', window );">Public Offerings | A T M Facility | Maximum | Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary Sale Of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_etnb_MaximumAmountOfEquitySharesIssuable', window );">Maximum amount of equity shares issuable</a></td>
<td class="nump">$ 150,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember', window );">Public Offerings | SVB Leerink LLC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary Sale Of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_etnb_SellingCommissionPerSharesSoldPercentage', window );">Selling commission per shares sold percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from issuance of common stock, net of commissions and offering expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 28,500<span></span>
</td>
<td class="nump">$ 3,300<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Shares issued and sold</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,948,611<span></span>
</td>
<td class="nump">186,546<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_etnb_BeneficialOwnershipLimitationOnExerciseOfWarrant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Beneficial ownership limitation on exercise of warrant.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">etnb_BeneficialOwnershipLimitationOnExerciseOfWarrant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>etnb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_etnb_CommonStockAndWarrantsCombinedOfferingPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Common stock and warrants combined offering price per share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">etnb_CommonStockAndWarrantsCombinedOfferingPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>etnb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_etnb_MaximumAmountOfEquitySharesIssuable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Maximum amount of equity shares issuable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">etnb_MaximumAmountOfEquitySharesIssuable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>etnb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_etnb_NumberOfPrefundedWarrantsIssuedDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of prefunded warrants issued during period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">etnb_NumberOfPrefundedWarrantsIssuedDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>etnb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_etnb_PrefundedAndCommonStockWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Prefunded and common stock warrants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">etnb_PrefundedAndCommonStockWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>etnb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_etnb_SaleOfStockPercentageOfBeneficialOwnershipLimitationBeforeTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sale of stock percentage of beneficial ownership limitation before transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">etnb_SaleOfStockPercentageOfBeneficialOwnershipLimitationBeforeTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>etnb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_etnb_SellingCommissionPerSharesSoldPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Selling commission per shares sold percentage.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">etnb_SellingCommissionPerSharesSoldPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>etnb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_etnb_UnderwritingDiscountsAndCommissions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Underwriting discounts and commissions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">etnb_UnderwritingDiscountsAndCommissions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>etnb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfStockIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for cost incurred directly with the issuance of an equity security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfStockIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the additional capital contribution to the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockDescriptionOfTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Description of stock transaction which may include details of the offering (IPO, private placement), a description of the stock sold, percentage of subsidiary's or equity investee's stock sold, a description of the investors and whether the stock was issued in a business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4582445-111684<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569655-111683<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockDescriptionOfTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=etnb_PreFundedWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=etnb_PreFundedWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=etnb_ATMFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=etnb_ATMFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=etnb_SVBLeerinkLLCAndCantorFitzgeraldCoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=etnb_SVBLeerinkLLCAndCantorFitzgeraldCoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139683190412608">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity - Schedule of Outstanding Warrants to Purchase Shares of Common Stock (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2022 </div>
<div>$ / shares </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class Of Warrant Or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Shares of Common Stock Underlying Warrants</a></td>
<td class="nump">13,966,283<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=etnb_WarrantTermLoanMember', window );">Warrants Term Loan</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class Of Warrant Or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Shares of Common Stock Underlying Warrants</a></td>
<td class="nump">25,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrant exercise price | $ / shares</a></td>
<td class="nump">$ 22.06<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMaturityDate', window );">Warrant expiration date</a></td>
<td class="text">Jun. 30,  2025<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=etnb_WarrantTermLoanOneMember', window );">Warrants Term Loan</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class Of Warrant Or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Shares of Common Stock Underlying Warrants</a></td>
<td class="nump">33,923<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrant exercise price | $ / shares</a></td>
<td class="nump">$ 19.12<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMaturityDate', window );">Warrant expiration date</a></td>
<td class="text">May 28,  2031<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=etnb_WarrantPublicOfferingsMember', window );">Warrants Public Offerings</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class Of Warrant Or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Shares of Common Stock Underlying Warrants</a></td>
<td class="nump">13,107,360<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrant exercise price | $ / shares</a></td>
<td class="nump">$ 5.325<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMaturityDate', window );">Warrant expiration date</a></td>
<td class="text">Jul.  01,  2024<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=etnb_PreFundedWarrantsMember', window );">Pre-funded Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class Of Warrant Or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Shares of Common Stock Underlying Warrants</a></td>
<td class="nump">800,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrant exercise price | $ / shares</a></td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_etnb_WarrantsAndRightsOutstandingMaturityDateDescription', window );">Expiration Date</a></td>
<td class="text">Do not expire<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_etnb_WarrantsAndRightsOutstandingMaturityDateDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Warrants and rights outstanding maturity date description.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">etnb_WarrantsAndRightsOutstandingMaturityDateDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>etnb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsAndRightsOutstandingMaturityDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Expiration date of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in YYYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsAndRightsOutstandingMaturityDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=etnb_WarrantTermLoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=etnb_WarrantTermLoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=etnb_WarrantTermLoanOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=etnb_WarrantTermLoanOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=etnb_WarrantPublicOfferingsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=etnb_WarrantPublicOfferingsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=etnb_PreFundedWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=etnb_PreFundedWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139683190740656">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation - Additional Information (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="3">1 Months Ended</th>
<th class="th" colspan="1">8 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Feb. 28, 2021</div></th>
<th class="th"><div>Oct. 31, 2019</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share base compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,356<span></span>
</td>
<td class="nump">$ 8,678<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=etnb_ServiceBasedRSUsMember', window );">Service-based RSUs | Employee</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share base compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,200<span></span>
</td>
<td class="nump">300<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted Stock Units (RSUs)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Unrecognized weighted average period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year 4 months 24 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions', window );">Total Unrecognised expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=etnb_PerformanceRSUsMember', window );">Performance RSUs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage', window );">Percentage of option vesting</a></td>
<td class="nump">33.30%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription', window );">RSUs description</a></td>
<td class="text">In February 2021, the Company granted performance-based RSUs that vest as to one-third on each one-year anniversary date, subject to achievement of a development milestone and continued service to the Company. In February 2022, a portion of the performance-based RSUs vested upon achievement of the development milestone and satisfaction of the continued service condition. <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">In February and September 2022, the Company granted performance-based RSUs that vest during the applicable performance period, subject to the achievement of certain corporate or department targets and continued service to the Company. In September 2022, a portion of the performance-based RSUs that were granted in February 2022 vested upon achievement of specific targets and satisfaction of the continued service condition. <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=etnb_PerformanceRSUsMember', window );">Performance RSUs | Employee</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share base compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,500<span></span>
</td>
<td class="nump">$ 800<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=etnb_PerformanceRSUsMember', window );">Performance RSUs | Executive Officer</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Vesting period</a></td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_EmployeeStockMember', window );">Employee Stock Purchase Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_etnb_NumberOfSharesIssuableUnderShareBasedPaymentArrangement', window );">Number of common shares issuable under the plan (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">225,188<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_etnb_PercentageOfIncreaseInNumberOfSharesOfCapitalStockIssuedAndOutstanding', window );">Percentage of increase in number of shares of capital stock issued and outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent', window );">Percent of purchase shares of common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">85.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=etnb_TwoThousandAndNineteenEquityIncentivePlanMember', window );">2019 Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_etnb_NumberOfSharesIssuableUnderShareBasedPaymentArrangement', window );">Number of common shares issuable under the plan (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,844,193<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_etnb_PercentageOfIncreaseInNumberOfSharesOfCapitalStockIssuedAndOutstanding', window );">Percentage of increase in number of shares of capital stock issued and outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage', window );">Percentage of option vesting</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAward', window );">Terms of award</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">The board of directors determines the period over which options become exercisable and options generally vest over a four-year period, with 25% of options vesting on the first anniversary of employment, and thereafter, the remaining options vesting quarterly, over the following 36-month period. The options expire within ten years from the date of grant. The exercise price of awards granted will not be less than the estimated fair value of the shares on the date of grant. The 2019 Plan also permits the board of directors to grant restricted stock units, which are subject to continued service conditions.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_etnb_ShareBasedCompensationArrangementByShareBasedPaymentAwardRemainingOptionsVestingPeriod', window );">Remaining option vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">36 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Expiration period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions', window );">Unrecognized stock option granted under plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Unrecognized weighted average period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years 2 months 12 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod', window );">Cancelled shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">243,506<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,161,917<span></span>
</td>
<td class="nump">2,406,668<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=etnb_TwoThousandAndTwentyEquityIncentivePlanMember', window );">2020 Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted average fair value options granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3.38<span></span>
</td>
<td class="nump">$ 16.18<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | Service-based RSUs | Employee</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | Employee Stock Purchase Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_etnb_PeriodForIncreaseInNumberOfSharesOfCommonStockReservedForIssuance', window );">Period for increase in number of shares of common stock reserved for issuance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | 2019 Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_etnb_PeriodForIncreaseInNumberOfSharesOfCommonStockReservedForIssuance', window );">Period for increase in number of shares of common stock reserved for issuance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum | Service-based RSUs | Employee</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_etnb_NumberOfSharesIssuableUnderShareBasedPaymentArrangement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issuable under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">etnb_NumberOfSharesIssuableUnderShareBasedPaymentArrangement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>etnb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_etnb_PercentageOfIncreaseInNumberOfSharesOfCapitalStockIssuedAndOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of increase in number of shares of capital stock reserved for issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">etnb_PercentageOfIncreaseInNumberOfSharesOfCapitalStockIssuedAndOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>etnb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_etnb_PeriodForIncreaseInNumberOfSharesOfCommonStockReservedForIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period for increase in number of shares of common stock reserved for issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">etnb_PeriodForIncreaseInNumberOfSharesOfCommonStockReservedForIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>etnb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_etnb_ShareBasedCompensationArrangementByShareBasedPaymentAwardRemainingOptionsVestingPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share based compensation arrangement by share based payment award remaining options vesting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">etnb_ShareBasedCompensationArrangementByShareBasedPaymentAwardRemainingOptionsVestingPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>etnb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost to be recognized for nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost to be recognized for option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Description of terms of share-based payment arrangement. Includes, but is not limited to, type of award or grantee and reason for issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5047-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Description of terms of award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of vesting of award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Purchase price of common stock expressed as a percentage of its fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=etnb_ServiceBasedRSUsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=etnb_ServiceBasedRSUsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=us-gaap_ShareBasedPaymentArrangementEmployeeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=us-gaap_ShareBasedPaymentArrangementEmployeeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=etnb_PerformanceRSUsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=etnb_PerformanceRSUsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=srt_ExecutiveOfficerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=srt_ExecutiveOfficerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_EmployeeStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_EmployeeStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=etnb_TwoThousandAndNineteenEquityIncentivePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=etnb_TwoThousandAndNineteenEquityIncentivePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=etnb_TwoThousandAndTwentyEquityIncentivePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=etnb_TwoThousandAndTwentyEquityIncentivePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139683190567760">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation - Summary of Stock Option Activity (Details) - 2019 Plan - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward', window );"><strong>Number of Options</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Outstanding, Beginning Balance</a></td>
<td class="nump">2,406,668<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Granted</a></td>
<td class="nump">1,149,816<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercised</a></td>
<td class="num">(151,061)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod', window );">Cancelled and forfeited</a></td>
<td class="num">(243,506)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Outstanding, Ending Balance</a></td>
<td class="nump">3,161,917<span></span>
</td>
<td class="nump">2,406,668<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Exercisable as of December 31, 2022</a></td>
<td class="nump">1,460,685<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward', window );"><strong>Weighted Average Exercise Price</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Weighted Average Exercise Price Outstanding, Beginning Balance</a></td>
<td class="nump">$ 16.46<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Weighted Average Exercise Price, Granted</a></td>
<td class="nump">4.48<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Weighted Average Exercise Price, Exercised</a></td>
<td class="nump">2.09<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice', window );">Weighted Average Exercise Price, Cancelled and forfeited</a></td>
<td class="nump">16.34<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Weighted Average Exercise Price Outstanding, Ending Balance</a></td>
<td class="nump">12.80<span></span>
</td>
<td class="nump">$ 16.46<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice', window );">Weighted Average Exercise Price, Exercisable as of December 31, 2022</a></td>
<td class="nump">$ 14.60<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_etnb_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract', window );"><strong>Weighted Average Remaining Contractual Term (In years)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Weighted Average Remaining Contractual Term (In years), Outstanding</a></td>
<td class="text">7 years 10 months 24 days<span></span>
</td>
<td class="text">8 years 1 month 6 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1', window );">Weighted Average Remaining Contractual Term (In years), Exercisable as of December 31, 2022</a></td>
<td class="text">7 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_etnb_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract', window );"><strong>Aggregate Intrinsic Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Aggregate Intrinsic Value</a></td>
<td class="nump">$ 16,612<span></span>
</td>
<td class="nump">$ 9,970<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1', window );">Aggregate Intrinsic Value, Exercisable as of December 31, 2022</a></td>
<td class="nump">$ 7,320<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_etnb_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share based compensation arrangement by share based payment award options aggregate intrinsic value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">etnb_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>etnb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_etnb_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share based compensation arrangement by share based payment award options weighted average remaining contractual term.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">etnb_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>etnb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=etnb_TwoThousandAndNineteenEquityIncentivePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=etnb_TwoThousandAndNineteenEquityIncentivePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139683190399632">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation - Summary of Estimated Fair Value of Stock Options Granted Using Black-Scholes Option-Pricing Model (Details)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum', window );">Expected volatility, minimum</a></td>
<td class="nump">89.90%<span></span>
</td>
<td class="nump">86.90%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum', window );">Expected volatility, maximum</a></td>
<td class="nump">91.00%<span></span>
</td>
<td class="nump">91.90%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum', window );">Risk-free interest rate, minimum</a></td>
<td class="nump">1.60%<span></span>
</td>
<td class="nump">0.70%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum', window );">Risk-free interest rate, maximum</a></td>
<td class="nump">3.90%<span></span>
</td>
<td class="nump">1.30%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected term (years)</a></td>
<td class="text">5 years 6 months<span></span>
</td>
<td class="text">5 years 6 months<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected term (years)</a></td>
<td class="text">6 years 3 months 18 days<span></span>
</td>
<td class="text">6 years 1 month 6 days<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the maximum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the minimum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The minimum risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139683191238080">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation - Summary of Restricted Stock Unit Activity (Details) - Restricted Stock Units (RSUs) - $ / shares<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Outstanding, Beginning Balance</a></td>
<td class="nump">106,394<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted</a></td>
<td class="nump">1,224,391<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Vested / released</a></td>
<td class="num">(103,703)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Cancelled / forfeited</a></td>
<td class="num">(131,344)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Outstanding, Ending Balance</a></td>
<td class="nump">1,095,738<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward', window );"><strong>Weighted Average Grant Date Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Weighted Average Grant Date Fair Value Outstanding, Beginning Balance</a></td>
<td class="nump">$ 5.77<span></span>
</td>
<td class="nump">$ 23.10<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted Average Grant Date Fair Value Outstanding, Granted</a></td>
<td class="nump">4.61<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue', window );">Weighted Average Grant Date Fair Value Outstanding, Vested/Released</a></td>
<td class="nump">8.61<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue', window );">Weighted Average Grant Date Fair Value Outstanding, Cancelled/Forfeited</a></td>
<td class="nump">5.53<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Weighted Average Grant Date Fair Value Outstanding, Ending Balance</a></td>
<td class="nump">$ 5.77<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139683121698016">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation - Summary of Stock-Based Compensation (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total stock-based compensation</a></td>
<td class="nump">$ 10,356<span></span>
</td>
<td class="nump">$ 8,678<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember', window );">Research and Development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total stock-based compensation</a></td>
<td class="nump">4,094<span></span>
</td>
<td class="nump">2,966<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember', window );">General and Administrative</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total stock-based compensation</a></td>
<td class="nump">$ 6,262<span></span>
</td>
<td class="nump">$ 5,712<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139683190075664">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Summary of Statutory Tax Rates Applicable to Income of Company and Subsidiaries (Details)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_etnb_IncomeTaxDisclosureLineItems', window );"><strong>Income Tax Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Effective income tax rate</a></td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=etnb_EightyNineBioLtdMember', window );">89Bio Ltd</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_etnb_IncomeTaxDisclosureLineItems', window );"><strong>Income Tax Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Effective income tax rate</a></td>
<td class="nump">23.00%<span></span>
</td>
<td class="nump">23.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=etnb_EightyNineBioManagementIncorporationMember', window );">89bio Management, Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_etnb_IncomeTaxDisclosureLineItems', window );"><strong>Income Tax Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Effective income tax rate</a></td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=etnb_UABEightyNineBioLithuaniaMember', window );">UAB 89bio Lithuania</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_etnb_IncomeTaxDisclosureLineItems', window );"><strong>Income Tax Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Effective income tax rate</a></td>
<td class="nump">15.00%<span></span>
</td>
<td class="nump">15.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_etnb_IncomeTaxDisclosureLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Income Tax.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">etnb_IncomeTaxDisclosureLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>etnb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=etnb_EightyNineBioLtdMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=etnb_EightyNineBioLtdMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=etnb_EightyNineBioManagementIncorporationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=etnb_EightyNineBioManagementIncorporationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=etnb_UABEightyNineBioLithuaniaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=etnb_UABEightyNineBioLithuaniaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139683121697568">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Summary of Income Tax (Expense) Benefit (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract', window );"><strong>Current:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentStateAndLocalTaxExpenseBenefit', window );">State</a></td>
<td class="nump">$ 3<span></span>
</td>
<td class="num">$ (2)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentForeignTaxExpenseBenefit', window );">Foreign</a></td>
<td class="nump">16<span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentIncomeTaxExpenseBenefit', window );">Total</a></td>
<td class="nump">19<span></span>
</td>
<td class="num">(3)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract', window );"><strong>Deferred:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredFederalIncomeTaxExpenseBenefit', window );">Federal</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">150<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Total</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">150<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax (expense) benefit</a></td>
<td class="num">$ (19)<span></span>
</td>
<td class="nump">$ 147<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentForeignTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentForeignTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentStateAndLocalTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentStateAndLocalTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFederalIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred national tax expense (benefit) for non-US (United States of America) jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFederalIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.1)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139683120620288">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Income Taxes - Summary of Components of Deferred Tax Assets (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_etnb_IncomeTaxDisclosureLineItems', window );"><strong>Income Tax Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment', window );">Research and development expenses</a></td>
<td class="nump">$ 18,927<span></span>
</td>
<td class="nump">$ 6,529<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost', window );">Stock-based compensation</a></td>
<td class="nump">4,328<span></span>
</td>
<td class="nump">1,969<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities', window );">Accrued expenses</a></td>
<td class="nump">317<span></span>
</td>
<td class="nump">220<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_etnb_DeferredTaxAssetsLeaseLiability', window );">Operating Lease Liability</a></td>
<td class="nump">98<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOther', window );">Other</a></td>
<td class="nump">244<span></span>
</td>
<td class="nump">191<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsGross', window );">Gross deferred tax assets</a></td>
<td class="nump">76,301<span></span>
</td>
<td class="nump">42,265<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Less: valuation allowance</a></td>
<td class="num">(75,982)<span></span>
</td>
<td class="num">(42,046)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsNet', window );">Total deferred tax assets</a></td>
<td class="nump">319<span></span>
</td>
<td class="nump">219<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_etnb_DeferredTaxLiabilitiesRightsOfUseAssets', window );">Operating lease right-of-use asset</a></td>
<td class="num">(100)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilities', window );">Total deferred tax liabilities</a></td>
<td class="num">(100)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsLiabilitiesNet', window );">Net deferred tax assets</a></td>
<td class="nump">219<span></span>
</td>
<td class="nump">219<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_etnb_IncomeTaxDisclosureLineItems', window );"><strong>Income Tax Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards', window );">Net operating loss carryforwards</a></td>
<td class="nump">45,002<span></span>
</td>
<td class="nump">29,094<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_IL', window );">Israel</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_etnb_IncomeTaxDisclosureLineItems', window );"><strong>Income Tax Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards', window );">Net operating loss carryforwards</a></td>
<td class="nump">$ 7,385<span></span>
</td>
<td class="nump">$ 4,262<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_etnb_DeferredTaxAssetsLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred tax assets lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">etnb_DeferredTaxAssetsLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>etnb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_etnb_DeferredTaxLiabilitiesRightsOfUseAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred tax liabilities rights of use assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">etnb_DeferredTaxLiabilitiesRightsOfUseAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>etnb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_etnb_IncomeTaxDisclosureLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Income Tax.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">etnb_IncomeTaxDisclosureLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>etnb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26)(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(15)(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26)(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from in-process research and development costs expensed in connection with a business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from share-based compensation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from accrued liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_IL">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_IL</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139683190495072">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Additional Information (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_etnb_IncomeTaxDisclosureLineItems', window );"><strong>Income Tax Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Deferred tax assets, valuation allowance</a></td>
<td class="nump">$ 75,982,000<span></span>
</td>
<td class="nump">$ 42,046,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount', window );">Deferred tax assets, change in valuation allowance</a></td>
<td class="nump">$ 34,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLimitationsOnUse', window );">Operating loss carryforwards limitations on use</a></td>
<td class="text">Federal net operating losses generated after 2017 can be carried forward indefinitely but utilization will be limited to 80% of taxable income in the period that net operating losses are being utilized.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_etnb_TaxableIncomeUtilizationPercentage', window );">Taxable income utilization percentage</a></td>
<td class="nump">80.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_etnb_DeferredTaxAssetsTaxCreditCarryforwardsResearchFederal', window );">Federal research and development credit carryforwards</a></td>
<td class="nump">$ 4,300,000<span></span>
</td>
<td class="nump">2,100,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch', window );">State research and development credit carryforwards</a></td>
<td class="nump">1,800,000<span></span>
</td>
<td class="nump">1,100,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease', window );">Increase in unrecognized tax benefits</a></td>
<td class="nump">700,000<span></span>
</td>
<td class="nump">500,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate', window );">Unrecognized tax benefits impact effective tax rate</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember', window );">Research and Development Expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_etnb_IncomeTaxDisclosureLineItems', window );"><strong>Income Tax Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_etnb_AmortizationPeriod', window );">Amortization period</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember', window );">Federal</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_etnb_IncomeTaxDisclosureLineItems', window );"><strong>Income Tax Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_etnb_AccumulatedTaxLossCarryForward', window );">Accumulated tax loss carryforward</a></td>
<td class="nump">$ 160,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember', window );">Federal | Research and Development Credit Carryforwards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_etnb_IncomeTaxDisclosureLineItems', window );"><strong>Income Tax Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_etnb_TaxCreditCarryforwardExpirationYear', window );">Carryforward tax losses expiration year</a></td>
<td class="text">2040<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember', window );">Federal | Research and Development Expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_etnb_IncomeTaxDisclosureLineItems', window );"><strong>Income Tax Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_etnb_AmortizationPeriod', window );">Amortization period</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember', window );">State</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_etnb_IncomeTaxDisclosureLineItems', window );"><strong>Income Tax Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_etnb_AccumulatedTaxLossCarryForward', window );">Accumulated tax loss carryforward</a></td>
<td class="nump">$ 169,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember', window );">Foreign | Research and Development Expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_etnb_IncomeTaxDisclosureLineItems', window );"><strong>Income Tax Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_etnb_AmortizationPeriod', window );">Amortization period</a></td>
<td class="text">15 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_IL', window );">Israel</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_etnb_IncomeTaxDisclosureLineItems', window );"><strong>Income Tax Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_etnb_AccumulatedTaxLossCarryForward', window );">Accumulated tax loss carryforward</a></td>
<td class="nump">$ 32,100,000<span></span>
</td>
<td class="nump">18,500,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_etnb_IncomeTaxDisclosureLineItems', window );"><strong>Income Tax Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_etnb_AccumulatedTaxLossCarryForward', window );">Accumulated tax loss carryforward</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 138,500,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=stpr_CA', window );">California | State</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_etnb_IncomeTaxDisclosureLineItems', window );"><strong>Income Tax Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_etnb_TaxCreditCarryforwardExpirationYear', window );">Carryforward tax losses expiration year</a></td>
<td class="text">2041<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_etnb_AccumulatedTaxLossCarryForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accumulated tax loss carry forward.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">etnb_AccumulatedTaxLossCarryForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>etnb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_etnb_AmortizationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amortization period</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">etnb_AmortizationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>etnb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_etnb_DeferredTaxAssetsTaxCreditCarryforwardsResearchFederal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred tax assets tax credit carryforwards research, federal.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">etnb_DeferredTaxAssetsTaxCreditCarryforwardsResearchFederal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>etnb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_etnb_IncomeTaxDisclosureLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Income Tax.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">etnb_IncomeTaxDisclosureLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>etnb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_etnb_TaxCreditCarryforwardExpirationYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tax credit carryforward expiration year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">etnb_TaxCreditCarryforwardExpirationYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>etnb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_etnb_TaxableIncomeUtilizationPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Taxable income utilization percentage.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">etnb_TaxableIncomeUtilizationPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>etnb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible research tax credit carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32559-109319<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLossCarryforwardsLimitationsOnUse">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A description of the limitations on the use of all operating loss carryforwards available to reduce future taxable income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLossCarryforwardsLimitationsOnUse</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in unrecognized tax benefits attributable to uncertain tax positions taken in tax returns.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The total amount of unrecognized tax benefits that, if recognized, would affect the effective tax rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the valuation allowance for a specified deferred tax asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxCreditCarryforwardAxis=us-gaap_ResearchMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxCreditCarryforwardAxis=us-gaap_ResearchMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_IL">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_IL</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=stpr_CA">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=stpr_CA</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139683120691760">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Summary of Loss from Operations Before Taxes on Income (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_etnb_IncomeTaxDisclosureLineItems', window );"><strong>Income Tax Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Net loss before income tax</a></td>
<td class="num">$ (102,007)<span></span>
</td>
<td class="num">$ (90,269)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_etnb_IncomeTaxDisclosureLineItems', window );"><strong>Income Tax Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Net loss before income tax</a></td>
<td class="num">(101,938)<span></span>
</td>
<td class="num">(91,141)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_LT', window );">LITHUANIA</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_etnb_IncomeTaxDisclosureLineItems', window );"><strong>Income Tax Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Net loss before income tax</a></td>
<td class="num">(7)<span></span>
</td>
<td class="nump">10<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_IL', window );">Israel</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_etnb_IncomeTaxDisclosureLineItems', window );"><strong>Income Tax Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Net loss before income tax</a></td>
<td class="num">$ (62)<span></span>
</td>
<td class="nump">$ 862<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_etnb_IncomeTaxDisclosureLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Income Tax.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">etnb_IncomeTaxDisclosureLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>etnb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126941158&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_LT">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_LT</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_IL">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_IL</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139683190413440">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Summary of Reconciliation of Income Tax (Expense) Benefit Statutory Tax Rate to Effective Tax Rate (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate', window );">Income tax benefit computed at statutory rates</a></td>
<td class="nump">$ 21,429<span></span>
</td>
<td class="nump">$ 18,757<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance', window );">Change in valuation allowance</a></td>
<td class="num">(33,936)<span></span>
</td>
<td class="num">(20,111)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential', window );">Foreign rate differential</a></td>
<td class="nump">1<span></span>
</td>
<td class="num">(19)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes', window );">State income taxes, net of federal benefit</a></td>
<td class="nump">5,824<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_etnb_EffectiveIncomeTaxRateReconciliationStateDeferredTaxTrueUpDueToChangeInApportionment', window );">State deferred tax true-up due to change in apportionment</a></td>
<td class="nump">6,517<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_etnb_IncomeTaxReconciliationChangeInEffectiveTaxRateDueToReorganization', window );">Change in Israel effective tax rate due to the 2019 reorganization</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationNondeductibleExpenseResearchAndDevelopment', window );">Research and development credits, net of uncertain tax position</a></td>
<td class="nump">2,130<span></span>
</td>
<td class="nump">1,331<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationOtherAdjustments', window );">Other</a></td>
<td class="num">(1,984)<span></span>
</td>
<td class="nump">191<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax (expense) benefit</a></td>
<td class="num">$ (19)<span></span>
</td>
<td class="nump">$ 147<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_etnb_EffectiveIncomeTaxRateReconciliationStateDeferredTaxTrueUpDueToChangeInApportionment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Effective income tax rate reconciliation state deferred tax true-up due to change in apportionment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">etnb_EffectiveIncomeTaxRateReconciliationStateDeferredTaxTrueUpDueToChangeInApportionment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>etnb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_etnb_IncomeTaxReconciliationChangeInEffectiveTaxRateDueToReorganization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Income tax reconciliation change in effective tax rate due to reorganization.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">etnb_IncomeTaxReconciliationChangeInEffectiveTaxRateDueToReorganization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>etnb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in the valuation allowance for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to foreign income tax expense (benefit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of income tax expense or benefit for the period computed by applying the domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationNondeductibleExpenseResearchAndDevelopment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to nondeductible research and development expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationNondeductibleExpenseResearchAndDevelopment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationOtherAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationOtherAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to state and local income tax expense (benefit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139683121690768">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Summary of a Reconciliation of The Beginning And Ending Amount of Unrecognized Tax Benefits (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Balance, beginning of year</a></td>
<td class="nump">$ 851<span></span>
</td>
<td class="nump">$ 329<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions', window );">Decrease related to prior year positions</a></td>
<td class="num">(19)<span></span>
</td>
<td class="num">(35)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions', window );">Increase related to current year positions</a></td>
<td class="nump">752<span></span>
</td>
<td class="nump">557<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Balance, end of year</a></td>
<td class="nump">$ 1,584<span></span>
</td>
<td class="nump">$ 851<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10B<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=SL37586934-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in unrecognized tax benefits resulting from tax positions that have been or will be taken in current period tax return.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139683210751824">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Loss Per Share - Schedule of Outstanding Potentially Dilutive Securities Excluded From Calculation of Diluted Net Loss (Details) - shares<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive common stock equivalents excluded from calculation of diluted net loss per share</a></td>
<td class="nump">17,423,938<span></span>
</td>
<td class="nump">2,571,985<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember', window );">Stock Options to Purchase Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive common stock equivalents excluded from calculation of diluted net loss per share</a></td>
<td class="nump">3,161,917<span></span>
</td>
<td class="nump">2,406,668<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=etnb_UnvestedRestrictedStockUnitsMember', window );">Unvested Restricted Stock Units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive common stock equivalents excluded from calculation of diluted net loss per share</a></td>
<td class="nump">1,095,738<span></span>
</td>
<td class="nump">106,394<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_WarrantMember', window );">Warrants to Purchase Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive common stock equivalents excluded from calculation of diluted net loss per share</a></td>
<td class="nump">13,166,283<span></span>
</td>
<td class="nump">58,923<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=etnb_UnvestedRestrictedStockUnitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=etnb_UnvestedRestrictedStockUnitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_WarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_WarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139683121442784">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Subsequent Events - Additional Information (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">1 Months Ended</th>
<th class="th" colspan="1">2 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Feb. 15, 2023</div></th>
<th class="th"><div>Jan. 31, 2023</div></th>
<th class="th"><div>Jul. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Feb. 28, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from issuance of common stock, net of commissions and offering expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 50<span></span>
</td>
<td class="nump">$ 144<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember', window );">Public Offerings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockDescriptionOfTransaction', window );">ATM Facility description</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">In July 2022, the Company completed an underwritten public offering of its common stock, warrants to purchase shares of its common stock and pre-funded warrants to purchase shares of its common stock. The Company sold 18,675,466 shares of its common stock with accompanying warrants to purchase up to 9,337,733 shares of its common stock at a combined public offering price of $3.55 per share. The Company also sold 7,944,252 pre-funded warrants to purchase shares of its common stock with accompanying warrants to purchase up to 3,972,126 shares of its common stock at a combined public offering price of $3.549 per pre-funded warrant, which represents the per share public offering price for the common stock less $0.001 per share, the exercise price for each pre-funded warrant. The Company raised net proceeds of $88.2 million, after deducting underwriting discounts and commissions of $5.7 million and other offering costs of $0.6 million. <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from issuance of common stock, net of commissions and offering expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 88,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Shares issued and sold</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18,675,466<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=etnb_ATMFacilityMember', window );">A T M Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockDescriptionOfTransaction', window );">ATM Facility description</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">In January and February 2023, the Company received aggregate proceeds of $13.4 million, net of commissions from sales of 968,000 shares of its common stock pursuant to the ATM Facility (see Note 7).<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=etnb_ATMFacilityMember', window );">A T M Facility | Public Offerings | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_etnb_MaximumAmountOfEquitySharesIssuable', window );">Maximum amount of equity shares issuable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 75,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=etnb_SVBLeerinkLLCAndCantorFitzgeraldCoMember', window );">SVB Leerink LLC | Public Offerings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from issuance of common stock, net of commissions and offering expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 28,500<span></span>
</td>
<td class="nump">$ 3,300<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Shares issued and sold</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,948,611<span></span>
</td>
<td class="nump">186,546<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event | 2023 Loan Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Line of credit facility, maximum borrowing capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDateDescription', window );">Debt instrument, maturity date, description</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">The term loans under the 2023 Loan Agreement mature on January 1, 2027. The maturity date may be extended to July 1, 2027, provided that the second and third tranches are funded and the Company achieves certain other financing milestones.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDate', window );">Debt instrument, maturity date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Jan.  01,  2027<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateDuringPeriod', window );">Debt instrument, interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8.45%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Debt instrument, basis spread on variable rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event | 2021 Loan Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAnnualPrincipalPayment', window );">Total principal amount outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_etnb_DebtInstrumentFinalPaymentFee', window );">Debt instrument, final payment fee</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_etnb_DebtInstrumentEarlyPrepaymentFee', window );">Debt instrument, early prepayment fee</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event | A T M Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from issuance of common stock, net of commissions and offering expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 13,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Shares issued and sold</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">968,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event | A T M Facility | Public Offerings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockTransactionDate', window );">Sales Agreement transaction date</a></td>
<td class="text">Feb. 15,  2023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event | A T M Facility | Public Offerings | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_etnb_MaximumAmountOfEquitySharesIssuable', window );">Maximum amount of equity shares issuable</a></td>
<td class="nump">$ 150,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=etnb_TrancheOneMember', window );">Tranche one | Subsequent Event | 2023 Loan Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Line of credit facility, maximum borrowing capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=etnb_TrancheOneMember', window );">Tranche one | Subsequent Event | 2021 Loan Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityAverageOutstandingAmount', window );">Loan Agreement funded outstanding amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=etnb_TrancheTwoAndThreeMember', window );">Tranche two and three | Subsequent Event | 2023 Loan Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Line of credit facility, maximum borrowing capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 25,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDate', window );">Debt instrument, maturity date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Jul.  01,  2027<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=etnb_TrancheFourMember', window );">Tranche Four | Subsequent Event | 2023 Loan Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Line of credit facility, maximum borrowing capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 50,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_etnb_DebtInstrumentEarlyPrepaymentFee">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt instrument, early prepayment fee.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">etnb_DebtInstrumentEarlyPrepaymentFee</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>etnb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_etnb_DebtInstrumentFinalPaymentFee">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt instrument, final payment fee.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">etnb_DebtInstrumentFinalPaymentFee</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>etnb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_etnb_MaximumAmountOfEquitySharesIssuable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Maximum amount of equity shares issuable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">etnb_MaximumAmountOfEquitySharesIssuable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>etnb_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAnnualPrincipalPayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the total principal payments made during the annual reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAnnualPrincipalPayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage points added to the reference rate to compute the variable rate on the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentBasisSpreadOnVariableRate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average effective interest rate during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495355-112611<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentMaturityDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Date when the debt instrument is scheduled to be fully repaid, in YYYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentMaturityDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentMaturityDateDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Description of the maturity date of the debt instrument including whether the debt matures serially and, if so, a brief description of the serial maturities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentMaturityDateDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityAverageOutstandingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Average amount borrowed under the credit facility during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityAverageOutstandingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the additional capital contribution to the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockDescriptionOfTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Description of stock transaction which may include details of the offering (IPO, private placement), a description of the stock sold, percentage of subsidiary's or equity investee's stock sold, a description of the investors and whether the stock was issued in a business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4582445-111684<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569655-111683<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockDescriptionOfTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockTransactionDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Date the subsidiary or equity investee issued or sold stock, in YYYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockTransactionDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=etnb_ATMFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=etnb_ATMFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=etnb_SVBLeerinkLLCAndCantorFitzgeraldCoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=etnb_SVBLeerinkLLCAndCantorFitzgeraldCoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=etnb_TwoThousandAndTwentyThreeLoanAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=etnb_TwoThousandAndTwentyThreeLoanAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=etnb_TwoThousandAndTwentyOneLoanAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=etnb_TwoThousandAndTwentyOneLoanAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=etnb_TrancheOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=etnb_TrancheOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=etnb_TrancheTwoAndThreeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=etnb_TrancheTwoAndThreeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=etnb_TrancheFourMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=etnb_TrancheFourMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>etnb-20221231_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:country="http://xbrl.sec.gov/country/2022"
  xmlns:dei="http://xbrl.sec.gov/dei/2022"
  xmlns:etnb="http://www.89bio.com/20221231"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2022"
  xmlns:stpr="http://xbrl.sec.gov/stpr/2022"
  xmlns:us-gaap="http://fasb.org/us-gaap/2022"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="etnb-20221231.xsd" xlink:type="simple"/>
    <context id="C_dbf7afe5-d66f-4aec-9806-312b0e5b4e3e">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_50e7e18a-0655-4c7d-95a8-7ac3e1648249">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IL</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_6047d52d-d8de-4ffd-998c-b1093834c8c7">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-07-31</instant>
        </period>
    </context>
    <context id="C_a1422313-a35e-45e5-a7d0-20aa6422feb3">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_3292f652-c40f-4507-b87c-efc3bf396c08">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ExecutiveOfficerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">etnb:PerformanceRSUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-02-01</startDate>
            <endDate>2021-02-28</endDate>
        </period>
    </context>
    <context id="C_a4e466da-eda8-431d-8082-79eb5a6b4d5f">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_b2381809-b584-4634-835b-de401b34febb">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">etnb:ATMFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-03-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="C_63713aa3-3b7f-4c18-95ec-d7881a249606">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">etnb:TermALoanFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">etnb:LoanAndSecurityAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-04-30</instant>
        </period>
    </context>
    <context id="C_ab53d079-3181-47b2-85e6-cb6ceba1d67b">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-07-31</endDate>
        </period>
    </context>
    <context id="C_5a34cef0-4d09-47ec-a8ce-379fe69ed741">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_46a37282-7c21-4f91-b5bc-d6bf1cfad31b">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">etnb:TrancheOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">etnb:TwoThousandAndTwentyOneLoanAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-01-31</endDate>
        </period>
    </context>
    <context id="C_7c6e4cd6-6b45-4e07-9ce7-b8efe5b967e5">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_dd9c4882-66d0-4386-bb9e-0f1c29a674cb">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_6d3eea61-86b7-46b5-8fc7-9a6e90984a96">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">etnb:TermBLoanFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">etnb:LoanAndSecurityAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2021-05-31</endDate>
        </period>
    </context>
    <context id="C_346ebc1d-56b1-4b67-95cf-d70e9efff187">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">etnb:TevaAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_d5d69a12-3d32-411c-82ae-eca2bf142f5c">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_ccc34858-a5d1-4e90-8bb9-0ff6d83c6b06">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_42e28a41-a2c7-4703-9012-632c3a4117b3">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_0fbbd6d9-9bd7-49b6-8f27-ad8d51a5afad">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">etnb:TermBLoanFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">etnb:LoanAndSecurityAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-04-30</instant>
        </period>
    </context>
    <context id="C_b714c872-cbb8-40d3-a8b0-eb87e6092698">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_64505050-8754-453d-9384-3e8a3e7ed1c7">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">etnb:LoanAndSecurityAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-04-30</instant>
        </period>
    </context>
    <context id="C_0d8efc73-e669-470d-b4ba-623e328b895c">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">etnb:LoanAndSecurityAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-05-31</instant>
        </period>
    </context>
    <context id="C_51c95b33-c300-4ddf-9044-8f1a7525082b">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">etnb:TwoThousandAndNineteenEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="C_7b31e452-ba3b-4180-9ddd-8faae2f90f0c">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_c47682c6-cd12-4afc-8813-6a33a11740fe">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">etnb:EightyNineBioLtdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_538d2ebd-ca46-4eb6-a0b9-787839675985">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_debc9f51-b90f-43f6-af8a-b00f128671e2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">etnb:EquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_0d9500dd-d242-4ed4-9f39-2450c5d10363">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_4fde072e-5fc4-4cda-9482-54bac5203fd9">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">etnb:TwoThousandAndNineteenEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_04dfbd26-115a-4a0f-a7b5-f27eb17ef112">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_dbe06daf-d12f-4df8-b30b-9d91c12d257a">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-07-31</instant>
        </period>
    </context>
    <context id="C_531e15c8-1e50-4083-9eba-30220f5c7c10">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">etnb:ATMFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_19145334-f911-4daa-9ab2-e1eab1d17cbf">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">etnb:LoanAndSecurityAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueOptionPricingModelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-05-31</instant>
        </period>
    </context>
    <context id="C_af7928d4-1306-45db-9bad-07933e9c282a">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">etnb:ATMFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_d18bd1f4-38fc-4415-8797-86a51c6f011c">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">etnb:PreFundedWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-07-31</endDate>
        </period>
    </context>
    <context id="C_da14e69b-ecb1-4491-93da-01275cadc2ed">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IL</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_b3ec4959-576f-4e65-ad23-76ebb075c512">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_8abdad68-ec68-4b1c-a08b-9c7a8ad9e2f6">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IL</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_c666f3b9-1ce5-4d4c-88e3-dbd7868d4edb">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">etnb:TwoThousandAndTwentyThreeLoanAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-01-31</endDate>
        </period>
    </context>
    <context id="C_a21cd459-9352-4988-ba87-d4355aa42746">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_7c501227-02e2-4e44-b377-8e6109e76507">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_cd860230-54ad-4af3-82dc-6e430002fe8e">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">etnb:TwoThousandAndNineteenEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_cd124b4e-13d9-4079-ac85-a4d1fd6601fc">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">us-gaap:ShareBasedPaymentArrangementEmployeeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">etnb:ServiceBasedRSUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_9153c97c-b82f-4cb0-9b13-074c71823603">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-07-31</endDate>
        </period>
    </context>
    <context id="C_3d0b52b1-23df-4031-9043-36966d3bfe8f">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">etnb:UnvestedRestrictedStockUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_5e92a8a9-dc98-44f0-9e1f-f9aa3e8099bf">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">etnb:TrancheTwoAndThreeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">etnb:TwoThousandAndTwentyThreeLoanAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-01-31</endDate>
        </period>
    </context>
    <context id="C_b88d9973-f0e9-45f8-b4fb-a6e4faea7667">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_c6fb4616-5254-4cb5-bb2e-278e7e88bcc9">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">us-gaap:ResearchMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_8aa0101e-eb8f-4a89-baf5-0cb6983f48c3">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">etnb:ATMFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_a901fd1a-d6e9-4b6f-a2ee-b46b58ae4f7c">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">etnb:TwoThousandAndTwentyEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_17df92a5-2cb5-48c9-9462-299e5b922342">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">etnb:PreFundedWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-07-31</instant>
        </period>
    </context>
    <context id="C_21f769c6-c78d-41d0-b871-ec3d93d7d343">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_2927c45f-85bc-4b1d-bb2a-c302c8ed2347">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">etnb:UnvestedRestrictedStockUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_23fb22c1-879a-41c9-8fba-6e9ff39f555d">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">etnb:TwoThousandAndNineteenEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_f6790208-fa53-4c6a-a9e8-0e12a839f2fc">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">etnb:LoanAndSecurityAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_d381e235-d260-40df-bd20-65af96cdfcaa">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">etnb:PreFundedWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_13fd21a7-f190-41ce-8a3b-79cba6a70fbb">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">us-gaap:ShareBasedPaymentArrangementEmployeeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">etnb:ServiceBasedRSUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_9e2050fc-7421-4f2f-bf7c-de15ccbc149f">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_0f35f69d-3f7b-4b23-8802-ee13a747affc">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_012d970f-64c4-41b0-8040-d4774ce38bd6">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">us-gaap:ShareBasedPaymentArrangementEmployeeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">etnb:PerformanceRSUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_f1a66cb6-d1cc-4146-839d-52664c4b4ab3">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-10-01</startDate>
            <endDate>2019-10-31</endDate>
        </period>
    </context>
    <context id="C_43d7ae38-fb0a-4a4d-a3e8-a44b58f48f12">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CashEquivalentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_8c4669a8-efdc-43fe-b27c-54cf3b35bd79">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_20129c45-1d42-4b18-a135-f79c3916f000">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AgencySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_0e17628a-1540-4372-9673-4bccb929190b">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
        </entity>
        <period>
            <instant>2023-03-03</instant>
        </period>
    </context>
    <context id="C_e7406d64-9fbe-4053-8474-7c07e64b9b1a">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">etnb:SVBLeerinkLLCAndCantorFitzgeraldCoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_71719056-4c35-44bc-be7b-ed47745f7284">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_85e3a5e5-8ff2-4682-901b-9d79336e863a">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_aecfb132-37f5-4d9c-98a7-d5475beefa29">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">etnb:TermBLoanFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">etnb:LoanAndSecurityAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-05-31</instant>
        </period>
    </context>
    <context id="C_486ea18d-a98b-4e2c-a648-7ba74ce82df4">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">etnb:TermALoanFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">etnb:LoanAndSecurityAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_9d22496e-a5ce-4a93-a7b9-674d6c8a803f">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:LT</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_034c3248-20ba-45f1-8c7f-941617fb2bea">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">etnb:SVBLeerinkLLCAndCantorFitzgeraldCoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="C_06c8eb12-56da-4f0a-a557-1a9ee843de7a">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_f85e5250-59a9-43e3-a14f-d55368e20822">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">etnb:TrancheFourMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">etnb:TwoThousandAndTwentyThreeLoanAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-01-31</instant>
        </period>
    </context>
    <context id="C_8bc8599c-0290-4c23-8007-773265c83e34">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">etnb:TwoThousandAndNineteenEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_e78e7a90-a47d-407c-a473-ef6d15843240">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">etnb:TwoThousandAndTwentyEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_4aecf5de-d743-4793-84fb-ed9efd04841d">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IL</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_4c47692e-9e97-459b-a109-c6bc7bbaa9fe">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">etnb:WarrantPublicOfferingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_eb4154dd-05cb-44b2-b1f9-253eb264f041">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201602Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-01</instant>
        </period>
    </context>
    <context id="C_2e474f95-87bf-4927-8cbe-0c9312719cd9">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">etnb:TwoThousandAndTwentyThreeLoanAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-01-31</instant>
        </period>
    </context>
    <context id="C_06409d28-ba8c-475e-bda2-06ff8506b41a">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">etnb:TevaAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-04-01</startDate>
            <endDate>2018-04-30</endDate>
        </period>
    </context>
    <context id="C_a518f01f-6e57-482e-afd5-51c9629b2a7c">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_dc1a49be-d8e3-4484-be45-e163fe0ca28e">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_2ab554fe-0a65-4e18-9da1-d18c79433fba">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">etnb:UABEightyNineBioLithuaniaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_b79c1273-b7ef-4512-a77c-8f09b7dd034b">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_acf3ac7f-4345-415e-b39a-8425a9a0a3db">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_6fdc6413-db9e-4bdf-ac0c-0aec29016321">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">etnb:SVBLeerinkLLCAndCantorFitzgeraldCoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_3b993bd4-a1f0-42fb-959d-d02b87902727">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">etnb:ATMFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_d417399a-7793-4c07-aa7a-f9d877495dd9">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">etnb:LoanAndSecurityAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueOptionPricingModelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2021-05-31</endDate>
        </period>
    </context>
    <context id="C_a8dbb74d-cae4-4460-96f9-3662ead67daa">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_48d6b2ed-10f4-4276-9857-7ff818488c18">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_9b3365b2-21c7-49a6-ad95-a43fd3b9d2c1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">etnb:TrancheOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">etnb:TwoThousandAndTwentyThreeLoanAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-01-31</instant>
        </period>
    </context>
    <context id="C_6cebf0eb-4166-4c8e-ac4c-8137ee3b770e">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">etnb:TrancheTwoAndThreeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">etnb:TwoThousandAndTwentyThreeLoanAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-01-31</instant>
        </period>
    </context>
    <context id="C_cf4ea6ad-4896-41f4-bc1c-7f4a0b1286f8">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">etnb:ExerciseOfWarrantsAndPreFundedWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_68ccb2ee-ab2d-44ed-a5ee-a3a09c44b31c">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">etnb:PreFundedWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_7120f124-ce25-4ba7-a030-21bd1b4579e6">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_3b1b99d2-654c-455a-a33a-422592ad8d08">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_0db42b13-ed32-4464-a128-9b3738d1e9ec">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_ba27f631-5055-4b5d-bcd3-1dcdfae2eb5e">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">etnb:AgencyDiscountSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_aa8067f4-0c3d-4c66-b916-2f5abd46e15d">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_276795d2-8680-4e1e-a7b3-60b4f187b181">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesShorttermDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_bbce1ed1-a8d8-49f8-afbe-c78e9685dbd3">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">etnb:TevaAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_17d9d5b5-1459-459f-8bc2-52f76629e915">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:CA</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_8ec6682c-a0df-42a7-9596-2e31ddf5f5fb">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">etnb:LoanAndSecurityAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2021-05-31</endDate>
        </period>
    </context>
    <context id="C_302d3395-cf3f-4431-8710-ee66bc04c06d">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_f983776b-3b07-4d5d-8f04-c89f752dbbb3">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">etnb:WarrantTermLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_6cd8e184-e243-4a3c-818f-9a1ebfd43667">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_9705961e-ee8d-42ab-94ee-ccd3d976ce3a">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">etnb:PreFundedWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-07-31</endDate>
        </period>
    </context>
    <context id="C_15a836b6-6096-4e2c-9574-cf11b7149853">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasuryBillSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_3f47fde3-7be3-4bb6-ae2b-29bc39fcd38d">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">etnb:TermALoanFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_1294a0d4-82df-4aeb-86a3-c974a5339679">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_8c46fb5d-0dfa-460a-9514-f05dd04eb080">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">etnb:ATMFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-02-15</startDate>
            <endDate>2023-02-15</endDate>
        </period>
    </context>
    <context id="C_f1364984-27a4-4b53-9cb3-49e5885e056f">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">etnb:LoanAndSecurityAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-04-30</instant>
        </period>
    </context>
    <context id="C_b49f5ccf-6e36-469f-8160-42229bc94d1d">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_fc374840-0f9a-49dd-a75c-57c70ae81f21">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_0ff1dce8-b806-4a8c-ae9b-bef81ddaf302">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">etnb:LoanAndSecurityAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_a099857d-ead8-4784-88ce-373b780df01d">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignGovernmentDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_f440b0bc-74ad-45cd-9077-8182fe07c5ea">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_0cf9d23c-1397-46c1-b3b5-e40c57e51864">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">etnb:TevasDevelopmentProgramMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">etnb:TevaAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-04-01</startDate>
            <endDate>2018-04-30</endDate>
        </period>
    </context>
    <context id="C_23eaed33-b0aa-4e33-a2c8-2f2897791170">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_69b35aed-7994-41dd-a070-5ef370bb6088">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">etnb:LoanAndSecurityAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_68b35e56-1e54-4bd6-9c91-36e41d1c9359">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">etnb:TevasGlycoPEGylatedFGF21ProgramMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">etnb:TevaAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-04-01</startDate>
            <endDate>2018-04-30</endDate>
        </period>
    </context>
    <context id="C_a858f07d-a85c-4d7d-b3d7-e709eceaafec">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-07-31</endDate>
        </period>
    </context>
    <context id="C_1993c206-41b8-40d0-bb47-7bbec84e9bd6">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_32b3ec32-95c9-46d8-a321-86d1f6774b73">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="C_a98c76fd-bd2e-47b8-b425-7f631d600233">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignGovernmentDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_28004ded-ab04-4f21-ace5-a081ac2e28b8">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_37523fff-f632-40a8-b39a-8f096f5c4549">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">etnb:TwoThousandAndTwentyOneLoanAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-01-31</instant>
        </period>
    </context>
    <context id="C_4052b109-a3b7-4114-87b7-faa0a4118dc7">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_42491eea-6b09-4865-930d-85d82115fafd">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">etnb:TwentyTwentyThreeLoanAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_92977a81-ddbb-4449-8219-ba10dfb38d5c">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">etnb:TwoThousandAndNineteenEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="C_7063e2f9-3a0a-44ed-964f-cc213bf88e2e">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CashEquivalentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_219ac1f1-456b-400e-b032-64201f1a5313">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">etnb:SanFranciscoOfficeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-01-01</endDate>
        </period>
    </context>
    <context id="C_59a670e1-2243-40d1-b43e-339c260c91b8">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_fda4865a-3df9-43f1-b274-1756046b954d">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_e79cc86e-7f21-4169-93d3-9ca5f3198b26">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">etnb:PerformanceRSUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-02-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="C_5c814fa2-557e-430f-a964-0b757b56fdfd">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesShorttermDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_293baad2-fb24-4c8f-af10-1f5af83b558f">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">etnb:TevaAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_cc8b62e3-7c1c-4b52-9dfb-ede005f6e5b4">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_336bc7db-2eb9-4265-a863-9aea3514e4c0">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">etnb:TevaAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_e7fc2234-7fe0-49dd-acdd-725cb91a9889">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">us-gaap:ShareBasedPaymentArrangementEmployeeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">etnb:ServiceBasedRSUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_6201b105-b38d-4bd4-81b7-a6dfd189c83e">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">etnb:ATMFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-02-15</startDate>
            <endDate>2023-02-15</endDate>
        </period>
    </context>
    <context id="C_6bb5134f-3725-49c2-9eda-5f0d3a108db3">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AgencySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_ebcdeb7b-03e6-4e92-b422-7eb9e015b4a8">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_46b0f71c-7508-426b-9a1f-56cebecab4e1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_2b1c0a70-b0ce-43af-b3bb-a102024bd750">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">etnb:WarrantTermLoanOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_830ace7d-9785-41d6-a516-94d2fda5e208">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">etnb:PerformanceRSUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-02-01</startDate>
            <endDate>2021-02-28</endDate>
        </period>
    </context>
    <context id="C_9179a407-98a4-4470-bd80-a8d43f35e053">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">etnb:LoanAndSecurityAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:PrimeRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_2b56b0d1-cc3c-4206-95ae-ff3e5aa3e43c">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">us-gaap:ShareBasedPaymentArrangementEmployeeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">etnb:ServiceBasedRSUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_a9902439-f289-45b6-ae67-7a0087e98dc3">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">etnb:LoanAndSecurityAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueOptionPricingModelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-05-31</instant>
        </period>
    </context>
    <context id="C_73cdaea6-5d5f-4d31-9b38-a90fc6b9008e">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_19418b37-9af5-4eb2-b38a-a9070fc599d5">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_e0c8525e-1484-4af4-8900-61b9edf6a79c">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">etnb:EightyNineBioManagementIncorporationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_c220af16-8191-4926-94c1-499324d13fdf">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_1987e38f-7346-406e-addf-f3687776929f">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_143dfe4f-b7a0-4c4a-acd0-9cacd6c072d0">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">etnb:EightyNineBioLtdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_0ec77485-e315-49c3-9a79-2d048ec76494">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_d924e5a5-d3dd-4acb-a359-d2a055d67e71">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">etnb:LoanAndSecurityAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-04-30</endDate>
        </period>
    </context>
    <context id="C_6abe1517-994e-40d2-af02-3d1364d02449">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_4e61ffe1-5dad-4c7d-9e54-54ccdddb6379">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedDividendPaymentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">etnb:LoanAndSecurityAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2021-05-31</endDate>
        </period>
    </context>
    <context id="C_81b08a03-90f7-43af-84a8-8e9dbb83a6d9">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">etnb:SanFranciscoOfficeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-08-31</startDate>
            <endDate>2022-08-31</endDate>
        </period>
    </context>
    <context id="C_94f92680-1f20-47c3-8d22-07184c19f444">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">etnb:ATMFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_400e8f6e-3cb0-4806-ab40-9ea3fbda15da">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">etnb:LoanAndSecurityAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_9e28330b-37ae-4c55-b6c8-5ab5971501f1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_9cece5f1-3203-491d-9c15-ee835dbf4586">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_2091a5b2-f30d-4935-bc83-ed0ef862f4d5">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">etnb:UABEightyNineBioLithuaniaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_cb2cbb74-aff7-499d-b6a9-60e3aa3581f8">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MunicipalBondsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_b7499103-4103-44cf-b691-30ec371253b5">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_cb272169-7edb-4636-b3d0-11b4570d0a11">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_3b188b92-032b-457e-ad3c-a951f340f11a">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">etnb:ATMFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_97306f73-aa83-44a7-88e9-fbb26c9074bd">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">etnb:EightyNineBioManagementIncorporationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_e52ac035-0be2-420f-b034-790f9ecc0826">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:LT</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="C_86dde930-3c82-4da9-903f-d12ea942a22e">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_f1c306e8-9d11-4882-bc7e-9eb378ceb757">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">etnb:PreFundedWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-07-31</instant>
        </period>
    </context>
    <context id="C_3c40b2dc-88af-4c40-8a0c-0d6d05ae9073">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">etnb:ATMFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-02-28</endDate>
        </period>
    </context>
    <context id="C_7333b298-4d64-4dc2-818f-293d2d952a7c">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_d6793a0d-ddc1-4bea-8729-61b96d2fd8c6">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">etnb:PreFundedWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-07-31</endDate>
        </period>
    </context>
    <context id="C_d0cc41a8-af59-48aa-9362-9afbe6438bb6">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201602Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="C_87d79f22-a66f-4528-9561-7c899b8a6f71">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">us-gaap:ShareBasedPaymentArrangementEmployeeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">etnb:PerformanceRSUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_24b84e4a-2d9f-418f-bf86-e74e1b8c81af">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
        </entity>
        <period>
            <instant>2022-08-31</instant>
        </period>
    </context>
    <context id="C_9b6ffafb-d759-4fb6-a478-e6f9c964ba52">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-10-01</startDate>
            <endDate>2019-10-31</endDate>
        </period>
    </context>
    <context id="C_a7b7da7e-fb0a-4f4b-a318-753b03bdad64">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001785173</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <unit id="U_pure">
        <measure>pure</measure>
    </unit>
    <unit id="U_shares">
        <measure>shares</measure>
    </unit>
    <unit id="U_Segment">
        <measure>etnb:Segment</measure>
    </unit>
    <unit id="U_UnitedStatesOfAmericaDollarsShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="U_USD">
        <measure>iso4217:USD</measure>
    </unit>
    <dei:DocumentFiscalPeriodFocus
      contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698"
      id="F_703f3df4-9b30-4bef-999b-4bd968b26d0f">FY</dei:DocumentFiscalPeriodFocus>
    <us-gaap:PreferredStockValue
      contextRef="C_21f769c6-c78d-41d0-b871-ec3d93d7d343"
      id="F_e1912fb5-f606-4ce8-b68f-a7633b9e5662"
      unitRef="U_USD"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="C_e7fc2234-7fe0-49dd-acdd-725cb91a9889"
      id="F_79bc5d0a-fb68-4600-adad-d1cd8af005e1">P2Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <dei:EntityCentralIndexKey
      contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698"
      id="F_defb74fb-9462-4aa7-89d5-78bfd546ccf3">0001785173</dei:EntityCentralIndexKey>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="C_f440b0bc-74ad-45cd-9077-8182fe07c5ea"
      id="F_4640215a-3a60-4f28-a85d-e6242af9c877">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:VariableLeasePayment
      contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698"
      decimals="INF"
      id="F_4a26968b-e9d0-4e69-8f86-01a61afe4e4c"
      unitRef="U_USD">0</us-gaap:VariableLeasePayment>
    <us-gaap:ShortTermLeaseCost
      contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698"
      decimals="INF"
      id="F_104effa9-00d2-42bf-9012-ca94303c5178"
      unitRef="U_USD">0</us-gaap:ShortTermLeaseCost>
    <dei:EntityIncorporationDateOfIncorporation
      contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698"
      id="F_334737a3-eb1d-48a1-9363-2f3248ac80ff">2019-06-30</dei:EntityIncorporationDateOfIncorporation>
    <us-gaap:CommitmentsAndContingencies
      contextRef="C_85e3a5e5-8ff2-4682-901b-9d79336e863a"
      id="F_efdfecff-bd47-4d7b-8ae8-57805d2e5e13"
      unitRef="U_USD"
      xsi:nil="true"/>
    <us-gaap:PreferredStockValue
      contextRef="C_85e3a5e5-8ff2-4682-901b-9d79336e863a"
      id="F_99a22a6a-88e9-4b21-a48d-ce39d2be3156"
      unitRef="U_USD"
      xsi:nil="true"/>
    <dei:AmendmentFlag
      contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698"
      id="F_0ace362a-a29d-4bd6-bec6-ad058eb196ff">false</dei:AmendmentFlag>
    <us-gaap:CommitmentsAndContingencies
      contextRef="C_21f769c6-c78d-41d0-b871-ec3d93d7d343"
      id="F_e78dfece-2abd-4287-b218-712a41c88b40"
      unitRef="U_USD"
      xsi:nil="true"/>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage
      contextRef="C_830ace7d-9785-41d6-a516-94d2fda5e208"
      decimals="3"
      id="F_f41dc902-b0a0-44c4-a2f2-3886c58e26bf"
      unitRef="U_pure">0.333</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage>
    <dei:DocumentType
      contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698"
      id="F_ebbbab57-a787-406d-91d6-11b602546437">10-K</dei:DocumentType>
    <dei:DocumentAnnualReport
      contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698"
      id="F_7c1e4f27-785f-4670-8cd4-9117682e5069">true</dei:DocumentAnnualReport>
    <dei:DocumentPeriodEndDate
      contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698"
      id="F_c39f9d88-cf45-4722-8658-54c3c891a18b">2022-12-31</dei:DocumentPeriodEndDate>
    <dei:CurrentFiscalYearEndDate
      contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698"
      id="F_c072aa71-ec96-4a03-870f-d29622870cc0">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentFiscalYearFocus
      contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698"
      id="F_fde47d20-d312-46ec-9c12-0be561e586d2">2022</dei:DocumentFiscalYearFocus>
    <dei:DocumentTransitionReport
      contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698"
      id="F_0065ab08-56fa-41d6-ad40-2003755bbc88">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber
      contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698"
      id="F_8a0b9cf3-9621-4843-8acb-fced9e8a4661">001-39122</dei:EntityFileNumber>
    <dei:EntityRegistrantName
      contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698"
      id="F_e42b3bf0-1655-47be-8403-2ffb74b012c4">89bio, Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698"
      id="F_8f7d2c11-75ac-4f26-b7e1-f99b004d315a">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber
      contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698"
      id="F_69916b46-784e-45a9-97ff-9692b00df284">36-4946844</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698"
      id="F_fdab1b92-03f6-4633-9093-51ff8b9e8e02">142 Sansome Street</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2
      contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698"
      id="F_c99dccef-997a-4a3c-88f4-11a93e490221">Second Floor</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown
      contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698"
      id="F_9517c09b-0138-42c2-941b-238421f8f318">San Francisco</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698"
      id="F_a1f5d1ae-1cf9-46ad-9529-0de7f0fd7151">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698"
      id="F_b09e032d-9494-4a74-8ac5-3dde63565fd6">94104</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698"
      id="F_4282684d-3faf-4f67-8d7c-32ef45abf457">415</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698"
      id="F_e3d6c59e-1056-4ded-a732-b5f9032b6bd0">432-9270</dei:LocalPhoneNumber>
    <dei:Security12bTitle
      contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698"
      id="F_d49f29b1-a3fd-48e1-b5e1-aab929f0c9d2">Common stock, par value $0.001 per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698"
      id="F_9df0f8ae-5b6e-4eb8-9969-a13b03823464">ETNB</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698"
      id="F_405d3d3f-adc8-4bb8-af22-548b275c6395">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityWellKnownSeasonedIssuer
      contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698"
      id="F_1c86da6f-143f-4d65-9cac-8a95c01a0d39">No</dei:EntityWellKnownSeasonedIssuer>
    <dei:EntityVoluntaryFilers
      contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698"
      id="F_ac411a00-3090-45ca-82b5-975237e19555">No</dei:EntityVoluntaryFilers>
    <dei:EntityCurrentReportingStatus
      contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698"
      id="F_6bfbed1a-08e6-49c5-a0c8-571377871663">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent
      contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698"
      id="F_d61ae325-a894-4f62-b955-7e16404a6998">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory
      contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698"
      id="F_40d0b1b7-82ed-4b95-a43c-ef785569a8f3">Non-accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness
      contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698"
      id="F_97c06ee3-0a0c-4184-9e56-0a8e82a6fada">true</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany
      contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698"
      id="F_c7808672-8689-4332-8c30-edb43f83aed4">true</dei:EntityEmergingGrowthCompany>
    <dei:EntityExTransitionPeriod
      contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698"
      id="F_f43fa156-01d9-4069-af64-93f8b8ea8315">false</dei:EntityExTransitionPeriod>
    <dei:IcfrAuditorAttestationFlag
      contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698"
      id="F_95717b3a-3c47-4d20-b156-32d91997abc3">false</dei:IcfrAuditorAttestationFlag>
    <dei:EntityShellCompany
      contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698"
      id="F_49adc556-cde7-4a51-b313-a2f6dcad16e7">false</dei:EntityShellCompany>
    <dei:EntityPublicFloat
      contextRef="C_32b3ec32-95c9-46d8-a321-86d1f6774b73"
      decimals="-5"
      id="F_44b64144-d7f2-4b8c-bbda-ff85137e7658"
      unitRef="U_USD">30400000</dei:EntityPublicFloat>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="C_0e17628a-1540-4372-9673-4bccb929190b"
      decimals="INF"
      id="F_4ab5e111-8d54-44cc-a2ff-f65cbd37feb7"
      unitRef="U_shares">52230621</dei:EntityCommonStockSharesOutstanding>
    <dei:DocumentsIncorporatedByReferenceTextBlock
      contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698"
      id="F_43b49404-9572-40bb-8cb9-ef21ce01b235">&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Portions of the Registrant&#x2019;s definitive proxy statement relating to its 2023 Annual Meeting of Stockholders, to be held on or about May 31, 2023, are incorporated by reference into Part III of this Annual Report on Form 10-K where indicated. Such proxy statement will be filed with the U.S. Securities and Exchange Commission within 120 days after the end of the fiscal year to which this report relates.&lt;/span&gt;&lt;/p&gt;</dei:DocumentsIncorporatedByReferenceTextBlock>
    <dei:AuditorFirmId
      contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698"
      id="F_befe64d6-e22c-4753-9cb5-53b8d3e63ae2">185</dei:AuditorFirmId>
    <dei:AuditorName
      contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698"
      id="F_16e47b55-bae9-4532-941e-ed2adf191677">KPMG LLP</dei:AuditorName>
    <dei:AuditorLocation
      contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698"
      id="F_190e5df1-370e-4f1a-b9bc-0b66ac0aa8dd">San Francisco, California, USA</dei:AuditorLocation>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="C_85e3a5e5-8ff2-4682-901b-9d79336e863a"
      decimals="-3"
      id="F_da09ee58-fd6d-491b-a5e6-b2e816d67e6f"
      unitRef="U_USD">55255000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="C_21f769c6-c78d-41d0-b871-ec3d93d7d343"
      decimals="-3"
      id="F_947944c1-262b-4a4c-ac66-112c8b71cc65"
      unitRef="U_USD">52432000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:RestrictedCashCurrent
      contextRef="C_21f769c6-c78d-41d0-b871-ec3d93d7d343"
      decimals="-3"
      id="F_8eb44520-e906-4c7a-9ff1-aa4258971181"
      unitRef="U_USD">25000</us-gaap:RestrictedCashCurrent>
    <etnb:ShortTermAvailableForSaleSecuritiesCurrent
      contextRef="C_85e3a5e5-8ff2-4682-901b-9d79336e863a"
      decimals="-3"
      id="F_bd1d7444-7bba-4eb8-956e-6da5c6307e92"
      unitRef="U_USD">132905000</etnb:ShortTermAvailableForSaleSecuritiesCurrent>
    <etnb:ShortTermAvailableForSaleSecuritiesCurrent
      contextRef="C_21f769c6-c78d-41d0-b871-ec3d93d7d343"
      decimals="-3"
      id="F_8cb54c51-6a09-48b2-a037-5b9529bd6a3e"
      unitRef="U_USD">98288000</etnb:ShortTermAvailableForSaleSecuritiesCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="C_85e3a5e5-8ff2-4682-901b-9d79336e863a"
      decimals="-3"
      id="F_f69f8d95-9036-43d7-837e-7f9afcacee7c"
      unitRef="U_USD">7920000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="C_21f769c6-c78d-41d0-b871-ec3d93d7d343"
      decimals="-3"
      id="F_6d4a68aa-2a44-40eb-9987-bd68d6786bcb"
      unitRef="U_USD">11237000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="C_85e3a5e5-8ff2-4682-901b-9d79336e863a"
      decimals="-3"
      id="F_86c5d835-da8a-4a4c-bf1c-bd55893a15f3"
      unitRef="U_USD">196080000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="C_21f769c6-c78d-41d0-b871-ec3d93d7d343"
      decimals="-3"
      id="F_4a7e329c-f42c-4aa7-b33f-d6045f68fb5d"
      unitRef="U_USD">161982000</us-gaap:AssetsCurrent>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="C_85e3a5e5-8ff2-4682-901b-9d79336e863a"
      decimals="-3"
      id="F_288da890-65c9-40ff-a0c8-a41ca5acf189"
      unitRef="U_USD">363000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="C_85e3a5e5-8ff2-4682-901b-9d79336e863a"
      decimals="-3"
      id="F_5eb3079f-0370-4f41-9e1c-cde33ba153f9"
      unitRef="U_USD">92000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="C_21f769c6-c78d-41d0-b871-ec3d93d7d343"
      decimals="-3"
      id="F_a1e94062-b129-40ef-ae53-35c756905836"
      unitRef="U_USD">150000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="C_85e3a5e5-8ff2-4682-901b-9d79336e863a"
      decimals="-3"
      id="F_4a9b850c-fd7b-43a0-95ca-8efea475b172"
      unitRef="U_USD">289000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="C_21f769c6-c78d-41d0-b871-ec3d93d7d343"
      decimals="-3"
      id="F_bbacf923-bf88-4c7b-b66c-413d7dcc54f1"
      unitRef="U_USD">290000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:Assets
      contextRef="C_85e3a5e5-8ff2-4682-901b-9d79336e863a"
      decimals="-3"
      id="F_79942e51-f048-40f8-a39b-326401c5445d"
      unitRef="U_USD">196824000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="C_21f769c6-c78d-41d0-b871-ec3d93d7d343"
      decimals="-3"
      id="F_f75c455e-c200-42f0-8ff3-7b5fc0706f5c"
      unitRef="U_USD">162422000</us-gaap:Assets>
    <us-gaap:AccountsPayableCurrent
      contextRef="C_85e3a5e5-8ff2-4682-901b-9d79336e863a"
      decimals="-3"
      id="F_8b9ede69-de43-447b-8cb3-6aa78457ae5a"
      unitRef="U_USD">12502000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="C_21f769c6-c78d-41d0-b871-ec3d93d7d343"
      decimals="-3"
      id="F_f8d3a521-5202-4f68-8daa-737c7d377362"
      unitRef="U_USD">6843000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="C_85e3a5e5-8ff2-4682-901b-9d79336e863a"
      decimals="-3"
      id="F_a004059c-d38a-47f3-8c4e-9189217f4054"
      unitRef="U_USD">11944000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="C_21f769c6-c78d-41d0-b871-ec3d93d7d343"
      decimals="-3"
      id="F_79240120-9ebd-423e-99e3-c5f257d88d2d"
      unitRef="U_USD">10194000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="C_85e3a5e5-8ff2-4682-901b-9d79336e863a"
      decimals="-3"
      id="F_3e4980ed-d2c8-4484-a49a-65915428503e"
      unitRef="U_USD">168000</us-gaap:OperatingLeaseLiabilityCurrent>
    <etnb:TermLoanCurrent
      contextRef="C_21f769c6-c78d-41d0-b871-ec3d93d7d343"
      decimals="-3"
      id="F_6c2db3f2-00e0-4696-b244-c06065718a9d"
      unitRef="U_USD">2500000</etnb:TermLoanCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="C_85e3a5e5-8ff2-4682-901b-9d79336e863a"
      decimals="-3"
      id="F_72f75644-8667-4184-9dfc-62000094d08b"
      unitRef="U_USD">24614000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="C_21f769c6-c78d-41d0-b871-ec3d93d7d343"
      decimals="-3"
      id="F_7c4aecec-a4e2-482e-bbec-06dc177c4330"
      unitRef="U_USD">19537000</us-gaap:LiabilitiesCurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="C_85e3a5e5-8ff2-4682-901b-9d79336e863a"
      decimals="-3"
      id="F_a85196be-33c5-45cf-917e-bb751c5464e3"
      unitRef="U_USD">186000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="C_85e3a5e5-8ff2-4682-901b-9d79336e863a"
      decimals="-3"
      id="F_1bb92955-cc7b-4334-961a-1ccdf99f1fd5"
      unitRef="U_USD">19691000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="C_21f769c6-c78d-41d0-b871-ec3d93d7d343"
      decimals="-3"
      id="F_b0ef7e9e-f5ec-41d4-8125-a62ea0ccc384"
      unitRef="U_USD">16898000</us-gaap:LongTermDebtNoncurrent>
    <etnb:OtherNonCurrentLiability
      contextRef="C_85e3a5e5-8ff2-4682-901b-9d79336e863a"
      decimals="-3"
      id="F_052289e9-8f39-4f6b-a9f9-87aa77eb6fa3"
      unitRef="U_USD">501000</etnb:OtherNonCurrentLiability>
    <etnb:OtherNonCurrentLiability
      contextRef="C_21f769c6-c78d-41d0-b871-ec3d93d7d343"
      decimals="-3"
      id="F_b7430192-8675-4b4c-ba62-0d7ff6112d89"
      unitRef="U_USD">30000</etnb:OtherNonCurrentLiability>
    <us-gaap:Liabilities
      contextRef="C_85e3a5e5-8ff2-4682-901b-9d79336e863a"
      decimals="-3"
      id="F_6a2ed62a-4e69-4c54-b72b-e8470effccba"
      unitRef="U_USD">44992000</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="C_21f769c6-c78d-41d0-b871-ec3d93d7d343"
      decimals="-3"
      id="F_b0838a8f-cc37-4eb1-9c6e-ca10472b6451"
      unitRef="U_USD">36465000</us-gaap:Liabilities>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="C_85e3a5e5-8ff2-4682-901b-9d79336e863a"
      decimals="INF"
      id="F_7a5f1e40-38fe-456f-9d54-7e60b5999b3e"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="C_21f769c6-c78d-41d0-b871-ec3d93d7d343"
      decimals="INF"
      id="F_d518864f-3206-4ee6-8e69-b7794db41190"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="C_85e3a5e5-8ff2-4682-901b-9d79336e863a"
      decimals="INF"
      id="F_ad405406-36c2-43d9-90f9-8a6c558dffbc"
      unitRef="U_shares">10000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="C_21f769c6-c78d-41d0-b871-ec3d93d7d343"
      decimals="INF"
      id="F_2c2c27e5-541b-4c6d-94ae-9d2260d98313"
      unitRef="U_shares">10000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued
      contextRef="C_85e3a5e5-8ff2-4682-901b-9d79336e863a"
      decimals="INF"
      id="F_28158db3-68d0-4827-b4bc-71e64693c876"
      unitRef="U_shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="C_85e3a5e5-8ff2-4682-901b-9d79336e863a"
      decimals="INF"
      id="F_63a966e1-b08b-4bff-bc4f-2b368e901740"
      unitRef="U_shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesIssued
      contextRef="C_21f769c6-c78d-41d0-b871-ec3d93d7d343"
      decimals="INF"
      id="F_6ddae077-04dd-4419-881f-1eab2ccfb1f8"
      unitRef="U_shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="C_21f769c6-c78d-41d0-b871-ec3d93d7d343"
      decimals="INF"
      id="F_19d4656c-f57b-4cef-9771-37bfd2c819e7"
      unitRef="U_shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="C_85e3a5e5-8ff2-4682-901b-9d79336e863a"
      decimals="INF"
      id="F_c5801225-72cf-4f07-a232-bd1390330ffe"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="C_21f769c6-c78d-41d0-b871-ec3d93d7d343"
      decimals="INF"
      id="F_fc156722-d64a-4402-ba4b-a791d2676fea"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="C_85e3a5e5-8ff2-4682-901b-9d79336e863a"
      decimals="INF"
      id="F_c57b1dc1-2719-48f1-9532-a102295552de"
      unitRef="U_shares">100000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="C_21f769c6-c78d-41d0-b871-ec3d93d7d343"
      decimals="INF"
      id="F_13f92f2a-8192-4483-8a04-c26f92e109d4"
      unitRef="U_shares">100000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="C_85e3a5e5-8ff2-4682-901b-9d79336e863a"
      decimals="INF"
      id="F_d96b6e9c-5039-4b5f-a4ca-1a4df08d9829"
      unitRef="U_shares">50560590</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="C_85e3a5e5-8ff2-4682-901b-9d79336e863a"
      decimals="INF"
      id="F_9701e0f4-1e08-44a0-9310-e2ad59b5013a"
      unitRef="U_shares">50560590</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="C_21f769c6-c78d-41d0-b871-ec3d93d7d343"
      decimals="INF"
      id="F_5ee8f27a-3126-45d0-84dd-21451dab77c6"
      unitRef="U_shares">20317204</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="C_21f769c6-c78d-41d0-b871-ec3d93d7d343"
      decimals="INF"
      id="F_9da7f21c-80c1-41a1-a67e-08e7a86a6d27"
      unitRef="U_shares">20317204</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockValue
      contextRef="C_85e3a5e5-8ff2-4682-901b-9d79336e863a"
      decimals="-3"
      id="F_8ee67c54-99cf-47f6-b098-90603da8f236"
      unitRef="U_USD">51000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="C_21f769c6-c78d-41d0-b871-ec3d93d7d343"
      decimals="-3"
      id="F_848dbb4d-8f8f-4c71-9da4-27048f739bf6"
      unitRef="U_USD">20000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapitalCommonStock
      contextRef="C_85e3a5e5-8ff2-4682-901b-9d79336e863a"
      decimals="-3"
      id="F_8bedc65b-04ee-4a08-a270-e417c0f8abec"
      unitRef="U_USD">467374000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:AdditionalPaidInCapitalCommonStock
      contextRef="C_21f769c6-c78d-41d0-b871-ec3d93d7d343"
      decimals="-3"
      id="F_b3544685-5a73-4deb-8700-ae2892a30e9e"
      unitRef="U_USD">339218000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="C_85e3a5e5-8ff2-4682-901b-9d79336e863a"
      decimals="-3"
      id="F_1cf0a93b-47ed-44a9-852f-91d759169f7f"
      unitRef="U_USD">-350000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="C_21f769c6-c78d-41d0-b871-ec3d93d7d343"
      decimals="-3"
      id="F_1c1eee46-6de0-4c62-936a-b3d29c81ed8d"
      unitRef="U_USD">-64000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="C_85e3a5e5-8ff2-4682-901b-9d79336e863a"
      decimals="-3"
      id="F_2aea3c25-edbc-4f91-abbe-7696801d46ca"
      unitRef="U_USD">-315243000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="C_21f769c6-c78d-41d0-b871-ec3d93d7d343"
      decimals="-3"
      id="F_61c041d7-ca5d-46fa-9e20-f7da04a6cc8b"
      unitRef="U_USD">-213217000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:StockholdersEquity
      contextRef="C_85e3a5e5-8ff2-4682-901b-9d79336e863a"
      decimals="-3"
      id="F_0c435a81-574e-447d-83a8-349233e1f2a0"
      unitRef="U_USD">151832000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_21f769c6-c78d-41d0-b871-ec3d93d7d343"
      decimals="-3"
      id="F_27501c4f-a121-4dff-9e2d-ad78fd3d5987"
      unitRef="U_USD">125957000</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="C_85e3a5e5-8ff2-4682-901b-9d79336e863a"
      decimals="-3"
      id="F_5e12ce00-f63e-4539-8d2b-835012bd116c"
      unitRef="U_USD">196824000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="C_21f769c6-c78d-41d0-b871-ec3d93d7d343"
      decimals="-3"
      id="F_e5d82ea9-3f95-4335-b6af-19261f16531f"
      unitRef="U_USD">162422000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698"
      decimals="-3"
      id="F_ed8c35bb-d4c4-40a0-a275-801199112fab"
      unitRef="U_USD">80796000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="C_7b31e452-ba3b-4180-9ddd-8faae2f90f0c"
      decimals="-3"
      id="F_c8fbc13a-e581-462e-82d5-f5f2e65c1258"
      unitRef="U_USD">70330000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698"
      decimals="-3"
      id="F_788f29a7-5c32-4ba3-a645-4fe6d64389ab"
      unitRef="U_USD">21453000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="C_7b31e452-ba3b-4180-9ddd-8faae2f90f0c"
      decimals="-3"
      id="F_6bdc9158-9244-4cea-8726-dc126afcaec6"
      unitRef="U_USD">19413000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:OperatingExpenses
      contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698"
      decimals="-3"
      id="F_e21d1ba1-0417-4669-b0af-c043bd05ed1f"
      unitRef="U_USD">102249000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="C_7b31e452-ba3b-4180-9ddd-8faae2f90f0c"
      decimals="-3"
      id="F_fb75a2af-2002-40cf-94d0-1c4d4c2160b4"
      unitRef="U_USD">89743000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698"
      decimals="-3"
      id="F_5a5fc69d-7504-49e9-ac2d-cec92f1e0221"
      unitRef="U_USD">-102249000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="C_7b31e452-ba3b-4180-9ddd-8faae2f90f0c"
      decimals="-3"
      id="F_ef645e63-d45e-49ba-b93b-aefa9505ef0b"
      unitRef="U_USD">-89743000</us-gaap:OperatingIncomeLoss>
    <us-gaap:InterestExpense
      contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698"
      decimals="-3"
      id="F_d678c3c3-0b47-4967-9675-867c1d8b1435"
      unitRef="U_USD">1922000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="C_7b31e452-ba3b-4180-9ddd-8faae2f90f0c"
      decimals="-3"
      id="F_78ede651-a71e-4553-94f3-c5b8e9ad8b02"
      unitRef="U_USD">674000</us-gaap:InterestExpense>
    <us-gaap:InterestAndOtherIncome
      contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698"
      decimals="-3"
      id="F_dc725776-f3f5-4608-be58-e17ff943b419"
      unitRef="U_USD">2164000</us-gaap:InterestAndOtherIncome>
    <us-gaap:InterestAndOtherIncome
      contextRef="C_7b31e452-ba3b-4180-9ddd-8faae2f90f0c"
      decimals="-3"
      id="F_ab1285d9-8e3b-4981-abf7-f35ea6a6b98e"
      unitRef="U_USD">148000</us-gaap:InterestAndOtherIncome>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698"
      decimals="-3"
      id="F_87dc0a22-176f-4f8d-bbe9-1addf5484b10"
      unitRef="U_USD">-102007000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="C_7b31e452-ba3b-4180-9ddd-8faae2f90f0c"
      decimals="-3"
      id="F_b7ae000d-b5cb-445a-bbf2-9875cfcd469f"
      unitRef="U_USD">-90269000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698"
      decimals="-3"
      id="F_d3a8da56-e9db-4c79-ab36-bdb8f2cf40ad"
      unitRef="U_USD">19000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="C_7b31e452-ba3b-4180-9ddd-8faae2f90f0c"
      decimals="-3"
      id="F_13d25d6c-3fbc-466b-adce-3efb58a15f43"
      unitRef="U_USD">-147000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:NetIncomeLoss
      contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698"
      decimals="-3"
      id="F_cc31fb6b-25ae-49f9-a9c8-89acac410532"
      unitRef="U_USD">-102026000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_7b31e452-ba3b-4180-9ddd-8faae2f90f0c"
      decimals="-3"
      id="F_2ea8e52a-f093-4e1b-90d7-5dd522c5b927"
      unitRef="U_USD">-90122000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698"
      decimals="-3"
      id="F_18fbd5f3-ca89-44d1-a0f9-a94fe6cd865b"
      unitRef="U_USD">-299000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="C_7b31e452-ba3b-4180-9ddd-8faae2f90f0c"
      decimals="-3"
      id="F_f3ec3fdc-ca53-4ab4-9bac-351176f48dc3"
      unitRef="U_USD">-71000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698"
      decimals="-3"
      id="F_57366eda-7bb3-4bb2-883f-3c4b963101c9"
      unitRef="U_USD">13000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="C_7b31e452-ba3b-4180-9ddd-8faae2f90f0c"
      decimals="-3"
      id="F_8b174395-01a4-480a-b5b8-14558f6c2f48"
      unitRef="U_USD">17000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698"
      decimals="-3"
      id="F_8063cde2-dcfb-41a0-83f7-3741834aefb5"
      unitRef="U_USD">-286000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="C_7b31e452-ba3b-4180-9ddd-8faae2f90f0c"
      decimals="-3"
      id="F_75173259-8a0e-4d21-8712-2a0c599e789a"
      unitRef="U_USD">-54000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698"
      decimals="-3"
      id="F_f139cd9a-26ff-4cfd-8c1a-2484cf534006"
      unitRef="U_USD">-102312000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="C_7b31e452-ba3b-4180-9ddd-8faae2f90f0c"
      decimals="-3"
      id="F_0895263f-045c-45dc-8bdb-a47e33af0b54"
      unitRef="U_USD">-90176000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:EarningsPerShareBasic
      contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698"
      decimals="2"
      id="F_282515fb-14de-479a-896b-664d23c0d0ba"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">-2.93</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698"
      decimals="2"
      id="F_410b9e1e-75b6-412c-9c77-48fc63875fe9"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">-2.93</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="C_7b31e452-ba3b-4180-9ddd-8faae2f90f0c"
      decimals="2"
      id="F_267fba5f-1036-4dc9-959d-4a42d9e7c85b"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">-4.48</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="C_7b31e452-ba3b-4180-9ddd-8faae2f90f0c"
      decimals="2"
      id="F_73c0d5ea-717c-444e-90aa-59472c975358"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">-4.48</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698"
      decimals="0"
      id="F_558dd7a8-baf8-4f21-88d5-9f45f9487dc2"
      unitRef="U_shares">34806349</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698"
      decimals="0"
      id="F_e7dec432-cc3f-4be3-a420-aa893b04212a"
      unitRef="U_shares">34806349</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="C_7b31e452-ba3b-4180-9ddd-8faae2f90f0c"
      decimals="0"
      id="F_1be38f71-68bb-40ac-accc-d32c6c8438da"
      unitRef="U_shares">20098340</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="C_7b31e452-ba3b-4180-9ddd-8faae2f90f0c"
      decimals="0"
      id="F_1dcbb390-fcd8-4cd6-bee9-6b24e1b2f167"
      unitRef="U_shares">20098340</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:SharesOutstanding
      contextRef="C_3b1b99d2-654c-455a-a33a-422592ad8d08"
      decimals="INF"
      id="F_54dcbe78-4cf1-4985-b596-7fbe6410f485"
      unitRef="U_shares">19931660</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="C_3b1b99d2-654c-455a-a33a-422592ad8d08"
      decimals="-3"
      id="F_61c461f4-e022-4fd4-a2e7-56de8ce5e4a9"
      unitRef="U_USD">20000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_9cece5f1-3203-491d-9c15-ee835dbf4586"
      decimals="-3"
      id="F_bb903fd2-57f0-446c-b74b-71dd1858f8f3"
      unitRef="U_USD">326046000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_48d6b2ed-10f4-4276-9857-7ff818488c18"
      decimals="-3"
      id="F_2f8d282a-ca70-4c63-8919-76b5aac8bb72"
      unitRef="U_USD">-10000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_7c501227-02e2-4e44-b377-8e6109e76507"
      decimals="-3"
      id="F_9ac75bcc-3327-4836-b6fe-818f646ddb29"
      unitRef="U_USD">-123095000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_19418b37-9af5-4eb2-b38a-a9070fc599d5"
      decimals="-3"
      id="F_04b757ad-8c08-459f-8938-9c147ea3e957"
      unitRef="U_USD">202961000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="C_3b188b92-032b-457e-ad3c-a951f340f11a"
      decimals="INF"
      id="F_5a5a04f2-69ae-455f-b7d0-da9b544c8a3f"
      unitRef="U_shares">186546</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="C_531e15c8-1e50-4083-9eba-30220f5c7c10"
      decimals="-3"
      id="F_b1cbaabb-786a-4520-8b01-339a1857cfb8"
      unitRef="U_USD">3289000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="C_af7928d4-1306-45db-9bad-07933e9c282a"
      decimals="-3"
      id="F_6b35287a-2053-4afe-807e-20cb3c952aed"
      unitRef="U_USD">3289000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="C_a8dbb74d-cae4-4460-96f9-3662ead67daa"
      decimals="INF"
      id="F_9c8a8348-5f28-4fc0-9008-758edca95fc2"
      unitRef="U_shares">188286</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="C_73cdaea6-5d5f-4d31-9b38-a90fc6b9008e"
      decimals="-3"
      id="F_1e68b03f-12aa-4cf8-9084-fb30bfa8fe4d"
      unitRef="U_USD">487000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="C_7b31e452-ba3b-4180-9ddd-8faae2f90f0c"
      decimals="-3"
      id="F_ab77b6c1-bd9d-47ca-8e4e-b47f79406378"
      unitRef="U_USD">487000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
      contextRef="C_a8dbb74d-cae4-4460-96f9-3662ead67daa"
      decimals="INF"
      id="F_2d2ba69e-ad75-411a-85fd-0f4b56995277"
      unitRef="U_shares">10712</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="C_73cdaea6-5d5f-4d31-9b38-a90fc6b9008e"
      decimals="-3"
      id="F_a4c7e668-eb52-48f5-8f10-0dde28932ceb"
      unitRef="U_USD">144000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="C_7b31e452-ba3b-4180-9ddd-8faae2f90f0c"
      decimals="-3"
      id="F_e235235d-b29f-43e2-a356-e5492fb43599"
      unitRef="U_USD">144000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <etnb:IssuanceOfCommonStockWarrantInConnectionWithTermLoanFacility
      contextRef="C_73cdaea6-5d5f-4d31-9b38-a90fc6b9008e"
      decimals="-3"
      id="F_d599e941-4898-42ef-8784-a1b8badb30bc"
      unitRef="U_USD">574000</etnb:IssuanceOfCommonStockWarrantInConnectionWithTermLoanFacility>
    <etnb:IssuanceOfCommonStockWarrantInConnectionWithTermLoanFacility
      contextRef="C_7b31e452-ba3b-4180-9ddd-8faae2f90f0c"
      decimals="-3"
      id="F_aa15bbd3-c4b5-4d88-8328-19303cc0b843"
      unitRef="U_USD">574000</etnb:IssuanceOfCommonStockWarrantInConnectionWithTermLoanFacility>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_73cdaea6-5d5f-4d31-9b38-a90fc6b9008e"
      decimals="-3"
      id="F_4d83e3ab-2e36-4064-b2cc-0a4c802949c2"
      unitRef="U_USD">8678000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_7b31e452-ba3b-4180-9ddd-8faae2f90f0c"
      decimals="-3"
      id="F_73f43674-32fc-4351-80f8-e6c64ee086ea"
      unitRef="U_USD">8678000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:NetIncomeLoss
      contextRef="C_6abe1517-994e-40d2-af02-3d1364d02449"
      decimals="-3"
      id="F_5bfe8f43-b833-48f1-8efb-9b8c04e46c45"
      unitRef="U_USD">-90122000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_7b31e452-ba3b-4180-9ddd-8faae2f90f0c"
      decimals="-3"
      id="F_ab7fd1de-2871-42a5-9609-2b58580a4d85"
      unitRef="U_USD">-90122000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="C_28004ded-ab04-4f21-ace5-a081ac2e28b8"
      decimals="-3"
      id="F_e628551b-9e63-4b74-b6e1-e809410e19ca"
      unitRef="U_USD">-54000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="C_7b31e452-ba3b-4180-9ddd-8faae2f90f0c"
      decimals="-3"
      id="F_c3e01b5b-09f2-49ab-b471-d33201de4a64"
      unitRef="U_USD">-54000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:SharesOutstanding
      contextRef="C_acf3ac7f-4345-415e-b39a-8425a9a0a3db"
      decimals="INF"
      id="F_c99fb41f-f125-4538-96c1-4350291d7b63"
      unitRef="U_shares">20317204</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="C_acf3ac7f-4345-415e-b39a-8425a9a0a3db"
      decimals="-3"
      id="F_0cf4f931-09a7-4d8f-922d-a0e6a77118c2"
      unitRef="U_USD">20000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_06c8eb12-56da-4f0a-a557-1a9ee843de7a"
      decimals="-3"
      id="F_124369e1-62f5-4e74-9ca4-0d5ad5945495"
      unitRef="U_USD">339218000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_86dde930-3c82-4da9-903f-d12ea942a22e"
      decimals="-3"
      id="F_1c5113f8-646f-4c13-a2fe-a262f0bcf6cf"
      unitRef="U_USD">-64000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_6cd8e184-e243-4a3c-818f-9a1ebfd43667"
      decimals="-3"
      id="F_4b017835-b552-4f49-82fd-8042adb63c66"
      unitRef="U_USD">-213217000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_21f769c6-c78d-41d0-b871-ec3d93d7d343"
      decimals="-3"
      id="F_70ef5614-f5dd-4c25-a201-43ddb4c5302c"
      unitRef="U_USD">125957000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="C_538d2ebd-ca46-4eb6-a0b9-787839675985"
      decimals="INF"
      id="F_cdec43f9-832d-4cba-90f6-e72ba0e4cdee"
      unitRef="U_shares">18675466</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="C_538d2ebd-ca46-4eb6-a0b9-787839675985"
      decimals="-3"
      id="F_5a4aabd5-91b0-4072-a117-0b96a33736db"
      unitRef="U_USD">20000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="C_0ec77485-e315-49c3-9a79-2d048ec76494"
      decimals="-3"
      id="F_c6617507-2c85-4ae7-b0e1-864605ff1dc8"
      unitRef="U_USD">88219000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="C_ccc34858-a5d1-4e90-8bb9-0ff6d83c6b06"
      decimals="-3"
      id="F_e070bea3-2dfa-4155-a84b-2628f699b08b"
      unitRef="U_USD">88239000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="C_8aa0101e-eb8f-4a89-baf5-0cb6983f48c3"
      decimals="INF"
      id="F_c94ef3a2-fe02-48e0-a6d3-c867ee209534"
      unitRef="U_shares">3948611</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="C_8aa0101e-eb8f-4a89-baf5-0cb6983f48c3"
      decimals="-3"
      id="F_4104b808-db65-45dd-ac6d-edde50aca731"
      unitRef="U_USD">4000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="C_94f92680-1f20-47c3-8d22-07184c19f444"
      decimals="-3"
      id="F_51a93ae8-37d3-4b2f-a9bf-933d031653d2"
      unitRef="U_USD">28449000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="C_3b993bd4-a1f0-42fb-959d-d02b87902727"
      decimals="-3"
      id="F_29954017-8b21-44c6-a794-8312856c347e"
      unitRef="U_USD">28453000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <etnb:StockIssuedDuringPeriodSharesWarrantsExercised
      contextRef="C_0f35f69d-3f7b-4b23-8802-ee13a747affc"
      decimals="INF"
      id="F_1f3ce629-c12c-4ef4-b156-8e84f628696b"
      unitRef="U_shares">4202499</etnb:StockIssuedDuringPeriodSharesWarrantsExercised>
    <etnb:StockIssuedDuringPeriodValueWarrantsExercised
      contextRef="C_0f35f69d-3f7b-4b23-8802-ee13a747affc"
      decimals="-3"
      id="F_afe9a43a-e875-4606-80d4-ea00b6c15e54"
      unitRef="U_USD">4000</etnb:StockIssuedDuringPeriodValueWarrantsExercised>
    <etnb:StockIssuedDuringPeriodValueWarrantsExercised
      contextRef="C_a7b7da7e-fb0a-4f4b-a318-753b03bdad64"
      decimals="-3"
      id="F_dfddbe8e-1ec9-4939-9640-4f22d713cceb"
      unitRef="U_USD">1078000</etnb:StockIssuedDuringPeriodValueWarrantsExercised>
    <etnb:StockIssuedDuringPeriodValueWarrantsExercised
      contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698"
      decimals="-3"
      id="F_a99d4451-38d4-42a5-83d6-18fe228be074"
      unitRef="U_USD">1082000</etnb:StockIssuedDuringPeriodValueWarrantsExercised>
    <etnb:StockIssuedDuringPeriodSharesCashlessExerciseOfWarrants
      contextRef="C_0f35f69d-3f7b-4b23-8802-ee13a747affc"
      decimals="INF"
      id="F_1d8e6738-7c05-4a00-8059-28303d1f4ca7"
      unitRef="U_shares">3143682</etnb:StockIssuedDuringPeriodSharesCashlessExerciseOfWarrants>
    <etnb:StockIssuedDuringPeriodValueCashlessExerciseOfWarrants
      contextRef="C_0f35f69d-3f7b-4b23-8802-ee13a747affc"
      decimals="-3"
      id="F_43f65416-164d-4862-b9b2-33c9f297b1a6"
      unitRef="U_USD">3000</etnb:StockIssuedDuringPeriodValueCashlessExerciseOfWarrants>
    <etnb:StockIssuedDuringPeriodValueCashlessExerciseOfWarrants
      contextRef="C_a7b7da7e-fb0a-4f4b-a318-753b03bdad64"
      decimals="-3"
      id="F_29188b4f-205d-47f0-ad2f-cbfaa86ac78f"
      unitRef="U_USD">-3000</etnb:StockIssuedDuringPeriodValueCashlessExerciseOfWarrants>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="C_0f35f69d-3f7b-4b23-8802-ee13a747affc"
      decimals="INF"
      id="F_f2937f30-2c86-4c32-a30b-c4cf1743324a"
      unitRef="U_shares">151061</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="C_a7b7da7e-fb0a-4f4b-a318-753b03bdad64"
      decimals="-3"
      id="F_261b6c8e-a514-493b-a065-10cc53ad60cb"
      unitRef="U_USD">305000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698"
      decimals="-3"
      id="F_c08e0580-fb5f-448f-bb97-3fb580e2a2a0"
      unitRef="U_USD">305000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
      contextRef="C_0f35f69d-3f7b-4b23-8802-ee13a747affc"
      decimals="INF"
      id="F_08d04161-af58-479a-8ac2-44cfc0658551"
      unitRef="U_shares">18364</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="C_a7b7da7e-fb0a-4f4b-a318-753b03bdad64"
      decimals="-3"
      id="F_c55b30be-9ff5-4384-b4d0-a7459bb6005e"
      unitRef="U_USD">50000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698"
      decimals="-3"
      id="F_a1e87752-b4c7-4ac3-bd37-2ac24180a6f2"
      unitRef="U_USD">50000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <etnb:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfWithholdingTaxes
      contextRef="C_0f35f69d-3f7b-4b23-8802-ee13a747affc"
      decimals="INF"
      id="F_aa2026d3-f084-401e-8628-3768d6c00e53"
      unitRef="U_shares">103703</etnb:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfWithholdingTaxes>
    <etnb:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfWithholdingTaxes
      contextRef="C_a7b7da7e-fb0a-4f4b-a318-753b03bdad64"
      decimals="-3"
      id="F_1dcbc011-6d1c-4ce0-b0d7-4257f1c8f613"
      unitRef="U_USD">-298000</etnb:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfWithholdingTaxes>
    <etnb:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfWithholdingTaxes
      contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698"
      decimals="-3"
      id="F_bb7bac03-98ad-4893-89c1-ab398f8650de"
      unitRef="U_USD">-298000</etnb:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfWithholdingTaxes>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_a7b7da7e-fb0a-4f4b-a318-753b03bdad64"
      decimals="-3"
      id="F_0d7748ce-126b-4a4d-9947-e7ea0a105290"
      unitRef="U_USD">10356000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698"
      decimals="-3"
      id="F_e82676c9-d435-4e43-9c18-d0f7872dd8b6"
      unitRef="U_USD">10356000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:NetIncomeLoss
      contextRef="C_0db42b13-ed32-4464-a128-9b3738d1e9ec"
      decimals="-3"
      id="F_328c0dba-f9f5-47b9-8ce2-95077e10b209"
      unitRef="U_USD">-102026000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698"
      decimals="-3"
      id="F_d8dad5ec-9e75-47cb-a519-cc1c4de5fe3f"
      unitRef="U_USD">-102026000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="C_ebcdeb7b-03e6-4e92-b422-7eb9e015b4a8"
      decimals="-3"
      id="F_02fcdc95-0041-4b9e-909d-dfa458dd6745"
      unitRef="U_USD">-286000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698"
      decimals="-3"
      id="F_b8597f43-ad9c-41ae-8f18-ad677c1f68fb"
      unitRef="U_USD">-286000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:SharesOutstanding
      contextRef="C_7333b298-4d64-4dc2-818f-293d2d952a7c"
      decimals="INF"
      id="F_5e438d05-eda3-49c2-b6f1-e8d7ae1aad8c"
      unitRef="U_shares">50560590</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="C_7333b298-4d64-4dc2-818f-293d2d952a7c"
      decimals="-3"
      id="F_a54e2709-3832-46e1-822f-e997af07b5cd"
      unitRef="U_USD">51000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_59a670e1-2243-40d1-b43e-339c260c91b8"
      decimals="-3"
      id="F_3d250aaf-7e96-488d-8543-b8594e394d04"
      unitRef="U_USD">467374000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_9e2050fc-7421-4f2f-bf7c-de15ccbc149f"
      decimals="-3"
      id="F_bd95d6c8-10a5-4906-ad28-a8efd3e60171"
      unitRef="U_USD">-350000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_a21cd459-9352-4988-ba87-d4355aa42746"
      decimals="-3"
      id="F_5d207642-49a6-458a-8ace-a2e15d9d1ec4"
      unitRef="U_USD">-315243000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_85e3a5e5-8ff2-4682-901b-9d79336e863a"
      decimals="-3"
      id="F_fa20a70c-9fc1-4dcf-a8be-3f5dac1f08a8"
      unitRef="U_USD">151832000</us-gaap:StockholdersEquity>
    <us-gaap:ProfitLoss
      contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698"
      decimals="-3"
      id="F_b9d73e7b-b2fa-4787-a410-665bb780731f"
      unitRef="U_USD">-102026000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="C_7b31e452-ba3b-4180-9ddd-8faae2f90f0c"
      decimals="-3"
      id="F_e92f6321-4d9d-4ee5-a022-663fc040369a"
      unitRef="U_USD">-90122000</us-gaap:ProfitLoss>
    <us-gaap:ShareBasedCompensation
      contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698"
      decimals="-3"
      id="F_601a561c-b305-493e-9be7-448ae0a529aa"
      unitRef="U_USD">10356000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="C_7b31e452-ba3b-4180-9ddd-8faae2f90f0c"
      decimals="-3"
      id="F_2e34ff36-9ce8-472e-84a6-b38404f833c5"
      unitRef="U_USD">8678000</us-gaap:ShareBasedCompensation>
    <us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments
      contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698"
      decimals="-3"
      id="F_3c2c2e8c-0d2e-490a-b686-747ae0ef62d3"
      unitRef="U_USD">980000</us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments>
    <us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments
      contextRef="C_7b31e452-ba3b-4180-9ddd-8faae2f90f0c"
      decimals="-3"
      id="F_95ecddef-b330-47fe-917e-04d56d440090"
      unitRef="U_USD">-865000</us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments>
    <etnb:AmortizationOfDebtIssuanceCostsAndAccretionOfFinalPaymentFee
      contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698"
      decimals="-3"
      id="F_d1397cd3-6c24-4ea6-9093-c3a1f2b669fb"
      unitRef="U_USD">-764000</etnb:AmortizationOfDebtIssuanceCostsAndAccretionOfFinalPaymentFee>
    <etnb:AmortizationOfDebtIssuanceCostsAndAccretionOfFinalPaymentFee
      contextRef="C_7b31e452-ba3b-4180-9ddd-8faae2f90f0c"
      decimals="-3"
      id="F_bfef1398-971f-4e8d-9939-34a239263f0d"
      unitRef="U_USD">-617000</etnb:AmortizationOfDebtIssuanceCostsAndAccretionOfFinalPaymentFee>
    <us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense
      contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698"
      decimals="-3"
      id="F_2169eeec-3d61-49c3-ae0d-6767469d958f"
      unitRef="U_USD">175000</us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense>
    <us-gaap:Depreciation
      contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698"
      decimals="-3"
      id="F_f8aaf113-2c94-4feb-9438-d7e8c82789b5"
      unitRef="U_USD">65000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="C_7b31e452-ba3b-4180-9ddd-8faae2f90f0c"
      decimals="-3"
      id="F_644eb05c-ff23-456d-a196-260d96371956"
      unitRef="U_USD">79000</us-gaap:Depreciation>
    <etnb:DeferredTaxAssets
      contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698"
      decimals="-3"
      id="F_0b849682-36ee-4c39-aaba-6db7c6d1e58a"
      unitRef="U_USD">0</etnb:DeferredTaxAssets>
    <etnb:DeferredTaxAssets
      contextRef="C_7b31e452-ba3b-4180-9ddd-8faae2f90f0c"
      decimals="-3"
      id="F_63f38bc0-fd47-41c3-9eec-ec30ee9970e9"
      unitRef="U_USD">150000</etnb:DeferredTaxAssets>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698"
      decimals="-3"
      id="F_7324e5d7-be24-46f6-8505-1c2ed69bd654"
      unitRef="U_USD">-3331000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="C_7b31e452-ba3b-4180-9ddd-8faae2f90f0c"
      decimals="-3"
      id="F_21533ecb-f307-4a7e-943d-1e4e3a565f74"
      unitRef="U_USD">5672000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698"
      decimals="-3"
      id="F_a5032463-0893-448e-af45-8dc2d1df9f2c"
      unitRef="U_USD">5659000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="C_7b31e452-ba3b-4180-9ddd-8faae2f90f0c"
      decimals="-3"
      id="F_38b9d654-070b-406d-b75b-ec034a6d698f"
      unitRef="U_USD">4778000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities
      contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698"
      decimals="-3"
      id="F_e6ad07ad-d0b9-41ba-bc7f-785a8dd9e62f"
      unitRef="U_USD">1750000</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities
      contextRef="C_7b31e452-ba3b-4180-9ddd-8faae2f90f0c"
      decimals="-3"
      id="F_b30d1420-b409-44a2-a12e-0a0af3107cff"
      unitRef="U_USD">4146000</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInOperatingLeaseLiability
      contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698"
      decimals="-3"
      id="F_5ccab3af-3c98-4820-b10f-672d5f38a62c"
      unitRef="U_USD">-184000</us-gaap:IncreaseDecreaseInOperatingLeaseLiability>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698"
      decimals="-3"
      id="F_cceb805a-5971-4d68-adfc-15dd5a50de0b"
      unitRef="U_USD">-81090000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="C_7b31e452-ba3b-4180-9ddd-8faae2f90f0c"
      decimals="-3"
      id="F_e549fe33-ed2e-48cd-bc5e-66f60ee10967"
      unitRef="U_USD">-76781000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
      contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698"
      decimals="-3"
      id="F_fcf28eb2-5288-4c1a-873c-f8cf4bfe41b5"
      unitRef="U_USD">118760000</us-gaap:ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities>
    <us-gaap:ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
      contextRef="C_7b31e452-ba3b-4180-9ddd-8faae2f90f0c"
      decimals="-3"
      id="F_4505642b-ee1c-4813-94cf-8509aafae377"
      unitRef="U_USD">148422000</us-gaap:ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities>
    <etnb:PaymentForPurchaseOfAvailableForSaleSecurities
      contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698"
      decimals="-3"
      id="F_0ccb4f04-11c9-4f5c-b6f4-eebd00c101dc"
      unitRef="U_USD">152696000</etnb:PaymentForPurchaseOfAvailableForSaleSecurities>
    <etnb:PaymentForPurchaseOfAvailableForSaleSecurities
      contextRef="C_7b31e452-ba3b-4180-9ddd-8faae2f90f0c"
      decimals="-3"
      id="F_9a9a9d41-b7d0-490b-ab69-353bb6d7e4c5"
      unitRef="U_USD">141200000</etnb:PaymentForPurchaseOfAvailableForSaleSecurities>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698"
      decimals="-3"
      id="F_6161098f-a99b-4e69-9b69-023608721e81"
      unitRef="U_USD">7000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="C_7b31e452-ba3b-4180-9ddd-8faae2f90f0c"
      decimals="-3"
      id="F_68c46389-600c-4d17-ba48-7edb370ecafc"
      unitRef="U_USD">63000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698"
      decimals="-3"
      id="F_7cdd8705-27da-491f-be3f-e3ca63534020"
      unitRef="U_USD">-33943000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="C_7b31e452-ba3b-4180-9ddd-8faae2f90f0c"
      decimals="-3"
      id="F_e074c0e6-906e-4fa0-bf17-bf7304098bbc"
      unitRef="U_USD">7159000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <etnb:ProceedsFromIssuancePublicOffering
      contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698"
      decimals="-3"
      id="F_00f7ad02-0569-4386-9de7-f364867e41d7"
      unitRef="U_USD">88239000</etnb:ProceedsFromIssuancePublicOffering>
    <etnb:ProceedsFromIssuancePublicOfferingAtTheMarketOffering
      contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698"
      decimals="-3"
      id="F_1445e165-fa9d-401b-8d1c-590798dc078a"
      unitRef="U_USD">28453000</etnb:ProceedsFromIssuancePublicOfferingAtTheMarketOffering>
    <etnb:ProceedsFromIssuancePublicOfferingAtTheMarketOffering
      contextRef="C_7b31e452-ba3b-4180-9ddd-8faae2f90f0c"
      decimals="-3"
      id="F_e30b4269-7740-49ee-978d-736b70c310c2"
      unitRef="U_USD">3289000</etnb:ProceedsFromIssuancePublicOfferingAtTheMarketOffering>
    <us-gaap:ProceedsFromWarrantExercises
      contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698"
      decimals="-3"
      id="F_fe37486a-4723-4790-8a26-34ddc379e9e1"
      unitRef="U_USD">1082000</us-gaap:ProceedsFromWarrantExercises>
    <us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
      contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698"
      decimals="-3"
      id="F_e65437cb-b460-489d-a32d-323860acb9fc"
      unitRef="U_USD">305000</us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions>
    <us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
      contextRef="C_7b31e452-ba3b-4180-9ddd-8faae2f90f0c"
      decimals="-3"
      id="F_9e1f75a6-7963-475f-91af-e3bf55a2da24"
      unitRef="U_USD">487000</us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698"
      decimals="-3"
      id="F_5a29fbf7-e8d3-4292-b61e-6e7cb7c29c65"
      unitRef="U_USD">50000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="C_7b31e452-ba3b-4180-9ddd-8faae2f90f0c"
      decimals="-3"
      id="F_a4cc769e-de67-4ebe-b2cb-3aeac2091a76"
      unitRef="U_USD">144000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698"
      decimals="-3"
      id="F_24348080-11f9-404c-a2c2-3156a7b4521a"
      unitRef="U_USD">298000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:ProceedsFromIssuanceOfOtherLongTermDebt
      contextRef="C_7b31e452-ba3b-4180-9ddd-8faae2f90f0c"
      decimals="-3"
      id="F_22377c54-f596-4ed5-8d82-626e27452603"
      unitRef="U_USD">19951000</us-gaap:ProceedsFromIssuanceOfOtherLongTermDebt>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698"
      decimals="-3"
      id="F_5e98a7ea-21cd-4d4c-9550-be033a2be27d"
      unitRef="U_USD">117831000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="C_7b31e452-ba3b-4180-9ddd-8faae2f90f0c"
      decimals="-3"
      id="F_c60938ca-4e30-49cf-937a-f9c1e76c1647"
      unitRef="U_USD">23871000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698"
      decimals="-3"
      id="F_d27e2957-bd95-415d-9e45-32401674ff4b"
      unitRef="U_USD">2798000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="C_7b31e452-ba3b-4180-9ddd-8faae2f90f0c"
      decimals="-3"
      id="F_23f41b95-9a5a-4e2c-9fd2-fc6193b03ef0"
      unitRef="U_USD">-45751000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="C_21f769c6-c78d-41d0-b871-ec3d93d7d343"
      decimals="-3"
      id="F_90a79a02-0fcb-464f-ab47-221c16e9b51b"
      unitRef="U_USD">52457000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="C_19418b37-9af5-4eb2-b38a-a9070fc599d5"
      decimals="-3"
      id="F_b77e291b-3196-46f8-b827-621eac17fc8f"
      unitRef="U_USD">98208000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="C_85e3a5e5-8ff2-4682-901b-9d79336e863a"
      decimals="-3"
      id="F_bac4bacc-6dd2-479e-be69-220f1f65bf16"
      unitRef="U_USD">55255000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="C_21f769c6-c78d-41d0-b871-ec3d93d7d343"
      decimals="-3"
      id="F_bab84bd9-1c7d-44b4-a68f-8203887367d6"
      unitRef="U_USD">52457000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="C_85e3a5e5-8ff2-4682-901b-9d79336e863a"
      decimals="-3"
      id="F_5e227785-e31c-468b-a202-be3277ceb08e"
      unitRef="U_USD">55255000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="C_21f769c6-c78d-41d0-b871-ec3d93d7d343"
      decimals="-3"
      id="F_d27b65d9-e159-4e24-bcab-c5104eb5b29e"
      unitRef="U_USD">52432000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:RestrictedCashCurrent
      contextRef="C_85e3a5e5-8ff2-4682-901b-9d79336e863a"
      decimals="-3"
      id="F_a089d72c-b93f-4353-a82a-f638f5babb30"
      unitRef="U_USD">0</us-gaap:RestrictedCashCurrent>
    <us-gaap:RestrictedCashCurrent
      contextRef="C_21f769c6-c78d-41d0-b871-ec3d93d7d343"
      decimals="-3"
      id="F_ed0d2fd2-b2af-4bef-96d8-50ebefe7462d"
      unitRef="U_USD">25000</us-gaap:RestrictedCashCurrent>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="C_85e3a5e5-8ff2-4682-901b-9d79336e863a"
      decimals="-3"
      id="F_ed3b1662-2b2f-45d4-9ba5-42b880b8bc9e"
      unitRef="U_USD">55255000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="C_21f769c6-c78d-41d0-b871-ec3d93d7d343"
      decimals="-3"
      id="F_a5e7751c-d45a-431b-a750-b9d7613a11ce"
      unitRef="U_USD">52457000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:InterestPaidNet
      contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698"
      decimals="-3"
      id="F_a7f63b04-3ca7-4cc0-92da-7e467819ca55"
      unitRef="U_USD">1076000</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet
      contextRef="C_7b31e452-ba3b-4180-9ddd-8faae2f90f0c"
      decimals="-3"
      id="F_e517021d-6a40-46d1-bdb6-a178adbcdfab"
      unitRef="U_USD">16000</us-gaap:InterestPaidNet>
    <us-gaap:OperatingLeasePaymentsUse
      contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698"
      decimals="-3"
      id="F_cd34ecf8-0650-4438-9d97-05ee6f5aa3c0"
      unitRef="U_USD">234000</us-gaap:OperatingLeasePaymentsUse>
    <etnb:RemeasurementOfLeaseLiabilityAndRightOfUseAssetInConnectionWithLeaseModification
      contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698"
      decimals="-3"
      id="F_676e8e50-4a8a-4b0d-8e5d-bb84e815cd84"
      unitRef="U_USD">338000</etnb:RemeasurementOfLeaseLiabilityAndRightOfUseAssetInConnectionWithLeaseModification>
    <etnb:IssuanceOfCommonStockWarrantInConnectionWithTermLoanFacility
      contextRef="C_7b31e452-ba3b-4180-9ddd-8faae2f90f0c"
      decimals="-3"
      id="F_8c30df29-d1af-4741-9f3b-6d8f126e4cb2"
      unitRef="U_USD">574000</etnb:IssuanceOfCommonStockWarrantInConnectionWithTermLoanFacility>
    <us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock
      contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698"
      id="F_2dc48b74-04b2-484d-b496-c04c295d281a">&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1. Organization and Basis of Presentation&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Description of Business&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;89bio, Inc. (&#x201c;89bio&#x201d; or the &#x201c;Company&#x201d;) is a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of liver and cardio-metabolic diseases. The Company&#x2019;s lead product candidate, pegozafermin (previously BIO89-100), a specifically engineered glycoPEGylated analog of fibroblast growth factor 21, is currently being developed for the treatment of nonalcoholic steatohepatitis and for the treatment of severe hypertriglyceridemia.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;89bio, Inc. was formed as a Delaware corporation in &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="-sec-ix-hidden:F_334737a3-eb1d-48a1-9363-2f3248ac80ff;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;June 2019&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; to carry on the business of 89Bio Ltd., which was incorporated in Israel in January 2018.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Liquidity&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The accompanying consolidated financial statements have been prepared assuming the Company will continue as a going concern, which contemplates the realization of assets and liquidation of liabilities in the normal course of business. To date, the Company has not generated revenues from its activities and has incurred substantial operating losses. Management expects the Company to continue to generate substantial operating losses for the foreseeable future until it completes development of its products and seeks regulatory approvals to market such products. The Company had cash and cash equivalents and short-term available-for-sale securities of &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;188.2&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; as of December 31, 2022.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The Company expects that its cash and cash equivalents and short-term available-for-sale securities as of December 31, 2022&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;, together with proceeds received in January and February 2023 from its ATM Facility (see Note 7 and Note 11), and proceeds available from the 2023 Loan Agreement (see Note 6 and Note 11), will be sufficient to fund operating expenses and capital expenditure requirements for a period of at least one year from the date these audited consolidated financial statements are filed with the Securities and Exchange Commission.&lt;/span&gt;&lt;/p&gt;</us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock>
    <us-gaap:CashCashEquivalentsAndShortTermInvestments
      contextRef="C_85e3a5e5-8ff2-4682-901b-9d79336e863a"
      decimals="-5"
      id="F_59cffc5e-66fb-4775-a2cb-e5c6508d23b6"
      unitRef="U_USD">188200000</us-gaap:CashCashEquivalentsAndShortTermInvestments>
    <us-gaap:SignificantAccountingPoliciesTextBlock
      contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698"
      id="F_0113dd9c-7a54-46d4-b2af-f75d5f600aae">&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2. Summary of Significant Accounting Policie&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;s&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Basis of Presentation&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States (&#x201c;U.S. GAAP&#x201d;).&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Reclassification&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Certain prior year amounts in the Company&#x2019;s consolidated statements of operations and comprehensive loss have been reclassified to conform to the current year presentation. Specifically, interest expense is disclosed separately on the Company&#x2019;s consolidated statements of operations and comprehensive loss, which had no impact on reported net loss, comprehensive loss, or loss per share.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Principles of Consolidation&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The accompanying consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries. All intercompany balances and transactions have been eliminated in consolidation.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Use of Estimates&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the consolidated financial statements and the reported amounts of expenses during the reporting period. Significant estimates and assumptions made in the accompanying consolidated financial statements include but are not limited to accrued research and development expenses and to the fair value of stock options. The Company evaluates its estimates and assumptions on an ongoing basis using historical experience and other factors and adjusts those estimates and assumptions when facts and circumstances dictate. Actual results could differ from those estimates.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Foreign Currencies&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Certain transactions during the year ended December 31, 2022 and 2021&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; were denominated in currencies other than the U.S. dollar. Gains and losses from foreign currency transactions were not material for all periods presented and are reflected in the consolidated statements of operations and comprehensive loss as a component of interest income and other, net. The Company&#x2019;s subsidiary in Lithuania uses the Euro as its functional currency for financial reporting. The re-measurement from Euros to U.S. dollars results in translation gain and loss adjustments, which are reflected as a component of comprehensive loss as foreign currency translation adjustments.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Fair Value Measurements&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Financial assets and liabilities are recorded at fair value on a recurring basis in the consolidated balance sheets. The carrying values of Company&#x2019;s financial assets and liabilities, including cash and cash equivalents, restricted cash, prepaid and other current assets, accounts payable, and accrued expenses approximate to their fair value due to the short-term nature of these instruments. The fair value of the Company&#x2019;s term loan approximates its carrying value, or amortized cost, due to the prevailing market rates of interest rates it bears. Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability (an exit price) in an orderly transaction between market participants at the reporting date. Assets and liabilities recorded at fair value are categorized based upon the level of judgment associated with the inputs used to measure their fair value. Hierarchical levels are directly related to the amount of subjectivity with the inputs to the valuation of these assets or liabilities as follows:&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Level 1&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;Observable inputs such as unadjusted, quoted prices in active markets for identical assets or liabilities at the measurement date;&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Level 2&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;Inputs (other than quoted prices included in Level 1) are either directly or indirectly observable inputs for similar assets or liabilities. These include quoted prices for identical or similar assets or liabilities in active markets and quoted prices for identical or similar assets or liabilities in markets that are not active; and&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Level 3&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Concentrations of Credit Risk&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Financial instruments that potentially subject the Company to a concentration of credit risk consist primarily of cash and cash equivalents and short-term available-for-sale securities. Bank deposits are held by accredited financial institutions and these deposits may at times be in excess of insured limits. The Company limits its credit risk associated with cash and cash equivalents by placing them with financial institutions that it believes are of high quality. The Company has not experienced any losses on its deposits of cash or cash equivalents. The Company &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;limits amounts invested in available-for-sale securities by credit rating, maturity, industry group, investment type and issuer, except for securities issued by the U.S. government. The Company is not exposed to any significant concentrations of credit risk from these financial instruments.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Other Risks and Uncertainties&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The Company&#x2019;s future results of operations involve a number of other risks and uncertainties. Factors that could affect the Company&#x2019;s future operating results and cause actual results to vary materially from expectations include, but are not limited to, the Company&#x2019;s early stages of clinical drug development; the Company&#x2019;s ability to advance product candidates into, and successfully complete, clinical trials on the timelines it projects; the Company&#x2019;s ability to adequately demonstrate sufficient safety and efficacy of its product candidates; the Company&#x2019;s ability to enroll patients in its ongoing and future clinical trials; the Company&#x2019;s ability to successfully manufacture and supply its product candidates for clinical trials; the Company&#x2019;s ability to obtain additional capital to finance its operations; uncertainties related to the projections of the size of patient populations suffering from the diseases the Company is targeting; the Company&#x2019;s ability to obtain, maintain, and protect its intellectual property rights; developments relating to the Company&#x2019;s competitors and its industry, including competing product candidates and therapies; general economic and market conditions; and other risks and uncertainties.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The Company&#x2019;s product candidates will require approvals from the U.S. Food and Drug Administration and comparable foreign regulatory agencies prior to commercial sales in their respective jurisdictions. There can be no assurance that any product candidates will receive the necessary approvals. If the Company is denied approval, approval is delayed or the Company is unable to maintain approval for any product candidate, it could have a materially adverse impact on the Company.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The ongoing COVID-19 pandemic has disrupted and may continue to disrupt the Company&#x2019;s business and delay its preclinical and clinical programs and timelines. The extent to which the COVID-19 pandemic may impact the Company&#x2019;s future operating results and financial condition is uncertain.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Segment Reporting&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The Company has &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;one&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; operating segment. The Company&#x2019;s chief operating decision maker, its Chief Executive Officer, manages the Company&#x2019;s operations on a consolidated basis for the purposes of allocating resources and evaluating financial performance.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Cash and Cash Equivalents&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The Company considers all highly liquid investments purchased with original maturities of three months or less from the purchase date to be cash equivalents. Cash equivalents consist primarily of amounts invested in money market funds and commercial paper that are stated at fair value.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:12.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Investments&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Investments have been classified as available-for-sale and are carried at estimated fair value as determined based upon quoted market prices or pricing models for similar securities. Management determines the appropriate classification of its available-for-sale investments in debt securities at the time of purchase. Generally, investments with original maturities beyond three months at the date of purchase are classified as short-term because it is management&#x2019;s intent to use the investments to fund current operations or to make them available for current operations.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Unrealized gains and losses are excluded from net loss and are reported as a component of comprehensive loss. The Company periodically evaluates whether declines in fair values of its available-for-sale securities below their book value are other-than-temporary. This evaluation consists of several qualitative and quantitative factors regarding the severity and duration of the unrealized loss as well as the Company&#x2019;s ability and intent to hold the available-for-sale security until a forecasted recovery occurs. Additionally, the Company assesses whether it has plans to sell the security or it is more likely than not it will be required to sell any available-for-sale securities before recovery of its amortized cost basis. Realized gains and losses and declines in fair value judged to be other than temporary, if any, on available-for-sale securities are included in interest income and other, net. The cost of investments sold is based on the specific-identification method. The Company has &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;no&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;t experienced any material realized gains or losses or other-than-temporary losses in the periods presented.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Leases&lt;/span&gt;&lt;span style="color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The Company is a lessee in noncancellable operating leases for office space. Beginning in 2022, the Company accounts for leases in accordance with Accounting Standards Update (&#x201c;ASU&#x201d;) 2016-02,&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt; Leases&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; (&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Topic 842&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;). The Company determines if an arrangement is a lease or contains an embedded lease at inception. The Company accounts for a contract as a lease when it has the right to control the asset for a period of time while obtaining substantially all of the asset&#x2019;s economic benefits. For arrangements that meet the definition of a lease, the Company determines the initial classification and measurement of its right-of-use (&#x201c;ROU&#x201d;) asset and lease liability at the lease commencement date and thereafter if modified. Operating lease ROU assets represent the Company&#x2019;s right to use an underlying asset for the lease term and lease liabilities represent the Company&#x2019;s obligation to make the contractual lease payments over the lease term. The ROU asset is initially measured at cost, which comprises the initial amount of the lease liability adjusted for lease payments made at or before the lease commencement date, plus any initial direct costs incurred less any lease incentives received. The operating lease liability is initially measured at the present value of the unpaid lease payments at the lease commencement date. The lease liability is subsequently measured at amortized cost using the effective-interest method. The lease term includes any renewal options that the Company is reasonably assured to exercise. The present value of lease payments is determined by using the interest rate implicit in the lease, if that rate is readily determinable, otherwise, the Company uses its estimated collateralized incremental borrowing rate for the lease term. The Company has elected not to record leases with an original term of twelve months or less on its consolidated balance sheets and recognizes those lease payments in operating expenses in the consolidated statements of operations and comprehensive loss. The Company&#x2019;s short-term lease is not material.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;In addition, the Company&#x2019;s leases may require it to pay additional costs, such as utilities, maintenance, and other operating costs, which are generally referred to as non-lease components and vary based on future outcomes. The Company has elected to not separate lease and non-lease components. Only the fixed costs for lease components and their associated non-lease components are accounted for as a single lease component and recognized as part of a ROU &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;asset and lease liability. Any variable expenses are recognized in operating expenses as incurred. Rent expense for an operating lease liability is recognized on a straight-line basis over the lease term and is included in operating expenses in the consolidated statements of operations and comprehensive loss.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Property and Equipment, Net&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Property and equipment are stated at cost, less accumulated depreciation. Depreciation is calculated on a straight-line basis over the estimated useful lives of the related assets, generally ranging from &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="-sec-ix-hidden:F_4640215a-3a60-4f28-a85d-e6242af9c877;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;three&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; to &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;seven years&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;. &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Leasehold improvements are amortized on a straight-line basis over the shorter of the assets&#x2019; estimated useful life or the remaining term of the lease.&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Upon retirement or sale of the assets, the cost and related accumulated depreciation and amortization are removed from the consolidated balance sheets and the resulting gains or losses are recorded in the consolidated statements of operations and comprehensive loss. &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Maintenance and repair costs are expensed as incurred.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Impairment of Long-Lived Assets&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The Company periodically evaluates its long-lived assets, including property and equipment, for impairment whenever events or changes in business circumstances indicate that the carrying amount of the assets or group of assets may not be fully recoverable. If indicators of impairment exist and the undiscounted future cash flows that the assets are expected to generate are less than the carrying value of the assets, then the Company will reduce the carrying amount of the assets through an impairment charge, to their estimated fair values based on a discounted cash flow approach or, when available and appropriate, to comparable market values. There were no such indicators for the periods presented.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Accrued Research and Development Expenses&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The Company estimates preclinical and clinical study and research expenses based on the services performed, pursuant to contracts with research institutions that conduct and manage preclinical and clinical studies and research services on its behalf. The Company records the costs of research and development activities based upon the estimated services provided but not yet invoiced and includes these costs in accrued expenses in the consolidated balance sheets. These costs are a component of the Company&#x2019;s research and development expenses.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The Company accrues for these costs based on factors such as estimates of the work completed in accordance with agreements established with its third-party service providers. The Company makes judgments and estimates in determining the accrued expenses balance. As actual costs become known, the Company adjusts its accrued expenses. The Company has not experienced any material differences between accrued costs and actual costs incurred. However, the status and timing of actual services performed may vary from the Company&#x2019;s estimates, resulting in adjustments to expense in future periods. Changes in these estimates that result in material changes to the Company&#x2019;s accrued expenses could materially affect the Company&#x2019;s results of operations. Contingent milestone payments, if any, are expensed when the milestone results are probable and estimable, which is generally upon achievement of the milestone.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Warrants to Purchase Common Stock&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The Company classifies warrants indexed to its common stock and meeting the requirements for equity classification within stockholders&#x2019; equity. This assessment is conducted at the time of warrant issuance and as of each reporting period that the warrants remain outstanding.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Research and Development Expenses&lt;/span&gt;&lt;span style="color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Research and development expenses consist primarily of costs incurred for the development of the Company&#x2019;s lead product candidate, pegozafermin. Research and development expenses consist primarily of external costs related to preclinical and clinical development and related supplies and personnel costs. Personnel costs consist of salaries, employee benefits and stock-based compensation for individuals involved in research and development efforts. Payments associated with agreements to acquire licenses to develop, use, manufacture and commercialize products and purchases of pegozafermin from contract manufacturing organizations that have not reached technological feasibility and do not have alternate future commercial use are expensed as incurred.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:12.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Stock-Based Compensation&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The Company provides equity awards in the form of stock options and restricted stock units. The Company measures its equity awards made to employees, directors, and&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;non-employee service providers based on estimated fair values and recognizes stock-based compensation over the requisite service period. The Company accounts for forfeitures as they occur.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The Company estimates the fair value of stock option awards on the date of grant using a&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Black-Scholes option pricing model. The Company recognizes compensation for the value of stock options awards, which have graded vesting, using the straight-line method over the requisite service period of each award.&lt;/span&gt;&lt;span style="color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The Black-Scholes option pricing model requires a number of assumptions, of which the most significant are expected volatility, expected option term (the time from the grant date until the options are exercised or expire), risk-free rate, and expected dividend rate. These assumptions include:&lt;/span&gt;&lt;/p&gt;&lt;div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;"&gt;&#x2022;&lt;/span&gt;&lt;div style="display:inline;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Expected volatility&#x2014;Since the Company has limited trading history for its common stock, expected volatility is estimated based on weighting the Company&#x2019;s volatility and the volatility of comparable publicly traded biotechnology companies during the equivalent period of the calculated expected term of the options granted. The comparable companies were chosen based on their similar size, stage in the life cycle, or area of specialty. There is a degree of uncertainty in determining a comparable peer group as each of the peers are engaged in varied research and development activities, the timing and progress of which differ within the peer group. &lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;"&gt;&#x2022;&lt;/span&gt;&lt;div style="display:inline;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Expected term&#x2014;The expected term of options granted to employees and directors is determined using the &#x201c;simplified&#x201d; method. Under this approach, the expected term is presumed to be the midpoint between the weighted-average vesting term and the contractual term of the option. The simplified method makes the assumption that the employee will exercise stock options evenly over the period when the stock options are vested and ending on the date when the stock options would expire. The expected option term for options granted to non-employees is estimated on a grant-by-grant basis.&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;"&gt;&#x2022;&lt;/span&gt;&lt;div style="display:inline;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Risk-free interest rate&#x2014;The risk-free interest rate is based on the U.S. Treasury zero coupon bonds in effect on the grant date for periods with an equivalent expected term as the option.&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;"&gt;&#x2022;&lt;/span&gt;&lt;div style="display:inline;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Expected dividend&#x2014;The Company has never paid dividends and has no foreseeable plans to pay dividends on its shares of common stock. Therefore, an expected dividend of zero is used.&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The fair value of restricted stock units is based on the fair value of the Company&#x2019;s common stock on the date of grant. The grant date fair value of restricted stock units with service vesting conditions is recognized over the requisite service period on a straight-line basis. For restricted stock units with performance vesting conditions, the Company evaluates the probability of achieving the performance condition at each reporting date and recognizes expense for such performance awards over the requisite service period using the accelerated attribution method.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Income Taxes&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Income taxes are accounted for under the asset and liability method. Under this method, deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the consolidated financial statements carrying amounts of existing assets and liabilities and their respective tax bases and operating loss and tax credit carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates applied to taxable income in the years in which those temporary differences are expected to be realized. The effect on deferred tax assets and liabilities of a change in tax rates is recognized as income or loss in the period that includes the enactment date. A valuation allowance is established when necessary to reduce deferred tax assets to the amount expected to be realized. Interest and penalties related to unrecognized tax benefits are included within the provision of income tax.&lt;/span&gt;&lt;span style="color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Basic and Diluted Net Loss per Share&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Basic loss per share is computed by dividing net loss by the weighted-average number of shares of common stock outstanding during the period. Diluted loss per share is computed by dividing net loss by the weighted-average number of shares of common stock outstanding together with the number of additional shares of common stock that would have been outstanding if all potentially dilutive shares of common stock had been issued. Since the Company is in a loss position for the periods presented, basic net loss per share is the same as diluted net loss per share since the effects of potentially dilutive securities are antidilutive. &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Shares of the Company&#x2019;s common stock underlying pre-funded warrants exercisable for nominal consideration are included in the computation of basic and diluted net loss per share, even if antidilutive.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Comprehensive Loss&lt;/span&gt;&lt;span style="color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The Company&#x2019;s comprehensive loss is comprised of net loss and changes in unrealized gains or losses on available-for-sale securities and foreign currency translation adjustments.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Recently Adopted Accounting Standards&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:6.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt; &#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;In February 2016, the Financial Accounting Standards Board (&#x201c;FASB&#x201d;) issued ASU 2016-02,&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt; Leases&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; (&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Topic 842&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;), or Accounting Standards Codification (&#x201c;ASC&#x201d;) 842, which requires lessees to recognize leases on the balance sheet and disclose key information about leasing arrangements. ASC 842 establishes a ROU model that requires a lessee to recognize a ROU asset and lease liability on the balance sheet for all leases with a term longer than 12 months. Leases are classified as finance or operating, with classification affecting the pattern and classification of expense recognition in the income statement.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;On&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; January 1, 2022&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;, the Company adopted &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;ASC 842&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; using the modified retrospective transition method and elected the practical expedients to not reassess whether any expired or existing contracts are or contain leases, carry forward its historical lease classification and not reassess initial direct costs for existing leases. Upon adoption of ASC 842, the Company recorded an operating ROU asset of $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;0.2&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million and an operating lease liability of $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;0.2&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million on its consolidated balance sheet. There was &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;no&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; adjustment to the opening balance of accumulated deficit as a result of adoption. Results for the year ended December 31, 2022 are presented under ASC 842. Prior period amounts preceding January 1, 2022 continue to be reported in accordance with the Company&#x2019;s historical accounting under the previous lease guidance, ASC 840.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Recent Accounting Pronouncements&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;In June 2016, the FASB issued ASU 2016-13, &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Financial Instruments&#x2014;Credit Losses (Topic 326)&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;: &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Measurement of Credit Losses on Financial Instruments &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&#x201c;ASU 2016-13&#x201d;), which replaces the existing incurred loss impairment model with an expected credit loss model and requires a financial asset measured at amortized cost to be presented at the net amount expected to be collected. As an emerging growth company, ASU 2016-13 is effective for the Company for the year ending December 31, 2023 and interim periods within that fiscal year and must be adopted using a modified retrospective approach, with certain exceptions. The Company is evaluating the impact of this standard and &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;does not expect the adoption of ASU 2016-13 to have a material impact on the Company&#x2019;s consolidated financial statements and related disclosures.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;</us-gaap:SignificantAccountingPoliciesTextBlock>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock
      contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698"
      id="F_7a9fe441-fa43-4796-8110-f5fa315cbd14">&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Basis of Presentation&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States (&#x201c;U.S. GAAP&#x201d;).&lt;/span&gt;&lt;/p&gt;</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <us-gaap:PriorPeriodReclassificationAdjustmentDescription
      contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698"
      id="F_56cbf108-fa42-4d24-9ba3-44b16e32b023">&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Reclassification&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Certain prior year amounts in the Company&#x2019;s consolidated statements of operations and comprehensive loss have been reclassified to conform to the current year presentation. Specifically, interest expense is disclosed separately on the Company&#x2019;s consolidated statements of operations and comprehensive loss, which had no impact on reported net loss, comprehensive loss, or loss per share.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;</us-gaap:PriorPeriodReclassificationAdjustmentDescription>
    <us-gaap:ConsolidationPolicyTextBlock
      contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698"
      id="F_4ceadd5c-c2d5-486b-88c9-3d770e940ddc">&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Principles of Consolidation&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The accompanying consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries. All intercompany balances and transactions have been eliminated in consolidation.&lt;/span&gt;&lt;/p&gt;</us-gaap:ConsolidationPolicyTextBlock>
    <us-gaap:UseOfEstimates
      contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698"
      id="F_38ab0099-3b70-4c2b-8d68-e0712d8bdeb4">&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Use of Estimates&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the consolidated financial statements and the reported amounts of expenses during the reporting period. Significant estimates and assumptions made in the accompanying consolidated financial statements include but are not limited to accrued research and development expenses and to the fair value of stock options. The Company evaluates its estimates and assumptions on an ongoing basis using historical experience and other factors and adjusts those estimates and assumptions when facts and circumstances dictate. Actual results could differ from those estimates.&lt;/span&gt;&lt;/p&gt;</us-gaap:UseOfEstimates>
    <us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock
      contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698"
      id="F_60864ff6-6971-4880-b410-5e2265136724">&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Foreign Currencies&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Certain transactions during the year ended December 31, 2022 and 2021&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; were denominated in currencies other than the U.S. dollar. Gains and losses from foreign currency transactions were not material for all periods presented and are reflected in the consolidated statements of operations and comprehensive loss as a component of interest income and other, net. The Company&#x2019;s subsidiary in Lithuania uses the Euro as its functional currency for financial reporting. The re-measurement from Euros to U.S. dollars results in translation gain and loss adjustments, which are reflected as a component of comprehensive loss as foreign currency translation adjustments.&lt;/span&gt;&lt;/p&gt;</us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock>
    <us-gaap:FairValueMeasurementPolicyPolicyTextBlock
      contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698"
      id="F_213170f3-46b7-4cfe-98e5-ef2422abd886">&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Fair Value Measurements&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Financial assets and liabilities are recorded at fair value on a recurring basis in the consolidated balance sheets. The carrying values of Company&#x2019;s financial assets and liabilities, including cash and cash equivalents, restricted cash, prepaid and other current assets, accounts payable, and accrued expenses approximate to their fair value due to the short-term nature of these instruments. The fair value of the Company&#x2019;s term loan approximates its carrying value, or amortized cost, due to the prevailing market rates of interest rates it bears. Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability (an exit price) in an orderly transaction between market participants at the reporting date. Assets and liabilities recorded at fair value are categorized based upon the level of judgment associated with the inputs used to measure their fair value. Hierarchical levels are directly related to the amount of subjectivity with the inputs to the valuation of these assets or liabilities as follows:&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Level 1&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;Observable inputs such as unadjusted, quoted prices in active markets for identical assets or liabilities at the measurement date;&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Level 2&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;Inputs (other than quoted prices included in Level 1) are either directly or indirectly observable inputs for similar assets or liabilities. These include quoted prices for identical or similar assets or liabilities in active markets and quoted prices for identical or similar assets or liabilities in markets that are not active; and&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Level 3&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.&lt;/span&gt;&lt;/p&gt;</us-gaap:FairValueMeasurementPolicyPolicyTextBlock>
    <us-gaap:ConcentrationRiskCreditRisk
      contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698"
      id="F_a4cbcfbe-a3db-4795-b210-164cce33363e">&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Concentrations of Credit Risk&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Financial instruments that potentially subject the Company to a concentration of credit risk consist primarily of cash and cash equivalents and short-term available-for-sale securities. Bank deposits are held by accredited financial institutions and these deposits may at times be in excess of insured limits. The Company limits its credit risk associated with cash and cash equivalents by placing them with financial institutions that it believes are of high quality. The Company has not experienced any losses on its deposits of cash or cash equivalents. The Company &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;limits amounts invested in available-for-sale securities by credit rating, maturity, industry group, investment type and issuer, except for securities issued by the U.S. government. The Company is not exposed to any significant concentrations of credit risk from these financial instruments.&lt;/span&gt;&lt;/p&gt;</us-gaap:ConcentrationRiskCreditRisk>
    <etnb:OtherRisksAndUncertaintiesPolicyTextBlock
      contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698"
      id="F_844a119d-a43a-45aa-a3c9-abb5ea397812">&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Other Risks and Uncertainties&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The Company&#x2019;s future results of operations involve a number of other risks and uncertainties. Factors that could affect the Company&#x2019;s future operating results and cause actual results to vary materially from expectations include, but are not limited to, the Company&#x2019;s early stages of clinical drug development; the Company&#x2019;s ability to advance product candidates into, and successfully complete, clinical trials on the timelines it projects; the Company&#x2019;s ability to adequately demonstrate sufficient safety and efficacy of its product candidates; the Company&#x2019;s ability to enroll patients in its ongoing and future clinical trials; the Company&#x2019;s ability to successfully manufacture and supply its product candidates for clinical trials; the Company&#x2019;s ability to obtain additional capital to finance its operations; uncertainties related to the projections of the size of patient populations suffering from the diseases the Company is targeting; the Company&#x2019;s ability to obtain, maintain, and protect its intellectual property rights; developments relating to the Company&#x2019;s competitors and its industry, including competing product candidates and therapies; general economic and market conditions; and other risks and uncertainties.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The Company&#x2019;s product candidates will require approvals from the U.S. Food and Drug Administration and comparable foreign regulatory agencies prior to commercial sales in their respective jurisdictions. There can be no assurance that any product candidates will receive the necessary approvals. If the Company is denied approval, approval is delayed or the Company is unable to maintain approval for any product candidate, it could have a materially adverse impact on the Company.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The ongoing COVID-19 pandemic has disrupted and may continue to disrupt the Company&#x2019;s business and delay its preclinical and clinical programs and timelines. The extent to which the COVID-19 pandemic may impact the Company&#x2019;s future operating results and financial condition is uncertain.&lt;/span&gt;&lt;/p&gt;</etnb:OtherRisksAndUncertaintiesPolicyTextBlock>
    <us-gaap:SegmentReportingPolicyPolicyTextBlock
      contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698"
      id="F_01d84835-a15f-4c19-9267-092704ebb4b0">&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Segment Reporting&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The Company has &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;one&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; operating segment. The Company&#x2019;s chief operating decision maker, its Chief Executive Officer, manages the Company&#x2019;s operations on a consolidated basis for the purposes of allocating resources and evaluating financial performance.&lt;/span&gt;&lt;/p&gt;</us-gaap:SegmentReportingPolicyPolicyTextBlock>
    <us-gaap:NumberOfOperatingSegments
      contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698"
      decimals="INF"
      id="F_7870d154-27fe-46a4-88af-712cf5ae81a5"
      unitRef="U_Segment">1</us-gaap:NumberOfOperatingSegments>
    <us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy
      contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698"
      id="F_b6872a82-5227-4294-932b-1fcadfd2b9ed">&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Cash and Cash Equivalents&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The Company considers all highly liquid investments purchased with original maturities of three months or less from the purchase date to be cash equivalents. Cash equivalents consist primarily of amounts invested in money market funds and commercial paper that are stated at fair value.&lt;/span&gt;&lt;/p&gt;</us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy>
    <us-gaap:InvestmentPolicyTextBlock
      contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698"
      id="F_8458bbdf-d81c-46f0-bb7a-67fae80d90dc">&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Investments&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Investments have been classified as available-for-sale and are carried at estimated fair value as determined based upon quoted market prices or pricing models for similar securities. Management determines the appropriate classification of its available-for-sale investments in debt securities at the time of purchase. Generally, investments with original maturities beyond three months at the date of purchase are classified as short-term because it is management&#x2019;s intent to use the investments to fund current operations or to make them available for current operations.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Unrealized gains and losses are excluded from net loss and are reported as a component of comprehensive loss. The Company periodically evaluates whether declines in fair values of its available-for-sale securities below their book value are other-than-temporary. This evaluation consists of several qualitative and quantitative factors regarding the severity and duration of the unrealized loss as well as the Company&#x2019;s ability and intent to hold the available-for-sale security until a forecasted recovery occurs. Additionally, the Company assesses whether it has plans to sell the security or it is more likely than not it will be required to sell any available-for-sale securities before recovery of its amortized cost basis. Realized gains and losses and declines in fair value judged to be other than temporary, if any, on available-for-sale securities are included in interest income and other, net. The cost of investments sold is based on the specific-identification method. The Company has &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;no&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;t experienced any material realized gains or losses or other-than-temporary losses in the periods presented.&lt;/span&gt;&lt;/p&gt;</us-gaap:InvestmentPolicyTextBlock>
    <us-gaap:OtherThanTemporaryImpairmentLossDebtSecuritiesPortionRecognizedInEarnings
      contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698"
      decimals="INF"
      id="F_352954e8-c29e-4444-9ab7-06966c782b08"
      unitRef="U_USD">0</us-gaap:OtherThanTemporaryImpairmentLossDebtSecuritiesPortionRecognizedInEarnings>
    <us-gaap:RealizedInvestmentGainsLosses
      contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698"
      decimals="INF"
      id="F_f710d6b7-69c3-4b55-99a1-12c23edaabe1"
      unitRef="U_USD">0</us-gaap:RealizedInvestmentGainsLosses>
    <us-gaap:LesseeLeasesPolicyTextBlock
      contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698"
      id="F_a8b136ae-4d1c-4160-94d8-d18b234cee3a">&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Leases&lt;/span&gt;&lt;span style="color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The Company is a lessee in noncancellable operating leases for office space. Beginning in 2022, the Company accounts for leases in accordance with Accounting Standards Update (&#x201c;ASU&#x201d;) 2016-02,&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt; Leases&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; (&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Topic 842&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;). The Company determines if an arrangement is a lease or contains an embedded lease at inception. The Company accounts for a contract as a lease when it has the right to control the asset for a period of time while obtaining substantially all of the asset&#x2019;s economic benefits. For arrangements that meet the definition of a lease, the Company determines the initial classification and measurement of its right-of-use (&#x201c;ROU&#x201d;) asset and lease liability at the lease commencement date and thereafter if modified. Operating lease ROU assets represent the Company&#x2019;s right to use an underlying asset for the lease term and lease liabilities represent the Company&#x2019;s obligation to make the contractual lease payments over the lease term. The ROU asset is initially measured at cost, which comprises the initial amount of the lease liability adjusted for lease payments made at or before the lease commencement date, plus any initial direct costs incurred less any lease incentives received. The operating lease liability is initially measured at the present value of the unpaid lease payments at the lease commencement date. The lease liability is subsequently measured at amortized cost using the effective-interest method. The lease term includes any renewal options that the Company is reasonably assured to exercise. The present value of lease payments is determined by using the interest rate implicit in the lease, if that rate is readily determinable, otherwise, the Company uses its estimated collateralized incremental borrowing rate for the lease term. The Company has elected not to record leases with an original term of twelve months or less on its consolidated balance sheets and recognizes those lease payments in operating expenses in the consolidated statements of operations and comprehensive loss. The Company&#x2019;s short-term lease is not material.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;In addition, the Company&#x2019;s leases may require it to pay additional costs, such as utilities, maintenance, and other operating costs, which are generally referred to as non-lease components and vary based on future outcomes. The Company has elected to not separate lease and non-lease components. Only the fixed costs for lease components and their associated non-lease components are accounted for as a single lease component and recognized as part of a ROU &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;asset and lease liability. Any variable expenses are recognized in operating expenses as incurred. Rent expense for an operating lease liability is recognized on a straight-line basis over the lease term and is included in operating expenses in the consolidated statements of operations and comprehensive loss.&lt;/span&gt;&lt;/p&gt;</us-gaap:LesseeLeasesPolicyTextBlock>
    <us-gaap:PropertyPlantAndEquipmentPolicyTextBlock
      contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698"
      id="F_1a4ac4f6-956e-4948-9e49-67d30c91a3cb">&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Property and Equipment, Net&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Property and equipment are stated at cost, less accumulated depreciation. Depreciation is calculated on a straight-line basis over the estimated useful lives of the related assets, generally ranging from &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="-sec-ix-hidden:F_4640215a-3a60-4f28-a85d-e6242af9c877;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;three&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; to &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;seven years&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;. &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Leasehold improvements are amortized on a straight-line basis over the shorter of the assets&#x2019; estimated useful life or the remaining term of the lease.&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Upon retirement or sale of the assets, the cost and related accumulated depreciation and amortization are removed from the consolidated balance sheets and the resulting gains or losses are recorded in the consolidated statements of operations and comprehensive loss. &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Maintenance and repair costs are expensed as incurred.&lt;/span&gt;&lt;/p&gt;</us-gaap:PropertyPlantAndEquipmentPolicyTextBlock>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="C_a1422313-a35e-45e5-a7d0-20aa6422feb3"
      id="F_327e735f-0ce7-4eb7-9f80-02c6635b0d08">P7Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentEstimatedUsefulLives
      contextRef="C_23eaed33-b0aa-4e33-a2c8-2f2897791170"
      id="F_a8f8825b-0591-4fff-8be7-2e05f61bd09a">Leasehold improvements are amortized on a straight-line basis over the shorter of the assets&#x2019; estimated useful life or the remaining term of the lease.</us-gaap:PropertyPlantAndEquipmentEstimatedUsefulLives>
    <us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock
      contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698"
      id="F_a31482b6-df2e-4bc2-894e-43ea967864dc">&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Impairment of Long-Lived Assets&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The Company periodically evaluates its long-lived assets, including property and equipment, for impairment whenever events or changes in business circumstances indicate that the carrying amount of the assets or group of assets may not be fully recoverable. If indicators of impairment exist and the undiscounted future cash flows that the assets are expected to generate are less than the carrying value of the assets, then the Company will reduce the carrying amount of the assets through an impairment charge, to their estimated fair values based on a discounted cash flow approach or, when available and appropriate, to comparable market values. There were no such indicators for the periods presented.&lt;/span&gt;&lt;/p&gt;</us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock>
    <etnb:AccruedResearchAndDevelopmentExpensesPolicyTextBlock
      contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698"
      id="F_45c813e9-bf45-4977-887b-319764dbf4ec">&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Accrued Research and Development Expenses&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The Company estimates preclinical and clinical study and research expenses based on the services performed, pursuant to contracts with research institutions that conduct and manage preclinical and clinical studies and research services on its behalf. The Company records the costs of research and development activities based upon the estimated services provided but not yet invoiced and includes these costs in accrued expenses in the consolidated balance sheets. These costs are a component of the Company&#x2019;s research and development expenses.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The Company accrues for these costs based on factors such as estimates of the work completed in accordance with agreements established with its third-party service providers. The Company makes judgments and estimates in determining the accrued expenses balance. As actual costs become known, the Company adjusts its accrued expenses. The Company has not experienced any material differences between accrued costs and actual costs incurred. However, the status and timing of actual services performed may vary from the Company&#x2019;s estimates, resulting in adjustments to expense in future periods. Changes in these estimates that result in material changes to the Company&#x2019;s accrued expenses could materially affect the Company&#x2019;s results of operations. Contingent milestone payments, if any, are expensed when the milestone results are probable and estimable, which is generally upon achievement of the milestone.&lt;/span&gt;&lt;/p&gt;</etnb:AccruedResearchAndDevelopmentExpensesPolicyTextBlock>
    <etnb:WarrantsToPurchaseCommonStockPolicyTextBlock
      contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698"
      id="F_30ab2a38-e7a1-4354-b37f-7c7d2ca3ff12">&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Warrants to Purchase Common Stock&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The Company classifies warrants indexed to its common stock and meeting the requirements for equity classification within stockholders&#x2019; equity. This assessment is conducted at the time of warrant issuance and as of each reporting period that the warrants remain outstanding.&lt;/span&gt;&lt;/p&gt;</etnb:WarrantsToPurchaseCommonStockPolicyTextBlock>
    <us-gaap:ResearchAndDevelopmentExpensePolicy
      contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698"
      id="F_1b58e503-377a-4f9e-a992-753c94220c41">&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Research and Development Expenses&lt;/span&gt;&lt;span style="color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Research and development expenses consist primarily of costs incurred for the development of the Company&#x2019;s lead product candidate, pegozafermin. Research and development expenses consist primarily of external costs related to preclinical and clinical development and related supplies and personnel costs. Personnel costs consist of salaries, employee benefits and stock-based compensation for individuals involved in research and development efforts. Payments associated with agreements to acquire licenses to develop, use, manufacture and commercialize products and purchases of pegozafermin from contract manufacturing organizations that have not reached technological feasibility and do not have alternate future commercial use are expensed as incurred.&lt;/span&gt;&lt;/p&gt;</us-gaap:ResearchAndDevelopmentExpensePolicy>
    <us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy
      contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698"
      id="F_c96fbbf3-7b4f-4ee6-aacd-916d902ec7fc">&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Stock-Based Compensation&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The Company provides equity awards in the form of stock options and restricted stock units. The Company measures its equity awards made to employees, directors, and&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;non-employee service providers based on estimated fair values and recognizes stock-based compensation over the requisite service period. The Company accounts for forfeitures as they occur.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The Company estimates the fair value of stock option awards on the date of grant using a&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Black-Scholes option pricing model. The Company recognizes compensation for the value of stock options awards, which have graded vesting, using the straight-line method over the requisite service period of each award.&lt;/span&gt;&lt;span style="color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The Black-Scholes option pricing model requires a number of assumptions, of which the most significant are expected volatility, expected option term (the time from the grant date until the options are exercised or expire), risk-free rate, and expected dividend rate. These assumptions include:&lt;/span&gt;&lt;/p&gt;&lt;div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;"&gt;&#x2022;&lt;/span&gt;&lt;div style="display:inline;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Expected volatility&#x2014;Since the Company has limited trading history for its common stock, expected volatility is estimated based on weighting the Company&#x2019;s volatility and the volatility of comparable publicly traded biotechnology companies during the equivalent period of the calculated expected term of the options granted. The comparable companies were chosen based on their similar size, stage in the life cycle, or area of specialty. There is a degree of uncertainty in determining a comparable peer group as each of the peers are engaged in varied research and development activities, the timing and progress of which differ within the peer group. &lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;"&gt;&#x2022;&lt;/span&gt;&lt;div style="display:inline;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Expected term&#x2014;The expected term of options granted to employees and directors is determined using the &#x201c;simplified&#x201d; method. Under this approach, the expected term is presumed to be the midpoint between the weighted-average vesting term and the contractual term of the option. The simplified method makes the assumption that the employee will exercise stock options evenly over the period when the stock options are vested and ending on the date when the stock options would expire. The expected option term for options granted to non-employees is estimated on a grant-by-grant basis.&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;"&gt;&#x2022;&lt;/span&gt;&lt;div style="display:inline;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Risk-free interest rate&#x2014;The risk-free interest rate is based on the U.S. Treasury zero coupon bonds in effect on the grant date for periods with an equivalent expected term as the option.&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-left:4.537%;text-indent:0.0%;display:flex;margin-top:6.0pt;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;text-indent:0;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;"&gt;&#x2022;&lt;/span&gt;&lt;div style="display:inline;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Expected dividend&#x2014;The Company has never paid dividends and has no foreseeable plans to pay dividends on its shares of common stock. Therefore, an expected dividend of zero is used.&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The fair value of restricted stock units is based on the fair value of the Company&#x2019;s common stock on the date of grant. The grant date fair value of restricted stock units with service vesting conditions is recognized over the requisite service period on a straight-line basis. For restricted stock units with performance vesting conditions, the Company evaluates the probability of achieving the performance condition at each reporting date and recognizes expense for such performance awards over the requisite service period using the accelerated attribution method.&lt;/span&gt;&lt;/p&gt;</us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy>
    <us-gaap:IncomeTaxPolicyTextBlock
      contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698"
      id="F_58ed21cc-54db-452b-956b-cc0cd95d76cb">&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Income Taxes&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Income taxes are accounted for under the asset and liability method. Under this method, deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the consolidated financial statements carrying amounts of existing assets and liabilities and their respective tax bases and operating loss and tax credit carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates applied to taxable income in the years in which those temporary differences are expected to be realized. The effect on deferred tax assets and liabilities of a change in tax rates is recognized as income or loss in the period that includes the enactment date. A valuation allowance is established when necessary to reduce deferred tax assets to the amount expected to be realized. Interest and penalties related to unrecognized tax benefits are included within the provision of income tax.&lt;/span&gt;&lt;span style="color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;</us-gaap:IncomeTaxPolicyTextBlock>
    <us-gaap:EarningsPerSharePolicyTextBlock
      contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698"
      id="F_8dafbc4e-a686-4c98-b0bc-e47280f82eaf">&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Basic and Diluted Net Loss per Share&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Basic loss per share is computed by dividing net loss by the weighted-average number of shares of common stock outstanding during the period. Diluted loss per share is computed by dividing net loss by the weighted-average number of shares of common stock outstanding together with the number of additional shares of common stock that would have been outstanding if all potentially dilutive shares of common stock had been issued. Since the Company is in a loss position for the periods presented, basic net loss per share is the same as diluted net loss per share since the effects of potentially dilutive securities are antidilutive. &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Shares of the Company&#x2019;s common stock underlying pre-funded warrants exercisable for nominal consideration are included in the computation of basic and diluted net loss per share, even if antidilutive.&lt;/span&gt;&lt;/p&gt;</us-gaap:EarningsPerSharePolicyTextBlock>
    <us-gaap:ComprehensiveIncomePolicyPolicyTextBlock
      contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698"
      id="F_813f3f8b-cb9a-49e5-8283-4dd4e52d1062">&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Comprehensive Loss&lt;/span&gt;&lt;span style="color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The Company&#x2019;s comprehensive loss is comprised of net loss and changes in unrealized gains or losses on available-for-sale securities and foreign currency translation adjustments.&lt;/span&gt;&lt;/p&gt;</us-gaap:ComprehensiveIncomePolicyPolicyTextBlock>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock
      contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698"
      id="F_a2a49d29-df24-4166-bf41-ea953bb6fde0">&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Recently Adopted Accounting Standards&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:6.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt; &#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;In February 2016, the Financial Accounting Standards Board (&#x201c;FASB&#x201d;) issued ASU 2016-02,&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt; Leases&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; (&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Topic 842&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;), or Accounting Standards Codification (&#x201c;ASC&#x201d;) 842, which requires lessees to recognize leases on the balance sheet and disclose key information about leasing arrangements. ASC 842 establishes a ROU model that requires a lessee to recognize a ROU asset and lease liability on the balance sheet for all leases with a term longer than 12 months. Leases are classified as finance or operating, with classification affecting the pattern and classification of expense recognition in the income statement.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;On&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; January 1, 2022&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;, the Company adopted &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;ASC 842&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; using the modified retrospective transition method and elected the practical expedients to not reassess whether any expired or existing contracts are or contain leases, carry forward its historical lease classification and not reassess initial direct costs for existing leases. Upon adoption of ASC 842, the Company recorded an operating ROU asset of $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;0.2&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million and an operating lease liability of $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;0.2&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million on its consolidated balance sheet. There was &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;no&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; adjustment to the opening balance of accumulated deficit as a result of adoption. Results for the year ended December 31, 2022 are presented under ASC 842. Prior period amounts preceding January 1, 2022 continue to be reported in accordance with the Company&#x2019;s historical accounting under the previous lease guidance, ASC 840.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Recent Accounting Pronouncements&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;In June 2016, the FASB issued ASU 2016-13, &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Financial Instruments&#x2014;Credit Losses (Topic 326)&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;: &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Measurement of Credit Losses on Financial Instruments &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&#x201c;ASU 2016-13&#x201d;), which replaces the existing incurred loss impairment model with an expected credit loss model and requires a financial asset measured at amortized cost to be presented at the net amount expected to be collected. As an emerging growth company, ASU 2016-13 is effective for the Company for the year ending December 31, 2023 and interim periods within that fiscal year and must be adopted using a modified retrospective approach, with certain exceptions. The Company is evaluating the impact of this standard and &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;does not expect the adoption of ASU 2016-13 to have a material impact on the Company&#x2019;s consolidated financial statements and related disclosures.&lt;/span&gt;&lt;/p&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:ChangeInAccountingPrincipleAccountingStandardsUpdateAdoptionDate
      contextRef="C_d0cc41a8-af59-48aa-9362-9afbe6438bb6"
      id="F_9c2549a0-5464-4473-96b4-e9924594fda1">2022-01-01</us-gaap:ChangeInAccountingPrincipleAccountingStandardsUpdateAdoptionDate>
    <us-gaap:ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted
      contextRef="C_d0cc41a8-af59-48aa-9362-9afbe6438bb6"
      id="F_114209c8-d181-47b1-b75e-c4e8b71cbb0c">true</us-gaap:ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="C_eb4154dd-05cb-44b2-b1f9-253eb264f041"
      decimals="-5"
      id="F_61ab1b21-99f0-482a-8569-c37a71533b30"
      unitRef="U_USD">200000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="C_eb4154dd-05cb-44b2-b1f9-253eb264f041"
      decimals="-5"
      id="F_aa094a7b-1392-482d-9513-982d879d7792"
      unitRef="U_USD">200000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="C_eb4154dd-05cb-44b2-b1f9-253eb264f041"
      decimals="-3"
      id="F_620d8eb0-dce7-46c6-8ba1-7f3fd876be92"
      unitRef="U_USD">0</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:FairValueDisclosuresTextBlock
      contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698"
      id="F_f37fdc10-16e1-4dad-831d-6104386e5cce">&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;3. Fair Value Measurements&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:12.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The following table presents the Company&#x2019;s financial assets measured at fair value on a recurring basis by level within the fair value hierarchy as of &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;December 31, 2022 (in thousands):&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:90.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:45.662%;"/&gt;
        &lt;td style="width:0.122%;"/&gt;
        &lt;td style="width:10.9%;"/&gt;
        &lt;td style="width:0.122%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:8.655%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:0.081%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:8.384%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:0.108%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:9.225%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:0.081%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:8.655%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Valuation&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Amortized&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Unrealized&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Unrealized&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Fair&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Hierarchy&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Cost&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Gains&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Losses&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Value&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Money market funds&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Level 1&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;18,224&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;18,224&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Commercial paper&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Level 2&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;104,279&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;84&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;104,196&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;U.S. government bonds&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Level 2&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;18,225&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;109&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;18,117&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Agency bonds&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Level 2&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;13,986&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;78&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;13,908&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Corporate debt securities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Level 2&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;10,488&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;62&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;10,426&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;U.S. treasury bills&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Level 2&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;7,414&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;21&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;7,394&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Agency discount securities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Level 2&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;5,216&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;9&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;5,225&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Non-U.S. debt securities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Level 2&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;3,975&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;20&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;3,955&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:5.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Total cash equivalents and available-for-&lt;br/&gt;&#160;&#160;&#160;sale securities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;181,807&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;12&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;374&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;181,445&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Classified as:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Cash equivalents&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;48,540&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Short-term available-for-sale securities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;132,905&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:5.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Total cash equivalents and available-for-&lt;br/&gt;&#160;&#160;&#160;sale securities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;181,445&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:2.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The following table summarizes the Company&#x2019;s cash equivalents and available-for-sale securities by contractual maturity as of &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;December 31, 2022 (in thousands):&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:90.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:77.695%;"/&gt;
        &lt;td style="width:2.196%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:18.109%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Within one year&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;175,243&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;After one year through two years&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;6,202&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:5.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Total cash equivalents and available-for-sale securities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;181,445&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:2.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The following table presents the Company&#x2019;s financial assets measured at fair value on a recurring basis by level within the fair value hierarchy as of &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;December 31, 2021 (in thousands):&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:90.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:45.662%;"/&gt;
        &lt;td style="width:0.122%;"/&gt;
        &lt;td style="width:10.9%;"/&gt;
        &lt;td style="width:0.122%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:8.655%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:0.081%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:8.384%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:0.108%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:9.225%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:0.081%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:8.655%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Valuation&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Amortized&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Unrealized&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Unrealized&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Fair&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Hierarchy&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Cost&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Gains&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Losses&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Value&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Money market funds&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Level 1&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;21,477&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;21,477&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Commercial paper&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Level 2&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;59,647&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;10&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;59,637&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;U.S. government bonds&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Level 2&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;21,662&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;42&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;21,620&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Corporate debt securities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Level 2&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;8,776&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;8,776&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Agency bonds&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Level 2&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;7,747&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;7&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;7,741&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Municipal bonds&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Level 2&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;4,251&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;4&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;4,247&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Non-U.S. debt securities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Level 2&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2,506&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2,505&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:5.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Total cash equivalents and available-for-&lt;br/&gt;&#160;&#160;&#160;sale securities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;126,066&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;65&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;126,003&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Classified as:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Cash equivalents&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;27,715&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Short-term available-for-sale securities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;98,288&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:5.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Total cash equivalents and available-for-&lt;br/&gt;&#160;&#160;&#160;sale securities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;126,003&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:2.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The following table summarizes the Company&#x2019;s cash equivalents and available-for-sale securities by contractual maturity as of &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;December 31, 2021 (in thousands):&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:90.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:77.695%;"/&gt;
        &lt;td style="width:2.196%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:18.109%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Within one year&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;120,726&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;After one year through two years&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;5,277&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:5.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Total cash equivalents and available-for-sale securities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;126,003&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;</us-gaap:FairValueDisclosuresTextBlock>
    <us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock
      contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698"
      id="F_fab889e1-ba2a-4959-b238-a6df438d4698">&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The following table presents the Company&#x2019;s financial assets measured at fair value on a recurring basis by level within the fair value hierarchy as of &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;December 31, 2022 (in thousands):&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:90.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:45.662%;"/&gt;
        &lt;td style="width:0.122%;"/&gt;
        &lt;td style="width:10.9%;"/&gt;
        &lt;td style="width:0.122%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:8.655%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:0.081%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:8.384%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:0.108%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:9.225%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:0.081%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:8.655%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Valuation&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Amortized&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Unrealized&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Unrealized&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Fair&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Hierarchy&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Cost&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Gains&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Losses&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Value&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Money market funds&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Level 1&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;18,224&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;18,224&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Commercial paper&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Level 2&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;104,279&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;84&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;104,196&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;U.S. government bonds&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Level 2&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;18,225&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;109&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;18,117&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Agency bonds&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Level 2&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;13,986&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;78&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;13,908&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Corporate debt securities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Level 2&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;10,488&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;62&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;10,426&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;U.S. treasury bills&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Level 2&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;7,414&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;21&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;7,394&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Agency discount securities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Level 2&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;5,216&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;9&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;5,225&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Non-U.S. debt securities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Level 2&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;3,975&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;20&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;3,955&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:5.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Total cash equivalents and available-for-&lt;br/&gt;&#160;&#160;&#160;sale securities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;181,807&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;12&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;374&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;181,445&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Classified as:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Cash equivalents&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;48,540&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Short-term available-for-sale securities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;132,905&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:5.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Total cash equivalents and available-for-&lt;br/&gt;&#160;&#160;&#160;sale securities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;181,445&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:2.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The following table presents the Company&#x2019;s financial assets measured at fair value on a recurring basis by level within the fair value hierarchy as of &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;December 31, 2021 (in thousands):&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:90.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:45.662%;"/&gt;
        &lt;td style="width:0.122%;"/&gt;
        &lt;td style="width:10.9%;"/&gt;
        &lt;td style="width:0.122%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:8.655%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:0.081%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:8.384%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:0.108%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:9.225%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:0.081%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:8.655%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Valuation&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Amortized&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Unrealized&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Unrealized&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Fair&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Hierarchy&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Cost&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Gains&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Losses&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Value&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Money market funds&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Level 1&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;21,477&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;21,477&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Commercial paper&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Level 2&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;59,647&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;10&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;59,637&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;U.S. government bonds&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Level 2&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;21,662&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;42&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;21,620&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Corporate debt securities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Level 2&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;8,776&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;8,776&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Agency bonds&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Level 2&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;7,747&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;7&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;7,741&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Municipal bonds&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Level 2&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;4,251&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;4&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;4,247&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Non-U.S. debt securities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Level 2&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2,506&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2,505&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:5.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Total cash equivalents and available-for-&lt;br/&gt;&#160;&#160;&#160;sale securities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;126,066&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;65&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;126,003&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Classified as:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Cash equivalents&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;27,715&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Short-term available-for-sale securities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;98,288&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:5.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Total cash equivalents and available-for-&lt;br/&gt;&#160;&#160;&#160;sale securities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;126,003&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;</us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="C_fc374840-0f9a-49dd-a75c-57c70ae81f21"
      decimals="-3"
      id="F_a35a6189-e82d-4816-965f-1fa64a96f795"
      unitRef="U_USD">18224000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="C_fc374840-0f9a-49dd-a75c-57c70ae81f21"
      decimals="-3"
      id="F_e7182cb7-9bd3-4e51-8711-11e0a0905505"
      unitRef="U_USD">18224000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="C_9e28330b-37ae-4c55-b6c8-5ab5971501f1"
      decimals="-3"
      id="F_819ce257-be3d-4236-91b7-501ca7ca670e"
      unitRef="U_USD">104279000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="C_9e28330b-37ae-4c55-b6c8-5ab5971501f1"
      decimals="-3"
      id="F_5f95696d-36a3-4ee4-9ba4-d48962c1f9d5"
      unitRef="U_USD">1000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="C_9e28330b-37ae-4c55-b6c8-5ab5971501f1"
      decimals="-3"
      id="F_c0d2d37b-607c-4316-881b-db648d7e97fc"
      unitRef="U_USD">84000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="C_9e28330b-37ae-4c55-b6c8-5ab5971501f1"
      decimals="-3"
      id="F_d53092cd-9fc3-4828-95ae-878803d38d55"
      unitRef="U_USD">104196000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="C_5c814fa2-557e-430f-a964-0b757b56fdfd"
      decimals="-3"
      id="F_705e05f3-7357-4bc0-b4c1-500527c9312c"
      unitRef="U_USD">18225000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="C_5c814fa2-557e-430f-a964-0b757b56fdfd"
      decimals="-3"
      id="F_82329a41-ef52-4459-b77c-30486f6a329b"
      unitRef="U_USD">1000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="C_5c814fa2-557e-430f-a964-0b757b56fdfd"
      decimals="-3"
      id="F_5e39789b-4542-4f5f-929f-4dc9637cb6a5"
      unitRef="U_USD">109000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="C_5c814fa2-557e-430f-a964-0b757b56fdfd"
      decimals="-3"
      id="F_b3858c51-93a3-4fe1-afe1-838cfff5dad8"
      unitRef="U_USD">18117000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="C_20129c45-1d42-4b18-a135-f79c3916f000"
      decimals="-3"
      id="F_d3eb2143-a97a-422d-b478-f80822e908ca"
      unitRef="U_USD">13986000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="C_20129c45-1d42-4b18-a135-f79c3916f000"
      decimals="-3"
      id="F_8ee7c5bf-93e4-4c24-95ae-56533a8a0165"
      unitRef="U_USD">78000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="C_20129c45-1d42-4b18-a135-f79c3916f000"
      decimals="-3"
      id="F_458c29d8-869f-47d6-a4d4-7a11705bb32d"
      unitRef="U_USD">13908000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="C_0d9500dd-d242-4ed4-9f39-2450c5d10363"
      decimals="-3"
      id="F_92056759-393d-4794-bd43-156ca2f0ee90"
      unitRef="U_USD">10488000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="C_0d9500dd-d242-4ed4-9f39-2450c5d10363"
      decimals="-3"
      id="F_77e6bb81-9281-4f83-935e-67d92c253f43"
      unitRef="U_USD">62000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="C_0d9500dd-d242-4ed4-9f39-2450c5d10363"
      decimals="-3"
      id="F_b2cd630c-b1b8-4de9-b362-188d502a1ae4"
      unitRef="U_USD">10426000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="C_15a836b6-6096-4e2c-9574-cf11b7149853"
      decimals="-3"
      id="F_e229c840-0411-484f-8ddf-428ab6b67d28"
      unitRef="U_USD">7414000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="C_15a836b6-6096-4e2c-9574-cf11b7149853"
      decimals="-3"
      id="F_a7d5b8e2-de69-485d-96f2-141a29d21a40"
      unitRef="U_USD">1000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="C_15a836b6-6096-4e2c-9574-cf11b7149853"
      decimals="-3"
      id="F_a9c61df8-1416-4e0f-ae6c-4ace4225c918"
      unitRef="U_USD">21000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="C_15a836b6-6096-4e2c-9574-cf11b7149853"
      decimals="-3"
      id="F_d56db9fe-b737-4d3c-beea-1b4494efc57c"
      unitRef="U_USD">7394000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="C_ba27f631-5055-4b5d-bcd3-1dcdfae2eb5e"
      decimals="-3"
      id="F_66934ec4-e323-44ed-86a6-204cd8389742"
      unitRef="U_USD">5216000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="C_ba27f631-5055-4b5d-bcd3-1dcdfae2eb5e"
      decimals="-3"
      id="F_78d83cea-a110-4680-91f4-6c360f1a0080"
      unitRef="U_USD">9000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="C_ba27f631-5055-4b5d-bcd3-1dcdfae2eb5e"
      decimals="-3"
      id="F_49186687-2134-44fd-8262-822001dfc503"
      unitRef="U_USD">5225000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="C_a98c76fd-bd2e-47b8-b425-7f631d600233"
      decimals="-3"
      id="F_40f44c05-ad16-4287-a3fa-09712b95b392"
      unitRef="U_USD">3975000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="C_a98c76fd-bd2e-47b8-b425-7f631d600233"
      decimals="-3"
      id="F_5f379c98-8db2-4148-be0d-cad80e422410"
      unitRef="U_USD">20000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="C_a98c76fd-bd2e-47b8-b425-7f631d600233"
      decimals="-3"
      id="F_bda3d27f-4b9e-4a7d-bb9c-da23e2ae76f8"
      unitRef="U_USD">3955000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="C_b49f5ccf-6e36-469f-8160-42229bc94d1d"
      decimals="-3"
      id="F_f3a5a101-7e49-4e36-ad46-8fa83fbecd5e"
      unitRef="U_USD">181807000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="C_b49f5ccf-6e36-469f-8160-42229bc94d1d"
      decimals="-3"
      id="F_7519b91b-536c-4b34-8aff-e0f24e204a9a"
      unitRef="U_USD">12000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="C_b49f5ccf-6e36-469f-8160-42229bc94d1d"
      decimals="-3"
      id="F_ae6e7061-fa66-42e3-bea7-d3dbba17bb53"
      unitRef="U_USD">374000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="C_b49f5ccf-6e36-469f-8160-42229bc94d1d"
      decimals="-3"
      id="F_11c0a24b-f765-4034-8a4f-b68a6ce610bf"
      unitRef="U_USD">181445000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="C_43d7ae38-fb0a-4a4d-a3e8-a44b58f48f12"
      decimals="-3"
      id="F_d86fe17d-c76b-4590-b736-11cacb8f1d26"
      unitRef="U_USD">48540000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="C_a518f01f-6e57-482e-afd5-51c9629b2a7c"
      decimals="-3"
      id="F_5301359c-f6d3-4667-9e2b-1e7a75309294"
      unitRef="U_USD">132905000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="C_b49f5ccf-6e36-469f-8160-42229bc94d1d"
      decimals="-3"
      id="F_bf66deec-f094-4fd8-a4e6-d2d4c4b830f4"
      unitRef="U_USD">181445000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock
      contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698"
      id="F_ced9b6d2-9d83-4ed5-9869-104a8dd26498">&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:2.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The following table summarizes the Company&#x2019;s cash equivalents and available-for-sale securities by contractual maturity as of &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;December 31, 2022 (in thousands):&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:90.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:77.695%;"/&gt;
        &lt;td style="width:2.196%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:18.109%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Within one year&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;175,243&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;After one year through two years&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;6,202&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:5.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Total cash equivalents and available-for-sale securities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;181,445&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:2.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The following table summarizes the Company&#x2019;s cash equivalents and available-for-sale securities by contractual maturity as of &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;December 31, 2021 (in thousands):&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:90.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:77.695%;"/&gt;
        &lt;td style="width:2.196%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:18.109%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Within one year&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;120,726&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;After one year through two years&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;5,277&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:5.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Total cash equivalents and available-for-sale securities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;126,003&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
      contextRef="C_85e3a5e5-8ff2-4682-901b-9d79336e863a"
      decimals="-3"
      id="F_223e85ec-e7c2-40d2-a00a-cba3720748d5"
      unitRef="U_USD">175243000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue>
    <etnb:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughTwoYearsFairValue
      contextRef="C_85e3a5e5-8ff2-4682-901b-9d79336e863a"
      decimals="-3"
      id="F_b5a45df0-7ab9-40d3-ac2d-987eaf6f1aee"
      unitRef="U_USD">6202000</etnb:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughTwoYearsFairValue>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="C_85e3a5e5-8ff2-4682-901b-9d79336e863a"
      decimals="-3"
      id="F_c7458e36-977b-4c6a-95e1-8e2fa206445e"
      unitRef="U_USD">181445000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="C_8c4669a8-efdc-43fe-b27c-54cf3b35bd79"
      decimals="-3"
      id="F_a04955dd-c5c4-4a50-bb44-9521e7722435"
      unitRef="U_USD">21477000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="C_8c4669a8-efdc-43fe-b27c-54cf3b35bd79"
      decimals="-3"
      id="F_191a1919-ddc1-4aa9-87e0-82a116ffc395"
      unitRef="U_USD">21477000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="C_b79c1273-b7ef-4512-a77c-8f09b7dd034b"
      decimals="-3"
      id="F_25bca5b4-b46a-4cd9-a2c1-77c861cba6b0"
      unitRef="U_USD">59647000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="C_b79c1273-b7ef-4512-a77c-8f09b7dd034b"
      decimals="-3"
      id="F_343b43da-b3f1-4271-8936-17b73c588f35"
      unitRef="U_USD">10000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="C_b79c1273-b7ef-4512-a77c-8f09b7dd034b"
      decimals="-3"
      id="F_35a73eb9-23b2-4040-8b16-9031f74ff38f"
      unitRef="U_USD">59637000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="C_276795d2-8680-4e1e-a7b3-60b4f187b181"
      decimals="-3"
      id="F_48a93900-9967-44a8-aa55-607fff1924a9"
      unitRef="U_USD">21662000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="C_276795d2-8680-4e1e-a7b3-60b4f187b181"
      decimals="-3"
      id="F_ab0cdfef-a489-4eb0-8e5f-719fac219b7c"
      unitRef="U_USD">42000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="C_276795d2-8680-4e1e-a7b3-60b4f187b181"
      decimals="-3"
      id="F_757a9143-4d49-4965-9141-bb3a3532a0b6"
      unitRef="U_USD">21620000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="C_5a34cef0-4d09-47ec-a8ce-379fe69ed741"
      decimals="-3"
      id="F_a376d0da-3e38-439d-ab92-7612ab070ba4"
      unitRef="U_USD">8776000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="C_5a34cef0-4d09-47ec-a8ce-379fe69ed741"
      decimals="-3"
      id="F_68953e26-9ffb-4638-9942-8b545d4280a5"
      unitRef="U_USD">1000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="C_5a34cef0-4d09-47ec-a8ce-379fe69ed741"
      decimals="-3"
      id="F_16ac5f3e-9893-423e-ac68-c5497d39f1d0"
      unitRef="U_USD">1000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="C_5a34cef0-4d09-47ec-a8ce-379fe69ed741"
      decimals="-3"
      id="F_dfed356f-2eb7-43eb-a4ea-c393330b1e20"
      unitRef="U_USD">8776000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="C_6bb5134f-3725-49c2-9eda-5f0d3a108db3"
      decimals="-3"
      id="F_d3c5acfc-9ba9-47da-a600-0857d96892c7"
      unitRef="U_USD">7747000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="C_6bb5134f-3725-49c2-9eda-5f0d3a108db3"
      decimals="-3"
      id="F_bf737465-540e-4b1b-9921-4050a84c265c"
      unitRef="U_USD">1000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="C_6bb5134f-3725-49c2-9eda-5f0d3a108db3"
      decimals="-3"
      id="F_d8f03420-243b-4af3-bb44-235cce55ec40"
      unitRef="U_USD">7000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="C_6bb5134f-3725-49c2-9eda-5f0d3a108db3"
      decimals="-3"
      id="F_bfd5caec-b18f-41af-8d3c-b1dc1ac5331e"
      unitRef="U_USD">7741000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="C_cb2cbb74-aff7-499d-b6a9-60e3aa3581f8"
      decimals="-3"
      id="F_8d243ace-9891-4b89-ba02-4f1440883e36"
      unitRef="U_USD">4251000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="C_cb2cbb74-aff7-499d-b6a9-60e3aa3581f8"
      decimals="-3"
      id="F_935370a4-dfcc-4538-bda6-f82faa2cc6e2"
      unitRef="U_USD">4000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="C_cb2cbb74-aff7-499d-b6a9-60e3aa3581f8"
      decimals="-3"
      id="F_4a371b7c-2ffe-4b70-a8bf-457d6b4cad0e"
      unitRef="U_USD">4247000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="C_a099857d-ead8-4784-88ce-373b780df01d"
      decimals="-3"
      id="F_3726da44-f45e-4d27-864f-fc91b197ef84"
      unitRef="U_USD">2506000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="C_a099857d-ead8-4784-88ce-373b780df01d"
      decimals="-3"
      id="F_53c5aaf6-4818-4975-9292-1346e5892c82"
      unitRef="U_USD">1000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="C_a099857d-ead8-4784-88ce-373b780df01d"
      decimals="-3"
      id="F_e8534637-bb95-47f5-bccc-6fa85f282a84"
      unitRef="U_USD">2505000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="C_7120f124-ce25-4ba7-a030-21bd1b4579e6"
      decimals="-3"
      id="F_394ee3c4-9972-4211-86ea-1b7dbc526bdc"
      unitRef="U_USD">126066000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="C_7120f124-ce25-4ba7-a030-21bd1b4579e6"
      decimals="-3"
      id="F_1c7aa7fe-5a6f-4b78-aa9a-38b569c4cddf"
      unitRef="U_USD">2000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="C_7120f124-ce25-4ba7-a030-21bd1b4579e6"
      decimals="-3"
      id="F_9a40297e-2490-4f9a-a3b9-fd696c412f08"
      unitRef="U_USD">65000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="C_7120f124-ce25-4ba7-a030-21bd1b4579e6"
      decimals="-3"
      id="F_582bf28c-e344-40a1-a0fe-4dad30f69625"
      unitRef="U_USD">126003000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="C_7063e2f9-3a0a-44ed-964f-cc213bf88e2e"
      decimals="-3"
      id="F_c10b9f9f-0610-42b8-a34b-0cb1d2756c57"
      unitRef="U_USD">27715000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="C_aa8067f4-0c3d-4c66-b916-2f5abd46e15d"
      decimals="-3"
      id="F_0b590360-e57b-4e2c-809a-0dc40ee26941"
      unitRef="U_USD">98288000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="C_7120f124-ce25-4ba7-a030-21bd1b4579e6"
      decimals="-3"
      id="F_1e8077e1-f2f6-480b-97e2-4bde5d770834"
      unitRef="U_USD">126003000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
      contextRef="C_21f769c6-c78d-41d0-b871-ec3d93d7d343"
      decimals="-3"
      id="F_490796d4-603b-48e9-aafe-b975500c95ac"
      unitRef="U_USD">120726000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue>
    <etnb:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughTwoYearsFairValue
      contextRef="C_21f769c6-c78d-41d0-b871-ec3d93d7d343"
      decimals="-3"
      id="F_de384d4a-446f-4557-884e-92497d3c86b0"
      unitRef="U_USD">5277000</etnb:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughTwoYearsFairValue>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="C_21f769c6-c78d-41d0-b871-ec3d93d7d343"
      decimals="-3"
      id="F_2cc2670f-dd59-4add-9975-ab1419d61517"
      unitRef="U_USD">126003000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:SupplementalBalanceSheetDisclosuresTextBlock
      contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698"
      id="F_ff7d5107-f238-4bd9-9ade-bea505cca9b6">&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;4. Consolidated Balance Sheet Components&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Prepaid and other current assets consist of the following as of the periods presented (in thousands):&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:70.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:65.777%;"/&gt;
        &lt;td style="width:1.589%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:13.515%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:1.589%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:13.530000000000001%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;As of December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Prepaid research and development&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;5,727&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;7,895&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Prepaid taxes&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;646&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;836&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Prepaid other&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1,547&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2,506&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:5.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Total prepaid and other current assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;7,920&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;11,237&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Accrued expenses consist of the following as of the periods presented (in thousands):&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:70.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:65.777%;"/&gt;
        &lt;td style="width:1.589%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:13.515%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:1.589%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:13.530000000000001%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;As of December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Accrued research and development expenses&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;6,499&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;6,195&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Accrued employee and related expenses&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;4,165&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;3,168&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Accrued professional and legal fees&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1,052&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;495&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Accrued other expenses&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;228&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;336&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:5.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Total accrued expenses&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;11,944&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;10,194&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;</us-gaap:SupplementalBalanceSheetDisclosuresTextBlock>
    <etnb:ScheduleOfPrepaidAndOtherCurrentAssetsTableTextBlock
      contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698"
      id="F_a3b9c4e9-2474-45e6-a889-8d3259ea2a7b">&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Prepaid and other current assets consist of the following as of the periods presented (in thousands):&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:70.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:65.777%;"/&gt;
        &lt;td style="width:1.589%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:13.515%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:1.589%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:13.530000000000001%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;As of December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Prepaid research and development&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;5,727&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;7,895&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Prepaid taxes&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;646&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;836&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Prepaid other&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1,547&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2,506&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:5.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Total prepaid and other current assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;7,920&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;11,237&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</etnb:ScheduleOfPrepaidAndOtherCurrentAssetsTableTextBlock>
    <etnb:PrepaidResearchAndDevelopmentCurrent
      contextRef="C_85e3a5e5-8ff2-4682-901b-9d79336e863a"
      decimals="-3"
      id="F_b8ffb099-e868-4be4-ae6a-c131a2673ec8"
      unitRef="U_USD">5727000</etnb:PrepaidResearchAndDevelopmentCurrent>
    <etnb:PrepaidResearchAndDevelopmentCurrent
      contextRef="C_21f769c6-c78d-41d0-b871-ec3d93d7d343"
      decimals="-3"
      id="F_f4375c76-261c-4b83-99ce-c5e77c438512"
      unitRef="U_USD">7895000</etnb:PrepaidResearchAndDevelopmentCurrent>
    <us-gaap:PrepaidTaxes
      contextRef="C_85e3a5e5-8ff2-4682-901b-9d79336e863a"
      decimals="-3"
      id="F_94e2312b-929f-46c4-8f76-c6d783e33c55"
      unitRef="U_USD">646000</us-gaap:PrepaidTaxes>
    <us-gaap:PrepaidTaxes
      contextRef="C_21f769c6-c78d-41d0-b871-ec3d93d7d343"
      decimals="-3"
      id="F_a5e4f3eb-a618-4bd0-85c1-a887f3db219f"
      unitRef="U_USD">836000</us-gaap:PrepaidTaxes>
    <us-gaap:OtherPrepaidExpenseCurrent
      contextRef="C_85e3a5e5-8ff2-4682-901b-9d79336e863a"
      decimals="-3"
      id="F_4d45478f-8e58-4ba2-acc7-8d514d13ff07"
      unitRef="U_USD">1547000</us-gaap:OtherPrepaidExpenseCurrent>
    <us-gaap:OtherPrepaidExpenseCurrent
      contextRef="C_21f769c6-c78d-41d0-b871-ec3d93d7d343"
      decimals="-3"
      id="F_dee67f19-3901-4a30-8fdc-7474be076657"
      unitRef="U_USD">2506000</us-gaap:OtherPrepaidExpenseCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="C_85e3a5e5-8ff2-4682-901b-9d79336e863a"
      decimals="-3"
      id="F_105b422e-b61f-4685-8773-6166915b2e03"
      unitRef="U_USD">7920000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="C_21f769c6-c78d-41d0-b871-ec3d93d7d343"
      decimals="-3"
      id="F_566043d3-e449-4671-bea3-3a6e6db0fb58"
      unitRef="U_USD">11237000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock
      contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698"
      id="F_85c8c31f-4638-495b-b98f-f062c313ad26">&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Accrued expenses consist of the following as of the periods presented (in thousands):&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:70.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:65.777%;"/&gt;
        &lt;td style="width:1.589%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:13.515%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:1.589%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:13.530000000000001%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;As of December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Accrued research and development expenses&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;6,499&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;6,195&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Accrued employee and related expenses&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;4,165&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;3,168&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Accrued professional and legal fees&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1,052&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;495&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Accrued other expenses&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;228&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;336&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:5.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Total accrued expenses&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;11,944&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;10,194&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock>
    <etnb:AccruedResearchAndDevelopmentExpenseCurrent
      contextRef="C_85e3a5e5-8ff2-4682-901b-9d79336e863a"
      decimals="-3"
      id="F_e9789773-7fea-4423-accc-ab4856106d28"
      unitRef="U_USD">6499000</etnb:AccruedResearchAndDevelopmentExpenseCurrent>
    <etnb:AccruedResearchAndDevelopmentExpenseCurrent
      contextRef="C_21f769c6-c78d-41d0-b871-ec3d93d7d343"
      decimals="-3"
      id="F_f24bf758-228f-44e7-a275-929f1b977b0c"
      unitRef="U_USD">6195000</etnb:AccruedResearchAndDevelopmentExpenseCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="C_85e3a5e5-8ff2-4682-901b-9d79336e863a"
      decimals="-3"
      id="F_785e79dd-1d09-4301-867c-f9712939c1cf"
      unitRef="U_USD">4165000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="C_21f769c6-c78d-41d0-b871-ec3d93d7d343"
      decimals="-3"
      id="F_434479a8-1485-422e-8c1c-47001e9dbfe3"
      unitRef="U_USD">3168000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:AccruedProfessionalFeesCurrent
      contextRef="C_85e3a5e5-8ff2-4682-901b-9d79336e863a"
      decimals="-3"
      id="F_e624f393-eb38-49df-940f-58e0cf3f63ee"
      unitRef="U_USD">1052000</us-gaap:AccruedProfessionalFeesCurrent>
    <us-gaap:AccruedProfessionalFeesCurrent
      contextRef="C_21f769c6-c78d-41d0-b871-ec3d93d7d343"
      decimals="-3"
      id="F_1cfca89e-b9a5-4f20-abad-555e6571e318"
      unitRef="U_USD">495000</us-gaap:AccruedProfessionalFeesCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="C_85e3a5e5-8ff2-4682-901b-9d79336e863a"
      decimals="-3"
      id="F_4caeabf2-9acb-4354-bf42-7b790e877c16"
      unitRef="U_USD">228000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="C_21f769c6-c78d-41d0-b871-ec3d93d7d343"
      decimals="-3"
      id="F_b15e0339-61c5-4533-8262-ecebe7c13f54"
      unitRef="U_USD">336000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="C_85e3a5e5-8ff2-4682-901b-9d79336e863a"
      decimals="-3"
      id="F_f213a3c0-abd1-4a70-9057-b26b1862d203"
      unitRef="U_USD">11944000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="C_21f769c6-c78d-41d0-b871-ec3d93d7d343"
      decimals="-3"
      id="F_3dda551d-94d8-4143-9b04-52dac5ce1842"
      unitRef="U_USD">10194000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock
      contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698"
      id="F_226e1fdb-01f4-4fc2-a05a-fb7e5adb5be2">&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:8.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;5. Commitments and Contingencies&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Leases&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:6.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;On January 1, 2022, the Company adopted ASC 842 (see Note 2), and the following disclosures as of and for the year ended December 31, 2022 are presented under ASC 842, while prior period amounts have not been adjusted and continue to be reported in accordance with the historical accounting under ASC 840. Upon adoption, the Company recorded an operating lease ROU asset and lease liability for its lease in San Francisco, which was due to expire in &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;January 2023&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;. Effective August 31, 2022, the Company amended the lease to extend the expiration date of the lease to &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;January 2025&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;, with one option to renew for an additional year that is not reasonably certain to be exercised. The amendment resulted in the remeasurement of the lease liability and ROU asset as of the modification date to reflect the extended term and the Company recorded an incremental ROU asset and lease liability of $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;0.3&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:12.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;For the year ended December 31, 2022, the Company incurred &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;0.2&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; in rent expense. For the year ended December 31, 2022, variable lease payments and short-term lease costs were &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="-sec-ix-hidden:F_4a26968b-e9d0-4e69-8f86-01a61afe4e4c;"&gt;&lt;span style="-sec-ix-hidden:F_104effa9-00d2-42bf-9012-ca94303c5178;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;immaterial&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;. As of &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;December 31, 2022, the remaining lease term was &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2.0&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; years and the Company&#x2019;s incremental borrowing rate used to determine the operating lease liability was &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;6.5&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:12.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;As of &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;December 31, 2022, the undiscounted future minimum lease payments due under the Company&#x2019;s non-cancellable operating lease are as follows (in thousands):&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:70.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:69.795%;"/&gt;
        &lt;td style="width:2.701%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:25.503%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;185&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;185&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2025&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;7&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Total undiscounted future minimum lease payments&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;377&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Less: imputed interest&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;23&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:5.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Present value of operating lease liability&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;354&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:12.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;In accordance with ASC 840, rent expense for the year ended December 31, 2021 was $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;0.3&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million. &lt;/span&gt;&lt;span style="font-size:12.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The total future minimum annual payments for operating leases in effect as of December 31, 2021 were as follows (in thousands):&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:70.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:70.024%;"/&gt;
        &lt;td style="width:2.946%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:25.03%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;212&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;7&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:5.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Total future minimum annual payments&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;219&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Asset Transfer and License Agreement with Teva Pharmaceutical Industries Ltd&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;In April 2018, the Company concurrently entered into two Asset Transfer and License Agreements (the &#x201c;Teva Agreements&#x201d;) with Teva Pharmaceutical Industries Ltd (&#x201c;Teva&#x201d;) under which it acquired certain patents and intellectual property relating to two programs: (1) Teva&#x2019;s glycoPEGylated FGF21 &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;fibroblast growth factor 21 (&#x201c;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;FGF21&#x201d;) program, including the compound TEV-47948 (pegozafermin), a glycoPEGylated long-acting FGF21 and (2) Teva&#x2019;s development program of small molecule inhibitors of fatty acid synthase. Pursuant to the Teva Agreements, the Company paid Teva an initial nonrefundable upfront payment of $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;6.0&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;and the Company&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;could &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;be obligated to pay Teva up to $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;67.5&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million under each program, for a total of $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;135.0&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million, upon the achievement of certain clinical development and commercial milestones. In addition, the Company is obligated to pay Teva tiered royalties at percentages in the low-to-mid single-digits on worldwide net sales on all products containing the Teva compounds.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The Teva Agreements can be terminated (i) by the Company without cause upon &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;120 days&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2019; written notice to Teva, (ii) by either party, if the other party materially breaches any of its obligations under the Teva Agreements and fails to cure such breach within &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;60 days&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; after receiving notice thereof, or (iii) by either party, if a bankruptcy petition is filed against the other party and is not dismissed within &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;60 days&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;. In addition, Teva can also terminate the agreement related to the Company&#x2019;s glycoPEGylated FGF21 program in the event the Company, or any of its affiliates or sublicensees, challenges any of the Teva patents licensed to the Company, and the challenge is not withdrawn within 30 days of written notice from Teva.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;During the year ended December 31, 2022 and 2021&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;, &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;no&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;ne of the development and commercial milestones were met and accordingly, there were &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;no&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; milestone payments related to the Teva Agreements.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <etnb:OperatingLeaseExpirationMonthAndYear
      contextRef="C_219ac1f1-456b-400e-b032-64201f1a5313"
      id="F_6720c86d-7a46-45b8-bcc7-4327f58c00f2">2023-01</etnb:OperatingLeaseExpirationMonthAndYear>
    <etnb:OperatingLeaseExpirationMonthAndYear
      contextRef="C_81b08a03-90f7-43af-84a8-8e9dbb83a6d9"
      id="F_1379858a-dd9b-48d7-9fad-ec219eb19dd2">2025-01</etnb:OperatingLeaseExpirationMonthAndYear>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="C_24b84e4a-2d9f-418f-bf86-e74e1b8c81af"
      decimals="-5"
      id="F_d801ff6c-d3d8-4595-8c7e-477a191eae13"
      unitRef="U_USD">300000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="C_24b84e4a-2d9f-418f-bf86-e74e1b8c81af"
      decimals="-5"
      id="F_1caea5a9-07b6-47e5-8c52-6249e230cda4"
      unitRef="U_USD">300000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:LeaseAndRentalExpense
      contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698"
      decimals="-5"
      id="F_b420af8b-f307-4d5d-84d6-ef9f918155e2"
      unitRef="U_USD">200000</us-gaap:LeaseAndRentalExpense>
    <us-gaap:LesseeOperatingLeaseRemainingLeaseTerm
      contextRef="C_85e3a5e5-8ff2-4682-901b-9d79336e863a"
      id="F_2aa968e4-bbe8-464d-9110-eb2033554c48">P2Y</us-gaap:LesseeOperatingLeaseRemainingLeaseTerm>
    <us-gaap:LesseeOperatingLeaseDiscountRate
      contextRef="C_85e3a5e5-8ff2-4682-901b-9d79336e863a"
      decimals="3"
      id="F_4acb8ef5-9f48-4ca3-aefd-06136da7d33e"
      unitRef="U_pure">0.065</us-gaap:LesseeOperatingLeaseDiscountRate>
    <us-gaap:ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock
      contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698"
      id="F_5d2492f0-28a5-4ff3-b8cb-d63dfb11ec27">&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;As of &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;December 31, 2022, the undiscounted future minimum lease payments due under the Company&#x2019;s non-cancellable operating lease are as follows (in thousands):&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:70.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:69.795%;"/&gt;
        &lt;td style="width:2.701%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:25.503%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;185&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;185&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2025&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;7&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Total undiscounted future minimum lease payments&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;377&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Less: imputed interest&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;23&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:5.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Present value of operating lease liability&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;354&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The total future minimum annual payments for operating leases in effect as of December 31, 2021 were as follows (in thousands):&lt;/span&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:70.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:70.024%;"/&gt;
        &lt;td style="width:2.946%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:25.03%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;212&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;7&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:5.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Total future minimum annual payments&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;219&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</us-gaap:ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
      contextRef="C_85e3a5e5-8ff2-4682-901b-9d79336e863a"
      decimals="-3"
      id="F_ac16b0b6-0312-4488-9517-fb82b1ffba96"
      unitRef="U_USD">185000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
      contextRef="C_85e3a5e5-8ff2-4682-901b-9d79336e863a"
      decimals="-3"
      id="F_45041c40-8110-4327-9c2a-87c010aadf71"
      unitRef="U_USD">185000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree
      contextRef="C_85e3a5e5-8ff2-4682-901b-9d79336e863a"
      decimals="-3"
      id="F_3d13af88-fa62-4068-8786-dd23c7139ff7"
      unitRef="U_USD">7000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue
      contextRef="C_85e3a5e5-8ff2-4682-901b-9d79336e863a"
      decimals="-3"
      id="F_08238efa-e4d8-4cea-bc7d-90e908456e91"
      unitRef="U_USD">377000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue>
    <us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
      contextRef="C_85e3a5e5-8ff2-4682-901b-9d79336e863a"
      decimals="-3"
      id="F_f541477e-188e-405c-8f2c-a9a5e7401319"
      unitRef="U_USD">23000</us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:OperatingLeaseLiability
      contextRef="C_85e3a5e5-8ff2-4682-901b-9d79336e863a"
      decimals="-3"
      id="F_53634014-d430-4674-803c-fbbf23d3f9f5"
      unitRef="U_USD">354000</us-gaap:OperatingLeaseLiability>
    <us-gaap:LeaseAndRentalExpense
      contextRef="C_7b31e452-ba3b-4180-9ddd-8faae2f90f0c"
      decimals="-5"
      id="F_95a01482-8b68-41f2-80aa-41fd1e3d7348"
      unitRef="U_USD">300000</us-gaap:LeaseAndRentalExpense>
    <us-gaap:OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear
      contextRef="C_21f769c6-c78d-41d0-b871-ec3d93d7d343"
      decimals="-3"
      id="F_8089bc20-6417-4ed1-80af-83833aa12907"
      unitRef="U_USD">212000</us-gaap:OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear>
    <us-gaap:OperatingLeasesFutureMinimumPaymentsDueInTwoYears
      contextRef="C_21f769c6-c78d-41d0-b871-ec3d93d7d343"
      decimals="-3"
      id="F_8a7f4413-424e-45da-8690-423449fddb3c"
      unitRef="U_USD">7000</us-gaap:OperatingLeasesFutureMinimumPaymentsDueInTwoYears>
    <us-gaap:OperatingLeasesFutureMinimumPaymentsDue
      contextRef="C_21f769c6-c78d-41d0-b871-ec3d93d7d343"
      decimals="-3"
      id="F_0b76ff50-1e3c-416c-91cd-9fb910c0d25e"
      unitRef="U_USD">219000</us-gaap:OperatingLeasesFutureMinimumPaymentsDue>
    <etnb:AssetTransferAndLicenseAgreementInitialNonrefundableUpfrontPayment
      contextRef="C_06409d28-ba8c-475e-bda2-06ff8506b41a"
      decimals="-5"
      id="F_7606b1c0-ca3e-495b-9aa0-47a665f5fa63"
      unitRef="U_USD">6000000.0</etnb:AssetTransferAndLicenseAgreementInitialNonrefundableUpfrontPayment>
    <etnb:ObligationToPaymentUponMaximumAchievementOfCertainClinicalAndCommercialMilestones
      contextRef="C_0cf9d23c-1397-46c1-b3b5-e40c57e51864"
      decimals="INF"
      id="F_57bc8d0d-bbdb-48e8-b45c-da2b590023a5"
      unitRef="U_USD">67500000</etnb:ObligationToPaymentUponMaximumAchievementOfCertainClinicalAndCommercialMilestones>
    <etnb:ObligationToPaymentUponMaximumAchievementOfCertainClinicalAndCommercialMilestones
      contextRef="C_68b35e56-1e54-4bd6-9c91-36e41d1c9359"
      decimals="INF"
      id="F_60a5356f-207b-4663-925f-8bebdf654e36"
      unitRef="U_USD">67500000</etnb:ObligationToPaymentUponMaximumAchievementOfCertainClinicalAndCommercialMilestones>
    <etnb:ObligationToPaymentUponMaximumAchievementOfCertainClinicalAndCommercialMilestones
      contextRef="C_06409d28-ba8c-475e-bda2-06ff8506b41a"
      decimals="INF"
      id="F_3e4332f4-5f81-49c7-8a8e-449aa4ab59f7"
      unitRef="U_USD">135000000.0</etnb:ObligationToPaymentUponMaximumAchievementOfCertainClinicalAndCommercialMilestones>
    <etnb:AssetTransferAndLicenseAgreementTerminationPeriodAfterWrittenNotice
      contextRef="C_346ebc1d-56b1-4b67-95cf-d70e9efff187"
      id="F_3bc2b452-a5aa-4c73-9c55-62eaf0aac6a5">P120D</etnb:AssetTransferAndLicenseAgreementTerminationPeriodAfterWrittenNotice>
    <etnb:AssetTransferAndLicenseAgreementTerminationPeriodNoticeOfFailure
      contextRef="C_346ebc1d-56b1-4b67-95cf-d70e9efff187"
      id="F_174294a0-a6e8-48a8-904b-0bab20d502cd">P60D</etnb:AssetTransferAndLicenseAgreementTerminationPeriodNoticeOfFailure>
    <etnb:AssetTransferAndLicenseAgreementTerminationNoticePeriodIfBankruptcyPetitionFiled
      contextRef="C_346ebc1d-56b1-4b67-95cf-d70e9efff187"
      id="F_07b1c449-001a-4f98-80f3-e327990648a9">P60D</etnb:AssetTransferAndLicenseAgreementTerminationNoticePeriodIfBankruptcyPetitionFiled>
    <etnb:MilestonePayment
      contextRef="C_293baad2-fb24-4c8f-af10-1f5af83b558f"
      decimals="INF"
      id="F_25bf8be7-db43-4b30-91c9-88a59fce3d7f"
      unitRef="U_USD">0</etnb:MilestonePayment>
    <etnb:MilestonePayment
      contextRef="C_bbce1ed1-a8d8-49f8-afbe-c78e9685dbd3"
      decimals="INF"
      id="F_870863c0-71b1-4e2b-8878-d95ef987d77e"
      unitRef="U_USD">0</etnb:MilestonePayment>
    <etnb:MilestonePayment
      contextRef="C_346ebc1d-56b1-4b67-95cf-d70e9efff187"
      decimals="INF"
      id="F_4b77db21-7694-4459-bb70-1073f79f4463"
      unitRef="U_USD">0</etnb:MilestonePayment>
    <etnb:MilestonePayment
      contextRef="C_336bc7db-2eb9-4265-a863-9aea3514e4c0"
      decimals="INF"
      id="F_181e2452-b947-4111-afd9-35f72dbd83ba"
      unitRef="U_USD">0</etnb:MilestonePayment>
    <us-gaap:LongTermDebtTextBlock
      contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698"
      id="F_3e5a2c98-4a17-463a-8778-16077508d368">&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;6. Term Loan&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Loan and Security Agreement&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;In April 2020, the Company entered into a Loan and Security Agreement, (the &#x201c;Loan Agreement&#x201d;) with the lenders referred to therein, and Silicon Valley Bank (&#x201c;SVB&#x201d;), as collateral agent. The Loan Agreement provided for (i) a secured term A loan facility (the &#x201c;Term A Loan Facility&#x201d;) of up to $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;10.0&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million and (ii) a secured term B loan facility (the &#x201c;Term B Loan Facility&#x201d;) of up to $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;5.0&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million that became available upon the satisfaction of certain milestones, each of which was available to be drawn through May 31, 2021. The term loan is secured by certain assets of the Borrowers (as defined in the Loan Agreement), including substantially all of the assets of the Company, excluding the Company&#x2019;s intellectual property. The term loan contains customary representations, warranties, affirmative covenants and also certain restrictive covenants.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;In April 2020, in connection with the execution of the Loan Agreement, the Company issued SVB a warrant to purchase &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;25,000&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; shares of the Company&#x2019;s common stock with a warrant exercise price of $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;22.06&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; per share that is immediately exercisable and expires on &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;June 30, 2025&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;, as amended. The fair value of the warrant at the issuance date was determined by using the Black-Scholes option-pricing model and the fair value allocated to the warrant of $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;0.6&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million met the requirements for equity classification within additional paid-in capital. Additionally, the Company incurred $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;0.2&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million in closing costs, which together with the value of the warrants, were recorded as debt issuance costs.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;In May 2021, the parties further amended the Loan Agreement (as amended, the &#x201c;2021 Loan Agreement&#x201d;). The 2021 Loan Agreement increased the Term A Loan Facility to up to $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;20.0&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million, which was fully drawn as of December 2021. The Term B Loan Facility of up to $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;5.0&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million was available to be drawn upon on achievement of certain additional milestones, on or before September 30, 2022, which expired unused.&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; The 2021 Loan Agreement provided for interest-only payments until October 1, 2022, which could be extended to April 1, 2023, if on or before September 30, 2022, the Company received net cash proceeds of at least $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;75.0&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million from the sale of its equity securities. In July 2022, the Company met the net cash proceeds requirement (see Note 7) and on September 1, 2022, the interest-only period was extended to April 1, 2023. Consecutive monthly payments of principal and interest commence on April 1, 2023 and continue through &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;September 1, 2024&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;, the maturity date of the term loan. The term loan bears interest at the greater of (i) &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;4.25&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;% and (ii) the sum of (a) the Prime Rate as reported in The Wall Street Journal plus (b) &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1.00&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;%. The interest rate on the term loan was &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;4.25&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;% at inception and &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;8.50&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;% as of December 31, 2022. In addition, a final payment fee of &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;5.0&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;% of the principal amount of the loan is due when the term loan becomes due or upon prepayment of the term loan. If the Company elects to prepay the loan, there is also a prepayment fee of between &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1.0&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;% and &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;3.0&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;% of the principal amount of the term loan depending on the timing of prepayment.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;In May 2021, in connection with the execution of the 2021 Loan Agreement, the Company issued SVB a warrant to purchase &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;33,923&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; shares of the Company&#x2019;s common stock with a warrant exercise price of $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;19.12&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; per share that is immediately exercisable and expires on &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;May 28, 2031&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;. &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The Company determined the fair value of the&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;warrant &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;at the issuance date by using the Black-Scholes option-pricing model with the following assumptions: risk-free interest rate of &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1.6&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;%, &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;no&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; dividends, expected volatility of &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;98.6&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;% and expected term of &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;10.0&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; years. Upon issuance, the fair value of the warrant of $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;0.6&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million was recorded as a debt issuance cost and met the requirements for equity classification within additional paid-in capital in the consolidated balance sheets. In addition, closing costs incurred were not material. In connection with Term B Loan Facility, if funded, the Company was to issue an additional warrant to purchase &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;11,305&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; shares of the Company&#x2019;s common stock with the exercise price at the Company&#x2019;s stock price at the time of issuance. However, the Term Loan B Facility expired unused and therefore no additional warrant was issued.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The 2021 Loan Agreement was accounted for as a modification to a credit facility. The related debt issuance costs incurred in May 2021, including the fair value of the warrant, together with the remaining unamortized debt issuance costs related to the Loan Agreement of $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;0.4&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million were recorded as deferred assets and recognized on a straight-line basis as interest expense over the availability of the draw period. &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;As of December 31, 2021, all amounts were drawn under the Term Loan A Facility such that all debt issuance costs were recorded as a debt discount.&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; The carrying value of the debt discount, together with the final payment fee, are recognized using the effective interest method.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;In September 2022, the parties agreed the extension of the interest-only period was met as a result of the July 2022 public offering (see Note 7), which was accounted for as a debt modification. A new effective interest rate equating to the revised cash flows of the carrying amount of the original debt was applied prospectively. The Company did not incur any costs in relation to the extension.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;In January 2023, the Company executed a loan and security agreement with new lenders (the &#x201c;2023 Loan Agreement&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x201d;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;) and repaid its outstanding obligations under the 2021 Loan Agreement (see Note 11). As the Company had the intent and ability to refinance amounts due under the 2021 Loan Agreement pursuant to the terms of the 2023 Loan Agreement, as of December 31, 2022, the current portion of the outstanding principal obligation under the 2021 Loan Agreement was classified as long-term. As of December 31, 2022, the Company&#x2019;s total obligations under the 2021 Loan Agreement were $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;19.7&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million classified as term loan, non-current, net and $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;0.5&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million classified as other non-current liability related to the final payment fee. The term loan, non-current, net is comprised of the outstanding principal amount of $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;20.0&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million net of $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;0.3&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million of unamortized debt discount.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;</us-gaap:LongTermDebtTextBlock>
    <us-gaap:LineOfCreditFacilityDescription
      contextRef="C_d924e5a5-d3dd-4acb-a359-d2a055d67e71"
      id="F_a1b9f431-67fa-4855-bc19-b160e30311e0">In April 2020, the Company entered into a Loan and Security Agreement, (the &#x201c;Loan Agreement&#x201d;) with the lenders referred to therein, and Silicon Valley Bank (&#x201c;SVB&#x201d;), as collateral agent. The Loan Agreement provided for (i) a secured term A loan facility (the &#x201c;Term A Loan Facility&#x201d;) of up to $10.0 million and (ii) a secured term B loan facility (the &#x201c;Term B Loan Facility&#x201d;) of up to $5.0 million that became available upon the satisfaction of certain milestones, each of which was available to be drawn through May 31, 2021. The term loan is secured by certain assets of the Borrowers (as defined in the Loan Agreement), including substantially all of the assets of the Company, excluding the Company&#x2019;s intellectual property. The term loan contains customary representations, warranties, affirmative covenants and also certain restrictive covenants.</us-gaap:LineOfCreditFacilityDescription>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="C_63713aa3-3b7f-4c18-95ec-d7881a249606"
      decimals="-5"
      id="F_43de351f-d1bd-46f8-ae02-db575e08e610"
      unitRef="U_USD">10000000.0</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="C_0fbbd6d9-9bd7-49b6-8f27-ad8d51a5afad"
      decimals="-5"
      id="F_4b4d6a45-9f53-4a37-befb-5a4c53504e83"
      unitRef="U_USD">5000000.0</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="C_63713aa3-3b7f-4c18-95ec-d7881a249606"
      decimals="INF"
      id="F_075dd073-be98-4574-9605-a9db8ba35757"
      unitRef="U_shares">25000</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="C_63713aa3-3b7f-4c18-95ec-d7881a249606"
      decimals="2"
      id="F_390a2b3d-653e-4a31-ae4b-563b4aece500"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">22.06</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:WarrantsAndRightsOutstandingMaturityDate
      contextRef="C_f1364984-27a4-4b53-9cb3-49e5885e056f"
      id="F_3b1359e5-0297-473c-9f75-0e924266557f">2025-06-30</us-gaap:WarrantsAndRightsOutstandingMaturityDate>
    <us-gaap:DeferredFinanceCostsGross
      contextRef="C_f1364984-27a4-4b53-9cb3-49e5885e056f"
      decimals="-5"
      id="F_a71a3e13-000a-472c-9813-a6659edcb43c"
      unitRef="U_USD">600000</us-gaap:DeferredFinanceCostsGross>
    <us-gaap:DeferredFinanceCostsGross
      contextRef="C_64505050-8754-453d-9384-3e8a3e7ed1c7"
      decimals="-5"
      id="F_897946a9-ec58-4055-a475-2bcd55771720"
      unitRef="U_USD">200000</us-gaap:DeferredFinanceCostsGross>
    <us-gaap:LineOfCreditFacilityDescription
      contextRef="C_8ec6682c-a0df-42a7-9596-2e31ddf5f5fb"
      id="F_ec539fd9-1cba-4c8e-bb72-9fb4a7a5d7e8">In May 2021, the parties further amended the Loan Agreement (as amended, the &#x201c;2021 Loan Agreement&#x201d;). The 2021 Loan Agreement increased the Term A Loan Facility to up to $20.0 million, which was fully drawn as of December 2021. The Term B Loan Facility of up to $5.0 million was available to be drawn upon on achievement of certain additional milestones, on or before September 30, 2022, which expired unused.</us-gaap:LineOfCreditFacilityDescription>
    <us-gaap:ProceedsFromLinesOfCredit
      contextRef="C_486ea18d-a98b-4e2c-a648-7ba74ce82df4"
      decimals="-5"
      id="F_b8a680c1-c8f1-4897-bfed-69fefdcbef30"
      unitRef="U_USD">20000000.0</us-gaap:ProceedsFromLinesOfCredit>
    <etnb:LineOfCreditFacilityIncreaseInBorrowingCapacity
      contextRef="C_6d3eea61-86b7-46b5-8fc7-9a6e90984a96"
      decimals="-5"
      id="F_5c25d4ee-2d68-4edb-8828-3df8744c26aa"
      unitRef="U_USD">5000000.0</etnb:LineOfCreditFacilityIncreaseInBorrowingCapacity>
    <etnb:NetCashProceedsFromSaleOfEquitySecurities
      contextRef="C_f6790208-fa53-4c6a-a9e8-0e12a839f2fc"
      decimals="-5"
      id="F_e1fbd306-e850-4cb8-b904-0a25c7f4c09a"
      unitRef="U_USD">75000000.0</etnb:NetCashProceedsFromSaleOfEquitySecurities>
    <us-gaap:LineOfCreditFacilityExpirationDate1
      contextRef="C_486ea18d-a98b-4e2c-a648-7ba74ce82df4"
      id="F_a5d48ece-d2fe-4494-9648-5aa9c4a4af7d">2024-09-01</us-gaap:LineOfCreditFacilityExpirationDate1>
    <us-gaap:DebtInstrumentInterestRateDuringPeriod
      contextRef="C_400e8f6e-3cb0-4806-ab40-9ea3fbda15da"
      decimals="4"
      id="F_55d01b50-b4e9-436e-8117-77a4336e0d0f"
      unitRef="U_pure">0.0425</us-gaap:DebtInstrumentInterestRateDuringPeriod>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="C_9179a407-98a4-4470-bd80-a8d43f35e053"
      decimals="4"
      id="F_04d6e119-5994-452a-b774-d67a2355d537"
      unitRef="U_pure">0.0100</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentInterestRateDuringPeriod
      contextRef="C_d924e5a5-d3dd-4acb-a359-d2a055d67e71"
      decimals="4"
      id="F_27f6dd67-97c2-4db6-854d-84a1645426a0"
      unitRef="U_pure">0.0425</us-gaap:DebtInstrumentInterestRateDuringPeriod>
    <us-gaap:DebtInstrumentInterestRateDuringPeriod
      contextRef="C_f6790208-fa53-4c6a-a9e8-0e12a839f2fc"
      decimals="4"
      id="F_57673a97-8448-4559-8081-539938facca2"
      unitRef="U_pure">0.0850</us-gaap:DebtInstrumentInterestRateDuringPeriod>
    <etnb:PercentageOfFeeOnLoan
      contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698"
      decimals="3"
      id="F_4ade9814-651f-41b4-b2a5-4c3a2c447de0"
      unitRef="U_pure">0.050</etnb:PercentageOfFeeOnLoan>
    <etnb:PrepaymentFeePercentage
      contextRef="C_400e8f6e-3cb0-4806-ab40-9ea3fbda15da"
      decimals="INF"
      id="F_24fc7f98-34cb-416e-8669-2af124120be4"
      unitRef="U_pure">0.010</etnb:PrepaymentFeePercentage>
    <etnb:PrepaymentFeePercentage
      contextRef="C_0ff1dce8-b806-4a8c-ae9b-bef81ddaf302"
      decimals="INF"
      id="F_16800543-b225-452f-992c-2819ffb6a488"
      unitRef="U_pure">0.030</etnb:PrepaymentFeePercentage>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="C_0d8efc73-e669-470d-b4ba-623e328b895c"
      decimals="INF"
      id="F_4066208a-6bda-4ba2-9431-f5b6b4b6e4b1"
      unitRef="U_shares">33923</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="C_0d8efc73-e669-470d-b4ba-623e328b895c"
      decimals="2"
      id="F_7ceb76fc-de33-45e4-ab4e-f15339c8be87"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">19.12</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:WarrantsAndRightsOutstandingMaturityDate
      contextRef="C_0d8efc73-e669-470d-b4ba-623e328b895c"
      id="F_0e861141-4d91-4339-b976-aa1603c76fad">2031-05-28</us-gaap:WarrantsAndRightsOutstandingMaturityDate>
    <us-gaap:DebtInstrumentMeasurementInput
      contextRef="C_a9902439-f289-45b6-ae67-7a0087e98dc3"
      decimals="3"
      id="F_b80ce7b6-76f6-4f18-a4cc-5e18253e6097"
      unitRef="U_pure">0.016</us-gaap:DebtInstrumentMeasurementInput>
    <etnb:FairValueOfWarrantsAssumptionsDividends
      contextRef="C_4e61ffe1-5dad-4c7d-9e54-54ccdddb6379"
      decimals="-3"
      id="F_cc54c9d8-b2d0-4442-ba87-c0edab0ce1b5"
      unitRef="U_USD">0</etnb:FairValueOfWarrantsAssumptionsDividends>
    <us-gaap:DebtInstrumentMeasurementInput
      contextRef="C_19145334-f911-4daa-9ab2-e1eab1d17cbf"
      decimals="3"
      id="F_9ed1ff01-5772-459f-bed2-bd726c980256"
      unitRef="U_pure">0.986</us-gaap:DebtInstrumentMeasurementInput>
    <us-gaap:DebtInstrumentTerm
      contextRef="C_d417399a-7793-4c07-aa7a-f9d877495dd9"
      id="F_3e16d252-b817-4983-8849-13a27308ae69">P10Y</us-gaap:DebtInstrumentTerm>
    <us-gaap:DeferredFinanceCostsGross
      contextRef="C_0d8efc73-e669-470d-b4ba-623e328b895c"
      decimals="-5"
      id="F_329e1645-9f3e-4665-bf9f-b6c792ac4408"
      unitRef="U_USD">600000</us-gaap:DeferredFinanceCostsGross>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="C_aecfb132-37f5-4d9c-98a7-d5475beefa29"
      decimals="INF"
      id="F_7a7e3d99-c3a7-4303-9d69-83d9cf2e4763"
      unitRef="U_shares">11305</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:DeferredTaxAssetsGross
      contextRef="C_0d8efc73-e669-470d-b4ba-623e328b895c"
      decimals="-5"
      id="F_77789bb8-dd3e-4d55-b0c2-9c8250538255"
      unitRef="U_USD">400000</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:LineOfCreditFacilityDescription
      contextRef="C_3f47fde3-7be3-4bb6-ae2b-29bc39fcd38d"
      id="F_3fde94e7-112a-40f5-811e-13c33229c804">As of December 31, 2021, all amounts were drawn under the Term Loan A Facility such that all debt issuance costs were recorded as a debt discount.</us-gaap:LineOfCreditFacilityDescription>
    <us-gaap:LineOfCreditFacilityDescription
      contextRef="C_42491eea-6b09-4865-930d-85d82115fafd"
      id="F_1e110157-dc4e-4bc2-9348-fc9078fb0e11">In January 2023, the Company executed a loan and security agreement with new lenders (the &#x201c;2023 Loan Agreement&#x201d;) and repaid its outstanding obligations under the 2021 Loan Agreement (see Note 11). As the Company had the intent and ability to refinance amounts due under the 2021 Loan Agreement pursuant to the terms of the 2023 Loan Agreement, as of December 31, 2022, the current portion of the outstanding principal obligation under the 2021 Loan Agreement was classified as long-term. As of December 31, 2022, the Company&#x2019;s total obligations under the 2021 Loan Agreement were $19.7 million classified as term loan, non-current, net and $0.5 million classified as other non-current liability related to the final payment fee. The term loan, non-current, net is comprised of the outstanding principal amount of $20.0 million net of $0.3 million of unamortized debt discount.</us-gaap:LineOfCreditFacilityDescription>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="C_69b35aed-7994-41dd-a070-5ef370bb6088"
      decimals="-5"
      id="F_a7a9cade-d646-4749-ac1d-755dc2bec35a"
      unitRef="U_USD">19700000</us-gaap:LongTermDebtNoncurrent>
    <etnb:OtherNonCurrentLiability
      contextRef="C_69b35aed-7994-41dd-a070-5ef370bb6088"
      decimals="-5"
      id="F_0c283b4e-fa1f-4f26-9df5-ca478ab74a42"
      unitRef="U_USD">500000</etnb:OtherNonCurrentLiability>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="C_69b35aed-7994-41dd-a070-5ef370bb6088"
      decimals="-5"
      id="F_55285722-48f9-4de9-8388-0f44cf986474"
      unitRef="U_USD">20000000.0</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentUnamortizedDiscount
      contextRef="C_69b35aed-7994-41dd-a070-5ef370bb6088"
      decimals="-5"
      id="F_8563e93b-88b4-466b-974c-48de2e2b1ccc"
      unitRef="U_USD">300000</us-gaap:DebtInstrumentUnamortizedDiscount>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock
      contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698"
      id="F_1e73f7d8-6f08-4d9b-88be-7b219529cbbf">&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;7. Stockholders&#x2019; Equity&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;As of &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;December 31, 2022, the Company&#x2019;s shares of common stock available for future issuance were as follows:&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:79.712%;"/&gt;
        &lt;td style="width:1.464%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:16.823999999999998%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Shares available for future grant under the equity incentive plan&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;241,635&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Shares available for future issuance under the employee stock purchase plan&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;729,218&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Shares available for future issuance upon the exercise of warrants and pre-funded warrants&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;13,966,283&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:5.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Total available for future issuance&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;14,937,136&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:8.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Public Offerings&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;At-the-Market Offerings&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;In March 2021, the Company entered into a sales agreement (as amended, the &#x201c;Sales Agreement&#x201d;) with SVB Securities LLC and Cantor Fitzgerald &amp;amp; Co. (the &#x201c;Sales Agents&#x201d;) pursuant to which the Company may offer and sell up to $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;75.0&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million of shares of its common stock, from time to time, in &#x201c;at-the-market&#x201d; offerings (the &#x201c;ATM Facility&#x201d;). The Sales Agents are entitled to compensation at a commission equal to &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;3.0&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;% of the aggregate gross sales price per share sold under the Sales Agreement. Pursuant to the ATM Facility, in 2021, the Company received aggregate proceeds of $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;3.3&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million, net of commissions and offering expenses from sales of &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;186,546&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; shares of its common stock and, in 2022, received aggregate proceeds of $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;28.5&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million, net of commissions from the sales of &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;3,948,611&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; shares of its common stock.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;July 2022 Public Offering&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;In July 2022, the Company completed an underwritten public offering of its common stock, warrants to purchase shares of its common stock and pre-funded warrants to purchase shares of its common stock. The Company sold &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;18,675,466&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; shares of its common stock with accompanying warrants to purchase up to &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;9,337,733&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; shares of its common stock at a combined public offering price of $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;3.55&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; per share. The Company also sold &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;7,944,252&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; pre-funded warrants to purchase shares of its common stock with accompanying warrants to purchase up to &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;3,972,126&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; shares of its common stock at a combined public offering price of $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;3.549&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; per pre-funded warrant, which represents the per share public offering price for the common stock less $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;0.001&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; per share, the exercise price for each pre-funded warrant. The Company raised net proceeds of $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;88.2&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million, after deducting underwriting discounts and commissions of $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;5.7&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million and other offering costs of $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;0.6&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million. &lt;/span&gt;&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"/&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The exercise of the outstanding warrants is subject to a beneficial ownership limitation of &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;9.99&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;%, or at the election of the holder prior to the issuance of the warrant, &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;4.99&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;%. The exercise of the outstanding pre-funded warrants is subject to a beneficial ownership limitation of &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;9.99&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;%, or at the election of the holder prior to the issuance of the pre-funded warrant, &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;4.99&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;%, which a holder may increase or decrease from time to time but shall not exceed &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;19.99&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;%. The exercise price and number of shares of common stock issuable upon the exercise of the warrants and pre-funded warrants are subject to adjustment in the event of any stock dividends, stock splits, reverse stock split, recapitalization, or reorganization or similar transaction, as described in the agreements. Under certain circumstances, the warrants and pre-funded warrants may be exercisable on a &#x201c;cashless&#x201d; basis. The warrants and pre-funded warrants were classified as a component of stockholders&#x2019; equity and additional paid-in capital because such warrants and pre-funded warrants (i) are freestanding financial instruments that are legally detachable and separately exercisable from the equity instruments, (ii) are immediately exercisable, (iii) do not embody an obligation for the Company to repurchase its shares, (iv) permit the holders to receive a fixed number of common shares upon exercise, (v) are indexed to the Company&#x2019;s common stock and (vi) meet the equity classification criteria. In addition, the warrants and pre-funded warrants do not provide any guarantee of value or return.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Common Stock Warrants&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;As of &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;December 31, 2022, the Company&#x2019;s outstanding warrants to purchase shares of its common stock were as follows:&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:57.363%;"/&gt;
        &lt;td style="width:0.996%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:10.953999999999999%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:1.384%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:11.152000000000001%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:1.384%;"/&gt;
        &lt;td style="width:12.766%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Shares of&lt;br/&gt;Common Stock&lt;br/&gt;Underlying&lt;br/&gt;Warrants&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Exercise Price&lt;br/&gt;Per Share&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Expiration&lt;br/&gt;Date&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Warrant issued with term loan&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;25,000&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;22.06&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;June 30, 2025&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Warrant issued with term loan&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;33,923&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;19.12&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;May 28, 2031&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Warrants issued in public offering&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;13,107,360&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;5.325&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;July 1, 2024&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Pre-funded warrants issued in public offering&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;800,000&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;0.001&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Do not expire&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:5.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Total outstanding&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;13,966,283&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);text-indent:25.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="margin-left:25.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <etnb:ScheduleOfCommonStockReservedForIssuanceTableTextBlock
      contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698"
      id="F_cb8f063f-da5d-49b3-a430-88237039d116">&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;As of &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;December 31, 2022, the Company&#x2019;s shares of common stock available for future issuance were as follows:&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:79.712%;"/&gt;
        &lt;td style="width:1.464%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:16.823999999999998%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Shares available for future grant under the equity incentive plan&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;241,635&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Shares available for future issuance under the employee stock purchase plan&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;729,218&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Shares available for future issuance upon the exercise of warrants and pre-funded warrants&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;13,966,283&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:5.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Total available for future issuance&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;14,937,136&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</etnb:ScheduleOfCommonStockReservedForIssuanceTableTextBlock>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="C_debc9f51-b90f-43f6-af8a-b00f128671e2"
      decimals="INF"
      id="F_617fdc1e-e24d-47af-9213-0fe9c688fdcc"
      unitRef="U_shares">241635</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="C_1294a0d4-82df-4aeb-86a3-c974a5339679"
      decimals="INF"
      id="F_21d6b732-8d07-4be2-9f37-e72de8c03500"
      unitRef="U_shares">729218</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="C_cf4ea6ad-4896-41f4-bc1c-7f4a0b1286f8"
      decimals="INF"
      id="F_da8360df-3441-43cb-b791-ae3d4dd29c96"
      unitRef="U_shares">13966283</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="C_85e3a5e5-8ff2-4682-901b-9d79336e863a"
      decimals="INF"
      id="F_bbc5ac90-69f0-41eb-a40a-3fabbcbe4665"
      unitRef="U_shares">14937136</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <etnb:MaximumAmountOfEquitySharesIssuable
      contextRef="C_b2381809-b584-4634-835b-de401b34febb"
      decimals="-5"
      id="F_b6d3bc41-d229-4548-a393-a93cab2b8b93"
      unitRef="U_USD">75000000.0</etnb:MaximumAmountOfEquitySharesIssuable>
    <etnb:SellingCommissionPerSharesSoldPercentage
      contextRef="C_034c3248-20ba-45f1-8c7f-941617fb2bea"
      decimals="3"
      id="F_170b55e1-5a95-41d8-af75-d5225b21442c"
      unitRef="U_pure">0.030</etnb:SellingCommissionPerSharesSoldPercentage>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="C_6fdc6413-db9e-4bdf-ac0c-0aec29016321"
      decimals="-5"
      id="F_962d02b4-6e86-4f06-a4ae-8fe5a4f067ee"
      unitRef="U_USD">3300000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="C_6fdc6413-db9e-4bdf-ac0c-0aec29016321"
      decimals="0"
      id="F_0ef9b358-9f02-48a2-97c1-735b1bd112c9"
      unitRef="U_shares">186546</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="C_e7406d64-9fbe-4053-8474-7c07e64b9b1a"
      decimals="-5"
      id="F_fcde17a8-5d79-456c-b0ec-6dd333b957dc"
      unitRef="U_USD">28500000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="C_e7406d64-9fbe-4053-8474-7c07e64b9b1a"
      decimals="0"
      id="F_d877c80d-803c-4b18-829e-65b19b749598"
      unitRef="U_shares">3948611</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:SaleOfStockDescriptionOfTransaction
      contextRef="C_9153c97c-b82f-4cb0-9b13-074c71823603"
      id="F_eb3734b4-e27b-4558-a54a-c79aaa9e5017">In July 2022, the Company completed an underwritten public offering of its common stock, warrants to purchase shares of its common stock and pre-funded warrants to purchase shares of its common stock. The Company sold 18,675,466 shares of its common stock with accompanying warrants to purchase up to 9,337,733 shares of its common stock at a combined public offering price of $3.55 per share. The Company also sold 7,944,252 pre-funded warrants to purchase shares of its common stock with accompanying warrants to purchase up to 3,972,126 shares of its common stock at a combined public offering price of $3.549 per pre-funded warrant, which represents the per share public offering price for the common stock less $0.001 per share, the exercise price for each pre-funded warrant. The Company raised net proceeds of $88.2 million, after deducting underwriting discounts and commissions of $5.7 million and other offering costs of $0.6 million. </us-gaap:SaleOfStockDescriptionOfTransaction>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="C_9153c97c-b82f-4cb0-9b13-074c71823603"
      decimals="INF"
      id="F_deb61b28-b865-4868-b235-b5caedec1401"
      unitRef="U_shares">18675466</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="C_dbe06daf-d12f-4df8-b30b-9d91c12d257a"
      decimals="INF"
      id="F_b494e5f3-e57f-4465-a934-0c2f3c1ef543"
      unitRef="U_shares">9337733</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <etnb:CommonStockAndWarrantsCombinedOfferingPricePerShare
      contextRef="C_6047d52d-d8de-4ffd-998c-b1093834c8c7"
      decimals="2"
      id="F_150bd0b7-2fda-4065-8ec9-9ebfe7862c57"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">3.55</etnb:CommonStockAndWarrantsCombinedOfferingPricePerShare>
    <etnb:NumberOfPrefundedWarrantsIssuedDuringPeriod
      contextRef="C_d6793a0d-ddc1-4bea-8729-61b96d2fd8c6"
      decimals="INF"
      id="F_7be8504b-a39c-4b95-b23d-30a9fa6c8d87"
      unitRef="U_shares">7944252</etnb:NumberOfPrefundedWarrantsIssuedDuringPeriod>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="C_f1c306e8-9d11-4882-bc7e-9eb378ceb757"
      decimals="INF"
      id="F_827419ec-51cc-405c-9234-ef5fb8555bad"
      unitRef="U_shares">3972126</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <etnb:PrefundedAndCommonStockWarrants
      contextRef="C_17df92a5-2cb5-48c9-9462-299e5b922342"
      decimals="3"
      id="F_bf2a8e9c-10c9-4f29-95ed-75cad9e9b55e"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">3.549</etnb:PrefundedAndCommonStockWarrants>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="C_6047d52d-d8de-4ffd-998c-b1093834c8c7"
      decimals="3"
      id="F_b2f6ca90-8c7b-4370-ade7-229ac8ddbf89"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="C_9153c97c-b82f-4cb0-9b13-074c71823603"
      decimals="-5"
      id="F_c9f4b15c-49f6-4f28-a153-5922db4b73f7"
      unitRef="U_USD">88200000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <etnb:UnderwritingDiscountsAndCommissions
      contextRef="C_9153c97c-b82f-4cb0-9b13-074c71823603"
      decimals="-5"
      id="F_85776f56-fca9-4b48-b634-d72f15b2febb"
      unitRef="U_USD">5700000</etnb:UnderwritingDiscountsAndCommissions>
    <us-gaap:PaymentsOfStockIssuanceCosts
      contextRef="C_9153c97c-b82f-4cb0-9b13-074c71823603"
      decimals="-5"
      id="F_1dc5a8e0-e813-4c41-8cfa-4ad8ab04a197"
      unitRef="U_USD">600000</us-gaap:PaymentsOfStockIssuanceCosts>
    <etnb:BeneficialOwnershipLimitationOnExerciseOfWarrant
      contextRef="C_a858f07d-a85c-4d7d-b3d7-e709eceaafec"
      decimals="4"
      id="F_8ab54452-8a9e-4a9b-8741-e5489695a0a4"
      unitRef="U_pure">0.0999</etnb:BeneficialOwnershipLimitationOnExerciseOfWarrant>
    <etnb:SaleOfStockPercentageOfBeneficialOwnershipLimitationBeforeTransaction
      contextRef="C_a858f07d-a85c-4d7d-b3d7-e709eceaafec"
      decimals="4"
      id="F_a0a52fe6-dbcf-4cd9-a88b-574a62cf8a22"
      unitRef="U_pure">0.0499</etnb:SaleOfStockPercentageOfBeneficialOwnershipLimitationBeforeTransaction>
    <etnb:BeneficialOwnershipLimitationOnExerciseOfWarrant
      contextRef="C_9705961e-ee8d-42ab-94ee-ccd3d976ce3a"
      decimals="4"
      id="F_35d4d080-cd83-42e7-8ad5-2e3c739dc985"
      unitRef="U_pure">0.0999</etnb:BeneficialOwnershipLimitationOnExerciseOfWarrant>
    <etnb:SaleOfStockPercentageOfBeneficialOwnershipLimitationBeforeTransaction
      contextRef="C_9705961e-ee8d-42ab-94ee-ccd3d976ce3a"
      decimals="4"
      id="F_1d599092-87b7-41c0-88e7-79bcb6728371"
      unitRef="U_pure">0.0499</etnb:SaleOfStockPercentageOfBeneficialOwnershipLimitationBeforeTransaction>
    <etnb:BeneficialOwnershipLimitationOnExerciseOfWarrant
      contextRef="C_d18bd1f4-38fc-4415-8797-86a51c6f011c"
      decimals="4"
      id="F_486972b5-715c-4bba-836d-3bc59f357537"
      unitRef="U_pure">0.1999</etnb:BeneficialOwnershipLimitationOnExerciseOfWarrant>
    <etnb:BeneficialOwnershipLimitationOnExerciseOfWarrant
      contextRef="C_ab53d079-3181-47b2-85e6-cb6ceba1d67b"
      decimals="4"
      id="F_b0ec2f6b-7dd1-49fe-8a08-fa65ab54b2aa"
      unitRef="U_pure">0.1999</etnb:BeneficialOwnershipLimitationOnExerciseOfWarrant>
    <us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock
      contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698"
      id="F_0e657d5a-048b-44f2-9ab0-70792a2b6001">&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;As of &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;December 31, 2022, the Company&#x2019;s outstanding warrants to purchase shares of its common stock were as follows:&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:57.363%;"/&gt;
        &lt;td style="width:0.996%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:10.953999999999999%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:1.384%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:11.152000000000001%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:1.384%;"/&gt;
        &lt;td style="width:12.766%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Shares of&lt;br/&gt;Common Stock&lt;br/&gt;Underlying&lt;br/&gt;Warrants&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Exercise Price&lt;br/&gt;Per Share&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Expiration&lt;br/&gt;Date&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Warrant issued with term loan&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;25,000&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;22.06&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;June 30, 2025&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Warrant issued with term loan&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;33,923&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;19.12&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;May 28, 2031&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Warrants issued in public offering&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;13,107,360&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;5.325&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;July 1, 2024&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Pre-funded warrants issued in public offering&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;800,000&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;0.001&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Do not expire&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:5.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Total outstanding&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;13,966,283&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);text-indent:25.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="margin-left:25.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="C_f983776b-3b07-4d5d-8f04-c89f752dbbb3"
      decimals="INF"
      id="F_75a99ede-0152-47b9-aee8-17cecb9f5452"
      unitRef="U_shares">25000</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="C_f983776b-3b07-4d5d-8f04-c89f752dbbb3"
      decimals="2"
      id="F_5358322e-2d4e-48ec-9d0f-9e892490c381"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">22.06</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:WarrantsAndRightsOutstandingMaturityDate
      contextRef="C_f983776b-3b07-4d5d-8f04-c89f752dbbb3"
      id="F_db8eb939-0454-4b04-adbb-88acade2111a">2025-06-30</us-gaap:WarrantsAndRightsOutstandingMaturityDate>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="C_2b1c0a70-b0ce-43af-b3bb-a102024bd750"
      decimals="INF"
      id="F_1163ff6f-b43a-4ed7-9961-6b6ff9fd1324"
      unitRef="U_shares">33923</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="C_2b1c0a70-b0ce-43af-b3bb-a102024bd750"
      decimals="2"
      id="F_1e32e94f-8208-49e1-a867-534555be7e36"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">19.12</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:WarrantsAndRightsOutstandingMaturityDate
      contextRef="C_2b1c0a70-b0ce-43af-b3bb-a102024bd750"
      id="F_6c3af337-04bf-4a2c-b489-22947de02602">2031-05-28</us-gaap:WarrantsAndRightsOutstandingMaturityDate>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="C_4c47692e-9e97-459b-a109-c6bc7bbaa9fe"
      decimals="INF"
      id="F_4070d5bb-3526-4b77-8195-bbaf1b8c9e9d"
      unitRef="U_shares">13107360</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="C_4c47692e-9e97-459b-a109-c6bc7bbaa9fe"
      decimals="3"
      id="F_362bb192-3644-4f09-b16d-7c866068a0ce"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">5.325</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:WarrantsAndRightsOutstandingMaturityDate
      contextRef="C_4c47692e-9e97-459b-a109-c6bc7bbaa9fe"
      id="F_dc7daf6b-023a-4330-97ee-e28912997ffc">2024-07-01</us-gaap:WarrantsAndRightsOutstandingMaturityDate>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="C_d381e235-d260-40df-bd20-65af96cdfcaa"
      decimals="INF"
      id="F_8736e0df-412d-444d-81f5-169a3d300dd6"
      unitRef="U_shares">800000</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="C_d381e235-d260-40df-bd20-65af96cdfcaa"
      decimals="3"
      id="F_28c4d671-443e-4a73-b4a5-e7aeb5268f90"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.001</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <etnb:WarrantsAndRightsOutstandingMaturityDateDescription
      contextRef="C_68ccb2ee-ab2d-44ed-a5ee-a3a09c44b31c"
      id="F_71f3b678-7023-4eb3-96df-21bbcba62838">Do not expire</etnb:WarrantsAndRightsOutstandingMaturityDateDescription>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="C_85e3a5e5-8ff2-4682-901b-9d79336e863a"
      decimals="INF"
      id="F_8a6d9887-81f4-43de-a24b-1dea17ab1090"
      unitRef="U_shares">13966283</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
      contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698"
      id="F_67fca452-e0fc-49a4-8775-2face657e749">&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;8&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;. Stock-Based Compensation &lt;/span&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Equity Incentive Plan&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;In September 2019, the Company&#x2019;s board of directors adopted the 2019 Equity Incentive Plan (the &#x201c;2019 Plan&#x201d;), which also became effective in September 2019. The Company initially reserved &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2,844,193&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; shares of common stock for issuance under the 2019 Plan. In addition, the number of shares of common stock reserved for issuance under the 2019 Plan will automatically increase on the first day of January for a period of up to &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;ten years&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; in an amount equal to &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;4&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;% of the total number of shares of the Company&#x2019;s capital stock outstanding on the immediately preceding December 31, or a lesser number of shares determined by the Company&#x2019;s board of directors.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:12.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The board of directors determines the period over which options become exercisable and options generally vest over a &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;four-year&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; period, with &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;25&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;% of options vesting on the first anniversary of employment, and thereafter, the remaining options vesting quarterly, over the following &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;36-month&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; period. The options expire within &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;ten years&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; from &lt;/span&gt;&lt;/span&gt;&lt;span style=""/&gt;&lt;/p&gt;&lt;div style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;the &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;date of grant. The exercise price of awards granted will not be less than the estimated fair value of the shares on the date of grant. The 2019 Plan also permits the board of directors to grant restricted stock units, which are subject to continued service conditions.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Employee Stock Purchase Plan&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;In October 2019, the Company&#x2019;s board of directors adopted the 2019 Employee Stock Purchase Plan (&#x201c;ESPP&#x201d;), which became effective in November 2019. The Company initially reserved &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;225,188&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; shares of common stock for purchase under the ESPP. The number of shares of common stock reserved for issuance under the ESPP will automatically increase on the first day of January for a period of up to &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;ten years&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; in an amount equal to &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;% of the total number of shares of the Company&#x2019;s common stock outstanding on the immediately preceding December 31, or a lesser number of shares determined by the Company&#x2019;s board of directors. Purchases are accomplished through the participation of discrete offering periods and each offering is expected to be six months in duration. For each offering period, ESPP participants will purchase shares of common stock at a price per share equal to &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;85&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;% of the lesser of the fair market value of the Company&#x2019;s common stock on (1) the first trading day of the applicable offering period or (2) the last trading day of the applicable offering period.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Stock Options&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:11.0pt;font-family:&amp;quot;Calibri&amp;quot;, sans-serif;"&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The following table summarizes stock option activity for the year ended &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;December 31, 2022:&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:95.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:55.851%;"/&gt;
        &lt;td style="width:0.081%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:10.520999999999999%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:0.081%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:7.231%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:0.081%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:8.775%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:0.269%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:9.112%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Weighted&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Weighted&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Average&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Average&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Remaining&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Aggregate&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Number of&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Exercise&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Contractual&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Intrinsic&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Options&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Price&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Term&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Value&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(In years)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(In thousands)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Balance outstanding as of December 31, 2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2,406,668&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;16.46&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;8.1&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;9,970&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Granted&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1,149,816&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;4.48&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Exercised&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;151,061&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2.09&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Cancelled and forfeited&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;243,506&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;16.34&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:11.0pt;font-family:&amp;quot;Calibri&amp;quot;, sans-serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:11.0pt;font-family:&amp;quot;Calibri&amp;quot;, sans-serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Balance outstanding as of December 31, 2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;3,161,917&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;12.80&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;7.9&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;16,612&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Exercisable as of December 31, 2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1,460,685&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;14.60&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;7.0&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;7,320&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;&lt;div style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The fair value of stock options granted for the periods presented was estimated at the date of grant using a Black-Scholes option-pricing model with the following assumptions:&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:90.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:59.283%;"/&gt;
        &lt;td style="width:1.994%;"/&gt;
        &lt;td style="width:18.364%;"/&gt;
        &lt;td style="width:1.994%;"/&gt;
        &lt;td style="width:18.364%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="3" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Year Ended December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Expected term (years)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;5.5&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;-&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;6.3&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;5.5&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;-&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;6.1&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Expected volatility&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;89.9&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;-&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;91.0&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;86.9&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;-&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;91.9&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Risk-free interest rate&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:5.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1.6&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;-&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;3.9&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;0.7&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;-&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1.3&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Expected dividend&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:15.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:15.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:2.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:2.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The weighted-average grant date fair value of stock options that were granted during the year ended December 31, 2022 and 2021 was &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;3.38&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; and $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;16.18&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; per share, respectively. As of &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;December 31, 2022, there was &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;12.2&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; of unrecognized stock-based compensation related to stock options granted under the 2019 Plan, which is expected to be recognized over a weighted-average period of &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2.2&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; years.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Restricted Stock Units (&#x201c;RSUs&#x201d;)&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The Company has granted certain employees service-based RSUs that generally vest annually over a &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="-sec-ix-hidden:F_79bc5d0a-fb68-4600-adad-d1cd8af005e1;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;two&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; or &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;three-year&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; period. The restrictions lapse over time for these service-based RSUs. In the event of termination of the holder&#x2019;s continuous service to the Company, any unvested portion of the service-based RSUs are cancelled. For the year ended &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;December 31, 2022 and 2021, the Company recognized expense of &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1.2&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; and $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;0.3&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million, respectively, related to the service-based RSUs.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;In February 2021, the Company granted performance-based RSUs that vest as to &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="-sec-ix-hidden:F_f41dc902-b0a0-44c4-a2f2-3886c58e26bf;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;one-third&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; on each &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;one-year &lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;anniversary date, subject to achievement of a development milestone and continued service to the Company. In February 2022, a portion of the performance-based RSUs vested upon achievement of the development milestone and satisfaction of the continued service condition. &lt;/span&gt;&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"/&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;In February and September 2022, the Company granted performance-based RSUs that vest during the applicable performance period, subject to the achievement of certain corporate or department targets and continued service to the Company. In September 2022, a portion of the performance-based RSUs that were granted in February 2022 vested upon achievement of specific targets and satisfaction of the continued service condition. &lt;/span&gt;&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"/&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;As of December 31, 2022, it was probable that the remaining performance conditions would be met for the Company&#x2019;s performance-based RSUs and expense was recognized using the accelerated attribution method. For the year ended December 31, 2022 and 2021, the Company recognized expense of &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1.5&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; and $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;0.8&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million, respectively, related to performance-based RSUs.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The following table summarizes RSU activity for the year ended &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;December 31, 2022:&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:90.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:53.677%;"/&gt;
        &lt;td style="width:1.783%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:19.008%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:2.253%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:19.279999999999998%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Number of&lt;br/&gt;RSUs&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Weighted Average&lt;br/&gt;Fair Value at &lt;br/&gt;Date of Grant per Unit&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Balance outstanding as of December 31, 2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;106,394&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;23.10&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Granted&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1,224,391&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;4.61&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Vested / released&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;103,703&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;8.61&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Cancelled / forfeited&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;131,344&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;5.53&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:5.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Balance outstanding as of December 31, 2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1,095,738&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;5.77&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:2.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;As of December 31, 2022, there was $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;3.9&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million of total unrecognized expense related to RSUs, which is expected to be recognized over a weighted-average period of &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1.4&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; years.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:2.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:2.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The Company recorded stock-based compensation for the periods indicated as follows (in thousands):&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:90.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:66.521%;"/&gt;
        &lt;td style="width:1.603%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:13.025%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:1.603%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:13.249%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Year Ended December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Research and development&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;4,094&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2,966&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;General and administrative&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;6,262&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;5,712&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:5.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Total stock-based compensation&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;10,356&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;8,678&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
    <etnb:NumberOfSharesIssuableUnderShareBasedPaymentArrangement
      contextRef="C_92977a81-ddbb-4449-8219-ba10dfb38d5c"
      decimals="INF"
      id="F_7dfb91c0-bcf9-4e4b-83d6-4baec09bbd81"
      unitRef="U_shares">2844193</etnb:NumberOfSharesIssuableUnderShareBasedPaymentArrangement>
    <etnb:PeriodForIncreaseInNumberOfSharesOfCommonStockReservedForIssuance
      contextRef="C_51c95b33-c300-4ddf-9044-8f1a7525082b"
      id="F_d1c16262-51c8-4ddd-9225-b3f6151eb700">P10Y</etnb:PeriodForIncreaseInNumberOfSharesOfCommonStockReservedForIssuance>
    <etnb:PercentageOfIncreaseInNumberOfSharesOfCapitalStockIssuedAndOutstanding
      contextRef="C_92977a81-ddbb-4449-8219-ba10dfb38d5c"
      decimals="2"
      id="F_a41ab557-7dc1-415f-8b2d-ee67cf3a7b01"
      unitRef="U_pure">0.04</etnb:PercentageOfIncreaseInNumberOfSharesOfCapitalStockIssuedAndOutstanding>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAward
      contextRef="C_8bc8599c-0290-4c23-8007-773265c83e34"
      id="F_c8c31bea-ec79-4d00-a0b1-73afb4bb0be6">The board of directors determines the period over which options become exercisable and options generally vest over a four-year period, with 25% of options vesting on the first anniversary of employment, and thereafter, the remaining options vesting quarterly, over the following 36-month period. The options expire within ten years from the date of grant. The exercise price of awards granted will not be less than the estimated fair value of the shares on the date of grant. The 2019 Plan also permits the board of directors to grant restricted stock units, which are subject to continued service conditions.</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAward>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="C_8bc8599c-0290-4c23-8007-773265c83e34"
      id="F_7cee5955-8158-4596-b82b-911b22bd4c76">P4Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage
      contextRef="C_8bc8599c-0290-4c23-8007-773265c83e34"
      decimals="2"
      id="F_c7479279-1f7f-4f8f-8c5d-a698d8d47c0d"
      unitRef="U_pure">0.25</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage>
    <etnb:ShareBasedCompensationArrangementByShareBasedPaymentAwardRemainingOptionsVestingPeriod
      contextRef="C_8bc8599c-0290-4c23-8007-773265c83e34"
      id="F_feac36f7-be3c-4817-9c8f-371f7b1e03a9">P36M</etnb:ShareBasedCompensationArrangementByShareBasedPaymentAwardRemainingOptionsVestingPeriod>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
      contextRef="C_8bc8599c-0290-4c23-8007-773265c83e34"
      id="F_10058569-3627-4a0f-91f2-61c6b07addd9">P10Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
    <etnb:NumberOfSharesIssuableUnderShareBasedPaymentArrangement
      contextRef="C_9b6ffafb-d759-4fb6-a478-e6f9c964ba52"
      decimals="INF"
      id="F_f6dc3348-60cb-4ac8-b1e5-763ab5f57f82"
      unitRef="U_shares">225188</etnb:NumberOfSharesIssuableUnderShareBasedPaymentArrangement>
    <etnb:PeriodForIncreaseInNumberOfSharesOfCommonStockReservedForIssuance
      contextRef="C_f1a66cb6-d1cc-4146-839d-52664c4b4ab3"
      id="F_3f988196-1c1b-4f46-abb8-e7451c19c191">P10Y</etnb:PeriodForIncreaseInNumberOfSharesOfCommonStockReservedForIssuance>
    <etnb:PercentageOfIncreaseInNumberOfSharesOfCapitalStockIssuedAndOutstanding
      contextRef="C_9b6ffafb-d759-4fb6-a478-e6f9c964ba52"
      decimals="2"
      id="F_1a195cbf-25d2-454d-927e-a41fe4a8ffcc"
      unitRef="U_pure">0.01</etnb:PercentageOfIncreaseInNumberOfSharesOfCapitalStockIssuedAndOutstanding>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent
      contextRef="C_9b6ffafb-d759-4fb6-a478-e6f9c964ba52"
      decimals="2"
      id="F_90ba07fe-60ff-4e3d-94f7-36102125ebfb"
      unitRef="U_pure">0.85</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent>
    <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
      contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698"
      id="F_c372db17-e895-407e-b22d-6c7edbfc75f9">&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The following table summarizes stock option activity for the year ended &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;December 31, 2022:&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:95.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:55.851%;"/&gt;
        &lt;td style="width:0.081%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:10.520999999999999%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:0.081%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:7.231%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:0.081%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:8.775%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:0.269%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:9.112%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Weighted&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Weighted&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Average&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Average&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Remaining&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Aggregate&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Number of&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Exercise&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Contractual&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Intrinsic&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Options&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Price&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Term&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Value&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(In years)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(In thousands)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Balance outstanding as of December 31, 2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2,406,668&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;16.46&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;8.1&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;9,970&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Granted&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1,149,816&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;4.48&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Exercised&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;151,061&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2.09&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Cancelled and forfeited&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;243,506&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;16.34&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:11.0pt;font-family:&amp;quot;Calibri&amp;quot;, sans-serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:11.0pt;font-family:&amp;quot;Calibri&amp;quot;, sans-serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Balance outstanding as of December 31, 2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;3,161,917&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;12.80&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;7.9&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;16,612&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Exercisable as of December 31, 2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1,460,685&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;14.60&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;7.0&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;7,320&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="C_23fb22c1-879a-41c9-8fba-6e9ff39f555d"
      decimals="INF"
      id="F_0237387a-81d5-4fcf-94e1-4afcf56b93cc"
      unitRef="U_shares">2406668</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="C_23fb22c1-879a-41c9-8fba-6e9ff39f555d"
      decimals="2"
      id="F_6e003a85-adf3-480f-b26f-3a661f8bcfd1"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">16.46</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="C_4fde072e-5fc4-4cda-9482-54bac5203fd9"
      id="F_3c3321c2-2a5d-4169-8eb1-058f1be0f24f">P8Y1M6D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="C_23fb22c1-879a-41c9-8fba-6e9ff39f555d"
      decimals="-3"
      id="F_8b8930b9-9abb-4a92-8af3-7c89544e0767"
      unitRef="U_USD">9970000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="C_8bc8599c-0290-4c23-8007-773265c83e34"
      decimals="INF"
      id="F_1a2b74e4-343d-448c-94b2-6d5464d97bfc"
      unitRef="U_shares">1149816</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="C_8bc8599c-0290-4c23-8007-773265c83e34"
      decimals="2"
      id="F_786835ac-5442-42c3-86e1-1700fceeda33"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">4.48</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="C_8bc8599c-0290-4c23-8007-773265c83e34"
      decimals="INF"
      id="F_db04508a-2757-44dc-b8e7-6ac82d42c8bb"
      unitRef="U_shares">151061</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="C_8bc8599c-0290-4c23-8007-773265c83e34"
      decimals="2"
      id="F_c75225de-2692-4a99-b092-0ca75787399a"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">2.09</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
      contextRef="C_8bc8599c-0290-4c23-8007-773265c83e34"
      decimals="INF"
      id="F_e72548a4-3cb8-465a-a14a-f61e4e9290ad"
      unitRef="U_shares">243506</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
      contextRef="C_8bc8599c-0290-4c23-8007-773265c83e34"
      decimals="2"
      id="F_c75dca32-a93d-4154-b345-32d246066cb8"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">16.34</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="C_cd860230-54ad-4af3-82dc-6e430002fe8e"
      decimals="INF"
      id="F_3146bffa-d72e-4c37-8460-0f902e52a1a8"
      unitRef="U_shares">3161917</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="C_cd860230-54ad-4af3-82dc-6e430002fe8e"
      decimals="2"
      id="F_2162f4e0-784b-4565-a056-ca2736ecb2dd"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">12.80</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="C_8bc8599c-0290-4c23-8007-773265c83e34"
      id="F_832ab5d7-e5cc-46e6-8602-5af663a9fb08">P7Y10M24D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="C_cd860230-54ad-4af3-82dc-6e430002fe8e"
      decimals="-3"
      id="F_6d8edb06-5d06-431f-b69f-82ebb2f93faa"
      unitRef="U_USD">16612000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
      contextRef="C_cd860230-54ad-4af3-82dc-6e430002fe8e"
      decimals="INF"
      id="F_40574c18-81cd-4636-97b5-660eb460b920"
      unitRef="U_shares">1460685</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
      contextRef="C_cd860230-54ad-4af3-82dc-6e430002fe8e"
      decimals="2"
      id="F_75221aa4-9995-4583-80e6-9e9fe05fda1b"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">14.60</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
      contextRef="C_8bc8599c-0290-4c23-8007-773265c83e34"
      id="F_eabe6a90-8b32-4062-95cd-0fc5989c97cd">P7Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
      contextRef="C_cd860230-54ad-4af3-82dc-6e430002fe8e"
      decimals="-3"
      id="F_526bfedc-7ac9-4756-baa2-e3592ee0d4e2"
      unitRef="U_USD">7320000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1>
    <us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock
      contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698"
      id="F_eb7aa860-c2dc-403e-a972-d7e1ef9cde20">&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The fair value of stock options granted for the periods presented was estimated at the date of grant using a Black-Scholes option-pricing model with the following assumptions:&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:90.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:59.283%;"/&gt;
        &lt;td style="width:1.994%;"/&gt;
        &lt;td style="width:18.364%;"/&gt;
        &lt;td style="width:1.994%;"/&gt;
        &lt;td style="width:18.364%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="3" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Year Ended December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Expected term (years)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;5.5&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;-&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;6.3&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;5.5&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;-&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;6.1&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Expected volatility&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;89.9&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;-&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;91.0&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;86.9&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;-&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;91.9&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Risk-free interest rate&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:5.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1.6&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;-&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;3.9&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;0.7&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;-&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1.3&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Expected dividend&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:15.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:15.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:2.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;</us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="C_f440b0bc-74ad-45cd-9077-8182fe07c5ea"
      id="F_0eef074f-633a-48fa-9d60-1cf32f173fff">P5Y6M</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="C_a1422313-a35e-45e5-a7d0-20aa6422feb3"
      id="F_5ee5eafa-60bd-4b5b-8a57-bcaa5687c6fb">P6Y3M18D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="C_dc1a49be-d8e3-4484-be45-e163fe0ca28e"
      id="F_4c3af7ec-1886-4331-aee8-bd234e923b25">P5Y6M</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="C_46b0f71c-7508-426b-9a1f-56cebecab4e1"
      id="F_3d7fdcb8-a846-4311-b7be-310b171b8dd4">P6Y1M6D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
      contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698"
      decimals="INF"
      id="F_11ad37f0-9c08-4a4f-9040-b49c569b9f64"
      unitRef="U_pure">0.899</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
      contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698"
      decimals="INF"
      id="F_49b4cb36-c5e3-478b-8687-a880c2afc839"
      unitRef="U_pure">0.910</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
      contextRef="C_7b31e452-ba3b-4180-9ddd-8faae2f90f0c"
      decimals="INF"
      id="F_253466f9-1d27-410d-ab85-e0b01904d632"
      unitRef="U_pure">0.869</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
      contextRef="C_7b31e452-ba3b-4180-9ddd-8faae2f90f0c"
      decimals="INF"
      id="F_9c4c072e-0349-4f86-8edb-4dc9525c8ae6"
      unitRef="U_pure">0.919</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
      contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698"
      decimals="INF"
      id="F_99b13a68-b746-4cba-97b0-0f6ebd0fdecb"
      unitRef="U_pure">0.016</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
      contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698"
      decimals="INF"
      id="F_4bd1ada1-b60d-4e91-980d-ac0cacdf29a9"
      unitRef="U_pure">0.039</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
      contextRef="C_7b31e452-ba3b-4180-9ddd-8faae2f90f0c"
      decimals="INF"
      id="F_e082fa46-28ad-41e4-9fa3-aa99c8274336"
      unitRef="U_pure">0.007</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
      contextRef="C_7b31e452-ba3b-4180-9ddd-8faae2f90f0c"
      decimals="INF"
      id="F_815f5fe9-73a2-48b7-a6cd-3e829983ce46"
      unitRef="U_pure">0.013</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="C_e78e7a90-a47d-407c-a473-ef6d15843240"
      decimals="2"
      id="F_db238d32-e8a9-40a1-a9e3-c7a9f0ef3d61"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">3.38</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="C_a901fd1a-d6e9-4b6f-a2ee-b46b58ae4f7c"
      decimals="2"
      id="F_ab13e6d5-a934-4807-bb9d-4b7a0253325d"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">16.18</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
      contextRef="C_cd860230-54ad-4af3-82dc-6e430002fe8e"
      decimals="-5"
      id="F_dfb0dfca-a15f-4e47-a45d-2ac5bfb10579"
      unitRef="U_USD">12200000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="C_8bc8599c-0290-4c23-8007-773265c83e34"
      id="F_c176ef9e-eb5c-4a55-9a20-74efaf043aad">P2Y2M12D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="C_2b56b0d1-cc3c-4206-95ae-ff3e5aa3e43c"
      id="F_8e75ed7f-74bc-46f2-a178-a1b94ff9629b">P3Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_cd124b4e-13d9-4079-ac85-a4d1fd6601fc"
      decimals="-5"
      id="F_788e02eb-cdae-4598-9952-dbc5a9483909"
      unitRef="U_USD">1200000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_13fd21a7-f190-41ce-8a3b-79cba6a70fbb"
      decimals="-5"
      id="F_2cb172b2-c202-4db6-b892-d686ecc52859"
      unitRef="U_USD">300000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription
      contextRef="C_830ace7d-9785-41d6-a516-94d2fda5e208"
      id="F_34650133-f234-46d4-8b53-9b00c6508f99">In February 2021, the Company granted performance-based RSUs that vest as to one-third on each one-year anniversary date, subject to achievement of a development milestone and continued service to the Company. In February 2022, a portion of the performance-based RSUs vested upon achievement of the development milestone and satisfaction of the continued service condition. </us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="C_3292f652-c40f-4507-b87c-efc3bf396c08"
      id="F_9afdf5c9-4b07-4b2a-9074-aa3763069224">P1Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription
      contextRef="C_e79cc86e-7f21-4169-93d3-9ca5f3198b26"
      id="F_ab86540d-dafc-4585-b349-1e8992df1096">In February and September 2022, the Company granted performance-based RSUs that vest during the applicable performance period, subject to the achievement of certain corporate or department targets and continued service to the Company. In September 2022, a portion of the performance-based RSUs that were granted in February 2022 vested upon achievement of specific targets and satisfaction of the continued service condition. </us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_012d970f-64c4-41b0-8040-d4774ce38bd6"
      decimals="-5"
      id="F_1ba5f397-1377-4474-b378-72435c40f24f"
      unitRef="U_USD">1500000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_87d79f22-a66f-4528-9561-7c899b8a6f71"
      decimals="-5"
      id="F_bc1f3277-780f-4fd1-ad90-3f59669c41d3"
      unitRef="U_USD">800000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock
      contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698"
      id="F_c91b9d92-b766-4819-b2eb-810f3044a491">&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The following table summarizes RSU activity for the year ended &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;December 31, 2022:&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:90.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:53.677%;"/&gt;
        &lt;td style="width:1.783%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:19.008%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:2.253%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:19.279999999999998%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Number of&lt;br/&gt;RSUs&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Weighted Average&lt;br/&gt;Fair Value at &lt;br/&gt;Date of Grant per Unit&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Balance outstanding as of December 31, 2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;106,394&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;23.10&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Granted&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1,224,391&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;4.61&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Vested / released&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;103,703&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;8.61&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Cancelled / forfeited&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;131,344&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;5.53&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:5.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Balance outstanding as of December 31, 2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1,095,738&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;5.77&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="C_42e28a41-a2c7-4703-9012-632c3a4117b3"
      decimals="INF"
      id="F_a3bb308f-9291-40fc-a60d-562a922bb132"
      unitRef="U_shares">106394</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="C_42e28a41-a2c7-4703-9012-632c3a4117b3"
      decimals="2"
      id="F_735d1e5e-d1d7-4287-bfc8-24d4f6a94b56"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">23.10</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="C_d5d69a12-3d32-411c-82ae-eca2bf142f5c"
      decimals="INF"
      id="F_f373d6f6-f96a-4b30-bcef-3fc59bac3957"
      unitRef="U_shares">1224391</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="C_d5d69a12-3d32-411c-82ae-eca2bf142f5c"
      decimals="2"
      id="F_74599355-226a-4383-8d71-401f05ddf660"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">4.61</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="C_d5d69a12-3d32-411c-82ae-eca2bf142f5c"
      decimals="INF"
      id="F_714830a7-5d54-45fc-b3d4-c5211964b792"
      unitRef="U_shares">103703</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="C_d5d69a12-3d32-411c-82ae-eca2bf142f5c"
      decimals="2"
      id="F_523d33b1-a158-4f82-9a80-056d4b56e10d"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">8.61</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="C_d5d69a12-3d32-411c-82ae-eca2bf142f5c"
      decimals="INF"
      id="F_2e4075d4-5a6b-4930-86c1-94c1005b43c3"
      unitRef="U_shares">131344</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="C_d5d69a12-3d32-411c-82ae-eca2bf142f5c"
      decimals="2"
      id="F_67d1fd20-deb8-4d60-a390-06564c545c98"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">5.53</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="C_b3ec4959-576f-4e65-ad23-76ebb075c512"
      decimals="INF"
      id="F_5c3e22c7-e437-4c01-a882-f195c8eff934"
      unitRef="U_shares">1095738</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="C_b3ec4959-576f-4e65-ad23-76ebb075c512"
      decimals="2"
      id="F_80018dbc-35c7-41e0-b2f4-9b844d286cfb"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">5.77</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions
      contextRef="C_b3ec4959-576f-4e65-ad23-76ebb075c512"
      decimals="-5"
      id="F_dc693a49-f801-4c58-b7dc-5a80d7d5bc5e"
      unitRef="U_USD">3900000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="C_d5d69a12-3d32-411c-82ae-eca2bf142f5c"
      id="F_8deb54ef-db19-4e8f-929b-da28ff99f015">P1Y4M24D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock
      contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698"
      id="F_60a629d8-f7f2-4f94-8346-62ee6bf960c1">&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:2.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The Company recorded stock-based compensation for the periods indicated as follows (in thousands):&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:90.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:66.521%;"/&gt;
        &lt;td style="width:1.603%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:13.025%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:1.603%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:13.249%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Year Ended December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Research and development&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;4,094&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2,966&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;General and administrative&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;6,262&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;5,712&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:5.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Total stock-based compensation&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;10,356&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;8,678&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_302d3395-cf3f-4431-8710-ee66bc04c06d"
      decimals="-3"
      id="F_36501638-eafa-4b69-8e8d-0e1737984b6c"
      unitRef="U_USD">4094000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_1993c206-41b8-40d0-bb47-7bbec84e9bd6"
      decimals="-3"
      id="F_16800c04-ee61-49f9-b827-f005905d2a54"
      unitRef="U_USD">2966000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_dbf7afe5-d66f-4aec-9806-312b0e5b4e3e"
      decimals="-3"
      id="F_96f4f085-b097-4401-84d7-f3257887aa46"
      unitRef="U_USD">6262000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_c220af16-8191-4926-94c1-499324d13fdf"
      decimals="-3"
      id="F_893a4ab1-2b28-4d1f-89a0-b9ba32c2f5ee"
      unitRef="U_USD">5712000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698"
      decimals="-3"
      id="F_9bae9e20-7882-4620-a13d-f50bbdafbc5c"
      unitRef="U_USD">10356000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_7b31e452-ba3b-4180-9ddd-8faae2f90f0c"
      decimals="-3"
      id="F_e3fba1d1-2fcb-4bd3-adb9-82ea8f6cf040"
      unitRef="U_USD">8678000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:IncomeTaxDisclosureTextBlock
      contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698"
      id="F_99c7a10b-dff2-4124-8154-32e99ba02921">&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;9&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;. Income Taxes&lt;/span&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Tax Rates Applicable to the Income of the Company and its Subsidiaries&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The Company is taxed according to U.S. federal and state tax laws and Israeli tax laws. The statutory tax rates applicable to the income of the Company and its subsidiaries for the periods presented are as follows:&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:70.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:60.742%;"/&gt;
        &lt;td style="width:1.438%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:16.341%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:1.438%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:16.04%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Year Ended December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;89bio, Inc.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;21&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;21&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;89Bio Ltd.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;23&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;23&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;89bio Management, Inc.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;21&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;21&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;UAB 89bio Lithuania&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;15&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;15&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;&lt;div style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The income tax (expense) benefit for the periods presented is comprised of (in thousands):&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:70.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:59.085%;"/&gt;
        &lt;td style="width:1.409%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:17.119999999999997%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:1.409%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:16.978%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Year Ended December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Current:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:5.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Federal&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:5.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;State&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;3&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:5.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Foreign&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:5.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;16&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:5.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Total&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:15.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:15.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;19&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;3&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Deferred:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:5.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Federal&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:5.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;150&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:5.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;State&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:5.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:5.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Foreign&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:5.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:5.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Total&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:15.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:15.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;150&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:5.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Income tax (expense) benefit&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;19&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;147&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Deferred Income Taxes&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Deferred income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. &lt;/span&gt;&lt;span style="font-size:12.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Significant components of the Company&#x2019;s deferred tax assets for the periods presented are as follows (in thousands):&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:70.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:58.709%;"/&gt;
        &lt;td style="width:1.422%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:17.192%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:1.422%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:17.253%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;As of December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;U.S. net operating loss carryforwards&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;45,002&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;29,094&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Research and development expenses&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;18,927&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;6,529&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Israel net operating loss carryforwards&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;7,385&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;4,262&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Stock-based compensation&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;4,328&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1,969&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Accrued expenses&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;317&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;220&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Operating Lease Liability&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;98&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Other&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;244&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;191&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Gross deferred tax assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;76,301&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;42,265&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Less: valuation allowance&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;75,982&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;42,046&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;Total deferred tax assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;319&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;219&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;  &#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Operating lease right-of-use asset&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;100&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Total deferred tax liabilities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;100&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;Net deferred tax assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;219&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;219&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;As of December 31, 2022 and 2021, the Company recorded a valuation allowance of &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;76.0&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; and $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;42.0&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million, &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;respectively, in respect of deferred tax assets resulting from tax loss carryforwards and other temporary differences. Realization of deferred tax assets is dependent upon future earnings, if any, the time and amount of&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;which &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;are uncertain. The Company regularly assesses the likelihood that its deferred tax assets will be recovered from future taxable income and, to the extent it believes based upon the weight of available evidence that it is more likely than not that all or a portion of deferred tax assets will not be realized, a valuation allowance is established through an adjustment to income tax expense. The valuation allowance increased by &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;34.0&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; in 2022, which primarily relates to significant taxable losses. The Company continues to record a partial valuation allowance against the deferred tax assets in Israel due to achievement of recent profitability and the expectation of future profitability in the jurisdiction.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Available Carryforward Tax Losses and Credits&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;As of December 31, 2022, the Company had an accumulated tax loss carryforward of approximately &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;160.9&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;, &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;169.8&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;, and &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;32.1&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; for Federal, State and Israeli tax purposes, respectively. As of December 31, 2021&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;, the Company had an accumulated tax loss carryforward of approximately $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;138.5&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million and $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;18.5&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million for U.S. and Israeli tax purposes, respectively. &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Federal net operating losses generated after 2017 can be carried forward indefinitely but utilization will be limited to &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;80&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;% of taxable income in the period that net operating losses are being utilized.&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; Carryforward tax losses in California will begin to expire in &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2041&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;. Carryforward tax losses in Israel have no expiration date.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;As of December 31, 2022 and 2021, the Company had federal research and development credit carryforwards of approximately &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;4.3&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; and $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2.1&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million, respectively, which expire beginning in &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2040&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;. As of &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;December 31, 2022 and December 31, 2021, the Company had state research and development credit carryforwards of approximately &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1.8&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; and $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1.1&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million, respectively, which will carry forward indefinitely.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Loss from Operations, Before Income Tax&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The Company recorded a loss from operations, before income tax for the periods presented as follows (in thousands):&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:70.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:57.78%;"/&gt;
        &lt;td style="width:1.96%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:17.165%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:1.96%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:17.135%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Year Ended December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;United States&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;101,938&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;91,141&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Lithuania&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;7&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;10&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Israel&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;62&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;862&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:5.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Net loss before income tax&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;102,007&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;90,269&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Reconciliation of Income Tax (Expense) Benefit&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The reconciliation of income tax (expense) benefit based on the statutory tax rate to the effective tax rate for the periods presented is as follows (in thousands):&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:83.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:64.941%;"/&gt;
        &lt;td style="width:1.837%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:14.007%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:1.208%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:14.007%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Year Ended December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Income tax benefit computed at statutory rates&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;21,429&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;18,757&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Change in valuation allowance&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;33,936&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;20,111&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Foreign rate differential&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;19&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;State income taxes, net of federal benefit&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;5,824&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;State deferred tax true-up due to change in apportionment&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;6,517&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Change in Israel effective tax rate due to the 2019 reorganization&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Research and development credits, net of uncertain tax position&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2,130&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1,331&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Other&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1,984&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;191&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:5.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Income tax (expense) benefit&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:5.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;19&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;147&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:2.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Utilization of U.S. federal and state net operating losses and credit carryforwards may be subject to an annual limitation provided for in Section 382 of the Internal Revenue Code and similar state codes. Any annual limitation could result in a deferral of the utilization of the net operating loss and credit carryforwards.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Unrecognized Tax Benefits&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;A reconciliation of the unrecognized tax benefits for the year ended December 31, 2022 and 2021 is as follows (in thousands):&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:90.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:59.438%;"/&gt;
        &lt;td style="width:1.418%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:16.875000000000004%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:1.431%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:16.837999999999997%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;As of December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Balance beginning of year&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;851&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;329&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Decrease related to prior year positions&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;19&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;35&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Increase related to current year positions&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;752&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;557&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;Balance end of year&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1,584&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;851&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;During the year ended December 31, 2022 and 2021, the amount of gross unrecognized tax benefits increased by &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;0.7&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; and &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;0.5&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;, respectively. If the total amount of unrecognized tax benefits was recognized, it would &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;no&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;t have an impact to the effective tax rate as it would be offset by the reversal of related deferred tax assets which are subject to a full valuation allowance.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The Company recognizes interest and penalties related to uncertain tax positions as part of the income tax provision. As of December 31, 2022 and 2021, such interest and penalties were not material.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The Company is subject to taxation in the United States, California, Colorado, North Carolina and several foreign jurisdictions. To date, the Company has not been subject to any federal or state income tax audits. The Company is currently under examination by the Israeli tax authorities for 2018 and 2019. As of December 31, 2022, all tax years remain open to examination.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;On August 9, 2022 and August 16, 2022, the Creating Helpful Incentives to Produce Semiconductors (&#x201c;CHIPS&#x201d;) Act and the Inflation Reduction Act (&#x201c;IRA&#x201d;), respectively, were signed into law. The CHIPS Act and IRA contain among other things, some income tax provisions that establish a corporate alternative minimum tax and provide tax incentives for semiconductor manufacturing and research. The Company has evaluated the current legislation and at this time, does not anticipate either to have a material impact on its financial statements.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The Tax Cuts and Jobs Act (&#x201c;TCJA&#x201d;) included a change in the treatment of research and development (&#x201c;R&amp;amp;D&#x201d;) expenditures for tax purposes under Section 174. Effective for tax years beginning after December 31, 2021, specified R&amp;amp;D expenditures must undergo a &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;5-year&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; amortization period for domestic spend and a &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;15-year&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; amortization period for foreign spend. Prior to the effective date (2021 tax year and prior), taxpayers were able to immediately expense R&amp;amp;D costs under Section 174(a) or had the option to capitalize and amortize R&amp;amp;D expenditures over a &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;5-year&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; recovery period under Section 174(b). The Company has evaluated the current legislation at this time and prepared the provision by following the treatment of R&amp;amp;D expenditures for tax purposes under Section 174.&lt;/span&gt;&lt;/p&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
    <etnb:ScheduleOfEffectiveIncomeTaxRateOfCompanyAndSubsidiariesTableTextBlock
      contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698"
      id="F_b006d36d-227f-471b-9d27-a6ad0dfc8d1a">&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The Company is taxed according to U.S. federal and state tax laws and Israeli tax laws. The statutory tax rates applicable to the income of the Company and its subsidiaries for the periods presented are as follows:&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:70.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:60.742%;"/&gt;
        &lt;td style="width:1.438%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:16.341%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:1.438%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:16.04%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Year Ended December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;89bio, Inc.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;21&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;21&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;89Bio Ltd.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;23&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;23&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;89bio Management, Inc.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;21&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;21&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;UAB 89bio Lithuania&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;15&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;15&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</etnb:ScheduleOfEffectiveIncomeTaxRateOfCompanyAndSubsidiariesTableTextBlock>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698"
      decimals="2"
      id="F_2c34583f-6a0a-4a57-bac5-20a3516c3931"
      unitRef="U_pure">0.21</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="C_7b31e452-ba3b-4180-9ddd-8faae2f90f0c"
      decimals="2"
      id="F_2fded13a-6a3d-4775-bdaf-25b76b9690a1"
      unitRef="U_pure">0.21</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="C_143dfe4f-b7a0-4c4a-acd0-9cacd6c072d0"
      decimals="2"
      id="F_1bbcc514-6f17-47db-a8c7-fa2f9959c226"
      unitRef="U_pure">0.23</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="C_c47682c6-cd12-4afc-8813-6a33a11740fe"
      decimals="2"
      id="F_8262b022-0a16-4f12-a4f0-5eaa3f0452c0"
      unitRef="U_pure">0.23</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="C_97306f73-aa83-44a7-88e9-fbb26c9074bd"
      decimals="2"
      id="F_ba67dd78-8cda-4844-8bff-afc6b8392ba9"
      unitRef="U_pure">0.21</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="C_e0c8525e-1484-4af4-8900-61b9edf6a79c"
      decimals="2"
      id="F_0aca0556-73eb-4580-a482-04f75f61b6cd"
      unitRef="U_pure">0.21</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="C_2091a5b2-f30d-4935-bc83-ed0ef862f4d5"
      decimals="2"
      id="F_59408670-cf32-4a57-8cd2-1523b5f40e66"
      unitRef="U_pure">0.15</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="C_2ab554fe-0a65-4e18-9da1-d18c79433fba"
      decimals="2"
      id="F_23b2bfb2-a9d4-4ff6-9f58-f369359cbfa8"
      unitRef="U_pure">0.15</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock
      contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698"
      id="F_1104fa9a-1d7c-4367-9f98-680c635be042">&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The income tax (expense) benefit for the periods presented is comprised of (in thousands):&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:70.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:59.085%;"/&gt;
        &lt;td style="width:1.409%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:17.119999999999997%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:1.409%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:16.978%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Year Ended December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Current:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:5.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Federal&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:5.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;State&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;3&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:5.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Foreign&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:5.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;16&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:5.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Total&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:15.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:15.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;19&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;3&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Deferred:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:5.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Federal&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:5.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;150&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:5.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;State&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:5.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:5.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Foreign&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:5.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:5.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Total&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:15.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:15.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;150&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:5.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Income tax (expense) benefit&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;19&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;147&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit
      contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698"
      decimals="-3"
      id="F_9c9025e2-95c3-4c31-889a-4553be9af70d"
      unitRef="U_USD">-3000</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit
      contextRef="C_7b31e452-ba3b-4180-9ddd-8faae2f90f0c"
      decimals="-3"
      id="F_2748fcbd-4d65-46b4-94cc-6ce2a4bf4722"
      unitRef="U_USD">2000</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentForeignTaxExpenseBenefit
      contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698"
      decimals="-3"
      id="F_e1cb0bcb-b587-43e1-b1b7-90b040cd1f72"
      unitRef="U_USD">-16000</us-gaap:CurrentForeignTaxExpenseBenefit>
    <us-gaap:CurrentForeignTaxExpenseBenefit
      contextRef="C_7b31e452-ba3b-4180-9ddd-8faae2f90f0c"
      decimals="-3"
      id="F_00a3d3ee-b06b-477a-9835-cb0442447e34"
      unitRef="U_USD">1000</us-gaap:CurrentForeignTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698"
      decimals="-3"
      id="F_8daf6e3a-8c61-4409-8b67-eb48fc98a946"
      unitRef="U_USD">-19000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="C_7b31e452-ba3b-4180-9ddd-8faae2f90f0c"
      decimals="-3"
      id="F_0eecc895-daca-477c-8670-a0d2fa4de14d"
      unitRef="U_USD">3000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit
      contextRef="C_7b31e452-ba3b-4180-9ddd-8faae2f90f0c"
      decimals="-3"
      id="F_78adf752-25f8-48f0-9568-e36be7e12164"
      unitRef="U_USD">-150000</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="C_7b31e452-ba3b-4180-9ddd-8faae2f90f0c"
      decimals="-3"
      id="F_d4f87b4d-36f1-47af-9311-27128b6c1df5"
      unitRef="U_USD">-150000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698"
      decimals="-3"
      id="F_50bac7b3-621d-49f7-8565-152b32def7f1"
      unitRef="U_USD">19000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="C_7b31e452-ba3b-4180-9ddd-8faae2f90f0c"
      decimals="-3"
      id="F_00ddbb10-14c6-4f09-92f5-2b2c1a2be965"
      unitRef="U_USD">-147000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock
      contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698"
      id="F_9ee8bc24-e03d-435b-af30-b742d720c103">&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Significant components of the Company&#x2019;s deferred tax assets for the periods presented are as follows (in thousands):&lt;/span&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:70.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:58.709%;"/&gt;
        &lt;td style="width:1.422%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:17.192%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:1.422%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:17.253%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;As of December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;U.S. net operating loss carryforwards&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;45,002&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;29,094&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Research and development expenses&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;18,927&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;6,529&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Israel net operating loss carryforwards&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;7,385&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;4,262&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Stock-based compensation&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;4,328&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1,969&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Accrued expenses&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;317&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;220&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Operating Lease Liability&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;98&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Other&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;244&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;191&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Gross deferred tax assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;76,301&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;42,265&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Less: valuation allowance&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;75,982&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;42,046&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;Total deferred tax assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;319&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;219&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;  &#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Operating lease right-of-use asset&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;100&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Total deferred tax liabilities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;100&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;Net deferred tax assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;219&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;219&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:middle;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards
      contextRef="C_fda4865a-3df9-43f1-b274-1756046b954d"
      decimals="-3"
      id="F_b18b43e0-c87b-436b-8d72-b0fbbe7bc05b"
      unitRef="U_USD">45002000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards
      contextRef="C_a4e466da-eda8-431d-8082-79eb5a6b4d5f"
      decimals="-3"
      id="F_4ba5aeb6-3dc9-4689-b8e6-8a632921308c"
      unitRef="U_USD">29094000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsInProcessResearchAndDevelopment
      contextRef="C_85e3a5e5-8ff2-4682-901b-9d79336e863a"
      decimals="-3"
      id="F_697d8023-7ee9-40d5-af80-e8b8b70ac349"
      unitRef="U_USD">18927000</us-gaap:DeferredTaxAssetsInProcessResearchAndDevelopment>
    <us-gaap:DeferredTaxAssetsInProcessResearchAndDevelopment
      contextRef="C_21f769c6-c78d-41d0-b871-ec3d93d7d343"
      decimals="-3"
      id="F_5d71d059-8937-4983-8fa6-2d85ac09ee9a"
      unitRef="U_USD">6529000</us-gaap:DeferredTaxAssetsInProcessResearchAndDevelopment>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards
      contextRef="C_4aecf5de-d743-4793-84fb-ed9efd04841d"
      decimals="-3"
      id="F_b3f669b0-917c-40d8-a65e-abae0f94682c"
      unitRef="U_USD">7385000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards
      contextRef="C_8abdad68-ec68-4b1c-a08b-9c7a8ad9e2f6"
      decimals="-3"
      id="F_6317aebd-fdc9-4fde-bd5a-1ed6f01d825c"
      unitRef="U_USD">4262000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
      contextRef="C_85e3a5e5-8ff2-4682-901b-9d79336e863a"
      decimals="-3"
      id="F_1bb39bb6-5354-46bd-bb13-0f6840c9b4c8"
      unitRef="U_USD">4328000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
      contextRef="C_21f769c6-c78d-41d0-b871-ec3d93d7d343"
      decimals="-3"
      id="F_37c179a7-38fe-48a7-9803-e25cd7d78af9"
      unitRef="U_USD">1969000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
      contextRef="C_85e3a5e5-8ff2-4682-901b-9d79336e863a"
      decimals="-3"
      id="F_9eb86cbb-e751-418d-895f-eda422b6ba31"
      unitRef="U_USD">317000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
      contextRef="C_21f769c6-c78d-41d0-b871-ec3d93d7d343"
      decimals="-3"
      id="F_e7232eef-7906-45a9-8897-add4b24ba226"
      unitRef="U_USD">220000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities>
    <etnb:DeferredTaxAssetsLeaseLiability
      contextRef="C_85e3a5e5-8ff2-4682-901b-9d79336e863a"
      decimals="-3"
      id="F_9f9676de-c7c6-4a76-bd29-a3c8c27eb05c"
      unitRef="U_USD">98000</etnb:DeferredTaxAssetsLeaseLiability>
    <us-gaap:DeferredTaxAssetsOther
      contextRef="C_85e3a5e5-8ff2-4682-901b-9d79336e863a"
      decimals="-3"
      id="F_083f6274-9cc4-4a3c-8ee3-1aa60427d20a"
      unitRef="U_USD">244000</us-gaap:DeferredTaxAssetsOther>
    <us-gaap:DeferredTaxAssetsOther
      contextRef="C_21f769c6-c78d-41d0-b871-ec3d93d7d343"
      decimals="-3"
      id="F_3388bb9b-a07e-4d1e-891e-24334bf62767"
      unitRef="U_USD">191000</us-gaap:DeferredTaxAssetsOther>
    <us-gaap:DeferredTaxAssetsGross
      contextRef="C_85e3a5e5-8ff2-4682-901b-9d79336e863a"
      decimals="-3"
      id="F_fbfc8448-f34f-4a99-ac40-fea38ccd916c"
      unitRef="U_USD">76301000</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsGross
      contextRef="C_21f769c6-c78d-41d0-b871-ec3d93d7d343"
      decimals="-3"
      id="F_7c86aad0-a9d3-4d80-b86d-3c7e52c67203"
      unitRef="U_USD">42265000</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="C_85e3a5e5-8ff2-4682-901b-9d79336e863a"
      decimals="-3"
      id="F_5f5574ed-45c9-42a3-8cce-7903e37faf7b"
      unitRef="U_USD">75982000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="C_21f769c6-c78d-41d0-b871-ec3d93d7d343"
      decimals="-3"
      id="F_aad6fc21-746e-468e-b3db-1eaf25c413c5"
      unitRef="U_USD">42046000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsNet
      contextRef="C_85e3a5e5-8ff2-4682-901b-9d79336e863a"
      decimals="-3"
      id="F_9c606ad4-d1ce-48d6-8fe4-95c93b4afe7c"
      unitRef="U_USD">319000</us-gaap:DeferredTaxAssetsNet>
    <us-gaap:DeferredTaxAssetsNet
      contextRef="C_21f769c6-c78d-41d0-b871-ec3d93d7d343"
      decimals="-3"
      id="F_8e542958-18ca-4b97-b326-cbf72e7ff8d8"
      unitRef="U_USD">219000</us-gaap:DeferredTaxAssetsNet>
    <etnb:DeferredTaxLiabilitiesRightsOfUseAssets
      contextRef="C_85e3a5e5-8ff2-4682-901b-9d79336e863a"
      decimals="-3"
      id="F_1a79c331-59c6-43d4-8fa0-d9ba21d7bcc9"
      unitRef="U_USD">100000</etnb:DeferredTaxLiabilitiesRightsOfUseAssets>
    <us-gaap:DeferredIncomeTaxLiabilities
      contextRef="C_85e3a5e5-8ff2-4682-901b-9d79336e863a"
      decimals="-3"
      id="F_9f2b0941-11b4-4601-92c7-fd544460b374"
      unitRef="U_USD">100000</us-gaap:DeferredIncomeTaxLiabilities>
    <us-gaap:DeferredTaxAssetsLiabilitiesNet
      contextRef="C_85e3a5e5-8ff2-4682-901b-9d79336e863a"
      decimals="-3"
      id="F_262577e5-e871-453e-9b91-9ef63bdb0a51"
      unitRef="U_USD">219000</us-gaap:DeferredTaxAssetsLiabilitiesNet>
    <us-gaap:DeferredTaxAssetsLiabilitiesNet
      contextRef="C_21f769c6-c78d-41d0-b871-ec3d93d7d343"
      decimals="-3"
      id="F_7af9d06d-e0e8-42fc-93ed-ce13f31b7602"
      unitRef="U_USD">219000</us-gaap:DeferredTaxAssetsLiabilitiesNet>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="C_85e3a5e5-8ff2-4682-901b-9d79336e863a"
      decimals="-5"
      id="F_cfc9cc06-f56b-4c9b-93db-8570b664567b"
      unitRef="U_USD">76000000.0</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="C_21f769c6-c78d-41d0-b871-ec3d93d7d343"
      decimals="-5"
      id="F_b59a0ecd-85f9-4354-a104-34d64cddc3f4"
      unitRef="U_USD">42000000.0</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount
      contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698"
      decimals="-5"
      id="F_6b7669cc-0cdb-40d3-8e3c-8e31ba46ceff"
      unitRef="U_USD">34000000.0</us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount>
    <etnb:AccumulatedTaxLossCarryForward
      contextRef="C_4052b109-a3b7-4114-87b7-faa0a4118dc7"
      decimals="-5"
      id="F_cb60df1e-a62e-4400-b875-a954e11c46b0"
      unitRef="U_USD">160900000</etnb:AccumulatedTaxLossCarryForward>
    <etnb:AccumulatedTaxLossCarryForward
      contextRef="C_cb272169-7edb-4636-b3d0-11b4570d0a11"
      decimals="-5"
      id="F_e667a75b-4e5d-4017-84ca-d47be55ab30e"
      unitRef="U_USD">169800000</etnb:AccumulatedTaxLossCarryForward>
    <etnb:AccumulatedTaxLossCarryForward
      contextRef="C_4aecf5de-d743-4793-84fb-ed9efd04841d"
      decimals="-5"
      id="F_2a2b20c2-74da-4a62-8a42-1088ecdc3b9e"
      unitRef="U_USD">32100000</etnb:AccumulatedTaxLossCarryForward>
    <etnb:AccumulatedTaxLossCarryForward
      contextRef="C_a4e466da-eda8-431d-8082-79eb5a6b4d5f"
      decimals="-5"
      id="F_a106afb8-6d50-495a-b68e-51bee674fb6a"
      unitRef="U_USD">138500000</etnb:AccumulatedTaxLossCarryForward>
    <etnb:AccumulatedTaxLossCarryForward
      contextRef="C_8abdad68-ec68-4b1c-a08b-9c7a8ad9e2f6"
      decimals="-5"
      id="F_2eed3462-1cae-42ce-aea7-ce175618b8fa"
      unitRef="U_USD">18500000</etnb:AccumulatedTaxLossCarryForward>
    <us-gaap:OperatingLossCarryforwardsLimitationsOnUse
      contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698"
      id="F_d61a43d4-833b-4bce-ada9-c4a680ea458e">Federal net operating losses generated after 2017 can be carried forward indefinitely but utilization will be limited to 80% of taxable income in the period that net operating losses are being utilized.</us-gaap:OperatingLossCarryforwardsLimitationsOnUse>
    <etnb:TaxableIncomeUtilizationPercentage
      contextRef="C_85e3a5e5-8ff2-4682-901b-9d79336e863a"
      decimals="2"
      id="F_f981b803-8be3-472b-978f-19640c5a146b"
      unitRef="U_pure">0.80</etnb:TaxableIncomeUtilizationPercentage>
    <etnb:TaxCreditCarryforwardExpirationYear
      contextRef="C_17d9d5b5-1459-459f-8bc2-52f76629e915"
      id="F_f03728b9-f3a0-4411-853f-c58b61d7fe4b">2041</etnb:TaxCreditCarryforwardExpirationYear>
    <etnb:DeferredTaxAssetsTaxCreditCarryforwardsResearchFederal
      contextRef="C_85e3a5e5-8ff2-4682-901b-9d79336e863a"
      decimals="-5"
      id="F_3923cb43-895e-47f8-8754-b43f58eb3457"
      unitRef="U_USD">4300000</etnb:DeferredTaxAssetsTaxCreditCarryforwardsResearchFederal>
    <etnb:DeferredTaxAssetsTaxCreditCarryforwardsResearchFederal
      contextRef="C_21f769c6-c78d-41d0-b871-ec3d93d7d343"
      decimals="-5"
      id="F_39c4a63c-7d1c-4a56-acd4-c5148de8b44b"
      unitRef="U_USD">2100000</etnb:DeferredTaxAssetsTaxCreditCarryforwardsResearchFederal>
    <etnb:TaxCreditCarryforwardExpirationYear
      contextRef="C_c6fb4616-5254-4cb5-bb2e-278e7e88bcc9"
      id="F_bd5b0e30-ced2-4393-83fb-1b30c1833f73">2040</etnb:TaxCreditCarryforwardExpirationYear>
    <us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch
      contextRef="C_85e3a5e5-8ff2-4682-901b-9d79336e863a"
      decimals="-5"
      id="F_f6b723c3-4b0b-45df-aa4d-6357788a87cf"
      unitRef="U_USD">1800000</us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch>
    <us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch
      contextRef="C_21f769c6-c78d-41d0-b871-ec3d93d7d343"
      decimals="-5"
      id="F_6f08064f-20f2-450f-a9e2-4ecaca6e8cec"
      unitRef="U_USD">1100000</us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch>
    <us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock
      contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698"
      id="F_b473e33d-3470-46ea-9f97-c44f10917a54">&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The Company recorded a loss from operations, before income tax for the periods presented as follows (in thousands):&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:70.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:57.78%;"/&gt;
        &lt;td style="width:1.96%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:17.165%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:1.96%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:17.135%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Year Ended December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;United States&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;101,938&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;91,141&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Lithuania&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;7&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;10&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Israel&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;62&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;862&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:5.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Net loss before income tax&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;102,007&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;90,269&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="C_b88d9973-f0e9-45f8-b4fb-a6e4faea7667"
      decimals="-3"
      id="F_9633075e-6cc9-4027-8faf-5f07ef2997f2"
      unitRef="U_USD">-101938000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="C_7c6e4cd6-6b45-4e07-9ce7-b8efe5b967e5"
      decimals="-3"
      id="F_4489adc4-7cd2-4d72-9fd3-b7a88bb526a7"
      unitRef="U_USD">-91141000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="C_e52ac035-0be2-420f-b034-790f9ecc0826"
      decimals="-3"
      id="F_e3aa685f-404a-4a57-a481-0f9c9e73dcfa"
      unitRef="U_USD">-7000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="C_9d22496e-a5ce-4a93-a7b9-674d6c8a803f"
      decimals="-3"
      id="F_701ae530-bbaf-4400-9efa-a4ec66bb6681"
      unitRef="U_USD">10000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="C_50e7e18a-0655-4c7d-95a8-7ac3e1648249"
      decimals="-3"
      id="F_7dac9011-f1d0-4013-b7bb-36f8fe4474a2"
      unitRef="U_USD">-62000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="C_da14e69b-ecb1-4491-93da-01275cadc2ed"
      decimals="-3"
      id="F_fe0f9912-3bc5-42c3-bde1-22dc9baa5f91"
      unitRef="U_USD">862000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698"
      decimals="-3"
      id="F_a63c2b44-66ca-490a-aece-f7db8b3094c9"
      unitRef="U_USD">-102007000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="C_7b31e452-ba3b-4180-9ddd-8faae2f90f0c"
      decimals="-3"
      id="F_7f9b91d4-2cc4-46b4-85ab-358994d05e12"
      unitRef="U_USD">-90269000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock
      contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698"
      id="F_63a28050-5c5b-475a-88a3-18753b1196ea">&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The reconciliation of income tax (expense) benefit based on the statutory tax rate to the effective tax rate for the periods presented is as follows (in thousands):&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:83.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:64.941%;"/&gt;
        &lt;td style="width:1.837%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:14.007%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:1.208%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:14.007%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Year Ended December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Income tax benefit computed at statutory rates&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;21,429&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;18,757&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Change in valuation allowance&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;33,936&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;20,111&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Foreign rate differential&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;19&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;State income taxes, net of federal benefit&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;5,824&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;State deferred tax true-up due to change in apportionment&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;6,517&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Change in Israel effective tax rate due to the 2019 reorganization&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Research and development credits, net of uncertain tax position&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2,130&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1,331&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Other&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1,984&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;191&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:5.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Income tax (expense) benefit&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:5.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;19&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;147&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock>
    <us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
      contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698"
      decimals="-3"
      id="F_c31d9355-1a30-4b09-ab8b-2e301e067e21"
      unitRef="U_USD">21429000</us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate>
    <us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
      contextRef="C_7b31e452-ba3b-4180-9ddd-8faae2f90f0c"
      decimals="-3"
      id="F_9b1855e7-0699-43a6-a085-79d68217b1a9"
      unitRef="U_USD">18757000</us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate>
    <us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698"
      decimals="-3"
      id="F_537eb6a6-a7e5-4045-8211-8bb061eda495"
      unitRef="U_USD">-33936000</us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="C_7b31e452-ba3b-4180-9ddd-8faae2f90f0c"
      decimals="-3"
      id="F_6b55e942-a21d-4134-b351-3f8f8cfeea3d"
      unitRef="U_USD">-20111000</us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential
      contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698"
      decimals="-3"
      id="F_b3d2a43b-81a9-4e36-b72a-35fb0c3ca2f3"
      unitRef="U_USD">1000</us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential
      contextRef="C_7b31e452-ba3b-4180-9ddd-8faae2f90f0c"
      decimals="-3"
      id="F_16d26989-5d15-454f-84ec-c7c6c77ff9ae"
      unitRef="U_USD">-19000</us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes
      contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698"
      decimals="-3"
      id="F_80e11b62-db05-46b9-91b6-3ea3898ad939"
      unitRef="U_USD">5824000</us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes>
    <etnb:EffectiveIncomeTaxRateReconciliationStateDeferredTaxTrueUpDueToChangeInApportionment
      contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698"
      decimals="-3"
      id="F_f2abfdbb-6bd3-405e-809c-059b439b683b"
      unitRef="U_USD">6517000</etnb:EffectiveIncomeTaxRateReconciliationStateDeferredTaxTrueUpDueToChangeInApportionment>
    <etnb:IncomeTaxReconciliationChangeInEffectiveTaxRateDueToReorganization
      contextRef="C_7b31e452-ba3b-4180-9ddd-8faae2f90f0c"
      decimals="-3"
      id="F_4e8ba513-6082-462d-91fa-7b68365cafce"
      unitRef="U_USD">-2000</etnb:IncomeTaxReconciliationChangeInEffectiveTaxRateDueToReorganization>
    <us-gaap:IncomeTaxReconciliationNondeductibleExpenseResearchAndDevelopment
      contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698"
      decimals="-3"
      id="F_2025a814-3ddb-4280-8b29-8afb272d1298"
      unitRef="U_USD">2130000</us-gaap:IncomeTaxReconciliationNondeductibleExpenseResearchAndDevelopment>
    <us-gaap:IncomeTaxReconciliationNondeductibleExpenseResearchAndDevelopment
      contextRef="C_7b31e452-ba3b-4180-9ddd-8faae2f90f0c"
      decimals="-3"
      id="F_adc2dfa5-d9ae-4b03-bb93-46da20cbf4ca"
      unitRef="U_USD">1331000</us-gaap:IncomeTaxReconciliationNondeductibleExpenseResearchAndDevelopment>
    <us-gaap:IncomeTaxReconciliationOtherAdjustments
      contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698"
      decimals="-3"
      id="F_30bdb12f-3eaf-47d1-8fec-78ab107001dc"
      unitRef="U_USD">-1984000</us-gaap:IncomeTaxReconciliationOtherAdjustments>
    <us-gaap:IncomeTaxReconciliationOtherAdjustments
      contextRef="C_7b31e452-ba3b-4180-9ddd-8faae2f90f0c"
      decimals="-3"
      id="F_015cd470-5b3b-4ed8-9806-7df40d881e0c"
      unitRef="U_USD">191000</us-gaap:IncomeTaxReconciliationOtherAdjustments>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698"
      decimals="-3"
      id="F_4a862614-a5cf-4264-9911-16dc65e06b5f"
      unitRef="U_USD">19000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="C_7b31e452-ba3b-4180-9ddd-8faae2f90f0c"
      decimals="-3"
      id="F_fd7402c2-9bbe-4f9f-ae48-f7b93fe3c095"
      unitRef="U_USD">-147000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock
      contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698"
      id="F_daf4dc8f-b063-4f98-b38e-d989757edeaa">&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;A reconciliation of the unrecognized tax benefits for the year ended December 31, 2022 and 2021 is as follows (in thousands):&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:90.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:59.438%;"/&gt;
        &lt;td style="width:1.418%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:16.875000000000004%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:1.431%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:16.837999999999997%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;As of December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Balance beginning of year&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;851&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;329&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Decrease related to prior year positions&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;19&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;35&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Increase related to current year positions&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;752&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;557&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;Balance end of year&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1,584&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;851&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="C_21f769c6-c78d-41d0-b871-ec3d93d7d343"
      decimals="-3"
      id="F_85bdfa09-b011-4321-9948-d4cf1cc12aff"
      unitRef="U_USD">851000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="C_19418b37-9af5-4eb2-b38a-a9070fc599d5"
      decimals="-3"
      id="F_fa2442a4-d7f3-44ae-a907-566077d26c9d"
      unitRef="U_USD">329000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
      contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698"
      decimals="-3"
      id="F_d310c51d-4889-42d2-a654-bb6f5f605f9e"
      unitRef="U_USD">19000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
      contextRef="C_7b31e452-ba3b-4180-9ddd-8faae2f90f0c"
      decimals="-3"
      id="F_c805c37a-1bbc-4fd1-8753-257b15164b81"
      unitRef="U_USD">35000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
      contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698"
      decimals="-3"
      id="F_ad159e97-7a89-4b73-bb80-8b4246e06691"
      unitRef="U_USD">752000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
      contextRef="C_7b31e452-ba3b-4180-9ddd-8faae2f90f0c"
      decimals="-3"
      id="F_3725cb1b-bfd2-4965-b60f-4f8ff8e0c6de"
      unitRef="U_USD">557000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="C_85e3a5e5-8ff2-4682-901b-9d79336e863a"
      decimals="-3"
      id="F_a24caedd-1ada-4ff0-9a22-a3c867c19bce"
      unitRef="U_USD">1584000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="C_21f769c6-c78d-41d0-b871-ec3d93d7d343"
      decimals="-3"
      id="F_f417cdbf-b023-4531-a127-373f86354d59"
      unitRef="U_USD">851000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefitsPeriodIncreaseDecrease
      contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698"
      decimals="-5"
      id="F_025d4e6d-3aa6-40c0-a67d-c80372f7e393"
      unitRef="U_USD">700000</us-gaap:UnrecognizedTaxBenefitsPeriodIncreaseDecrease>
    <us-gaap:UnrecognizedTaxBenefitsPeriodIncreaseDecrease
      contextRef="C_7b31e452-ba3b-4180-9ddd-8faae2f90f0c"
      decimals="-5"
      id="F_1b6e71cd-258c-41b0-9a9c-9ad1d40f959d"
      unitRef="U_USD">500000</us-gaap:UnrecognizedTaxBenefitsPeriodIncreaseDecrease>
    <us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
      contextRef="C_85e3a5e5-8ff2-4682-901b-9d79336e863a"
      decimals="INF"
      id="F_580b5a69-d6e6-42ca-87d1-84b11e3ba06e"
      unitRef="U_USD">0</us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate>
    <etnb:AmortizationPeriod
      contextRef="C_dd9c4882-66d0-4386-bb9e-0f1c29a674cb"
      id="F_3ceb63ea-3508-49db-98a8-ced42885516a">P5Y</etnb:AmortizationPeriod>
    <etnb:AmortizationPeriod
      contextRef="C_cc8b62e3-7c1c-4b52-9dfb-ede005f6e5b4"
      id="F_939d8b67-e191-46a8-b86f-cc943be314ab">P15Y</etnb:AmortizationPeriod>
    <etnb:AmortizationPeriod
      contextRef="C_302d3395-cf3f-4431-8710-ee66bc04c06d"
      id="F_9e710c9a-e162-4e63-9ce2-b5cc35930214">P5Y</etnb:AmortizationPeriod>
    <us-gaap:EarningsPerShareTextBlock
      contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698"
      id="F_958dcfd7-9392-4a9d-a62a-7601e603d03b">&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;10. Net Loss Per Share&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The following outstanding potentially dilutive common stock equivalents have been excluded from the calculation of diluted net loss per share for the periods indicated due to their anti-dilutive effect:&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:83.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:55.149%;"/&gt;
        &lt;td style="width:0.996%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:18.892999999999997%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:1.009%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:19.953000000000003%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Year Ended December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Stock options to purchase common stock&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;3,161,917&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2,406,668&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Unvested restricted stock units&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1,095,738&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;106,394&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Warrants to purchase common stock&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);top:-4.6899999999999995pt;white-space:pre-wrap;font-weight:normal;font-size:6.7pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;position:relative;min-width:fit-content;"&gt;1&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;13,166,283&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;58,923&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:5.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Total&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;17,423,938&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2,571,985&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;p style="margin-left:9.067%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;vertical-align:super;font-size:5.36pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; The table above excludes pre-funded warrants issued in connection with the July 2022 public offering (see Note 7).&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock
      contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698"
      id="F_f5b34c47-599f-4c39-843e-856714774c61">&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The following outstanding potentially dilutive common stock equivalents have been excluded from the calculation of diluted net loss per share for the periods indicated due to their anti-dilutive effect:&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:83.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:55.149%;"/&gt;
        &lt;td style="width:0.996%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:18.892999999999997%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:1.009%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
        &lt;td style="width:19.953000000000003%;"/&gt;
        &lt;td style="width:1.0%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Year Ended December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Stock options to purchase common stock&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;3,161,917&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2,406,668&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Unvested restricted stock units&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1,095,738&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;106,394&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Warrants to purchase common stock&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);top:-4.6899999999999995pt;white-space:pre-wrap;font-weight:normal;font-size:6.7pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;position:relative;min-width:fit-content;"&gt;1&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;13,166,283&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;58,923&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:5.0pt;word-break:break-word;white-space:pre-wrap;vertical-align:top;"&gt;&lt;p style="margin-left:5.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Total&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;17,423,938&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2,571,985&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;p style="margin-left:9.067%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;vertical-align:super;font-size:5.36pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; The table above excludes pre-funded warrants issued in connection with the July 2022 public offering (see Note 7).&lt;/span&gt;&lt;/p&gt;</us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="C_1987e38f-7346-406e-addf-f3687776929f"
      decimals="0"
      id="F_bdffbec8-ec37-4dc0-a3bd-6731737fc62c"
      unitRef="U_shares">3161917</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="C_71719056-4c35-44bc-be7b-ed47745f7284"
      decimals="0"
      id="F_24abac54-d10e-4031-9ead-051e526446b1"
      unitRef="U_shares">2406668</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="C_3d0b52b1-23df-4031-9043-36966d3bfe8f"
      decimals="0"
      id="F_c3f189e8-44bf-453f-82d9-180a9e7a3d77"
      unitRef="U_shares">1095738</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="C_2927c45f-85bc-4b1d-bb2a-c302c8ed2347"
      decimals="0"
      id="F_bd839aef-8499-4c9d-ae62-3e40aca7e67d"
      unitRef="U_shares">106394</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="C_04dfbd26-115a-4a0f-a7b5-f27eb17ef112"
      decimals="0"
      id="F_590cb022-b1e5-419e-8da0-41c3c99bb51c"
      unitRef="U_shares">13166283</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="C_b7499103-4103-44cf-b691-30ec371253b5"
      decimals="0"
      id="F_4483d3b1-4fde-425c-bc22-b781fd3b52c1"
      unitRef="U_shares">58923</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698"
      decimals="0"
      id="F_be001b23-0505-4a64-98ea-b9e913be8d64"
      unitRef="U_shares">17423938</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="C_7b31e452-ba3b-4180-9ddd-8faae2f90f0c"
      decimals="0"
      id="F_492cf17d-d8d1-4720-9aa9-dceec23d0569"
      unitRef="U_shares">2571985</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:SubsequentEventsTextBlock
      contextRef="C_b714c872-cbb8-40d3-a8b0-eb87e6092698"
      id="F_b162cc02-fa22-44c5-aac6-1ee53d5fa363">&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;11. Subsequent Events&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;2023 Loan Agreement&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;In January 2023, the Company executed the 2023 Loan Agreement with the new lenders named therein. The 2023 Loan Agreement provides up to $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;100.0&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million in aggregate principal in term loans, consisting of a first tranche of $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;25.0&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million that was funded at closing, two subsequent tranches totaling $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;25.0&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million that may be funded upon the achievement of certain time-based, clinical and regulatory milestones, and a fourth tranche of up to $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;50.0&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million that may be funded upon discretionary approval by the lenders.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The term loans under the 2023 Loan Agreement mature on &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;January 1, 2027&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;. The maturity date may be extended to &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;July 1, 2027&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;, provided that the second and third tranches are funded and the Company achieves certain other financing milestones.&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; The term loans bear interest equal to the greater of (i) &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;8.45&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;% and (ii) the sum of (a) the Prime Rate as reported in The Wall Street Journal plus (b) &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;2.25&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;%. &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;Consecutive monthly payments of interest commence in February 2023 and consecutive monthly payments of principal commence in February 2025, or February 2026 provided that certain extension milestones are achieved.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;2021 Loan Agreement&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;In January 2023, the first tranche of $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;25.0&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million that was funded pursuant to the 2023 Loan Agreement was primarily used to repay the Company&#x2019;s outstanding obligations under the 2021 Loan Agreement, including the total principal amount outstanding as of December 31, 2022 of $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;20.0&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million, the final payment fee of $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;1.0&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million and an early prepayment fee of $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;0.4&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million (see Note 6).&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;ATM Facility&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;In January and February 2023, the Company received aggregate proceeds of $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;13.4&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million, net of commissions from sales of &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;968,000&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; shares of its common stock pursuant to the ATM Facility (see Note 7).&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;On &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;February 15, 2023&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;, the Company entered into Amendment No. 1 to the Sales Agreement with the Sales Agent, &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;pursuant to which the Company may offer and sell up to $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;150.0&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; million&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;shares of its common stock, from time to time, through the ATM Facility (see Note 7).&lt;/span&gt;&lt;span style="color:rgba(35,31,32,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;font-style:italic;min-width:fit-content;"&gt;Banking Relationship with SVB&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&amp;quot;Times New Roman&amp;quot;, serif;min-width:fit-content;"&gt;The Company has a banking relationship with SVB. On March 10, 2023, SVB was closed by the California Department of Financial Protection and Innovation, which appointed the Federal Deposit Insurance Corporation ("FDIC") as receiver. On March 12, 2023, the Federal Reserve Board approved actions enabling the FDIC to complete its resolution of SVB in a manner that fully protects all depositors. Based on the foregoing and the Company&#x2019;s analysis of the components of its relationship with SVB, the Company does not expect these events to have a material impact on the Company&#x2019;s consolidated financial statements.&lt;/span&gt;&lt;/p&gt;</us-gaap:SubsequentEventsTextBlock>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="C_2e474f95-87bf-4927-8cbe-0c9312719cd9"
      decimals="-5"
      id="F_250f3579-32aa-4067-b30a-c6c850e2392b"
      unitRef="U_USD">100000000.0</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="C_9b3365b2-21c7-49a6-ad95-a43fd3b9d2c1"
      decimals="-5"
      id="F_3a81caaa-614d-4afe-9463-37608eef01b3"
      unitRef="U_USD">25000000.0</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="C_6cebf0eb-4166-4c8e-ac4c-8137ee3b770e"
      decimals="-5"
      id="F_c8ae72d1-a08d-4c31-9a5d-d0fb52057a2d"
      unitRef="U_USD">25000000.0</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="C_f85e5250-59a9-43e3-a14f-d55368e20822"
      decimals="-5"
      id="F_e1d0f6d1-65f0-4a0f-b8ff-8210c3a8fe5e"
      unitRef="U_USD">50000000.0</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:DebtInstrumentMaturityDateDescription
      contextRef="C_c666f3b9-1ce5-4d4c-88e3-dbd7868d4edb"
      id="F_00fd9a69-ea1e-4ce8-a7ed-1f0236dbca13">The term loans under the 2023 Loan Agreement mature on January 1, 2027. The maturity date may be extended to July 1, 2027, provided that the second and third tranches are funded and the Company achieves certain other financing milestones.</us-gaap:DebtInstrumentMaturityDateDescription>
    <us-gaap:DebtInstrumentMaturityDate
      contextRef="C_c666f3b9-1ce5-4d4c-88e3-dbd7868d4edb"
      id="F_818878ce-e2f2-4cad-a293-90cc035a783d">2027-01-01</us-gaap:DebtInstrumentMaturityDate>
    <us-gaap:DebtInstrumentMaturityDate
      contextRef="C_5e92a8a9-dc98-44f0-9e1f-f9aa3e8099bf"
      id="F_38c8456c-2931-41c2-8f17-ce28f37db620">2027-07-01</us-gaap:DebtInstrumentMaturityDate>
    <us-gaap:DebtInstrumentInterestRateDuringPeriod
      contextRef="C_c666f3b9-1ce5-4d4c-88e3-dbd7868d4edb"
      decimals="4"
      id="F_ebd67b85-3c4d-4e59-8fd4-9daa4e1cd52d"
      unitRef="U_pure">0.0845</us-gaap:DebtInstrumentInterestRateDuringPeriod>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="C_c666f3b9-1ce5-4d4c-88e3-dbd7868d4edb"
      decimals="4"
      id="F_4fd19ea5-c95f-44ce-bd71-4b84ce1a40ac"
      unitRef="U_pure">0.0225</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:LineOfCreditFacilityAverageOutstandingAmount
      contextRef="C_46a37282-7c21-4f91-b5bc-d6bf1cfad31b"
      decimals="-5"
      id="F_ec1d53a3-ac20-4683-9cb9-ab7e91a74720"
      unitRef="U_USD">25000000.0</us-gaap:LineOfCreditFacilityAverageOutstandingAmount>
    <us-gaap:DebtInstrumentAnnualPrincipalPayment
      contextRef="C_37523fff-f632-40a8-b39a-8f096f5c4549"
      decimals="-5"
      id="F_6b02aa1f-0ea5-46d2-b15a-be5ecdb3d257"
      unitRef="U_USD">20000000.0</us-gaap:DebtInstrumentAnnualPrincipalPayment>
    <etnb:DebtInstrumentFinalPaymentFee
      contextRef="C_37523fff-f632-40a8-b39a-8f096f5c4549"
      decimals="-5"
      id="F_c092b305-ae4f-462f-9e01-347412132d4c"
      unitRef="U_USD">1000000.0</etnb:DebtInstrumentFinalPaymentFee>
    <etnb:DebtInstrumentEarlyPrepaymentFee
      contextRef="C_37523fff-f632-40a8-b39a-8f096f5c4549"
      decimals="-5"
      id="F_0626e92e-01c2-406c-afb5-45150d4651cc"
      unitRef="U_USD">400000</etnb:DebtInstrumentEarlyPrepaymentFee>
    <us-gaap:SaleOfStockDescriptionOfTransaction
      contextRef="C_3b993bd4-a1f0-42fb-959d-d02b87902727"
      id="F_6ed6bb53-49a7-4407-8cfa-543542aefddb">In January and February 2023, the Company received aggregate proceeds of $13.4 million, net of commissions from sales of 968,000 shares of its common stock pursuant to the ATM Facility (see Note 7).</us-gaap:SaleOfStockDescriptionOfTransaction>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="C_3c40b2dc-88af-4c40-8a0c-0d6d05ae9073"
      decimals="-5"
      id="F_5e35967c-2dbe-4613-bf07-12a501e39854"
      unitRef="U_USD">13400000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="C_3c40b2dc-88af-4c40-8a0c-0d6d05ae9073"
      decimals="0"
      id="F_4062acbb-5208-4011-91d1-dd07822f6b73"
      unitRef="U_shares">968000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:SaleOfStockTransactionDate
      contextRef="C_6201b105-b38d-4bd4-81b7-a6dfd189c83e"
      id="F_9d2d50c2-71ba-4686-9667-01ed53611669">2023-02-15</us-gaap:SaleOfStockTransactionDate>
    <etnb:MaximumAmountOfEquitySharesIssuable
      contextRef="C_8c46fb5d-0dfa-460a-9514-f05dd04eb080"
      decimals="-5"
      id="F_754f7ed1-f421-4d1a-b9ce-c78ddea47202"
      unitRef="U_USD">150000000.0</etnb:MaximumAmountOfEquitySharesIssuable>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>72
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M!,E G%C,_"B(1G8)I+.C=-(9[*.+@FLCG=1^MR5*4^:L3 $O>O>GT R%[ZW
M?X(GD767^?) Q\FW7$M\I\"XT2+]MA%YQJ1Z^TM,\.)#+27U@WUO[63N9V^N
M7RG:<>XMBQ,WB\-&:\U@^61(F5F8HC?>F>=AD!T2P4Z[8E.$O:GGU1^D-A1
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MY8EWF,[;'L4[C'";!="VA2A:=Q:WA@[R/D>'S+(A1PZ>S5#3!I1F06DVZ9M
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M55N@- M*LZ$T!TIS+Q@I#YK1A]("*"U$T;JJ:]T^]"/KMUQ\I;H\R^ *"34
M06D6%3EQ--X';$.3.E":"Z5Y4)H/I0506HBB=:7:6H2HW"(TY I9*E@(1-4,
MDR^(4&,/E&9!:3:4YD!I[F6#Y4&3^E!: *6%*%I7:*T-B,IM0+)K9&G?X3(F
M*E5I3UI0FPZ49D%I-I3F0&DNE.9!:3Z4%D!IX073O+M&?&O3T>0VG2%7R6I]
M+\BXMT+>0IYPJ-*@- M*LZ$T!TISH30/2O.AM."B61FB<G9EUOIV-+EO1WZ=
M+!6J[4A\;1PC1O7=AC>_R3,/UAO4?B/H@\'_=@G-Z$!IKJ#]NCG5>LL20;/Z
M4%H@Z,-8XW_A"85;$8/JVID*T]I@-+D-YK(+9<420-H,%E#:$DJSM+XEQ% -
M4S7FO1N10(TM4)H+I7E0F@^E!5!:B*(=%3IY=:N[^C:1OT3Y8Y(6RH8]5'CU
M\]08*?GQSHO')V6V.]S][EM6EMGV\'#-HA7+ZPVJ]Q^RK'QY4M]0[W3_RYO_
M U!+ P04    " "9E6Y6-PV, AL(  !?)P  &    'AL+W=O<FMS:&5E=',O
M<VAE970V+GAM;+5:;7/B.!+^*RINZVJF:A@LV<8FEU"587;K]L/>I2:[=Y^%
M+8)N;(N5!$GNUU]+.!@L60DYYDL"IM7NI[O5_>CE^E'([VK-F$9/==6HF]%:
MZ\W59***-:NI^BPVK(%?5D+65,-7^3!1&\EH:0?5U81$T7124]Z,YM?VV9V<
M7XNMKGC#[B12V[JF\OD+J\3CS0B/7AY\XP]K;1Y,YM<;^L#NF?YC<R?AV^2@
MI>0U:Q07#9)L=3.ZQ5>+)#$#K,2_.'M41Y^1@;(4XKOY\FMY,XJ,1:QBA38J
M*/S;L06K*J,)[/BS53HZO-,,//[\HOT7"Q[ +*EB"U']FY=Z?3/*1ZAD*[JM
M]#?Q^'?6 DJ-OD)4ROY%CZUL-$+%5FE1MX/!@IHW^__TJ77$T0 \'1A V@&D
M/R 9&!"W V(+=&^9A?65:CJ_EN(122,-VLP'ZQL[&M#PQH3Q7DOXE<,X/5^(
M1HF*EU2S$MUK^ <QT@J)%5I0M4:_0)P5&J,_[K^B#S]]1#\AWJ#?UV*K:%.J
MZXD&&XRF2=&^[\O^?63@?9B@WT2CUPK]W)2L/%4P >,/",@+@B\DJ/$K*SZC
M&']")"+$8]#B[<-QP)SXX-#8ZHN''&J\MK)>6TE1(YAPDFK>/.PSEFO.U)7/
M;WNUB5^MF<U7:D,+=C."Z:J8W+'1_*]_P=/H;S[,%U)VXH'DX($DI'W^#R@^
ME5#>Y-B/S.Q(4V%V\S&.P//3Z\GNV'Z/W"S")KX[CV7IP;(T&)O;\C\PH_8)
MK@54H4(T!:\8:EJ3S5/SN3!!W"J8$I#M;XY@>LD(7DC9B9^F!S]-@Q&\UZ+X
M/C;5L42%J*%E*&J*K@_T7M/T*%(XBM-^/%VI?)KE_FAF!RNS5_/L RT*R8QM
M'Q&MA=3\O]929#K$CO**+BLVAFXW5A3BK%BQE3: /BB98^1XED<])*Y0/DW]
M0/(#D#P(Y/;$\!5TH:5&7*DM;0H& 5"0KE!MT0&K$5KQAE9H0Y]-.J,58SY$
MN6-L-DUZ@%R9*<[\@&8'0+-P9$0SME.HFSH5@VQ"[,GDDM?4F9M'6=HS-?C6
M=\X)''6=,@JB^LI ;<$'9T([_,23?00>F6SF=S8^:N'X%<-63$J8JYH^(:H4
MT_[&C)UW]Y/;(S+&:31@(.D,).&>N*;- U.]8FH-M8E=<;KDU7!A;=5?J+)>
M2MNI,SI^@(/-=WXGV8;RT@(7>LTDT#R('DSB0.AB)RYQ'.-^]%RI<3K-!IHF
M[OHY#C?TVZ(06],SH=J8>NJU,''>G4[36=]"5RK)AOH [MHZ#G9#8Z#<0OZW
MY<7OPM178)P)X$HE.)D.&-CU4QQNJ/_LU<&7A'_V6NHVRS'.^V4[_,;W9G'7
M>_'KS?=5EN1%Y^FR.8YF3B0\<AEP!CP0BZ[9XOPL@LZ;'5-OH7<XV,7/KD(7
MTG;JA:Y#XW"+OI.B8*QL?6#(T;X4P\*X94B&9)Q-H;"GC>,\FSK1]<@E>3)$
M\$G7I$FX2=]M9;&&*?8^\XG;GJ'_D>FLSV>]@@DFT4"O)%TS)^%F?@)@(\VT
MTL\V-.S/+=\8MN>UW-.YL[[1'IEI/&!PU]Q)L%]VE>!#6PH^&K-W'%;W:/GL
MG5Y> ,0U+HYG2=P'X<IE.!W@4*3KRN2\9;NAU[ V?+TJD(NNVR^E[=0+7:<G
MX4Y_6A4.2Q#(1%@&UK#P4&9E:+/QD4I)#2F VK_9+BM>@!CP4'#9)[N&AD&G
M:QBO]UQ"D.<D[O.&L-GO=4O'+TB87[S1+> )JL= Z<8UE=_!!?^'7UP>0O(D
M=2:#*Q:3?&@R='2%A.G*&_%N-_"1/3%9<&5_?<D)+R+?1D%.^H!^!*LA':LA
M85;S7N#[QV)CEH9^]"Z;B:/^XM CE.0#2W'2\1T2WETX!]//]W=WD+5M!_("
M<;<+'!+MD<%),H"C8RSD%<;2;G68/.-ZO195:<HSK'FA5TI6V1ULNZNGM.2%
M^=8B:_A 2KHD9$QF>1_-C]AUB#M"$[]":$["IYFL425H@U:TL"N(,XI*^$UG
M;S&[% C/9ND /X\[ A2'"="!3QRS"%\[]D)T*0[&6>XLE3UR),ZS(>,[,A2_
M@0S9W0[3#2P,TRSM!\/?=L!!H4!^LD^/,M4(>/&X;(=D3HIZI,9)F@W&XN@L
M([Q7L3@+ '0_M&0/O&E,H Q]A;8G2B\N=ZLB)6!R'Y@K-LM)-+!A$'<\)P[S
MG/-Q,;-;$T3DV0!)2=JO\3ZQ$^"GB#J*$H>/-A:BA@+^<G1W7N+YCZ,N>IIQ
M*6VGWND(31PF-(/Q]B)WF8HWDAXQDL0#*]BXXR!QF(-\>T-5<(E"OP=[1,C
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M 'Y?":%?OI@7'.[4S?\'4$L#!!0    ( )F5;E:F]TGNHP4  +T,   8
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M*&4K95=Q*&GD.%[+5M5H9"=*R6N51G(>MO:A"33)MD" :0##H7_]GN^<TQ>
MX,PXR=8^).:00/>YW[OUW:'UG[NMM7UQMZN;[OLGV[[??_OT:5=N[<YTRW9O
M&_IEW?J=Z>E/OWG:[;TU%;^TJY]>/GOV]=.=<<V35]_Q=^_]J^_:H:]=8]_[
MHAMV.^./KVW='KY_\OQ)^.*#VVQ[?/'TU7=[L[$WMO^T?^_IKZ=QE<KM;-.Y
MMBF\77__Y.KYMZ^_PO/\P"_.'KKL<P%,5FW[&7^\K;Y_\@P V=J6/58P])];
M>VWK&@L1&/_0-9_$+?%B_CFL_B/C3KBL3&>OV_KOKNJWWS_YYDE1V;49ZOY#
M>_BK57S^A/7*MN[X_XN#//O5BR=%.71]N].7"8*=:^2_YD[ID+WPS;,S+USJ
M"Y<,MVS$4+XQO7GUG6\/A<?3M!H^,*K\-@'G&C#EIO?TJZ/W^E<WPHRB71<W
M;M.XM2M-TQ=79=D.3>^:3?&^K5WI;/?=TY[VPUM/2UW[M:Q]>6;MYY?%3VW3
M;[OBAZ:RU7B!IP1HA/8R0/OZ\MX5W]AR6;QXOB@NGUU>WK/>BXC]"U[OQ9GU
M9M L_OMJU?6>I.5_YC"6];Z:7P\:]&VW-Z7]_@FI2&?]K7WRZH]_>/[ULY?W
M0/M5A/:K^U;_%WEU_]J7R^+1RQ==\=ITKL.3[X%FTQM6L8];6Y1MT]%CE>EM
M5:Q=8YK2F;KHZ!%+RMQWQ=;<VF)E;5,0C?;&TW.NP7LP,:X_D@;T6U+7N.W>
M.UID7Q-S-K:QWM3U$;_;?2_O]K3OI\;AKQOLTQ5?_/$/WUQ>/GOY:7FS+/YR
M=?6>_W[^\LME\<&6M>DZ1H^AOK:^)^N%;5I?'*WQA=EA[RZL?=WN]J8Y8HWG
M?W[9C7',,"-ZD+7TO&Q7F*:B)W>$Y!9&C)"NVRY'WT=(:)F^#23 1^Q:#M[3
ML@+1/J,SL6IO2T: *+$@*'M+/_>%O2-;W=F"6%.YKJ3M !]H3" 2S=I_/SJ+
MXK!UY9:PJHJF+1RM7/8%&^Q]Z[%@0YY%GIQ[FRC.5*%]BFY+PK DD8KL)@BN
M(W!!PB 9C !DXV%QH\7JH;*,N0H5+YQ1@G%S]/5AVT*VVD,#2@RKSE7.>%*H
M97%5UT)HW9Q\04V;62$,&8RF,Z50*G'8UHYLMNFCB"=4EL4GXA3!\4/7NQT+
M+9 3E1!DZ<?'H'>B.E'HB0G_&!R)!GF,AEPLWH!T[<QG6]BX+Q @.1QV>X&_
MWYJ^,.LU.4ZF4F1E4 L"C)ZWO;Q:.[-RM>N=+J6B-WBK&$")L?.Y=R([@&;X
M_##F3/<SX*DFD!X,'F*2GF.#8DG5J^7(S)TGQ\Z0]*@E^"=E;S40]D2/IB5=
M()'H1>%I-3_01^BV\:1%3#Y[2Z'2GGD5T6!<Q2RLC?/%K:D')A4%".5G4E,&
M=<DB%(3:XB'&"*)]'C_$1B1LS:8%4BNV[$.'SUM'RWN8&8:$%($$GM]O"1)/
MH)3TNZY8_4K1"H2'K,X]NQU(__E%M2C.E\..2,:J5+D2Q"-M*_N!=B7"4'0%
M"S74$"R22=K5M[OI-LN"8C2*P,B:L]5D3QX,^T@Y,X%@PVH1FA046-C=BA8/
MP04#1Q^>%P>RK<24ILTU.6TBE""543<$W:O(BAA/.DB[J[R3C:.'&?2U0JJ+
M',?P\7:0$^#E(4_T?$&&7J6V"ZX  @_:>DCV&E%N<H;_DH,B?33\?=M !NF=
MZ&!(GMM=)@$+6/>1U$6G$JWG$4"]([LTF,89DBS;,8P_#+[%7A#.]= P^H1M
MI K03DH5E5=V\_9B9PUL#.L)TQ4+=M"2C ==%*$@![78U@T$(W!&A9=I%!S:
MF*ZG-)DGW#QO=<]L%Y)7J/$OK,8_)4RZXL>(\CESR8"5K8?<DJ'.[0'M@=]H
M\Z3*<R*AOJO@O$'-1FF\9[/&:ZGO'?-T_0!L"S5X;!Q-)_:,/\ /T;I"8(@2
M614 @A\7XO1<E5F6$/O(/HODN/?F:%:U78CLJ_U,9G*_]^T=FP0UE\[G!*J&
M\#VA3O)T07*]*TBMU5G1#PB?&H)O4#Y]/#&Y<R$4KU.W9 0R$$2VQW3EB(<<
M%<GR;\"_[?I%#A:1XM80.>EY"L8_4^SD>:5<"[VN33$&2;B*DH"'R,\2FT1D
M94%76G'I![:B*Q8?2U+++H42Y!KVGRD-X)@3@ :2"WMK(HN/Q1?TI+VCK7G9
M+PLGOH-DT=<C0T;;] >$0(H%!34]Y0Y$-(A-/W'(E1C]>8$_(^S0 XK@[88\
MU&\LTXAVA[T&N37<*,CVZU!M=BI++0DOQ([#)#SEFOW0P]T),=2FG C.LOBK
M([-)+IJ=(:\MFEA1>%7VA+NWM5&WSH$"QR+LH8?5KRA!W,;X+-M8GQ9/K3&?
M"*%J&.+C<:RT)L/6'KIOBW>,X?."A?#RY<\KY)M0CK!X-\".$7:-6!Y;+8I_
M#"V@9/:Q;9"RB+*)#5CAR-OUC.@9((1]N0$& U\J1)<!HK<"QA>9BYQNS^$1
MNRW%YDNFJG7\2B0N@&K27R>8 NJ.XJH:N=L<S*S'K-H2D(WA&"/]T%HS5(/(
M_JM+AK4D^M8@0/9YR1L(A5X$ZGYJ3ND0W^V&O0;%JR-MU/?T#&W9M$$?39!(
MB:+#:UE /!MNLFC/$Y@2M9+P#<$%W >E]F0J/KCN<^;6,NLJ&^^);D0GSNI5
M64;)&0)EN*^T.OM?6=QC<?@V"E5!>T+/U5S#..N ^,O,_!L87%#Q@IAVT=%#
M9!3) 2E>KTWSF8SJONU@S4&EK:V9KG _ &(4_0,]UP\IPA)UC@OLS)$5R.V(
M[2M.+.P=28R:>&A4)3G"))R7[\2E9+A/K=IYM GB?6U*C7YW\O@9P)DQ[&%J
M1V(G>!. 6[?9DJ0;.(,Q>%LR-)#8E"C GQ]#Y$M, ^21#(%!)$530&?13A49
M@D8CW7L9!W0#G0R<S (1-7[DBDE%]I!"TXUOA_U"5Y7T^+B7 -=1TH((%]S9
M]V)BTNK\*TM!C/HW[:WU#1898^ B85IU,_@V5[7R1'5R#FN^ RE:SVG1LOB9
MK27T3$3N$RW'J0^#.A>=KP<.>4)P/,X+B!IM3=;-%,W 21%^YBU\W&+(MT (
M(ID@RXUD:UD!X<SNNB7)8X!#Y': ^QLG@$2T6Z02(2DB%6>R0-K*/L+-QGUQ
M)MU>S,)"(13L3F\V$F65%'NQS:[\L,F3\9>SKX? "%RM;CFHIOBO&@AS8FW%
M\38@P_9L=X82RKX>@ )RB-KV!''<M0=V7:C4P4J@4LO1'JT+V]@] A#2)JGX
M57;70E(0$'?#>HWR+0E<9]96;;_%EZ9DDPE%.X7^P?ULXUODI\2&4))B%=>*
M G91CD_0?'#E$;5VIAE0.,!"0LK]GKZ>!YKU]?=NUZZX7F JTCW-1LW>]5B@
M5=VS@EI4EI=C39B&@<JSH-:<>%"TBL]*+G)_^Z%6"0:++.=N0>E13:,X2W/F
MS*3TQF\LE.>16,'\$8S\"=0CR'KH)_L4RBQJ9+I0.?J!L*-7/1I:A&"F XH?
MNY#V3"UYMR>P8EE(EA=K.TH/Y3FN[I_P3MVF)^)#_+3H7U >@"I,R;]K'$-?
M";.ZEUGZ>-9.S=G"&0 .KJY#\50RNEMH960*V_L?VU92UC>P%%?5CH2M"Q%*
MJ*T8S_%9J MXNP&S6S)E9'"D@B1]!Z[_[W;62PW1U#:D[A1_D1G<6PDY?R4/
MU*%.%@M^G <AX4)XAU*;9SF5H(Z$Y3Q^G 4R0HV%GL'"1FR7Q=OU5.@HH$6O
M(CRSB)_DQ]H<Z5<@,WZ-$A 0@2O/(H/I1:YNS4&Y@,T35\(%=9,;?[*UUB.>
MC_V&;$MA<S _US__\O;-Q?/_)(5KR!R2^"!4(;7RPSX4T1"42:%:,G']=5;"
M5ZB-(EZ38BWAK";(1G/#S ]_$&(;;W8JU<&@"XSVKM>2O!2=>+\3> &=(OJ[
MO6F*&**F"$=4+9;%C97T^$/,QJ=A7=ODJW?R_+PN48)LU]G#E2T=]^_1<O +
MIM0U/_/#'053+-$_PP/A1VE2=+-(9N$)5[DFY2P4NM8J>/O!(]*2-@7ERF6D
M2COXT+#1XCB;VD@BVH/''(@XE,^$0)H__) %TCE]./6H+*P=J13"XQHQ*SU=
M95%E!Z#*+5<H..QNR;@Z.!B-29U5_^ M9972-$>"!3F+5B>L(7T2$IJ5G0F>
MKZ=Q_VQV-!=/T[[V& SK>FBJ6"(.9FEO]I+):[K8,_E'=1DR&QG:^>?4%LO:
MGBBLGH;QH;"-VIF3'4*IOQK5@&!UD,1QQ2NK &DR'HI/DI.CN$6?N+;65JC@
MY'6#/.?[*;7+XOHBEVRW:!5P8-)'U@!J!IU<$(C.E5WU>2ZA]138!@X,E,W+
MXB^AV[T8+7%6@E;VV++KS*1(%P^MM2A#3-X1'[*4>&4E"B<+[/+F851'1 QB
MN/"8%+02@(B6!DB.5G%SY?6Q <E):*26!&PG+RPIF?&6\DV4^#;3?@K7BNZT
MB,1Z$KK-66\D= <?4<(?)V[2<)$N>]9-.VRM5*?8X(N;3C+9W2,'>7:*<2CU
M[IA9RHJ:',)<H%Q&S"!P/;EE $:<L*E0J%K-VW44H2% DL3<L%65DA1EE^&+
MT*RC$,3X*O3 ^-50!ZH&GU<AR4M$TH<&QX'+Q?,V.L2<'/=% =FVM?1ISQ/D
M6&#2@];E.(E,6L]-T1()-5FKDAY"!SZ&Y5"(4?L>PM!EK"&YA>/:UZ;I8I%;
MT-4-6Q^$FW8D@_T9V1*7*)$TTD\<(G&MG*/ O%9^?)"W0"-#0 5B5/47IX5Q
ME+/"S?'%G(QQ35M 6ME1!S+("QF,-2!=L+>\%UJ(7%Z(?4RSCQ'@>E52^@Y\
M)H**%=:(K--!E0NIA49;N2,^H0-_6D$J3DM(L1,Z,00Z.R*6?4YKPL_: CMI
MH"Z+=Y);3<HUAAVOY>)<TS8E H):K%0*;6IY%6:KY0BFX,FO9?':DF%N\ B]
MCE[R1%A#*VO-#MYTH:*,+@='[FS?L[&KFYYX0#K;%9_V;,?#=-/5S:<PUT0;
M/?_ZXAGMI2A]47QL]Q0\?O/59?'EF-"92V,I(1&@E$']G:(/%P&#W'*X#F$L
MT""O("3RJV$)L7L99OEX#D,.U7B>3BRPO,Q3 *JEW I"KJDS4+UOZU1HUD6$
M=VR8X"8I7 8S.+/EH'18889 J\@(Q?)B=2KVA QR19YUS276'[%\PE]+6#O,
MP[+?1#?-!:.HX(\9.HD0^''$V^/H@-.,K&.B1H$1OVC7%_"C@:\??DY\%2*P
M66#*I5Z<>G;YFH,T8D?LQL0DVIIU#Y.X1M##SGY9_#R6XH(V#&5]\I>B'K,F
M/O*):W0-V6WN_'&9)W(K027U]1/8I5!RWS[MJG8;(5P6+D11&K@)AR7WYJBC
M#;=VNK-(9<2MX&:X4QE17G!L*5U82<$X*'#=A)FIG9>VR#BA[;6DT@DNGAXR
MW%E5OW /TQ;DLH:.C5[86;I>#")7.!$A59(8<'F<%W)</W:WTBWEWJXFP1-&
M)YC/$D.[T,R:4=]G:+@U/,'O?BD4*&;VAL*29Z7G)MM/O*0,(F$'R_5D0NTB
M>JC<BV0"I]Y,"$3QI#V@!9</MTWJ$Z0C78L:Q5'J)^):[1VRGDYQ."')A YN
MG(H<,\A'C7MD\IBB[8-74HOBU@*:/,,P5:Y.UD6F'MC+'=S4!/%033[E!>K5
MJ$1Z]9A$$S$\1(I5ZWU[X)P8FYVJ[*E?MCH'@^"(2",M^>"]9%ZW22D)<P%2
M0]'B[4D^JZV@>P92V&1@CTU#P(>9LBG!FTRZXP3(OV$ ZLP\4\J.5.>ZT9@6
M\MY8.9YO-2BY4,X)M47'Y-RC)Y@5G:'KB]2^[^-X#9?/+->A%UFY,]%!7TTC
M3&E@VMNU]2K:'&DU%U%I)2<2@G"?)09QH;@T] @&N_.20:N"'&':. 0)336[
M$[F@II;>V=K=J;)G(=$4*$F4LE[G//@^COBJ,>:0 XI8V^G"8R'C_!!#*N+F
MD].8\;R4BA#R1"?'(6&:/M*@7Q><%U"3K#B"_S3DJ970^TUVMCR7P5!OY@@"
M68+6P68\H38T1W'^_Y7RO _] SR LAEW#A;%?Q$Q1[_9\-NDEB3>6#P<I7Z[
M03HJ%0(&<)_CS3?97\",DO12'WR8,,E*DN%<#Q1+L.M4/Q=:.&'V+%,ABA*S
MY@RJ+)P5WE(PBV'2KM",@G->,O2>MMPET8RN[6$0V=Q(ZS7-7*@EF8-_;4/=
MG<R\!L71# =96%("P:/YO0M1J.=6PWB;A4I!%W1$Z7&&&5)J$=ST"U:$77L;
MJC(G4C5C[P5V5*X!^S3#&TT]_EOD]*=D2Q7-/1)L,4126&*UJ,8J^W:'QT((
M_ZYM-A?O>)9.I]<>44""]ZOQ8LTO!J*GYMA^5DT6,E24]D<2A?)- 0&4B9QR
MBT2&-3GV*<8CUIBC*KE^' *A.* X#G+3F \/261#_W!@L/4KLEF#N!:N=, :
M<M=(]T"U"6E.@MC>.14J"2AQ5"!8:^T0HWJ]QH!; C ,FRI/@KL1O>RE:,;F
M(DYACV<N9Z1[U"\*[;!J*.TC*$**WPX;CG@RU(CR?H.P+(R=SA6LL^J(*3+D
M(]927S8EZKL+R9)3A93U+-6?%]HS##U&+7;+1J$SJ./D$DQD?(G-DM.:R)5.
MU7[(3R6\R4XE_!#\12[K:>+_;">LZX?JJ+JF2T?7,ZX:67_+%7MMR&!P<3_X
M;M"YM) &:N@95SL=84+3"UU%:?*AC'T_>.$,2UPR@J)1Z\IN3;T>AT%BE[IH
M-5GJSY[IT,D[%Y&.(ZM)8A(!R(,XF#R,M$#GCLACF]O6E=JZC,E.SQ-"(4\\
MG8U^Y!QX7(,]UKA@/EL1>.CLRDEMR \VRE_<+06<6J8.T6^2*P4 IWSCY$PU
M5SHS&_+,X@KH;=(-1_AIX\VQ CM?72#8.P9*!T+[";BH/'1QA%A;AQ$B[N5(
M>A9RO1.R*XDQW1R&FA1CR^75STU[:"850CU*PT7CR7J/&[J+%5,Y,F/9\H>)
M[+"DLIGGZ#.XDJO[:WN >Q'@X%^'V,0&NG (\N*IOK*/X$PB^O^3P:M QD7F
M]MWHE(1DX7JF,>8B:K*6Q75R=B)*B3.22O.R,ENK] C^\<STR@GW9/X@'SPX
M/]4V.TS'<['A -S.D9OJT4X/66RJTX\BCD/P4.F-V-3W+*RKZ!$$::X.2-KG
M\F.R;%P,VO*WL>XX6GA9_)W+GT+M]Z$]2,A1VE[<\/&R4<,[] S)^(87R:_8
M.W'*DMGSNW(T3>J>,NHC(1YGOL)?6 '\W1^GY5(HJ],U$$V39L;HEU_0CIBT
M?D+E6LU]*F2%GJJ"RF.;,>*3@X<6WG9Z-C %'Q%)B:N1"2.4JO@HTL,N\L.#
M1_OFAY?'Y;[@K?,%SMAC"O2KN6&:O=VTOYDU&ZOE/PL6YE5\+%'DPVYGO>K(
M]679!$_O!7=+1._:IK&Z,"61XR\B-&AVDD'U7 VQY /:H[6QFB]C@1"9"_$G
M/&76=")2:SU%0'9^P#27CKFR"SGOQ=;T&D,4"YZ3@>O,V_"13BGLU&0/F8Z8
M)I+U%LC6%B=CC&F\ H.!RCDEBVHCRVG.0+&JL;&2EF2[[#>FT51,+2&/7L!1
M>$@[.&;+;=/6[89YM*;DT&7-VTIJ.3)V53/+42?4"#V-@PPZ1S"?*;'MN'C-
MC+C.&3%*D<3O=L$,F ,WNC18X>/PTU.N(4 +9\CDQZ$YF9C7LK)61D?K<U4>
MWD5%B*1)"NT4>BQBU2H*V$F4D.*5^3!_4L \*Y,QWV>SV+D^VTL/*9_MK-'_
MUM;UC*&TT;17OCP3F#-%SYX>#J318#0,C&S8;DHQVQ2O:T.(W)1DDB&5\N)H
MJ.8T-%8:G.@B=ID_QZR@I+L%2 X)#L3!Z#?S,'\JKX_K*-(3>)BPT?3S7@+U
MP]BE$_7Y<'QVOGG!WB8.\^U01,E'_4=)+-D?P\7=XR)]J=MR\>:+Z,-B&"7\
M8.[(T$3/;1ZE&Z\N;0L>Q*15"=HO%SP1>[%&Q<JS.^#((6S)-M%"9$/+1@Z@
MQ4/;FF1\RV>/+K]^R?YM@H(>2[IQC6;1>9 :I_")B^EDN1SRG88,BSD"P;LG
M58O:=^!;=X(D3'UA]GJH.61?Z0209L_[@?*$4@XQ<L+EVF@D95*?C.KX0H$T
M9)>WI[E^$(N1J6"1%>,"NYB7H567P9)VX_2]1/NC&:7(+IM;(^U:R &&V%)"
M.; \EK4>-R6KSSJ&80RRY\=0'.!>?V7AP/![FI4^3E,;,R*5M:$HA 2-JQ5K
MK2;P)"2DL-F8C?A6%,KM/9<<I(1X$6*V<&R 9V?U;)0HE=X!H.%AV%.@69Z*
M)S!0P02-3[@QX<3()0B@P2M,&GS)_&C/ON.^'MKKVKJ/W<E/Z)$CZ>QB=4<0
M'4/CI @S[.)@C\3IU;XECL3LC6-2EGI;71A4W8CO:A53K7_:+#^5/A&Z!'4P
MG)+Q:KE+#4"*AJ-'Y))9,#43ZXUR).+%8()5.6)2,['U7N#7>H;ET'KDA<Z\
M*,>9Q<*%<>H9&\H#.J=LSOU[-[8N7)WC1R]6QPLQN#JM%03L0S2GH^9N)FI^
M_HF3"2D^2O#1<ZAR+'ZS'N4MSMI6;2.1D'2^PPN9 P!JH8 7FK"941K+ET[:
M!.Z?J$IP AD.HS(#5YIY B \*1JB8UL8;>BL%0,1YN[0V$Q/:PF-K_GIU/Q&
MJZ\V"<LL&(\3YT0O,'F<G->>.YH_'Q6>T/SA\_RC%'8N(I+=<UX\!A!F4HA#
M@M*F(RS3#M_#,<R9/I*,-=T'1#;J/@/(N!Z5.A>LS5Q\B"Y4:@O!&.;+I@,'
M&-\>9]EQ0BD+$/,^*%?_\L5"</H@29)AQ@UA-7<(4 X@2JR&T>SA6YEO_&CN
M;!?^Z/F/TS[RH#;<YEWAV)B=L?3RU0+S8]IU-W</W>BA; ^QL>9;>!'I+T_+
M\/$%Q26<J9FK\9U4>F>O)YKT.?3F)"?2<,\-3_WT4!)@7)DPM)IUL,,D-B,A
M9UIY4\*1&8I&[N,(%&>$A,&V,6+:Z"VY#\-P/4%.WID[/17/3-5 03JT]$<(
MSUONCH=9T9R,TU83SP'+)(UZFFB2'\-@'BF0TB,#$V$>Z[MDSX XW(HV&EP5
M+YS7^X4*V;#557:3!(Z^'.3$XJ0.#G>:#GSQ. ^WON90&5]G<98F;X./DVI.
M0U'FY#0D9LDCIBPOL6B3#R#G@1V2[2Z<K(CZN>3+!^40X!M7#U@?LP7OPC5R
M-_ O^M#X;CDI$>[V@UZ,P*X%TA1/#>AY[I, *^5Z\]XK+POF*4)(X@.@_R_P
M].U&QN+C[2-9ZIK&CLZLE%T=DT[PY,N[M5Q/E5WC4 %=&(8S:^*V0%Y'CM'C
M)K9IUB@W%QFE&"X-R.L&)VW+!3N^,E%N1&0.'LU.#@PI*V:>["(4HM]2=YO%
M:SP_C\GC\-M2!'!ZQ^!\:)'-SQ(J%S@U R4(-6<-L./Y&+F$K(ZGSM*X13[9
MTVLV.?3Q-,<JJLQY]!<<N$M#(D?G>C0\P6KV<1ZOZ858*MY>JA'K\>&<;%1A
MF![QR2;['SR^T%2_X]:M#[:4D=.KJN73G[-C]F^;XD>[\@/,(^;J)1Q*5YC,
MOO2ZI?_$$>X?KVY>QQENO2SBZN;3_6/ZG*W/+G[-H]O:&TGC_]=Q"WH_E,MB
MB4H.,71A8)-M;QA"U)AVU !6^9"+0XO/%E4 N?:9Z;@BI>?7.3K(1N;)[]Q<
M,P;)S70Z1"=5,VW'Q=*9'J\8 ?; T-T\Q.%NO-$D:KB-B^#3<S'/+W4(-9[X
M.#W^%L[WM]D\Y4+O5)F,\LLD<C#Q%(]9KR>^3TX$AJ!6\91Q-<%$75J,QS 3
M6?S--"QVX1K":6=8I5;IG8+=,-N/X2[?IL ,BN"RL%=R[#"SR5X6]9=PQ6/E
M0B-#NP7<7HOGJC@;X(1;JXLN9@XZD,$'V.*Y$>7+0H*^0J,^S@*SNR5U,//T
MO,0(AMF!^'4.A6RF0VY,*F6"DFM,RW2M6#X+F620WON/XMGR$JW2.HZYW3>?
M>?+&@Y/.<4I'<NADJD+<A<O7Y2H_>8L3KGP,;\VCY#SFJNUN=NHAR_^@7>/@
M-^^_\M+;Y% UY5'2\:V\L=H0\P5T_2P' 5.YS4_3K[)3F#/C&G-.,I..["+H
ME(7AFCS7#CI376P&5\E0M,#[+%CZT>W5OFW:04\GL)'_VT )<V;@R6:?V.KG
M+Q:9Y7^;KMW1.HE><O5.W-478LU?7'[]9?%M?K%C=A_6N^C99M?-3W<%$(*9
M3R8>-SF%)"#(?SH=PLXWS::)$8X5HA#$:T+&3\LCDI%',SVY[_&^<QK"YNQJ
M4JD7PN//YPXXG\!_RV0,CI=9S].U&]\>^JT6P8^+G!6<RH1S(%&H@T9/A1R+
M3:7\13R=ZMUN5#QS6N9<DP,DC.4>< PO#!V/.@;;&UIA9RQN*O&*Z] [:.46
MJ=-+>K-#O>&TB%YIL99"0J<Q@#9F;1KXT3&4L:%+I,+1V_&]&?.W9<Q? W[V
MQN60TJ5;GKOEW-WV3[-_DP"<Y7]Y@0=JFE[^>8+X;?S'':[DWS1(C\N_#/&3
M@6! U]?TZK/EG__T1 ZBA3_Z=L__PL&J[?MVQQ^WUI"MP /T^[JE&%[_P ;Q
MG[QX];]02P,$%     @ F95N5L *J3[)!   ,PX  !@   !X;"]W;W)K<VAE
M971S+W-H965T.2YX;6S-5]MNVS@0?==7#-2B2 '%EJBK<S&02[M=H%D$3=,^
M+/:!EBF+B"2Z)!77^_4[I!S%R=J.@WW8OM@4R3ES9CAS))XLA+Q3)6,:?M95
MHT[=4NOYT7"H\I+55 W$G#6X4@A94XV/<C94<\GHU!K5U9#X?C*L*6_<\8F=
MNY;C$]'JBC?L6H)JZYK*Y3FKQ.+4#=R'B2]\5FHS,1R?S.F,W3!].[^6^#3L
M4::\9HWBH@')BE/W+#@ZC\Q^N^$;9PNU-@83R42(._/P^_34]0TA5K%<&P2*
M?_?L@E65 4(:/U:8;N_2&*Z/'] _VM@QE@E5[$)4W_E4EZ=NYL*4%;2M]!>Q
M^,16\<0&+Q>5LK^PZ/:&D0MYJ[2H5\;(H.9-]T]_KO*P9I#Y6PS(RH!8WITC
MR_*2:CH^D6(!TNQ&-#.PH5IK),<;<R@W6N(J1SL]_DBYA&^T:AE<,:I:R3#C
M6IT,-8*;+<-\!73> 9$M0 &!*]'H4L&'9LJF3P&&R*JG1AZHG9.=B)<L'T 8
M>$!\0G;@A7VHH<4+7P[UDJN\$B9:!7^>39266!U_;0JZ@XPV0YJ..5)SFK-3
M%UM",7G/W/&[-T'B'^\@'/6$HUWHKSF;G4";:88#V.( OI8,"E%AP_)F!II.
M*@;6T"QJ7+P0]9PVRW=O,A*DQPH*WM FY[0"JA3#374'-P6JH3!>[JT7TX;8
MRGDKI4'&=N(*)DNHV#TSE:]+WE@':S8E9Y+*O%PB-H@"L"Q8/6&R+PTXL$:B
M5;29JO='CHF(VIX_JX74_&_D<=N@9%7/AR8!SJ?>P850&GY#)5/P66 @JDN.
M@X7-EMAU\@Y5LFC1"WRVC -X"T'F$1+AP&:#'#\9=8L.YJMFTB9H3N?(O3,G
M$/B11](1 AU %L%[.Q&,$N=V<#. F;AGLC%G A/QZ)5TL+&U"OR1,<N\($B=
MLQEK\N7SS:$WRI*>U &DF;' 63]#9G(N)-4,I6RB09FSX9JS-7/?B[)LS3PA
MEJ<7D15-+>UIHU]>58^&J1<%D>5( K1(O7 4/3"<8@.*MMGH,/9(D,"H]QB;
M6)T_1'-HO6WCB?&D\1I-XJ-3G(QCYZO0F/F<JA+8CY9C7=E*QG(!>D]Y90K\
M$%]PA_;$ B_S4S,B^', 86K.I5N(HMBYJ+#&><%-<:LCY^(YZEN(,B^.?.>F
MQ.([U$S6S[PHW+D>01 2/(O7TT0V&UNU>\%B@6]NUCT</&>(+9JCN!N5;)$B
MO@S-ROX=^;WK;&PC6#(J#?\4CS4*G;,"$_2XH$LIVED)>B'LA(+$0\3]4_.<
M^>Y,_;*B%OS/HD8P9VFZ1=2ZQ>VB%H^\)$K76C$PK6AFP_0%84/H!/7ET30R
M8F-FB;^'5F5>FB:=+**9?=JLB:F7(D.S,;72E$:!<]4V/.=S#.?I7E3H.%BG
MA!8X%Z4O:Q+Q8G]=>0TK,_?*7B>)YR>)R;Q5I"3N!,E,^^$>@D0PP"#>7Y!&
M^'K)LM=S],-?4H_^W4P;](CX7HHOM!?U"&4+:_^_Z-$J4YL^$(=K'_+86S-[
M7<$,F5=E]TW?S_8WHK/N(O"XO;M.75$Y,SU?L0)-_4$:NR"[*TKWH,7<7@LF
M0N,EPPY+O-4Q:3;@>B&$?G@P#OI[XO@?4$L#!!0    ( )F5;E8HD:37& ,
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MB,8[D+W6VAT7/L#PT"Z_ 5!+ P04    " "9E6Y6\P6C%BD(  !Q%   &0
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M0(/8;BN"Y5%*)Z,)&^?[X/[XPUDR/7WC]X!=6.<BUS@*5NTI,A:=G.2!&EE
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MVVU@&E"3 VYB) ):'"9&Q-N2!'$NLB.J(VB6IASH[0BP3E!0G^R#1"L4I7Z
M,C<YEET8;)]:#];Z>("_0]T"8<2MI09D!OK]WP.J*[/B\:7G<FRCTZ:-GIX
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M3 8+*9 D;!I7O4GE#>!@@6! JK>D[5>$1.1[[1J/Q.PXMB&.(CKSF-+C"[/
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MY6@!OB^5LNT#;=#=X5[^%U!+ P04    " "9E6Y6]ZU>ZO$)  !7'0  &0
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MCQO?\#JQB4S3!U$G(!:!-YM,/'\^%B5AI"2/(YUE"+^DO BPGTC*LI)P4E3
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M\%91D2'WZS0%.#V#W?H#8*,\YW=@ T=*MDL1F+B58OB7;R)$3KU Y%VBXC5
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MRP\RR+,39^?"\6J@\8]H:MP-<LJP4VZ#PZS"OG!V6T\\_:C)!/'Q'G_]23\
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MMJI^@]97G81E%GR.$^-$+S!Z2KEU9.J"F6FO\ 3G]]]*,XCTISPBV3VEQ4,
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MA =9"SEM((-G(%D 7T6MEPHNZASSGP$&9%]G9+ U<AH<1/R(F0<A<R'P@^
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M+W=O<FMS:&5E=',O<VAE970R,RYX;6RM5MN.VS80??=7#)0B;0#7NOFV&]O
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M#'WW5Q!:H&@!-;(D7U/;0"XMNHMMUZC3+19%'\8290TRFE'G$J=_OYR1['6
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MXY#U#EG@W04*+&^99:N%5GO0WIK0_")(#=Y$CDM?E(W5=,O)SZX^4]W_5,;
M&C5L:J817M^QK4#S9I%8"N#-DJ('N^[ LA? T@P^*6EK ^]EB>53@(28'>EE
M!WK7V5G$6RPN($]CR(99=@8O/\K- U[^ MY[IB67NU.YWZ^VQFKJCA_/">[@
M1L_#^1=S:5I6X#*B)V%0/V"T>O5;.AF^.T-V="0[.H>^VM ++)U 4!7\Y:RQ
M3)9$'M;*HK2<"?$+;KEPOJ]A@X73W'*DY#\6PE'^X8-6#=PP43C!PAL@H.!
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M;FW<L8_K5M,Z'5Y>#N(D7._2#7=&IT*]\@O"0*8::=LIZK7]#KIN1^^?>;O
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M&:0)P/>Y$'H[,7M^=\0G_P!02P,$%     @ F95N5N+$@; !!P  )#D  !D
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MSAA-F# 'Z-\GG*OUADFP61@Y_A=02P,$%     @ F95N5OV5R,;+ @    <
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MXEB##;K!]%VY$"6.86JIRR" ;\"*WKYQ ^=3#U6_I>KWH4<_F,04X1<!3NL
MDR; 791KT," ZMNXB=S!Q!^Y?A#:FPXZ@Y;.H)=.\U?,U;&%OD-H07'11: 7
MYL"8#5N2PV/*.SP!U:"E&IQ"WN"5O-[ #?QAM[BCELRH7]R\I.P1H(G;HN)Q
MIK+<7HU[T0X,W+CE.CZFQN,34)VT5">GT'CR2N.1-_'<<;?&KO.<Y9U^E1^
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M:J/F^?$@'TB69!WVFDG5KV>7H3I2 =<!ZG[ F-P/] /*0YK[#U!+ P04
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M0@B/"4SIJS;G[,U-G5;&.02WR+6_(<=RG 9!L_?#[18Y;KW7KN9S+_#-"L:
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MH<H?4LK?&+G.GO.92V-DFKU<,1HS91O YPLIS=,;.\#N4;'I_U!+ P04
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MV&6&LQJD,<#G"R'T9F->T$[_^"]02P,$%     @ F95N5B;2'7NS P  \ \
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M&[MD#+9+QE"[!$H+H+002J-0&H/2(A3-U&!CEXS_%+O$GDMG9?HGL6#+=(@
MFFD(I5$HC4%I$8I626Y8K(60 9?\]GHC\@=Q)Y)$_U34+I7ZV7=PE.1BI?>I
M?OO.[0U/CM\Y;T.GY3ASWD;E\6&#O[W>\@?QB></*J@DB5BIK$:#Z;A'\OAA
MO7\CL^U-3P4@\TS*;%.^7 N^%+D^07V^RC+Y\D9G\)3E7\OJW/X74$L#!!0
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M  \8$H;5>W#G?>2OWE/^^C^8@[]02P,$%     @ F95N5I>*NQS     $P(
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M?GNOS>U*ZUOVO97*SK.-<]O3R<36&VBY_4MO0?F:M38M=_[0W$SLU@!O[ ;
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M9[[L4OEY>;/[]\;NGR?O?@)02P,$%     @ F95N5HHQ=E_/ 0  ,Q\  !H
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M*^JM!'HKZJT$>BOJK01Z*^JM!'HKZJT$>AOJ;01Z&^IM!'H;ZFT$>MM@LX1
M;T.]C4!O0[V-0&]#O8U ;T.]C4!O0[V-0&]#O8U ;T>]G4!O1[V=0&]'O9U
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M?X5//P%02P$"% ,4    " "9E6Y6!T%-8H$   "Q    $
M@ $     9&]C4')O<',O87!P+GAM;%!+ 0(4 Q0    ( )F5;E:D#'&\[@
M "L"   1              "  :\   !D;V-0<F]P<R]C;W)E+GAM;%!+ 0(4
M Q0    ( )F5;E:97)PC$ 8  )PG   3              "  <P!  !X;"]T
M:&5M92]T:&5M93$N>&UL4$L! A0#%     @ F95N5GVGF^VW"   ^S4  !@
M             ("!#0@  'AL+W=O<FMS:&5E=',O<VAE970Q+GAM;%!+ 0(4
M Q0    ( )F5;E;=R=UJ]04    :   8              " @?H0  !X;"]W
M;W)K<VAE971S+W-H965T,BYX;6Q02P$"% ,4    " "9E6Y6]S47']X"  #A
M"0  &               @($E%P  >&PO=V]R:W-H965T<R]S:&5E=#,N>&UL
M4$L! A0#%     @ F95N5N8A$IBY!   U1$  !@              ("!.1H
M 'AL+W=O<FMS:&5E=',O<VAE970T+GAM;%!+ 0(4 Q0    ( )F5;E:?%4%H
M\@D   MS   8              " @2@?  !X;"]W;W)K<VAE971S+W-H965T
M-2YX;6Q02P$"% ,4    " "9E6Y6-PV, AL(  !?)P  &
M@(%0*0  >&PO=V]R:W-H965T<R]S:&5E=#8N>&UL4$L! A0#%     @ F95N
M5J;W2>ZC!0  O0P  !@              ("!H3$  'AL+W=O<FMS:&5E=',O
M<VAE970W+GAM;%!+ 0(4 Q0    ( )F5;E9/.Y/L*Q\  /YB   8
M      " @7HW  !X;"]W;W)K<VAE971S+W-H965T."YX;6Q02P$"% ,4
M" "9E6Y6P JI/LD$   S#@  &               @(';5@  >&PO=V]R:W-H
M965T<R]S:&5E=#DN>&UL4$L! A0#%     @ F95N5BB1I-<8 P  = <  !D
M             ("!VEL  'AL+W=O<FMS:&5E=',O<VAE970Q,"YX;6Q02P$"
M% ,4    " "9E6Y6\P6C%BD(  !Q%   &0              @($I7P  >&PO
M=V]R:W-H965T<R]S:&5E=#$Q+GAM;%!+ 0(4 Q0    ( )F5;E:,'(,V4 H
M '0=   9              " @8EG  !X;"]W;W)K<VAE971S+W-H965T,3(N
M>&UL4$L! A0#%     @ F95N5G___I7T!P  SQ4  !D              ("!
M$'(  'AL+W=O<FMS:&5E=',O<VAE970Q,RYX;6Q02P$"% ,4    " "9E6Y6
M]ZU>ZO$)  !7'0  &0              @($[>@  >&PO=V]R:W-H965T<R]S
M:&5E=#$T+GAM;%!+ 0(4 Q0    ( )F5;E;\]SZ4X@P  .PC   9
M      " @6.$  !X;"]W;W)K<VAE971S+W-H965T,34N>&UL4$L! A0#%
M  @ F95N5H'^$V4[ P  Q@8  !D              ("!?)$  'AL+W=O<FMS
M:&5E=',O<VAE970Q-BYX;6Q02P$"% ,4    " "9E6Y6-Q!BHD8&   T#P
M&0              @('NE   >&PO=V]R:W-H965T<R]S:&5E=#$W+GAM;%!+
M 0(4 Q0    ( )F5;E;W#AV4E"   )YN   9              " @6N;  !X
M;"]W;W)K<VAE971S+W-H965T,3@N>&UL4$L! A0#%     @ F95N5FSHT<$+
M!0  ,0\  !D              ("!-KP  'AL+W=O<FMS:&5E=',O<VAE970Q
M.2YX;6Q02P$"% ,4    " "9E6Y6Y,EG!S\#   !"   &0
M@(%XP0  >&PO=V]R:W-H965T<R]S:&5E=#(P+GAM;%!+ 0(4 Q0    ( )F5
M;E:Y T2Y#@,  !L'   9              " @>[$  !X;"]W;W)K<VAE971S
M+W-H965T,C$N>&UL4$L! A0#%     @ F95N5@K.26 @!0   @T  !D
M         ("!,\@  'AL+W=O<FMS:&5E=',O<VAE970R,BYX;6Q02P$"% ,4
M    " "9E6Y6I^U/]I@#   $"0  &0              @(&*S0  >&PO=V]R
M:W-H965T<R]S:&5E=#(S+GAM;%!+ 0(4 Q0    ( )F5;E;1W(BMPP8  !83
M   9              " @5G1  !X;"]W;W)K<VAE971S+W-H965T,C0N>&UL
M4$L! A0#%     @ F95N5I"H[\YE P  "P<  !D              ("!4]@
M 'AL+W=O<FMS:&5E=',O<VAE970R-2YX;6Q02P$"% ,4    " "9E6Y6RT6]
MT)("  "E!0  &0              @('OVP  >&PO=V]R:W-H965T<R]S:&5E
M=#(V+GAM;%!+ 0(4 Q0    ( )F5;E819"ED[P4  /\H   9
M  " @;C>  !X;"]W;W)K<VAE971S+W-H965T,C<N>&UL4$L! A0#%     @
MF95N5I Y)BK/!P  GCX  !D              ("!WN0  'AL+W=O<FMS:&5E
M=',O<VAE970R."YX;6Q02P$"% ,4    " "9E6Y6,8:?$;4"  #6!@  &0
M            @('D[   >&PO=V]R:W-H965T<R]S:&5E=#(Y+GAM;%!+ 0(4
M Q0    ( )F5;E9]CI*\N@(  $@'   9              " @=#O  !X;"]W
M;W)K<VAE971S+W-H965T,S N>&UL4$L! A0#%     @ F95N5H\N)['7 @
M[@<  !D              ("!P?(  'AL+W=O<FMS:&5E=',O<VAE970S,2YX
M;6Q02P$"% ,4    " "9E6Y6XL2!L $'   D.0  &0              @('/
M]0  >&PO=V]R:W-H965T<R]S:&5E=#,R+GAM;%!+ 0(4 Q0    ( )F5;E;]
ME<C&RP(    '   9              " @0?]  !X;"]W;W)K<VAE971S+W-H
M965T,S,N>&UL4$L! A0#%     @ F95N5IY[ 3]; @  7P4  !D
M     ("!"0 ! 'AL+W=O<FMS:&5E=',O<VAE970S-"YX;6Q02P$"% ,4
M" "9E6Y6T%"A/B@.  !6;0  &0              @(&; @$ >&PO=V]R:W-H
M965T<R]S:&5E=#,U+GAM;%!+ 0(4 Q0    ( )F5;E:047$JY (  " *   9
M              " @?H0 0!X;"]W;W)K<VAE971S+W-H965T,S8N>&UL4$L!
M A0#%     @ F95N5HDSLM/N"P  ;7\  !D              ("!%10! 'AL
M+W=O<FMS:&5E=',O<VAE970S-RYX;6Q02P$"% ,4    " "9E6Y65%CP0. #
M  "!$0  &0              @($Z( $ >&PO=V]R:W-H965T<R]S:&5E=#,X
M+GAM;%!+ 0(4 Q0    ( )F5;E;W==FMJ P  !Q^   9              "
M@5$D 0!X;"]W;W)K<VAE971S+W-H965T,SDN>&UL4$L! A0#%     @ F95N
M5JZ)G_JT!   8A8  !D              ("!,#$! 'AL+W=O<FMS:&5E=',O
M<VAE970T,"YX;6Q02P$"% ,4    " "9E6Y6&#YZ[8X#   S#@  &0
M        @($;-@$ >&PO=V]R:W-H965T<R]S:&5E=#0Q+GAM;%!+ 0(4 Q0
M   ( )F5;E9^YK;=[@,  '@/   9              " @> Y 0!X;"]W;W)K
M<VAE971S+W-H965T-#(N>&UL4$L! A0#%     @ F95N5L=^#MTJ P  T0L
M !D              ("!!3X! 'AL+W=O<FMS:&5E=',O<VAE970T,RYX;6Q0
M2P$"% ,4    " "9E6Y6^2G$&3,#  "P#0  &0              @(%F00$
M>&PO=V]R:W-H965T<R]S:&5E=#0T+GAM;%!+ 0(4 Q0    ( )F5;E8&VC_.
MZ (  ,$)   9              " @=!$ 0!X;"]W;W)K<VAE971S+W-H965T
M-#4N>&UL4$L! A0#%     @ F95N5KNS4QTJ!   9Q$  !D
M ("![T<! 'AL+W=O<FMS:&5E=',O<VAE970T-BYX;6Q02P$"% ,4    " "9
ME6Y6[#90;RP&   V)@  &0              @(%03 $ >&PO=V]R:W-H965T
M<R]S:&5E=#0W+GAM;%!+ 0(4 Q0    ( )F5;E:B%LU^00,  )H-   9
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M970U,BYX;6Q02P$"% ,4    " "9E6Y6E.LI\D8#  #.%   #0
M    @ %[;@$ >&PO<W1Y;&5S+GAM;%!+ 0(4 Q0    ( )F5;E:7BKL<P
M !,"   +              "  >QQ 0!?<F5L<R\N<F5L<U!+ 0(4 Q0    (
M )F5;E9?E8B_+00  /TB   /              "  =5R 0!X;"]W;W)K8F]O
M:RYX;6Q02P$"% ,4    " "9E6Y6BC%V7\\!   S'P  &@
M@ $O=P$ >&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E;'-02P$"% ,4    " "9
ME6Y6,N&!X<<!   2'P  $P              @ $V>0$ 6T-O;G1E;G1?5'EP
=97-=+GAM;%!+!08     /  \ %L0   N>P$    !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.4</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>182</ContextCount>
  <ElementCount>348</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>78</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>5</UnitCount>
  <MyReports>
    <Report instance="etnb-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>100000 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.89bio.com/20221231/taxonomy/role/Role_DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="etnb-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>100010 - Statement - Consolidated Balance Sheets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.89bio.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets</Role>
      <ShortName>Consolidated Balance Sheets</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="etnb-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>100030 - Statement - Consolidated Balance Sheets (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.89bio.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheetsParenthetical</Role>
      <ShortName>Consolidated Balance Sheets (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="etnb-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>100040 - Statement - Consolidated Statements of Operations and Comprehensive Loss</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.89bio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss</Role>
      <ShortName>Consolidated Statements of Operations and Comprehensive Loss</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="etnb-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>100050 - Statement - Consolidated Statements of Stockholders' Equity (Deficit)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.89bio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfStockholdersEquityDeficit</Role>
      <ShortName>Consolidated Statements of Stockholders' Equity (Deficit)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="etnb-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>100070 - Statement - Consolidated Statements of Cash Flows</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.89bio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows</Role>
      <ShortName>Consolidated Statements of Cash Flows</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="etnb-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>100080 - Disclosure - Organization and Basis of Presentation</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureOrganizationAndBasisOfPresentation</Role>
      <ShortName>Organization and Basis of Presentation</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="etnb-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>100090 - Disclosure - Summary of Significant Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPolicies</Role>
      <ShortName>Summary of Significant Accounting Policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="etnb-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>100100 - Disclosure - Fair Value Measurements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureFairValueMeasurements</Role>
      <ShortName>Fair Value Measurements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="etnb-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>100110 - Disclosure - Consolidated Balance Sheet Components</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureConsolidatedBalanceSheetComponents</Role>
      <ShortName>Consolidated Balance Sheet Components</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="etnb-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>100120 - Disclosure - Commitments and Contingencies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureCommitmentsAndContingencies</Role>
      <ShortName>Commitments and Contingencies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="etnb-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>100130 - Disclosure - Term Loan</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureTermLoan</Role>
      <ShortName>Term Loan</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="etnb-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>100140 - Disclosure - Stockholders' Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.89bio.com/20221231/taxonomy/role/DisclosureStockholdersEquity1</Role>
      <ShortName>Stockholders' Equity</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="etnb-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>100150 - Disclosure - Stock-Based Compensation</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureStockBasedCompensation</Role>
      <ShortName>Stock-Based Compensation</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="etnb-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>100160 - Disclosure - Income Taxes</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxes</Role>
      <ShortName>Income Taxes</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="etnb-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>100170 - Disclosure - Net Loss Per Share</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureNetLossPerShare</Role>
      <ShortName>Net Loss Per Share</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="etnb-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>100180 - Disclosure - Subsequent Events</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureSubsequentEvents</Role>
      <ShortName>Subsequent Events</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="etnb-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>100190 - Disclosure - Summary of Significant Accounting Policies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies</Role>
      <ShortName>Summary of Significant Accounting Policies (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPolicies</ParentRole>
      <Position>18</Position>
    </Report>
    <Report instance="etnb-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>100200 - Disclosure - Fair Value Measurements (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureFairValueMeasurementsTables</Role>
      <ShortName>Fair Value Measurements (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureFairValueMeasurements</ParentRole>
      <Position>19</Position>
    </Report>
    <Report instance="etnb-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>100210 - Disclosure - Consolidated Balance Sheet Components (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureConsolidatedBalanceSheetComponentsTables</Role>
      <ShortName>Consolidated Balance Sheet Components (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureConsolidatedBalanceSheetComponents</ParentRole>
      <Position>20</Position>
    </Report>
    <Report instance="etnb-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>100220 - Disclosure - Commitments and Contingencies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesTables</Role>
      <ShortName>Commitments and Contingencies (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureCommitmentsAndContingencies</ParentRole>
      <Position>21</Position>
    </Report>
    <Report instance="etnb-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>100240 - Disclosure - Stock-Based Compensation (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureStockBasedCompensationTables</Role>
      <ShortName>Stock-Based Compensation (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureStockBasedCompensation</ParentRole>
      <Position>22</Position>
    </Report>
    <Report instance="etnb-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>100250 - Disclosure - Stockholders' Equity (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.89bio.com/20221231/taxonomy/role/DisclosureStockholdersEquityTables</Role>
      <ShortName>Stockholders' Equity (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.89bio.com/20221231/taxonomy/role/DisclosureStockholdersEquity1</ParentRole>
      <Position>23</Position>
    </Report>
    <Report instance="etnb-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>100260 - Disclosure - Income Taxes (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesTables</Role>
      <ShortName>Income Taxes (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxes</ParentRole>
      <Position>24</Position>
    </Report>
    <Report instance="etnb-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>100270 - Disclosure - Net Loss Per Share (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureNetLossPerShareTables</Role>
      <ShortName>Net Loss Per Share (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureNetLossPerShare</ParentRole>
      <Position>25</Position>
    </Report>
    <Report instance="etnb-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>100280 - Disclosure - Organization and Basis of Presentation - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureOrganizationAndBasisOfPresentationAdditionalInformationDetails</Role>
      <ShortName>Organization and Basis of Presentation - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>26</Position>
    </Report>
    <Report instance="etnb-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>100290 - Disclosure - Summary of Significant Accounting Policies - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails</Role>
      <ShortName>Summary of Significant Accounting Policies - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>27</Position>
    </Report>
    <Report instance="etnb-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>100300 - Disclosure - Fair Value Measurements - Summary of Financial Assets Measured at Fair Value on Recurring Basis (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureFairValueMeasurementsSummaryOfFinancialAssetsMeasuredAtFairValueOnRecurringBasisDetails</Role>
      <ShortName>Fair Value Measurements - Summary of Financial Assets Measured at Fair Value on Recurring Basis (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>28</Position>
    </Report>
    <Report instance="etnb-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>100310 - Disclosure - Fair Value Measurements - Schedule of Contractual Maturities of Cash Equivalents and Available-for-Sale Securities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfContractualMaturitiesOfCashEquivalentsAndAvailableForSaleSecuritiesDetails</Role>
      <ShortName>Fair Value Measurements - Schedule of Contractual Maturities of Cash Equivalents and Available-for-Sale Securities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>29</Position>
    </Report>
    <Report instance="etnb-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>100320 - Disclosure - Consolidated Balance Sheet Components - Schedule of Prepaid and Other Current Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureConsolidatedBalanceSheetComponentsScheduleOfPrepaidAndOtherCurrentAssetsDetails</Role>
      <ShortName>Consolidated Balance Sheet Components - Schedule of Prepaid and Other Current Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>30</Position>
    </Report>
    <Report instance="etnb-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>100330 - Disclosure - Consolidated Balance Sheet Components - Schedule of Accrued Expenses (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureConsolidatedBalanceSheetComponentsScheduleOfAccruedExpensesDetails</Role>
      <ShortName>Consolidated Balance Sheet Components - Schedule of Accrued Expenses (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>31</Position>
    </Report>
    <Report instance="etnb-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>100340 - Disclosure - Commitments and Contingencies - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails</Role>
      <ShortName>Commitments and Contingencies - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>32</Position>
    </Report>
    <Report instance="etnb-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>100350 - Disclosure - Commitments and Contingencies - Schedule of Future Minimum Lease Payments Under Non-cancellable Operating Lease Obligations (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumLeasePaymentsUnderNonCancellableOperatingLeaseObligationsDetails</Role>
      <ShortName>Commitments and Contingencies - Schedule of Future Minimum Lease Payments Under Non-cancellable Operating Lease Obligations (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>33</Position>
    </Report>
    <Report instance="etnb-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>100360 - Disclosure - Commitments and Contingencies - Schedule of Future Minimum Annual Payments for Operating Leases (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.89bio.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumAnnualPaymentsForOperatingLeasesDetails</Role>
      <ShortName>Commitments and Contingencies - Schedule of Future Minimum Annual Payments for Operating Leases (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>34</Position>
    </Report>
    <Report instance="etnb-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>100370 - Disclosure - Term Loan - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureTermLoanAdditionalInformationDetails</Role>
      <ShortName>Term Loan - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>35</Position>
    </Report>
    <Report instance="etnb-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>100380 - Disclosure - Stockholders' Equity - Schedule of Shares of Common Stock Available for Future Issuance (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.89bio.com/20221231/taxonomy/role/DisclosureStockholdersEquityScheduleOfSharesOfCommonStockAvailableForFutureIssuanceDetails</Role>
      <ShortName>Stockholders' Equity - Schedule of Shares of Common Stock Available for Future Issuance (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>36</Position>
    </Report>
    <Report instance="etnb-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>100390 - Disclosure - Stockholders' Equity - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.89bio.com/20221231/taxonomy/role/DisclosureStockholdersEquityAdditionalInformationDetails</Role>
      <ShortName>Stockholders' Equity - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>37</Position>
    </Report>
    <Report instance="etnb-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>100400 - Disclosure - Stockholders' Equity - Schedule of Outstanding Warrants to Purchase Shares of Common Stock (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.89bio.com/20221231/taxonomy/role/DisclosureStockholdersEquityScheduleOfOutstandingWarrantsToPurchaseSharesOfCommonStockDetails</Role>
      <ShortName>Stockholders' Equity - Schedule of Outstanding Warrants to Purchase Shares of Common Stock (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>38</Position>
    </Report>
    <Report instance="etnb-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>100410 - Disclosure - Stock-Based Compensation - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails</Role>
      <ShortName>Stock-Based Compensation - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>39</Position>
    </Report>
    <Report instance="etnb-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>100420 - Disclosure - Stock-Based Compensation - Summary of Stock Option Activity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockOptionActivityDetails</Role>
      <ShortName>Stock-Based Compensation - Summary of Stock Option Activity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>40</Position>
    </Report>
    <Report instance="etnb-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>100430 - Disclosure - Stock-Based Compensation - Summary of Estimated Fair Value of Stock Options Granted Using Black-Scholes Option-Pricing Model (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfEstimatedFairValueOfStockOptionsGrantedUsingBlackScholesOptionPricingModelDetails</Role>
      <ShortName>Stock-Based Compensation - Summary of Estimated Fair Value of Stock Options Granted Using Black-Scholes Option-Pricing Model (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>41</Position>
    </Report>
    <Report instance="etnb-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>100440 - Disclosure - Stock-Based Compensation - Summary of Restricted Stock Unit Activity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.89bio.com/20221231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfRestrictedStockUnitActivityDetails</Role>
      <ShortName>Stock-Based Compensation - Summary of Restricted Stock Unit Activity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>42</Position>
    </Report>
    <Report instance="etnb-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>100450 - Disclosure - Stock-Based Compensation - Summary of Stock-Based Compensation (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockBasedCompensationDetails</Role>
      <ShortName>Stock-Based Compensation - Summary of Stock-Based Compensation (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>43</Position>
    </Report>
    <Report instance="etnb-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>100460 - Disclosure - Income Taxes - Summary of Statutory Tax Rates Applicable to Income of Company and Subsidiaries (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesSummaryOfStatutoryTaxRatesApplicableToIncomeOfCompanyAndSubsidiariesDetails</Role>
      <ShortName>Income Taxes - Summary of Statutory Tax Rates Applicable to Income of Company and Subsidiaries (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>44</Position>
    </Report>
    <Report instance="etnb-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>100470 - Disclosure - Income Taxes - Summary of Income Tax (Expense) Benefit (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.89bio.com/20221231/taxonomy/role/DisclosureIncomeTaxesSummaryOfIncomeTaxExpenseBenefitDetails</Role>
      <ShortName>Income Taxes - Summary of Income Tax (Expense) Benefit (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>45</Position>
    </Report>
    <Report instance="etnb-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>100480 - Disclosure - Income Taxes - Summary of Components of Deferred Tax Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesSummaryOfComponentsOfDeferredTaxAssetsDetails</Role>
      <ShortName>Income Taxes - Summary of Components of Deferred Tax Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>46</Position>
    </Report>
    <Report instance="etnb-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>100490 - Disclosure - Income Taxes - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetails</Role>
      <ShortName>Income Taxes - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>47</Position>
    </Report>
    <Report instance="etnb-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>100500 - Disclosure - Income Taxes - Summary of Loss from Operations Before Taxes on Income (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesSummaryOfLossFromOperationsBeforeTaxesOnIncomeDetails</Role>
      <ShortName>Income Taxes - Summary of Loss from Operations Before Taxes on Income (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>48</Position>
    </Report>
    <Report instance="etnb-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>100510 - Disclosure - Income Taxes - Summary of Reconciliation of Income Tax (Expense) Benefit Statutory Tax Rate to Effective Tax Rate (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.89bio.com/20221231/taxonomy/role/DisclosureIncomeTaxesSummaryOfReconciliationOfIncomeTaxExpenseBenefitStatutoryTaxRateToEffectiveTaxRateDetails</Role>
      <ShortName>Income Taxes - Summary of Reconciliation of Income Tax (Expense) Benefit Statutory Tax Rate to Effective Tax Rate (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>49</Position>
    </Report>
    <Report instance="etnb-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>100520 - Disclosure - Income Taxes - Summary of a Reconciliation of The Beginning And Ending Amount of Unrecognized Tax Benefits (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.89bio.com/20221231/taxonomy/role/DisclosureIncomeTaxesSummaryOfAReconciliationOfTheBeginningAndEndingAmountOfUnrecognizedTaxBenefitsDetails</Role>
      <ShortName>Income Taxes - Summary of a Reconciliation of The Beginning And Ending Amount of Unrecognized Tax Benefits (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>50</Position>
    </Report>
    <Report instance="etnb-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>100530 - Disclosure - Net Loss Per Share - Schedule of Outstanding Potentially Dilutive Securities Excluded From Calculation of Diluted Net Loss (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureNetLossPerShareScheduleOfOutstandingPotentiallyDilutiveSecuritiesExcludedFromCalculationOfDilutedNetLossDetails</Role>
      <ShortName>Net Loss Per Share - Schedule of Outstanding Potentially Dilutive Securities Excluded From Calculation of Diluted Net Loss (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>51</Position>
    </Report>
    <Report instance="etnb-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>100540 - Disclosure - Subsequent Events - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.89bio.com/20221231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails</Role>
      <ShortName>Subsequent Events - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>52</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <Logs>
    <Log type="Warning">[ix-0514-Hidden-Fact-Eligible-For-Transform] WARN: 5 fact(s) appearing in ix:hidden were eligible for transformation: us-gaap:PropertyPlantAndEquipmentUsefulLife, us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1, us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage, us-gaap:ShortTermLeaseCost, us-gaap:VariableLeasePayment -  etnb-20221231.htm 8</Log>
  </Logs>
  <InputFiles>
    <File doctype="10-K" original="etnb-20221231.htm">etnb-20221231.htm</File>
    <File>etnb-20221231.xsd</File>
    <File>etnb-20221231_cal.xml</File>
    <File>etnb-20221231_def.xml</File>
    <File>etnb-20221231_lab.xml</File>
    <File>etnb-20221231_pre.xml</File>
    <File>etnb-ex23_1.htm</File>
    <File>etnb-ex31_1.htm</File>
    <File>etnb-ex31_2.htm</File>
    <File>etnb-ex32_1.htm</File>
    <File>etnb-ex4_2.htm</File>
  </InputFiles>
  <SupplementalFiles>
    <File>img32108071_0.jpg</File>
    <File>img32108071_1.jpg</File>
    <File>img32108071_2.jpg</File>
    <File>img32108071_3.jpg</File>
    <File>img32108071_4.jpg</File>
    <File>img32108071_5.jpg</File>
    <File>img32108071_6.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="570">http://fasb.org/us-gaap/2022</BaseTaxonomy>
    <BaseTaxonomy items="40">http://xbrl.sec.gov/dei/2022</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>78
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "etnb-20221231.htm": {
   "axisCustom": 0,
   "axisStandard": 26,
   "baseTaxonomies": {
    "http://fasb.org/us-gaap/2022": 570,
    "http://xbrl.sec.gov/dei/2022": 40
   },
   "contextCount": 182,
   "dts": {
    "calculationLink": {
     "local": [
      "etnb-20221231_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "etnb-20221231_def.xml"
     ]
    },
    "inline": {
     "local": [
      "etnb-20221231.htm"
     ]
    },
    "labelLink": {
     "local": [
      "etnb-20221231_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "etnb-20221231_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "etnb-20221231.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd",
      "https://xbrl.sec.gov/country/2022/country-2022.xsd",
      "https://xbrl.sec.gov/dei/2022/dei-2022.xsd",
      "https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd"
     ]
    }
   },
   "elementCount": 563,
   "entityCount": 1,
   "hidden": {
    "http://fasb.org/us-gaap/2022": 9,
    "http://xbrl.sec.gov/dei/2022": 4,
    "total": 13
   },
   "keyCustom": 61,
   "keyStandard": 287,
   "memberCustom": 30,
   "memberStandard": 46,
   "nsprefix": "etnb",
   "nsuri": "http://www.89bio.com/20221231",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "body",
       "html"
      ],
      "baseRef": "etnb-20221231.htm",
      "contextRef": "C_b714c872-cbb8-40d3-a8b0-eb87e6092698",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "100000 - Document - Document and Entity Information",
     "menuCat": "Cover",
     "order": "1",
     "role": "http://www.89bio.com/20221231/taxonomy/role/Role_DocumentDocumentAndEntityInformation",
     "shortName": "Document and Entity Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "body",
       "html"
      ],
      "baseRef": "etnb-20221231.htm",
      "contextRef": "C_b714c872-cbb8-40d3-a8b0-eb87e6092698",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "etnb-20221231.htm",
      "contextRef": "C_b714c872-cbb8-40d3-a8b0-eb87e6092698",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100110 - Disclosure - Consolidated Balance Sheet Components",
     "menuCat": "Notes",
     "order": "10",
     "role": "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureConsolidatedBalanceSheetComponents",
     "shortName": "Consolidated Balance Sheet Components",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "etnb-20221231.htm",
      "contextRef": "C_b714c872-cbb8-40d3-a8b0-eb87e6092698",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "etnb-20221231.htm",
      "contextRef": "C_b714c872-cbb8-40d3-a8b0-eb87e6092698",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100120 - Disclosure - Commitments and Contingencies",
     "menuCat": "Notes",
     "order": "11",
     "role": "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureCommitmentsAndContingencies",
     "shortName": "Commitments and Contingencies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "etnb-20221231.htm",
      "contextRef": "C_b714c872-cbb8-40d3-a8b0-eb87e6092698",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "etnb-20221231.htm",
      "contextRef": "C_b714c872-cbb8-40d3-a8b0-eb87e6092698",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebtTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100130 - Disclosure - Term Loan",
     "menuCat": "Notes",
     "order": "12",
     "role": "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureTermLoan",
     "shortName": "Term Loan",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "etnb-20221231.htm",
      "contextRef": "C_b714c872-cbb8-40d3-a8b0-eb87e6092698",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebtTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "etnb-20221231.htm",
      "contextRef": "C_b714c872-cbb8-40d3-a8b0-eb87e6092698",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100140 - Disclosure - Stockholders' Equity",
     "menuCat": "Notes",
     "order": "13",
     "role": "http://www.89bio.com/20221231/taxonomy/role/DisclosureStockholdersEquity1",
     "shortName": "Stockholders' Equity",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "etnb-20221231.htm",
      "contextRef": "C_b714c872-cbb8-40d3-a8b0-eb87e6092698",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "body",
       "html"
      ],
      "baseRef": "etnb-20221231.htm",
      "contextRef": "C_b714c872-cbb8-40d3-a8b0-eb87e6092698",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100150 - Disclosure - Stock-Based Compensation",
     "menuCat": "Notes",
     "order": "14",
     "role": "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureStockBasedCompensation",
     "shortName": "Stock-Based Compensation",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "body",
       "html"
      ],
      "baseRef": "etnb-20221231.htm",
      "contextRef": "C_b714c872-cbb8-40d3-a8b0-eb87e6092698",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "body",
       "html"
      ],
      "baseRef": "etnb-20221231.htm",
      "contextRef": "C_b714c872-cbb8-40d3-a8b0-eb87e6092698",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100160 - Disclosure - Income Taxes",
     "menuCat": "Notes",
     "order": "15",
     "role": "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxes",
     "shortName": "Income Taxes",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "body",
       "html"
      ],
      "baseRef": "etnb-20221231.htm",
      "contextRef": "C_b714c872-cbb8-40d3-a8b0-eb87e6092698",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "etnb-20221231.htm",
      "contextRef": "C_b714c872-cbb8-40d3-a8b0-eb87e6092698",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100170 - Disclosure - Net Loss Per Share",
     "menuCat": "Notes",
     "order": "16",
     "role": "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureNetLossPerShare",
     "shortName": "Net Loss Per Share",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "etnb-20221231.htm",
      "contextRef": "C_b714c872-cbb8-40d3-a8b0-eb87e6092698",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "etnb-20221231.htm",
      "contextRef": "C_b714c872-cbb8-40d3-a8b0-eb87e6092698",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100180 - Disclosure - Subsequent Events",
     "menuCat": "Notes",
     "order": "17",
     "role": "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureSubsequentEvents",
     "shortName": "Subsequent Events",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "etnb-20221231.htm",
      "contextRef": "C_b714c872-cbb8-40d3-a8b0-eb87e6092698",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "etnb-20221231.htm",
      "contextRef": "C_b714c872-cbb8-40d3-a8b0-eb87e6092698",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100190 - Disclosure - Summary of Significant Accounting Policies (Policies)",
     "menuCat": "Policies",
     "order": "18",
     "role": "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies",
     "shortName": "Summary of Significant Accounting Policies (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "etnb-20221231.htm",
      "contextRef": "C_b714c872-cbb8-40d3-a8b0-eb87e6092698",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "us-gaap:FairValueDisclosuresTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "etnb-20221231.htm",
      "contextRef": "C_b714c872-cbb8-40d3-a8b0-eb87e6092698",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100200 - Disclosure - Fair Value Measurements (Tables)",
     "menuCat": "Tables",
     "order": "19",
     "role": "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureFairValueMeasurementsTables",
     "shortName": "Fair Value Measurements (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "us-gaap:FairValueDisclosuresTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "etnb-20221231.htm",
      "contextRef": "C_b714c872-cbb8-40d3-a8b0-eb87e6092698",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "etnb-20221231.htm",
      "contextRef": "C_85e3a5e5-8ff2-4682-901b-9d79336e863a",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unitRef": "U_USD",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "100010 - Statement - Consolidated Balance Sheets",
     "menuCat": "Statements",
     "order": "2",
     "role": "http://www.89bio.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets",
     "shortName": "Consolidated Balance Sheets",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "etnb-20221231.htm",
      "contextRef": "C_85e3a5e5-8ff2-4682-901b-9d79336e863a",
      "decimals": "-3",
      "lang": null,
      "name": "etnb:ShortTermAvailableForSaleSecuritiesCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "etnb-20221231.htm",
      "contextRef": "C_b714c872-cbb8-40d3-a8b0-eb87e6092698",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "etnb:ScheduleOfPrepaidAndOtherCurrentAssetsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100210 - Disclosure - Consolidated Balance Sheet Components (Tables)",
     "menuCat": "Tables",
     "order": "20",
     "role": "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureConsolidatedBalanceSheetComponentsTables",
     "shortName": "Consolidated Balance Sheet Components (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "etnb-20221231.htm",
      "contextRef": "C_b714c872-cbb8-40d3-a8b0-eb87e6092698",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "etnb:ScheduleOfPrepaidAndOtherCurrentAssetsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "etnb-20221231.htm",
      "contextRef": "C_b714c872-cbb8-40d3-a8b0-eb87e6092698",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100220 - Disclosure - Commitments and Contingencies (Tables)",
     "menuCat": "Tables",
     "order": "21",
     "role": "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesTables",
     "shortName": "Commitments and Contingencies (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "etnb-20221231.htm",
      "contextRef": "C_b714c872-cbb8-40d3-a8b0-eb87e6092698",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "etnb-20221231.htm",
      "contextRef": "C_b714c872-cbb8-40d3-a8b0-eb87e6092698",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100240 - Disclosure - Stock-Based Compensation (Tables)",
     "menuCat": "Tables",
     "order": "22",
     "role": "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureStockBasedCompensationTables",
     "shortName": "Stock-Based Compensation (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "etnb-20221231.htm",
      "contextRef": "C_b714c872-cbb8-40d3-a8b0-eb87e6092698",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "etnb-20221231.htm",
      "contextRef": "C_b714c872-cbb8-40d3-a8b0-eb87e6092698",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "etnb:ScheduleOfCommonStockReservedForIssuanceTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100250 - Disclosure - Stockholders' Equity (Tables)",
     "menuCat": "Tables",
     "order": "23",
     "role": "http://www.89bio.com/20221231/taxonomy/role/DisclosureStockholdersEquityTables",
     "shortName": "Stockholders' Equity (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "etnb-20221231.htm",
      "contextRef": "C_b714c872-cbb8-40d3-a8b0-eb87e6092698",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "etnb:ScheduleOfCommonStockReservedForIssuanceTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "etnb-20221231.htm",
      "contextRef": "C_b714c872-cbb8-40d3-a8b0-eb87e6092698",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "etnb:ScheduleOfEffectiveIncomeTaxRateOfCompanyAndSubsidiariesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100260 - Disclosure - Income Taxes (Tables)",
     "menuCat": "Tables",
     "order": "24",
     "role": "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesTables",
     "shortName": "Income Taxes (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "etnb-20221231.htm",
      "contextRef": "C_b714c872-cbb8-40d3-a8b0-eb87e6092698",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "etnb:ScheduleOfEffectiveIncomeTaxRateOfCompanyAndSubsidiariesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "us-gaap:EarningsPerShareTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "etnb-20221231.htm",
      "contextRef": "C_b714c872-cbb8-40d3-a8b0-eb87e6092698",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100270 - Disclosure - Net Loss Per Share (Tables)",
     "menuCat": "Tables",
     "order": "25",
     "role": "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureNetLossPerShareTables",
     "shortName": "Net Loss Per Share (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "us-gaap:EarningsPerShareTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "etnb-20221231.htm",
      "contextRef": "C_b714c872-cbb8-40d3-a8b0-eb87e6092698",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "etnb-20221231.htm",
      "contextRef": "C_85e3a5e5-8ff2-4682-901b-9d79336e863a",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:CashCashEquivalentsAndShortTermInvestments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100280 - Disclosure - Organization and Basis of Presentation - Additional Information (Details)",
     "menuCat": "Details",
     "order": "26",
     "role": "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureOrganizationAndBasisOfPresentationAdditionalInformationDetails",
     "shortName": "Organization and Basis of Presentation - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "etnb-20221231.htm",
      "contextRef": "C_85e3a5e5-8ff2-4682-901b-9d79336e863a",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:CashCashEquivalentsAndShortTermInvestments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:SegmentReportingPolicyPolicyTextBlock",
       "div",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "etnb-20221231.htm",
      "contextRef": "C_b714c872-cbb8-40d3-a8b0-eb87e6092698",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:NumberOfOperatingSegments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_Segment",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100290 - Disclosure - Summary of Significant Accounting Policies - Additional Information (Details)",
     "menuCat": "Details",
     "order": "27",
     "role": "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails",
     "shortName": "Summary of Significant Accounting Policies - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:SegmentReportingPolicyPolicyTextBlock",
       "div",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "etnb-20221231.htm",
      "contextRef": "C_b714c872-cbb8-40d3-a8b0-eb87e6092698",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:NumberOfOperatingSegments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_Segment",
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock",
       "div",
       "us-gaap:FairValueDisclosuresTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "etnb-20221231.htm",
      "contextRef": "C_85e3a5e5-8ff2-4682-901b-9d79336e863a",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:AvailableForSaleSecuritiesDebtSecurities",
      "reportCount": 1,
      "unitRef": "U_USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100300 - Disclosure - Fair Value Measurements - Summary of Financial Assets Measured at Fair Value on Recurring Basis (Details)",
     "menuCat": "Details",
     "order": "28",
     "role": "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureFairValueMeasurementsSummaryOfFinancialAssetsMeasuredAtFairValueOnRecurringBasisDetails",
     "shortName": "Fair Value Measurements - Summary of Financial Assets Measured at Fair Value on Recurring Basis (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
       "div",
       "us-gaap:FairValueDisclosuresTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "etnb-20221231.htm",
      "contextRef": "C_b49f5ccf-6e36-469f-8160-42229bc94d1d",
      "decimals": "-3",
      "lang": null,
      "name": "us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock",
       "div",
       "us-gaap:FairValueDisclosuresTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "etnb-20221231.htm",
      "contextRef": "C_85e3a5e5-8ff2-4682-901b-9d79336e863a",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100310 - Disclosure - Fair Value Measurements - Schedule of Contractual Maturities of Cash Equivalents and Available-for-Sale Securities (Details)",
     "menuCat": "Details",
     "order": "29",
     "role": "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfContractualMaturitiesOfCashEquivalentsAndAvailableForSaleSecuritiesDetails",
     "shortName": "Fair Value Measurements - Schedule of Contractual Maturities of Cash Equivalents and Available-for-Sale Securities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock",
       "div",
       "us-gaap:FairValueDisclosuresTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "etnb-20221231.htm",
      "contextRef": "C_85e3a5e5-8ff2-4682-901b-9d79336e863a",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "etnb-20221231.htm",
      "contextRef": "C_85e3a5e5-8ff2-4682-901b-9d79336e863a",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:PreferredStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_UnitedStatesOfAmericaDollarsShare",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "100030 - Statement - Consolidated Balance Sheets (Parenthetical)",
     "menuCat": "Statements",
     "order": "3",
     "role": "http://www.89bio.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheetsParenthetical",
     "shortName": "Consolidated Balance Sheets (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "etnb-20221231.htm",
      "contextRef": "C_85e3a5e5-8ff2-4682-901b-9d79336e863a",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:PreferredStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_UnitedStatesOfAmericaDollarsShare",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "etnb:ScheduleOfPrepaidAndOtherCurrentAssetsTableTextBlock",
       "div",
       "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "etnb-20221231.htm",
      "contextRef": "C_85e3a5e5-8ff2-4682-901b-9d79336e863a",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "etnb:PrepaidResearchAndDevelopmentCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100320 - Disclosure - Consolidated Balance Sheet Components - Schedule of Prepaid and Other Current Assets (Details)",
     "menuCat": "Details",
     "order": "30",
     "role": "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureConsolidatedBalanceSheetComponentsScheduleOfPrepaidAndOtherCurrentAssetsDetails",
     "shortName": "Consolidated Balance Sheet Components - Schedule of Prepaid and Other Current Assets (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "etnb:ScheduleOfPrepaidAndOtherCurrentAssetsTableTextBlock",
       "div",
       "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "etnb-20221231.htm",
      "contextRef": "C_85e3a5e5-8ff2-4682-901b-9d79336e863a",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "etnb:PrepaidResearchAndDevelopmentCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
       "div",
       "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "etnb-20221231.htm",
      "contextRef": "C_85e3a5e5-8ff2-4682-901b-9d79336e863a",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "etnb:AccruedResearchAndDevelopmentExpenseCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100330 - Disclosure - Consolidated Balance Sheet Components - Schedule of Accrued Expenses (Details)",
     "menuCat": "Details",
     "order": "31",
     "role": "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureConsolidatedBalanceSheetComponentsScheduleOfAccruedExpensesDetails",
     "shortName": "Consolidated Balance Sheet Components - Schedule of Accrued Expenses (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
       "div",
       "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "etnb-20221231.htm",
      "contextRef": "C_85e3a5e5-8ff2-4682-901b-9d79336e863a",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "etnb:AccruedResearchAndDevelopmentExpenseCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "etnb-20221231.htm",
      "contextRef": "C_24b84e4a-2d9f-418f-bf86-e74e1b8c81af",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:OperatingLeaseRightOfUseAsset",
      "reportCount": 1,
      "unitRef": "U_USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100340 - Disclosure - Commitments and Contingencies - Additional Information (Details)",
     "menuCat": "Details",
     "order": "32",
     "role": "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails",
     "shortName": "Commitments and Contingencies - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "etnb-20221231.htm",
      "contextRef": "C_b714c872-cbb8-40d3-a8b0-eb87e6092698",
      "decimals": "-5",
      "lang": null,
      "name": "us-gaap:LeaseAndRentalExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock",
       "div",
       "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "etnb-20221231.htm",
      "contextRef": "C_85e3a5e5-8ff2-4682-901b-9d79336e863a",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100350 - Disclosure - Commitments and Contingencies - Schedule of Future Minimum Lease Payments Under Non-cancellable Operating Lease Obligations (Details)",
     "menuCat": "Details",
     "order": "33",
     "role": "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumLeasePaymentsUnderNonCancellableOperatingLeaseObligationsDetails",
     "shortName": "Commitments and Contingencies - Schedule of Future Minimum Lease Payments Under Non-cancellable Operating Lease Obligations (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock",
       "div",
       "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "etnb-20221231.htm",
      "contextRef": "C_85e3a5e5-8ff2-4682-901b-9d79336e863a",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "etnb-20221231.htm",
      "contextRef": "C_21f769c6-c78d-41d0-b871-ec3d93d7d343",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100360 - Disclosure - Commitments and Contingencies - Schedule of Future Minimum Annual Payments for Operating Leases (Details)",
     "menuCat": "Details",
     "order": "34",
     "role": "http://www.89bio.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumAnnualPaymentsForOperatingLeasesDetails",
     "shortName": "Commitments and Contingencies - Schedule of Future Minimum Annual Payments for Operating Leases (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "etnb-20221231.htm",
      "contextRef": "C_21f769c6-c78d-41d0-b871-ec3d93d7d343",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     }
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:LongTermDebtTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "etnb-20221231.htm",
      "contextRef": "C_b714c872-cbb8-40d3-a8b0-eb87e6092698",
      "decimals": "3",
      "first": true,
      "lang": null,
      "name": "etnb:PercentageOfFeeOnLoan",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_pure",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100370 - Disclosure - Term Loan - Additional Information (Details)",
     "menuCat": "Details",
     "order": "35",
     "role": "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureTermLoanAdditionalInformationDetails",
     "shortName": "Term Loan - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:LongTermDebtTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "etnb-20221231.htm",
      "contextRef": "C_b714c872-cbb8-40d3-a8b0-eb87e6092698",
      "decimals": "3",
      "first": true,
      "lang": null,
      "name": "etnb:PercentageOfFeeOnLoan",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_pure",
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "etnb:ScheduleOfCommonStockReservedForIssuanceTableTextBlock",
       "div",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "etnb-20221231.htm",
      "contextRef": "C_85e3a5e5-8ff2-4682-901b-9d79336e863a",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:CommonStockCapitalSharesReservedForFutureIssuance",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100380 - Disclosure - Stockholders' Equity - Schedule of Shares of Common Stock Available for Future Issuance (Details)",
     "menuCat": "Details",
     "order": "36",
     "role": "http://www.89bio.com/20221231/taxonomy/role/DisclosureStockholdersEquityScheduleOfSharesOfCommonStockAvailableForFutureIssuanceDetails",
     "shortName": "Stockholders' Equity - Schedule of Shares of Common Stock Available for Future Issuance (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "etnb:ScheduleOfCommonStockReservedForIssuanceTableTextBlock",
       "div",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "etnb-20221231.htm",
      "contextRef": "C_85e3a5e5-8ff2-4682-901b-9d79336e863a",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:CommonStockCapitalSharesReservedForFutureIssuance",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_shares",
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "etnb-20221231.htm",
      "contextRef": "C_b714c872-cbb8-40d3-a8b0-eb87e6092698",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:ProceedsFromIssuanceOfCommonStock",
      "reportCount": 1,
      "unitRef": "U_USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100390 - Disclosure - Stockholders' Equity - Additional Information (Details)",
     "menuCat": "Details",
     "order": "37",
     "role": "http://www.89bio.com/20221231/taxonomy/role/DisclosureStockholdersEquityAdditionalInformationDetails",
     "shortName": "Stockholders' Equity - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "etnb-20221231.htm",
      "contextRef": "C_9705961e-ee8d-42ab-94ee-ccd3d976ce3a",
      "decimals": "4",
      "lang": null,
      "name": "etnb:BeneficialOwnershipLimitationOnExerciseOfWarrant",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_pure",
      "xsiNil": "false"
     }
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock",
       "div",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "etnb-20221231.htm",
      "contextRef": "C_85e3a5e5-8ff2-4682-901b-9d79336e863a",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:ClassOfWarrantOrRightOutstanding",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100400 - Disclosure - Stockholders' Equity - Schedule of Outstanding Warrants to Purchase Shares of Common Stock (Details)",
     "menuCat": "Details",
     "order": "38",
     "role": "http://www.89bio.com/20221231/taxonomy/role/DisclosureStockholdersEquityScheduleOfOutstandingWarrantsToPurchaseSharesOfCommonStockDetails",
     "shortName": "Stockholders' Equity - Schedule of Outstanding Warrants to Purchase Shares of Common Stock (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock",
       "div",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "etnb-20221231.htm",
      "contextRef": "C_85e3a5e5-8ff2-4682-901b-9d79336e863a",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:ClassOfWarrantOrRightOutstanding",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_shares",
      "xsiNil": "false"
     }
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "etnb-20221231.htm",
      "contextRef": "C_b714c872-cbb8-40d3-a8b0-eb87e6092698",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "reportCount": 1,
      "unitRef": "U_USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100410 - Disclosure - Stock-Based Compensation - Additional Information (Details)",
     "menuCat": "Details",
     "order": "39",
     "role": "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails",
     "shortName": "Stock-Based Compensation - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "etnb-20221231.htm",
      "contextRef": "C_cd124b4e-13d9-4079-ac85-a4d1fd6601fc",
      "decimals": "-5",
      "lang": null,
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "etnb-20221231.htm",
      "contextRef": "C_b714c872-cbb8-40d3-a8b0-eb87e6092698",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:ResearchAndDevelopmentExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "100040 - Statement - Consolidated Statements of Operations and Comprehensive Loss",
     "menuCat": "Statements",
     "order": "4",
     "role": "http://www.89bio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss",
     "shortName": "Consolidated Statements of Operations and Comprehensive Loss",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "etnb-20221231.htm",
      "contextRef": "C_b714c872-cbb8-40d3-a8b0-eb87e6092698",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:ResearchAndDevelopmentExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     }
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "etnb-20221231.htm",
      "contextRef": "C_23fb22c1-879a-41c9-8fba-6e9ff39f555d",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "reportCount": 1,
      "unitRef": "U_shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100420 - Disclosure - Stock-Based Compensation - Summary of Stock Option Activity (Details)",
     "menuCat": "Details",
     "order": "40",
     "role": "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockOptionActivityDetails",
     "shortName": "Stock-Based Compensation - Summary of Stock Option Activity (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "etnb-20221231.htm",
      "contextRef": "C_8bc8599c-0290-4c23-8007-773265c83e34",
      "decimals": "INF",
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_shares",
      "xsiNil": "false"
     }
    },
    "R41": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "etnb-20221231.htm",
      "contextRef": "C_b714c872-cbb8-40d3-a8b0-eb87e6092698",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_pure",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100430 - Disclosure - Stock-Based Compensation - Summary of Estimated Fair Value of Stock Options Granted Using Black-Scholes Option-Pricing Model (Details)",
     "menuCat": "Details",
     "order": "41",
     "role": "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfEstimatedFairValueOfStockOptionsGrantedUsingBlackScholesOptionPricingModelDetails",
     "shortName": "Stock-Based Compensation - Summary of Estimated Fair Value of Stock Options Granted Using Black-Scholes Option-Pricing Model (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "etnb-20221231.htm",
      "contextRef": "C_b714c872-cbb8-40d3-a8b0-eb87e6092698",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_pure",
      "xsiNil": "false"
     }
    },
    "R42": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "etnb-20221231.htm",
      "contextRef": "C_42e28a41-a2c7-4703-9012-632c3a4117b3",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100440 - Disclosure - Stock-Based Compensation - Summary of Restricted Stock Unit Activity (Details)",
     "menuCat": "Details",
     "order": "42",
     "role": "http://www.89bio.com/20221231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfRestrictedStockUnitActivityDetails",
     "shortName": "Stock-Based Compensation - Summary of Restricted Stock Unit Activity (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "etnb-20221231.htm",
      "contextRef": "C_42e28a41-a2c7-4703-9012-632c3a4117b3",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_shares",
      "xsiNil": "false"
     }
    },
    "R43": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "etnb-20221231.htm",
      "contextRef": "C_b714c872-cbb8-40d3-a8b0-eb87e6092698",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "reportCount": 1,
      "unitRef": "U_USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100450 - Disclosure - Stock-Based Compensation - Summary of Stock-Based Compensation (Details)",
     "menuCat": "Details",
     "order": "43",
     "role": "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockBasedCompensationDetails",
     "shortName": "Stock-Based Compensation - Summary of Stock-Based Compensation (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "etnb-20221231.htm",
      "contextRef": "C_302d3395-cf3f-4431-8710-ee66bc04c06d",
      "decimals": "-3",
      "lang": null,
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     }
    },
    "R44": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "etnb:ScheduleOfEffectiveIncomeTaxRateOfCompanyAndSubsidiariesTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "etnb-20221231.htm",
      "contextRef": "C_b714c872-cbb8-40d3-a8b0-eb87e6092698",
      "decimals": "2",
      "first": true,
      "lang": null,
      "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_pure",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100460 - Disclosure - Income Taxes - Summary of Statutory Tax Rates Applicable to Income of Company and Subsidiaries (Details)",
     "menuCat": "Details",
     "order": "44",
     "role": "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesSummaryOfStatutoryTaxRatesApplicableToIncomeOfCompanyAndSubsidiariesDetails",
     "shortName": "Income Taxes - Summary of Statutory Tax Rates Applicable to Income of Company and Subsidiaries (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "etnb:ScheduleOfEffectiveIncomeTaxRateOfCompanyAndSubsidiariesTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "etnb-20221231.htm",
      "contextRef": "C_b714c872-cbb8-40d3-a8b0-eb87e6092698",
      "decimals": "2",
      "first": true,
      "lang": null,
      "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_pure",
      "xsiNil": "false"
     }
    },
    "R45": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "etnb-20221231.htm",
      "contextRef": "C_b714c872-cbb8-40d3-a8b0-eb87e6092698",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:CurrentStateAndLocalTaxExpenseBenefit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100470 - Disclosure - Income Taxes - Summary of Income Tax (Expense) Benefit (Details)",
     "menuCat": "Details",
     "order": "45",
     "role": "http://www.89bio.com/20221231/taxonomy/role/DisclosureIncomeTaxesSummaryOfIncomeTaxExpenseBenefitDetails",
     "shortName": "Income Taxes - Summary of Income Tax (Expense) Benefit (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "etnb-20221231.htm",
      "contextRef": "C_b714c872-cbb8-40d3-a8b0-eb87e6092698",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:CurrentStateAndLocalTaxExpenseBenefit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     }
    },
    "R46": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "etnb-20221231.htm",
      "contextRef": "C_85e3a5e5-8ff2-4682-901b-9d79336e863a",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:DeferredTaxAssetsInProcessResearchAndDevelopment",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100480 - Disclosure - Income Taxes - Summary of Components of Deferred Tax Assets (Details)",
     "menuCat": "Details",
     "order": "46",
     "role": "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesSummaryOfComponentsOfDeferredTaxAssetsDetails",
     "shortName": "Income Taxes - Summary of Components of Deferred Tax Assets (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "etnb-20221231.htm",
      "contextRef": "C_85e3a5e5-8ff2-4682-901b-9d79336e863a",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:DeferredTaxAssetsInProcessResearchAndDevelopment",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     }
    },
    "R47": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "etnb-20221231.htm",
      "contextRef": "C_85e3a5e5-8ff2-4682-901b-9d79336e863a",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:DeferredTaxAssetsValuationAllowance",
      "reportCount": 1,
      "unitRef": "U_USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100490 - Disclosure - Income Taxes - Additional Information (Details)",
     "menuCat": "Details",
     "order": "47",
     "role": "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetails",
     "shortName": "Income Taxes - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "etnb-20221231.htm",
      "contextRef": "C_b714c872-cbb8-40d3-a8b0-eb87e6092698",
      "decimals": "-5",
      "lang": null,
      "name": "us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     }
    },
    "R48": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "etnb-20221231.htm",
      "contextRef": "C_b714c872-cbb8-40d3-a8b0-eb87e6092698",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
      "reportCount": 1,
      "unitRef": "U_USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100500 - Disclosure - Income Taxes - Summary of Loss from Operations Before Taxes on Income (Details)",
     "menuCat": "Details",
     "order": "48",
     "role": "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesSummaryOfLossFromOperationsBeforeTaxesOnIncomeDetails",
     "shortName": "Income Taxes - Summary of Loss from Operations Before Taxes on Income (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "etnb-20221231.htm",
      "contextRef": "C_b88d9973-f0e9-45f8-b4fb-a6e4faea7667",
      "decimals": "-3",
      "lang": null,
      "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     }
    },
    "R49": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "etnb-20221231.htm",
      "contextRef": "C_b714c872-cbb8-40d3-a8b0-eb87e6092698",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100510 - Disclosure - Income Taxes - Summary of Reconciliation of Income Tax (Expense) Benefit Statutory Tax Rate to Effective Tax Rate (Details)",
     "menuCat": "Details",
     "order": "49",
     "role": "http://www.89bio.com/20221231/taxonomy/role/DisclosureIncomeTaxesSummaryOfReconciliationOfIncomeTaxExpenseBenefitStatutoryTaxRateToEffectiveTaxRateDetails",
     "shortName": "Income Taxes - Summary of Reconciliation of Income Tax (Expense) Benefit Statutory Tax Rate to Effective Tax Rate (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "etnb-20221231.htm",
      "contextRef": "C_b714c872-cbb8-40d3-a8b0-eb87e6092698",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "etnb-20221231.htm",
      "contextRef": "C_19418b37-9af5-4eb2-b38a-a9070fc599d5",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:StockholdersEquity",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "100050 - Statement - Consolidated Statements of Stockholders' Equity (Deficit)",
     "menuCat": "Statements",
     "order": "5",
     "role": "http://www.89bio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfStockholdersEquityDeficit",
     "shortName": "Consolidated Statements of Stockholders' Equity (Deficit)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "etnb-20221231.htm",
      "contextRef": "C_19418b37-9af5-4eb2-b38a-a9070fc599d5",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:StockholdersEquity",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     }
    },
    "R50": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "etnb-20221231.htm",
      "contextRef": "C_21f769c6-c78d-41d0-b871-ec3d93d7d343",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:UnrecognizedTaxBenefits",
      "reportCount": 1,
      "unitRef": "U_USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100520 - Disclosure - Income Taxes - Summary of a Reconciliation of The Beginning And Ending Amount of Unrecognized Tax Benefits (Details)",
     "menuCat": "Details",
     "order": "50",
     "role": "http://www.89bio.com/20221231/taxonomy/role/DisclosureIncomeTaxesSummaryOfAReconciliationOfTheBeginningAndEndingAmountOfUnrecognizedTaxBenefitsDetails",
     "shortName": "Income Taxes - Summary of a Reconciliation of The Beginning And Ending Amount of Unrecognized Tax Benefits (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "etnb-20221231.htm",
      "contextRef": "C_19418b37-9af5-4eb2-b38a-a9070fc599d5",
      "decimals": "-3",
      "lang": null,
      "name": "us-gaap:UnrecognizedTaxBenefits",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     }
    },
    "R51": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
       "div",
       "us-gaap:EarningsPerShareTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "etnb-20221231.htm",
      "contextRef": "C_b714c872-cbb8-40d3-a8b0-eb87e6092698",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100530 - Disclosure - Net Loss Per Share - Schedule of Outstanding Potentially Dilutive Securities Excluded From Calculation of Diluted Net Loss (Details)",
     "menuCat": "Details",
     "order": "51",
     "role": "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureNetLossPerShareScheduleOfOutstandingPotentiallyDilutiveSecuritiesExcludedFromCalculationOfDilutedNetLossDetails",
     "shortName": "Net Loss Per Share - Schedule of Outstanding Potentially Dilutive Securities Excluded From Calculation of Diluted Net Loss (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
       "div",
       "us-gaap:EarningsPerShareTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "etnb-20221231.htm",
      "contextRef": "C_b714c872-cbb8-40d3-a8b0-eb87e6092698",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_shares",
      "xsiNil": "false"
     }
    },
    "R52": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "etnb-20221231.htm",
      "contextRef": "C_b714c872-cbb8-40d3-a8b0-eb87e6092698",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:ProceedsFromIssuanceOfCommonStock",
      "reportCount": 1,
      "unitRef": "U_USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100540 - Disclosure - Subsequent Events - Additional Information (Details)",
     "menuCat": "Details",
     "order": "52",
     "role": "http://www.89bio.com/20221231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails",
     "shortName": "Subsequent Events - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:SubsequentEventsTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "etnb-20221231.htm",
      "contextRef": "C_2e474f95-87bf-4927-8cbe-0c9312719cd9",
      "decimals": "-5",
      "lang": null,
      "name": "us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "etnb-20221231.htm",
      "contextRef": "C_b714c872-cbb8-40d3-a8b0-eb87e6092698",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "100070 - Statement - Consolidated Statements of Cash Flows",
     "menuCat": "Statements",
     "order": "6",
     "role": "http://www.89bio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows",
     "shortName": "Consolidated Statements of Cash Flows",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "etnb-20221231.htm",
      "contextRef": "C_b714c872-cbb8-40d3-a8b0-eb87e6092698",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "etnb-20221231.htm",
      "contextRef": "C_b714c872-cbb8-40d3-a8b0-eb87e6092698",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100080 - Disclosure - Organization and Basis of Presentation",
     "menuCat": "Notes",
     "order": "7",
     "role": "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureOrganizationAndBasisOfPresentation",
     "shortName": "Organization and Basis of Presentation",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "etnb-20221231.htm",
      "contextRef": "C_b714c872-cbb8-40d3-a8b0-eb87e6092698",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "etnb-20221231.htm",
      "contextRef": "C_b714c872-cbb8-40d3-a8b0-eb87e6092698",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100090 - Disclosure - Summary of Significant Accounting Policies",
     "menuCat": "Notes",
     "order": "8",
     "role": "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPolicies",
     "shortName": "Summary of Significant Accounting Policies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "etnb-20221231.htm",
      "contextRef": "C_b714c872-cbb8-40d3-a8b0-eb87e6092698",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "etnb-20221231.htm",
      "contextRef": "C_b714c872-cbb8-40d3-a8b0-eb87e6092698",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100100 - Disclosure - Fair Value Measurements",
     "menuCat": "Notes",
     "order": "9",
     "role": "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureFairValueMeasurements",
     "shortName": "Fair Value Measurements",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "etnb-20221231.htm",
      "contextRef": "C_b714c872-cbb8-40d3-a8b0-eb87e6092698",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 78,
   "tag": {
    "country_IL": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "ISRAEL",
        "terseLabel": "Israel"
       }
      }
     },
     "localname": "IL",
     "nsuri": "http://xbrl.sec.gov/country/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetails",
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesSummaryOfComponentsOfDeferredTaxAssetsDetails",
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesSummaryOfLossFromOperationsBeforeTaxesOnIncomeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "country_LT": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "LITHUANIA",
        "terseLabel": "LITHUANIA"
       }
      }
     },
     "localname": "LT",
     "nsuri": "http://xbrl.sec.gov/country/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesSummaryOfLossFromOperationsBeforeTaxesOnIncomeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "country_US": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "UNITED STATES",
        "terseLabel": "United States"
       }
      }
     },
     "localname": "US",
     "nsuri": "http://xbrl.sec.gov/country/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetails",
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesSummaryOfComponentsOfDeferredTaxAssetsDetails",
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesSummaryOfLossFromOperationsBeforeTaxesOnIncomeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AuditorFirmId": {
     "auth_ref": [
      "r614",
      "r615",
      "r616"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "PCAOB issued Audit Firm Identifier",
        "label": "Auditor Firm ID",
        "terseLabel": "Auditor Firm ID"
       }
      }
     },
     "localname": "AuditorFirmId",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "nonemptySequenceNumberItemType"
    },
    "dei_AuditorLocation": {
     "auth_ref": [
      "r614",
      "r615",
      "r616"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Location",
        "terseLabel": "Auditor Location"
       }
      }
     },
     "localname": "AuditorLocation",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "internationalNameItemType"
    },
    "dei_AuditorName": {
     "auth_ref": [
      "r614",
      "r615",
      "r616"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Name",
        "terseLabel": "Auditor Name"
       }
      }
     },
     "localname": "AuditorName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "internationalNameItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentAnnualReport": {
     "auth_ref": [
      "r614",
      "r615",
      "r616"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an annual report.",
        "label": "Document Annual Report",
        "terseLabel": "Document Annual Report"
       }
      }
     },
     "localname": "DocumentAnnualReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus",
        "terseLabel": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus",
        "terseLabel": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r617"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report",
        "terseLabel": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "auth_ref": [
      "r612"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Documents incorporated by reference.",
        "label": "Documents Incorporated by Reference [Text Block]",
        "terseLabel": "Documents Incorporated by Reference"
       }
      }
     },
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two",
        "terseLabel": "Entity Address Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r611"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding",
        "terseLabel": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status",
        "terseLabel": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r611"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityExTransitionPeriod": {
     "auth_ref": [
      "r620"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.",
        "label": "Entity Ex Transition Period",
        "terseLabel": "Entity Ex Transition Period"
       }
      }
     },
     "localname": "EntityExTransitionPeriod",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Securities Act File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r611"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category",
        "terseLabel": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationDateOfIncorporation": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date when an entity was incorporated",
        "label": "Entity Incorporation, Date of Incorporation",
        "terseLabel": "Date of incorporation"
       }
      }
     },
     "localname": "EntityIncorporationDateOfIncorporation",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureOrganizationAndBasisOfPresentationAdditionalInformationDetails"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r618"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current",
        "terseLabel": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityPublicFloat": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.",
        "label": "Entity Public Float",
        "terseLabel": "Entity Public Float"
       }
      }
     },
     "localname": "EntityPublicFloat",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r611"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r611"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company",
        "terseLabel": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r611"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business",
        "terseLabel": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r611"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_EntityVoluntaryFilers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.",
        "label": "Entity Voluntary Filers",
        "terseLabel": "Entity Voluntary Filers"
       }
      }
     },
     "localname": "EntityVoluntaryFilers",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "auth_ref": [
      "r619"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.",
        "label": "Entity Well-known Seasoned Issuer",
        "terseLabel": "Entity Well-known Seasoned Issuer"
       }
      }
     },
     "localname": "EntityWellKnownSeasonedIssuer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_IcfrAuditorAttestationFlag": {
     "auth_ref": [
      "r614",
      "r615",
      "r616"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ICFR Auditor Attestation Flag",
        "terseLabel": "ICFR Auditor Attestation Flag"
       }
      }
     },
     "localname": "IcfrAuditorAttestationFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r610"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r613"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "etnb_ATMFacilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ATM facility.",
        "label": "A T M Facility [Member]",
        "terseLabel": "A T M Facility"
       }
      }
     },
     "localname": "ATMFacilityMember",
     "nsuri": "http://www.89bio.com/20221231",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/DisclosureStockholdersEquityAdditionalInformationDetails",
      "http://www.89bio.com/20221231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails",
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureOrganizationAndBasisOfPresentationAdditionalInformationDetails",
      "http://www.89bio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfStockholdersEquityDeficit",
      "http://www.89bio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfStockholdersEquityParenthetical"
     ],
     "xbrltype": "domainItemType"
    },
    "etnb_AccruedResearchAndDevelopmentExpenseCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureConsolidatedBalanceSheetComponentsScheduleOfAccruedExpensesDetails": {
       "order": 0.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accrued research and development expense current.",
        "label": "Accrued Research And Development Expense Current",
        "terseLabel": "Accrued research and development expenses"
       }
      }
     },
     "localname": "AccruedResearchAndDevelopmentExpenseCurrent",
     "nsuri": "http://www.89bio.com/20221231",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureConsolidatedBalanceSheetComponentsScheduleOfAccruedExpensesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "etnb_AccruedResearchAndDevelopmentExpensesPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accrued research and development expenses.",
        "label": "Accrued Research And Development Expenses Policy [Text Block]",
        "terseLabel": "Accrued Research and Development Expenses"
       }
      }
     },
     "localname": "AccruedResearchAndDevelopmentExpensesPolicyTextBlock",
     "nsuri": "http://www.89bio.com/20221231",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "etnb_AccumulatedTaxLossCarryForward": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated tax loss carry forward.",
        "label": "Accumulated Tax Loss Carry Forward",
        "terseLabel": "Accumulated tax loss carryforward"
       }
      }
     },
     "localname": "AccumulatedTaxLossCarryForward",
     "nsuri": "http://www.89bio.com/20221231",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "etnb_AgencyDiscountSecuritiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Agency discount securities.",
        "label": "Agency Discount Securities [Member]",
        "terseLabel": "Agency discount securities"
       }
      }
     },
     "localname": "AgencyDiscountSecuritiesMember",
     "nsuri": "http://www.89bio.com/20221231",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureFairValueMeasurementsSummaryOfFinancialAssetsMeasuredAtFairValueOnRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "etnb_AmortizationOfDebtIssuanceCostsAndAccretionOfFinalPaymentFee": {
     "auth_ref": [],
     "calculation": {
      "http://www.89bio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortization of debt issuance costs and accretion of final payment fee.",
        "label": "Amortization Of Debt Issuance Costs And Accretion Of Final Payment Fee",
        "negatedLabel": "Amortization of debt issuance costs and accretion of final payment fee"
       }
      }
     },
     "localname": "AmortizationOfDebtIssuanceCostsAndAccretionOfFinalPaymentFee",
     "nsuri": "http://www.89bio.com/20221231",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "etnb_AmortizationPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortization period",
        "label": "Amortization Period",
        "terseLabel": "Amortization period"
       }
      }
     },
     "localname": "AmortizationPeriod",
     "nsuri": "http://www.89bio.com/20221231",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "etnb_AssetTransferAndLicenseAgreementInitialNonrefundableUpfrontPayment": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Asset transfer and license agreements initial nonrefundable upfront payment.",
        "label": "Asset Transfer And License Agreement Initial Nonrefundable Upfront Payment",
        "terseLabel": "Nonrefundable upfront payment"
       }
      }
     },
     "localname": "AssetTransferAndLicenseAgreementInitialNonrefundableUpfrontPayment",
     "nsuri": "http://www.89bio.com/20221231",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "etnb_AssetTransferAndLicenseAgreementTerminationNoticePeriodIfBankruptcyPetitionFiled": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Asset transfer and license agreement termination notice period if bankruptcy petition filed.",
        "label": "Asset Transfer And License Agreement Termination Notice Period If Bankruptcy Petition Filed",
        "terseLabel": "Asset transfer and license agreement termination notice period if bankruptcy petition filed"
       }
      }
     },
     "localname": "AssetTransferAndLicenseAgreementTerminationNoticePeriodIfBankruptcyPetitionFiled",
     "nsuri": "http://www.89bio.com/20221231",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "etnb_AssetTransferAndLicenseAgreementTerminationPeriodAfterWrittenNotice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Asset transfer and license agreement termination period after written notice.",
        "label": "Asset Transfer And License Agreement Termination Period After Written Notice",
        "terseLabel": "Asset transfer and license agreement, termination period after written notice"
       }
      }
     },
     "localname": "AssetTransferAndLicenseAgreementTerminationPeriodAfterWrittenNotice",
     "nsuri": "http://www.89bio.com/20221231",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "etnb_AssetTransferAndLicenseAgreementTerminationPeriodNoticeOfFailure": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Asset transfer and license agreement termination period notice of failure.",
        "label": "Asset Transfer And License Agreement Termination Period Notice Of Failure",
        "terseLabel": "Asset transfer and license agreement, termination period notice of breach"
       }
      }
     },
     "localname": "AssetTransferAndLicenseAgreementTerminationPeriodNoticeOfFailure",
     "nsuri": "http://www.89bio.com/20221231",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "etnb_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughTwoYearsFairValue": {
     "auth_ref": [],
     "calculation": {
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfContractualMaturitiesOfCashEquivalentsAndAvailableForSaleSecuritiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AvailableForSaleSecuritiesDebtSecurities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Available for sale securities debt maturities after one through two years fair value.",
        "label": "Available For Sale Securities Debt Maturities After One Through Two Years Fair Value",
        "terseLabel": "After one year through two years"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughTwoYearsFairValue",
     "nsuri": "http://www.89bio.com/20221231",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfContractualMaturitiesOfCashEquivalentsAndAvailableForSaleSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "etnb_BeneficialOwnershipLimitationOnExerciseOfWarrant": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Beneficial ownership limitation on exercise of warrant.",
        "label": "Beneficial Ownership Limitation On Exercise Of Warrant",
        "terseLabel": "Percentage of ownership limitation"
       }
      }
     },
     "localname": "BeneficialOwnershipLimitationOnExerciseOfWarrant",
     "nsuri": "http://www.89bio.com/20221231",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/DisclosureStockholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "etnb_CommonStockAndWarrantsCombinedOfferingPricePerShare": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Common stock and warrants combined offering price per share.",
        "label": "Common Stock And Warrants Combined Offering Price Per Share",
        "terseLabel": "Offering price per share"
       }
      }
     },
     "localname": "CommonStockAndWarrantsCombinedOfferingPricePerShare",
     "nsuri": "http://www.89bio.com/20221231",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/DisclosureStockholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "etnb_ConvertiblePreferredSharesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Convertible preferred shares.",
        "label": "Convertible Preferred Shares [Member]",
        "terseLabel": "Convertible Preferred Shares"
       }
      }
     },
     "localname": "ConvertiblePreferredSharesMember",
     "nsuri": "http://www.89bio.com/20221231",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfStockholdersEquityParenthetical"
     ],
     "xbrltype": "domainItemType"
    },
    "etnb_DebtInstrumentEarlyPrepaymentFee": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt instrument, early prepayment fee.",
        "label": "Debt Instrument, Early Prepayment Fee",
        "terseLabel": "Debt instrument, early prepayment fee"
       }
      }
     },
     "localname": "DebtInstrumentEarlyPrepaymentFee",
     "nsuri": "http://www.89bio.com/20221231",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "etnb_DebtInstrumentFinalPaymentFee": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt instrument, final payment fee.",
        "label": "Debt Instrument, Final Payment Fee",
        "terseLabel": "Debt instrument, final payment fee"
       }
      }
     },
     "localname": "DebtInstrumentFinalPaymentFee",
     "nsuri": "http://www.89bio.com/20221231",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "etnb_DeferredTaxAssets": {
     "auth_ref": [],
     "calculation": {
      "http://www.89bio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred tax assets.",
        "label": "Deferred Tax Assets",
        "negatedLabel": "Deferred tax assets"
       }
      }
     },
     "localname": "DeferredTaxAssets",
     "nsuri": "http://www.89bio.com/20221231",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "etnb_DeferredTaxAssetsLeaseLiability": {
     "auth_ref": [],
     "calculation": {
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesSummaryOfComponentsOfDeferredTaxAssetsDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred tax assets lease liability.",
        "label": "Deferred Tax Assets Lease Liability",
        "terseLabel": "Operating Lease Liability"
       }
      }
     },
     "localname": "DeferredTaxAssetsLeaseLiability",
     "nsuri": "http://www.89bio.com/20221231",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesSummaryOfComponentsOfDeferredTaxAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "etnb_DeferredTaxAssetsTaxCreditCarryforwardsResearchFederal": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred tax assets tax credit carryforwards research, federal.",
        "label": "Deferred Tax Assets Tax Credit Carryforwards Research Federal",
        "terseLabel": "Federal research and development credit carryforwards"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxCreditCarryforwardsResearchFederal",
     "nsuri": "http://www.89bio.com/20221231",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "etnb_DeferredTaxLiabilitiesRightsOfUseAssets": {
     "auth_ref": [],
     "calculation": {
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesSummaryOfComponentsOfDeferredTaxAssetsDetails": {
       "order": 0.0,
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred tax liabilities rights of use assets.",
        "label": "Deferred Tax Liabilities Rights Of Use Assets",
        "negatedLabel": "Operating lease right-of-use asset",
        "terseLabel": "Operating lease right-of-use asset"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesRightsOfUseAssets",
     "nsuri": "http://www.89bio.com/20221231",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesSummaryOfComponentsOfDeferredTaxAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "etnb_EffectiveIncomeTaxRateReconciliationStateDeferredTaxTrueUpDueToChangeInApportionment": {
     "auth_ref": [],
     "calculation": {
      "http://www.89bio.com/20221231/taxonomy/role/DisclosureIncomeTaxesSummaryOfReconciliationOfIncomeTaxExpenseBenefitStatutoryTaxRateToEffectiveTaxRateDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective income tax rate reconciliation state deferred tax true-up due to change in apportionment.",
        "label": "Effective Income Tax Rate Reconciliation State Deferred Tax True-up Due To Change In Apportionment",
        "terseLabel": "State deferred tax true-up due to change in apportionment"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationStateDeferredTaxTrueUpDueToChangeInApportionment",
     "nsuri": "http://www.89bio.com/20221231",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/DisclosureIncomeTaxesSummaryOfReconciliationOfIncomeTaxExpenseBenefitStatutoryTaxRateToEffectiveTaxRateDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "etnb_EightyNineBioLtdMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "89Bio Ltd.",
        "label": "Eighty Nine Bio Ltd [Member]",
        "terseLabel": "89Bio Ltd"
       }
      }
     },
     "localname": "EightyNineBioLtdMember",
     "nsuri": "http://www.89bio.com/20221231",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesSummaryOfStatutoryTaxRatesApplicableToIncomeOfCompanyAndSubsidiariesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "etnb_EightyNineBioManagementIncorporationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Eighty Nine Bio Management, Inc.",
        "label": "Eighty Nine Bio Management Incorporation [Member]",
        "terseLabel": "89bio Management, Inc."
       }
      }
     },
     "localname": "EightyNineBioManagementIncorporationMember",
     "nsuri": "http://www.89bio.com/20221231",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesSummaryOfStatutoryTaxRatesApplicableToIncomeOfCompanyAndSubsidiariesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "etnb_EquityIncentivePlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity incentive plan member.",
        "label": "Equity Incentive Plan [Member]",
        "terseLabel": "Equity Incentive Plan"
       }
      }
     },
     "localname": "EquityIncentivePlanMember",
     "nsuri": "http://www.89bio.com/20221231",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/DisclosureStockholdersEquityScheduleOfSharesOfCommonStockAvailableForFutureIssuanceDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "etnb_ExerciseOfWarrantsAndPreFundedWarrantsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Exercise of warrants and pre-funded warrants member.",
        "label": "Exercise Of Warrants And Pre Funded Warrants [Member]",
        "terseLabel": "Exercise of Warrants and Pre-funded Warrants"
       }
      }
     },
     "localname": "ExerciseOfWarrantsAndPreFundedWarrantsMember",
     "nsuri": "http://www.89bio.com/20221231",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/DisclosureStockholdersEquityScheduleOfSharesOfCommonStockAvailableForFutureIssuanceDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "etnb_FairValueOfWarrantsAssumptionsDividends": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of warrant assumptions, dividends.",
        "label": "Fair Value Of Warrants Assumptions Dividends",
        "terseLabel": "Fair value of warrant assumptions, dividends"
       }
      }
     },
     "localname": "FairValueOfWarrantsAssumptionsDividends",
     "nsuri": "http://www.89bio.com/20221231",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureTermLoanAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "etnb_IncomeTaxDisclosureLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Income Tax.",
        "label": "Income Tax Disclosure [Line Items]",
        "terseLabel": "Income Tax Disclosure [Line Items]"
       }
      }
     },
     "localname": "IncomeTaxDisclosureLineItems",
     "nsuri": "http://www.89bio.com/20221231",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetails",
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesSummaryOfComponentsOfDeferredTaxAssetsDetails",
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesSummaryOfLossFromOperationsBeforeTaxesOnIncomeDetails",
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesSummaryOfStatutoryTaxRatesApplicableToIncomeOfCompanyAndSubsidiariesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "etnb_IncomeTaxDisclosureTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Income Tax.",
        "label": "Income Tax Disclosure [Table]",
        "terseLabel": "Income Tax Disclosure [Table]"
       }
      }
     },
     "localname": "IncomeTaxDisclosureTable",
     "nsuri": "http://www.89bio.com/20221231",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetails",
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesSummaryOfComponentsOfDeferredTaxAssetsDetails",
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesSummaryOfLossFromOperationsBeforeTaxesOnIncomeDetails",
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesSummaryOfStatutoryTaxRatesApplicableToIncomeOfCompanyAndSubsidiariesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "etnb_IncomeTaxReconciliationChangeInEffectiveTaxRateDueToReorganization": {
     "auth_ref": [],
     "calculation": {
      "http://www.89bio.com/20221231/taxonomy/role/DisclosureIncomeTaxesSummaryOfReconciliationOfIncomeTaxExpenseBenefitStatutoryTaxRateToEffectiveTaxRateDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Income tax reconciliation change in effective tax rate due to reorganization.",
        "label": "Income Tax Reconciliation Change In Effective Tax Rate Due To Reorganization",
        "terseLabel": "Change in Israel effective tax rate due to the 2019 reorganization"
       }
      }
     },
     "localname": "IncomeTaxReconciliationChangeInEffectiveTaxRateDueToReorganization",
     "nsuri": "http://www.89bio.com/20221231",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/DisclosureIncomeTaxesSummaryOfReconciliationOfIncomeTaxExpenseBenefitStatutoryTaxRateToEffectiveTaxRateDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "etnb_IssuanceOfCommonStockWarrantInConnectionWithTermLoanFacility": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Issuance of common stock warrant in connection with term loan facility.",
        "label": "Issuance Of Common Stock Warrant In Connection With Term Loan Facility",
        "terseLabel": "Issuance of common stock warrant in connection with term loan facility"
       }
      }
     },
     "localname": "IssuanceOfCommonStockWarrantInConnectionWithTermLoanFacility",
     "nsuri": "http://www.89bio.com/20221231",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows",
      "http://www.89bio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfStockholdersEquityDeficit"
     ],
     "xbrltype": "monetaryItemType"
    },
    "etnb_IssuanceOfCommonStockWarrantsInConnectionWithDebtFinancing": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Issuance of common stock warrant in connection with debt financing.",
        "label": "Issuance Of Common Stock Warrants In Connection With Debt Financing",
        "terseLabel": "Issuance Of Common Stock Warrants In Connection With Debt Financing"
       }
      }
     },
     "localname": "IssuanceOfCommonStockWarrantsInConnectionWithDebtFinancing",
     "nsuri": "http://www.89bio.com/20221231",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfStockholdersEquityDeficit"
     ],
     "xbrltype": "monetaryItemType"
    },
    "etnb_LineOfCreditFacilityIncreaseInBorrowingCapacity": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line of credit facility increase in borrowing capacity.",
        "label": "Line Of Credit Facility Increase In Borrowing Capacity",
        "terseLabel": "Line of credit facility maximum borrowing capacity"
       }
      }
     },
     "localname": "LineOfCreditFacilityIncreaseInBorrowingCapacity",
     "nsuri": "http://www.89bio.com/20221231",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureTermLoanAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "etnb_LoanAndSecurityAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loan and security agreement.",
        "label": "Loan And Security Agreement [Member]",
        "terseLabel": "Loan Agreement"
       }
      }
     },
     "localname": "LoanAndSecurityAgreementMember",
     "nsuri": "http://www.89bio.com/20221231",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureTermLoanAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "etnb_MaximumAmountOfEquitySharesIssuable": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum amount of equity shares issuable.",
        "label": "Maximum Amount Of Equity Shares Issuable",
        "terseLabel": "Maximum amount of equity shares issuable"
       }
      }
     },
     "localname": "MaximumAmountOfEquitySharesIssuable",
     "nsuri": "http://www.89bio.com/20221231",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/DisclosureStockholdersEquityAdditionalInformationDetails",
      "http://www.89bio.com/20221231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "etnb_MilestonePayment": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Milestone payment.",
        "label": "Milestone Payment",
        "terseLabel": "Milestone payments"
       }
      }
     },
     "localname": "MilestonePayment",
     "nsuri": "http://www.89bio.com/20221231",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "etnb_NetCashProceedsFromSaleOfEquitySecurities": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Net cash proceeds from sale of equity securities.",
        "label": "Net Cash Proceeds From Sale Of Equity Securities",
        "terseLabel": "Proceeds from sale of available-for-sale securities, equity"
       }
      }
     },
     "localname": "NetCashProceedsFromSaleOfEquitySecurities",
     "nsuri": "http://www.89bio.com/20221231",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureTermLoanAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "etnb_NumberOfPrefundedWarrantsIssuedDuringPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of prefunded warrants issued during period.",
        "label": "Number Of Prefunded Warrants Issued During Period",
        "terseLabel": "Number of prefunded warrants issued during period"
       }
      }
     },
     "localname": "NumberOfPrefundedWarrantsIssuedDuringPeriod",
     "nsuri": "http://www.89bio.com/20221231",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/DisclosureStockholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "etnb_NumberOfSharesIssuableUnderShareBasedPaymentArrangement": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issuable under share-based payment arrangement.",
        "label": "Number Of Shares Issuable Under Share Based Payment Arrangement",
        "verboseLabel": "Number of common shares issuable under the plan (in shares)"
       }
      }
     },
     "localname": "NumberOfSharesIssuableUnderShareBasedPaymentArrangement",
     "nsuri": "http://www.89bio.com/20221231",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "etnb_ObligationToPaymentUponMaximumAchievementOfCertainClinicalAndCommercialMilestones": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Obligation to payment upon maximum achievement of certain clinical and commercial milestones.",
        "label": "Obligation To Payment Upon Maximum Achievement Of Certain Clinical And Commercial Milestones",
        "terseLabel": "Payment upon achievement of certain clinical and commercial milestones"
       }
      }
     },
     "localname": "ObligationToPaymentUponMaximumAchievementOfCertainClinicalAndCommercialMilestones",
     "nsuri": "http://www.89bio.com/20221231",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "etnb_OperatingLeaseExpirationMonthAndYear": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating lease expiration month and year.",
        "label": "Operating Lease Expiration Month And Year",
        "terseLabel": "Operating lease expiration month and year"
       }
      }
     },
     "localname": "OperatingLeaseExpirationMonthAndYear",
     "nsuri": "http://www.89bio.com/20221231",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails"
     ],
     "xbrltype": "gYearMonthItemType"
    },
    "etnb_OtherNonCurrentLiability": {
     "auth_ref": [],
     "calculation": {
      "http://www.89bio.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other non-current liability",
        "label": "Other Non Current Liability",
        "terseLabel": "Other non-current liability"
       }
      }
     },
     "localname": "OtherNonCurrentLiability",
     "nsuri": "http://www.89bio.com/20221231",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureTermLoanAdditionalInformationDetails",
      "http://www.89bio.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "etnb_OtherRisksAndUncertaintiesPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other risks and uncertainties.",
        "label": "Other Risks And Uncertainties Policy [Text Block]",
        "terseLabel": "Other Risks and Uncertainties"
       }
      }
     },
     "localname": "OtherRisksAndUncertaintiesPolicyTextBlock",
     "nsuri": "http://www.89bio.com/20221231",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "etnb_PaymentForPurchaseOfAvailableForSaleSecurities": {
     "auth_ref": [],
     "calculation": {
      "http://www.89bio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Payment for purchases of available for sale securities.",
        "label": "Payment For Purchase Of Available For Sale Securities",
        "negatedLabel": "Purchases of available-for-sale securities"
       }
      }
     },
     "localname": "PaymentForPurchaseOfAvailableForSaleSecurities",
     "nsuri": "http://www.89bio.com/20221231",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "etnb_PercentageOfFeeOnLoan": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of fee on loan.",
        "label": "Percentage Of Fee On Loan",
        "terseLabel": "Percentage of fee on loan"
       }
      }
     },
     "localname": "PercentageOfFeeOnLoan",
     "nsuri": "http://www.89bio.com/20221231",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureTermLoanAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "etnb_PercentageOfIncreaseInNumberOfSharesOfCapitalStockIssuedAndOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of increase in number of shares of capital stock reserved for issuance.",
        "label": "Percentage Of Increase In Number Of Shares Of Capital Stock Issued And Outstanding",
        "terseLabel": "Percentage of increase in number of shares of capital stock issued and outstanding"
       }
      }
     },
     "localname": "PercentageOfIncreaseInNumberOfSharesOfCapitalStockIssuedAndOutstanding",
     "nsuri": "http://www.89bio.com/20221231",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "etnb_PerformanceRSUsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Performance RSUs.",
        "label": "Performance R S Us [Member]",
        "terseLabel": "Performance RSUs"
       }
      }
     },
     "localname": "PerformanceRSUsMember",
     "nsuri": "http://www.89bio.com/20221231",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "etnb_PeriodForIncreaseInNumberOfSharesOfCommonStockReservedForIssuance": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period for increase in number of shares of common stock reserved for issuance.",
        "label": "Period For Increase In Number Of Shares Of Common Stock Reserved For Issuance",
        "terseLabel": "Period for increase in number of shares of common stock reserved for issuance"
       }
      }
     },
     "localname": "PeriodForIncreaseInNumberOfSharesOfCommonStockReservedForIssuance",
     "nsuri": "http://www.89bio.com/20221231",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "etnb_PreFundedWarrantsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Pre-funded warrants.",
        "label": "Pre Funded Warrants [Member]",
        "terseLabel": "Pre-funded Warrants"
       }
      }
     },
     "localname": "PreFundedWarrantsMember",
     "nsuri": "http://www.89bio.com/20221231",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/DisclosureStockholdersEquityAdditionalInformationDetails",
      "http://www.89bio.com/20221231/taxonomy/role/DisclosureStockholdersEquityScheduleOfOutstandingWarrantsToPurchaseSharesOfCommonStockDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "etnb_PrefundedAndCommonStockWarrants": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Prefunded and common stock warrants.",
        "label": "Prefunded And Common Stock Warrants",
        "terseLabel": "Combined price of prefunded and common stock warrant"
       }
      }
     },
     "localname": "PrefundedAndCommonStockWarrants",
     "nsuri": "http://www.89bio.com/20221231",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/DisclosureStockholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "etnb_PrepaidResearchAndDevelopmentCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureConsolidatedBalanceSheetComponentsScheduleOfPrepaidAndOtherCurrentAssetsDetails": {
       "order": 0.0,
       "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Research and development expense prepaid current.",
        "label": "Prepaid Research And Development Current",
        "terseLabel": "Prepaid research and development"
       }
      }
     },
     "localname": "PrepaidResearchAndDevelopmentCurrent",
     "nsuri": "http://www.89bio.com/20221231",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureConsolidatedBalanceSheetComponentsScheduleOfPrepaidAndOtherCurrentAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "etnb_PrepaymentFeePercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Prepayment fee percentage.",
        "label": "Prepayment Fee Percentage",
        "terseLabel": "Prepayment fee percentage"
       }
      }
     },
     "localname": "PrepaymentFeePercentage",
     "nsuri": "http://www.89bio.com/20221231",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureTermLoanAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "etnb_ProceedsFromIssuancePublicOffering": {
     "auth_ref": [],
     "calculation": {
      "http://www.89bio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Proceeds from issuance public offering.",
        "label": "Proceeds From Issuance Public Offering",
        "terseLabel": "Proceeds from issuance of common stock and warrants in public offering, net of issuance costs"
       }
      }
     },
     "localname": "ProceedsFromIssuancePublicOffering",
     "nsuri": "http://www.89bio.com/20221231",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "etnb_ProceedsFromIssuancePublicOfferingAtTheMarketOffering": {
     "auth_ref": [],
     "calculation": {
      "http://www.89bio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Proceeds from issuance public offering at the market offering.",
        "label": "Proceeds From Issuance Public Offering At The Market Offering",
        "terseLabel": "Proceeds from issuance of common stock in at-the-market public offering, net of issuance costs"
       }
      }
     },
     "localname": "ProceedsFromIssuancePublicOfferingAtTheMarketOffering",
     "nsuri": "http://www.89bio.com/20221231",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "etnb_RemeasurementOfLeaseLiabilityAndRightOfUseAssetInConnectionWithLeaseModification": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Remeasurement of lease liability and right of use asset in connection with lease modification.",
        "label": "Remeasurement Of Lease Liability And Right Of Use Asset In Connection With Lease Modification",
        "terseLabel": "Remeasurement of lease liability and right of use asset in connection with lease modification"
       }
      }
     },
     "localname": "RemeasurementOfLeaseLiabilityAndRightOfUseAssetInConnectionWithLeaseModification",
     "nsuri": "http://www.89bio.com/20221231",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "etnb_SVBLeerinkLLCAndCantorFitzgeraldCoMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Svb leerink llc and cantor fitzgerald &amp; co.",
        "label": "S V B Leerink L L C And Cantor Fitzgerald Co [Member]",
        "terseLabel": "SVB Leerink LLC"
       }
      }
     },
     "localname": "SVBLeerinkLLCAndCantorFitzgeraldCoMember",
     "nsuri": "http://www.89bio.com/20221231",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/DisclosureStockholdersEquityAdditionalInformationDetails",
      "http://www.89bio.com/20221231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails",
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureOrganizationAndBasisOfPresentationAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "etnb_SaleOfStockPercentageOfBeneficialOwnershipLimitationBeforeTransaction": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sale of stock percentage of beneficial ownership limitation before transaction.",
        "label": "Sale Of Stock Percentage Of Beneficial Ownership Limitation Before Transaction",
        "terseLabel": "Percentage of ownership prior to issuance"
       }
      }
     },
     "localname": "SaleOfStockPercentageOfBeneficialOwnershipLimitationBeforeTransaction",
     "nsuri": "http://www.89bio.com/20221231",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/DisclosureStockholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "etnb_SanFranciscoOfficeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "San Francisco office.",
        "label": "San Francisco Office [Member]",
        "terseLabel": "San Francisco Office"
       }
      }
     },
     "localname": "SanFranciscoOfficeMember",
     "nsuri": "http://www.89bio.com/20221231",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "etnb_ScheduleOfCommonStockReservedForIssuanceTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of common stock reserved for issuance.",
        "label": "Schedule Of Common Stock Reserved For Issuance Table [Text Block]",
        "terseLabel": "Schedule of Shares of Common Stock Available for Future Issuance"
       }
      }
     },
     "localname": "ScheduleOfCommonStockReservedForIssuanceTableTextBlock",
     "nsuri": "http://www.89bio.com/20221231",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/DisclosureStockholdersEquityTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "etnb_ScheduleOfEffectiveIncomeTaxRateOfCompanyAndSubsidiariesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of effective income tax rate of company and subsidiaries.",
        "label": "Schedule Of Effective Income Tax Rate Of Company And Subsidiaries Table [Text Block]",
        "terseLabel": "Summary of Statutory Tax Rates Applicable to Income of Company and Subsidiaries"
       }
      }
     },
     "localname": "ScheduleOfEffectiveIncomeTaxRateOfCompanyAndSubsidiariesTableTextBlock",
     "nsuri": "http://www.89bio.com/20221231",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "etnb_ScheduleOfPrepaidAndOtherCurrentAssetsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of prepaid and other current assets.",
        "label": "Schedule Of Prepaid And Other Current Assets Table [Text Block]",
        "terseLabel": "Schedule of Prepaid and Other Current Assets"
       }
      }
     },
     "localname": "ScheduleOfPrepaidAndOtherCurrentAssetsTableTextBlock",
     "nsuri": "http://www.89bio.com/20221231",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureConsolidatedBalanceSheetComponentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "etnb_SellingCommissionPerSharesSoldPercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Selling commission per shares sold percentage.",
        "label": "Selling Commission Per Shares Sold Percentage",
        "terseLabel": "Selling commission per shares sold percentage"
       }
      }
     },
     "localname": "SellingCommissionPerSharesSoldPercentage",
     "nsuri": "http://www.89bio.com/20221231",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/DisclosureStockholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "etnb_ServiceBasedRSUsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Service-based RSUs member.",
        "label": "Service Based R S Us [Member]",
        "terseLabel": "Service-based RSUs"
       }
      }
     },
     "localname": "ServiceBasedRSUsMember",
     "nsuri": "http://www.89bio.com/20221231",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "etnb_ShareBasedCompensationArrangementByShareBasedPaymentAwardAnniversary": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period of share based compensation arrangement by share based payment award anniversary.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Anniversary",
        "terseLabel": "Anniversary period"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAnniversary",
     "nsuri": "http://www.89bio.com/20221231",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "etnb_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share based compensation arrangement by share based payment award options aggregate intrinsic value.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Aggregate Intrinsic Value [Abstract]",
        "terseLabel": "Aggregate Intrinsic Value"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract",
     "nsuri": "http://www.89bio.com/20221231",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockOptionActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "etnb_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share based compensation arrangement by share based payment award options weighted average remaining contractual term.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Weighted Average Remaining Contractual Term [Abstract]",
        "terseLabel": "Weighted Average Remaining Contractual Term (In years)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract",
     "nsuri": "http://www.89bio.com/20221231",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockOptionActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "etnb_ShareBasedCompensationArrangementByShareBasedPaymentAwardRemainingOptionsVestingPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share based compensation arrangement by share based payment award remaining options vesting period.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Remaining Options Vesting Period",
        "terseLabel": "Remaining option vesting period"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardRemainingOptionsVestingPeriod",
     "nsuri": "http://www.89bio.com/20221231",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "etnb_ShareBasedCompensationArrangementByShareBasedPaymentFirstOfferingPeriodCommencementDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share based compensation arrangement by share based payment first offering period commencement date.",
        "label": "Share Based Compensation Arrangement By Share Based Payment First Offering Period Commencement Date",
        "terseLabel": "Commencement date of first six month offering period"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentFirstOfferingPeriodCommencementDate",
     "nsuri": "http://www.89bio.com/20221231",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails"
     ],
     "xbrltype": "dateItemType"
    },
    "etnb_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantDateFairValue": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sharebased compensation arrangement by sharebased payment award options grant date fair value.",
        "label": "Sharebased Compensation Arrangement By Sharebased Payment Award Options Grant Date Fair Value",
        "terseLabel": "Total grant date fair value"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantDateFairValue",
     "nsuri": "http://www.89bio.com/20221231",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "etnb_ShortTermAvailableForSaleSecuritiesCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.89bio.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Short term available for sale securities current.",
        "label": "Short Term Available For Sale Securities Current",
        "terseLabel": "Short-term available-for-sale securities"
       }
      }
     },
     "localname": "ShortTermAvailableForSaleSecuritiesCurrent",
     "nsuri": "http://www.89bio.com/20221231",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "etnb_StockAndWarrantsIssuedDuringPeriodSharesNewIssues": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock And Warrants Issued During Period Shares New Issues.",
        "label": "Stock And Warrants Issued During Period Shares New Issues",
        "terseLabel": "Issuance of common stock and warrants, shares"
       }
      }
     },
     "localname": "StockAndWarrantsIssuedDuringPeriodSharesNewIssues",
     "nsuri": "http://www.89bio.com/20221231",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfStockholdersEquityDeficit"
     ],
     "xbrltype": "sharesItemType"
    },
    "etnb_StockAndWarrantsIssuedDuringPeriodValueNewIssues": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock And Warrants Issued During Period Value New Issues.",
        "label": "Stock And Warrants Issued During Period Value New Issues",
        "terseLabel": "Issuance of common stock and warrants"
       }
      }
     },
     "localname": "StockAndWarrantsIssuedDuringPeriodValueNewIssues",
     "nsuri": "http://www.89bio.com/20221231",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfStockholdersEquityDeficit"
     ],
     "xbrltype": "monetaryItemType"
    },
    "etnb_StockIssuedDuringPeriodSharesCashlessExerciseOfWarrants": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock Issued During Period Shares Cashless Exercise Of Warrants.",
        "label": "Stock Issued During Period Shares Cashless Exercise Of Warrants",
        "terseLabel": "Issuance of common stock upon cashless exercise of warrants, shares"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesCashlessExerciseOfWarrants",
     "nsuri": "http://www.89bio.com/20221231",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfStockholdersEquityDeficit"
     ],
     "xbrltype": "sharesItemType"
    },
    "etnb_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfWithholdingTaxes": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock Issued During Period Shares Restricted Stock Award Net Of Withholding Taxes.",
        "label": "Stock Issued During Period Shares Restricted Stock Award Net Of Withholding Taxes",
        "terseLabel": "Issuance of common stock upon vesting of restricted stock units, net of withholding taxes, shares"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfWithholdingTaxes",
     "nsuri": "http://www.89bio.com/20221231",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfStockholdersEquityDeficit"
     ],
     "xbrltype": "sharesItemType"
    },
    "etnb_StockIssuedDuringPeriodSharesWarrantsExercised": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock Issued During Period Shares Warrants Exercised.",
        "label": "Stock Issued During Period Shares Warrants Exercised",
        "terseLabel": "Issuance of common stock upon exercise of warrants"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesWarrantsExercised",
     "nsuri": "http://www.89bio.com/20221231",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfStockholdersEquityDeficit"
     ],
     "xbrltype": "sharesItemType"
    },
    "etnb_StockIssuedDuringPeriodValueCashlessExerciseOfWarrants": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock Issued During Period Value Cashless Exercise Of Warrants.",
        "label": "Stock Issued During Period Value Cashless Exercise Of Warrants",
        "terseLabel": "Issuance of common stock upon cashless exercise of warrants"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueCashlessExerciseOfWarrants",
     "nsuri": "http://www.89bio.com/20221231",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfStockholdersEquityDeficit"
     ],
     "xbrltype": "monetaryItemType"
    },
    "etnb_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfWithholdingTaxes": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock Issued During Period Value Restricted Stock Award Net Of Withholding Taxes.",
        "label": "Stock Issued During Period Value Restricted Stock Award Net Of Withholding Taxes",
        "terseLabel": "Issuance of common stock upon vesting of restricted stock units, net of withholding taxes"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueRestrictedStockAwardNetOfWithholdingTaxes",
     "nsuri": "http://www.89bio.com/20221231",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfStockholdersEquityDeficit"
     ],
     "xbrltype": "monetaryItemType"
    },
    "etnb_StockIssuedDuringPeriodValueWarrantsExercised": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock Issued During Period Value Warrants Exercised",
        "label": "Stock Issued During Period Value Warrants Exercised",
        "terseLabel": "Issuance of common stock upon exercise of warrants"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueWarrantsExercised",
     "nsuri": "http://www.89bio.com/20221231",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfStockholdersEquityDeficit"
     ],
     "xbrltype": "monetaryItemType"
    },
    "etnb_SummaryOfAvailableCarryforwardTaxLossesAndCredits": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Summary of available carryforward tax losses and credits.",
        "label": "Summary Of Available Carryforward Tax Losses And Credits",
        "terseLabel": "Summary Of Available Carryforward Tax Losses And Credits"
       }
      }
     },
     "localname": "SummaryOfAvailableCarryforwardTaxLossesAndCredits",
     "nsuri": "http://www.89bio.com/20221231",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "etnb_SummaryOfSignificantAccountingPoliciesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Summary Of Significant Accounting Policies [Line Items]",
        "terseLabel": "Summary Of Significant Accounting Policies [Line Items]"
       }
      }
     },
     "localname": "SummaryOfSignificantAccountingPoliciesLineItems",
     "nsuri": "http://www.89bio.com/20221231",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "etnb_SummaryOfSignificantAccountingPoliciesTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information related to various accounting policies of the entity.",
        "label": "Summary Of Significant Accounting Policies [Table]",
        "terseLabel": "Summary Of Significant Accounting Policies [Table]"
       }
      }
     },
     "localname": "SummaryOfSignificantAccountingPoliciesTable",
     "nsuri": "http://www.89bio.com/20221231",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "etnb_TaxCreditCarryforwardExpirationYear": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tax credit carryforward expiration year.",
        "label": "Tax Credit Carryforward Expiration Year",
        "terseLabel": "Carryforward tax losses expiration year"
       }
      }
     },
     "localname": "TaxCreditCarryforwardExpirationYear",
     "nsuri": "http://www.89bio.com/20221231",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetails"
     ],
     "xbrltype": "gYearItemType"
    },
    "etnb_TaxableIncomeUtilizationPercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Taxable income utilization percentage.",
        "label": "Taxable Income Utilization Percentage",
        "terseLabel": "Taxable income utilization percentage"
       }
      }
     },
     "localname": "TaxableIncomeUtilizationPercentage",
     "nsuri": "http://www.89bio.com/20221231",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "etnb_TemporaryEquityIssuanceCosts": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Temporary equity, issuance costs.",
        "label": "Temporary Equity Issuance Costs",
        "terseLabel": "Temporary equity, issuance costs"
       }
      }
     },
     "localname": "TemporaryEquityIssuanceCosts",
     "nsuri": "http://www.89bio.com/20221231",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfStockholdersEquityParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "etnb_TermALoanFacilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term A loan facility.",
        "label": "Term A Loan Facility [Member]",
        "terseLabel": "Term A Loan Facility"
       }
      }
     },
     "localname": "TermALoanFacilityMember",
     "nsuri": "http://www.89bio.com/20221231",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureTermLoanAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "etnb_TermBLoanFacilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term b loan facility.",
        "label": "Term B Loan Facility [Member]",
        "terseLabel": "Term B Loan Facility"
       }
      }
     },
     "localname": "TermBLoanFacilityMember",
     "nsuri": "http://www.89bio.com/20221231",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureTermLoanAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "etnb_TermLoanCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.89bio.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term loan current.",
        "label": "Term Loan Current",
        "terseLabel": "Term loan, current"
       }
      }
     },
     "localname": "TermLoanCurrent",
     "nsuri": "http://www.89bio.com/20221231",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "etnb_TevaAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Teva agreement.",
        "label": "Teva Agreement [Member]",
        "terseLabel": "Teva Agreements"
       }
      }
     },
     "localname": "TevaAgreementMember",
     "nsuri": "http://www.89bio.com/20221231",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "etnb_TevasDevelopmentProgramMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tevas development program.",
        "label": "Tevas Development Program [Member]",
        "terseLabel": "Teva's Development Program"
       }
      }
     },
     "localname": "TevasDevelopmentProgramMember",
     "nsuri": "http://www.89bio.com/20221231",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "etnb_TevasGlycoPEGylatedFGF21ProgramMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tevas glycoPEGylated FGF21 program.",
        "label": "Tevas Glyco P E Gylated F G F21 Program [Member]",
        "terseLabel": "Teva's GlycoPEGylated FGF21 Program"
       }
      }
     },
     "localname": "TevasGlycoPEGylatedFGF21ProgramMember",
     "nsuri": "http://www.89bio.com/20221231",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "etnb_TrancheFourMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tranche four.",
        "label": "Tranche Four [Member]",
        "terseLabel": "Tranche Four"
       }
      }
     },
     "localname": "TrancheFourMember",
     "nsuri": "http://www.89bio.com/20221231",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "etnb_TrancheOneMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tranche one.",
        "label": "Tranche One [Member]",
        "terseLabel": "Tranche one"
       }
      }
     },
     "localname": "TrancheOneMember",
     "nsuri": "http://www.89bio.com/20221231",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "etnb_TrancheTwoAndThreeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tranche two and three.",
        "label": "Tranche Two And Three [Member]",
        "terseLabel": "Tranche two and three"
       }
      }
     },
     "localname": "TrancheTwoAndThreeMember",
     "nsuri": "http://www.89bio.com/20221231",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "etnb_TwentyTwentyThreeLoanAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Twenty twenty three loan agreement.",
        "label": "Twenty Twenty Three Loan Agreement [Member]",
        "terseLabel": "2023 Loan Agreement"
       }
      }
     },
     "localname": "TwentyTwentyThreeLoanAgreementMember",
     "nsuri": "http://www.89bio.com/20221231",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureTermLoanAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "etnb_TwoThousandAndNineteenEquityIncentivePlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2019 equity incentive plan.",
        "label": "Two Thousand And Nineteen Equity Incentive Plan [Member]",
        "terseLabel": "2019 Plan"
       }
      }
     },
     "localname": "TwoThousandAndNineteenEquityIncentivePlanMember",
     "nsuri": "http://www.89bio.com/20221231",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails",
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockOptionActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "etnb_TwoThousandAndTwentyEquityIncentivePlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two thousand and twenty equity incentive plan.",
        "label": "Two Thousand And Twenty Equity Incentive Plan [Member]",
        "terseLabel": "2020 Plan"
       }
      }
     },
     "localname": "TwoThousandAndTwentyEquityIncentivePlanMember",
     "nsuri": "http://www.89bio.com/20221231",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "etnb_TwoThousandAndTwentyOneLoanAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two thousand and twenty one loan agreement.",
        "label": "Two Thousand and Twenty One Loan Agreement [Member]",
        "terseLabel": "2021 Loan Agreement"
       }
      }
     },
     "localname": "TwoThousandAndTwentyOneLoanAgreementMember",
     "nsuri": "http://www.89bio.com/20221231",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "etnb_TwoThousandAndTwentyThreeLoanAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two thousand and twenty three loan agreement.",
        "label": "Two Thousand and Twenty Three Loan Agreement [Member]",
        "terseLabel": "2023 Loan Agreement"
       }
      }
     },
     "localname": "TwoThousandAndTwentyThreeLoanAgreementMember",
     "nsuri": "http://www.89bio.com/20221231",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "etnb_UABEightyNineBioLithuaniaMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "UAB Eighty Nine Bio Lithuania.",
        "label": "U A B Eighty Nine Bio Lithuania [Member]",
        "terseLabel": "UAB 89bio Lithuania"
       }
      }
     },
     "localname": "UABEightyNineBioLithuaniaMember",
     "nsuri": "http://www.89bio.com/20221231",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesSummaryOfStatutoryTaxRatesApplicableToIncomeOfCompanyAndSubsidiariesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "etnb_UnderwritingDiscountsAndCommissions": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Underwriting discounts and commissions.",
        "label": "Underwriting Discounts And Commissions",
        "terseLabel": "Underwriting discounts and commissions"
       }
      }
     },
     "localname": "UnderwritingDiscountsAndCommissions",
     "nsuri": "http://www.89bio.com/20221231",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/DisclosureStockholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "etnb_UnderwrittenPublicOfferingMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Underwritten Public Offering [Member]",
        "label": "Underwritten Public Offering [Member]",
        "terseLabel": "Underwritten public offering"
       }
      }
     },
     "localname": "UnderwrittenPublicOfferingMember",
     "nsuri": "http://www.89bio.com/20221231",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureOrganizationAndBasisOfPresentationAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "etnb_UnvestedRestrictedStockUnitsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unvested restricted stock units.",
        "label": "Unvested Restricted Stock Units [Member]",
        "terseLabel": "Unvested Restricted Stock Units"
       }
      }
     },
     "localname": "UnvestedRestrictedStockUnitsMember",
     "nsuri": "http://www.89bio.com/20221231",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureNetLossPerShareScheduleOfOutstandingPotentiallyDilutiveSecuritiesExcludedFromCalculationOfDilutedNetLossDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "etnb_WarrantPublicOfferingsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Warrant public offerings member.",
        "label": "Warrant Public Offerings [Member]",
        "terseLabel": "Warrants Public Offerings"
       }
      }
     },
     "localname": "WarrantPublicOfferingsMember",
     "nsuri": "http://www.89bio.com/20221231",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/DisclosureStockholdersEquityScheduleOfOutstandingWarrantsToPurchaseSharesOfCommonStockDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "etnb_WarrantTermLoanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Warrant term loan member.",
        "label": "Warrant Term Loan [Member]",
        "terseLabel": "Warrants Term Loan"
       }
      }
     },
     "localname": "WarrantTermLoanMember",
     "nsuri": "http://www.89bio.com/20221231",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/DisclosureStockholdersEquityScheduleOfOutstandingWarrantsToPurchaseSharesOfCommonStockDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "etnb_WarrantTermLoanOneMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Warrant term loan one member.",
        "label": "Warrant Term Loan One [Member]",
        "terseLabel": "Warrants Term Loan"
       }
      }
     },
     "localname": "WarrantTermLoanOneMember",
     "nsuri": "http://www.89bio.com/20221231",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/DisclosureStockholdersEquityScheduleOfOutstandingWarrantsToPurchaseSharesOfCommonStockDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "etnb_WarrantsAndRightsOutstandingMaturityDateDescription": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Warrants and rights outstanding maturity date description.",
        "label": "Warrants And Rights Outstanding Maturity Date Description",
        "terseLabel": "Expiration Date"
       }
      }
     },
     "localname": "WarrantsAndRightsOutstandingMaturityDateDescription",
     "nsuri": "http://www.89bio.com/20221231",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/DisclosureStockholdersEquityScheduleOfOutstandingWarrantsToPurchaseSharesOfCommonStockDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "etnb_WarrantsToPurchaseCommonStockPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Warrants to purchase common stock.",
        "label": "Warrants To Purchase Common Stock Policy [Text Block]",
        "terseLabel": "Warrants To Purchase Common Stock"
       }
      }
     },
     "localname": "WarrantsToPurchaseCommonStockPolicyTextBlock",
     "nsuri": "http://www.89bio.com/20221231",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "srt_ConsolidatedEntitiesAxis": {
     "auth_ref": [
      "r198",
      "r424",
      "r425",
      "r428",
      "r429",
      "r496",
      "r576",
      "r654",
      "r657",
      "r658"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidated Entities [Axis]",
        "terseLabel": "Consolidated Entities"
       }
      }
     },
     "localname": "ConsolidatedEntitiesAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesSummaryOfStatutoryTaxRatesApplicableToIncomeOfCompanyAndSubsidiariesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ConsolidatedEntitiesDomain": {
     "auth_ref": [
      "r198",
      "r424",
      "r425",
      "r428",
      "r429",
      "r496",
      "r576",
      "r654",
      "r657",
      "r658"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidated Entities [Domain]",
        "terseLabel": "Consolidated Entities"
       }
      }
     },
     "localname": "ConsolidatedEntitiesDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesSummaryOfStatutoryTaxRatesApplicableToIncomeOfCompanyAndSubsidiariesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ExecutiveOfficerMember": {
     "auth_ref": [
      "r644"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Executive Officer [Member]",
        "terseLabel": "Executive Officer"
       }
      }
     },
     "localname": "ExecutiveOfficerMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MaximumMember": {
     "auth_ref": [
      "r286",
      "r287",
      "r288",
      "r289",
      "r342",
      "r530",
      "r547",
      "r577",
      "r578",
      "r593",
      "r598",
      "r608",
      "r659",
      "r708",
      "r709",
      "r710",
      "r711",
      "r712",
      "r713"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum [Member]",
        "terseLabel": "Maximum"
       }
      }
     },
     "localname": "MaximumMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/DisclosureStockholdersEquityAdditionalInformationDetails",
      "http://www.89bio.com/20221231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails",
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureOrganizationAndBasisOfPresentationAdditionalInformationDetails",
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails",
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfEstimatedFairValueOfStockOptionsGrantedUsingBlackScholesOptionPricingModelDetails",
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails",
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureTermLoanAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MinimumMember": {
     "auth_ref": [
      "r286",
      "r287",
      "r288",
      "r289",
      "r342",
      "r530",
      "r547",
      "r577",
      "r578",
      "r593",
      "r598",
      "r608",
      "r659",
      "r708",
      "r709",
      "r710",
      "r711",
      "r712",
      "r713"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Minimum [Member]",
        "terseLabel": "Minimum"
       }
      }
     },
     "localname": "MinimumMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureOrganizationAndBasisOfPresentationAdditionalInformationDetails",
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails",
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfEstimatedFairValueOfStockOptionsGrantedUsingBlackScholesOptionPricingModelDetails",
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails",
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureTermLoanAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RangeAxis": {
     "auth_ref": [
      "r286",
      "r287",
      "r288",
      "r289",
      "r335",
      "r342",
      "r372",
      "r373",
      "r374",
      "r506",
      "r530",
      "r547",
      "r577",
      "r578",
      "r593",
      "r598",
      "r608",
      "r650",
      "r659",
      "r709",
      "r710",
      "r711",
      "r712",
      "r713"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Axis]",
        "terseLabel": "Statistical Measurement"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/DisclosureStockholdersEquityAdditionalInformationDetails",
      "http://www.89bio.com/20221231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails",
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureOrganizationAndBasisOfPresentationAdditionalInformationDetails",
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails",
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfEstimatedFairValueOfStockOptionsGrantedUsingBlackScholesOptionPricingModelDetails",
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails",
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureTermLoanAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RangeMember": {
     "auth_ref": [
      "r286",
      "r287",
      "r288",
      "r289",
      "r335",
      "r342",
      "r372",
      "r373",
      "r374",
      "r506",
      "r530",
      "r547",
      "r577",
      "r578",
      "r593",
      "r598",
      "r608",
      "r650",
      "r659",
      "r709",
      "r710",
      "r711",
      "r712",
      "r713"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Domain]",
        "terseLabel": "Statistical Measurement"
       }
      }
     },
     "localname": "RangeMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/DisclosureStockholdersEquityAdditionalInformationDetails",
      "http://www.89bio.com/20221231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails",
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureOrganizationAndBasisOfPresentationAdditionalInformationDetails",
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails",
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfEstimatedFairValueOfStockOptionsGrantedUsingBlackScholesOptionPricingModelDetails",
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails",
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureTermLoanAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_SegmentGeographicalDomain": {
     "auth_ref": [
      "r251",
      "r252",
      "r567",
      "r568",
      "r569",
      "r570",
      "r571",
      "r572",
      "r573",
      "r574",
      "r575",
      "r594",
      "r607",
      "r661"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographical [Domain]",
        "terseLabel": "Geographical"
       }
      }
     },
     "localname": "SegmentGeographicalDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails",
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetails",
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesSummaryOfComponentsOfDeferredTaxAssetsDetails",
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesSummaryOfLossFromOperationsBeforeTaxesOnIncomeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_StatementGeographicalAxis": {
     "auth_ref": [
      "r251",
      "r252",
      "r563",
      "r567",
      "r568",
      "r569",
      "r570",
      "r571",
      "r572",
      "r573",
      "r574",
      "r575",
      "r594",
      "r607",
      "r661"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographical [Axis]",
        "terseLabel": "Geographical"
       }
      }
     },
     "localname": "StatementGeographicalAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails",
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetails",
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesSummaryOfComponentsOfDeferredTaxAssetsDetails",
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesSummaryOfLossFromOperationsBeforeTaxesOnIncomeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_TitleOfIndividualAxis": {
     "auth_ref": [
      "r644",
      "r705"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of Individual [Axis]",
        "terseLabel": "Title of Individual"
       }
      }
     },
     "localname": "TitleOfIndividualAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_TitleOfIndividualWithRelationshipToEntityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of Individual [Domain]",
        "terseLabel": "Title of Individual"
       }
      }
     },
     "localname": "TitleOfIndividualWithRelationshipToEntityDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "stpr_CA": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "CALIFORNIA",
        "terseLabel": "California"
       }
      }
     },
     "localname": "CA",
     "nsuri": "http://xbrl.sec.gov/stpr/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies [Abstract]"
       }
      }
     },
     "localname": "AccountingPoliciesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountingStandardsUpdate201602Member": {
     "auth_ref": [
      "r476"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accounting Standards Update 2016-02 Leases (Topic 842).",
        "label": "Accounting Standards Update 2016-02 [Member]",
        "terseLabel": "ASC 842"
       }
      }
     },
     "localname": "AccountingStandardsUpdate201602Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountsPayableCurrent": {
     "auth_ref": [
      "r13",
      "r606"
     ],
     "calculation": {
      "http://www.89bio.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets": {
       "order": 0.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accounts Payable, Current",
        "terseLabel": "Accounts payable",
        "totalLabel": "Accounts Payable, Current, Total"
       }
      }
     },
     "localname": "AccountsPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments": {
     "auth_ref": [
      "r43"
     ],
     "calculation": {
      "http://www.89bio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The sum of the periodic adjustments of the differences between securities' face values and purchase prices that are charged against earnings. This is called accretion if the security was purchased at a discount and amortization if it was purchased at premium. As a noncash item, this element is an adjustment to net income when calculating cash provided by or used in operations using the indirect method.",
        "label": "Accretion (Amortization) of Discounts and Premiums, Investments",
        "negatedLabel": "Net (accretion) amortization on available-for-sale securities"
       }
      }
     },
     "localname": "AccretionAmortizationOfDiscountsAndPremiumsInvestments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r16"
     ],
     "calculation": {
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureConsolidatedBalanceSheetComponentsScheduleOfAccruedExpensesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.89bio.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Liabilities, Current",
        "terseLabel": "Accrued expenses",
        "totalLabel": "Total accrued expenses"
       }
      }
     },
     "localname": "AccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureConsolidatedBalanceSheetComponentsScheduleOfAccruedExpensesDetails",
      "http://www.89bio.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedProfessionalFeesCurrent": {
     "auth_ref": [
      "r16"
     ],
     "calculation": {
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureConsolidatedBalanceSheetComponentsScheduleOfAccruedExpensesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Professional Fees, Current",
        "terseLabel": "Accrued professional and legal fees"
       }
      }
     },
     "localname": "AccruedProfessionalFeesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureConsolidatedBalanceSheetComponentsScheduleOfAccruedExpensesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r26",
      "r27",
      "r28",
      "r166",
      "r542",
      "r555",
      "r559"
     ],
     "calculation": {
      "http://www.89bio.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.",
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "terseLabel": "Accumulated other comprehensive loss",
        "totalLabel": "Accumulated Other Comprehensive Income (Loss), Net of Tax, Total"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "auth_ref": [
      "r25",
      "r28",
      "r111",
      "r495",
      "r550",
      "r551",
      "r627",
      "r628",
      "r629",
      "r638",
      "r639",
      "r640"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.",
        "label": "AOCI Attributable to Parent [Member]",
        "terseLabel": "Accumulated Other Comprehensive Loss"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfStockholdersEquityDeficit"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdditionalPaidInCapitalCommonStock": {
     "auth_ref": [
      "r8"
     ],
     "calculation": {
      "http://www.89bio.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.",
        "label": "Additional Paid in Capital, Common Stock",
        "terseLabel": "Additional paid-in capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "auth_ref": [
      "r381",
      "r382",
      "r383",
      "r638",
      "r639",
      "r640",
      "r699"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
        "label": "Additional Paid-in Capital [Member]",
        "terseLabel": "Additional Paid-in Capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfStockholdersEquityDeficit"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentsForNewAccountingPronouncementsAxis": {
     "auth_ref": [
      "r151",
      "r152",
      "r153",
      "r154",
      "r155",
      "r203",
      "r204",
      "r205",
      "r206",
      "r215",
      "r253",
      "r254",
      "r266",
      "r267",
      "r268",
      "r269",
      "r270",
      "r271",
      "r381",
      "r382",
      "r383",
      "r407",
      "r408",
      "r409",
      "r410",
      "r420",
      "r421",
      "r422",
      "r433",
      "r434",
      "r435",
      "r436",
      "r437",
      "r438",
      "r439",
      "r440",
      "r441",
      "r442",
      "r443",
      "r444",
      "r454",
      "r455",
      "r457",
      "r458",
      "r459",
      "r460",
      "r461",
      "r462",
      "r472",
      "r473",
      "r478",
      "r479",
      "r480",
      "r481",
      "r490",
      "r491",
      "r492",
      "r493",
      "r494",
      "r495",
      "r532",
      "r533",
      "r534",
      "r548",
      "r549",
      "r550",
      "r551",
      "r552",
      "r553",
      "r554",
      "r555",
      "r556",
      "r557",
      "r558",
      "r559"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by amendment to accounting standards.",
        "label": "Accounting Standards Update [Axis]"
       }
      }
     },
     "localname": "AdjustmentsForNewAccountingPronouncementsAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": {
     "auth_ref": [
      "r96",
      "r97",
      "r344"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.",
        "label": "APIC, Share-Based Payment Arrangement, Increase for Cost Recognition",
        "terseLabel": "Stock-based compensation",
        "totalLabel": "APIC, Share-Based Payment Arrangement, Increase for Cost Recognition, Total"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfStockholdersEquityDeficit"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Adjustments to reconcile net loss to net cash used in operating activities:"
       }
      }
     },
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AgencySecuritiesMember": {
     "auth_ref": [
      "r59"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities issued by government sponsored entities.",
        "label": "Agency Securities [Member]",
        "terseLabel": "Agency bonds"
       }
      }
     },
     "localname": "AgencySecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureFairValueMeasurementsSummaryOfFinancialAssetsMeasuredAtFairValueOnRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AllocatedShareBasedCompensationExpense": {
     "auth_ref": [
      "r376"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.",
        "label": "Share-Based Payment Arrangement, Expense",
        "terseLabel": "Total stock-based compensation",
        "verboseLabel": "Share base compensation expense"
       }
      }
     },
     "localname": "AllocatedShareBasedCompensationExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails",
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockBasedCompensationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "auth_ref": [
      "r224"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "terseLabel": "Antidilutive common stock equivalents excluded from calculation of diluted net loss per share"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureNetLossPerShareScheduleOfOutstandingPotentiallyDilutiveSecuritiesExcludedFromCalculationOfDilutedNetLossDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": {
     "auth_ref": [
      "r48"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of antidilutive security.",
        "label": "Antidilutive Securities [Axis]",
        "terseLabel": "Antidilutive Securities"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureNetLossPerShareScheduleOfOutstandingPotentiallyDilutiveSecuritiesExcludedFromCalculationOfDilutedNetLossDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]",
        "terseLabel": "Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureNetLossPerShareScheduleOfOutstandingPotentiallyDilutiveSecuritiesExcludedFromCalculationOfDilutedNetLossDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AntidilutiveSecuritiesNameDomain": {
     "auth_ref": [
      "r48"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented.",
        "label": "Antidilutive Securities, Name [Domain]",
        "terseLabel": "Antidilutive Securities, Name"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureNetLossPerShareScheduleOfOutstandingPotentiallyDilutiveSecuritiesExcludedFromCalculationOfDilutedNetLossDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ArrangementsAndNonarrangementTransactionsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.",
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Domain]",
        "terseLabel": "Collaborative Arrangement and Arrangement Other than Collaborative"
       }
      }
     },
     "localname": "ArrangementsAndNonarrangementTransactionsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/DisclosureStockholdersEquityAdditionalInformationDetails",
      "http://www.89bio.com/20221231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails",
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails",
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureOrganizationAndBasisOfPresentationAdditionalInformationDetails",
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureTermLoanAdditionalInformationDetails",
      "http://www.89bio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfStockholdersEquityDeficit",
      "http://www.89bio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfStockholdersEquityParenthetical"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r126",
      "r139",
      "r161",
      "r195",
      "r239",
      "r247",
      "r249",
      "r262",
      "r290",
      "r291",
      "r292",
      "r293",
      "r294",
      "r295",
      "r296",
      "r297",
      "r298",
      "r424",
      "r428",
      "r453",
      "r606",
      "r655",
      "r656",
      "r706"
     ],
     "calculation": {
      "http://www.89bio.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "totalLabel": "Total assets"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets [Abstract]",
        "terseLabel": "Assets"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r157",
      "r167",
      "r195",
      "r262",
      "r290",
      "r291",
      "r292",
      "r293",
      "r294",
      "r295",
      "r296",
      "r297",
      "r298",
      "r424",
      "r428",
      "r453",
      "r606",
      "r655",
      "r656",
      "r706"
     ],
     "calculation": {
      "http://www.89bio.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets": {
       "order": 0.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Current",
        "totalLabel": "Total current assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Current [Abstract]",
        "terseLabel": "Current assets:"
       }
      }
     },
     "localname": "AssetsCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax": {
     "auth_ref": [
      "r56"
     ],
     "calculation": {
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureFairValueMeasurementsSummaryOfFinancialAssetsMeasuredAtFairValueOnRecurringBasisDetails": {
       "order": 0.0,
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of unrealized gain in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Gain, before Tax",
        "terseLabel": "Short-term investments, Gross Unrealized Holding Gains"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureFairValueMeasurementsSummaryOfFinancialAssetsMeasuredAtFairValueOnRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax": {
     "auth_ref": [
      "r57"
     ],
     "calculation": {
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureFairValueMeasurementsSummaryOfFinancialAssetsMeasuredAtFairValueOnRecurringBasisDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of unrealized loss in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax",
        "negatedLabel": "Short-term investments, Gross Unrealized Holding Losses"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureFairValueMeasurementsSummaryOfFinancialAssetsMeasuredAtFairValueOnRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis": {
     "auth_ref": [
      "r257",
      "r277"
     ],
     "calculation": {
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureFairValueMeasurementsSummaryOfFinancialAssetsMeasuredAtFairValueOnRecurringBasisDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-Sale, Amortized Cost",
        "totalLabel": "Short-term investments, Amortized Cost"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesAmortizedCostBasis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureFairValueMeasurementsSummaryOfFinancialAssetsMeasuredAtFairValueOnRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue": {
     "auth_ref": [
      "r58",
      "r258",
      "r540"
     ],
     "calculation": {
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfContractualMaturitiesOfCashEquivalentsAndAvailableForSaleSecuritiesDetails": {
       "order": 0.0,
       "parentTag": "us-gaap_AvailableForSaleSecuritiesDebtSecurities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One",
        "terseLabel": "Within one year"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfContractualMaturitiesOfCashEquivalentsAndAvailableForSaleSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtSecurities": {
     "auth_ref": [
      "r55",
      "r255",
      "r277",
      "r535"
     ],
     "calculation": {
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfContractualMaturitiesOfCashEquivalentsAndAvailableForSaleSecuritiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureFairValueMeasurementsSummaryOfFinancialAssetsMeasuredAtFairValueOnRecurringBasisDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-Sale",
        "terseLabel": "Short-term investments, Aggregated Fair Value",
        "totalLabel": "Total cash equivalents and available-for-sale securities"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtSecurities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfContractualMaturitiesOfCashEquivalentsAndAvailableForSaleSecuritiesDetails",
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureFairValueMeasurementsSummaryOfFinancialAssetsMeasuredAtFairValueOnRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AwardTypeAxis": {
     "auth_ref": [
      "r347",
      "r348",
      "r349",
      "r351",
      "r352",
      "r353",
      "r354",
      "r355",
      "r356",
      "r357",
      "r358",
      "r359",
      "r360",
      "r361",
      "r362",
      "r363",
      "r364",
      "r365",
      "r366",
      "r367",
      "r368",
      "r371",
      "r372",
      "r373",
      "r374",
      "r375"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of award under share-based payment arrangement.",
        "label": "Award Type [Axis]",
        "terseLabel": "Award Type"
       }
      }
     },
     "localname": "AwardTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfRestrictedStockUnitActivityDetails",
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location on balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Axis]",
        "terseLabel": "Balance Sheet Location"
       }
      }
     },
     "localname": "BalanceSheetLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureTermLoanAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationDomain": {
     "auth_ref": [
      "r115",
      "r116"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Domain]",
        "terseLabel": "Balance Sheet Location"
       }
      }
     },
     "localname": "BalanceSheetLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureTermLoanAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BalanceSheetRelatedDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Balance Sheet Related Disclosures [Abstract]"
       }
      }
     },
     "localname": "BalanceSheetRelatedDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).",
        "label": "Basis of Accounting, Policy [Policy Text Block]",
        "terseLabel": "Basis of Presentation"
       }
      }
     },
     "localname": "BasisOfAccountingPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r44",
      "r159",
      "r580"
     ],
     "calculation": {
      "http://www.89bio.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets": {
       "order": 0.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      },
      "http://www.89bio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows": {
       "order": 0.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "terseLabel": "Cash and cash equivalents",
        "totalLabel": "Cash and Cash Equivalents, at Carrying Value, Total"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets",
      "http://www.89bio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy": {
     "auth_ref": [
      "r45",
      "r125"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Entity's cash and cash equivalents accounting policy with respect to restricted balances. Restrictions may include legally restricted deposits held as compensating balances against short-term borrowing arrangements, contracts entered into with others, or company statements of intention with regard to particular deposits; however, time deposits and short-term certificates of deposit are not generally included in legally restricted deposits.",
        "label": "Cash and Cash Equivalents, Restricted Cash and Cash Equivalents, Policy [Policy Text Block]",
        "terseLabel": "Cash and Cash Equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CashCashEquivalentsAndShortTermInvestments": {
     "auth_ref": [
      "r625"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash includes currency on hand as well as demand deposits with banks or financial institutions. It also includes other kinds of accounts that have the general characteristics of demand deposits in that the customer may deposit additional funds at any time and effectively may withdraw funds at any time without prior notice or penalty. Cash equivalents, excluding items classified as marketable securities, include short-term, highly liquid Investments that are both readily convertible to known amounts of cash, and so near their maturity that they present minimal risk of changes in value because of changes in interest rates. Generally, only investments with original maturities of three months or less qualify under that definition. Original maturity means original maturity to the entity holding the investment. For example, both a three-month US Treasury bill and a three-year Treasury note purchased three months from maturity qualify as cash equivalents. However, a Treasury note purchased three years ago does not become a cash equivalent when its remaining maturity is three months. Short-term investments, exclusive of cash equivalents, generally consist of marketable securities intended to be sold within one year (or the normal operating cycle if longer) and may include trading securities, available-for-sale securities, or held-to-maturity securities (if maturing within one year), as applicable.",
        "label": "Cash, Cash Equivalents, and Short-Term Investments",
        "terseLabel": "Cash and cash equivalents and short term available-for-sale securities",
        "totalLabel": "Cash, Cash Equivalents, and Short-Term Investments, Total"
       }
      }
     },
     "localname": "CashCashEquivalentsAndShortTermInvestments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureOrganizationAndBasisOfPresentationAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r39",
      "r44",
      "r46"
     ],
     "calculation": {
      "http://www.89bio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents",
        "periodEndLabel": "Cash and cash equivalents, and restricted cash at end of period",
        "periodStartLabel": "Cash and cash equivalents, and restricted cash at beginning of period",
        "totalLabel": "Total cash and cash equivalents, and restricted cash"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents [Abstract]",
        "terseLabel": "Components of cash and cash equivalents, and restricted cash:"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "auth_ref": [
      "r39",
      "r119"
     ],
     "calculation": {
      "http://www.89bio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "totalLabel": "Net change in cash and cash equivalents, and restricted cash"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashEquivalentsMember": {
     "auth_ref": [
      "r159"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash Equivalents [Member]",
        "terseLabel": "Cash equivalents"
       }
      }
     },
     "localname": "CashEquivalentsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureFairValueMeasurementsSummaryOfFinancialAssetsMeasuredAtFairValueOnRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted": {
     "auth_ref": [
      "r151",
      "r152",
      "r202",
      "r253",
      "r254",
      "r263",
      "r264",
      "r265",
      "r266",
      "r267",
      "r407",
      "r420",
      "r421",
      "r430",
      "r433",
      "r434",
      "r444",
      "r454",
      "r456",
      "r457",
      "r458",
      "r461",
      "r462",
      "r472",
      "r477",
      "r478",
      "r479",
      "r480",
      "r490",
      "r491",
      "r532",
      "r533",
      "r548",
      "r549"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates (true false) whether accounting standards update was adopted.",
        "label": "Change in Accounting Principle, Accounting Standards Update, Adopted [true false]",
        "terseLabel": "Change in accounting principle, accounting standards update, adopted [true false]"
       }
      }
     },
     "localname": "ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "booleanItemType"
    },
    "us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdoptionDate": {
     "auth_ref": [
      "r151",
      "r152",
      "r253",
      "r254",
      "r263",
      "r264",
      "r265",
      "r266",
      "r267",
      "r407",
      "r420",
      "r421",
      "r422",
      "r430",
      "r433",
      "r434",
      "r435",
      "r438",
      "r444",
      "r454",
      "r456",
      "r457",
      "r458",
      "r461",
      "r462",
      "r472",
      "r477",
      "r478",
      "r479",
      "r480",
      "r490",
      "r491",
      "r532",
      "r533",
      "r548",
      "r549",
      "r641"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date accounting standards update was adopted, in YYYY-MM-DD format.",
        "label": "Change in Accounting Principle, Accounting Standards Update, Adoption Date",
        "terseLabel": "Change in accounting principle, accounting standards update, adoption date"
       }
      }
     },
     "localname": "ChangeInAccountingPrincipleAccountingStandardsUpdateAdoptionDate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "dateItemType"
    },
    "us-gaap_ClassOfStockDomain": {
     "auth_ref": [
      "r163",
      "r164",
      "r165",
      "r195",
      "r218",
      "r219",
      "r221",
      "r223",
      "r230",
      "r231",
      "r262",
      "r290",
      "r292",
      "r293",
      "r294",
      "r297",
      "r298",
      "r317",
      "r318",
      "r321",
      "r325",
      "r332",
      "r453",
      "r579",
      "r621",
      "r634",
      "r642"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock.",
        "label": "Class of Stock [Domain]",
        "terseLabel": "Class of Stock"
       }
      }
     },
     "localname": "ClassOfStockDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfStockholdersEquityParenthetical"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ClassOfStockLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Class of Stock [Line Items]",
        "verboseLabel": "Class Of Stock [Line Items]"
       }
      }
     },
     "localname": "ClassOfStockLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/DisclosureStockholdersEquityScheduleOfSharesOfCommonStockAvailableForFutureIssuanceDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ClassOfWarrantOrRightAxis": {
     "auth_ref": [
      "r83",
      "r85"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of warrant or right issued.",
        "label": "Class of Warrant or Right [Axis]"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/DisclosureStockholdersEquityScheduleOfOutstandingWarrantsToPurchaseSharesOfCommonStockDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ClassOfWarrantOrRightDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the class or type of warrant or right outstanding. Warrants and rights represent derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months.",
        "label": "Class of Warrant or Right [Domain]"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/DisclosureStockholdersEquityScheduleOfOutstandingWarrantsToPurchaseSharesOfCommonStockDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1": {
     "auth_ref": [
      "r333"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Exercise price per share or per unit of warrants or rights outstanding.",
        "label": "Class of Warrant or Right, Exercise Price of Warrants or Rights",
        "terseLabel": "Warrant exercise price"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/DisclosureStockholdersEquityScheduleOfOutstandingWarrantsToPurchaseSharesOfCommonStockDetails",
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureTermLoanAdditionalInformationDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ClassOfWarrantOrRightLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Class of Warrant or Right [Line Items]",
        "terseLabel": "Class Of Warrant Or Right [Line Items]"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/DisclosureStockholdersEquityScheduleOfOutstandingWarrantsToPurchaseSharesOfCommonStockDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights": {
     "auth_ref": [
      "r333"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.",
        "label": "Class of Warrant or Right, Number of Securities Called by Warrants or Rights",
        "terseLabel": "Warrants to purchase common stock",
        "verboseLabel": "Warrants to purchase shares of common stock"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/DisclosureStockholdersEquityAdditionalInformationDetails",
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureTermLoanAdditionalInformationDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ClassOfWarrantOrRightOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of warrants or rights outstanding.",
        "label": "Class of Warrant or Right, Outstanding",
        "terseLabel": "Shares of Common Stock Underlying Warrants"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/DisclosureStockholdersEquityScheduleOfOutstandingWarrantsToPurchaseSharesOfCommonStockDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ClassOfWarrantOrRightTable": {
     "auth_ref": [
      "r83",
      "r85"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure for warrants or rights issued, which includes the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.",
        "label": "Class of Warrant or Right [Table]"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/DisclosureStockholdersEquityScheduleOfOutstandingWarrantsToPurchaseSharesOfCommonStockDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommercialPaperMember": {
     "auth_ref": [
      "r69"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unsecured promissory note (generally negotiable) that provides institutions with short-term funds.",
        "label": "Commercial Paper [Member]",
        "terseLabel": "Commercial Paper"
       }
      }
     },
     "localname": "CommercialPaperMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureFairValueMeasurementsSummaryOfFinancialAssetsMeasuredAtFairValueOnRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommitmentsAndContingencies": {
     "auth_ref": [
      "r21",
      "r131",
      "r143"
     ],
     "calculation": {
      "http://www.89bio.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.",
        "label": "Commitments and Contingencies",
        "terseLabel": "Commitments and contingencies (Note 5)"
       }
      }
     },
     "localname": "CommitmentsAndContingencies",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "auth_ref": [
      "r66",
      "r283",
      "r284",
      "r564",
      "r653"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for commitments and contingencies.",
        "label": "Commitments and Contingencies Disclosure [Text Block]",
        "terseLabel": "Commitments and Contingencies"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureCommitmentsAndContingencies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommonStockCapitalSharesReservedForFutureIssuance": {
     "auth_ref": [
      "r22"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate number of common shares reserved for future issuance.",
        "label": "Common Stock, Capital Shares Reserved for Future Issuance",
        "terseLabel": "Total available for future issuance"
       }
      }
     },
     "localname": "CommonStockCapitalSharesReservedForFutureIssuance",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/DisclosureStockholdersEquityScheduleOfSharesOfCommonStockAvailableForFutureIssuanceDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r638",
      "r639",
      "r699"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]",
        "terseLabel": "Common Stock"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureOrganizationAndBasisOfPresentationAdditionalInformationDetails",
      "http://www.89bio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfStockholdersEquityDeficit"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r7"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of common stock.",
        "label": "Common Stock, Par or Stated Value Per Share",
        "terseLabel": "Common stock, par value"
       }
      }
     },
     "localname": "CommonStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/DisclosureStockholdersEquityAdditionalInformationDetails",
      "http://www.89bio.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "auth_ref": [
      "r7"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Common Stock, Shares Authorized",
        "terseLabel": "Common stock, shares authorized"
       }
      }
     },
     "localname": "CommonStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r7"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Common Stock, Shares, Issued",
        "terseLabel": "Common stock, shares issued"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "auth_ref": [
      "r7",
      "r75"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.",
        "label": "Common Stock, Shares, Outstanding",
        "periodEndLabel": "Common Stock, Shares, Outstanding, Ending Balance",
        "periodStartLabel": "Common Stock, Shares, Outstanding, Beginning Balance",
        "terseLabel": "Common stock, shares outstanding"
       }
      }
     },
     "localname": "CommonStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r7",
      "r606"
     ],
     "calculation": {
      "http://www.89bio.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Common Stock, Value, Issued",
        "terseLabel": "Common stock, $0.001 par value, 100,000,000 shares authorized as of December 31, 2022 and 2021; 50,560,590 and 20,317,204 shares issued and outstanding as of December 31, 2022 and 2021, respectively"
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "auth_ref": [
      "r29",
      "r174",
      "r176",
      "r183",
      "r537",
      "r544"
     ],
     "calculation": {
      "http://www.89bio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "totalLabel": "Comprehensive loss"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomePolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for comprehensive income.",
        "label": "Comprehensive Income, Policy [Policy Text Block]",
        "terseLabel": "Comprehensive Loss"
       }
      }
     },
     "localname": "ComprehensiveIncomePolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConcentrationRiskCreditRisk": {
     "auth_ref": [
      "r136",
      "r234"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for credit risk.",
        "label": "Concentration Risk, Credit Risk, Policy [Policy Text Block]",
        "terseLabel": "Concentrations of Credit Risk"
       }
      }
     },
     "localname": "ConcentrationRiskCreditRisk",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConsolidationPolicyTextBlock": {
     "auth_ref": [
      "r110",
      "r582"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.",
        "label": "Consolidation, Policy [Policy Text Block]",
        "terseLabel": "Principles of Consolidation"
       }
      }
     },
     "localname": "ConsolidationPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CorporateDebtSecuritiesMember": {
     "auth_ref": [
      "r595",
      "r597",
      "r717"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt securities issued by domestic or foreign corporate business, banks and other entities with a promise of repayment.",
        "label": "Corporate Debt Securities [Member]",
        "terseLabel": "Corporate debt securities"
       }
      }
     },
     "localname": "CorporateDebtSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureFairValueMeasurementsSummaryOfFinancialAssetsMeasuredAtFairValueOnRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CurrentFederalTaxExpenseBenefit": {
     "auth_ref": [
      "r637",
      "r695",
      "r697"
     ],
     "calculation": {
      "http://www.89bio.com/20221231/taxonomy/role/DisclosureIncomeTaxesSummaryOfIncomeTaxExpenseBenefitDetails": {
       "order": 0.0,
       "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current national tax expense (benefit) for non-US (United States of America) jurisdiction.",
        "label": "Current Federal Tax Expense (Benefit)",
        "negatedLabel": "Federal",
        "terseLabel": "Federal"
       }
      }
     },
     "localname": "CurrentFederalTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/DisclosureIncomeTaxesSummaryOfIncomeTaxExpenseBenefitDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CurrentForeignTaxExpenseBenefit": {
     "auth_ref": [
      "r637",
      "r695"
     ],
     "calculation": {
      "http://www.89bio.com/20221231/taxonomy/role/DisclosureIncomeTaxesSummaryOfIncomeTaxExpenseBenefitDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Current Foreign Tax Expense (Benefit)",
        "negatedLabel": "Foreign",
        "terseLabel": "Foreign"
       }
      }
     },
     "localname": "CurrentForeignTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/DisclosureIncomeTaxesSummaryOfIncomeTaxExpenseBenefitDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CurrentIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r108",
      "r404",
      "r414",
      "r637"
     ],
     "calculation": {
      "http://www.89bio.com/20221231/taxonomy/role/DisclosureIncomeTaxesSummaryOfIncomeTaxExpenseBenefitDetails": {
       "order": 0.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.",
        "label": "Current Income Tax Expense (Benefit)",
        "negatedTotalLabel": "Total",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "CurrentIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/DisclosureIncomeTaxesSummaryOfIncomeTaxExpenseBenefitDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Income Tax Expense (Benefit), Continuing Operations [Abstract]",
        "terseLabel": "Current:"
       }
      }
     },
     "localname": "CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/DisclosureIncomeTaxesSummaryOfIncomeTaxExpenseBenefitDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CurrentStateAndLocalTaxExpenseBenefit": {
     "auth_ref": [
      "r637",
      "r695",
      "r697"
     ],
     "calculation": {
      "http://www.89bio.com/20221231/taxonomy/role/DisclosureIncomeTaxesSummaryOfIncomeTaxExpenseBenefitDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction.",
        "label": "Current State and Local Tax Expense (Benefit)",
        "negatedLabel": "State",
        "terseLabel": "State"
       }
      }
     },
     "localname": "CurrentStateAndLocalTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/DisclosureIncomeTaxesSummaryOfIncomeTaxExpenseBenefitDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Disclosure [Abstract]"
       }
      }
     },
     "localname": "DebtDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentAnnualPrincipalPayment": {
     "auth_ref": [
      "r3"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the total principal payments made during the annual reporting period.",
        "label": "Debt Instrument, Annual Principal Payment",
        "terseLabel": "Total principal amount outstanding"
       }
      }
     },
     "localname": "DebtInstrumentAnnualPrincipalPayment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentAxis": {
     "auth_ref": [
      "r1",
      "r2",
      "r3",
      "r127",
      "r129",
      "r138",
      "r198",
      "r299",
      "r300",
      "r301",
      "r302",
      "r303",
      "r304",
      "r305",
      "r306",
      "r307",
      "r308",
      "r309",
      "r310",
      "r311",
      "r312",
      "r313",
      "r314",
      "r475",
      "r588",
      "r589",
      "r590",
      "r591",
      "r592",
      "r635"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.",
        "label": "Debt Instrument [Axis]",
        "terseLabel": "Debt Instrument"
       }
      }
     },
     "localname": "DebtInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails",
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureTermLoanAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentBasisSpreadOnVariableRate1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage points added to the reference rate to compute the variable rate on the debt instrument.",
        "label": "Debt Instrument, Basis Spread on Variable Rate",
        "terseLabel": "Debt instrument, basis spread on variable rate"
       }
      }
     },
     "localname": "DebtInstrumentBasisSpreadOnVariableRate1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails",
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureTermLoanAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentCarryingAmount": {
     "auth_ref": [
      "r3",
      "r129",
      "r138",
      "r316"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.",
        "label": "Long-Term Debt, Gross",
        "terseLabel": "Outstanding principal amount",
        "totalLabel": "Total principal repayments"
       }
      }
     },
     "localname": "DebtInstrumentCarryingAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureTermLoanAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentInterestRateDuringPeriod": {
     "auth_ref": [
      "r18",
      "r121",
      "r311"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The average effective interest rate during the reporting period.",
        "label": "Debt Instrument, Interest Rate During Period",
        "terseLabel": "Debt instrument, interest rate"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateDuringPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails",
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureTermLoanAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Instrument [Line Items]",
        "terseLabel": "Debt Instrument [Line Items]"
       }
      }
     },
     "localname": "DebtInstrumentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureTermLoanAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentMaturityDate": {
     "auth_ref": [
      "r168",
      "r588",
      "r701"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date when the debt instrument is scheduled to be fully repaid, in YYYY-MM-DD format.",
        "label": "Debt Instrument, Maturity Date",
        "terseLabel": "Debt instrument, maturity date"
       }
      }
     },
     "localname": "DebtInstrumentMaturityDate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails"
     ],
     "xbrltype": "dateItemType"
    },
    "us-gaap_DebtInstrumentMaturityDateDescription": {
     "auth_ref": [
      "r19"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of the maturity date of the debt instrument including whether the debt matures serially and, if so, a brief description of the serial maturities.",
        "label": "Debt Instrument, Maturity Date, Description",
        "terseLabel": "Debt instrument, maturity date, description"
       }
      }
     },
     "localname": "DebtInstrumentMaturityDateDescription",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentMeasurementInput": {
     "auth_ref": [
      "r449"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of input used to measure debt instrument, including, but not limited to, convertible and non-convertible debt.",
        "label": "Debt Instrument, Measurement Input",
        "terseLabel": "Fair measurement input"
       }
      }
     },
     "localname": "DebtInstrumentMeasurementInput",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureTermLoanAdditionalInformationDetails"
     ],
     "xbrltype": "decimalItemType"
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "auth_ref": [
      "r20",
      "r198",
      "r299",
      "r300",
      "r301",
      "r302",
      "r303",
      "r304",
      "r305",
      "r306",
      "r307",
      "r308",
      "r309",
      "r310",
      "r311",
      "r312",
      "r313",
      "r314",
      "r475",
      "r588",
      "r589",
      "r590",
      "r591",
      "r592",
      "r635"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.",
        "label": "Debt Instrument, Name [Domain]",
        "terseLabel": "Debt Instrument, Name"
       }
      }
     },
     "localname": "DebtInstrumentNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails",
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureTermLoanAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentTable": {
     "auth_ref": [
      "r20",
      "r76",
      "r79",
      "r80",
      "r81",
      "r120",
      "r121",
      "r123",
      "r135",
      "r198",
      "r299",
      "r300",
      "r301",
      "r302",
      "r303",
      "r304",
      "r305",
      "r306",
      "r307",
      "r308",
      "r309",
      "r310",
      "r311",
      "r312",
      "r313",
      "r314",
      "r315",
      "r475",
      "r588",
      "r589",
      "r590",
      "r591",
      "r592",
      "r635"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Schedule of Long-Term Debt Instruments [Table]",
        "terseLabel": "Debt Instrument [Table]"
       }
      }
     },
     "localname": "DebtInstrumentTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureTermLoanAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentTerm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Debt Instrument, Term",
        "terseLabel": "Fair measurement input"
       }
      }
     },
     "localname": "DebtInstrumentTerm",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureTermLoanAdditionalInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_DebtInstrumentUnamortizedDiscount": {
     "auth_ref": [
      "r120",
      "r123",
      "r660"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after accumulated amortization, of debt discount.",
        "label": "Debt Instrument, Unamortized Discount",
        "negatedLabel": "Unamortized debt discount",
        "terseLabel": "Unamortized debt discount",
        "totalLabel": "Debt Instrument, Unamortized Discount, Total"
       }
      }
     },
     "localname": "DebtInstrumentUnamortizedDiscount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureTermLoanAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredFederalIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r637",
      "r696",
      "r697"
     ],
     "calculation": {
      "http://www.89bio.com/20221231/taxonomy/role/DisclosureIncomeTaxesSummaryOfIncomeTaxExpenseBenefitDetails": {
       "order": 0.0,
       "parentTag": "us-gaap_DeferredIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred national tax expense (benefit) for non-US (United States of America) jurisdiction.",
        "label": "Deferred Federal Income Tax Expense (Benefit)",
        "negatedLabel": "Federal",
        "terseLabel": "Federal"
       }
      }
     },
     "localname": "DeferredFederalIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/DisclosureIncomeTaxesSummaryOfIncomeTaxExpenseBenefitDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredFinanceCostsGross": {
     "auth_ref": [
      "r122"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.",
        "label": "Debt Issuance Costs, Gross",
        "verboseLabel": "Debt issuance costs, gross"
       }
      }
     },
     "localname": "DeferredFinanceCostsGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureTermLoanAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredForeignIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r108",
      "r637",
      "r696"
     ],
     "calculation": {
      "http://www.89bio.com/20221231/taxonomy/role/DisclosureIncomeTaxesSummaryOfIncomeTaxExpenseBenefitDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred Foreign Income Tax Expense (Benefit)",
        "negatedLabel": "Foreign",
        "terseLabel": "Foreign"
       }
      }
     },
     "localname": "DeferredForeignIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/DisclosureIncomeTaxesSummaryOfIncomeTaxExpenseBenefitDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r42",
      "r108",
      "r405",
      "r413",
      "r414",
      "r637"
     ],
     "calculation": {
      "http://www.89bio.com/20221231/taxonomy/role/DisclosureIncomeTaxesSummaryOfIncomeTaxExpenseBenefitDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred Income Tax Expense (Benefit)",
        "negatedLabel": "Total",
        "negatedTotalLabel": "Total",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "DeferredIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/DisclosureIncomeTaxesSummaryOfIncomeTaxExpenseBenefitDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Income Tax Expense (Benefit), Continuing Operations [Abstract]",
        "terseLabel": "Deferred:"
       }
      }
     },
     "localname": "DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/DisclosureIncomeTaxesSummaryOfIncomeTaxExpenseBenefitDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DeferredIncomeTaxLiabilities": {
     "auth_ref": [
      "r4",
      "r5",
      "r128",
      "r137",
      "r398"
     ],
     "calculation": {
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesSummaryOfComponentsOfDeferredTaxAssetsDetails": {
       "order": 0.0,
       "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences.",
        "label": "Deferred Tax Liabilities, Gross",
        "negatedLabel": "Total deferred tax liabilities",
        "negatedTotalLabel": "Total deferred tax liabilities",
        "terseLabel": "Total deferred tax liabilities",
        "totalLabel": "Total deferred tax liabilities"
       }
      }
     },
     "localname": "DeferredIncomeTaxLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesSummaryOfComponentsOfDeferredTaxAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsGross": {
     "auth_ref": [
      "r399"
     ],
     "calculation": {
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesSummaryOfComponentsOfDeferredTaxAssetsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.",
        "label": "Deferred Tax Assets, Gross",
        "terseLabel": "Deferred tax assets",
        "totalLabel": "Gross deferred tax assets"
       }
      }
     },
     "localname": "DeferredTaxAssetsGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesSummaryOfComponentsOfDeferredTaxAssetsDetails",
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureTermLoanAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment": {
     "auth_ref": [
      "r106",
      "r694"
     ],
     "calculation": {
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesSummaryOfComponentsOfDeferredTaxAssetsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from in-process research and development costs expensed in connection with a business combination.",
        "label": "Deferred Tax Assets, in Process Research and Development",
        "terseLabel": "Research and development expenses"
       }
      }
     },
     "localname": "DeferredTaxAssetsInProcessResearchAndDevelopment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesSummaryOfComponentsOfDeferredTaxAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsLiabilitiesNet": {
     "auth_ref": [
      "r693"
     ],
     "calculation": {
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesSummaryOfComponentsOfDeferredTaxAssetsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting.",
        "label": "Deferred Tax Assets, Net",
        "totalLabel": "Net deferred tax assets"
       }
      }
     },
     "localname": "DeferredTaxAssetsLiabilitiesNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesSummaryOfComponentsOfDeferredTaxAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsNet": {
     "auth_ref": [
      "r693"
     ],
     "calculation": {
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesSummaryOfComponentsOfDeferredTaxAssetsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.",
        "label": "Deferred Tax Assets, Net of Valuation Allowance",
        "totalLabel": "Total deferred tax assets"
       }
      }
     },
     "localname": "DeferredTaxAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesSummaryOfComponentsOfDeferredTaxAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsOperatingLossCarryforwards": {
     "auth_ref": [
      "r106",
      "r694"
     ],
     "calculation": {
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesSummaryOfComponentsOfDeferredTaxAssetsDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.",
        "label": "Deferred Tax Assets, Operating Loss Carryforwards",
        "terseLabel": "Net operating loss carryforwards",
        "totalLabel": "Deferred Tax Assets, Operating Loss Carryforwards, Total"
       }
      }
     },
     "localname": "DeferredTaxAssetsOperatingLossCarryforwards",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesSummaryOfComponentsOfDeferredTaxAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsOther": {
     "auth_ref": [
      "r106",
      "r694"
     ],
     "calculation": {
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesSummaryOfComponentsOfDeferredTaxAssetsDetails": {
       "order": 0.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other.",
        "label": "Deferred Tax Assets, Other",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "DeferredTaxAssetsOther",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesSummaryOfComponentsOfDeferredTaxAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch": {
     "auth_ref": [
      "r104",
      "r106",
      "r694"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible research tax credit carryforwards.",
        "label": "Deferred Tax Assets, Tax Credit Carryforwards, Research",
        "terseLabel": "State research and development credit carryforwards"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxCreditCarryforwardsResearch",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost": {
     "auth_ref": [
      "r106",
      "r694"
     ],
     "calculation": {
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesSummaryOfComponentsOfDeferredTaxAssetsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from share-based compensation.",
        "label": "Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-Based Compensation Cost",
        "terseLabel": "Stock-based compensation"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesSummaryOfComponentsOfDeferredTaxAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities": {
     "auth_ref": [
      "r106",
      "r694"
     ],
     "calculation": {
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesSummaryOfComponentsOfDeferredTaxAssetsDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from accrued liabilities.",
        "label": "Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Accrued Liabilities",
        "terseLabel": "Accrued expenses"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesSummaryOfComponentsOfDeferredTaxAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsValuationAllowance": {
     "auth_ref": [
      "r400"
     ],
     "calculation": {
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesSummaryOfComponentsOfDeferredTaxAssetsDetails": {
       "order": 0.0,
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.",
        "label": "Deferred Tax Assets, Valuation Allowance",
        "negatedLabel": "Less: valuation allowance",
        "terseLabel": "Deferred tax assets, valuation allowance"
       }
      }
     },
     "localname": "DeferredTaxAssetsValuationAllowance",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetails",
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesSummaryOfComponentsOfDeferredTaxAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Depreciation": {
     "auth_ref": [
      "r42",
      "r62"
     ],
     "calculation": {
      "http://www.89bio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.",
        "label": "Depreciation",
        "terseLabel": "Depreciation",
        "totalLabel": "Depreciation, Total"
       }
      }
     },
     "localname": "Depreciation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": {
     "auth_ref": [
      "r346",
      "r377",
      "r378",
      "r380",
      "r385",
      "r599"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for share-based payment arrangement.",
        "label": "Share-Based Payment Arrangement [Text Block]",
        "terseLabel": "Stock-Based Compensation"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureStockBasedCompensation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Payment Arrangement [Abstract]"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DomesticCountryMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designated tax department of the government that is entitled to levy and collect income taxes from the entity in its country of domicile.",
        "label": "Domestic Tax Authority [Member]",
        "terseLabel": "Federal"
       }
      }
     },
     "localname": "DomesticCountryMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EarningsPerShareAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share [Abstract]"
       }
      }
     },
     "localname": "EarningsPerShareAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareBasic": {
     "auth_ref": [
      "r184",
      "r207",
      "r208",
      "r209",
      "r210",
      "r211",
      "r216",
      "r218",
      "r221",
      "r222",
      "r223",
      "r227",
      "r442",
      "r443",
      "r538",
      "r545",
      "r583"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.",
        "label": "Earnings Per Share, Basic",
        "terseLabel": "Net loss per share, basic",
        "totalLabel": "Earnings Per Share, Basic, Total"
       }
      }
     },
     "localname": "EarningsPerShareBasic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareDiluted": {
     "auth_ref": [
      "r184",
      "r207",
      "r208",
      "r209",
      "r210",
      "r211",
      "r218",
      "r221",
      "r222",
      "r223",
      "r227",
      "r442",
      "r443",
      "r538",
      "r545",
      "r583"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Earnings Per Share, Diluted",
        "terseLabel": "Net loss per share, diluted",
        "totalLabel": "Earnings Per Share, Diluted, Total"
       }
      }
     },
     "localname": "EarningsPerShareDiluted",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerSharePolicyTextBlock": {
     "auth_ref": [
      "r48",
      "r49"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.",
        "label": "Earnings Per Share, Policy [Policy Text Block]",
        "terseLabel": "Basic and Diluted Net Loss per Share"
       }
      }
     },
     "localname": "EarningsPerSharePolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EarningsPerShareTextBlock": {
     "auth_ref": [
      "r224",
      "r225",
      "r226",
      "r228"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for earnings per share.",
        "label": "Earnings Per Share [Text Block]",
        "terseLabel": "Net Loss Per Share"
       }
      }
     },
     "localname": "EarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureNetLossPerShare"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateContinuingOperations": {
     "auth_ref": [
      "r390"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Effective Income Tax Rate Reconciliation, Percent",
        "terseLabel": "Effective income tax rate",
        "totalLabel": "Effective Income Tax Rate Reconciliation, Percent, Total"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateContinuingOperations",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesSummaryOfStatutoryTaxRatesApplicableToIncomeOfCompanyAndSubsidiariesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EmployeeRelatedLiabilitiesCurrent": {
     "auth_ref": [
      "r16"
     ],
     "calculation": {
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureConsolidatedBalanceSheetComponentsScheduleOfAccruedExpensesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Employee-related Liabilities, Current",
        "terseLabel": "Accrued employee and related expenses",
        "totalLabel": "Employee-related Liabilities, Current, Total"
       }
      }
     },
     "localname": "EmployeeRelatedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureConsolidatedBalanceSheetComponentsScheduleOfAccruedExpensesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]",
        "terseLabel": "Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockBasedCompensationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": {
     "auth_ref": [
      "r379"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition",
        "terseLabel": "Unrecognized weighted average period"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions": {
     "auth_ref": [
      "r689"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost to be recognized for nonvested award under share-based payment arrangement. Excludes share and unit options.",
        "label": "Share-Based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount",
        "terseLabel": "Total Unrecognised expense"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions": {
     "auth_ref": [
      "r689"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost to be recognized for option under share-based payment arrangement.",
        "label": "Share-Based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount",
        "terseLabel": "Unrecognized stock option granted under plan"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "An Employee Stock Purchase Plan is a tax-efficient means by which employees of a corporation can purchase the corporation's stock.",
        "label": "Employee Stock [Member]",
        "terseLabel": "ESPP Purchases",
        "verboseLabel": "Employee Stock Purchase Plan"
       }
      }
     },
     "localname": "EmployeeStockMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/DisclosureStockholdersEquityScheduleOfSharesOfCommonStockAvailableForFutureIssuanceDetails",
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EmployeeStockOptionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time.",
        "label": "Share-Based Payment Arrangement, Option [Member]",
        "terseLabel": "Stock Options to Purchase Common Stock"
       }
      }
     },
     "localname": "EmployeeStockOptionMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureNetLossPerShareScheduleOfOutstandingPotentiallyDilutiveSecuritiesExcludedFromCalculationOfDilutedNetLossDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity [Abstract]"
       }
      }
     },
     "localname": "EquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r75",
      "r153",
      "r178",
      "r179",
      "r180",
      "r199",
      "r200",
      "r201",
      "r204",
      "r212",
      "r214",
      "r229",
      "r269",
      "r334",
      "r381",
      "r382",
      "r383",
      "r409",
      "r410",
      "r441",
      "r463",
      "r464",
      "r465",
      "r466",
      "r467",
      "r469",
      "r495",
      "r550",
      "r551",
      "r552"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
        "label": "Equity Component [Domain]",
        "terseLabel": "Equity Component"
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/DisclosureStockholdersEquityAdditionalInformationDetails",
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureOrganizationAndBasisOfPresentationAdditionalInformationDetails",
      "http://www.89bio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfStockholdersEquityDeficit"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]",
        "terseLabel": "Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureFairValueMeasurementsSummaryOfFinancialAssetsMeasuredAtFairValueOnRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": {
     "auth_ref": [
      "r445",
      "r446",
      "r451"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis.",
        "label": "Fair Value, Recurring and Nonrecurring [Table]",
        "terseLabel": "Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Table]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureFairValueMeasurementsSummaryOfFinancialAssetsMeasuredAtFairValueOnRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "auth_ref": [
      "r307",
      "r336",
      "r337",
      "r338",
      "r339",
      "r340",
      "r341",
      "r446",
      "r503",
      "r504",
      "r505",
      "r589",
      "r590",
      "r595",
      "r596",
      "r597"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.",
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "terseLabel": "Fair Value Hierarchy and NAV"
       }
      }
     },
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureFairValueMeasurementsSummaryOfFinancialAssetsMeasuredAtFairValueOnRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByMeasurementFrequencyAxis": {
     "auth_ref": [
      "r445",
      "r446",
      "r448",
      "r449",
      "r452"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by measurement frequency.",
        "label": "Measurement Frequency [Axis]",
        "terseLabel": "Measurement Frequency"
       }
      }
     },
     "localname": "FairValueByMeasurementFrequencyAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureFairValueMeasurementsSummaryOfFinancialAssetsMeasuredAtFairValueOnRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Disclosures [Abstract]"
       }
      }
     },
     "localname": "FairValueDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresTextBlock": {
     "auth_ref": [
      "r450"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.",
        "label": "Fair Value Disclosures [Text Block]",
        "terseLabel": "Fair Value Measurements"
       }
      }
     },
     "localname": "FairValueDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureFairValueMeasurements"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "auth_ref": [
      "r307",
      "r336",
      "r341",
      "r446",
      "r503",
      "r595",
      "r596",
      "r597"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.",
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "terseLabel": "Level 1"
       }
      }
     },
     "localname": "FairValueInputsLevel1Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureFairValueMeasurementsSummaryOfFinancialAssetsMeasuredAtFairValueOnRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "auth_ref": [
      "r307",
      "r336",
      "r341",
      "r446",
      "r504",
      "r589",
      "r590",
      "r595",
      "r596",
      "r597"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.",
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "terseLabel": "Level 2"
       }
      }
     },
     "localname": "FairValueInputsLevel2Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureFairValueMeasurementsSummaryOfFinancialAssetsMeasuredAtFairValueOnRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementFrequencyDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement frequency.",
        "label": "Measurement Frequency [Domain]",
        "terseLabel": "Measurement Frequency"
       }
      }
     },
     "localname": "FairValueMeasurementFrequencyDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureFairValueMeasurementsSummaryOfFinancialAssetsMeasuredAtFairValueOnRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities.",
        "label": "Fair Value Measurement, Policy [Policy Text Block]",
        "terseLabel": "Fair Value Measurements"
       }
      }
     },
     "localname": "FairValueMeasurementPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "auth_ref": [
      "r307",
      "r336",
      "r337",
      "r338",
      "r339",
      "r340",
      "r341",
      "r503",
      "r504",
      "r505",
      "r589",
      "r590",
      "r595",
      "r596",
      "r597"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.",
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "terseLabel": "Fair Value Hierarchy and NAV"
       }
      }
     },
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureFairValueMeasurementsSummaryOfFinancialAssetsMeasuredAtFairValueOnRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementsRecurringMember": {
     "auth_ref": [
      "r450",
      "r452"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Frequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, frequently measured at fair value.",
        "label": "Fair Value, Recurring [Member]",
        "terseLabel": "Recurring"
       }
      }
     },
     "localname": "FairValueMeasurementsRecurringMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureFairValueMeasurementsSummaryOfFinancialAssetsMeasuredAtFairValueOnRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FinancialInstrumentAxis": {
     "auth_ref": [
      "r259",
      "r260",
      "r272",
      "r273",
      "r274",
      "r275",
      "r276",
      "r278",
      "r279",
      "r280",
      "r315",
      "r330",
      "r431",
      "r500",
      "r501",
      "r502",
      "r503",
      "r504",
      "r505",
      "r506",
      "r507",
      "r508",
      "r509",
      "r510",
      "r511",
      "r512",
      "r513",
      "r514",
      "r515",
      "r516",
      "r517",
      "r518",
      "r519",
      "r520",
      "r521",
      "r522",
      "r523",
      "r524",
      "r525",
      "r526",
      "r527",
      "r528",
      "r529",
      "r586",
      "r645",
      "r646",
      "r647",
      "r718",
      "r719",
      "r720",
      "r721",
      "r722",
      "r723",
      "r724"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of financial instrument.",
        "label": "Financial Instrument [Axis]"
       }
      }
     },
     "localname": "FinancialInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureFairValueMeasurementsSummaryOfFinancialAssetsMeasuredAtFairValueOnRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ForeignCountryMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designated tax departments of governments entitled to levy and collect income taxes from the entity outside the entity's country of domicile.",
        "label": "Foreign Tax Authority [Member]",
        "terseLabel": "Foreign"
       }
      }
     },
     "localname": "ForeignCountryMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock": {
     "auth_ref": [
      "r471"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.",
        "label": "Foreign Currency Transactions and Translations Policy [Policy Text Block]",
        "terseLabel": "Foreign Currencies"
       }
      }
     },
     "localname": "ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ForeignGovernmentDebtSecuritiesMember": {
     "auth_ref": [
      "r662",
      "r717"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt security issued by government not domiciled in United States of America (US).",
        "label": "Debt Security, Government, Non-US [Member]",
        "terseLabel": "Non-US debt securities"
       }
      }
     },
     "localname": "ForeignGovernmentDebtSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureFairValueMeasurementsSummaryOfFinancialAssetsMeasuredAtFairValueOnRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_GeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r34"
     ],
     "calculation": {
      "http://www.89bio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.",
        "label": "General and Administrative Expense",
        "terseLabel": "General and administrative",
        "totalLabel": "General and Administrative Expense, Total"
       }
      }
     },
     "localname": "GeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GeneralAndAdministrativeExpenseMember": {
     "auth_ref": [
      "r33"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing general and administrative expense.",
        "label": "General and Administrative Expense [Member]",
        "terseLabel": "General and Administrative"
       }
      }
     },
     "localname": "GeneralAndAdministrativeExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockBasedCompensationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IPOMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "First sale of stock by a private company to the public.",
        "label": "IPO [Member]",
        "terseLabel": "Public Offerings"
       }
      }
     },
     "localname": "IPOMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/DisclosureStockholdersEquityAdditionalInformationDetails",
      "http://www.89bio.com/20221231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails",
      "http://www.89bio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfStockholdersEquityDeficit",
      "http://www.89bio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfStockholdersEquityParenthetical"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock": {
     "auth_ref": [
      "r60",
      "r65"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets.",
        "label": "Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block]",
        "terseLabel": "Impairment of Long-Lived Assets"
       }
      }
     },
     "localname": "ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
     "auth_ref": [
      "r31",
      "r124",
      "r132",
      "r145",
      "r239",
      "r246",
      "r248",
      "r250",
      "r539",
      "r585"
     ],
     "calculation": {
      "http://www.89bio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss": {
       "order": 0.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest",
        "terseLabel": "Net loss before income tax",
        "totalLabel": "Net loss before income tax"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesSummaryOfLossFromOperationsBeforeTaxesOnIncomeDetails",
      "http://www.89bio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "auth_ref": [
      "r281",
      "r282"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location in the income statement.",
        "label": "Income Statement Location [Axis]",
        "terseLabel": "Income Statement Location"
       }
      }
     },
     "localname": "IncomeStatementLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails",
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetails",
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockBasedCompensationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "auth_ref": [
      "r282"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the income statement.",
        "label": "Income Statement Location [Domain]",
        "terseLabel": "Income Statement Location"
       }
      }
     },
     "localname": "IncomeStatementLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails",
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetails",
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockBasedCompensationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxAuthorityAxis": {
     "auth_ref": [
      "r102"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by tax jurisdiction.",
        "label": "Income Tax Authority [Axis]"
       }
      }
     },
     "localname": "IncomeTaxAuthorityAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxAuthorityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Agency, division or body classification that levies income taxes, examines tax returns for compliance, or grants exemptions from or makes other decisions pertaining to income taxes.",
        "label": "Income Tax Authority [Domain]"
       }
      }
     },
     "localname": "IncomeTaxAuthorityDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "localname": "IncomeTaxDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "auth_ref": [
      "r196",
      "r391",
      "r396",
      "r403",
      "r411",
      "r415",
      "r417",
      "r418",
      "r419"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.",
        "label": "Income Tax Disclosure [Text Block]",
        "terseLabel": "Income Taxes"
       }
      }
     },
     "localname": "IncomeTaxDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r197",
      "r213",
      "r214",
      "r238",
      "r389",
      "r412",
      "r416",
      "r546"
     ],
     "calculation": {
      "http://www.89bio.com/20221231/taxonomy/role/DisclosureIncomeTaxesSummaryOfIncomeTaxExpenseBenefitDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.89bio.com/20221231/taxonomy/role/DisclosureIncomeTaxesSummaryOfReconciliationOfIncomeTaxExpenseBenefitStatutoryTaxRateToEffectiveTaxRateDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.89bio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Income Tax Expense (Benefit)",
        "negatedLabel": "Income tax (expense) benefit",
        "negatedTotalLabel": "Income tax (expense) benefit",
        "totalLabel": "Income Tax Expense (Benefit), Total"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/DisclosureIncomeTaxesSummaryOfIncomeTaxExpenseBenefitDetails",
      "http://www.89bio.com/20221231/taxonomy/role/DisclosureIncomeTaxesSummaryOfReconciliationOfIncomeTaxExpenseBenefitStatutoryTaxRateToEffectiveTaxRateDetails",
      "http://www.89bio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxPolicyTextBlock": {
     "auth_ref": [
      "r177",
      "r387",
      "r388",
      "r396",
      "r397",
      "r402",
      "r406"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.",
        "label": "Income Tax, Policy [Policy Text Block]",
        "terseLabel": "Income Taxes"
       }
      }
     },
     "localname": "IncomeTaxPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance": {
     "auth_ref": [
      "r690"
     ],
     "calculation": {
      "http://www.89bio.com/20221231/taxonomy/role/DisclosureIncomeTaxesSummaryOfReconciliationOfIncomeTaxExpenseBenefitStatutoryTaxRateToEffectiveTaxRateDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in the valuation allowance for deferred tax assets.",
        "label": "Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount",
        "terseLabel": "Change in valuation allowance"
       }
      }
     },
     "localname": "IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/DisclosureIncomeTaxesSummaryOfReconciliationOfIncomeTaxExpenseBenefitStatutoryTaxRateToEffectiveTaxRateDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential": {
     "auth_ref": [
      "r690"
     ],
     "calculation": {
      "http://www.89bio.com/20221231/taxonomy/role/DisclosureIncomeTaxesSummaryOfReconciliationOfIncomeTaxExpenseBenefitStatutoryTaxRateToEffectiveTaxRateDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to foreign income tax expense (benefit).",
        "label": "Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount",
        "terseLabel": "Foreign rate differential"
       }
      }
     },
     "localname": "IncomeTaxReconciliationForeignIncomeTaxRateDifferential",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/DisclosureIncomeTaxesSummaryOfReconciliationOfIncomeTaxExpenseBenefitStatutoryTaxRateToEffectiveTaxRateDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate": {
     "auth_ref": [
      "r390"
     ],
     "calculation": {
      "http://www.89bio.com/20221231/taxonomy/role/DisclosureIncomeTaxesSummaryOfReconciliationOfIncomeTaxExpenseBenefitStatutoryTaxRateToEffectiveTaxRateDetails": {
       "order": 0.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of income tax expense or benefit for the period computed by applying the domestic federal statutory tax rates to pretax income from continuing operations.",
        "label": "Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount",
        "terseLabel": "Income tax benefit computed at statutory rates"
       }
      }
     },
     "localname": "IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/DisclosureIncomeTaxesSummaryOfReconciliationOfIncomeTaxExpenseBenefitStatutoryTaxRateToEffectiveTaxRateDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationNondeductibleExpenseResearchAndDevelopment": {
     "auth_ref": [
      "r690"
     ],
     "calculation": {
      "http://www.89bio.com/20221231/taxonomy/role/DisclosureIncomeTaxesSummaryOfReconciliationOfIncomeTaxExpenseBenefitStatutoryTaxRateToEffectiveTaxRateDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to nondeductible research and development expense.",
        "label": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Research and Development, Amount",
        "terseLabel": "Research and development credits, net of uncertain tax position"
       }
      }
     },
     "localname": "IncomeTaxReconciliationNondeductibleExpenseResearchAndDevelopment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/DisclosureIncomeTaxesSummaryOfReconciliationOfIncomeTaxExpenseBenefitStatutoryTaxRateToEffectiveTaxRateDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationOtherAdjustments": {
     "auth_ref": [
      "r690"
     ],
     "calculation": {
      "http://www.89bio.com/20221231/taxonomy/role/DisclosureIncomeTaxesSummaryOfReconciliationOfIncomeTaxExpenseBenefitStatutoryTaxRateToEffectiveTaxRateDetails": {
       "order": 7.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments.",
        "label": "Effective Income Tax Rate Reconciliation, Other Adjustments, Amount",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "IncomeTaxReconciliationOtherAdjustments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/DisclosureIncomeTaxesSummaryOfReconciliationOfIncomeTaxExpenseBenefitStatutoryTaxRateToEffectiveTaxRateDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes": {
     "auth_ref": [
      "r690"
     ],
     "calculation": {
      "http://www.89bio.com/20221231/taxonomy/role/DisclosureIncomeTaxesSummaryOfReconciliationOfIncomeTaxExpenseBenefitStatutoryTaxRateToEffectiveTaxRateDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to state and local income tax expense (benefit).",
        "label": "Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount",
        "terseLabel": "State income taxes, net of federal benefit"
       }
      }
     },
     "localname": "IncomeTaxReconciliationStateAndLocalIncomeTaxes",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/DisclosureIncomeTaxesSummaryOfReconciliationOfIncomeTaxExpenseBenefitStatutoryTaxRateToEffectiveTaxRateDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayable": {
     "auth_ref": [
      "r41"
     ],
     "calculation": {
      "http://www.89bio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.",
        "label": "Increase (Decrease) in Accounts Payable",
        "terseLabel": "Accounts payable",
        "totalLabel": "Increase (Decrease) in Accounts Payable, Total"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccruedLiabilities": {
     "auth_ref": [
      "r41"
     ],
     "calculation": {
      "http://www.89bio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.",
        "label": "Increase (Decrease) in Accrued Liabilities",
        "terseLabel": "Accrued expenses",
        "totalLabel": "Increase (Decrease) in Accrued Liabilities, Total"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccruedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Operating Capital [Abstract]",
        "terseLabel": "Changes in operating assets and liabilities:"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingLeaseLiability": {
     "auth_ref": [
      "r631",
      "r704"
     ],
     "calculation": {
      "http://www.89bio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in obligation for operating lease.",
        "label": "Increase (Decrease) in Operating Lease Liability",
        "negatedLabel": "Operating lease liability",
        "terseLabel": "Operating lease liability"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": {
     "auth_ref": [
      "r41"
     ],
     "calculation": {
      "http://www.89bio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other.",
        "label": "Increase (Decrease) in Prepaid Expense and Other Assets",
        "negatedLabel": "Prepaid and other current assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestAndOtherIncome": {
     "auth_ref": [],
     "calculation": {
      "http://www.89bio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of interest income and other income recognized during the period. Included in this element is interest derived from investments in debt securities, cash and cash equivalents, and other investments which reflect the time value of money or transactions in which the payments are for the use or forbearance of money and other income from ancillary business-related activities (that is, excluding major activities considered part of the normal operations of the business).",
        "label": "Interest and Other Income",
        "terseLabel": "Interest income and other, net"
       }
      }
     },
     "localname": "InterestAndOtherIncome",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpense": {
     "auth_ref": [
      "r122",
      "r134",
      "r181",
      "r237",
      "r474"
     ],
     "calculation": {
      "http://www.89bio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.",
        "label": "Interest Expense",
        "negatedLabel": "Interest expense",
        "terseLabel": "Interest expense",
        "totalLabel": "Interest Expense, Total"
       }
      }
     },
     "localname": "InterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestPaidNet": {
     "auth_ref": [
      "r188",
      "r191",
      "r192"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.",
        "label": "Interest Paid, Excluding Capitalized Interest, Operating Activities",
        "terseLabel": "Cash paid for interest"
       }
      }
     },
     "localname": "InterestPaidNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentPolicyTextBlock": {
     "auth_ref": [
      "r261",
      "r716"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for investment in financial asset.",
        "label": "Investment, Policy [Policy Text Block]",
        "terseLabel": "Investments"
       }
      }
     },
     "localname": "InvestmentPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of maturities of an entity's investments as well as any other information pertinent to the investments.",
        "label": "Investments Classified by Contractual Maturity Date [Table Text Block]",
        "terseLabel": "Schedule of Contractual Maturities of Cash Equivalents and Available-for-Sale Securities"
       }
      }
     },
     "localname": "InvestmentsClassifiedByContractualMaturityDateTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureFairValueMeasurementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LeaseAndRentalExpense": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of rent expense incurred for leased assets, including but not limited to, furniture and equipment, that is not directly or indirectly associated with the manufacture, sale or creation of a product or product line.",
        "label": "Operating Leases, Rent Expense",
        "terseLabel": "Operating leases, rent expense"
       }
      }
     },
     "localname": "LeaseAndRentalExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LeaseholdImprovementsMember": {
     "auth_ref": [
      "r63"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additions or improvements to assets held under a lease arrangement.",
        "label": "Leasehold Improvements [Member]",
        "terseLabel": "Leasehold Improvements"
       }
      }
     },
     "localname": "LeaseholdImprovementsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LesseeLeasesPolicyTextBlock": {
     "auth_ref": [
      "r486"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for leasing arrangement entered into by lessee.",
        "label": "Lessee, Leases [Policy Text Block]",
        "terseLabel": "Leases"
       }
      }
     },
     "localname": "LesseeLeasesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LesseeOperatingLeaseDiscountRate": {
     "auth_ref": [
      "r604"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Discount rate used by lessee to determine present value of operating lease payments.",
        "label": "Lessee, Operating Lease, Discount Rate",
        "terseLabel": "Incremental borrowing rate used to determine operating lease liability"
       }
      }
     },
     "localname": "LesseeOperatingLeaseDiscountRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": {
     "auth_ref": [
      "r489"
     ],
     "calculation": {
      "http://www.89bio.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumLeasePaymentsUnderNoncancellableOperatingLeaseObligationsDetails2": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumLeasePaymentsUnderNonCancellableOperatingLeaseObligationsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease.",
        "label": "Lessee, Operating Lease, Liability, to be Paid",
        "totalLabel": "Total undiscounted future minimum lease payments"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumLeasePaymentsUnderNonCancellableOperatingLeaseObligationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "auth_ref": [
      "r489"
     ],
     "calculation": {
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumLeasePaymentsUnderNonCancellableOperatingLeaseObligationsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year One",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumLeasePaymentsUnderNonCancellableOperatingLeaseObligationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": {
     "auth_ref": [
      "r489"
     ],
     "calculation": {
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumLeasePaymentsUnderNonCancellableOperatingLeaseObligationsDetails": {
       "order": 0.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Three",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumLeasePaymentsUnderNonCancellableOperatingLeaseObligationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": {
     "auth_ref": [
      "r489"
     ],
     "calculation": {
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumLeasePaymentsUnderNonCancellableOperatingLeaseObligationsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Two",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumLeasePaymentsUnderNonCancellableOperatingLeaseObligationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": {
     "auth_ref": [
      "r489"
     ],
     "calculation": {
      "http://www.89bio.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumLeasePaymentsUnderNoncancellableOperatingLeaseObligationsDetails2": {
       "order": 1.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.",
        "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount",
        "negatedLabel": "Less: imputed interest"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumLeasePaymentsUnderNonCancellableOperatingLeaseObligationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseRemainingLeaseTerm": {
     "auth_ref": [
      "r703"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Remaining lease term of operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Lessee, Operating Lease, Remaining Lease Term",
        "terseLabel": "Remaining lease term"
       }
      }
     },
     "localname": "LesseeOperatingLeaseRemainingLeaseTerm",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_Liabilities": {
     "auth_ref": [
      "r15",
      "r195",
      "r262",
      "r290",
      "r291",
      "r292",
      "r293",
      "r294",
      "r295",
      "r296",
      "r297",
      "r298",
      "r425",
      "r428",
      "r429",
      "r453",
      "r584",
      "r655",
      "r706",
      "r707"
     ],
     "calculation": {
      "http://www.89bio.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets": {
       "order": 0.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.",
        "label": "Liabilities",
        "totalLabel": "Total liabilities"
       }
      }
     },
     "localname": "Liabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r12",
      "r130",
      "r141",
      "r606",
      "r636",
      "r648",
      "r702"
     ],
     "calculation": {
      "http://www.89bio.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "Total liabilities and stockholders\u2019 equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities and Equity [Abstract]",
        "terseLabel": "Liabilities and stockholders\u2019 equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r17",
      "r158",
      "r195",
      "r262",
      "r290",
      "r291",
      "r292",
      "r293",
      "r294",
      "r295",
      "r296",
      "r297",
      "r298",
      "r425",
      "r428",
      "r429",
      "r453",
      "r606",
      "r655",
      "r706",
      "r707"
     ],
     "calculation": {
      "http://www.89bio.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets": {
       "order": 0.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities, Current",
        "totalLabel": "Total current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Current [Abstract]",
        "terseLabel": "Current liabilities:"
       }
      }
     },
     "localname": "LiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LineOfCreditFacilityAverageOutstandingAmount": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Average amount borrowed under the credit facility during the period.",
        "label": "Line of Credit Facility, Average Outstanding Amount",
        "terseLabel": "Loan Agreement funded outstanding amount"
       }
      }
     },
     "localname": "LineOfCreditFacilityAverageOutstandingAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityDescription": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of the terms of a credit facility arrangement. Terms typically include interest rate, collateral required, guarantees required, repayment requirements, and restrictions on use of assets and activities of the entity.",
        "label": "Line of Credit Facility, Description",
        "terseLabel": "Line of credit facility, description"
       }
      }
     },
     "localname": "LineOfCreditFacilityDescription",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureTermLoanAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LineOfCreditFacilityExpirationDate1": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date the credit facility terminates, in YYYY-MM-DD format.",
        "label": "Line of Credit Facility, Expiration Date",
        "terseLabel": "Credit facility maturity date"
       }
      }
     },
     "localname": "LineOfCreditFacilityExpirationDate1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureTermLoanAdditionalInformationDetails"
     ],
     "xbrltype": "dateItemType"
    },
    "us-gaap_LineOfCreditFacilityInterestRateDescription": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of interest rate for borrowing under credit facility. Includes, but is not limited to, terms and method for determining interest rate.",
        "label": "Line of Credit Facility, Interest Rate Description",
        "terseLabel": "Line of credit facility, interest rate description"
       }
      }
     },
     "localname": "LineOfCreditFacilityInterestRateDescription",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureTermLoanAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": {
     "auth_ref": [
      "r14"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.",
        "label": "Line of Credit Facility, Maximum Borrowing Capacity",
        "terseLabel": "Line of credit facility, maximum borrowing capacity"
       }
      }
     },
     "localname": "LineOfCreditFacilityMaximumBorrowingCapacity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails",
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureTermLoanAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtNoncurrent": {
     "auth_ref": [
      "r162"
     ],
     "calculation": {
      "http://www.89bio.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation.",
        "label": "Long-Term Debt, Excluding Current Maturities",
        "terseLabel": "Term loan, non-current, net",
        "totalLabel": "Term loan, non-current, net"
       }
      }
     },
     "localname": "LongTermDebtNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureTermLoanAdditionalInformationDetails",
      "http://www.89bio.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtTextBlock": {
     "auth_ref": [
      "r71"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for long-term debt.",
        "label": "Long-Term Debt [Text Block]",
        "terseLabel": "Term Loan"
       }
      }
     },
     "localname": "LongTermDebtTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureTermLoan"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LossContingenciesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Loss Contingencies [Line Items]",
        "terseLabel": "Loss Contingencies [Line Items]"
       }
      }
     },
     "localname": "LossContingenciesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingenciesTable": {
     "auth_ref": [
      "r67",
      "r68",
      "r285",
      "r286",
      "r287",
      "r651",
      "r652"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Discloses the specific components (such as the nature, name, and date) of the loss contingency and gives an estimate of the possible loss or range of loss, or states that a reasonable estimate cannot be made. Excludes environmental contingencies, warranties and unconditional purchase obligations.",
        "label": "Loss Contingencies [Table]",
        "terseLabel": "Loss Contingencies [Table]"
       }
      }
     },
     "localname": "LossContingenciesTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_MeasurementInputExpectedDividendPaymentMember": {
     "auth_ref": [
      "r700"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement input using expected dividend to be paid to holder of equity or financial instrument.",
        "label": "Measurement Input, Expected Dividend Payment [Member]",
        "terseLabel": "Measurement Input, Expected Dividend Payment"
       }
      }
     },
     "localname": "MeasurementInputExpectedDividendPaymentMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureTermLoanAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MeasurementInputExpectedTermMember": {
     "auth_ref": [
      "r700"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement input using period financial instrument is expected to be outstanding. Excludes maturity date.",
        "label": "Measurement Input, Expected Term [Member]",
        "terseLabel": "Measurement Input, Expected Term"
       }
      }
     },
     "localname": "MeasurementInputExpectedTermMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureTermLoanAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MeasurementInputPriceVolatilityMember": {
     "auth_ref": [
      "r700"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement input using rate at which price of security will increase (decrease) for given set of returns.",
        "label": "Measurement Input, Price Volatility [Member]",
        "terseLabel": "Measurement Input, Price Volatility"
       }
      }
     },
     "localname": "MeasurementInputPriceVolatilityMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureTermLoanAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MeasurementInputRiskFreeInterestRateMember": {
     "auth_ref": [
      "r700"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement input using interest rate on instrument with zero risk of financial loss.",
        "label": "Measurement Input, Risk Free Interest Rate [Member]",
        "terseLabel": "Measurement Input, Risk Free Interest Rate"
       }
      }
     },
     "localname": "MeasurementInputRiskFreeInterestRateMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureTermLoanAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MeasurementInputTypeAxis": {
     "auth_ref": [
      "r447"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of measurement input used to determine value of asset and liability.",
        "label": "Measurement Input Type [Axis]",
        "terseLabel": "Measurement Input Type"
       }
      }
     },
     "localname": "MeasurementInputTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureTermLoanAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_MeasurementInputTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement input used to determine value of asset and liability.",
        "label": "Measurement Input Type [Domain]",
        "terseLabel": "Measurement Input Type"
       }
      }
     },
     "localname": "MeasurementInputTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureTermLoanAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MoneyMarketFundsMember": {
     "auth_ref": [
      "r662"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fund that invests in short-term money-market instruments, for example, but not limited to, commercial paper, banker's acceptances, repurchase agreements, government securities, certificates of deposit, and other highly liquid securities.",
        "label": "Money Market Funds [Member]",
        "terseLabel": "Money Market Funds"
       }
      }
     },
     "localname": "MoneyMarketFundsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureFairValueMeasurementsSummaryOfFinancialAssetsMeasuredAtFairValueOnRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MunicipalBondsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Long-term debt securities issued by state, city or local governments or the agencies operated by state, city or local governments.",
        "label": "Municipal Bonds [Member]",
        "terseLabel": "Municipal Bonds"
       }
      }
     },
     "localname": "MunicipalBondsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureFairValueMeasurementsSummaryOfFinancialAssetsMeasuredAtFairValueOnRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r190"
     ],
     "calculation": {
      "http://www.89bio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Net cash provided by financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]",
        "terseLabel": "Cash flows from financing activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r190"
     ],
     "calculation": {
      "http://www.89bio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Net cash (used in) provided by investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]",
        "terseLabel": "Cash flows from investing activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r39",
      "r40",
      "r43"
     ],
     "calculation": {
      "http://www.89bio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows": {
       "order": 0.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "Net cash used in operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Cash flows from operating activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r32",
      "r43",
      "r133",
      "r144",
      "r156",
      "r172",
      "r175",
      "r180",
      "r195",
      "r203",
      "r207",
      "r208",
      "r209",
      "r210",
      "r213",
      "r214",
      "r220",
      "r239",
      "r246",
      "r248",
      "r250",
      "r262",
      "r290",
      "r291",
      "r292",
      "r293",
      "r294",
      "r295",
      "r296",
      "r297",
      "r298",
      "r443",
      "r453",
      "r585",
      "r655"
     ],
     "calculation": {
      "http://www.89bio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss": {
       "order": 0.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net Income (Loss) Attributable to Parent",
        "terseLabel": "Net loss",
        "totalLabel": "Net loss"
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss",
      "http://www.89bio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfStockholdersEquityDeficit"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.",
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "terseLabel": "Recent Accounting Pronouncements"
       }
      }
     },
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NoncashInvestingAndFinancingItemsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Noncash Investing and Financing Items [Abstract]",
        "terseLabel": "Supplemental disclosures of noncash information:"
       }
      }
     },
     "localname": "NoncashInvestingAndFinancingItemsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NumberOfOperatingSegments": {
     "auth_ref": [
      "r643"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.",
        "label": "Number of Operating Segments",
        "terseLabel": "Number of operating segments"
       }
      }
     },
     "localname": "NumberOfOperatingSegments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_OperatingExpenses": {
     "auth_ref": [],
     "calculation": {
      "http://www.89bio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.",
        "label": "Operating Expenses",
        "totalLabel": "Total operating expenses"
       }
      }
     },
     "localname": "OperatingExpenses",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingExpensesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Expenses [Abstract]",
        "terseLabel": "Operating expenses:"
       }
      }
     },
     "localname": "OperatingExpensesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingIncomeLoss": {
     "auth_ref": [
      "r239",
      "r246",
      "r248",
      "r250",
      "r585"
     ],
     "calculation": {
      "http://www.89bio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss": {
       "order": 0.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net result for the period of deducting operating expenses from operating revenues.",
        "label": "Operating Income (Loss)",
        "terseLabel": "Loss from operations",
        "totalLabel": "Operating Income (Loss), Total"
       }
      }
     },
     "localname": "OperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiability": {
     "auth_ref": [
      "r483"
     ],
     "calculation": {
      "http://www.89bio.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumLeasePaymentsUnderNoncancellableOperatingLeaseObligationsDetails2": {
       "order": 0.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease.",
        "label": "Operating Lease, Liability",
        "terseLabel": "Present value of operating lease liability",
        "totalLabel": "Operating Lease, Liability, Total"
       }
      }
     },
     "localname": "OperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumLeasePaymentsUnderNonCancellableOperatingLeaseObligationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "auth_ref": [
      "r483"
     ],
     "calculation": {
      "http://www.89bio.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.",
        "label": "Operating Lease, Liability, Current",
        "terseLabel": "Operating lease liability, current"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails",
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails",
      "http://www.89bio.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r483"
     ],
     "calculation": {
      "http://www.89bio.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.",
        "label": "Operating Lease, Liability, Noncurrent",
        "terseLabel": "Operating lease liability, non-current"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeasePaymentsUse": {
     "auth_ref": [
      "r484",
      "r488"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow from operating lease to bring another asset to condition and location necessary for its intended use.",
        "label": "Operating Lease, Payments, Use",
        "negatedLabel": "Cash paid for operating leases",
        "terseLabel": "Cash paid for operating leases"
       }
      }
     },
     "localname": "OperatingLeasePaymentsUse",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "auth_ref": [
      "r482"
     ],
     "calculation": {
      "http://www.89bio.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's right to use underlying asset under operating lease.",
        "label": "Operating Lease, Right-of-Use Asset",
        "terseLabel": "Operating lease right-of-use asset"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails",
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails",
      "http://www.89bio.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense": {
     "auth_ref": [
      "r632"
     ],
     "calculation": {
      "http://www.89bio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization expense for right-of-use asset from operating lease.",
        "label": "Operating Lease, Right-of-Use Asset, Amortization Expense",
        "terseLabel": "Non-cash operating lease expense"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAssetAmortizationExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeasesFutureMinimumPaymentsDue": {
     "auth_ref": [
      "r148",
      "r149"
     ],
     "calculation": {
      "http://www.89bio.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumAnnualPaymentsForOperatingLeasesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of required minimum rental payments for leases having an initial or remaining non-cancelable letter-terms in excess of one year.",
        "label": "Operating Leases, Future Minimum Payments Due",
        "terseLabel": "Present value of operating lease liability",
        "totalLabel": "Total future minimum annual payments"
       }
      }
     },
     "localname": "OperatingLeasesFutureMinimumPaymentsDue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumAnnualPaymentsForOperatingLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears": {
     "auth_ref": [
      "r148",
      "r149"
     ],
     "calculation": {
      "http://www.89bio.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumAnnualPaymentsForOperatingLeasesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingLeasesFutureMinimumPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the second fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.",
        "label": "Operating Leases, Future Minimum Payments, Due in Two Years",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "OperatingLeasesFutureMinimumPaymentsDueInTwoYears",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumAnnualPaymentsForOperatingLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear": {
     "auth_ref": [],
     "calculation": {
      "http://www.89bio.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumAnnualPaymentsForOperatingLeasesDetails": {
       "order": 0.0,
       "parentTag": "us-gaap_OperatingLeasesFutureMinimumPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the remainder of the fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.",
        "label": "Operating Leases, Future Minimum Payments, Remainder of Fiscal Year",
        "terseLabel": "2022"
       }
      }
     },
     "localname": "OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumAnnualPaymentsForOperatingLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLossCarryforwardsLimitationsOnUse": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A description of the limitations on the use of all operating loss carryforwards available to reduce future taxable income.",
        "label": "Operating Loss Carryforwards, Limitations on Use",
        "terseLabel": "Operating loss carryforwards limitations on use"
       }
      }
     },
     "localname": "OperatingLossCarryforwardsLimitationsOnUse",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock": {
     "auth_ref": [
      "r0",
      "r114"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.",
        "label": "Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]",
        "terseLabel": "Organization and Basis of Presentation"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureOrganizationAndBasisOfPresentation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OtherAccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r16"
     ],
     "calculation": {
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureConsolidatedBalanceSheetComponentsScheduleOfAccruedExpensesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.",
        "label": "Other Accrued Liabilities, Current",
        "terseLabel": "Accrued other expenses"
       }
      }
     },
     "localname": "OtherAccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureConsolidatedBalanceSheetComponentsScheduleOfAccruedExpensesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsMember": {
     "auth_ref": [
      "r115",
      "r117"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other assets.",
        "label": "Other Assets [Member]",
        "terseLabel": "Other Assets"
       }
      }
     },
     "localname": "OtherAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureTermLoanAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "auth_ref": [
      "r160"
     ],
     "calculation": {
      "http://www.89bio.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncurrent assets classified as other.",
        "label": "Other Assets, Noncurrent",
        "terseLabel": "Other assets"
       }
      }
     },
     "localname": "OtherAssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax": {
     "auth_ref": [
      "r169",
      "r170",
      "r171"
     ],
     "calculation": {
      "http://www.89bio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss": {
       "order": 0.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax and adjustment, of unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale) and unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.",
        "label": "OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax",
        "terseLabel": "Unrealized loss on available-for-sale securities",
        "totalLabel": "OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax, Total"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax": {
     "auth_ref": [
      "r24"
     ],
     "calculation": {
      "http://www.89bio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax",
        "terseLabel": "Foreign currency translation adjustments",
        "totalLabel": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Total"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r30",
      "r75",
      "r173",
      "r176",
      "r182",
      "r463",
      "r468",
      "r469",
      "r536",
      "r543",
      "r627",
      "r628"
     ],
     "calculation": {
      "http://www.89bio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss), Net of Tax",
        "totalLabel": "Total other comprehensive loss",
        "verboseLabel": "Other comprehensive loss"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss",
      "http://www.89bio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfStockholdersEquityDeficit"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossTaxAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Comprehensive Income (Loss), Tax [Abstract]",
        "terseLabel": "Other comprehensive (loss) income:"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossTaxAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherPrepaidExpenseCurrent": {
     "auth_ref": [
      "r624",
      "r649"
     ],
     "calculation": {
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureConsolidatedBalanceSheetComponentsScheduleOfPrepaidAndOtherCurrentAssetsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for other costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.",
        "label": "Other Prepaid Expense, Current",
        "terseLabel": "Prepaid other"
       }
      }
     },
     "localname": "OtherPrepaidExpenseCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureConsolidatedBalanceSheetComponentsScheduleOfPrepaidAndOtherCurrentAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherThanTemporaryImpairmentLossDebtSecuritiesPortionRecognizedInEarnings": {
     "auth_ref": [
      "r256"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of other-than-temporary impairment (OTTI) on investment in debt security, recognized in earnings.",
        "label": "Other-than-temporary Impairment Loss, Debt Securities, Portion Recognized in Earnings",
        "terseLabel": "Other-than-temporary losses"
       }
      }
     },
     "localname": "OtherThanTemporaryImpairmentLossDebtSecuritiesPortionRecognizedInEarnings",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PayablesAndAccrualsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Payables and Accruals [Abstract]"
       }
      }
     },
     "localname": "PayablesAndAccrualsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_PaymentsOfStockIssuanceCosts": {
     "auth_ref": [
      "r38"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for cost incurred directly with the issuance of an equity security.",
        "label": "Payments of Stock Issuance Costs",
        "terseLabel": "Other offering costs"
       }
      }
     },
     "localname": "PaymentsOfStockIssuanceCosts",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/DisclosureStockholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation": {
     "auth_ref": [
      "r187"
     ],
     "calculation": {
      "http://www.89bio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.",
        "label": "Payment, Tax Withholding, Share-Based Payment Arrangement",
        "negatedLabel": "Payment of withholding taxes related to restricted stock units",
        "terseLabel": "Payment of withholding taxes related to restricted stock units"
       }
      }
     },
     "localname": "PaymentsRelatedToTaxWithholdingForShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "auth_ref": [
      "r35"
     ],
     "calculation": {
      "http://www.89bio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "negatedLabel": "Purchases of property and equipment",
        "totalLabel": "Payments to Acquire Property, Plant, and Equipment, Total"
       }
      }
     },
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PlanNameAxis": {
     "auth_ref": [
      "r663",
      "r664",
      "r665",
      "r666",
      "r667",
      "r668",
      "r669",
      "r670",
      "r671",
      "r672",
      "r673",
      "r674",
      "r675",
      "r676",
      "r677",
      "r678",
      "r679",
      "r680",
      "r681",
      "r682",
      "r683",
      "r684",
      "r685",
      "r686",
      "r687",
      "r688"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by plan name for share-based payment arrangement.",
        "label": "Plan Name [Axis]",
        "terseLabel": "Plan Name"
       }
      }
     },
     "localname": "PlanNameAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails",
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockOptionActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PlanNameDomain": {
     "auth_ref": [
      "r663",
      "r664",
      "r665",
      "r666",
      "r667",
      "r668",
      "r669",
      "r670",
      "r671",
      "r672",
      "r673",
      "r674",
      "r675",
      "r676",
      "r677",
      "r678",
      "r679",
      "r680",
      "r681",
      "r682",
      "r683",
      "r684",
      "r685",
      "r686",
      "r687",
      "r688"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Plan name for share-based payment arrangement.",
        "label": "Plan Name [Domain]",
        "terseLabel": "Plan Name"
       }
      }
     },
     "localname": "PlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails",
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockOptionActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PreferredStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r6",
      "r317"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.",
        "label": "Preferred Stock, Par or Stated Value Per Share",
        "terseLabel": "Preferred stock, par value"
       }
      }
     },
     "localname": "PreferredStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.",
        "label": "Preferred Stock, Shares Authorized",
        "terseLabel": "Preferred stock, shares authorized"
       }
      }
     },
     "localname": "PreferredStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesIssued": {
     "auth_ref": [
      "r6",
      "r317"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.",
        "label": "Preferred Stock, Shares Issued",
        "terseLabel": "Preferred stock, shares issued"
       }
      }
     },
     "localname": "PreferredStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesOutstanding": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.",
        "label": "Preferred Stock, Shares Outstanding",
        "periodEndLabel": "Preferred Stock, Shares Outstanding, Ending Balance",
        "periodStartLabel": "Preferred Stock, Shares Outstanding, Beginning Balance",
        "terseLabel": "Preferred stock, shares outstanding"
       }
      }
     },
     "localname": "PreferredStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockValue": {
     "auth_ref": [
      "r6",
      "r606"
     ],
     "calculation": {
      "http://www.89bio.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets": {
       "order": 0.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Preferred Stock, Value, Issued",
        "terseLabel": "Preferred stock, $0.001 par value, 10,000,000 shares authorized as of December 31, 2022 and 2021; no shares issued and outstanding as of December 31, 2022 and 2021"
       }
      }
     },
     "localname": "PreferredStockValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "auth_ref": [
      "r625"
     ],
     "calculation": {
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureConsolidatedBalanceSheetComponentsScheduleOfPrepaidAndOtherCurrentAssetsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.89bio.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.",
        "label": "Prepaid Expense and Other Assets, Current",
        "terseLabel": "Prepaid and other current assets",
        "totalLabel": "Total prepaid and other current assets"
       }
      }
     },
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureConsolidatedBalanceSheetComponentsScheduleOfPrepaidAndOtherCurrentAssetsDetails",
      "http://www.89bio.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Prepaid Expense and Other Assets, Current [Abstract]"
       }
      }
     },
     "localname": "PrepaidExpenseAndOtherAssetsCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_PrepaidTaxes": {
     "auth_ref": [
      "r581",
      "r587",
      "r649"
     ],
     "calculation": {
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureConsolidatedBalanceSheetComponentsScheduleOfPrepaidAndOtherCurrentAssetsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for income and other taxes that provide economic benefits within a future period of one year or the normal operating cycle, if longer.",
        "label": "Prepaid Taxes",
        "terseLabel": "Prepaid taxes"
       }
      }
     },
     "localname": "PrepaidTaxes",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureConsolidatedBalanceSheetComponentsScheduleOfPrepaidAndOtherCurrentAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrimeRateMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest rate charged by financial institutions to their most creditworthy borrowers.",
        "label": "Prime Rate [Member]",
        "terseLabel": "Prime Rate"
       }
      }
     },
     "localname": "PrimeRateMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureTermLoanAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PriorPeriodReclassificationAdjustmentDescription": {
     "auth_ref": [
      "r622"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for reclassification affecting comparability of financial statement. Excludes amendment to accounting standards, other change in accounting principle, and correction of error.",
        "label": "Reclassification, Comparability Adjustment [Policy Text Block]",
        "terseLabel": "Reclassification"
       }
      }
     },
     "localname": "PriorPeriodReclassificationAdjustmentDescription",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfCommonStock": {
     "auth_ref": [
      "r36"
     ],
     "calculation": {
      "http://www.89bio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from the additional capital contribution to the entity.",
        "label": "Proceeds from issuance of common stock, net of commissions and offering expenses",
        "terseLabel": "Proceeds from issuance of common stock upon ESPP purchases",
        "verboseLabel": "Proceeds from issuance of common stock, net of underwriters discount and commissions"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/DisclosureStockholdersEquityAdditionalInformationDetails",
      "http://www.89bio.com/20221231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails",
      "http://www.89bio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfOtherLongTermDebt": {
     "auth_ref": [
      "r37"
     ],
     "calculation": {
      "http://www.89bio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows": {
       "order": 0.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from issuance of long-term debt classified as other.",
        "label": "Proceeds from Issuance of Other Long-Term Debt",
        "terseLabel": "Proceeds from term loan facility, net of issuance costs"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfOtherLongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions": {
     "auth_ref": [
      "r36",
      "r94"
     ],
     "calculation": {
      "http://www.89bio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from issuance of shares under share-based payment arrangement. Includes, but is not limited to, option exercised.",
        "label": "Proceeds, Issuance of Shares, Share-Based Payment Arrangement, Including Option Exercised",
        "terseLabel": "Proceeds from issuance of common stock upon exercise of stock options",
        "totalLabel": "Proceeds, Issuance of Shares, Share-Based Payment Arrangement, Including Option Exercised, Total"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromLinesOfCredit": {
     "auth_ref": [
      "r37",
      "r635"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from contractual arrangement with the lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.",
        "label": "Proceeds from Lines of Credit",
        "terseLabel": "Line of credit facility fully drawn amount",
        "totalLabel": "Proceeds from Lines of Credit, Total"
       }
      }
     },
     "localname": "ProceedsFromLinesOfCredit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureTermLoanAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities": {
     "auth_ref": [
      "r54",
      "r185",
      "r186"
     ],
     "calculation": {
      "http://www.89bio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows": {
       "order": 0.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from sale, maturity, prepayment and call of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Proceeds from Sale and Maturity of Debt Securities, Available-for-Sale",
        "terseLabel": "Proceeds from sales and maturities of available-for-sale securities",
        "totalLabel": "Proceeds from Sale and Maturity of Debt Securities, Available-for-Sale, Total"
       }
      }
     },
     "localname": "ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromWarrantExercises": {
     "auth_ref": [
      "r630"
     ],
     "calculation": {
      "http://www.89bio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the amount received from holders exercising their stock warrants.",
        "label": "Proceeds from Warrant Exercises",
        "terseLabel": "Proceeds from issuance of common stock upon exercise of warrants"
       }
      }
     },
     "localname": "ProceedsFromWarrantExercises",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProfitLoss": {
     "auth_ref": [
      "r156",
      "r172",
      "r175",
      "r189",
      "r195",
      "r203",
      "r213",
      "r214",
      "r239",
      "r246",
      "r248",
      "r250",
      "r262",
      "r290",
      "r291",
      "r292",
      "r293",
      "r294",
      "r295",
      "r296",
      "r297",
      "r298",
      "r423",
      "r426",
      "r427",
      "r443",
      "r453",
      "r539",
      "r585",
      "r602",
      "r603",
      "r629",
      "r655"
     ],
     "calculation": {
      "http://www.89bio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows": {
       "order": 0.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.",
        "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest",
        "terseLabel": "Net loss",
        "totalLabel": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest, Total"
       }
      }
     },
     "localname": "ProfitLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentByTypeAxis": {
     "auth_ref": [
      "r64"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.",
        "label": "Long-Lived Tangible Asset [Axis]",
        "terseLabel": "Long-Lived Tangible Asset"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives": {
     "auth_ref": [
      "r61"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Describes the periods of time over which an entity anticipates to receive utility from its property, plant and equipment (that is, the periods of time over which an entity allocates the initial cost of its property, plant and equipment).",
        "label": "Property, Plant and Equipment, Estimated Useful Lives",
        "terseLabel": "Leasehold improvements amortization, description"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentEstimatedUsefulLives",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "auth_ref": [
      "r64",
      "r142",
      "r541",
      "r606"
     ],
     "calculation": {
      "http://www.89bio.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Net",
        "terseLabel": "Property and equipment, net",
        "totalLabel": "Property, Plant and Equipment, Net, Total"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": {
     "auth_ref": [
      "r64",
      "r565",
      "r566"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.",
        "label": "Property, Plant and Equipment, Policy [Policy Text Block]",
        "terseLabel": "Property and Equipment, Net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTypeDomain": {
     "auth_ref": [
      "r63"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.",
        "label": "Long-Lived Tangible Asset [Domain]",
        "terseLabel": "Long-Lived Tangible Asset"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentUsefulLife": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.",
        "label": "Property, Plant and Equipment, Useful Life",
        "terseLabel": "Property and equipment, estimated useful lives"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_RealizedInvestmentGainsLosses": {
     "auth_ref": [
      "r146"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of realized gain (loss) on investment.",
        "label": "Realized Investment Gains (Losses)",
        "terseLabel": "Realized gains or losses on investments",
        "totalLabel": "Realized Investment Gains (Losses), Total"
       }
      }
     },
     "localname": "RealizedInvestmentGainsLosses",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis": {
     "auth_ref": [
      "r99",
      "r100"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by form of arrangement related to research and development.",
        "label": "Research and Development Arrangement, Contract to Perform for Others, Type [Axis]",
        "terseLabel": "Research and Development Arrangement, Contract to Perform for Others, Type"
       }
      }
     },
     "localname": "ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain": {
     "auth_ref": [
      "r99",
      "r100"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Listing of significant agreements under research and development arrangements accounted for as a contract to perform research and development for others.",
        "label": "Research and Development Arrangement, Contract to Perform for Others, Type [Domain]",
        "terseLabel": "Research and Development Arrangement, Contract to Perform for Others, Type"
       }
      }
     },
     "localname": "ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpense": {
     "auth_ref": [
      "r98",
      "r147",
      "r714"
     ],
     "calculation": {
      "http://www.89bio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss": {
       "order": 0.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.",
        "label": "Research and Development Expense",
        "terseLabel": "Research and development",
        "totalLabel": "Research and Development Expense, Total"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpenseMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption in which the reported facts about research and development expense have been included.",
        "label": "Research and Development Expense [Member]",
        "terseLabel": "Research and Development Expenses",
        "verboseLabel": "Research and Development"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails",
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetails",
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockBasedCompensationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpensePolicy": {
     "auth_ref": [
      "r98"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.",
        "label": "Research and Development Expense, Policy [Policy Text Block]",
        "terseLabel": "Research and Development Expenses"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpensePolicy",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ResearchMember": {
     "auth_ref": [
      "r105"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Research tax credit carryforwards arising from certain qualifying expenditures incurred to develop new products and processes.",
        "label": "Research Tax Credit Carryforward [Member]",
        "terseLabel": "Research and Development Credit Carryforwards"
       }
      }
     },
     "localname": "ResearchMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestrictedCashCurrent": {
     "auth_ref": [
      "r623",
      "r633"
     ],
     "calculation": {
      "http://www.89bio.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      },
      "http://www.89bio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.",
        "label": "Restricted Cash, Current",
        "terseLabel": "Restricted cash"
       }
      }
     },
     "localname": "RestrictedCashCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets",
      "http://www.89bio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestrictedStockUnitsRSUMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met.",
        "label": "Restricted Stock Units (RSUs) [Member]",
        "terseLabel": "Restricted Stock Units (RSUs)"
       }
      }
     },
     "localname": "RestrictedStockUnitsRSUMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfRestrictedStockUnitActivityDetails",
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r9",
      "r82",
      "r140",
      "r554",
      "r559",
      "r606"
     ],
     "calculation": {
      "http://www.89bio.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings (Accumulated Deficit)",
        "terseLabel": "Accumulated deficit",
        "totalLabel": "Retained Earnings (Accumulated Deficit), Total"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails",
      "http://www.89bio.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [
      "r153",
      "r199",
      "r200",
      "r201",
      "r204",
      "r212",
      "r214",
      "r269",
      "r381",
      "r382",
      "r383",
      "r409",
      "r410",
      "r441",
      "r550",
      "r552"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings [Member]",
        "terseLabel": "Retained Earnings",
        "verboseLabel": "Accumulated Deficit"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfStockholdersEquityDeficit"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SaleOfStockDescriptionOfTransaction": {
     "auth_ref": [
      "r109",
      "r112",
      "r113"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of stock transaction which may include details of the offering (IPO, private placement), a description of the stock sold, percentage of subsidiary's or equity investee's stock sold, a description of the investors and whether the stock was issued in a business combination.",
        "label": "Sale of Stock, Description of Transaction",
        "terseLabel": "Public offering description",
        "verboseLabel": "ATM Facility description"
       }
      }
     },
     "localname": "SaleOfStockDescriptionOfTransaction",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/DisclosureStockholdersEquityAdditionalInformationDetails",
      "http://www.89bio.com/20221231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SaleOfStockNameOfTransactionDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sale of the entity's stock, including, but not limited to, initial public offering (IPO) and private placement.",
        "label": "Sale of Stock [Domain]",
        "terseLabel": "Sale of Stock"
       }
      }
     },
     "localname": "SaleOfStockNameOfTransactionDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/DisclosureStockholdersEquityAdditionalInformationDetails",
      "http://www.89bio.com/20221231/taxonomy/role/DisclosureStockholdersEquityScheduleOfSharesOfCommonStockAvailableForFutureIssuanceDetails",
      "http://www.89bio.com/20221231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails",
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureOrganizationAndBasisOfPresentationAdditionalInformationDetails",
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails",
      "http://www.89bio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfStockholdersEquityDeficit",
      "http://www.89bio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfStockholdersEquityParenthetical"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SaleOfStockTransactionDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date the subsidiary or equity investee issued or sold stock, in YYYY-MM-DD format.",
        "label": "Sale of Stock, Transaction Date",
        "terseLabel": "Sales Agreement transaction date"
       }
      }
     },
     "localname": "SaleOfStockTransactionDate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails"
     ],
     "xbrltype": "dateItemType"
    },
    "us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of accrued liabilities.",
        "label": "Schedule of Accrued Liabilities [Table Text Block]",
        "terseLabel": "Schedule of Accrued Expenses"
       }
      }
     },
     "localname": "ScheduleOfAccruedLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureConsolidatedBalanceSheetComponentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable": {
     "auth_ref": [
      "r48"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule for securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by Antidilutive Securities.",
        "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]",
        "terseLabel": "Schedule Of Antidilutive Securities Excluded From Computation Of Earnings Per Share [Table]"
       }
      }
     },
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureNetLossPerShareScheduleOfOutstandingPotentiallyDilutiveSecuritiesExcludedFromCalculationOfDilutedNetLossDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock": {
     "auth_ref": [
      "r48"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.",
        "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]",
        "terseLabel": "Schedule of Outstanding Potentially Dilutive Securities Excluded From Calculation of Diluted Net Loss"
       }
      }
     },
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureNetLossPerShareTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock": {
     "auth_ref": [
      "r107"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.",
        "label": "Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]",
        "terseLabel": "Summary of Income Tax (Expense) Benefit"
       }
      }
     },
     "localname": "ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": {
     "auth_ref": [
      "r103"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.",
        "label": "Schedule of Deferred Tax Assets and Liabilities [Table Text Block]",
        "terseLabel": "Summary of Components of Deferred Tax Assets"
       }
      }
     },
     "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": {
     "auth_ref": [
      "r101"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.",
        "label": "Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]",
        "terseLabel": "Summary of Reconciliation of Income Tax (Expense) Benefit Statutory Tax Rate to Effective Tax Rate"
       }
      }
     },
     "localname": "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable": {
     "auth_ref": [
      "r92",
      "r95"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about amount recognized for award under share-based payment arrangement. Includes, but is not limited to, amount expensed in statement of income or comprehensive income, amount capitalized in statement of financial position, and corresponding reporting line item in financial statements.",
        "label": "Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table]",
        "terseLabel": "Schedule Of Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Table]"
       }
      }
     },
     "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockBasedCompensationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock": {
     "auth_ref": [
      "r92"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement.",
        "label": "Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]",
        "terseLabel": "Summary of Stock-Based Compensation"
       }
      }
     },
     "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureStockBasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock": {
     "auth_ref": [
      "r445",
      "r446"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).",
        "label": "Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]",
        "terseLabel": "Summary of Financial Assets Measured at Fair Value on Recurring Basis"
       }
      }
     },
     "localname": "ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureFairValueMeasurementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock": {
     "auth_ref": [
      "r150"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of future minimum payments required in the aggregate and for each of the five succeeding fiscal years for operating leases having initial or remaining noncancelable lease terms in excess of one year and the total minimum rentals to be received in the future under noncancelable subleases as of the balance sheet date.",
        "label": "Schedule of Future Minimum Rental Payments for Operating Leases [Table Text Block]",
        "terseLabel": "Schedule of Future Minimum Lease Payments Under Non-cancellable Operating Lease Obligations"
       }
      }
     },
     "localname": "ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock": {
     "auth_ref": [
      "r637"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of income before income tax between domestic and foreign jurisdictions.",
        "label": "Schedule of Income before Income Tax, Domestic and Foreign [Table Text Block]",
        "terseLabel": "Summary of Loss from Operations Before Taxes on Income"
       }
      }
     },
     "localname": "ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock": {
     "auth_ref": [
      "r70"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of maturity and sinking fund requirement for long-term debt.",
        "label": "Schedule of Maturities of Long-Term Debt [Table Text Block]",
        "terseLabel": "Schedule of Repayment of Principal Amount"
       }
      }
     },
     "localname": "ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureTermLoanTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": {
     "auth_ref": [
      "r343",
      "r345",
      "r347",
      "r348",
      "r349",
      "r351",
      "r352",
      "r353",
      "r354",
      "r355",
      "r356",
      "r357",
      "r358",
      "r359",
      "r360",
      "r361",
      "r362",
      "r363",
      "r364",
      "r365",
      "r366",
      "r367",
      "r368",
      "r371",
      "r372",
      "r373",
      "r374",
      "r375"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about share-based payment arrangement.",
        "label": "Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]",
        "terseLabel": "Schedule Of Share Based Compensation Arrangements By Share Based Payment Award [Table]"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfRestrictedStockUnitActivityDetails",
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails",
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfEstimatedFairValueOfStockOptionsGrantedUsingBlackScholesOptionPricingModelDetails",
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockOptionActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock": {
     "auth_ref": [
      "r87"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the number and weighted-average grant date fair value for restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock units that were granted, vested, or forfeited during the year.",
        "label": "Share-Based Payment Arrangement, Restricted Stock Unit, Activity [Table Text Block]",
        "terseLabel": "Summary of Restricted Stock Unit Activity"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureStockBasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": {
     "auth_ref": [
      "r87",
      "r88",
      "r89"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.",
        "label": "Share-Based Payment Arrangement, Option, Activity [Table Text Block]",
        "terseLabel": "Summary of Stock Option Activity"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureStockBasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock": {
     "auth_ref": [
      "r91"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.",
        "label": "Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]",
        "terseLabel": "Summary of Estimated Fair Value of Stock Options Granted Using Black-Scholes Option-Pricing Model"
       }
      }
     },
     "localname": "ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureStockBasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfStockByClassTable": {
     "auth_ref": [
      "r72",
      "r73",
      "r74",
      "r76",
      "r77",
      "r78",
      "r79",
      "r80",
      "r81",
      "r82",
      "r163",
      "r164",
      "r165",
      "r230",
      "r317",
      "r318",
      "r319",
      "r321",
      "r325",
      "r330",
      "r332",
      "r593",
      "r621",
      "r634"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule detailing information related to equity by class of stock. Class of stock includes common, convertible, and preferred stocks which are not redeemable or redeemable solely at the option of the issuer. It also includes preferred stock with redemption features that are solely within the control of the issuer and mandatorily redeemable stock if redemption is required to occur only upon liquidation or termination of the reporting entity.",
        "label": "Schedule of Stock by Class [Table]"
       }
      }
     },
     "localname": "ScheduleOfStockByClassTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/DisclosureStockholdersEquityScheduleOfSharesOfCommonStockAvailableForFutureIssuanceDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock": {
     "auth_ref": [
      "r83",
      "r85"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.",
        "label": "Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block]",
        "terseLabel": "Schedule of Outstanding Warrants to Purchase Shares of Common Stock"
       }
      }
     },
     "localname": "ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/DisclosureStockholdersEquityTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock": {
     "auth_ref": [
      "r601",
      "r692"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the change in unrecognized tax benefits.",
        "label": "Schedule of Unrecognized Tax Benefits Roll Forward [Table Text Block]",
        "terseLabel": "Summary of a Reconciliation of The Unrecognized Tax Benefits"
       }
      }
     },
     "localname": "ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentReportingPolicyPolicyTextBlock": {
     "auth_ref": [
      "r240",
      "r241",
      "r242",
      "r243",
      "r244",
      "r245",
      "r251"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for segment reporting.",
        "label": "Segment Reporting, Policy [Policy Text Block]",
        "terseLabel": "Segment Reporting"
       }
      }
     },
     "localname": "SegmentReportingPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ShareBasedCompensation": {
     "auth_ref": [
      "r41"
     ],
     "calculation": {
      "http://www.89bio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense for share-based payment arrangement.",
        "label": "Share-Based Payment Arrangement, Noncash Expense",
        "terseLabel": "Stock-based compensation",
        "totalLabel": "Share-Based Payment Arrangement, Noncash Expense, Total"
       }
      }
     },
     "localname": "ShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": {
     "auth_ref": [
      "r599"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period",
        "terseLabel": "Vesting period"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription": {
     "auth_ref": [
      "r85",
      "r86"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of terms of share-based payment arrangement. Includes, but is not limited to, type of award or grantee and reason for issuance.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Description",
        "terseLabel": "RSUs description"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod": {
     "auth_ref": [
      "r364"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period",
        "negatedLabel": "Cancelled / forfeited"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfRestrictedStockUnitActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r364"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value",
        "terseLabel": "Weighted Average Grant Date Fair Value Outstanding, Cancelled/Forfeited"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfRestrictedStockUnitActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": {
     "auth_ref": [
      "r362"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period",
        "terseLabel": "Granted"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfRestrictedStockUnitActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r362"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Weighted Average Grant Date Fair Value Outstanding, Granted"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfRestrictedStockUnitActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": {
     "auth_ref": [
      "r359",
      "r360"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number",
        "periodEndLabel": "Outstanding, Ending Balance",
        "periodStartLabel": "Outstanding, Beginning Balance",
        "terseLabel": "Outstanding, Ending Balance"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfRestrictedStockUnitActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfRestrictedStockUnitActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r359",
      "r360"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value",
        "periodEndLabel": "Weighted Average Grant Date Fair Value Outstanding, Ending Balance",
        "periodStartLabel": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value, Beginning Balance",
        "terseLabel": "Weighted Average Grant Date Fair Value Outstanding, Beginning Balance"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfRestrictedStockUnitActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]",
        "terseLabel": "Weighted Average Grant Date Fair Value"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfRestrictedStockUnitActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": {
     "auth_ref": [
      "r363"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period",
        "negatedLabel": "Vested / released"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfRestrictedStockUnitActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r363"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Weighted Average Grant Date Fair Value Outstanding, Vested/Released"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfRestrictedStockUnitActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": {
     "auth_ref": [
      "r373"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate",
        "terseLabel": "Expected dividend"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfEstimatedFairValueOfStockOptionsGrantedUsingBlackScholesOptionPricingModelDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated measure of the maximum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum",
        "terseLabel": "Expected volatility, maximum"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfEstimatedFairValueOfStockOptionsGrantedUsingBlackScholesOptionPricingModelDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated measure of the minimum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum",
        "terseLabel": "Expected volatility, minimum"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfEstimatedFairValueOfStockOptionsGrantedUsingBlackScholesOptionPricingModelDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum risk-free interest rate assumption that is used in valuing an option on its own shares.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum",
        "terseLabel": "Risk-free interest rate, maximum"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfEstimatedFairValueOfStockOptionsGrantedUsingBlackScholesOptionPricingModelDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The minimum risk-free interest rate assumption that is used in valuing an option on its own shares.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum",
        "terseLabel": "Risk-free interest rate, minimum"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfEstimatedFairValueOfStockOptionsGrantedUsingBlackScholesOptionPricingModelDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]",
        "terseLabel": "Share Based Compensation Arrangement By Share Based Payment Award [Line Items]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfRestrictedStockUnitActivityDetails",
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails",
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfEstimatedFairValueOfStockOptionsGrantedUsingBlackScholesOptionPricingModelDetails",
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockOptionActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant": {
     "auth_ref": [
      "r93"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant",
        "terseLabel": "Number of shares of common stock available for issuance under ESPP"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": {
     "auth_ref": [
      "r353"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number",
        "terseLabel": "Exercisable as of December 31, 2022"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": {
     "auth_ref": [
      "r353"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price",
        "terseLabel": "Weighted Average Exercise Price, Exercisable as of December 31, 2022"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod": {
     "auth_ref": [
      "r357"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period",
        "negatedLabel": "Cancelled and forfeited",
        "verboseLabel": "Cancelled shares"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails",
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": {
     "auth_ref": [
      "r355"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gross number of share options (or share units) granted during the period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross",
        "terseLabel": "Granted",
        "verboseLabel": "Shares granted"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r365"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Weighted average fair value options granted"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": {
     "auth_ref": [
      "r93"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value",
        "periodEndLabel": "Aggregate Intrinsic Value Outstanding",
        "periodStartLabel": "Aggregate Intrinsic Value Outstanding",
        "terseLabel": "Aggregate Intrinsic Value"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockOptionActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": {
     "auth_ref": [
      "r351",
      "r352"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of options outstanding, including both vested and non-vested options.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number",
        "periodEndLabel": "Outstanding, Ending Balance",
        "periodStartLabel": "Outstanding, Beginning Balance",
        "terseLabel": "Outstanding"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails",
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward]",
        "terseLabel": "Number of Options"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockOptionActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": {
     "auth_ref": [
      "r351",
      "r352"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price",
        "periodEndLabel": "Weighted Average Exercise Price Outstanding, Ending Balance",
        "periodStartLabel": "Weighted Average Exercise Price Outstanding, Beginning Balance"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]",
        "terseLabel": "Weighted Average Exercise Price"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockOptionActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAward": {
     "auth_ref": [
      "r86"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of terms of award under share-based payment arrangement.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Terms of Award",
        "terseLabel": "Terms of award"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "auth_ref": [
      "r347",
      "r348",
      "r349",
      "r351",
      "r352",
      "r353",
      "r354",
      "r355",
      "r356",
      "r357",
      "r358",
      "r359",
      "r360",
      "r361",
      "r362",
      "r363",
      "r364",
      "r365",
      "r366",
      "r367",
      "r368",
      "r371",
      "r372",
      "r373",
      "r374",
      "r375"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Award under share-based payment arrangement.",
        "label": "Award Type [Domain]",
        "terseLabel": "Award Type"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfRestrictedStockUnitActivityDetails",
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [
      "r356"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares.",
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price",
        "terseLabel": "Weighted Average Exercise Price, Exercised"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [
      "r357"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.",
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price",
        "terseLabel": "Weighted Average Exercise Price, Cancelled and forfeited"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [
      "r355"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.",
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price",
        "terseLabel": "Issuance of common stock, weighted average price per share",
        "verboseLabel": "Weighted Average Exercise Price, Granted"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy": {
     "auth_ref": [
      "r350",
      "r369",
      "r370",
      "r371",
      "r372",
      "r375",
      "r384",
      "r385"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.",
        "label": "Share-Based Payment Arrangement [Policy Text Block]",
        "terseLabel": "Stock-Based Compensation"
       }
      }
     },
     "localname": "ShareBasedCompensationOptionAndIncentivePlansPolicy",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ShareBasedPaymentArrangementEmployeeMember": {
     "auth_ref": [
      "r345",
      "r347",
      "r348",
      "r349",
      "r351",
      "r352",
      "r353",
      "r354",
      "r355",
      "r356",
      "r357",
      "r358",
      "r359",
      "r360",
      "r361",
      "r362",
      "r363",
      "r364",
      "r365",
      "r366",
      "r367",
      "r368",
      "r371",
      "r372",
      "r373",
      "r374",
      "r375"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Recipient, of award granted under share-based payment arrangement, over whom grantor exercises or has right to exercise sufficient control to establish employer-employee relationship based on law of pertinent jurisdiction. Includes, but is not limited to, nonemployee director treated as employee when acting as member of board of directors, if elected by grantor's shareholders or appointed to board position to be filled by shareholder election when existing term expires.",
        "label": "Share-Based Payment Arrangement, Employee [Member]",
        "terseLabel": "Employee"
       }
      }
     },
     "localname": "ShareBasedPaymentArrangementEmployeeMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage": {
     "auth_ref": [
      "r663"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of vesting of award under share-based payment arrangement.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights, Percentage",
        "terseLabel": "Percentage of option vesting"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod": {
     "auth_ref": [
      "r600"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period",
        "terseLabel": "Expiration period"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": {
     "auth_ref": [
      "r371"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term",
        "terseLabel": "Expected term (years)"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfEstimatedFairValueOfStockOptionsGrantedUsingBlackScholesOptionPricingModelDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1": {
     "auth_ref": [
      "r93"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value",
        "terseLabel": "Aggregate Intrinsic Value, Exercisable as of December 31, 2022"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockOptionActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1": {
     "auth_ref": [
      "r93"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term",
        "terseLabel": "Weighted Average Remaining Contractual Term (In years), Exercisable as of December 31, 2022"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockOptionActivityDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": {
     "auth_ref": [
      "r90"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term",
        "verboseLabel": "Weighted Average Remaining Contractual Term (In years), Outstanding"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockOptionActivityDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1": {
     "auth_ref": [
      "r366"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of options vested. Excludes equity instruments other than options, for example, but not limited to, share units, stock appreciation rights, restricted stock.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested in Period, Fair Value",
        "terseLabel": "Estimated total grant date fair value of options vested"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average grant-date fair value of options vested.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested, Weighted Average Grant Date Fair Value",
        "terseLabel": "Estimated total grant date fair value of options vested"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Purchase price of common stock expressed as a percentage of its fair value.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Purchase Price of Common Stock, Percent",
        "terseLabel": "Percent of purchase shares of common stock"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_SharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued which are neither cancelled nor held in the treasury.",
        "label": "Shares, Outstanding",
        "periodEndLabel": "Ending balance, shares",
        "periodStartLabel": "Beginning balance, shares"
       }
      }
     },
     "localname": "SharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfStockholdersEquityDeficit"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShortTermInvestmentsMember": {
     "auth_ref": [
      "r560",
      "r561",
      "r562",
      "r609"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Investments which are not otherwise included in another category or item that the entity has the intent to sell or dispose of within one year from the date of the balance sheet.",
        "label": "Short-Term Investments [Member]",
        "terseLabel": "Short-term available for sale securities"
       }
      }
     },
     "localname": "ShortTermInvestmentsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureFairValueMeasurementsSummaryOfFinancialAssetsMeasuredAtFairValueOnRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShortTermLeaseCost": {
     "auth_ref": [
      "r487",
      "r605"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of short-term lease cost, excluding expense for lease with term of one month or less.",
        "label": "Short-Term Lease, Cost",
        "terseLabel": "Short-term lease costs"
       }
      }
     },
     "localname": "ShortTermLeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SignificantAccountingPoliciesTextBlock": {
     "auth_ref": [
      "r47",
      "r193"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.",
        "label": "Significant Accounting Policies [Text Block]",
        "terseLabel": "Summary of Significant Accounting Policies"
       }
      }
     },
     "localname": "SignificantAccountingPoliciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_StateAndLocalJurisdictionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designated tax department of a state or local government entitled to levy and collect income taxes from the entity.",
        "label": "State and Local Jurisdiction [Member]",
        "terseLabel": "State"
       }
      }
     },
     "localname": "StateAndLocalJurisdictionMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StatementClassOfStockAxis": {
     "auth_ref": [
      "r163",
      "r164",
      "r165",
      "r195",
      "r218",
      "r219",
      "r221",
      "r223",
      "r230",
      "r231",
      "r262",
      "r290",
      "r292",
      "r293",
      "r294",
      "r297",
      "r298",
      "r317",
      "r318",
      "r321",
      "r325",
      "r332",
      "r453",
      "r579",
      "r621",
      "r634",
      "r642"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by the different classes of stock of the entity.",
        "label": "Class of Stock [Axis]",
        "terseLabel": "Class of Stock"
       }
      }
     },
     "localname": "StatementClassOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfStockholdersEquityParenthetical"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r23",
      "r75",
      "r153",
      "r178",
      "r179",
      "r180",
      "r199",
      "r200",
      "r201",
      "r204",
      "r212",
      "r214",
      "r229",
      "r269",
      "r334",
      "r381",
      "r382",
      "r383",
      "r409",
      "r410",
      "r441",
      "r463",
      "r464",
      "r465",
      "r466",
      "r467",
      "r469",
      "r495",
      "r550",
      "r551",
      "r552"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]",
        "terseLabel": "Equity Components"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/DisclosureStockholdersEquityAdditionalInformationDetails",
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureOrganizationAndBasisOfPresentationAdditionalInformationDetails",
      "http://www.89bio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfStockholdersEquityDeficit"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]",
        "terseLabel": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows",
      "http://www.89bio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfStockholdersEquityDeficit",
      "http://www.89bio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfStockholdersEquityParenthetical"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r199",
      "r200",
      "r201",
      "r229",
      "r531"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]",
        "terseLabel": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows",
      "http://www.89bio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfStockholdersEquityDeficit",
      "http://www.89bio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfStockholdersEquityParenthetical"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans": {
     "auth_ref": [
      "r6",
      "r7",
      "r75",
      "r82"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued during the period as a result of an employee stock purchase plan.",
        "label": "Stock Issued During Period, Shares, Employee Stock Purchase Plans",
        "terseLabel": "Issuance of common stock upon ESPP purchase, Shares"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfStockholdersEquityDeficit"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesNewIssues": {
     "auth_ref": [
      "r6",
      "r7",
      "r75",
      "r82"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of new stock issued during the period.",
        "label": "Stock Issued During Period, Shares, New Issues",
        "terseLabel": "Issuance of common stock, shares",
        "verboseLabel": "Shares issued and sold"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesNewIssues",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/DisclosureStockholdersEquityAdditionalInformationDetails",
      "http://www.89bio.com/20221231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails",
      "http://www.89bio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfStockholdersEquityDeficit"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "auth_ref": [
      "r6",
      "r7",
      "r75",
      "r82",
      "r356"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of share options (or share units) exercised during the current period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period",
        "negatedLabel": "Exercised",
        "terseLabel": "Issuance of common stock upon exercise of stock options, shares"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockOptionActivityDetails",
      "http://www.89bio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfStockholdersEquityDeficit"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan": {
     "auth_ref": [
      "r6",
      "r7",
      "r75",
      "r82"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate change in value for stock issued during the period as a result of employee stock purchase plan.",
        "label": "Stock Issued During Period, Value, Employee Stock Purchase Plan",
        "terseLabel": "Issuance of common stock upon ESPP purchase"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueEmployeeStockPurchasePlan",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfStockholdersEquityDeficit"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueNewIssues": {
     "auth_ref": [
      "r6",
      "r7",
      "r75",
      "r82"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.",
        "label": "Stock Issued During Period, Value, New Issues",
        "terseLabel": "Issuance of common stock"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueNewIssues",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfStockholdersEquityDeficit"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised": {
     "auth_ref": [
      "r23",
      "r75",
      "r82"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of stock issued as a result of the exercise of stock options.",
        "label": "Stock Issued During Period, Value, Stock Options Exercised",
        "terseLabel": "Issuance of common stock upon exercise of stock options"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfStockholdersEquityDeficit"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquity": {
     "auth_ref": [
      "r7",
      "r10",
      "r11",
      "r53",
      "r606",
      "r636",
      "r648",
      "r702"
     ],
     "calculation": {
      "http://www.89bio.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.",
        "label": "Stockholders' Equity Attributable to Parent",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance",
        "totalLabel": "Total stockholders\u2019 equity"
       }
      }
     },
     "localname": "StockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets",
      "http://www.89bio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfStockholdersEquityDeficit"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity Attributable to Parent [Abstract]",
        "terseLabel": "Stockholders\u2019 equity:"
       }
      }
     },
     "localname": "StockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityNoteDisclosureTextBlock": {
     "auth_ref": [
      "r84",
      "r194",
      "r318",
      "r320",
      "r321",
      "r322",
      "r323",
      "r324",
      "r325",
      "r326",
      "r327",
      "r328",
      "r329",
      "r331",
      "r334",
      "r432"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.",
        "label": "Stockholders' Equity Note Disclosure [Text Block]",
        "terseLabel": "Stockholders' Equity"
       }
      }
     },
     "localname": "StockholdersEquityNoteDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/DisclosureStockholdersEquity1"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SubsequentEventLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.",
        "label": "Subsequent Event [Line Items]"
       }
      }
     },
     "localname": "SubsequentEventLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventMember": {
     "auth_ref": [
      "r470",
      "r498"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event [Member]",
        "terseLabel": "Subsequent Event"
       }
      }
     },
     "localname": "SubsequentEventMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/DisclosureStockholdersEquityAdditionalInformationDetails",
      "http://www.89bio.com/20221231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventTable": {
     "auth_ref": [
      "r470",
      "r498"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Discloses pertinent information about one or more significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued.",
        "label": "Subsequent Event [Table]"
       }
      }
     },
     "localname": "SubsequentEventTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventTypeAxis": {
     "auth_ref": [
      "r470",
      "r498"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Axis]"
       }
      }
     },
     "localname": "SubsequentEventTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/DisclosureStockholdersEquityAdditionalInformationDetails",
      "http://www.89bio.com/20221231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventTypeDomain": {
     "auth_ref": [
      "r470",
      "r498"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Domain]"
       }
      }
     },
     "localname": "SubsequentEventTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/DisclosureStockholdersEquityAdditionalInformationDetails",
      "http://www.89bio.com/20221231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Events [Abstract]"
       }
      }
     },
     "localname": "SubsequentEventsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventsTextBlock": {
     "auth_ref": [
      "r497",
      "r499"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.",
        "label": "Subsequent Events [Text Block]",
        "terseLabel": "Subsequent Events"
       }
      }
     },
     "localname": "SubsequentEventsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureSubsequentEvents"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Different names of stock transactions and the different attributes of each transaction.",
        "label": "Subsidiary or Equity Method Investee, Sale of Stock by Subsidiary or Equity Investee [Table]",
        "terseLabel": "Subsidiary Or Equity Method Investee Sale Of Stock By Subsidiary Or Equity Investee [Table]"
       }
      }
     },
     "localname": "SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/DisclosureStockholdersEquityAdditionalInformationDetails",
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureOrganizationAndBasisOfPresentationAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsidiarySaleOfStockAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of sale of the entity's stock.",
        "label": "Sale of Stock [Axis]",
        "terseLabel": "Sale of Stock"
       }
      }
     },
     "localname": "SubsidiarySaleOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/DisclosureStockholdersEquityAdditionalInformationDetails",
      "http://www.89bio.com/20221231/taxonomy/role/DisclosureStockholdersEquityScheduleOfSharesOfCommonStockAvailableForFutureIssuanceDetails",
      "http://www.89bio.com/20221231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails",
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureOrganizationAndBasisOfPresentationAdditionalInformationDetails",
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails",
      "http://www.89bio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfStockholdersEquityDeficit",
      "http://www.89bio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfStockholdersEquityParenthetical"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsidiarySaleOfStockLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Subsidiary, Sale of Stock [Line Items]",
        "terseLabel": "Subsidiary Sale Of Stock [Line Items]"
       }
      }
     },
     "localname": "SubsidiarySaleOfStockLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/DisclosureStockholdersEquityAdditionalInformationDetails",
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureOrganizationAndBasisOfPresentationAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SupplementalBalanceSheetDisclosuresTextBlock": {
     "auth_ref": [
      "r626"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for supplemental balance sheet disclosures, including descriptions and amounts for assets, liabilities, and equity.",
        "label": "Supplemental Balance Sheet Disclosures [Text Block]",
        "terseLabel": "Consolidated Balance Sheet Components"
       }
      }
     },
     "localname": "SupplementalBalanceSheetDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureConsolidatedBalanceSheetComponents"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SupplementalCashFlowInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Supplemental Cash Flow Information [Abstract]",
        "terseLabel": "Supplemental disclosures of cash information:"
       }
      }
     },
     "localname": "SupplementalCashFlowInformationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TaxCreditCarryforwardAxis": {
     "auth_ref": [
      "r105"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by specific tax credit related to an unused tax credit.",
        "label": "Tax Credit Carryforward [Axis]"
       }
      }
     },
     "localname": "TaxCreditCarryforwardAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TaxCreditCarryforwardNameDomain": {
     "auth_ref": [
      "r105"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The name of the tax credit carryforward.",
        "label": "Tax Credit Carryforward, Name [Domain]"
       }
      }
     },
     "localname": "TaxCreditCarryforwardNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain": {
     "auth_ref": [
      "r259",
      "r260",
      "r315",
      "r330",
      "r431",
      "r500",
      "r501",
      "r502",
      "r503",
      "r504",
      "r505",
      "r506",
      "r507",
      "r508",
      "r509",
      "r510",
      "r511",
      "r512",
      "r513",
      "r514",
      "r515",
      "r516",
      "r517",
      "r518",
      "r519",
      "r520",
      "r521",
      "r522",
      "r523",
      "r524",
      "r525",
      "r526",
      "r527",
      "r528",
      "r529",
      "r645",
      "r646",
      "r647",
      "r718",
      "r719",
      "r720",
      "r721",
      "r722",
      "r723",
      "r724"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms.",
        "label": "Financial Instruments [Domain]"
       }
      }
     },
     "localname": "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureFairValueMeasurementsSummaryOfFinancialAssetsMeasuredAtFairValueOnRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TypeOfAdoptionMember": {
     "auth_ref": [
      "r151",
      "r152",
      "r153",
      "r154",
      "r155",
      "r203",
      "r204",
      "r205",
      "r206",
      "r215",
      "r253",
      "r254",
      "r266",
      "r267",
      "r268",
      "r269",
      "r270",
      "r271",
      "r381",
      "r382",
      "r383",
      "r407",
      "r408",
      "r409",
      "r410",
      "r420",
      "r421",
      "r422",
      "r433",
      "r434",
      "r435",
      "r436",
      "r437",
      "r438",
      "r439",
      "r440",
      "r441",
      "r442",
      "r443",
      "r444",
      "r454",
      "r455",
      "r457",
      "r458",
      "r459",
      "r460",
      "r461",
      "r462",
      "r472",
      "r473",
      "r478",
      "r479",
      "r480",
      "r481",
      "r490",
      "r491",
      "r492",
      "r493",
      "r494",
      "r495",
      "r532",
      "r533",
      "r534",
      "r548",
      "r549",
      "r550",
      "r551",
      "r552",
      "r553",
      "r554",
      "r555",
      "r556",
      "r557",
      "r558",
      "r559"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amendment to accounting standards.",
        "label": "Accounting Standards Update [Domain]"
       }
      }
     },
     "localname": "TypeOfAdoptionMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TypeOfArrangementAxis": {
     "auth_ref": [
      "r698"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.",
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Axis]",
        "terseLabel": "Collaborative Arrangement and Arrangement Other than Collaborative"
       }
      }
     },
     "localname": "TypeOfArrangementAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/DisclosureStockholdersEquityAdditionalInformationDetails",
      "http://www.89bio.com/20221231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails",
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails",
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureOrganizationAndBasisOfPresentationAdditionalInformationDetails",
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureTermLoanAdditionalInformationDetails",
      "http://www.89bio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfStockholdersEquityDeficit",
      "http://www.89bio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfStockholdersEquityParenthetical"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_USGovernmentAgenciesShorttermDebtSecuritiesMember": {
     "auth_ref": [
      "r715"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt securities issued by US government agencies, for example, but not limited to, Government National Mortgage Association (GNMA or Ginnie Mae) which have maturities of one year or less. Excludes US Treasury securities and debt issued by Government-sponsored Enterprises (GSEs), for example, but not limited to, Federal Home Loan Mortgage Corporation (FHLMC or Freddie Mac), Federal National Mortgage Association (FNMA or Fannie Mae).",
        "label": "US Government Agencies Short-Term Debt Securities [Member]",
        "terseLabel": "U.S. government bonds"
       }
      }
     },
     "localname": "USGovernmentAgenciesShorttermDebtSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureFairValueMeasurementsSummaryOfFinancialAssetsMeasuredAtFairValueOnRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_USTreasuryBillSecuritiesMember": {
     "auth_ref": [
      "r715"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This category includes information about negotiable debt securities issued by the United States Department of the Treasury which generally have maturities of one year or less, are interest bearing, and are backed by the full faith and credit of the United States government.",
        "label": "US Treasury Bill Securities [Member]",
        "terseLabel": "U.S. treasury bills"
       }
      }
     },
     "localname": "USTreasuryBillSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureFairValueMeasurementsSummaryOfFinancialAssetsMeasuredAtFairValueOnRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_UnrecognizedTaxBenefits": {
     "auth_ref": [
      "r386",
      "r392"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unrecognized tax benefits.",
        "label": "Unrecognized Tax Benefits",
        "periodEndLabel": "Balance, end of year",
        "periodStartLabel": "Balance, beginning of year",
        "terseLabel": "Unrecognized Tax Benefits"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefits",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/DisclosureIncomeTaxesSummaryOfAReconciliationOfTheBeginningAndEndingAmountOfUnrecognizedTaxBenefitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions": {
     "auth_ref": [
      "r394"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in unrecognized tax benefits resulting from tax positions that have been or will be taken in current period tax return.",
        "label": "Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions",
        "terseLabel": "Increase related to current year positions"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/DisclosureIncomeTaxesSummaryOfAReconciliationOfTheBeginningAndEndingAmountOfUnrecognizedTaxBenefitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions": {
     "auth_ref": [
      "r393"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.",
        "label": "Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions",
        "negatedLabel": "Decrease related to prior year positions"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/DisclosureIncomeTaxesSummaryOfAReconciliationOfTheBeginningAndEndingAmountOfUnrecognizedTaxBenefitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease": {
     "auth_ref": [
      "r691"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in unrecognized tax benefits attributable to uncertain tax positions taken in tax returns.",
        "label": "Unrecognized Tax Benefits, Period Increase (Decrease)",
        "terseLabel": "Increase in unrecognized tax benefits",
        "totalLabel": "Unrecognized Tax Benefits, Period Increase (Decrease), Total"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsPeriodIncreaseDecrease",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate": {
     "auth_ref": [
      "r395"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The total amount of unrecognized tax benefits that, if recognized, would affect the effective tax rate.",
        "label": "Unrecognized Tax Benefits that Would Impact Effective Tax Rate",
        "terseLabel": "Unrecognized tax benefits impact effective tax rate"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UseOfEstimates": {
     "auth_ref": [
      "r50",
      "r51",
      "r52",
      "r232",
      "r233",
      "r235",
      "r236"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.",
        "label": "Use of Estimates, Policy [Policy Text Block]",
        "terseLabel": "Use of Estimates"
       }
      }
     },
     "localname": "UseOfEstimates",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount": {
     "auth_ref": [
      "r401"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in the valuation allowance for a specified deferred tax asset.",
        "label": "Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount",
        "terseLabel": "Deferred tax assets, change in valuation allowance"
       }
      }
     },
     "localname": "ValuationAllowanceDeferredTaxAssetChangeInAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ValuationTechniqueAxis": {
     "auth_ref": [
      "r118"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by valuation approach and technique.",
        "label": "Valuation Approach and Technique [Axis]",
        "terseLabel": "Valuation Approach and Technique"
       }
      }
     },
     "localname": "ValuationTechniqueAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureTermLoanAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ValuationTechniqueDomain": {
     "auth_ref": [
      "r118"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Valuation approach and technique.",
        "label": "Valuation Approach and Technique [Domain]",
        "terseLabel": "Valuation Approach and Technique"
       }
      }
     },
     "localname": "ValuationTechniqueDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureTermLoanAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ValuationTechniqueOptionPricingModelMember": {
     "auth_ref": [
      "r700"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Valuation technique calculating price of option.",
        "label": "Valuation Technique, Option Pricing Model [Member]",
        "terseLabel": "Valuation Technique, Option Pricing Model"
       }
      }
     },
     "localname": "ValuationTechniqueOptionPricingModelMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureTermLoanAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_VariableLeasePayment": {
     "auth_ref": [
      "r485"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow for variable lease payment excluded from lease liability.",
        "label": "Variable Lease, Payment",
        "terseLabel": "Variable lease payments"
       }
      }
     },
     "localname": "VariableLeasePayment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_VariableRateAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of variable rate.",
        "label": "Variable Rate [Axis]",
        "terseLabel": "Variable Rate"
       }
      }
     },
     "localname": "VariableRateAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureTermLoanAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_VariableRateDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest rate that fluctuates over time as a result of an underlying benchmark interest rate or index.",
        "label": "Variable Rate [Domain]",
        "terseLabel": "Variable Rate"
       }
      }
     },
     "localname": "VariableRateDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureTermLoanAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_WarrantMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount.",
        "label": "Warrant [Member]",
        "terseLabel": "Warrants",
        "verboseLabel": "Warrants to Purchase Common Stock"
       }
      }
     },
     "localname": "WarrantMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/DisclosureStockholdersEquityAdditionalInformationDetails",
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureNetLossPerShareScheduleOfOutstandingPotentiallyDilutiveSecuritiesExcludedFromCalculationOfDilutedNetLossDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_WarrantsAndRightsOutstandingMaturityDate": {
     "auth_ref": [
      "r701"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Expiration date of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in YYYY-MM-DD format.",
        "label": "Warrants and Rights Outstanding, Maturity Date",
        "terseLabel": "Warrant expiration date"
       }
      }
     },
     "localname": "WarrantsAndRightsOutstandingMaturityDate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/DisclosureStockholdersEquityScheduleOfOutstandingWarrantsToPurchaseSharesOfCommonStockDetails",
      "http://www.89bio.com/20221231/taxonomy/role/Role_DisclosureTermLoanAdditionalInformationDetails"
     ],
     "xbrltype": "dateItemType"
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "auth_ref": [
      "r217",
      "r223"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "terseLabel": "Weighted-average shares used to compute net loss per share, diluted",
        "totalLabel": "Weighted Average Number of Shares Outstanding, Diluted, Total"
       }
      }
     },
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "auth_ref": [
      "r216",
      "r223"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "terseLabel": "Weighted-average shares used to compute net loss per share, basic",
        "totalLabel": "Weighted Average Number of Shares Outstanding, Basic, Total"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.89bio.com/20221231/taxonomy/role/Role_StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss"
     ],
     "xbrltype": "sharesItemType"
    }
   },
   "unitCount": 5
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "205",
   "URI": "https://asc.fasb.org/topic&trid=2122149",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "730",
   "URI": "https://asc.fasb.org/extlink&oid=6420387&loc=d3e23221-108380",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32559-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32559-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32632-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569655-111683",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(31))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=d3e5614-111684",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c),(3)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4582445-111684",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "810",
   "URI": "https://asc.fasb.org/topic&trid=2197479",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "182",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=127000641&loc=SL5629052-113961",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28541-108399",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "940",
   "URI": "https://asc.fasb.org/extlink&oid=126941158&loc=d3e41242-110953",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(1)(a))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(13))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(15)(2))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(16))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.17)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(15))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04.9)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "825",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126941378&loc=d3e61044-112788",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(15)(b)(2))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(16))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(b),22(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.(a),19)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(8))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04.3(a))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "985",
   "URI": "https://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(Note 3)",
   "Topic": "840",
   "URI": "https://asc.fasb.org/extlink&oid=123403562&loc=d3e38371-112697",
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "840",
   "URI": "https://asc.fasb.org/extlink&oid=123406913&loc=d3e41502-112717",
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "840",
   "URI": "https://asc.fasb.org/extlink&oid=123406913&loc=d3e41502-112717",
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6904-107765",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(17))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(18))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(27)(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(9))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(2))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e637-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL116659661-227067",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(210.5-03(11))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(21))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(24))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(25))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3151-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3179-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3367-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3000-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(2))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4297-108586",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18726-107790",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(e)(1))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04(a))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(20))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(4)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.25)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.M.Q2)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=122038215&loc=d3e31137-122693",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1448-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1505-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1252-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1278-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1337-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e3842-109258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "260",
   "URI": "https://asc.fasb.org/topic&trid=2144383",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=6373374&loc=d3e70478-108055",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8864-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8864-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8864-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8864-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8864-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8864-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=126986314&loc=SL124402458-218513",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=126986314&loc=SL124402458-218513",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=124260329&loc=d3e26610-111562",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=124260329&loc=SL6284422-111562",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27161-111563",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27198-111563",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27232-111563",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e637-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=SL120269820-111563",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL120254519-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL120320025-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL120320025-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e681-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(3)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(4)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919244-210447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919253-210447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919258-210447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919230-210447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124258926&loc=SL82898722-210454",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922888-210455",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922895-210455",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669686-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922900-210455",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "440",
   "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "440",
   "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q4)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e557-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124507222&loc=d3e1436-108581",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(10))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496180-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(4))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21475-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(i)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(03)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(d)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=SL116886442-113899",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=d3e4534-113899",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=d3e4549-113899",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r372": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r373": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r375": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(v)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r376": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r377": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r378": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r379": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r380": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(l)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r381": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r382": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r383": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r384": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 14.D.2.Q6)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=122041274&loc=d3e301413-122809",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r385": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "718",
   "URI": "https://asc.fasb.org/topic&trid=2228938",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r386": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=SL37586934-109318",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r387": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e32247-109318",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r388": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e32280-109318",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r389": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r390": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r391": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r392": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r393": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r394": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r395": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r396": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r397": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32840-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r398": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r399": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(26)(a))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r400": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r401": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r402": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32847-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r403": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r404": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r405": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r406": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r407": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r408": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r409": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r410": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r411": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.5.Q1)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r412": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r413": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.1)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r414": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.2)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r415": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.C)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r416": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r417": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "270",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r418": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r419": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "740",
   "URI": "https://asc.fasb.org/topic&trid=2144680",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r420": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092918&loc=SL128093175-196984",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r421": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092918&loc=SL128093175-196984",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r422": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092918&loc=SL128093175-196984",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r423": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569616-111683",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r424": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r425": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r426": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r427": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r428": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r429": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r430": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=121483254&loc=SL120254523-199619",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r431": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=d3e90205-114008",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r432": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=SL126733271-114008",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r433": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)(1)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r434": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)(2)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r435": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)(3)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r436": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)(1)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r437": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)(2)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r438": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(c)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r439": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3044-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r440": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(2)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r441": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r442": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(4)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r443": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r444": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL126732908-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r445": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r446": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r447": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r448": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(1)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r449": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(2)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4273-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r450": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r451": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19279-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r452": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=SL6742756-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r453": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r454": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL120254526-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r455": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL120254526-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r456": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL120254526-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r457": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL121967933-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r458": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL121967933-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r459": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL121967933-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=SL98516268-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r460": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL121967933-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r461": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL122642865-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r462": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL122642865-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r463": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r464": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r465": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r466": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r467": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r468": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r469": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "235",
   "URI": "https://asc.fasb.org/topic&trid=2122369",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r470": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32618-110901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r471": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "830",
   "URI": "https://asc.fasb.org/topic&trid=2175825",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r472": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "832",
   "URI": "https://asc.fasb.org/extlink&oid=128342835&loc=SL128342857-244232",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r473": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "832",
   "URI": "https://asc.fasb.org/extlink&oid=128342835&loc=SL128342857-244232",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r474": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r475": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r476": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL77916155-209984",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r477": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL120154346-209984",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r478": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL126838806-209984",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r479": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL126838806-209984",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r480": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL126838806-209984",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r481": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL126838806-209984",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r482": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r483": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r484": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918643-209977",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r485": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918643-209977",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r486": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918666-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r487": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r488": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(1)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r489": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918701-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r490": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL122150809-237846",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r491": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r492": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r493": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r494": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(01)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r495": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r496": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=124437977&loc=d3e55792-112764",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r497": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "855",
   "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r498": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r499": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "855",
   "URI": "https://asc.fasb.org/topic&trid=2122774",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(26)(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r500": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)(i)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r501": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)(ii)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r502": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r503": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r504": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r505": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r506": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r507": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r508": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r509": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r510": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r511": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r512": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r513": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=66007379&loc=d3e113888-111728",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r514": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=109249958&loc=SL34722452-111729",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r515": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r516": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r517": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r518": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(4)(i)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r519": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r520": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r521": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r522": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(4)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r523": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(5)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r524": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(6)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r525": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(7)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r526": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(b)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r527": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r528": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r529": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.E)",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r530": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "910",
   "URI": "https://asc.fasb.org/extlink&oid=126937589&loc=SL119991595-234733",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r531": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "https://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r532": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "926",
   "URI": "https://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r533": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "926",
   "URI": "https://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r534": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "926",
   "URI": "https://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r535": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(6))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r536": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(23))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r537": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(26))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r538": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(27))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r539": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=124260329&loc=d3e26853-111562",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r540": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Subparagraph": "(a)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126980459&loc=SL120269850-112803",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r541": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r542": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r543": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(19))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r544": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(22))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r545": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(23))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r546": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(9))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r547": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r548": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r549": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(aa)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27161-111563",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r550": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r551": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r552": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r553": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(1)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r554": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r555": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(ii)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r556": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iii)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r557": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iv)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r558": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(1)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r559": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27161-111563",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r560": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column B))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r561": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column C))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r562": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column D))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r563": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "310",
   "Subparagraph": "(SX 210.12-29(Footnote 4))",
   "Topic": "948",
   "URI": "https://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r564": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "440",
   "Subparagraph": "(a)",
   "Topic": "954",
   "URI": "https://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r565": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Subparagraph": "(d)",
   "Topic": "958",
   "URI": "https://asc.fasb.org/extlink&oid=126982197&loc=d3e99779-112916",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r566": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "958",
   "URI": "https://asc.fasb.org/extlink&oid=126982197&loc=d3e99893-112916",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r567": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column B))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r568": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column C))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r569": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column D))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27161-111563",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r570": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column E))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r571": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column F))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r572": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column G))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r573": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column H))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r574": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column I))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r575": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Footnote 2))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r576": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Footnote 4))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r577": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(c)",
   "Topic": "976",
   "URI": "https://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r578": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(b)",
   "Topic": "978",
   "URI": "https://asc.fasb.org/extlink&oid=126945304&loc=d3e27327-108691",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r579": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "1402",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27161-111563",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r580": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r581": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(g)(4)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r582": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r583": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "52",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e4984-109258",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r584": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r585": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r586": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=121590138&loc=SL82922954-210456",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r587": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "05",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "340",
   "URI": "https://asc.fasb.org/extlink&oid=126905020&loc=d3e5879-108316",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r588": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r589": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "320",
   "URI": "https://asc.fasb.org/topic&trid=2196928",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r590": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r591": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69E",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495743-112612",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r592": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495745-112612",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r593": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r594": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r595": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r596": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r597": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r598": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r599": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "05",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=109226317&loc=d3e202-110218",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r600": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r601": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "217",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126976462&loc=d3e36027-109320",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r602": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4J",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r603": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r604": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918673-209980",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r605": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "53",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123414884&loc=SL77918982-209971",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r606": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r607": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783719-158441",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r608": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117819544-158441",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r609": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column A))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=126905813&loc=d3e1205-110223",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r610": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r611": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r612": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-23",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r613": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r614": {
   "Name": "Form 10-K",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "310",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r615": {
   "Name": "Form 20-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "220",
   "Subsection": "f",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r616": {
   "Name": "Form 40-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "240",
   "Subsection": "f",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r617": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r618": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r619": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "405",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r620": {
   "Name": "Securities Act",
   "Number": "7A",
   "Publisher": "SEC",
   "Section": "B",
   "Subsection": "2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r621": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70229-108054",
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef"
  },
  "r622": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=124429488&loc=d3e326-107755",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r623": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r624": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(7))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r625": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(9))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r626": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "210",
   "URI": "https://asc.fasb.org/topic&trid=2122208",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r627": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r628": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r629": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r630": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r631": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r632": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r633": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=SL98516268-108586",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r634": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(d))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r635": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(f))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r636": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r637": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r638": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r639": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r640": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r641": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r642": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "55",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e2626-109256",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r643": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8672-108599",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r644": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4647-111522",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r645": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "321",
   "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r646": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "321",
   "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r647": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "321",
   "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r648": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r649": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "340",
   "URI": "https://asc.fasb.org/extlink&oid=6387103&loc=d3e6435-108320",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.CC)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=27011434&loc=d3e125687-122742",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r650": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "410",
   "URI": "https://asc.fasb.org/extlink&oid=6393242&loc=d3e13237-110859",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r651": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r652": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r653": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "450",
   "URI": "https://asc.fasb.org/topic&trid=2127136",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r654": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r655": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r656": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r657": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r658": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r659": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "440",
   "URI": "https://asc.fasb.org/topic&trid=2144648",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r660": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r661": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r662": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r663": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r664": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r665": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r666": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r667": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r668": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r669": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "https://asc.fasb.org/extlink&oid=124440162&loc=d3e12021-110248",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r670": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r671": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r672": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r673": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r674": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r675": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r676": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r677": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r678": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r679": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "https://asc.fasb.org/extlink&oid=124440162&loc=d3e12053-110248",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r680": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r681": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r682": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r683": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r684": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r685": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r686": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r687": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r688": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(v)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r689": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=99376301&loc=SL5988623-112600",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r690": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r691": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r692": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r693": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r694": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32621-109319",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r695": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r696": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r697": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r698": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "808",
   "URI": "https://asc.fasb.org/extlink&oid=6931272&loc=SL5834143-161434",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r699": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123465755&loc=d3e1835-112601",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r700": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r701": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(2)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r702": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r703": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(1)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918673-209980",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r704": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(1)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r705": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39599-107864",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r706": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r707": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r708": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r709": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "470",
   "URI": "https://asc.fasb.org/topic&trid=2208564",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r710": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r711": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r712": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r713": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r714": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "730",
   "Topic": "912",
   "URI": "https://asc.fasb.org/extlink&oid=6472174&loc=d3e58812-109433",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r715": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Subparagraph": "(b)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126980459&loc=d3e62557-112803",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r716": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(3)(b))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r717": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124508989&loc=d3e19393-158473",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r718": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "1402",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r719": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(1)",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(CFRR 211.02)",
   "Topic": "480",
   "URI": "https://asc.fasb.org/extlink&oid=122040564&loc=d3e177068-122764",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r720": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r721": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(3)",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r722": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(i)",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r723": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(ii)",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r724": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(iii)",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=65888546&loc=d3e21300-112643",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21553-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21475-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21484-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21488-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21506-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21521-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21538-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "50",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=6784392&loc=d3e188667-122775",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "505",
   "URI": "https://asc.fasb.org/topic&trid=2208762",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5047-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=SL79508275-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 14.F)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=122041274&loc=d3e301413-122809",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126964447&loc=d3e11149-113907",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126964447&loc=d3e11178-113907",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "730",
   "URI": "https://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "730",
   "URI": "https://asc.fasb.org/extlink&oid=6420387&loc=d3e23199-108380",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  }
 },
 "version": "2.2"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>79
<FILENAME>0000950170-23-007929-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0000950170-23-007929-xbrl.zip
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M51FN(5P0(C6IL:00 'N164=46L"I4,D #H7-O%YZZI^JVC5^^.R7\4GM?8)
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M^D ??QN[#4 0_HZH K(6<,43I@VLCLF"P!E+4E"F!;52&I'> U4>5*9?V4J
MZ:T"X\&D&GBKL *.'*#+I<PM'#7+35@JU,WM0MU\2:BWAB>(=@M/]?%U9..(
M P5(%Y"!> @ _(SF((<="P[0D*67.=L(#/!%U@9'A H>K#N]S"_ X'+5>#H0
MN-\VY_SZ:3V_K'9&Z@!P^>:7G] RW&FB[0/O3J*EN(/VP<_/&M!W!V@(Q>]
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M&I0./1S[N*S2+]:NWD?#[!QCDG\MJ]_U4!]/6;"MZE%5ZT=HK;$>9+:,I3J
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MM><U75 ;5C L$U)X9XC(>8[%ND&J42.R(G6IIIU596]+M(YJ Q@E>',]^!N
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M/3_ZLC[]"-@N5WF@/_RNZS^2-T/_XS*.U+GE)E<@/\9BI<NH4$_&U8P8<*U
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MOY!,4CQX,LE(.]1_6G@#?RJR<K@L8&\VKH7>;.!=P_B*I\,YBU5RSNFU>7*
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MKG_?G%23P9+O[0U?Z^&2Q2P?ZS]C>=3KWQL_*/VR-3J/%LV2B9IQ"=B[Y!?
M2K$VZY('5208O>20D*BN?XN\!R.%E[UE#"+"+WD) -D# BP\J>K(_X;^N&VC
MVO+#QK<0;S-7FA*8N:X3.!ZPW)I(U"UTID1Y.PY]$=V14H;5^#H3Q)<#]0\
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M/=(5H7+[>USF#H;UEO;F:L5WJ*,R&0Y0L,V5/!3WGY")3X/P(T?^%#7QBV<
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MWO*J"UL"U"H@;=_BR;2V#4R-%7>/VXLLY&IX38>T<3R8V*II_QZ4H]+-9VH
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MA#,%X;4+L(;#E&(@C'X(HOY"K2Y,;2:-7A#L; ".3*./^.:CVL@%[(I+B1R
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M;)XE%_#+/$L_JR7?ZJ)!![I%=)0QUG2D"7">(2*T?1=<509Z=!E39NTB;&R
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M7G24_X7+5DE*4K<(-ZO&K_D&UGS1WM+I$4&OWM^WZ$_V8Z&R=QQ,B_SQW3@
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M1.$J2Q[WSA#4HA^/\3_](_SOX!#^NXM,M=&Y:H=_'Q[0[UJU:2A]<)N,G5:
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M,'K1"TYK,[;>)!+'^C6H-&9 E2@.R=@/%]Q!3.9Q=/2"9G78?U&[CX="&E>
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M.-AY\^O[=_]^\^MN<*Z9>0.[88#G:<B -Q^%@SVN7LNWG_:C/F/?H18AQ,,
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MHLXZZPE<N!"I@B>GG/EF:JAUJJ!>P=S4@A)=@*U '3,UD)MV<F#4&OM]4VD
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M-M6'+E2G""?64RMUA=JTZ'0&1LJ(8K=RL6Q<YGW,5NAE0]&K++C?K,B6;/L
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MEJ2V#'GM;ML)L8./BI((Y=#RH1@OG$#>$I@VM,%ZE$O=XQ"(Z-9[*Y@^.'G
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M7]*51M")Z37\S&BCX9(Y"]@BLTIS)<TV%?4;,I-/@TPTCE%_RGF+G:N[L2S
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MU_ A1>HJM.BYAEI0>Q,2%6!,6504@]RWK%]+O^XDN&@PA MM,:1/* ZHNYT
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MR [JR(X,))@QJC:C3@Q5/-3(A+'3")[/#: XS*L) XB(MV[1 %_U:"Y^N&)
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M*#ZP>K_I74\2_\_X5=O*WY!4507V#N?=A1O!U=(:WVU-0>J,_K8IF!S 6W<
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MSBF"#*=E/P=%1;Z#V6WJ]R'!IKR@SPD#EMS\P"U,-FUX2>3@NR9A9P$<7'5
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M"@TBLLJ;W]!$'0 ]>%OT&F#B.#4WH&R6K"K[I9RX')BR'^2"M+E 73>3CDI
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M1AQ\M2L9-=:<._XVS32,ZE4XPY!%#8=U:%+'44WT9-[XUVY$MF>=@T[4 .H
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MJ;8+'DOB31<EA,$Q^=Y[QPP,5C&BW]+-C!DI"DFXJ+@XM7G2_-:)*'A4.A3
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M[?/.^OT&1[!KE, @L-6V_FANA*^/@4"HXX"/ES4):<N\YEO-WHC=](OD;:2
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M-'A3E/YO<HX]*!\9J2-K]J4X0C%$^V)&DG*> H$9'C_J7]:BC2 [SP13H$9
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M"]F8P!,9Z7+@J7?=OK% 5,C;L'D;+QXZ;R.H-KSS=^3PO8E:#^Q\^T;81 @
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M!BZG3_Z@$Y32P'33(;<(M*U=(')"<Y/N&QT.Q\YAN '3*IGWM/9EB%#KG.7
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MGJFI<J81/9UX0T?V\9 Z;T@\-[IG+"C@L7^EGW09V%:Y_\W+P*Y5((/^N$[
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M.)Q\3IT%E"_]YSD3DS/OS9EX</ZBSQN\N"+M/2\LL)9*:XQ_8*(V HI(Y8$
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M4R'W!>*$%8H[AU:F2-'H)&C"UI_Q8RG/*V@1"96=<^4+_FNF<N0,I@Q25_S
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M2@@3A)DE\B2;G2H:T :GSW;4C2!Y;M,)7;<\XOSHHG-@> "^UDZ-D5#3H,(
MZFU?C;.&%%'R-JB+I0<VJ3^,G9&;Y0)[+Z');O16#$>(2^9&SB>&:OVCI=@"
M.UEP*)VN%W'#,^RD!;M,3='5TL%N+1D@R[V1:"/H&:+<H0SO#.%1N-K(36G7
MJ\(K;NI]R<:OKY*%8=U==UF>J9;:%7&#02>"%7=4^,UV6%8;Y#&A->-WZYHU
M73]<)EAV:QUP0>E_7"[Z(S=.CMQ(8\AGN,<-Q^01+C8DK#\PM#$#DN*=6$DJ
M?7UT"9?C=3[Y2Q>(0%MGCNO9K\027(1+975'8+J^<<Z]-)<K^N(T;U4A$$"Z
MC!,[0Q.Z4NTZ-1U#0L!8$7;4*NF)!)\9<I;1(X)HW6Y"(=V0']1$D2P[&L71
MX<'A(4,*KEZQV-Y 1UW??-=<V3(&IH%=,$BH2G]%N!E_4(%QG\_/ER@K+1JW
M/D-=Q[E$B15;Q"GQLMO;;0%-S,UF'P5=7+G,NL33=W/XWG*52UD<U8^Y4V^X
M)R./A!2DJ@L:@,PK2?>W,1<L!4O*"@:FHFZ$MTYT;K?G572[UU[/4&Z]@<E$
M\, O%$<AKFP55R?G6^\@*P1>76<RG8+EZFH6E)*!SMVE57MH4.N,)<V!*^XX
M<Q.Y4VTZ0UZ"94SZ#.A22Q?\&I-^TJSF+I1>'1Z>O92;P7R7&E*'7B<:#BP"
M0T>V^:)U$WNY[KI<#8,B>;*4IEZ4T"VA%JK"K]9POLY.N"I1)L7QGF,&G2&%
M$_Y9LN.,*^\2?/,\:^>Z;:L3&.Q38FN3!I=0<+1[+%OBRJNL;0M<>3V+O0=^
M^I__,3H]>!7R<;:=CW/VP/DX0>O?I(2:,FKA3:99_$2E;:7<YLC2@)Z9VX30
M&R)@<BCC2@+Y)8XSK9(V= 3=OMLD50+Q7M[LW$A$".S&DL$XI7C!K:_705L9
M4$6F4P.Y\"DQA#J>C=%"L*[VMU]$JF'N1D9X&RTAE$J;;90Y(*HF.G?>J@2Q
M=!"?$))SS%.N:_QGW<[A.+&%MSR#\U"I[J5,K@)TK^B<4T2ER::9;3[ U?OX
M6URA*8K_^/8-U8[I"AFNZ"^6-]E&#1Q46&.J^PPV(=&(LXC]BG"N>Z1*9)>R
M%*F:@35B_HCN,UX6'C9*S)4AX[K$,'7<!5!EN/$_.)!@UJ95BGI9-VI.=6MS
MM;64]I#I8'/:B3AF# #AQDR<Q"L\S)S#2'1D?[3IA<FR2>&R(B#9WCSY3/:0
M9!(E8 *9E@#P(Q* &"#G9"/. G#@.FIR$#+G%9S*)OFLP*0RD9U\&=O+*N^9
M9!60*+)PBY^.%8IP$UNNM[0M5^&VUI2>-EX2!DVK@=2:J])8# M5+I@[C,DK
MVQ;2#Q[I%_T-E=-G6,\&9CF9D&5S@9/LH)"LV5\-$>)<]!B7[62SI>QA-9M"
M4LC)HL#=E3H"EE[J9C(J.!6_1KU(X'!2P\WIN+B\D2H]&BF;A_NP*"N!BNG]
MR7A);7GQLQ_ X*(20?A/IY36J\!EHY&CEQ0EKJ-G2M".,(1@[6[3)1G]&<V*
M]?6<8=;81>8:O3WI0BQT.=6E!^#(CL&>;I'&)@*@@<K152%]N!8)P=5\+1)*
M4+5NS.GO=&\-UM6FZSOQG2?6B2 " ;'.2L$9(O@?KJCU;K4;D2\K U2$:5GL
M;%@E =!+Y@O=U\W\V'%%M"YBP"7)*!LKS1-!SM,T)GH?YS'K(7 ];]B!X"1#
MW/&^>QFIU]U^WQ^6H%?1L B/L4A1O^.S)F(NFFP/Q2<YR)WUP[L^BC?O\.!(
MK]$,K4,F;YP[\%-RI=WJNM_ZNNEHV-X+/C9R9#F ?/.Q[FZUHN+BE6IU$^2D
M,"XLK(UR?/#/J)T )\#XOWPNMXJ5:%X8^LJ6*D'_VK01#3^5>RX!.NV!M UF
M).6^QM5D5=T(#GN]?E;8L"S70;_>Y;JMW"A:>4GZ+RH8GF]9E!?JE^#Y/D4=
MP>]=[UF#N),8M[TJ]XA"C/[L>JA3S'VS$S?%@LHM-+_CS7 QO#;X$1U:V^ \
MO&&+KZ"\/*CRHNVZVMIK;[ -"#[X9H87N3*7EX#B.%XC]T:'":8JI?M#2(F8
M%R:M1.2'/M"<#FIP]JYNE D$+NY@'X EH1SH>M'B3\>JN5*@#[46J'%]YC-S
M\NXS!CG%B0,8"$\+  M6$,6)G'F966A,2P%.<&(8)G)1W@,F9%!V'NV>9_7:
MVZJS<33V3^FW[6#ODQF(Y5E9+37X:4E]/QC=]BL6I7/4S>*V2I$(?I1?,MP2
M]5 %:R%#Q:JN5:5YOK:)1>0F%2=EKRN>TNK;9%9* @V_SU%GK F3N"1LDW8<
M$A[KN!5V^F'=I$/".JT'(8YJA]+O0-I=T%>$G4QXA[F?*1<Q,6]<NT"==\MJ
MPUI%?.,%8-!*T$1L,1;,S^O9T(&\=9/D&?&VKLM)EFB?I7/8G*%K-*@^U*XA
ML[:G&GB[ERCDKN@WEN)UH] "VS^:A.V\1.T\J:HE$ !6Z[A9!$WR!4W+*AL3
ML4N G5C,#5UK04Q_?6H/5>"FT;_V/^X;,46 'R1V>X[SF485^><O/]F>\OXA
MPZN^!PK<?P$6.ACFXMV CU[LG^N/NEV.65G4:1:FJ1LJA--I#?,0:QZN#7V!
MK'>N* UH[<K$5DHC."V8NEX?WKQ)!3H!B^#OC_>/[*R\>;0"\+XR!8(-S-A3
MKX4G;(CDZICQ._LBHOTBD\*G!58Q96@%'A_L1_^RM2$P5 _=K!V7S5C*X&5X
MZD3DI,TN HN10@8KH.[^?AJEG4'+QDKB?FE/,:)VUV#:"P\+%@)K& ZNJ#:F
MW]=5HO*,R9[=_-Q^J*3:ZW-:(:H2OMW@5'2L;$KH1+3UU(KS!TZMV))XC;+T
MO[Z#K9O_/AK_WA:L-:GT=^!BT^GO!*97-/53D<)KBZ4Q/COZ&Y8JR H?"LOV
M7I=%EL]T2F!XRFVJ_-6E6?<Z[6UA 005A??SGV6AAN64M%SE\'>I3P2)M1-<
MY' _^E#M!/?0QQ*XQD-RC:.3&#3MH\,A,([?%,5F=*IZ1#/!B,WH^##ZF!24
MD/*QJ10B/<'?T3O,B<*@9QR]@<T =;+(DNC%\>C@V"J?19T)I ?%D[[H+MY'
M\>G!053_NR6 ;QA3,K]Y"JS3DR;^CZ1H,?E^=$P6R<EJ IF;>\^3QNA5JO[=
M2L=N,:D5J+KX8VG?PB-<J96"!.TYMTXE&I6"FC@*9H]=UUAK1]#Q0WGW5TJ\
MH]\)1?]WQWV^$X+O:#_Z"1>V$[(/9+@YG2#_ODFM^3=.2K$.&,H =G)]BJ5M
MEK72KF8?9"'VEL2<:,QGR>8V0L')&)AM0[8TE8*OMKN1P))DB)B*LPGA &IW
ME@'=B'Z%$:HT-VWJ&W8Z.>"[F&S*3;YLLVWM!*)8LR1JZIZ Y*PDP##IC5$W
M5/>'OY1D"R>)SG0.B0T@C<#N43UZI18M9XW".JF#A?57&Z>:Q-DKI1-CB])F
M6DM(<Z5YJ8WKL90>6O:HY?S'OV/OU]_K9*J:Y>\VP7TW^/_Q?O0SMK;]F$QW
M0@3 &44_V#,*<9-M.R4:!ULS.)RW[G!^\=0<SGKKB6&BF/T]RYXZ9_SP^M>=
M8(:?HO?O'X=$KY6J)[\SR,WO8-;_KF&.BZ;^G?..?@>C_ZG?(I*O)R!?&>4'
M_1>_FH7:/"'I><-0R[%ICX,]<';B$NH$ZI\%"0+5Q??84*J*/H#J.4L$T5:P
MIC_> PKRXUMP =CG1GLII/+>UM,&_6WKZ:D^H%E-8&'<H <3\_^9U&GR[^C'
MO!R#S2<'8O,DZ^4<;H!II?/VTS__9EKH[)2/,=3RWC:;ZF?J7WA$WOTCW:*>
M,D[]B,'I"A8+UZ[W5R-]S+!>Q>VB:FN7?!P6>-%,Y52*.Z[*SSY&C^YXI$%9
MQVJ6Y%.& ?1R]-E_U!8ZB*#@=SAQ+MLI&[^QAKN02DD' 5,.3 W<:6FZW<-.
MD4BHAKG99OZ )>$*KN*'$@SG91!IV_;X<HM5A06'J9KD0, I=R?,TFB2U+,H
ME1.PH)X>R!^R"6G3:KJ 9#2^I+$O"*F]=R"7!0E>%/X7!E&<P4]IA?O47HXP
MK$PBH(QKAQ1 4U7U%F;:\"874: GLE(&5PO=RF7"7-2'2N-.#902N2DC$D>0
MYB:,S*%S&QE3CN?D]#G.,U#84[)95%(5Z/XF[)$_&,M<[[!EP;2!@E5/B4VQ
M.-#]SSQ4:]UR <''&)?@ NM*"UWN@>0RAM=1W>-*LY;8UD1B5VS,KJU7/=@V
M^-RS@2F\MS:M?X?JHS[]7;?S>>J\DHSFT_WH_]L-#XR<RO_[IFS9@%07O-N]
MVWIZ\-2\VUU&>_:[#9[6% QL:PRK_JY[MO\^W0D.?(9N2[U0ZZO\P2R8Q.AK
MW:B^W(W@8?3.Z#]OM/Y#"_W5JD"_&!7HF^+IWV!^)?_^)L5__UNV"/W/S6<2
M01TP#9U3GV@22S3K=&Y=8[NJ=AOD8"Z'%1BO&NS*E*(&=C 'RHM'X[!"43;*
MTX'-#UP00T%@2R.5U^J*'#G7]^#>CYY8LN3-#_BCX+0S2HK=)Z](FK9GW6'+
MCE)]%Q9K[>5E^9D;1OD-1"6_**JR^C,?5%M(&3\7UU&E*3<)TE=$H(48VUEG
M-^4"5]33#ATA&.>+/',=5>OGM:\[&+@]AJ2B7E#DJ&:54.NQ*ILGHBC[1]:-
MEEA#GC7,QY*B5FJ9P=-#"[AA6![J+B5)131SWE$'=D>P8IJLP2ZI?5W=35/W
M#1?YZR[KL!G2>B+=61(=EFG^Q!6A7R[!;,W4U6ZX*@=6G$'81-$DSQ#--X?;
MC7V7QEFYP 1+F%?;X.<:/AX8\X3*KJ6?9ZHN@4$N# 2BK5[(_C1P6EE1E)><
MS8E2/EGHRF+&'E-)P^T%I\"*T6M* P'WS\J]N6J2,?JID?%B#8>(G!P5FT55
M4N>X">)[H<811PMU4?Z93,FO&3U#I*VL;&L0/G][_\OYB[W1P<'S&"%2&':-
M.T:I @Y;*7337N3+2?GA[8]+C72<Y"4U/YUFXZH<YX@Q!J=\!<H.N^NBPY&M
MN7_WX[O#D:FZC_W2Z[$B[8OW2QI=KZR_P-3623FC%=<-?%/.U"+!7H!N;?_K
MCW]_8IQSO6M#8Q0(JO/JGM3H25?1;(FE9%6&1Z00>G:>)79+/O[]TX]FK*<G
M2]>*D0C/F@J/]#Z@NK=R5:9)TRR%>H10GIKZNVX+G%O_[J<?+'7MSB$C!F %
MW$0QM#*U.)SFR7QNH4>)_;#B3@3")\T*, ..7W"WM1)QH*L9/AO+4],DRZGU
M.W&2<J+RO,4N\<!A)UD!T]RYF_+W-V\L7]F=>X(7(07&."-(DVJUM,1B:XID
M7"-ED:<08LCAP>&!('L()HO-&>"VARBR2[#-"F7,.S+CD/$@1MK(M/<]%?E/
M/0?/.O Q MKU =/KHM'XKX<)S C-_!VY>K"IGN:Q.Y<.%D,B")40<@MP!2X<
MI+@>E'2_8BA7?<7(%20Z961:6\I@5"X+WS4,I9;(O3@<RZ5X]O:?/[W_G[?_
M?!ZIRR1O&=[(V]^LL"R1-=9#M/Z/.G.%Q_[1PM6%ZSUZ<OZ@M1YQ%@&R1[QE
MH/CNSI73IZ<[8%TI]1GX6UK6W*\#UH>JT)+0?O%+^BKJTB"F7"!2^[AD%*-C
M&J@65R@+VB0:YQGA"()UIPIRE"UFB: S>L7:SN\)M)MRKRQ;M7#+Q^?\X+XY
M(D*!5'C555'!V^><T1&];B^P-PLR7TZ-8);.#70%,)N;I!@F#%9.HAUIE"S)
MOE+)=L-4-\W81\3/[:N32"PZ=*BIANR+-EVN;-LJP:-KEUJ2%S6C+&H-(WK6
M(<)WQ\]!0LW+@BB>V^9A*Y;HZ"":7^P* ?;>MMTA/V3M=0:C@(Z(U:.YVJ,5
M=ZZ/=,F1#]-E 2^>$,M]=XR0!ED#9$DN5S15]OC2X+4S$L!77QQ63\CC)24\
M83M%IR\>TE[WMHK#N'L3S04V[R* !C' 5R1*KZ*$5B71DY8B EQ7%"6ZP:]3
MDIA-?_KU_8__>JMEG)!L#]7ARYQ)TY]D^-E C.N77HI!B%N'Z4!(F3DNCH%K
M'4-9/ >'IR>O3@Z0$/^:_O1<0VEDJZBFA.\^0>@)^ 0=_UIGC,4K<YG4$S(A
M",><+T(R09\[7'[\(?DK&%F=ESM7B">+>4_9' N059$N2H3%];D%>OFSNM&=
MO+.+@IPTVK<D^@1\-5<))EU-6XPZH*9KTK.\==,IC&$==#8XQF>%^X8[ZDZ#
M[PCEW(G021$\)$4"MD?Y[H?74=W2;=2WM*/U=(X4V#>?^A%O$3;5R>'R"&O7
M&A 'Z AB7UKP8)KN7 !N]0BTD;43=8 U1(ASTG#RK^']"S F\USE@AYYJ1RG
M$[Z>K,1RT0")_ZE\1<WUYI%-F6"+%4)G')=P,["?T$2'_I"S<VL5O';4KIUF
M1I7))*APYWG[\"UTH?5J].@4I%EP7 !!!$GR\'=T)KJ9/($$HU-1";WS2KB=
MP94Y._02J[2/"AUE:5>:9PU):/RFV/5+7-$)$!-\IL!'ZKM84O>%%>1ZL1H,
M!@!I/PD#&$CZ9NPT_.'^KAF)B!Y'L+#*):=FINOX/CI))JCXX4L$GEP'IQLU
MF16PW1?<;8O8##R&%C)I6\ZP[/]&<Y=A,Y_91%8X#<<0@L\DX&T^9,)^KIO.
M76;TLPMI,T&,(X699LPEJ?\W$XR(+%1&5K- PMU^F,;;E$;, 0OX!Z8.@QYC
MI&*-WI ]3+.VH+E[<&Y[U)FWMBCO9$XH1.$]/]\_U'BW^]'?$@FVN&A4%O,7
MN2#Q^57DJNW,*UFW=C_S@WL $?!(;45H9F&V\*7OU+BB/U!46;GP^M//&"AG
ML.IGNJD-Q=V?FZX9]).?2KA*KW7R=?=9VP*\;A%J#/4H:DVI%&\)<IM)MF ;
MIIO]O=(UQ_24*0MNGF.E2<I">V/Z"2I6V%TSM1OD@/KCLDR+32RYS3A)P\8S
MWEH79J#I^RO3(*!_C/PAEC8B:"LT?@KI[X;_6#1$B+\(?+H\H\T%NABLJ*T0
MB?:LCKCL[/O1 1R C[G]XF!_U ^YO1DZ&U&SJ<N=[<J*Q##)2(7\_FATXC(1
M3X_"/<@*1NGA-@>NGHW/%;7<4+$"2-IZ,./,&*Z,_NLKOIQIM-00UBO"N38^
MXXX,Q$-3GV$;+G!-V/F#'=K<E^*6+XEQ+;KSC7Y1[ P>H_:<4\4(7)L6X[EM
M)>K"-;F40[K)6ZJ-"WGA-B]\],!YX8$QV\U?32 !W=^ ^5-)%S4G9_;<*+!T
M.?M0(("7^(A:)-)9$&@YII:@$AF+M9K"K+ G6>4KN,Q-=/:VF$C%FH/^SQ:-
MXVSFOGL%&O'"B&_2CL8R:>J3R,AI.G-G181A<=HT;W'W0)UQA(!.U13G ES1
M/>UGP,F@R,//\+^Q5/*1B# =O.FO3@Q(W!=ZJTC.P'):@6/E]-\;F%8AL>Y>
M\Q9_*2Y*/+XWO_S/^Q_V1B^B#W 4:IY-0N[=/;0<AYO?V>Z%;#<%6-.LKMI%
M(UVND%Y=Y4V^]2 <A7"HJ2OVY')("-$CT0W*;ED*=Y$^:)M]KDZ"6F'9%A_"
M!2V;T7XV3E%9+1S(:ILNOH^V$3? =7/6*X*<I,$HQ=PX7[A_Z]H- D;.F,Z@
M,G)K=G142U(>NGZ\;.SK]YJ7XFRUWZ66O\8/76U9CD!*(7H9GFF!9H[(K5IV
M>ZDPK*:% ]7PFKJ):.&==.PDE0.1@FAY'T?<@N(UUP9LKHX(;'1[E(RM=LJ"
MO BP\[W56=]<U=,#RZU?7<WA!X?MO16#-LBO;=_Z7]<I:\:'(##]$O6#US%*
M3DV9.>)WT8X4=P#1'6^2X\U:[5J]<?-44 A65IUV1(_KM/><]<[@K@:_,H"-
M4Z"_4;M=UQ@L9I9F5QCABD,3'MX$F1;V3\G-*!K,'[7;4%8722$VC40;X!_
ME1+"M-@P6Y9^KC?$%VA&/'D&#$]W[;S\ 5<GQP+R$@P" @%9F1Y[E]&H,U::
MXR.JV[&X3WDTLYO."'DRQC:@_#@"QHJ'"_$0,L*;)G]6GN-_C?'%,]F//O@?
MF,N$R>E)#M>)[$!I<1J-P0J<9MK1CE@I>V/RXIL<&FH0CU5O!:&MM!S7M4#>
MZZ_S=(I9E\$A?"\.8;DX%(R\GJ.(?L@! _K3:-)+"O5K8N;\D\FD:MDET6&
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M]W5P/$_@=@R(T@._'<(I&'Y[^,#\-E#*,"DEG,M-SB4H_$_Z^(( &LPI/)H
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M'MJ)#0]ZQ,,SN?_\CR^'!Z/C0%/?)DT-;,N#,!G"*>S$A@=A\O#"Y/2N8;)
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MZ>>$UC.B.[IKFDS(3KI-=M+Q0V<G!2GEY-,:*3-:)V60!TWR-C76,&% 6#'
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M^B(V[99"JVM4(\S;NR"^8(UZXPTS'O1L@Z]= N P93^VPLQ"1K*18N/N[[$
M8TL%[12#O*IHK(Q'"]"$V<6?!']G94IV?X,2&E@ D#@GW9@WI2Q]0-2]+HJ6
M<BH6L&MX.,#-Y]'H8.^_49N89ABLLJ[WMV_VH[^75\PBG=>C.6OHB1E(JN!B
MH/^0SYN.JM*9&\0;))&Z4^PR)VX.?*:LA#D**P8-X+-A=:BEMCA\7<+J4/[
MKN$4"I62.Z4B3H@;5Y3P"IV8S')4.;M*7'C:D@\EF2 '(#[GOX<^PNV$>UK?
MX"A01K%+IG:2AN#A]O$XRP[;3J@/BVS1I^75.=%IIPHU63P7_XKY)M449%-Y
M!7^][)Q3FEWJ39)]Q?VCDSK[RZL5LS?-:KB.RY?37'U933;ZHP5.-EWJ)=!3
M>V"S5<TK.IL]V,]Y_1*]8JA!])ZDW0QW#CN4D>3MJ=G0K, =V:-]W?C>+C5L
MV'-W*\].#D\/3T_/#D>CH_,#($(QS0\/3;&K<Q7\6>T&-8G  Q&$ZBGKCO";
M"?"W6!BU#O-(W(88?*<0$SYV[< 53;EN@.A8G>_Y*<N018E3RLC'L:)>BEB8
MS,JR5A*#J5NE4SV9'W3)6RO@\+@J*J#U: $LFY@$SI%U]B5R")0JNCZR,T%;
M]0PW0?XWL(C (KXM%L'43X88FY=(MN1W\$J)?7\#ER%GDCP*:CL2LR9.YS&_
M.IJ4YIHUW!6F@L)<V,5:)I'A#8&3=:V-0,6!B@,5(Q7'KH.H;!LL$ZG9*VPB
ML-J!&(1?()M -JL>57*X%,L^IRHJD2R?.$I6:]^XZ\>?)Y^5EQ+0[]_V7*?X
MW:K#.Q!H(-!OFT"-76K]>24&??9L'&.MPDCZK)K,"EC:!>BI@9H"-7W;U$3B
MCCS9OJT'8BX9YUD]TX(0$V:-^=<)\8F8<@,$-8R4)Y47L@O4%J@M4)MX5NJZ
MG&24;T,!N*0AX#ARQLXD2D59LIKFG)@55H]ETPPKCS3D$(4[VRH:MS7F)-18
M0W85""X0W#=.<)19,)V6%1=RJ&+&P#@ZF(L^RV6-%U2 :3"IR5*:I2_X,19S
MUE-)S7;2L2G$+:4_!#=1+-W A+PS950)')50(DL,A5QB&"(KX/N,4E0P3 ^_
M>863";0;:/>;IETM+"G8B%G(%4G':9;3?\&\PW0?%IFIFBI)Y  R5@50_(3_
M6F(,D#+O\B2;NRHJTF.>JTG3<@@2B+U91H1%[N1Q^-3W5/,Y!D)*W_W?WVSF
M5^ED^)8V.13KD9J$ \,V 4E 2:Y-&H;!$\G869N$9M,<*7^9\D?<J?3E_-A\
M:ETG##<O=U#)W*Q5EZ7KG"C.^N6?.A*&2C-KSO'F1$5$;D@O64QMS-W5H_7G
M)L,P\G<LGA+E^4G43:+PDHCIYISK7+3^4W 2R*@X#M/,5E.T*)E3Y_+H9"V;
M,D>95!&] Q[.;&HT!R YS; W_8I2??%A*:W#CTB]=I*Z.+,,G;)*-2+,,84U
MNZ0D<4H>RG*\45B,A<=S3=G48&@KU$QMO6;JY!NKF1K,SFMNF# 3HB3R0JF4
M8&<Q\9LPK!*+4*5QW#@AU7)@&)*9+4M^_MI)%)*\(L]XMMFN!%^LT%5\'0S$
M8';NT3 @=O4J?N(J(5@7Y01+CC%)!E>2&_DM8AD1ED&EJ6?9HK:Q/%)*_3H(
M2K]&X!O"9%:U*4^A*TX5P2#A08+7,\RI:4G<L9JJ:[5617>LU2)=Z@$W625S
MFHE1C"@/4#Y$%0P!#ZPSUPA94V>-I2=8:]W)>8[>3V^V(P*/0>5MEZC"8(BT
M65KL):ZE*:]DWRP0HRA8\&VQ9RH%"'AA5N94D:]UA!1D=X/U)*;,BM; ($NU
M5R) N4-DIV-I$8(1FL"KCB"!60':UT37:(%B!N_"'$*G[L2=!A=SOGBES8B;
M;@UAV@K30GM&;H!?8#,IX2@)DR+/YHS,P:?95-F$__1Y6X-AYQJT;83W([67
MW/5<2U,+ F#'N8@SP585G[D6@Z?IU0F6F/X/UE3%T""H9X%&I9>*H6];$2:E
M:DF*D%>-LDMT.?K*A4\5V+*8C0J7FNOH*#^5;@'L=UM+KC=IM/.22_1ZTU2K
MOJS4>$-]BD,1;AT=7PSM28(OF58L%<H@$BK!PKPUA(D5: 46.V&= DDRNFM7
M#%B"]VW-<'1J/>/!:^!&7JK!(+&+@^,I093R[V^";_P&*UW>(1#F;N"3#LGA
M\\FMT(BX!+=NYVAW_\D7W<,A%2.42Z+00@>B+C"@\HR2Q,NVQA*EY]U2C]#2
MR]D,V>15?W+2-J7N(H<3Q)J9@U?T^!XPY[)M8/@O*GW%KSJG#93G*3R\J-7+
M&IUVP*3TWA"[Y*&_XY9KC;&G+K,Z8\GU4O]>'G)[Y_';3D_VS\_))=K;8(\?
M&NV?G)]>^\S!=4\<[1^?'7_],(\W&=W6SMWL&=,SL_K577Z89I4]Q'&C!H3G
M6Z?-?G_%-=2Y*B>?2H/8+37JW?XYW(%'/N0IP)[C-__UW>EW#WLB?C?/@WUL
MYEF7>9:N;^HZ2(JZ#^._H_]M]3[\+Y95OUWI93 ,,KWF4JPV>!WZ[1@&I0=Q
M^:2/+XC+P9R"$9>'05Q^$^(2DU.&09-!-@;F&IAK8*Z[Q5Q'PZ#)P%P?VO 0
M1_"-+8^#L_CP^ !.X/!!F? #><V?8 K!/U7#H8MGA/*=%<]UAAHV9KPC6>_V
M*3]N;.2NPG;+9W)7SGD/9W0GUOF@IQ1.)IQ,X&.!CP5J"2<S9.W<-\?<33ZA
M@>Y^IG ,W@&Z"1TG=KN#^GY;!%I3AF1+AX9ABP=A]T#G4)1/YQ3N0&$/2$S?
M#X-R>@7/8YTB)<;M *-\=CZ*#UX<!)I\8C3Y?!@T.; S"])L"*<P;,H)TFR'
MI=G9:7QV_E!1MT"3]RK-[BV\%@SXX5/R^^)2U=LQX(.W>A@JSVW/X2FQUYW8
M\*"Q/(+&<G04OS@^"B2U"QI+$$9!& W@%'9BPX,P>GAA=!:/3EX$@AH 087@
M]3=L^[XSD#LA>+TCZL9678LW+>@8V&GMQ,%LO]8FJ"_;N@BCT5E\?C0([_^M
M*VX"K09A%H19$&9#(I @S!Y1F!T>Q>=G098]25(=8&%HUU8?P+D\0:*DJM 9
M0D%'6<'UH=1/'?^!R,B728X0T01E_'_&5?17N23N_VKT7\6_&X8[=6!7X^GH
M0EMU>_J<]G#_$%EM6K8$'SYD;6C8L;J[9OQMF<9N?KI!H;H/A2H^>W'^)*@\
M:%0#H-:!;7F0B$$B!HD8).)6<\^.3^*SD[OZ&(),?$($OS'!'OZ+70)""Y+;
M[37_'N=Y70L26XW^NB^@'YJ1;.6._]!2?R/L,+)$&'"U @,>(=YI'!4:VTN@
MO9RFI3;A(KI*ZNC[\]'^*(*)Y5E9Q!&L<#+#_G1U5J/_IIQ2/[N&>IWB7]^/
M#@[W#^P/J#]8DN?4,*N&!\?8DJO8H[=/9G R2O]N_UC_C%Q*/*[XFN2)4_-$
MQDWQ\!%G[C6\@9O@Y1GWE**&J=BD9>6E5]CJT[9(Q2[855;SFOS99'@MRLGG
M/>PIG=*3JJBIO5(<?7^P?^X^F<RQ'[;ML4I=LK*Z;JF5*/8&Y@DFDTFE]$/4
MF#2C[MW)DIHZ316V0<L3W&1IF(9-P6"?X9).DPEU'8GUIL)[<:-Q<[\?V>W'
MSW&'O'>E63V!BTUM!TW_TKUI6>W52>[V&N-]L\X^I[OLVKVF.V,W->7FM$GT
M_9FWGS =V$K:K@E-IL:%4U\7O3<M+)Q:>&%;-[X/WQ_M'YE!4F4'H4[+6>KT
M2=8=:&66,H\FFU/'L:G>YIOUGWH"C0>?'A<:W8H+G9U:*KL)%WIQX'*MVS"A
MT68FY%[!>^9!Y_MG-V9!+S:Q(+@$\ZR=7TOP-.GO.USV!OSLSHS"LH=S;P6W
M90^:O+%SHB%QZBNX\G/<\YQ:M.KNV2GWWZZ=GMBV;70?AX7IGGA'\V",Z &T
MT =D0P^L@MIZRJ""/C;S[U-!LYYZ5V;^1T>6.ZPR?\L^B8.?'/IL<]%6P)FD
M7_U&]A<[TN'[$9"2I]<MJG*B5%I'TZJ<1_C36CI=-II]7O>"+=%XZ'5N;MOI
MZ79[G0=-[YXU/0=!>@/!G^T?WIC>C\]]2VT+=.HS@N.1G<WM&$J0Z?<MTVV=
M2)#ICTWFAVO(?-I3R\-D/AJ=;;+J/$+'H0UIDW5T[I ET3KUW$8*A*^Q#W8I
M-A.1_Q4UL&^$+5";:^GL+GW<X]57')[OGYA7 -FCS=-H0Z/W36;PUY]^CMZ)
MEX;-*L>-IMTR/JO"0=47;-Y=T\!FQO!"S7.XG[#SQN"_&)I46W_=#S>JL73A
M#GS?G7]!UOD NSZ)_JM%]Q5OHK'=NY?7O>']=[CC&EA]R=JQVP6VHG=N-W]<
M+LC*IM'5?)&72Z7L;/C*+_+$$;I!IMY[MWCX5P5WMTWRZ!=@D1>)/:,W<*99
M0PZ+K9S#-RAD;WX0/Z"GS3F!1U)L3I_^GJ_;X=<DYWL4&7("MDW=P*4G65 V
M&)L!N3#)%O"O9$X1%%BNJNAA% C13\B77U]42E$(AYF^P]+WH_=%](^D:)-J
MB;\XBB7P4]7 =$'83V;L9#X\<>1 ,TMXK&E+@@C^FN1EC=/J<FP<LV\65I,B
M9PL\C7[*);W=76;ID/O&M<7H]<S;5,O)-?OCC=V1;['SP]70%YEVSB:0VQ<D
M2%+!(LC+ZC_KA.N,A'#OYT O8/18ZML.$S7&(HR:U+G'*]1!7@&%D1%-E\P#
MSCBF(4Z#990F#?ZUC,:HI#>L$@(=_:/-S4]BJP<2S9+6I6!B' ]H9EF5:C('
M<0JO98J.V4 ![6PRR]2EBB:J:A*,HU $P2J4L#,*E*-"AY.<58Y14<W0JP=/
M8"$&T),8*K!6F'R%9/(L>QZ=[Q^?_(7>^"R#/VF2&!N";Q/^\P-P"Q7]BBL&
MW@&T5E8-NVCQI;\E>1Y];& #F^@?L*U$N7E;1\_&SR-,6_K+/J@)!7I!0/V%
M38.#F2'12J #WV0FBCJB0GT1!G^GQI7AC%Q4<LTPEM^L&^<$6'GE?7+:.22]
MUW2H% .RNTQG)(>2?H.*YX-K/+_0A=^B CI\/\]@7.F_H&<!C=D*R[@JQ52F
MF0?0"O"C0BQB-S&%HYS.D96=(YO8(Q.M0;':4^9Y>05\[>6.^# &<Y2@9;X&
MWI@#OQN=QRA9*-Y#/!R%PE49)5H" M_&P_C/__@"#T]>?5*7B16/-7^<OGH>
M767-+*)O/\P2F/U$M93$"BIMVF(Y'TSSIP:$BCN2_3E+8?9YD*2C.Y8:]KM(
M&IH,.2A@LGFN^#8!MU[ ,TN^<ZR+TPK@BXLJF8,H_-#QS'760!LP*=L\1>$M
MMY,O+^K ]'2[P#^_/SUS''X\907\7[\KACM;18DHK:2B'IVX&BUY.7 *(C1(
MQ4!7B*QRDF<%;5H*7^;E@K[7-(*^$?C*%?)PD$F:9ISE@=M6K5M D]'Y5N4R
MR3F5HXE@WS#0EV"B2<;S H(#4MF;9VF$!D2N]M+L(D-I6D17996G<)T4.9 X
M<(*:=TZ'D+:3AG,F8"%:[:=78RX*D@?,=ZT]Y61F<![(9Y5GL[+DU!W:+#VF
M*W[AT0M5Z$02F86.Z<!>M(7L[*ZX00?#0GZ#NT))+>5TFH%>13.AZ\\>Z J4
M0E009RI)0=D$!;&B2_815OT.55Q,,A022F0HTK?4EP40/CWK6,(G&^X.#"(9
MBW#!IRWIZS#M; Y:*P_LZH2N)0@\8TYZ-*<DT</AIFQ?V'@\BD0-"QI'R C_
MX;D@-Z[8#3QN@0^INF;YHM4(.+@:] S@O&5UD122?0:<W#P TVNGJ'"0J]Y[
MRDF^N@0[K82+B??6#(E?N_P7EG<)5QS8U\<6O[:39MZ3D\>!; 8:"*TN,,DH
M'XX8_A58B+ 9L+@&267<-H9)1VW-WI9L/J8ENS-*BB4R184F"N<%@WJ$Z6)H
MFL EN)C1GI'IB3G"]KTAD63KB21GVTTDV2U#<"L1B+7Q!DR60*7H-2=K(D&_
MK8$PX-[OB)$W)/<8VGGP,%QJ9'*LH;]X55-90%O7UMF:Y,LZJW5*K'BAB'D7
MS.[I.6"K;<ZBUV;-1O [3E06T8N>',3+(;W5#E4W\(%6TLDVF"67P$&5DE1:
MMEDHC;=**;!(<N)?188#?<2?NVP:GE,+_":Q5TF<1+EVFO&XB5-Y4:OKYZ>M
MXEHX^CSY#*).WU+>L;INYQ+/)%4GF4[!B"$>;IQH[!CGU*'^O&AV%2HZC[RL
MR3LYE63E"R>3>.5WM2XD,0)C=H.%Q6Y*M#=5DUUMI%)J ^/\%.TOW+82E7^\
M6,Z.P+R]*S#+0*NOB-!Q9# 8\3A)5A?190*#P,Z*QQ,$.PI)CGS@?<C)+XIC
M8JIU65 N-VN7M,JLFK1S##5,,'N+)VCN)=\LD+@<HX9992R X1!Q!7^TZ04?
M<C(N6SZP25)52_SR,LE;M>&X^*0K5&U0;4E2C+(D"[RZ&)Z@N#TMJH9-("WC
M-1NV>H+H5$XS3$(Q8?3:O5J\2GY"CM]<,U(<A!IAY-_L5AD'M$L)<!$F.&<A
M=<Q7 "WHBJ8_T5RX$;7=!F[\P\,-$"T<3A%W%7<]ENN#VKA^#7N)M%4^+^$7
M-?#2# P*M-83/$I, BQS,O[ZF))S-)@A()O2%^!Y@CK'SA0?#69'?YME.>=(
M>1>MAP3PRJ>JAEL_9A'#U@D2G,12KQ<)XLR$>YG7ZFJ&I3PT$'"7UT6!-/XK
M<4ED<.^0^XP.]OX[=AF:H5+C"[5TN&[6<[ 4HFR. XO/RR=7(A3D6NPTP:48
MEFZ7(=QG-X(:-[]_#YQ*\UH*E7YU;<\?'-OSK<C8W5!SA\,'4/ZCRKA:*H9R
M7\L13#%5QB=+?EC]1U-E\I'Q&Y@AG.@'AWC9?Z#%(8I5T")0'UA2X=AE"5^G
M7K*&]F.(W\.\(RM@:DW;]7;TNT/\&6_RB'"D$S0%=)]R,CS*6F_Y==.FE/N^
MN@_RH9F%6;&H=F,U2_+I?O1!^^'(34+*@'G4TP<;"5Y+,#C-+K,4^:7C>\$7
MZB0/\1P[FI+#WD'=,NF'K(LB%V:=SSL>KK749[117]4*:$T.(=:+K\KJ,_FZ
M<]5@S-XFP"Q@EW&:JJB C=.,<Z1QULCF)1@KL!]KGY*]Y3LE.:-+?;DH+-U8
MK7<)P@",-%T)269(OY)$/K=4L==(J^V:',9)GDBXG (<776^NSODI>_69'=/
M=$H7FJZ/JX]'GXORJHA$TJ'#:S]Z/T4Q2()+OP25V?+2^9OB%;A#E"ZZ2F2E
MZ/[D.3.6G'XPEOI/TK7-G#D,Y*K;I;M.\D++;WC<,;"1N>(E< @F19P.75SJ
M[0C8ER497_0@6;+(!*RUDWIJ"=?+UKI@UMOL'L+LY4\X Z#/W1#C0TZ*_4C%
MUW^CZ_[&*;X.@GO;@GL.K Z-2[?$W16Y&(]$7PSFI%\E58HY"DDA7^H<<B#_
M- ,:0B[.P@M+[VV&.3,)[=;'9RP[7\U,=_!J)9N]P)BIQ_RL3C%-LHK=!L3_
M41$!HO^3@@=3E:'E7(M064;E9-)6P0[<_C7RQ(@]DF[I@;Y#<HK:=497*C:^
M.+:6S.7H!6%H:RUD_Y;#CNU]G,Q*"J'3>_86<(%(B2E3E;,GDE["K[QV@IY_
M%'Z(9J=43\;H;36W#/V0E"G+0LF9%MSA!#=_#V0(DEDSP_#[I;C0R+]9P[%9
MXF!E"N9#*@+-0T\C<[VN^'-=R6E_)/NV4!/*W^-EA)N^_9O>UNJ&UXXXY.WH
M@BP'X_O&W[12O].._]!'ZSJ^2Z-S]KW"8]Q$!;7_>_&I=%/"P$+0A^2V6,.;
M<O:7;H^UO[Q*LWJ1)\N7TUQ]616S K2F=Y&> BT@J9I7=#?VX$CG]4LD<B25
MWIMDS\.=PPY=+6]/S89F!>[('NWKQO=VJ7'#GKM;>79R>'IX>GIV.!H=G1\
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M\Q)\S:;%N/UADOY]/%MC2Z5A"^E>UV502%>[##X>(8T"="M 21!<.D-!:I%
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MK-U#,]QJA4_TMKJ'Z@$KU# #MKL*M3I6LBKSYW 4'RX8[&NN])<Z(J=^B3=
M<,3TUG52-01.LR\"E4G7=HW-%IP-!HQUP05!B>07VF?<);U5*&J73>L)4[AL
M.W04'EH)&NH7C)PZ(@?U"^J7QZE?6'(F2>8@$\M!).K!DJA!QB@9"]);IOM(
MM>U0O]AB7FP^.GP0QJJSQY1SZS:"%V Y+%]^D!;-[&.:?-<FX;[?;A!]5L?R
M4F6>KDG-%JNWK_SXI,QP']0G]>NDFMR$KD'7()(ADF&XH&L&M2Q^WL;;*_6G
MVK<&;Y'IY.(5@.( A?P_%L41\W+=N.GRLEQ,W$<WFSL_3U"F[="4J7VY1CA>
MS=:SA(OLM9/AX\V/C,+@@Z>U 6(@YIBO+><TV4?9GBGAC 4A(@5'NH5RD9,*
MT2AYX635.QWOWJ:47IS/*)VEG)^?4-*OR]6[0DCO3OGH>?SOXV9]6![@=5J_
MR7^X3_VFIYG%'='CS$VC:D'54H$71F%P5"VH6NI2+9FGP',,1;5(#L)Y ;8\
M''!)V^9UPL30RR:4.E6+IBA:1BE:=K:@CMFZ(6!= 9+R/8M)P9%56H3/D_7*
M+9IYUT9JXDY!Y:Y9.ERRJD-^X>;G2G4Q;G[&S<_7ZTZIN5(I.M#>%]WI/0-C
M> 8>A+>*4T)#+R=Q7:<[MRSQ8DL2?[0<L;G)YXOXQQECW$>%7K<CA>..:01$
M5 PU^P$50Z6.0<7PV!2#\50+;B40Z@0(0QQX670 %5*:K ++PNPZ4[5OQ8 ]
M5L8!B ]23,9VF9YBF)ZZ^\#X8[EV\\V!\%_M#<'^+(.7F+VN! Q48M:]8E#)
M/NCQ:-0!0C"N"E^KM8GB(28&,>16-SL"AF<-7!<-S85K.Q3N.CMW]Q7?GYBI
ML\_+T(5RW;".U6LHG% XH7!"X83":5_"24NJ.9,6C",)1&04C*8,F"-!6INT
ML6[72<I[""<I4#<].E3'CC2/*??XHJ]\(RYIUR&;=[B4PYZR%FKC\MC/$PKG
MAQ?..UT5O\Z[*)U1.C_T3A3*;8C6 5,Y@PBY*.! RZ_"E%\D%X2H/G*.EZCF
MW6PN:3M.<]I;R\:'Q7G4U'BL&HHJ%%45QQB**A15**JN%U7$6,D4ST"$#"!D
M#&!\]."$3IR[3+P4?>0C'TQ4M6VP=6^KNZBI!H3WN\Y3XFEU->'9R6EUDZ-4
M''O@5FDZ\:Z9A8E;Q$F<S8_7*=:Q'EF9LX>CLG>X2(0J>\QK_JBR4657I+*9
M89+*[(&*F$!HZ\!8Y4$I$1D/)!)_8=7_+JG+EVZUF"T^-&_3ZEW+B#^W?/BE
MOBX_IOAN[=:I>9.?'Y:'">Z7Y7SN5DWWD5/U3<ZK;W8[\7WYTPM*O$TT@99>
ME?D""V"#UB!,#HH;+7/J92OWUT__RT8#/.#SLZ?VLCW;U5=,X%RDEOPN*D]4
MGO7XJ^X80^6)RA.5YPW*4^GLG<Q "2_:*P8+5MH(P@D6;=+!7&PZ?9?\;IW*
M4[?:6B8'FNH 0H@$EC@'T@K-@M62RUY: NQ?>8JGPJ#R1%;$:MW'E07_9_<M
M*8(KYG4?TB83WDR.FQ0GZV77/:! T61Q,5O^=[^:_&VKDL__V5<2'4M5ZIC*
M8*G*XVQJ->R9""KXDT:8TL2HG2EZ-!L0N=TQ9J($FX7,5A@= ^LC>WK"),\W
M1/+Z^-"GU9O<2=/FS?&Z61=**"+WHK+?4,YYT4KNH-63+F\0O-QSX!F$3^6>
M!2/@G+'<$\$HZR5'?L5S;B7[A<>]UY-R,35$3;FX[.P;K%!!F$<E5+,?4 E5
MZQI40H]/"=&B"4S6%)3QOK"]"^!""! Y"RH8P4WL9>_\OI40C47.<$L@AUA4
M38@*?$H6E&<B4<\R57J'S[D3)<3*R+*F*"&"2FBL,'^29"Q_MX<U=3]>99&_
M/C:=<G=CL/L:XXS7!I+LW'R^O<UGLW5YAG!UH]2#-"D<L#PL#_:Y8-1DL5R7
MZQ9LFI0GG96W?5BY^>3(K=:399ZL#U*36N3LFH.X@G*3/%NX19B5-S7MTDQW
MZL_37OQ&O]5QVP\,V7-7^4GSKTQZ<+H,<52H9P/4X')YVF=N_J?[W/SP9/*W
M?2+(PYG>+^=Q9X8WUL^6T\FK1>AG4/=FUT[KG(_$]V?Q5WY<AG\=%+ND5?,^
M_?MXZ%YX<1YQWIT^Y^2RTH7!/5S!U7?G_/4__N,3(]3^,'GY[^/9^G-=HVXP
M0'I["OSNU:+PVO*X*2J]F4[2IY#:[E<''0<>EH=;-]_7X80Z15FG54]NYWP'
M>W>\7I[, ]H;+/+B&?FA>SO,W>?E\;I<_E,JDXKNJRCI++C]0&@+.XZ:]*Q)
M17R4@#\Q3C?%WUS[R=<K\A]GS<S/YB5JGIU\_I)U^<W7"?)4*_[7UIZ7S9$V
M;R)/#6,WO(>V=WWM.]13*^SY_]W[BKW=%Y-X7R.X+T-KN1==HDI\XU6N*:XQ
M^]EA^HT+!:8&J#?5Y*+1"P_CA6+S]I5-C2-ZI */H!?0"^@%1*<Z/8)>0"^@
M%Q"=ZO0(>@&]@%[8,SI=8J(]>6AOZX>]^OEY",>'QW-732NMVAU<41 B%-;@
M!11JM7D$O8!>0"\@.M7I$?3"GKU0[6HN2E\,HJ$$$68!,%+0+T/Q"R(8(AA&
M"OIEN'Y!!$,$&_E*3(RS=G>TF]<1<;7[MZ(81"2LP0N(A"-!PC?K@[2J(]AJ
M=VU%X8<@6(,7$ 0Q4M O _ +(A@BV+AEW!_+-<YEAP2"N# ^:/<AAU7CA5,.
M4P_,85]V-21/VZ:&76.BJYNB5AE10^.Z%\O#P^5BTR:ICMB\822<_SK2=;>L
M?4A4%-X(LC5X 2<*(P'/MVX6B\WJ"+?:G5M1 "(,UN %A,&1P&#1D.4[#]*B
MF7U,=01=[2ZN* P1#&OP H+A2, 0]Z4C%"(4(A0B%/YT6>_U.F*O=D_7$8VX
MK#9H]R&E5>.%O5$:+JOMB?JZ0^CJB$I<4$-X17A%>!T1O#[?G!Y41U@BOB*^
M(KXBOHX(7U^XHUDU-="(KXBOB*^(KR/"U]^6#8I7!%<$5P37^B-J:.#Z2\JS
M,%O7$9:(KXBOB*^(KR/"UY?_/IZM/]<1E0BOE5=^$#UE@A0'L/OYNYB\,@@>
M6MC^[.9N$=+$-9-EGOR20CKT:37A=#IAA)$[QG-?_D66O8_6^58O+):#\<$8
MS'W[<K8S4KB5"RCIW0>K%HAZ=L(NH'*Q7!VZ^:ZB\>^S3^4;%K^N7&A;FTYF
M\<<GO[Z7(@:?M $1,@5AC00OK0*=?5*"DBR,?#+IKO)I_7O*/SYY\9Y[ZJV-
M#)04 824#ASG#@1CTC(7323FR63A#HN9CQOXX-S1LTWUT)OC=;-VBSA;?'@R
M.5[,-E?\Q_NF>_7))*8P*R9H?GSRZO6O3R:Y-<CZQR>S3\4XQX=QN=Z^X<E/
MU$YMP7FE"LI_^6 _(> \0L"IR^#(LOOWP1T0^N' ^"]U1 W2]$!H6M$@%,T"
M$F$,1(X"'$L:I(K)A"23<+87FCZWOV63%/F"I__Q[I<GDZ8,H_(1?IZN@3_Y
MB2$5(Q579W"DXOW[ *D8J7@T5.R])3P76I4Z$Q!"!?!:>- T1FJDR2;SKZG8
MAE1(NDRP.2.\S+)I!!NHA)0,E]%G(8WJD8JOFSASIJ9$**1JI.K:#(Y4O7\?
M(%6/@:J'Q[7?G;@6%<<%Q<&RB<PP!\'IHCB"XF LM:"5E\X%X[UF7RL.8:+R
M+$5H4_AERJ\56",UZ)P--<*80/N<_$^:,A;+3T]^HI@%&#C*?E\'RM;E,=0F
M^_=!U5&#V@2UR2/4)M8%+7T(P#G3( Q7X%5.4$1&5D+%Z-F%A0D=)*&LO)VP
MQ$ D(<!SK<$D18E-6DFB=Z%-KJTG8'Q*K$3M,FP41NV"VJ5*'U0=-:A=< GD
M6TB?"*^E=A%,( :$M!F,Y:9=TQ Z.9ZLU%^3/K6"FD+S8%V6A?0]*Z1O'#A+
M-,E!6AOE RV!,,*F5E'D^OJ60.KKS_DX=FGL%D5>-<UQMU%CF0LJ=*=S-6UH
M3V:+B5O#^B!!L<._TGIR=.SGLS#YNU]-_K8=)N?_7.9<OFCQH9E.%N7=Y7*S
MDTN'95-+]ZRZALM@U-^W>@%QM*;-Q"C>JH/=*W9\..F(R R4=:DM"\W@=200
MG?52B& <SY>4DAKC+0/"F2^?T0E<Y*&(-TDS%R13ZBX5;RWRI_C+<0O:;\O-
M+N-F(TAYDNZEYK[;0(R:ROZJ61""A@Q!=1D<>7?_/AB#N7?&N_V[8"3K/9N#
M/03&TV.,I[H,CB2R?Q^,P=PX>1L:"5VQ^8 &[YSWH(UR92+&"!A/*'!N'352
MA^S-UY,WR6FB,AB@21(0Q'"PR3O@A#&29="!DEM.WO[+S8_3Y7.W.^]'F#)C
M<?Z&*%2;P9%Z]^^#,9@;YV\X?\-X0A)!$L%!CR2")(+Q5'\\U65P))']^V ,
MYL8DX-!(Z(IF8)Y+9K0#1B0'X=KM-D2G\FOP/%C)7(I?)P%=UI:9*(!RHD#(
MZ,%Z%X%HRWFRH=U?C$E 1"'LFOZ8ZW&/C\J/Z5-:A5G3O;KYY^51&X]WK:[%
MO54UB 7<I5"UN5&;#0U$K]@/'8PS7!B0F1D0.1"PA!C0TJ08G)4Y7.C5XDST
M7HORY"Z)MJ-<^8S*%KA2++FH='3?5EW;O?AF ]HOMV@>[UUI:XI(P[YQ"$?5
M&1PY>/\^&(.Y,<D^L"0[QM.0XZDN@R.)[-\'8S W3N2&1D*73^1H4L83GH$R
MY]K3L4R9R!D!V7/BLS,YB0M)=LU#=,DID%%F$)%3L)Z;ML=%#LJW$\'T+4GV
MF^=QUQ[((8S&Z1J"3FT&1Z;=OP_&8&Z<KN%T#>,)201)! <]D@B2",93_?%4
ME\&11/;O@S&8&W-^0R.ARW-^SFOM5:#@HXT@='!@DDC@A<[:"J*XOK"[7GM.
MDY ,O.,>!#4$;(P13'8NL6Q))@%S?H\==+"O[<U.&1Z*7%]'^_+=V[>3H^-5
M.'!-PM:T0]9?N*6@:G.C_AH:<EYQT&%DWBG;-I?5LF@I6O27S!%(%EXJ:R73
M%\X5Z+UX]N7AT7SY.6V$V-LM?+^=N\6]>]62J:8,=SDA)-5F<.3A_?M@#.;&
M9/K DND83T..I[H,CB2R?Q^,P=PXF1L:"5V13!=!)Z4,)"\9"),EF$P)D!@3
M,Y:SD/RN"VBOG,O=/J%.A< I&P)/;09'MMV_#\9@;IRRX90-XPE)!$D$!SV2
M")((QE/]\527P9%$]N^#,9@;\WY#(Z'+\WZ)<5G^OWB;V0R")P:.2P5)"LNR
M%UQ:N^LB6LS[C15XL"'MS4X9'I)<64C[IUNMW&(]F2U:Q%BD#=#\.5L?3 H%
M'$[FR_+8V879?+;^7,=NC[K&PF#4&>XVJ-K<.,4?V!0?XVG(\527P9%$]N^#
M,9@;201)!.,)201)! =]?22">>('S1-':6VR@H(PUH!@*8/11H"CWG@7VS:K
MX3[UH6F]\,].$DMO\HLNK=0EA/^Y22J]6KPX32G]<[8^^".M#G];NL6OVW32
M[7/%4O>6*T;P&3+XU&5P9-S]^V ,YL9I&T[;,)Z01)!$<- CB2")8#S5'T]U
M&1Q)9/\^&(.Y,?<W-!*Z8F^XH]+[R"$(+T%$8\!P9H!:3G@(Q!O![U,CBKF_
MQPX^V'!UC'6B70@7 &A2;.M$C]*B<6W$U;%%H2[O#D9S87E\U>;&B?O )NX8
M3T..I[H,CB2R?Q^,P=Q((D@B&$]((D@B..CK(Q',_CYH]E=$PQ-W'ECB"@11
M CP+ 8@3P1!FA0VLC\Z@S^-_'S?KPW(KS1_+YS'.VGMP\[=N%E\M7KBCV=K-
MNS,?NH32BW/YI-_3OX]G33'=N[3Z. MITUK@]Q26'Q;=5;HN [=.$E]W*H29
M*FVPTP "6&T&1];>OP_&8&Z<^N'4#^,)201)! <]D@B2",93_?%4E\&11/;O
M@S&8&_.'0R.AR_.'FF?!E1; 60X@N*1@2#:05% B)6)4<GUT&,7\(0)8#16H
MV*FT'D1ZG=:3^;)IZMCP4)<W!Z/3L-"^:G/C9']@DWV,IR''4UT&1Q+9OP_&
M8&XD$201C"<D$201'/1((D@B&$_UQU-=!D<2V;\/QF!N)!$D$8PG)!$D$1ST
M]9'(0]6N#(]%OCMQ+9;@7"C!D3XGDP4';S@'83(%D[('ZTT@(@D5A/RZ!$<Y
MGZBD&JP5"02)#%PF#'BD7(E(F!#VZQ*<UVG]:A&6A^FW9=/<OEZF*<.P_'1M
MX8PMUF4,>[?MHDCCX8;G]W7@;UT>0]&Q?Q^,P=PH.E!T5"0ZG-<YTIB &4U!
M,"?!*F*!>6FD(4Y$<T%TW*7N%T7'_N%S>*(#.\[NQ*M[1J(WZX.TZGK-KM)!
M6C2SC^D^];^X3ZL&'=3K-@=?WIU69X:21^M)LYS/XN3+@5R7K\;@EAN"X[:.
MP068VA9@'C(^SW]9<0<&*K(8LABR6#7!@2R&+(8L-H! K<O@R&+(8A4%![(8
MLABRV  "M2Z#(XLABU44'+MG,5P8QX7Q;U\83XH9*:D'FQ0'X;4 KQ*%9(@5
ME"1JPX6&6,P0(F**X#P1(#*C4)Y)@B.&NL 2,]Y\O3#>+8:].+\6=K9._CJM
MW^0_W*=O7R__2?9V@BJ*E2&OH*/:0;6#:N<1J1V<L^.<'0,566P87D 6J](M
M>V<QG+/CG/W;Y^R!)T*]]$!L9B"L\^"%IA Y+]0?DW!*]%',CG/V 8F5X<W9
ML<OU3KQZ(V3YY3SNRM$_N[E;A#1QS629)[^DD Y]6DTXG4X88;2.S6=UN7@P
MHG?$6X;&8.[![[A$=;=1=]9F+VB&3)D$(;D!JP)M#RLAS-*HO>)?JSL7,G=!
MY_(F43Y#90+/K0,CF'36$<>C_UK==<>/-&^.U\W:+>)L\>$+*==TKY[7<*]>
M_WKM_D1&IIR6,4MZDW<(.$,&G+H,CBR[?Q]4/47Y2QU1@S0]$)HF(8ML.05B
MG08130;+6 1'DG):4VH"ZX6FU\OPKX,R94NKYN6_CV?KS[=.N11*1BI&*J[-
MX$C%^_<!4C%2\6BHF#+!E4T4%,N%5I,68(,30*)T45HAA;W0W(>H8)*G#*2*
M#D0F#IR4&JBS*1G!8]*N1RJ^;N+,N9TRVMM!G"-&K3&0!%)U#5X8T*!'JAX#
M50^/:[$"XQK%$22E/!M00I79?* <',NI_%$D"/$AJY"_5AQ&Q9@L)\"#82"B
MLV )SQ I2\X*YAA+?2J.TWH+A0GY@:,L=BI&;5*E#ZJ.&M0FJ$T>H381GE!M
MN 0O9=$965@P+$<PI&B,Z!4/2ETX7R%$DZ@1D)C@(!P/8&B[HN%H\CD*KI3>
MA3:YMIZ \BFC&K7+L%$8M0MJERI]4'74H';!)9!O(7U-4I:*"L@R1A"!27",
MM$6#,7H1)"<L7&CC0+-6-B@(VI3/T$C MZ<CI,"CY5%'+O@#+8%0)J=6(M=7
MN 2"9Q/LA$KVC"*OFN:XVZBQS.T)!8?+]EE*:$_<(D[^=*N56ZR;R6PQ.3KV
M\UF8_-VO)G_;CI+S?RYS+M^S^#"=+-*ZO=CLY,)AV:SQJ(,A:[]>=]?5Y8,Q
MF!NEV]! ]XK]'D4%"9XM&,Y:Z>8=6)(5),V\(TF4U]/7TDUR$UGRY<F=4""2
M5^"(MZ"--MPJ+6U[G-4ETJW%_11_.6XQ^VVYV67<; ,I3]*]U-QS$P@UT_+M
M4Z%4E7M\$860>I%Z<= C]2+UMD=1.^&<CQ(L]00$T0P<I1H*E2K'N>:JW8^Q
M,^K]+S<_3I<S[UT3*?WM^$ (&C($U65PY-W]^V ,YD;>'0?O!J6HED0#"T:"
M<$F#)XF"44(1F3.-P5S8L)&"UJ*\/7%:/F,#!^NT!1:),.4U):S8'^\:,V74
M(O<B#-5F<.3>_?M@#.;>&?=B)^<KW5M/)V>,)R01)!$<]$@B2"(83T.)I[H,
MCB2R?Q^,P=R8!1P:"5UQ]!S1Q"?'@<7LVFYH$IP1'IAB)BMK/3$75M]""%P8
M:<#)2$$D2\!X;X'DK*+A07FB]IL%Y)@%K!"&L-?\S4X9'JY<6<4\6TS<&M8'
M"8H=_I76^RECQBUL-<@+W Q2M;E1S0T-=:]J6R]2YHY!3H2!,(F 4Y%#,$JG
MQ(B5_,*A1,8Y0@E-D+S)()RQX%V60()7UO L3+A\!]JNRYCYU HS593BCC0$
MH=H,CLR[?Q^,P=S(O.-@7D&)\(88B%ZU!\;$""ZH""G&)(D+3G.Z0^;=01X%
M&]8A E5G<*3=_?M@#.9&VAT'[4KJ+'?) -=EFBL\R^"LSV YCX13)7F\< ",
M%=DR90C0S @('3B8R!@038T(U&8A]EC$S,Q4B-Z6+Q"&A@Q#=1D<N7?_/AB#
MN;'^;&#U9QA/0XZGN@R.)+)_'XS!W$@B2"(83T@B2"(XZ.LC$<P"/F@6D%DK
M!:$:C&<4A @*G+8"#*?,2!6XT!>Z]W%O+?=1@*.9@&#9@Y4V0B3,&VT)T^SR
MTQ8>+ LH.68!ZX,A;,5\LU.&ARM7%C$?'Y4?TZ>T"K.F>_6D+W,=^VSJ\OM@
M=!GNZJC:W*C+AH:?5YS0F7E(BED(E 40*0OP5"HPR8BLF%%67=A<1C*7614A
MQK/V[8HN!V,(@Y0H=UIHEW,XT65IO?#7UR+_<XO6+[<('N]9DRRFC+"IL+B_
M#)&H.H,C_>[?!V,P-]+O..C7Y62=X Z2T1*$(H5Y2120'"%>!2J3O+ ;J"_Z
M[7(BU[/OW@N3$8:&#$-U&1RY=_\^&(.YD7O'P;TQQ^B324!3L" LMV"5(" R
M8U%3'D*Z,/5UVNOH=(+LB6L/C?;@.#6@)?>$^^BB$GOF7CHEVB#_(A359G#D
MW_W[8 SFQKJR@=6583P-.9[J,CB2R/Y], 9S(XD@B6 \(8D@B>"@KX]$,!/X
ML*MPUD8A) 5NH@#!G 3#HP)J<F+,^$3TA54XKZD(1C,(WAL0)')PQI.V49!.
MBEBFK-E_)M PS 36!T789?EFIPP/6ZXO4 ZN.9BGINFS4AEWD-6@&G#K1M7F
M1I$V-""]HE(YFJ0T-Z #:0_#)00,D1:8X81'FD5P>K>5RB^V$'ZBTM[D$]UV
M[S;*5/"IZD^L(20-&9+J,CCR\/Y], 9S(P^/@X<%STH*JH J$4$8Q<!;SX#S
M8#.SVE.G=EJR?$L:OFO6!+=T(QY59W DX?W[8 SF'CP)#X]%OSMQ+6J)2[K"
M4&.\R,"(+%I"9P(NL@S!9^>,<D&;O-,2[#ZT1%,&:_D)1<7#9_P?;OQ^7P=
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MIZ$T;X[7S=HMXFSQX0OIV'2OGM>,KU[_>JU6E&0J5?G/DBKW2]X8*;6+QD>
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MN5GLY/MR?9!6DW!<IOV+-:[C#H/\'F_^9!0&'SR-859VFY75G(DDHP:?VCZ
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MZ7%\9R <*T59($V5P7>8&=26)QKENI"BD)C)/#N?8^:%D^,.JIT$HV4QY&2
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MG,D<R8(J TQ5C 0M$J1EJEBJ"I62]*3 ]#0]BO&"9&&.DH 0:?BR+[ M!W
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M!]X"WO*\-9<:I)ZW7GJ&^G;D,=EG).?#=UZ,3KQ\YS2=KMQ7!H5GV6NU_>V
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M6MT+/"Z.R0(;(MQ:=(.1YU^W!V0'/NW1]_O\[-&?NL$07:;QS48L*VE[^WC
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MOFVQM=^X]%#F>E&[779OMONTSZX@IH-XVTR2P=_HBFIZ,+GG.[ %2S;:V3L
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MW%LVYEN-TR?<Y7\[;X;YH]N<;GYMYQ!VS4/M+WW(L79MV/OQDN-MW&^_XJ8
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M>[J4^(+2KB"Y:6IJ[W_ZE*/)'(4OS^9\DES\:  5./IQ./I%W:XGS,RA'X?
MV!O@4BB4 $'[Q 3M7WBU"JB+"$A:D+0@:4'2SE#2_E*W[5?5R8.H!5$+HA9$
M+8C:^R1PZW"8$R3M='L600/,QRV[_6N]TK>1>=??]#HJS<JATU"8=;Z/10O+
M9E\J+\] F-G,U/K%E?@G 5 8N"VPOEZ!40*Z=<&@@;GUX.(Q85FFS&MDDB#"
MLQ@)00AB&4YT46!,TL-! Y+D.>,4Z5))1-)2(X$+B3(BRU2DF5 %^UP/KMW.
M6T,]G@W'_F";OYRD%Q=.%J0H@FW%%9AXFXU. ?T>#BVFQ "@WV>CWR>HGWW3
M- +,"=HIH&T'[10*)4 [@78"[10H<\Y&(H)V"H<64V( T$ZST4[@&^U\HPE+
MN/D?0TK)!!'.&:*%CA'%/$GRLI0I.XMO]*SS"< G&KY>AVFK,T\V>5%?7^O&
M]<6_X3<ZH%8*@=%V6@#OE$P&J2;G2C7! 5 8N"VP6<:!46(VFP[6T/3$Y'%K
M"&="\DP0)$C.$9&*(8Z-7504DN:)%#P7\;XU) HF$URD2!2Z1"1+,.+F>D3+
MF(E"J3@E(HA,D8PM<G)2JPBDT_2E4V#;#NHY%$K,9M,GKYXGJ%Y/$$H#WIH^
M;P6V[:!<0J'$;#8=E,O#*Y=OCTU!!1NVLV%3D@J2*HY$6B:(X")!E*4Y2@I1
MI#*CM#RL=CB##2OEYGJSY&NM_M+4;;MM,6];=_R@C9VJW_*/IQE''H-1.X<,
MAN_"D=N!T0V 2RB4F,VF3QZX@,+O%7[&BU0+AG J,"(QB1$528Y8G"9E0<HR
MI>4Y%/Y94WBLLSH%9W704@GZQ<P\A>?=Q9N+Z+(V>[NZ-G^)1 TM8^8"TJ!E
M3-B\]_5Y/,!MT^4V !\!B3@PB<(5D\=-(D(Y2UD<(\;R A'"*>(\RU >%V59
M)@P3SO9-(ESD!<L41C2G,2(ZT<8D$JGYCB!E0@N1T"2(/!Z<+/(<0W4#2*>
MMQW4<RB4F,VF3UX]3U"]0DD\\%9XVP[*)11*S&;30;E 'D]8-BP7L52E+A$G
ME!E[5,2(ZJQ$1<)*+G'"1"$?P(9]P#P> D;MD\_C > R71TZ)0Z:S:9/'KB
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MC.>EK?>EB'/&44I%EC-)I%+E X",!YP*B %S .8 S#$10@#F ,PQ$\PQ0<P
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M)^LNKI+<E&,N_W_]=AY&;=AGX(H,X"UZ&[@JK5P/0[[U;-D+$"A H)^,4H#
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MAA#^.2_5MKFDE-:!1&\1)I$C'AU%!@N#HI5!&&^%#1MBX"YS25^/S\Z::>J
MU;X:^==PO6;T.8P<R(,W3>N&XW8V^=[9I#<2<[-C=T^=@U>:QN]W0XB3:F7U
M<V7=VOKO;<3H@[[%'@:,UL]J.W3GIX=\V4SA^=W.I?U;,%=\Q;T:!7R#]-RD
MZE[54J^6X@#1Y_M1]5<SFIG)144&51H>-,B3CT$DP8M=5,:/SU.3M%<?7U<
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M\632Q8(FR=DS:Y-G9PSX);% ,PKY"E>C(Y>>FX?BD0-<]1W-#8RS*D2!=.3
MU<X V@S1(UP35GLC/6-[:1NYC:M3+D@*B_T!E%T#J^>S25BB5417X>H-T]%.
M=C>R.G"F^>%(WJ/X8G;X8GSSY8$UN/"4:QHQHBJWI8L,6>4L\C7ST1(2')7[
ML$8_NM/@9\/P/KZ=38&5?P/5?38[ZXS3#W/[ HR3=6G0?DI6R*ZLL&7PW;^:
MWO9=_DEV)9,5%]?M.Y,] W@-KS!718 N8MZSU5FW::]:Q2EAHDOAV I=@.?
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M&]L $7)N8#13V++&-8"6+D;34P!Q)]6'V:2=&;A*VL'PT%=X;9VSSPV<FX\
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M I)Q0J":!A.Q,:[>Q':,U\$ZXI&H+8AR6TNDA8O(2QQTB#$2);_+._9IOD#
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M.8S")*.[+P' 7+Z >4RX)ET(0@N!%!$J-6*HD06TA30AEE+KN9-/NPOS7_^
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MT@5UGU86\\5P)#&:0;\_M[WT("\EB#:XV;<D!@BE-U3Z),80* -06"% 8;!
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MO8X%,#,;]B/F%IE)8C2#7F)68^$!$D(DG;& L%3:"GD(# X4*",I=5AR&\Q
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M^RXWZ\FMQWD]=[\LHO+O[;>\LCOYSW<_7FQ.)KM[DT'\JXD:&C_=6GRDU\X
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MGU5NW?9KL!?;Q/39V6*9..!I/#>#2'^)%91UKLP@LZQSE5C!C;&"@+4)SAC
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MK)[SI;>+#_-X+U=%7E=M&%US*+PWA!>J=I4E4HV^&-$%\]X0F0WQ=CI09V4
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MTSFE5VHZ9M3-N[I&*2I=>$ONDAC-H!?>4GA+7KS%2L@L$1H@8RR@(37+$(P
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M<SRCBA-I)67<@JC7*&V)Q4 &)(#U6 8BG.$87E=QYA76LDTQ4*E&7/3\RJ,
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M(8_<;-<M1GX=5?XC L O>7D/O@+U/)B F2] CZ,] -,08G]6& A,%5<&.Z\
M: T"63C$$S9.?9D:EG.'%0< ZZH9A5'<8N]PUSS+MM?# HK;4%8*K>[.698J
M\8#[\]B3%@DOP.&$P:(\5XYI R57W1 W!-8)PH2);S,8%7X7"R9D9S&<XX3#
MHN TP%M!RGEP&UR6C7)M3%CMBR<"<23=>$'O.$'W%9_Y=./&K6T"7RM6\KKV
MA3I6[J-CI?U@12O9L5)71MS38DAG%E9@.AP,G0D/;D4\](*AZ\4\CY#$0]1R
M0^XX94%&6[.4,$\V:+$S-5%I3, 0G!<GR_Y$E7[J..&A?,47G7(:)+(_,-@6
MG!/\F9N_)7" ^2/82"/1VH4U*;R^\^I_!.CPE#>JS6#9?@SDGK;R%!03'^(@
MH]"/A[)4P$TQW59RP52ZZ!2443:W2J@;J5FN%T3:29\\R5*ET28'=NLO[KB?
M\MP[6FKQ!4L]H,;>%-&!Y[F38B*KM+.0GF[>)M-@81JA;PW@76W 6:3&,.#@
MX2:-171!'N%PY\49\^&=RZTYJL\P;DX-QV//R9)+J]<L_=CLF@8XR)*?A;K4
M7?*S4^3GI0E@;W@,SCX\2>V,_YQB L^T>=/LO!%OY=5FQ\W^6FXVNOBFD"X@
MHN1M:]F.0GG<SLG3;VZH2]T3]OP1--A48!N,E5>IYB"%J<H&LDX67Y"!#]R"
MZXH8^%+MOQ*!'+'\S@M4K@>I$XF_4B]2UXQ$OJPJLK1\I*=B#ZK10)P])0$J
MR?*D"-MU3C'ZL7D.S)-1(3PKQFVH8<>R6V&<3G&;V/]F#5'R/@:*M;)WR@C_
M3%;9Q"R>"<<;>VHY95;VXFP9"8GD^N*3<'YQJZCTMC&)VD4FU"O#-&&^!S/)
M F/;;M)I8<'Q2J?8YC%;1$R2I-@#,E'OWA@S*HKQ<A\=OFB3F*K9;Q5-;"D9
MJ_@=7(4EF_!:[OOAO22>/Y>)1E75AC6=D:M"GMGZ+.6IQ3XLQB49YC8 WLA6
M!5=KF[RQ(,1P&?:"F<!;[X4,\V4TD@(##,0E9SF@F[.=[.#U^%AQRN,P4 >I
MQ'F,$^5)[E_/XH]>Q,+1OS%\>I=QV'(%62"0G]5V1U@%WT.V@J7\=^K>R@MP
MFWQFC+-PIA/&"7!% +HA60T9XO;\,(X]',^6Z:Z$+8$#Q,+0-_:A:?&UZHPK
MM? [:MM[ 5^*\5@MTM;-EL :^?)O7/DU.;H74I<5Q2F7)5S8%<FY%U)REH+S
MXPJIL:*1=E-(H(P>ZJ!&%DN&P<6I,UF9V0["^]#D+F5U+R9U56P;/RRW6KF&
ME0/RA7B4[*>$.SHS#,_".Z#U,E;S6?(KD(G ?$EXZ>53CJ \I6X&&^DL.0EU
M@Y=SDU/DIJ6>B')N>A1*CU> ['@KE&8A*+M(:@Y9.2VO^"L%WP&N5JT@-Y@+
MU)R8*\VS86ACI9%!%0UZ7FKRS([, ;Q]1;V5A.O7-[YORJ337E3.ET!O"4K5
MAO],AR&Z6=-VGY[0=J0T]E/VO8(ZE(C%,SRN!+$: !@F8CQZT /$FJ4+IAPD
M"_Z7?[O8I1%S]/O2+UN=\ZN=WX!@*T=Z2]]@^>!BQ (GM"6XD04S7A"3/060
META,.8Z^QT>JR W&MFGF>3&#W!\?+::QJ5) T?9;MJ:S- )7)$N$.8B6Y0#D
MRMR"[Q(I[>HX8B;QZS*!E$W05_?BR_\5>'C-#;YJM[COJS53+Z' [ABR0RZ2
MCHXDR<)7"U D,L;>7633>.',1IZTM3#(!#D(V&.T:/4#3EBBNC'<H 8)I>7_
M%-UR<.VS/C]9+<T7[']XS^?J+KD+;A/D;>('M]*;9Y<1GXK[,/J*A4@J.@?_
MV,O/\T#<VX<^LUH))< /%FF#^[O[JF!IUI-.<-UR?E04LRB*:5-1S"M69Q$:
MWV(_0$?'*NB]@-]C^.W6B]6.J6MU+G2A1N32BZ849"@).[T\_, N3%.!D[UE
M,/I[P !9BJ.11W"QXK48Q<U1;M8H?X/_=PG#9J;1_'U9,INE:_!]O,"TT>*>
M[S/7V;GHHRV="9$59D+R ^+N7!JR4](+@'<,TM!BZ#=Q< 6PMAA@LN_+(8]6
M@]<R_HO .9R!NY-7]3X3C!5W\=UD5=YMHXW]OC-T=<.C$8>'-S]]\\5<!L'A
M&\LP+(9S\)=48GX(#E;T*$E7W35UAOQT!M0 (N JO$-TB#.YP8_26;Q\(=:"
MR[Y=JR^#WX,F^A*^RM3(0'ZD5Q2F4'0T&H;1L!#,+XM->+S>"+<<R-1R):J-
MKI;DV1_B?MGZ*#),5&"IG:YSALM4WW 1?JJ&QCM;%(E40N5A@O[S(D (^ G>
M&8!MCKS8];)]53*J<1W)_4:XK6NF\,+>HG*D?'+EDZAR$ <CN'530Q3S6<1\
M.A3S*?%&J)P/I4'$9-#0\[RR&[_KT\]?*@+RKZXJA.T/H%<?PCO3 '@7 08(
MHWBXR%D.567GT,'-WF7G=@GUX)$ ];*)-MC%(CO[:5P)05 $DZ&5?(>^8+]B
MQ C#17O$'Z\O)01"OZOEQ,:J=!GR]&*6R0;61WB!DS..R[!NS OPLDB,X7=9
MFQNNUJ\&635#^&V^+"*0-03XN3P;)HOI?A!"QBDQ#8S=>R; 0\BM;S!TN$S=
MP@W7\FDW^=,6"=R\2\6]6+1-D'7U&"8L5&M@"6Y6JVM:!G,!3>414('5%RJP
M.O:P"1;#IG[;*L^*=1W+*I&)X/*3?,A;%,I3LIC/BNH@]LOM?XJL>88;JI(4
M=A]A_4' G-"510BC/#"-9_2F3B)I)(!?G'R;05; GQ5?NTL"AT6RBNG,#^<"
M]Q[L7/_3>+SPIW!VT3*QD)<.A5&>!/#Q6OAS!D-!=QY^HDCBQ;$'"P@L/4Z#
MS*5GIW#;;+YL5P*K@-4/=QPNQ+JB+&-R+T8QD([YH2H]QUKZ^_M6?S#RPI83
M3AN9#.1\_RA7LS]5Z5>P6JS_X%7RU..\!R.NMYS5/<?6,:K[<6,YYITH]V"7
MP,JFFX=M90L;&K)[%J<C2HW8:1D=V3\'4U#]YN^Y4AGC%!9#D>IE'&+)?%X,
M(X\XSY9[,;WES'1-:)AF ?MAFD<$<742&Z;96NCG2H ]E:O,:438KI;6;D=L
M9SX#VVV"9.O(*$-%\<(\++%0D4V7NV)!<Q\00;V&.K6&> (O@(_Y,+P/8"H3
M;S;,SLP=RHU_U5"L5@OK#>1$V:=\HFC_SK+S@=_)38X2Z<#WU5"^&6,6-JOB
MG[)]HJQQ7C@X< EN2J74RNMH/NOPFN][A&&=CS9JR,W*M)F]"7V5TS29A&H;
M/3K?^7DL[%]RC*HK],K-[-KGX!WHKD3MA<8L;I&.U5_"'291-92HW5IP2+$'
M:[RB5BJA.@OG+61;HW/[SZX6M784K"2U_IA:MP^OUG\,I6Y4YT]+^C6/0%\7
M145[3=T>+J)7PV7T:C@6(AYBDU^O&LTAS7:++0ZDSJKA*Z&7L0LDNQ19YXH;
M2;'"/CU2PZ2&U]1P^\75\*:,RV=XSA@;I.1=OX6?U;MCZ+90K__D[I7]*E4J
MNJ'JKXW57UVJ_JI6]===V:$,%G]5 K6PJS\JA%!>H_:K,Q3?)M[(2^+A(B,]
M7)1R#&-G4G9F5UBE@_D_-=%&UD"F$A* D<0%@&(WSD2XV#JEI,#=]>[RP6:,
MC R+T-WJ_W*R)BNN%\]\/C\>^^+;.H[_=QH#4ISGKY-7->4.Q1,I#$V4@/AX
MQ&/A>X'8*#K+@:/[T/NE<F!_94T7"^H%N")-N:Z/OO>A^GEDS8M+V>M89J_?
M;0\LN]?N69U?8!W?\+<Y-Q388'5$I5]NY5LM"T;<T$E5W0D6KZA2-GDN%"(-
M544BFR_A-M_CI;3@D3W+@WNV2,V@970[)#75D9I!?V#U^D:GT^NT36,@A<:L
MA= L.[XM;%V\11AFFT3!M%LV!G^J>:S "R_^C1 RKO(-0SEGQ;/&-I$%*P<Q
M?LVNKE28J+^(W&R^',.-Z6SFR[_Q8.ISGO!MH1E2=?55=59=5=T2UF]# *3T
M7@2FK3=(9/&"% C80MG<3D*V9"+F\C/AR08:P<KF7ZS_3;9%U3ULNB]B(8_>
MS+JI;&S.B+H2GBL;XHM(@#I687+2M]5A/7WTK5T+?9M'A8Z?4JV4__C!_$>/
M\A\5R'^4/$Z:B;ER9!ZL;"(M] 8SQ],D/!GA(2&1'+@7W().EI<W00F&*>A3
M[YMP3]0;34.2([L!UL#GLU@<QZKK\L*>17*V\MD_X?MA -'6=?UY+/];7RCL
M5*W:/A_G;\H>!\]S%VPK!]9O=0<]U.G_.$K<+=>8+<-H/W'-P&A9@\'*1?!+
M]' 2$S5,562T/J;-O&-U.HW\?^066$2E&HZ5@L /-O/0G<#^W-S/&%8Q<DZ%
M!5MW9@#>T'/=).G;9"OG/\F0_>K(UGK]U_-%JWC&.*WG<]H&I;@/>>7(]@T2
MN9,4S;B+M3/YZII>\ S!@H=LERJV]GI\WW($2NEE8]!= I\P]GNE]IJMUX3:
M3ZK14E*V;+K@7,1.Y,TP7K")18K6]]!V%M7!KN3MZH#1UT-;>H@MD>#52;!W
M.[E1.1*I'M=@#_R'7FOP'?[#0H<?AI8_:NA*[:&_<*3(:ID_)LV+69$J/;PJ
M/;#@O:*@Y53B;!*),>BI))G%QT='V"@G%D[K-KP[.HV<"1X1?"3<6QX=N3SA
M1X9AF+U^Q^S9\E=S8)M6QQQ8W6ZO:QRYO;;=[IFN^&:9K4DR?98<YY!B1TF6
MDW/Q'%R9DCJ6Z209V'\I&9=G.'FC='%0_/(\M]M(9-M 5'6!.COI!L\6DXVY
MS!XVYC('#7F -AX@, V#6]8?O/-"]CYQ6XWB&0[R"CR$.9[P2"S:C6WH%@;O
MR:.#H(&VGI@M&P'=-,VL2@N&_\E)0CDP4PULD2\YXO4V<K8>?KJMG8H\C'W:
M__+_@'W2;_'ULD]U(M(C^B^S+M^M )]'.4+O^[?L=DG0>RT2QN77CR7 [X#@
M^X#?^]:@U^\#?K=K@-]O!';?9*=3U357=:V0)6JN;&&CMF8+M1<[WQF>;<XN
MHO,G@+C]"! _PS/DY?[NE6/BL$?G II_#.\RIZ%#V)RPN3[6ITZP3SN9(2(1
M-J\I-K?*>/J4OFJ<G(A2*/(R.A%6O9V(=W.?W\??[2Y8K^ NZ"D;Y!B08Z Y
MYM1.9HA(Y!C4TC%H4]">\':M\':OTS9ZA:*;=AV"]C/AP'UX"-IT&N(L0^<K
M<U;#]=\!M]L[E,D<G:X7REC]_:/K5ZGD)8Q=XDKX.H$X3>6'2/62>'NO4D6H
M^Z60G_JWW;+^7B+E24"\1.KS '!<),&H"2AZ6(.P=6$SIJI,S\_?VB&W]IV3
M>_GLVNYE,/9SC _A\?TE6O<*1!CA=HW!H*9R1J0BW%YCW-YNV272EP352Z0Q
M-8J<KX?-+<,TVOU._\@=F)9EUB5L+D/9 /3_Y%&$Q^,E(;M.8<%X+./>&$F7
M1SW+,W=O/-^#6]D?W/?%G+WCP=>5,/IWA-!WJ5@YG46>STP; ^J64?J .@&+
MTI@5(@%)BX:D>C$8KG<$@^#Z8W"]72*]2EUE7ET(2PC6-Y:Y $3O6_V!>>2:
M5J_=[Q)>_WZ\_IUE+[M@]O]. \':$K&;I4?LNH?<]4 EFMJ:.@%#3>6'2$48
MGC#\#AB^4R*]2AC^U86PA!A^ X"WS'ZW;=M'KMWK=MJ]F@+X%\?C_IS)WHV6
M17B<\#CA<2U)H)?=J!.I"(\3'E_#X]T2Z57"XZ\NA)7%XS4H>,_Q^#6,ZC*5
MO5IVAN;/:\A"T)R@N1XFI$YX3U/Y(5(1-"=HO@,T[Y5(KU)UN@9BJ &Q]@#.
M;0")?;-_Y'8[AE&;IB[?5>WRN\5^$]Q/)G_ S6D$;WO__NQEXNO%QB^78A2E
M/)HS2T)YFZ \07F"\EJ20"^#4R=2$90G*/^ 6>!I/]B7D; \J=8R8WG3&-BV
MV3YRS8[1M0W \F8- NTWW(>;UDY _<!AT9C5427C#\X]+<#R!KOYXUVA'XT$
M]WCE&3@&@/XOO>1_;T7$?9?]C4]G)W!?ZRGP;SX2P<]Z/-I+H+\Z4H+Y!/,)
MYFM) KUL49U(13"?8/XZS+=(L6HIK9I*835 OFVTC?:@=^2V+:O=L6H"\N5Q
M1PCOV4> WS*TO@7W+\+FZC@BR]8'^N]2O+,<?I?"_N0/D-G2F 1ZF:TZD8KZ
M1M8&YQ?[O<.3[?\HD?:DV'Z)]*?6L-\<6-UNKVL4#E\RC1H5ZES!FZ:!.G$)
M6\@O8+^LT'&]2#B V&.)WL4W0/0)K"G<"#<(^/@IT&[L<"C3^I%,IDE',A%$
MUPU,$%%(HDI"/(+Q=87Q;8+Q!..K#N-W/4;5-.H2P0?\C C]LX@3&:Q'],PN
M_DJ]9 X0'Y4=PO9K'U8!KQMGZ)_G:#]&B!X).=H=0/V353ATTBJ!D)* "R(*
M251)B$>POJZPOD.PGF!]U6']CIC>KCZF5_!].O/#N1#9CMG%/EJ)XI_&Z#9A
M=$(4A-'K0!22*'V(1QB]KAB]2QB=,'K],#J@1=MJFX,CMS_H=_OMNE307"RJ
M8110ET4SG\9C -'O10(:+B^<STY%557SQJ)J?B22>R&"(D17,?QP FMVS7WQ
ME>\2BW]>N_D/?)Z=_E3^\UH)H&@(^:G*NG+FJ$ZD(CA?5SC?(SA/<)[@?%U"
M[B\%YW_#,UP_\""&]9H\*VQ/<)[@?&D,4ITPHJ;R0Z0B.$]P/H?S?8+S!.<)
MSDLXWR8X_Z-P_I]IZ, 3FA]OT[G8I0RG37B>\#SA^3*!1$WEATA%>+[&>!Z>
M-B ,3QB>,'Q==K:^6(7-G,OF\(D7[-+!YGE])PG!$X+7PA[5"19J*C]$JNT(
M'G[RD2_DK]L6Z9='+;9I$5;.EGO0+RPUKNADX1W-^*U0;-WD8YCM,??O^3P^
M^8D=/6/M*PAM<3$D2^;#R6: (SWF:1*>C$ AB$@.$$3]V#B1ES=]/@_3!![_
M38"^D*\R#;F"V0W ,3Z?Q>(X%C,.:$KDBZ.4A7SV3P^]VC4N_'DL_UMAJU'H
MNR=W7@S0Q?>2^7'^I@U>L!I8O]4=]'[!A=^D.K/!MPRC_<0U X!)@\'*18^X
MYOW7\<P5[^546'!B9Y:P./0]]X?Q3;_$7KMDF8=3V1N ER"ZJ/9I/9^QGA_3
MZ4A$>@*>K5+%UEZ/[WN[7P_C4!SSA$G:*[5UA;=/JM%24K9LNN!<Q$[DS3 4
M0X%QO=G@ .>R&A09U\Q]T$195SLROK%[^Z#ZD?'SK"_[QFCX?Z?^G*D.ZOVU
M6'A_\,X+V?O$;<F//WC.A N?_<;G[D[E+ -JY_[]UJNK!SKM:JKP#F-U]D^$
M'S ZNI) +YM3)U(14*\-4']0D6Z:!-H)M-<)M'>Z[<[ L RC8W=[O2.1!*.F
M[!8SK$4]R\<P:"Z:.BX@/ )I$<3J^*7KT/><^;.ZOOPSY1'H2_ !'I2EF$;S
MGTMP_C&\$U.)SFVJ3M$!G>M:&D'5*:]. KV,2YU(1>B\MNC<(G1.Z+Q.Z/RQ
M U%KT,_Q-(Y%PKY$/(@QIH[1\?<>:+=8+ ]%52B[?7+YZZ5EYJ%U/@V#VT)@
MO<'DF&<3#J#[U^GHMP;[(NXX>P>/QH.:KO$+F'\JF8I=1Z&;.DG,/O^-3V<G
MYPT\L$E%Y^5M#RZ_"MPT3B(/)@@ORV/^X!R$X[P.OJMB_[MX$9J>SDI=QC54
MHN0(O#H)]+)C=2(5.0*U=01L<@3($2!'0#D"->@$>9.._(? _XDRFC7 _SQ4
M_O31383*"943*M>$!'H9E3J1BE!Y;5%YFU YH7)"Y0J5UZ"AXP<>@R)C-R*Z
M W >[PS-X8]$.!,)SCG[U^F[57".[5EZ>:T\?,3AD1BDWP&E;^_L2*7PA.9U
M-D=U@HB:R@^1BM!\C=$\VL].B30F ?@2Z4Q- ?RB^MTTNW:W4/W>&7:L7O41
M_*?Q&) [>R]X+-9!^\@+"Y4OOP/QV:5\);N*(G$7.K(5TY<HC9-5!'\N'%7(
MWE'0>A?HWMD*W4^#(.7^AM+YE9:.0&F&#L-:W7R1?#KJ7?:4W=59_LGG()^C
M%$!64_DA4AW0Y]!;)9)O\KAOTB7-JJ6X:BJ&U?!,3*/3[9K=E7VY@QI4_E]Z
M49RP4XS\RX0"^ 9%7V75W9#==2R9,K#,M?8ZC_HM\LIB,_J#;O.UU) I\T!>
M -DJ+4F@EZVJ$ZG("R O8(,7T"/-JJ6X:BJ&U? "+,/NM:W.BA=0@^8\-_ R
M@.<[>@&GZ2T">EN6\UA6F?P 0PVY]'X *4:R354@ 4E+Y5 _U1OIB.;[I#&U
M%,.2:TQ-T7QV=*QM&'87MPNTVQVKW5';!:J/YM^',#6$V0#KT\A+YLO] @_"
M^3P  )T?T6HWLFX^!:C=4,5)[ ,/^&WV!*Q3:JRT_/G=8K\)[B>3/^""-,+N
M/._/Y A.@Z]IQ#/DOW@F?OL<V/_DT;/YQ+IJ8K0MF,+Y9*9J;*;J1"H"]K4!
M]I;9HC;ZM)&@AM!^PTY@JPY].M][@*,!N<?I*/9<C\M6F$] :=02>N[6)?"L
MH18B\/SJ)-#+$-2)5 2>ZP.>[9;Y]Q)I3 +/)=*9!P#/68F*90]K@'O/PB#&
MB"] WRMXV4S(96>?Q:V'G7&PL;QL7,E.'0<FG<@*%"^:$G8E[$K8M;YZN$ZD
M(NQ:'^S:)NQ*V+6\V/7G67@OHF$X'G*X(0K$O-KP]1JG*TNGL^D2+B5<2KBT
MOCJV3J0B7%H;7&J;A$L)EY87EV8Q5=NL14P5Z3,&"N'[$)Q>1U[@>#/NLXMO
MPDD3[TYDNP C=IU&<<K5SL#/J0]O,VW>--MO^%M9Z&MVW.PO.7!5AZ#*C[%$
MX>*;,^'!K6"GC@SBF@.[7?8]>(25"2N7 H!I*C]$*L+*]<;*%F%EPLKEQ\HU
M:)#Q"%:^] (.O\)OA)4)*Q-6+C< TU1^B%3?AY6[K4Z'P'*%P++5,G\ND<HD
ML%PBI7E L&Q18/E!8!D!\:Y@VNRS?[5N6F<MA,ORX:;=,<J.C<FVET:M$PE(
M6C0DE:918PWL;\EA+[:KNOIX4R(-2<"W1#J2!&\;R:\"1,CL_[[[_)Y=!7$"
MH%2P\]!)L04:J> :<0*JX)NSWT@%DPHF%?Q:*O@+_Q8&X73.+K[!MS%Z_C?.
M1$PYZ>0ZL@;JY+/3]Z2322>33M9()Y]QWTE]%?9][P5?1WC8.6GH&C(*:NCS
MBTO2T*2A24-KI*'/Q=@+/%+0M><35-#O3]^1@B8%30I:(P7]GH^$3[JYUBR"
MNOGZ\P7I9M+-I)LUTLW7D< FE!3?($XQC;;LH6^-%QJB.",=A\S(GI ](7MR
M2)$["^^P@IG?"G:%&S&X(TN?SWG"V:7GB\=,!OS$0[/EK]O(\,L+4&$$?".B
MY6>=6<+BT/?<_&K%(SV[9=OV+UK71QYZZ:K'P'^7;.JRB8@$'B_3HM7=X^K^
M!_8RQVT2<.MT<< FPPM05; P@M^G,T"?/ FC.9OY/" *[%EEV.T3=AU&B.GE
MF:BX&5MD)R=-.&CKD1 !"Z=>@N>FCB5-@K&'Z^S!6B1 EC2:A;&(B33[),W/
M[#*- B^>%-2/W"P4A ES\31;%[<$C013AUDY)_($*_6'>R(IE5,&Z;K8,=3/
MJ5S<9]^0CXXGW/?E"^"Q*^_P B>$9T7R\-S1G$5B#&/"HE O@"MX,,<#M/#4
M@8U;^I<[^?&0W9CQ*1Y@X#90Q!\.93]L9%K/Y:/*[!T=#!ZLZ&3AB\] YRK4
MW.1CF.TQ]^_Y/#[YB1WI)L*OZZL\@Q'[^UD-YKG_^1,LP71H=H<@W/#3^#J,
MTRG<_;SNT;LQZ2CTW9<+/,&\F-EMJ>/X-D442C<ETVC^SFX4>5I[BY&\Z)#9
M+@S?;G70[WF,Y;MDPN5Z?@P#0=9L[W)ED#DK<60@9T1ISV+XA"=I).*R6[";
MJU\_GGZIA.7ZU^>+FSU9@N?KK8J8@F(7!W1X(O%7ZD4RWK'JG=GH$IF=-^[;
MW$U[HC/:JC^%-ZA#X2)\VP2^<U-_SAR>QNC,3;P8O@='+LD<.Y1 =>ZQ!R,9
M"?  Q^C@X8.D*Z<ND$^.1(K.GGP@3Y-)&,%"N97@>8UC%Z]O*60@/A].-@,<
MZ3$P09@'S'& X/\?&R?R\J;/YV&:P.._"?=$O0I,-ZY@=@,P@<]GL3B.Q8QC
M8&$UP"Z?_=/#Y/&=%WLC#\-.Q_G]&U+(ZG7M?FLPZ/Z"Z[DITY2-J648[2>N
ML7=X3KN[]J 72W[7,OVEHU9GNN8TU<(275^(KC!F_.8_?[)^(AI7$[#U!R,O
M;+"KP&D=M+!IKRPR]5S7%Z5@$1UY@-0[T97H2G0ENFI+UW+8X1+1OX10[9PG
MXIA]X)$S86:[P2S#LNM5E%Q79M62HKH:H;($>DJH@=[-C_6C=R;'#^N9K45!
M,UM=Q+V>6T*]_+=SRU%\!)=/8 [7W!=?>43 AFR%EKJ#Z%HQNE8](/BRY7&Z
M4O4Q::VE 7]1-B#370I54%<53W0ENI:1KF2ZR72_-!N<33PQWG(&U[D7"2<)
M5RQZ]9=[3]I4W8_#//82F(.SE01O9HNSSL2"#J&BPUM"4Q1?I0P/,:OF%-45
M3%"&AS(\Q\6.-00K#YG2F<,4P$8E7A 3D"';H*6N(+I6C*Z4T:DB52DL=-",
M#EGN$FB"NFIXHBO1M8QT)<M-EOLP"9U++^"!XW$_3^CH%AO>/3W"*/UTJ/33
M>,$UF/[CC@-32["#Y2[9J-?J3JU]KQ#J;_;\PV^HOUE5^IO-PGL1#</QD,/%
M42!*WZCS^M.?%Y_9I\MJ].@\_?+ET^>/%_]#W<[VNZZ_?_ST)SM]_YY=7WR^
M^?3QAKW['_;EMXN;"W;]&?[]^.4&^XGQA GN3-A,1'$8L/M)&*M^9+(C(..S
MF> 1]B3SPWO9 GLTQ][C<>(E*;:,EV9[-@L][*&V4I6KNED7PSKJ$_DZU59M
MJGJE)5$JY%<^OQ^G  4R.8V![+ 03J+><IOW:5MKBR;;<L.=/I.RCM?$Z4B-
M$1NZX>V1*'[4D*VY\7,OD,\+^%0TL+F]HX82)X*[&U^6A')]\$;LN"V'!F]V
M./;>DAWBW@"Z\5-T/=30PC1AOC?UU*%-:LZ%RWTOE@V]<8G?-E1[N-,@2 $4
M95WB8 JR)R^VLVVLO%7VG%,-[&1ON"14BPR#Q$[D\E6QG)IJ7>[[>5_Y!S?@
M-R%^PMSL**D89PBD#K*N>$G> #U[UH.V>/B016N\LW Z]>)8SA:_R!CG%OOA
MQ7(%4V""Q^B\B5<*%)87JNYWR1P?Z(;R,V!C;,NL;I1/ -<0EBM_=C"'Y05X
M"9,2<<RC>=:!SPT#@;^*0+994]T!%QW\X L\ \&?+V<^BT)L@U;HU[^M16"^
MNILZ#NZ\AK&<O!PM/LN30JYN6/27Y_%#9F535#3J"(?4=W&1@*9*U!LY42+@
MRO$<%P6?)L\5B*;R3SEH4! Q]]PGB"6%:;XDE6HI[T7X"_(S_@"R+410R$N6
M?\(CIGR>*0"8)XP41XT-$XL4@N'>>5$"Z@(''XYWZAA(1F-_+3)_H!?FLMDE
M-L*4!UEDW*F,2M;G<ASZ\!?RG>+/&+5>U@HS>W&AIV:FM0M:%+E1:2GFRL-,
MO.Q8$Y?:2E:OK:1MM@;]WI-M)=M/MHRT.RW#,O?Q(#G_W3I/]G7+5[W._O1^
MB8-F#URB]?,EGM.R'K2GMD'UIUBE. 1\YQ:>>3T>>:G<REY90/?4"BD,G;CE
MBY=L/L>Q%+Q"&H,T!FF,PW(+;N;YSBHK2S?0NE=&L0[$*/O@A/5@187UQK-L
MP?ZI^E*V@&A*DEL'*I/D5H^F)+DU[:5,;2UUR]_LU-:R%+RSYZB SD7:5'Q/
MRN$0C/"]G7?TYQ*2?I)^DO[=&&%SYYX=L:=V&6N*$A\@2EP.)%G5;-&:/JA5
MOH@$_"!L\.90>PCV,PUU^RZ;S!YI<5BN*6^;X,:M<?J*+BGD*BIDHNJ+A'HI
MUUZWN+^^5*Y QFY-Q(FJ1%6B*E&5J%IUJE(^G8+F+]Q3N!2L0^GT6IL0T@T'
M[WM6#L8@@2>!)X&G#'J-$VPOFD$O W:DR#Z9A0K+-R70GYE ?ZI):[E6@/+I
MI)^)JA6D*N73*9]>(1&G; Y1E:A*5"6J$E7UH2KETRF$_LQ\^DTB[D3 3OTD
M=B:IKW'&C)+JE&.C'-M!&8'VH9.$ZT-7DG#*HE.6[=6SZ&N(L<$^M,Y;Y=(E
M%-JOHH4@JA)5B:I$U:I3E9*KE%RMD(A3:)^H2E0EJA)5B:KZ4)62JQ19?69R
M]5Q$XBL[]SZ'CA-JJSDHL4II%TJ[4&*5$JLDX23AE%BEQ.HK'0-91(L-=CVA
MK*H&]H$R-415HBI1E:A:=:I25I6RJA42<8KI$U6)JD15HBI151^J4E:5PJK/
MS*K^&HG;,)K#SS08B>A66^5!B55*NU#:A1*KE%@E"2<)I\0J)59?)['Z$##2
MAE4]+ 2E:XBJ1%6B*E&UZE2EU"JE5BLDXA38)ZH258FJ1%6BJCY4I=0J!5:?
MF5K]X#D3+GSV&Y_#^FFK.BBQ2FD72KM08I42JR3A).&46*7$ZNLD5E?A(J95
MW[4:[&PB?]#^52VL!25NB*I$5:(J4;7J5*4D*R592R#BE:0RI7*(SD1GHC/1
MF>A,R5H*UAXB6?L[3R:^$ $[;['W_#J,$J&M1J&,+>5S*)]#&5O*V)*$DX13
MQI8RMJ^3L2T39J0$06VL U&5J$I4):I6G:J4HM4Q"$PIVCI0F5(Z1&>B,]&9
MZ$QTIA0M16</D:)]'R:<_;\PF6BK1R@Q2VD;2MM08I82LR3A).&4F*7$[.LD
M9A=(L<'.6M>M4]HY^^K&@5(]1%6B*E&5J%IUJA;1F.9DUCW$NYW(^X_=EE%,
MB7Y$/Z(?T8_H1_1[.?J5.G6YR$!1P/*0N<H+]YY'+OL01E%XSTZ3KUX0AP&[
MNKK25D-LY9P7R5T>QG-Z0H'LU26JDP$@\:]K1I+D5@=JD=Q2GI'RC*^>9RPA
MRB/E7WKE3]0B:A&UB%J'HE8.>^ G'_E"_KIMD7YY#;#YJF'"5UR-'V"9_4+F
M/2Z&N4XE;2'E"SLBIF$]6-+)PMV8\5NAM%Z3CV&ZQ]R_Y_/XY"=V!%?^XV@4
MNO/_^C__.)HD4_^__C]02P,$%     @ F95N5OJ3UD1D%0  !ND  !$   !E
M=&YB+3(P,C(Q,C,Q+GAS9.U=6W/;N))^/[\"ZY?-U%G%ETPF$]<DI^1;RE6V
MY;+EF;-/4Q )2:A0H 8$;6M^_7:#]RM(76+J+.<A(Q/=C6[TQP;0N/"W?[TN
M'/+,I,==\>7@^/W1 6'"<FTN9E\.GAX'P\?SZ^N#?WW]QV__-1B0BZOK.W+'
M7LC04OR977#/<ES/EXR\>[S]B?S[[.&&/%ISMJ#DPK7\!1.*#,A<J>7IX>'+
MR\M[>\J%YSJ^@NJ\]Y:[."2#02C\7#**S\D%58R<GAR=?!@<?1@<_SP^_G1Z
M\NGTXZ_O/W[Z^,L_CXY.CXY2;.YR)?ELKL@[ZR>"7%"W$,QQ5N2*"RHL3AWR
M&%7Z/^1:6._)T''( W)YY(%Y3#XS^WT@\]6S3[W !D7EC*D[NF#>DEKLRT'*
MDE\_3[BK+8 J3XY//AP?$*J4Y!-?L2M7+B[8E/J.^G+@B[]\ZO I9S8TKL.P
M53($J6+PAO!.+=<72J[B^EXGTGGO,>O]S'T^# MUM1&#K>1 K9;,RZBHV5PY
M.X3B0RQ&GJ/!T?'@Y#CB!&LS/"\?-,?)T='QX;]O;P)G1L0.%]_+:P#Z#X=8
M/*$>B[5BO-P$*,BHCX6VRM*&4C\>!H5I4EZC \!+@<MC'9@2$Z/?0E+A+T[*
ME#@Y.F2OB@F/3QPV0#(F-5*]P0F^, &[)Q,+IM2;:&9XF+'44TM9WB98DB'U
MO<&,TF519EB0;<&":T)''G_^_/E0EQY\_0<A&MU\L72E(@'(;UQ+VU+3IOC7
M(&K8 3X:')\,/AR_!V$'1)2^'A5>.=Q,B0AA:RD1PW-=)2(L8NT?J^HM!6^C
M&KU*2.A? _Q56VL12NO5&[V>^*-YK?%+W:[24E@?,D=YT9-:%<K?BO7L3D?6
MZ(_F]F?B<F,%3'%:_^TU GE9E%_3%U'8"OP ?S7S01SMDFJI$*[2=>&CZ.%R
MR<74#9[ ,WPS3Z/7\X%-B0Y8IU1:TG58?5@[7$IWR:3BS$MW0%K 7++IEP/L
M @91L/_3H9/W$#,CDD(%V9B!Q8? PIR;1+V(5W&%S#=8[!$=8Z,2<,.7 P_:
MW G#S0^W<RE96SN!Q8.QB?96M;GW*:JN&6VS:5NC@84+7F_R14S3-8,MZK0U
M&%@LWS$X^3PA:FPR2A]#.<$?3P_7AF'7H:*OKG 7JT"M!_CGSVC2$/U_*.Q+
M 2JMKB%<R(76YX!P&+(V)X^4C-1,'/[U^ C_@QE*:K(2_Z3")H$TDA+WVV%>
M2$Z\[S%[)+[JW_D7*F0.26H8<SYJS)<%<RE;^#!RUM9=^ CFZBG.N8LS/6[#
MG_89=7#X]SAG3'DI!S8@-KCO&-T7BR$X'4PDD5 4"63UOJOV73*5/W<7"ZZP
M-3UXGZ Y%1<S!K-HYN%LT/8=-II>^0I(;T'AA;^X81!#[NE*\SP)F\D[5UC8
M\ YTG4"^U/,E,=.$HXG#9\'TZ8(IRAWO)$#$VZI@P-F)#A-)O@.!%BNI8T5&
M301EJ"EQIR30E83*$JT$B=0E6E\""@]2&I-8Y9 \I31Y%ZK]$SGI0;UQ0+JG
M$HKG3'$PLU5TRG(:(/2A1:@B[S*B?^J]O(Z7XX?>:!J^3E"J0\H"&FF.*9UG
M=N-ZQCZIA20#"GZN14%2#X:-I*8PPJ3J(EA9#XM-8?&H7.O[W'4@ GN7?_DP
MVL/!OL55&T14"S& X6,+,*0K^6\25(,=@:ZH#Q [0$*K?J&-* ,J?MD8%7WG
ML5ULG%-O?N6X+ZWZB83)X.]/+?R-0HF6VGO5E$R(1^LC.:."_ZVM@#[[C'H<
M_)-.9*63"FW8#)[]M3!K2,O4G;J6BIY-R^U]V]BWC_YB0>4*@BZ?"0Z=(15J
M:.ED/,R=[N$UPOE8J7\;LAI\_+G@XU"N#L^)9)*()I'LWL^-_7Q%N?R=.CZ[
MA=DP_*TC8JE;RRGKO7A\5/ BBB%:#DD+ZEW6V&55TV:<Q[BBTG\-V S./"Y)
MUE1-M4DBMG=M"]=69N@J?%I-;W!FR\Q;[\3&3APSN;AQ:?G@)RXTN.=#P3W(
M29"U=T63?'MQLGB<SX>7D1C<\G-Q5%(R4^P]U'R<B<T'@W6F4WY,>-7SA@I2
M@\<^EGMLH 61M*3>:XV]=BV EHWI:T6_E"XW^.>7@G\"9J*Y>Y\T]LD=4YB[
MOF?R<4XE*_5+GL;@FT\%WX  G2$G(()H&;V'6LRI)Q[[RX<&N'RN'*87B P^
M*N9"$@DD$-&[:,MICRVD/QJF08XW28.0=]&O/E>]849DC'L'6N1%0OIZYYXT
MSHZ0=X' WH_;3)/4.+4QL\'#:Z9,>G]O-7=2ZV@3E\'#;7<P]9Y=.Z%2X\8<
MB<%G-<F5WC_;FL/7>*N6P>"[B@Q,R7R^=^6&";.T!QO0&1Q7D8@I;++HG;9!
M-J;FI2M2&1Q6GYGI';5QBJ;&6>64!H<U2=?T;MO%/I>A;6MEJ9,ZTQ)N)E]S
M#TRM2 ,0UMT? X1)M>GC.<G.^!XV6\XEM8;.%L0:X+-1SJF'T*YS43$ XFLX
MAI['E!?2V$,5LXW$ [-\*<%#^H6OP]6NZJH'VX?F.; ,#),K2 *%(E*;4)66
M ,"+U0J#7@_$;0$Q/C2&*0Y)+>53YY8J7W(\:1MLU<5A_3-UP@3+\!E:'@<@
M5ZY\A*>/Z!M-W1Z:NZC= -9B.J\&K*F#:BD-2:)BO/$XI:7NG&,]!Q ^!Z@I
M253M\;N39' ")Q@1+2FW 2\C-6?R'((''H+68:8.I=NNPX#%LL1CD]1R%IFA
M(AIV6A42ZA+%U1YMNT4;C*&DS^S+5\Q;U8?!+8@U8*J8&%T'4V'=)*J\Q]!V
MES-:3QG6E65 2S$5:SJ\W4\-?@0^VASF/V]^F+\MM':EA@&5Q3QS)ZX4Z*&]
MFULRAD+ J#KR$ SLL_C)@O='5&2 9S&KO@$\ YT2?$)(S:.QA^ F2\ZMN]I&
MC :(%//XR?)TWX?N:K4S>>WU0@DF$.#%=(6F3&<.@G?PVO-\[ ,JXLO6Y1LP
M4[(-M&QU-1M- D6"! 6J$O DZ0<=3\*0$^G3 VU3H)ECRMK<!I"4)/;+0=+'
MF%W'F)&O\.Y>O!#\#RHEQ1V%[KTOK3GTV24!8HTPLVX5]2#ZN9BP;Q!I4KJ0
M2!FB7!*I4Q6*>L1M:SM6^W7&]F(,R"EFSRNW;O4A:.> 2-:1L7BTU-[%[P_H
M>Y;:XJ*)- ,\B@GM&GBD5Z1UI BJ)%&=/5"V#Y1+3_$%)H*3-=^TN[UO&-:9
M_>3A$K!#K>_0 T %7E!\+[D%!;>NS9P-\+5])0RP+.;$F\$R5C2S')V%JT="
M=8G6EVB%!Z'&(<T@U)EHI7M<KS$&FU2BZ8%Y"II77S$%A$^@<FD,W*9  ]Y:
M;'#.X"VI.808UMW'PUUWG(7B3?O.2H$&W#0_Z%[2?99NG^\1L\E6[)17J?*5
M*U?P^ $Z!&^X7#K<P@3+V T8]#QL2<5J*&P\OLMM3J5A4\R.JC*@S+ I/(>L
M4!LL)%H?DBB$T[^0-YCUH5(Z 9Y6JT=AN_ZN#!7QLW!!_HP)T%95='!K2#!@
MIIC/KL9,4D+>A97]1,+J>BQL*2(E.S=&TPLV95(R&RC,6YS6%F9 2#%[78V0
MU+83^"NJ42.FW[*T#9BTSA0UY36 H)B=SH&@3PGM-"K@0:$KZ2Z2Z]'/&+1R
M0#42 4O;Z-!*:#U /A8SS]510I]ZFD+%Z=O>@ZI#<D!.R-X#:.,AQ@.S7&%Q
MAVNS*@<,^?'IV+V<3IG^Z&GXI,6@9.MU&N!73%]7PR^KFW%@4QPIX^@XUC-Y
MVD-U8Z@.\[@9SP$J,RX$%S/]J2M<I1HN\&33:/HD))#/!/];CVI"AU7M*MIY
M?0:(%E/HU1"E)2 %U4BL&QGJ3W7I-;M /21)*ZAQ&:G88W/S$\&EB[?WKH(&
MXM1Q5A<</[?\G#JX<OEJ.;[-;.QC4U^7@Z$XDC([K*"NV_[1.A@P7,RWEYQB
MKEY=3FE*(E73IV<B90EJ2](?Y,/91*!P4F./Z7;9]MSE=:VVNK3A-6"H)(>>
MOQ3O_^U\XK?#W+=BPP>9+\KJ[\F&'U77?L+O8_ZIW[WBE@#<SC'3I&>KA"3<
ME#I\H=(.5[N&LYED,QC'7 LEN?"XI5?%AA-/GXX+/H+[Y6#GU02?V]3?/#_%
M11,QNU9L@4UT0#P BN)*?]7^FW3]943(@>2 !+]A2L%=>ZS%V'XPO0#M>; A
M_,N!DCZ(HF&%X=^'NVO8/QB?S2%P#9]AKC-C#VQ!.7;AJ7.'N(5TVPW=NMK.
M-7QX5.D!WETJK3F,>"[8,W/<)9*%P_3P0%S4:*U8T@8O7 &!1:XV,#GXX+NJ
MLWA*'?UM6\T["0YL?3FP)(-89V@)?X%Q2(\[L?,[IU*NKER)#D\97TO5%7MM
M-C&8NW"E"B_$P+SE1$4;7,]=+S@L#'YF03$>-H]V_E\Q%C?&1C*VW%1-WH:U
ML9$R]%[76=8$44G:L$BK'V)8G068&1Y#7/.F3()C;KB%[^D0.@I->8T]*77N
M7)C=3'UA8S5/RZF$0!;Z++9X"Y(ZXWKS:V*P%L,[ !MKOW,5% 8@N)Z>4?%=
M^DMEK>[A!<#R*^XPNVDKMI>[CZA+61G8-YPJ)O^ F0K,80*[UVBP:E'_$6T4
M& ,!%<;HOER_@0IR.MDZ-3=63%1RE83V]DBP\1Q4F\W'+^[_PNC$B_?(Q:VT
M-7E[T],'^2F\*F;T(ICTYGQYPQ<\F.N,Q.4KDQ;W  CAOO2HJ=KS!4UB*SG
M7Q[:9V&/\,882A\S$G:T^QZ>3KB V>(4WA?,\,@@RH8?#PC:8"W6DF;0)3\"
M'37-H,=G($?Z>J!.I;/2EU_D1W5FNKV!?M:4BE&L@6B/C,WM/4@,+!1T9@!F
M'GL7M->G>F\XG7"'JU6ED7FR_?4C_#C7S:2GFM-@JNE%\^\K9C.)WQ&N:(>&
MW/O8/)%WH;]^P$2,-YH^P8BG"OSUY%UI /,;$2^+QJMMN#2:7<S27_=-V3Z&
MNI^6%SX;N^=SS&Y=B^%RB7-75Z1G=[N1W9EP8T17ZE!%U-L#0/Q%D.^[X,_<
M9L*.T=68?']:('%\QNF19PM[!]#M#\Q-W:\:-<XV).U1NX6IK\R1TA 4U^+<
M%0*M=<4?7,VC2Q*NJ)7IQ#:3T9FV,H>P.D.]O*4X0 NONQ2S)DUEDK!'#74#
M\PPP4=-%GH;W2N+@YEJ<N5*Z+[C@0)=0F "I-=L>-<DM?=77T80;1L)3W_KX
MM 8%5!8U0R/2?3*=.\Q3H&,N)UM\OD=&W3&%EX#>2]=BS-:;)3$S$[LKSM!$
MUK9@Z$PS&+N/.W\Q85)?C(E9<Q8G&Q"HS+[P=:(AL_;0BB6S\AB\ 6^<EHG4
MS[Z/^H:QXJ)KLB2;M[XU>_=:(KDO;>R&&C\M71%%+VO.V;-F@9#.I*)<G#M<
M<(LZ^NJNQ0(S<=2)HT#\INQ <&?>*'-@R=Y/=OFZY$%=MZY0N&R-&=VXI1K1
MIHV?X2-=_.;PP6MK\0[!8-&]D!JI+M^?.6^4D7-E=&/*:%J=RX\L;\NU1^"^
M#W+K=(8K.(R-1/#%]=#N\L*.YN?3VB:#U&Q\Q]O,EUQ11X_S@PX.+X].-CZ6
MV;Z)M.XV%@@$[-;8EDR(,,TGGYFF#R=,J7;:5% 7%PSCP5#8@^5FAK'U)K*.
M+N*$UY67;[[*;=1J1MN5/L X0LXL0B5O><;:LN*NOLBIZ4OT2MW[,&"SHF7%
MQ#(S96=ZK@9N-%DS5.,YNZ7R.U/MFZ*4>7]:YP'^CK^B,9IF%['@#=8+%\FZ
M13[1I>EO75M_H"B=B]V^W,ZTJ7FL%&0'=(!/CPYJ-SB$IS1Q/PVUTBVY)6$=
MC4J/S''T!N;%@GM>L%<H& X\NHY=C+K-Z;=O\#;ZT[5W@ ^%X,_@9T#]QKO)
M,[*Z.*C2:A?N?"I:-JG8)Z\O^;J@BA7V8^U"\CY%IG4A$Q\U"-OA=^:I0H)P
M5](["]&6MEYQZ<6CA, XG?0"YV$QPFJ3IFPD/M.6>&3GS=O1E7JO:'6>)#?-
M:,.Q-Y.-_):_8DH]Z.7NV(LNBB>6:S!V+R%M-D*'VC6,S_/M4ZQ.<D5%=^*"
ME,,\K[ K-MLVZ[!W%!Y5IN0N@-3]R1U.QG >@9=D [T^C=^H85I(V[-VBAP<
MN=QNU!XE7'MCMW[WUWY1C-S['TJTB=MZ?]H*^P]IOK:O5173'C4'.! %!MOM
MGA1WDO.(N=EZ$\INSM-+=S$GR[3II=Q&I(65W+>.F6.V6+H20!9L8LD<I(TM
MJZ7I#&*-@^MHZV)N(E%XW)79@OD5U-M.7G"R(V9X[0;N-_/"I:4@+Q8[L1'I
M_O@RWO8<YI"]U")J>)QN=:'WBWN6Y,MT)G4MULQHYT?<H&!\<^-MSLE]*[C]
M$M6*G5Y/\\-M,E['$=^GS&="Y_R%&EH:JOHN)(?CI_D*5K9FZYSA0_SJX"IZ
M+9,$QBW#E?'X$*F!*M^%VBZFT][:M/%MM!,X9TVQH),&G+OBF4G%@1E7[_7I
MDV!2E+7'3-=)\RXQ!*[NX.4XX^Z-LK-&595VWY1;*N@LO!G"<B4.8/3&NFKS
M#!S=-#D8D0D<*O-G=@_=9\[":H)N&E2884,W#>_356:G<<[&5CR=-%M_NE38
M84Q?Q;<G9 TU4772-)CDZ3O> ((/CT\YUU44=M.0>A3N%^ >J;B2># )!A.C
M*8R96-::ZO)NFL/D,^BHE\&***LJ[:8IOY_=,%R[^WYS<XX3-,"2*Z^X^GN&
M1Z9API8SKC%])\W5*WCI X59ZRJ+.VO,6;TQI<4=->:95G1$I46=-<)+[3^]
ME^Y,TD71G!JB[AKVS5E9[OWEMY6^&?#JV]7)<;6!9N)N&HK=T)Q=N;[,&54L
MZ+(!(\%*]4\][[+ZXQ<7.I?Q'%[Z4C-*RKMIS@O\N0K_16WUH+HBS#6B[:B9
M[GCN^AX5>-0 9[B*,6&<+K9FVP/C _^U--W(M#>&0WRIA7ASCKTQV?Q>M^'I
MI-E/P[-L;HZKN4\%IUE+C63=-"Y:JU),9(]9Y*PSTG74O&?F*7V5=?Z;M5[>
M0#-E)TT,<R!9I^2,JZ?ILEG1BG&I/?G"?3"D,#:M+N^D.27KG./TA2S5Y8$Y
MK98";74Z7^'V%'^B%Q3?=C4T8V<KE@Z;WN2N?T^;LQJS5W7F0%",UQ77XLW#
M6D5%;[W,KV]1>.#>=US4>(*1J+XO Y=]*^QOP=!9HY-O(=6?!==(+K3 NMQ[
MT!SE]R16?5O:U#R;2=N#Y@J/HN,="_A6A#N\H@M*ZQNG#6]WFR+^&EYT2":]
M.S'\E C3^\#T9K/BGIKFC)UMA&A!;NQ&U[&DXD)%%&W'\^:F!]^2\@"\"_KU
M_P!02P,$%     @ F95N5O:7-$;^$   ]>P  !4   !E=&YB+3(P,C(Q,C,Q
M7V-A;"YX;6SM7=USX[81?\]?H;HOR;3RY[7)W>22D>USQC/VR2/KFO0I Y.0
MQ80B%(*TK?[U78 ?$DF !$C* )V\Y&(;"^YOL;M8+(#%]S^^K/S1$PZI1X*/
M!R>'QP<C'#C$]8+'CP=?[L>3^XOKZX,??_CJ^[^-QZ/+J^O/H\_X>31Q(N\)
M7WK4\0F-0SSZ^O[VF]$OY[.;T8T7_/Z *!Y=$B=>X2 :C4?+*%I_.#IZ?GX^
M=!=>0(D?1_!!>NB0U=%H/$Z[OP@Q8K\?7:((CSZ<'I^>C8_/QB?OYB???CC]
M[L/QZ>'QZ?&[?QP??S@^WB$CZTWH/2ZCT=?.-R-&!=\. NS[F]&5%Z# \9 _
MNL\^^L_1=> <CB:^/YHQ*CJ:88K#)^P>)GWZ@."#G\%XH=X'ZBSQ"MT0A[/W
M\6 'S\M#Z!^2\/'H]/CX["BGDK9@/XVS9F/VJ_')Z?CLY/"%N@<C&(V \F\K
M?"1K_E)I_WS&6Y^\?__^B/\U;TH]44/H]N3HE]N;>XYS#",4@=3PP0]?C4:)
M.$+BXQE>C-B_7V;7A4Z^>__@$3Z4(/O3D].SDZ,(O9" K#9'K/W1#/[SZWT$
M@\KTX8(P!?!<^-$]1S[[T/T2XX@"D_Q;RQ O/A[@*'@89QTRZ?Q=LYMHL\8?
M#ZBW6OOXX*@G*%N5OR"KE1<Q3N@D<(&;"&P&;,?#E(G1C7T\75S%$32]]0)O
M%:]N, S:'=IPFB^!B\//)' 8X[Z/'J#Y&H>(]<(;3A]\[Y'K&[W$$?)\>MHD
M("N8VXO8Y4.?_Y).%RF/\%<.>K4.\1('%#S5#:$=U$O_&P:%<('H\LHGSSWA
MK72W/VA;];U"7O@?Y,?X%I0-?N:\W,>K%0HWH+>93Y]0"O:>MG$G44XV#6;8
MB<,0U/4<42_3426)O!H7Y@29>P#F&$+D1#'R;Q$X R\"!Y&,^:<_8N\)^:D'
MF3P!Y\P-7)'P'GY[SX#QUGV*=H]\O8:P93,2\Q(D*"*\"_$:>2Y F$9+'%Z
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MD#D+U<"OW4?$^7U)?)@(*(OPHDTN12*D.1B1$!I_/#@^&#UCEL;AV2OX*:;
M(EFSSR,_D;LE.-,P2X0,@@P2@[F"UV;37]YR(" 3QU*#CT7N;/HJ!?#1!0K#
M#<Q,?"TP&+@%/:Q5TV$.I%!#BT,\$#QJ?@660\D<R9L/5A>5_6A-3)GC/AD.
M[AJ_4PQ],YI-68UWP5J'M-&YSC"-0L^!*9[YUSILE@^DT)F2X'&.P]4E?HA8
M1GI@Z.0.]2XDH)S1Y@ZBL@C,D)GKFMGD9SP<>.K^A@0"YVH[O#;.5=0JA7LZ
M'+CUL2I+B-5$.;;CE'I4MG3\]7Y)PHBY''ER>6B &WRL9)84N-M3^R?*9H!\
MUW^Z^$(QIQ@&.#7G,W%=+^'X#GGN=7"!UEZ$_!T'/$2=E5DJ,](;@H*R.9Y9
M#JTQHDOW9]($5+9-(UZ"V0Y6XGOX ')8+/.?8,H]SV# U;B<[8@)_*CMN!2]
MC>/$*\8:3O<1=X]#)&E4=B@" MKI8HY>WACZ&4OW!MC]A,( IA:Z(XU+O/ <
M;SO<[S0 ^Z2(TF>GSDA8S'$SF!1P<HP+1!\XT)0SGAH^PGY$L]_P=#A/A>M&
MMA#_8%\C(#8+I9EKPPR6?+Z<SZRA 79EN6@ARY+&)M@63:IE;@MM##"IF <7
M,J]&:TSRM2(WP9:R4[/#C0F3T$)^12U-Z')=%EFLP344!@ T)8>%&!J(#,"0
MI'^%W(O;FI@3)6E=\;PH;FS$2.N2MA)KK2$Q9+;%9*S45@O-S$0BLDRC+!B1
MM-=GOGJ*1#LY6.!1E]H>?]AHGLUTQL%44GX*0,HT)@Q (9TGMH1FPMY,HI*%
MJ^I]N8F9\*HYI28+MQHI>Q.F/"-6E:JTK0ES$Z>[Q&8F;&MF?M'+7\EF':U>
MC(2(S:DJ2;S82)B<;#PJ)^MNX.?7.O-H]MZ;Z6SE#093PI)).$-VN0WT%';^
MA*>?K$O3=@%>2PMJ !K%\EKLWH<#32<K]I/^>:%76DQI"J*\O%(E-Q[&R:;#
MIM:VC8E<P?0'2-J7!8ZYERNUIMU,+O?L"ICD#!Z&3EF"]A(_89_P)7Y*,9C#
MI#I14&6S4T(G7^I.W-]B&J6ID.(.H>V" H:W"$42V?[U"@B30"0&'=KJ^CE>
MD,*%E$\O48@ OQ>@<',-G^;1,;L)2WSH__$:+#S$=#B'K_<J@YI89G=D!B(J
M@>W4V5M)_08"4LF1_H0#:.6SN]WN"D)T&C&:)UQVI;8?'=V'*P4/"I#3];ZS
MF8<HH,CAL *7_Y2"E#M6V\6FZ%@KM_-$ ,=6(GQEKYC]K<9^QO8M[33]H=;I
M(]M-P)""9(G-I%O]0[&OO!XLSR&RE6#>SLS.;-VB0+9#6T-C*K/;+C-J:SJT
MO^6*-FRM[@V(1CC_EO 5VQA@\A4\9 GR/K]HTHLVCK6HI9E#"TWQ0/7\@I3"
M (#&98T01!.59;ZSR_I$VY-V^)@QER58MM2XFVIK(XR7U@\2AHNM##):CF-K
M^2TU'DS*?%N5T?1JA9\C+!Y)+AXR!!$7?['34K0>>5NE0L#G,"1W(7GR0"_.
M-U\H=J^#M'AD\,@+*4LO9@*9@['+@XYK2F.V+3U=<(W=/1,Y&&ET4I8[''H$
M9.>$;/_K$B?_PL]^[/*%GK-$P2-FE9B2RDR2S*EH//(P9W<\!B)4'4A"%8.9
M95!Y9 G@Z^ )5$?+IM@*#%0NK3&ZF2[DR[/!2*=WASSL\B+M'# _7R?ROG?Q
M@^\Y4_ OK*SO8*1@K>,5&NU A-K-\=XO48C/09#\R -$S?QS0P??X(03NTJ.
M%(&+O8M#T!V*E1RO]3L[>W4UDVB^Q+<H_)TM8DO>Q^K"%=:Z'N&X#*0X1C?7
MP^[)8,[OBH21]S_^M>GB,CU'QHYAW85XY<4KFMCS*HD-JL(9E"&J!HCIB<<Y
MF3B@B2&6WN :O$1:+$-_AF4X8AM2.'0\NF,R9S8[H7;VPEUSR49@N9TYZ M"
MDT<(,G-*'H7(2F]?82P2SIM4D-1D9IA?#9B3.7KYV8N6[%(U$+,YO3[:>6?U
M:81NWK;V5MFN=I6/:+P;H$5U2FQQ)4DN8< 4#PKE/;'EN5AWF#>F>23 [[1-
MN72V+NE?;WH6O\3K$#M>T9 &"KF3VHBJF_U[F')0F9 J!?U%H <URR@J?'49
MD%[-S"0BO**92^?;/YMT2K5Y<D%\]R9MHU8.I;( N2C>_\E$T73?[T3YPM_K
MU4OJG,P6U%%JW^=?1:-Z.VBF&0A43Z&I=F"F4(S:SJT0FRKUT"RR=3JO3Q/6
M9\(>\ZAQ_&KF(>K C'GDN\XR"\@:V"/]F@2BFO1%'1AV3EI;X(W.2J>W/TFI
M-$FA%Y7-Y0)?JE0F*BU*DGM"N4H:]R=8S=U%@9#U>GA%E1!N K;1$E%'A@J\
MM=F($BI6R\Y,^%^-'2:QRU7OP/#T4MTN:IQ#*B2]&5BWK9RJG77JSZ#>Z6_3
MU&JA=G?&Z\BH;,(((6MW8\W2L[>]%8T%:U_?-"#$XN:*$'.AB37CW%P;LIFN
M-X<KV*JH>M%J(S/W<UKM+0@EW+(S*V!7-@T4$9;I; %3R?RKXRF36@%)KR":
M.KTM5Y^VM1ROD!?R]/0M< H_\U@C?[4[S?,B/S&>M(T[B7*R:3!CBS2VMH')
MQLO?/3>]IU->2K*X<><:>!)$L+F11IQOX0F^^CZV53I_"@F%&1@&WV>=_H2\
M(+FI+*FV9>?.J$F1L1QD562V'\_>A\2V],7>6IV:?:4$0TLQE%,+NMW8!U75
M);3!K]CW@(12,OI>A5+LVP*AR.U:";>4?"@A15X8FM7U")$3Q<A/=S  1G+9
M>G?S/'#K1&!GD-$TQNI^?RL9ENOQ@FF _XM1F(MV,!<EVX@H2?LIRF>RB' (
MXIDO0Q(_+N?/A F*5B6E$TR\01=A$[1F[6X!N+'3_C+<O:FF(-O=5]_VS0N[
M93;.D<\R8O=+C".6GR1!<9)(4SE9[B;=&$Y6H;9X?XW'3G:N('(:<?VY\JUO
MVWV[I@!*9+Q^UV"6>BVQ\E9%VB[/VO_UBD]A)U_%ED0;]PITYL2>VD6=?),F
MINJ22=19O)4G)QCV!)5FKK/"I[;,28V/^6WCZZ1E;274H4U(2NBSQI]6:Y]L
M,$XWUD5$ YF;M&"GC=G13TPI1W"%JYAMOYNOA3F9A>04@LO5=LS$%K[-J>4W
M!.L;#7(# E=P"D+!-].9TQZIJ=>ID(S(V*N'FI;00&1C\-'+HWH7ZH_J&0]6
M]O:TW XMRXK,01'%&5/KIK57$\DST7]G[ZT*Y#,8\_P9^T_X%LQN*=YJM2 :
M>,,O$+8PYTX8M_W8#I89:G>HT(O%0*L&V EQI3L+9OLN$_TD".+\5#LKR5X4
M@37S>8FM @:M)W+%I#.\0AX+<]BY- H F68/8UK?LV2 ]#K(MH!L?3]74P:U
M=P+DU)8"D^AN:ZCB_BP%7U+/+N.[TX]53GWG29K\\*SD?0E;O'6Z%&YX,Z/P
M:$!"<85=]EZ*_'5 V]/$V04!#>@928J]Z7U$VR6@/^A#1]Q:V_F#(!"HW8#[
MK-%YV_<(NNA\\@:0QIN@]@5@+6#KX+5QQ-O[]V2\Y<CM.[&@AK5<WZ:>R!P,
M^01;AT-*9>1BIY*WJ=SUK*<R"*1IWJ_%TT#\UT-IVA;2-"G7V4D#K4DE:YAH
MZY6LGMB@-Y-.)[7>3$9EP;*OM',G6OMMCPRQDA6EJ]>VK  KC/$[-'4Q4=Z2
M;Z\.(_=6X7UG._@S5@L!155-"_<Y[4?= #5OQTZ/)ZSZ/GEFN\D#0RP>M"WR
M<CF$G6:\U C=UAH1OT=F+?(6=@S_4RJ7L%LM!&;)U.U2<3D1=A=S& O #EZ@
M:$*#!*N*,%6<06)45WI6*80XF%+Q*;1AO/C4J]$S081/."NF%2.?UM3SMOH1
MFF:YB.OA2&IU6_T\2)< +M]O 0I>IWI!PF<4NN*'/2S(\=2#E:R*2HUM8#L-
MG=783AK;P+9XOFSBOT1E0RJJN4Y1+8D-8Z$Q (:E7KNL4$,@H-Q'Z;3Z94"!
M52U2&X3?2Y2O-EI]?,H&D37&B&KB:.K&!JBMP\&V&J'6_?[J(]86=5,BL6'8
MZB(XQ>!"WH,%6=;Z!.L,.R1P8#3XYZ6';5BR/X;!V,!?V%L3<Y*\-N$]X?0W
MMB1C-?9I\Z9%(4AZF&0[@[DLMO2 ?S G.+H+Z((_.7(=Z.0\;=_E[RZ5PG[8
MCJD-(PVB@)][]-SL"\HOD,2.<LQA2OJROHS!:V2J,UFO61DZ$A02158G1+IK
M2'EKD;M-C[UHP*I- T91LF2@QL*5I<%_5*80IB$S#"RA(*U,/IBG0KMKQV?"
MYOD8!/+@XYT(KR:Q:ON[H=V%DEP_=7^+R\^Z?VO=V:G!G@7I.0RJA]O+-^P1
MDE8HI",9G8[M$8<\!M+!+NVEMZ7L?J*8ZOIW+]^Q9[B; QJ=86_LK;?A[R,N
MJ0YV#[W:,[0ZT8C.(&OT:X\PJE&(#N0*=6U2*/T]^\\#HOB'_P-02P,$%
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M,H\#<;8:9[!)MC]=5__\/R%H3]A_7E^C%Q0)\CPE)YM$JRZ\VS *.5)MC?>
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M50AZH->D9*3ATQ9SD>D2X>L '6ZWZTMYUG']([T8_,I;U[3#1]7XH:207C=
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M;AXPY\#6CVUH#^;;-I2SY/ 6-X7L)Q5;1M_X00>#0S;ZA''*BK:JC+22D;T
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M+_5 $ <^W%E8$!-3 M%E? ]*R\[0/E# (>0.Z@L6,,A#LV(+E(_M59\1GY'
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M.[0[1!1'^[\EH'B!1A^&(#^X(/^ZKM["'-*7GE8!HU<^KL\L<M6T)\!+H )
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M-2I1!SH"71BYU.I+VM]:I)^\EEH<-QF[3<XW]._4BS&IL64*ZK^.6!3U;3:
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MU4UCO?>]N4S94OGM H/"2HYR)TGSUCAG1:;[P>4H[0AT;:-Y7$99 $K-=%N
MZRYZQ]D5C!5EFI!"[Z-.A'*' &DTH'XG4^^^[C!UTR8@Y#A%*=$ ZQ 6G2N
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M4*@@SNGB.0Q^VU"AX($N#25@D4]9>T^!GH7H:92:3^1,!*<:HZ#L0!F=PPG
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MF$CV-D1E>Z2<F$@;-:-4FROY;R<9-3<T!49NX^@E\*E_NGW@6_0JU&4:4T#
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M31*5W'BY";FNK7:&E7XPG.K)$LEJ[XVK@\*2 /(U<&I$D,M\;HY]JY8$**0
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M:S1_CC8)_Y@!:ON5[X_M+*37D1=.GV**AES[4,#']Q\_$*!)--'1R2-?$Y^
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M A0"ZIV^"7V^;AX3;E@#V.>+E0RYC"!!B@-GG95S[3I3#L&W47]9TAB;+RU
M4=7)<X!Y%80"Y0)#[#=1RH?,EOS\9OR4;W6JPMPDE9.C)L7$]%FFW82D&0<R
MRL^W)O  $9/'F'H+!\'S7M:&F<NBYI7MN\2R9 F4QMPJXUO,#LDA<OXWLBR%
MTZG)KJG?-$O!A\,DSCOJ,4C=SRK\/GE!F$ ;I'9Y\8HP>0)ZT&6:(4THLPRZ
M*">T*ADK")41)4B5O!-TG8+3V7Q31LQGOU 3@G$AEZ[\0H^%3S&?N8U02(#X
MN]T5!B]$+I0R.O99@7.S6RP2[+ 77.L.E67-X%QW5[0C!>M/@*O5FAO,<(K,
MXO,@64>)QV;+ZRA\N@Y>J"\V@T6'7C8?W)@PSPE.)+?=N 5ENS+&1$U6*F\_
M^"FZ-89(L;K<@%]%)O-+]TPB\+5]R,:]#)*%Q_Y.O;;]#!WF'74FDC+*\WV:
MP$.%4Q)5$Z$FG1 ]+>P ,3&!F5VIT7!V;!4V1%;9W=[R%92)+TD[+?1W( K+
M2:&HFJW&7-O$5L4IFB^5+\>I/9+PC;QXYM;:.2!>1&OLJB*"4NVT7$$8S3"#
M=-:VWK&.:U>R?'Y^)IF?D1Z)**S9^W&=;YP_[K6#4AVZYT<$C7;RZC:A^IB@
M^: XW5?R=.\J'\25M$KCE*G6A=MLDGF8)Y#!\TCY=18X"()E"1=G%)IXL"M^
M3W[Y+]K*X2\S+B1%@B0)ISE@]EG7G&?Y1FPC HZ,1:\0]RP:EF?8-?<*P*XV
M[9*I2NSC"9%->8.0O"A6B*=X&:_<\H7J:8B>!VHDB]:V ;[Q[IR*G[Z>$#&U
M<Y!@R&ZX@X"JB5#WV4NQ;S+$5"U '4-V;Q"+I?"=EHR[$HKEY!'Y&6*"?/*
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M0ONQX?W+M.S3 PWL0I?%-;&/;U<'45/[5)0FGWXS9=A[L8FX*6:HMT.>]S\
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MF?ERL_UHW<,>QL(4WIVH)8M8>5(7&YEAV)+JCR6 O5_:T& B_\/XP6V-D9B
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M?5)F,!R^<+M>Z5UM??\3:&#KAG7<Y^L#CV9;-J/B>S3'9N34 (92Z]!T#55
M8/QJ.YVCH4MF[#XOXCQ,16"@)2BKT6@JRH"X5DZHSN+N.86M?<JKXMILU;/-
M(U]$PLNH5NVC1Y^.90F@)G)"XE-M2YW])^8Y;]WWSH;HEGR!*FJ74^LM,->:
MF]"A6 N(!*^L;0K^!##3.;"#CNLY 9\XCS'C^1MNU+!F.^Q:(1#/ J(:S\62
M5[YI/QD;8C\*I20FCJDHRE =6?9_61ZMV*RE=^*85+632&(OB#?O*X_ZMR6-
MN;,.)C>Y:5@\S4$4W(0)QCT [51H8Y$KR7)$LJAY^1!MIR!+(9P^6L$-,WM/
MB32V1.!&?$QB 8P'$W_=,P)Q;C-!#B>)?3D;"C'=QSE)V1WT;%?#3^@^ :.#
M0L!8Q+:"F+:&V"8@"/@5$7H\_)=#K)!X!7[(?C'2QU&8^AO3E81<NL_0TJ"/
MFL'4E_OD5[.$CW].*)V+$J7G?;=-,YA^*#*$_KA"AHXD@6[LTGRFSJI%_7I@
M^_E._&@3_E)JBH\D=P,AU!H@3[;$WUR2U3:.?BN(./-PI8(C(%D3:C=>].\]
MU<HHS^Q>8Y/-)>PEOP_Y/H(D$LBV8<U;E:;&HXI]"LW0NRY,2F>/B=C62W19
M)C= 6%"6F:O[N*SL?6E@BQT59(]FPB9<0-4P0Z4W?+V(GR'X%;8K$P.BXS"!
MA@^ +328D5L<.4NN#MC,:'(TF/'9+*N_:)FTCN2E(TE@1P1* *IGPF6V9<*.
MJ':?0G"W40(V1@N>2&N"AH;;;_M(P(J#\<SH >[1;6HW=_7.,!GIAFW+PT;H
M'<Z@R1[=)W-?5TB3B\U#PN0!DNX @?*8*[D?#73-Y9F\\V*"<6[" 32UP9:+
M'%J&]"<(B6=UT*Y)"-2'_Z)"\1Z<MW+Z2-B6MC #*:E9SCGG!Y$=2GL>5I^.
MV&"1,KU*54%R'E5KX\E<0V:3D%Y^L"K14,5&''-)C3$"]G*I)".)GR:TNJZ,
MI&9C]#?V+:^,?'J(G_E)M;7&_A:]A;Q)B7"J6-2>*1)F3=*@=??NA"V:VZHW
ML ?)*'X[VD_JE+S&X0YRWW\G:X4=TWU8#)TF>6;Z>&($?">;'/M*\+5 .+/#
M2_H8!WOI2NP 9\&Q5BM$H5OF-Q]^_.EM&>6T)7 W?[_(+(@RWT#)$!#OHXRP
M;6.MEV&PQ6QQ]UL"@85[NN!3)T+3=R93G4X-/V>^45%.5E#)V(>T)0=T=L+^
MMI7KSEUPN]9H@EX6X7A4R2;*8V\XH4=UQWX43DVIJ*QN'= L8Q#'WL)&9;YR
MC9E_M]?R&$(/WR4,TV)B+^ "K*\/KQG@XY16RAE$ @I$$L<-?3P5;%-)'9+#
M+C<:&TZEP(Z622HV4X]2NKT[X[^=RMC(_FYZY!N!U83=P6QK)>DZBL/TP$5=
MJ. .29\)I;RZ@XA<M+RZOH:;0&1DMDR>"J:ALWM9>YF[DB>.Z8QNR9<5[[FZ
MLTCY312O+!9]<UMD\\N<U^I6:VX)8+6T0X39*?7+.P*([/MMM I;!;Z<#;&]
MU3VKKH$3-H*082BVYDQ3&$9Q K)1ER!3_X,NTG#IKJW!K&BQYF 8*P[<"*'C
M(LO )DV=;P932/QB(S0O*OTW])=8O&,0:&*QFC::X )QRX#@>J#;:QQ9+]7N
M+D@,<;4_/?SC]46?<_57]$?W94LH=<(.Z2VP;S93A2%+I'+?/L@;XV%IVA@/
M2^PGE5* LR5KLW'3D2/:K^=4]*^>X88B@"VM11\^N&SVHPZ [K5J!$!!#JS\
MF_R<$F<-^.05S4*:M6O+]PJN.I'V9(V3(-Q0IJDHZV(%Z7B<E=).YSLX2E:8
MG=&(HQ\AW8=;R[_4OG2W]]?6$SMT% (A]8Q%Y]UH;ST=X!,!BLL4.T@R+9.%
MC\#3-7>=@.-6Z4^F:$E3FVF(?/QN=.XJ8T-L*8IM\G5$"TC%KTP(;'69*DO6
MPDRYVQ>BU-IBTPSH<_([%FW,,]=Z_>N)/ZV#UM$>VW$7O<>\"DB<2W\OW,]@
M9 60!6<\8Z^>%^-G&N9?PMV0^FO+S@P]\ @Y[@>=DS8T5%<';"?9;D^3 V$7
M1/H1K8A9)2LSL+FC-ULFHN!T^3O 1#\F^=](#FC_;*?^3M9"[)@GJ?P3M#.F
MAYQW!M@WP,#BD9I9HB<"ZD^C.OE/GP:VE- '/,,9H'0, 50Q50*?V )Z&[]/
M#&%91_CL#Z_<[H6/O-<R,S^_O#J!^.P=L"^M,IGB%31G>;TR$4M&YV7/%3#'
M,:D9QU+#/%6B9IM,)\EXJ0# @8+JGNW0S>H>;9V^$^F@WYZJ>@J$=W4'H+C:
M([,BC6+VDUAK,)F39Q:+3+>&"&@7PO+AM$RI 4-,?,'TO*_QUJB;*KIF]JFI
MC6D2LW]=B92(WD%EQ]) O[+ZX17U:8]M)%JM4L(%=)'8(PTV>CEIIE+NHF*7
M:75@C2:ADRA-Q7_ 1;WL =+/?K+?WX[FV-_1&3-4_=?Q\4;5?Z%?-$8CCMA,
M0T.-'520V;9(LBI$"6*;"@HSYU97H7@)\P1K_90(I&?C=Q^'\@3N8HON?*2J
M/0%&:H^$<,;V>D]$4US+P$?8Z:EJMT''B$LCN/BX1],:P]]NA1@O^S6*H4I#
M>XE;/V*+RZ<F)G9@"H]!=PK:_I. ?*Y"L=O!%U8-OT??R1BI>#BN'7;/V/!2
MMZZIV I4CYBS2T^/GCA7H1?'V-A!&R3+".$>5%<1CA[-+W6OU)&@X7T9'85Z
MG*&Q-9L2 PI@HQR6 AMJS5$$D)EE@K4 L].1W6R,61MC?[%6@*3C_K<VGE30
MG.T3M%MA7T>@% #6(TDSD7OJ4H;MK2<BF/,;WU!=P]4./:M!I@?*_WN(8E)S
ME#L;8BNALC*HJBQT1#%12Q=L Y\5:3"K0PWVD4).)H9]*7BKG\!69$.BO  D
MBVE59#IF9MCO98D099-@] ;HA?0>$Q7?88^5M#7$/@C%6T9^*R!8[L-HIW(V
MG')Q*HA.B6(-(N4QR5D3CFU.V2%H?:&A!-'M"R$%NW7E2KH+HSB#Z'ZSX=?9
M 5W6;$06WZ66 AOFEMBZ?#.EPII18VZ)G9^\V[.' ';$(OT29?LD"ZD G7Z(
M/MBKP=>YAW1P"AUL-.A:S8ML7L![*8W(%9 \6+S78':<1]DJI( V8.+_9&*H
M]RILQ(-R4E>^3HL+P]T<_4XTX:@ZLF6='; O%6[QLQ1E4=OIBUFJ[-L775.\
M(1#(3._9B?CV5V))@6\T0M?,%:(UI<EGR-HWWZ0;GKUU#W$@%E#98VE,(ZP/
M=#R>OZ^'[W2!3??MBRK5O]'H712[2N3I>-TGL704S%;;B%T._%W;W(@"V#>,
M!(?? 1?Z;@?&XI!^C2B3K)+84%%J]!$NX-W\ E%"R\\$7CBC+'<T$6PUM94<
MYC(MVEMCZX #\U-^YKE"IUL[_ ^-G2%R#2D@JAJ/-1;$V [;6JB6\/J@I8',
M4VX*6!UL]ID>W::PZ4^QL]5S"O1(0;[O1K7I=8R%K:27F5BBE'D5Q,X+;4&6
M8-;BRYUY.Y DYCGG\ +Q6N7L=X5^N9MC'XZZL<]JO3"U0Y[Z'8G9(P!2TFR]
M8Z(#O+"0D^]0^CJZX$+F)RDW/-HCDFV9A_V[3BPI$<SZ]M!#>VML"3A]#V,9
MY%_+R!)A_AF;L$P F$<QT_"8]%X">#KEQE$(8U\H P-S["G0WF.">@X]94N7
M,Q&VJ]NE[IS>T7]"OQQUZQPY-N8+H]S&*S9W]N9!/1Z+Q&)MB:V%5]%LRP30
M)]@52$FM\/HR&0&2W\<XZ+<&6);(6J$1N2X*4TM<@##V)0[RGUMVL/I!@W5W
MFF+ H[L45T>7"_'2"W>ZA)O>7(?QKVFQSU>')Y+SO*HY.VWM!("Q!\ 6AI.8
M'+Z&Z:\D!UAZQXDTM[S(^EZS.&8/2IJ%:3MN9@RBV-_4H++8#&>VMMC 51S9
MO:Q8S"X<$%],13U,3/7OC<UF'W0LB:C,-:XF_A4W4#VX< )''@)=@##I#]KI
M5,!4RX3-GKU,NWF2\E"X[/K@.@>C$$9'(6:SM^>C":/N(_GD/UGPAX^A, 5-
M[11?#O^'++8H7,*,/= RF(X]JM/(-1!ZY /7"T-^37X)\]!@UNMJB\["4_%&
MH]6<)J%EWEH#;&M=Z6J& #Q-;&97ZRX2!K5L$;^:+<;]>U](S- C^98SK8A^
M$"96YELS3O2)M-"7@,T3,GKN=WNFF NSJ%VL=C3'=K?)B*"1:L .((=XT3PP
MN8@^;9GN(WRCS7NF^3NJ"%#L=DS[6&R<>,)&:?&4_M-$93%M/4O3*<@O)VF:
MFE@A!#,C].Z8]-&OHK>\'Y"KN>6E?FFG9C><*O*R\/(<BTWCBNF#5M>OYZ5^
M]38X0/OM\38(=BK(T\(N*Y4_(J+_5!YQLN9*!GA7#,4R;>VP;8-%S%[Q?4BO
M$[>UU]#NPL_3G;!JR&0Z:X*7AV&F*2F9"VT>(3^9"6!?(%R]* -2'J1=T^[,
M<G; /JT-Z[S1I]\;1]W>&[7<Y^SZ%FQCAT<FEEQ'R4.4;XLPCD);K4]W>U07
M,3OZJRU9?B8 1@#N7IM;V-+P4F_83BR LL*'!TGFV,&GL,A=>,53 RENEV/F
M96ZB=:-8(]O.?/5%JJWENCV!$O8WZX (UW9I9MNF]J#FL8BCV^/A*4WWB;#>
M04+,8E/[D\VYX.Z%_>W'B^?TI\:U!IF P::ZD=W11+:VB-M9U6ZO,N3G["]9
M<_]:FB&OO;Q/C?>H]-RY+&A'=,>&RC*5]K8Y^*V-L7/U9CUS]0SMT#U=_1QT
M<#"8J#O$QR=)H$M!0G%2AT*HCF8IQ]02.]JH40,4K*@KT^R-#;$=Z+",];O)
M@6EI;XU[W'<@U*0'J;) ?2C6@T=8&<Z\O?'W(Q*Y4ER>$TIEG(-GF:GG++ 3
M#T01=%?*0*T%^FW9U/3:2+/]-,1VOTF)M[,X+D+*-DO,+>8.L-0^_=!9:]98
MKE;]D3@C.RQ=L*5$ +5G_X-K]".DA&-@Z8CW  Q3^X/6TEDS= S"EWJ3FS+.
M5)W.GQ/ 8 4)[ISY;L[1IR"\@$6R?-0KJ#H(Z:M7>7J"ZEV 0:!\+O>QDLBL
MLLX8Q*>OMYZHKV)CFJ@TZ6XT<TM3]"^3, V-*604(L)B;G'?B_/IBJGOT>U2
MK[^V"/E<U;7U+*QJ(V$; *IW'J!%C@*^[]MWJEN_1Y12W[[8:D6<1^N(%A#=
M7[T3;IMM5Q]\U4/$&,^*?)MPO!O+'65N.16$QR59;>/HM\)ZQ9I;3DV%Z*LW
MX"L+[,AN(BXU60ZT_!73BE17(D%B4*KCG+11QIVML6^>OCZ)B_$^U"Q'Y8^9
M_#4SQFF?1 A;<"I]UJU#S'/BR[?]F/+;1Y%"!1FHUU>&$Z9;9P'82Y5B%B!)
MK@,ZA!BV8J/4<"W2+"O_^)>(,&5TM3W8Q8BC"$PSBM)<JY<=VR3U4 /80A?[
MU0P/<#;57BU"ZC2<.9I/<$.7(*+';>-&-\SK2CX>(AEVL6&7K!E[I[,QOE3?
M< R4CN.;<!_E(77MNOZ]T=/X;9GWE359Y.ISV!V2,_$@RK>@/;/V[%JPY?8/
M)HOK._T(LSMZ6"5/MW<'CLXZOYO_]".3R=_3T%"-N7\O;"N*(09"5.E0_P7A
M'WVC)]H]$>.H;I(/DIH.9>O'2>3-ELBE>HH]V_FB1!$ X7/4*T?F;%\*V.*[
MMUAK 9"NLE]&M80>.3:V3)0F*T+6&4AM2J!?;/B4H2 1'$R0]2UFACY=L:^M
M5KW8GN;>::CQD*,GJU^TWX[6CYC7D\0;@EWP_/)JD]N,K;"OF5*U'P>%JJ<=
M8>3!D!>126(FD$]11:\&\FE:E?Z])[-7S+Z%VV\K6C .X%*$[U@H$.IFL&*/
M/(LQ1L!>+I= SW^L)W@3\UM\-!5T%5#5CLRXV33:1+"I%3A;$5*]I%.W\7$(
M/6Q[5 97'3O$.S8SLV6IU@+=*:3[(3B P\N>*>+K1:Q*B$.\CM%"WK<O.HL-
MA*..0$=7>W16]!5O)A)W?Z-FCVG>EMQF-_2RM!/!9IJ\P_H_DSTX&(Y 5^G5
M$;5<7LWB<?MM'XE,08[_QI3L9GW4WITF885PHF^UI)MC^^*KQ>:8&/98;0KZ
M$&V,LEN/;MBN@R0E;/%O8,U30QZ7JQVV)/%R!Z:XF%M:9%EH7LTGEY8&5U'>
MDXE,ZH7CYCI0AZP54UWML2,1DMTNB?D3) NWB5BFW\WOF*,YHJEXF8;@9W@Y
M[-X2JD^[]2-N[$TC1,$0;]-H@6C?6D8YY=GT:Z;CKYDR PX=7MH.Y)1MM%\F
M(@6_[=H\H3NVN-.H#><(3+8T1;^1&CN'6WQ=BD.])7:.0]T-!6%*BPU[GOD,
M]2 71V6\8VF@RFLAA^R :[1"]5YL1/P&A/ O/F.2PC&I,)JOR88]_[QZ"*!I
MUQ$QQJ.*CNM(P0S]LB6DA-.R'45;6_PG=9^2+=MC914)[A%G)\[RI-J:HWMI
M8BAMRKV."CQ 9KEJ*05VL>>8_MC1I$+AR61XD2-ER-P2>_J-LIEUF9E-N=@5
M/("!0PI"U%A(068#U[*\ <R;<Q3"Z#$QSL(4W 8SI+)%G0"VCLRN1$BEL.95
M:;]/2;HTP: :&Z$[$515(%E4+^+/C@68?I;/R1KJ]0)$9)$GZ:%65<CL51AQ
M .S-:+.\@-1L#XGLT0U=W-85>EN(5;L5OF2BM/>G,%VD'+A4W%_*/]FA]-NZ
MH</'_4(H_6N<?,8O3/I/8K+FMW&KY(*S,?[7:0J"O<WN??M.ROYA+ 69J6I:
M\F+K-I+T(H-M8/ 6N%:'C#9:+,XT]@30<^=)D;IA<ZL64WT;E=-]K=P3'V8/
M\%$$IK[]K>"DQITV>EGU\8;'5MFU&$_G@V%LB!RI6%JLYH0L8H L;)UB8ZM)
M"8,/KK(KEJ;8UH-A(6UV ] HA%&3-05XF+G I]3$,H=X=C(1)*97PK/\C_L'
MG8OJK]CAK*Q)F&VK -1X+4%OXG=^D%Q1Y+T[5TS^[S]7/++#^NN__R?U%_8/
MJ-CY[_\/4$L#!!0    ( )F5;E;4H%1!25$  $,Z!@ 5    971N8BTR,#(R
M,3(S,5]P<F4N>&UL[7W==^.VDN?[_!6]V9>9L]OI=.=^Y9Z;F2-_]7K';OG8
M<C)W7W)H$I(X39$*2+JM_/4+@*3$#P $2)" 0#[,W(X%@(4?"H5"5:'J'__Q
MM@O>O0(8^U'X\W<?O__ANW<@="//#S<_?_?\]'[Q='E[^]U__/N__.-_O'__
M[NKF]LN[+^#;NX6;^*_@RH_=((I3"-[]Z]/]O[W[KXO'NW=W?OCUQ8G!NZO(
M37<@3-Z]?[=-DOW?/WSX]NW;]][:#^,H2!/TP?A[-]I]>/?^?3[\)00._ON[
M*R<![_[^Z8=//[[_X<?W'_^T^OC7OW_ZZ]___+?O?_SKCQ__UP\__/V''TK=
MHOT!^IMM\NY?W7][AWNA;X<A"(+#NQL_=$+7=X)W3\5'__>[V]#]_MTB"-X]
MXE[QNT<0 _@*O.^S,0,T@[\'Q33>8O_OL;L%.^<N<@EY/W]7FL_;"PR^C^#F
MPZ<??OCQP[$7LP7^K_=%L_?X3^\_?GK_X\?OWV+ONW=H-<*8?%O@(T7SMT;[
M;S^2UA]_^NFG#^378]/8IS5$PW[\\%_W=T]DGN_1"B4(-?#=O__+NW<9'# *
MP"-8O\/_^_QX6QGD;S^]^!%92H3]IX^??OSX(7'>HC#:'3[@]A\>T?_[K6"'
MXG\7H7<=)GYRN W7$=P19!&9Y&M;"-8_?P>2\.5],23&YW]*#Y0<]N#G[V)_
MMP_ =Q]43N<I03R*/W\987[V/?2?WH438-R>M@ DL=!DQ(?1.94'!Z*?MR#Q
M72=0-"_JF"-/\OC'>+E>[@$DO!,CAKJ,=GL(MB",D9B[B^(>BRG_#8T@/"61
M^W4;!1XZ$:Y_3]&FN@)KW_43-?-O'=ZHJ2OB^@X?T0C#I1-O;X+HFR*.;PPW
MW-1.VL@2;IS0_X/L-+31+IS81Z0\0'3,AXG$0=-AP#&F]Y3N=@X\(&[R-Z&/
M]H^##D'7C5)T"H:;![0,K@_$UJ_KH&-,\\;QX2].D()[X.#_)APE.2ON&&-,
M@G7\8>$?A1UF)#[@.-/;[?R$H$I.-,(LZ (ASW\"(XTQH16 N[O(D140]6Z#
MD%K:K(UCY&,;P4*=1Y%>^/-(@@*B "'MIXM Y@\RQC30'3+:@97S)LWIE)YC
M$/P%)%C)? #P:8MT#DFB&;W'.>Y>8O![BB3#]6L'@<GJ;LY)/>B);<S)O7)>
M NDY"HQDQBG>:7:RPVH^T3O.47"\,4_W3C.A=]9W9'::A,A0HRLO8C,1'V'D
M\[_30C#[:] %.DV .X89M_R%Y_GX?YV@9!J^ HGC![*S5?,Q<W0.A="H^Z V
MW>0XA:.[:!''((GS-MXB.79;AH_ 32%$4R-,T VS@:G0!Z2[!5X:@.4:G_30
M<9/4">Z=)(5H\4%N#\0B^]4)<I5@\8HHQ\+C)H)/Z*]/>&*DM4IH!Z3+# 7T
M-$,DE/:.[Z$I+),M@)>(3;"7C+!2-T@'^KIIP"&A!5/@7;]AO:@K^ZG[H&9M
M7^$)T?,KFH$XK==-B@0&N/=#?Y?N[I!X 0_.@?1Y#I$N^B4*+_%Z!T1LY+Z^
M<$,:+E\"?Y.Y_I1C.#"! U\'Y">V"$,DO8N9(?%<G8DHP".2,.;=5N&^E1ER
M]$OC:67(_0.?X6@9HY"T+!_>V<+=QG&*>5^:.8;Z\NB ]6&,ON-JY(YEFN!H
M)AS1]JL#H8.M:M%#"MTMVJB4!53*(#T_KL^XI/)^V/D#^J9_NM/BGY=[0C&.
M>20A*^I0D/B. 6!<QXF_PXKMZ1Y:)CS^C!D<>,\QOI8&COL5;03T@3C[^0'Z
M+OKA/O) , B&@Y$WAO1Z84[K$<0)HHT$UJ"&SZ&?2++B )\R@!OI/P^W.]L^
M-;+5N42<DZ1)! _HSX^(_>/%?A_X+M9!5E'6@9PQ>R<\(/46^T-]SW=@9PO+
ML$0,O-EHQ!__EM_$+T (UGXBO;NZCZV+=TY6B>7Z"JP!A,!#+?H8B_I^9F0H
M%"HZDJ/J6G/LM;F!T>X4C'P!$(U9JV68=5&W]ET^IT$&/ (W0C?^P"<T,O=M
M7<ZMHNOU&I#7,/E?E$B-H:C1 .RB/I?5%I&_\<,0:5OD[0:^'2UVV%^T7#^'
M$#7?A/X?1$+D\Y0WZ8Q%B09O+?5V^1 E2+SZ3A <KGS\T.FUY+"X?G.#U$-Z
M,=J&ET[@ID$. &D*O/P#W?:\)NJ&ULEK46.*C"<=1F5-=%_R/=^A/^3-\3P&
M?IV%_HR_42>@2C!X0TN.5I6\(2MH#B*WTBC +^HB6 40TQXCXLFCMQBXWV^B
MUP\>\ G]^!\$78(L^H_?+J-7 !<O,?'J%2,%S@L(?OZN^?N'H<DI %RA$2G4
M5'X>G)@%^I2'/W<3.!L*-=7?1\,&R0H_PN(6O_/D@%1M-QIY-VB_.L$_@0-O
MT%]B#H'UEB.3F.$C1F2Y[>!D9J+C$9VM>-N%R1=G1UMG:K.1B+L$. X R5T/
MO/TG.#"IJ[<;B[S,;_X(]A'$;B6BZ=%6F=M\)&)_B0*D,B$=Z\8/ &1366\W
M$GFW80*P\,<OUIW$R;%B4LEH/CBQ^8=.,H4M()E-1T*4K-\E^N &W3V80%9;
MC43:KR (_C.,OH5/P(FC$'C8_08@DTA6^Y'(?4A? M^]"2*'S9#E-F.)GY-+
M*O=2G91YMA#B=1J<\%MW#1<ITJ<CN$@2$&>**4/QX30>">&G+6*\W"#*1+32
M:"S"=NB:=I'&?@ABMBBOMAJ)M.L=@.BZOOD,HV_)M@T\>NNQ2'U;(8TF)K>[
M3/5BT]EL.CB1^>W[\/'3RPK?YBC$-9H,3A2" 8N*I\/N)0HH%%5_'PVCZS=W
MZX0;P%!BJ<U&/(>_I+L7SOE6:C*:NN5&$.FAF0L-YP*XQ!8UB,X'CWT+X/<:
MB?25\W;K84L5CF+'A+2 RVH_$KD+ST.G;)S_SQV2Q1^9I-+::B/SDP29GT8F
M\Q+]<PE72"-L([+4<EP2R?98P@<8O?HX35,+G?7FXQ+[$"'M*OA__IZ[_:F-
MA[]RX2]#X#!(J_P\.#$XO5CPL$5W$*;4:309S>"4!;QF]@6.K:G2;#Q;ZU%_
M:B6PT70T(N/3"0>\B\,C=H,#M!U7X"VY0!_ZRJ&ZO>_PIN3LMG3CP]TM39>M
M_CX6.0R=K/SK6*04V0'9Y!Q;5$@JNU$6L$J> ]UB./3/AFNGFA8P;_%A3S)*
MO7>W?G!<J#6,=C1W2/&UB.*=>!=!#\"?O_O33S@KY!Y=3+":^_-WZ/!.8T1(
MM,]<5_BW/*;C+ILSDT1"7P)@#$A+<X&H.4YR)/[\P_208/AL"D0^3A>1AINH
MP.33U#&I^*4*5'Z<'BIT-U@!R)^F"DC#]58@\N?)(L+P]A7 _&6JP#0\BP4B
M?YTJ(BQG9@',WZ8'#-MQ6H R00V6ZJC-\?C+!/78%N]P@<P$]5F*([I 8X*:
MK(C_NX!G@BHMS\M>P#)9Q;;JTR_@F*Q66XLD*/"8K#++"%\H<)FL2DN+E2A
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M-H4A+H3U$M*,VY3E3D'QJ]C1$]-^,;(<,^Z-JLQ6TK<82X&C7GHP4(T+B.T
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M-3JH?[S+%<^TX$SI[B/3W+CBR--]IRKDIPN[?$GQ;ERNCXF$\Z+%+/YGM]=
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MFFK'-F[1!PJ8/H/@P+Z;P7+'K"B<BO>>Y0X7M4Q*,<NI]9O4XM&T*2.G\M_
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MGS(3,KR^\!7$.(#?=6'J!#'Y7Z0A^<X++EON V&)TG5X95*^0=$=0&M1?.I
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M61OOH'$"  #!"@  #P   &5T;F(M97@R,U\Q+FAT;=U644_;,!!^YU?<F(9
M:IJF@;8D626$ $T#A&#2]NHX3F*1V)Y]5>A^_2Y)BQAHO&Q -^4ACN^[\W>?
M[QPG)=;5? N24K",WI"@Q$K,3[YYXS#Q^P\R^RM[DNIL"0Z7E?BX73-;2!4!
M6Z!^)VNC+3*%L6%9)E41P<S<Q=M=4+-V07&'GE294!B-AJ,/<:X5>D[^$%%
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M;0D%(QD+.X0)FHQ'3D'L-P/5%(-ICJ 9(^%DW@PE!VPA!S2WFP,XB44**$/
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M&[<1_]Z_ FW'&7N&I/6*4Y-J9A1%23Q-[8PD3]N/N#N0A'UW.!]PI-B_OOL
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MZ]N#!G?JO<WY+N[C@3'B+N[C(>[*LS\B:>K**L[,%*?840U8^"KU4<\C<:T
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M^'BL5$*7RA7ADKI??#-0!3AQQ;5=J1 H_#06S_=?<.%V6.N"LQQ#\?MVAW7
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MV%T$U?TEO&R">0'YP+BE)(X'DB1,\0 <C#/^E)IG:84,GK62>A^FH%WP2R7
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M$N8UA2/>I%Z'L Q*^8[5Z)6WHOF0BA.?O9E@)8.C4W7DW^OZ.XX5)\]"4W>
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MM#Y/K#&"YM9TV+Q)@;YT'V><:SP&]<A"_AM]+])V'O-D3$I%<KB;4C-^^TJ
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M\>_^D,=?_O)O&1JO+/"UX'O5'C[?E>#Z  KL[[S49.']XJ;BOE:J#Q:R)B1
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MW1/U#4N9KG;UB*^G#7H7EXLY%^J4="LDNM<A)X'--B\_9+H]#\S]MP^J]3I
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M&^]W(5.""]K#Q*E%U5IT&LES=5(&$[.=RL"+LQ<GN8M7^<9XDYU?)X1K*J&
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M>C<$V5R')'O=-I%T]6Y?QP%4Q3RR]&?"::]FPNC(VBU!@;9K^LXNCW/+$#B
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M?"@^W4TZ _;MLPZ')15ZF9]]<]*K;74O<4"N8C,>F-%TOU1V90\4^!#^F.L
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MCCO=9B^C/[7<%^T@K*6K>%#?[GX!%&J:#P2,%XR9TW9PP(?09ZU44N/T$*2
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M)/D>P[^T<2(!;]HQ]7OUOPE?%>?ONWRL$.\G07^8C(]80_$VK._%&B+;!I9
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M^5'7*/Q0LG#MZ5!.[!/90HG,104C:NP4#M@6&T=+IZ'E5UE!!^-_#OH5PSZ
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M&#R/;OH('51ZGJ$(VO;6I#A3Y![SVD_W$T0D)7T[EX'$<F4=RTBM#FA!"19
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MP.>#FJ5$HX+-4WLE878K9A#T&72RW,-'NUL<V_8G5S%'?I,"Z:FXFP8:L#E
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M723:@O=;L^\)$ /%X /E726Q(T[FLC)'/2^L+N*XQRERP08X1I^::/RR]@W
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M@]X6B$=^\?BSNYPW(,:C7WM,MX6;@M^KG',CBVA+LH'3-,GY\7G:Q>](NND
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M(X+M^A"$J!''-/>^_?!07^D:RX78T&)=YM7,%=G9 XV@V]G1 .(9Y;!F1?M
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M_QA'K4?&_[ @*-\2'4_=6VZ;Z9T %BAP\:/.Q?Q3X,9N.6\%TY$)[.?M&R2
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M% >(PJ@=OGAN1;DEJ/YXC,PM0-T+L*%C,UN1F.,Q[7QQ'W"1_53Y$O"YS44
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M,1S IC'2GK*X#.Z0P]XE7\W^G\E?#YK0#(;B'S@$/R]6V$2H>L8MC+,^<)8
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M(^AE8C=82*NVR@PMS;?FFW;"SV62YC2 'D]!7I>"9=] $?QHP^991J&,_$?
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M_!YO3<8>E#GPF,%?Q^ B2AS;1"!B_M$X+_2:,?!1T_5^F'Q\=->HVN&8SR8
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MEVN=[V>X]>ON)'3/-:A\4[=1*0)4\L[[47W0EI+_Y$A<YHXL#68,54Y!T"5
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M%KD>V2J1X=1O/=4,G<:IVCZ-\^NM8B@A(-TE9(?T7>]0.G7TQ$#IM.ZN*4\
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M%TT#]\7<"\]OGM?XM)SOJ63\RWM,ZH$B'%LGVQ^QW7;< F\)^;\%+7;M$^O
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M^ZT'W>3J#!B.O^A<[_&);3ZL<%I]8&8>?7S=5& L)6;GH++,9BT9H:'Y7LR
M35EU46981;5MX_?&><U!?I3#Z]@(X')?X;0I"I3DRP4WS 44S(0(N'GP,JZ'
M,?E6)=RN!R<:5P\[NX>6+2>0PD9I[<;XFF1)+=/4!O[*3YV[9A.) ;H7.NE
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M[H4=5XWK. D_B?;77%HC4EDY=JK;/L9X)!V#ZA.C7S#6EK!'YW[P??9PCC+
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M+D;8CVFM!O*&XS^LCAB8W%FRJ8R2?!X6S1*]&X%\(YQACW/KU_.) /<D=_9
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MW3 US"7"2L^94VSAI31B?%+!]#[/ZZ/O6>ANX'I#*; %8T&:%[0W]OOPQ)_
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M-7KZNP7]LC UBKN0YGU>BY=A/R8FQ>SOU(>-LTGK[:F#D:>??%?V6KA9_04
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M]N3F?=$)/X/&SJ\@2(J% ([ !U( 8\5Q!)E+SZS;#P3G>&0MLCH,B<=[[F2
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M0'I,KI<5!99UO*8-V,[^^#'^JNL15TA')](U2,$BB-@(-8$>XC5B55#/L7
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M_60T^3C]9;SP\(*WE)?:$@J6&-_\P85)XR.@25$%BJ)JQQ/TWCVJ'I*->0N
MKCR@<7_(^Z/C(O3)"WU1%3W;K[@GT@](T_4N<=D?&:]?J#@FQE!2#P\8'9U+
M:RCGH[X1(D;/2/-;Y@]O^E44,E*+FF[-7U@G26^%ZZB%_8CY9\[1SP,BG0H#
M_S/R343D@YU Y&5 Y(7Z1G$)]U?Z"%6_4L W91]S/?L\?U"8FBT))+$(4,_"
MOM]?-G8S.K*7[1]59\!=O(+<69X\&3\?IH5VF !T9Y_CW-*^[-K;8-Q\'+4D
MHA'F&+M;MI]F)%AZ?H:1KZQ7$\+8\1+QDC*L]'+@K:T)9A4.RAA3;#*=H$2^
MXUOVP)FQ+)HE[?L5I:@FRN735Y!?=L/O=.GR+Z;C5Z\@R)+K!.7KX18"?<\@
MXHIW1E<5\H87/XYP)NO'9,<P)Q:&L&Y+-99&R]2:.!Z>^-W@52-/>C=/ 1_R
M%<G:IQL0P7WYWX?W$ =_M3C!+Q)<'VC:9RM^4\Q[K/N(@)W[-DWH2PE"H@_V
M>H8S2+NX*Y%[-9Z-C\^#L[O(35E<MQ[(BE@1SXH\>'T#_%'7;/C5]W)XCR'N
M"F(PF3SG+A2POTZ*E")H3Y20,&HL8BQ=L"I@Q$LPG"Z=MQA7TWF,\?6H\=%
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M4C[R+7-YI9X+9>AU!@\>J1 \74MN'\U0(O_)A*EY;/!]BW?UL6'2\R\O6S]
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M><13)B*[F(7@IRA]4<R(Q&NM'-0. C&Q@.@V.JYT/*XC_=*%+&IC<J,+;(<
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M8J W@+TAP=I<JHT6R\C_K#)YO=L*H7M-$?GIM512ERND21;P$+2!(5!QWKJ
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MK1%G;OE"<,'&+W\FHC]^[+5J*UFD0051DFWM%R#N_,Z:N'$/D!"  T@? T-
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M@] C[EAE"KEC,"@6TBU>\F2W(Y W9>(^)\2(L//14GRG %2XYU.6()7$@X,
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M07+MC75SG;  Y;+I.FQ)%-;1 @MEW%^*98SC=BEXKC4,>'03 O+DO^\R,1=
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ME2X<,;T_R)7R"F,Q12?+8;]DTV@HTT3Y9LO (C/OAE(A$2XRP$L;5B)J'"#
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M35<@T4K-5G:%X\9_+ >1SU=YI;C-#,"%;&<DVMO;&4%#GXB#,/^4\I[>=%D
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MF&@/M>NZJDG>^, 0V5>'%,H@I#?P"<<!,B'QE^EZUDB'KR QVH^['Z EKAK
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M[KP85UTE2H3IB9=GRK+^QSV-,7Y!]EDE@Q5X.X5P()SM0#1OH0A5SJV/L_Y
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MWWVF=,AKS->F,E7WWWV,;SB0A(;<1RAL",8-+2I6N'4PRU*&2]^Z7<0:*K+
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M[RJ&1U=7ASV4'IE5J=>:"8]@L8%+A!>ZPE<G1YZ0F:]3&MK-G(<0\'ZGP%1
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MZ\00P-!+]^V*5P]M=V4F:YKS+7&F#L%5$TN&>?=WEJY$H;?4]>.;V:N?#EM
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M+(;GF;'Y#V=S:J(U3OT@SA(DK;-)MY(V_6$N1]B!*TLRK^2?M]]^PSE3WH5
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M,=EZ2E7]B=7_],7=_['_9D">HVZQ56CU9S'VWZ^8%_?R^=J^MT2TO4P#Y$D
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M')N<,TWJ?JW[G'ONV>_<>][[_WO?/O?[=O/5:M9:W9.:5;/F&*.J%L@)Y )
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M*H003]@$IZG]@WF+3[BN_Q"A]229QC_MSX4]S!;U"I:7SR0@ZUG+BD0PP9@
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MD,&IAKA&87C'#W^N%X_ T.@\\$XJJJ4=C6GW)?.7["25IEEW&*/N\Q+SEXD
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M@O*_+B@+G:@HSLL/6S?6S*\\0;M+P13O")PQO=X8$"ZU^!U*Z!NC)$V<)!)
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MX38.I:9.Y-N9^0'JO>?(G[A[:X&/CW^N\O,:BW7*G 9G_5 ;V]JK.)%_V^Y
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M(= N2YZ&JB_I^2"[G8S+W=KJYKQ LDBY50!$YC@*,W:VH!>>D$OO@Z56I/&
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M#'R<8)/PZ.>]QP.?,>J8EE=E0 \W \2\M!^?M'DT&*!9%=Y=G%C]0O'EX@'
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M2XMLTR0G.C3O1D>5ATD9?:J:69+XIE/FL.XLK,<KQ)\SJ/>H:KP:]8N(< 9
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MZ:.I2?R9,9L8/KP>XY?BQ@ P\42&K:(FC7'\[FPTHEA%@EL)?T2')N61G=Q
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M6Z_('\M^$M-3<-/:S0/BJ/!?K'7 _%\;+32JO= GE!_=93 N].3/:&\U.,
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MQ(_T,(YL_9YK.R1CZE-\8L4#=MKT)NV7Y-IDH138IP=-.,;S];XM!FC6U2O
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MK@"U'G$4*2=4$*U+V</3/YOX#A;,_GE@AS ]B7ARY>[2*AP+XKX+.P]R$[@
M-6&>I W$[#[K+[&H.@#=:">\N,\&I2T1=V$X7ED-HT0])]4]3E>3&S)*R*7Y
M2^UXHX%<WZ]F>'/&I3O#'O:?VC'#@2!=-'TKA)""\PI0^?,*H"XDNTUVB]F
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M@_E54J'/%+93.9G<N>BB")"6_Y"7GE.!UM!,$KDFI_$$6"C@)])9O=G'9CU
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MUL4BN_G"WH3J$WOM"C9S;+DG:0/IO)XS CC5JPAO^[PYKY\/:[5\T73D9I9
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MF_>:),-T;?*/[+[DG&@L^7PCO"2JFD>-I%XB;U8G,&!Y3<D+CIL]_TFRJE5
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MA7>MZZ7JG7+(GK?L7DZ^>()044'A/[Q2>JWR+ASLP]'CE02H+W#F\?= )A
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MX:*Z6#PU7OVH->53]5!O$T.2_PR_UP\K%,]8UL/IHVJC"?1J[H=]NCHL@FU
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MG:69Y*.;QJKT"?2D"=B*DB]?LJ6<F\-C.70W2 >!"3I24%.@72/R]S>Q86)
M2" )V$@MR@ZFC)Z5[_$@[)3EZ90%?G+WR"9[_D#L'F=1B6Z@L'W(WR=_U# H
M^CB6^=MG4J\>\(.MWI/?"H)[F;GLP2&@;'G05?E)F^A+DO_-?\V/RK*)YQ3'
MBM[EH4<.JH<?X(4CX,5H@B8+22CH_)"5/W[V>T.^CZKHV830FQBA\J864_2
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M&,_I<9_0U# \ZX*V0]U?V:'5;D1ZGSWI8CG-@VK1Q@.<W)DZT%<?+T8 =@B
M_1=?BA;]]Z;9.02$Q]LS>2AD#=2^/H%,@I'Y_:C='B*E/GE0*XX6EI7]XNH*
M394@59?\H+P=R"3%42ERU2*_M*;U\A5J-RN>I"]J]U L1'<I-9MU-FH-N(NB
MW(I"+Z&B8[<Z5) >\=S,P"=B%^='ZI!;780XTJ(RZN<ENE))97"?NCQK;)VY
MJ9$ Q9.WA=I"2Q:Y5NO>C#UXQQRV&%=\+.%,\MNY=.4W!LE6#X&)D,:<5A*F
MDH>I=,),<\(TZ9R/1V$[.$.PWDO[\[;OP:9=:X:OPE@5X#1BRW$64*;N2M^I
M,00@7ARMV-H4$IJ\,BMEFSZLN69KQB'*<_K+3?IY4"0209%/;3!D+V4:^&D_
M_D6A?K517.1R)*W;"5TRK)?*3IVYK$]7'T(B+N"2^@5W]1+W$N<2C)^\8\"&
M^4@%7GPR ?T$X21JV@\U+70;]=@$!XJ<YO'X[?P/\*7B(FAQCV'S2 DGHV/N
MH/?S8J3E%Y^F=N/.N!9#XI$;.3O$"_W%CW'<0,[$ '+KBL/^HK_WR /YN.0&
MTFF;H"Z($2JP(F<?3R,GCAE0TW D1TE26!DX%*!/H4G>8I>0"97X\_RH5HDJ
M$$"N&0)(5'_=^_A7#T@JU%=(UY\[[I7M(#^;.V.%?'"KII<W5GE15XTL,A9S
M284^6OV^IW#CL7J2TS,>KO'*6N$*V'&F,!P[[7C>];WL;,:+EI$^CPUNW14@
M9VW!5YMSX\GE5]Q6')<1;#9EL0QK9O(B=1!JL6JB NQ(CP715VMM23-U2UW6
M.2\$QMW^R;7ZZX2=EV7B-SLNA,,F@H*K1CT'U<72]G5Z<P3"J[QZ=CF'IEF5
M"?-B)J;UP^_2;//AZYEU<UI>,"&[^&P#3PEG2@VG+<TP1.JBWZ2"QFE'&O(@
M1;V[XQ"B[8L*,9\N^ XOC1G;=%CN7?YX<NJ#:.D'ZG,5QF%MDQ?E7]C)J'V.
M58M=L:S;TE;;Y"\G7O7F%W WP)I@2F5KR*QAXJ$H4[<V<S1WLR@ACCJG<W-G
M@%:.0N[,&9R)#)KEO(AD-95C(ZZ./.]=XVMYEJ)J K=.UY->FS2[7S4VY9%E
MQ;X:,"[',T-?)1U#H"[Z](4#_T>&I(*K_\7'/GFQ&^7SK>3;74\,PDA3]SB?
M:SR_Z</:IW'[]0T95IJG<0 )Y?PX?^;" ]9LW?X/4X/"]SCRA8[U?_3Q]JZ9
M=,RCV%:\2]$;H&9LK%94$FI2&^(E1U.S61?_[E1'W.,"^IR0A?YK0= $*/'N
MO4?6EL EF=?3!E)&M+NA4A.!3H"UCGK]37S?JS9\IB<10%)JWB]Y ML-".!R
M:M"!SWD$(":EC/_XC#:E?K*3C,[*B>0AJ(/0 ]9& Z,U1:NW&$]9L9/Q6XI@
M8UK;Y7!/R X[&*43Z2* FM8=HNO5"]0(8)>);YVO0Y7,@4Z8X\'&\II.E-2*
MN8=4ZA[=PA/,]@8OVJ$($>%U(VR:8/; %*I$LQEY"E"/W'.:5].62I,X?Y!H
M./)0PI[ \-S3.R\")S#F]<6ZNKXTG,D ^[SIU?_+AV,4^EX(8&H/_AD!+'2[
MOJ]>Q:+:Z(:%9 GA(H"HKWM@[%2H+@J[<R;9?%*^W&ATA+&F672P.'_:_HL>
M^>.DMASO2>(3;X5\0B%R,#)_*MQ9:[YRD8X(WN,2M.XTB93U>2.FQ/WFI9'C
MLLG;*C9-;D#:4 TS>>_3:?&XCK-U36+&-&T$8&7;9.5'6S= $[F^D6NI4!6E
M6!DZK8=+SA3H7_EPYVOTK  I/.WKP12\2-"GV#".%8PK<&&[\P=XMKMX*1>B
MF\[IV'BS%!8&LQW;_+KMHBX\0;6]7 +ZB>JV7G*2S(^A.$N,.9Y++D3UQ:FS
MGSU:/),G/CXRS'N-C9$Q.IY4O'(MUIZOEJ+]V9AC[C&AY[ELG1+593Z<.>$!
M)!B6OV"Z$K^EF56/JBU+)CAMG;%Q#9+*?&DHUB\]K2ZSOT@IZVO-ZF0#@QML
MMWOZY<N4[$PU<B)!X?4\]3RV;I[N/,@\J)6_B,>(T2C7:5TV)> <:KR"\P*7
M%-/2 E]OU+V2_ZPK[HMR7;Y!@=6KK*<9)M8!%3)R*.5#P_/\6D3N;AH6D)92
M?*+!#URE5V_A2!(I8CGQ'GO<8/%FG]&BH8!O0-?U5F5\H]>LE@C/Z9>EFY@>
M)S=S^=]SM0V8W7J5E%2 Q92,P?GT[5EA4NP,#EGFUSN&SG0/#",-FF#G52(>
MVY3Q5>-NN_,&FU[PIQ4?9WAFO=30V^?FLA(P)*^7WZ%[]UEYH[B#^#%JEY@0
M+>+EG.(B!?JA@./X"22Y$HK+::EN&8,Z.YOO)"=SI^_[+@A]36-R=(DH:!ON
MV)AGT1SFP4UYTO(!P Q2]#+#?E]&J"ABSZQZ;M23[5A-"W!GME5?9Z;W6D<%
M<P9T-[6R4_:^&M>'_B8YG)H&2K\R%A.,Q)%)C"?.^$*)4JF%;=Q:<<Y'\S$;
M6 I?5-9IL"JJ14#GOQ%U8$\TN\HJ&?M0(:4S<@SO:4^\Y/)B06TK!:B./&2X
M[P?S"O)USVN7N_;]'_;>.BC.?=L6[01-@@=I' (!@@9W&@D>(+A+@KN[-!(@
M(6ACP0,$=W<+#L'=W=V"!)K;L-;>*VOOM>\^^]U3]]2K]_Z@JJOZJP^:;_;\
MC3G'G&/ CP_GER2S9#6EGK*O5CWMMK>E/.%V-;#\WEE3&-C"*4-2\+QQ9:T7
MGQ<\38R^%D_D@!7S%<H\N%)%H5BIG;N+:T#\8'=^:A.,MCI!#8^EK24.+UTK
M":0-L]?)6$9^=85P3.+[[!9P/M!W0Q=\J/2"Z0/GRW4:]8F=\*;N$+93Q I>
M5$*A\J%%>0*Z6<R3[^+4$R1^TW&.RR'/^IT"I/.[LE PG^C="+9++Q/6T#L\
MJ5GN"J=1)EL,:6,$HZS7?QF6^AE29^&.FK27F66Y/B,5^<I+,6Q5:.MB GWY
M%H NKJ<"[>-HWJN4Z'QEU>8&-S 2ID-^*#KDI_/2>*TZ.(<DPPN6A<N\'*<O
M G!26B>V;^!AI6A02.NE?!GZ1Q*).XS*GAH^_?>1F<S[IBC&/2TH<<=H_YG]
M?=C_EQ1U'N2O5]+OIGJD_@WEAZ2ZV'3I=><]_I-=Y\CZVB?PQE%WU2SLEP0U
MN# IDCWC^G1_JIJSQ\;^S3F#A6L2#'D^,RFGT[M$\+%!3Z4,&TGI2 O\=J4E
M6SA8GB$K&-%-^F%3O"3O?-J_,L'*L#K2!(I#5$8J^*+*1JJ3?84[(JO\_<L3
M3/6N4WAOT.E3#1TLV&>!I9C"@FM_.P+_T]J0W5B60[4E)0?E7=" QX3N$M,E
M'.G5]D+7FQ\(>:P>?[27HK],"[GFM^!TTK#,\'+#D9%:W0(",\PN!J "#* Y
MZW6Z.!2E-4EX9^SQMH8!X>KQ\@;>E_B#;!ZN\BC1/YH7'8F(E%0:GX\49JF)
MU+(2,9XU4X^P=VB8G)^_":@HC4@'6&YZA[V;A/>D/;Y05=+W(S+CEP[;DNK*
M*RL>/9UTY%4)4M:^$-#ZO(9>= O0J!^+CHIVI&WUS<H6B-X^6^<I>92K2_+-
M%)WT@, 6.^06@&(B+T.PS2E=C^61'6?#U47OZ5GGO!'L4%4;G9R8:Y6EUFJ3
M#A]Y\3@>.69^GDMQOR,5:1!%-='<F47;G-.:C,*@@,#7WCL+CB2N TP@K<*9
MQELGHRLS.K7DZQA1BVU(5Q?:XMUUI8I0T$)<6>:(38O+[H7M@(^?2Q9MJ"=A
M2.;+BSDX8F"'D_2ISJXMII?Y*CEK!Y:4K#;4E\#HG2RHPD>O/LR*/D7CG[SZ
MB5ZDPUR7LS/.(YUOC^>*W-_53(FN"*$3GL>IK R"_UGR1>@4#J=K6P![M*B"
M\%.*P.1'HNC9OO"&P+G3=MD#A4H-PFF=!L,\WLX'#A&N4V2 B.V7,GH754)!
M-*$99FE\1*^];>R]@6[V$Q/<9[WE18^W";QRK!U&-'%"2IW*GOJ^M.U,+?RD
M =ATO@0LSXL,9"N86IRBCF<E;>H>DY3"(B6M032*!X<?N:6(<;!IE=\0%OZB
M;N^#%:C?CKY@6ZL6T6?/&N;CM2@NZ[3*2OJ"U3=#B28W7J0Q-S/?3%49;1A\
M%,U_@YY:1%F=+)WPD3JNMY?"RHB_ST'G4:W)F2G#.2FC6O<,=' 33#^X\B6J
M@OHH-)"XAB"I=$]5KXQL$]WHQX#(A3-5#:\+96UU*'*L ^2E,LEZ@W0;QL?3
M)ZO\\**W@(.4A"M5O,5L!6VP/=H[_R2OFB?7GT?D!,T52X;*"65($##3&EI(
M^=KL/&TW^7-B=6B&Z3=,#&J_!]FT8%2BCZ(H-9+703H%ZY+I/S[T5T!#GA7>
M..PW[T&E+*J>J>PLGIJ?-G.:MRS/81-?XX*^(DD)L8&^/#QU0K#>';% FS$(
M=A#C1SY%2LDBJ1=9_)2.6*\WT&N+K\ O=0TK"HVN=RJ.4.A @45C5\CJ,"!%
M&'B<;D2*Q1=^W\0Q,?B%T]?[Y;7PGZ8L[UN5#Z'_O(F_[O#/0R=*=S,7-/]F
MYL)I_M=VM_*U,31SY&8=&JW_2]/17$Y^N.#L58@5Y_7[B/*5 I'9QL $U<RM
M(3X"PWR%A\3/WC3_X-I2VN/CSIQ^'4G_?%6N=IB9ZR#188#8METFU^S'M!)O
MAN5P2@W6F?X-4M/9<L#^([4U#W46R0(+%?AVK/0PD6[H*Y6-]TVK*."=/#"Y
MEG)[6Y5B_0G'%M'^.Q[CF>DZW3]XF(1):7O.#O#1D2ET!\RL=,UD:.F:4U/]
M4(Z1I9?0<]@.4>(@K#<E0^LHY=I# UR[\%WUI<1D\\TPLIX;YBRIF;F>>[*?
M[3(#XVC43\&(J,5\$2=>?7ZNSM?#DQ>^WZ"V*+*]Y#]S=T(6I%;T!L]XH]")
MHQ(D.W0?A7DP(Y%*#8U<LV>W@ZW9<@B^VJ4G5G,#-H(52HFG&I91&>GV!-1?
MZ<VV^4=XKZXD-86=%0FP[Q";=\?YYN@/HHQ\^.JH QQ,BV<?M8IUH;R49UFT
M#5>[^NET, #<LG:DX^=6FI,M"5@2>T1]B,.&R=!0;Y,U%R(,PR%%7./[!K7C
M5O."8MT:[/ ;#V01^5F#H6PQ^=:OG)WB&Q-RREKA=R@<:'I4G8G]'D2<%C[1
M].6U--JF4:(WNZ;99&%5$J+M:0[O$8)WHDC-L53<(_"O5X@%\QB(O9O2K_&F
MC)PH4%!Y7I<4&% /(FZH7=#.AK@"3,8",8NLV\X&K/A/W.6/.%(R9R^Q7$LE
M! X_P%5-K@9-%A+((9E!NHXE;<WZ5\NP]KI!AP3^A6O\N(&*F=OC;FV,>M1K
M2ROA ,%SDNANER*1,+D()@9!:5=-<S&0_R6?.ZGLY'4%&RF:KJG&Y^H83:?@
M5#'DMF2O]-''3<O-H"7"&LJ'0J_=/1;!&N[\<(XY/2Y_Z\SJ^-A;$X^5QQS[
MZD<X%2,1J:;\T;0=S^.+J54>/<*@E(B+BD@DDF?XQHNS/EH>@JDPMAXTBP8O
M\76%[QBPLFUVK=!NCPRAEGQFV_JBBWUE5YK9Z-WW-LAW.TE^2?X^)QV$6OT?
M=6+OE"PCQ+/T;VAL2Q'HREC;XRG=#*=G9UYHNOMZR7;--9\B99/J3.8CDT&V
ME[F>:0]+M"BYQY_J K\]/]P-=6O;7#F9N:LMF/\I*0EKC.XZ6"*.B/N\,BFR
M$1]@)DK1<D,W,YP(8OO$/8W/6/8L\>4K!K\S.!RF#U:K)8.,&Y^>":8J^?ER
M8M1<L\8?^TG2[2LZ3?X@Y)V1D9WIJXRF^G"=1=KE-W)42-I!0A+:7' 3;^DS
M8Q$1^J$SE<3[Y'1EXH,'IH/>1##^I14%K7B.[F?P[D*24R.YO_'AV563T!/0
M<KH-5,FB=5D<<M]J+D!Y_U_O09NY.$-%?J0<D-[ CY^=7X-EH)?YI'])D]QQ
M=&[_AJ,CKO*[!:P^9;IQ!ET]'@/CWP)RRF\!KDT9:H?@:U_8P5.X<0L0TA@9
M=<CSE*?0A!WSY)267#MOSIE2U\>V:AWD$./,L;T#):)>\H?R*//*H9E61E+V
M/H(AJO)@6=X-8M9.+5M%L_B&RFBT+4V'K/U7#6JP^QW<N*36^:IPZ^*^AIAK
MXO@PO\I>&3P&1^",N("A@BI-^RGKYM[5U3';SLE&<Q1)W\5?_W17!=]I"#_0
MN 74@N,R?R#4?+\H@XKH_N@&%W!^^Z$R$9^0X$UYO$)?4C5'3680>G%=<Z58
M#TO_Y$4_#9K&BS\2 DEKA5#0A7G]]N12^>6$JH]P8\VD/+](]-BHD-<1ER0G
MZF>:6G@(O05S!5 ;AM^,.78<9-@6F[@E]2"%]LA\76%ZW]D(] O+,-F"$HR^
M:ZJ*5PI1X);OUR+RMN]XH8[C9.WB)QWT4RY&'LC)3&Z@Q\VU8;UR8SX0XM:I
M<;PC,6S^T^1K?S?5*ZY3>J2S+-P7% 6'\_[8N$<+LXR7JV^Z\JN/1Q=#T8_<
M?VSM)+G/Z;3*.4KG>8>VDMNHK1SB.-5G+J]+]WYD-(3GR]?*X9Y)7@B4DM0.
MJ:,8VBLZW7N')V$@.1+>M2UT"VB4Z.??Z=M?42NB"A'8EN@1\![!2>9 )ZSE
M^ED8K!P(7 P5U_#\:LY^5L[X2-T(=O&3!S=FD!*&V5T/]J6+O;WQJ[U7D5UP
M8OE<(>Y>U(7NM@<)TV$?RV\X5KHB^R!"Y^\%B1L[*57:;89=>)5BQ"/V&=1G
M8]YIUU!#X=Y4S&:E#6X[S&D,J/E_A[^NY[,#().L#-<PX6S:;AT_7\M^9$UG
M:=)YV$0=IK\U0QJ3Z;?4NT>GB(?5:S441=,"C!P8=?-1O59#NJ9PIO26>!%F
MG8B^(V?\Q:J"6^YN&JX5[V?8==X@H^5*;25D_LUK.\9QP$K0R6^C<K^]63MF
M#)F0JDU^!O_Q*0N$U2_H>;7XN_KIF(@T6HWZ(4V?YH_8B<;)@D2>,KI!:H5O
ML5YM4<IR&7(CUGM^-*+_KOX9HAXJ29U#75/8VUSUVFO"Y+M42"G-Z2XX XU#
M,,/)R*7L5=CK.LT$0SIK&[GN*<)J$N\SN)T9G) L->F<A793/%3RM:9:WOB#
M:WWDV-92[IVGZ6$#UM ^M<:'_@3K/^P$'%X)G;Z3O 4,BK+!:H,DG80,]2T.
MJ';Y6UD!5_1YZYQ<A8LJT2!%_+HY/]^>8/%U))"_Z IO#8,#HMHQRC'R9[]!
M#,GKH[".^M%A^<9\*Y4ADG:BF-KHSP[,LYH]_"SY_,A%/$<JOK7\RY)6Z%-4
M_8.NDW,3 LDI81FF%XB;!>USR5XJ\B])5@ I8V#:Z:.O=-0!F4ZPO[)HPD;W
MYO-@N=Z9*E_7OP!*OT^!DOTS4((S_K9P3.IW,W[7>C'7!G?.+IP--249_!5?
MEN,>4_GLW^S+/)AQ 4&%6& PQ!Z6T@I4CU*N$N3.$ZZ4PY!@3YI*]VH??(I3
MP"\N536&Q5Z]<(PE-A):@6YW16*IDY#UZM TID0"V>&C"-SD2H9B^>%Z@BG+
MZ^+8"($=B;:51ML1/L=.'(Z<O!G3-_O155)>J])C8:<DL-\51%C]7#_ZR*";
MJJ)$[2FV5"@_.O4EIC9G("Q%(IA#MZ!&U4\^?;3*<EVW'.:>;7,8J*IPAI+"
M0!U.T<^LRWAK/<W$@;^S#B,>_P(N\;:G'!/ JE+I&W/DB!*?GU\QFD\IJ@5&
MKYZ.GA*&89HZ?<V:A@^NQ_E@U?F.=238H8\A[ ,]TP9&VVXI:6UA]=QI(0<J
MNE*-X-&49'FBX>'G\U8,V],"8E"K1K#JCQ.IB%QQ6NY>OW TEW:Z9X5]!QBF
MMKJFQST4B.N4],%(U$1[U^ "U[/[I,3U?SLII6/.]V'K[:GC*SD>M#.KK]@<
MU:4'[SF\R^?JA+?C&;MY^#RA#5>^F(L%=Z5$F1X4?8^5 OR^B&;,Y)?1=KLL
ML'*3VM]$WP)(KG\L<IRTQUMF] J^&HY>+)="'LB4Q"EQ@'2;L@BV/#>9I"#I
M"T7?T!*_)M>(O3Z'G6F-,'CP,5MC7[%V<F?WP.(L >O(AU+FN-ZJ@?]#X=.V
M>)8MO)ZWH,V1A_KPJX7,$<DW;C^A[",7]B+U0QM)61!<2244,4ENI- O;O&!
MG0"P@68EHM<@HF=EU<5C<S%T):,+4J@PI^Y9%YAGMXA^L=&OJUK[:!]%E=_&
M7LO:!Q9 %(ZW *W D\)/;1.*&B:<6()K1$O.+UH B40DG?.!L"0EZ5CP[)M2
MF7EVFN&E,!G7:R<NH&Y'^>-V>T1DR7<1;D0LQ:#OJJ&+  #P80-<"Z<,1P0E
M6MLERUO[*8E^$-_@BIY"38_+)W$"@33]3[95X=8?2OJ1' <\P/1&V5OC6-O.
M1QJBK=SWR6FWWA794F#<:^L%[-$\A)WY4V:QWJEB-0V)84F8&)Y "/@44QGL
MD.#>"2L]5-QDFF(M@8IAR2+G"=MF48T,0^^B.JS.,6S4Y3]<-V\<9M<;.S\O
M].XE$4H6>HKA]O 1*)GY8B*>()IPN\>N\L,/KM6*T?S6U-#E>?FMZ+>;HJX3
M0>4X0P=8TC9>W1Q.?OT=Q*J_Y*>U_T)^:KNCI@:[?AM9OM\^:KY_C1&0(,LV
M+?C\;SSLW<CY;V/HA(V8L*_IQDVI]9;&4W!AY,W*]0[H&^B8"/8]E+FA$[8^
M&P;7@Y-$9BN*>_[-'@0_TJ]DJ-J=ETZX?].-'32SJA[VS7]V4W0-J_-$V*G2
MTZ;-[+[&DN@9:J?KZP>%Q#G5\AUS3:LKL.$[Z^7R2V[I9*:;^4!LF"/GR_(=
M&$!RGV50N*-0D)SHQ4>*^9)%10O,P[?"RVU+&V;@2GC\!0KV!F2S3LBL%J-#
MI77CJ">LYCG@$9$ESMX\N!$J[/R5#=5Q^][?'O>)E0@B*\F^J?-'AK*;E)]=
M]_@[*,IWD>H?5ZVI3:3KQAU,O2);W;\ZFJCDZF37_2-%/4& OC:V)67*&2 M
M?''Z9"KI=)YZ. W$T)ET@#$K\.648DN%[<:L5\$NG!OK05+H2]L=+2T>Q#R>
M=(;(W.+M52J!+XG0Z*(T%R_H@%+ MF.(/*>!5?>:!+0\/]!)\T@V%KN2R9U(
M3PX?(2A4VXWHAF=C4/6I3D(NN.O9.;0:!/4U[[=8D2S:2XODI8S#6!DL)AU/
MU/&%C.YX<*:*(M0[G],UNF*ST#'R57!1^%WKW-2Z;>B<JQ:/S"EL+U(4=VGA
M<ETC:!>]J*Z!'"]+QPFAT^'1RCIM5"T-0U3UK;I.W<UO>-7\A_&Q'%99>,+!
M!Q#6,+<3]^PVYS)1(*^*F#*Q^]%K%9=9/JO-E?U:9A4B?5]N8C.H#U;?\A.:
M22+\)[:3N3&D/3ET6'/]K8*#SX;WQB6C#>JMXQ+#:J ],!CNY6Y#Z+K<QS&\
M]N69J=2AQG-XXQ'*H,E:28/R.#(]2+D%9IA1)]))(044HT :ZCX-7K"\!;2-
M,CB_F+-P_.%<Z=;WT:490G6IPZF3W*;Z:%D&W^'3VLN44U,?9E\[56#7@-?=
M\B/!UC5WZKS)R2S;L7 WK<^';FJRHU%TQ3<7B^B[GYR:!Z8! Y6PD_F!C$G+
M=O "'.P$%=N!UJ!O:$>O)>(-NN(]:>1O"=HH1#,/.01=O[=JV@F'.@ZYQ&^;
MRR N2Q"E)S*N<9$]]?.;_#EXCKPKR5CQ54TJQM(1^W43S2ND1Z&=<$\NQGW4
M"O5:'M$K,(D$J"!=!AW- @!P -4O+E1;F<.4/I,I5*\9W5_@=V[$$UD\5N66
MPS19$1]];6O%<8QZA,O=O%]S$+86/,I# KGJ2*M<C X1VR)RTCTJS.L,#QC9
M,]Z'1)$>DJ?<Q(0]^.8G4YN(GI0YZ>4C1'J%F05V4#D/#9H>[Y4LIWLL#D_#
MR>IP+7EPQIYP"WCD]''=XB<LV-U[+<"T?4=KLQ'J&M.%PJ^_]POM5 %)XP:6
MM#!3Q1;7]"?7 R84RJ9H._GK_2BJ*49)M^F^\XFD5X;D?!9B@ LY8MX)$]E'
M/STK+&IV%I/A6!Y-)HNT"Q.< GU_>C'B 7Z<Q#)N?PZQ]-M4BH2AE2!I<3VW
MO&2ON[5#$Z/[9 08D90R??'[NN3=JJ'";_N5<#*_=,#ATOYAG7#*A1,J@@7#
M)7>S/S'5TSO?K)EBMUVX]T>AX"_RHCC3'A?_H4K\;^N2O$/B;B]0']UQY31I
M08AWR([\;NL!X7XP]'Y_,/7^C;O]B3OB_)Y@3T6]VZ]\^[=+PMN^# EE,F<&
MH6('P"X4DMAO!(*[5$Z@-450?YT9G>>'K5#AJI2S/O I[8_IXR/=-N-APX7]
M>\MK^Z26NQ:]5N?'>N>O%RH_GDA/%J[%JUW/%9/QJG+!QU#D(&6ZV8>RCDS$
M>X@?RI8MHZKP2\M(4$D40$C)>BO%+'=E61ZNH*#3\Y!:C"I8RTO]&&P9]7II
MSDD8\ZUCN(^ I<;.*$(W)4ZNI_$S@AQ%X@9.M_:.%]G1\][I 4]/S^?CK";!
M[0;3K&W2QT=5?&A3YU^;#J%5J5+#"Z;.& 5E%&RE(HT8DL!>O724<&8(+ZG4
MW)  E;D;0[G*)X3WXWF,-RG&F!A?UZ(]&G)K5E=SUCYR;VE.,?GC:S=TG1X$
MZ-",<L24AO9S?) H<J21[W^9H4J/SO\X6&\CF:Y@Q M5$_G1F*/ZM(HRK\78
M&[')RX!UU&IC()=.$O?R?.016*K6EB3'D-\/ETPB9$,,&\57XD&IK-C#Y-FS
M3MU,ERSA<;[HXC%+0XCEO-;S'U*3_5YBK4[46;)N*G91/?(?T9(6%]!,-64*
MP\R(#;"^0HKB-UN!M ,09F\Q=*3XN;2@GG.V_XZ]CKP<M?9<4V<WC]T=G%%T
MN%(,(-T+!3$A_);3HI1ZG!RPGLMPA_MX_/CSB"\U8@(Z<\V%E/#!M"4H]B-6
M;D%7C/6:R['^5"5C7R<L&6#!S6AC_")L[K4+I3<BG(U]OUJE;432B\:PG*?:
M<J;Y>\;"(QY"IL2%.98;K42^RKK,D2@/\'O"W9B+: ]CVZF&=BE&*MQ5DL>G
M$4+G]MX\ N@\+*;'#JD&!&-6)6Y0#-%[N"YY"O:0CQ=$]G8<E!NA;/#S-7,Z
M["7:;M-J&>*R4_81$\)^ \CT>6&LY:H(98"*+G,*O2!^+Y8;3=Z(#$X]EAS?
M1VSF'.>(2=I<'X@D/X!XY^%YIQ?>R/=WEF93U]_W?G*SZ@-WBHD<#X*A..LD
M3!>QKD6B'"F9'>/Q%D&IO<$RU$@VE%@/$WU\NCNIX0O8D:C0)(GZ<^QMEQ=P
M9"BM/SK2I6(CVN"]*X,/YI@])13J<',NRMCI;,1RL9.L>,3^\[.VGL]KIWPQ
M^%"[_-9DX> B,E^UDVCV7;9M?HO:QT^D_;'EU6/N6LP<?U9;H!NB_$=!AES>
M2(;@*YJT;.__W3Q8WA\K*WR2SOS),<^KPCN@>O@DB>-_3>_#:KK&I]&1FJ-K
M,@7N+TEWD[).<*0D2529*,IJMK_;R7 $I3'B3+BPWL@L_.R],8\HK&M)V;:Z
M!<SK[DAIHO%"7#JA?+! V"DZ98];DD;>/\B,-SFG?YPA@O8$!M'HO=+*K_5A
MJ!\7%I 35P3IBS_+@_;=C2GQH["[@5W]XJ,;IQF#1>4.!/WYM:*YDFOX!D[3
M>8F>D@(IRP(5?>!O;[-7H>L3^"NK5BGG8PZUX^&U#:7BZY^_AE31Z9-=^?*#
MFCW1M /?ZP<XQAP;1JNF,*@";N1.4S6S>4]YS$X85*'"YTUG<S"\1Z$3C5TR
M (10JXIM]MBANA;FP;"4^\+5_BW@"C.-G&+0(88A?8J9K"H\CF+"I,]6X(68
M',:L5?-\]LX K],**#ZEIY+O>9[HZBW 2&K&4$&#>*$#31*PD;VZ,I(E$M(G
M)U$QIJ]4C8(OU[-I\\T_'2F7KVO4^H0N-UP3V.%&I/IE^D):MBI*DAQBAR9<
M0P@F'X>=#7CU,@4(P84*SU7A2E97CI_EGE/']&RXY>.+O.BB()O ]UR>$QMY
M4U.%^V/I772$<YZ!MPO(O;JE0/>)6;=K5D9^:).IM^7,B!W:>R\@K+PN4C G
MP:\8,V3-^\R(W.+X1L0-BS<1Q3%;@U_*K0#-'?K44AKJH@%>0+T%M"N[#^!N
M<\9 9E@TTR0RU-*(%L^((L<K5)OSZO%&)74617S!Q*-]SJW33K&I]25TY4NC
MCX@ON?E?<MW0%OJ; @GPK@/SFW:RBV2C</U'42!?'Y\0/X&*C.N>C:IFS,VU
M&EI-X*&7/J=]XF;@#5*4T@PE)'FUW=5.+%6:B"&&S#YX08L8J<GB[=2.2?DS
M&0 %1SL2A 64S[TSK#.*(/;N_;:"A6*;Z,M[1G2:%Z\2:9X^ [3T(^YDW+?K
M]Y2S;M9[L_8ERJ+K[#(&]>'EI#>**/>9=9179@TZG(2J1ARG'AM2F (^^.H,
MW#%=>FF:*7QIV;+>LLG[ @KV/BM4?-WDR:G@N\=]/+,.W,[R!=&/2 M:*PYY
M*#_M6TH8$WZ@C":Y5:'&?/.@B(%]UVGBI>YT_B%/-XJ?WPVJ?94 0G'\N\,!
M>A@8M6GV?"$Z::<ZN5&/9S'B$L MYM0<O'HCMK"CW?F!2H(/Y+4OB(@KZZEF
M29J#O4<M5CY4,$VGUU;3VW5=!C[+BSI*;B!NAGZO\.PIB)MTH'30!8-M^#?G
M KI6[L%%.<LO:^?-EO==G'L)E'LM%;U?-K11 >I_S;7;:?S5CM)=&^<%#%-X
M_^^64+>O?]DWDL/2'C#.^&BYRMST&5$\BSWV+^EYG;6B]VL&XV?<BN8ZWY%^
M4IM>MRM Q*-[NW;WW<J((F72LC_Y.PO\PJG;C,U>2$,%.Z&U5<?8&27RLWU_
MYZ.4P8_5Q)T]V4;$:_24:8$V:AN7^F<X^G^GM%X?>DZ+.O.705!Z'AL$&QA3
M;-M?*6R2FFRR)ZD[?%**[&'IVJM0Y;J">(+:/,WC;P'O6^6[;_H*63N[YD '
MN5N.!>2.[@9A?<R2A%8J'4)G\&Y@[RNB.G3D3O@=AM5>VB(!C<('5RE;PE7R
M=?>91*EXK$AJQ2;YM?&$;9%4D-I&L.33O'2'N_[CA#+L(S4<W#B#;Y"',"*V
MO'T?()&=%K&.8Z:/%T4< E^W>=M[RRY=88 )=JZ9\D2=]6)>3]94"=9IYGU9
M?+F1W'P^,*K<H"A</J:N8[E%&XP4["UQRIW*^])L\\1>OFJ $($L65SGAF[(
MPH,I:^IU&<:)1'U.N.^#LV9H19=+D,3JQ/[TL\?[@'!W;UA!F2N[6F$I)Z&"
MDAJUBAEN'MQX9)5NFJTU\\G=ID2JJVZL5)"/M&%6;[S(O\*@?F1X7%RWO)EC
M;ZL&21B$ BLP)G+8PU"FMTOCQK[CP>O59I,W/"+N1^0992#)X%<)Y(>!\\J,
M6P ? ^@@X!:PG-NP\<F1L%?2,HYAZ+E"OCR:C5NHY(Y&WJ+R_)-MRB(;\A90
MZ+91W=(>K_3@O%KTM,TV?.AU8O)G(J]H5>'R4/ O@SN^@[4^$"4?G;=_7[?J
MK:NV*)A>7OKQ*D/(^G4XTK:IM&VK?E>2.E%ZCHJB+W(+8BTI@N"P>0@-DH4\
MEES-(OK&I:I\]H6YS#BU9J4IYB1*/2,S62=^%T63_(!4388I1RU_2< D\ZS=
M_@;]QNB/:T0$3@;X="/QHN_%)GC];8!W+P;R/-+/V+M<<(5K1[OK'GSA<POO
MA?U/\J <8[&],BQXO5;H'.A"4W(GUT@%=O&&/[=JH_!,!V(67G8J\V%>&KTO
M1SSCQVN7YYO';U BPWFSFIR@[$<Z2' \HM-I:8]PDSL EQ_>Q04:G."U7]1\
ME,F$<OSMZX8Q"M)PE';@<_OD0^TRF66:-?R9AZR19X3@ F<2LCBRPYN?-0"@
M.O?9VW*OKXKE200C8E4F!7Y8&TP4QWVW@/%"Q0ZW4V>XGRQCY[25QF\'(X8\
M;VZ:S].=""E"[GDI#?S_B1VR/_%30\N??N8!"T+*.UAV9XJ1^&G^Q%$5K8#.
M.%(..$]SMG5%4F(U1C, [+NMI'.633TY6.J?F"F3)?FW:'*?+6D/_$%_L_\I
ME;RP4'+^90 '^Q: K";^K,^=TM4!S,C?F@6 @/B\$.-60!<7Y7>2/)_S2-#J
M1*SYXZB_JY[@4=HA U:VPL9CA6[2H#6%(=0](>0GAN%/NYO?\*;H@",V)D@Z
MVU7/\2H/)7$J*:/E@]+1'G62LEN8NV&,Q;_  M.JM1 5BL#M;(5M>Y:HOCX<
M);!(,:]+,C#I6(JH>!.ZFMR4\7@<R3T)QY6;GEO+BIAU1Z<POS!H6T@%']X9
M9PTQ491BK 7^(9K0EHYQ/H5X@2[%XLNXCX -0%+K*1F4?>)"5R5HOX4^KL3>
MRL>I2E6H^>T O\]!2G:>6Z:_:6YI_<RP,A ='Q"Q:2_)RUSAX%J3<SI..ETI
M4V-3Q;RZX1.(#U6>4[O0E2N-,R)?CW!5)(>'V_&Y,0\_0HGH+IHK?_TX ([L
M' !WY:?LOBE3D+/%_HV4P"S(YL=X5ZMO?DBX)WJ?MEA@'E6.7K"V3 _-4QK@
M98/@*;NXTF%TP4VKELB+RHA^+7B4K^=<*Y%GV1I6BG63;;",.Z-P"TC&33EO
M!1\IRRD<L4.S3"P-U12HR*IBLAA"!5>3+T#^EN*+)FW>O5[?D[Z)ED-=03TY
M%PFB)</Y#/%30*F!BKA$2"M)$HA<.94C.B@9\Q80$<!T3GJI:IW?<;Q9]9$@
MQO[)6\%N/E7,)=)+X+M;@.TM(-JY2K7RAS"%+5F(862O"C^KKRM_+8'";/:N
M*WYA4W,X<_SQ"I*)LJ"GG.XFB&>\Z3 @ >QPCI#EL_#\/3V >@*>B#0+I^#M
M6^O,:8:*4LL0.U=NRN2O\42%[].-#%TZ##^UEJ9CH!1^:-S@;8+$;_ ](=<V
M,YCS'B3AEX %],Y(O7$>P]RJTQN!S2_==N@( Q?HZ^9(,,C!"H,<B!Z5EX&Y
MR<C793(,#YI<3G5Q7IVX&)V]\586@;A9JJ" !<U[9=R)*[[C_<CC0RL5(5N\
M!8AH[0WX6%!]KF?M?1R9E/B25$K>B2BZW[W%J8_S0WJ4L05RO]RH);1BUL77
MP*_U?'\5\-9@8RQ@Z"I"=MC!7(9@+JT213JQ/JR7\Q:@42.'OS,TB[[;JSJ;
M.Y44*"PN>GY^#C<?,FD1RO:?4T>*?Z7:I7?Q3RSW'>"@&_HW@&.O_M=]J3!L
MW3FU=@O+3.98HSEO[BWQ?T%VRRE<$5W7CF?0/"@R D)W+*'*$I#OZA\ICR4/
M)$7E\1Z?@OY8PG-=<R/]@Q#*%'WU2T.U\$+X&S>N^11%;_JE[3XQ%WS$Y<HA
MN_0?W53IE@D3RXTRRLL@Z+O54"$ D2?SU> /A".\LSX'4P$E4_0$>N]DV8<^
MLU<GUV$"U3\$:)NJ&ZI\)0I**'.#E8$VLER7>?J:@P'Y0Q*1EPH=R&MV0%+=
MUV#%O:!:XX O(P8_M6=W*,0X44)RWSM3GMW0J!3/[3LHKVN8XXSE3V(P\QBD
MR+2",MS>E=;2Y2"H&6#.JD:][**@-'#B B5A/B(IT9%YQF;'9QVRV0Z$2WS)
M17&"LSE-54128$!H@X?I74;U4NBL,[5#?&V4X)/"X5Q,!G=2<(24^'=]"M0S
M^#=)/GG)KHI;^5E*)3:]57N8'+M'(<WK=3>\K>,$!LD69L-2/'R!O%Y)@2=%
MH"8(-SMA'#E9VW 9.9(OBZVR.V0L3+D0XV)$28=D>@IHHQQ1BIYZF9<U>&8P
M9H'Y*:=&]*$A'"EG-DE CEDR5D53M?D'0XYA[EYOGZCD#2([KXHG,CW.[L"4
MPP0SW9-O(] +:RAMSK8.5=/H'FI^WN-7;;C'HVLE7421"TB'!=G7J,!P?.NI
MR&J)RI0!ZDMET%.32AYE_S)-BD?J/\I8(6KZ(UFKM.54PR6*WT#'+]NAL'J:
M=N_L\[PV[A&%0O];"QI\ZJ#E.S%L"A3=?=!QX8_M'_-=KZPH,?-+7<TZ,VWD
MJ*M$I#2CB<,H8'D7"Y%51TMO[W$V>L[.#=*&Q@048\1Z/WFQ_)!WM=C?&_YJ
MT<_O=+DBGY[A=$:TLE*FI%".FC)R-%(D>C#*XGL1\'N)BY/2NP?10WBS&\['
MBNH"#\)O 5D=FF%SQ:3GX^ ,I:/D_"KGB"G!GVE^S[ON5OQW8.F"KG4ZZX=L
M =$^V&;Q:[W!'G_GX"+48?A<J,EEY]K^::-WX5>$($?C@50$\>UO]9L3I2PM
MGB9*>S'S!IU(Y%$3K-3>N_&6W8X\XBDUWA+7)L'Y6"'?#QYHLNK.:=M7/,.\
MD22[!>Q6-*QP0YA098,%66J?_4QJ@26ST9'3'4NJ;LN]6 OS7E82M7/*JPF$
MY3TG?H4MA@)=QW+XM4!QJSB2UI)SMBK]:6JV>Q!1SO(?2"&5_94(4*D' ^QK
M> &:LX:EC(J):T\8JM$FO+R30\+\=V7*_Q>RAM9@0.%O6>/Q<0T*>E$F*.='
MNS9KZQO34L_"?<>(=,( L3%A7H@;-(I.S>J<A_:$@3EH>]P"&9C$(I>YE#+<
MP*RNC3/JF\^"O$_7 S3 A+!NVH!YGF'QOZN/?V6RZK) .!3T$HE+ST9\G6ZH
M7$:'7Z.+8Y&1XH'1:SV_G3"1X+#>;';<C*4Z!BE[7OQG46&?.\0(MY%3>>%4
M^8[+ZUEZ/$3?+<5::2:>];P$7K<[Q3L'YK-U\TV.?8UR<$5SNN%%W]#"Z>OO
MTS'/$].A-GUFE7=>BEZ]I>P>:6[FIKU;JCFI)?/8.H8K;HCY_ .\CY;J-55M
M[/7A'?-+> L(*NR4'24;W<-=1@2"7.U[4D34G!N?5"2_^U&%."79':9G2-+;
MU7R]C5,;=3#8\P^P(RG/_#R^7K[=YIG$4!5"B&WDR)V!-L_FVT,VVM4!3XJL
MMT1OT=<E\U-P3)W<M,:[3?PY4YEB*9,_\XW1:<4D5=#_P0W/'QE84P<6<KRP
MS%!;=  $Q[?\0;E,]KE:(WSG&)' E6QU?5O+P1QQMJK@'E7)]V'"==$$GZWW
MXV<,RM@G^X"=*V@T'_3)\'JUJ7+A,Q3[M8X5:ZU$ RS6K63>=U66>TMEE1+D
M@A%BU?+)?MLF=M5B',:L*S71#CMJCPB3%1;=:6#?W$WA/!=$$6@*OA7(J1F\
MH Z-#EM.4G;D5_J@ZU@/]P[#17^NB23%.Q=*.@8N=339L/\9B/!\A=IT7^ ]
MW.5(52W=ST[=E<])IPB.9/2*>0*>R+0@%9P-JH;HF"<[PED6E2=47-PHF35Q
M?$@&([C2.<-\-]\?BJ^\,M2+LC)V09R*AV[O)'W$"-N61+H%&!8<X'^/<#%S
M^"W'[:->1XUGIF1IFG)(6UO4Z>NH?S[NK*$>KV;",R_9CI6T-)LI^$)-S\/K
MT/6#.*PFHXYPF)KEGFTQ^(UMN:>!?U]=O)?Q(KM7NM+[0\=+AOP+ZL(_ZVNE
M_--*;>J^QJ3AO]$!)/%;*KK$VP,O@J_P\P>>;CO'J!9GE.\1E+N2/>CN+@"A
M@KN:S&\!L+)X$(9K.J'"=VW,WJOXY(R&X#A'3S%PD[L /TZ/WZ4R+4TN&=W@
M->AN'5[W7.Z$?2-ZT^L/^C8.YVG<D?%U0-,>!(;")@^3WMMN?3M+OSG-;\8E
MRO45)]4R/L()^_OZ=<V29GF*A!J+1Q?0]Q&1KQWZ2*(7-G] %6&A2TCY3%CI
MS+<BQK[VV>M<.2&?[AM>+QP',);.PK:-1A]QM?@<)$AH27)?+D-CO)[+D;>I
M0L2&PLY''=\.C8?HC"3I"BUI+M/$J99Q)^_CV"K1(Z"ET@"1>W*4J=[X>DP.
M[.__M' %@YU7CXKX1X"%!4;-/A]'**^L\&_H!BOD+N%U8.4PTMVLD&LDBB^+
MF"<:^H8L[V/-Y/\C *(@VPJIV4C:D6ZESVI38<1W6JL9T$I_$/9=U33+Q:WU
M=61_B(:DN'CXAO5(,=2Q16MV=VR]MMQPV0E"M=WD3O8S-%JUAJ,R*V.^]WF#
M?]M@YJ7^QZ2GI"[>$CCMX&_F.>"!)W(_EYHN<G<=]H1198>LR-[ZG<?RY9RR
M![HOUJFOLVC,$AI24_'[1+DS4<"=9*ML*S:)T/VI7:KB5% T;W8DCM/\D4)L
M%I>]0^[UL5S.]4YJ8/-@7B3_:2CLB;X'Q5&5>BAG3&W9:SY/PYY_WZ@%<=,[
M42JPTW :+?MC2=B]/:(^F:1Z,J,R6M]G\"&+.5+S+> 8LQ96R8I<3NBSK]7C
MO9R1(5.G1ET+V)SL$)^(D-Q7F#RFT-[P^6(PPDBE)PC18JJ&*]JY4CJY8)*.
M7\I0J?[ /!!+&-)@9QLN,9#ILA<T5U45T#]%YO]0E&!)S T])[5G"3B5.!"Z
MKCQ2H$=IY2KML_L%=CBF/HYL'L8=,A*>FN%N/B54O5JO*<+>SLO9SNKV'#]$
M_2"T%.9T[>;U\.MA<G&\3MJ0%I>FN3<<,ZECH$B*K 1(?DMV?K/H@* )XYD]
MZOLI$HVRU 'MMH<@4;.E/G?BM:3&=*,?YT\:J8G#5H4*S:$8=$R<5,<KO=!]
M/% R* ,S.ER*4]\#SJ+;V-7.OE)5B?00 WR1ZQR6*3J\IT=I[5KELXM]_T=N
MO0V:>%V"^47"<DEG X"V&G\"PMH141^M:J_;'4(M><B<HA@&WGS!H-VR10B\
M8VE5 M[=R]FAW@G#?;Y?BWY(<)=H?L\G;+_*3O,P(<+RR3O=JW/0%=8$H7:L
M'WB5F>G&/>7FD7E(83W5\:57EE_RGMS&%2QG:&<-^/]G#LN_*?8];<!V3@L?
MO->MNU.'55 85KA?<'YS)Z1RO_7\5[*Q]TJWB-B_7_("10H5FT"?P.3+D,3=
MA=BA.W]6@EW610&MTKG> K0F;@'"199%3#C78IY4VM#]QK>BV*K<LW];:;B3
M/]$4'N=;;QHN,(18-AJT<$A-=@@XMCK!%<GR*/&$!5]S9ECA:;07GD:U';7-
MFZ<'K[)D2G0@<Q.1T$6,-C)/"G')<$HG[\&QU$.ZR.'A6N0#*$G<]BA"^5^(
MR;WEJ(5L+R"SY66QF#J733+KO;9J='@KV + (J1<7"TYZ'QM6]OT;0\L[6L>
MY4Z79S)5VLL5G*_W=!T45Z&D9\=)9%R]#CE9S@JRJB]B=-=DB9O[X6XCLD'L
MT3?'/$/L/HZ3&;>,CJM-6=SJF=/#BEP='?=MC[ 2'[CDM@$?UG"@^?QY':L5
MDP&GW!%N16I/B9I9%49&&4^^?%\CAB3WM^-@%LE^Y &*\8:JI8T/U$=X_N_/
M(=WLJT_K67LV\VJJWWI7 Q]O\Z )7:6 AKTPS54_4(X6ZHU$Y5R")B3RT0!D
M&-44U.1A5CPK8WSL2S_!*)LVIL4OPPLUU"L16&JVV]";45:] =WMHN*XY41/
MM\V'1'$BOOP?ZK:_C@<6DD/PTR6?14CQ\ 2H*+P40LI^EJ*VTMY(2$'1QB,'
M1>R$LCUHV[D%(%L:(>JBS][$7=P"Q&J,3 ;FB$#T7+.N<Q#WQRO[7L"+TB>Q
M0?S\C/*V'].J@RELDSDQYF=]AAL2H%@#L%0WV)(!7K0 KXA?/T^&P:]4/ZE;
M0//D+:"C7!%"WD%_E& =($"7O/8L4D[:P&+=U(J"IMXXZ6M5%>"LL%7P0L0<
M&>O"=V./:>"*O8RE0^!P[4*_8Z1C%E:OWCF)&0? XE1ON.F0 W24_N??)Y+X
MF::=H+@5IQZS!=X46S[[50@V;:Z/-X 8@'W55W&$]M'3+F8\OB/%EG?#XLUL
M>IF>P2)<9#-5>1[+M_]>64#ULE'&7?SI<7M,VX!F))#/<HIS[L*"<(FV5GEV
M035J;OT*L?> 1I8H[I/[3*!1-FK-=@M@W8TLUS'BU$/<VA4BWB[ ?F!UH-C0
MI*19%Q!%91N.M G(_1*MUR-!MHHY#0D"C%<>4>58)*!VQJ?[K&=3>O'+K<0'
MG&N-,@VEQ7L(MR*R >!VDC>*A&W53Z/4$::\%C1']\@E].H,/O(PMO.?C :/
MO3!P-72EM.S?50_+89M&Y47H.-5S]P62"G,C5A1<R^1J?I'CD_JBYYH+A'K*
M+9M303XA[)K-N<0JUPBGF!Q'!R!_%$X9@)73!B1?SRDAGI*K\;",6%QD(^XR
MR\-*E]-ER$4V7DY"._;E3:9CM& S%AFH2%'M-$J-2=].%\]LF%P90A-V#F%.
MF7A66L1.V/NC;ZP-<A(./!3P^Y*['CYDP%LR)/.\?JCO:12$ R6?%U.5B;U/
M 3I5L%]$(*%)&/F.T4:(R!M=7@F5/.U;37K6SE5H'#!TWJ,-S:.*,'!IZT+Y
M4Q&NV3GS[M-\LD./#$!*)P2$HO+B*YLZVJ[8.UBQ1B\KR;]57A[5!GM<10[K
M#,;VE)1G,[[HHR3HRW1O/2SS<KU?HXC;DU(?L_?'BTAU,?9I'F!M3QR5V\WA
MA-1^U:.Y,K 37U%'A%6G3D]F?T.6(O]SZG^X%F=/ZA"=*A+;M-X6/QA8=,F:
MVZXZ'\Q7566@I;.",ROBZM1C'<\9$O6]%U9596#7_ G4H-.,^8A?A5FAF:A?
MS;6EM/GE"9[SA.HQW=QK0T-"(3+T0=LW#Y7]7I#YA8N;2=' :<RTQ6>46G"2
MF(4BQ7^)N#@#A9H1SMF_:1(+-3UZ@@(<!* 7NB<W/&HW'I8WP#/\Z6FM6.Y/
M[KL'H=RLPSX?4&!5RHA8BUZ-J.(M,1+X.F+"MHN'J9X>82!FX,BMHNB;!>SB
MKXV?_-2ND2\=$$UY.N\7UHL3(BGJNSM<=X26XY0?YM 52$HO8KW-?6-.0Z/\
M^ L $4"<TQ$^]%9G,?2HVL%(53&\QT:HP(1/.4\P]?4.#1S<=T&P3F;)%DVQ
M3L=J(^/85^$\2GG2 TI]4*&HH8X99^Q>0M['YQMD3YNOT'SSXD5$P_<[1=EB
M3L399!4D)EF*=T4UZR?8I7\:5=76FY);6&E_J&F!MP/PB\JS!7QZO!Z:4K3-
M\PYY;^.[X$:O;;4728J_6NV149$]20O/-W3=%X+41ZMAK3A!IIF?R.?\F(WH
MVV*H*9-/IS6DWM%/;:O6VN.6U4"PW/9:D+;1D8YP"ALYQL8$J1 %,@7D5LV3
MV0*BP_=_"[O-H5X'%8[M"._TK8ANTA"#.QYW4O6WILG#?VR@_/Z:_"\:*.!7
ML ";2[EQQ!DQTSW&2-@&1=OS4%\'[,)",;LP 5;ZAK]?D/]-'SSJWTA8,4R;
MQ8YCECM5,6"5=!,*;1PA0D[DZT?YFBKZAR]=9\+QBHH!3KGE\GK5]X=7KXP*
MM ,W:'PM3<RRS5)E [B/QJ/,0_.P?>YL[#KH7!%?76Q0 NZ42(GF@# P9(K(
MP9 2\_19@BC HG4Y1(%R>H2R_F9#*"4+F*LZ7?$C[;%6OP;?JAC@,8\3L2O^
M!KLLY'VX=CSSSE6^?+ZIVS?V-ZE.U  4QPZP1A];>4"2[V+^4%<I!0M/8MZ+
M%L5@ Y(Y&0O1Y0*5YZU2$#=KH<ZUH(ZO:2U.IMH7@4IU*N*U!B)A,>159T30
MBBALFK\%6CPLP=D>R3#4ITD8N,PZ&%A@:ARY5*E\>)L1*G>^0CJ"\Q$6K'N$
M]BY5JN& 2$J=+>#&29^!MH[6O&3CNNOSMX-UQJ1R4A^&">A]=R'3V^YT_M65
M49VT&R@ ?C$>$O05Q05S@H ,@DY7A^&.@@;5=]E(\,;>K"W\9G%?V=08S=5=
M$I2*/[X+M3FB^9;_J8XT3$-ZX>GV1,Y:Q4 T/I .8R:ELVA'G2K>I)1X\@X5
M_F5JT_X]M7F^]DCIFN S1:4CGXNOFG\^5C24'K.9;SE&\4!\A ("(NABRPP?
M*4[X%S'V?TNO7+-\C"F?PF3/2N.Y/H3#;V 9]?EZNFNV*]@\*>/XI(J,25</
ML*=LDM9B<S?"E#=^U9]A:A6N.5=N6VC#0>?(O2V4R_8&CZJV-OG8GKTM0!)=
M =Q:(09+%BYS$9UB"D*DPB_*WR!^%Z 9>R93P"(],.^ ?V4;E.&9IVM&EO%]
M+;W_E1X@/>OM1$2RO=(6C23"5#I)4VX[04=L/H7R8[QW-H!.+>.S_!%IV->1
MD0<_HS+)R%<L5'F1)Y'(QO9TT5;CZ*),6;15DBAP+!W_AEFM_.XT=ONI,<J.
M/$WW*8:9PY[ .U<(V-(IOVNOWG&GUZGEH"AM30/!)^$DQB>$5VG381A+ YKJ
MQ]Y<=)ZVOU.0UZL3FYUG&%L%4';CU8IQ7Y^HXZG&<D*L:Y(EU1P8ISI'AM-@
MJ8FLCK*R-KEGR8HA@[FGIA6 +A\:Z'<Q>C[=D9HC5C*OS5:29ZT\F?N@!7\1
MY5!.(],4%?=)_+@.U1C],[7T1#ZIEWG/]CM7QB'G;5<5VZZ6]FMB8H_;.#:.
M=J[&)3/CZ0.=[J@=9CSZBA 1&6!YK<MH8O12[#$W3AX,I#46 H!5 E#U6P#!
MA@QYA@%OF? M0&?TC/)XW^ISYTW[ Z4;P9V+<=.[4[+PM\X,_/_@PI'5B%)C
M<4AZ18U)=*C$-#KH UML?,AZZMI-H5-L;_^L=X.G-UR%<MHGA'N86*2YPQ.=
M42MD[3344=,\63"ZD8.8/22H%;^][=[]?0(+GY)?\A: -D; V[&TXB1.C"\)
M[XF<.21(B'&1KO21H[R;">0Z:+S509OTH\ SVS>6-2:,&]/[86A2H(Z8:Y_B
MUU1*/*-@-V@>MCF!3G&($HWVQV8X8MN4\3)3TQ>_15BB#'P(45ZS(Q?7XLI6
M\W+%RI%1[J< "#=ZGACKU;L24YK2)Z5G/RJRS3#+5?'HWUFLLS]0\F7V"TV?
M7"_+Z4@03'A>65==%MM7%;<,5N8:F!BO2#]RRH?=X<5O=RC>@MVAW&)@N4%'
MR[):+= F(A3,%]^9[%IH<$(=O>:5D/015, V(H/[I%*MK*EN))-EJG^(EW%8
M$(F">U.(.,>Z@G=.<L6\-^!S9U*<LG9-A]N#39ZQ.W"HG> T3S]6D(YYV4OK
MX[->*''MEM*1IWL1J#BJU,G>K1:FM@*+#?>45*[\5DG82=QV+R/_*4:C(S4S
M6$.;STQ6ZK#WDBAH[!;P?D$5@**9 J:_!8389\:;PE#=4--$!;\D7UU")O,M
MP%90&?2&!\K^^4Y_A.I>K![Y?V9KA$G3G" DJ=IW>BL]F,BG0I/T,SO"W%[?
MZ3?-G->AV#24#SH';>>__(?A-3II'#,M3X_%9\7#DJCD\ 9QU.O%&,4'.DFB
M8"3&H>"47KC3_)T^L9,WAN9Y 9&F/:$ Q0%!WI/@L]S1*$K?W:%8G3'C((F,
M>J-04=K>M2^+-XCF'#&0)&\'5FE+ECY8?.6^))9%X^*ZLN$J<+E6STU;^AHJ
MLCT4#/V<KP'#2-II_S+ 9)X_K&&HF&M/;+2L'WAZE=/AU5A10/JIPF0"E5*!
M5"78^+3][=WYMT?(>E&D&A52]01C'XMY8"-2[62 _7NRP7%]T8A]"?59)H$(
M["B-H3_8/]T*KK0OE^TM#W_0U>^&(6ZFN2=[KN R?;R4R;QAI*QJ99OL[896
MH02[*Y[17-4G=G.3-B^['ECID@<!D60=Y4Y R4?/<)C[[%0HQKF:E4$Z&YNR
M="]A")6WY'X6GT*X5V?T=$VILLX6> N(L8!C&DE.": 3K;?."Q?$79D5 W?4
MM$K<A5@=.-^,(!EA;J0K/>T0[YA(&0Z&[IF9[^?CA?__AM&_:ACAK)#B?:VN
M/I()383(T%M;$HJ; 4O+,U;?"#O,V@>O\.=-;>9^*JN.KRTYZ8@\O 6TU=:%
MQ%O$E%C1#,_#(2L@>FU==O&A^%. 1$([)2\X'B.-.XI4YR#2/?]9D(SL3!3L
M-,G-[[+1-.XAGW;AD;;M]OZ-Q,4,$&$!B8M7"0MOC8*K0XQ52_N@0YN;82R?
M+:$[D\$WEK$$4,VWYGR2:!O6411O-QFJ5M ?*W,!7@KA@ ,.Z]7" LN]_>13
M.,]2*79BXA[ W88NLXCFTXJL<;#,TDT$[D,QZ;[O><D2B,R1H5.D\MJX"4=R
MK:HGP S(>EN,LH@C+DXWUW:&K\]L)1)(2SJX-BJ#)-!<E 4_K3J .S6",D@4
M+3087UVBBRST2Y"GD-#?^C1*Y+"\4W\+V ?[Z^9BP*)$!WP.^N;-- 0[J'YI
M[(P]0;^XK+L%@*_BF_YX]!Z7U*VZ>")T';6@^.SV5Q_MT2;@JGO]_/8?_, Y
M)<:1CPQMJ\ZJ.1FXIDL!@@<?RUT_\KL%?$J'X@P$@S81J*'P+;> ]HG!L<!E
M$.Z6 +!JP9/9-72NLCC:5 U+;/%K,!-2I$\'SR*A,F5[5QC.+<#??@7]Z@$L
M'_F\!!\Y#NBJSVY5#1@[8^5W)RU1A;YYC_48$BRH)]3%%R:U?2U]1*%VA%I?
M^2'G[5O:* @P=-V1S( UG(4%7; &1:B/]=L".KLUEA@C\,:W,Z1,!O^[=Z%0
MB,ML?1$W7/*C%IPT2_-G],D?N@^_RG%^.C4,Y8CPWV7PUTI$@D_Y HC<1#3?
MTF@^7/!S #]!<D=.VC?0#K-GM8J(I5PIALL29/5)C(A?R#=F-#(%3OW=!G$*
M- ;ZF5E_H'8+"+L%7 "*7D7>*-X":LW[S\(N[H3OO!]G[[^N9(5!U+2'OUAB
M_=N?.\R"@!CTF^^@S^_H9?J?+>3^;O'TCW9(]V<0ZA\&0WJ_W,C;\A\MA;SI
MMYJ.<<IN 85;=\WN'4?K2^3N4]*>&@9.J' E^&P.=$JN;54  ^#X G[WBC78
MV?]EEZ!?'-=HV-Z8W%LF_K,Y%>!/XMWPOXX%WK]!_H<#X.^><YF_O/Y*_B??
MH'M_)*;-E&/"N\^45FLI#15^ZBE^7&C\S\7KG1J8PO\+//ZR L&K(%/HT1UH
MM=8%=YXN',2W'!Y<!^Z!YD$PR+IS< %-N#FY<_=3_7_D*'DO'_Q+8?:[P=2O
M88+QWV=)]=\^A_&//_<!<1\A"O<V:G>@[1<3J;]_I%_LB7Y]P^<7Z[__VZ3P
M7[MDWH7*;Z!SY ^+J#^9##[\0X+W)<&?'3]AF.(WRR; O1YO\Q\W>O&[IU3F
M+YY;#X;^87UP]Q^T>AV7.&-[S_B(SLW H$'8?WM/P.,_>3:PG]_<LI(VTQNP
M _[*3^DN==TO#/X5_@BX,\]Z^;=+)-Z],?DR AP110P2N;OPJ_,_0@JL/[LO
MN;H4+;-NL1R<.Y[ \'5-_^*].;#T,M(G]  VP<J!*H6ZGIFG)(M?,!M"719?
M=MAW$V&@.E8LI>"<D;NN/#4IX)@!8G&(@ZA^$/;2##@:P!]ZZ;Y517!ZG10Q
ML,7#6+5\(S,^*>W,-6U<G:S@A(:-Y\3-AY8(P5XD4C6W/GQWM!=16%%-7LT]
M&Z&)KV3? 2R-[.!%W]'Q6[S!=$!_HC8%]*@+HY>T0QOV&,?7DSJT\7KCNB1.
M5666(7^*Y;OM2G-!Q^%Z1 !>?' +6*F(*+JF'7?(]K@1$!TC5^[--RU5;J9<
M>L0; 'M06#9X#>XA.+1? [O"DJ\IEG<6$,WLVND5&B*[/]4)O^QI]>U!%P>V
M(.%WH+U$OD+$3_\%6CS^S4ZIB/*B-2U?U8EGE%GO-0H>VF.?>I0L8DD*FP$^
M,B+G;0&<;3LSDB<2&6@:/<Z5:,>XC-5H/*< KC?\V)X(LGWVY.+B^I5I073/
M[FN3;!'88X ]%U@4/6[Z!:@ =&%/X*%_X+7'W"V@Z49&-_>7'<(_:J'^L;,]
M.B$?HS&FM$J5GT&=C-?>3MF]')PHB[;)YF*-&HVC116:?H[9VKV.-JVQT66A
MDLW$V :)#[Q9F_/><W^,RG<6H+[(RC&3_7'%^/,)U1L4?_%I0K* 52P,^XZ%
MSSA(-OU(H+0+D3:2%]&%# 63G72L_&LC.&+O-*F=G_<O"DVC/=K T6^M$D I
M/MYG3_"4>U,#M*9\]>EQ2M3I0FP+O+VWT)KY(/E%Q5*>"84O*N^;(.#H,['P
MCMQ<1   !*OH\^H=@BC '^.3@1>.7UU<L4R'V%&%U(IK8OC@5_\7>^\=U62W
MK8N'(B@"49!>@H#2!)0B12 "TD2D*" = 6F1WFL :=*+%!$(" @(A-Y[!VG2
ME1Z*]-X"A.0&_?;>W[?W=\[9]Y[].W?_QKA_O&-DD#<OR5ISS?7,.9_U3(H)
M_ZA,0\^IY.4H4L*7^EX8P-6@5@Q@?SD7B]=RL."B!HRP14+1GH?@LT,0!D"E
M)=R]I6TGES:HB^MIN(-P(I/,:?,/'Q+CE")=1+QM.L(_TX2J#>N$"QQAQRZJ
MY5]7G/K#==')L2G26">5JNA,/X?-B8#+KF[Y# -H[?SAL':)+82W832/.JZ4
M'L^P4VFV'0T*H!IKK4BX=]&0)O@_0@.:99NWCS5<=.1]K[3*+UMR=$I!T[H7
M[?2(]2^)T11V/E5G7O'.Q  >*V4*4O:+#=&NV8A==[GA4<!C7,7RF6]#^&C1
MS[L*KC>8X2RGH?DL4(.:Z?2ZTH,W2B0"31??=C>5!,QZ3;*98G;M7B09\O&#
MQ,[M4<]1 *BAFOC>+/@NR#=SVI<KU0/K69[?_#=&5?@^?$\O,=T,E,1W#UE%
MW7SY0U?1B]FO.#SZ^"3RV::O+P: *QA;8.#5J)[TRFKP30E8*6-XO1MEWI!1
MD<"_^I]-@+:[Z1NO/-[WUB%%@<WQT@'"8@O5V\-A828:>ZX4MBYK^*F3+SO
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MDDVH]1#!^KEU7V"P<=@"?\=N9(\+NN>I#CE#[[1EE\5IWVB)SW4#=D 3D1O
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M9)0K1?,Z9?2WM6.-00"+ FD['H[D(LX&?V1+;2'P1470QP?Z-1G\-";=" (
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M;U O['%"7M%8R+)2IGY/CJN7]:?.]VQ)3T4!-#Z@*(H?!/5TK> ]#NF#! Q
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M\)I&PL ('==:M,\R!H#[$@.87\%"::OY[5,\&.I*$ 806IBVDC'1)9XD1CJ
MJ Q5.JRZ;Z\%%'1P3+A.^29ZWP?$6J@O,E^_%\)YBXW[BZH\^\>0Z NZ*,D_
M4-D.%/Z.[O8Y8K''6"*$_3/3/Y-?Y>Q/ECO*2GP9919FO-:D;EF<[7N>;:H5
MC#M_G]7CKL!=.9T%AMGO=PWGO-+,IJQLT.5VZA.NW31E.9?[*>?(!ZSRP05V
MCAG%:E/?=AI102\O--2B"X TNCT_)B>"F,D:C-G1+*G\!YW+!]0#?[LCSYOO
MKR+[D64@DQ_K)3NO\U_#C5BC2@AH)#(P@ )=*R<T,0;PS 6]AP&P_,3J8_E^
MXD8'N$_-'+H/63$ ;44]C=,O+!3EK;+^6TV=VM[EV#G/&SA=F^TO=V0@5QZY
MHPW)352H@W^=,S2$AC/@3JQ@W5.+=!YT8!TMC>( (YA'&Y>Q /,FFF(8^P9W
M!G3  KR-G2DB9:1,F<W).MOY.0B!#<]*1-[,<[_PDYAD6P2WE-00$VW-MM3<
MDSU'A7;.D!4RHD(00(9CCP4:%,>G&K)AG6 +X[?+<<QO%1]$?<ZH3E=/\?L<
M;RH,((Z!U'P58#\PIU,9H=%8L%CS?J%Y&CN%QJMF<<:'ZPP7&.Z,^0_8MMHR
MFO22VL^\.0&BZ]T.SS=JPC<J'0",TBEIB^P;8)QV<]<@;2^CC4M?)A]U?C%X
M-FQWW+D('!?^X5\3H?SQVEAA('5A\$87>A^(<AQ3+3 @)D;&=-OCW/DVX,D!
M'KKH  ?MS"&FY$5))@/;@#MPQEHH8]6U;Y](%450Q6C!-K6(UOA?H;8J\V]5
MKU_E\[)?U3DL 'CRLR;]*TD41?(/K,!+*7]62M>\A0UPNC0&T+79:'^N@M'&
M11:VKU#."V09=T-5_I_:\LO%A.50K)0^88L5X.U \%#)NG)K&K1%TK0]>*)O
MN$$UZ#!]XZJ#0<>'RA=SJ*I8EMFESD.X1DTA+0M5D;>S+Y/8\8,'W@35VJK?
M[/\[!@LN<7#Z[GI?X[[F/3)Y+3QBF.J%WN)]+%PF@.;68@!NT.AL[@"&?HB&
M)&.Q.PX;?_7B:0RTX!8\S^O5]9 )1(:4BZ%Q 5@;^\C1Y7,GFV7M&M*WV6N4
M)((CO:PSFN:V=^^".R)\K1SYH8B;?['1&["=:,O9?6Q,C@T1B%8Q  3E8.-R
M&>SX !K AF*>$$(=QJ+1D3M9CA):],V[E/F2(*O8/1!"2^^2BPU"CSK#&RVS
ML'U%,]);QC9%N'_;TQ@<(# NI0UQT'S84%Q4'Z.XXMEV#^']\)L(0[CCCNL'
MR? >3FI2B9TW&,#;;OCE(5IZ:R(EQNB<[[S!=THM<FO:/&0EI=>HB4%-J>)<
M S8;9L,VM&-+4E_20.\6K[E?WVQ&Y1FT4*FUPCMQA;:6B1D\Z#F8SEW/E5XC
M?TS3MDPL8@#Y"I[%!TR_2>P;I7Y>)H9\W%&\#B]BF#.$WM-=A8<VLXCN[_%Q
M?UN8Y 3G?#JZ_2 &N0D8Y88APX3!;T"[<+6:1H8JT8(2PT5)6%\D4I/CD?,5
MZY]6.'KY+PCAK]S5/_1C^_5:7NH?^[$9#((7A2ZRE3*.$PDH_]NGD4NZ_?_8
M-O+"<+/^;QCN"HH!^V6N1IXNG<M(ST^^?S7J3[S<'2#Y:+,J0F>]7P+V['W=
MW^YXOBN'"L*N/"=H5,8F<"-Q= :IH1$K+6.D'+^1%IO*#UO7I?B#9";9-Y;J
MEI++4VFL <+XR;$:!4XZZ^QA&N,DM.2U> R6=;/KV)ES'9=,6TGR3C<<UGO2
MHK3D'(2'AX>RJ/>/KZ%IW(E:^ZN9*B/ERVU.SJ%=T("+#%.H^>S^A/+9*;@E
M%GW=B@[MWHT!0.60:C6@.Q&&R% -ILB*[A/@3GZ,% >K3YJ]\D.N.BC12CO=
M\1XOR/5QG<<>5\+. 8=0\.L,3U&;.ZXLPFIRPU'L2E>R1]8$OK'L= 9EU5;3
MI#ZD26APYW1$G?-Y:%ZU$TL0(E/FHHR1O=.6O ?-+G?7+\R0R[^CP-U6G&F2
MDAM&O@;A0E_SX#TYK3H'M\286XE';5]TU&!<0#<HHWWBVBW!>V07(BP#J#YW
M_>C,]HR)NFM=6X4WHQ(Z''P>>'%=U=A)R7<>KVR9-UJ+O*M_+YD\XAU;CL"&
M'4$-+WXQ[3K.# 'A/D5_TDH=&7\AF(5Y.D*\).,T)+OXWE1"ISE![FL,H.UE
M,XH: PBWCQM%;C:/6L42,A.C7T-;JA^S%"G:_;3.WQ@W_P<4A'^I'.-?+BZ/
M%GSHZRH6V,U@#* A 04AJ*QC!HQ-AU[S[O]":+S/@7Z7VJH3ND R.WG=!-5H
MI@OTZH.MOJ!HG#]X62"+VKR_1BC>*F33IG'IJF'\LMS<]LEE7>@X[QHGB'*J
MAR>?R4SB"2<1FU6;_:R^W<%I<M_?;L@. 2^*"YWEH0) YE"3#OAQ2TE9$BT7
MF6?E*_SDW60L+IC+J]Y)0/E&8CWK(GM\,T,_191L.PXK1Q/K8E(U06G.1%-1
ML^,J[8$*(86&S>'>Q8DOQU/EH(.>>CZ:Y?>HSFY#5@"I78A5GB4K3)H.3<:@
M@X8:8#VI @9PA1*[G8$+L38*A_VT8 ^%7Q8,_0D?M'[!!TWII>@O?? UAY:=
M'N=-NEP-75+)-5$-*V?WH,"R1,>SM\95CH[A[Y43@4PF=A&0L$])*XI*UM:N
M'FK#KRGG#)I_\,=]FWGQVJEK.=MRI:!.*9WE&FSEI&D@-@RMWD0K+1W>D3FX
MHCT6>;OZ]:WRD<1<&OD>/'+HK,1Y/V1@RS!F[(>B6\+KXHIQ ^GQDVM0VC6Q
MZT[L]55ETXE/3)6R2W$)0; 5]MW1FENC*4UG>RPL7C?\P <L"N8;0I^KNVG7
M402=_0WZ[2K8"'V1Q&D&CR8)M>B9QRCGK0CUS>9^&_'#(/0K;_ R2QXG.0;@
MZ7O.A9UZ?42=@BT S)P&/NX"CQ59%/AA4="%$;;].R:H;%P?1FXFX#LLW@,=
M#V&7G>'8L?]#VLEB(^#W[P\WO%^!AV*_0>P\7]:>&=V!)6RL^VY7EYYSX5:B
M],,$<V93/DT_7*XRW42&-*6_)IM:KZ-!?]H^7T*7!\U??6_ME(L:OV5D3 _Y
M+E<Y3@,^?QD^\!=04. P,8 *M &OYT%%*1<\;D#J*XR=YE B-DF#42E3.YEF
M$G6:E_1^?,  F+&+"@X\-X]Z-&>Y0=N? <%MO32<"1E\2*_.N58& ZXFN)OP
M#_"?1,8TR0/H%VY,ZCV*73&&_I]A6ZWRZ:>N^C36TQE.G#V^7>)RC_O5+5CE
M1UZE^.4<LLX!^VNYI5NUGX@ZM15/B8K*]F;W$D;Q"7<*QLTA-?0\''P>V986
MEKZ2V[L=FF?.]6#-YO$J0IDDWU):3Z0)/!-U*"Z*@PHJL&6-L>_M55;K9#U7
M6->/S7/UYC9"W$KZ\>IRK3H5-6,VZE0#BF(Z,M@_M#N%!K .T2G%U_%C!^(=
M6 %Z<+]01'"=DM;1W3LI_EYM"?O+ZIH]!71Y][H^1?FPP/M"EE0SUR.$#K6(
MH;CX2N@5EAC!;ZXDD2F>]2'I:*?.I'44/K_@2=>)AE@$:@L#P%/_:<1AU_Y@
MQ/ACQZ%30L%; ,+%YX3H$\+3L2O9#!=6_%,=V_^W R(7:86?+)BON#_Y2+]U
M /IYCL'G'\\K^ AYLF#G8.#,9':H[#;6@-G..D_&H'^6# NJAKQ\]T^F&2CJ
M$;C@"MWK U%MT%E%M. ;G9GK (AU>S#8[!5>\<D[#."Q\LN"]MW [<W@$F^#
M4CAAPX^!@WRBV5WWNV,9WLX?G/!2$1\JY[EP XH4'> [9J<?&H\33L= P3RO
MJL>R]W7CWH;9%;YBG-4UP0;&@4)B?['P 0AXCZ;N)TY8T0G?4(4??0\??[.S
MU "1E7)Q:(E./MW%HHDD&U0("[H*?/A1DMPW;W>])EGUCH4KXL8E5=\F4( *
MO&,8:TX5MEW[U2X/>Q_YV,L-?8#DQ-@8PS  _R -#  VC@JZ\*@ROUDS5S;V
M#1U9#"!U"#H[> &$+W#$V$\<$??UQ,1>4[L_W0U/TLYQ[]&W6_+4PB(4#\>U
M"I#0)R5#6565*6TYFN8\U/?EJ3O$UV,%AO6N6!3T#0 MM:U\JJAVW,+.G(7B
MZ1CL158G:KALR,WEV]A.)6SY%Q? <6XGF0+"4Y9*C$$%YGN0^!8=/860Z'=A
M1?>$SO>WIW[4H7]<X;8VJ7SOW$,SL;[BCC57X(*>G!]/%E4EY8?2*Y&]$QYW
MF>Q.T'Z1##H?];2F@(W,?$*#\EB3D!*(CVAUSTM^"]]ORH>6P*F*8&#D"IQX
MW&T.&TN0Y<7C@V87&(,L86L</2_E'*+'56[7>E)E)W?NB^0O:(NNOQ6<G,>A
M3@F2Z 0-E88+%J7^Z@WQ)W:*IW2+ QN?_3S%&ICT^)F"_$]66B+)[]-HI*'-
MC7O4">CZ ;1_><?XJ[G9$V)%#$!_&?M-M1<@A5?J&@QRYY9KGYV@?65N:%KL
M(_ZD1$]P%( @T3&0%*Q3I"AF==M+YNC4=0$'T3O!&V81SW' 0X(*-(VKR9(/
M4=U]EEJNA;*#GAR?:.#JF90Y^-=?)D=5B3DO,E;EI^]J@,"$"K'= [/['1O0
MVDI0@=M0KGZ&YP>0HC(PX>4"A58VVRPJODVSD:@KK#PB*P'//U4,B]AP&<"<
M<X<,][<5ZCT4OSUYQF;\-5+%(^2X3P(]^ZPH\&CTN)5SZ]GI-:_F+KC<O.D'
MAHX "J3!K(X\P?9SZ\NH(W1#68Z167\&W^Z)'J',Z,?\H<98N:25&MVDL6*;
M[';FCF'R_:(N *X"RA<^CJ9XTGA I7RV T5^7J@#?PXGURL?T6;A;'FJ0D]&
M% ?NQWI\I+8SZ("T&HN/XBOAZQS>V\8#/>F^<6R'L)#SF0EG=JQ?SDU ^V%#
M.6\@!D AA^)\#UWA@1W/80"[ZAYHRI2@<SPX=#L+7BD]&EB9U>E=L8UO3W9=
MUT^>D&9A5K"/LRJ8J^= _+&P6$7ITB?XN<%)JLZ\,NX XORN@5<Y#WGOY2\L
M$[(>A^#%\5OZI;NB)S>_&I8.;%O?)HD\TLQ%?1F/U32EM4_F96GO,U=+-XB)
M*:E<.'_!_C&%7NT)@EG619Q"5@$>^FT_QNH[R<?,^"L%DZ\'Q:S&23-!8QGI
M#S9(>7AZ.3A="WC8I'8F>Y@CKCQB!7Y)9R$D"/TD=.66<^#QQX@#%=9;-PY#
M% C4A%ZNW4BRP">[S!21-J3$-\4:-T$G<^/919U^)3UFWA7Q]FHW"[X,@X(8
MCGSFAT'R%ZO'[BE#$]\?[O=.4Q"N>1%6P]>5D<]<6%\>DD@)7\$ XNUN[Y_$
M@ M<&*EWEAJ#!,K]!#6J;4G:IJ?K)=X4H3/'7$+$7%XA5ANZZ677#HC+7E;D
M>W^(+*S<*Y1P#8F[U2-_*BIB#0(J3QBE-@8AJM]YDZ\B%]1J!L[R7IPFM-1+
MS=R/5:X/V8CPK#3@CBQ:##N7S\YN#W^H^%Y@TC3R[/,&<'E@#[[=ZLU>O,N=
MH6"3N!S)^)K4^]4Q8\9,UL!U92W:EGB]MY[OCD\RFN%6V:55'AZ)J1P9PB9V
M?IP80)#CLWD22VYAW5O54?=F>FK3!O"J"]5W,8# CZ,'%KSIP5X-@U?S<'K2
M%G,/%U@]SB%?Q,2AYPGS7%?[FC5$$MS 4V)"*TI.4J6Y2E5;;DY%$)*W89P0
MJA.&K/$6+:/R>'DGWSLA67$D%5_;2-]/V9UH?A@?=MIO#'X-+?64R=$*F"CN
MGR0\8UV"2G'=X;90*K_M^".1\SD+S9#&RJOQS$E/UB1%\YD%S1=9KRYEZ'@U
M/Q4ULT6K=R"-.L\4VVF=X#@:*5J^6WG[0BLD7E=E.<O2AD(9-?VRM<E29+R#
M!M"<.[TS5"/&%3%V8O:=];>N5HK-A9GLHYF+(./>=UZX30BF[.5RV]R392FI
MPIH]*,6-PBHH9_EJ??\3KTM2M6$:*:21+?ID">TN5.R5BE84-;DN''5+I3X$
M<NG;VHR<.S@[_3&5&,!$J"VQGW@@0U"4NV>G.%<I4LOX"'JUV[')NB8E$72D
MN03*L>Q"5N?895M\;D7"Z5W0:Q<MKH(JDO/LV=)G#T7O-GMH%;K/IG8F7!01
M]++#_M5RBOH."]N,EFBJ\?22HL!V1,RHZ6W7Z0]V9H11"V'LF^M*MZ>C/A2O
MC&ABP5[+W"X;ZG35X'A>&2TBA^(!DD$'X'%8Q\"* 2S$>?<_VL^8S"F\C@$$
M-,\KGQP.-6ZWP5#VD4A=1NP-,#TN- H;AW2R']F3.EJB+#  G71HK1T&4)8'
M1T(P .P]3S" BL93P?4.E-+\IF)[N/F$OT;T^3MAY=(,'A>K?OO.LX_UL8A"
M5.PY/WH"^RO'LUE'R(Q"ZR+@(>SYX;C_BISZJC>K:UT.>/(U%N[ S*'(D%/*
M$M.=RB X6XS; 0./EHG1-LOWCM[>IPJL$0J"JC$Z'TT^?-L%(5^@>;%@?Q@Z
M)P!&R8!VBE$&&(#D)PR@Z>(91X7(1V)8H"BU%8T!^&#WSET!:,M-!.R4RC$2
MA1N) ;S-6XY\:=^P'((=Y,Y=Z#D!%E[CI&, \UCW&Q YCP&<D@BA\:0O&)\&
M\P;77*\J^KUP+""4&;&I0&]FE(2GR38QE?KN$],C'+[Z:1:XO?OH!5&?)8 !
M)TRZ(F9:!E5P>EZJ$@K3+"X5B;!1V"D<W)QV>@ B]93<E1EXZ]@#*9#7E13O
MM5.@F^S T3#,CE.QYX\>4!&-X)J"?/$DW_FR-ZP6I#[N)[-X-^;JB\6I&4-C
MOR77IB8F7(?H9,,W:Z-QLH7IF;Q64B'L.>P7@??K/YX.T_RH\'?GQYZ[W-:A
M.5"54?VG:'4/6>ESF2+\G;%/WG8:.,  B+L%JXEIR%Z)RT[Y07>GQB_I#00M
M*2FV_ABS260WUV5<DP,%DH*)YE^]34N2-Z!;,"IX,T5/J[KQO#:I@0IK$QO@
MK<H]09L.@[UKV$4*-Q@9NQ6^4>,U,=5TK<8/8!=E?Z\/K#JR):@0H^-+_4HO
M33:3-/.8;2S4DFO5*.7W*7_= '.+FKZ9F)*KK_Q/_,E_< AWN!M&:EOIX3J;
MN(^C @M_QE'ISW3[CS75!FX+=;5'B#JH#$MY_ H\+U^<_ (XHV\,L@3.B,O:
MU5C@W'N#PAM?@Q;(S#^P<GF>W'PI-E1 S/N0,-%+N>^$J+MTUS3]E1E%B9SU
M*O5$UL@RR)=""'5[XG>2X[FE]3TUY2'@G5 (='\.NKT!1:EKUGTM5[QJ6E5=
M:A(@3]P\6!SKVR2R)@.!MMC\36 X-\?U,P:@6APS]&).?K'CB673CL/ZIK*J
M!Q;_O&F.NN*T?3?R\![_FXCEJZBW<,]QASG(,X;PODD.1HB_[C&1:&1;-%*5
M.X"A=Y9!UV9D<[,97X9RJ_X;UN(IOJB?&QV?26O65"] JJ]$K D_.\%YSE'@
M^QMCZ=I?*O8_T=[/,?F-RO2W(V:9%ZS.OX7?/VG]9G^J6-AM\:=GYRXX<UG_
M+&<N=R-;!W+F-EV1:<]U[X@0-I3VT>>!#57+GL6]+A\C$5]/#,#1#_R>HFW<
MC5&P\>IK%L](RME$#*!'9D5Y'@=.^NYQ=#$">D+:BEZ'LFB@7EUD.J&G2^=*
M1B]F>K*G"WIQKN8P$=(0LM /'S(\77C^_E;5]4#U"7S+AVO*]E[F%944!\5/
M?Y^JATN5"4R;;BMH72II\6RYLG\CV5C\KES!?;CO SYQ"%I:$W8XVIBBD@LW
M\\C+-8NE6S3J9!#)L4@7_T7!P;^?]/1&LEG$N[7'@-5R7@+=]AHE"4G;Q*[P
M+LU3O*_'!_FQB/,7$@-%/<D+V2#8XYC.MJ34E&LA(O[1.0_47E8!.T4Z*R J
MKC\6;]/VDZ'3@T%QRG6:-3TSM#LC%50@JWJBVRJ/[/Q(>W<46!J$41#^#NU,
M%TW5[P\1,;A/ I[*HA-1X,+RYPV[^KD>-&'R43?7;N*3(V.4EUX\O 0  .@!
M#U3B*PTGRJ-HUSVO " ?>OQ$'CTG9,QFPWI1BF[: UZBMAJ7P/"1N33[_0JY
MFW)X.RW+N]G<?@^2&T.WQ#" :[W5EUZJAUWS*H&J00BRJE*VX*^JH@![U<YX
M::R+(\_'VNK_*2[2_^QAP&??GU:,'^W76LDO:AAO ,%9DC( YQG>@,4AXVA
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M6()EV:,Y1EE&#I6GA%UOZ@4W+=[;DCO95+749QYQ$DZBR7P>$$@K'$C14*_
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M R_/XWG[@OF"%SE-9[H9NU,.NL)LVP(>)Q/Z_;R]1Q@ B25H(I5V>.O8VBQ
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M9#S_(:(Y$4M7\A(Q?1*V?!Z,O53U- %N>W;3:ED2$O"#7[1W-',BGTRGI=-
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MU>_OV1#CTBIU5U_:.KR2 SG\O$=ZYJP+YSNDN#SM=6J_PML9T#0C@PW6/MV
MEYD&TWI!PWI'^^4UR\T9-:G:@]H2WMZ\^>V%FO9$,OW]4(06*C#=1L^S5]7>
MFM:)7=%"E__I3(2!/ZUVS3N3+%I;X]-0ZDLVV?,S4I!Q5;G:7E5K>\J*W()H
MS(@XJ8^$G]A8NNOSNI(JSAC&2^,!@D?9SW!QY!A,Q,G>Z=;4-DEN?9VLPFBD
M7?DRNGR@7>=>,*/:47&Z 5A-1R^IZRY7(&S)SM-;/^-%4JIF)/<*^^TOO;7#
MWV\BKPKK7QF#T%4?J3VTF1:C_&0EK#F7[1V)$=)#V/WJ<T?A4P+1UB02-RI.
M\#2RU08M9S%K12CV\A<=C7:ZOLV'&5$XBI8567"'!JY[W:>[B@P+9' ZD<0'
M?\"&")!W&.?@2VW?RK\9.7@^9ZD$X\T=WC0.IZY8XNE^+TKSY$)VSR8H:!X+
M1L7I]MIGVXF0KXV'"EQ6S3V<>M9.#.04[N6:M8VF'BU_<PN>7'\,!XI]V CA
M.JOS88<^X.(WTX6+]V:A9\^(H?NP]Q.2]1[!+YJE=014CZ7I;$;9_.!KP98Q
M#I\R"T0SNIO7WZYO5)H>^#R^S.DM,J;SW76@7B4G*B_O1+%@\=BWRQ8/&UB?
M%P%KU#^51^Z'5/  -47/$J6F[B?\*5R[F_];2H4UE3+ZJZ)4I+4AC>[PZY)P
M,\.0Z"_2NK3'7:SMG'RW C3@2$9PLD-AU+N9ZS :B8_WYMIU4_DX.N+&NG>5
M5,]='@I\%X9.I^0;\U_N>6J35_?@G1W?89-Z6(60LLPX1!T&2?JX4\3WX#',
MYE[VV^@1>.*'V%J]KHK&&.9R\6ARGZ^U[4_1(6X-<"GZ%&L]?9L85]>C83JC
M0Y%G=RS#ML<^A?#I=Q<J?ROSZJI1_Z'QM:2;C?+!7*QDMS.&Q1IY6__##\:)
MX%/ZK&3'Q+)=1V>U8AS=V?P-:JE>?.A1ZM?M0C:]2WY2!JM;N%?_E0]:4O3^
MWK6@109!DE E*22=_!.U=_<K)]QH!>FL)+N>2&1Y-.QD5Z9*/\L=D+5G/U)G
MXW+UI&.X.N/A4D YG@JF2_#+<H]*;M$8BHDA?R'@*>Z-?&)T]\GUX' _G0"\
M3YFSXEAO5J&OJ3ES]W..;>0A92V)RV\KPHHN6KAK_'R6^;*L*L,Y:U;+^,=E
MZV0.=H7#/I=!;%$*K\,+E;G,37G%17D?UA%<:?#$AY 2,("++(A2,$3XME62
M($ 4*12=EVNQUTOB-EI@ZQ<V^U<$_N':H>@@+(=,Q"4<R,7X,H!#[Q8)-"K1
M(\%:(KC&=D'HZ^SM<I*VAZ'5C]2$%&]%;/?,\I!P8*F-3P+,A@1 N,]B.% -
M'"6//TJ]1BF  X$ ^D8QZ2FW KW9^?!(U?M3/9S,*DVTU:8@/U>'D^-='QJD
M'QW-/K,U5A)T::%7+*F@P&$@N+C=/.QI/>=%091E:%'"LS<G-11S835\H\,[
M(&L8BAQ,N,<RYSEL^E R0!998*-&O/1U.?2*4H^NYDRF7SXO6OS2UL>=Y:R8
M3!W3=.%P</2,(%/*&[N+M[X>*N)G/C<U*79O(%30-VH&&4NN)MMVNA,V2K>\
MA $)(] D<#2?)D]BB3][@' H3_>%<SP4Z6*@0^VZQL_1JLFHF([4+LM+9OU<
M@4C;.J76H^AZ!=FS(^^8D!]=9C7W$[_\'\=33(VFPU%WF$1)GEX2F]E]PS=M
MLSTWFH..I 3/"6 #W3O!Q\_I)T[K 19"$-OYG@KIDV_8HA[QQXPF67-29Q33
M7@(-'FUH:6,<<4+*^!IIK:1B36"; /!;=_I5%+&\#YLN._(-&<O2N9AM+J0N
MDJ2I-'&H-.BP&AEH8C.+J6D9@0[2$\6X5N- ";U%Z48_.::JA0O0>L/"< Y*
M%Y-+=:\R'(L4I7U 5->.>)$;2]7B0%P&.%#?Y^$=3=MIF[+W1Y_?!I:.$"$%
MSDW'XW&;J@[](8&?RH:GZN)X&.Y79\\2N?VQ%1P('8S8K(9DV3]/7K!L]F!!
MQ?SXRM);^AUF$;>]4X(#57W$-D/6-NQQ("]HN(8AXC9V:\0!9@4LSQ5I^]V+
M@%+K06 V%#?OXD!Q&;#=V8KP()EXS-)G2"&L'!5;@GD-FYH=QNXD'A0U4I8'
MXRL!]T.&T.KZ![5K[!?-X4R ?X1Y+%,M@!>QW(#:_-N>*'9#*E'DF_ MV.E>
M'"B_#8W1QX&&M0^ZG='$DS@+_H$FV57<103.P;Y;8KV!NI;2(?ME=28B-3:H
MEKP/81(QPW4;B/D"' BB"VCP'O!!X=6;/#O/MQ @; =V:<Q]^$!*^*_";ERT
M7G*[PS[_/6.2!LF'[XM3J+$!/A G9S[QESB*^^+HR2EVPP[&#9&OOC=L<=_Y
M#^3AYP)K$/H"!OJBAVVTWQ_]!OOM7>+0\E(*?,2!/);!F\^)XY\W@/5>P+>@
M/G\?$+H<+S3 .V62 :EE$,3^Z.[] #_X5/&J4V-# .CR!K W"6+=@Z Q S"@
M/WUPH#]/AO'#RP76!+H#R2$,K],N)0XTM3J W4G"UL"VT<6$_@"<=0."KV>)
M6(TI!(W5!ZJ!F2 ('W0F[K_J^%4B&V:R5R"N#[#"(:_Q[3 F)<["?J#)B24
M#)7!@=:V 5#VTH350+C1^,@MH"+MR"I ]+?+5-DY/]'JACC0,W?U;?S10]7T
M;Y\S&D/8$V?AVPC0SBS6N&YC&*5HCC^'-MY=C,!2-T&F-I'8W9QS2<)> (Z*
MCD .*GNDOHW%5S #&66.P,*R($MEJQ?D%'N,UX"^?T$#*WEX.409Z'-OW-9W
M@($_LP$>P(?0M+A1<@FD(R;1)',OMV&GD8A1QFC"\P5 Z:/?$&L8:T"4F%4F
M2K .[!LD"]^@$?#\/>.]Y[G1YU:!Y;B1BMFT;50%>I^S_73.EEC5&:"J!: J
M0G@XH&,@FT#K +*N,MTTUH5] ^L9-Z-B$4 [F0@ $2V!AN*6\9W3-=[&@8"=
M4M6&@KZ*L4Z<;?N$+41$KTC'M-4*U7K8\U86FH3SF0@V5;<\'.YC7.Q7E^%L
M9+EBLIYSHATR8=:) \TM"F!.0"W&X=M,V;!!=0RI9BASC&?)M/B]4NNUU0U)
M^-_O6CY[_&ZY_#]VV_[_#\HT81;@?7&L$F<A!^(8'Z#3[U 6 "< S-[ P<Q_
MP1WS 9;=E$DD] 0"]*0(\VIX?_!#A]>VB$.KR62,AS+( A5Q^,U* '@AX%U?
M"QY?"$(#%J*7"B"U%XPPNGU9^[^ ^T+V08@Q 9X&S",8B0,1Q'X!8,.6'4&L
M>Y ]B(F,_*V:N#[[/6#AWCP-#,W/$F!H%*PI!=((8N7 "%AV; _+$G>/['W*
M.2<< /^MC,ONH0.\^PS@W1ZXT'JI TUA*_&SW892',;"^&'  (Z"8?OXD\9+
MA!:P(7ZZE] <G;"VA1S,%AX-UN/6=O' A@QC J %C(>6'B*TA#8!O2Y&; UQ
MHSG"B0\8R:L>H)3 'FC\^U&*4!D5$7]PH%&&WTI5X#&&6(Q$R6HG VNRTX_'
M6,#NE@?(:-RN^NX\8' #> ;@1QL&P#-8345 >'1/W!IY;_0JEAO0)#5\ H"=
M#T#8L"7^/A>ZMU@8\ P <'039("FL$37[G0"=6Z^EZP-[Y_577L[ *7^9)?>
MP#VC3Q_C%K.H+--!,;%^?\+12'"4:IMY/6<'I3<M!0 XAPX.M#N'OW1-H]9)
M_36&_*(QO\Q#H\JV:W^+#L7X+4GR_^#A?Q)D<F]J[$OS.F@/8F $B(G<EX9G
M7QH58 '"#T8-N:F\]V3$+CN"* Y7TA[8R1'!CO)@Z/L6#B"("^ O '4CP;83
M!U\2UC8$5*^,"3Z ,F!'=", F?<1*&CO%PW,BV$B%$'#8GAVHK<0AS![0+9/
MH;@W.?812%GY]UI*,0%XCD/$,5/( 57JW(D#9-K9 D87"<F- \ %@6=V](!P
MS?; L 0#S"X5S^P(^#,\3[[W0P01K) $&-/ \RV2O4KPP$3 +@#5GWFK_]\'
MJ1O6*?!TR"1 W_;@)Y0 /\1"CV!X6@,@&0$N[#_+?,)S$ \L=1ID:J<+NRL<
M]PNM<MB3DC>@: #''6$"8^Y;: ZA/59D#3D *R,Y0DVF&#M\&<"&XJ#Y58A^
MCRP97;,F<"VP_CX[*MQ'+B([TL.SH\)]=O2?,"G[WY@4?D#B'#'60.,>]R-&
M9RYN*%UB6OU>0_,DD4:=K'"Q<)R_&[[Y NID>:24;D(&T"UAR%M 58AULBP(
MT-/&9F :D$^2602$M^W;G;ZL:DW^G!M<M_]_7.K_&V#Y_[C4?\"EDK#5^W9A
M8PL[P:8CF1L&QL^00*"*"9+G@HF,:95#'JQ%L"X)E6"IM_!09@S,)$IQ@FBP
MS58$ =SA%_X@EN'*O_"G\P!_*,':L!8 6:%XA@&KD=RS&!_'$:$(7]Z-.B5&
MAF ]@I'TQ&+BW  /T2.6"VDB8M"0&QW!_ (@> Q/;)90"@ $Q,T!O*835B-"
M> (V?)_ :7YG7,'-OS&N^\8'C(M0V?.-(GPI'&@Y6.6W8D;[&-3B=@B8.X"]
M7/;:![7?^!-@M%K#IK  5D)&C:Y;\WK=Q1>TWB^8CR\8MU?P+F(*VT8H>,V:
M9Z=@$9*%IXT.'<+'+HHH+3(M]E^+#^A^$!$&3>D<F@I#HQ0FN4EWD:\]Q0"8
MZNW"-$'62?3+X@B._N4XT+1"^FNJ?M6&MQ9],7U+%JHJT2Z# %7+-\9ZGR5L
M_B;8-NHI=B>;(F@&VXP%N"(.1#J![<5.C>- H"787PN2!4& _B)0L&JJ!?M%
M;\CRR=U=+F#QC%'A-W T,-(O($OI(U:)NP*[.-!S]*F#RA!_4UDX?!ZQA 4O
M*V*R,&T-V$/#.) Y HV6)>R><&!IKY!C-@R.T"(*(+\W";#$O[:YML.#_;8G
M J0(48K"@3Y+DQP4C-CE0DQ- A\^4=R$_*DZJFO8)OOM[:=X\-@K4X$%>M:&
M[YG<KOYN'!Q-T@[+U\=ZFQ"[3RR=(Y/P7R@DG20,NP^#+>- ?I %8T)[<G]M
M;S4\>M,>V#Y4*'9,!F$HIHFG2I?Q!S'F)6AT-1Y'WC/Q8%L.9(019:3?KP4^
M_QH8BS_P8Q$#R BK),A(;%-QO\VD@YZ))R7NBNX./T=3XT V.)#3"@[DXRZZ
M*0=K^P;&8\X2L7F=*=H ^/S2DC=>3BV"G!TX4-XPUOL# 0WRXHB?,EIYDC'O
M,4NUV*,P&QBQ-L@FWQX:*Q.0BJAHW@$J>-,%X%H$?;Y?DN.@9,!?2H* S4-8
M1>OP>=$#EDBAOG>DULK+ VP:/-3#!M&P$38X!C!@B/@*,VDZP-<O7 )X.P50
M3JG$(<:!^F@ LEB";]27FW!X!D@;";,D'L]%;T' */)$P."!$'_4AM5($S\I
M5 QV[&G+7Z6 W_  K !LX^\P IR* +41%9GUWH@HHCGRB2B\#K =EF@"/4PT
M<CS0500! +@_.H@@DDLFP$R,)@ N4$Q9!:]_R?':E2C <H@*$1\["):B,9$<
MAKBUT'K)$\@A7OL!-;[$6XC#1%((U,@ V&QV^!J=]CEX.\"=\*N)&4L=B,"?
ML.U 1@D&X]Y#X.4<B81]77@$C< O \CHF;UZ\#E!^$2)H*V(YFN=X=EY"7!%
M2"& U,#JNX$G88!UC<=*./X"15X($8>!LFT IQ#8_JT'Q['40,-X;@ET01%]
MSHG(#M<!0W0S2":!<'ZXUX,>87XR0TG-M1^3Q\AJRC4"16Q4>?L5[ NO"RGO
M]GQQ)<$J&.\"V[$S$<!".+ 0\(X%?YBXS8JMV3WTU_XFSINVNCBL5;(/2(D'
M:/'I J4])AJ# ]5BC[7M@=./OP4G2EJ8!0Y$V-_@_F'\[+%N;0)STE:'WT3?
M!8#9.04LJ\\=BIO&>QM\#^M@?U<;%_@[;!@-&8'O00KB;_I&P;N/*/LMXD!_
MT^34N@;F#4&$HS#;O>5'?E".>U.%N-$=R/Z"=9"_PAA$./(?&F5[B@D?7ELC
MQY.RO:K<-FC_"X46V!-WKQ"4P^_  ][_';R/>SI3D9&( ACB-Q2[\5?DG 8&
M]A^0$_$WR/GNWX^(<?\1(EK_JH[O@,ON0YZ1 T" O@_C-_8O9(+_,JF9_[$<
MR:XZH=E.2.[P'@M5G^>%3"WBJ;Z8\!Z"42U ]B0%F 7Q#0,DUWS_]<%()Y/Q
M=QP(7YG*O@RY^#O;R@G&Z&$ 7(M_!U?(@@"Q-J(12OCQXV^?0]Q*]VV,7P7=
MU8FD,83[%^[9 C42#8#.?5!'*5H0K>!I@*.)"Q!AM&+LZ8%!0H!86(VHP '"
MEL((MK+(E'!D%=X.@.T!'3!L1[L1>T"GCE)()A+1:>0[ +#QA \33\1.Q')P
MRQYT)AY@'E!=P#^ '&*4_@#DXI9?[C^# U&LI?/\&3M/ T1O'SL!X"H@T%L\
M;LUW:FS0H_'V#,#F@$X&XFU48,_O6A.0%0_=FC BY82CH+$:>SW] %C:^#5#
MCSX7<0""<-2-*2*AQ6=N<5LX /KCVS!@E#)0,+D(581;[.0QN1M:U.'JMV')
M;BT/T1( 0?0;QU8"9HW<S9I4A;B"=XD>"SNQ]^VA_5VI?/ICA'B$B+I_R3^1
M)^$/O!<<B-N=9TF>/;Y&F>YF1JY6-TEUBH;\&7GQJYE]>.<FO-,7NS_PSQ&"
M Q8^-[9O/$]"$!D7K<:U.GPZ(4+:H7C"S0>F^T5>U7WHD$T13 FBI T "LHJ
M+58QP!IUU["E.5A_HP$CKC]Y JRN&-=9=EH,+\Y-TFK(.[VO)N1?=EJQK-.\
M8^UH5?Q%=#B#L>^F7))),&5BP:J0*_L=DRFX CYAM@<_,G1Q-.PV?Y*C'./M
M1]H?(N(\R[T9,E)RSMV?]U^VK-W-H>6M^!26)=QC0OKV4=<I;Y,WTX)AY:^H
M&,3$UE_"_&-I [Z?BVGUB#:8M'YH>+>T39(B5,)!$JJ<,!,V7<;U^BWC=?[X
M.\U)IB2YX"MF>6;A[JLV&)JW#V@UQ0\M(ZI'<*!&7D"3"\&PE_)%@*408S$H
M<S^0[XY:1IWF%>73KZ@TE2TXHZ8X03(S(M/=FIJV'[<UU@*9IGP\51L6!4RG
MW:RF@K'ZK\;[_"0OCT_S\VD6]PJ7VRETE,@Z,CA/T%2E.R@UBI-:^AW-D40U
MI2CT2CS,I+@8R%MLPL'\[O+%4GOYOC[P0NS[]2IJ@S;(T\D@Z!!KY7C#T<_,
MVNGB+,[;;^ R14Y;B=]N/'XB.<N3D/]_[NW[$T,%+6UWMC74[+AGO;!%>S<R
M2C(RK9&4+=@#V4WWM6EYN$;SZ^K55Q_*S[!S1VE;=LB!R'-'=&J4C2:^\L^[
M#?_C+91MJ+?U3-%!V&9,/%V"UUOO-OS5D6;BS>#%H$V!_SCV>+9[I$@IFE$F
M-:8/K8U<7Y#I_\IL=_F+/4V-_^BK/!W0B=$&*9U_O,V2KQWQYUJF_R$,.KGE
M9+6UBY2M7%GX;D.,UT3UC1*)=+51,MHKWQC&Q<?/5X5E/VSX+,/091]?6=39
M8^E?HM F'$I7SG*%.JS;L7HJZW'4E?#77^1%/FG(TQWY/>*VQA.& W$(8'+5
MYXP6N'=2<:#'R&< ^!"83EQO^67(EVT6\>?+WI;\\K307%?3?\7[$_]'B*;"
M[U@2PKTC<B2$>_@$"7N3F+V>X$1XENA/?&+/:1(?<$Y,NE-'<$0D/DN(80R4
M37BJ=(_P$ G^BU>'"*Z@<L+"5-L,ZXB=78":RM%]=QW'*F3$;9W&W_U6/PU>
M%9R!;6S18P/X\E<:T"%0R"(WUH]7"RNTC@.Q]V!)-HPCQ+_R))2?//6O>((2
MO$$)_2/T#"\K._%2Q@#VA*?RQ/X1[XR[1G229@@ \(?@YQJP]X66JD2,%0/>
M2Y(09 @,"O[CGH!XQZ6])QF+_MG+C2DT._!?;V#Y&A\W)'^)F+!! &H MDXM
M+S#NB=#HP9*WK>.]G>;$KO]7[_[9_\,/.QDA P?![S/@-R%.X/UPY8C31O00
M!3K-(WS[,&%2B5^8$+RH??WQS_K@RY/]5DW[94+(&]$=.^#Q/ST9S6P[#'R>
M2X%5#>^0Z,8%PB8LNF%SY1HJJ+:N#5;[$0'C]J\)07R9H_^BJO$A^%HSX.>"
MX(S;R?";%,14=<1+(XENKNPOK#YT$%Q^]R:'W9>P\,CP4;V$O X\#+]5<^TS
MX8(=@J]O@#/L)&3"&5#'C]0QH-[%5&)LQR(.M$.=*? <O"K1#ROEQOK8NF@1
MD]RYP#!'>S^ICZMT,)I!?,'0;3JKA*!U]8LW?W/DQT.?' U^DO#N^/O?$ ?8
MA^@"3LO$2Y@ET&^= Q3HWA+=DX[@R8S7NNSXW'W7ZO"^<<0YQ/O7XT?G!*$E
M@A<W\(F4=N\K0BBKLPP(F+9H;!]D_2,@S_@J;&=ZN#5IF9S@R80#)2NZX$!@
M@&T@%;#.PA"X@/Q.U LLJ;3QM!RPCPU3CT;^YH6,]^C'Z^9KAP@>TH2,AT<(
M.AW88Z_P?3Q[JD,VP?<%P1.9T ^"MS0^\^#>-B,CKE 0P>UO#VN(4RE/%D1P
M(Y<CQ/83/^'S$A( "NC!81)"2D*-O;0P<U6LL,9J1QP('[@8GVRJNU2;L\UP
M"3+7@U@7SKPP:?PENGE#\!ODJ0KV!Y[J9%%Q_N=QJMG6$H]CBK/L3,^XJ)XU
M +#6!>+3A.:]&EY^X913>+"+A01?E\Q9^62K'<KB.&LS.Y:NRQ0U[*4:[N\V
MFL38MD4FG=\SQ79*]>9U!-=@]'(*)LMS 4!/^_K7;(PJ]O8B@S-'*M0OMCI\
M?!D.HV NSOR8RFTN)__DB?&)C>8D*H?>31\<Z 2\%,%%ZEW$/U6S8$0K8.=D
MZ^C[_@U/0Y^YV=JYW)TO?/U3CYH=/2L&XZ)_EM9JZKQLEGQ[/+6XW'_TS4E&
M%A/XVIS.G/E2NEB_XQ-39<U:TI(KG)<55K].4;P04MZDZ^M#7^[--H.6ON[O
M9OOX[6[#"!E$+[#GF<SYQ[=K>G/08H-CO'QEE2C]S&IFZ:(O1:T0'T$%R*V5
M'22]LZUTU+?72$$I+06'Z7%2)G;=TZ@[<Z:VM[&<#^24U4/0I=2;&79G%TQ?
M>2=V5MK625QZ/T9%<CXY^;M^M="-2Z?DF-(^@X583CJVL7W0ULZ8[U>U:LG]
MI/CBV:!1WLS@*A-/0K$X*8#?A/T?@%]+M(2]2DA/R4!8_Y$ $-0+ PON51U0
MD)<5^><@K+H_\T<C/E3PSJURS)!G#4!\G3X1F$FM#-],0EO]^05=NY)VSN!%
M&=79JW1:H5\_*DV@?XQ5MG["@5YXTT1_89)2M2C8O=[R9@S*>8P6_N;*N\,.
M2:>''#]S]E3WWV@R9/I!T\N!E!(T?7*I<W+D>N#C6= YDT37LX>>QKJ;D5)7
MTQ497YWV/M];P>N. YE%=9D^?MTZ(AA<(E<J=/GSQZFG]1+F8(4"5'-*X47[
MPI>-R4/^^B[*L@8GE>_](=[&@/9B22O*C41J=?'D +S>OQFP-MM%H3@0PA&V
M\K6UQUOH4F>,S.M'VM3\XV:VEF%YZARL6R?5U<2CCCT!"X%7X'>>SV\RG<N>
M:<9D#83E73,WZA/GVETI23U7Y$VMKT[^=/*U=G\T/9R3^^SB[8_/5KHF=5EV
MH!%WO\]B+Z^0*%+;5E[_^;+IXO-#BJ""4S(Z+"?)64 2%#L"*EUVA5Z7!M0*
M#7/UZZE=0249+" A-66QB7";J<6&R#]F%PT X.>XAE?#Z:< )6$$VX+4Y/0<
MA4T(0';C1J_13P.3$&\*() H##"VM:"SOSF;_M)RGUJHQHS@.7-GRBRR4CY$
M&"SV=R8<8=;.:V6)#7(G,7SON;&,Q-XD@V]$XT W*@WNQ3QX(RGL=5S'OHB/
M]=*1N-N5Q86!;TW"QW1"5$S>F8>U'D*G][@IUL=M^^)  S!,ZLT+B[4/OTZE
MRPE#+RM*T23E-L9WWC#Y^E5!EM29U"6U5]T?!YK0[$#,U5-ASA1E:=8[='FJ
M%!@SR7^0M>#L8/:UY>K%)%L,:OL\>T1B<CIL&#1B69H3"X@5G@V;-[''\(JL
MBQB,167>,EP$D$#V3R%DRW%@O";%@1Z<WD&6[UVA/2H#(:(V]T;V-ZH5;\63
MIFCPFV8 2^;9&/Z5\"M""!8^=IY@B1%Q^O-O3(ZXN\@(>I48_2*W%RV"Q]]]
M?"9>](!_MH[ @&Y;?=C7H@1S#D0,QFJA),$J2 M@J\: Y?GEB1'^'47Z%*8.
M^)^\8QF@<=R-,5Y? +0.FJ]PQ!.DMMU /#\"QB&X$M+H#//!0"=:'P&[L_;9
MOW*W /[OUV44O_,S(B<@]%&02%>/_F)_1#MUCP[2=JG]<ZI ,$_WGK1SE<,J
M8/BP56?*J.AAC3TP[ X.-'VN%+#P88W#R3!D#5)V;&F;*0<'&C;&D (L:%B@
MVQGFNX;!:\&RUO\M_DI(VTN\^>!?YJ_$T"93_+-G_T*#3U 28H"(@_6>RA<V
MX=P%&;;'',I0KT.L"LU"-H8RKGQ&K$K,Q"V58'UZ4L>,MQF=P3N+W9K8*^L8
M17W4<>2ZT,?_N=P5("+L[XUKX=NL=I!!@.9<$RE/P\<\KF'+$=AGML='&]"A
MQ7&+ROAKU(:Z@6V.OR++<!@'NBZ2?1K5N:YPIVU$L0<KK\>34'FZF6:_[P1*
MQT-4//AXLX-OB*-[EJ#L\92&8!,1XQN(W0/HT[[QL"<?/C+M$(&VXC\)XEDA
M<0)I]\Y22 @M$>P8? M']K_"4R]6=1_(A 4.5$R%N2")0*'CL&6B:VE2AXA&
M(VQ& P#3A@G -N] O%>E&F_N\$Z^!_&E@NZ<:K?Z@+2NX?HMN!'/L@CIG4$$
M_D86'ME)L!$) $#@H0!& 'O_'I'X_;(9@6'9VU^^Q&7E0S ?042@(<XEH*8)
M5MBK&OR51,1/P$@2=BNA!SYXW"$#NG 6SZ EEIX;KUXV@"$S8-/6=W3*E^>P
M"L?A.QOV&$H^BM+H%8M5S"TGJI%.'*@$@8] DVOZ3ZV)=;!_O^4;#[>TLG<W
M$AC:[!HB4#[DF TC+Z.V$6:=_&7GBN"K;]Y,>F(<J#"K":6.X462+M*>KZ-E
MN-]@HF#M:X"6LH'TLUWX)/^@X0'I\:>#7DMHUS 45%#+T$!Z:&)+R&L[R9IY
M5DU5HE[X[>WB(-E(-YT[EA\Y[Q?[3?@9AC*M.:_01 -L^P0TH=*^+O9(8651
MX4OE@H!^,P?2\&"?O(4'X9*K].C)%^MP,M1=75;9A>12CDE1CF]F2P6DAU#>
MYW-W!NT>%TE3S>NEV]U4YNJ)59;WD*IB6D:\6%_CC[SZ-=4_IIWT@M?G\>5S
M%6_O=$YU.-^=OR3N"C]!?B+UE6*W;J$C]<>% O&\-\ZW+FH/5!AK:R1E]*M%
MN&099[V/X;OYN>1;'^CD1CL.5%.\0KYEAU@"5+)>MK,IO?45BCL2&V8M:OR)
M\"5Y9QQH.:M"%C-@O[N+ _7BHZU?0,KM<" 8;*<'?"<978_XWI<S80DVA/E6
MR*6@7&VTAOF$6U^P'WUSOUK21QKQ/"?9=$Z/;M/W\>NMQO36\N[$AZ2/Y^Y&
M:6ID'#=6D!?OJ=&=+$HJWT[,[Y;AFG,1 N=M7P7TQ5'MD\.!ID^W*?J6X77'
MRUO46"6AJ\-M[!SOM7E_N).1A+H[2"!C=%,#%B;*5JZ^H;5188XT"_U\2AD-
M.I__GL*&2BZ'ZH][R4;\3>5%J>J?UA&!>C>@WF")%P8&=W.W?2823QU%-T)\
M-W+8<NQ1O@ZYKD+K-"0W-47(2P>/80ZA,^JN7?P,4I8"7;ALMROJY+G(>X^N
MQ&JC[3D3J2X39+.R!EXXZ*?Q%L6! \V-0VY!17+0BMV+]D/"@?Y%"334?H<[
M/=[7PI-=JLYQ*"YS#3JR)C#+'G[E;DX*;JTX7U#[12<R55KM74U2;F3\]8CB
MF(+*Y>$Z.P7^FSPB@:_'.G4I+"ZD=UA6*0A).^%3_#X?TWW*NACDK/3**[V+
M^05+A?DJ59<X&F/;R#?,?ZQ7BIH^QD6D-9:N+8WWZ4['BZ!DL58),F/-.V5:
M\3K#16V'<_11T(^8U!ME74,ES-8N/-)AN]ZF"(G5FPM5](8,GAJ<1ZKN+O29
M=?L=!42?\]1V2T-P/.?[.!H(CWTN/F9X91=<Y])[UI0C\H^&7?(HS-',]'6J
MH,U[_ ^_+I\X-L+C]35NV70;&M?3$2TB_"VO,.KBC9%RK#L +KJIE_^=C)XG
MH:)@3/UET0)YW2N]F1C?$M_YSNNQM^S6Z!W4[BI/D_]4$YQ\<AT@>V: -3)M
MQ,G//Y03]:2OI:>*1F[+_=VI01[P93%600.@Q>HWO>+#:KT<85OW&;+9>:Y.
M)4I$-++6K"K*QDI?D:N,T&H7'MB..J/_]DZ*@X__B<9C]1Y.T)DTY0?<M&VG
M($>E5$(O/7X'&-9N$-20?;\G8Z'R'S_FM%J.&1SQ.W2:;/Q=>"VK:\.XABMD
MS*ADC.JT]8[=4%7LJT'['^UUHP$<]QFX&F<3B]RSM)-%$FF"C>J?A'V8T3M!
M>?*-&5U^R; %H^5$6&FHBIECO3KC6*%50L'%@T3JSR"K]'&8MN6,C>O@[>-M
MV"G4[2,[  +R_'8X^SOIGC[@&CFQ54PX4-.U#FP^0&JB<^)M)]VDN,<8WL='
MR':KL%\8L#-$<H0>):5>/$EIJW[_1>Q,W"UH)#[-SQ]@##X3DO.4\7*0;=RZ
M@(TQBH0;!SI]4TH@1V"H741P/1_0OH'IP30NI9>@NGGKW'_FU,9"8(JY9Q,H
MF&8;Q@W0QG4=P(9/ 5C5]<UD',A'"+8B_%YDT!.KD E9U6G#!%/B0,GGJP)R
MXJ0$1D.<I;22RJU*5A19!Q])-C_H2$_/O:=L AH!Y\BV>)%K:7T8[08&YELN
M(.*A?%@Z;$O551T.-(_7F\<PMD-)?\?%[Y.C@"5_&4OU[2? ;S:I3OS3!+0J
M*LO8K,PX5'2?*F"=>9[@QJP[0/1>*@5(OG]8<PSZ^-&@0FC5AUQ2:(5-+&=[
MA2"%_J"!_#&=PY)6T(OD#WBF93[1-;_(N6"G0+'P_H\'4C:IO.6<;C:> BL<
M9\]+ZG"C;@W"&W45<D8P+C>"F]U,Q@[UWFET!FM*>(OE:.:AXD;GFI-]6UJR
MQWVYZDS.>S5R@[6^/+E!IIEY2/.R[+3\(RE#=_MAQ7O5H[,"0P4_=_A25Q8#
M3_J/!9H6WWZ]]B%6F/44C2SXUE/X ZB@T;OSJ71<W:OILC5J A\ <^/&P>4'
M>/)"/&TB'NGLG?Z*M,]4'5DYG\;41/;FW(TAMGL<8(.KQ]!'W-5]T.1D$;9G
M4M-J\FV$0(VA0OP-#R&5LQZ/69MF-^).6;N3'K^4_.05V>[+)LL=G@ED')1A
MN]0Z(S;J(LW/R?1YMT,HK3&#QP60S0$<*.N.>^I33]G$&YT_K,-?0,5?"W'>
MEE;6=)#YE'-7/2B6T>V)< D/8MCJ).167&=9,^7U-NU"E0SF%XMGO4.?<TQ[
M4159;J2WHY CMALW3W?2H!]ZEMGTODW^,4>?9IDZ4+AUXMC1I)/DFLHCWB(S
M,!I/2M*KG;;]!M?YGS%_I/;6/%:_09**>(@M':N@^H@#W7=MN_4N(N_GJC$;
M?'5MG1-<4S:N'_OVG:A8LEQX^K--SE*4QUB&OC5WM++])9&+7^Z'A(*:1@2Y
ME[--D#V9\9$9)_PNRWM69GQG%;U3F7<6!TIL70G> KVBM'Q>)Y&5QC26VY$4
M$:B$5+5;7OL"?;+2=C(<:Q#$J-+"Q,+F?H945^%Y*@YD,]=[AEGY[M2-![#'
ML>H_8W9\0""0R<GN>XXG(VZR^]<JI#]4;(XIAG^T<D&8=V?%_/"*K\DCO^#4
M>/:5._CK1VB.IV77%@"0X;ZKDM?0SHV#B)WCWLX3(LE,L9T4M[Y6"EAJ?&'2
MD_%-=_4;'>F<_S$Z;MCF1\NSQ>FK6P30DZ>R!?3NK]^U?[YS:>6<&.EZ:Z<C
M"IF"9NY"OR?;O6W!GFU)[>>13K5R'YT.">Y_\5(AMROJA?6D4"YX2#84=@8<
M9;)"X^QVIN%ZK;S&9KA[K"">-3N_NTZTW0@\&*#[UL0C4.)["!#QHK_[ 8#1
MSL$&6/K&CK#I>^4"+( 1YH0=@TV?^S3TS^W/"[!ZH[@)"<1G[XQ52W%Y6JAI
MS3_-:9J8;*674L*N*O'U[B9FDH1")M.!?$H+928'H[;MW7&]KS0@P)>C(]N-
M\?!2]=BHK Q]F?(B7BGKP4)[1"C=M8EPF*9MQ.F@3?77$@4EQY]M-L>H-:Y\
M01F.7?\06:0U?7]F1_=\SJB7K9SAUJ:0(CUZPT#"F].<JKY2%LMG==SEYT5H
MUIEYMQK!DCD_)WBM3$]?_69,2BRK9_E+E1>[P1EIK-79]EG0E*Z/A1)5J<\_
MQJ1LR-Q/* ,SN7IY2H[QVIF2S^?SO#[Q[E5JR0BPKZ'21I'$33U%?DRLLOT_
MW-3XX99A,/\4*\9^?;6QFAJ:0>, 2A(,RES\&'3WCQ&0D')V3.WH4F 1Z5UZ
M-2L.TU?(DZ=Q(%:(Z(Q1QL@P:;^K3<?Y-S1VJO7F?P3/XT 6TN0(K1U*:?LO
M>J+/B[,37?.^UO+1^+4J9I/++MJVI@5'1/-SNC]>UM# ;W@^3]X5'LWK_8+K
MIYTQ?+$]G@)9TX&3-A*/VQMP(&DQ<["N@:]1K?V*8NWIK]2IGYZ!Q\)/P[M$
M>K_P%V$2FDY_<;076OXJQY>&.?IQI\<*XN4=$*>5*+*HLB%S5\1>M7/)^>5$
M0=="OT< Z3--<I(TSF4(TP*6T_4\/W5]5DK* &_<@US?NDL><'E(_(Z/^!+)
M+.1[[)4N;LYY-\_HAD1T!>88^7+V%VC,VW<GP69-.M?-HR%44CJV]IRK,_P_
MZY/_R.S(^SRQS!"!@EZRG9V\_54G0);A7)51SWSHV\P??:]@'5.N]1X^2F3Y
MM6.LNMTA>7>L.I7K$FQ3BU%N8QGEKE//E6&7Y$\D3X:<I)(^?IB/0ZX+!RIR
MGCM.F92YEG 54J;.O=KB=0W8YI?);03%GBLGGZH93=01Y?C9HJ_8+2S9EF^C
MVV(OTSYZYVF4^,0I)6FJG]I\R*HK,[M9CUN4KVVS?O"6F'AHC#D"L#RFSA!U
MZR/G+8SB"MX&"3_V(M%>.5);G?R]LK:^/(Z41V-1^7"6+1OE"MG3^Y<V^,7C
M?7)5QVXX')MYGS2^DJ.&$DW=EJ#<_/!5SJ"5@W1+&SS6LJT-8RRB/A-BFLIW
MJNN;A0FD["D+]B+D0O48Y^PJ?ZA_0%#B N>&U+T8Z^XN0\O_SK=IV=9E.ILY
M3_@?[UK&WKM2Y'YH5GF$*NLQV_%E?52"LF4,[%S]&8KYBO(2@Y.UH5,#3P>^
M%U9RJW?PZW;6_! [M>,U)9.T<?[3"D.1^E!HYF*M2;*.D\H-5W^DKY2*A;5(
M3_W;?(;;31QN*^]X&+D/%726?MT1K4.L7I@#;_P4Q?K83EVHX'?346U\9\0F
M;![I[G^G(*^L^Z'NC]8?=R<?!C*]AABG5EX[=)_B0[@:B'5NVO@XZLE ;8R4
M;D?"VX#;2)HMEZ6V#]-'I-0X^I)3,M]=8AXH<3&'\Y2@+,?N)@YNMM=BOT6<
MP+[YN"3#@GK=*C369'E;R#.0A!KEH#["U^[<%JAG!/_8;,9:@=2L&3 W/WNA
MQ#&B&Y[\P-7VBSLL<#0JBS2L^:148S(#AS05"W5UMFA@G;Q346K\8.ZGNS(W
M-C9DO,)% W2#M,W#CNGJ,IS=H5;-,4*EQLM>?57VS2K#B21=Z;.9^VG?.,V3
MD"M&<H;=?!=R)Z7FY<D5/.,!ZE]_\,:9<'*U]]9X_\VR/%D0&9?=C-%)Y,;'
M7GW^J[K^>8'F-;QL'XJ%9-YDKXTB?48\K(I:C-AY7STL+G&,.OZ]SZ7-M(ME
MBV'=3ETWM^-!2V^\,VL%A\^=#1F?D\J;=-7Z]-:/NJ#2%&*<XVT:?2N^RXEU
M220O!?%1UW.Z1LDC C0S+SI54Y0Y5= .U-S3XAB^;O@7XQ/'GKB5Z#MMH9_"
M5S!\J9W.69(&A;MJ;YU9Z]RJ!ZJUIF4GO$6B>VT;[@I\'C)U6.L46)$Q$4X/
MX4@_]_J)F(Y&N/J'G >HYR/Z7IKU=L9J+Q0_7D^>T#;BUF@:@=''+W5UL9T/
M[6C,#M:)]#LZ;YL?9:$KJGC$YE)D%G_H!\^K*XZ&M4IB6Y]>XD!!V0]7.\=J
M5O55/L;PCMX+#>FF-E:;$6U.FSGC,GWY$KNRX\RKDWQU6+X[7O!ZN(3?F47:
M:.E\&2U@ESQ%]=(*"KW;-@]]IW"&=K3MC$-/29*KI#$R2[7W;:I4.QE?1>.+
M8ZR.GX)[N;QX1UHD=P6J^PVS.[,FCK&PQ<=-0M)$7(-:PW4'FX_+ZD14-2Y+
MV]:X3ST?";73K/X0I-"74VEPIMXQBKL=J_/"=KKMA3ML$^Z[P<DP3''<7VPF
M=Q&"FA99>Y-(I=,=TG?/*ETSOR^V]>N41D509R=]S)AN?]B'B9CI2\ BS>_M
M5PE\'$!=GSSP ,!/1BDR3BQ=UC)<;=<X6+6+E\^2I)'*I&45WO%V-0>Z4I\D
MG$-F$\T<5/JL[IGS( [$@W5#\TGT!2JD<JI:F29*>*Y:M@@'O'Z%U*C_S:>!
M> $5 Q,AYS3QE%L"_+<OK74M_^X(]&,RVG)F)[1DF3YGV@)0H+T._G]S/QB-
MK+U(=S-EA9 JGU=WB(K@SB%#Z=1:^&G#\^/FKRX)2<UHGT:="$,AXSVO%N07
M+#\6_1J6U/6&R4W=@._5(6D?D"-6)%D4+B5XI"%\IT)^+3A!,@>S?@B<Y=;C
MZ"P^:)T%UWQ],OK<^[OVJU+%2Z.(0+M[0OQ)3K[=<CR<WN2,:+ZH&$:[22O+
MD+&HDXRL-Z-D1I!=5[=.#0TD?ZE(NRA$V3C]B,&#::SJO*L[,X9RXT[BX=6N
M(W^<-)(:>;K>"B.9NQEZ5>WF%59/4FV6M'6IASRQUIH\KRI"JW6TS<-=05!Y
MP!XC#X),T^! 6QL05'ICQZ5[^<C"N;2!![<-Y3G>65)D'L,<\4"@SQNQ  NP
M)16SI3]FVYW2Z5?:YE_;E?[V;=XX#K3LXYJ(]17 @6# *@U*Q)ZBHH6U<^%
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MS@6V>%YHU+AF)F ;6/%Z?@:ML3SVN>]:&>5+Q2=KZ?^+N/>.:NKMND6#(%A
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M7-FH*E7/-&6P.J<U(4+ ?4=2FYK.(,E?O,?BCH1D.$ ,(9C]"*1V11+-^P=
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M=K]W,Y[6LP]/[Z?_#!1H 2Q!.R*QX,135JK[L2]>;N^:<@D\,!]0,G=1DDP
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M]Q2F>E26>9VZ3";_3M$SIO<-LPL.P =\J83A2D(I6%:W:\"EWB>:F=IG<^
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M7<V!#;41;\8V:]\]8+ VZ#G5H<,F'J^--9XH"9;6*]%6\!\H]0KI"PV*J>(
M>JSTES9==]'EI_#_O1H.'63,B8(X=E/SDB2NI6(LKM.A:*"0YS)Q]CF4=$Z_
MXL9Y0GKV*./[@,S=ABM&T S080:/7ER]\]@AUYBANISY9WU<(SOA.F9TH"?O
M_%Y-0"K\R M%NRZSK\0CSQ8\H",)*+TA^2;?5?GLKVZ#/(K] L:BIRTS\$$X
MYS&U2:WB3/I5&NTT.+?AIN!X85Y]],M_1L3\RZ29_QSY]5?2??J/868"=O]U
M>3?-,.J_'*L2;MIU&9!=C"&';IG_6^.]FQ[P_T%>?YVJW]U98%&"J@6:L#R2
M$ BFDZK;'6N WT )&(XTRO/Q+46Q'!N\^%W,F&81:/P]Y=?:-[["V>!LK1EY
MCY$#/WP:>UQ6CL]/6I MXF876,Y9L8VC&Y/\&(!T?*:7_H9SDN6C@+Q&2RP]
M*ETC=<^YFMB)PQ@Z58?4,;M5Q6%1#)1WC7?6$]OG4DO6G2S]R"+JO7:[@6Y&
M OK7:^54_D>>P5:]FX>'\]?E2/>#[@;J.<07%.^.!!_M=L(;IPR'-G^1&]EG
M0J=$Y27EDO87)LK0S-SO2B=/3YF-:(_%W.M6I3E0$86VXH&J3U945)Y"GVJ%
M)C#]04,J+C?J<8 ;7ANJ ;)Y.YQ99]0NRMDWWHJO>4BA5K?!D$(488>X_VPG
MTY=D#>(V5< <H\]J 9I^)X#92T)[_ RZ;R)/:,_H_+N;(:ZNEW;[#T%&E4YV
MZ#EX5P^CF,FM7GV14+%8/H$Z>16DCQP<"":9L6>UR702HZ7C0@6.(Y@3UQ9(
M_DX'_ L"\*MG,*LCATSFU&4396_:&^^L1WPJR/ _:I7Y7Z_)#7$YIU9W1-TT
MG]!]G&HT'V#5_#^2?J>IVK\LU'FO3/DFTH;W,'@XFL120+J3\'%CPHJ5+_4S
MPO]+EWYL<S?VTZ3>,@G&VQ9^-H:G"HA.^.5#;OCN'F2+#"\Z!DP'$-AW6(48
MO3$?$<RG2AP ?1[S-^Y.+/TYLB$]=]7Q1,,:!SBE-/P M-I$TUE"[=;1&< C
M0JQ"NOKU&AY7'S3 O]2(_+9.UCUN"^B^7Q>BZ9-P\<U?%!3E!*4 K7GC$7=!
M_9K ;@I#;#_\N7*XPGZ&E>7H&I,^C7&5?ZS;WFI4LT9KO4@CX@^[3+##4HQB
M%-A<%EL6W"RLDY[,S/J3%Q2ZJ9/;@&DK$S^:4W)AQOI9UU.9<\X9K_1X2E$B
M'<>[%X8A43!ORCGA<X4?JZTMM&V?;ZW\@F&!J*EK X<SKS*$V"S[7*3 WJV6
M,NONE&?B*1X3.]_FWL_DP_Q!+V(ZH ^,=FM^_=&7OI+09<]E8G/M4OC%:-6L
M_I%^:=#.3IIA\I18H]"@D;/[[A-95J"Y*$9\2@FF&6E&RTX6\[@Q_UF-%&U(
MO3I@CAT6[5;(](E8/H9C,O%;0(Z>L*V*]UI57?C*@UEN-2:&D:!8VWQFZ]H+
M&C&7097R,QZ_UF(#X=3B!8,7B<_?'"U%MRP!^YJC1MQ3_2'R-1/VW^WC MP/
MHL4+T<"C,JTN'("<Y*L#I-)MVB($]8G-0%3)>63-312#V@:#Z8MRA7-\4/5J
ME=0A^5_I&[+_"!>6&NAG)0D,%#C_H>[%$*NZ62S'A ]@3?^PWDWSSEL6Q@$D
ML8E;&;=0_L"0')&+L=RNGWJV>U=QA BZ'?52#YV.-GZ_LKWE[.#"9V66[SUI
M3I*C#ZFNNM EHVD%J?W#5^%XHK0EM+_P_(A-FF[D0STOW#;V?G7DL<$1@CFH
M$,^RPB\[YW,\/,T'NMG#>CGPF>"MIZNX\QG--^D/B* JX!Z,UL;3M'WSZV*:
M'^PX 44(;6N.K@OD+;6L^4;(6* 1>'"K%99(Y@_Z:0N<60".'PZ)J-^06*VP
MV !FV%A8%,5:GHQV+&,IMX;-[$N,U?A%9@+Z_$F2$<"(@,2X(ZC&HG^>35'W
MA7/E05.S13 ^3HU.8/J5%2&];(K:3^/U?C1-?R\'_8!! UAV@#/2HA-ITFO!
M';?W?[V+N=KUW-22N5*>&VA\I5W@PK=;B,?*6T+ 2A38]Q]%$,ST2K0'!^BN
MF52/,&38$1&_/[(DB0":<S#-?8;W%J>C9 K]4SL%_E0 DF,9R?74%+:;F[)V
MAAB&.8;>+KPI?F%5<2\DK]BM6.SQ5J[NYPC&-[JZ[Y&QK<"U(E"+7C]]U.H.
M?>+D7A"YLT!?NUBKN?H9[">6U=9TNIEX@I:R>5FN_K//H2@(=;!S.3!5^W1K
MS2PZJ8CE;Z6U1]J-?['6^X_!0_\XV/PWE,E$\F&BZZVN]G& GT(VJ&2LO(D"
MMJ'J@]=#K(*)P#5>T(W05V+PF8B5-QN?26;P,!, +=B%$/A@0W3N:YA8W?HO
M!JD1\%15(I+Y9V<[Q@99;[[6B%?U3?Z,82()^8C9]N@M&( W)?PF/^"K*3R\
MU(6TQ]R5R;?1L*,&7-0HU9%;KTH!+J24,-)-X/+K'+=I/46*B"Y:^>_+6HN9
MO3 .FC!7O[@_Y[^^ZZA)CQFE(:(;[9@#/TX)O^"R=>$#9U% OEZAR3NN4-D-
M_:Q*K (-5 ,#+DI22D+SJDAX1XU X[CQM!)WI,%\GKE^QN9ZP7 ;E.*3>JJY
M_Y=2'* #(<^L;2,_-Y-6^QU1RG7<P"AU?YO5*\=Z3;/L2_&SG5O[1M)4H_?@
M*Q)&CW-:R'^(G4;Y8/W(NQK8A6CKI**?MO8I<[E.23-90_Y@Z:)M'CX4J?UQ
M_6IU'9@,TK036<FK.9>BY^%\TE$35?_&(PK2L7HLM(C,_G6CV?<HH-+]D&I^
MOO@#8$$;>,!'>+*&%5I;SMK5W4PNW%O)*7B[%I,9:D*"5W-K[F/XK03#]ME!
MRX):<(!C\6W(&9X86 KMZ&(9F^C6WF*Y_?4V?/=P@*-#CJO\2[T!G=-_7;0G
M^\.2=WSHH-.7V-!BS",<((9'#UNO@(DR1-7@,7T]^=H_YIJ@"-9&CCJ>A.SF
MX#D&+ )RS&L 0?SY&PYX1?P=_@.&:<7$,,-R3ATO"6QP@+-](/8SUT8?6ET>
M!XA] ,7S@M&_M*1R0'IX^/1%OS2B_TP2M$*"B1&'7O7B@XW')[3=+G4VAF2V
M=(U=\\DSHB\X0$FDF^CY6@#-.@[PKS@Q>RKK,$,36#E[#JGH7M_?CLK*I^:;
MDS%"EWLI+C0IF<)V+.T";HZ<[2Y6F\@\-J8,]3)UP+@-?[R:"H'FVX ?CAER
M.3.5YGA[>@,+#P:Z:B-BB+R:%S7J$E2.:%6\W]L O-=DD]C2"HBL%LK/R$,#
M^)N,YW?XP=^NLE1J7%$.-.&?XY5U!"]3Q6JK5]5-X\)6AZD55NR=E.P;]G1W
MU]MKW]5(5DM8Q;3<2^Q+&9FL-%%Y74MAJQMOU-/.U4 D,A*-EQ(;38:V_.$:
M?XXY^S137>=D33@^.5 ANL6UHUL(6142=OKZ0)I<J4+LC<>&<YW.=^V3..Y%
M;<GT"*I)CCH?W%_O%^+MGJ@Z(2Y]/^, \W[?I]TJT/U9@O 3A!,M(C-E?W9-
MOZA1;58M=XFH%]W)WX)TU:DS8"296>JPH^.6T0PK@+CWR^S=LG$CJR>KN=Y>
MMD7?9N)V5[;%1]3H,Q[9'L2\F\FKLC0/UQ]^D=G]3IT#22<T&A,BS25P"7D7
MR>N\D?IE%G."ULOR8ET^#:"/75Q43J8/-"FN.'A-;FQ5*%TUK4=]J_.XH2(D
M^D%.7EUBW)S>$%BB4>608:="WB7+D0]T\%06_\@1-5[M';$H*YF4K?KKHI>:
M,P*]5MW&/O?R\3R':_.A1]ST?(0 8Q('&]1PLU5F?F"[>T+W[64J^-X$Y'>C
M6>X\A#R#-<#Y&-ZGOG0/<@<MOD%47Y6T\);4)5.>I):5N%E;Z!0;6 "Q\X*H
MPT7G)6\=1@_&? _PSHV*+I))'E:@#D4I9$L%5Y<[BW8LVEP].V4V-0[@0>LJ
M=/DK^)__R"L&SG>-UY]?1C_$TQW'H2;SL2$&MCB6MUE*X \7'\P[L!^:_5&A
M!1!KU*JFTU7\0PJ.ZM;/H,/2Q715DGTNUQ='MS4S>^!E^=G_<5CDO6<0Z*LT
M=-_]UBHKGJ$MZDCS6#L6S&UIR7XZ,?;_FN;I<@<'>%*&%R&YYX[WA\T';H!?
M.DF9B 'ST.<1Q:*.DE Q6>\7);T9 ^+T*:5C)6L168F&=[B=^0T,$MIDB2#Q
M!3@ @2FWK4A,@:V>WF]2J8YA+M+-FV&@J>8@5%0AY .*X>T[^:O@!SNW=QN7
M_CF+VQ0P7%K-C@L1-RSX.PQ0:,;I?Y<@?V?9:1+\TYDC4(SZ.WRR-/\J'D_Q
M:]Q!_U@H>>)S0)29W[^KDJYJ@]"#O_;386ZAX3W%<O?ULKS-__M\3<U_QN3]
M?/"NZ#;')T"O8.JOL>:O]KZ.P: UG7'X[E<8GH1\H>[@P!HG8W$ #A0B?^M!
M@KZUL&[-G0?6V7=V[CD%9#5^;*L2CPL/JCM8_\:IF98V&2.-2L9_31KXM0\?
M-N2L2R\'-=LN7E91TNYLX?#[=?7.EQ\TWJ3==1<T[3LS#[*S!%]AR;D&B3+O
MT3):2)'7E@TPV3JDO<O(OR<>+*>K0S]>]\=/8H0E$:A?]W(/]ONF60MKL;\O
M^1OZ+8S)BBE*H<2"XJ=OW?%CLM&7.]TGC#J.H<G\@\ON8>K#1&4ETOE.6$BN
M["J<;'Z7W\CX3T&\-8%NA"AW/F/D4?<93-A!H!-N7X4#+,?HWM%&*HT:SI[,
MK58.,]H)/XP2_'^8>\^P)M=M73@J19 B2*\JO2."=$*1WGL' 2DA"M([093>
MNR*]=Z1W4'J1WA20WI$2:H 03H)SKK7G7G/M:Y_K?/N<[\?+1=Z0D#QEC/L>
MSQCC/L-U>U!KPJ)*>_  #@RBF=QYQA^]K7/_YQ<GG%XRZ_*1:P K](,W2]D@
M=XAS4P!34]DD?)AX9X8D948E!&2^1[VL]!3O4TA?3ZVRCJC:Z'@-/&0@C4Y;
M6]@C37O%^#$';2<7=6. O_.#Q[?:5Z-EU_$7I=W2\2&K6E&(QK:C,N%EAE]N
M)HR'V8*7(FR4D);8GO/07[XTUX#>0MHK%\B&@;E1&AZ>X0+\VT$1&R4?=2E"
M!K^+%@8;!_Z,.R]]PXV$/YV0??P-X[._O:MG>J:-1$V:4>0(V)4NTIT5?ZE)
M/\?;ICTY8D*\!R^ __(PBAVVMNFZOH#FHY*_!($'V2%]'M+Y;"H:VW?BGS\H
M0WH&5,2-N,^;"^EN=A>NO&BOL,"E,*2#?.RR<(ER/>99=9?;)Z:9SL YVIPV
MS<%F:@<W^^5/SZJ"^W_-4C\-S[Q<B-XX*+=IK:B=*%FM;@JQ])<(U$2X\ZV;
MXN#<,6K"CQ*91>R+?0K\Y9LP RN7;)GFX)AJ/_LU_I7I0X-Y1HI%P2K!\+I-
M=Y\BP>O2U[)^89$4E_,7][?F[XP<SZXV10I:QCYM0"N/SJ_HQMQ1APUW/9MY
M]HFO1"-H@DDR.-31 LUG_?CT!!CQ0G&)BZ+9C-($KX6;BV%CIX=OR-8$8_H7
M09Z7^IMWB>ZT'O!&1/S6V/N\5(,D1'-?L4[.PTD*98B)+!]R=U6ZFU.<1@7I
MWN-_5[JB@14H3] 2N;S0%^#>4':TE-= G9;Y+,F!<:+Q4>:P*K<K7/:0IJ8K
MZET"M9"MV]HD$1MX6LIPN31;/D_/V$\N4"?BLY =X!KPJZW40[T\JT94:$%G
M/*^BT7BDOUY@6_3N&6;R883L4E[=ZR<DYFR]58>5]3(]]>:8J\I.BQ7<X8*,
MOYQ7#JKBKW*(AWA:=)>TXZ1S34T^/U1ES5IUN8M/!S4'8G\90Y#OD#XM/WT;
M.82#9*D";G3?<:*^31?KZ<UN)7+_F)&A\V>8*0)^/!,%63APQWL\W!/!('%(
MKTZNL_@(2W"M1=Q/)/0%AVAPBP6Y(09,N(RC.KD(9$NVMUZ#'WHIBFMQ;^[Y
M0FFR_3!7=HS6H_+D2VQ/&[WM"/)]FH*'1B?2>RDVVV5_J#6WJ+QZ=55+ERB&
M) +8,).-SD:_"#=9$/FW(XN]*(D]R,7)[FEBHN>SY,0#5@FP7>H0X$ZL_)5\
MWI:!<5E$OK2%U2?S<+?5BCWY$[XA]V$9*$DK>NK[VI&MQ=M+JX]R[;WQWHU?
M TI-7 R&"83Y7WK&V[#S/1MKCJ3MH>%Y[;GR2X=S(*_;-]"*MM.G!7/9RR*B
M;!9!;-=V#1!]!=G?@4#Y/I:Y,^D<7/DU-QW2$"YAA0P0,^4Y8A)OJ1=*8DGB
M'!:/=2HWQH4,3H\F<UP#3M-"+'VZK0*,_7Y]7_7U*$_9^2%&:GJ5W[YOVVE7
M\S$>_]1PG;;0MH<[8#'W^P)[:I& &[/!II?O$R/%ZKNQ=.[-+NRWD3OF>7I[
MK1C]@D_4U_%NLJ#&F$=&/FZTHW)P<#[)F["SEMG+C1!S#D0O_<J1A8DUU.[2
M92HUO]BG$Y3BN;H(V>0XGZ8FV9[R]^& 44_&9LN\=FE;MH:SM5T"0QBKK&[9
M90C0E#5'C;NXS8M]OH2\L_<#-&,S&9W..$*@/R=7Q&C:$ -0W("MU\5$_4;7
M@$H5RF/&UJ"_]OV9^M#5IZ\,T>'YT@:2&(=,#D&^N )?'-BEY> >9GX,WJ]?
M]?U0_@06 3G=)YLK^*KX4H_H2A!83'&:93;N/)="3S*"4,B&HWLON#F>)57]
ME$=4@BAD+N+BX-N?%=-*BH#;JRL+#,SCII/!*+Y4KG:(*B.50+G(]E#F')0D
M"Z;F(OXY.63WW35 (7(? 61"0I<(^+8J ')S+$Y[H>4&@9X#KYSM-S2E8(?'
MIH5Z48M2DXCWO!3,2'>+DHR]479!O2<ZD<Y"0#4S7*)('L0^2)C#P;A&+HAV
M"[[-JBS)J?&#0C-O6UY2N(J'6N9T!LAY;R X[K*0C1G^MA07V&4PE"H0*WR>
MJ^81:<V9?R *Q-%)O09T[-I.29U:1NZ)'/0NJ8AV6!PS9E4<D#2X".4<<)3H
MG^?$3"QZ 1Q5SP<=^VM)'%[7V.^LN\@$\A JL"Q<G-.4FKG67?C4++-HI_%%
ML^S&I.BFPA7'E_POQB[XL,^P!QB%$[KQIS%I_<JE*VLBN[OOR56M=5!TYYP\
MQ-%-\5:8L$A7KZD(]W\=7_W>E2,<O]<:6LZ&#BGA5&Z3^O&-_?-PNH_8D?72
MIPW)QJCPTC[[05TX2]L#"NG1TMM5=V>\!3#??:4#)KSTYIL@Q%78[IK%6+K#
MJ*ICM(K_)0ZF"UZ.(-J9H4\,UK;2(7QNF+>$>!@#FYR\FGJ:;&BR[JQ;\^6P
MPTL/2G$Z?/?G@,^2(=:Z^=@K9KTTE2FVX3;B]3<PILX'1L'*;Z-22-V,B_>C
M/>!/31KR]&1SMQ*GU*E*F$E=G]2? 4/Z2JM8JS?("IJJJ,HBY!14Y'/7/>HZ
MN]27[UE1*Q<,7QU/3GK_A^3G>BZ*[9CM5H:/2R]&Q;/0S!;(^^!]96?_H=Q(
M(+A^<3$=<L2&R\#N/.<%B7D'E46(\0Z?O42 C7" 4"CM9<?YM,_?W30AO9KT
M!$ZL=$-:@=KG=)NV!QQ@A%1CT)5W'^J Z&SFKX]7!L0$/:D;ZK[2:A;"3*\!
MCV;;+DZ!%X33AM [B.<[;6?9**TW1]-[2 XIC 1Q)CW7 $F#'=^'D-Y4-\0Q
MY(*LH!1QT:*[:8Q_AKG%-7%DCVED/ O+&RQ9YFEZUJ.TPNQ[MBH(9YOA*GE=
MPR;(P;FL_R+:+/X:D(;KD=1Q!S#-V;$RC,1O3<-Y2TVTN:ZM;"/E+@.*+I];
M+GD/Y-<Y]0J8R+8%T9S.DY]4:G0:@@W5%Q^O!+:>M;X7<O,[%GUVSKD2J?\R
M?$^";97EE\/;BPG?IU#EVHB\03!1Y@G62-;CE ]?:3U:1%M45_0(88K=Y60R
MT^_*E>[U>5Q !YV2D][67**!TB:,'JZE8<Y#.-MRA9PS6?)U<J\!Y3RVDX5W
M^63B3*=C!E'*\&ED@2W92Y/M@XL[[A/^9K'/[2WJZP[-3#C!S3!0F:QU@7+N
MG'P-9["-T_@WZC8">%"I@\7BFJQ*<NJYBS3VS,G(%*S89@R42/J"\%%"]BN\
M3WZH)O0F6N#-4E65NLGJK1*[)&>>,CRA*$G1K^O-V>HP4.FLDO2'T$-V>*X1
MG<7<DSN'C T'>A]DJ.)<A1Q@^OV^8]@;9.!)7V)]7@/MDYW;:(=%G+)J?H=
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M<S[X#]]]Q8R6P$RNTMXU-?=)%K,4(YG66X5!-)GF^U41C'$( F4G1,"NXC4
M\/+F/1HSBW<,7-^9V[L(Y]:]>R/>2<+>DX%]B_Y$!,\OS6]TU_3%JNQPHUM
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M2#?[<ELV)O]GS#7 R!#.IDM?]T3=_J5&3O'"#XKTJSMEUX#]#D@ TZE,_C5
M?*?M\F!A23%-M/_4\9=ZKMR\OH; 1%4#=A&&/%-&87YE4XW:-$F5)-DB.1U;
M^M GD..I[F?CYT1].&&/]ZA>4H4CM$RV-SFL033I2^4!![/==0BZF#?9D!_O
MEK0@M0LC#GO@D>-/+4*'7PT5;)*'>,Q56=Z\LR<SM<]UYPIN-BN&Q4#=@$FO
MQ':K];7@LE#:\J70$_N :\ A/4K)6Q]XS'H(Y=UF/IKP/!7UYC"P\QU*'IL]
M$P%W @]Y;--/SOD1@>!GU<U(ITK'B-SUIG&03:LJ\%A0>Q0KY('P<*"!782#
M6&[!SFW"6C9*IK0.\[V?B0]/NC$WCLNR-6!-.3."42J5R0=<M_H.HZ]XL*[0
MW2<9S$1XK?E9GN:1%6KZOR=N'O8^J.ODX.^L>_RM\]0MUXW]?['WGF%-;EO;
M:*R@"(@""@)1$1 04*G2HB @("(@!"E!1*4MFO0:!2G2BX""@ B(U(CT&GHO
M4B-->F\)-0DIYPFXUG:O=ZUO[_WC.]<^UWE_Q$O"#)ES/'.,<8^N>?4I_'[.
M2-A=^CF#K@8AZJ&:I\1*X^-RK1/6$4</64O+RMC7;'6X[OBQ:F-@X<97P"L1
M!XJ)F*2>RO))SB;PBRWY\\U\@52ECDU+'<\[.1H+7"43'.96YE63DC=:$*I8
M #8ZZG=P#>\X,^"ZO=TDT79;5&00.T)$M'A\:2K=I4FYA%WV6U[Q5V0S7%%T
M$,;6-R1ANS&=^2X/(Z_(:A24FGAIF'8=-W4HA'C6RX,,JLX*1%AB:])IPNCT
MQOB\M_-7>+K9'I&2+1OXKO;.?JH(:JB+S"HVI(#OG$Z[?5;>*R7[V\@)!0(>
MV%_8@:"&-X^EP5&UJ%N3:SA6 )&,&1$/0R$3]+ASFP@\5F]>VI#B_"&#=I<H
MWA]>^+D9?"@"+0M/?OUO&;1,&1,=0KN6]6*27M<CFZ4[[=;I]#>/?EWJEF7X
M_MK1?7=VKOF5(A(J ^>")#P-2.(2OV3CE[["UWAE%)N502-S</AN@*^XYM,W
M].-WV2B#*C&+*U6\,&)ZPYCIX<F!PW>=6G#(*/K6DK@N*CH]U?;><[(676TW
M/Y9C93F&VL:C<L_A7DUVYWI4^MB WKMM-YI[W$!7K6GX"A::QW6>8='5AKLI
M5;D8]>T>MV%2YE[[$D.79<Y5.K<)18P *DZ/F7G(=_GYE-^;%,0TB.0X&T=Z
MZ3[1H9R]QG@ZI+L9Z:2P!9ZXEW@Q0<FL4CG+-T,9IBHO&-X;_7"$+^.9R0M0
M"S>%G2V,]E68 (DI*U(_GXEY6X%5I9(8\:N>>V+QAYYC+)T:09@*-K#&=79.
MW:\([.GACG'5M[BXQ?UZQ5I 5Z"AXDO,]+&3N7#)O!2+?+.XAJ(TZX#UZGI?
MC_'IDV[NI^5MHDM">7FY!,+N?Y-E6XAC1V['!LQZFP9;7YX[V;35]0,"DPEQ
M=MIQVAE2&1FZ:NEZD?OZT0,&=@T>.[G8J <8IJ;XSP8Q]Y^'(QC2N^$<E9Y+
M(]* *791,!ZP GQPT*C7Z1)IO.5%[F?UOD39?LJ.V,@#+'&WN6!+%_<Z-__7
M-J2V1T'K(3TJ<S1GMR#C_"B'L!,N-M7=-3++W6UPSL/*G\#73!HY8:-N6W-1
M@>MA="Z 3*N=W%@^=LSRC;; Q:@OWK9*LG,YT((^(5'(Z4%#(X,6.RF#IMB(
MKU[8<3=ZXP:[@71-JR4SDJG5\3<9:4]=(=7;-J^1ZQ?&X)5G2,%ZZ-,P(D:<
M=%MJ;><C ."#8 <M;(WJO-),R*" 2DB[/*P.[:XC;%X\=#<DRGK2;!WN6W+>
M_: P&700P2'ZG2!4)>8E41B&M4YQT26=\U_\6%!?%Q>_?KU6/29SXUL;YE.P
MB!"ST</&^$="LW+77N:5@MSIE"9TF1:1+ 7C7+VB7!HQM(>*>V>-9OMG'LRK
M)\8]KI>/S+I#\;_TU?\GH<T]I[(D^"_CO3JF+^'3CKV0,1OB@2SU>N3Z]47(
MUNCG-(+I CZT&'T&,?_TW_?QG6VI_E@LS?Y8%'QF(6:E%5>KR)%\=!*"&7G0
M:9#W?-F LXN+8RY;@H,&:RLW8>H]AC :@P#W>BP<08. 88O=9\R*Q!Z%F[XO
M;;+U(>A"PU'<1V6GXD?S\Z]&SMW7O\0(-1]/.CSL\K%S<7)R7=<CXR!?8TJB
M<*0:=S1ZZ7Z_HWZSC@:M;V%]N&?F[5FU;.@,C"ACMZ:ORJ F%O^]QMBBA3MF
MCN6.Y?>F6K4S;365?>)3:]9WO?3A.;8_!- *<W['.R_MJ@45=5\V8)+QH5\B
M9!H'IHNWOM.^ZFC>]"Z'3K.XXMH$NWS#Z2]%PTP%3XY9@S_N'AC9A?/5Y!#/
M-$JF^V_&Q]-*UWN[2G>)Y!K27;4;_K*BISTW0_PQZ^"9!%D3D[%4[*ZX,8Y;
MR9YRZ4Q[[L3?XO>.:$?LG_IN-S( :5C#,2_OSR PH/<1Y"[#K,:+UG]5X^^(
MB52\TK&>F(KRQ+B3%,J%\+M@_"%HPO*H]&TM9].,%>V[(N^U(Z7-@(>N[T7_
MQ5"U 6^8'YS\7NJ$(\T& T[ 33/VBD$YQP/.#H#\F2["M4ZR9[H5LS+X:*;
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M"/L&;@_LP99/,JY_^/;(UL@V;H[J XD)TH7F*.Q=PL^^&Z>G;; T97O\*%[
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MEW,[>8%0JRM;S04+SUP%K&_=SQVDKCY%3<C##O@W\(O2IO_(#&GRN/?CPR-
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M-:K'521M[649E+93C-[]3BX45MMK+4!AL2._O[7GXE5_ =GS:M$3^:206 *
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M P* W;"VL8)VY?B>X86ZVDG=\.DKPH GG9$F[TJ] >A&!Q@>4!OG@QG#S"M
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M-X=OB'_V9&97QC<46^6F67,/^RRARE#&L(BG^^I#RG(HS1/V'E<-?]GE!&P
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M^>#QGQW'ZG]5S325W>WU5=L@H\UHO ='QO=?5"/)H?RVTL\[CS:R\^DA"^\
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MV1%"G@M0*CJ=D5:.+GZ6,P+!?X"^>*(+6=AW85;^M=8CGX*F74,I!,JO5&!
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MH:8YWUM=&_7#[+-^3RTY"@V=/KF^U;(HY=G6BW:*!LYV''-RI;S7K]\1*^,
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M'A_#3;[3*>-PH9#0AH9R'@ATCQPJ27,WMO5-"N6^N03Q/('.Z>VHCDGBCA@
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M$BG6X7XAC) Z(=N_2K?_QQLJ,J8_!'>\CV%]L>E3WRP"RC94A7P!K5$WGPV
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MUF67X;F1*3*,'A+0Y$^P.&#=C<SR;7OX[6Q'WI'J/GAU50\!V,]>]6N GB"
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M%..Z2=8%(^9UZM+>F%$1>/*ML%145-5&8^<N/ZN5#QA.%Z!.^[11MW.YK5Z
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M3*E>\M_ACO^.4W,"5&J?.."_'_)*MXT)"&#XCYQ ]:$(UAS"9U;(\:= _8<
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MX"/9TW\LP(W)K!O^!P)_'@D!J'*"!ZD:[^((;/9^#P% OO>.ZIC^ X4_CU5
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MQUALRJX.BJU<@CW N;I<C]5U6;ZZV<69$\:9"#\0KO/7-<]TU>N "XT9WQ7
M*BF%!KCG>E7U@G*,K**H(];ZQ@*T!Z&KV(N7.UUL',LJ76FHKR0M<2L>:/MU
MJLI,F))LWBORY$8 T5XY7A_O)EG#[U.R''DAM'KM[DX'<<LW6L)25X<VCSCC
MG3\:RG%^,JFE-C5C*"%_&%<@2?S==+ADY\@,1&Q=J?5M/1K;Z\U170>*4?V@
M4FBD8,FA%J7 9935"@6NXS[7PL&#!=&+YTYORR THO>;OV((8*RC1LHKC>ZS
M09JX>JU<;(@[\/)U#T.4'Q;Y<I+>S;TPCB 2T 3_"O2C^&P>,I6BPO.J0P>B
M^,A"^5JB2$S4..$'(HU?T#[-R&L//A\O+5_:9[EYTJ;I%5P7LFOQY"1C_:G'
MDRM%NQ-]REM;[I!5[T<[B>'9MZ7G-S<%S:QBY</??\RF<?/WKO)3Q5&AG[$$
M[[T4YI6:OU_03:=!%W?"=T!AB_Z!'[!7O_B9=A^TP0??;X9/Y%OT22@:+-!-
M52X2NW8V\"WWYU:$C,[Q0!NB#IPP[*)B393)TTE:^04$M$UWTG#.0)C;+II-
M$46<\22]WT0#?\&B^A^U#MGYV'79=5.C.K1R=5)UX7KI*G^@J7^MJH]=G9R+
M.K&L?HL"4:FO"^SJ\ZA/F$;#KRCCQ9SYR:6 P> [$WCE*!IW9LIR=-%9YIHE
M$\?!BP#,-,I^=(K=DZ1=]_Z&MNR+6K?I(PH1BGD']<Y:'523&ZW4VFL<''B%
MT]%-I&OPM':H)1V':RG</\:__DB7B?AE_EMK6J-[A0$*D[0#/1@3QL;./6=Y
MGO@\2IZZ4Y.R^&2J]3+M+^[/#N/Z[MC^6!VA>N,L6VH=)=%!B3W9\"BWP]V[
M[*1W YRM4+ NP_>"NDK]RJ>)"\_3&#]:\":";'[>DS6M@_?C H4D$/Q+\=LS
M!VIQ6W>*0A+49&-3V]U\*.ER1(M@1NKL_@/5%X1N;SFCQ*ND+]0#N[UJ#K4O
MVO;9*21:W -RLLPW-'5T:V>?1=+I1(7FGYOPTV;H*;VY"/N];VIL8"8"-$.M
MO^=>!H()YMB&G_$F/D^4J9)IL8KLP5.*VDX\Q68C5%=$X8UQR>-);(YCU,JN
M2PC&YJ8YX??$BZ4R",7OM*V&8T"?^(4=0)9O]9_*&''U8,[2*-4'BF.)_*);
M6TU>%NORL E:>-8 90AL&O?./__VG/?P&71C6?F0VA9SOH?<V-B('ZWX3 O-
M@WRJ38]PWL(*G+.XT.OP_%>M;XYI5-_MU%4P->/M @9Y.:4'%>'9H,K+(@;Q
MT6+KI9HXSZY'/;0$Y54]4]YB2P5KY'C?*.VZ/N;U+R& T"@=#)E]#@J32*_T
MGY\3F/=IA/3Y3;L58QWW4A^K0%TZO\Y;&@K_>#B>]=5>J<V77&#^0@]%VS0Y
MHX4B)>XJP(O5?3+%BBWUN[FE<+_V( [3TZ&E#54L%*-H-SK3_%U5L\PRGG_/
M;SU$K"]+$0#]T_<(P)GJEJBR4\T2:B)S&987S<^$276Q;QD"(8- Z7>\XQ(0
M0-W=I[!@?O]8=;$,%(PW8>0C@,_%MZ4MI;2@(YZ?&;#7)DG@6N53X96[6ED;
MMM4--84%UVW>^A^ 3K74_,PU%<^# CW%7,@]<DHL9:5^5]>*FZB1[A3TV+L;
M")Q17JP,7Q$Z#=]@S(&WJB "EWPX:K@KC QA]"$R1:.K3CB%N4-HC]S]6&3J
M)<OHBH>ZEZM*;XN6^E4X]SRH3GG;EF4DG\JL(0!,[=--(2/B+M?.\2XP(0\"
MP&MW@H?9?-/Q5:JL=:MZ@;$QDV'KSH7OVRO@3?DK;;DZY&42A6A#'HTQUD\@
M4?(JXR.MG6A+5)?=!DXXEZ#-YQFKP8ZZW&".!,<I:Z/P]U@)]-5O9D6QQ*P:
MPG?:PP_FBGK4FH+8EM4-JRX'2L0()''<XX[IS#)4E%E;  Q1#(N%RW%XM?@=
MZ54$8*[*$(@ UJJJ;P,X$$#LKVIH[JUU 'R_&SZ6T\1#99*HJ=@1@6?6A#]:
ME*KU-2G/RL!/7?_S.JD1$*UE$?F@&^VL$ $$Q+O'P9OS73-72,9F]DUT=B/I
MXG[@S*(,]SV@I3M;C7[XDOJ(/68%+ZCN0[<ICF"2>920&N9-0]]H_L WJA=T
M]C(,:*MHOQ0_)PYV)W@LSP[/5Z:?4 =D,F]A4_'PC7YW%5J/>,>?(J 35/2K
M+XT,/+FE=S 'WF<^A-$@@&<*_@A ?Q=\^[BRQ=,< 6AE@.OM$$!%04[E*,1I
M.$B$O*IDDF$L6T[.G,Q,PB2AMVN!U+47 V)!U>;K^79OM[?I[H(4C33/UR"
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MERKNW+;5"N-Z9&1(%AW.*G7(0K%#QXNXNO!/GH7U8'P$L MY*A2[O1RGSF9
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M#^X^^DNGE2]"&D[%YM77GPA?SIVT#.R]"<9V0N?BKOQR^&''&QNZT%2JM;-
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M'L6C>!2/XE$\C##C_YL 4$L#!!0    ( )F5;E8F=!>O]$<  /J#   1
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M&CH1&JH-H ?UO(GVYPOXCQ?:#72,FYA8M[!Q<,$)E;>!&VCHZ#<PT&_>Q,
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MU;#X5JIC8'053:?&$+VDOO^EL,[2J9 H4);0KZ.B$%UA,/7!2FU#C,FFM[-
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M\_2]RLA5.+6BLTV;/,2??IYLV;^<PURR$SP;-SFH9@0N@VO91G^TG0N;3X3
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MK/K41ZR<\/HY!S:)>20Y) BRP0K;I[)',D;!=9 D(!YDH("OULWPL/TP5N1
MB!O]E ;RN7<S* D']J<@?E#0=5<&%"$%XH?_".R ;)%4[2J-8 =2D8?(/[M4
MH8'#5-^WF[LZ.M\U;&?XDM)%R^>?(D*?8O#[@:W1_P87-8ZD<0\.LP9;M5PS
M>K\+>A4W'G>PFC9HX=;S32K=ZAP;Q3L:*3;*#/NZ\:_^V)Q5+FNRLT R/=/9
M:1E*7AO]/M)C2M\.<SD@ N] 37IQ5W".TB22\H8"_7OI9[M5D#TNE>]-K3<J
M6?/<R-GPN?KL@S;"22)?\TP1"*[;.28[)EO2:-:Q9F,J-2/>UD5=>8 &V.@)
M&R_Z^$L!7:P4"N9C>; P5+VII(&4$FH^^0;R(!+-AFOX*2D#J9P&; .S:"OM
M$+L11!.PBDI/*EX"&9-KU,4A:-Y' @[P:!*X<<;1-2P\]OEZ';G']L'-*YI#
M($GZ3G\%:.68PZ%@&J!'-H!F&KQIH]T_L&0Y,@(G6I@'69_/GZPO[.GJ=OXU
MVC*M_0UMU;6YC4[H%SN'Z,6,X5].8!] S,B(GO.Y9K^?MI$-(".3?GJJ=U#Z
M&J1[AK")6'!_UD8]1H)"\+QZ?R1VS^](/>?W*^6<]$=2@YR/*9P7R79\I0.*
MG_)<-%:=Z!D[P?>LC9H\1X84QON6)FR1'26$@@8?AVR?VE_A30Q5_O)Y=!4%
MD'#SPAG-AV3(MNB$M;\@KE74VD8V&X/'\_3@TZDQJ"+;+&QB&U01V^##_")M
M#>$R;<0_!>BI?\H]R=&OEB"0[I3SJ,N*)N,D\0N0V6=)&K#_"M6Z)[\PSOR"
M?<CC31_'$XGK0B!6LO?\%'POE62^IC2GW+\B->CMOY+.TO@V&)5?Z9%D,S[B
MEA=W%WA3V\Q_3Y3"@.XQ4 X+J,C$$6R3_Z185_2O^%E01GGQ"SCN"#2?HP^@
M #3018(<CX/_2E1?>M@C'_/")I@0[:YD/?!_?/A;HOB&T+L^\0EDLP9XXE[7
M)_XKY!CU8\'E@J*0#T$CCSO^G832KO]6G%#]S@M,86'>-80+(',U"+'Z7W2N
M*@OOSR-E9^60#;:P8_-VJ(;)W_M@:!K/4< [I9]7#K KC#'[/XL2D F\G[]
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MQ7B11[_']W_)MF7-[1(S6/O*QJ#P-UY_$UY@A&]T]$L;NJ07:W^^])Q&-^%
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M]HS!TOJ2D9J;43HN:/Y\/A9U)Q@S",ACZ;H'=.:-^VT=JB$@+0P!::I_SJP
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M<Q^83>X;GKDN5+\R)^X;B7;?URK,G=7Y^_[X_Y>'Q/W<_P)02P,$%     @
MF95N5OW*9W3T@@0 "]0& !$   !I;6<S,C$P.# W,5\U+FIP9^R]!5A<R[HF
MO$@3)!#</4!P">X6@H5 !W>W$(*[A0 ! FD\0/#@#L$=@EN X*Z-NSO=/_N<
MF;E[G__>^\S<F7WOGCDLGK<?JI=\5;6JWO?[JJK7@D_"%P&LE])RT@#" P!
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MZ3"CR_RTLN)-U8_ 1[V]Q$D6?JXXF>%["*-JF$CR2Z_/?[GE4QO9D\4> 7"
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MN"B^,)D05=-(HHR,O(>:9%@2&Q)0_/THK]<'49(TV1DLA?FRH=9F#[O)$<Q
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MF0DZSX#D*&:KJ%IG&SQF:"PB=$U 0#@*0TW00T_(+Z7*PN"0Q?< #J@,WG+
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MT-XVJL4C?I'M]85@.' D8N4C"P=.GFL8' 2UZ^A#V\XY[:921AQ=8=S$8M(
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M1XC[V*73ABYAT3>R^_@RXFQ4O,>P\&-+0YI&!K/CA<XGGZ@M;F%B/GFRU W
MY9X/.2@YJ8I/J33KLEN=9,G$9YFQV2M5W/ME_7=Y_UI,SH>B.\+<$['WUK*P
MT#L@%7#X#^G%)@1(QSFDV6/807@^9]&PW\GQDOB]S5O=3I&N3E.?@<7V.C!4
MKN"((LJ[.-,[PS;[1,1F5MNRXB'MR;7.3HFM^JQ87!CX1+UV_/O*M>COXE3]
M@S6?KPG,D8)/#_?12V*56,[(>V_Y?]4B ;@,\\?E%Q5%5V'[XHXG,EXNHSE1
M#5EGJZ==/5*L9IDKX>-2J1<SJ:_5:<8E7+%UHH5UF%9S>37]SB6\J.M\] L.
M2!E-X/UT\OJU*N3QA!1[^_%-]P=/(+A8OB1#/AN@D*!U1DKO!F-8:Y6]F(3&
MKA<ZN[#FW%")_+G5PV'RKH?OF]:;B4+"E6\DX7<S%Q"$6S82L.F&4A^TB/;?
MB")HYN'%Q?I]J[_;! _7C>;F*6+OSWFBZ[R#?J.2WSA.B*WS?6+PR,/^\ID4
M?L"!VZXS$JCC"(>H*#$?$V9[]TD4'Q HWO.RIDL=I^H_HJ2[_H4$@E?\C*^-
MD,"!\G;[X[L"[PM+_^_3B%=F-MK6\L^@\;38C-*9PQAGS.1F)S S\Z/:N,AV
MQJ;)/$>U=165SI+JHKFEE$S;Q<$&K^'$YX/C])QCMSK?.F);W>@,#<,4YNSL
M^ZB<-)2X.ZV@K LB:PK,(89)L[<\;<2C#*7%NY][6\J@>@%%%2,&C%O;V 0*
M=+XYP]W-13TW#E#'S\/.]Z=:[Z6*DJ^PRO?YR*LIFL4SJ(O\?EW@H>C;1BO8
MZ@>^RUYU-+2DS&!@9';:!Y<]DC@[Z! YB@:9\J\>J!C^Y''B$9!D/KADT(]8
MV3\9WBP6A1 '\FE[(([H3P\13)/@>@G);W9K#[T:@WY*BUAC?KJB@H'"NL;X
M>!-,>6';1N$][SE3);7LRBQRA!H\_$L*6L(( L\@U*X*PXW;&&P?_9^R-HL1
MP=7:'X)_5""!Y(4X!$?CG8/RL5Y$76;40AS1<N'HF@Y'?:("E?@+0J/#V'M*
M(K]_MH>%V9:;QWJS*EDDR!9\[$I)C@[&V<,Y,FB08IUX=_Y1(/W\,0G"<S;^
M</!^X/-W+@4;YD+"-M$_7]</.$G.E<J1Z5IG%?567+%?Y_[5Y:[8.+S+# Z?
M00*+]0C7&;-_-!5Z"--#2 DB@4NNCJRZ/ 3MP]LWMW9(P.@+N 6$!&I+2^&6
M2(#E\A42\'6^HSL?\O^?7 3?T9U)!Z'#/_FKACWQQWI_(A\[(:!.;8V9[Q/9
MQ!".&?=%JBX=YH>0X^RX1OQI=>G@KXP$$L'%2&"!YXXF)>GOU_!7B6H]3#E0
M=":- EX%[E_-P9+\F5 GYL$WV"C+)?]1A<&QWFW$]<J=MSJ*[N9;,]>P;V,G
M_]BI9G?4Y _@5-(1],X0Z2ORI^!]IMQK#N5_IC!-_)U.*]]3P!M>_>0Z=(^1
MUZXC&7%B;DKIAJC]PM+/;>G>(.W:< &EIJQ27L995.2XHVX99Z5WV,A/?9F%
M)G<V>73P\=@;%BBCT#3[I&2+7@,\JE=7BG:2M;DEYX%PZBA6RV!=D45<BCSN
MGC8)&L35NX(.KO/5V-A[:'X=$PDH5,4LOV5:10\E0[\G3#+7U8^WG/PE[QT*
M-XS_=[S;@Q%_/58:T&^6CSP9Y%<<^DQIP<FM7MS][1IMU[@#DGO>3'G3P'BC
MW-SQ]_9+LG!BGIAL#__3U2/X-\0CNTMA<(M?5'T;B @0.TS#$+WRXI8$K;0%
MW#>3=  9P\77"6KZL9,K3>Z^XJRRL7BK..$4T3TQ_M+)?$0(DI/ZQO[CFJ)Q
M)5*W<M&;9,_@M=N""ED574)=U ?VV [.RNWI9D=AG<II+JSI;"_R$7:@UC&[
M"%@+UQ%A#@GF-_4ZUNL3TK*3E:UJ4W)B,'=*Y2HO^:8^T%_CC.<B2JL&RGF+
M>_IP<$<&9FA =+$AK\?+$S],;5FG?Q48+TX:.G@4M&N<TT+63@"/>EI_W-SO
M[-Z@P6)OKA<1>\0%RDW#[$_HQX[-:Z-<D_HX[Q6V.<46;G4=$JZE@FYA2LH$
M$^7NC/T2-/X5#.%B'IW<%_2&#G<]#'Y3997LI%WCJ2&#(?%6;>E,?<6J[C ;
MNY?>"9\'S42%H') $)/B!QVE$H7,*;%>W+G?@&@_1H7LD#_=Q"DKHO&G2_Z^
M;>020N]-#^.A)7:+E7LYML8Q_5C^V@&/0K)RE5V[S1'-:F4F:&@3!.E*H<LA
MHMHUO5FC?W*FCKO;[%_R6\#E,(7^G^FQ=H+#M/>E;-Q&W_.9765L91;YZ M=
MC$JGMQSYQ#10]5.=--_<N!&&KL=1[]+0%Z:FK\5<*&;F@2L7I6"]58X+E:Y*
M$J!Q*O*ZXRC%1",3:;TP3$XT6R<6;7'8[)-$["7,9QLP8\LR.W_>8Z[0F7!'
M 1_GN(N4)O<':DA ("K5^N3DO7DI!'L)_P>!]<JB(?X!W?*7]16&/4/'7Q^6
MJ3PBMRA#YP1^!W;I$X-2?X]*K^F&E.K#<_9.+E6;ZX+>S7-=/J Z&=EYCE:I
MCN/K?C2E5ZXJ@#*M!7ZR@.0+EY:"2[Y1LR3]0-,6R 8KS[S_*3 \>ZA:FV/<
MPG^2TY]3XN+2$Q(2#-(<+4SD3#-:/)&.9CP1-0+/2DG?47/Y-GQ  ANJ/Y#
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M(_>;G\0KQ@3S%5C1,2B0]]RJ3'IU69?(YPJ\,T_^;L"JSF'0\I@ID(@ZJ2&
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M0ZGVX]W[_J^&9:VTPRF8B2.^B4HL.2%)/]!^X%6L.Z(3D=J^WJWI2#6[3[:
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M6C7H0U:'@(R96Q=K_TID%CO;CL<>,^R)P@TPU"1^W)D[S-QV[*/J(H%%!I]
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MO,)?4%8-.3](M+U65+QQ6J@RS%7(ZSV2RJ02J"2QQ)QXO%F4# PQK=5V73!
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M&G 'K> U[<9IY+_^6M/0),ENE547( N-^5L?![,[0*?6ZH+%#5"^KVR>Y@Y
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M<-Z*"QV+, UV22TF*1ESP#O M%HQL,!5WXIL^8O]IU*MP?2GRM(G"Y(1Y51
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MZ#!T[@">KV_QR?6$N=^V$GCY'^6'8%)MD:A@%' [(!TD1R#1'0"B7G$'* \
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M\%5NX%"MP4$%R^_@'8-VZ,P>S %Z?+GSUJZ'H135\-3N!_P:6-.XSV!-Q6?
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M,86OA?UK9HF,C.H)F/%6Z*U93]? GH9$E#<ERM&D-D0H232K+L$PG'N+-/K
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MJWK:[<K.,G<XY@?&B\XBE6-\8)],GTPLXL;LHM$Q3'WQNUO]5Q5?9-EL/.E
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M)XK^_B*GJ^;?HVY&E.K@^<R; ;7\#J2 [ZPB/MSIZCM/5=GA-SO"GP?>8-Q
MI_B9*HRH"<CTD&RQ(."89G]\<O'FG4<F?XF7TZ SJ%3QF0;:FI6,$IK+7.;4
M.W/9AO'#..$/Y%'2WU?AL>HCA*K)#^1*WZ%"!)T9"!UQ_DJ: 6-CONKO.(BE
MZ*2*L[U,9H<M>Z^%[I.D=X[W@L$-]?G(M4DYOYF;?OKVJI1 Y];A[X5)8?M4
MOJVS7K'F^I\MU'> ?LD)R</2VW"W-0EV5,&@ACNWR)MF^207:*)SF(7,R/.Y
MZEX5-,N-R*1Z6K9K(V^<%8]G]:G[;<]4XXF:I_09G7R_0('DMC\+L-;T_NB]
M3E@[I&'LUL2'5=B$@UBP.>CFVAA]I %M)+/^>G0?+]G_30/&_ST%7S62KF61
M2R-ASH2QF2,?FM_(V_)_L2F0ZC*1@Z12G;4MS#@3L"Q%)574[Y)K#&5VN=U_
MM+]=%-\!?/\,3JG->(@A91HE0P\$&\/5M]='3&.SY -/M8)#@J\6N#!5:1]@
M;9LOL<3VOWMS,<"64<G%5@I!1G;]K)*?F7#X]J&Q,3(D&QX2P=)W92-J!-N!
M^T?D,KJ&K\"NY3WY!X7KW>A4>8],GN8#66/?X)_. *\+Y28L@P0CLSZ5)MP!
MUMB06#=8CI+7^#'7%CD(D0A'=TGBN=F5%=UE+;V1QR8)33,:=A2: K0^A(NP
MC8=UPR+0;)MW;RXYV$K)D*9=AR]N?\D)TB1P"Y[+1 YA8\28^LV!V&]'GKJG
MVCP"47*'VLE=#'!N&Z"@Y^M.=X#/>PEGORWO;_NCL!+A??_K^8L9I>DMG236
M]Y3SQH^-@\!H"2%H7XV8:H?[1<'MN="LUXFFE6.O*!+>OW)EZ#JFD3L=7#OD
M<3AY<-@<)\R<4"$5)@Y@Z(;MB"D^;3MI04<4+8-F,HU-0J=[Y+;KHO@TT$75
M]+*>&E6M^=+8*-H!GK&9.<D*U\C^F%1^]6\"BW_$/SZS_^?$?\S^EB*IR.*7
MNJ\UZQ3OAUKU+=6M%,1SL;<F232!-H0"PY*RTU6'7FWZN_&<MM::Z8;9K\OV
M<*.PQ8E Z5CIY)J$.KV21!E(=LIYU\ %52K"<6.FP8GM-E8;.D(B="P8Q8E[
M)+9+FD)"AN>C:\@8X Y@"ALH2JJL3H1$%!#B'!!ENV^V,/\P3%A+TIDP^M-!
MNI0#:M(22T&(S=(0L2[.M_Z_#&XQ96^%LDR9TPG94]$D_->UBE<#/6DTHVD\
ME]]8F7%B7]+6C$7PNVT4.R\3HG0$G<T\U^4R3B:^5BPRV!O? 8IZ!VM];'!&
M7'NP)?SO #@:0=X_);/O *O&WANRU\SZ='> [[?Q]TD:?@<(%Q%]JBPWDY%
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M+_6A@1D[TO5@,]<)U7V-F?V9EQ$:[?<7'R_V]K;(GE5P]WPF985[Y$KS_0Y
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MUH8F"P>7XN)@4F&<"%E#2N F:884? '4*N&/I+\I@N#E41V1 C_B/;#NT14
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M/1R;5($UQ=%FSM@7NI'?O_I>0YP2""#E1AEU/HN/%.H__FSZ=>$JJ927YEC
MT"-LP8FO]Q75QI'_X?RC@/=K2QSBDDK!1?*G K6\H-22WGKP+WS 4P"Z?-ZG
M6I"6VZ,B+FZ'02K+HN]R?[E G#&L0S=C^EE9FF8VQ(?VK3+G"]>79>-DWQ!J
MO0@0W6]SNKZ-W5-;NP-0(N_A<W9KZ86#]R]^[42WOOQKYDA,#T'_+FJ(6TFZ
M-Y>-4M,KBC*TGNF%Z"'L/1J8&^U%R8A!@#YE=)M.$27?$(7&(53T%(>JOWW
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MV?.U<[?/0*K#-B>'CS]:%Z[Z#\S6FZZQ)AJ;46[%OR&@N1"[ 1BCAW[ZK]X
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MJAVSTTM-WT9 1<)VJ0^'/@_+\U610 /^%07\HXD$_V;"0=.@&X#6WGORY56
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MU8\[=%Y^XT%#JBPZM=$@LTX!L@]P04U.X<Y=&2G[R,YZ-W-_;DD8>LBD/7[
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M*>GA"'$Z?L8BS&"5T:?1"AMI5WI5\=X@23"TEOV &*H@/I.I]8NTN0]R6LR
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M&\?YARQ+3U27EL*(<S*F *7UQ>H/HQF/EXOR3!V;(W4_$3< @B-5HC9L/GV
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ML90HIQ^>%&4U(WKM/;H\7FC2B-EC$[V,Z1TO$C#L%.4;-8L"ASCF:]VVSSC
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MO2 X#._'WX?+7UV$&**JS5TCM38AEQX-%#HI1>E;YFQX1->>1*#.4D*0D'W
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MH;=Q27#S/F=O<RJM\-V]RV5F448M!TR["0>NP)OO%10? !UPUH0A\*C#GCT
M>BV:82%BR3? B></ .&;WQ._]>)O61>!#X!APP< 0_:_E@;^FW=1#GKY[A)
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MUV<I5ZQS][S]2$;^LAV+) "7/B\ANZ9.E'1_C _3C*NB3,]YMV_Q\M)K5OU
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MJ!X]C"$J+\Y)^C<MA@=,HQGM0]Z<?H\G/.R2<$=F3<OR&86U(D?)ZX2R7;S
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M193.I%J8L&C9,/M4;(X#-DN#"R9WX5QF[85[N/U8\EJ&TB4[WK)6.:27-BZ
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M\0OGD02EYVX\@4[U7+)KP_"2PCM8X;K'Q8(&49J+=J*)D]AK)$06?S_S7_Z
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M![I5S482Z8?" K*?UM4KQ(MJ$8&T93D=QV89@%J[9&<VVZV%JFIR"]T6?ZK
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M_BXXT".Q5KK^UO"I6@O";5;CO]WMY*^]#_]Z8-3.VD86W&O/U]4SZ"IIDG7
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M.H^'0'](GRZ$Y1 WHS$P/9*_. M_J&I_2ZE<R6\E0^%W9U9?%Z/15/G4S09
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MDE@D6M_U&47;>*GVB^,[H+K$;<UU\T>&0<0MEX'F(^Y?_ 9.2Y-Z?SG&$(9
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M^G(B:F+J7Y*@\0M'XGB>_"3(ZOOQY0Z8AE)=/[626B9OH=M)AAOI7L_6<XZ
M:LSW<6;'>3$H/YIJ%^\ =I6S^<]);5L;(H+A>"V!><&7K?I&N.[I)RHA"R6?
M_/4.3603LP!?<68RY/)(3-+M)HX5G .CH-FS&XF&'<@YIZU;_TU96E/EQ%&_
MDE#9NX0V/'P\]WLMR>#-6&X.;!VK3!5A7(1'/:RY4H/1RORL.C 1U.>+;Q/H
MPTU*#X<_%6W#IYK;:\&I3O;PGBMRM-VRX77C6*"O733Y@"ZPJSSB'A7*G3,J
MK)J_TX=K&FBZ4?C4N/PK5@!CZ@?SX5:GJ4:Q@.O6F*+%'4[Y]PWA"@^L[/GR
M5(H60E-C!;I\(.VJAGQH0D*4O4;<[KF/:2"N%14]D/*63_X-T7+L<L+GU/XB
M$@2GS1ZM71F(BD4/2W:L6@[Y.X;M@KDX(\/KUNO(C;>H 0& ?&=@6&VS-%)L
MI3>,39BK8"'W"\P@8<+4N8A,0/9%PK*3/R8V@L#<R.OF@;'C6=@/=IM#FCJ_
MDQH=?<$:;&RT-7\T*,N&O10@@43Y7BLPH>3-2XI!?2NWBMF^):]7R$;^*!L"
M]R-Z25!)2AB54S2>6=CBY.67"8/=NK;/&B?&72Q?537&!;^."([4HH=^%"[H
M>=H_[S2R3"553&HM\R;9ZZ<3:1'J+0V1:40-+:MJ]%';7!PBC,A2<#W^^) T
M[J24.+R<GSZJ3UL17&0TZ9+O0ES-,EVOH.GW:I'('HE?P,8\9%: /EVTNMT;
M[HC$^A7< 7,<M_@)4]Z$=\#'K=NO=\!L0E/L.J?B"459) _+=[KVBXOSAQY\
M3SV\J"QM7DNC^J-M*[I/!T%M2W:22VHS2A9%XN:ES\NJ!.IN9UXUDM7B'L==
MV"LOLTS!&$#]8C\91Y-@$<^OSD,=E 3?S[TX:%* <.E.F2=2B&J/%_-Y^S^L
M>:WOC\DO@$K'KV_?1;%@?8^#P#V0)"O!94&NXHDQY<X/>51A?WO9\N5IK^6C
M#^7S+Q]EKG)_4H".S@0^_M"^*2F &BWIC]8VK):%N4H5P-;$(5+2DVY'.K:3
M2A!MIZ/S0#+HE!J,(T8C())LW\K\4*UZ**S#"!_RRHTHA)Z#I^FUY2&N!O>:
M/:7AJ%\KZ]/()^C\L_+K+L/!Z313.5?L2\JU6O/1/^HE!?CGUS9- P)&E1!F
M61)#'S]*H WEBY4US@_.^12R#*"J&[:O1'T@?*K+T!NLN=48H[1G%E_L8$&,
M5(K^*B 6>U&NO<V$AWBW74!!ZML:1#G8)%% VV#B@@Z%K#0M4&*8.A5W7P*U
MV0NG<YA4+*0XNZIUEH=%$WG^@?#I3A/3MD2;#999N"D_I<%:%$;>!Y[\$MOU
M^N0QRV<Q@YQ86_2<AP *'0!&0<06^@0CZ:=UOP.4-&)&]9^7$@1CM^B14ZE&
M8XN(GWZ1?\XGGJ+T[?I>B_T=\'ZZ:VG6:)9JSBT==.$&VSL\N ,T+P1!E=/I
M3=.C9\<)BO1IAYHRGNQ%$#UU6\Z.:848K>67W>>-/VC)9FT>VX;*C'#5X4D,
M*0' PUX<O+U=@/2\Z')Q '3^9EOXX3(Z5.GE\5E.]=@T,_T+U$\-KSC1VD1T
M_/G;^OL-M[K$,*MTJ_2B]O5D:R=P7T2OOG:@ :!!7L:(X\+&RZ=][."PKR6,
M!5WN;U?M*K/D\?F.1;-,R+;PTL:9CY6F&>/B1BM' .T2KVRU7@<,1:P0>C4F
M,V=CS?AC-+K\L@0))#-G'OBO0>?!=5HAJF!#\V()TGPF]D3VJO/)L*L% !8U
M,GV>K5D:A.YL;A3V<C$O9\ZJYMKG=*K 9?,JEW"VURJ\E-A[<.*43F"SW@@=
M*CO!G?2)QVLO94[GP&@?+$JR_K%AC?.!'C%;/SW""#F"7@8I:!/U#K"] \[3
M/#0<^KD+\%6;8H60GTFS?E,&  'Z:TW)Q[VJ\M5T;VYZ1&E:6I(/JL-F7I0T
M#M;6N:\IM3$'^ )09?6X.,-*<)%:RP2416AIX;LSQ%#8\H1W$[.:##F*,5'$
M:6<$0<>3J@/3P[DN9YK]\$LSZ%-FM?,<\7YV@L!;-?XM1/[^;=:J&1B9.Z:J
M@SO[:\F3JXIGDMS?"'!=_>74)!&''1U1Y5+"M*1"K182FJP@M!PX^M]S=LXW
M?91$/LR:B3Z_QV?JCTENFD?%I^_/,G D;+ZJMY.H6SVXO-L(<GK\0:Y?N-#8
M(KUN>$.G0IY^3+BB[UAN7W=AIO*I<*S\>MR>8?.R<I"G?@-%:5'Q'%E*BG]E
M]\-Z=%(+EHY4WA5_*0=_%'Z!1AE,-;OU82Y1ANF^]NEJHXYSU3N@4MM\)2-T
M-J'Z6FH5G7!W0$8H3\>_']LAX / &4X>;K<>K70OO;=;[/YIVNO^)<7: .4)
M7-EX"'O?',F5@2RQP$V;';D+HA78Q7B F-R?DTF_4OSHX4[:6]5CX<?YNZ[:
M:-Z-)';4:6@N*Y@LV)\C@T:F_:37J/"D\LDFIX["<S[5-'5G]0^!7!T_;OF%
M8S\-QS@#?2"M2@[Z0#KE,;I1_K$KK"D)]P'&8;^P645D *;?6).;P5B*U'19
M50\V<E7W@[[V3UF[X7)K#,_3%SRQ$[C'&E\4U)J-'E$B0I!:Z,!5?&Z<V4DQ
M0E*.JA@1;>M>9IF2#CWR.R/.U>L9*&=:1(*1D1L#%9CYOJK5<C1&C*5*IFWK
MWGEY[XYZKN,;E/W/%.H0KUJTX\-C\<W8V_G\!9#=[*""D=5X$3DF<6-;D>XI
MO8)#9<5*YPW-WW@?LX2I6AX!3[<PE)YT12-<-> YP)$/YLKKLE)K0K[C-TG*
M3E:H"<B5+0MSO@SM=)N,**)Z L/ZFTU*+>_!'^)%"<'WFY("^G\@&AJ4^V85
MT'G,9]%7E!)-;Y!C)^0\B[<)#K"-AXL.]EPGYZW_$'W31.C&2 L>5GB!MPMC
M0&U I",GU[K;NZ<0MM-!UNL#L(M*1GU\1[99NI9(EO!9#XAY:,(%,TU;K6Z"
M?<ZENRM0MIT>ZYR$?AD;& 80# O X^T-(M-!X[JMM:$PO>;M<OUGI/P)^@4=
MJ?[R^NOGRZ:IB2K:K]P8,[=P+XNZGBJ2%Y7N2L<$ --* W("ZP_]1:)0FC';
M00^WZINJQUPF.0>%6_3=\C_C?9/I-E.-S([HO$V-+#% #8/B9NM?:EU:)4OG
M5*\__;1BK2!.\<ECYIYQ6B=+I ?U<C1+>S#2 QF)W/K7[X\(??0,$5;?$KK[
M"1MYFTYQT.DIU-,%\J\_)M:(J?$/P%C,>") 3CY=X2ZK;>O6X>F:2>.:*%<S
M,)2I(/<^JP:5F#4[RH2?@J4-"I=T.KO*.\!H_ [8[LG/K79C?JN(W:(<.IMJ
M2%)9ZR^=HNW ,5N:$XQ O-A^CPD@G*O:0K+G-U$2(!'67"5Y':LU[4(]U!VL
MEZ<:Z]2&"GAA(UNZ\[4GO6-I[5] 27GX#K9&=;GJ60[U73]';8;@='RGY, 9
MY$VL#?&RLAO*U!FPTQ7G-X=!VA%?CR9NNQ.XO3?X8,7C% D^ZBIY*]OH]_;P
M]03WV4 _UD>K)TIN+!D?O^X3KY$[M%/@A+][K"_K>4Y)'DN##V)-RI%*M(DZ
M,X8VNM/1DV^%&S_<<)EU9VQ[>)E:O;&G8)U3JFGVGRH_8!PQ-<$Q7*M8OG\[
MTML]R0B1:FZV;,V+\7^P]]9A<2W=FO@F$"!(B$""0P($@@5W#<&#!M<$#>[0
M:./NFA#<O8.[!7<(TFAPA]!XX[_..?>[O^3,9W?NF7GFF3E_%$\W>[.+JEVU
MUKO>6G(#X&D;>WL\W2+TR,0.+W>B^I;*BGXY-?NXFBIB4+N6;H@W L#2Q^>Y
MYH';99M,XW469W;9X<8O8FH^8<EDW&&UBT=![>%NN3.:#Z%)MQU ;E _MG@'
M*NQ0$< =%1BU=>L+8F'8C?L\RG0MQ<(R5\83C52^F$^9\*7N58S$0>^)?'GW
MCOJ'6 +*E*QS:/"EY,2,ZKY?OR3CA2;9T?M82X#I!E"3X#]=,4"*+(02%+TC
MJB>44E%],G%-#@]1JXW-26>/*XUQD]=HCM<'WF)O^UN]B?%V;EG @L E$4;%
M^=VM5#C1;V-\T4:&I08/4*FK:;Y:42'5#+$54%>OUG<J" M8W>L$=0N44_LT
ML%(JBKD)YM XT&KP*HFU'KU%0ILEG@A7"*D,5+#23%%8G _6:(JCB5!^D3^U
M\PJ(4]<'%CZ;NZT3=.OW(*\1K\\P,"XVEWD?3)VV\IG1FRN%];:1+QQP\6^O
MR:C*)DB,EQQM5B=4?<R<'8G]AK18E>+EC[X"$W_6:+5P7619033 T!=?&LOS
M((TF_'4D$G%,K0&UX#?B$XPLY=K(16I7YN9'E8URTE6C%D<7F\6*VP.'KQDJ
MPT<)M)C.$O(WQ.P&;%-PX1%YFR]XMJ#5G!.E&LU3"S%8!Z^U'==>8NK?/J-<
ML$<#5/8Z4\^\$(@3?)6KHVMHZ)"OTV%LB#QD1V<A,9HO..Q$"4-[5G!?EC!8
M)O^]I6D3W_XSB'593_Z Z>/O'0:[&%B>."(QHX+,7#V=M,7-(0WB9M8Q'25;
MMT>Y'LRRA71WT;;G;\^2:1S+X"R*A9CH-<]@G$+#TWJ"U"G$UI]P+$1U$YBO
M$[0,TO7SO5O,7-1VK]BWIO9;?OARY5W5 R'L&6M:<6+2!F,@)&3D3CZ#^BXI
MQKZ;#OTH2;^'S''3>&TH<C4UEZ%  %IX)OZZM]O%$ED(>Y_5_:US2M49^_4P
M/:8S"0_5("?L&;O!Y?E&PTO&AGAHEV.46)[*UO-WD9^Y,7";2<_"P%C0+-#,
M%PV2SH@2,]LIRS&57O57W\Q"65XY)M>7=H[,5(K&&N9K]%+[J KG@&;:-3B2
M\?S\TU>F.^KUG)FK6#HBJ"2W9.R.=TAOP^0"'%)1)^?G-Z\=QG*T]]8E:MN+
M,CU;[&]5?I(T??7&E0B,[3 @K0L['I_(MSL)BM[/5)G,]T,/P)?GC3D;)POT
MX*V#S>Z;N)A+,:X%#)@%/;8.DUTE$G?LC1E"1O9)X;DB>CGJ)FA"59)@M2)"
MZ:^BRYQ*+T30]W!*U+FZ WS7]'1Z/"?7T)!]KK9:TY9A),O>>G"*%M4Q<I9,
M7KA3S":"+JJP+DBW]09XZ. XP6"_:^AWI&I7),W2F4]IOJKL\1TWCQ\T1+FR
M@+RCO-"$#3.J=5@RN[,^6K*S6\RHGZ)N^>1Y6"X(X, T*)D-7;9^UK@5'*0K
M_/)DC"8CN/]_MAS=GQ" ? .@FHJW7O-<\"^_TG_ [S<6[*%\5EKS0!7@\9:\
M)MY//+_5,+_TN&WS."1^PMZ019=;N:;:&) ", BDB6\!! 2 5]30MT,)=O #
MD,[2-[RZ,?N3,.D.,X%CF2()ZEYPK+>3 XGS%IU1[+&8R<'&4-9VMP?3MIYF
M'\,# MO/R/Q?PK*L^,B'Y%]^YUH.>#-DR7,#= E0-1U,KVO5R=%Q,0E&)2V7
M#-37.0UR'[.7+@H&\)1 7(GK_#+536"O,PQJQ<-6%7J4=.[B(#L*$=7TH,BG
M]Q6B,5K<W[P![A;G5L(>Q9%\,7<4C\7RB74F&-O?*L)9UA9EP=>K\N8B#WKJ
M_U/-'^1*@3++[VLA0AG!S_\*^?DKY.>OD)__*T)^6-EE&" $QEZ>24 6+TE1
M[:6UF!PT?4=,_,0H?=7J@NA[U^RWCS? <.DY5%F4-[C3*"&[\A/;X6?62"44
M_4I507_)EG-[DI[1_WQ\WC](U)=WBT15L7KDJ+!8;&.)"-0?B@14\=#T(%,N
M(*5(XATV![G)@)>2Y;_I1 ;6JC&,K3[1%=Z21=5L_@Q@?F/93X8&[WDBI8VF
MF[=:RG%O-NZ/1ZR@(=>RN;%F3FT3IH4HC%NP;=/ 1J7Y-HF8KK=0^6*VAQWX
MO39\G96G8K/=[[NV-F'5[QON4S80VC,$?0?6H7K&WNT> '%*RQ62B1EV6.PC
MQYXR= JU3,7V1:6W6"ERR(UZDV;?[H_2ORLKFZ@ 6:1KYQ-^$_<4W"N1LY6C
M3$HL1;P;*_^NRWX>N6O4KFOVV)65OF")?G@,:RL,(=% *^][[C^AG:1DR\MR
M1Z>\/TNL.E1YK#3<88<2*?= &BM88=D!JRCKK3>.O+AI]PW@*](F>,2X20:_
M38;0H;(/5U5P,^W6>D\05P3?(WX(6/$.'%Q/7XM=[DY5LI;S5UMM=CHY#=BG
MP@)!QM=^<Q0W )!Y RR9Z?S=@FU!8VLJZ%_Z83A!N@?R[((7AC= 1G3=D/?\
M(3%BCY)=*-8*_GPE"X862@$KR:75[JCK/-0;>.JM\[2V#6G6K8L"8C.*)@;!
M1I?]RG_>(+BTPRRZC*_#%46HR>9,H'1KMQ9*/;8H-)1&&K=SL,7!I(9Y!F%8
M+J<M8B15OA\Y.>WT$&'BNZRH#J;0C[^;N%3/-U79#C2*1>$69"GPQ>Y&,:#A
MH@A=RH@>JVW$Q@D@.Y"OB#C-0<@4%N6]8"C+T+)QN+2QG\7N<C"G^9+AZNE=
M'L/>TU6Y836X> YF,^Z &\PJO/>6B@S\8!4<:Y-BVV2L)TBLU(Q?O";W4&VV
M3.^.>;M-DWA_[XZ:/@1I]/!\?/[45W.6Q8.@"Q-^(6=BR9<K&I<AX]<P<3!I
MT7W1_-RHY_H[+[09.N#Q8/S=\*5JKJDJYH=WD4%WY7J+LC&M[W!AR0+K^) L
MO7C>0,7W!I)/HT0H,F\5Y48*DXB**N?;GW#K!OE&!$RG\+]##*)'5Q *N=38
M9Z@SV5Z\,/.V3'D5O8DGC(F/XJ?GPFP1"JPC)]UB78D_.=2>;;.P_+3^<8(K
MAMS2B N9VBM:7*-.XU70=W>*13[P%Y+TY=P3-[)S!K,6OE\-34B6^2[YYS+O
MP2D.82O"#D(#Q/X## Y )-MK>[C@[IDBA$0X0E@LS 4FEKTI785NI A!+;5W
MW?Q#@W6)=Y*=X18+;I\)'FG%_I-+S:L+UZVK H\1-U2+(=3HAN"1'O3K\:&X
MWPVP8C'2O'V.<X5?>=2(Y_0RMW2EF;!Y>5GH!K!=/^O00O,'KYB/@+>O?]PQ
M?VF* &5AR%=]J>MXUJ0$B.>5BR*>!T<\;[QMX9GN_:,!MV2T2]>.ZX5KY>,P
MMXPG\7.O'G;N2^-/[M?%&;YK12'U)4SDE\ISU6T=.L-[T;Q#CA@<+<\1SZ&@
M3\))ZB1TVBHEU>+QL^4>/N;0#,;%+98:KLVH) /CD<R&JL0MU_<E[UQ#W)OL
MI18:7/U5K;=8N FVU8>6#,7U3&DRLC)[FMAN@.+AYKF:&V!:N<^-_0>1G@.>
MT;W"/1Z[-+D!--/!]38W0$5A//Q'NDKDUXCMU'S^?#M#L(T%3+!+2C?\ICV%
MI&XT4)B5\<+)W"TZ7&D=#3BBQ-JE=()\2B9]3LBM#UIYJ3PR5OB<^)[PROU-
M765HZ*4:;$S#X9)P/.DY\>-0Q05RP'FVZGNCFC$7B5),GY)B7'( ^]AJJH;)
MY:TZ^J+4C<1H&4M.H(.46QJHZ4&J98BY_GR7B1;R\U0G1'RMY&-%K!6C$,1:
M@8$W.HJ+#?KW'-U9=23W8Y2-:D<K[!GOR\])8(052=)^X+=E?B8N]\%A=]OA
M\$5@901<@D_$M>#,0V-6,E:QY@F 4>\O-U"!M;#,W?%.4GMVPNHER=,SM@&]
MP6L)'<.JCT;WL[PP\;B1N?@,L/9'^7F@6> OFU;GC[NN46^ D[H5/MX%&=T.
M'K>$.OL).EP[?#4MJ:T9[T)'D4Y\E>9+6IR'X*'.J!O ZP%XO^ZK+/;6RS5-
M_!2F_9>@<D7OBQT&$TKK,_HF\(<B),K[!Z%D']9+0)OA=D?8RA6"]]2VI+0P
MG7T$.K Z>+B _>CL@.4Q57$PK+J=T#+9 6QCD_W!(MTY:XK/KRJ/<@&_BXNT
MLD-9/*[P"6^NH[LRUHA6*S%,*KKMYP/L;ZE:X#8&Y4K!VYJ4?M/2U&8J1O)I
M?JU"S),43U<.(SUR>5_!*[.V7'SC3ZOV<E^VNZ<XZX+<DM[!!!VMA;>4[**9
M6(=Z!TK";H![< J1_2<FC+NAJN+7.L7=DCAS6]8BUFEN+0OV': ;(+@!J0"D
M\<3^@&K5ZVWS^R"I6$J<IH9=E&BD'F*L2 F\WS,7]=@9_YZYZ,OB^&=K:W&T
M2/%%+4B[MMWKT4L&=T/[B<.YV?8'=.)O->FM*3OOWHI4>P#T>D7:*-]AVWDN
MRF[7$HCR]@B2V7 _7[( SBI=_PG\:=59]JN$=E(ZC5KI2OQ,:E>SQEEGDS_<
MR8H=XEF1E<S!2]&-*MS+6_Y\>5R-K+.DI/W-["8"QK6,G9TNJ5[&8LM=3X$W
MLDK*%ZHONP1W Z['2N3^P>^#P%@=;L:J^W37DM>Y-X!Y\Y$I0C4>/6Z'G%&?
M_^Y^DJ\K,"*]B/$I506:ZO;NAQ0:O6Z.04BA'AT?'??]@&M1.KGS:[FKQU3Z
M.$&$TOJ];B]^"$'$_.H.(Q8V)'M[+0+S!NB>R01#C\@0 '33I:X^PV3'6; S
MM3']BE'P)-FV&1N\DF:2>@)%/);?09?0XR3@Z,<F=^B]_'F3VUP3O%@6\(;$
M%FY-GTGE1"@6V MX_]CJE#? [WN=?;L0\AS^;EGS??$";!RNIL;\*,9X-;+\
M86DC$>7"$3\7U]P\/*1=18!XE*JN/N4^4U@BIF.,F6P;&6VXG&):Y%W6F(Y7
M,6NT#&IG>^WR'59+%AKH>A(9X0<&$B-"RO(K +#!/-V(N0 YWW6%6E1?CT-H
M1=&#,S-",4Z:?7G>5L'F!C-@YO$';O2?#ILH\8F-0[DC[=%@'69O)#ZV+;$*
M( 18/\[US VPR[,B0"*">\W_]>O[:%&L[WAC]PCTC=X,60N1GY"KZN[G7K\%
MG\S? "90:ACT6@H5 ?LLP$=O1L@6?>!#:87!\'P[>E*T1,HJY_@ET'(4E,M/
M>+YF?Y3V<36]0$!EB>X20P-4 &E<$>7;5A %EI>ON(K=4$:^H-\[DI'"R;.M
MID38BG7;HOM37K.(BI9X^2*[G>=K><+^T\X$Q L(,=^G*WS)/['K $:?$L%\
M.J2/H2F#;EYF0:24@H;U6"!93!*UJJ""-;=V7+7_VS-*>+G&T.4-, M&J+P,
M]@';MK8ZK43_=,;NA%5EA?BH"%&%V=31:&LD]D/^CG9H LOL;,^:'.M'*C>D
MVJ >+F*LF.DXJC$'' 4X0P2K]G%'\_5X 1B?+:)\F\.E0F&1,8-92I$8Z:D]
M_=54[ +R(,5>. ^9+R%BLL<'TV"[T0>VCV3.Y@FMN8;P[<@W<!:#H?"H;,;\
MA9"U+\Y5^KLVY:5(C@:UR_F36@"HAX3'=]5DUK%![C$L)?TJ;FF7]JB")M^Z
M8(_Y2X9@]XZL&%-1%S^:RUX3BVE?M<Q(9+KYIUKA-[4N&?=<WJZ]#F^XFWR9
M47%\I6?AI'1A?RA#[X^N$%J#;Q@FLHOLF=W&@2IP8LVJ4?--\F-N=@!<7TK;
MKOW<,7&1D'N-5*\>#YO0>Y"%&Z6@BGF>.+SR"">8&Q9>^;?8+P@/G#.;5=N4
MIRT /9!!_XG_!&6 6W@M?@2:UR%I8R.G9GF"PK #$3[!([-/ZN]":Y^(L$2R
MAN['J"MY[&<]"NC'2R<+<OCP5$(/ZH"^'/:R@&HY3YX+ $"WRKU0;G&C-O8M
M6@4R6%URWHV&RIZ'15KL]WKH$]@J00H\E=T_HP)TR48[$'VNPO)NP44ZJ.#&
MN[%F& )-TY9=(@!Q4W.RNZ[27J4V[^N#Z_D\C6GGCU,G0?'\DYTV,8,L@CP#
MRCLA*X?,3623VB8IZ*/%5F]!C+@2 T17J]@43-T[UN(DXB(#(*M@P16+"?#V
M.?@*?_RHT6UD*>*,R"'U_!J!:<38<9-GWO%';<VC-:\HUB-@QSI"]MA TQ!"
MYQ?HH^/S&R+07Z4]QUR$7,9<L5Y/(Z8/"DDUVWCAWWP@=S1T@9 (F3I5A;"/
MH[-CO\33-9E LAM^A-QY_&?('2311'$J//VH^0=:4D2@I4Z<JT>5AWO!7/N6
MB'>C>_@;D$MK0 BUI_$(H:;#!-ZHA*#L)V?%"[!-//D8E33'U_R$\G;DGL*0
M>Q'KGE1J>Q=_5+)9\9:&N1@1O^+WKQP6'4]JW[?RLWJ*\^'T(J2L+T3K!D@/
M4+P!6C8%X06[ @]!WE"9,<NC^IG<B-U.P;( P?I#U 7Q<@XE'.TT8U[A$Q?;
MY.0BFLYMNU7-3YLO& F7MG;7/^[721HP#GAY1<O* :I%EP2EM<&CRLW1CS0U
M8QZ(/-E\(O)LQQ6[Q3C'EI?817M\KC*L7$M[5M3JEKY]68VH5A)63)<BVK)H
M\7CC;MVLAI:H#?*Z>127 Q<7%T5X6G"04EUEL'QY[>H-\-,1JRWX%T&=^@\O
MF9 M1EZS;M BK"\$PCG@%;X!WFXT'QE4?L=;O $04'7%T>>Z=02\T6/& [Z?
M=<(J0 3N$?[:A% X&PD0DWWP91#/Z95/B>"1IFJ(&P="!_ADNR.LH9$7.C-+
M'PQK8/Z5*/<;RGK>\5"^S_[XH;,%0%.4X6F^SS1YEM%X RQ&7,;,L5YMW@!'
M=E!/U?I+^N:*&IAR8Q)KYNPTGS>H.8A3HK^6U)<41Q9]ZRYC2?OH[&Y>GL4>
M0\GE?+E6&V?,DV!=AC9SFW%-$O3NA4,M:*B;G<GB$RRQJ9*]9XJ;&-UY>,+(
MC,ZT. ,1L2OYQ"IW.#,X++M41:T%'L,SC2&FJ6\;R[5Y)*VK=HP/'XE3?X^I
M=(SIY%G/10-.Q]@FEF3X_QW"\W\=D]IQ^7P9C L*Z)AVCYTN:[O=WO&-:U>?
MKE+8UH?"&N6YUDI4TDKB2?#9<ONN<1IHT.22,Y^G!_> )*IEY),Z\KUNEG1U
M'J]0;Q9TBO@C=YRESA G@^89K!/.P,S^]M?[W;,K.;.17&C8H<9 %:O&(.?X
MTZ>[F?RW@E<0+\8()'[MW74#(!DA[&.:&\#OXR+9.2;9Y>U/-T!@T9FN7DEX
M6;#_Q!;1#!?C[KS;P\XRL4D*VM]/5+9,_RYKPO=K7#"$?+_K,JZ8Z&K;ZHK0
M#+JU7O:,]W-&,"W&W^XGHCY';$)[Z"#[D?W?(H;3O2YT*=;@/BY@P6&:C. ]
M ?L_A8F;YT/ EZ=-<0BQ@0#0&T\;[C8>MND>T&WJ'F^277O3A9# ,K]U@T,$
M112#:2!LYY[_Z*T51>"!N].+$?:B+\*D8BC4^6/D<"[)")X VH9;FRBN:I[;
MAS\K(]>Q.^32N?4&T(*>*8UC__1YE4SK1^YFKW\= _J_H?V!X<PJL>J:/Z R
M)3L90B@6!A-I>-2Q. ?KU70N7'<%E(RKH#,%$_XSR&P-PL>7H3S&5^X="'D>
M//1K+,+KID>_]SR,JR *$M_X9SVBI?XA;_J<P"^Q"',!<)S4_N:( \245W/]
M&43VW<Q%Z&7$M-R5O=454N'&]%G?K]^7VB\E3FV;%P5U1Q!3K+6>]>_PJ#_G
M3B__*0Y!)NC?B<%"TDIMKTFQ"IC.Z"+J%H]=H8U^6937OC\)2/)[/JOK?9YK
M;&W<JZ0Z7J'2--,]-'66^EQ!5V5$O.H QWA-'RY'!@MX[^H"-FX-!4/9BX-I
MBF1^(^Q3/:C /4*_N\,%2W6.'I%(JY35UXWNZJQH5)C1V]SZZG;Q^66X1.]A
MN)AP)XO8T,^>]]K&K59GX> 9G*M\;<X*1GVSWJX8SZSO@/%$D;KZK"GGL+KZ
MEU&MP1G],)?2&P!@D>0#[O"I?JT6(!N!6.JL;4M\3G'J/#.L$C-J:>FAH/9$
M6U2AK]AFX'CD_V7PV\0SBYW(5WG9GU$ED$N RP)^2.35QX %R)VN17Z2-),'
M9CV3DC:T><A<+:)</0J#K+.ERUR/^>06^W1QWP_DSM9WBMQY$L?318Z"'+&$
M3WG/E;0+Q7Q$7?O;6OS7KO[$;WYY<)>K8G8BQR"?>]%OSVR]PA6: ]]&Y%A;
M@PKB3ZM5HK1$+>S8F&=+>KYR8P2IHKSSO&A#@;G+N(NS,6L)4S[LC.YX&@N:
M$Z%[CD_N,W9?7?]+$PDRLO#7%@0V^Y$NHE+9-8,_57\M;]F$,AP_LB*\]?X]
M@_*'G@"))'_AI <QZ*X,>SJT4BF:]TO6C"9Q?B 3>7G$WCV):1?D(;X78/VL
MS3KUR,US]^ST!-)WU7X_2LIR(7/U7 YHY<>)'8F$TN,="@9S_PS"<N@$+H1'
MCB7;S_UC])U82EJI.NHD6FUE6827*??WI!ZL$F?:A</YA&%Q\_POYG_FR:X$
MC[3BYD6P5(;%4>Y3RG>F/V"3+RA !0![P#'C[P>C,%JY?N"V+SU4]4<G91BQ
M!:_^1MP<=1A/;O ()'"GRGTUMWAF.&E072TQ62+<*41L<)>_\&72:O_]L @:
M^"A6=@5WNZ6>7 6%!.XNEEL9DD 6W5M7,JG#>:Q(/O6,E>4K@?D?PLF=X6^S
MW?;S;$\73+X_-XI; QN;3,1[6/(-E;>4[G7:)*<9$P@F<XU5F%-CUB>8M0I0
M@(RV1??Q.JX[S3#/$M76J+D<SS[B(*/Q!I) :\F7OVW&B."U/Q#F,Z%G>2X>
M-L92%N6-SB],4J#/J&K3RRG>ZXN*3TY6[#+4^C[I6?7S,-_7;T7=FY]3./^H
MP 4Z):V<!W]YOMBO?X$LU77EW'6-EX_%K-E*?$\L2I305V+D94$>/H TC*1*
MFZ""^\[8YDA!U$!]99XP\+#B?HK4+&+/T:XV$48*D)NX'1\BK%=H\P"6ZCU)
ME/VL4HEL4D[YWEXQ=/)C%&5M0?%1ME36"U[9\O)#FS7WE-L1'JRAN[^MAO>Y
M[R<#B!"#Y=4=68(>T0TP&DU7WU_4C2GUZJU"(F@#;%)L@D<RRNG/K!1*4Z7'
M&2LNHD)"3+ LF82X-L2$N"A0B&W1^;?V_*)6]SV"HS)YW>L>30=+MEA+MNP
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M*7.(C?*,#>X"V&;-:$2SL4P1.HMPXH6<J'^Y,_$NL0+#C2$XG?RY20]%7:+
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M6#+V[=IECFW(%(#2Y6FSNBS23FS3.0]-#-[[]0ETHZ0%ONWN.L8Q%ANNN'!
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MZ_F(PA1U$U#0NT"WJT)2E2\+!(!^Q3FC/NCS=7;D<&JKE7PL^/)[:22_"GI
MG0HTISF)YK8H:'V/@.SQ$K#S+,%:O#,CX-Y[WX$')R6[5LI:C%J&< "K].6Q
M@N ,WID!XD\BKR^P9B1J2B6-4EU"H"74IQ-P@':2RPGUP2YPKQA6 306;3DY
MNDA^K8Z_CQ5YYJ9_L0<'%"J(TCG  ?=ZX0 ?.. X_P+C!*] ===N2'=_GP4.
M&"R# ^9!EU:6^T*(POM?"J+%JB4-'Y5JAH9TI_;E(\^<?VN)&71V],NSTN:Q
M$-;6D]I4'J+>]%M=P-5^T%XCK((;\DD<T9DU'  "GH_Z:!<;G,_=6U>3= SI
MN(EWYJA_<08'C.>DD\H 5[M!>^L(_M/'K$Z()YA.!:=9HD2Y8V'>&C 8Z#@_
MMV,8-!@*FF^%$<+R-4H::J0;UURY-<B\'6C@@ 04.* Q!'HWMU,%P70 :'X$
M1NBC6&7HXQH":D[-)FI+IY(#KE&EGQ[! 4'<D'-E.. ^XK$Q%WKW4K'*KDNT
M7J)Q86 I=#&R#4,:VAH+@Z6#<])?J$2>A3!>7@(7E3;5+GR9]/5;X0"^A8'=
MT(7(-EE$/=5?ZXV /O, ][[" 9BBF?I52T&7[T)@=LVIET3KZTL/6V&&+Q'2
M1T)4E=KR0Z"M!# X@!J<>XP)!_1"WH$L%AN3P>;OE/5<?>\\ JX14U_"@(N(
M2 J+U^[\>N?W%Y4OTU_ ]-O13N+)SQI1/=F(UO7!'\T00%87= I!"$3]4PFX
M#94^@#$!RTOF^R%<0Q;%B-@L*)GO\MHR0N!.*-//)=A@&XA]*?!"'@<Z'RAR
M*_2P&*+U$?3Y'O ""FJ)_/'YJMFK9J^:O6KVJMFK9O]VLT+4!'> AUB1OS@[
MO)>JU&?!C-]<F_PF2>0J]#'(TO!7OX< (5BT=N>HW_^J2(V?@W!E5K]X<*E&
MNW:\"VD\1.="YRP!U/@,P$,<I8MS4$N*Z&TYT!K%+PZ=/6]B!_(6]ODW[[PH
MW8:A]*L7S\6C1E3\U?.SYVOLG.%M'0$1/3M(.M!UEJ6?A>1^<_"*B$![4_\,
M_+WQR/SQ;6#QXST(5WE&=?-R(AZTFO$2BJA$Q8> (PBG3PW./I:;"SF>IH0#
MN$HS:I"6M8#K[;_ E]?N Q((P"/_"^!I^*!1XN,8Z52440.$/$*@RG0&A&;3
M+ZWL][U#8+H3WZ!-WGFA7NOY'-4W5+3<7D9]YO0+HE*D8G%"M/3J5YSFHYUK
M>&F5X)234?-N*0%XL-%X.H_H+T48P?OAYB^%A+%-5^IQ2S=!098T*H9O;W_X
M]>W6-EO0ZM1W2$;5DFMPWBZZ=DD4(/Q@'?8T 7:!",94@QLZ84\[+X\1>"Q[
MFW'2]TNZDV-H.]D6]9G;+\ RA:<2>- $FG_B17I"717B9!3:1=9+_1V(VH]-
M(M ,/J(OE1.5;:IIRGYMEOM6A7" , *N*I(E4Y^9  7U!B1.2A$0=S\O%H%C
M0]85B5<0+W&<#77?OI!)R'MO=)2^0)W*_S06BGR8W=4Y\.J)FH.C$AA6GN$(
M"CG.[FE-)!A2QFB<RL7@FGZ%N^%#Z+<6']5WE4O@*I? ?RM=Y1+X7Y=+8.01
MS?F3<M7J @UF'YS['SRI>PJ'E-XH,MP,OQPY4\4$GNH<%)+=/7P5U<O1>$I^
MD$.R EOV52N6!%JPFQF]R8(#TFS.5+%50(-\<$"#@NV0TG1#VP71['H?)R*Z
M_/[;_69VZ 'H8F5"6A+X[ )K\MXZIT$RS -X>6 9_,7N;)GQ\L Z/R.]RB?H
MV&5VI;\.8:([E"Y61G#*$4\M2A<+$_J2P +1MDLM-_X1:X1%$4;XA0:<^].S
MH$$,T%[@TT)"6-D%UN:'FM9D^?2STP08A+O5$F'010\0$3EJ[:>[EY8GQ*,3
M3OZ\;OJ'.WR78,O@@2V8#\)Y-IK5HX86%S:TG,?L>DR5?4+X',O&O:D<<I;&
ML^-DV&72D>?=2P?$RQI._0KA\]#S03C M__^I!YH$"'YZ?9$SI#25G$I\''D
M(97>,W;@^C#HX@34\L;Y8O[LL!K1OCF4970C]WA]4G]J'V;<HZ-4C^A"*/+B
M:'[QD:#+*?1L%C2/X /S..GNI:]^#_LVPC=PK-CDS(,&XSHOS^W .92\< #,
MNPBT-P(*\KPDA /*&: 9L#Y$AX+.O7# V?ZW[(P*,,+6'"OJPV6$U+[)4)8I
MB]S+;/95QHM[P#[WFN%CO+-]A&R-;(AJV9O4AXN(L>6K V69WLB]S&5?)3YY
M GJS3Y!M!?SM+W=#9$=!&]2_5IM%M);_K=I#T!OPQZQ-_2.\VE]:F]\.EX?Y
MGX).5QM;ZJ=#0=-E,&60<>=9) :L:[1Q@]KM>P-,/Q98YO(R+]2_B>H.XE@$
M3I$E7"+OP@%[O: @ZA\+7A6$(*O>,XD+*NH^=Z43J6S$++AHO#B87Y3^L:"W
M(TF-Z/4QK#/DD(K@,CH?]%ET#P:M@BC_\*Q1JRQ]4M#X&EBZ".U$6&D3J_\0
M ?1#@6AW5/GR _LJWA5O5[Q=\7;%VQ5O?S=OM[A3_^(*TGYYUO_N%CI"@14,
MT$Q8%\)ET7 72L.\[S5^ZT384CL2"GD*FH]'^+^3GKL@R]XSZ<M8ZC5A34O/
MD+_\)<HR"5&817CR[_6T$?7DS^1@/8C6^+E_<(!$-"-V<,!ZSSKLD@^B43PD
M?R&EWP/<KO[F3R44&A!NER7]F]M5P1&\@'GO K_[TWXBX/1-F#(<8(;P64QD
M+GM_<<CN(WN@]8%EV"4UN/A)1F3Q-]Y2$;Q5:_[F^Q$QLO!?"A.YRJH(+U^\
M#4'TMQ;0L0?S,?\&+])8;1%,C2-0@?4P4_;QQ"3H&U1P9BWZ]JO=Q8F5N#G"
MR8J.@.8_Z@5*LA>)MIZ'[MK3_@I/&G#XM741,*JN\;2YZ"!47\<GY)AG=C$H
M>Q!Z@1#=F\R] B%?VLWO,,?JKH_E"<OFJYH.+)W(LT5V!,Q9F@:=+3)>@JU+
M,A+&]0TOU=P$.&R T/U8V!GWHAW?]P>>,67Y+;P26$%M2E> W=DJ HU9MF"
MUA'(<_[.)[F[7FZ3((VG ^X2OX"XD3;.7Z&>G;+\=$.[%]%L&[XL I/-'.2C
MJ( <&IDG,A+*J<N>]I4B<"NB:"\-V_)5RY94XK],?$@'<H8] 1<BD*7:I[M.
M>%$%A.=D4<A?58;D5C6M1O(R_EB(BFZ[^ZZD+.U@]40<Q88UC+"22$JV:04L
MI!%A!0<05=2K?*7YO -K":?1[&CF'HZ1048A(NV!OB6(;B7;$+V_.:*]<:*M
M:_UB+S5-H^NB-.ZVO;2KJ0"*L9E _Q.(Q.+&(V*RRS[RG$-LWF"9KDG V9PL
MO\!<%8U#1; ';7FHG'!?\(RK]!V78JJOG+-63KV%387I'+OOG#!W#8=TG^G9
MHP*V_">(9MW)EY1.*EHL/9<E*6=V=+R"R-6-_7A+-BC2I.[CV@/XT899UMF)
MO[(LIA//:6MB);O3FL2/3;TPP SNX5-!-D&>6-V4X9$;&6YQB\@=4E4@JKNI
M)/SRYTN\M]K9H>9+Q:1;!)KN7CN\)\/WC*O\WLL0*;K5U1$Q^MDW.1*GK-;?
M.3EX*K\8U[[3\C9I7<K2Y D*D]GS& !]BLGY! %8CR1I7?M-1_ 3&6439C[F
M4D<Q$7_F&JK6X1SF[M)Z;2EA*N;]2'^7ZQ_'$G>]VPEX*K:7S)AU2&^B&C4Z
M^*WXQ[@FG<S(Y]D5+-16^8"5R'K)#<)[6FD6#OA%MOI%N72DQCTEAVHDXP48
MPFT&^/@-LJK7,[8!^U#C7-_(Q1?(B[N)D7M*<$!FVDNM=IE;$1T3+RIF]'$M
MJLC">^\HRX3RVN18WG=]NY"2XDF!G>8W\0;""R*$-+9+J%:/LAN-W'XC:W\[
M-3.$QM3HX0K^J2.P-B4E.F7P%B1TN;.!H7R$.Y:CC!.]<-G^0==*2E\/JEAG
MD5P>(S(KRZ2WT#MMB)-DU4AA'&<H=AGS#I>L?\T@_<KRZ(*!\[7(8-%GHG>^
M;21-_#'<OMH@>[5!]FJ#[-4&V?]#](<VR.X#PSA[O'4L\>/ZY(W"2N.%U,)B
MKHEM*Q(S3GIJ^(#;UA=WWX"FT[]=E>YQVH&,\-VI")B3YPTZY]0^H@ZFH\9S
M'CS-A0.&!K5[%Z2LE\R?ZM'M^\$![:;/1+@A@["'\?6?ZB26 7! Z,#L^=?]
M2.A+-F;0C?72:0A5TZ8^^O+(N#[]G(0;>JSM3M!*E#DI:8>G6=V,]%B%?H@>
M0[76#IE27$;\W-22[&L.+-J; J2JP<SNK*A<T5O4.$8QU"'GVKWD'9W]!D59
M-W,TF'V?WQ#?12\*O5 L'5W4M-O>V5U2_Y(O+$\;W$P*B*AF/,Q,ZL^Y]4DZ
M"!+9)IC>IB#5@<5&%"]O8A#5LJ;>6Q;0-PE@1^<40XY1$G:FXAUC@[(LZNA?
M_QI+U[UJ=/+0%=LO:CTLQ>-Y*;-L2XHQ-HXKC&;4>? :Q&QIJ:?GRU2648G$
M]6KTPS@A^>N=)+JQT2T+3OYZ#N#3EGEPG#6QYW@IF>Y45M\P*@U&$0:N! T)
M2W WQ349BK#0K!&-C><C,_D34 %PC[NU1++F&-K4[B[='$TU9KI9D*QP6B8=
M]A0=R6,Q9NO2D>-P+O5#X,<*<J%!%BKSJ74M7G/^@6&'%.JNB1!=72M] F]K
M0GFZK.LI8F1<E>.XV6^N^1H!N@=9GYA@&RD1N7->-'TPS=.QBI%?DQFZS" Z
M(+O#TH0B8)?H=B BL'F7?V[S^#H+VZV0>F7=O0!AQ%S%8 QFVUVQF5"FIEV/
M/+-X:W*$O'9=)P)UV[4H]*/5-!G"L\E<2]HMS10J45..Z;,'Y*HIJ+=9)2FL
M!LH8$]^ODVP:F&LE;0=03R>!H'# - +-?DO^":S@1H0,< #"D33VPGC6@> <
M-H2)YF.'(4?"F",AJK?@@"/R!(2AZT0,.PV+TSL'VV;NPVL8OLP6A]+"=C<K
M*I_JWN"X/<BS!?RYY</TOWI9&GKW%>@<!X'3_9:_)4;T+F1[6),@,=3X$PO<
M("M+.. 0#OBVZR<!:CT 6GRD@["WMOI0-&JH&O5/_.4,[0KUEF[,_Q&9)#-G
MV>]U9O[<K05L= 01D< F8'  .V0B!0YH>5.%,+ZSC1!<(.0]\">>;D7:U]52
MO;R3GWMF TNU1DS^7E,$&V=;GB /D. 1]>_KH2B4*%/NTM9C$HK<X3@W/0%5
M$OV2_D5_(/SKY2ITZ_/OB5]UON)%!3K!.X4#\"",Z79*>^SK4D>P YC+QN_+
M+#U!-PDL 35"0,W"%]^YY,L]33@L%D?$<!R(J%&\!@2F .T_ ?TDM6@-5?-E
MX"4<T K#6)\9N>@]&ZH'UC6F>N+]+%$FC+"]\1(5\2F:'!!&2/FXZP1OFWH/
M1@W^^T6++)(N 2%\+0@,!P1XG'P3ROF[?'J!WS+#S\,"'>& !02L7,K[*YY]
M'$4"+] NX( 0*,%@U3>Q,O^N[Y"Y%;U-/0F<AP(7TGR^RT7^3<2)M[_[[:EU
M(PU@S8A1L@@'H!SN?!-LX[N,]6A_I86_9AOQ[="N/MW_[4]WJH1KI7YWL9!#
M[V1*4[L#G3./9H?JN /T.UP;:Y=;945LX^J"8QP53T7(+U0186'ZA?X%M'%9
M^B0' 1* )XVG9Z".NO7?E^)#TM"NIUN"\1^QOZ^DJ_6>1DK]9"R'+O,14&3P
MLO@2IK]?+/"[PY*-:M'#]0_(D%?N%;0Z>62WHP"$@79 >P=P0#CU/^:&,H9V
MB?_EE*"EQSCZS 2<5O;2R[9OG,LO0XT^G:UZ2]?M=V>KJMS=+RN]B3D%[E_P
MLDE$X[;3?W<X/@5JOD2\BG!5[OMUU'+W?5BF@+\WK0L> LO@@+J_KW'I<5KJ
M*= 783NTX3!JN1.EOS6!\?&V&_>H^ *_2N%E>S'^#:/T(N1$_S22O/DH$VVX
M/O9O3=8VB0OVB\[PA7/EP*]ZW7_+!!G=ODRX7.X ^S U'Q6;_+Y1+;T!ZX7M
M+[N+OC8XURC[O5E+K?D"=*7H?P=%BZ!.J(ZT9]',ZR"O%D,K]94*Y?^!N;Y:
M[I7VWG';D^]'*Q?YH_GR&/S];V)Q2OGO:/&NS/Z5$JZ4<*6$*R5<*>%*"?^Z
M2N 9@&P]+DMHKOI*N5I;<P#^P$0/V_?92OY=8?(<.^0T)@?**>4<<^=X3O^!
M&-WUTE$D$NO_U)K U7+.U:?[-_IT^D,,X3R7 DF2F/<RZ&.;R(-<]7]7J[++
MM&.AP9*]#/=\ZAH7TL)_M)F9/YI#/:??ET&MU>)4Y.)?Y;\#_[P<3[1%6@[^
M6,2(]>^B!2U(C9>UTR+Z3:PWIJ#*V],QJ/S3L+@ES;\9O.N,?"!AH2 )(R@4
M==W^^^)]C>,7;Z[6;/XMUFRN%/W/*]H>B+<BX^V2+<ORGK9KRHP?><7V^(CQ
M'_I' UE,V-RNZV*>(+Z#]A\QZ*F9LU__!4UI>411Z$9S7+ $<I2D!^CG!HJE
M1UB#D[.U)D,XL2QNWE@Q=AU#YH?>Y?[$D7,>GY<1&OV?;6C[P_>=7M'O[+#Z
M8^GJD1!?G'2'WIJ2]H@3W3A>1DM6Z)5@,,E)FTUZ2X'W[?'Q=:F:H=4$+FT9
MDY>X0Q<Y6V&.]A<OZ1WJ/;:%^C44JL:Y/Z0*?G7":3,E\</0/3*,DA)O1J.X
MP=+F0AT"8P:OCCS5S*K"(N:8L]Q]Z'=38Q>YCA?OMB- 1!''^E:*AQ;NUSFJ
M8WU!R(P*;&Z_\&C<AJ?/3#)@CO LN=*O.NR:(ZD_#6[MQ[ D[Y,T_C&CX);-
M^3:"EAEC_('89W;I]O=T H,%9N< %'ZH0GO(4!Y83[6"ZE/-[-H'Q7:VN8XM
MDVA.5$'-"\8TQC2Q 84,.#H$=>5"<W?:OB;Q1*29'BH4UMDG\N[,5SQ8)^4?
M$#0KZ&5U!=>-R$2WDR6XN2*I2=/'>&+Z>(2TVVBHQ7@IX6AI"4?I=:[?BN#<
M$Z(C*)4"AEB5=BC1O;V88G#5<95F]' ![?-U?$7!X[Y5&(TIQ_?*PH_\3= R
M?<1ZOMJ<'XZ7;UR.SL:T6E&J%0=.G2%A%-(S%V,_U"5'V4[Z6-W35L1<I\:V
M""J*M<UV"ZZYIM#SEJ!4VA9IG70E3>;:I^G\GG.V(**Q-$IPJ$7F?MC[@PSN
M2A5ZPS?7=FK(D4<7-9<_4\OM-+#59T!XKO<I'E1,8YFIML@&TZ=)DR-'0*,[
M'3HA@4V"\\$N@>\A5J1IPZ3(,Y>I?;$2IU*8RZR<???Y3,7GYGD&$O:1._KB
M/[WX=*/)#;7AN8Y4@7ASDYCF?IC?Y-PD697Y/>NHHKB(UH5%M):$)M=1"NJ+
M8TI/2G,+P8?:N$'FV2TS\5]$"B!T7E1:);(=FK%A^RGJX::,;DX/"_XC6] 5
M7=$?HZO,_?^M]-^<N?^*KNB/T-^3D>Z*_FG;RB4!!T0* +?R80_*MWXL?"UE
MNU+P%?U/TY7S_^^UKE?._XK^=>G*^?^WVM;_/<[_@_Z\SM=XSB]/.61H 1\!
MB@*=XL<%>!!-/0HX(+T&N-<+!P3I6O9HM^MVY-"&,UK%R)Y]S,NH ?U<@QI<
M4B< !P =0?,)< "F;T?NP4=@T6+C^M+%T*BR;B.4E1T7-#B;?KH*![1$_OPN
M%:)RR?DN.<R7O9Y2D@CQ4TL+>!UZV0T'^.I_3Q\8M#AX=A$+@S9"E+>M0"QX
M_U7#E4>%VH-:'R^>O@Y:G-5@D#L0";^KFJ(V?2_M3KAT+\8=:*)K*%,>W_^O
M<XV%2W?B: ]7BV$MET42JXM6)4]GC28M<))L'0Y8M(0HP4#9<$"3&T)IV1@B
M*IQQ5O:NKV/,S24=TL'E4$:$2H?A@ 6A[RK^N0PT%VV[-(L\+*[;WBCB@MU*
M?PX'K)_K0]% X,R?2U.#)3Y_L&+1!Z6&JM%MFOH*(["B_] +.IH+,D5.G8Q%
M]92YC!'6(4FB._[_TUG5_HT)]8>CN1]^P&U/)K]=X1#\/WU3Q_]V,K, [:\S
M7KH N]13?WSF92CY5U*O@?L,[.&.]&4['/ YR-W%*S*\<45Q%#2K?XFN$:*1
M&P"ASC](/+UH\P&J(ZJ[4M'\]A\*C1(H+\+=/P)-N,'BEL>V@3B-*ZK4QW-P
M0+;C,C#8\XSQ8J([U8=064_Y>/'[D"-ZM;2C=:2$L:G]_-$6M_W.RVBU4)DV
M6E[R .3[C)-4>'*WWJHE=\*(*QMC>GS4:-,$'MVCNDNDYC_MV.[JA^>]W.#P
ME,&[_DXXZ-9+W"+P]9&<Q,*A091JT@W/?'(_.N%,Y BN(^#S"HUQZ-V<S9M<
MY<,/;JF[8&I+,CPMX0>4Q8B\6' N9$2II.5L6/8V+'AJ(4I4/[H]?JLZQ&R(
M,U[QZ9.5:W@/O(86+HVV],"%\;GN)85M,Z?H3][;;V<"8CR1ON1YR\$!,:!\
M.&"&_9+LM3?/MU(.:$;_DNR85[>*\G*+L'&1??2;"4;X#:[5*3C ' [PZK7C
MNY1./*TRW@-]'#DL6JK+A=DB0^& P4+/BINRFK1[]AFA/;7[=Z*-"V<L)C0"
M6"[B<+"?A0>C1(D^LT&)H[GFJ"@B*2M52!14X-[9>H[35#7JPK2<<AR.GV6Z
M0/V&AL$1G8Y_T*HJ<^M<O='6?'C/J%KMHH>34H#&5C58=X>_B[23<+ME+8ZP
M.R=T&H,Q[4DHR6AMUS:1FE@W?9H?[G&_+E02G)K=VWRG).QKV!NCF"<"I(MQ
M<FGUD148?"6ZFTP%.]1ZP\<7QJ()7I0M[%^0;X_$H*[RFP[@<J(ZM)NX;[6Y
M:A.'%"TD'>A8S_3*CO>U16AV$2!C9ZX*F*Y$GRO;/",6# W>W20GO[MW3]_D
MAM1P%X31*J^;GR(-S6I?/UB484B8XS+_,M?AQ*[<0U2OB_+49CZ].I=D5O!\
MHG!J_BL5Z^<U:ZWXW99%/0RQV1 4P]>!P:J!V_;BE.*Y3 >EC,YF$//.)*70
M8K./'T-W29<C^Z?L0_GNB=$3T=O+'7?J<0T(>A[NA6AK/']77U\'WLWT 0D^
M+)4YE>E>_7#3'K4-C4%@*SPSQV,O)XG%@C[-0X7)6&6/KD1-#9D^QA,@-!Q7
M_):M@EK2\50?WYO1TA$L6T GN'R')"M.4<K=1"6WV%@GR?:#88%6X9=4%Z(^
MG,@DKM1<P&*(&C]=8 "7Y)NGQ$P%<]9Z(]Y"9@F>V<T!:%$/"VC=>F\HWG^;
MYC?BPHZ_,2WYW*UJ.@Q_IN?=DL%,WWN'GNO=AH>X8L(41QE];CQ,!6QT';Y4
M$[;AE>GYG0R=X+:-(2ZP4@\%SB2F;(?#E\(MSY/DQ1GNVK%[V#>$ Q@,";KC
M:5(,Q44(A\R(N?.*TV'D6R=DQ"^*>-BL5I>YICF%^\E[]N@$.08^RS*BQ%A/
M'RGA?Q6E"]9R_M!L7WI?"TE*2L6#5!VP<!@81D$MH:AL$<>25*Y^JW@9B&>A
M\6#F\>ARA.\^+7=!"O(A"IJMQ#6NL)/<KZ+W/O-T:AY=JF PF#&5-!A'OR"/
MP/<SXA@0ZT3[//QQUHTW#Q&BWA<V7N)8!.')^^:5Z7*A%RY[[YB+5F\#C&?X
M.\1I(]&LDHHJ%C>.*;71:6+<V# ?1#1^6K@F0=!-$QV!&<>S-D]D9S(N_-0T
M8XI6@:<,?>R^6MU7&2%Y7E1T_(4C4@'1M'9+:YSPE%OQW67H=)J9NK$53PRP
MTY20ZW740QF$RJQ8[@K+9G4O87#CNZ/FDNW>Y^1<L<%IQ:^(0.='23'_/,8F
MW^E+.FQ'-KRG%J98,ULJ=;!#$R7.A(YRPQ&/-J?/35I24G6$QQK'K-_V:*NZ
MR(#_>N:S'7KDBA"U9_A1]E(>1(Z_9$GZ6.'C)?_9@,#*K52'Q6?,.-Y73.B)
M224?]H)#FE7QJV(>(3PL?=T-<-VG@"#->/Y'!7S\*LU2CF+T1W01XD0KGP8#
M>/*X%33:OM"F8+4HQ],LSJ5F/6'H.A/#^GQ7&/_4=6'4*&VENZ)T.XFW)M?Z
M)-(E1]<#G!5\QR:LV@"I@P3Y<^A0L0@$@>AH4]<O08VP5Q&?[$@V#S?T;H[R
M8!DF+HN5ID3&I0:@KMQPJ.6G2S$*KM^ZG9O=\X5F?RUHL3N[\E.:;#&=FK&U
M'=5Z*Y4 _V.' 2SD"*^PST,P)G<GM6H+DQ@?@<:@XH ,/I3T1$W_,! ^I127
MKGEK,=J4>P:;M-IXZUQN\BISXIQF=ZM0*0D]M#>PMM;$F>?=\A[ PI,OF'Z,
MNWJEW,M<8</4 ^7=G"J:UTUT^AO2U30K^+JE]2_K"IW&M@:@DOMHRN")\ G%
M^O(*,MF#^?Y64N$<$O,SV8UFR$QL%65SOB^!M4*>N]5304NW_MPN?'%LF:":
M1['-*X)^@M>1*;ETEF^EKF^XD@44](V/O)DQZ&'F7TV.$#41PW4X-*[.BLLV
MXSWZ)$(;NE:']*&W ,+9L;3DG+1V_W.?6B_ODRB^E=CJHG&!K5H1'.<*-JW)
M;Q>NT@CO+;-#0V^E'\/2S^_)@3=/J<,:#YBT01/GH(T:EM8/C7A@:N ;.(!Z
M!5'[F?U?-EOXL"U$GMWD!IV?:)_E-,2#I:$OR8"77FQ.1KZ$GA[Z^PP;=@C
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M5GZICF<"F2G.Q0[%J$>GHR+0=-4$I0B?BD,,/+UGQJPTQ!= 7WY)G .G+-D
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MF)K?CZT*@0>V6"3F*%A3.H(4(I9@.6R^J1:]3U9G76_7V[X>*TXT#;;E?]U
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MA\B%]UDLO-KM3VY^_,\Z_:LOF&3'^+BLK+*U1=S0U,$[#)D?KMHY5?W].,^
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MLG<%E.PL%77TIBJPFNC&++!ZTV(CJ565&ZEO9\/[R#0S")@?LS<Q9(R<70
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MA3KZ.IZA)DVIR)[@A[E6@PAU?"*TH* X$/Z,YZHDC"(J-><\P=KD9EK'-\9
MCG?2;OVF=]BY2X1I3?@I-%/[1SZQJA<!^TTUPO#5&VZC&_N ZRR&L39M,HUJ
M[^]X*CHD_]5/"_V-O_&?";RJ*S_.Z=]ZJW:"<QAM#3]G\-#K1145?R+1TR*Z
M;%3/_DN'UAWEAX?YI\]TX\.W1R"GYI7O9D?+&52$_V@^JN.?6KFPUK.J_C2L
M&NI)NMC#-_%&R?5 -%3G7L#"@O(S/7+>$?F@W/GCJBIJ\PUP2R18=1F)'W )
M%+BN4/^G:?T'35'V_[XI:B9-8G9O 26/-QE,MV_FY'R];XK9"O' R8S!I%C&
MSWN:R_M'0&:>QXCM3D:QL?.B8?=/_K-D<Z=,>Q!Q[WWY"1XP:ARU@;H5S!W%
ML$ M'86O(=X+8 >B_]4W)O7?8>@$<QCXG5I7LJR_K"?2#_F*J[VM.A=[!S#F
MF@9J93IS8G,DB5!$6:VL*1AH7\[ M0UIUI_<"DI1RY+KU_O.=*7P;M+O5(MN
M;+A'O#\7?\(I60&GP1A:9ZVDSE#@96+8Z+[-+$/)5%$2?D<HGHJJ2@Y!2$%?
M*?E;\M?#0G.3/W=9OLFU-;2>(@D("(A<V+S]M^E8Q)3I^&)#PR$?MQ)=)0]L
MX;+=(-UW?:.00=./%QS_8^M4>V:OIK0F'F;_ZJVKO VP##)=R;0@#1IV%&-L
MPN30ZR-[(9TH2?+I'[>F$ $(WQ @.5* I(>%38#M]5+JM[75;KXA3I!FW^BH
M,(4X#WE<!KBH_]O!M>9B(I>#Z7_;0UK@2:K=:90S ,4*F%HOY)!AA76R111\
MRN/CTJA4OY#5]G/1-4E$OQ9YY:Q W(IR,N*YCL^9?6"9%I;$PTH_K4_^:<F?
M\(PIB_)#9U?4]9%B8_8IF9?:!&)C9$AB4\1HWP]PE\%_[U=D3,TK.$AO2?M3
M5*)KZ.6U<OV%0.'KL%,KF072147COQD0Q2\NI.# I?&W?S+8BHMU@*ZK77K(
M&9L3@%(YG>C^\XGXGZW6DYES$IFT!/-3Q5*'\: FYH=J*+,#2+E(3:)_Y<:U
M?HM^+;\-@ BZ%>VEY+"=O&#.X(J!.O)/@W:U+'-1)#$UO\D@X] J#^?A<BN7
MEZ, @"O@GF]ITAHL2Q]+%R7% &L/TU1EEP"54C]M@&KMTT28)A^FYZN8[]>\
M<BR"P)LQ4"'Q:<X P8Y_NNQ($Q3K6E'ET$_XVR^I8&T4)]&@.8SQ<'FF#",H
MFRLF<;%EOSBK"6E,F&,G ,?38Z"Y7=>37JWM19JH320-O4O#GTT&*&G=4I.2
M5=%1-C=L/:ZCS/+B0).7CKV>0^LU5Y<TD5G]R9(EJ03QZ-YWAO*?QY&[3X<O
MMT#T3F+VE]P@)"P9[,%8W7M#<$#S;(Q_#!23/-)E^1_=TZIYIU#WG4J;!X/)
MIC6E)>*46@>/%W4:57@K9[I*1?P%1 >RK%O4E-7(NWB05?<V",?9V1&$E*0$
M5?O?X)+9O_$W_C.!GUSN&3RBU+@ $8KV.N.^TV$U;7A9FHS>T4:6 F*:%HO0
M;/),&RPP9HOB$3L^8E%IXK=[!.;-GKBK:]VM32H$P033H:E-G'_KQ\_\ZL'U
M>)GSGNAYH]GA/!_K=-T)MVL;MU3?R&D$4C2,),7MH&SU!_)GW]>;8AOT-_2E
M'! _<C?P2Q'S$]/'R2'!:C(;9XU+)LR\=OP$?Q]]2*>_$TOA5U:1#P,\!C*W
M.,$" NLAI_Y\?CS"E*7DAD+A=:_PA^H0Q>5+5=NH3#G49LA<13 ^VPX1&^#Q
M&)%EL!%8>=.EIK/-*\<1:_XDAJM[F#$#:FUORVSWB*Z.#!2ZUILV,ZY](HHO
M"CGD=EOMX@3+1MZ*,/TL,"LU.%2!+.L<<G2FAE;EIDP(B6NL-&>5DNO=A*,+
MK,G07AYNHE4W"AP[J+VO;VOID"!N]RK!C42P$N[$">J=.6<SVAFV&D=CBN+L
M$/RC-D@@Z%=</+NF-^-5 AESH?N2]>Z+QOKHCU(!0Z?[MPWW;#M72U=.I8:0
MXM3Z=;_T=;,<:I= Z?ZW/Y);/UJDB(5G^K[GQ847J#U,UW\G50O;_,.KG7,C
M3YG:9I=+0#5\I_<9*0Y;\?_B[2W#HFR[MN%!4EI"&!E"&4#I9NB2$NGNE)#N
MH4,!@:$E)*5!NKL;I+MA!J132B5>\+KS>9[KNI_M^][O^\%/S@V.\USKV/=]
MK;4O]U1.3<N3.7UHNGQ+PP1MR,W(ACP1D?*:'_G1)@0[<5C>S; :U>I=?-ZX
MLY*$J59D!C1/\I@E_3K6=89"1(76"'I^,"QT KN>&*]AZ&_!]/UJ=[W@>UV@
M%W<1627(H=LT7OV0IB9FBGC>7$3IPJ8C7UDS/05DLT5Z2JP<GAI-KZV7*DC<
MKN.E=[0X02_[.,,ZF#\GGI@^$;A.S7:^2E&]/&Y9W)/DB4H<#5<@T(0:O":9
M@:M+14D\$6O\-!M@SRZR17HBI:"+>;P2O,Q1>53XUNEMU++NB)>)60Q^R=?!
MIG+CKP_!M?J>$THVNO(R'%-7_X\\H9'AX>L>D7Z<C5MQT_S)B;D2]CR ,5X
M0N"[DL4*$2<.7:>'8%C.?E?9K%@,J1& X0LJP_<X,,P%&726-^CRV<FJ8'M2
M7=\?CB/<E>2VX+SI"N/NU1 KBJQB4TE[B!1,%7U@1=?EB^]L@+V2$SY:E[9:
MLOUX3JTIHX?G3=##88?^7CH@,)E_UDU*3<+A;R;<_6:1@D7C%=G/-@ $Y2.
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MR,[+6T DN8KPTLE]Q&1G+G?:4(]N?7DB69UG-2UL/<$<#\?9P *(JI.+HCS
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MG@C\3)UT[,<F<V,4><R?^+Q'FERA6'KHMRE$Z5JAQ?X<SE2G+*F;M(FR\4
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M]O;=/O1)3(+? KQ(9H6 ,-R&H6NZ6"C9H:FW=CADQJI+N@];F"TZ2AI"AU8
M3;@#L8%Y$?,7^P2+?1E=K%(Q^ =D%=*Z;Z1[G"9@2N9W$'6CE!":-MC1X,63
M,*8K ZK$(!+Y(FU<-,=+#7MQS?"JXT102KZZ)5#+N#Z$5@2!C0R0=%A).FZE
MA!Z^.M8/M+$T(5Y4$?>(@4/;L%MT_:)4T]Z7ZKJ0CD#.[+#N]P-E^<[ *'\R
M6=;-O04?#+VE#ZHNG+?@D^C)\]#5:4.R"8LWEE8#>,2(;$:X4SGI,ZRM .>V
M??BFFD2]<=:/EQ_&"V9HJZE':R$-(OE]04."M"&'4C_N68_>TZ>;7NAL(6^8
M4I_53>3VV>JO=-U4^S4+V4U++5@FFZ$^I@S>Y[)8LT!9\P^/<*TH5P<>L.>A
MPV#V?!IL\"6SE2[*AZ5<LIH;$<!S&RT_;.[A+TX!4DJ[FA1XER&94+?V!M=T
MQUHGW:R1;]F/\):^J1O%=(OV&4T(?@_U:L!*5IG>*A+&N:R4/58EZ,^K:E_K
M328:VS?M-ZP7*!@>A]*M$!T20+/DCJI#=5<JRZ-KNE%$@."S-C VP%&&R@>,
MS.U6=G?)YY>@_>GGV5AG%@K'V QX&0\DXI.& ;6D^Z@B/D><<DZO)IEL9=;9
MB,-[@ZR988^:A_Z[PCKZF\4,$<>NK3S2O$R7_>7M%V="0+I$JU=4Q&IO+[WU
MVX.,>'CGGDF9N!J&EY02>PQ9AYH,2[<Q=@IR1$>)DM)&:)3IW3&A :@3'#<,
MKB=:9!/8W=RS-)8S\.5'LR,)MJ,(L!<=!%N%W[3"FX4[$SR<2>"*+"F9 XUB
M4@&?*^.-_'B0TZ!H8?RSS+4\STLP-^&'0:NIB% FL0T2TIB_>1ZFVXIL:WNT
M=@GC;3_F=O.U\*QNTCNFR<=>X$5-9".3%-6E<,3H1<>+.\<U=5'5X%EK!5G<
MO$B3M6*IDG(,U>T4@-*@C352Q?5H8IL+0KLM=Y,V(H.K"ERP?F!VI="SL/QS
MX0-GT;UYUUAFTPT+C (48QI>?$;:R8J]3X#OEY:'*X]>1C??Z"VL6#5E_;2E
M/-6\YI,;.&SE;V(">M(3*WLYP3"N_M+PCUYB=I@RAAK4C_08ZQ>7%6.Q$TE)
M%]D?KN/R(HI*@5-G_'*4B(2%PPTV[2Z$YWNS'AO7""+"R5 'C;KL/4\NXLWC
MNR2\V_^DNB3G225@>.Q?-]FZS$>TYEAJ:[]U2QBC^9CL5:]Z2&"[;K,0,P<Z
M3D,21*5[')1D%G=O'$KYVSA4^[-0FJ[[+6 L;G9+>S_R0U7^&8Z0W!@/=GAG
MU])8L#''SP!VC#^DQQP)AY^_=PF[C9B#8Y?DR-A?,T6QA@1!:#Z@G$@!VU%
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M-JJ@PP*P>,A)M_SH/(XYP_>I9FR@Q,:Z[4!6O3!<'D ;*\>/.I8EX7YE0"K
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M[^F/F#*:+S,RM'5I+^DBYE^0@-]HNZ&8.D($O_Q0B0MIK!YNO7D<_.X6L,5
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M^>G8$:*.[:9\="HG,I_LZ5NCW?N6%%0EAB +V9+?OX:0]D+ %P:DONO*5;>
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MD&#TJ%_='OSK(A1$XVDROUSVXR__W$AD&(A[O>HO\U:K(-MF\ 'O5\T3Y(O
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MWB_*):6EM7K1&O7KCC\7F-.7VY9F-XW-1AN4)(R!LHCY?H7S*4K'.<?KN9X
MOW27<NZI+6;=A:FUK]E+L260\<W;_IR?BLUANC9X/4F&X$_62/R$@E9-S'DI
M.Q> -FPBDN9">*E+:V%3,6Y5*7#$9!32"JE??B>SJ?ZK^C/^-^//^Z]/)O[%
M\716A'FAYHI:M=BOB9YKZ6:%U_Y6]FA;F#OX$S#EF F,"'942/TWOLE!'VDM
M?+-%%A&:]V, OTG$[EO"U^N.3YCOI=^J?6E46,IA_^SEFU]0M#>3&M2DNZ1]
MC2/+VW=,K)LRVR[>^Q797:_EU-I]_3(JB02-I%0M=(9@DDE>@ H_*!"-XJ-A
M2[Y0;'P$O/77,5?/-B)8B=)D+;/@R_IDP$@X@:PTZV:_?]U$ 0.MB->F'!>L
MN3?^3H+/2R8H3U<NMB$CL/!,_C3P**XXT(\%I$;I@F$WFGK_O&FS<L'R)B^U
MKW.W@AYSR\],Y\W!*:$Y9PE8(WZJ;O%!]&::O_.0#ZQ+<Z8<-T'8&G[QGU@6
MAH&7U7RU( !V'G9UGS?Q8N_V7N)C#;(];WQ?)8,E[&GN_)]]U^7>?^VY^^#G
M.NNKE%#<;;MV'-GDNX#6Y]._+I"+6KF)CEDA:)^<V<ZYFMEJ'EKK]\)#7?7A
M5UM=V$68L7+;.\E\4V*%CO1G:Z$#5#]TG&O@!CP> 0]OVX/;5ZH? 1/Q*K4S
M?J@^*K;ZNC76MX(FEMDQK[DD=%YV-KRR&/DUY$9:&9>?46$OJ=?+3N'1W;W,
M4E?O34J:?$&D;YEI*IG\PZG FNRN!SNV3P"LZ,LEWWC\@"^Z.72=1$A"G:C>
M09J2/2! A@&R.K,GAT%%U(V?E05%G,QV,PVP5!>N;,5TJF_22\R3G3HY+EB.
M?EMX! R0?7GHA3X"\LZ!%@%V/[,"]4^9]B@OL>WO\?&]6/_N@FLER/'#91.F
M0/U_(#)8SN7)N@QC(FE*K6,&J27R5_&,+4JS2 ^@J3PG>Z4\!RA'6E'(G6BI
M4Y!7/;GSZOO,>E2V/&\=3SK4^GX#*R\$,P@-#PE-#H%J]:A"=:J-2LI\U5K7
MT;:'O[YR:WID-;UQ!!7-J1_Y)R9I@)ZDH8Y:ULGRL?J)SGQ+Q.F^^CLV6RF=
M#2!VI_  T>*U<9S7YP&=6L9FW1_6.:+B7:DO/)R[$YL<4,Q45QQV/U%\&");
M-<'PC\W(]E)/]=#_8]^R]-_[EI<^MDH_O554'R6*LF_YL:]ZI[-PBG&&;F>]
M7KWG^*A4"Z)<$J1O6+,5>?U #,LHW:/Y54Y-2(B]6!SX-2R?V, +GM1<#\,1
M[(2866A;AE$-H4^HN.3+*O1$O1RM1?43<#T=%+85RV5"&7V7[BH(\3%?5RI[
M^J=\T"$WD_#AO/21%98HHMZ&4R=W:>J!;<PC:0M8'Y@5TLAS3R@]:4[UDTZ)
M$5X]"0T X(1['0=D6#Q\ 5R ):QY)YR8Q1B:-2K08-(X54(X#]Z;[G>0(LD*
MH,<YY$U&);X#:<_:Z./ZH&)$4\0T*71.C@%8EXDR,# .8G0VMM,SG4>UHE<3
MNH$8U819K;C]M@&GQ3T"=!@]AV17'><E7GY@!8%9R?OO^<M?AMM;^8HCL<5*
M&CL[]P,G!0; (-#J(X"H;QUVO!'>Y6UQ:#9;ONW4CR&WX>+ H>D)WMS8^K[$
MD#U=X3SJPY\WMT])6)M<\0VX%BS?>%>$K4EV_8VC(S#V+/X"OI6VYS)Q.O,Y
ME'*N;"UDI*HI$<0*?^Q,:AHE%+]X48[[9U99+Z-4P\]J)^G&/6W3MWQ>3F2X
MN<Y>N1$LXYB9\IV_$%+9>T?Q&UT=/[1G/3F2/KU />I5?7+)-5+M0W[5ZD9&
M\^42/*F?LN 9S,9@SEH'SAAW\UIO7URMSWK!LN'M&Z#I1\!^E]\]P:]M"I0Q
MW)XL--=(@<^X:=O>[CX^<:&Y3,Z!_EXX2&[5<-.ME+WZIPS[?A=KOZMP&P\8
M?OU%OH\ 0^1'P+C26$VHZ(AUU\W=Y1/[9_A<2Q,[8&_L>FEZ[51>_&#CB;PE
M2!\,MW.W^F+WXU^_FR;LC<;4T=H#KI/2)TLY4L:[0>-/^?C@%3TP"LP ")N=
MF]>M)PLJT3(PY[(]91N:^2/9%Z>(&,LJWA]$OY#!'4E_F.9_4T:>\@6"[J[P
MZX%^OL_/P7B"9_<--V'8E@RCO!R:Q\-+"DT!00"%+-YH6.I5B(@">20XR7M;
M5[KIU?NY_B (+562*=DK9(2L-A#9UFAW-,KN V/M5"VY$[=7CFL8T>)@E6?R
M$K51GKGP9!QPQ,M]OQ8SJ(W$EV_7Y5YXJ)6CH=Z3G8&IRN"084L$(:IO5WK"
MNI]E7@B$OM>M>[(9_+T1=12%ZT"YF(Y, '#FWQGR,0.D=79OOJ8P' %^!'0U
M?1Y7H-B2HU".:D2/)<O-_,R(?B2OQA\@HEDTYZ&O7CEI?&N[0<.<1NJ,%A=7
M1I/7\NHVU^D' EDUA6>?O#4T2=;;Q+J,[T$PRIU%F$YRE,AH$$1T^,!31K<4
MXC*=VT(,$36SQQY8J\ !?_$H7M;)U)LQ)S8JQ;.EJJ .1B*$U2-HB.-F-S3"
MPO(6Y@8V=>7MX:5>GC:3_5Q3E*5%1J9-U7]&#NK-PJ&#@N:,@Z<9[ 6"A56N
MI0EX&8[Y7L2/N8J82M9"*JZ9,\D> ?6@>T:K[WDU!%#B1P *?X_]#?$3XD=*
M$K^3-H59]2E-?N28T[*:H=FZX?/C,V0&-O/]E/W9@=N)D/7VZL7IAT<  U+[
ML=]AQCN3)?"$FJA5XU^M)DU-FV+T?@/B4X^ PZ2'R+?)=W)%-DHP]?S9WM5]
MA;?"<FJ7SEP#8HO-<,R,Q'M(V!YD)N9ECM!AR[6LR&!4C<SEX7+:^E,# 66S
M2 ?.=-OEM<HQ P.'9^*=^MAE+?QK.S7#(%"316S&H6F]9)*:&VO,3R&Q590;
M _R!M([UV]XL;#L15?J&^OK/E;Z!3@2G=[71CK0L>,%T&$N$#B75"G72DU6R
MJJ4>T5T4J+_*36YI,M36ZA=1Y53Z$=#B?LH!R+,31H#4E0.\6\N\4+?X4JO$
MINE 6][R7/ND1$LEKH/F=^9PR3@<GK3YR%1H>I,5?0$BWH6@=7EB>S8B.:A.
MWXLP\I3VZ>QE;"GT:[#<;2XEAV [UIW^(^"YM10=@9-DP4)>&.I@NW#C"WTZ
MG%Q*!D#\"/#:'X.S&M==MMCG_2,@SK/(KQWY(3HJ#V;]"*![!+Q[!-2UW_#N
MK43Q-/)&/]MS<R0\$ZED8I+130=W261C &T;[KS/RS'75J++6%SV*3&7%D8F
M6D<3;.D8F_GZ.R(WZIP;T[)WHRZ>ZPD1+.5Q__^V!ASZF&?/#:^2OQZ91_76
M*,OEYV1Q8)MB=,_(-GX6O!9[#YGY!FGQ>P30ZW?K'\\] G:!%=)_;1%.\W[N
M*E+)"Z.!4=GDW+YQ)NTVT.2 ,UKV=L)P^TH/*J(S)ILQ/*E^]^-+YV7J5[=8
MUO,MTSB(G:[_UW)^"HDN=H2(B(OR#YWSQ%#,KF&G03K9)I) >?M&21KI<!H
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MZF<EEA^R;6^Z T@2S(P3#5[?W(XEG./Z*N9"*/+^FQW/)A[>Z_R!Y_9HDGG
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M%'894NUOSYXXRO4KH!:M/O:@#^8C(-I7_W[(?I->"IJEO.);8!EZ6B*%JM/
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MA$PD#A_D]9"3A-Y?F^ L1[X4%S5BLRCNA%@IKB#C( 8TI\81%-$?=OOS+8\
MW)8/!;LWINDQ"Z]1-,FEY,)[?0;(D.;Q# S,TUV' /R69RO?$F98(_W"U :*
M+)K8(VJ.:WII^[ 6LT/D%CUC*YD<@C1B8Z<:M@/46]0AW.+=J*3))B&'7DTH
M],]/#SMH? L[XKX%@&Q7M_.],_QD0_3'*G@:%ZP67^)?"Y.1E1A@IW,@$V\3
M\:[J450U3]])Y\$^7B\NR#I=US:P9+Z_G:3J6,P+'24S;'W^,I_/6B](7G;/
M6[S[$/M<''F^6T1,]5<G/VZYMG#:T2?2HY@ .*+5P)FB/<:<:KNCS3),>ACE
M(X#BIOTV<67P[=Q??=4-HR^L!TZV>[3J4OS0SA9>G<K+HFAJQMQ%('# :6I&
M?RR)$KKPP[.GG?)!^+[RFMBHL3'<! -)PB(] M+.6]9Z_O/X:':GA3!W]P>,
M79%S5KNH[4=8>73B\^0JDV.&8[1J!P_ JN.3;QYEEX.JA_(0N*>Z[')(% ^A
M?J6+. '&8 D>CU9X_SV=LD+L1/8N41SK$=#H^0CXCCW%F@)R<;H!A;M8M+B[
MKK,:H7Y)L]0#'JJ>3,AL=D;$:%,RF6 HHNBX(.I!KZ)$A-?32!T-K<97Z(;:
MUCT@:$9/?O#E:@_$&2$JPVKS?FFE>R7L2NOK)7A]XC[/8'9>[Q6Q[J5S9/\L
MD>@3#@L@O?(C/@\]-/&V9;O?(IJO1Q(8.QO1X,8&>W_4M;K)CQ5EF5OP,%//
MZDH5^0<:1+!,"-NQO87_79POT4HXU])+<B]4+!_7ZCIK^&=#BF.Z<X"RYN)]
M%7CY'T3 &S^8X=:?0CS?78VV&JWE,];KB!@#(I''"U>"N**5YAG\UH :67@2
M=NYKV+OZZCT<BMPNN(;VB91J!L0,_*/XG1?<'[@0/-_E06?2-4,W+#4BB: /
M7V13C5(W7(IN/3WA-R>OU!->&]8[6TL*/;9Q38.'CGS92E;4"%JJA-#Y#P(-
M1S#'BCXL6CP"L/*A[.$VI3617([Y:VT+(E"<\8R(#PGT[W$:!A@$.Q#(=GF.
M72NQK:9%(,#_1=Q;QT6UM7_#@R!=(DB'A,002G>(E$AWHX#DT U*"<@X#"4@
M-71*=TE(UY 20TA*Q] *XCOH.??M_7ON<\[S>9[W\[X?V/S#WGMF7^NZOK'6
M7FLA52/)H7O-<L4R+FX@8)]$40N5XES]@U@\B[4G07WM>-# -PN2R)YP?RT+
M1TXN0['5)*\Y-9JG$!FSU3F*5$=SE_$2XW\<DV-ZN;\B&4-;' 7*_=S<0:V[
MV$-%YS. ^4QXV&F@1$][C%Q9T!#)7";5KO\E5C=!B=-A)L=SSC@!$JOF^L(N
M(-07!#$EK)Z('2/[D#I8:0P:*">I7)'X8\Y#X>4+M]/A,*%$TR<C/J/MK/&B
MNS%\C+3%8O?AV"?YESS7DT+R?@!:I:ZB8K.N]@?+JEUAU&&S'>F4-03\! /N
ME3DWV#YR^@7#R2D7;VHV^Q)B6?P'0RK]NPLH][SD)CQQV82ZT_/<4TY_U)37
MPH#1C7'//."-RTK(*ZG0[[D;:O*^G[Q;/]+>@_\ Z$V4<6<JY50I^L?'D,4;
M)$&1,=%MW?=E*/HN)>@_7CT8OS0Z;2UO]R"?J76Z>%@ WYWNGI2:%_AX28;B
MJ\@ %%^M<SUN?,.^-3IGGR!Y>^RXR:#&CU:2FEJ(<9YJCDS7/[@(+ )78L)P
M:3IW%8XBN50Z:'WM#DP3!0E^S;6\-]<?$\5M3!L9_96"M>Z9 D.,EK_9^/[,
M\:Z&NO'FY);&DN7'[K5PSG[9IU<Z*Q2(^S)V(<;GZ?D+YZXKBB/5;PH0BE3$
ME9W@F(?$^QP%G0<9B\Z U8/[QO\TK;U"_-8/ $M4I]2>R0_ YB./]P?V5W(F
MLE<?N7X LK**TS$"^BR01!>)Z=\T:(EVL2PFMX=;[E_OJ8RR<V9]J'-6RV3*
M)/\#T++H26AJ!7\A$O :D:+J]!]-&4!NBUCV$?Y[P2HB-)/V[$N-B>J"5WT@
M\2G!\L[BQR'45>P.,.>"-CJUH3T5HQ%)]MF-*XJ:\?WJIH3FFCK%Q5N!A8P8
M= ;/>H QD&CJJ'<>;>E+)J$GIS5%YUEKX@6ES9TFA:_B%U3V]%B%->OWIRC[
MDYOXT[K<=RW\])'TK\3)WQOWG<J)EG0XU=^)+HS&I&1Y%PT0DP&FQLI:Q-H/
M-=LO[[+J?^+R*,%$V)O(?^;A',NRFO%\!T>_SVQ^J/"$4)KB0[Y9U WO,_7T
MS@3>!>/[,<L-4#(2,;Z $IEFQC#J(TC,F;RDN=O+N^>M5R2388J<JR%J=4HD
MY/$OO5Q)6Q19Y"55T5A3XXX -!;/E;T47B 34>&6NOH(1(4RM[3U/Q;D6+_B
MV(PJ\.;Z FEQL#:*!8>^X:8D&@&L11QKG5!> 9"[)2<M\4N;N^ODV[=>*[[.
M8BS(*6.ILWX&04Y)%'%Y)_HI=DXXE-300[?_]8[<JN LJ(.IOA\J2A?6J 86
M%6B&X2AE*F90.<2\BV>DD7>A3VB=I^>%2=5C2MRW_/=PML"T_^-K5U[X S#+
M\YTJ7N\LNI$O<;+FG*B=2ZKWXI'\)N/X2"GI'B3Z:_M%SJ.5N?L8KBXU_S !
MJC@-3U;R[CD+P5O%*%?\P]D]=;5W5;W2&#'5Y?WKXI@",8N?7T]>_;$B11;(
MRH6R3J.99-#$4N]I\/4:4?B6"8VV7G@S\^&=BL.AXCY/RV80/NJ-)1U?-7>.
MUG0E[9!I36\SQ,WW))0$W'X;2MMZ=6-[6:$3"%*X$,@> \U86'O7Y<=3\E0^
M5!T;-+LI[TR??9-YX><@SK=?@SCV[J].+:6H/&1.AZ14==_Q$TN,EP9XSD(G
MA(<Y!:4<T5TFI@H-;))-T_)JTVR?.I%EE\XPW@IF[@\5.SJ+ -Q05=HW9NW:
M)U(*R&U_/]M&6X+. N_MWF<^JH<U:8=T$PK%M6%FU9P/6/)7"_F:#-@Q\C4\
M1=RUIKW?5<<F'H#SK^52<^8'6[$H_060SXX>$8M[GO&JX,JMDQ0$4CYSFW*9
MKE]==9(X9(=1-U2,O>39YMT:(LM*XFY.;#3)-,G!IR"1-,Z[%*(DF/I".7IN
ME;6P8/\M'"P E&)6:5C\3(C>G.\G[@>5!BS2N=) #NRC:FZ*JY7H?][0](9J
MN-V-Z]<+T]QD8H_V\4$4ZZ^Y0.*/O]0YI!6[-\X/M;Q'1BDDRL#84^[[',X*
MH_57\2<][7BY#5A,#:I#U%W]A O;/^&B-. 1,BQF2<44:-!,]4TH?;!J@*]/
M5'[.$DNEBS<DT*6=X7;[_'D=OQX=7@4,AT3?LCER[)%Y?[^%*S93 6,B0G:C
M5V#HSH71N=32^?&Y_R:H!.1(]> LZ1$&;7;#URKHN7!?F\ E*Q*]8ZJ1("&H
MU"C'10Y?=YMY405C]L9-KIY^)<I5$+5;8[4:1.V5/^425IQ*[!9BJYLTUC+.
M*?[U>%#[S=><TLS6MF=,T?\XIV"4S..YX(XO>1<1RL8D7AP$;)QOJ?W>WY4Y
MR0],:7VUHN3NO;<TOG2/V>S!FTZR4T!^[&/0BH3?%/O!?L]D@JA'5/C>[KJM
MZ7I_;2RI28JEN?RAD<C<T(A[CZ^2J:!L2WZIAC$]Y-+CQ=+P;=M&4&ZLL1Q'
M3E40M1(G&*YG:4?A/ZT%66>&8HKL<U#9>.&R945_!+-EW/C_ZRBTHY),>N\3
M@##TR%U/3$NW#;*<2;6F#NIVEN)HD@.0:L@!R CFTTJ^5\V:&LFZ.9Y_)NVE
M-<)B8CCP 4Q,J-\THA7L40[*&-\I*6%\OF!1%V&A.8TN#' +E.*HD2,%Z"5<
MLHWR<*FV$K[/'<87NB6=PKW;7YQ]EAE&\30,N_?LK$PS*]E3EZRF0;='I7QL
MT8;_ FBOF%17[8GDM#,"6 9B":.GVZ'N%&8]D+%QM(6NGJ)4$7O,6]_@Y\Z+
M:0P2>PV7QR1RP!W) @-R [(WD\L2OV?G&YKZ&!Q>C=[HJQ*&"Z%#%E_JV%$\
MJPT69HA@#!/ CLD*U5&_#T#/0*^1! /"]N"35S.[95R9#77^3BB]7A(2$^TM
M'FA375537J-L+V8#*AD7>Q9Z@W%U=9$0BSF].R\K$-5L/P^.S[:UHCEXF)E6
M("^26B1MIS)C6#ME.U;J[:\3"0F>M7<*0=8@@II&:P?UC$?&J:EH;:MQYZBP
MH1D@;43%J8(F[HXY6'S@A#MJSF.$IHA!%_GBXN(^WZO^U3C8CCN[3KLPQ"&"
M.L6K^SQ/>FM:A!(KI!<SNV+<P;V>BD"R'S%V#_1%S#M!@"N0[SI6A^^UU='D
M2-6Q^)"8D\MG;=\B/Q23#(M]-;*(P.-[)L<*<!NAREU\@4O90K=92[7P%FJ1
M8"UX5KNX*^GP3LS8V7F.7G;?)(UT/S<4Y,C[5S%CQP=*<F$IA*B+OA)5@7CE
M)@WU&V7$N5F[S&&ZNKKZK4Z&_K&? L_."[X+-=2/Z/B%[-7+YM"CEWN?6R''
M*V6J'+ND *U[8<#7S,'>8_HYFE'4!5963!C$OL'LQW^352*G61<J%9\8] 7P
M@/;U\76O]Q@-2 6QX=CBB^GP$@UI8H0!8MHPMR:M6G!R,ZWB8= M5U=G+/18
MM16MZTSNOY1-UXKZZ&:TJ:LUK^:]/'_Y;N M)%A_M[V7 ;0;^14NYZ&MI3I(
MV7\I/F(U(LZ*[T7=-32>4FCA$,59#N#&QB N:L ZKW,#;Q5DA>WMX>AS)&2B
MDJXN\7ON==+YS)R^NZ.2U.U23V.-:HIJ34 6F.WZN/&WIVE(WR35D*;361QB
MTI_T#_!:?O&\?ZNS*Q'*GLVFY,%6V _H+XQ6P[JKYF;Z7HYTMCZV(IT[)'NX
M@. AZ%ZW\DC_\MKN2"^E2_4>DP@%A40Y\"&JA?ZA&.I0#1O)"/ZM86^DRP%D
MO:SM QQ.IQ)&YF9;A+IXL73;>WO%Z:0%:*$I%KD?1S9/=2=C^)PL?[4',T"D
MC>9"IX@-/7"\&5BX97:+I^:[+V.T85^DI$3_)F-D?SCUN](1]!7T=0>(.7A_
M(RO%BT07-_=[5%X BF-0O]:& 38!PU/1+4[SLV=(6*K'9I?)+SPDNG_>E6LG
MFDJE/[[#7=K/U8UTPE.JN_L@%?4 5SH;>J*223Y^9+N3:=82<V+^A6M!!N-8
M3/:W8D)Z>WR;Y 2/%74G..+A47FFIEU^'OF&:EZ$XJB3#!^U]R(Z+<T/'RR4
MCBH^1=7)=:W<--H5[-$.,I_@+"E=UEU@JH^P5)]F$F8X"@X0C1V#3WZ<X2K>
MS:RM>[(#)L5^'Q<7*$P3:V?WLUT!174($+3P1GN!@9%)9TFS@@M);V:YO+/,
M.L:5AQT*7*XO__3'Y;NHR]_\NCR *OE78J#%R9)UDLB(VW)JLBM$3O!6Q@1C
M2\B0W;R.=]N([:]X/YCMK"AT0$O],]Y_9A6@^((62V%LW?;X^[WN,5V3,&4_
M]TCP*HTE6K?TY?N'8 !'_%54GEV+V2DTS=9GS7K@XA'>O<$5X3E"OJ"O.@@V
MM.@.LN9;[1BVI!H%CR)).8J" @&T -)OU[1@^TTR*>=K^@S"(S<])8IOYX#3
M#YEJ;4/9K;:N9Y-QH^BO@>]3T6\W?O#;C6D+CS6D24N.7_#"OQG-@D3'\!JJ
MO@R3XE9*JJI^06=EON&&:A44Y?3]^2(C^V\O,H)?D**A**+BWQ3Q;G=9?Z(6
M  ?0+!*^*/I$JHXAY.E9=SH,\@$1##6M^&LQ>#C00$+:5]$UIC=K18T),-.M
M0+:W!8]HFY6I$MHHV]!3T89K#/\ \[^B 51#WZ!6%C/"TZZMJ@U#S//5LJDS
M<JNJ A9=E2Y1__S%HE4[[K3TRFGYX\<IU$H&GI1<NV."P&B7:"Q*],,2W%^-
M57;_X&5\ >)2;\J)FY,[JR;>L;EA-32>GB^3XME]5S2F:;W\414Q(,[[M]7?
MZ9^,^0_O[(K"AX=ZDDZ][TB<P_FJ\5=8CP0\4;4]G"@SNCZ!F2D89\&R8>7B
M>KIAB5^/\+J5"L'W-=<-_2.K@6GT3YH_@$^W5:MA>S0^6@,WJB-"8FI>][:O
M6GPP0?$EVV\'4/)"9O1$J1,1%F?AQ5':=G9GD^EFGW ?%B2NYX/-+X#Z>;A)
M$8,<>?R)"F81[9Q'K?&UPM%5@LR:SE@2:*7)8-N9.;I\RG_BEU?WNT 8SC(D
M<OAVMYCD<(LRS %8TEAV+TB%G.7^IA9A?\+6_^0C:3+E"_HG5^.H'WCUU<@/
M0'K97?_/377[*Q+"V^/@/V4,RA4IC N8\5PHJ%8W'U:M?<^Z&??<)=41B[+M
ML@A%1[U/P0O8B\'\8(H)1GDPF8YT&X PD'#BNARJ]JMIZ;5350IL!85<BW:(
M7!QC[QO'0:*]^\3]KME.+ZJ8ZBSDBM$.D6I*WSBQTD3R+K+<-=0R6I@E6) "
MU*XI]>3V#JF6ZD>[];?VB#-PLU&.9 1Y"/<NU=K;ZMB$V5 Q9$,,F:JVJUJ=
M)G!$G"<[X*/4TGM:SI:S4)R8$$NG9P;ESL)S/336%$/VHRK]6VV)ZL7GU;1T
M!-);MVP%'RPD6 NQ.P:K#*7U>/ZI( HI=/XA P+O-E75M-;ZV0_8.((^4R\G
MH;\W7[6D(V*@@EX7VI*-^Z]"JS3Z"3^Q?Q;:-;>C_4/$4<7Z+Y[V^T^>AKW8
M/$WP;'Q19#AC) MR3)HE9;M%SLH*<!9AOA*0^#^_$*#[ AJ2O>E6_>UEG(4M
MD+N#Y4.C?)<K(2]@A>&E3B8J =+OA&2W%] ^Y+K7+38V^&6-:T2IH:I^K_M?
MHN6/.R3]Q-/GFK_CZ0JB^E]YD&8]P9]"W:#CB</--2:/%^L22T3)>G1=YP5_
MI=A0FO'NWPA*%%27G*98%$F7V]W1G7(!.MV:>U3)YG KE=BG72H-A5&4^ ^,
MVFF(Y6-DJ5[]7"6> H V@H9(_[5S%5JZ1<;&-^-=R?2<:<3C@?(^)\>8"N,0
M2*!P+WV\S77NIP>@3LCY"))5JFAZR_V_EK?F!/\+/MW#'X#JZFWE81XQR?'?
M](+G?V+%\!N9T<4)PDS". O:S>=NK@D;S)PS<UYHJ:FIWZ[#^ ?\O*!_4M62
M<#JK6AV\Y_"UJNM&<51<7$-@7Q\@]>Q:\_PS$VBVCAX/Z0U<C8Z7\(@7?PVP
M^<V;U* "(D-#_.A_"0B ]\\MN,"_;<'%6#1M\^UY_)< :]O)A)>.XL-5;17[
MW2YI&=:44FDF_Q;TUP??\HB[MP!Z@6S.=(^O0>I<;B,.GJ 7;9LU*ZMD@T#F
MM:LA0_)U\-I?T1N]430UVK[#0V.#P\MD+AH4S=?F^.JRGM:^!N5JO&[K\5X*
M^7@$+ W@O=EP9&R^'YKFR'@XU]L*?&#:%JVXV4Z#.Y$%EOWYN6M7=U7\842-
M=>,ECGO<CKUU-Q!$_$5T9L[M'^/Q&WIT:46A62AX#1$)"$< -V"$U6!O__?O
M(7.J^9ZR0M*R%O88V-@]&/37PQ@H88HG\W^@*]C_W @-35D-%7C6P2OX> GG
MY9Q/NG60Q6?(BI@TG#= %%7;?R/<@00HZFJ^IJZQ_TE=?^I<_&2*4H98G!6E
M9S&/?R[D""&6V<(NX'2?I>7&#%&KK*V.2/&!+K!$*IOC+Z+! >N(DE\7$L_/
M(#[/2M2L50L)[D<BGP1]*G?E)<**)E"PR)O>=.:G>A%?D_-D=O"7=;0&$#IC
M27ZR^W?>YCIE;R9XC2W,VDY&FPRE"WIGZ,0<NGK=IQ1AN T[\?S?5'/_10S:
M'OVW8*-TU(V2O]5Q&;C_UK&V$G/"A_D)-VUO_Z9C_[4U'=J?T$7[+^A2-$!!
M%[J(B,A)'PIY_C#S1AO?K-*.ZVH1'CGD;M9#,#8R2__4M$%,546,]6O$1\F<
M2>IM]IT]+?_;W=>K++F6MU/20(GLDL& H^%PT9>%2_-Z!B-.H-+(HM8T)U=S
M/+R5-4YJF,$3:T=50=@KFF^TI%J.>\N/V^5(-2EU_\J*P5YL_*5#O7;SO_CX
M2SHIJ.:%W9G2J/LLL.$NSQ=EH9D!Z=*>9W<\,$I'F^LRS'UV-]VU5.'+=JN"
M">73,^VV#BD,P0)@@3XQ'7E W^J!V,2$AJ(5$"67/OFW[M**CAWU#R>>OO[-
M6ZEWD%6CA*C2_Q2B/S$*3?O?2NN_I*LZFHY3]2RMYLT0]<K:I@@C;^@R2XRL
M.60Q!(YSN?6)%(T@-ZTDM-+(8/::C690;*3WBXU&_\I&"?RA8?^26E%?J=3]
M!>_A*7"V1'3,K]YE38T3=^P>H?PD$Q-6#/3D#R3^)VOSLUQ(__;A_I!SF@VC
MQP,#TV6.U=M*>TL]\>+E0,5W(M3Z$ B=O-@G!!L@3P5?CU@) YE3H9A+)Z3>
MWR^/S7""H;61@5LK"H(FHLODSQ@9/AIJ[G$BZ<XMQW0&K /<=G4+?B$I^S_D
M(XI+6D;<7VAZI*N/.3BNZ4PSU]<I47 K=2N*6Z;#JU%WH.1_8"S#?+L[MHOQ
MK?>\+)"=@B%DXI:. XJM'A])5:'(2DJ(SGIF4?]L11@^P@=)A__Q]#^/O^DS
MDKB/LLF_@DG=)&9T85W;7!OV91[9PAXM6DLH+[-XB%98D($-XMQUX-)$P!'4
M]N[PZ4SIUPTBPNA!?:S(PNM'_#N3C6HJ]O\*PO\[N& 8AO)M"V:G"=>^;=T:
M86X@:$W9O>B22M1_38S_]%RH#_AK-:'V5U+B9U7^=_;,^/MRUIUPM*H:Y][+
MJ+5/R@Q=A=YDIM1GORN/MAH##2_Q6>^@)]IRV?)-?RWP>N]N4VJU# NDT[@*
MRXM#VR6MGBFJ^<'8!UX4M^GK3BY=PXJR.HI]C :NQJYIOWGGXLE_F-:?2(?Y
M7[-2Q^COV.<?O+[/62'77S?V__DGHCWYKWR7/RI-YO!WE(<"R+^GX5\@VN&O
M4]X\X<\#(HC,.>-]\^E9M+QQ4$6W,Y:JPKK)$.EX57UR8P7<II$@].P5/X5
MY#W$LI$?MM9 <ZV>3<J >@>^I%9;[VDI%&4KW[_(F]Z*YJ0*C:^9>SS;Z76+
M$TR-88U!YZRVKM6!KWN@@'$K1[T[DX1?O:@(\^=2]:B'N*E9AT(0L4TG4/6V
M(O>7X11Q=8[>KR)B[_!3HW&&??_?\%YK(^X^)V@%*CG3?;Z4QL8?&BG1N073
M.JV9T+%J;UZ+5^_6,*+7E^@!1;,!'WE\"IKS^#]C(LG[ZH.+;]6AMTY#S -=
ML:HUM-.J;^N)1W62FW(@CP4;G[PD2U=57+O=7,?9'M!(^$6'@KJ/ =-BVMEM
MR]<#XOL\R?8IGIB</>Y#R.H=CB( *\4ZN$J.X+/TXW:#4U'"J%RX]4^SG_3X
M=[,?93>2E?-4N[7B>'A7:E=J9UMME^CKMT/RH8NFEU=\X] /PJBLP""900QY
MW)RH'>ES<6KJBQ\ACW+N $G(*V#1VOG^?]3M7W%21KH!HV-KS,ND(9$4[$3S
M:H=3VP7/OM3D@UA:"%28,N784@6\O@)N"S8.QJH0)Z_%4+GFZ>HA"E/W/I8J
M B 8M$%D&GIS*M,GM$S=DO13CBJU:84*S"LYCB740AB7F6WS@3C"<+%/1%3>
M,_[4]V!6Y4+J<XF\O ,UV=JSL>08#SKH<$S3?)99SBV6Z@7PJ&>%2T',U4G/
M\6AVEN5U\86<YESB=Q2T=J%&OT^LRTDMOH=0R+8W91SSER#5M*N+<+SWK"*R
M>'!Z.U1=%8M20H0NJ\Q@OCW ZN9:U7[PLD""8#MU?)A,^ZJSWQ3?RMG!;DL<
MR&.92]!H6C> FX<I7-Z*^:A!%=M4WC>HA\9A9MXV09*BKKG&-?G)'7M.E7 '
MZ<)HYY<6AU%E*UH@K!<JHNON 92;B*G73M5&-HZQ7P9[F6W)'M)"B1?#6 M7
M@KK,AY A':-]C+FEN6RZ=PT8I6D(5[@)B>JQILB&+P4;P&?+IA^\T.^$N7AP
M.FA']D_A7G\S!<-<<FL7-T^)8' 7DA7,_QE//W?H0HR2VD']$5JLFO$-Z38L
MYEBL96GQ^;JN?0(UT1YFKX.[\$W+4 ,MR.&MI _U6"6/W_@1;M*>D*ENZX[O
M5"=\LFZ.<+CS@ =&[5H)>W7KK"H&8BU" ;=_D[)"%,Z4M&+T0EZ]^&'EHT!A
MVFYC&GIGHO),N0]!U5'269DU#6&G<.HFK\\8R.*86NRY8EY"(J80G9H2TW&9
M,6X!L;'E!0">@W$5R<,"](E8+'&W/O1D69$ BDO%ZH.2@W)P[\)\T?M>\9-(
M)BT83@?Q''N[1@=Z,N(@'<S5;)2=<N'-'#X0UQ=#$XP>JBNFN-4JI(DFO 'L
M=8^BT.] WCCK;*SY,/^QZC'HT>/,E>'^E+#%_%M6:JPP'_&IXBA*V]W%S^=*
M5\->IYPK X@6IV_#/'D['NME:OW5;T&YKU%J1L.89:HKG7"6WZYB88X\E-D"
M]RZVOO53EIY!83@OVHH(!F&4.E(R/N_<0V F_UZ__J2B8-FPX%*\CA94<<<%
MJM2&\7K-RH2:5 \6\''EX$IJI4=[^,R__N@'(!M8/290(F9:<?$\R;V.V(E-
M_P9N^18V [$OG<)#HH=L+O;.*KS?R7J&D<".TZHM=>.:3M[I_J?3O7BJ*U[?
MRG%65K=FI><:F/CGR9<=0TJV8FR1)9^JJURHYXJ*^#R?A(G#9K;'"P$MNC2]
M.P6E=RZ6>\(=RO)J]?<=7ZG4P>L>/6@M'3.VM(:L8-7*$WA\,RVT+MX<-9M6
M_C*KW&2Q8P6G*%P*E)#)&3<*MDW8OFV$] Q=ZLL*UVDE5N9(U-:'R<^F6K["
M0A^7<'89F9SW(>I4MG%ZR6:CFXC3@K/RQR2,7U[ 1>\IJZ77'3/B9O8 /KD[
M5?A6V@WVK[S)*='W%4FM84G#:R8"/@%0<?2E>>!'+]^P=+2J^CI+\UW^TK($
MO/*0IM*]!U"76$Q[^R63M=W/P:..GVJ-X".S39@#G0"FN(D;!O+":-*[*KGV
MF??VGSO97K&/UJ@\7U>L:K+E*?'Z.OK.Q'/'O.2(#+ 8+8P"(I5%LZ] &-,/
M0%WK=S;#DV1-70O5)3FRH&4I2ILK<MS$([&YQGUE&SUW2$.W'T#TA$E,E5>>
M0[-^Z!MP>.6\8VDJGG363K&XC>]=]"N,$V%79]$#G&/,)N6TQXA9A11M@G5$
ME^,46N;=N@R3&:U4&FCJ<LH;HPC^@;=Z1#Q= 01=3V_"'6%*OK/,=I80JS"C
M+PC)/9<F82OA]A(U N\5!>230R.#%UEB;S6_4*ZTL^%&SF"4\K99B&QWT11S
M0V.+MOYB9U0=CQ\ 8MLKZO&6^8*F8JM:QN[0I,^VYMDT-Q["E- GP(LUPV#?
M.X5+NUIJX,_J4.44]F6%6!8$17>[#*+ST%G4:QW]7O(;<X2"VU(KB<%YMFKL
MMV[V%;#($V;5#)I HF?>7T,=]-+]_\?RWH_BTX*Y-]9K FB\W1ZV"HI"L]?F
MBL)LQBB9$41/WFJB]0B++X;,Z="?&](1_0!D%*>?8TG] -PRULW/,]B6HK$:
MWU_F10S*'Q,.I!J&T11B%9"A*+?B(/S[#:,?@!M??@"6-VO(ZDL7>O3P1XUE
M: X48SL8PY5NA0#9*3%N3=Q::/BNT .C&"LSA._K0%23%BKD#T,9HF78L/&Q
M1;!B-O732?SEA,+X@5Q"2O16L1O\-D@&#7PVP-W[\N-';!0T!-/M[44+E.=&
MF;41]F[OVSU</%QP%9&*^T31BGWJ13(8ENCU,+V,5?78FFG!?4L/0P7(I43I
M/#5(2@NJ=/%H8Y3O0*T?=1=<I6Z7A=PI?ZWL<X?92,/=C OY?2!QW[W=^N%Y
MK:AFT:DT[[,V04/,Y.2]4*:9DFS6I%OQTZOUN!N="?@4T/-N['9Z(;5LA*W4
M+7&N/#-[SVT/#X>RVSOU5AQ?T=Y@<*"9%TTS!7;0>% 9'>-]B/@!6++QEKH*
MK@Q8I/D!N)03Y8F $2=81GJ\R)UFXS5Z N;;&@Q$VU.\T7RV'!7F'D70DY=V
M;V(VJ7/AN947?/[=1>=*X:9I!'F'&787AV*C]#,(!0XWBX?PB6;GK1UY L&L
M^,Z4#]!2,##M!^#5L!KJ3Z^W66^34$-/4HU_YD4K7^G.\4J^&3P3F."NK<L3
MT:QBO60B"9R==F0!&[QBD"Y29#&H=%6@9__.<958:+1-95*;;3.;40\1/<0Q
MTQ%FMJ0)YFO'T'#,=)TG&]QX*3KF+UMFO"G([CPF'<6:ZDF1H^/<H(OO2K@H
MT_,XJC. V-T,_W-NY$@];+%T\\Z,3G-FMY!5& [<I:^'E9)2Q&0'F%V45?_]
M]K)9>$W3:I4";-+60/.6:R"._GJ@=C01Q3HE,UJLO5EG"TO506T*[<F.$$D/
M<Q9Q.4="'\894]3;T?Y]\\:YF:QZ^[(W=%0U$Y8U][;TLU]$>I#:C5HTH3>Y
M: PST*Q D*AHD'AGJQS4@(T_5U7$U'9A2%,RG[0QXP-<E1A>,M]P+6\4+"C%
MG%T^"\M/LX@5.R=>=Z]\6%S8[8,]N#"'/ME4_QR\C+T>_"B!DE14$4)IH-C+
M ,V 'O-/+B9;;&0UO-FGM_%]WN"3:T>B#&(I E;# [/W9D/5<RJDA(5G1QYL
ML"E]"/>CE2#[.'UI<+"[MB,X3+M;$%^;5'H+P\;/\2X<RV$%77S1\E.D_?+S
MD"R[RLU#KD^#%2Y,1AR5[[V,$VB@YYOC!0R2>M/&O3OOR961CN$E=IJ;WT#?
MYN8Z(3NWJ!T_F>>$=8_Q*CQT2X5R@+ ZJ0(B^/=K-\?$Y*DMWF?J*B H"H<Q
M CNB%<\$AKQU+AG$+8H,-[XYU!J6U">(>#EB;S"CG0*ZI/%O0W@PS"V$N3Y\
M7'>3<S.E1;:D+*L\7E<-7CB=W)O':]9SP1#&LG=GQ2!!P\*"G0NKV/>(ZKXI
MGMV\R<W#\\5*AJ#TH\:[0'!7DC173! L-?4&;_$I7G9>5E7-D&M/!T*[,?0R
M])DJ&7EB3!,'=/4'($(8D+S*>-Z^U'=/$?%9 \('@(_>Q<;9<EY=]+OQHD##
MR1S$-,)6A'B9:5LT+?O"0G08Q+NG1-YZ@D$33,003"30M]5*ZB^5:\>G7VDZ
MIX3'JSCR\<;[, Z]=0XE# \ 5)X 1ZA<,":_Z'Q8=4Q<V3IC3M9]2N\9'W5W
MD;J3:PASN83V.C1^5"_<#L98B93JW">RNP/DE:>:O*<49P_$"Q<69J;#%K\]
M-<7@%RDBWX<C%DIFI#[!Q?\>IZPL7Y$KTV28R9TV?"(N$+ :"RAE-(/0T4)M
M;X%J*&]4X&Z3 !;ILG]J/D3L&S^"ZCJ)&^"N@\]@]\^D,Q)PV%X)-2@!1YI$
M80HC4+$=G2%806."F-W,^T)V7&!@"*@>:V3+I6&2YWZ3WG..(Y0EXFM[]T)0
ME(P<K-W=_5CO)@CIU>'VI)#3,+229B]!7[O(W#H:TC,;Z#OE)ZOBB)-?KB?:
MPC>>TLVU%$0P-:N]V%?CWWKRTMID9L-EO&Q=/Y&>W%\(?Y=&PXX<^T&M_I)Z
M2;<W8?_"7-!8@P2>;NW42T&%PIFOP7A128_>U 3="216*&" \@HOQ@QIAFRQ
M<O=4C\KY"'6UWC:<D_T!P)YO4G5DA(DX'CR@-($\I'MID1#9>&L\%:+=93(-
MFC$^25Z=ZNZ7O"L4REP.C'E=FF"\Y\2F%/8$']^1$N,0BP:9N)A.M^E5L7%%
M$S9VPAT[\W2A-UB\AUX\#"ZI!94 )GTZ$5.A7TF?W5][8-BYXO?J>3?($TIZ
M>P*<2VOXS'7'3X"LW<C?Y&!NG$/Y3J9#N%AN AG'.\I5I@>GBW0U"Q/5DRLJ
M*$V]Q-/"Y>W:_\W>/#$1[S;H=MMK"[?/MMPXE"O"[3V4% )U2\.4-@ML<PFW
M18VS]OUL$QW *"41+.K.2AWFK(J2=>J-HKAL9??.ZY;MC5X'+%'7V0YU:O5P
M+6 R 2M>RPX/NH[6/11UBP$SENX0_'SJDU9J[H@56J&'"6U]9!N0%YDL7V/2
M9D@=>I@8+/<VU+ H1%[B(/<2_>BBEGI!/)J;7 FT.Z^9!EV.>AU6UH17QAI0
M)2*D/N.O/.*X1U%,C&=@:9Y;_MZY,Y50#7!<I#$YJ&IH0M<NYVQV4"<N<MK*
MVM]Z>#D$"XAM>I#JU+T[O3\NO L#EL7IU:C</'G+P_6N1NBQCO,PW?P<9@^S
MIW"AB[U+7I(O>.G>>=72=$E)[JV%WO'W?')4=VV<.PE^  31A)D!2MTXW?*^
MRFJW;?5,J<R(7V3WC_>36\<K H.U"VGABWKH(A)\,;)O9-SM1TV])7F] ^B1
M*T685_N)=P*.K3R3Y6OR[2>E',:Y$Y8)UO  ,KJT,A@WB&1[-V0VY BY'''R
MS+(:S&Y=RHSZ\[U,$'JX[!?<E&-DI7L83C&?0,$JTL-*DVKYG/;O*<)FS;/>
MQ,&35$/N;BA9_Q:*=TSH=2?XMT==:"8U<' 0]6^C<QC]9SB]H!EHP4J Y^E+
M972V=.PM"? ^[JQZJ)20)3*HP16-H9 I6*]4% ES_FI2"LS.SZI7WG]C2E/9
MDCS-LO:Q<_;1 2/%W!E".5C>&W[?I5N> '3NUFTH!!9B>05/9&M:0%C-,I:Z
MP!:A:3C=2ZFWP32&$]S08/#:I=S*=Z(./2G+AEB#O2G'<ZZW?/+8S'>80VGK
MX2_-74*2!RO/:Y8&FE"5P@.*U458IQ'+PT)?NTKOIII;LZ(S2^K5F]#.D^K=
M=$&5O#-\M.M.IG,(M164#'?..G"G9+>7EIUYH0UAE&*_(B'2_&R!@GC^18TJ
M?HK>P ^ WA>/>5@XK>B5QZC>&QO#FMHF9*6$ZO @L;%_/[-),78U(%A"!L,E
MI@<#:C]^J;0<*?1QDMWM);Q;?I;T%L R;@H0?1^MCSGH/!KO+<CR55*-G+/@
M9_)F ?%MFIC/;:A"BR6S4N7KE7]^76@SQENZDPAQ1$& Y*289ST!#L&'&WO]
MJ8NK[NNDJ89SMGG&6?5*+9SGGD![VT=>E?Q;@Z/RKPUI'J '# 6JX@!(7()=
M8F!5\I]V!789/VM5<H/6,4I/$&W!.D%T&<$2U]A#(%!_+^DE&)C8@KP*S]VN
M2];-9)X<,\QJ>KR!*[G[3@=7^?912.0'=+K@5RG37J+@:^'?OC050U;BP?;I
M':9G!+:TFE8X*WH9(%W:OG3"XSOP\=BX5G,+6$Q$\*MKX0+S?.]L'4NER(KX
M#5]<&D,2VV1M/1@1Y"5]SZ6/7> W'Y?U'P!Y/;U\[^S'$Y>BWW:$*"K!@K$O
M.M;#;>;Z^WE=L9ZF'LC+8$"O$]M!1T7W>+-18O?\]6-0R>H[>2/'W2)5OA#(
M2BF!=P0R+36=% O,$H;<R:9^%A&<I.&?]@[=$["@OTBW>B*PJ;)L)$5ZCF[:
M4AFVS+926_^J>"NSDA'^4A,EY[5"C"*4>'\ 0IHU85RCL*\@JDG%?!OFURT'
M%( 9@J"8,-,,MY@]7URD4_B5\)@XU]+ @-]^M9(+RU<7TENKKQXPS,<^7.&0
MYTNW.S;[>^="\N8):9SH8Z"8\12GOT2N<H%9KR[SDH:/#W5EP9[:>5P@3JG0
M%3E]./('@$XT+Z!IK2?].Z5FUD('BK:WXT;\'1JGW@BHH.W@D\Q0XCZNW#<@
M8YY6HJ!6XY!>;Q5W:\JQ-_3\8'$ZQ+OIR+"@7HY!]G2"6)KA6!SZBNZ57K(W
MTY4R_>N N:8?@+'7F[G9MWVS)PM*O3JO!,;\V<R5/XO:?EDSK\.%DZ>GK@9B
MRHNNP@(75T@^HU3<EVL5=^$-]U)AYNBO1_' '51Z5K/5%>Q!3\&O3&:I>6K?
MO%;)3_SR]:)[Z!U\=_X!U&V<[*,2,KRC8G"C%O$V2#_4(P+@3*2.%Q(R%4U4
M0!K[4XG8WY&ZL^%F_WG:Q:PX&7JJQG[K]5R10=BBX"K ;5A=P11(+7N>F+W]
M;:@ET=ZZ0$&@>[>$5YX4I-DC[.K+OJO^\8KXS;*;X;T43JIS+L8Y@H_LM%ES
MTV@5L9#.V&SFVZDQB0-S/--[-J5FG:92(\T"KB#'W 2_FMD6/ _\T6"<FQ$,
MA'/64O>%VX=XPL2]<LY+#^V-*/:RDMDN!U7!Z-S.BAQJ#Q6,/5;$EUR;C+EK
M17V!'\4U5J@)['M\=<N<3I/<YR6RK/34A<C>5HFRBSN:I#E[4W8#/_ESK0")
MKC?;$SQS_I[R_ >@F@.R-P\!67P?5VG/=6&_M^.NK:'O^P, /MXGF-\<,8N0
M;HG.ZF]ZJ!"<497P-% ('>:-F0M\ZZAA3-;3]9F@0ZR'U#"T'_^9?N8O53'G
MODH8/V%+QS@ND';[PA2QIOM).PF2PQX8E$ $)PWJ6Z=8)<'FGS.<4\JS&S4F
M&T;=H]T9V4/[_2/^,YN?R@2__4,#>B[HW**[40V,\-Z!C,S)]@4O<C2QT@NW
M,T!2/7J%>RDI?P(N&-PQ=:F7?^ZZKQI\^?CFT5L#/1O% ^T[KH/W,1?=A@%3
M$F[7,*J*1,&HZQN(,BD'6?TPVHP:K0AZ+B[7#D&.5[6.!(]VU:3[1MD."R]B
MH,GB[9]=*J461N<I&3:^Q8W^[SU<F,453[<@K^='8CMB/M/@KQ0PX B2*U@;
MIT>*.[00Q*GQ3E,7."HG45HA1HM ?7C!%$M1&&6JS4C6</^ 3._8#4,C)4YR
M4'T..1M9#N#&X^C'L'S(^AHK!66IT._S'K+I?0=5-MU]/Y'J>C85SYX'R*=K
M-RF98GONZ0=R>MW7@$2+QBQD9,N#X2,U*0'$&R-V"15#-'R.B"H !>C9]:KI
M6@N5QZTTMKYE$8[5%"OU87OS:T\&;^G*1Y8_?!K!&JQ BR;^+.U=J7NU+GD$
M*G3>FI,X^YV5E*ML,;+5#6U]#GQ$;YUQ=O1]QTN;=?(,O WIB8VK>NS%<?@U
MHL5[N)OB 7 \^E(LYM0;-E5X*>YZZ5W(D([8)S$U+=D4S]'2LAX2WYY8ZFL[
MQ;C0<\K?NI-<\DIHDJ_X=)Q[-<;O!T!=II?A$)OAZ*=HK7@.7B+J2B=\@]%X
MN.]5G2=5]4J6 8#>''F.!\=458*CM??(9ISG/T$21G(7VC-U.>%5JIP&$G=J
M8XI!72)S:$(@],:!PM7D3Q!9S5=J$$E:)9.;M3E+^D6-G8'"6 4WV]NW>[$F
M<+?\I99!P,[)$LD4E^:>.GC$E'VG8B^^U(.8:$5A5LSP.W48XP+;<<C\R,3V
M2MLO1N@>!'UN3)Q-A@(J#7>=96D>+,9O3L%$^P_-(E<$OTG3SS=<:8P'-Y4K
MS="A"%+OI[3>OY;6; \BGH4^K*-<% .ZC$>+ZNEEVM=*,HYE3_!_Q7LTQRM$
M=-M+GO;U\!9V+\/8=:\A'[D,LG+;E/,3/U;Y?65+2W:.@0^6VG%/F<U!XH7H
ML$LD_.U+KI$O4ZWERZT& K0[,$VF6PW:501MH%[ .BP#VJR7?OX[:FYGAE[>
M)>_\4JTBJ"]P8"A73_U*4TRNH1S=@H4R@D5>D56$B7^YE'D>^@6\[A%%M2E*
M6$>85)#TS)9!B,Y'8ZTH<H[.B\23&(#%'"@ZR7K)-4SXHJSOL.RRE<\Z?;5T
MT)H:V>0I=@P7LP8_YH)N[-L4@+@S6RJ##V?.VL7M.1VT(>_Q0T)Z%\]*977.
MLY>^ S62NV)/EQ4-8N7#B,F,'VBVBF@J,A5@N-ZWO58P\K#W*Q)BBD@N6(@+
MP;B)R>M!)ZI"F0_]^+%M)UHP43TY4]HB;_! Y_6T8XD"_>(^"GO]I'LJQ<7<
M-(N+T=X,!VIFQD$[5%\:+)9V.4P>7CVL8,5],] ['Z_@&M"9"E#1BBQFWG>3
M!Q^=M]SW=E6*%:R;L,!OXZM6?'C#-U5$F*XMW6[W^/O#<9WRL&_='C"$U5PL
M3\ 6M@@&G0P&G9TA2BS#NI+7/<PH-Q$*$0['U*\=D[=VY"V\/STFV%.W3, J
M2D6.50F8@27IQVHHBPUX')E#DYAMGJ+I=) !C^*9@T4#%9@PZR6T.G5-6<_3
MEG8?=CU7[##L[.,%63UU7L?""&G'"O;]MHH+H=<0\93H!@.9.F',Y0<M[WC*
M.HNC&,#\H5Y\%1B+ED$C#U:AL'JRFU3'>B'^DLBT]% CK13ML,,O?BO4_-&A
MGL]-UM[<,5=B:3Q:^)!]X=@E+D57Y\(S4PR[6<_%HZ,+")2&JS&@M&50<J%<
MWN/8YY%DZR$K].&]?16?T*XVH>(_ !O]V^*_:B3RO]=(W!NC2/XA7[8RXO/W
MRT8J;AHARM6VR1*2!K&+PIU.//W9Z.+QC')]Z(7=,OD41V+HG@IU4_=:!#60
M.,WL+$'&$#GWRG4WGX=/>,W-+9Q[6:.%U\.]K7L0UF /=DZ'$J=GL<)/NO(?
MX05*]_3WI+_3PWJ_Y9DLU2-5][G_64U$]QGV$ 2Q2\/&6D@ZX?5$U23J>58]
MT.E-"W6RE=*S":[H=??*C[E:Z.*OGDM>]]\46D&Q36US%)<CE<4:/A;0Q"IM
M<%PWY[MOP.'5\XZEB?@1(SM5,O#[8D7T0-] 8QJZYL 7TJ7Y'5?WQII5[,8W
MZZ@'_?PWTCR;'T$".XXH*3%"@IUM?A:L*1C8U\)UGCRY3'\NOXMP<R%%#G@%
MO>[?>49\=$13#1J!IJX^>_V^"=U33^)YA072,5SPP_=PLF]]!?N6AS$4D?VY
M[QS1':6QQ$\P/)8;TC'.SY0_1"D<K HF%KHG#!">/KKU1?CKJJ#+8:K+IM;_
MAH  =;WL<9-S:^R)=$_#,@I_,O&D@C^:.DJ\X/"3_!Z16(08-@ ]5IK6GOC2
MY&"QZ=#__0\ S^#,^E=@%67WI>,\]#L?=&8Y]$Z/NU>U'DOII=R(._4[\U@E
M)SK]SM8-/V/&:-Q89;0C]!@(<O@A7_92ZQW;EQS!!ORG[\2%CYXE2Q0G<9*S
MQHL@U# NEA.!-1^W+5S!Z_YJ*RJL'\,P6OB4Q>=><WVL"EU?%V% BX$VL.8Y
MN\3D7^H?#)V,=3"9&+QWOM<0^<BGEX)%?Z74U1F%.QK]N\Z-8LDH!3H).B:@
M>Z&Z)6(91M"4P(!'.TAJP4R8/]GPIA5\154+G8^>-^:O"'</$[C'67!7/P%=
M2A!;TUD&B^+G@!9T&?4]^%9,6+M XI[R-J5W5]N=R4P2HU+-H^5515=I+/$A
MT[\-N?%'UK+=!?2QEJ(QF*/'*J'GNZ)Q7G<V7O,*#X2.-E9;OG;"0M>\>)>$
M.!"63ZB*5<XZ/?5W]/;&*-AVQ]H6!=\G)8]-I%1:C5+>Q:0%,X$0Q:31TPAY
MQ0U5MY@ND![!DMY!(!)::)^]63EC5[NLOS9?SY01C36-3@:XKWJ_^5809.7Q
M10^"+JG4U-;P5>RLDAUXER^#[:)V29N=4PU.*'B,[XL+LL]@S<M7DW/6_8PB
M(_[^V*X"H[OP3:O0QWF8/MB#+^JQ2F216IVGM8:<WVZ(KZ@W1]"?6>!6^(2(
M017PR:;0)8X"?41,=FCZIR0(P8?I .^CQ^/5D:P=D;8^IPGO/M+QJW%2LC#3
M[&'1WQ^FJUFP-^4<N13C=]Y*W,:HO.L!81(#P7D?!DMO0TY0C"W[1K4MV>[+
M)U(-S?M9S4Q== _*)YN]<NU.?P!L$U7&$?=T/-!=#)3YLN*ZUV:FL()2GWW0
M^[C 6XYT0EQU.'D1_>?<;54"8&Q.2H5>NZ2@&86"+U7;S)"->F6$?Y>5_V+8
MQ]0U(R:ZU%3DI-ZK2U'D\Z0EL]U"#_0'/K&?^\$49_PI3X+*54DMG,5C=I./
MT]"7N<.7N>0<N+HFR'D#BI26?P ,0CF=M:/ODY[T.#Q/S1@?80)FEV2]__P9
ML>G)9[H +Y]]V 23W\ Z8<U CU6]Z1RRPOK+_&0X[7UUL4:Y0^V"NO)9Q6-1
MX,U+LURAL%*![7LIZE6!RW(U4;S<V%@<TTR /9&>@>$GVE<T2-JHB... ',6
M;0-\U3CN27F*?W4X,KZYWU FYP9C1L+2EU*:C)1V]_;V2F4>M#\O.O0 6"FC
M'Y%(]V@2Y;J[%]_/*A=76.&B_KBD>65MGVBR"<+=BTD4'C;',LVQMNU6+/X!
M(+I4'!57>-^3A^CR(3T$DO+)-^D'Q?(6.SOCK$-%URG]2Z?()GO,Y*SMD^>C
MPJL;//"^"G:F<I1Q,7GJT/;] ) XHPGT*J!D71D'D^&6QOO[^/_*>U,TR<"1
M+!1[*V1H:._5&.%)L-<H[2T;D4&4U\/F<M4>/I@2H>AVBX'6=%X;::9[/=I8
M%WG"U\.H;+_Z=S>*HXC.4QXC!;+5\N:<'NP>97D@D"2\Z$2#EI8DA#CM1<D]
MD?S78*;\)Y@%_:<R&;4N-Z$E(^O9D"+A-R/>&MFL/5AH=^&MB!J.E'Z&N=R@
M*RR,<=1#ZP896I9Z+<H3YC36O6&LYJSG_L:A:$%]A;JR V-=>'4E#@))+3W%
M*X$7@5>.U2)>TDWNQP[1^1GD6BG*]0-8+&!HFM+B%JF6T9A*I7':GSB/0:)&
M%U^?Z%: %I8H*Q)PA=75--EL2VYL-!COA_I;YWM_X*97"]NZZTC<BB#3$SN"
M/(TZ4S'O045QF-ENLO'MT__9(4&^&,CX60_#/+3N2E/'=4:P:ZBH8EM;PQ2$
M5#9N(9GVMG^<>':V<C9:UK]7W&ZAO@[ %&O_AK]X.^GQ7H=C[X;C2\9SU;&E
MQ3A]>8]N0XJ<>$)Y;TO-_#(+H^3G[Y\6SY0LI'F1#6+1\X/2<@*=.XIJL1<7
M(5,2.?XB!Z<IN0*Y7:E>X\IT?7OWZ/GH7+72YT^$9T/:^IB?U_&#\%0.3K)1
M);#PB.=N?.*@]0 QIFLG#,S>8AI8-O&!?]2HG?FH-T:.*M&'-KBH@)(Y;@3-
M."#0WZ30N^[BL?T 6\GNDCLQQ:>F/1;EN#"&FW# =JHK>SJI0#?*R4^6-^)%
MRK0,!W<X1V$TW618M<#UM? 6@;/[ [/LJ.@[#)Y5O^HJGC,:<'T/\_^BM1;,
MO*2/1L$ L:1W5?:K(SL15;$P'3NF=I$L]"-KK)O7[?-:1:^1-ZB(246''.GN
M_BY(0<%"P%^"M(P(F1]2=@SBM$_NSN,1$)OM@FI0?)6>O0M?"?;6!@ RI9EB
M("C+&QJPJC8JM?WQ>A,LX9Q2G-H=XXD:95JZH=(3O(*2#./+,4$AFMNAM/J+
M=)A*79:V+6('\!+OVH3DXN=>W9\2A-ZX, /0G-&88P)%!-:?#YY?+'>MD@_4
MPMOZ;G?3XS^+Z%^\;WP)GXURI@CT)BM#4K<G<X6_@F?G(Q1LN=+C*=DHOL8D
MS%0?!<\X*T?K[[;S?]6-"%W8./X&3#X@++M7M3A+';&NY&B!20EN>'Y3%?,R
MUHL,T2/A9?W!O8;+8#JW0,/8'U6]EU+VDKDW!XQE!2!Y]%S1=]+"EB[^_1J"
M@.; \E2XX_[3.N]]4,*O_L?T?>+5(!@?!']UT3*\_P(OB7:>3%9OTGT7MV<W
M.6W,J+V>X1D.9T\&P#)NXD#TAB^ZL?YYS])E0$]" 5%^(EW L17+G5/,,11Y
MK,=U)_/#;L=UVO.E"+>1,!CWQI( (*7>#I70^E6:Q2_-Z1TM?%5CEQ[OO8._
M4?>M--_F]'M8753"6(F>@(ZFC7_#)1"+=(+Z=JQ"O=DO%/ZL&FWT$X6E.G\-
MO!1]$VS*.P\>4R[A7A\.$\%_LF!TCP+@$@8X?FHP]-Y6DO% H+O0S8JST3):
MF3GAL&@?2"G230U8<R7T%A;!S#R@6:"K'[%*[$@8FS6B3CC*>E=AE6BW+O+\
MBC8\!/K"[3&"\%N:'%FW?<!M=P(BG42U>,=2YO (NGF-&.I&$GU7L96@5 \,
MO)>TR*O09>5,6Q!SN4GM<K1QAFXT (=#AL,7QI?^-M7\.53//G2R1T/NZ?85
M</Q2Q"M?YB7+C:_]G.^KF;TY\$2>4Z [BZP'VL,:SIN6ZEF]E]^H-\AULX!_
M=?/F0U.#QD*O8RJ& *9.B+MDZ7L[TOH-)?N)K!V:'V;=7776)T:WH)CN275?
M$:$\3 ]?X*LZ>&_G9A>]8#SL;_$\EKAT<*"YXMD@#G.=J=^X.@BGCVG!IIA
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MH'YEH S!>-6<_:_(M5^58USW5)AG*X.O3U/%N;"E1'K9/% 5+O:ZBP*+77R
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M^V8NB3@F'L.$?PE#BJIX *5+VBL27Q\R7^N'M0@M["0ZO4[0PI0AK>NEM=!
MC<7SQN((P4E=C!*9''\@F[8QGV+C86"A]%ZHT'V[;SY,]2UF4^Z^PZ<FTD)X
M5DF3V!X=:#M]MO!9:$\&LX_ (/JMI8_G,+#W^BX:[GH6RO-'O>6\J#>\%_6F
MIJGRUW.;^VD:O3K<5Z0Y2 N:7W#H%):Y]L:VC"YL(9A.!J7/P6.H.=!#C*VR
M0COY_=3NY+J<-;+K]*I\FL<$%4KZ#DPDR57LF.>QH2U$1KYQFF=4K,]-$U+]
M?O)[=.)E:=$&> I#@K+1<&$)WO-5Z2K0O/IIR-DJ?Z7\ARGQ^SY%I,?+K@8,
M@1.NZ,VQ=U:UI?AR+0F^F*NK"]9+A:%G6ZXQTN8N5TY5<L1PQH !FG-"BF<
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MD(\/DE- /OR1F$^?.1[BZ!Z$4U@NTZ5_]@"N8@<WS!\49VU912DD7B]DG+A
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MH^Y0ZY<=!LXX<T&A.<6M_YF$^=+<(>%B6/!/Q;CFOA/=T$[M@F #-<KZ(#2
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M^DY\>NI51:"B(>FG:/7ZG6? CGS=,P#9B]"E:+-^VN[S7%X4IM;P*[R4#1+
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M4X,C7)Q4"V,3<W0C>;RUF05),LD%XWQ4JW'%Q='4UF2.3ET"9H).XHBE%F=
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MP>'&;NDJ35A6/P M/B[TY'<ENUYR^O3L\?3LDE-*C$14C:]:&63K*1P2G)J
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MMFZF6= (R9C?I2#.GK.*072ZLC4 "A]23WQ<#B?F[!4,FAK).]ANC=(V@HR
MX#-+;H N&!1N9A/5Z]PY:)3A7$=*I-#45,-,H2(3K*X H%.=5D+S\9F_+4?G
M<%0\9+F^4I-S]A8.82[([T:_J'_[GWM/'G^D:H]F@V@1@9G3QIFAH6W>R0-
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MZ=CZ3R@P Y+-A8MG<I8QNKN@W5@_Q<'8X1,&_+9(R1O9O<M"0J-3$5#KP<F
M VZYG @3^=G/JU?=HO0)^B(S".\+.$/"W_LSE.SC@-03D82ZJ]JZ<>+===HF
MIE]Q$M3IMQ7K3<:9C ._HURZ? KD4],[SI"M]._"LYL]S!FB:E^QOC'ZPU+
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MZ)$8<Y 59%BSLM2H5N_<8&9NV&AZ/DU3CB;]QW]O.OS/EG]OTZ&@(/,Y;=G
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M$9^UT/QLB4?-MWQ"C#X36A&'8@(+H5LE4#Z3]B7X.4TY\\62+<(5!YR3&N
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M5'Q+9P<^,H?H6I%<"H%LH4-)7J]6=XP<LBO.,\D[YEC'7,/?/?!Y .?BJ(2
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MT<)O4S5 +7W@L'JPKM\]30SQU@5K# X(LL.'Q4#?Z15&'<N1;]-(<=0CQ7&
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M-JQ["OX1#3PH33H> 2>XGOJ!E\R'8)O0(YY^E[Q60:>2-"HAS4+LD ?EQHH
MUCY/Y[NQCDQ+\F_%C(+B]*9J&U)EUGX9/'[QVB.S!P+[T3E=]VXQ.12<)4Y
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M!C0;L$E:^G=&'DWOA#/:Y&:;(:+@.9[8Q(>C:=XO8J,;@I_T8QW@C!681,J
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MYIO6?(C]*-09SY.GS+(F1=D]R.%+I>^'R(*K'( 7U5[>A?0Q8>H@)RS.@3B
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M!3<(8-174&)7:^S-%%>RC+I#R@RK;-K?JMCG'TRPUON8@@Z2MGI44!_O9Z&
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M#O\<2JV_^)S$2041:F[J$I!7Z666^W^0];*BSK2>S/*43H^P]P=F_/=+1+J
MRY*7H]$%HQH:2);$:$1O.\@^MW#])[UX-$ ?:A806>V_XNY8UWW/ANUD2(K[
MM32)Y/S7N;D#D5]D7YP7#0@GVG,>I4=^4)PO6'3]AH-,QW9:CX7X%I@5[Q5\
MO?>TE#-DR\C6!TOH:?N6C12-E)=EFZ#&$RH<O*%8:PF,7-QL,3*3O!,96HPI
MV*T/P49$ .D[FH7C@-$ L=1?+_6U"!*VNU_H> JB7 +I9<C20]-]?7WNX81+
MR"!_Y$+Z&54Q;R8E!!Z[YH(O^!L2)!!C%.B6"_$5R7H]PE;VY9GS6W#<+<.J
M254?(3)Z8GCH)]ICN\I9_VJ][1"_D9[92897_DHTI>V*F=/+)XEB[Q?#">_0
MBI%-:/S0)O:3HJA)=QMF8AY2CBPQOE=1?NX87^%L%Y <Z"QT1Q[G)W74^+4.
M8;P&-.#W<1YZAHI# \ J&EA@O;>@=I[T<SU7,5RNRR>+=431=PB'T]AQSF&W
M0</KWK7[I6=+O[,2OG2;2.9](G$26>@]F%4L"=H950*1%"Z]P6T_IQ4[QHE0
M.Y8SDQ]((=FX)X-+'ZVO-7W]VF0:V_@TU\=6RT"XI5>7HWO6,[M0GWE J4R:
M03-J#$1Z<J8@?X)B-!^K",F4LS03:7SY4.- L4IY"G?./NSK8;#M#E?O7B=_
MF E3EGV&808;7[E/S9;%O\;+?QZ;P?FA[6OM&[+%/^ES:,1P4@K7EH<?ED)/
M:3U*!/?A*=:UQV%P3=K[:"!I';9'"$$]R*C8[_-_8J89I30NS>30+T-R^0XF
M$R;TN+XDYZN0UI]LW7' ,7_WQADX-\;J>Y!QGQ;Z["!*&L:&!A[/O-_@=%D*
M!VA7@WZ8')$?(H)"30*B"XA^):XJZNE/:K86Z^N)?PB>(LL,IV?WL;FUZPUA
MZ=Q7",#Q/_K%\J##D>N]'V5EKX A5V1::$([M1EC^X</A=8?[B_L+.@$Q@E$
MJG>TRC0<43(!;_#W;MB]M5$NK(HK%GKF I^?9=$PRV<*K>5?9%1\>USQ%<*3
M0<N_MRD;@0;>W>G])?94FI3$MF/*6Z3O>NU@4]-D:Z;?-O?ZS/4\'!M&=8)V
M%IUK_C0E4\.J]\[54S*E.]S-N"G>U$P0-DKW8H5%AXK<6O-D+7KSM.<@9W,C
ME.F[8>2*S=! XHR5H[7[APKRDA9A]O#BEY=OW5RHH \8+Z96ZL7H!VX"J6VG
MAJ<VY.\"&Z*EGGNVRA.]3VSVW=+6S[#.6_\Y.[E[8()S;<SR^BULXBTQ:MLU
MZ95*6TT91<\A$?Q'G/Q^$X5^G>W#M0IIYGP/?A^<*1N-$-]_48MU:(5CC4T<
M;U;V%K[9/+3N(\+9@J@)3.-@2V-(>V'#&V\$^KPJ0.5FAWOHKJ/UH9"AM"R@
MMOBI]*(8IFD3"[7O!^2L_!HNI-UE0]N;[GUW9[X0M#@0,:^UGQ^A%/R(8%\&
M7[!;CEOPNF7D3D_H@O:I[;*B05B?:53G0@EQH2 (KDO0XZ6(HQ\O'L0(&8=T
M &9^ZJ"D-US*</98\'VM1ZLAIZ]( R.S/KU/(S),\YV1RM![348KQ:)25T=)
M6C2"3'^K3EZ?H+0Y*!W>?-"Y$9$:8V;DG>P(.B'[B 9NM?E+S$[ 2HE^K+BZ
MUP;RFO'W(FML4:.VL_P%-,XHB>U_?'':Q<_,MU&R5B=J?(PF)(961D)_M5Z"
MS;XQ2OR!#&D0)0T%F8FP#^X&\_&W>=@966G8^8$_ACR2K:)X]D&3"8AS73;R
MQDF]X)MB,1+".^W4K->!]8@:IF#[@:;.,GGI!++]9VFO)J6W33"=O&'E._GT
M_*[@4ENAE/8^_.2<S?%!(BJX0^=E:'G\+;0 T&)4Q65G[FJ:D&&P<=!!GF1Q
M2G1_QP97,3D>/X;>OH]R%:=_Y,LLH:6V54IU[9!)$%GO"G[Q>X#DU7LF +!3
M(%L3)KS/$=UGH.J:][1%QK[UOAO7Y(,8@5090\=(/L7V-3L*6C&<RJRQ)(]G
M=O*Y'SL4IBM?(Y(3YN+=PG%$FP;K;M9V'M5%2]W^W9;G7["=DQM3UOCG)4A7
M]O]/PV%G?S#8_S3UWR^B_R?:M:]*$M?_/#K%=?Q7*;I]OHOX,IF$='N%X6;W
M]_%.#J ^^EF^<0C;(Q%H$^2 U9SN>)D(Y<VJ7(S@NSQ[']-FZ"NB@;7K9:RM
M2<U]=G1X&*5"!6E/\40#[]' D>%8J (:H#V 5$*BW>G^ ^U96P(G&CN2\HW%
MW"GZY= ,IJ<CX6K.D[]939GV;DE1NC/"AU. FG9D_NZ+D[&[.K+M@[\8)1B"
MEYV966SC;<,M9UD[Z^DU>: !J!'_9[\EJ;F>,KIYYR<3/@<85FMHW0E?%V>Q
M2^$,;_:8VRNKZ(%5TN&.V6SGH'+L9'<9&;Q<J?:EGZ C4#DJP?L\L;4VK.'\
MVPDD,"5D]CV?Q1NKP2W%MJ_\:ST1I80P@;:4(S"Y?M?;><NS>:(5BF:+]F5*
MOO"XCS1X.WWS4P4FP:FCC-&.2,A<W)N\K,_*$+,C#(UQE:S(?I)7\-L@Y464
MM"QGCE[[S6$0K7WI$T^DH$:RA^!/36X!ZX 7IW;QG$7@!R3)Q/UWILZ=&/<.
M'Z=&NJ;Y8,^R!9-PMU-]C[\6U= !=2HN>T5%Y2X],4$?:*AN'\,@>8U_M\5I
MA5-U7?(K)(]:P)A&=K" 8[W$'XXAA4]A%Y9HH%CCV1P:.*/A#CM?YT %1E9#
M_M"C,(P>?=8!XDSO[P(IIW3*4$6;S(7B+ME((RQUN:GW+&X7H %>HR_9.8NZ
MLY(PD/LVV7S2Y#D4>>.8#H$?=3D#")U'94%LH0I6MA![8;GW@^]C59BZ*9_3
M%X$\%X<*7==8?0H-!&WLK=ZY<=L_5HOU^3)\%+2'=WJ^A[?663_;=2Q0$E9T
MB"32W:-#!)8;[/:@@33]9+C/:%H3?Y*H><(-V.\+Q&H6G3U$'TRM09GNTJ<T
M4-J>SSY?]BZ-32Q"LZ*[)4R2IB._0$>C=O0#:@0"_MY.(5EYS5#9[D585U1'
M0P<_J3B6RB;MP!K4)E'TVTA=[,CD[,<DYNM,3)E#L>=XM5V-HB2P*#4?%&JB
M8/N-J&%^<E[[7#Q0=</FN8"(2P-]I AO47>>I+U2:#E?YYI\/'5Z@4UJ$&N/
MB/CJ$4.$+'*0DW6P]EKA).\/\A"V+S1+5@R!,N"ZU[N]MMY>AKQ+\<RBE:W[
MW_P*MWENUZE/,CS\]"-1.>N[ E7%=3LQ4+D48$8/W%H,P']J(X:T7,NB,'J<
M!X;CGP7(9MXLJ48#/F')+*R6.NZLQA6E/H_IY4D>A[- O8 YC?!W]:PC#L\C
MQ/F2WE72F24]5),<\!/1\&O 6J;L'=(ORMB(J6X)TM?JJ.:=\SV-J,DC;$,#
M8X.U'I+D&41?C*:;C)@71&DN[K%VU3-"VKN(D*Y9J,_'&SS+L\2P)1-_5.T0
M&A!W&WJ"$CS[80K9V1W!:4HZHS1% U#,>]\_6"=96S/?AP@N@8QAHFS-7#]-
MT@CA?(!?@IQQ^PD%H! H4)B?MXV J43Q7]"!^X^3,'SEX.$$9$P&TRK8C\GI
M$]],@5C>^3RK6.=#+T/<8K>6QL0$4#N"AO\(,(Z_!UA.3DROBMV*=K0"3Q;N
MX\HZXAT'-1KR!9TZ'/FJ'X@.T_)0*8]K54$^\CADKUJJPTZL/UN#-*:X\Y9:
M CW*IZ=-%'2SNVR1OV<LNQ4_>'SQ#--6(_$7FAP33M.$Z6GHU _?>RNS_)"2
MM' )8"$AHM]6ZX.]'83JK2E/P26;U%G.8A:>;Y[8X:4!=TH@SL\B;U&(OFNK
MEZ@E<K0G*)4@UTK7#*]JW#$$>H6,@T[T-%X&'38>OCO9SU8"0F?T)?'RO2D.
MFIBN1=N/\:_R;"]8LH%+/KEY27W\E+PO.FBW>5:G\'" 8^S5&!LT/EG:Y,;$
MU_)A^CQJ0OO2<A&DY33KZI)C)(^#@#K@N\$Z5DOD55%/5J80Y9EUSLK"?.W%
MXIO5G''%2/X.$4%\>UD# HDUZZ\C\!RP2AJ4<!0-++W!T./- VLD_ECEF+\E
MY."I!>3XC _UV5(8NO@M)=,:P7^>^'%O"B5Q 3U'6".OL185"EU^Q.C4X!A^
M^1$C(]WOL,6NX9U?D)JF_OTD<H.$5RWW!I=/7J !TV!!;U5):<;0Y/H3RE6"
MJ>2JN8*;4[HC)I8M6E969'KS3+LE=TN?MK$>E$M*VN#01VCR5418\)WR]=_4
M+#0Q#^?EQ")IXM_M<6-J>I=VGWVID9NDK+?5)LU6,>@Y4^6-.#J53?URAFK^
MEVE+8??PH]\;V8VI]PXFUQ67#[]?+JWQ,_51\I?<73^B/\!=(HY0&="_[C1"
M)SER9.9G(>AQKIXF$O*+ ,1>^A.PIA%_<S<XF-HL>*'&^O,W[R<I;[3)A&+F
M[_$[@ZSL@P]NCK?)<^VPQNY_N;LHH@IQ7*0[NRG8#W? 03Q4ID4#AI@(% ^M
M0TCM/O7H<W_DL4+ISF;-YE0CCF(DQI![$!;<+_4N&O"L,X6_TO05'Y/H&7@P
M,>^2;D/QE?HI@RI)&\M-\&2?Q6ZMV?R98P\G7RF>-?OW4HLV6L.(0WJ!!B8\
M,='O<R12T;I3/6;.[ 7-I@+S5L4,&UEH8*1=Y%</&RC%@&@K;CC?V.+MON@$
M.Y_( K-1+"B&28O1$3\TB^'CFM@.<Y))Q879)"*@?M#HH';;UZM[]<-.91\_
ME. GK'9PY_Y"X\HK<YU=;N.WE?0?5)J,F"AQ**%R>UE?QG1Z"M:"J/9D%'_<
M8CD^LU.@=Z3<CI@F A-_S)&P9U=:FR_!<TQB'8C3_A=*@/RK;G%:-L"NDZ>>
M70Q+V?:B0@,1.M*81N(QY.B:OE1!N(=83O3Z294_2M1R3/BOC*%*@<I%_6!7
M43 S@2B>!DA\".9G$=WK6+H#3 JT4U/'V\U92B:8,SL*%AT]5/^DZUB$T[3M
M--AC.KB3KIGH[GVRU8S8ZO*I>PJS,6**'*<^/K(X0VKIB3/C9Z7@T(]F1BS0
MJ+R@8GOR#+?O7#C-0P\-^#-:L\E,2BKHCLFS<CB"-E3<ZOV?W.547<@9UGZ2
M5?++TMH"1+XG013'$*/ ?GW7?B14,&IZN"PZ>7.T&NF=2!2IUA!+8F=DO4%D
M-#N^1*"]OTHI*<\Y?<KPN)=%:?QQ:E"DSW\#AGQE5^KD?Z;]%ZJ32AJFMDF3
MSR%&9NP%FS+6UM2OE>YBYWK;QJRWZ%YN>4B']"6FH $/*330,I; ]M"9::=D
MZ#.G3Y#NVN!^!2+HWNQ)'QJ09'=90@/[NTP7_F<:A?#"#:K=ZPK.'R[F$OE-
M0GY*+IN]("1B]/U=&P2!GT8AFQ!Y0UT0'R3DI:L =']Q#<;KB:.;U$P@M)U(
M>T_Z1TSO\S/-BB+Q@Y\XN:'B=X>65H<=HPE&2OG*[2=UG\#-0M(BQ(FCW_Y=
MZ2PJQV7Q\/2?6@RIT<^=)Y)9"TW.B-N3I,G@?V'!H=3K%*-L>_]1#]I,8WI[
MRHIS=&)4>EG,/8KJYF1#0#L3C9A':"UA CSP;>2DJU6&L?F;B-3P5AF]#=ER
MKE!. @;7)%J'0[E2*X5G7>^5!C1$2)VP@LX%!D)DP_/&SUS4HUGLT\_1P.MU
MX=M9GK#F(MGU:BHU+MZU"N8/05S]U E-R*8PI4VUMC\)EW!*S:2(6XJX:[A6
M2"'B(YH0E^\;B8,E!_VG!^?ZO3X[Q_Q$_Q0<=O7D/E10\G4;W9>1C0?2M *D
MG.4,X<&^8^%$\WH:S;-G?FA@R@ 963ES3U&.T:!HV"1(R[#"^4F$D>U-/GW.
MYQM-=6ZJ=UU8I=S!/8GZ#"U&N^R%,) ;&D P3G(@KV$4%^*FPEX>;ZQC]&<T
M4#0Q-;7;B@8>/90;7X\G=$OJK>* :TT:(+%X%"Y6.% "RF+[3+*Q"X]C.U%D
MSG@F7U]F>\=_,%JQP5'V9.UT>$8^PC46RDC@"0KMK+U>AZJ]7G, K3A *@C]
MC=9N>_#,?2&P%*\8_L!A'2ES_[E12-JM@YK'&Y^.:,NZ+>_K3O+F\ 2OV@;[
M%-]@ 2ES4I@=\/?B,C*1K?_&PG25O%W(,]B1Y:A"LR=[1FGYB*$J&I!ZQ(Q2
MI,@C+HWIM:$*?H,&\OLHN+,-,XN>D+CQCIT1$?M^^IF;3A:+X=$_B)K0P!T9
M1MX0YZ=O<N+DQMNQ<LT$A-]\# 4^V  T2!?VLIF6D&$-)VBYBZ8@B?PMFE#<
MAPHON-I!&M53NA+.E@3=!-7,X=(A/ISIQM2T4F2?C<14<GIHDE8<3+[[*R>!
M*@PBV$G5Y-0W7K'3GNS09TJS+T5@!?NHR5">+%22U!2+D&\5=CGV6'K=&CSV
M/'R9V;E?[+'V?++;F;K:X7U,!R.^C:C%\E%8P+?1=*G<1HX':"!Q (@,S<K"
MFVT$^P-W.PKC4'>W<;82G9/XXI9W+\"14X?!6WTS?=9UP:=M/*-[\%C.4Y4S
M:LN[?E BUSPGL[A-;8E6_YRZZ%_J]#@APWMK,M>*IE(H1'YM/)7/^LB1.-1B
M\QR+4Y^QL4$ #U=Y/@#U@/>."!]=2M\^>?$DJOBTE1@/F_AEG<X;D,_OI2)A
M&ZY0VZB:O4-9/L&F#4Z)[P6D =,[%!&?^;=L,HJ)Y+K:W(XM^8XE-W:MF_?7
M),&ZLJ%C"")YZ!-X"!I@9 ,?KR2=4XUECWWSD,0\S!BZ\T,%),%F=Q<LM-XL
M[P<:J(&ITA%"EDSB4+6S&"(I>WS_8-<??,")$;GZUF@@)<,MA#)L?[:=L^_4
M<:/Q[^%577P97O*O%[<\,$F&A(G2S;\EDI0F;LJ7)II&OAE\=;V$^O6<<<0:
M4.B/(MZ^A_(^AZ"PF. :M^:3J";>N6'?=VSQ0T0V'T3NXW:&#W+AF_Q::RJS
M1 .-O8,8UD69"YE]!MGO7,Z3NK/Z*&HFX:OE?#1_YLA6Z&3M[H+<!4]+3&Q&
M8VZ<_PW)42:62A&[IZC9IYM3!7MH(&!;6,*:NWR@Z_:+"WWF(&L@^'-CT=S!
MM6.5=7WQ'(/RO%P]@R+(4>"K;$>\S@1B:6KCQTJS62JC4(YD9-E2_5VVKCO1
MMR40!N'FL9_.Y3-N'/\49P.%@[!S.J-7L=W.+X7A;2IM3(C<AR QF)YD[/7Y
M6#D64%KO[.PP<DHW\E28M(X(>5EUNDY3I;0^TP'O%7!#S]# ,&2W\G)V?!,:
MT%A5IJ170"@L2D5YWWS(24&E9^=1Y,J&^P]I3@76SG$*H(2\X82RQ8F.T)&.
M2;5J:&;O&[%_,'<EYB&J[<A&RE#/"YWXM^@3^(K]##KH7=@QYG2UR\\M*"5N
M,GG>T-XF\HHPX6SF$;*T3GOT[-4")=93B1M!#F^X6F4CP;0CI57/^)U2D)J-
MPG!=64=1"-?T9E,9[(R"!WR.P&AD<9[M_AZRYF<]?UO6X7"YK"/8!W>#P"6T
M A-,-S&<WR *LF9::0<+U?=/P20@%,U*]N#%!);7)@J&(=;/9;<L0^%6& Z-
M'$-Z\:&\H\?''G' #XZ%?AKL[!T)\VG;/H+E_!2^W?'M(,+_J'!JOC"%TN=4
MCH%<PM:F"O+CUS6=VVLU&DS(HJ%ZA68:]FV>EN%K3I^/\*,B2204>8\:;CRG
M-XX4/R'[F+9AMS99>F\OI(>2(<I6Z4&$3Q;=]][G]-34&M#'2#.\K\Y(I05)
M [56/G8HG&OZ7:&" MPW74_2:_11<82:#&'-2. &::$,UK!?KQ2-;72AAUC0
MPN!"W^N*A-=!^U3?(&S9:Y2\\0><8@^E%T-'EJ1N:2LO+YN5L5GAML7]H&X+
M^D"RVZ+]=2 O^["VF!JP\V8 O]!@G*Q W=>1>)0'<="K7:.7;O0]V(X(!(7I
MMCZ#CY$&:$7R]Y<\P\OV!44U (19DW51C=4" PX45DO*%21>)S8*4O2VPZ'
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M?3.Q^4AQSJ@]WZ;L4+"VN/BQ2!=A$ZN\0*O!QSSQ(C%.:%?$["' I8/\SJ7
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MIG\5F4!=X[\3E_LDED#]S?\>B_@C?^3_G2#=P(#^.ZUKY,[S0$+1%Q'_2=@
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MS)V^M(:ZCJA*B+-<!3#<'?B*QMY_&N'7.?^Y?;):ZQH6LV%%>AA]?AI#=2$
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M>K;4?MA/23;1N4DUYQ14[7Y:_SO%IPT&U!2E=9I3+%=G+NZ*NIF(;Y )&\(
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ME8-+DFQ2=!W&F1%)S>\SL "%+M)*Q"W5QRX8<-P)G:[2J6*^FX8!G.*_G&!
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MC"2BRBQ_Y<[Z]C\_#]MZU 8'*+V>-6^H,Y2-^J:/DTG&X[C2=4'BTG5LH%'
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MCT%;O^!LI.I3]N^G95.C@<R^E#IV9](SMQ@;'DX(:\HE*T9Z1A+OLF2_?/K
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MBXI"=6.BX[OL12E&T17O-^*L7S3]MV4SS%D*V8X#K.C]F.R:'*Q?9%BZ\0X
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M!?PYURQ4U>J>N HT_TTEZ5X977)(=6@3]_1D<V%.+#HO;--9>&M\E>4Z16E
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M5P&P]E1Q8!(;848PHC&Y58:3A0?53Y\6RKX=E6&S%-]3'L2NI&=H.C9^N)2
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ML_[H>VUF+.H]=VY_L8ROP8.BK K(\ )VB(&NLNKB]9_R5#^0*F@@;I$5U;0
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M=HT\U_3;I &1.GBJP6BXKH!03:F!^0Z1-:<!$3X*<\'RRLV!*_O\&;'@*%>
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M3R^Q^KC<E70O\7'/)+;*?YH'EZII;[OI3+P7[Z+_:.]?7_%ZSKS2QZ9&=#]
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MQ@9-GGU?ZFXQ@9TK_BU/];\XD??_B48QCP:H5W4F'_SC#."+R/].!:O_-UK
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MU3D?<77M3SEJ20>C=D!3W4CZ9?Q[UK+^XMTHQLD^)^1/[R)MEYRCN"!(_E%
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M/@(P=';K2G%&64&%B5$YEJ']W,CG7Q>R\*QFQ\AH'P'1L7^4W\.1#R^+GRA
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MQVP;#0SSQEC4O4"["/%@$3_-K^#H$\B'=PW]5D)ZTNK<DWY6KI8@:(65* ;
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MUI)QA7UC-$(O-S=I?F'5K :"1ES4GJRJZM#VU:4;B(4>$$M\4^JQZ1MG'4]
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M_^*%_TT(U[P.1LUJ<063($"KS#L/Q<,$ +@ ;JI7_XFVP>R]!JTAGO4"-SA
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MLN'PJ@)ZO55O [BF%X6KA+LP'HYT:G?9XV-*_BSV<!V,<=77S+@$]W$_,ZM
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M%",X/B\5_1.<^CL(2?HLL6)$7)S;"(\FEO&./P>9-2R#5%]R0."!=-UV44^
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MU1ZR-;JC[X-M!6W5$OD  &PO5Q($/H3BE5<6;!;NV",.(\.L!$9>F<(Q"&@
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M:4@M?^GMSZ'X(D:$_:D*&0'G=(6ECW#[18OJVI7O6%#):*:GQ/1'RKG^DH1
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M.[@L;DAGTJ;N4W[\1\,?:_($5L:CHLS%2[/UJ@'[XV(O\PJ%<<R(Y4=80:8
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M<="S:W\C()+<.AQK*]F6%FXIB&^412@9#:ZO_/H]?AWO@G;;$UF);5@3.AR
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M@;5=E?PE<_JV_88>65R-0"I"!6=MFR< X#)L&([3N=+E_CW#]([7*T5$0OB
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MEU+S;J#>B1%Q&Q4U.*/"EW:A^EIGR]1XP<C7A$E<_QN4@B(1-@@/ ^1::M?
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MG69FE0 #X :Y9&"]"XQ-6[)JX>"O%C%@SLXU_]^J\./_2/OO$G&T.>@XY_H
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M';.6+/NP!SD 1?/(N&Z'V!#K91+TXUKW5-I=%=]MZM0 I?V:,BZ'O/XR?_.
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M%V&ZNK"0PJNFRIM_:"$TL$-"];V4"A<8_CJS:Z&5^T#$-V[ BC>;89+PO5H
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MEO:%(I1GI3F5Q<?N0=+*#W%.\SIC9N54798@ME+'ORD?]''W8@ZU-5/0Z43
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MM:M.$N&-S/6^6@;G9,*7Q.]Q(J+0,4X5YIQ=_D@[3]N6A^DUUR:SFWSA_TA
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MJY'\2B=+%E^79>9?3:#^L\W5_]6I[B/#B=GJ I4E89!T--/P:L??(/0L!PR
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M'CLAZO&UG\:8F#*E1+R9BQS:]!7U(%":^=MDM4F:VM-'>WI-/HX%^K X7D@
M.K; U1)?_'G4CZ(.K$=*7_Y\_MY+== 'H_--5W,5'DI7Z4W+V,X_4NB'A3DI
M"UWU#6C=9_(AA[Z:^63V,73IO [',EO9%H_3:U8^D"I Y" +DWD&DV#GD>\[
MJ/9,TB[QU^7-6+UR(/U'(8EYH2O^74J<4XKD$,:X(T>KYK8X/CR%[O?(RVFL
M6$:<KJK+$!+:YD'6M,7QMRR4RF?A6M9-4[4AG#CXRPIHD:6*K)\IFXCCZ0(O
M,-N:N4)25:]!GY..%:['_&@2CL,MD*A8,:[,.\V\?1^],T0-3YG"W#N(5I:5
M/\BVC:RKN[7355,L:M>'(JT_.YN&S+2%C4ZBHS.S'\5;$IZ5JI<K+A1S/U=E
M"EPI5F;._:9D& \GARDV.!MPP-IQFGC LT^UD&F%ZECI!;)93>,3<&L$^>2+
MZF ]LD3?1\-Y7":<QYF4R&JD)7U58<G0_H>U.5,1"B4!=8EOH!MK/I@>4<K!
M ,M^/QR/^G7++Z*:]DP"906%>5Q_ELOW@K!J3_#&KGL32T^N0_AH0_4!="<5
M)-3/$) HY5P!!+/J&C\,LE.;-EZO8WT]&YE)P*J=!)TU[XH)GJ:PGU"WSAQG
M-9^?*Z<IO+.J.=\:1><49JMU U.3WSL0J.2FB!6RQ/U-PR+NCX:%.[*^*A*V
M=Y@? 3*E=ODC#0?7CY\FM&R" C<1SL'QYXU(,1)J""3[2J2#T>O/VZTCE'SR
M2V4#//3IK;7'Z%\&,U%4\^VS+126:-.KT@I'OP"RCG5YG!/$&)LJQ3),*!<X
M K5)1.7?G;MZ72(69(<E+?Y.2(R2W*#(_.;^DI9,%:NO6I:/=SE;H8B.4PA0
MA>ADW"TLR;S7_.,4!NC<Z3:P,#*5);K.&^.49\2'X.S04\HIDN.!1:7+!\.$
MTTO9[)U+)?&!)N!>$?/ZIF?"4XPKFYP&C)(C*L]UVT6Q7RQEQWF0;+CY4L[V
MC&T9VSD&?HU<420(VPF2ZPX^BH_6- E<IT*8!VK8<<YL&Y;,T_&\BA"@-I[O
M^GG5M4/_M,(3QU::7332AI0= U\%=/\17;+DM;7A2E)P'OSSV7^G89@2VFO<
M^G03->?BT-?(%.,8Q;2D! 6Y3+^<!Y/T\8K,)F9&4-)U]I8G8+7R@LX&+[F^
M99ZKUDF62MX+LW5R'!Z?B$'L'2_0@1%3'S=SS0(,*7ZQ\T4%9P2D+J1IZEJ[
M.8ACY8KQ;:"#\&R=]]68D@S9V!FZB=/<->37Y)P5J-=L""I,B$Z'>K%R[(OR
M1D:2<FCS%2VVE/HU /UWW]" 5%V*71?'B6F0P4,MXW'=:%L8@,#]Z;7A5&E^
M_=0;3R)UF2W:&.S2-7*K^[79RMGA%1(8(+9&%HX>;R4OW__65"QP4:Z=N!S!
M5]=/(H L5/2.Z+Q\?TZ&[L!_"$F)(Q+-7?FY)K#V"WNN_]>NRYCF;@;W+%XW
ME*BM[:*U)"B4[;U $F]EUYH@"A4P"JCA[&(JN;O ,=/@SM^6]G'D96T#!HZG
MP+11 !%UW$@=<."N)CAL)DWG\%M#M7CR.@P0>>RK-3MS_UDG9JFS#H(=)YC5
M+\E"_YB+D0;9043L<#$5 G+I0GO./-*!DQ\#!K;>O6LW^ A*2!(7*'^]=I9(
M(1*=L_]!;MC94UJ[XN3H4PMJA9.-'D>6\1C=)ZH-Q36$ 7H$'?M^?Y[]*?ZG
MT# B;/KW1U'2*YO5F/-D4HZ/)WN_\H@O1#%5!B'\8Q%$\4GA;VH,;<-B=XPB
M)RT#@_ IBJ7'C'^=';/]D,1Y-).3K%_R>4K%@M(V0(EN9;H-HPZTI]<-O_Y,
M>1]*NT/61Q+.!8?]SQ2$/T8E[D&Z,LA1Z*0F:PZNA6" KEI''(\J5,4#M[%/
M3A$:_#WJ]@:^;'@#7YKJV<5RP2CF2X89C711 ;'!!_S;WK.=#VS?DHP)KTJG
M*[&0?@T&^JN]K?>T? E&2HM[KJ6;KZ64?)A(=L7]:%ZZM$M)V#I]A,N4@4?Y
M.T51LUE6,^:%..J)D>YG"<8/S3MA'*]*#D1Y"/K=L0!6EE9RON=@NBTZ<O=1
M8.>>/R-H0.)O7:*;%0RW;C   Q8\(OH[/>$P:&DX?]1P2J%Z_>?+G T79 S?
MZ%93)O1\\D5^AGUBH._2D5$)#ST&7A><+3<=!8>L25+NMS//;E>U!0T*:?S.
M?XYDMAA,O:]W%BI>>#L$ ]"6P^.R.0&<KFC,<IV"H/+H%?>GH"<2B@]QFQ]#
M5_FC'> HE?:_>F7K22\(_[!V9*:9*M[/0X!*+/UZ'XO>2H]0"*SR_+@)V3[U
M-F6C3+_N8.2Y:#1MW[,F[+@R;F!"+,W8L(0U)'",>HUTW7S*R9&=DRN[+K$,
MCE!FQAHV-1.)EZ>$W2'EF-XZX_D-UJZ9;SQ@@--&7VD80,+;YND^'@8(KS"9
MX+*<KJ40N3<+YQ@IU122D@FU0H((0U+O@MJ33BL>O]TS_5O]55BLHBVVP[']
M;#*P>T.G+ N8<:!455/-8_@9>4?7P[6?3(QWS?>714;*F!!ECHDQ!"NTN;YE
MPZ=,H^^\7]89.R$]G03MIY%S6>QY<(8(A-RRA\/O;>)1UA<8 #VXQ_1B+P\&
M6$V1O-VB.FT4@_NK1*KITQW\)T:IPY,:"'[#G_[6U3W)VV6JTX)'^ V2WJ9/
MT#_E23,=+72K6+=&E+0P0*8R%_1Q  8 LT*_G1D:M,_6/HB6L#T/VEZG!K%0
M$#N9-2%5D>-BJ;A$\<7NB$3&VS4GCH0/X5<;]D^(]K8X;@F9"0* PA2B+K'!
M!NWH4^7NDL1[ZHN<[P1YEA1ZR%GE.K_'(?2Y!&;P2ITH]PDT)J2/Y>QFAVW_
M^>X:(-;1)XGK[H#2<R-B')D7&[:L1I1NG!+._/&T&W$;D?QRU.M7%PP0TKG!
M=7<Y"0.<#&<^NE:W,X &I*9A@*-D:-C;O/7H%_N4[#ZU4UMU$0N?N:Z_6(T^
MS?7APP#.T,3Q' *R&L(M'[KL?WY(.E4?A9?5:XZHU+-0Y-\XO[][ I*%)&XE
M7RO#[Y2$W_FG..7D,O/1,9VJ<]DK3S;I05EA"' <=3@H&B. D?DQNC#OH>IA
MI^X_:FIWT$TUMGQLS>&A8.V,Z/'>#G2SK0H5EG_DQ,(!C>4GP]W.$@: )("Z
M,N&7G_9 -_>J4$'Y1Q88 '[]CR(#*!=^W;WBN/\&'GQ1OG;L3"G! !U_\DU'
MMJ_.3$7=D<3H_F#GSZ9&!:I!>3FR.4YI=GFDX*DTBXA-K]$<RP7'/+?WY[WL
M2>>O5,X<%YM4B%_^HL245UFR-)NI"+H\2%?M$]'R&(I_.>R)RX."%EMI31_@
MDF9F$Q$C.N426<[ Y+;[TEZW;OR33[K*!2CV65 7_]*P(@ @KDCM%CA&CVG?
M5^<4UD[;WJA;";SLU\UUR1X<B9&X$+D(PN0FJA N_P(1[QERRC%$@0'D/9/D
MWV$:RX0('_SR?(0F#OMR37WD-R4<>)YE1S"M/C_ "F8]-NZ,==4Z!;K-'DRC
MC?*\%1LN$O2A^;0:)L%8TZ;O>!P'Q41\S<Z<9HG[FC:(#!"@(B_^TAL^N8^*
M#AOI!/SHP!5&#(M4QIVA&( "RFWH"^HH<%4_I?F9Q>NI3^'+K X2,VSJ+OA?
M)Z1)<T$T&F1H*$S#U)GF\IV+W^)[;F8&;X,,^>CR488']_%W*A!6+^XU$S2C
M>9$6$E..^,,WHG$-;@WE'&2V!1-3/JOU9)Y/_OV^[&R2WM&Z5WXL71@_^_'A
ML^(H1?I+@HN&"%]MIG#^6,\M,8$JKF0G= $%H\T:C#4>B- E(A,)SXL+WCPV
M6D5?BXUT"^.&) Z-+4[+%-P7U,F#X2Z@1(]--E>INXO8 ,4*T-3DL3CO;ZY-
M12="?+S^3/?<7TORB$%N<W[(7O#E!0.@^ 7]=G^X##GFM-"IH0+VDJ!LC[HD
M(?D$KFY3>ROC?;B6"?)H@;OGS\KL,&; _R:&D* N^^Q?K:#R'VW4S=5U[9$6
M+?6AZP0-Q4/$SF1(EHBK2-!/B\8B?;VY]DJB/AXQ@&WB1'0+H5$4H8''$?WL
M].523FV?1;7L,!:,?W5!X/^U_SESG9SDX$#\'UDIPI)_QQG&)'!?$X##N+)2
M7\6QO-K#F9AE'33AED8IY-\%X4EN9GX Z8$N774S'RGA2+[^!-IJ"@/(R1N
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ML<R,@5A_A2(9MHUO4<:JHD:[-^?^7[]:D[;W%(^FO]"[M8W $7(EE=@[+X;
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ML".?,^N5NTB<\NAY?*01\PM<H=(>;TD*2ND<?FZU+IE')/?B4+\J<IQAYIS
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M4%XY.3G8W[U1<8G77\X]5]NOSW\S;6!R,NWX3/DJB0TZ'*"T)'Y%5K"\=$W
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M^H'N%'B+,JO92P9:L(XEJ3M9_*-V$L6-4$7RI:P)JA4_*M 7&Z?%"TM "N)
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M.W%P9#B%]"U5"\OI^!( [W$D/Z.BS@:>Z&^R]]BAV$L02V%:XE)+/2W,> ]
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M95:G9;#06_I[=XG?5;6;U?[Y>X5^3_%]Z:QFP+"_Y.$8!!EX_37?0Y1&O5:
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MEO6#IN]T%S9&W2\.>5>SKBC+EE5[OI->?KBD$+=D<&/]YD:>SBCE.=:XT(<
MN- PNL9WK)*ZBDD:T.=Y,YZAW);7M-0I6.%[B_2EB3IC(IVW+[H1])-\Q1:
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MDJH3],[$YAK11=B1+?T!.PV-#%/RH)ET'=D%>5IZDC2WR1%"V G3%M"C3@O
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MLAB3\X)56'J* #9&&5[NH)NP"Z%@,IK)AT\IN9ZE_0O$KJ$Y("8%/YM9)'-
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M>:_%PH#P7 'KA@Q)<YIYLU(AZ&57!,>U8:"FXOYM;! GQC>BNRS^W43:5 >
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M@GT;@@\^MQME1RFNCEGJ\^KRI4%]7XXNYK\M?->N?]HRHZ^_H,7PW#!E.&G
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MZ#DF^]/G!7$K<" D].7#+:'I@.ER+]+J&"=KA>V%!@FZ]L[J+4'E. =UQ\G
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M/=9AWS76<=8_7:2C5WYD.Y 6;:!?%^V.^J<+/]91E98JJH?]M&@80"+ZSU=
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M!FE!7]"0=TD:K(TD.]3@B+3C<,D"!@_\'-S(IMG7L#['NT[CZFQ?^AJX+L
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MG[W@4F&I9*3"\3&0H7(A@M"K=8D05!RKQEO;O(YT0IA?".I_TW.=W_KKLL<
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MG7+O<E<_#\P241UX-1.D2W:LBL:062;P'[]]V[%4:+"_-78$CEQAQ-+[9CN
MK+QU_8D:"+15BD_X^4["L:3#KD;I+;B5D..MM-J"5F8R!,#<$IDL+<O?OR^N
M9+_I$K7<+STB)\=3UB#]A_Z CS_8J>KR4WMH7C^(1.H3:KL_V(Y?R$/M&0Q
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M-?-$NR(^>7I]F.W"A&IK8\MC)L/:&%DD,/%Z .,L\O/IK'E?W==TB7 ,A'\
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M_6OO)&7>=ZYD8QA4Q#-]\>2,@7RMW;7126 J7UPC_'F=2A("7=4> ^_TV]T
M$_&;"0[;@J?A<3D$?8RX3:M,B73^F)TJW#,"Q6J')/ PP>(;CSY4/<B/%;'
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MAR:\3/:&]IY<'4-#7BJ)Y4[/2]:9U4@^>@=0O.?H@,0&M2N:4<=OQC?!I9"
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M_BF,NC3K!V7^G'C&@8/^?.HBMI!E1O+9UMZT !]F,WIX$#^. $.:IZ\[NHE
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M^XZZ KY"ANLZV<8Z;- 3YI!LUW)2,II1[2VS&D2&UD(N3A T?N_U2VDZ- S
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M2X8!P,^C]?2<^ H70,'3;,.KHU@D\#JB#D0![OR.0IX?;C<O'8_?%.>/E_\
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MTVBK3+6FK@NBG$-8;"6WW'KJI]'(:G5-X"A?$FTX5CQN5".GR*LF-.A*.!+
M%MU!^"HA@44')+"B'KYB=TFQ#X6E(\)T,GYLD@>'/*^):)R.+,OG3EHU[8=-
MMA-!:ZUK2=_R6+1G*?0<\C- VF3K\T8V%VR#%?]96,52,05;7:Y(?%NR=K>F
M,W_U,?HG%\K\E)44G /\MT[=J$RB]A#__ 0*QT2U]O#Q_4!A(K<LJP6[,?*Q
M9"*0N1:]:\M#,9,H:+-T._X\S$]+(^*!ZL=(PZ0A<?<-92^)'/V(.I71=\/E
M6\5%;A[*.%$!]#'VP%4,1DZA ^B@3!?F!2[MF*KO]4BWNCPS+YK[TB_0OFL.
M.2\*;E\X>F$(G@'=D%:L$A[PR[KDU2A6E^&8Z? 2&DUOE/UW>\VNYN?_3J\Y
M^_(^=)ET/>A-#".AH" '4[>D&+K+_1J'+W9&0JQ)8WYMWL:I\SM.R8<@2&++
MN>7_P]Y;A[79-?VB:=%2"J5 2R!8@>)0M,%+*5Z@:'!*<2CN&J1(4UQ;H*%8
M<2ON3G!W@KN[VPG/M]^SGW>?Z]K^G>_=^^H?<W,%R.3.O69FS6_6K/4S(??3
M1G*R9#BD<&/+XE48)!:\,\ J,$]JJJ,7IH4M=1B=:% 9=>;6??Q=".9K6*7:
M#Y-W70PY0XT;S3N]XV7*FT Z<P].E ]D_-NY'J[Z6;GTI67U>^]H8-G[=6TW
MNU=H]?FOU,X"]4WH8S)>6X_SDI^>V_JT@S\]05 YD% MD9JT6,JOC#8-MF$:
MAFY5?A\IBGF/V6V0/!WE*[S#ASX&'U='FCOO36AFEQSR$G%9DG-*"WO?]W29
MHXC>^P:6IQC-;VI;S,"!MT4.;X>UC$ZUA7*MGQ3<-)5QBY";7>0@K!T".G<D
ML#-[:D&1-FAS]@T;6"R 'E0X:"J*\X*615EG3.!!13A_?[IBSEN?H1LR@+>F
MB=J#X [T'EHJ.1S3;4AHR3U:D'&^RI[RUR4GJ,APT#!B*/($MG[A%9@[EJ1]
M)6?TP_]7*%U@2![/6"P"-8>3X-DCQWZ.>:NIHW(+)'+3@G0%'!_-YYDP@XK4
M6]"]Z EH$\=U_9+V=9S7++OY>=*F8,VB$__A6$8]\9U1]MVQ#!")G(&@9R.Z
M R59/ 7^ ^-B3)(LP5NY<Q$Q%<:-B'?;;:YM]GZ#12+SVIOUAV/RMX#ZOEM
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MLIZ'@6^D&VF*&M']^H,/'A!/7/'"^*8T82H:-"[S$$D@+OXW;)J*?(CFX-)
MJ?O79T@UWFZK601P6=Z&T[:QH4V4/&?(7Y6I.)5]4ZPS2[PIA'__YL>14))"
MG9_RT%QM.1_,$/<>5<RQLJ^$:#M-$6;-4_RST[#KQJN<^C// A:ELJ\V.QZC
M[):-'_ >&/6ZD !!]WX@EV!SK.V\ P3]/V]4 W"^IJJE4<9M6(?EYBAE\*R>
MKKG#_5%0_^0?)#,U7ULXI/&_\'!_YZV?U"D*]U(3B-[?2*-LJW5^@\++[N]0
M3T>J_NB>AC#C'LS%9[$J8+&])H378X+Q^<%KFC-7$1<G>JK]4!:VY]P670G&
MS@M[@P6!82_6%@6I%WQ^OCL9P^XSLF4J?DES2H_^M(USXIR3JT';6P%KL*36
M1'Y4W\SA,NT;^XQBC,.23Z4\=B\>)U^;N$OK29)K>F^AWF2');-G_YQ^!?JV
M?OAX>^^#-G/LI4B@FKIA)"-$P#"D\_?2A_E &E])XFD]#/GZ7:ICJ.WJ_/[Q
MRUM =6:)GNMN*>*.B2'";?8_D<!$-7FQAT'>%M4YRKW%903?M\&4IMS^\$2R
MB";8A[(%>OXL[Q:PN0T]PBK@]>=3:FGCG%G-"LHAK="0)U,__.?*30'.D,@2
M7_HM8.RZ_"9$\U1SEON&UA//(_5,Z1AGK\?@1FPRX]H+E;FFDM;VUG"IWP+"
M3[)N 7K%=T>G9\3< I[H^B3< O"$,Y(]>%'WZ+5Y4T^&ND>9U/U7-_K0$]3]
M&N;,/JI?TD/ES 5M* -]DGDEA\(C>M>E*#S"D'%S"SB$AF=#VZN7ZKGMO1ZA
M='2AW,%+X9KH>,MQ$?Y?_ *8M!^7<1YO)-+@5;]$O$+YS[9?*US3_/?"YO#R
M+.*<.!Y:7:\BN;=Z(_$=NMFI<(W'OW5U5RCR/[U&?8V!K]HFS4GGI$8H)8PB
M1^#-XOWR*]BSV1/4EY9@M;C; Q*6S=ET"ZB0'92,U)RDN[[^D1BZ%H5L)>,$
MO<08!IG4"A\,NC_LR&.#?.JOE&@ @W<X[S5NX/&AD\9)WCTOE+?K%4+76O.;
M%]A"?JL[!M&<ZQ%H6^JB\AH$VLU]:1'D_5K@V%+^SQ.+?<%.!Z%?I,I:K3>8
M@<W3)MN:%NOVTM_SO$S+7[$27$3*#R%> QB8D_X)X.FON>7&\Q99NR7 :#ZJ
MZ"V*->,:&BY&P#GO;6O."%0%G.J55)9[#LAEB#$]27N2._C8QA7D-L9MZB[X
M,7("N1Y+,SF7J+O1-M;,?@Z#3K%?PZLOYH2!T&[EFPGHUO'L6!(J^+C$=1U(
M9L1!JR57SPMSV8&MM#,$PT]ID9W92X:X3(7&@A< A7FM$@@+70<=7?]&%@88
M+%Q%*1(.E**AVK,8XJ:DU)"S )'6!,PL.TF\T*\TI@5H;[\G3(Q*9$"W'R.I
MH]HC[O%V#Z&5=K2L2*+)C6  SD7%K4F>5GDN1FF[8N@,^$ D&#8D< K!5*$M
M%".[G=RVA6K0E;#$X)PYXYT2J+W0#J,!G"@>^%0J[7W[FETN/I4O/\S3!1Z8
MKVOZ*H>GN.AS$>=4+#5M+Z?4&IE/P 8'TI!2=[#40LB\U6HK?>;[9*?7D>5P
M#AXBXNRQA"AF3:+\$P>*JOS54O\VL<>Y)9YA;"BS"#G]RRS$\TP]!(<_.6SV
MJ,_,3$T]H/'3AZO*C7.N @47:0YS;P%DT/;9_U24TQQE+?TQLLD_J=EG\_[^
M LGWDU5P+Q:P\2K$[:9'M:F-TVF @KXTAD4[@]C9R9W]BC;^V35FR>X5CL)^
MSLGI2]W7Q9-]H+TRIP[" &4_/U_P!G/++:"(!WJ!OD%YAG,+F-<-FWOX,.<1
MIJVS)5VUK,,@4WNU>OZ(=K@K*&MS?1UVR &6<4CN 2*/"RLZ8S*Z&#2>UOS=
M^'6E+4SC3D^<[ 12%.R)/K7;-#Q[;PL_WO2Z\^8WES<3*$=O+6 90/F9T%V8
MV**\X+ H &P')/4=2%)\+( %IEQ-$"^GG3R+TM3.GTBV"_&VL44:HOD-@^RP
M>=;J\1V32LT*TGM>&)>>IR"1)9(;T@(*Y # 3]1C"JKB[= ?I0I;]A"W+75'
M(0@0_MD#VEN #<[2D9":')EZ>:U<*\%?Z?-\ ">G;7L?$'"21QO+]<BQ?L,(
M<T\]1R3PZ!;@;>4A<5<49;\X^(LCK?0_&^_7Q>I,:\=+V03G::))!\YD)E&F
M'FHLK A$GN7?JR)\*._VG/V>*[)D<'HC5O="G#KPW3?Z'=4TB4^A)/Y4!@74
M6@?YE')U4>^&MPN2+_>DR- H7ZYUM8,[([E"N1 \V_R_$C +?O7HV]>(,P"B
M+7.QJ7SQBP"'B$P:V$&><Y-F;(#FFQ!'XVR2Z;??'C:R5MK)^/AU+)*LTA,5
M@F%6245)5T*(;_K9;07E&;> 1P;U U=F:1LYUH2]9>6_,[N?+ $F'I9J>^=*
MTZ!ED0=2.:BBX RZFY^.@K^@%MM7AM+:2&F'DP8@73 )X%'J907:,J5BKV@?
M06Q%!I/\C<2W3P/2F2-JAT*Z-?=K#X I%0%\R1&T,'&\T&"<WQ'AHN2B!6@Y
MG76S7<<TX$M*D?[COCN.N02CFZO9"Y[-U'S[!NC!BPEH_:N;$+>US>Z"*PVW
M^NYCFUM (VKLP]C^BD4L(L<K21=D W=15J-^LP=E^=RI"Z^N@@M1-A,/7;.6
M1,58H#$JQKY"!>K!VK!SGW,*]JMN89/, 7'B><K7+AANJ]XH(Y-##8B7]37I
M\9+C)AP--:R\7=?G]4<68]7QT =N-\'G5ZEG?4/'DF3[]QOS/"1/<OE"#U[.
M?_<A&\8P M@![N$+C1^.B\U9RFY1T,'H/0NGL_S+94O%')5#@^UXPT[/CH2@
M+8\$MN$4SZ2^Q_:^/E<O+Q([*,3*#A4C'%I:'7:UDV5Y0MLOO=Q#AA6RAS>*
M136W9V,[&LQU<@;!JIM=8E&ZJ.-0T1*"=I].'BB -O2L]UF*:'8"!MXRE^ET
M:N6 ')2C2FX!E7T_C]8<95VYI8Y-9HF+M;Y&U=JU^SO;8;JB%?:XV'>Q# J.
MX:_(T3R+V,-<H:>=L^&4%H3P:L@<@V;%"GARS,T?9DU?\18:V+IGO;3)3IG&
MUB_]0IU DR]!.+4BY.[P3\Z9Y4&7 35V,>]](5<L5>=0^;7+LJ>7Q+&=1!=:
M/94NOFA]3L1^5[ -UFQ3]?S%*MOC9;R?OE4H+S(-C5B,N@4@:I)V*)?U1,?Z
M_OY"WJ)&&)K<$;4M$K=!O#AS=ZAPL^(%XA:0,E@;4./>EG0 -A>YHTS35.,S
MV4_*."=;F6W0K4_EQP_0V^2Q3A.Y5*K%K+F<C[OHT5K'OQDN$,VUO07L/CGW
MDIAPOBSQ@B8P;? ^-H]W.'E%P_'.7QKP)*,8UY<3#QL\YZ-+[6@A%((<C6,N
M<]%.]<9[0-[VFI;BYV*X:(%K@<#9UY2M>')C[!M("T0 4K_'UW!T+DW_^YZ6
MT<@YDYU0THK!]_GK=!'3\K E8WH8NA>:)3EMS^JW#Q\.K*RIRSD^D-CQ(WQ.
M1;%H?+2W\W)/QVPFM=C65VR"L,'HIV!T;_ZH4,"+9 3?KLY8<QY9-]S2V.5&
M_?!1V?+&;-LB36&3+[XS9BU3XC=-NT1GZWW!*NVSSL+/9;)[DLX9ZJ+IZ_WJ
M4[CB.!CHW@\IMFP '7RTBY%RFBFP\]&=G;Y?TG2&1(KB?QAU_R\7/$U-\?2?
M_YX4S?\W"QI#"@S][\<XF?QS0\34?XFBE_70:Q6P7ITMKKGK!:"F$+5!D<U.
MRFL Y,$^Y8T$&?3B2._ZT6;UWNP5;%+RVE4,!;9QYO^+Y5F[.9$9O>[-;I%I
M2'OE'N)&F =Z2G5CIY84QHU>/]2;\ZS+W@3([IW:_96/CQYK>3E0:-R /K@O
M0&1_/P<5[K$.(VOQ,@@5AUHK$>GUS_>B4R&8R6SE5WWHY=_S\G]6BDNXT$F_
M!W?NJ.%RG?FH;O>W6A)9CKQGO,+XY/)5^J9E+)\E[AKRI+'OJOC38J7@8PA]
M5 G\.$YWF4_"3"5,>35;0F4J@RWXY/KAC?CVWYA6_QD$.\N,\;!RZMN;N#-]
M)^N.T2A/:PF7_N 6Y?W0<\OA>0V.BP8D^EP7,3#<BL GL6<%;I?SEIV6;5L[
MHBLWC;.",H'R>!*BBYE8>P5,^TF!V]P/IQ2*GJFS*1811D[A6&*MT$;]:"[@
MZQ.<,]?RD*V2(K J:3=*^-%'](M'<-^?.FB1_!; %M.Y,=ES4^[$9KVL9O0^
M"_0AUS;T4I0^:RE2^K0!X#A76+JN4E.B]QT1VCJ_,5CBZ,D]+O=D04OO\;I=
MPR5H1HS"!K]SAR!0.+O%BV>-\@D)/OX4VLSVZUM '47E+2 PWD)GT\X<O1#6
M3A 13BJ!;KGNYT\;$2X!*<H_;>'GMXCG'C6D3PC9$S!8"G?@:VS8D@(V"I<4
MJ::"M/4L$7[)?!^6*5=JP\@*XYDMY3M7YF'-&-W*4@V$_A!<>2QZGWY(#<2G
MB[!1L% *$$EO.BV*9<'8" 39B.;[O=F'IZ9,-1JK"20P?&F2#M^HF%<M;O+;
MP ?AXAIX.#U5W>9W2SSW8B-BQXFGJ-0ES)(C[LWSM$6S#K#X3B?1"%2SD\2*
M&"T[[B,UU^PFU&1"6)@P J4.5X@13'UP46%OV\;V7M<S*OC&@H"[J:;9LH!!
M"'_1+4!P:0]3>B$8CU2%\(<<&B4LE+J-J%2(?;Y*JHZRDIV,J72*B"4-D^RQ
MH5NPK_#/$?PO]8</;P%E]9=T3IH2"101:5/J;YU9F'V15]WR&H72;=+TP$5P
M_JO_W!NA[>*:_:W7:*2^X\=XMA4<*^)(]E#RU=SL.:BD_G0)!1$4=!&ZQ+]F
M>]+-W^M-!4V:/B1^<E]E629Q+K3E-#_JYBDO"L@+HO*#2U0J?J7CL&@38Z&R
M$C#*9T/2J6(&[G.'I^KJ_]T1)9MG^(8=A;R&%*K+2@]V9//7_!C?$"0)1D4<
M1(3RKPI^6/6XJW8$S-[4/D.E\VX(+ F'(L'BF;:SR;T\?[N ,9H[LE6:=_7'
MR_0W@>1._Y0,Y7/-]UV%H%+[L>BD"Y#CQ-G?5DV"%2ZW/-_K0Y%TZS1=W-!S
M?#/H\246*B\Z^2&KX*<Z9,5B)?'Q.TXD@$[!&(ANA84.LD'%ETF1J\"2^HMK
MO[MR@/L/8&JI5.FXADPM(SUR+T^^28Y=N;+HF^^>\"#R47,F&'V1RB]X/SZ[
M=V<_2T5](4@B0>+!^72'\'GX6/*5Y*"S5F.NY"B+J+#"7M$Y/GTQZ /NC\7"
M L$"V4>JD%^_3O6^KWS,K!&2%D5!1YK^OX/P>WM=-Q^33KIN 2;Y-S7:T,N6
M.KU((63U]:2(2(\_$81\GR[LBB9<0GTK=EMU3! \OHKN# 0LCD.$F+P&S<E[
MXT>$8EX)(PPT-!&!W+6V]JZ?!/>JU19$8L5!BRL[F M.B<&'L$-+YK:JT6]/
M>2N>A5NAYXWJ^"[%XISWRKN5S;U\^9)#T_D60+";4<HQH2%NQFP(U%3@]O$[
ME0!@@?GX0 X\8\>X;^EVKD_!]24V0X&UI^I+;'.7=,<]69XK#^!/+IUVF%KM
M0VT3(?9[;0MJGIK#]3LT!T8J#?,)+@;PFL]Z79O:N)&4<&E#%E<35S):>%JD
M6Y*];OU<#^M1/=Z;8BR-?/Q)<M!C91L2[<?88#2J([[\JR89;B*C:L&K,CSU
M0/!6O@W%G2W4_9LME.8E!5#N7Z)PYI@ =)75P&7J1N+R+U-(&<U<J[I)GC_/
M-RQ\FK&- UMPF=@O=^((T-LES1J,T:8U(-\*RE#C+OJ=>%)]K6"94I-Q\Y0]
M"%J) L!S@DE7=F6"'(N>DLIC/PN'E<:,FGZW6<X;43?%+A7#>7.<-F$'&3YY
MV)4\*4)!!FOR,AQN]33N?VLH6([_NT6Y)874+[VO0[DL% 6L_\DL=QN@U0JK
MYS2]W2(S\P=7$]O\L4F8.;^0ZLC@5DYB6H ,O)L3&WF7,7M;M/((/."NE5]I
M^_BPX5+6YA7>SSG"8%\\KC:+:0N_L["TG7(_];!<=5^/I'F# PH%8W #4 "A
MKUWI"351CMBZ!7 5<#9?RFAONMQ(PKFJ:\Q5GX)3"'X-^'HYVRG4&:(B,6[]
M"N,MX%/]B=OAQ='?.F[<U)=B2:6AFG"U^_+JF>77ILY'D&]7;^&F5PJ6R]IR
M9*VFI%R@X%^<W7,Q5$M/,!^0O_YE5O_XV.+]DPNP=3CC>=!!&HN\**U'!1K-
M/4DKM]7.4,RT]:QF+7A+,<[[S/4^67+\KQZ,Z5WIL^;A;\K*;=I.<?=Q'SCM
M&./6/OB4E)!O&_FZ\1!GO7273&]3K6V08;1WI.&0&%1<K^V+],@(!?2!(A\0
M]VE.R;J[6YL NH?::41]785Z[X'1:!-M[@GE##<VI9-:3]:?846$9LF4JFY!
MK@A'/1[9LH[YY5*8(+M6WN(!FM*"8> C5;2] NH"E^)2668R=ZF)[U0A=TSJ
M_B3HB_7$<\<!FL/IB@7LP^L]SQ=Q;#T)K_&U[_B<RO1V45@X5;<*%=BP4).U
M9=SE(71M+#^T)OL6T!J7<]6GAW]%XL;>?K ;-'O V8R:RLWN\A%*/.B24<)-
MS2PJ LH(TT#;N_"O73-N H[N2%HB8JTO#J'7CYC';P'?*",6[O8BK+B%$"GJ
M$AQA>4/R7?!OWDZQGZZ@@G>!KJ1NY9S(.>&G^MD$E+W5NE=F[,45K/4E=8H$
M7XNH6.MHB;N:\>1N5@%339?>2W5&^'+R@2A&Y@G?G(P1:LFT#S;2B%,'1U9'
MQWRZ6T(_[3Q("GKZR&Q!V3&08T8B'_B-H/:UFBI:. #;=0<!;XYBR>E2;#SF
M/]34'HX>4QC&_R*R,!O"U4MI<7@5[)ES6J<P.UV>WW=N$OIM=[+(019CQ+&+
M^1FVDMEK1V/F2@#+(DWB]J,PJ'QI4JGS3L-TL,ED=5_ *.[8JZHH+)P@UOX
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ME0V#&K.V#)D66A"ZJ)0757ZI>]O+^AII2UG>QY&ZQW%U$DAB=]H5TW%,=]'
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M(^/BN$6PC.JIOLA7NV4*;S1KHG]Z?B"HPFO18$6N\1 YN[GLX/:T[ [K'C5
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MD+9Y8L,7:EK_Q8QU6G"Q6;15G'SWU3XW1*Z6[X*3C8OXI01#HME"W( HFF@
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M#7 &Q"C]SULR=#\9V!',ASIUC,B:X EN/;;:6L*H&CLP;<[T>EE.-X*D4GD
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M<#<U_B+I>&[5]!3_F_0[DP#)QVF""Z)<4==0\36/.U\KF@/E.V@Q$%<<9MH
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MGM..,,JJ+ER=N2S4O*C)%=O@_^(V=72113132X*T@4_$;=O!TB>*ZW_ =6A
M<L=F_ 0.<%&  SJ\$(G,=1D?#H 9(:9N12V"PU.WK'4];IK8VT__&K<@\_O(
MOX!ZM"_YV9&G-W<NA-=EH.^]35=[=0&KK5NB,8$;Z1VD?E8/DFY[PB]57^X2
M.[N_?365D=53(L?(ZE,P](A8I>+I%T<,V(^NKVA4W,HBWF7+W?K\7Z0RLT6X
M[8=>]3,\]@-0.'J[9'4UB*HK-(T>9HX<:\A_HQJ(!:&/:'SE%K:DDCPK+E!
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MK0R)=]>$92YAHH<TAXB5%-ZP*>3(1S7E)5DX<RMDJ/,W8;NELXG8H-F]HY#
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MT5+SZ=I,CA;8#3[UD[-0O),;13-B[*:6D1%US?B[BYS<[>*S@&-QC\O[L@?
M,%@N^@& ?^.973][]73RS&BSE?3J:AR.9GVON[4$ ]PE+'YLGZRHSLK"F;58
MU6U;29>R(1)Q+)":,@4Q ?4X@!I*@121^F+4#D$&Z0T2EO"6B*-2LVB!L5SO
MFO5(GZ$D- OOKIT(]4+GB9I,UI5VQ\*Z8P].0N%C^II @## !P$0JCF)N=0
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MAU)X1='U^2:$R3@RB$FSA&& GX-2OPEH?KW:K?#.N]%\Z<03]69QGE##6)=
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M6%EMYSQM2^NN5''Y[AN$0P?@[I @6UKU6H@>U-#H=W+ *2@WDEBW*.EH4'T
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M]B\]("55W1<F$?RO]D_7CV.;)_\1Q&7_GF;4QR9(_L/JOB?A5G'9?2IXMLV
M3C].29;_E."7ACI4F@R>R)SC.C\>V:QT'&BM?[QQ[LQ]W 5R'&-+\3_]++_X
MH>9X5FOPRP51MGXWYZ ,]YIT)<0Y;"70G=NDC@BW<@ZR27<Z[?!?T]-EN<]X
MN$]541M@Z"/L+WH( S:Z*3/?D0L0P[DT!";ZS[TBF\=MBL\.^FNI!17M'@!_
MVQZA5V_=>1\ \.UU%TS] ,#10L:!J!;<'1X:>*A_.6&NP5*;GC6]")^9>5O<
M@O<S-01HZ]$-HCJGVBBN:$(VK5T_G%F+.UAP? "H#O' 3KU0WM$C>/'JYPR
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M[?^)@B(G@OWXO[I/]1_Y([^+[<@((R/B?[5C^3]5\$7DN,H>V9A#>&2J9!X
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ML*.5AL@3*>$)&YHI0"!=1@R&>+1^I,Y.!'W$G-R*%#![P,0;E6:S]9<X\M]
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MINC.L.FAAJEY8A/"L3YO<Z(#[)F=E_ATS12'P)/DU3;O_+,N;VDFI54F'1&
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M%);/_+TY_F@T250U2JCPJBR^.5Q6*J[S# /<Z^/UR#2M8!<8O[6].%NR>HT
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M+CF*1E!0[R51SZX);D;\8+)E7\VURJ$E\D0*%F"FEQ25]G"O1U&'@J@[;^5
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M!A<'"U42PX(]\G TG<&:$-'@P0!5:J.N"%,$Z#4#T1'ORHWXW6>7J)O;ZD?
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MB%".@T*(FVBOL92\S<)J3,^[1OY:K1H3G54DQSVKJH5@P,<Z*U58SSLXLGG
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M6]]JH/2=DQG7D!TM/-ONQ[/'_V&A%#!'Q6U>QD![OC[NDHJK^&N98Z?:<:[
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M,I%;FU1<V\P@.W1I/JME>%E[OF- 27ZL-:A39F+C_[:TU.-@]*2K;;D,".#
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MR]*RFDHU!/+L%)ZT]UJZIL\:'&.%MZ#Q$8\ S!>=XO-CCX!C2I4'0:U&VT<
MC>_E_=/B& 4;;86<^;+Y85H3*/V<Z6--4*UH:(5]^XH4*[<^5<2XLCWV&8:Y
M0,G#\*5$W_'S_A])G0=B]C"_.M@C8%DD_<ZI(0K]*M $SSIV7LDN>@!I46K_
MG51T6)>_N(MEO<79KLWE!7'4(T"B@.H.5>6X(%H2NY %NU&M"W_+1N:'IOLR
MQGJ)]N<L&X<*X0_JG6]T\H0SY4^+G'MNXJM+'&US)&VB6P_P;A45]P<+)6G
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M0G3V,AM-PZKY>[TZWTX^@SD"8 <>\_ I+7B=D*NWVB!Y2L=6<%PAZ(L!JV0
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M?0JFJHN7M3*=E*Y]$LX^;T_J@VR):JTM'/,'.SR3<]$F#E6"%L2PYJB"-VL
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M\N%P3]+AA3>/#SWKP#2+UI:XV5A%..=58/#-X.;/%R(/T<CM$FN8H=LG:9Q
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MW5U)&L6/[:40*_;C2N[2<;/V\GW''F=,F7,](T_-],W4$=^E@2V]8.R=I<T
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ME:P\%DK B4Z"?$".Q!; .#? </-\Q#MDZ6?.K7?DN5DF\;/O8NR3A7A<@=;
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M\;%@7+[92L@X<66,FP(K1JU=T:F/3F=P9FY.57>9P]]UFY^+0.O<BT+^!7B
M_@',S*=F.8X7D\S$"83V(\609(<P_]SY\N"I6X+)''5.*.O>\U*C0TDFTCT1
MV@3-+JJ36_HQL\;F**8,X!>N=5.P3\EW0)PL/B:OET4[./4\OM@^9?05\6&6
M/E_"@<>3$.$[@#_40X^V+D%$M3AL+>/7Q&R^I4JWR_@W7:7D#\N1# )T1,]-
M98[9.S)#1#V>46,NRQ#X.?B^-0%6Z"->K&PDGGGQ3]=(5^L.H.DE8O3DXL7
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M2B66.VG-FT57E^X UM.DB-V4AHC3SP(YB1H7(75IN(9#!GFLZ.R.O(J\3C,
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M;6C7()ZHZ7<,XC)EQ*I[201:_,"R1U&=PJLEN;$#-[R"'L&C)"/LAU7?9.2
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MJ<S/?-8"Z<#/2V^<BXA "/YZVG0%@YH4\%?J/BT)=*(=1W\53D&/,9\O^<N
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MZ7[\_>DF+\$\#.3CV'Q_?[K2%,/ $SM.^,&#81>HBF?L@--3]S2C1R4/TMR
M&,$C<,IMUG*S]^7,%D]-0!R4[6;DCD4(NYS6VI0IMR7\_F_]38QL,MC]F]G%
MEF4*(Q[RAP;Q>3OFMW2U,-XF^,LXG\HU;@9'3!G*Z%0/J<5F-M:2M'4A3]%8
M7*>@6O(8=1HEF?&Z3XEBS\>$ZV^0P@1_'_@L7_"(<.F$BD*AJRJLE"_*(?3R
MQ:L#SA^3VN^Q:;BS,H*?I1&DQ5GK.KSS CV1$FYI(8SPK+'['G'"$P+=;/=R
M1U2'?U\M%; W-ZK\2/KYR558^7Y63:!1?1"$06\_B@DWEX4%X!UGTWNJ&X^
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M<^7'(1O._2CE),B;PE# *6;J!]WW_&><RGKV#4="4E]/8:X7&CL;6HVQ^PE
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M-NM1KKSDP*T.?7UAA$9_@G'[TBQOL<N.L3JGJ>(1?%/VZ*]CW>^^.>"/*AM
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MUY<C38GU2UIDONA'N9<XHT'HA>QS6NC>+QTKN4G\RKH/RP:4SFW^=LWF7W>
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M*.+[D(WT U^WVYDX<65$'U!0+1KBN+C!MZ-*$%5J=:8AML/@M6R.'!7] ?7
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M#1VG.>\7L0G]!_E74N3I$P+!T\V-9*:3[&E[CO!_/UM5AQ4CO<#J-TAAS%^
ME$=_%:0CNQG0:A$KU^<@O=-'^7*0>U%$A_;#T<K^8,($H>>W' 'GZ!JJ#\A9
M2#Q#M_PGOF$A]JRP]EAUHHT>X0'XBL'D4O*>-$6BM#(%\M=I1!R,G)J@NVC7
MBUEDR=B09UY\_:N2*CY2)^.V;4SKEH-7Y'+1N#-H[O6BL"AU$UPKV'\C)4CU
M:2UG_IR2@M"U4?A^*DL#O<!RK$2OL^@K1. Z>)3@6+INBJ%)H\'T^V>P-&VD
M\IM2SE#:5#O'^&^QCAI^C+L-O%3D\'*";U8L+%^A<BH$@9?2'(EH^I^BU^+Q
M"BRMVUC@K)GK^@J*OXR?@(>UZABPI"7O*Y(-9!Q: L;U?O@L['S]W)SL%UK4
MN8;VJ?+N>/518?7KC<?4QG".;VB''52X[,NR,'@;\J)_TY09[41S"@Q.Z!RW
MWFW#\Q\H>-1RAN./ A=63AT^QZY[J_RK*$LQ 5Q0/LF+ 8T2(G 0^(U##8DZ
MR)NNO:-^/^DS?G H.#8^VI]VZ4$L@ACCJL6&,9[QP!X C%NQPGUM:$A?GFW#
MRTG^'D=Y9&F%8Y3O"8-('N,42=%K<5H3PHIYB+CQ^Z$6/BKI52X.P?_S5)&B
MYS]DN15S<4T+;Z0_"7>%Z- #\#YK=NP50ZO.:+=TBT\7)D4\/TNJ;5:1<-93
M/<1X*>LAGX+<=U7=O0]N_ATFD/G+SQ^IJZQ%>?S[^P+OM\;/(LM]S"9UP2)B
M6K$HK_%MO".(<&]Y,4T#KR26!$3T3(XU90Z6E$N6+>]?3)PKLM3>*+R*5I/9
M&INDL6BD> #*^:_;SAQ_60!(O9YZ.)!U_QAS+'\!%MU=H].-#NIV*5H'=E[F
M@58W3,$$_<+4$YGN'U9N524&=UG7>50^;Z%O2^]PV4D@C F#_'3"<\SK-Z^%
M[4^8# E8@F4*) 6'^K1ICM\]8>>8^5[<XX(<I"2]&VE]16X%[8V+:7>6>@#<
M'FL9JXF3; U]J%U*DFENW73UP0,0T+=8<_BJ0\Q@VN??OXO^-R^I'K?P?,]=
M5RSDW/>Y D1T<HB.,.':N3:<] A-;!]7U+YUR86T W TT$8&>QC"=()6QQ2T
MFC_X-%:C'4_(ZF'C1)ZR40;%YFM;%=RJP@^@^F5[VNT6;9;]V<_JXTO;):-1
MR>4VG930QWF&$'Y#RN2W\JD]41\G=E7&OM<D#PA- -'8KK:E')3 6E)"DQ2/
M=TSMH;%A1&*X*(VEVFJ8H"Z(=>,=&_X3D^UU!PDAMTU CMRW3'*#(6==:!4M
MW/:8>_#H4(=@2$A.,UJ2AC,@;$L_ .YG\*)1MQ^1YDK?$,MB.E/QK7U*#7MQ
M@7Y16CY>@BWZL]!-8"@F&HC"U*K!'X_[IK<Q<:Z'+'0B >=70*$$"@%AI9<)
M&DV0$XZ:+@/#A>4%7FBS^Z5[P/F%C4NHW-42[Y)9=Q-33VQ^X5AK ' 8N>F'
MZ7OG?+=H?U=FD)2SGR)*.YD[_0;$\AP^L"0,6?[@1B<V$!V$XVG198.H_<G7
M2_9I[Q"GHI:K41R+2)69PH)B3>/<9"^2BF@F#^%8N:=BXZ7?/3(1#DLDZ;!E
MKJ;G.QRQDW9.R P.7IP3%G/.L>:=LM8ET/W<&']]VHV7,K:6Z!Z-G"6W<[-P
MK/=S+JX5J\K*&$<G?3A)K+&QULURG+F1$Q7300E=@/3 )ANA?G-,8L-'YN/4
M7>"I&/Y5N:GY?0^)Z590&.D.Q=DXJ_QN/<;BV_;_#AO.A]MQ/LA\VZL7E,XV
M,6.Y*.MZKU(NWU/V=+G6"16V/SV7>2O=%#2WX1<B?&H;N<QBGE"M-*TSGQ0X
M+F[3X!\N2B7(<UEBX\BS1"Q-R]F+Q8S'<<F*?(B6[3==X$VCU2)\UI'%4@,W
M7MYM'DMWMW?FZ>)2W SX72"-$NG0J7V,;7J[@SPWZ_)?;@4VCEKTM>-='')(
M%U<X[5.=?X(.T$MV$VH#3T$!N!3(L4I,V9T>1R&Q5<PIO*$?)CG:F4! :M=.
M<&@<(\7);B>]JX/26'_QA!11VK]Z6/[+_O]D*'Q:*7.SA_;N]D0]>#$30X'3
M:YNF5((!_IA@&[ WLVM#7= KFO=_#3,H2TH*X-]35) "B)35)LMYHGAKIR'&
M38$_3@>X:M>B2_:*4$[9I:VW")%"BCRXNK^J$=5-'#:QG(VT.:^GV@#CB4AZ
MT184V>I@XMGZ2ZU]>QL4%?&T10I9(FU&1L!Q^FM*)"NJ:-VZ_O,>>G*-*5C6
MNPZ"4,O-CK$77O&+?L:.&:8[1"+U@?FZ5OX+\;OUN0,P%Q82,R>.H(6;T=,J
M1L9 76[U%JQG4"CXPV+%SX)6+3B#6S\!BNK?OUKNUH9/%UX?L4$9]OBO,Z?(
M3;$'$*0=2_F\JU].,BPRM'H)*U%9$]8ID=]^_..7ANU4]D+'D%,V/YI"*+'#
MI)I_\\_7R=;J']-&'ZHJ:)HCP YR,%RD3M).2D^QS ^Y40$#1I$K).NAW+&O
MIE^^?(59B@H +D_*%G=U70N6&MQFB:N7AK,Y+=<UW0<'AY&2D@:OREQ4GHHH
MRU?/VD*G5&LCMY&3ZJ7&IH+X7N]5!#E(HX^CEOQN(YX0%FG=]?)Q$-KA)+;P
MH3"U-P93OX+Q#XS:JDIU;-O[42'4[C43]<E(AHK%ZX_@K)S*R]&!65XPGE^Z
MT,4%\#]X07-PL(/"%30]_>BBIY*N5A!?N]DKMQ,]<<0R13$E&(V.YF0:65U5
M%M?_/5PLM#;"9U'Q)3674W-K;^&K(2?,5$:K<<?8E:#Z-P=OSG^_Y^6-U^T!
M.\K2H>>?CP'[';>EO81'7?U<WO"KKM33\L3?O_HTWSYM< ]T3/0[,,4^FR.M
M#)J=71E:AARR;#0$<M7SQ[^L5%("8"4,A;E1U37C>WYH\-DJMG3W?,EM.PN+
M3[7T"[%RQI_L!(Z<5Z=G"],+YG]?VE@5Z?9"GL"VHDT<.TA-9F*!S<T,S:%7
MCS%?U@4;@NM^+K=J/Q/EDV)"T^H<&!!V!>8$K. [76[:KX5UW_XH=&#X*J>Q
M:9+L1G-QQ%R2&U5+3'M#6?/]YL5"S@UCZI8G.>KHE[[EGQRQ'%-$X\/PFZ[O
MJU&S$QL$H5K0V'TJ;9*[>5J.?CH2D;.ON\6YAT]#I0C=X/_S4+H=MO\\)E.J
M4M"_TO-_&9@9$1/QR58)6YJ9-WF-4C?E3I5_#2CI9G7@"N**)IO,C:>X3UOS
MQ[$\(RT___*N);E[1-<XNHBFQ,DMXX])P[?*H,A7/SNV31'>ZW+V(>L3.3K(
MS"@R+G%;?6@IZ.\=!_KP?+;KI^2G\K)6/ Y8U&P\>E1DJXLMXY\\*>D?8I?M
MN"AS^2LQ"%5EL8\1,N>&=;YE-R^[#ZDL,G=\T_B.QPX7^MPM,BY&/_R<.JA[
ME<*\+^1=/--0JDS0B!/$B43I(#O>5,:MZL"L8W6IZZ)(%)/YL]QV<8$FG(8E
M@%.<T@%M2[%MLO90V6+Q@,7NTL("2JO#NT/:)T/ZF#G+A( VKS#RNFKQ7:-E
M_8H=Q];9YMUR^]Z/'T4W(IY_CYUP8-*STG6=67)W)R;^H=<;QVI%J^72.="-
MGQ \<%7V7)*HAT!"V.J-VFN9F&G.[PE!Z"(2A']>/?F9&9*5B1':-XEEF=9
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MIJBUR3<>W#<YL"@'+>540F,,A+;&K6=^W\\2F'&]BGCV;ERPSY0^+]'-U@1
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M<+7]2!1,"IN\MAY&?G1Q^+J4GIN"%N,[R)=ZOGV+5ZC'/QN*3DO;7YQ72&I
M*#[,Z^NC@ .VT745TTY/,G"Y@J_)?JP'GM!XQ$[=>.;_]:#%0>--3,.1SZJW
MO?*608Q<BU#LG)9PIB@#(D\^<'NNE>N3FT9$CQJT\H! @I4:%-C'\>OB\+<H
MQ0EE7"1WM_]'!@T=,D:Y)!OF?VAG],;&V>J796I5F6S-[C:QW# 'J1:Y+"PC
M8\TD4;:?9X?ZZ48\:P-'3(_=1ZGX$FB/YZ< [X1&4^\X76['1NO,F ^UXV0-
M/4F^W"-?Q;)Z4)I8T)*K0ZA4'=SQ Y38*5(ZD;,E2OVA?RPN4R_M+V.*%A^
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M/F*;,,X6_V['3N^IU]+M#Z\K2V^OU2WK)QD>B%SEC.,X2PAR:I$!G3H.W1*
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MQ?#_S&84C3].-*W[^Y<'>1=9U:5&HKQQK$WMC2HV7S@"S=(P=9/JSK-*&/X
MA-7%16B=&=H(WE98X$S2B:N[76J21Q9W2;M5(P4(IPQ<),]4/%M]-WA+2;03
M(LK8$)K7QL>;SSG$/A#=1Y3JH=B#>JWIY-SG:[W3JRB_MV,XU<H[EP#=;< B
M3&K!1;+"//))2-9OJ4D8&/S-D;9^1[;8O4IF,EE^VVUO-UH]&-/O6@_+  1K
M#@TR-Y0Q=OU>![VZ>/I%6."T(/)M>1H3&#E9X!$O;HS3K>1X0>F*%#-57>DL
M7."I.A8NS9:0"G,"_F3-D0#\TU#]%@GRSQ<#]J.B'*_LT:&HP -05&3X9X?>
MR5WKSUP71!?ZH2JOM;J)==7B:8)9A^)64GS, %(@X]9.=(5K.XG_IEKM_T@V
ME:J1+RX6ZNNT<:B6XOZ_1/^Z%5+A>1R0+--;11#_C6#N+[ @;GD T!0(5[ F
MR%X32(%?J7S^*&XF7LY_A$X3VT-V]NC821F^7K%GP\_+$V19,RG1F88LU-#I
MBE\6N)+_UD3D.7I:G* I-DUE:;3%3K+1Y^B/@4?BGR*W.4<[9\ RYB37LT-3
M!=G"*UR'1\WL[)Y[#U/'RUFX?.P?84D:?I[8)+I0GDWE/PB&K\Y./0#R9#^M
MTR&@>'JW<>+O42J(B@UPM[.W2%N,[?#+=T 7ZP:^FUU'?.5M^V@0^FZ@&B*I
M6^V6MZ5F[IS\&C/U1CC".6A$EB6X%AAX>\I/$R QA@GS$85G)6SL5N5-LYK)
MA-!YJ+T0'RMR@X6BT?AD"MI=$2W'/=8,Z@FN)<B'(/];*74K(8(DZZUL<H,'
MP/H6E'*7@^];BJ4S FZP709!HM<L2/<C8<)<:[[J?;KT=2M%97*4(=_EG@:Q
MG\F2&L5S\A8[H K&I_NI$,[9PX;YSX]#4GDYN&K=)L!=T9O$M*;13QQC/4KN
M21[Q661*;"7[ 9 1D7>+#=$]G3ZCY&5[CO#O2;U_-LG:VF2WR>'T-MK$(4V6
MT8@C.L-T#?8TV=&^EQJG %X8@UMA4<S3#1[(LI+]),W5>)B@=!!-_>:CZ0Y+
M/#_9SKT2CO_* [ HN']/[S\H]@A9AZGW,?*5%J[;S):#/D(;VBT(7]QVO]AQ
MG-HXT1'B^!X=G8!K<9;J# =4QV,#[_5E-!5$FJ=SF0TT>M\*99& OZ:60R\Y
MFL"G6LP]^_/1N)J333Y\\2F"TJ%G#8MYP_^XQ.8S_$6@BR&QE;;VBSD^+%?L
M&^%&D,0G*&8B9M+@"M?4UB5W<O*\B*UR&53?A_&$Z.=1LH.=K;W*<?V7]7R,
MF*$>;(OMH6I24CH4"W>%DQA)#_F19^@W7H_%8*63BBBNAXL%9"6_Z0CT%ZH4
M_-,6RZ>I1"SNM,""6X$987"!9/F^UU3%R.7O^MZI,:-GBW5?CBBU'3MVWI!D
M'!'9K)M=%IA4[1F0-'X58($0:T$YWSF! L%&_-=R(!BEYUI2UE^W!_^+MD/,
MR]S]-A^V;OW7SM9?YS7>3W@?U]>.84]L2#2@[=AF'K@[.0B,4\SE(=C6!^&Q
M=:S?7&6/6H?=@HVAGA^&'PN2\2LODY\??>Q)&R:!^\/QT]B?UA%RI]_D]$,\
MV7J];6+X>IK9PG,D:,.9BCTBWB4RGKUP1KX%QU%0QY_M[FL.^LA/^=?ZX'D-
MHJ7SE("_W/NV\&9G-@<XA"!N0QW5T<PU4CY1B<U]- Q36];5.]27HXM=;OWN
MTY.$W8WB^*7[HD\DECD-P5;R"J*LP(533K!-\M:_P]0V\ '0"\7X@ULW7%_U
M &"@A=URK+NVI8$4ZD/7AM(O4QUHS1A+2UM>Z<5^Z>/]NC(#JH7S]0[8+:B-
MRR?2^S,,\I;V#)A<)XB3$+QV0O5"'MRHW?J^]?+/4KJZS ECW[YEGB6416#C
MB:7Z"+3&[R0X8XV:_;M%- $JUUS.B5C !1LA(FFT=3;R=P =?;':>]O69R^.
M-H-V1@3HW-C%RY4_N?'Q-6=5;##WN2>?X7W!#$F4,0)]*B9%,4+_+6HR5[/A
MJ]ZCV]\3N&Z#HU/.<O5-^M-GNBL#$R[.VQ$',%9\$=:OV^FZGZGBNVYF'HN=
M'!Y,6/J&<C.LOVJ[EB6$S*1?;58G. ;6FI <>1X:Y+JF)ZQ)5A*%'4J^OS%8
MHF;S3VXG&7/;6>4_-E"$L86E&#R#;R5ONG/JK0RZT";<ULE>)KL-&,B*,<5^
MN+J S=VR/29F2LP#8,#N_[NN@$7-!#Q_VH[FH335WP[UJJ\K6?IY#'WR_=T
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MLA\!V#/=X$= +.01T)G2@6R&E @,6#2+BG&^'E$-SZ]J;6B.TC$1)RKQ6\!
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M@<+/L[ZH2['9+BF]$M\&SJMGN2G+PF=?6LU%,+/7G9K^RO=!=USU9\.?"IX
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M_P%02P$"% ,4    " "9E6Y6;/Y:K?<^ P"PBRX $0              @ $
M    971N8BTR,#(R,3(S,2YH=&U02P$"% ,4    " "9E6Y6^I/61&05   &
MZ0  $0              @ $F/P, 971N8BTR,#(R,3(S,2YX<V102P$"% ,4
M    " "9E6Y6]I<T1OX0  #U[   %0              @ &Y5 , 971N8BTR
M,#(R,3(S,5]C86PN>&UL4$L! A0#%     @ F95N5H2MXTJZ-P  #A,$ !4
M             ( !ZF4# &5T;F(M,C R,C$R,S%?9&5F+GAM;%!+ 0(4 Q0
M   ( )F5;E;4DSM.&;D  *-K"  5              "  =>= P!E=&YB+3(P
M,C(Q,C,Q7VQA8BYX;6Q02P$"% ,4    " "9E6Y6U*!404E1  !#.@8 %0
M            @ $C5P0 971N8BTR,#(R,3(S,5]P<F4N>&UL4$L! A0#%
M  @ F95N5ED;[Z!Q @  P0H   \              ( !GZ@$ &5T;F(M97@R
M,U\Q+FAT;5!+ 0(4 Q0    ( )F5;E;% 'N+#PD  *]0   /
M  "  3VK! !E=&YB+65X,S%?,2YH=&U02P$"% ,4    " "9E6Y6?WEP4A$)
M  "[4   #P              @ %YM 0 971N8BUE>#,Q7S(N:'1M4$L! A0#
M%     @ F95N5F.HPIOF!@  4T4   \              ( !M[T$ &5T;F(M
M97@S,E\Q+FAT;5!+ 0(4 Q0    ( )F5;E8BD8>(\A$  !1\   .
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M,5\S+FIP9U!+ 0(4 Q0    ( )F5;E;@<*;3I'X  )&;   1
M  "  1Q]"@!I;6<S,C$P.# W,5\T+FIP9U!+ 0(4 Q0    ( )F5;E;]RF=T
M](($  O4!@ 1              "  >_["@!I;6<S,C$P.# W,5\U+FIP9U!+
M 0(4 Q0    ( )F5;E9QNA_ M7<% *W1!P 1              "  1)_#P!I
F;6<S,C$P.# W,5\V+FIP9U!+!08     $@ 2 ',$  #V]A0    !

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
